<SEC-DOCUMENT>0001144204-16-109504.txt : 20160623
<SEC-HEADER>0001144204-16-109504.hdr.sgml : 20160623
<ACCEPTANCE-DATETIME>20160623163746
ACCESSION NUMBER:		0001144204-16-109504
CONFORMED SUBMISSION TYPE:	424B3
PUBLIC DOCUMENT COUNT:		9
FILED AS OF DATE:		20160623
DATE AS OF CHANGE:		20160623

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AmpliPhi Biosciences Corp
		CENTRAL INDEX KEY:			0000921114
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				911549568
		STATE OF INCORPORATION:			WA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-193458
		FILM NUMBER:		161728995

	BUSINESS ADDRESS:	
		STREET 1:		3579 VALLEY CENTRE DRIVE
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92130
		BUSINESS PHONE:		804-827-2524

	MAIL ADDRESS:	
		STREET 1:		3579 VALLEY CENTRE DRIVE
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92130

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TARGETED GENETICS CORP /WA/
		DATE OF NAME CHANGE:	19940331
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B3
<SEQUENCE>1
<FILENAME>v442814_424b3.htm
<DESCRIPTION>424B3
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Filed Pursuant to Rule 424(b)(3)<BR>
Registration No. 333-<FONT STYLE="background-color: white">193458</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Prospectus Supplement No. 2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(to Prospectus dated December 29, 2014)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: Red"><IMG SRC="logo.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 1pt; margin-bottom: 1pt"><DIV STYLE="font-size: 1pt; border-top: black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">This Prospectus Supplement No. 2 supplements
and amends the prospectus dated December 29, 2014, relating to <FONT STYLE="background-color: white">the offering and resale by
the selling stockholders identified in the prospectus of up to 1,467,244 shares of our common stock, par value $0.01. </FONT> <FONT STYLE="background-color: white">These
shares </FONT>consist of <FONT STYLE="background-color: white">1,440,140</FONT> shares of our common stock that were issued pursuant
to a subscription agreement, dated as of December 19, 2013, and 27,104 shares of our common stock underlying warrants that were
previously issued to certain of the selling stockholders in December 2011 in connection with our acquisition of Biocontrol Ltd.
All share numbers above reflect an adjustment for our 1-for-50 reverse stock split effected on August 3, 2015.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white">This prospectus
supplement incorporates into our prospectus the information contained in our attached:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; background-color: white; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="background-color: white">Quarterly Report on Form 10-Q for the quarter ended March 31, 2016, filed with the Securities
and Exchange Commission on May 12, 2016;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; background-color: white; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="background-color: white">Definitive Proxy Statement on Schedule 14A, filed with the Securities and Exchange Commission
on May 20, 2016; and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; background-color: white; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="background-color: white">Current Reports on Form 8-K, which were filed with the Securities and Exchange Commission
on June 1, 2016 and June 23, 2016.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white">You should read
this prospectus supplement in conjunction with the prospectus, including any supplements and amendments thereto. This prospectus
supplement is qualified by reference to the prospectus except to the extent that the information in the prospectus supplement supersedes
the information contained in the prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white">This prospectus
supplement is not complete without, and may not be delivered or utilized except in connection with, the prospectus, including any
supplements and amendments thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white"><FONT STYLE="background-color: white">Our
common stock is listed on the NYSE MKT under the symbol &ldquo;APHB.&rdquo; On </FONT>June 22<FONT STYLE="background-color: white">,
2016, the last reported sale price of our common stock on the NYSE MKT was $1.71 per share</FONT>.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 1pt; margin-bottom: 1pt"><DIV STYLE="font-size: 1pt; border-top: black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 30.6pt"><FONT STYLE="background-color: white"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 30.6pt"><FONT STYLE="background-color: white"><B>Investment
in our common stock involves risks</B></FONT><B>. See &ldquo;Risk Factors&rdquo; on page 5 of the prospectus<FONT STYLE="background-color: white">,
as updated or superseded by the &ldquo;Risk Factors&rdquo; section beginning on page 21 of our Quarterly Report on Form&nbsp;10-Q
for the quarter ended March 31, 2016</FONT>.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 30.6pt"><B>&nbsp;</B></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 1pt; margin-bottom: 1pt"><DIV STYLE="font-size: 1pt; border-top: black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B><I>Neither the Securities and Exchange
Commission nor any state securities commission has passed upon the adequacy or accuracy of this prospectus supplement. Any representation
to the contrary is a criminal offense.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B><I>&nbsp;</I></B></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 1pt; margin-bottom: 1pt"><DIV STYLE="font-size: 1pt; border-top: black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>The date of this prospectus supplement
is&nbsp;June 23, 2016.</B></P>



<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;<B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>FORM 10-Q</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 10%; font-size: 10pt"><FONT STYLE="font: 10pt Wingdings">x</FONT></TD>
    <TD STYLE="width: 80%; text-align: center; font-size: 10pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE</B></FONT><BR>
<FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>SECURITIES EXCHANGE ACT OF 1934</B></FONT></TD>
    <TD STYLE="width: 10%; text-align: center; font-size: 10pt">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">For the quarterly period ended March 31,
2016</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">OR</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 10%"><FONT STYLE="font: 10pt Wingdings">&uml;</FONT></TD>
    <TD STYLE="width: 80%; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE</B></FONT><BR>
<FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>SECURITIES EXCHANGE ACT OF 1934</B></FONT></TD>
    <TD STYLE="width: 10%; text-align: center">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">For the transition period from _________________
to _______________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Commission file number: 001-37544</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>AMPLIPHI BIOSCIENCES CORPORATION </B><BR>
(Exact name of registrant as specified in its charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; text-align: center">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Washington</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(State or other jurisdiction of</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">incorporation or organization)</P></TD>
    <TD STYLE="width: 50%; text-align: center">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>91-1549568</B><BR>
        I.R.S. Employer Identification Number)</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: center; font-size: 10pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: center">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>3579 Valley
        Centre Drive, Suite 100</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>San Diego, California</B></P></TD>
    <TD STYLE="vertical-align: bottom; text-align: center; font-size: 10pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>92130</B></FONT><BR>
<FONT STYLE="font: 10pt Times New Roman, Times, Serif">(Zip Code)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; font-size: 10pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(Address of principal executive offices)</FONT></TD>
    <TD STYLE="text-align: center; font-size: 10pt">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Registrant&rsquo;s telephone number, including
area code: <B>(858) 829-0829</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Indicate by check mark whether the registrant
(1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding
12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Yes&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Wingdings">x</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"> &nbsp;&nbsp;&nbsp;&nbsp;
No&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT STYLE="font-family: Wingdings">&uml;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">
&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Indicate by check mark whether the registrant
has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted
and posted pursuant to Rule 405 of Regulation S-T (&sect;232.405 of this chapter) during the preceding 12 months (or for such shorter
period that the registrant was required to submit and post such files).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Yes
&nbsp;&nbsp; </FONT><FONT STYLE="font-family: Wingdings">x</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"> &nbsp;&nbsp;&nbsp;&nbsp;No&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Wingdings">&uml;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Indicate by check mark whether the registrant
is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company as defined in Rule
12b-2 of the Exchange Act. See the definitions of &ldquo;large accelerated filer,&rdquo; &ldquo;accelerated filer&rdquo; and &ldquo;smaller
reporting company&rdquo; in Rule 12b-2 of the Exchange Act. (Check one):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; font-size: 10pt; width: 65%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Large accelerated filer&nbsp;&nbsp; </FONT><FONT STYLE="font: 10pt Wingdings">&uml;</FONT></TD>
    <TD STYLE="text-align: center; font-size: 10pt; width: 35%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Accelerated filer&nbsp;&nbsp; </FONT><FONT STYLE="font: 10pt Wingdings">&uml;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; font-size: 10pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Non-accelerated filer </FONT><FONT STYLE="font: 10pt Wingdings">&uml;</FONT><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> (Do not check if a small reporting company)</FONT></TD>
    <TD STYLE="text-align: center; font-size: 10pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Smaller reporting company&nbsp;&nbsp; </FONT><FONT STYLE="font: 10pt Wingdings">x</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Indicate by check mark whether the registrant
is a shell company (as defined in Rule 12b-2 of the Exchange Act).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Yes
</FONT><FONT STYLE="font-family: Wingdings">&uml;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"> &nbsp;&nbsp;&nbsp;&nbsp;No
</FONT><FONT STYLE="font-family: Wingdings">x</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">The number of shares of the Registrant&rsquo;s
Common Stock, par value $0.01 per share, outstanding at May 6, 2016 was 8,242,528.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>TABLE OF CONTENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 10%">&nbsp;</TD>
    <TD STYLE="width: 83%">&nbsp;</TD>
    <TD STYLE="width: 7%; border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Page</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2" STYLE="text-decoration: underline"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><U>PART I.&nbsp;&nbsp;FINANCIAL INFORMATION</U></FONT></TD>
    <TD STYLE="text-align: right"></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Item 1.</FONT></TD>
    <TD STYLE="text-decoration: underline"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><U>Financial Statements (unaudited)</U></FONT></TD>
    <TD STYLE="text-align: right"></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD STYLE="text-decoration: underline"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><U><A HREF="#a_001">Consolidated Balance Sheets</A></U></FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">3</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD STYLE="text-decoration: underline"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><U><A HREF="#a_002">Consolidated Statements of Operations</A></U></FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">4</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD STYLE="text-decoration: underline"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><U><A HREF="#a_003">Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders&rsquo; Equity</A></U></FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">5</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD STYLE="text-decoration: underline"><A HREF="#a_004"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><U>Consolidated Statements of Cash Flows</U></FONT></A></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">6</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD STYLE="text-decoration: underline"><A HREF="#a_005"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><U>Condensed Notes to Consolidated Financial Statements</U></FONT></A></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">7</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Item 2.</FONT></TD>
    <TD STYLE="text-decoration: underline"><A HREF="#a_006"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><U>Management's Discussion and Analysis of Financial Condition and Results of Operations</U></FONT></A></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">17</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>Item 3.</TD>
    <TD><P STYLE="margin: 0pt 0"><A HREF="#b_001">Quantitative and Qualitative Disclosures About Market Risk</A></P>


</TD>
    <TD STYLE="text-align: right">20</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>Item 4.</TD>
    <TD><P STYLE="margin: 0pt 0"><A HREF="#b_002">Controls and Procedures</A></P>


</TD>
    <TD STYLE="text-align: right">20</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2" STYLE="text-decoration: underline"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><U><A HREF="#a_007">PART II.&nbsp;&nbsp;OTHER INFORMATION</A></U></FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">21</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Item 1.</FONT></TD>
    <TD STYLE="text-decoration: underline"><A HREF="#a_008"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><U>Legal Proceedings</U></FONT></A></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">21</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Item 1A.</FONT></TD>
    <TD STYLE="text-decoration: underline"><A HREF="#a_009"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><U>Risk Factors</U></FONT></A></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">21</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Item 2.</FONT></TD>
    <TD STYLE="text-decoration: underline"><A HREF="#a_010"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><U>Unregistered Sales of Equity Securities and Use of Proceeds</U></FONT></A></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">36</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Item 3.</FONT></TD>
    <TD STYLE="text-decoration: underline"><A HREF="#a_011"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><U>Defaults upon Senior Securities</U></FONT></A></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">36</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Item 4.</FONT></TD>
    <TD STYLE="text-decoration: underline"><A HREF="#a_012"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><U>Mine Safety Disclosures</U></FONT></A></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">36</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Item 5.</FONT></TD>
    <TD STYLE="text-decoration: underline"><A HREF="#a_013"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><U>Other Information</U></FONT></A></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">37</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Item 6.</FONT></TD>
    <TD STYLE="text-decoration: underline"><A HREF="#a_014"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><U>Exhibits</U></FONT></A></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">37</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2" STYLE="text-decoration: underline"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><U><A HREF="#a_015">SIGNATURES</A></U></FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">38</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">&nbsp;</TD><TD STYLE="width: 50%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_001"></A>AmpliPhi Biosciences Corporation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Consolidated Balance Sheets</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">March 31, 2016</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">December 31, 2015</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP>&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center">(Unaudited)</TD><TD NOWRAP>&nbsp;</TD><TD NOWRAP>&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center">&nbsp;</TD><TD NOWRAP>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD NOWRAP STYLE="font-weight: bold">Assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">Current assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 70%; text-align: left; padding-left: 9pt">Cash and cash equivalents</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">6,173,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">9,370,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 9pt">Accounts receivable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">14,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">125,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 9pt">Prepaid expenses and other current assets</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">566,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">521,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">Total current assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,753,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10,016,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Property and equipment, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,170,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,131,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">In process research and development</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">12,446,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">12,446,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Acquired patents, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">330,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">338,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1pt">Goodwill</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">7,562,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">7,562,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total assets</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">28,261,000</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">31,493,000</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Liabilities, Series B redeemable convertible preferred stock and stockholders&rsquo; equity</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">Current liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 9pt">Accounts payable, accrued expenses and other</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">2,003,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1,464,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 9pt">Deferred revenue</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">142,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">245,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 9pt">Accrued severance</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">138,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">308,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 9pt">Dividends payable</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">368,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">368,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Total current liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,651,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,385,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Series B preferred stock derivative liability</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">91,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,493,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Warrant liability</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Deferred tax liability</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">3,005,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">3,005,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Total liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,749,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,889,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Series B redeemable convertible preferred stock</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>$0.01 par value, 9,357,935 shares authorized at March 31, 2016 and December 31, 2015, 7,527,853 shares issued and outstanding at March 31, 2016 and December 31, 2015 (liquidation preference of $13,706,000 and $13,383,000 at March 31, 2016 and December 31, 2015, respectively)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">13,615,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11,890,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">Stockholders&rsquo; equity</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 9pt">Common stock, $0.01 par value, 670,000,000 shares authorized at March 31, 2016 and December 31, 2015, 5,883,503 shares issued and outstanding at March 31, 2016 and December 31, 2015</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">59,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">59,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 9pt">Additional paid-in capital</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">374,472,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">375,177,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 9pt">Accumulated deficit</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(365,634,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(362,522,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1pt">Total stockholders&rsquo; equity</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">8,897,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">12,714,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total liabilities, Series B redeemable convertible preferred stock and stockholders&rsquo; equity</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">28,261,000</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">31,493,000</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">See accompanying condensed notes to consolidated
financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">&nbsp;</TD><TD STYLE="width: 50%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_002"></A>AmpliPhi Biosciences Corporation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Consolidated Statements of Operations</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" NOWRAP STYLE="font-weight: bold; text-align: center">Three Months Ended March 31,</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2016</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2015</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP>&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center">(Unaudited)</TD><TD NOWRAP>&nbsp;</TD><TD NOWRAP>&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center">(Unaudited)</TD><TD NOWRAP>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD NOWRAP STYLE="width: 70%; font-weight: bold; padding-bottom: 1pt">Revenue</TD><TD NOWRAP STYLE="width: 1%; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP STYLE="width: 1%; border-bottom: Black 1pt solid; text-align: left">$</TD><TD STYLE="width: 12%; border-bottom: Black 1pt solid; text-align: right">106,000</TD><TD STYLE="width: 1%; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1pt solid; text-align: left">$</TD><TD STYLE="width: 12%; border-bottom: Black 1pt solid; text-align: right">102,000</TD><TD STYLE="width: 1%; padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">Operating expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Research and development</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,980,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">972,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">General and administrative</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">2,644,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,397,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1pt">Total operating expenses</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">4,624,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">2,369,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1pt">Loss from operations</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(4,518,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(2,267,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Other income (expense)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Change in fair value of warrant liability</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(4,690,000</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Change in fair value of Series B preferred stock derivative liability</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,402,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(7,105,000</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Other expense</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(431,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1pt">Total other income (expense)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,406,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(12,226,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">Net loss</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3,112,000</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(14,493,000</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Accretion of Series B redeemable convertible preferred stock</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(1,725,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(338,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Net loss attributable to common stockholders</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(4,837,000</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(14,831,000</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Per share information:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Net loss per share of common stock - basic</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.82</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(3.49</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt">Weighted average number of shares of common stock outstanding - basic</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">5,883,503</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">4,245,816</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Net loss per share of common stock - diluted</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.82</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(3.49</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt">Weighted average number of shares of common stock outstanding - diluted</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">5,883,503</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">4,245,816</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">See accompanying condensed notes to consolidated
financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">&nbsp;</TD><TD STYLE="width: 50%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_003"></A>AmpliPhi Biosciences Corporation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Consolidated Statements of Redeemable
Convertible Preferred Stock and Stockholders&rsquo; Equity</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="6" NOWRAP STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">Redeemable Convertible</FONT></TD><TD NOWRAP STYLE="font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="6" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 8pt">Preferred
    Stock</FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="18" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 8pt">Stockholders'
    Equity</FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="6" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 8pt">Series
    B</FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="6" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 8pt">Common
    Stock</FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">Additional</FONT></TD><TD NOWRAP STYLE="font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">Total</FONT></TD><TD NOWRAP STYLE="font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">Paid-</FONT></TD><TD NOWRAP STYLE="font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">Accumulated</FONT></TD><TD NOWRAP STYLE="font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">Stockholders'</FONT></TD><TD NOWRAP STYLE="font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 8pt">Shares</FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 8pt">Amount</FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 8pt">Shares</FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 8pt">Amount</FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 8pt">in
    Capital</FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 8pt">Deficit</FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 8pt">Equity</FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 30%; font-weight: bold"><FONT STYLE="font-size: 8pt">Balances, December 31, 2014</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 7%; text-align: right"><FONT STYLE="font-size: 8pt">8,671,040</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="width: 7%; text-align: right"><FONT STYLE="font-size: 8pt">1,990,000</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 7%; text-align: right"><FONT STYLE="font-size: 8pt">3,983,182</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="width: 7%; text-align: right"><FONT STYLE="font-size: 8pt">40,000</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="width: 7%; text-align: right"><FONT STYLE="font-size: 8pt">365,403,000</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="width: 7%; text-align: right"><FONT STYLE="font-size: 8pt">(362,006,000</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="width: 7%; text-align: right"><FONT STYLE="font-size: 8pt">3,437,000</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 9pt"><FONT STYLE="font-size: 8pt">Net loss</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">(516,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">(516,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 9pt"><FONT STYLE="font-size: 8pt">Accretion of dividends on Series B redeemable
    convertible preferred stock</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">1,307,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">(1,307,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">(1,307,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 9pt"><FONT STYLE="font-size: 8pt">Accretion to redemption value of Series B redeemable
    convertible stock</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">8,971,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">(8,971,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">(8,971,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 9pt"><FONT STYLE="font-size: 8pt">Conversion of Series B redeemable convertible
    preferred stock to common stock</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">(1,143,187</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">(378,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">228,637</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">2,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">1,504,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">1,506,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 9pt"><FONT STYLE="font-size: 8pt">Common stock issued in March 2015 financing,
    net of offering costs</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">1,575,758</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">16,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">8,250,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">8,266,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 9pt"><FONT STYLE="font-size: 8pt">Warrants exercised</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">56,645</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">1,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">1,072,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">1,073,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 9pt"><FONT STYLE="font-size: 8pt">Warrants reclassified from liabilities to equity
    due to amendment of warrants</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">5,462,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">5,462,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 9pt"><FONT STYLE="font-size: 8pt">Warrants reclassified from liabilities to equity
    due to increase in authorized shares</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">3,281,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">3,281,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 9pt"><FONT STYLE="font-size: 8pt">Exercise of common stock options and other</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">39,281</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 9pt"><FONT STYLE="font-size: 8pt">Stock-based compensation</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">479,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">479,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 9pt"><FONT STYLE="font-size: 8pt">Stock-based compensation
    - severance</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-size: 8pt">4,000</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-size: 8pt">4,000</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold"><FONT STYLE="font-size: 8pt">Balances, December 31, 2015</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">7,527,853</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">11,890,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">5,883,503</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">59,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">375,177,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">(362,522,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">12,714,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 9pt"><FONT STYLE="font-size: 8pt">Net loss</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">(3,112,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">(3,112,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 9pt"><FONT STYLE="font-size: 8pt">Accretion of dividends on Series B redeemable
    convertible preferred stock</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">323,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">(323,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">(323,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 9pt"><FONT STYLE="font-size: 8pt">Accretion to redemption value of Series B redeemable
    convertible stock</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">1,402,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">(1,402,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">(1,402,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 9pt"><FONT STYLE="font-size: 8pt">Warrants issued for Novolytics assets</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">204,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">204,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 9pt"><FONT STYLE="font-size: 8pt">Stock-based compensation</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-size: 8pt">816,000</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-size: 8pt">816,000</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">Balances, March 31, 2016 (Unaudited)</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-size: 8pt">7,527,853</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-size: 8pt">13,615,000</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-size: 8pt">5,883,503</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-size: 8pt">59,000</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-size: 8pt">374,472,000</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-size: 8pt">(365,634,000</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-size: 8pt">8,897,000</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">See accompanying condensed notes to consolidated
financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">&nbsp;</TD><TD STYLE="width: 50%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_004"></A>AmpliPhi Biosciences Corporation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Consolidated Statement of Cash Flows</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" NOWRAP STYLE="font-weight: bold; text-align: center">Three Months Ended March 31,</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2016</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2015</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP>&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center">(Unaudited)</TD><TD NOWRAP>&nbsp;</TD><TD NOWRAP>&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center">(Unaudited)</TD><TD NOWRAP>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD NOWRAP STYLE="font-weight: bold; text-align: left">Operating activities:</TD><TD NOWRAP>&nbsp;</TD>
    <TD NOWRAP STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 70%; text-align: left">Net loss</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">(3,112,000</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">(14,493,000</TD><TD STYLE="width: 1%; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Adjustments required to reconcile net loss to net cash used in operating activities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 9pt">Change in fair value of warrant liability</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(4,000</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,690,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 9pt">Change in fair value of Series B preferred stock derivative liability</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,402,000</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,105,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 9pt">Warrants issued</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">204,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">213,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 9pt">Amortization of patents</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 9pt">Depreciation</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">73,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">58,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 9pt">Stock-based compensation</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">816,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">52,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 9pt">Changes in operating assets and liabilities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.25in">Accounts receivable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">111,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">100,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.25in">Accounts payable, accrued expenses, deferred revenue and other</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">436,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">158,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.25in">Accrued severance</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(170,000</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(122,000</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 0.25in">Prepaid expenses and other current assets</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(45,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(74,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1pt">Net cash used in operating activities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(3,085,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(2,305,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">Investing activities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Purchases of property and equipment</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(112,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(35,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1pt">Net cash used in investing activities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(112,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(35,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Financing activities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Proceeds from issuance of common stock, net</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">12,384,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1pt">Net cash provided by financing activities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">12,384,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Net (decrease) increase in cash and cash equivalents</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3,197,000</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10,044,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Cash and cash equivalents, beginning of period</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">9,370,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">6,581,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Cash and cash equivalents, end of period</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">6,173,000</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">16,625,000</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Supplemental schedule of non-cash financing activities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Accretion of Series B redeemable convertible preferred stock</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1,725,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">338,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Fair value of warrant liability upon issuance</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,211,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">See accompanying condensed notes to consolidated
financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">&nbsp;</TD><TD STYLE="width: 50%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_005"></A>AmpliPhi Biosciences Corporation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Condensed Notes to Consolidated Financial
Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>March 31, 2016<BR>
(Unaudited)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>1. Organization and Description of the Business</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">AmpliPhi Biosciences Corporation (the &ldquo;Company&rdquo;)
was incorporated in the state of Washington in 1989 under the name Targeted Genetics Corporation. In February 2011, Targeted Genetics
Corporation changed its name to AmpliPhi Biosciences Corporation. The Company is dedicated to developing novel antibacterial therapies
called bacteriophage (phage). Phages are naturally occurring viruses that preferentially target and kill their bacterial targets.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>2. Liquidity</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Company has prepared these consolidated
financial statements on a going concern basis, which assumes that the Company will realize its assets and satisfy its liabilities
in the normal course of business. However, the Company has incurred net losses since its inception, has negative operating cash
flows and has an accumulated deficit of $365.6 million as of March 31, 2016, $50.1 million of which has been accumulated since
January of 2011, when the Company began its focus on bacteriophage development. These circumstances raise substantial doubt about
the Company&rsquo;s ability to continue as a going concern. The accompanying financial statements do not include any adjustments
to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of
liabilities that may result from the outcome of the uncertainty concerning the Company&rsquo;s ability to continue as a going concern.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">As of March 31, 2016, the Company had cash
and cash equivalents of $6.2 million. Management believes that our existing resources will be sufficient to fund our planned operations
into the third quarter of 2016.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Company&rsquo;s ability to raise additional
funds will depend, in part, on the status of its product development activities and other business operations, as well as factors
related to financial, economic, and market conditions, many of which are beyond its control. The Company cannot be certain that
sufficient funds will be available to it when required or on acceptable terms, if at all. If adequate funds are not available on
a timely basis or on acceptable terms, the Company may be required to significantly reduce or refocus its operations or to obtain
funds through additional arrangements that may require the Company to relinquish rights to certain of its products, technologies
or potential markets, any of which could delay or require that it curtail or eliminate some or all of its development programs
or otherwise have a material adverse effect on the business, financial condition and results of operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>3. Significant Accounting Policies</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Company&rsquo;s significant accounting
policies are described in Note 3 to the Consolidated Financial Statements included in the Company&rsquo;s Annual Report on Form
10-K for the year ended December 31, 2015. Since the date of those financial statements, there have been no material changes to
the Company&rsquo;s significant accounting policies. The interim consolidated financial statements include the accounts of the
Company and its wholly owned subsidiaries Biocontrol Limited, Ampliphi d.o.o., and AmpliPhi Australia Pty Ltd. All significant
intercompany accounts and transactions have been eliminated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Basis of Presentation</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The accompanying unaudited condensed consolidated
financial statements of the Company should be read in conjunction with the audited financial statements and notes thereto as of
and for the year ended December 31, 2015 included in the Company&rsquo;s Annual Report on Form&nbsp;10-K, filed with the Securities
and Exchange Commission (SEC). The accompanying financial statements have been prepared in conformity with accounting principles
generally accepted in the United States of America (GAAP) for interim financial statements and in accordance with the instructions
to Form 10-Q. Any reference in these notes to applicable guidance is meant to refer to the authoritative United States generally
accepted accounting principles as found in the Accounting Standards Codification (ASC) and Accounting Standards Update (ASU) of
the Financial Accounting Standards Board (FASB).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In the opinion of management, the accompanying
financial statements reflect all adjustments, which include only normal recurring adjustments, necessary for the fair statement
of the Company&rsquo;s financial position as of March 31, 2016 and the results of its operations for the three months ended March
31, 2016 and 2015. Interim results are not necessarily indicative of results for the full year or any future period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Reverse Stock Split</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">On August 3, 2015, the Company filed Articles
of Amendment to Amended and Restated Articles of Incorporation with the Secretary of State of the State of Washington that effected
a 1-for-50 (1:50) reverse stock split of its common stock, par value $0.01 per share, effective August 7, 2015. On August 3, 2015,
the Company increased its authorized common stock, from 445,000,000 to 670,000,000 shares. The par value of its common stock was
unchanged at $0.01 per share, post-split. All warrant, stock option, and per share information in the consolidated financial statements
gives retroactive effect to the 1-for-50 reverse stock split that was effected on August 7, 2015.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">&nbsp;</TD><TD STYLE="width: 50%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Use of Estimates</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Management considers many factors in selecting
appropriate financial accounting policies and controls, and in developing the estimates and assumptions that are used in the preparation
of these financial statements. Management must apply significant judgment in this process. In addition, other factors may affect
estimates, including expected business and operational changes, sensitivity and volatility associated with the assumptions used
in developing estimates, and whether historical trends are expected to be representative of future trends. The estimation process
often may yield a range of potentially reasonable estimates of the ultimate future outcomes and management must select an amount
that falls within that range of reasonable estimates. This process may result in actual results differing materially from those
estimated amounts used in the preparation of the financial statements if these results differ from historical experience, or other
assumptions do not turn out to be substantially accurate, even if such assumptions are reasonable when made. In preparing these
financial statements, management used significant estimates in the following areas, among others: the determination of the fair
value of stock-based awards, the fair value of liability-classified preferred stock derivatives, the fair value of liability-classified
warrants, the valuation of long-lived assets, including in-process research and development (IPR&amp;D), patents and goodwill,
accrued expenses and the recoverability of the Company's net deferred tax assets and related valuation allowance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Warrant and Preferred Shares Conversion Feature Liability</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Company accounts for both warrants
with anti-dilution adjustment provisions and other features and preferred share features with anti-dilution adjustment provisions
under the applicable accounting guidance which requires the warrant and the preferred share features to be recorded as liabilities
and adjusted to fair value at each reporting period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Recent Accounting Pronouncements</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.25in">In May 2014, the
Financial Accounting Standards Board (&quot;FASB&quot;) issued Accounting Standard Update, or ASU, No. 2014-09, <I>Revenue from
Contracts with Customers (Topic 606)</I>. The ASU creates a single source of revenue guidance for companies in all industries.
The new standard provides guidance for all revenue arising from contracts with customers and affects all entities that enter into
contracts to provide goods or services to their customers, unless the contracts are within the scope of other accounting standards.
It also provides a model for the measurement and recognition of gains and losses on the sale of certain nonfinancial assets. This
guidance, as amended, must be adopted using either a full retrospective approach for all periods presented or a modified retrospective
approach and will be effective for fiscal years beginning after December 15, 2017. The Company has not yet evaluated the potential
impact of adopting the guidance on its consolidated financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.25in">In November 2015,
the FASB issued ASU 2015-17, <I>Balance Sheet Classification of Deferred Taxes</I>. The ASU is part of a simplification initiative
aimed at reducing complexity in accounting standards. Current GAAP requires the deferred taxes for each jurisdiction (or tax-paying
component of a jurisdiction) to be presented as a net current asset or liability and net noncurrent asset or liability. To simplify
presentation, the new guidance requires that all deferred tax assets and liabilities, along with any related valuation allowance,
be classified as noncurrent on the balance sheet. The standard is effective for public entities for annual reporting periods beginning
after December 15, 2016, and interim periods therein. Early adoption is permitted. The adoption of this guidance is not expected
to have a material impact on the Company's results of operations or liquidity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.25in">In February 2015,
the FASB issued ASU 2016-02, <I>Leases (Topic 842)</I>, which amends the FASB Accounting Standards Codification and creates Topic
842, &quot;Leases.&quot; The new topic supersedes Topic 840, &quot;Leases,&quot; and increases transparency and comparability among
organizations by recognizing lease assets and lease liabilities on the balance sheet and requires disclosures of key information
about leasing arrangements. The guidance is effective for reporting periods beginning after December 15, 2018. ASU 2016-02 mandates
a modified retrospective transition method. The Company has not yet evaluated the potential impact of adopting the guidance on
its consolidated financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In August 2014, the FASB issued ASU No.&nbsp;2014-15,
<I>Presentation of Financial Statements-Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity's Ability
to Continue as a Going Concern</I>, which defines management's responsibility to assess an entity's ability to continue as a going
concern, and to provide related footnote disclosures if there is substantial doubt about its ability to continue as a going concern.
The pronouncement is effective for annual reporting periods ending after December&nbsp;15, 2016 with early adoption permitted.
The adoption of this guidance is not expected to have a material impact on the Company's consolidated financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In March 2016, the FASB issued ASU 2016-09,
<I>Improvements to Employee Share-Based Payment Accounting</I>, which amends Accounting Standards Codification (&ldquo;ASC&rdquo;)
Topic 718, Compensation &ndash; Stock Compensation. ASU 2016-09 simplifies several aspects of the accounting for share-based payment
transactions, including the income tax consequences, classification of awards as either equity or liabilities, and classification
on the statement of cash flows. ASU 2016-09 is effective for fiscal years beginning after December 15, 2016, and interim periods
within those fiscal years and early adoption is permitted. The Company has not yet evaluated the potential impact of adopting the
guidance on its consolidated financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">&nbsp;</TD><TD STYLE="width: 50%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>4. Fair Value of Financial Assets and Liabilities&nbsp;&mdash;&nbsp;Derivative
Instruments</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">ASC Topic 820, <I>Fair Value Measurement</I>
(ASC 820), establishes a fair value hierarchy for instruments measured at fair value that distinguishes between assumptions based
on market data (observable inputs) and the Company&rsquo;s own assumptions (unobservable inputs). Observable inputs are inputs
that market participants would use in pricing the asset or liability based on market data obtained from sources independent of
the Company. Unobservable inputs are inputs that reflect the Company&rsquo;s assumptions about the inputs that market participants
would use in pricing the asset or liability, and are developed based on the best information available in the circumstances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">ASC 820 identifies fair value as the exchange
price, or exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly
transaction between market participants. As a basis for considering market participant assumptions in fair value measurements,
ASC Topic 820 establishes a three-tier fair value hierarchy that distinguishes among the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.2in"><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Level&nbsp;1&mdash;Valuations based on unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Level&nbsp;2&mdash;Valuations based on quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active and models for which all significant inputs are observable, either directly or indirectly.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Level&nbsp;3&mdash;Valuations based on inputs that are unobservable and significant to the overall fair value measurement.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">To the extent that the valuation is based
on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment.
Accordingly, the degree of judgment exercised by the Company in determining fair value is greatest for instruments categorized
in Level&nbsp;3. A financial instrument's level within the fair value hierarchy is based on the lowest level of any input that
is significant to the fair value measurement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Items measured at fair value on a recurring
basis include common stock warrants and embedded derivatives related to the Company&rsquo;s redeemable convertible preferred stock.
During the periods presented, the Company has not changed the manner in which it values liabilities that are measured at fair value
using Level&nbsp;3 inputs. The following fair value hierarchy table presents information about each major category of the Company's
financial liabilities measured at fair value on a recurring basis:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">Quoted&nbsp;Prices&nbsp;in</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD><TD NOWRAP>&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP>&nbsp;</TD><TD NOWRAP>&nbsp;</TD><TD NOWRAP>&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP>&nbsp;</TD><TD NOWRAP>&nbsp;</TD><TD NOWRAP>&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP>&nbsp;</TD><TD NOWRAP>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">Active&nbsp;Markets</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">Significant&nbsp;Other</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">Significant</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD><TD NOWRAP>&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP>&nbsp;</TD><TD NOWRAP>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">for&nbsp;Identical</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">Observable&nbsp;Inputs</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">Unobservable</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD><TD NOWRAP>&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP>&nbsp;</TD><TD NOWRAP>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Items&nbsp;(Level&nbsp;1)</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">(Level&nbsp;2)</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Inputs&nbsp;(Level&nbsp;3)</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Total</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold">March 31, 2016</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold">Liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 48%; text-align: left">Series B preferred stock derivative liability</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">91,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">91,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Warrant liability</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">2,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">2,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total liabilities</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">-</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">-</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">93,000</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">93,000</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold">December 31, 2015</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold">Liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Series B preferred stock derivative liability</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1,493,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1,493,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Warrant liability</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">6,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">6,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total liabilities</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">-</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">-</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">1,499,000</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">1,499,000</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">There were no transfers between Level 1,
Level 2 or Level 3 of the fair value hierarchy for the three months ended March 31, 2016 and the year ended December 31, 2015.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The following table sets forth a summary
of changes in the fair value of the Company's Series B redeemable convertible preferred stock derivative and warrant liability,
which represents a recurring measurement that is classified within Level&nbsp;3 of the fair value hierarchy, wherein fair value
is estimated using significant unobservable inputs:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP>&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: right">&nbsp;</TD><TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">Series B Preferred</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">Warrant</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">Stock&nbsp;Derivative</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Liability</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Liability</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD NOWRAP STYLE="width: 70%">Balance, December&nbsp;31, 2015</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">6,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">1,493,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Changes in estimated fair value</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(4,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(1,402,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt">Balance, March 31, 2016</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">2,000</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">91,000</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">&nbsp;</TD><TD STYLE="width: 50%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The fair value of the warrants on the date
of issuance and on each re-measurement date for warrants classified as liabilities is estimated using the Monte Carlo valuation
model. For this liability, the Company develops its own assumptions that do not have observable inputs or available market data
to support the fair value. This method of valuation involves using inputs such as the fair value of the Company&rsquo;s common
stock, stock price volatility, the contractual term of the warrants, risk&ndash;free interest rates and dividend yields. Due to
the nature of these inputs, the valuation of the warrants is considered a Level 3 measurement. The following assumptions were used
at March 31, 2016 and December 31, 2015:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">March 31, 2016</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">December 31, 2015</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Series <SUP>(1)</SUP></B></FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Series <SUP>(1)</SUP></B></FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2011</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2011</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD NOWRAP STYLE="width: 74%">Volatility</TD><TD NOWRAP STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">108.00</TD><TD STYLE="width: 1%; text-align: left">%</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">112.05</TD><TD STYLE="width: 1%; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Expected term (years)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.73</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.98</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Risk-free interest rate</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.48</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.64</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Dividend yield</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.00</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.00</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Exercise price</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">23.00</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">23.00</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Common stock closing price</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">3.94</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">3.98</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(1) See <I>Note 7 &ndash; Warrants</I>
below for further description of the respective series of warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The warrant liability is recorded on the
accompanying consolidated balance sheets and is marked-to-market at each reporting period, with the change in fair value recorded
as a component of change in fair value of warrant liability on the Company&rsquo;s statements of operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The fair value of the Series B preferred
stock derivative liability on each measurement date is estimated using the Monte Carlo valuation model. For this liability, the
Company develops its own assumptions that do not have observable inputs or available market data to support the fair value. This
method of valuation involves using inputs such as the fair value of the Company&rsquo;s common stock, stock price volatility, the
expected term of the Series B preferred stock, risk&ndash;free interest rates and dividend yields. Due to the nature of these inputs,
the valuation of the Series B preferred conversion liability is considered a Level 3 measurement. The following assumptions were
used at March 31, 2016 and December 31, 2015:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">March 31,</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">December 31,</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2016</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2015</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD NOWRAP STYLE="width: 68%">Volatility</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 14%; text-align: right">108</TD><TD STYLE="width: 1%; text-align: left">%</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 12%; text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">108 to 117</FONT></TD><TD STYLE="width: 1%; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Expected term (years), weighted average</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">0.04 to 0.75</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">0.50 to 2.50</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Risk-free interest rate</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">0.18 to 0.49</FONT></TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">0.49 to 1.19</FONT></TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Dividend yield</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.00</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.00</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Exercise price</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">7.00</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">7.00</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Common stock closing price</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">3.94</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">3.98</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Series B preferred stock derivative
liability is recorded on the accompanying consolidated balance sheet and is marked-to-market each reporting period, with the change
in fair value recorded as a component of change in fair value of Series B preferred stock derivative liability on the Company&rsquo;s
statements of operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 15pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>5. Net Loss per Common Share</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The following table sets forth the computation
of basic and diluted net loss per share for the periods indicated:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" NOWRAP STYLE="font-weight: bold; text-align: center">Three Months Ended</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">March 31,</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2016</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2015</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD NOWRAP STYLE="text-align: left">Basic and diluted net loss per common share calculation:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 70%; text-align: left">Net loss</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">(3,112,000</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">(14,493,000</TD><TD STYLE="width: 1%; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Accretion of Series B redeemable convertible preferred stock</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(1,725,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(338,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Net loss attributable to common stockholders</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(4,837,000</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(14,831,000</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt">Weighted average common shares outstanding - basic</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">5,883,503</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">4,245,816</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Net loss per share of common stock&nbsp;&nbsp;- basic</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.82</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(3.49</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt">Weighted average common shares outstanding - diluted</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">5,883,503</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">4,245,816</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Net loss per share of common stock - diluted</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.82</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(3.49</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">&nbsp;</TD><TD STYLE="width: 50%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The following outstanding securities at
March 31, 2016 and 2015 have been excluded from the computation of diluted weighted shares outstanding for the three months ended
March 31, 2016 and 2015, as they would have been anti-dilutive:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">March 31,</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">March 31,</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2016</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2015</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD NOWRAP STYLE="width: 74%">Options</TD><TD NOWRAP STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">872,977</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">440,695</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Warrants</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,379,649</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,266,293</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Series B redeemable convertible preferred stock</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">7,527,853</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">8,671,040</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; padding-bottom: 2.5pt">Total</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">9,780,479</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">10,378,028</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>6. Redeemable Convertible Preferred Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">On June 13, 2013, the Company&rsquo;s Board
of Directors approved a resolution designating 9,357,935 shares of Preferred Stock as Series B redeemable convertible preferred
stock (Series B) with an initial stated value of $1.40 and par value of $0.01. As of March 31, 2016, each Series B share was convertible
into 0.20 shares of common stock and was entitled to the number of votes equal to the number of shares of common stock into which
such Series B share could be converted. The Series B shares were convertible into common stock by the holder of the shares at any
time. The Series B shares were subject to automatic conversion into common stock upon the election of the holders of at least two-thirds
of the outstanding Series B shares. In addition, pursuant to the Company&rsquo;s Articles of Incorporation, the Series B shares
were automatically convertible into common stock upon the occurrence of an underwritten initial public offering by the Company
that satisfied certain conditions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Holders of the Series B shares were entitled
to receive cumulative, cash dividends at the rate of 10% of the Series B stated value. Such dividends accrue from day-to-day commencing
on the original issue date, whether or not earned or declared by the Board of Directors, and were compounded annually. No dividends
had been declared or paid on the Series B shares through March 31, 2016.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Series B shares were redeemable by
the Company at any time on or after June 26, 2018, upon the election of the holders of at least two-thirds of the outstanding Series
B shares for an amount equal to the original issue price per share plus any accrued and unpaid dividends.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Holders of the Series B shares were entitled
to a liquidation preference in an amount equal to the Series B stated value of $1.40 per share plus all accrued and unpaid dividends
in the event of a liquidation, dissolution, or winding-up of the Company, or in the event of a merger or acquisition of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In connection with the private placement
of Series B shares, the Company recorded a liability for an embedded derivative that required bifurcation under the applicable
accounting guidance. The embedded derivative includes a redemption feature, multiple dividend features, as well as multiple conversion
features with specified anti-dilution adjustments for certain financing transactions involving the issuance of securities at a
price below a minimum non-diluting issuance price of $7.00 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Company re-measured the fair value
of the derivative feature and recorded a gain of $1,402,000 for the three months ended March 31, 2016 to adjust the liability associated
with the conversion feature to its estimated fair value of $91,000 as of March 31, 2016. For the three months ended March 31, 2015,
the Company recorded a loss of $7,105,000 to adjust the liability associated with the conversion feature to its estimated fair
value of $19,425,000 as of March 31, 2015.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">At March 31, 2016, the Company accreted
$1,402,000 from additional paid-in capital to Series B redeemable convertible preferred stock to adjust the redemption value of
the Series B to actual at that date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The March 31, 2016 balance sheet reflects
dividends payable of $368,000 to former holders of preferred stock, which are classified as current liabilities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">On April 8, 2016, the Series B redeemable
convertible preferred stock was automatically converted into common stock pursuant to the election of the holders of over two-thirds
of the then-outstanding Series B shares. See <I>Note 13 &ndash; Subsequent Events</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">&nbsp;</TD><TD STYLE="width: 50%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>7. Warrants</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">On January 4, 2016, the Company entered
into an Asset Purchase Agreement with Novolytics Limited (the &ldquo;Purchase Agreement&rdquo;), to purchase certain preclinical
materials and intangible assets, including patent rights, from Novolytics, an unrelated third party. In consideration for the
assets acquired, the Company paid cash consideration of approximately $205,000 and issued warrants to purchase an aggregate of
170,000 shares of the Company&rsquo;s common stock. The warrants have an exercise price of $12.00 per share and contain certain
registration rights. The fair value of the warrants issued was $204,000, based on a Monte Carlo valuation model and are classified
as equity within the consolidated balance sheet. The Company expensed the total value provided for the acquired assets of $409,000
as in-process research and development as of the acquisition date given there was no alternative future use of the acquired assets
due to the early stage nature of the technology and pre-clinical materials.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The following table provides a summary
of warrants outstanding, issued or exercised for the three months ended March 31, 2016. Also included is the average exercise
price per share and the aggregate proceeds to the Company if exercised as of March 31, 2016.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 8pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="54" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">Series</FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" NOWRAP STYLE="font-weight: bold; text-align: center"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">June
    2013 and July<BR>
    2013<BR>
    </FONT></TD><TD NOWRAP STYLE="font-weight: bold"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">Novolytics</FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">March&nbsp;2015</FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">Series
    B Warrants</FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">December&nbsp;2013</FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">2013&nbsp;Convertible&nbsp;Notes</FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">2011</FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">Totals</FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">Weighted</FONT></TD><TD NOWRAP STYLE="font-weight: bold"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">Average</FONT></TD><TD NOWRAP STYLE="font-weight: bold"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">Exercise</FONT></TD><TD NOWRAP STYLE="font-weight: bold"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">Exercise</FONT></TD><TD NOWRAP STYLE="font-weight: bold"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">Exercise</FONT></TD><TD NOWRAP STYLE="font-weight: bold"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">Exercise</FONT></TD><TD NOWRAP STYLE="font-weight: bold"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">Exercise</FONT></TD><TD NOWRAP STYLE="font-weight: bold"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">Exercise</FONT></TD><TD NOWRAP STYLE="font-weight: bold"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">Exercise</FONT></TD><TD NOWRAP STYLE="font-weight: bold"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">Shares</FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">Price</FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">Shares</FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">Price</FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">Shares</FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">Price</FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">Shares</FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">Price</FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">Shares</FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">Price</FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">Shares</FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">Price</FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">Shares</FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">Price</FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 9%"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">Balance, December 31, 2015</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 3%; text-align: right"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 4%; text-align: right"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 3%; text-align: right"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">488,484</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 4%; text-align: right"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">10.75</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 3%; text-align: right"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">467,046</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 4%; text-align: right"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">7.00</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 3%; text-align: right"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">86,408</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 4%; text-align: right"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">8.25</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 3%; text-align: right"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">140,608</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 4%; text-align: right"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">7.00</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 3%; text-align: right"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">27,103</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 4%; text-align: right"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">23.00</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 3%; text-align: right"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">1,209,649</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 4%; text-align: right"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">8.96</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font: 7pt Times New Roman, Times, Serif">Issuances</FONT></TD><TD><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">170,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">12.00</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">170,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">12.00</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1pt"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">Exercises</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">Balance, March
    31, 2016</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">170,000</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">12.00</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">488,484</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">10.75</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">467,046</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">7.00</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">86,408</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">8.25</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">140,608</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">7.00</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">27,103</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">23.00</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">1,379,649</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">9.34</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">Aggregate
    proceeds if exercised</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">2,040,000</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: right"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">5,251,203</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: right"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">3,269,322</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: right"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">712,866</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: right"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">984,256</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: right"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">623,369</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: right"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">12,881,016</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: right"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font: 7pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>8. Stockholders&rsquo; Equity</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">On March 16, 2015, the Company issued and
sold 1,575,758 shares of common stock in a private placement at a price of $8.25 per share, for aggregate proceeds of $13.0 million.
In conjunction with this private placement, the Company issued warrants to purchase an aggregate of 393,939 shares of common stock
at an exercise price of $10.75 per share to the purchasers of the common stock. The Company paid $833,000 in fees to its placement
agents, along with the issuance of warrants to purchase an aggregate of 94,545 shares of common stock at an exercise price of $10.75
per share. The Company valued these warrants as liability instruments and recorded a liability of $4,210,000 as of March 16, 2015.
In the first quarter of 2015, the Company recorded $213,000 of other expenses representing the portion of the initial warrant value
of the placement agent warrants related to the initial fair value of the warrants issued to the purchasers of the common stock.
The remainder of the initial fair value of the warrants of $3,996,000 was treated as a reduction of additional paid-in-capital.
In addition, $218,000 of the fees paid to its placement agent were expensed as other expenses in the three months ended March 31,
2015 as they also represented issuance costs related to the initial fair value of the warrants issued to the purchasers of the
common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>9. Stock-Based Compensation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Company&rsquo;s 2013 Stock Incentive
Plan (Stock Incentive Plan) provides for the issuance of incentive awards in the form of non-qualified and incentive stock options,
stock appreciation rights, stock grants and restricted stock units. The awards may be granted by the Company&rsquo;s Board of Directors
to its employees, directors and officers and to consultants, agents, advisors and independent contractors who provide services
to the Company or to a subsidiary of the Company. The exercise price for stock options must not be less than the fair market value
of the underlying shares on the date of grant. Stock options expire no later than ten years from the date of grant and generally
vest and typically become exercisable over a four-year period following the date of grant. Upon the exercise of stock options,
the Company issues the resulting shares from shares reserved for issuance under the Stock Incentive Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Company accounts for stock options
and restricted stock units related to its stock incentive plans under the provisions of ASC 718, which requires the recognition
of the fair value of stock-based compensation. The fair value of stock options was estimated using a Black-Scholes option valuation
model. This model requires the input of subjective assumptions in implementing ASC 718, including expected dividend, expected life,
expected volatility and forfeiture rate of each award, as well as the prevailing risk-free interest rate and the fair value of
the underlying common stock on the date of grant. The fair value of equity-based awards is amortized over the vesting period of
the award, and the Company has elected to use the straight-line method of amortization. The assumptions used in the Black-Scholes
option valuation model for the three months ended March 31, 2016 are set forth below.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">&nbsp;</TD><TD STYLE="width: 50%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Expected Dividend</I>:&nbsp;The Company does not anticipate paying any dividends on its common stock.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Expected Life</I>:&nbsp;The expected life represents the period that the Company expects its stock-based awards to be outstanding. The Company&rsquo;s expected life assumption was based on the simplified method set forth in the SEC Staff Accounting Bulletin 110. The Company&rsquo;s estimation of the expected life for stock options granted to parties other than employees or directors is the contractual term of the option award.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Expected Volatility:</I>&nbsp;Expected volatility is the measure by which the Company&rsquo;s stock price is expected to fluctuate during the expected term of an option. The Company&rsquo;s expected volatility represents the weighted average historical volatility of the shares of its common stock.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Risk-Free Interest Rate</I>:&nbsp;The Company bases the risk-free interest rate used on the implied yield currently available on U.S. Treasury zero-coupon issues with an equivalent remaining term. Where the expected term of its stock-based awards does not correspond with the terms for which interest rates are quoted, the Company performs a straight-line interpolation to determine the rate from the available term maturities.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Forfeiture Rate</I>:&nbsp;The Company applies an estimated forfeiture rate that is derived from historical forfeited shares. If the actual number of forfeitures differs from our estimates, the Company may record additional adjustments to compensation expense in future periods.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The weighted-average assumptions used in
the Black-Scholes option pricing model to determine the fair value of the stock option grants were as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">March 31,</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2016</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Risk-free interest rate</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">1.58 to 1.63</FONT></TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 85%; text-align: left">Expected volatility</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 12%; text-align: right">113.0</TD><TD STYLE="width: 1%; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Expected term (in years)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6.0</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Expected dividend yield</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.0</TD><TD STYLE="text-align: left">%</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Stock-based compensation expense is reduced
by an estimated forfeiture rate derived from historical employee termination behavior. If the actual number of forfeitures differs
from the Company&rsquo;s estimates, the Company may record adjustments to increase or decrease compensation expense in future periods.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 15pt">The estimated grant-date fair value of the
Company&rsquo;s stock-based awards is amortized ratably over the awards&rsquo; service periods. Stock-based compensation expense
recognized was as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" NOWRAP STYLE="font-weight: bold; text-align: center">Three Months Ended March 31,</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2016</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2015</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">(Unaudited)</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">(Unaudited)</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD NOWRAP STYLE="width: 70%; text-align: left">Research and development</TD><TD NOWRAP STYLE="width: 1%">&nbsp;</TD>
    <TD NOWRAP STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">26,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">29,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">General and administrative</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">790,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">23,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Total stock-based compensation</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">816,000</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">52,000</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 15pt">The following table summarizes stock option
activity for the three months ended March 31, 2016:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 15pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="14" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Options&nbsp;Outstanding</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP>&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP>&nbsp;</TD><TD NOWRAP>&nbsp;</TD><TD NOWRAP>&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP>&nbsp;</TD><TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">Average</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD><TD NOWRAP>&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP>&nbsp;</TD><TD NOWRAP>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP>&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center">&nbsp;</TD><TD NOWRAP>&nbsp;</TD><TD NOWRAP>&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP>&nbsp;</TD><TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">Weighted</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">Remaining</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD><TD NOWRAP>&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP>&nbsp;</TD><TD NOWRAP>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">Shares</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD><TD NOWRAP>&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP>&nbsp;</TD><TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">Average</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">Contractual</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD><TD NOWRAP>&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP>&nbsp;</TD><TD NOWRAP>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">Available</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD><TD NOWRAP>&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP>&nbsp;</TD><TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">Exercise</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">Term</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">Intrinsic</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">For Grant</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Shares</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Price</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">(Years)</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Value</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD NOWRAP STYLE="width: 40%">Balance, December 31, 2015</TD><TD NOWRAP STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">723,431</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">669,769</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">8.68</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">9.29</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Granted</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(207,208</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">207,208</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.83</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Exercised</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Forfeited</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1pt">Expired</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(4,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">10.00</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 2.5pt">Balance, March 31, 2016</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">516,223</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">872,977</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">7.29</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">9.26</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">229,076</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Vested or expected to vest at March 31, 2016</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">704,778</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">7.63</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">9.18</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">141,846</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 2.5pt">Exercisable at March 31, 2016</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">99,394</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">9.19</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">7.69</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">-</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 15pt">&nbsp;</P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">&nbsp;</TD><TD STYLE="width: 50%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 15pt">The intrinsic value of options exercisable
as of March 31, 2016 was $0.0, based on the Company&rsquo;s closing stock price of $3.94 per share and a weighted average exercise
price of $9.19 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 15pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 15pt">During the first quarter of 2016, the Company
issued 207,208 common stock options to its employees and an executive with an average exercise price $2.83 per share. Included
in this amount were 99,919 stock options, with an exercise price of $2.85, to its Chief Financial Officer, pursuant to his employment
agreement dated January 18, 2016. There were no grants of stock options to employees or directors during the three months ended
March 31, 2015.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 15pt">As of March 31, 2016, there was $2.8 million
of total unrecognized compensation expense related to unvested stock options, which the Company expects to recognize over the weighted
average remaining period of 2.72 years.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 15pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Shares Reserved For Further Issuance</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">As of March 31, 2016, the Company had reserved
shares of its common stock for future issuance as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Shares Reserved</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 87%; text-align: left">Stock options outstanding</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">872,977</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Available for future grants under the Stock Incentive Plan</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">516,223</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1pt">Warrants</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,379,649</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 2.5pt">Total shares reserved</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">2,768,849</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>10. Collaborative and Other Agreements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In June 2013, the Company entered into
a Collaborative Research and Development Agreement with the United States Army Medical Research and Materiel Command and the Walter
Reed Army Institute of Research. The Collaborative Research and Development Agreement is focused on developing and commercializing
bacteriophage therapeutics to treat <I>S. aureus</I> infections. During the three months ended March 31, 2016 and 2015, the Company
recorded no payments to Walter Reed Army Institute of Research under the Collaborative Research and Development Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In March 2013, the Company entered
into an Exclusive Channel Collaboration Agreement with Intrexon Corporation (the ECC Agreement&rdquo;). This agreement allows
the Company to utilize Intrexon&rsquo;s synthetic biology platform for the identification, development and production of
bacteriophage-containing human therapeutics. The Company paid a one-time technology access fee in 2013 to Intrexon of
$3,000,000 in common stock. Pursuant to the agreement, the Company is required to pay Intrexon, in cash or stock, milestone
fees of $2,500,000 for the initiation and commencement of the first Phase 2 trial and $5,000,000 upon the first regulatory
approval of any product in any major market country. With regard to each product sold by the Company, the Company is required
to pay, in cash, tiered royalties on a quarterly basis based on net sales of AmpliPhi Products, calculated on a
product-by-product basis. No milestones have been met and no milestone payments have been paid to Intrexon through March 31,
2016. During the three months ended March 31, 2016, the Company recorded $54,000 in expenses under the Exclusive Channel
Collaboration Agreement, with cash payments totaling $56,000. During the three months ended March 31, 2015, the Company
recorded $22,000 in expenses under the Exclusive Channel Collaboration Agreement, with cash payments totaling $3,000. On
April 13, 2016, the Company provided written notice to Intrexon of its election to voluntarily terminate the ECC Agreement.
As of March 31, 2016, the Company had a liability of $54,000 recorded for amounts due to Intrexon. See <I>Note 13 &ndash;
Subsequent Events</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In April 2013, the Company entered into
a collaboration agreement with the University of Leicester to develop a phage therapy that targets and kills all toxin types of
<I>C. difficile.</I> In August 2013, the Company entered into a collaboration agreement with both the University of Leicester and
the University of Glasgow to carry out certain animal model development work. Under these agreements, which are referred to collectively
as the Leicester Development Agreements, the Company provides payments to the University of Leicester to carry out <I>in vitro</I>
and to the University of Glasgow to carry out animal model development work on the University of Leicester&rsquo;s development
of a bacteriophage therapeutic to resolve <I>C. difficile</I> infections. The Company licensed related patents, materials and know-how
from the University of Leicester. Under the Leicester Development Agreements, the University of Leicester will provide the bacteriophage
and act as overall project coordinator for the development work. All rights, title and interest to any intellectual property developed
under the Leicester Development Agreements belong to the Company. Under the Leicester License Agreement, the Company has exclusive
rights to certain background intellectual property of the University of Leicester, for which it will pay the University of Leicester
royalties based on product sales and make certain milestone payments based on product development. In November 2015, the Company
renewed this collaboration, effective as of November 12, 2015. This agreement expires November 12, 2018. During the three months
ended March 31, 2016, the Company recorded $43,000 in expenses to the University of Leicester under the Leicester Development Agreements,
with cash payments totaling $46,000. During the three months ended March 31, 2015, the Company recorded $35,000 in expenses to
the University of Leicester under the Leicester Development Agreements, with cash payments totaling $50,000. During the three months
ended March 31, 2016, the Company recognized no expense and made no payments to the University of Glasgow under the Leicester Development
Agreements. During the three months ended March 31, 2015, the Company paid $61,000 and expensed amounts to the University of Glasgow
under the Leicester Development Agreements of $13,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">&nbsp;</TD><TD STYLE="width: 50%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In September 2015, the Company entered
into a non-exclusive patent license agreement with Takara Bio Inc. (the Takara Agreement). Under this agreement Takara licensed
certain patents from the Company related to AAV1 Vector gene delivery systems, for which the Company is an exclusive licensor with
the University of Pennsylvania. The Company received a $40,000 non-refundable, up-front licensing payment and is entitled to receive
royalties from Takara of 12.0% of net license product sales and 6.0% of service revenues associated with the licensed products.
The agreement calls for minimum annual royalties of $15,000 commencing on February 28, 2016. In addition, the Takara Agreement
provides milestone fees to the Company of $30,000 of the first $1,000,000 of licensed product revenues by Takara and an additional
$40,000 when cumulative net sales of the licensed product by Takara exceed $2,000,000. During the three months ended March 31,
2016, the Company recognized revenue of $4,000 under the Takara Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>11. Severance Charge</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In September of 2014 and 2015 two executives
separated from the Company. The Company recorded severance expenses in the respective periods and accrued severance related to
the cash portion due over time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The severance accrual as of December 31,
2015 and March 31, 2016 is as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 87%">Accrued severance, December 31, 2015</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">308,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Cash payments in 2016</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(170,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt">Accrued severance, March 31, 2016</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">138,000</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>12. Legal Proceedings</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Company determines whether it should
accrue an estimated loss for a contingency in a particular legal proceeding by assessing whether a loss is deemed probable and
whether the amount can be reasonably estimated. Claim estimates that are probable and can be reasonably estimated are reflected
as liabilities. Legal proceedings are inherently unpredictable and the matters in which the Company may be involved often will
present complex legal and factual issues. Because of the uncertainties related to the Company&rsquo;s pending litigation, investigations,
inquiries or claims, management is currently unable to predict the ultimate outcome of any litigation, investigation, inquiry or
claim, determine whether a liability has been incurred, or make an estimate regarding the possible loss or range of loss that could
result from an unfavorable outcome. It is reasonably possible that some of the matters which may be asserted could be decided unfavorably
to the Company. An adverse ruling or outcome in any lawsuit involving the Company could materially affect its business, liquidity,
consolidated financial position or results of operations. In view of the unpredictable nature of such matters, the Company cannot
provide any assurances regarding the outcome of any litigation, investigation, inquiry or claim to which it is a party of the impact
on the Company of an adverse ruling on such matters.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">On April 14, 2016, a complaint was filed
against the Company and certain of its board members. See <I>Note 13 &ndash; Subsequent Events</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>13. Subsequent Events</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Series B Convertible Preferred Stock Conversion</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">On April 8, 2016, certain holders (the
&ldquo;Holders&rdquo;) of over two-thirds of the Company&rsquo;s then-outstanding shares of Series B redeemable convertible preferred
stock (&ldquo;Series B Preferred&rdquo;) elected to automatically convert all outstanding shares of Series B Preferred into shares
of Common Stock in accordance with Section 4.4.4(b)(ii) of the Company&rsquo;s Amended and Restated Articles of Incorporation (the
&ldquo;Conversion&rdquo;). As a result of the Conversion, the 7,527,853 shares of Series B Preferred outstanding as of immediately
prior to the Conversion have been converted into an aggregate of 1,505,560 shares of Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">On April 8, 2016, the Company entered into
a Common Stock Issuance Agreement (the &ldquo;Agreement&rdquo;) with the Holders pursuant to which the Company agreed to issue
the Holders an aggregate of 853,465 shares of the Company&rsquo;s Common Stock (the &ldquo;Shares&rdquo;). Pursuant to the Agreement,
the Company and the Holders also agreed to amend the Common Stock warrants issued to the Holders pursuant to that certain Subscription
Agreement, dated June 25, 2013, in order to reduce the exercise price of such warrants from $7.00 per share to $4.05 per share
and extend the expiration date thereof from June 26, 2018 to March 31, 2021 (the &ldquo;Warrant Amendments&rdquo;). As consideration
for the Shares and the Warrant Amendments, the Holders waived their right to receive approximately $2.2 million in aggregate cash
payments to which they were entitled upon the Conversion in respect of accrued dividends on their former shares of Series B Preferred.
The Holders also waived their registration rights with respect to certain future registration statements that may be filed, and
certain future public offerings that may be conducted, by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">&nbsp;</TD><TD STYLE="width: 50%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Pursuant to the Agreement, if in the future
the Company conducts one or more bona fide equity financings in which it sells shares of Common Stock or Preferred Stock at a price
less than $4.05 per share (each, a &ldquo;dilutive financing&rdquo;), the Company will be required to issue to the Holders additional
shares of Common Stock based on a specified formula. The obligation to issue additional shares in the event of any such dilutive
financing (i) only applies to the lowest priced financing conducted after the date of the Agreement, (ii) is subject to limitations
under applicable NYSE MKT rules relating to the issuance of additional shares in a private placement at a price less than the greater
of book or market value and (iii) will expire at such time the Company has raised $10.0 million in gross proceeds from the sale
of Common Stock and/or Preferred Stock in a bona fide financing or financings or June&nbsp;30, 2018, whichever occurs first. The
Company has agreed to seek shareholder approval of the issuance of up to 1,037,053 shares of Common Stock to the Holders in the
future as required by the Agreement in connection with one or more dilutive financings. To the extent the Company is not permitted
by applicable NYSE MKT rules to issue any additional shares of Common Stock that would otherwise be required to be issued pursuant
to the terms of the Agreement as a result of a dilutive financing, the Company has agreed to pay the Holders a cash payment equal
to the difference between the price per share in such dilutive financing and $4.05 for each share issued to the Holders pursuant
to the Conversion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Litigation</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">On April 14, 2016, NRM VII Holdings I,
LLC (&ldquo;NRM&rdquo;), an affiliate of Third Security, LLC (&ldquo;Third Security&rdquo;), filed a complaint against the Company
and certain members of the Company&rsquo;s Board in the Superior Court of California, County of San Diego. Third Security is one
of the principal shareholders of the Company. The complaint alleges that the Company breached the implied covenant of good faith
by entering into a scheme to force NRM to convert its Series B Shares into Common Shares. The complaint further alleges that the
members of the Board who were named as defendants breached their fiduciary duty of good faith owed to NRM, as one of the Company&rsquo;s
shareholders, by participating in this transaction. The complaint seeks unspecified monetary damages and other relief. The Company
plans to vigorously defend against the claims advanced.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Collaboration Agreement </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">On April 13, 2016, the Company provided
written notice to Intrexon Corporation of its election to voluntarily terminate its ECC Agreement dated March 29, 2013 (see Note
10). The effective date of the termination will be 90 days following delivery of the termination notice. The Company will not incur
any early termination penalties as a result of the termination of the ECC Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">&nbsp;</TD><TD STYLE="width: 50%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><A NAME="a_006"></A>Item 2. MANAGEMENT&rsquo;S DISCUSSION AND ANALYSIS OF FINANCIAL
CONDITION AND RESULTS OF OPERATIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; text-align: left">The following discussion and analysis of
our financial condition and results of operations should be read in conjunction with our unaudited consolidated financial statements
and related notes included in this Quarterly Report on Form 10-Q, and the audited financial statements and notes thereto as of
and for the year ended December&nbsp;31, 2015 included in our Annual Report on Form 10-K filed with the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Statements
contained in this report that are not statements of historical fact are forward-looking statements within the meaning of the U.S.
Private Securities Litigation Reform Act of 1995. Such forward-looking statements include, without limitation, statements concerning
product development plans, the use of bacteriophages to kill bacterial pathogens, having resources sufficient to fund our operations
into the third quarter of 2016, future revenue sources, selling and marketing expenses, general and administrative expenses, clinical
trial and other research and development expenses, capital resources, capital expenditures, tax credits and carry-forwards, and
additional financings and litigation-related matters. <FONT STYLE="background-color: white">Words such as &ldquo;believe,&rdquo;
&ldquo;anticipate,&rdquo; &ldquo;plan,&rdquo; &ldquo;expect,&rdquo; &ldquo;intend,&rdquo; &ldquo;will,&rdquo; &ldquo;goal,&rdquo;
&ldquo;potential&rdquo; and similar expressions are intended to identify forward-looking statements, though not all forward-looking
statements necessarily contain these identifying words.&nbsp;</FONT> These statements are subject to risks and uncertainties. Our
actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors,
including those set forth below under Part&nbsp;II, Item&nbsp;1A, &ldquo;Risk Factors&rdquo; and elsewhere in this Quarterly Report
on Form 10-Q.</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif">These forward-looking statements speak only as of
the date on which they were made, and we undertake no obligation to update any forward-looking statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Overview</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We are a biotechnology company focused
on the discovery, development and commercialization of novel phage therapeutics. Phage therapeutics use bacteriophages, a family
of viruses, to kill pathogenic bacteria. Phages have powerful and highly selective mechanisms of action that permit them to target
and kill specific bacteria. We believe that phages represent a promising means to treat bacterial infections, especially those
that have developed resistance to current therapies including the so-called multi-drug-resistant or &ldquo;superbug&rdquo; strains
of bacteria.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Our goal is to be the leading developer
of phage therapeutics. We are combining our expertise in the manufacture of drug-quality bacteriophages and our proprietary approach
and expertise in identifying, characterizing and developing naturally occurring bacteriophages with that of our collaboration partners
in bacteriophage biology, synthetic biology and manufacturing, to develop second-generation bacteriophage products.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Our lead product candidate is AB-SA01 for
the treatment of <I>S. aureus</I> infections, including methicillin-resistant <I>S. aureus</I>, or MRSA. We also have AB-PA01 for
the treatment of <I>P. aeruginosa</I> infections in development, and AB-CD01 for the treatment of <I>C. difficile</I> infections
in preclinical development.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We have generally incurred net losses since
our inception and our operations to date have been primarily limited to research and development and raising capital. We have raised
approximately $43.6 million in capital to support our operations since the shift in our focus to novel phage therapeutics in February
2011.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">To date, we have not generated any product
revenue and have primarily financed our operations through the sale and issuance of our equity securities and convertible notes.
As of March 31, 2016, we had a cumulative deficit of $365.6 million. We anticipate that a substantial portion of our capital resources
and efforts in the foreseeable future will be focused on completing the development and obtaining regulatory approval of our product
candidates.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We currently expect to use our existing
cash and cash equivalents for the continued research and development of our product candidates and for working capital and other
general corporate purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We expect our research and development
expenses to increase for the foreseeable future as we continue development of our product candidates. We also expect to incur additional
expenses associated with operating as a public company. As a result, we expect to continue to incur significant and increasing
operating losses at least for the next several years. We do not expect to generate product revenue unless and until we successfully
complete development and obtain marketing approval for at least one of our product candidates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We may also use a portion of our existing
cash and cash equivalents for the potential acquisition of, or investment in, product candidates, technologies, formulations or
companies that complement our business, although we have no current understandings, commitments or agreements to do so. Our existing
cash and cash equivalents will not be sufficient to enable us to complete all necessary development of any potential product candidates.
Accordingly, we will be required to obtain further funding through one or more other public or private equity offerings, debt financings,
collaboration or licensing arrangements or other sources. Adequate additional funding may not be available to us on acceptable
terms, or at all. If we are unable to raise capital when needed or on attractive terms, we would be forced to delay, reduce or
eliminate our research and development programs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">&nbsp;</TD><TD STYLE="width: 50%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Recent Events </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Series B Redeemable Convertible Preferred Stock Conversion</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">On April 8, 2016, certain holders (the
&ldquo;Holders&rdquo;) of over two-thirds of our then-outstanding shares of Series B redeemable convertible preferred stock (&ldquo;Series
B Preferred&rdquo;) elected to automatically convert all outstanding shares of Series B Preferred into shares of Common Stock in
accordance with Section 4.4.4(b)(ii) of our Amended and Restated Articles of Incorporation (the &ldquo;Conversion&rdquo;). As a
result of the Conversion, the 7,527,853 shares of Series B Preferred outstanding as of immediately prior to the Conversion have
been converted into an aggregate of 1,505,560 shares of Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">On April 8, 2016, we entered into a Common
Stock Issuance Agreement (the &ldquo;Agreement&rdquo;) with the Holders pursuant to which we agreed to issue the Holders an aggregate
of 853,465 shares of our Common Stock (the &ldquo;Shares&rdquo;). Pursuant to the Agreement, the Company and the Holders also agreed
to amend the Common Stock warrants issued to the Holders pursuant to that certain Subscription Agreement, dated June 25, 2013,
in order to reduce the exercise price of such warrants from $7.00 per share to $4.05 per share and extend the expiration date thereof
from June 26, 2018 to March 31, 2021 (the &ldquo;Warrant Amendments&rdquo;). As consideration for the Shares and the Warrant Amendments,
the Holders waived their right to receive approximately $2.2 million in aggregate cash payments to which they were entitled upon
the Conversion in respect of accrued dividends on their former shares of Series B Preferred. The Holders also waived their registration
rights with respect to certain future registration statements that may be filed, and certain future public offerings that may be
conducted, by us.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Pursuant to the Agreement, if in the future
we conduct one or more bona fide equity financings in which it sell shares of Common Stock or Preferred Stock at a price less than
$4.05 per share (each, a &ldquo;dilutive financing&rdquo;), we will be required to issue to the Holders additional shares of Common
Stock based on a specified formula. The obligation to issue additional shares in the event of any such dilutive financing (i) only
applies to the lowest priced financing conducted after the date of the Agreement, (ii) is subject to limitations under applicable
NYSE MKT rules relating to the issuance of additional shares in a private placement at a price less than the greater of book or
market value and (iii) will expire at such time we have raised $10.0 million in gross proceeds from the sale of Common Stock and/or
Preferred stock in a bona fide financing or financings or June&nbsp;30, 2018, whichever occurs first. We have agreed to seek shareholder
approval of the issuance of up to 1,037,053 shares of Common Stock to the Holders in the future as required by the Agreement in
connection with one or more dilutive financings. To the extent we are not permitted by applicable NYSE MKT rules to issue any additional
shares of Common Stock that would otherwise be required to be issued pursuant to the terms of the Agreement as a result of a dilutive
financing, we have agreed to pay the Holders a cash payment equal to the difference between the price per share in such dilutive
financing and $4.05 for each share issued to the Holders pursuant to the Conversion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Collaboration Agreement</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">On April 13, 2016, we provided written
notice to Intrexon Corporation (&ldquo;Intrexon&rdquo;) of our election to voluntarily terminate that certain Exclusive Channel
Collaboration Agreement, dated as of March 29, 2013, by and between us and Intrexon (the &ldquo;ECC Agreement&rdquo;). The effective
date of termination (the &ldquo;Termination Date&rdquo;) will be 90 days following delivery of the termination notice. We will
not incur any early termination penalties as a result of the termination of the ECC Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The ECC Agreement is directed towards the
research, development and commercialization of new bacteriophage-based therapies for the treatment of bacterial infections caused
by <I>P. aeruginosa</I> and <I>C. difficile</I>. A summary of the material terms of the ECC Agreement is contained in our Annual
Report on Form 10-K, filed with the Securities and Exchange Commission (&ldquo;SEC&rdquo;) on March 30, 2016, under Item 1. Business&mdash;<I>Exclusive
Channel Collaboration with Intrexon</I>, and is incorporated herein by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Results of Operations</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Comparison of three months ended March 31, 2016 and 2015</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Revenue</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">For each of the quarters ended March 31,
2016 and 2015, we recognized $0.1 million in revenue primarily related to sublicensing agreements from our former gene therapy
program.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Research and Development Expenses</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Research and development expenses for
the quarter ended March 31, 2016 totaled $2.0 million compared to $1.0 million incurred in the same period of 2015. This increase
of $1.0 million was primarily related to higher compensation costs of $0.2 million, $0.1 million of professional recruiting fees,
and $0.4 million for the expense recorded related to the assets acquired from Novolytics.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We anticipate that research and development
spending in future periods will continue to increase as we initiate non-clinical research studies, hire additional research and
development staff, advance our clinical trials, and continue our discovery efforts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">&nbsp;</TD><TD STYLE="width: 50%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>General and Administrative Expenses</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">General and administrative expenses for
the quarter ended March 31, 2016 were $2.6 million compared to $1.4 million for the same period of 2015. The $1.2 million increase
was primarily attributable to $0.9 million of compensation, including $0.8 million of non-cash stock-based compensation, related
to two new executives, and $0.3 million for professional fees for legal, accounting and recruitment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Other Income (Expense)</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We recorded a gain of $4,000 for the quarter
ended March 31, 2016 related to the change in fair value of our warrant liability, which was primarily attributable to a decrease
in the value of our common stock price during the period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We recorded a gain of $1.4 million for
the quarter ended March 31, 2016 related to the change in fair value of our Series B preferred stock derivative liability. This
gain was primarily attributable to a decrease in the estimated term of the derivative liability associated with the Series B preferred
stock at March 31, 2016.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We will continue to adjust the liability
related to our outstanding Series 2011 warrants to fair value until the earlier of exercise or expiration of the warrants or until
terms of the warrants no longer require them to be accounted for as liability instruments. We continued to adjust the liability
related to our Series B preferred stock derivative feature until the conversion of our Series B preferred stock into common stock
in April 2016.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We also recorded expenses of $0.4 million
for the three months ended March 31, 2015 consisting of placement agent costs from our March 2015 private placement of common stock,
which related to placement agent fees and the initial fair value of warrants issued to the placement agents. We had no comparable
costs during the three months ended March 31, 2016.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Liquidity and Capital Resources</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We have incurred net losses since inception
through March 31, 2016 of $365.6 million, of which $315.5 million was incurred as a result of our prior focus on gene therapy in
fiscal years 2010 and earlier. We have not generated any product revenues and do not expect to generate revenue from product candidates
in the near term.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We had cash and cash equivalents of $6.2
million and $9.4 million at March 31, 2016 and December 31, 2015, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Net cash used in operating activities for
the three months ended March 31, 2016 was $3.1 million, as compared to $2.3 million for the three months ended March 31, 2015.
Net loss recorded during the three months ended March 31, 2016 was $3.1 million, inclusive of a $1.4 million non-cash gain on derivative
liability. Net loss recorded during the three months ended March 31, 2015 was $14.5 million, inclusive of a $11.8 million non-cash
loss on derivative liability. The net increase in cash used in operating activities of $0.8 million, in addition to the effect
of the non-cash derivative liability effects noted above, are primarily related to an increase in research and development efforts,
payroll and non-cash stock based compensation, as well as an increase in professional services.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Net cash used in investing activities was
$0.1 million and $0.0 million for three months ended March 31, 2016 and March 31, 2015, respectively. Net cash used in investing
activities for the three months ended March 31, 2016 was primarily attributable to purchases of property and equipment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Cash provided by financing activities
for the three months ended March 31, 2015 was comprised of the gross proceeds of $13.0 million from the March 2015 private placement
of common stock and warrants to purchase common stock, less commissions and other cash expenses related to the issuance of approximately
$0.6 million. There were no financing activities for the three months ended March 31, 2016.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We will need to raise additional capital
or incur indebtedness to continue to fund our future operations. Our future funding requirements will depend on many factors,
including:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">the costs and timing of our research and development activities;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">the progress and cost of our clinical trials and other research and development activities;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">the cost and timing of securing manufacturing capabilities for our clinical product candidates and commercial products, if any;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">the terms and timing of any collaborative, licensing, acquisition or other arrangements that we may establish;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">the costs and timing of seeking regulatory approvals;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">the costs of filing, prosecuting and enforcing any patent applications, claims, patents and other intellectual property rights; and</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">the costs of lawsuits involving us or our product candidates.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We may seek to raise capital through a
variety of sources, including:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">the public equity market;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">private equity financings;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">collaborative arrangements;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">&nbsp;</TD><TD STYLE="width: 50%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">licensing arrangements; and/or</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">public or private debt.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We believe our existing resources are sufficient
to fund our planned operations into the third quarter of 2016. This estimate is based on our current product development calendar,
projected staffing expenses, working capital requirements, and capital expenditure plans.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Our ability to raise additional funds will
depend on our clinical and regulatory events, our ability to identify promising in-licensing opportunities and factors related
to financial, economic and market conditions, many of which are beyond our control. We cannot be certain that sufficient funds
will be available to us when required or on satisfactory terms. If adequate funds are not available, we may be required to significantly
reduce or refocus our operations or to obtain funds through arrangements that may require us to relinquish rights to certain of
our products, technologies or potential markets, any of which could delay or require that we curtail our development programs or
otherwise have a material adverse effect on our business, financial condition and results of operations. To the extent that additional
capital is raised through the sale of equity or convertible debt securities, the issuance of such securities would result in ownership
dilution to our existing stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">If we are unable to secure additional financing
on a timely basis or on terms favorable to us, we may be required to significantly reduce or refocus our operations or to obtain
funds through additional arrangements that may require us to relinquish rights to certain of our products, technologies or potential
markets, any of which could delay or require that we curtail or eliminate some or all of our development programs or otherwise
have a material adverse effect on our business, financial condition and results of operations. This uncertainty around our ability
to secure additional financing creates substantial doubt about our ability to continue as a going concern.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Contractual Obligations and Commitments</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">As of March 31, 2016, there have been no
material changes, outside of the ordinary course of business, in our outstanding contractual obligations from those disclosed within
&ldquo;Management&rsquo;s Discussion and Analysis of Financial Condition and Results of Operations&rdquo;, as contained in our
Annual Report on Form 10-K for the year ended December 31, 2015.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Off-Balance Sheet Arrangements</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">As of March 31, 2016, we did not have off-balance
sheet arrangements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Recent Accounting Pronouncements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Refer to Note 3 of the Condensed Consolidated
Notes to the Consolidated Financial Statements contained elsewhere in this report.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><A NAME="b_001"></A><B>Item 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET
RISK</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We are a smaller reporting company as defined
by Rule 12b-2 of the Exchange Act and are not required to provide the information required under this item.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><A NAME="b_002"></A>Item 4. CONTROLS AND PROCEDURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Disclosure Controls and Procedures</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Our management, with the participation
of our Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures
(as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act), as of the end of the period covered by this
report. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information
required to be disclosed in the reports we file or submit under the Exchange Act is accumulated and communicated to management,
including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required
disclosure. In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures,
no matter how well designed and operated, can provide only reasonable and not absolute assurance of achieving the desired control
objectives. In reaching a reasonable level of assurance, management is required to apply its judgment in evaluating the cost-benefit
relationship of possible controls and procedures. In addition, the design of any system of controls also is based in part upon
certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving
its stated goals under all potential future conditions; over time, controls may become inadequate because of changes in conditions,
or the degree of compliance with policies or procedures may deteriorate. Because of the inherent limitations in a cost-effective
disclosure controls system, misstatements due to error or fraud may occur and not be detected.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Based on this evaluation, our Chief Executive
Officer and Chief Financial Officer, have concluded that our disclosure controls and procedures were not effective at the reasonable
assurance level during the period covered by this report.&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">&nbsp;</TD><TD STYLE="width: 50%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Changes in Internal Control Over Financial Reporting</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">An evaluation was also performed under
the supervision and with the participation of our management, including our Chief Executive Officer and our Chief Financial Officer,
of any change in our internal control over financial reporting that occurred during our last fiscal quarter and that has materially
affected, or is reasonably likely to materially affect, our internal control over financial reporting. That evaluation did not
identify any change in our internal control over financial reporting that occurred during our latest fiscal quarter that has materially
affected, or is reasonably likely to materially affect, our internal control over financial reporting, other than the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in; text-indent: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">the appointment of an experienced Chief Financial Officer in January 2016 with significant experience in public company reporting and complex transactions; and</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0.25in">&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD>the engagement of consultants with experience in the review of unique and complex accounting topics, who consulted with management on complex transactions and reporting.</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Remediation of Material Weakness</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We continue to review, document and test
our internal control over financial reporting.&nbsp;We also continue to take steps to remediate certain identified deficiencies
in our internal control over financial reporting as of December 31, 2015 in the area of complex and non-routine transactions. Although
efforts remain in process, steps taken during the last fiscal quarter that resulted in improvements to our internal control over
financial reporting included the following:&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in; text-indent: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">commenced designing additional training programs for relevant personnel and development of specific review procedures regarding the review of complex and non-routine transactions; and</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0.25in">&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">implemented standardized financial control and reporting processes.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The remediation actions will be monitored
by the Audit Committee of our Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><A NAME="a_007"></A>PART II. OTHER INFORMATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><A NAME="a_008"></A>Item 1. Legal Proceedings</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">On April 14, 2016, NRM VII Holdings I,
LLC (&ldquo;NRM&rdquo;), an affiliate of Third Security, LLC (&ldquo;Third Security&rdquo;), filed a complaint against us and certain
members of our Board in the Superior Court of California, County of San Diego. Third Security is one of our principal shareholders.
The complaint alleges that we breached the implied covenant of good faith by entering into a scheme to force NRM to convert its
shares of Series B redeemable convertible preferred stock into shares of our common stock. The complaint further alleges that the
members of the Board who were named as defendants breached their fiduciary duty of good faith owed to NRM, as one of our shareholders,
by participating in this transaction. The complaint seeks unspecified monetary damages and other relief. We plan to vigorously
defend against the claims advanced.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Claim estimates that are probable and
can be reasonably estimated are reflected as liabilities. Because of the uncertainties related to our pending litigation,
investigations, inquiries or claims, management is currently unable to predict the ultimate outcome of any litigation,
investigation, inquiry or claim, determine whether a liability has been incurred, or make an estimate regarding the possible
loss or range of loss that could result from an unfavorable outcome. It is reasonably possible that some of the matters,
which are pending or may be asserted, could be decided unfavorably to us. Although we maintain liability insurance coverage
to protect our assets from losses arising out of or involving activities associated with ongoing and normal business
operations, our insurance may not cover, or may not adequately cover, any liabilities that we incur. An adverse ruling
or outcome in any lawsuit involving us could materially affect our business, liquidity, consolidated financial position
or results of operations. In view of the unpredictable nature of such matters, we cannot provide any assurances regarding
the outcome of any litigation, investigation, inquiry or claim to which we are a party or the impact on us of an adverse
ruling of such matters.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.65in; text-indent: -0.65in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><A NAME="a_009"></A>Item 1A. Risk Factors</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><I>You should consider carefully the following
information about the risks described below, together with the other information contained in this Quarterly Report and in our
other public filings in evaluating our business. The risk factors set forth below that are marked with an asterisk (*) did not
appear as separate risk factors in, or contain changes to the similarly titled risk factors included in, Item 1A of our Annual
Report on Form 10-K for the year ended December 31, 2015. If any of the following risks actually occur, our business, financial
condition, results of operations, and future growth prospects would likely be materially and adversely affected. In these circumstances,
the market price of our common stock would likely decline. </I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Risks Related to Our Financial Condition and Need for Additional
Capital</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>We have incurred losses since our inception and anticipate
that we will continue to incur significant losses for the foreseeable future, and our future profitability is uncertain.*</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We have incurred losses in each year since
our inception in 1992. Prior to our merger with Biocontrol in January 2011, our accumulated deficit was $315.5 million. Since January
2011 through March 31, 2016, we have incurred a cumulative deficit of $50.1 million, and we expect to incur losses for the foreseeable
future. We have devoted, and will continue to devote for the foreseeable future, substantially all of our resources to research
and development of our product candidates. For the three months ended March 31, 2016 we had an operating loss of $3.1 million.
Additional information regarding our results of operations may be found in our consolidated financial statements and in &ldquo;Management&rsquo;s
Discussion and Analysis of Financial Condition and Results of Operations&rdquo; included elsewhere in this report.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">&nbsp;</TD><TD STYLE="width: 50%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Clinical trials and activities associated
with discovery research are costly. We do not expect to generate any revenue from the commercial sales of our product candidates
in the near term, and we expect to continue to have significant losses for the foreseeable future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">To attain ongoing profitability, we will
need to develop products successfully and market and sell them effectively, or rely on other parties to do so. We cannot predict
when we will achieve ongoing profitability, if at all. We have never generated revenue from the commercial sales of our product
candidates, and there is no guarantee that we will be able to do so in the future. If we fail to become profitable, or if we are
unable to fund our continuing losses, we would be unable to continue our research and development programs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>We have never generated any revenue from product sales
and may never be profitable. </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Our ability to generate meaningful revenue
and achieve profitability depends on our ability, and the ability of any third party with which we may partner, to successfully
complete the development of, and obtain the regulatory approvals necessary to, commercialize our product candidates. We do not
anticipate generating revenues from product sales for the foreseeable future, if ever. If any of our product candidates fail in
clinical trials or if any of our product candidates do not gain regulatory approval, or if any of our product candidates, if approved,
fail to achieve market acceptance, we may never become profitable. Even if we achieve profitability in the future, we may not be
able to sustain profitability in subsequent periods. Our ability to generate future revenues from product sales depends heavily
on our success in:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">completing research and preclinical and clinical development of our product candidates;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">seeking and obtaining regulatory and marketing approvals for product candidates for which we complete clinical trials;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">developing a sustainable, scalable, reproducible, and transferable manufacturing process for our product candidates;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">launching and commercializing product candidates for which we obtain regulatory and marketing approval, either by establishing a sales force, marketing and distribution infrastructure, or by collaborating with a partner;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">obtaining market acceptance of any approved products;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">addressing any competing technological and market developments;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">implementing additional internal systems and infrastructure, as needed;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">identifying and validating new product candidates;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">negotiating favorable terms in any collaboration, licensing or other arrangements into which we may enter;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">maintaining, protecting and expanding our portfolio of intellectual property rights, including patents, trade secrets and know-how; and</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">attracting, hiring and retaining qualified personnel.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Even if one or more of the product candidates
that we develop is approved for commercial sale, we anticipate incurring significant costs associated with commercializing any
approved product. Our expenses could increase beyond expectations if we are required by the FDA, the EMA, or other foreign regulatory
authorities to perform clinical trials and other studies in addition to those that we currently anticipate. Even if we are able
to generate revenues from the sale of any approved products, we may not become profitable and may need to obtain additional funding
to continue operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>We will need to raise additional capital to continue operations.*</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Our consolidated financial statements for
the quarter ended March 31, 2016 were prepared under the assumption that we would continue our operations as a going concern. However,
we have had recurring losses from operations, negative operating cash flow and an accumulated deficit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We do not generate any cash from operations
and must raise additional funds in order to continue operating our business. We expect to continue to fund our operations primarily
through equity and debt financings in the future. If additional capital is not available to us when needed or on acceptable terms,
we may not be able to continue to operate our business pursuant to our business plan or we may have to discontinue our operations
entirely. As of March 31, 2016, we had cash and cash equivalents of $6.2 million. We believe that our existing resources will be
sufficient to fund our planned operations into the third quarter of 2016.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Developing drugs and conducting clinical
trials is expensive. Our future funding requirements will depend on many factors, including:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">the costs and timing of our research and development activities;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">the progress and cost of our clinical trials and other research and development activities;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">the cost and timing of securing manufacturing capabilities for our clinical product candidates and commercial products, if any;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">the terms and timing of any collaborative, licensing, acquisition or other arrangements that we may establish;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">the costs and timing of seeking regulatory approvals;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">the costs of filing, prosecuting, defending and enforcing any patent applications, claims, patents and other intellectual property rights; and</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">the costs of lawsuits involving us or our product candidates.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">&nbsp;</TD><TD STYLE="width: 50%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We will need to raise additional capital
to support our product development activities in 2016 and beyond. We may seek funds through arrangements with collaborators or
others that may require us to relinquish rights to the products candidates that we might otherwise seek to develop or commercialize
independently. We cannot be certain that we will be able to enter into any such arrangements on reasonable terms, if at all.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We may seek to raise capital through a
variety of sources, including:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">the public equity market;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">private equity financings;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">collaborative arrangements;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">licensing arrangements; and/or</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">public or private debt.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Any additional fundraising efforts may
divert our management from their day-to-day activities, which may adversely affect our ability to develop and commercialize our
product candidates. Our ability to raise additional funds will depend, in part, on the status of our product development activities
and other business operations, as well as factors related to financial, economic, and market conditions, many of which are beyond
our control. We cannot be certain that sufficient funds will be available to us when required or on acceptable terms, if at all.
Raising additional capital through the sale of securities could cause significant dilution to our stockholders. If adequate funds
are not available, we may be required to significantly reduce or refocus our operations or to obtain funds through additional arrangements
that may require us to relinquish rights to certain of our products, technologies or potential markets, any of which could delay
or require that we curtail or eliminate some or all of our development programs or otherwise have a material adverse effect on
our business, financial condition and results of operations. In addition, we may have to delay, reduce the scope of or eliminate
some of our research and development, which could delay the time to market for any of our product candidates, if adequate funds
are not available.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">If we are unable to secure additional financing
on a timely basis or on terms acceptable to us, we may be required to cease or reduce certain research and development projects,
to sell some or all of our technology or assets or to merge all or a portion of our business with another entity. Insufficient
funds may require us to delay, scale back, or eliminate some or all of our activities, and if we are unable to obtain additional
funding, there is uncertainty regarding our continued existence.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>A complaint has been filed against us and the members
of our Board of Directors by one of our principal shareholders.* </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On April 8, 2016,
certain holders (the &ldquo;Holders&rdquo;) of over two-thirds of our then-outstanding shares of Series B redeemable convertible
preferred stock (&ldquo;Series B Preferred&rdquo;) elected to automatically convert all outstanding shares of Series B Preferred
into shares of Common Stock in accordance with Section 4.4.4(b)(ii) of our Amended and Restated Articles of Incorporation, as amended
(the &ldquo;Conversion&rdquo;). As a result of the Conversion, the 7,527,853 shares of Series B Preferred outstanding as of immediately
prior to the Conversion were automatically converted into an aggregate of 1,505,560 shares of our common stock. On April 8, 2016,
we entered into a Common Stock Issuance Agreement (the &ldquo;CSIA&rdquo;) with the Holders pursuant to which we issued to the
Holders an aggregate of 853,465 shares of our Common Stock (the &ldquo;Shares&rdquo;) and amended the common stock warrants issued
to the Holders pursuant to that certain Subscription Agreement, dated June 25, 2013, in order to reduce the exercise price of such
warrants from $7.00 per share to $4.05 per share and extend the expiration date thereof from June 26, 2018 to March 31, 2021 (the
&ldquo;Warrant Amendments&rdquo;). As consideration for the Shares and the Warrant Amendments, the Holders waived their right to
receive approximately $2.2 million in aggregate cash payments to which they were entitled upon the Conversion in respect of accrued
dividends on their former shares of Series B Preferred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">On April 14, 2016, NRM VII Holdings I,
LLC (&ldquo;NRM&rdquo;), who was not a party to the CSIA, filed a complaint against us and each of the current members of our board
of directors in the Superior Court of California, County of San Diego. Prior to the Conversion, NRM held approximately 28.5% of
our outstanding shares of Series B Preferred. The complaint alleges that we breached the implied covenant of good faith by entering
into a scheme to force NRM to convert its Series B Preferred into common stock. The complaint further alleges that the current
members of our board of directors breached their fiduciary duty of good faith owed to NRM, as one of our shareholders, by participating
in this transaction. The complaint seeks unspecified monetary damages and other relief. We plan to vigorously defend against the
claims advanced.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Litigation is subject to inherent uncertainties,
and an adverse result in the matter described above or other matters that may arise from time to time could have a material adverse
effect on our business, results of operations and financial condition. Any litigation to which we are subject may be costly and,
further, could require significant involvement of our senior management and may divert management&rsquo;s attention from our business
and operations. In addition, our share price may be negatively impacted due to the negative publicity, expenses incurred in connection
with our defense, management distraction, and/or other factors related to this litigation. In addition, litigation of this nature
may negatively impact our ability to attract and retain strategic partners, as well as qualified board members and management personnel.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">&nbsp;</TD><TD STYLE="width: 50%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>There is substantial doubt about our ability to continue
as a going concern, which may affect our ability to obtain future financing and may require us to curtail our operations.*</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Our financial statements as of March 31,
2016 were prepared under the assumption that we will continue as a going concern. Our financial statements do not include any adjustments
that might result from the outcome of this uncertainty. At March 31, 2016, we had cash and cash equivalents of $6.2 million. Our
ability to continue as a going concern depends on our ability to raise substantial additional funds through public or private equity
offerings, collaborative or licensing arrangements and/or debt financing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Taxing authorities could reallocate our taxable income
among our subsidiaries, which could increase our overall tax liability.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We are organized in the United States,
and we currently have subsidiaries in the United Kingdom, Australia and Slovenia. If we succeed in growing our business, we expect
to conduct increased operations through our subsidiaries in various tax jurisdictions pursuant to transfer pricing arrangements
between us and our subsidiaries. If two or more affiliated companies are located in different countries, the tax laws or regulations
of each country generally will require that transfer prices be the same as those between unrelated companies dealing at arms&rsquo;
length and that appropriate documentation is maintained to support the transfer prices. While we believe that we operate in compliance
with applicable transfer pricing laws and intend to continue to do so, our transfer pricing procedures are not binding on applicable
tax authorities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">If tax authorities in any of these countries
were to successfully challenge our transfer prices as not reflecting arms&rsquo; length transactions, they could require us to
adjust our transfer prices and thereby reallocate our income to reflect these revised transfer prices, which could result in a
higher tax liability to us. In addition, if the country from which the income is reallocated does not agree with the reallocation,
both countries could tax the same income, resulting in double taxation. If tax authorities were to allocate income to a higher
tax jurisdiction, subject our income to double taxation or assess interest and penalties, it would increase our consolidated tax
liability, which could adversely affect our financial condition, results of operations and cash flows.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Our ability to use our net operating tax loss carryforwards
and certain other tax attributes may be limited.*</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Our ability to utilize our net operating
loss carryforwards and certain other tax attributes may be limited under Sections 382 and 383 of the Internal Revenue Code of 1986,
as amended (the &ldquo;Code&rdquo;). These limitations apply if an &ldquo;ownership change,&rdquo; as defined by Section 382 of
the Code, occurs. If we have experienced an &ldquo;ownership change&rdquo; at any time since our formation, we may already be subject
to limitations on our ability to utilize our existing net operating losses and other tax attributes to offset taxable income. In
addition, future changes in our stock ownership (including in connection with future private or public offerings, as well as changes
that may be outside of our control), may trigger an &ldquo;ownership change&rdquo; and, consequently, limitations under Sections
382 and 383 of the Code. As a result, if we earn net taxable income, our ability to use our pre-change net operating loss carryforwards
and other pre-change tax attributes to offset U.S. federal taxable income may be subject to limitations, which could potentially
result in increased future tax liability to us. In addition, at the state level, there may be periods during which the use of NOLs
is suspended or otherwise limited, which could accelerate or permanently increase state taxes owed. We have not completed a study
to assess whether an &ldquo;ownership change&rdquo; has occurred or whether there have been multiple &ldquo;ownership changes&rdquo;
since our formation, due to the complexity and cost associated with such a study, and the fact that there may be additional ownership
changes in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>If we fail to maintain proper and effective internal control
over financial reporting, our ability to produce accurate financial statements on a timely basis could be impaired and our public
reporting may be unreliable.*</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We are required to maintain internal control
over financial reporting adequate to provide reasonable assurance regarding the reliability of financial reporting and the preparation
of our consolidated financial statements in accordance with generally accepted accounting principles. In connection with the restatement
of our consolidated financial statements for the second quarter of 2015 and for the quarterly and annual periods of 2014, we determined
that we had a material weakness as of December 31, 2014 and December 31, 2015, namely that our internal control over financial
reporting, including control over the evaluation and review of complex and non-routine transactions, were not effective. A material
weakness means a deficiency, or combination of deficiencies, in internal control over financial reporting such that there is a
reasonable possibility that a material misstatement of the registrant&rsquo;s annual or interim financial statements will not be
prevented or detected on a timely basis.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We do not expect that our internal control
over financial reporting will prevent all errors and all fraud. A control system, no matter how well designed and operated, can
provide only reasonable, not absolute, assurance that the control system&rsquo;s objectives will be met. Further, the design of
a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative
to their costs. Controls can be circumvented by the individual acts of some persons, by collusion of two or more people, or by
management override of the controls. Over time, controls may become inadequate because changes in conditions or deterioration in
the degree of compliance with policies or procedures may occur. Because of the inherent limitations in a cost-effective control
system, misstatements due to error or fraud may occur and not be detected. As a result, we cannot assure you that significant deficiencies
or material weaknesses in our internal control over financial reporting will not be identified in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We are taking steps to remediate the material
weakness in our internal control over financial reporting, including designing additional training programs for relevant personnel
and developing specific review procedures regarding the review of complex and non-routine transactions. However, we cannot assure
you that these efforts will remediate our material weakness in a timely manner, or at all. If we are unable to successfully remediate
our material weakness, or identify any future material weaknesses, the accuracy and timing of our financial reporting may be adversely
affected, we may be unable to maintain compliance with securities law requirements regarding timely filing of periodic reports
and we may experience a loss of public confidence, which could have an adverse effect on our business, financial condition and
the market price of our common stock and other securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">&nbsp;</TD><TD STYLE="width: 50%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>We incur significant costs as a result of operating as
a public company, and our management is required to devote substantial time to compliance initiatives.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">As a public company, we incur significant
legal, accounting and other expenses. We are subject to the reporting requirements of the Exchange Act, which require, among other
things, that we file with the SEC annual, quarterly and current reports with respect to our business and financial condition. In
addition, the Sarbanes-Oxley Act, as well as rules subsequently adopted by the SEC and the NYSE MKT to implement provisions of
the Sarbanes-Oxley Act, imposes significant requirements on public companies, including requiring establishment and maintenance
of effective disclosure and financial controls and changes in corporate governance practices. Further, in July 2010, the Dodd-Frank
Wall Street Reform and Consumer Protection Act, or the Dodd-Frank Act, was enacted. There are significant corporate governance
and executive compensation related provisions in the Dodd-Frank Act that require the SEC to adopt additional rules and regulations
in these areas such as &ldquo;say on pay&rdquo; and proxy access. Recent legislation permits emerging growth companies to implement
many of these requirements over a longer period and up to five years following their initial public offering. We intend to take
advantage of this new legislation but cannot guarantee that we will not be required to implement these requirements sooner than
expected and thereby incur unexpected expenses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We expect the rules and regulations applicable
to public companies to result in us continuing to incur substantial legal and financial compliance costs. These costs will decrease
our net income or increase our net loss, and may require us to reduce costs in other areas of our business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Risks Related to Our Business</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>We are seeking to develop antibacterial agents using bacteriophage
technology, a novel approach, which makes it difficult to predict the time and cost of development. No bacteriophage products have
been approved in the United States or elsewhere.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We are developing our product candidates
with bacteriophage technology. We have not, nor to our knowledge has any other company, received regulatory approval from the FDA
or equivalent foreign agencies for a pharmaceutical drug based on this approach. While <I>in vitro</I> studies have characterized
the behavior of bacteriophages in cell cultures and there exists a body of literature regarding the use of phage therapy in humans,
the safety and efficacy of phage therapy in humans has not been extensively studied in well-controlled modern clinical trials.
Most of the prior research on phage-based therapy was conducted in the former Soviet Union prior to and immediately after World
War II and lacked appropriate control group design or lacked control groups at all. Furthermore, the standard of care has changed
substantially during the ensuing decades since those studies were performed, diminishing the relevance of prior claims of improved
cure rates. We cannot be certain that our approach will lead to the development of approvable or marketable drugs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Developing phage-based therapies on a commercial
scale will also require developing new manufacturing processes and techniques. We and our third-party collaborators may experience
delays in developing manufacturing capabilities for our product candidates, and may not be able to do so at the scale required
to efficiently conduct the clinical trials required to obtain regulatory approval of our product candidates, or to manufacture
commercial quantities of our products, if approved.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In addition, the FDA or other regulatory
agencies may lack experience in evaluating the safety and efficacy of drugs based on these approaches, which could lengthen the
regulatory review process, increase our development costs and delay or prevent commercialization of our product candidates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Delays in our clinical trials could result in us not achieving
anticipated developmental milestones when expected, increased costs and delay our ability to obtain regulatory approval for and
commercialize our product candidates.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Delays in our ability to commence or enroll
patients for our clinical trials could result in us not meeting anticipated clinical milestones and could materially impact our
product development costs and delay regulatory approval of our product candidates. Planned clinical trials may not be commenced
or completed on schedule, or at all. Clinical trials can be delayed for a variety of reasons, including:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">delays in the development of manufacturing capabilities for our product candidates to enable their consistent production at clinical trial scale;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">failures in our internal manufacturing operations that result in our inability to consistently and timely produce bacteriophages in sufficient quantities to support our clinical trials;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">the availability of financial resources to commence and complete our planned clinical trials;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">delays in reaching a consensus with clinical investigators on study design;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">delays in reaching a consensus with regulatory agencies on trial design or in obtaining regulatory approval to commence a trial;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">delays in obtaining clinical materials;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">slower than expected patient recruitment for participation in clinical trials;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">&nbsp;</TD><TD STYLE="width: 50%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">failure by clinical trial sites, other third parties, or us to adhere to clinical trial agreements;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">delays in reaching agreement on acceptable clinical trial agreement terms with prospective sites or obtaining institutional review board approval; and</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">adverse safety events experienced during our clinical trials.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">If we do not successfully commence or complete
our clinical trials on schedule, the price of our common stock may decline.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Completion of clinical trials depends,
among other things, on our ability to enroll a sufficient number of patients, which is a function of many factors, including:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">the therapeutic endpoints chosen for evaluation;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">the eligibility criteria defined in the protocol;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">the perceived benefit of the product candidate under study;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">the size of the patient population required for analysis of the clinical trial&rsquo;s therapeutic endpoints;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">our ability to recruit clinical trial investigators and sites with the appropriate competencies and experience;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">our ability to obtain and maintain patient consents; and</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">competition for patients from clinical trials for other treatments.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We may experience difficulties in enrolling
patients in our clinical trials, which could increase the costs or affect the timing or outcome of these clinical trials. This
is particularly true with respect to diseases with relatively small patient populations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>We have not completed formulation development of any of
our product candidates</I></B><I>.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The development of our bacteriophage product
candidates requires that we isolate, select and combine a number of bacteriophages that target the desired bacteria for that product
candidate. The selection of bacteriophages for any of our product candidates is based on a variety of factors, including without
limitation the ability of the selected phages, in combination, to successfully kill the targeted bacteria, the degree of cross-reactivity
of the individual phages with the same part of the bacterial targets, the ability of the combined phages to satisfy regulatory
requirements, our ability to manufacture sufficient quantities of the phages, intellectual property rights of third parties, and
other factors. While we have selected an initial formulation of AB-SA01 for the treatment of <I>S. aureus</I> infections, there
can be no assurance that this will be the final formulation of AB-SA01 for commercialization. In addition, we have initiated final
phage selection for AB-PA01, our <I>P. aeruginosa </I>product. AB-CD01, which is our <I>C. difficile </I>product,<I> </I>is at
an earlier stage. If we are unable to complete formulation development of our product candidates in the time frame that we have
anticipated, then our product development timelines, and the regulatory approval of our product candidates, could be delayed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Our product candidates must undergo rigorous clinical
testing, such clinical testing may fail to demonstrate safety and efficacy and any of our product candidates could cause undesirable
side effects, which would substantially delay or prevent regulatory approval or commercialization.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Before we can obtain regulatory approval
for a product candidate, we must undertake extensive clinical testing in humans to demonstrate safety and efficacy to the satisfaction
of the FDA or other regulatory agencies. Clinical trials of new drug candidates sufficient to obtain regulatory marketing approval
are expensive and take years to complete.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We cannot be certain of successfully completing
clinical testing within the time frame we have planned, or at all. We may experience numerous unforeseen events during, or as a
result of, the clinical trial process that could delay or prevent us from receiving regulatory approval or commercializing our
product candidates, including the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.2in">&nbsp;</TD>
    <TD STYLE="width: 0.2in"><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">our clinical trials may produce negative or inconclusive results, and we may decide, or regulators may require us, to conduct additional clinical and/or preclinical testing or to abandon programs;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">the results obtained in earlier stage clinical testing may not be indicative of results in future clinical trials;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">clinical trial results may not meet the level of statistical significance required by the FDA or other regulatory agencies;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">we, or regulators, may suspend or terminate our clinical trials if the participating patients are being exposed to unacceptable health risks; and</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">our product candidates may have unintended or undesirable effects on patients that may delay or preclude regulatory approval of our product candidates or limit their commercial use, if approved.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Results from preclinical studies and Phase 1 or 2 clinical
trials of our product candidates may not be predictive of the results of later stage human clinical trials.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Preclinical studies, including studies
of our product candidates in animal disease models, may not accurately predict the result of human clinical trials of those product
candidates. In particular, promising animal studies suggesting the efficacy of prototype phage products in the treatment of bacterial
infections, such as <I>P. aeruginosa </I>and <I>S. aureus,</I> may not predict the ability of these products to treat similar infections
in humans. Our phage technology may be found not to be efficacious in treating bacterial infections alone or in combination with
other agents, when studied in human clinical trials.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">&nbsp;</TD><TD STYLE="width: 50%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">To satisfy FDA or foreign regulatory approval
standards for the commercial sale of our product candidates, we must demonstrate in adequate and controlled clinical trials that
our product candidates are safe and effective. Success in early clinical trials, including Phase 2 trials, does not ensure that
later clinical trials will be successful. Our initial results from early stage clinical trials also may not be confirmed by later
analysis or subsequent larger clinical trials. A number of companies in the pharmaceutical industry have suffered significant setbacks
in advanced clinical trials, even after obtaining promising results in earlier clinical trials and most product candidates that
commence clinical trials are never approved for commercial sale.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>We must continue to develop manufacturing processes for
our product candidates and any delay in or our inability to do so would result in delays in our clinical trials.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We are developing novel manufacturing processes
for our product candidates at our facility in Ljubljana, Slovenia. The manufacturing processes for our product candidates, and
the scale up of such processes for clinical trials, is novel, and there can be no assurance that we will be able to complete this
work in a timely manner, if at all. Any delay in the development or scale up of these manufacturing processes could delay the start
of clinical trials and harm our business. Our facility in Slovenia must also undergo ongoing inspections by JAZMP, the Slovenian
agency that regulates and supervises pharmaceutical products in Slovenia, for compliance with their and the European Medicines
Agency&rsquo;s, or EMA&rsquo;s, current good manufacturing practice regulations, or cGMP regulations, before the respective product
candidates can be approved for use in clinical trials or commercialization. In the event these facilities do not receive a satisfactory
cGMP inspection for the manufacture of our product candidates, we may need to fund additional modifications to our manufacturing
process, conduct additional validation studies, or find alternative manufacturing facilities, any of which would result in significant
cost to us as well as a delay of up to several years in obtaining approval for such product candidate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Our manufacturing facility will be subject
to ongoing periodic inspection by the European regulatory authorities, including JAZMP, and the FDA for compliance with European
and FDA cGMP regulations. Compliance with these regulations and standards is complex and costly, and there can be no assurance
that we will be able to comply. Any failure to comply with applicable regulations could result in sanctions being imposed (including
fines, injunctions and civil penalties), failure of regulatory authorities to grant marketing approval of our product candidates,
delays, suspension or withdrawal of approvals, license revocation, seizures or recalls of product candidates or products, operating
restrictions and criminal prosecution.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>We may conduct clinical trials for our products or product
candidates outside the United States and the FDA may not accept data from such trials.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We are currently conducting an investigator-sponsored
clinical trial of AB-SA01 at the University of Adelaide in Australia for chronic rhinosinusitis, and may seek to conduct one or
more other clinical trials in the future outside the United States. Although the FDA may accept data from clinical trials conducted
outside the United States, acceptance of such study data by the FDA is subject to certain conditions. For example, the study must
be well designed and conducted and performed by qualified investigators in accordance with ethical principles. The study population
must also adequately represent the U.S. population, and the data must be applicable to the U.S. population and U.S. medical practice
in ways that the FDA deems clinically meaningful. Generally, the patient population for any clinical studies conducted outside
of the United States must be representative of the population for whom we intend to label the product in the United States. In
addition, such studies would be subject to the applicable local laws and FDA acceptance of the data would be dependent upon its
determination that the studies also complied with all applicable U.S. laws and regulations. There can be no assurance the FDA will
accept data from trials conducted outside of the United States. If the FDA does not accept any such data, it would likely result
in the need for additional trials, which would be costly and time consuming and delay aspects of our business plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>We may need to license additional intellectual property
rights.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The development and commercialization of
phage-based antibacterial agents may require us to obtain rights to intellectual property from third parties. For example, pursuant
to our Collaborative Research and Development Agreement with the United States Army Medical Research and Materiel Command and the
Walter Reed Army Institute of Research, we are currently focusing on developing bacteriophage therapeutics to treat <I>S. aureus</I>
infections. To the extent the intellectual property is generated from the United States Army Medical Research and Materiel Command
or Walter Reed Army Institute of Research that is used in a commercial product, we may be obligated to make payments such as royalties,
licensing fees and milestone payments. We may also determine that it is necessary or advisable to license other intellectual property
from third parties. There can be no assurance that such intellectual property rights would be available on commercially reasonable
terms, if at all.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We are conducting an investigator-sponsored
clinical trial of AB-SA01 at the University of Adelaide. To the extent that intellectual property is generated as a result of the
study that is used in a commercial product, we may be obligated to make payments, such as royalties, licensing fees, and milestone
payments. There can be no assurance that such intellectual property rights would be available on commercially reasonable terms,
if at all.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">&nbsp;</TD><TD STYLE="width: 50%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>We are subject to significant regulatory approval requirements,
which could delay, prevent or limit our ability to market our product candidates.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Our research and development activities,
preclinical studies, clinical trials and the anticipated manufacturing and marketing of our product candidates are subject to extensive
regulation by the FDA and other regulatory agencies in the United States and by comparable authorities in Europe and elsewhere.
There can be no assurance that our manufacturing facilities will satisfy the requirements of the FDA or comparable foreign authorities.
We require the approval of the relevant regulatory authorities before we may commence commercial sales of our product candidates
in a given market. The regulatory approval process is expensive and time-consuming, and the timing of receipt of regulatory approval
is difficult to predict. Our product candidates could require a significantly longer time to gain regulatory approval than expected,
or may never gain approval. We cannot be certain that, even after expending substantial time and financial resources, we will obtain
regulatory approval for any of our product candidates. A delay or denial of regulatory approval could delay or prevent our ability
to generate product revenues and to achieve profitability.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Changes in regulatory approval policies
during the development period of any of our product candidates, changes in, or the enactment of, additional regulations or statutes,
or changes in regulatory review practices for a submitted product application may cause a delay in obtaining approval or result
in the rejection of an application for regulatory approval.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Regulatory approval, if obtained, may be
made subject to limitations on the indicated uses for which we may market a product. These limitations could adversely affect our
potential product revenues. Regulatory approval may also require costly post-marketing follow-up studies. In addition, the labeling,
packaging, adverse event reporting, storage, advertising, promotion and record-keeping related to the product will be subject to
extensive ongoing regulatory requirements. Furthermore, for any marketed product, its manufacturer and its manufacturing facilities
will be subject to continual review and periodic inspections by the FDA or other regulatory authorities. Failure to comply with
applicable regulatory requirements may, among other things, result in fines, suspensions of regulatory approvals, product recalls,
product seizures, operating restrictions and criminal prosecution.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>A variety of risks associated with our international operations
could materially adversely affect our business.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In addition to our U.S. operations, we
have operations and subsidiaries in the United Kingdom, Australia and Slovenia. We face risks associated with our international
operations, including possible unfavorable regulatory, pricing and reimbursement, political, tax and labor conditions, which could
harm our business. We are subject to numerous risks associated with international business activities, including:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.2in">&nbsp;</TD>
    <TD STYLE="width: 0.2in"><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">compliance with differing or unexpected regulatory requirements for the development, manufacture and, if approved, commercialization of our product candidates;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">difficulties in staffing and managing foreign operations;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">foreign government taxes, regulations and permit requirements;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">U.S. and foreign government tariffs, trade restrictions, price and exchange controls and other regulatory requirements;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">anti-corruption laws, including the Foreign Corrupt Practices Act, or the FCPA;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">economic weakness, including inflation, natural disasters, war, events of terrorism or political instability in particular foreign countries; </FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">fluctuations in currency exchange rates, which could result in increased operating expenses and reduced revenues, and other obligations related to doing business in another country;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">compliance with tax, employment, immigration and labor laws, regulations and restrictions for employees living or traveling abroad; </FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">workforce uncertainty in countries where labor unrest is more common than in the United States;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">production shortages resulting from any events affecting raw material supply or manufacturing capabilities abroad;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">changes in diplomatic and trade relationships; and</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">challenges in enforcing our contractual and intellectual property rights, especially in those foreign countries that do not respect and protect intellectual property rights to the same extent as the United States.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">These and other risks associated with our
international operations may materially adversely affect our business, financial condition and results of operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>We do not have a sales force and do not currently have
plans to develop one.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The commercial success of any of our product
candidates will depend upon the strength of sales and marketing efforts for them. We do not have a sales force and have no experience
in sales, marketing or distribution. To successfully commercialize our product candidates, we will need to develop such a capability
ourselves or seek assistance from a third party with a large distribution system and a large direct sales force. We may be unable
to put such a plan in place. In addition, if we arrange for others to market and sell our products, our revenues will depend upon
the efforts of those parties. Such arrangements may not succeed. Even if one or more of our product candidates is approved for
marketing, if we fail to establish adequate sales, marketing and distribution capabilities, independently or with others, our business
will be materially harmed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">&nbsp;</TD><TD STYLE="width: 50%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Our success depends in part on attracting, retaining and
motivating our personnel.*</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Our success depends on our continued ability
to attract, retain and motivate highly qualified management, clinical and scientific personnel and on our ability to develop and
maintain important relationships with leading academic institutions, clinicians and scientists. As of May 6, 2016, we had 30 employees.
Our success will depend on our ability to retain and motivate personnel and hire additional qualified personnel when required.
Competition for qualified personnel in the biotechnology field is intense. We face competition for personnel from other biotechnology
and pharmaceutical companies, universities, public and private research institutions and other organizations. We also face competition
from other more well-funded and well-established businesses and we may also be viewed as a riskier choice from a job stability
perspective due to our relative newer status than longer existing biotech and pharmaceutical companies. We may not be able to attract
and retain qualified personnel on acceptable terms given the competition for such personnel. If we are unsuccessful in our retention,
motivation and recruitment efforts, we may be unable to execute our business strategy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>We must manage a geographically dispersed organization.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">While we are a small company, we currently
have operations in the United States, United Kingdom, Australia and Slovenia. In the future, we may also locate facilities in other
locations based on proximity to personnel with the expertise needed to research, develop and manufacture phage-based therapeutics,
costs of operations or other factors. Managing our organization across multiple locations and multiple time zones may reduce our
efficiency, increase our expenses and increase the risk of operational difficulties in the execution of our plans.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Risks Related to Our Reliance on Third Parties</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>We rely on third parties for aspects of product development.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We rely on third parties such as the University
of Leicester and the U.S. Army for certain aspects of product development. We are working with the University of Leicester for
research and development of product candidates to treat <I>C. difficile</I> infections. We are working with the U.S. Army for research
and development of product candidates to treat <I>S. aureus</I> infections. Because we rely on third parties to conduct these activities,
we have less control over the success of these programs than we would if we were conducting them on our own. Factors beyond our
control that could impact the success of these programs include the amount of resources devoted to the programs by the applicable
third party, the staffing of those projects by third-party personnel, and the amount of time such personnel devote to our programs
compared to other programs. Failure of our third-party collaborators to successfully complete the projects that we are working
on with them could result in delays in product development and the need to expend additional resources, increasing our expenses
beyond current expectations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>We will rely on third parties to conduct our clinical
trials, and their failure to perform their obligations in a timely or competent manner may delay development and commercialization
of our product candidates.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We expect to use third parties, such as
clinical research organizations or the U.S. Army, to assist in conducting our clinical trials. However, we may face delays outside
of our control if these parties do not perform their obligations in a timely or competent fashion or if we are forced to change
service providers. This risk is heightened for clinical trials conducted outside of the United States, where it may be more difficult
to ensure that clinical trials are conducted in compliance with FDA requirements. Any third party that we hire to conduct clinical
trials may also provide services to our competitors, which could compromise the performance of their obligations to us. If we experience
significant delays in the progress of our clinical trials and in our plans to submit Biologics License Applications, the commercial
prospects for product candidates could be harmed and our ability to generate product revenue would be delayed or prevented.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Risks Related to Our Intellectual Property</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>We are dependent on patents and proprietary technology.
If we fail to adequately protect this intellectual property or if we otherwise do not have exclusivity for the marketing of our
products, our ability to commercialize products could suffer.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Our commercial success will depend in part
on our ability to obtain and maintain patent protection sufficient to prevent others from marketing our product candidates, as
well as to defend and enforce these patents against infringement and to operate without infringing the proprietary rights of others.
Protection of our product candidates from unauthorized use by third parties will depend on having valid and enforceable patents
cover our product candidates or their manufacture or use, or having effective trade secret protection. If our patent applications
do not result in issued patents, or if our patents are found to be invalid, we will lose the ability to exclude others from making,
using or selling the inventions claimed therein. We have a limited number of patents and pending patent applications.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The patent positions of biotechnology companies
can be uncertain and involve complex legal and factual questions. This is due to inconsistent application of policy and changes
in policy relating to examination and enforcement of biotechnology patents to date on a global scale. The laws of some countries
may not protect intellectual property rights to the same extent as the laws of countries having well-established patent systems,
and those countries may lack adequate rules and procedures for defending our intellectual property rights. Also, changes in either
patent laws or in interpretations of patent laws may diminish the value of our intellectual property. We are not able to guarantee
that all of our patent applications will result in the issuance of patents and we cannot predict the breadth of claims that may
be allowed in our patent applications or in the patent applications we may license from others.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 30; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">&nbsp;</TD><TD STYLE="width: 50%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Central provisions of The Leahy-Smith America
Invents Act, or the America Invents Act went into effect on September 16, 2012 and on March 16, 2013. The America Invents Act includes
a number of significant changes to U.S. patent law. These changes include provisions that affect the way patent applications are
being filed, prosecuted and litigated. For example, the America Invents Act enacted proceedings involving post-issuance patent
review procedures, such as inter partes review, or IPR, and post-grant review, that allow third parties to challenge the validity
of an issued patent in front of the United States PTO Patent Trial and Appeal Board. Each proceeding has different eligibility
criteria and different patentability challenges that can be raised. IPRs permit any person (except a party who has been litigating
the patent for more than a year) to challenge the validity of the patent on the grounds that it was anticipated or made obvious
by prior art. Patents covering pharmaceutical products have been subject to attack in IPRs from generic drug companies and from
hedge funds. If it is within nine months of the issuance of the challenged patent, a third party can petition the United States
PTO for post-grant review, which can be based on any invalidity grounds and is not limited to prior art patents or printed publications.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In post-issuance proceedings, United States
PTO rules and regulations generally tend to favor patent challengers over patent owners. For example, unlike in district court
litigation, claims challenged in post-issuance proceedings are given their broadest reasonable meaning, which increases the chance
a claim might be invalidated by prior art or lack support in the patent specification. The United States Supreme Court is currently
reviewing whether it is proper for the United States PTO to give claims their broadest reasonable meaning in post-issuance proceedings.
As another example, unlike in district court litigation, there is no presumption of validity for an issued patent, and thus, a
challenger&rsquo;s burden to prove invalidity is by a preponderance of the evidence, as opposed to the heightened clear and convincing
evidence standard. As a result of these rules and others, statistics released by the United States PTO show a high percentage of
claims being invalidated in post-issuance proceedings. Moreover, with few exceptions, there is no standing requirement to petition
the United States PTO for inter partes review or post-grant review. In other words, companies that have not been charged with infringement
or that lack commercial interest in the patented subject matter can still petition the United States PTO for review of an issued
patent. Thus, even where we have issued patents, our rights under those patents may be challenged and ultimately not provide us
with sufficient protection against competitive products or processes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The degree of future protection for our
proprietary rights is uncertain because legal means afford only limited protection and may not adequately protect our rights or
permit us to gain or keep our competitive advantage. For example:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">we might not be the first to file patent applications for our inventions;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">others may independently develop similar or alternative product candidates to any of our product candidates that fall outside the scope of our patents;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">our pending patent applications may not result in issued patents;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">our issued patents may not provide a basis for commercially viable products or may not provide us with any competitive advantages or may be challenged by third parties;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">others may design around our patent claims to produce competitive products that fall outside the scope of our patents;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">we may not develop additional patentable proprietary technologies related to our product candidates; and</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">we are dependent upon the diligence of our appointed agents in national jurisdictions, acting for and on our behalf, which control the prosecution of pending domestic and foreign patent applications and maintain granted domestic and foreign patents.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">An issued patent does not guarantee us
the right to practice the patented technology or commercialize the patented product. Third parties may have blocking patents that
could be used to prevent us from commercializing our patented products and practicing our patented technology. Our issued patents
and those that may be issued in the future may be challenged, invalidated or circumvented, which could limit our ability to prevent
competitors from marketing the same or related product candidates or could limit the length of the term of patent protection of
our product candidates. Moreover, because of the extensive time required for development, testing and regulatory review of a potential
product, it is possible that, before any of our product candidates can be commercialized, any related patent may expire or remain
in force for only a short period following commercialization, thereby reducing any advantage of the patent. Patent term extensions
may not be available for these patents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>We rely on trade secrets and other forms of non-patent
intellectual property protection. If we are unable to protect our trade secrets, other companies may be able to compete more effectively
against us.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We rely on trade secrets to protect certain
aspects of our technology, including our proprietary processes for manufacturing and purifying bacteriophages. Trade secrets are
difficult to protect, especially in the pharmaceutical industry, where much of the information about a product must be made public
during the regulatory approval process. Although we use reasonable efforts to protect our trade secrets, our employees, consultants,
contractors, outside scientific collaborators and other advisors may unintentionally or willfully disclose our information to competitors.
Enforcing a claim that a third party illegally obtained and is using our trade secret information is expensive and time-consuming,
and the outcome is unpredictable. In addition, courts outside the United States may be less willing to or may not protect trade
secrets. Moreover, our competitors may independently develop equivalent knowledge, methods and know-how.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>If we are sued for infringing intellectual property rights
of third parties or if we are forced to engage in an interference proceeding, it will be costly and time-consuming, and an unfavorable
outcome in that litigation or interference would have a material adverse effect on our business.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Our ability to commercialize our product
candidates depends on our ability to develop, manufacture, market and sell our product candidates without infringing the proprietary
rights of third parties. Numerous United States and foreign patents and patent applications, which are owned by third parties,
exist in the general field of anti-infective products or in fields that otherwise may relate to our product candidates. If we are
shown to infringe, we could be enjoined from use or sale of the claimed invention if we are unable to prove that the patent is
invalid. In addition, because patent applications can take many years to issue, there may be currently pending patent applications,
unknown to us, which may later result in issued patents that our product candidates may infringe, or which may trigger an interference
proceeding regarding one of our owned or licensed patents or applications. There could also be existing patents of which we are
not aware that our product candidates may inadvertently infringe or which may become involved in an interference proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 31; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">&nbsp;</TD><TD STYLE="width: 50%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The biotechnology and pharmaceutical industries
are characterized by the existence of a large number of patents and frequent litigation based on allegations of patent infringement.
For so long as our product candidates are in clinical trials, we believe our clinical activities fall within the scope of the exemptions
provided by 35 U.S.C. Section 271(e) in the United States, which exempts from patent infringement liability activities reasonably
related to the development and submission of information to the FDA. As our clinical investigational drug product candidates progress
toward commercialization, the possibility of a patent infringement claim against us increases. While we attempt to ensure that
our active clinical investigational drugs and the methods we employ to manufacture them, as well as the methods for their use we
intend to promote, do not infringe other parties&rsquo; patents and other proprietary rights, we cannot be certain they do not,
and competitors or other parties may assert that we infringe their proprietary rights in any event.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We may be exposed to future litigation
based on claims that our product candidates, or the methods we employ to manufacture them, or the uses for which we intend to promote
them, infringe the intellectual property rights of others. Our ability to manufacture and commercialize our product candidates
may depend on our ability to demonstrate that the manufacturing processes we employ and the use of our product candidates do not
infringe third-party patents. If third-party patents were found to cover our product candidates or their use or manufacture, we
could be required to pay damages or be enjoined and therefore unable to commercialize our product candidates, unless we obtained
a license. A license may not be available to us on acceptable terms, if at all.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Risks Related to Our Industry</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>If our competitors are able to develop and market products
that are more effective, safer or more affordable than ours, or obtain marketing approval before we do, our commercial opportunities
may be limited.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Competition in the biotechnology and pharmaceutical
industries is intense and continues to increase. Some companies that are larger and have significantly more resources than we do
are aggressively pursuing antibacterial development programs, including traditional therapies and therapies with novel mechanisms
of action. In addition, other companies are developing phage-based products for non-therapeutic uses, and may elect to use their
expertise in phage development and manufacturing to try to develop products that would compete with ours.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We also face potential competition from
academic institutions, government agencies and private and public research institutions engaged in the discovery and development
of drugs and therapies. Many of our competitors have significantly greater financial resources and expertise in research and development,
preclinical testing, conducting clinical trials, obtaining regulatory approvals, manufacturing, sales and marketing than we do.
Smaller or early-stage companies may also prove to be significant competitors, particularly through collaborative arrangements
with large and established pharmaceutical companies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Our competitors may succeed in developing
products that are more effective, have fewer side effects and are safer or more affordable than our product candidates, which would
render our product candidates less competitive or noncompetitive. These competitors also compete with us to recruit and retain
qualified scientific and management personnel, establish clinical trial sites and patient registration for clinical trials, as
well as to acquire technologies and technology licenses complementary to our programs or advantageous to our business. Moreover,
competitors that are able to achieve patent protection, obtain regulatory approvals and commence commercial sales of their products
before we do, and competitors that have already done so, may enjoy a significant competitive advantage.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Generating Antibiotics Incentives Now
Act, or the GAIN Act, is intended to provide incentives for the development of new, qualified infectious disease products. These
incentives may result in more competition in the market for new antibiotics, and may cause pharmaceutical and biotechnology companies
with more resources than we have to shift their efforts towards the development of products that could be competitive with our
product candidates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>There is a substantial risk of product liability claims
in our business. If we do not obtain sufficient liability insurance, a product liability claim could result in substantial liabilities.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Our business exposes us to significant
potential product liability risks that are inherent in the development, manufacturing and marketing of human therapeutic products.
Regardless of merit or eventual outcome, product liability claims may result in:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">delay or failure to complete our clinical trials;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">withdrawal of clinical trial participants;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">decreased demand for our product candidates;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">injury to our reputation;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">litigation costs;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">substantial monetary awards against us; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 32; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">&nbsp;</TD><TD STYLE="width: 50%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">diversion of management or other resources from key aspects of our operations.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">If we succeed in marketing products, product
liability claims could result in an FDA investigation of the safety or efficacy of our products, our manufacturing processes and
facilities or our marketing programs. An FDA investigation could also potentially lead to a recall of our products or more serious
enforcement actions, or limitations on the indications, for which they may be used, or suspension or withdrawal of approval.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We have product liability insurance that
covers our clinical trials up to a $10.0 million annual per claim and aggregate limit. We intend to expand our insurance coverage
to include the sale of commercial products if marketing approval is obtained for our product candidates or any other compound that
we may develop. However, insurance coverage is expensive and we may not be able to maintain insurance coverage at a reasonable
cost or at all, and the insurance coverage that we obtain may not be adequate to cover potential claims or losses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Even if we receive regulatory approval to market our product
candidates, the market may not be receptive to our product candidates upon their commercial introduction, which would negatively
affect our ability to achieve profitability.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Our product candidates may not gain market
acceptance among physicians, patients, healthcare payors and the medical community. The degree of market acceptance of any approved
products will depend on a number of factors, including:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">the effectiveness of the product;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">the prevalence and severity of any side effects;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">potential advantages or disadvantages over alternative treatments;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">relative convenience and ease of administration;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">the strength of marketing and distribution support;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">the price of the product, both in absolute terms and relative to alternative treatments; and</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">sufficient third-party coverage or reimbursement.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">If our product candidates receive regulatory
approval but do not achieve an adequate level of acceptance by physicians, healthcare payors and patients, we may not generate
product revenues sufficient to attain profitability.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Foreign governments tend to impose strict price controls,
which may adversely affect our future profitability.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In some foreign countries, particularly
in the European Union, prescription drug pricing is subject to governmental control. In these countries, pricing negotiations with
governmental authorities can take considerable time after the receipt of marketing approval for a product. To obtain reimbursement
or pricing approval in some countries, we may be required to conduct a clinical trial that compares the cost-effectiveness of our
product candidate to other available therapies. If reimbursement of our products is unavailable or limited in scope or amount,
or if pricing is set at unsatisfactory levels, our profitability will be negatively affected.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>We may incur significant costs complying with environmental
laws and regulations, and failure to comply with these laws and regulations could expose us to significant liabilities.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Our research and development activities
use biological and hazardous materials that are dangerous to human health and safety or the environment. We are subject to a variety
of federal, state and local laws and regulations governing the use, generation, manufacture, storage, handling and disposal of
these materials and wastes resulting from these materials. We are also subject to regulation by the Occupational Safety and Health
Administration, or OSHA, state and federal environmental protection agencies and to regulation under the Toxic Substances Control
Act. OSHA, state governments or federal Environmental Protection Agency, or EPA, may adopt regulations that may affect our research
and development programs. We are unable to predict whether any agency will adopt any regulations that could have a material adverse
effect on our operations. We have incurred, and will continue to incur, capital and operating expenditures and other costs in the
ordinary course of our business in complying with these laws and regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Although we believe our safety procedures
for handling and disposing of these materials comply with federal, state and local laws and regulations, we cannot entirely eliminate
the risk of accidental injury or contamination from the use, storage, handling or disposal of hazardous materials. In the event
of contamination or injury, we could be held liable for any resulting damages, and any liability could significantly exceed our
insurance coverage.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 33; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">&nbsp;</TD><TD STYLE="width: 50%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Risks Related to Our Common Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 26.9pt"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>The price of our common stock has been and may continue
to be volatile.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The stock markets in general, the markets
for biotechnology stocks and, in particular, the stock price of our common stock, have experienced extreme volatility. The market
for our common stock is characterized by significant price volatility when compared to the shares of larger, more established companies
that trade on a national securities exchange and have large public floats, and we expect that our share price will continue to
be more volatile than the shares of such larger, more established companies for the indefinite future. The volatility in our share
price is attributable to a number of factors. Our common shares are, compared to the shares of such larger, more established companies,
sporadically and thinly traded. As a consequence of this limited liquidity, the trading of relatively small quantities of shares
by our stockholders may disproportionately influence the price of those shares in either direction. The price for our shares could,
for example, decline precipitously in the event that a large number of shares of our common stock are sold on the market without
commensurate demand. We are also a speculative or &ldquo;risky&rdquo; investment due to the early stage of our drug development
programs and our lack of profits to date, and uncertainty of future market acceptance for our potential products. As a consequence
of this enhanced risk, more risk-adverse investors may, under the fear of losing all or most of their investment in the event of
negative news or lack of progress, be more inclined to sell their shares on the market more quickly and at greater discounts than
would be the case with the stock of a larger, more established company that has a large public float and broader stockholder base.
Many of these factors are beyond our control and may decrease the market price of our common stock, regardless of our operating
performance. We cannot make any predictions or projections as to what the prevailing market price for our common shares will be
at any time, including as to whether our common stock will sustain their current market prices, or as to what effect that the sale
of shares or the availability of common stock for sale at any time will have on the prevailing market price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Price declines in our common stock could
also result from general market and economic conditions and a variety of other factors, including:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">adverse results or delays in our clinical trials;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">adverse actions taken by regulatory agencies with respect to our product candidates, clinical trials or the manufacturing processes of our product candidates;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">announcements of technological innovations, patents or new products by our competitors;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">regulatory developments in the United States and foreign countries;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">any lawsuit involving us or our product candidates;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">announcements concerning our competitors, or the biotechnology or pharmaceutical industries in general;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">developments concerning any strategic alliances or acquisitions we may enter into;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">actual or anticipated variations in our operating results;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">changes in recommendations by securities analysts or lack of analyst coverage;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">deviations in our operating results from the estimates of analysts;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">sales of our common stock by our executive officers, directors and principal stockholders or sales of substantial amounts of common stock; and</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">loss of any of our key scientific or management personnel.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In the past, following periods of volatility
in the market price of a particular company&rsquo;s securities, litigation has often been brought against that company. Any such
lawsuit could consume resources and management time and attention, which could adversely affect our business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>We may be required to issue a significant number of additional
shares of common stock for no additional consideration and/or make cash make-whole payments to certain of our stockholders.*</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We may be required to issue a significant
number of additional shares of common stock for no additional consideration and/or make cash make-whole payments to the Holders.
Pursuant to the CSIA, we agreed that if in the future we conduct one or more bona fide equity financings in which we sell shares
of our common stock or preferred stock at a price of less than $4.05 per share (each, a &ldquo;Dilutive Financing&rdquo;), we will
issue to the Holders, for no additional consideration, a number of additional shares of common stock (&ldquo;Additional Shares&rdquo;)
based on a specified formula (such rights of the Holders to receive Additional Shares, the &ldquo;Additional Issuance Rights&rdquo;).
Specifically, in the event we conduct a Dilutive Financing, the Holders will be entitled to receive (absent consideration of any
applicable restrictions on the number of shares that can be issued in a non-public offering under NYSE MKT rules and interpretations
without shareholder approval) in the aggregate a number of Additional Shares equal to (A) the product of (x) 1,037,053 multiplied
by (y) a fraction, the numerator of which is $4.05 and the denominator of which is the lowest price per share paid by investors
in such Dilutive Financing (the &ldquo;Effective Price&rdquo;) less (B) 1,037,053 and all Additional Shares issued previously to
the Holders pursuant to the Additional Issuance Rights. The CSIA includes a provision intended to limit our obligation to issue
Additional Shares to the extent such Additional Shares would exceed the 20% limit on the number of shares that can be issued without
shareholder approval pursuant to Section 713(a) of the NYSE MKT Company Guide.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Pursuant to Section 713(a) of the NYSE
MKT Company Guide, shareholder approval is generally required prior to the issuance of common stock or common stock equivalents
in connection with a transaction other than a public offering involving the sale, issuance, or potential issuance by the issuer
of common stock or common stock equivalents equal to 20% or more of the outstanding shares of common stock as of immediately prior
to the transaction for less than the greater of book or market value of the stock (the &ldquo;NYSE 20% Cap&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Any Additional Shares that we issue pursuant
to the Additional Issuance Rights would be aggregated with the 853,465 shares of common stock issued to the Holders on April 8,
2016 pursuant to the CSIA for purposes of determining whether the total number of Additional Shares to be issued would equal or
exceed the NSYE 20% Cap. Accordingly, absent shareholder approval, the maximum number of Additional Shares that we can issue pursuant
to Section 713(a) of the NYSE MKT Company Guide without shareholder approval is 323,235 shares. We agreed to seek shareholder approval
at our 2016 Annual Meeting of Shareholders (the &ldquo;annual meeting&rdquo;) of the issuance by us to the Holders of up to an
aggregate of 1,037,053 shares of common stock as and to the extent required pursuant to the CSIA (the &ldquo;Proposal&rdquo;).
If the shareholders do not approve the Proposal at the annual meeting, then in lieu of issuing any Additional Shares that would
have been required to be issued to a Holder pursuant to the operation of the Additional Issuance Rights but for the limitations
imposed by NYSE 20% Cap (the &ldquo;Excess Shares&rdquo;), we will, to the extent legally permitted, pay to such Holder a cash
amount per Excess Share equal to the difference between the lowest price per share paid by investors in such Dilutive Financing
and $4.05, less any cash payment per share previously made to such Holder pursuant to the CSIA (the &ldquo;Cash Make-Whole&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 34; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">&nbsp;</TD><TD STYLE="width: 50%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Shareholders will incur dilution of their
percentage ownership interest in our common stock to the extent we issue Additional Shares to the Holders pursuant to the Additional
Issuance Rights. Shareholders will incur greater ownership interest dilution to the extent the Proposal is approved and we become
required to issue some or all of the 1,037,053 Additional Shares. In addition, because the Additional Shares will be issued for
no additional consideration, any such issuance would reduce our net tangible book value per share. However, to the extent Additional
Shares are not issued when otherwise required by the CSIA due to the NYSE 20% Cap, any payments by us in satisfaction of the Cash
Make-Whole would also reduce our net tangible book value per share of as well as our overall net tangible book value.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">If the Cash Make-Whole would be triggered
by a proposed Dilutive Financing, the potential payment obligations could make such Dilutive Financing less feasible and financially
viable for us, particularly if the proceeds to be received by us in such financing would not significantly exceed the Cash Make-Whole
payments, and thereby jeopardize our ability to raise capital in a Dilutive Financing that could otherwise provide us with needed
cash resources. Even if we are able to complete a Dilutive Financing, any Cash Make-Whole payments would deplete our cash resources
at a time when our cash resources are limited.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">There can be no assurance of whether the
Proposal will be approved at the annual meeting. Any issuance or potential issuance of Additional Shares and/or payment or potential
payment of Cash Make-Whole payments could adversely affect our stock price, make it more difficult for us to raise capital, and
have a material adverse effect on our business, results of operations and financial condition.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>A significant number of shares of our common stock are
subject to issuance upon exercise or conversion of outstanding warrants, options and convertible securities, which upon such exercise
or conversion may result in dilution to our security holders.* </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">As of March 31, 2016, we had outstanding
warrants to purchase 1,379,649 shares of our common stock at an average exercise price of $9.34 per share, and outstanding options
to purchase 872,977 shares of our common stock at an average exercise price of $7.29 per share. The exercise price and/or the number
of shares of common stock issuable upon exercise of the warrants may be adjusted in certain circumstances, including certain issuances
of securities at a price equal to or less than the then current exercise price, subdivisions and stock splits, stock dividends,
combinations, reorganizations, reclassifications, consolidations, mergers or sales of properties and assets and upon the issuance
of certain assets or securities to holders of our common stock, as applicable. Although we cannot determine when these warrants
or options will ultimately be exercised, it is reasonable to assume that such warrants and options will be exercised only if the
exercise price is below the market price of our common stock. To the extent any of our outstanding warrants or options are exercised,
additional shares of our common stock will be issued that will generally be eligible for resale in the public market (subject to
limitations under Rule 144 under the Securities Act with respect to shares held by our affiliates), which will result in dilution
to our security holders. The issuance of additional securities could also have an adverse effect on the market price of our common
stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Our principal stockholders and management beneficially
own a majority of our stock and will be able to exert significant control over matters subject to stockholder approval. *</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">As of March 31, 2016, our executive officers,
directors, principal stockholders and their affiliates beneficially owned a majority of our outstanding voting stock. Therefore,
these stockholders will have the ability to influence us through this ownership position. These stockholders may be able to determine
all matters requiring stockholder approval. For example, these stockholders, acting together, may be able to control elections
of directors, amendments of our organizational documents, or approval of any merger, sale of assets, or other major corporate transaction.
This may prevent or discourage unsolicited acquisition proposals or offers for our common stock that you may believe are in your
best interest as one of our stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Provisions of Washington law and our current articles
of incorporation and bylaws may discourage another company from acquiring us and may prevent attempts by our stockholders to replace
or remove our current management.*</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Provisions of Washington law and our current
articles of incorporation and bylaws may discourage, delay or prevent a merger or acquisition that stockholders may consider favorable,
including transactions in which you might otherwise receive a premium for your shares. In addition, these provisions may frustrate
or prevent any attempts by our stockholders to replace or remove our current management by making it more difficult for stockholders
to replace or remove our board of directors. These provisions include:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">authorizing the issuance of &ldquo;blank check&rdquo; preferred stock without any need for action by stockholders;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">providing for a classified board of directors with staggered terms;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">requiring supermajority stockholder voting to effect certain amendments to our articles of incorporation and bylaws; and</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">establishing advance notice requirements for nominations for election to our board of directors or for proposing matters that can be acted on by stockholders at stockholder meetings.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 35; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">&nbsp;</TD><TD STYLE="width: 50%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In addition, because we are incorporated
in Washington, we are governed by the provisions of Chapter 23B.19 of the Washington Business Corporation Act, which, among other
things, restricts the ability of stockholders owning 10% or more of our outstanding voting stock from merging or combining with
us. These provisions could discourage potential acquisition attempts and could reduce the price that investors might be willing
to pay for shares of our common stock in the future and result in the market price being lower than it would without these provisions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Although we believe these provisions collectively
provide for an opportunity to receive higher bids by requiring potential acquirors to negotiate with our board of directors, they
would apply even if an offer may be considered beneficial by some stockholders. In addition, these provisions may frustrate or
prevent any attempts by our stockholders to replace or remove our current management by making it difficult for stockholders to
replace members of our board of directors, which is responsible for appointing the members of our management.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>We have never paid dividends on our common stock, and
we do not anticipate paying any cash dividends on our common stock in the foreseeable future.*</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We have never declared or paid cash dividends
on our common stock. We do not anticipate paying any cash dividends on our common stock in the foreseeable future. We currently
intend to retain all available funds and any future earnings to fund the development and growth of our business. As a result, capital
appreciation, if any, of our common stock will be our stockholders&rsquo; sole source of gain for the foreseeable future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Maintaining and improving our financial controls and the
requirements of being a public company may strain our resources, divert management&rsquo;s attention and affect our ability to
attract and retain qualified board members.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">As a public company, we are subject to
the reporting requirements of the Securities Exchange Act of 1934, as amended, or the Exchange Act, the Sarbanes-Oxley Act and
the rules of the NYSE MKT. The requirements of these rules and regulations increase our legal and financial compliance costs, make
some activities more difficult, time-consuming or costly and place strain on our personnel, systems and resources. The Exchange
Act requires, among other things, that we file annual, quarterly and current reports with respect to our business and financial
condition.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Sarbanes-Oxley Act requires, among
other things, that we maintain effective disclosure controls and procedures and internal control over financial reporting. Ensuring
that we have adequate internal financial and accounting controls and procedures in place is a costly and time-consuming effort
that needs to be re-evaluated frequently.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We currently do not have an internal audit
group, and we may need to hire additional accounting and financial staff with appropriate public company experience and technical
accounting knowledge. Implementing any appropriate changes to our internal controls may require specific compliance training for
our directors, officers and employees, entail substantial costs to modify our existing accounting systems, and take a significant
period of time to complete. Such changes may not, however, be effective in maintaining the adequacy of our internal controls, and
any failure to maintain that adequacy, or consequent inability to produce accurate financial statements on a timely basis, could
increase our operating costs and could materially impair our ability to operate our business. Moreover, effective internal controls
are necessary for us to produce reliable financial reports and are important to help prevent fraud.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In accordance with NYSE MKT rules, we are
required to maintain a majority independent board of directors. The various rules and regulations applicable to public companies
make it more difficult and more expensive for us to maintain directors&rsquo; and officers&rsquo; liability insurance, and we may
be required to accept reduced coverage or incur substantially higher costs to maintain coverage. If we are unable to maintain adequate
directors&rsquo; and officers&rsquo; insurance, our ability to recruit and retain qualified officers and directors will be significantly
curtailed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>If securities or industry analysts do not publish research
or publish unfavorable research about our business, our stock price and trading volume could decline.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The trading market for our common stock
will depend in part on the research and reports that securities or industry analysts publish about us or our business. We currently
have three securities analysts and may never obtain additional research coverage by other securities and industry analysts. If
no additional securities or industry analysts commence coverage of our company, the trading price for our stock could be negatively
impacted. If we obtain additional securities or industry analyst coverage and if one or more of the analysts who covers us downgrades
our stock or publishes inaccurate or unfavorable research about our business, our stock price would likely decline. If one or more
of these analysts ceases coverage of us or fails to publish reports on us regularly, demand for our stock could decrease, which
could cause our stock price and trading volume to decline.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>We are an &ldquo;emerging growth company&rdquo; and we
cannot be certain if the reduced disclosure requirements applicable to &ldquo;emerging growth companies&rdquo; will make our common
stock less attractive to investors.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We are an &ldquo;emerging growth company,&rdquo;
as defined under the JOBS Act. For so long as we are an &ldquo;emerging growth company,&rdquo; we intend to take advantage of certain
exemptions from reporting requirements that are applicable to other public companies that are not &ldquo;emerging growth companies&rdquo;
including, but not limited to, compliance with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced
disclosure obligations regarding executive compensation in our periodic reports and proxy statements, and exemptions from the requirements
of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously
approved.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 36; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">&nbsp;</TD><TD STYLE="width: 50%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We could be an &ldquo;emerging growth company&rdquo;
for up to five years, although we may lose such status earlier, depending on the occurrence of certain events. We will remain an
&ldquo;emerging growth company&rdquo; until the earliest to occur of (i) the last day of the fiscal year (a) following the fifth
anniversary of our initial public offering conducted after we became a reporting company under the Exchange Act pursuant to our
registration statement on Form 10 (File No. 000-23930), (b) in which we have total annual gross revenue of at least $1.0 billion
or (c) in which we are deemed to be a &ldquo;large accelerated filer&rdquo; under the Exchange Act, which means that the market
value of our common stock that is held by non-affiliates exceeds $700 million as of June 30<SUP>th</SUP> of the prior year, and
(ii) the date on which we have issued more than $1.0 billion in non-convertible debt securities during the prior three-year period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We cannot predict if investors will find
our common stock less attractive or our company less comparable to certain other public companies because we will rely on these
exemptions. If some investors find our common stock less attractive as a result, there may be a less active trading market for
our common stock and our stock price may be more volatile.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Under the JOBS Act, &ldquo;emerging growth
companies&rdquo; can delay adopting new or revised accounting standards issued subsequent to the enactment of the JOBS Act until
such time as those standards apply to private companies. We have irrevocably elected not to avail ourselves of this exemption from
new or revised accounting standards, and, therefore, will be subject to the same new or revised accounting standards as other public
companies that are not &ldquo;emerging growth companies.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Sales of a substantial number of shares of our common
stock in the public market by our existing stockholders could cause our stock price to decline.* </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Sales of a substantial number of shares
of our common stock in the public market or the perception that these sales might occur, could depress the market price of our
common stock and could impair our ability to raise capital through the sale of additional equity securities. We are unable to predict
the effect that sales may have on the prevailing market price of our common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Certain holders of our common stock are
entitled to rights with respect to the registration of their shares under the Securities Act. Registration of these shares under
the Securities Act would result in the shares becoming freely tradable without restriction under the Securities Act, except for
shares held by our affiliates as defined in Rule 144 under the Securities Act. Any sales of securities by these stockholders could
have a material adverse effect on the trading price of our common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In Amendment No. 1 to Schedule 13D filed
with the Securities and Exchange Commission by Third Security on April 15, 2016, Third Security and its affiliates, including NRM
and Intrexon Corporation, declared their intention to liquidate their holdings in our equity securities. The timing and actual
liquidation of securities by such persons is subject to compliance with applicable law. Furthermore, such declaration is not binding
upon Third Security and its affiliates and thus such liquidation may never occur.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Future sales and issuances of our common stock or rights
to purchase common stock by us, including pursuant to our equity incentive plans, could result in additional dilution of the percentage
ownership of our stockholders and could cause our stock price to decline.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We expect that significant additional capital
will be needed in the future to continue our planned operations, including conducting clinical trials, commercialization efforts,
expanded research and development activities and costs associated with operating as a public company. To the extent we raise additional
capital by issuing equity or convertible securities, our stockholders may experience substantial dilution. We may sell common stock,
convertible securities or other equity securities in one or more transactions at prices and in a manner we determine from time
to time. If we sell common stock, convertible securities or other equity securities in more than one transaction, investors may
be materially diluted by subsequent sales. Such sales may also result in material dilution to our existing stockholders, and new
investors could gain rights superior to our existing stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><A NAME="a_010"></A>Item 2. Unregistered Sales of Equity Securities and Use of
Proceeds</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">None.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><A NAME="a_011"></A>Item 3. Defaults upon Senior Securities</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">None.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><A NAME="a_012"></A>Item 4. Mine Safety Disclosures</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Not applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 37; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">&nbsp;</TD><TD STYLE="width: 50%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><A NAME="a_013"></A>Item 5. Other Information</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">None.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><A NAME="a_014"></A>Item 6. Exhibits</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">See the Exhibit Index following the signature
page of this report, which is incorporated herein by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 38; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">&nbsp;</TD><TD STYLE="width: 50%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U><A NAME="a_015"></A>SIGNATURES</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pursuant to the requirements of the Securities Exchange Act
of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">AMPLIPHI BIOSCIENCES CORPORATION</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Date: May 12, 2016</FONT></TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 5%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">By</FONT></TD>
    <TD STYLE="width: 40%; border-bottom: black 1pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">/s/ Michael Scott Salka</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Name: Michael Scott Salka</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Title: Chief Executive Officer</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;(Principal Executive Officer)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">By</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">/s/ Steve R. Martin</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Name: Steve R. Martin</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Title: Chief Financial Officer</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;(Principal Financial Officer)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 39; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">&nbsp;</TD><TD STYLE="width: 50%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>EXHIBIT INDEX</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD NOWRAP STYLE="width: 10%; border-bottom: Black 1pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Number</FONT></TD>
    <TD NOWRAP STYLE="width: 2%">&nbsp;</TD>
    <TD NOWRAP STYLE="width: 88%; border-bottom: Black 1pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Description</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">3.1</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Amended and Restated Articles of Incorporation of the Registrant, as amended (incorporated by reference to Exhibit 3.1 to the Quarterly Report on Form 10-Q, filed on November 16, 2015).</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">3.2</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Amended and Restated Bylaws of the Registrant, as amended (incorporated by reference to Exhibit 3.2 to the Quarterly Report on Form 10-Q, filed on November 16, 2015). </FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">4.1</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Reference is made to Exhibits 3.1 and 3.2.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">4.2</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Form of Common Stock Certificate (incorporated by reference to Exhibit 4.1 to the Registration Statement on Form 10 (File No. 000-23930), filed December 16, 2013, as amended).</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">4.3</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Form of Warrant to Purchase Shares of Common Stock issued to purchasers in June 2013, July 2013 and December 2013 in connection with private placements (incorporated by reference to Exhibit 4.2 to the Registration Statement on Form 10 (File No. 000-23930), filed December 16, 2013, as amended).</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">4.4</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Subscription Agreement to Purchase Series B Preferred Stock and Common Stock Warrants, dated June 26, 2013 (incorporated by reference to Exhibit 4.3 to the Registration Statement on Form 10 (File No. 000-23930), filed December 16, 2013, as amended).</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">4.5</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Registration Rights Agreement, dated December 16, 2013, by and among the Registrant and certain purchasers of the Registrant&rsquo;s Common Stock (incorporated by reference to Exhibit 4.4 to the Registration Statement on Form 10 (File No. 000-23930), filed December 16, 2013, as amended).</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">4.6</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Subscription Agreement to Purchase Common Stock and Warrants, dated December 16, 2013 (incorporated by reference to Exhibit 4.5 to the Registration Statement on Form 10 (File No. 000-23930), filed December 16, 2013, as amended).</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">4.7</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Subscription Agreement to Purchase Common Stock and Warrants, dated March 10, 2015 (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K, filed March 19, 2015).</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">4.8</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Form of&nbsp;Common Stock Warrant issued to purchasers in March 2015 private placement (incorporated by reference to Exhibit 10.2 to the Current Report on Form 8-K, filed March 19, 2015).</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">4.9</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Registration Rights Agreement, dated March 10, 2015, by and among the Registrant and certain purchasers of the Registrant&rsquo;s Common Stock (incorporated by reference to Exhibit 10.3 to the Current Report on Form 8-K, filed March 19, 2015).</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">4.10</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Form of Amendment to Warrants to Purchase Shares of Common Stock issued to purchasers in June 2013, July 2013 and December 2013 in connection with private placements (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K, filed on May 15, 2015).</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">4.11</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Form of Warrant to Purchase Shares of Common Stock issued in connection with the Registrant&rsquo;s acquisition of Biocontrol Ltd in December 2011 (incorporated by reference to Exhibit 4.11 to the Annual Report on Form 10-K, filed on March 30, 2016).</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">4.12</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Form of Warrant to Purchase Shares of Common Stock issued in connection with the issuance of convertible notes of the Registrant in February 2013, March 2013, April 2013 and May 2013 (incorporated by reference to Exhibit 4.12 to the Annual Report on Form 10-K, filed on March 30, 2016).</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">4.13</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Form of Warrant to Purchase Shares of Common Stock issued in connection with the Registrant&rsquo;s acquisition of certain assets of Novolytics Limited in February 2016 (incorporated by reference to Exhibit 4.13 to the Annual Report on Form 10-K, filed on March 30, 2016).</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">4.14</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Common Stock Issuance Agreement, dated April 8, 2016, by and among the Registrant and the persons and entities listed on Exhibit A thereto (incorporated by reference to Exhibit 4.1 to the Current Report on Form 8-K, filed on April 8, 2016).</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">10.1</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Asset Purchase Agreement, dated as of January 4, 2016, by and between the Registrant and Novolytics Limited (incorporated by reference to Exhibit 10.26 to the Annual Report on Form 10-K, filed on March 30, 2016).</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">10.2+</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Offer Letter, dated as of January 18, 2016, by and between the Registrant and Steve R. Martin (incorporated by reference to Exhibit 99.1 to the Current Report on Form 8-K, filed on January 19, 2016).</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">31.1</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Certification of the Principal Executive Officer required by Rule 13a-14(a) or Rule 15d-14(a).</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">31.2</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Certification of Principal Financial Officer required by Rule 13a-14(a) or Rule 15d-14(a).</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">32.1</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Certification of the Principal Executive Officer Required by Rule 13a-14(b)&nbsp;or Rule 15d-14(b) and 18 U.S.C. 1350.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">32.2</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Certification of the Principal Financial Officer Required by Rule 13a-14(b)&nbsp;or Rule 15d-14(b) and 18 U.S.C. 1350.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">101.INS</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">XBRL Instance Document.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">101.SCH</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">XBRL Taxonomy Extension Schema Document.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">101.CAL</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">XBRL Taxonomy Extension Calculation Linkbase Document.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 40; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">&nbsp;</TD><TD STYLE="width: 50%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 10%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">101.DEF</FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 88%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">XBRL Taxonomy Extension Definition Linkbase Document.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">101.PRE</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">XBRL Taxonomy Extension Presentation Linkbase Document.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">101.LAB</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">XBRL Taxonomy Extension Label Linkbase Document.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">+ Indicates management contract or compensatory plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 41 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">&nbsp;</TD><TD STYLE="width: 50%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 31.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>CERTIFICATION OF PRINCIPAL EXECUTIVE
OFFICER PURSUANT TO </U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>SECTION 302 OF THE SARBANES-OXLEY
ACT OF 2002</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">I, Michael Scott Salka, certify that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.</TD><TD>I have reviewed this quarterly report on Form 10-Q of AmpliPhi Biosciences Corporation;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.</TD><TD>Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact
necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with
respect to the period covered by this report;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">3.</TD><TD>Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in
all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods
presented in this report;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4.</TD><TD>The registrant&rsquo;s other certifying officer and I are responsible for establishing and maintaining disclosure controls
and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined
in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">a)</TD><TD>designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our
supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known
to us by others within those entities, particularly during the period in which this report is being prepared;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">b)</TD><TD>designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed
under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of
financial statements for external purposes in accordance with generally accepted accounting principles;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">c)</TD><TD>evaluated the effectiveness of the registrant&rsquo;s disclosure controls and procedures and presented in this report our conclusions
about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on
such evaluation; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">d)</TD><TD>disclosed in this report any change in the registrant&rsquo;s internal control over financial reporting that occurred during
the registrant&rsquo;s most recent fiscal quarter (the registrant&rsquo;s fourth fiscal quarter in the case of an annual report)
that has materially affected, or is reasonably likely to materially affect, the registrant&rsquo;s internal control over financial
reporting; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">5.</TD><TD>The registrant&rsquo;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control
over financial reporting, to the registrant&rsquo;s auditors and the audit committee of the registrant&rsquo;s board of directors
(or persons performing the equivalent functions):</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">a)</TD><TD>all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting
which are reasonably likely to adversely affect the registrant&rsquo;s ability to record, process, summarize and report financial
information; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">b)</TD><TD>any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&rsquo;s
internal control over financial reporting.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Date: May 12, 2016</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 50%; border-bottom: black 1pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">/s/ Michael Scott Salka</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Michael Scott Salka</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Chief Executive Officer</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(Principal Executive Officer)</FONT></TD></TR>
</TABLE>


<P STYLE="margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 42 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 31.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>CERTIFICATION OF PRINCIPAL FINANCIAL
OFFICER PURSUANT TO </U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>SECTION 302 OF THE SARBANES-OXLEY
ACT OF 2002</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">I, Steve R. Martin, certify that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.</TD><TD>I have reviewed this quarterly report on Form 10-Q of AmpliPhi Biosciences Corporation;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.</TD><TD>Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact
necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with
respect to the period covered by this report;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">3.</TD><TD>Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in
all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods
presented in this report;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4.</TD><TD>The registrant&rsquo;s other certifying officer and I are responsible for establishing and maintaining disclosure controls
and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined
in Exchange Act Rules 13a-15(f) and 15d-15(f) for the registrant and have:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">a)</TD><TD>designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our
supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known
to us by others within those entities, particularly during the period in which this report is being prepared;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">b)</TD><TD>designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed
under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of
financial statements for external purposes in accordance with generally accepted accounting principles;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">c)</TD><TD>evaluated the effectiveness of the registrant&rsquo;s disclosure controls and procedures and presented in this report our conclusions
about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on
such evaluation; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">d)</TD><TD>disclosed in this report any change in the registrant&rsquo;s internal control over financial reporting that occurred during
the registrant&rsquo;s most recent fiscal quarter (the registrant&rsquo;s fourth fiscal quarter in the case of an annual report)
that has materially affected, or is reasonably likely to materially affect, the registrant&rsquo;s internal control over financial
reporting; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">5.</TD><TD>The registrant&rsquo;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control
over financial reporting, to the registrant&rsquo;s auditors and the audit committee of the registrant&rsquo;s board of directors
(or persons performing the equivalent functions):</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">a)</TD><TD>all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting
which are reasonably likely to adversely affect the registrant&rsquo;s ability to record, process, summarize and report financial
information; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">b)</TD><TD>any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&rsquo;s
internal control over financial reporting.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Date: May 12, 2016</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 50%; border-bottom: black 1pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">/s/ Steve R. Martin</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Steve R. Martin</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Chief Financial Officer</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(Principal Financial Officer)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0"></P>



<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 43 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 32.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>CERTIFICATION OF PRINCIPAL EXECUTIVE
OFFICER</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>PURSUANT TO 18 U.S.C. SECTION 1350,</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>AS ADOPTED PURSUANT TO</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>SECTION 906 OF THE SARBANES-OXLEY
ACT OF 2002</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In connection with the quarterly report of AmpliPhi Biosciences
Corporation (the &ldquo;Company&rdquo;) on Form 10-Q for the period ended March 31, 2016 as filed with the Securities and Exchange
Commission (the &ldquo;Report&rdquo;), I, Michael Scott Salka, Chief Executive Officer of the Company, hereby certify as of the
date hereof, solely for purposes of Title 18, Chapter 63, Section 1350 of the United States Code, that to the best of my knowledge:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99.35pt; text-indent: -27.35pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 9%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 3%; font-size: 10pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(1)</FONT></TD>
    <TD STYLE="width: 88%; font-size: 10pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">the Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99.35pt; text-indent: -27.35pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 9%">&nbsp;</TD>
    <TD STYLE="width: 3%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(2)</FONT></TD>
    <TD STYLE="width: 88%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">A signed original of this written statement required by Section
906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the
electronic version of this written statement required by Section 906, has been provided to the Company and will be retained by
the Company and furnished to the Securities and Exchange Commission or its staff upon request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This Certification has not been, and shall not be deemed, &ldquo;filed&rdquo;
with the Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Date: May 12, 2016</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 50%; border-bottom: black 1pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">/s/ Michael Scott Salka</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Michael Scott Salka</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Chief Executive Officer</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(Principal Executive Officer)</FONT></TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 44 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 32.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>CERTIFICATION OF PRINCIPAL FINANCIAL
OFFICER</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>PURSUANT TO 18 U.S.C. SECTION 1350,</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>AS ADOPTED PURSUANT TO</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>SECTION 906 OF THE SARBANES-OXLEY
ACT OF 2002</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">In connection with the quarterly report
of AmpliPhi Biosciences Corporation (the &ldquo;Company&rdquo;) on Form 10-Q for the period ended March 31, 2016 as filed with
the Securities and Exchange Commission (the &ldquo;Report&rdquo;), I, Steve R. Martin, Chief Financial Officer of the Company,
hereby certify as of the date hereof, solely for purposes of Title 18, Chapter 63, Section 1350 of the United States Code, that
to the best of my knowledge:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 9%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 3%; font-size: 10pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(1)</FONT></TD>
    <TD STYLE="width: 88%; font-size: 10pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">the Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 9%">&nbsp;</TD>
    <TD STYLE="width: 3%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(2)</FONT></TD>
    <TD STYLE="width: 88%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">A signed original of this written statement
required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed
form within the electronic version of this written statement required by Section 906, has been provided to the Company and will
be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This Certification has not been, and shall
not be deemed, &ldquo;filed&rdquo; with the Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Date: May 12, 2016</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 50%; border-bottom: black 1pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">/s/ Steve R. Martin</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Steve R. Martin</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Chief Financial Officer</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(Principal Financial Officer)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 45 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<DIV style="text-align: center; min-width: 708">


<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<H1 STYLE="text-indent:0pt; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 9pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">SCHEDULE 14A INFORMATION </H1>

<P STYLE="text-indent:0pt; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934<BR> (Amendment No.&nbsp;&nbsp;)</P>


<DIV ALIGN="CENTER"><BR><IMG SRC="line.gif" ALIGN="MIDDLE" STYLE="width: 180px; height: 1pt; text-align: center"><BR>&nbsp;</DIV>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 1px"></TD>

          <TD STYLE="width: 240px; text-align: left">Filed by the Registrant</TD>

          <TD STYLE="text-align: justify"><FONT STYLE="font-family: wingdings">x</font> </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 1px"></TD>

          <TD STYLE="width: 240px; text-align: left">Filed by a Party other than the Registrant</TD>

          <TD STYLE="text-align: justify"><FONT STYLE="font-family: wingdings">o</font> </TD>

</TR>

</TABLE>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Check the appropriate box: </P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 20px; text-align: left"><FONT STYLE="font-family: wingdings">o</font></TD>

          <TD STYLE="text-align: justify">Preliminary Proxy Statement </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 20px; text-align: left"><FONT STYLE="font-family: wingdings">o</font></TD>

          <TD STYLE="text-align: justify">Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 20px; text-align: left"><FONT STYLE="font-family: wingdings">x</font></TD>

          <TD STYLE="text-align: justify">Definitive Proxy Statement </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 20px; text-align: left"><FONT STYLE="font-family: wingdings">o</font></TD>

          <TD STYLE="text-align: justify">Definitive Additional Materials </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 20px; text-align: left"><FONT STYLE="font-family: wingdings">o</font></TD>

          <TD STYLE="text-align: justify">Soliciting Material Pursuant to &sect;240.14a-12 </TD>

</TR>

</TABLE>

<H1 STYLE="text-indent:0pt; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 18pt; line-height: 20pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 9pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">AMPLIPHI BIOSCIENCES CORPORATION </H1>

<P STYLE="text-indent:0pt; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 8pt; line-height: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(Name of Registrant as Specified In Its Charter) </P>

<P STYLE="text-indent:0pt; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><IMG SRC="line.gif" STYLE="width: 252px; height: 1pt"></P>

<P STYLE="text-indent:0pt; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 8pt; line-height: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(Name of Person(s) Filing Proxy Statement if Other Than the Registrant) </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Payment of Filing Fee (Check the appropriate box) </P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 20px; text-align: left"><FONT STYLE="font-family: wingdings">x</font></TD>

          <TD STYLE="text-align: justify">No fee required. </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 20px; text-align: left"><FONT STYLE="font-family: wingdings">o</font></TD>

          <TD STYLE="text-align: justify">Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. </TD>

</TR>

</TABLE>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 44px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Title of each class of securities to which transaction applies:</P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 44px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><IMG SRC="line.gif" STYLE="width: 100%; height: 1pt"></P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 44px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Aggregate number of securities to which transaction applies: </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 44px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><IMG SRC="line.gif" STYLE="width: 100%; height: 1pt"></P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 44px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (Set forth the amount on which the filing fee is calculated and state how it was determined): </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 44px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><IMG SRC="line.gif" STYLE="width: 100%; height: 1pt"></P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 44px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Proposed maximum aggregate value of transaction: </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 44px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><IMG SRC="line.gif" STYLE="width: 100%; height: 1pt"></P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 44px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Total fee paid: </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 44px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><IMG SRC="line.gif" STYLE="width: 100%; height: 1pt"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 20px; text-align: left"><FONT STYLE="font-family: wingdings">o</font></TD>

          <TD STYLE="text-align: justify">Fee paid previously with preliminary materials. </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 20px; text-align: left"><FONT STYLE="font-family: wingdings">o</font></TD>

          <TD STYLE="text-align: justify">Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. </TD>

</TR>

</TABLE>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 44px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Amount Previously Paid: </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 44px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><IMG SRC="line.gif" STYLE="width: 100%; height: 1pt"></P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 44px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Form, Schedule or Registration Statement No.: </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 44px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><IMG SRC="line.gif" STYLE="width: 100%; height: 1pt"></P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 44px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Filing Party: </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 44px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><IMG SRC="line.gif" STYLE="width: 100%; height: 1pt"></P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 44px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Date Filed: </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 44px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><IMG SRC="line.gif" STYLE="width: 100%; height: 1pt"></P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"></P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<H1 STYLE="text-indent:0pt; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 9pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">AMPLIPHI BIOSCIENCES CORPORATION </H1>

<P STYLE="text-indent:0pt; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">3579 Valley Centre Drive, Suite 100<BR> San Diego, California 92130<BR>&nbsp;<BR><B>NOTICE OF ANNUAL MEETING OF SHAREHOLDERS<BR> TO BE HELD ON JUNE 20, 2016</B> </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Dear Shareholder: </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">You are cordially invited to attend the 2016 Annual Meeting of Shareholders of AmpliPhi Biosciences Corporation, a Washington corporation (&#147;AmpliPhi&#148; or the &#147;Company&#148;). The meeting will be held on Monday, June 20, 2016 at 9:00 a.m. local time at the offices of Cooley LLP located at 4401 Eastgate Mall, San Diego, California 92121 for the following purposes: </P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 20px; text-align: left"><B>1.</B></TD>

          <TD STYLE="text-align: justify">To elect two Class I Directors of the Company, one Class II Director of the Company and one Class III Director of the Company. </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 20px; text-align: left"><B>2.</B></TD>

          <TD STYLE="text-align: justify">Approval of the AmpliPhi 2016 Equity Incentive Plan. </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 20px; text-align: left"><B>3.</B></TD>

          <TD STYLE="text-align: justify">Approval of the AmpliPhi 2016 Employee Stock Purchase Plan. </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 20px; text-align: left"><B>4.</B></TD>

          <TD STYLE="text-align: justify">Approval of the Company&#146;s reincorporation in the State of Delaware, to be effected through a merger with and into a newly formed and wholly owned Delaware subsidiary. </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 20px; text-align: left"><B>5.</B></TD>

          <TD STYLE="text-align: justify">Approval of the issuance by the Company of up to an aggregate of 1,037,053 shares of common stock as and to the extent required to be issued pursuant to the terms and conditions of that certain Common Stock Issuance Agreement, dated April 8, 2016, by and among the Company and certain former holders of the Company&#146;s Series B Convertible Preferred Stock. </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 20px; text-align: left"><B>6.</B></TD>

          <TD STYLE="text-align: justify">Approval of the issuance by the Company of up to an aggregate of 4,706,000 shares of common stock and/or warrants to purchase common stock in a financing that does not constitute a public offering under NYSE MKT rules, for gross sale proceeds of up to $12,000,000 and at a discount to the then-current market value of the Company&#146;s Common Stock not to exceed 15%. </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 20px; text-align: left"><B>7.</B></TD>

          <TD STYLE="text-align: justify">Ratification of the Audit Committee&#146;s selection of Ernst &amp; Young LLP as the Company&#146;s independent registered public accounting firm for the fiscal year ending December 31, 2016. </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 20px; text-align: left"><B>8.</B></TD>

          <TD STYLE="text-align: justify">To conduct any other business properly brought before the meeting. </TD>

</TR>

</TABLE>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">These items of business are more fully described in the Proxy Statement accompanying this Notice. </P>

<P STYLE="text-indent:0pt; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><I>[continued on next page]</I> </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"></P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The record date for the meeting is May 20, 2016. Only shareholders of record at the close of business on that date may vote at the meeting or any adjournment thereof. </P>

<DIV STYLE="padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt; border-style: solid"><P STYLE="text-indent:0pt; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><font style="font-family: Times New Roman, Times, Serif"><B>Important Notice Regarding the Availability of Proxy Materials for the 2016 Annual Meeting of Shareholders </B><B>to be held on June 20, 2016 at 9:00 a.m. local time at the offices of Cooley LLP </B><B>located at 4401 Eastgate Mall, San Diego, California 92121</B><B><BR> &nbsp;<BR>The proxy statement and annual report to shareholders are available at<BR> <B><I>
www.ampliphibio.com/investor-relations.html.</B></font></DIV></I></B></P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 244px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">By Order of the Board of Directors,<BR></P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 244px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><IMG SRC="sig_jcook.jpg" WIDTH="146" ALIGN="MIDDLE" ALT="[GRAPHIC MISSING]"></P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 244px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Jeremy Curnock Cook<BR> <I>Chairman of the Board of Directors</I> </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">San Diego, California<BR> May 20, 2016 </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>You are cordially invited to attend the meeting in person. Whether or not you expect to attend the meeting, please complete, date, sign and return the enclosed proxy, or vote over the telephone or the internet as instructed in these materials, as promptly as possible in order to ensure your representation at the meeting. A return envelope (which is postage prepaid if mailed in the United States) has been provided for your convenience. Even if you have voted by proxy, you may still vote in person if you attend the meeting. Please note, however, that if your shares are held of record by a broker, bank or other nominee and you
wish to vote at the meeting, you must obtain a proxy issued in your name from that record holder.</B> </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"></P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<H1 STYLE="text-indent:0pt; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 9pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">AMPLIPHI BIOSCIENCES CORPORATION</H1>

<P STYLE="text-indent:0pt; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">3579 Valley Centre Drive, Suite 100<BR>San Diego, California 92130 </P>

<H1 STYLE="text-indent:0pt; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 9pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">PROXY STATEMENT<BR>FOR THE 2016 ANNUAL MEETING OF SHAREHOLDERS<BR>TO BE HELD ON JUNE 20, 2016<BR> &nbsp;<BR>QUESTIONS AND ANSWERS ABOUT THESE PROXY MATERIALS AND VOTING<BR> </H1>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Why am I receiving these materials? </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">We have sent you these proxy materials because the Board of Directors (sometimes referred to as the &#147;Board&#148;) of AmpliPhi Biosciences Corporation (sometimes referred to as the &#147;Company&#148; or &#147;AmpliPhi&#148;) is soliciting your proxy to vote at the 2016 Annual Meeting of Shareholders (the &#147;annual meeting&#148; or the &#147;meeting&#148;), including at any adjournments or postponements of the meeting. You are invited to attend the annual meeting to vote on the proposals described in this proxy statement. However, you do not need to attend the meeting to vote your shares. Instead, you may simply
complete, sign and return the enclosed proxy card or follow the instructions below to submit your proxy over the telephone or through the internet. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">We intend to mail these proxy materials on or about May 23, 2016 to all shareholders of record entitled to vote at the annual meeting. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">How do I attend the annual meeting? </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The meeting will be held on Monday, June 20, 2016 at 9:00 a.m. local time at the offices of Cooley LLP located at 4401 Eastgate Mall, San Diego, California 92121. Directions to the annual meeting may be found at <I>www.ampliphibio.com/investor-relations.html</I>. Information on how to vote in person at the annual meeting is discussed below. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Who can vote at the annual meeting? </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Only shareholders of record at the close of business on May 20, 2016 will be entitled to vote at the annual meeting. On this record date, there were 8,242,528 shares of common stock outstanding and entitled to vote. </P>

<H4 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: italic; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Shareholder of Record: Shares Registered in Your Name </H4>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">If on May 20, 2016 your shares were registered directly in your name with AmpliPhi&#146;s transfer agent, Computershare, Inc., then you are a shareholder of record. As a shareholder of record, you may vote in person at the meeting or vote by proxy. Whether or not you plan to attend the meeting, we urge you to fill out and return the enclosed proxy card or vote by proxy over the telephone or on the internet as instructed below to ensure your vote is counted. </P>

<H4 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: italic; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Beneficial Owner: Shares Registered in the Name of a Broker or Bank </H4>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">If on May 20, 2016 your shares were held, not in your name, but rather in an account at a brokerage firm, bank, dealer or other similar organization, then you are the beneficial owner of shares held in &#147;street name&#148; and these proxy materials are being forwarded to you by that organization. The organization holding your account is considered to be the shareholder of record for purposes of voting at the annual meeting. As a beneficial owner, you have the right to direct your broker or other agent regarding how to vote the shares in your account. You are also invited to attend the annual meeting. However, since you are
not the shareholder of record, you may not vote your shares in person at the meeting unless you request and obtain a valid proxy from your broker or other agent. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">What am I voting on? </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">There are seven matters scheduled for a vote: </P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">Election of the four nominees for director named in this proxy statement, consisting of two Class I directors, one Class II director and one Class III director, to hold office until our 2019 Annual Meeting of Shareholders, 2017 Annual Meeting of Shareholders and 2018 Annual Meeting of Shareholders, respectively; </TD>

</TR>

</TABLE>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">1</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">Approval of the AmpliPhi 2016 Equity Incentive Plan; </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">Approval of the AmpliPhi 2016 Employee Stock Purchase Plan; </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">Approval of the Company&#146;s reincorporation in the State of Delaware, to be effected through a merger with and into a newly formed and wholly owned Delaware subsidiary; </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">Approval of the issuance by the Company of up to an aggregate of 1,037,053 shares of common stock as and to the extent required to be issued pursuant to the terms and conditions of that certain Common Stock Issuance Agreement, dated April 8, 2016, by and among the Company and certain former holders of the Company&#146;s Series B Convertible Preferred Stock; </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">Approval of the issuance by the Company of up to an aggregate of 4,706,000 shares of common stock and/or warrants to purchase common stock in a financing that does not constitute a public offering under NYSE MKT rules, for gross sale proceeds of up to $12,000,000 and at a discount to the then-current market value of the Company&#146;s Common Stock not to exceed 15%; and </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">Ratification of the Audit Committee&#146;s selection of Ernst &amp; Young LLP as the Company&#146;s independent registered public accounting firm for the fiscal year ending December 31, 2016. </TD>

</TR>

</TABLE>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">What if another matter is properly brought before the meeting? </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The Board of Directors knows of no other matters that will be presented for consideration at the annual meeting. If any other matters are properly brought before the meeting, it is the intention of the persons named in the accompanying proxy to vote on those matters in accordance with their best judgment. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">How do I vote? </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">You may either vote &#147;For&#148; all the nominees to the Board of Directors or you may &#147;Withhold&#148; your vote for any nominee you specify. For each of the other matters to be voted on, you may vote &#147;For&#148; or &#147;Against&#148; or abstain from voting. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The procedures for voting are fairly simple: </P>

<H4 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: italic; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Shareholder of Record: Shares Registered in Your Name </H4>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">If you are a shareholder of record, you may vote in person at the annual meeting, vote by proxy over the telephone, vote by proxy using the enclosed proxy card or vote by proxy through the internet. Whether or not you plan to attend the meeting, we urge you to vote by proxy to ensure your vote is counted. You may still attend the meeting and vote in person even if you have already voted by proxy. </P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">To vote in person, come to the annual meeting and we will give you a ballot when you arrive. </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">To vote using the proxy card, simply complete, sign and date the enclosed proxy card and return it promptly in the envelope provided. If you return your signed proxy card to us before the annual meeting, we will vote your shares as you direct. </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">To vote over the telephone, dial toll-free 1-800-652-8683 using a touch-tone phone and follow the recorded instructions. You will be asked to provide the company number and control number from the enclosed proxy card. Your vote must be received by 11:59 p.m. Eastern Time on June 19, 2016 to be counted. </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">To vote through the internet, go to <I>www.envisionreports.com/APHB</I> to complete an electronic proxy card. You will be asked to provide the company number and control number from the enclosed proxy card. Your vote must be received by 11:59 p.m. Eastern Time on June 19, 2016 to be counted. </TD>

</TR>

</TABLE>

<H4 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: italic; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Beneficial Owner: Shares Registered in the Name of Broker or Bank </H4>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">If you are a beneficial owner of shares registered in the name of your broker, bank, or other agent, you should have received a voting instruction form with these proxy materials from that organization rather than from AmpliPhi. Simply complete and mail the voting instruction form to ensure that your vote is counted. Alternatively, you may vote by telephone or over the internet as instructed by your broker or bank. To vote in </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">2</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">person at the annual meeting, you must obtain a valid proxy from your broker, bank or other agent. Follow the instructions from your broker or bank included with these proxy materials, or contact your broker or bank to request a proxy form. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>We provide internet proxy voting to allow you to vote your shares online, with procedures designed to ensure the authenticity and correctness of your proxy vote instructions. However, please be aware that you must bear any costs associated with your internet access, such as usage charges from internet access providers and telephone companies.</B> </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">How many votes do I have? </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">On each matter to be voted upon, you have one vote for each share of common stock you owned as of the close of business on May 20, 2016. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">What happens if I do not vote? </H2>

<H4 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: italic; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Shareholder of Record: Shares Registered in Your Name </H4>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">If you are a shareholder of record and do not vote by completing your proxy card, by telephone, through the internet or in person at the annual meeting, your shares will not be voted. </P>

<H4 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: italic; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Beneficial Owner: Shares Registered in the Name of Broker or Bank </H4>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">If you are a beneficial owner and do not instruct your broker, bank, or other agent how to vote your shares, the question of whether your broker or nominee will still be able to vote your shares depends on whether the New York Stock Exchange deems the particular proposal to be a &#147;routine&#148; matter. Brokers and nominees can use their discretion to vote &#147;uninstructed&#148; shares with respect to matters that are considered to be &#147;routine,&#148; but not with respect to &#147;non-routine&#148; matters. Under the rules and interpretations of the New York Stock Exchange, &#147;non-routine&#148; matters are matters
that may substantially affect the rights or privileges of shareholders, such as mergers, shareholder proposals, elections of directors (even if not contested), and certain corporate governance proposals, even if management-supported. Accordingly, your broker or nominee may not vote your shares on Proposals 1, 2, 3, 4, 5 or 6 without your instructions, but may vote your shares on Proposal 7 even in the absence of your instruction. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">What if I return a proxy card or otherwise vote but do not make specific choices? </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">If you return a signed and dated proxy card or otherwise vote without marking voting selections, your shares will be voted, as applicable: &#147;For&#148; Proposal 1, the election of all four nominees for director; &#147;For&#148; Proposal 2, approval of the AmpliPhi 2016 Equity Incentive Plan; &#147;For&#148; Proposal 3, approval of the AmpliPhi 2016 Employee Stock Purchase Plan; &#147;For&#148; Proposal 4, approval of the Company&#146;s reincorporation in the State of Delaware; &#147;For&#148; Proposal 5, approval of the issuance by the Company of up to an aggregate of 1,037,053 shares of common stock, as and to the extent
required to be issued pursuant to a certain Common Stock Issuance Agreement; &#147;For&#148; Proposal 6, approval of the issuance by the Company of up to an aggregate of 4,706,000 shares of common stock and/or warrants to purchase common stock in a non-public financing for gross sale proceeds of up to $12,000,000 and at a discount to the then-current market value of the common stock not to exceed 15%; and &#147;For&#148; Proposal 7, ratification of the selection of Ernst &amp; Young LLP as the Company&#146;s independent registered public accounting firm. If any other matter is properly presented at the meeting, your proxyholder (one of the individuals named on your proxy card) will vote your shares using his or her best judgment. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Who is paying for this proxy solicitation? </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">We will pay for the entire cost of soliciting proxies. In addition to these proxy materials, our directors and employees and Georgeson LLC may also solicit proxies in person, by telephone, or by other means of communication. Directors and employees will not be paid any additional compensation for soliciting proxies, Georgeson LLC will be paid its customary fee of approximately $10,000, plus out-of-pocket expenses if it solicits proxies. We may also reimburse brokerage firms, banks and other agents for the cost of forwarding proxy materials to beneficial owners. </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">3</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">What does it mean if I receive more than one set of proxy materials? </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">If you receive more than one set of proxy materials, your shares may be registered in more than one name or in different accounts. Please follow the voting instructions on the proxy cards in the proxy materials to ensure that all of your shares are voted. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Can I change my vote after submitting my proxy? </H2>

<H4 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: italic; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Shareholder of Record: Shares Registered in Your Name </H4>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Yes. You can revoke your proxy at any time before the final vote at the meeting. If you are the record holder of your shares, you may revoke your proxy in any one of the following ways: </P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">You may submit another properly completed proxy card with a later date. </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">You may grant a subsequent proxy by telephone or through the internet. </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">You may send a timely written notice that you are revoking your proxy to our Secretary at AmpliPhi Biosciences Corporation, 3579 Valley Centre Drive, Suite 100, San Diego, California 92130. </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">You may attend the annual meeting and vote in person. Simply attending the meeting will not, by itself, revoke your proxy. </TD>

</TR>

</TABLE>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Your most current proxy card or telephone or internet proxy is the one that is counted. </P>

<H4 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: italic; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Beneficial Owner: Shares Registered in the Name of Broker or Bank </H4>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">If your shares are held by your broker or bank as a nominee or agent, you should follow the instructions provided by your broker or bank. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">When are shareholder proposals and director nominations due for next year&#146;s annual meeting? </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">To be considered for inclusion in next year&#146;s proxy materials, your proposal must be submitted in writing by January 23, 2017, to our Secretary at AmpliPhi Biosciences Corporation, 3579 Valley Centre Drive, Suite 100, San Diego, California 92130. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">If Proposal 4 is approved at the annual meeting and we reincorporate in the State of Delaware, and if you wish to submit a proposal (including a director nomination) that is not to be included in next year&#146;s proxy materials, your proposal generally must be submitted in writing to the same address no later than March 22, 2017 but no earlier than February 20, 2017. Please review our bylaws to be adopted if Proposal 4 is approved at the annual meeting, attached as Appendix E to this proxy statement, which contain additional requirements regarding advance notice of shareholder proposals and nominations. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">If Proposal 4 is not approved at the annual meeting, and you wish to submit a proposal (including a director nomination) that is not to be included in next year&#146;s proxy materials, your proposal generally must be submitted in writing to the same address not fewer than 60 nor more than 90 days prior to the date approved by the Board of Directors to hold the 2017 Annual Meeting of Shareholders; provided, that if we provide less than 60 days&#146; notice of such date, your proposal (including a director nomination) must be received by our Secretary not later than the tenth day following the day on which the notice of the date
of the 2017 Annual Meeting of Shareholders is mailed or publicly disclosed. Please review our current bylaws, which contain additional requirements regarding advance notice of shareholder proposals and nominations. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">How are votes counted? </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Votes will be counted by the inspector of election appointed for the meeting, who will separately count, for the proposal to elect directors, votes &#147;For,&#148; &#147;Withhold&#148; and broker non-votes; and, with respect to other proposals, votes &#147;For&#148; and &#147;Against,&#148; abstentions and, if applicable, broker non-votes. Under the rules of the NYSE MKT, abstentions are considered to be votes &#147;cast&#148; and will have the same effect as &#147;Against&#148; votes for each of Proposals 2, 3, 4, 5, 6 and 7. Broker non-votes will not be counted towards the vote total for any proposal, except Proposal 4, for
which broker non-votes will have the same effect as &#147;Against&#148; votes. </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">4</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">What are &#147;broker non-votes&#148;? </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">As discussed above, when a beneficial owner of shares held in &#147;street name&#148; does not give instructions to the broker or nominee holding the shares as to how to vote on matters deemed by the New York Stock Exchange to be &#147;non-routine,&#148; the broker or nominee cannot vote the shares. These unvoted shares are counted as &#147;broker non-votes.&#148; </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">How many votes are needed to approve each proposal? </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The following table summarizes the minimum vote needed to approve each proposal and the effect of abstentions and broker non-votes. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"></P>

<DIV style="text-align: center"><TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="608" STYLE="vertical-align: text-top; text-indent:0px; text-align: left; font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: -15pt; *margin-top: -20pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR>

          <TD><IMG HEIGHT="1" SRC="spacer.gif" WIDTH="66"></TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none"><!-- GUTTER -->&nbsp;</TD>

          <TD><IMG HEIGHT="1" SRC="spacer.gif" WIDTH="176"></TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none"><!-- GUTTER -->&nbsp;</TD>

          <TD><IMG HEIGHT="1" SRC="spacer.gif" WIDTH="176"></TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none"><!-- GUTTER -->&nbsp;</TD>

          <TD><IMG HEIGHT="1" SRC="spacer.gif" WIDTH="61"></TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none"><!-- GUTTER -->&nbsp;</TD>

          <TD><IMG HEIGHT="1" SRC="spacer.gif" WIDTH="64"></TD>

</TR>

<TR STYLE="vertical-align: top">

          <TD STYLE="line-height: normal; vertical-align: bottom; font-weight: bold; font-size: 8pt; text-align: left; border-bottom: 1pt solid black" ROWSPAN=1 COLSPAN=1>Proposal<BR> Number</TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="line-height: normal; vertical-align: bottom; font-weight: bold; font-size: 8pt; text-align: center; border-bottom: 1pt solid black" ROWSPAN=1 COLSPAN=1>Proposal Description</TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="line-height: normal; vertical-align: bottom; font-weight: bold; font-size: 8pt; text-align: center; border-bottom: 1pt solid black" ROWSPAN=1 COLSPAN=1>Vote Required for Approval</TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="line-height: normal; vertical-align: bottom; font-weight: bold; font-size: 8pt; text-align: center; border-bottom: 1pt solid black" ROWSPAN=1 COLSPAN=1>Effect of<BR> Abstentions</TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="line-height: normal; vertical-align: bottom; font-weight: bold; font-size: 8pt; text-align: center; border-bottom: 1pt solid black" ROWSPAN=1 COLSPAN=1>Effect of<BR> Broker<BR> Non-Votes</TD>

</TR>

<TR STYLE="vertical-align: top">

          <TD STYLE="text-align: center" ROWSPAN=1 COLSPAN=1>1</TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD ROWSPAN=1 COLSPAN=1 STYLE="text-align: left">Election of Directors</TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD ROWSPAN=1 COLSPAN=1 STYLE="text-align: left">The four nominees receiving the most &#147;For&#148; votes will be elected to the Board of Directors.</TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD ROWSPAN=1 COLSPAN=1 STYLE="text-align: left">None</TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD ROWSPAN=1 COLSPAN=1 STYLE="text-align: left">None</TD>

</TR>

<TR STYLE="vertical-align: top">

          <TD STYLE="text-align: center" ROWSPAN=1 COLSPAN=1>2</TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD ROWSPAN=1 COLSPAN=1 STYLE="text-align: left">Approval of the AmpliPhi 2016 Equity Incentive Plan</TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD ROWSPAN=1 COLSPAN=1 STYLE="text-align: left">The number of shares that vote &#147;For&#148; the proposal must exceed the number of shares that vote &#147;Against&#148; the proposal.</TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD ROWSPAN=1 COLSPAN=1 STYLE="text-align: left">Against</TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD ROWSPAN=1 COLSPAN=1 STYLE="text-align: left">None</TD>

</TR>

<TR STYLE="vertical-align: top">

          <TD STYLE="text-align: center" ROWSPAN=1 COLSPAN=1>3</TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD ROWSPAN=1 COLSPAN=1 STYLE="text-align: left">Approval of the AmpliPhi 2016 Employee Stock Purchase Plan</TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD ROWSPAN=1 COLSPAN=1 STYLE="text-align: left">The number of shares that vote &#147;For&#148; the proposal must exceed the number of shares that vote &#147;Against&#148; the proposal.</TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD ROWSPAN=1 COLSPAN=1 STYLE="text-align: left">Against</TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD ROWSPAN=1 COLSPAN=1 STYLE="text-align: left">None</TD>

</TR>

<TR STYLE="vertical-align: top">

          <TD STYLE="text-align: center" ROWSPAN=1 COLSPAN=1>4</TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD ROWSPAN=1 COLSPAN=1 STYLE="text-align: left">Approval of the Company&#146;s reincorporation in the State of Delaware, to be effected through a merger with and into a newly formed and wholly owned Delaware subsidiary</TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD ROWSPAN=1 COLSPAN=1 STYLE="text-align: left">&#147;For&#148; votes from the holders of at least 51% of the shares outstanding on the record date.</TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD ROWSPAN=1 COLSPAN=1 STYLE="text-align: left">Against</TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD ROWSPAN=1 COLSPAN=1 STYLE="text-align: left">Against</TD>

</TR>

<TR STYLE="vertical-align: top">

          <TD STYLE="text-align: center" ROWSPAN=1 COLSPAN=1>5</TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD ROWSPAN=1 COLSPAN=1 STYLE="text-align: left">Approval of the issuance by the Company of up to an aggregate of 1,037,053 shares of common stock as and to the extent required to be issued pursuant to the terms of that certain Common Stock Issuance Agreement, dated April 8, 2016, by and among the Company and certain former holders of the Company&#146;s Series B convertible preferred stock</TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD ROWSPAN=1 COLSPAN=1 STYLE="text-align: left">The number of shares that vote &#147;For&#148; the proposal must exceed the number of shares that vote &#147;Against&#148; the proposal.</TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD ROWSPAN=1 COLSPAN=1 STYLE="text-align: left">Against</TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD ROWSPAN=1 COLSPAN=1 STYLE="text-align: left">None </TD>

</TR>

</TABLE></DIV>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">5</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<DIV style="text-align: center"><TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="608" STYLE="vertical-align: text-top; text-indent:0px; text-align: left; font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: -15pt; *margin-top: -20pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR>

          <TD><IMG HEIGHT="1" SRC="spacer.gif" WIDTH="66"></TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none"><!-- GUTTER -->&nbsp;</TD>

          <TD><IMG HEIGHT="1" SRC="spacer.gif" WIDTH="176"></TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none"><!-- GUTTER -->&nbsp;</TD>

          <TD><IMG HEIGHT="1" SRC="spacer.gif" WIDTH="176"></TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none"><!-- GUTTER -->&nbsp;</TD>

          <TD><IMG HEIGHT="1" SRC="spacer.gif" WIDTH="61"></TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none"><!-- GUTTER -->&nbsp;</TD>

          <TD><IMG HEIGHT="1" SRC="spacer.gif" WIDTH="64"></TD>

</TR>

<TR STYLE="vertical-align: top">

          <TD STYLE="line-height: normal; vertical-align: bottom; font-weight: bold; font-size: 8pt; text-align: left; border-bottom: 1pt solid black" ROWSPAN=1 COLSPAN=1>Proposal<BR> Number</TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="line-height: normal; vertical-align: bottom; font-weight: bold; font-size: 8pt; text-align: center; border-bottom: 1pt solid black" ROWSPAN=1 COLSPAN=1>Proposal Description</TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="line-height: normal; vertical-align: bottom; font-weight: bold; font-size: 8pt; text-align: center; border-bottom: 1pt solid black" ROWSPAN=1 COLSPAN=1>Vote Required for Approval</TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="line-height: normal; vertical-align: bottom; font-weight: bold; font-size: 8pt; text-align: center; border-bottom: 1pt solid black" ROWSPAN=1 COLSPAN=1>Effect of<BR> Abstentions</TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="line-height: normal; vertical-align: bottom; font-weight: bold; font-size: 8pt; text-align: center; border-bottom: 1pt solid black" ROWSPAN=1 COLSPAN=1>Effect of<BR> Broker<BR> Non-Votes</TD>

</TR>

<TR STYLE="vertical-align: top">

          <TD STYLE="text-align: center" ROWSPAN=1 COLSPAN=1>6</TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD ROWSPAN=1 COLSPAN=1 STYLE="text-align: left">Approval of the issuance by the Company of up to an aggregate of 4,706,000 shares of common stock and/or warrants to purchase common stock in a financing that does not constitute a public offering under NYSE MKT rules, for gross sale proceeds of up to $12,000,000 and at a discount to the then-current market value of the Company&#146;s Common Stock not to exceed 15%</TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD ROWSPAN=1 COLSPAN=1 STYLE="text-align: left">The number of shares that vote &#147;For&#148; the proposal must exceed the number of shares that vote &#147;Against&#148; the proposal.</TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD ROWSPAN=1 COLSPAN=1 STYLE="text-align: left">Against</TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD ROWSPAN=1 COLSPAN=1 STYLE="text-align: left">None</TD>

</TR>

<TR STYLE="vertical-align: top">

          <TD STYLE="text-align: center" ROWSPAN=1 COLSPAN=1>7</TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD ROWSPAN=1 COLSPAN=1 STYLE="text-align: left">Ratification of the Audit Committee&#146;s selection of Ernst &amp; Young LLP as the Company&#146;s independent registered public accounting firm for the fiscal year ending December 31, 2016</TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD ROWSPAN=1 COLSPAN=1 STYLE="text-align: left">The number of shares that cast a vote &#147;For&#148; the proposal must exceed the number of shares that cast a vote &#147;Against&#148; the proposal.</TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD ROWSPAN=1 COLSPAN=1 STYLE="text-align: left">Against</TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD ROWSPAN=1 COLSPAN=1 STYLE="text-align: left">None</TD>

</TR>

</TABLE></DIV>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">What is the quorum requirement? </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">A quorum of shareholders is necessary to hold a valid meeting. A quorum will be present if shareholders holding at least a majority of the outstanding shares entitled to vote on a matter and be counted collectively upon such matter are present at the meeting in person or represented by proxy. On the record date, there were 8,242,528 shares outstanding and entitled to vote. Thus, the holders of 4,121,265 shares must be present in person or represented by proxy at the meeting to have a quorum. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Your shares will be counted towards the quorum only if you submit a valid proxy (or one is submitted on your behalf by your broker, bank or other nominee) or if you vote in person at the meeting. Abstentions and broker non-votes will be counted towards the quorum requirement. If there is no quorum, the holders of a majority of shares at the meeting in person or represented by proxy may adjourn the meeting to another date. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">How can I find out the results of the voting at the annual meeting? </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Preliminary voting results will be announced at the annual meeting. In addition, final voting results will be published in a current report on Form 8-K that we expect to file within four business days after the annual meeting. If final voting results are not available to us in time to file a Form 8-K within four business days after the meeting, we intend to file a Form 8-K to publish preliminary results and, within four business days after the final results are known to us, file an additional Form 8-K to publish the final results. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">What proxy materials are available on the internet? </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The proxy statement, Form 10-K and annual report to shareholders are available at <I>www.ampliphibio.com/investor-relations.html</I>. </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">6</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<H1 STYLE="text-indent:0pt; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 9pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><FONT STYLE="font-variant: small-caps">Proposal 1<BR> &nbsp;<BR>Election Of Directors</FONT> </H1>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">AmpliPhi&#146;s Board of Directors is divided into three classes. Each class consists, as nearly as possible, of one-third of the total number of directors, and each class has a three-year term. Under our current bylaws, any vacancy occurring on the Board (other than a director removed for cause by the shareholders) may be filled by the shareholders, the Board or, if the directors in office constitute fewer than a quorum, by the affirmative vote of a majority of the remaining directors. A vacancy occurring as a result of the removal of a director for cause may be filled only by a vote of the holders of two-thirds of the shares
then entitled to elect the director removed. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The Board of Directors presently has seven members. There are two directors in Class I, whose term of office expires in 2016. The two nominees for Class I director are Louis Drapeau and Michael S. Perry, Ph.D. Each of the Class I director nominees is currently a director of the Company who was previously elected by the shareholders. If elected at the annual meeting, each of these Class I director nominees would serve until the 2019 Annual Meeting of Shareholders and until his successor has been duly elected and qualified, or, if sooner, until the director&#146;s death, resignation or removal. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Pursuant to Washington law and our current bylaws, the term of a director elected by the Board to fill a vacancy expires at the next shareholders' meeting at which directors are elected, regardless of whether the term of any other directors in the same class expire at a later date. Vijay Samant and Paul C. Grint, M.D. were elected by the Board in November 2015 to serve as a Class II director and a Class III director, respectively. Consequently, Mr. Samant&#146;s and Dr. Grint&#146;s term of office will expire at the annual meeting. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">If elected at the annual meeting, Mr. Samant will serve as a director until the 2017 Annual Meeting of Shareholders and until his successor has been duly elected and qualified, or until his earlier death, resignation or removal. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">If elected at the annual meeting, Dr. Grint will serve as a director until the 2018 Annual Meeting of Shareholders and until his successor has been duly elected and qualified, or until his earlier death, resignation or removal. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Directors are elected by a plurality of the votes of the holders of shares present in person or represented by proxy and entitled to vote on the election of directors. Accordingly, the four nominees receiving the highest number of affirmative votes will be elected. Shares represented by executed proxies will be voted, if authority to do so is not withheld, for the election of the four nominees named below. If any nominee becomes unavailable for election as a result of an unexpected occurrence, shares that would have been voted for that nominee will instead be voted for the election of a substitute nominee proposed by the Board
of Directors. Each person nominated for election has agreed to serve if elected. The Company&#146;s management has no reason to believe that any nominee will be unable to serve. </P>

<H1 STYLE="text-indent:0pt; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 9pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><FONT STYLE="font-variant: small-caps">The Board of Directors Recommends<BR> a Vote &#147;for&#148; Each Named Nominee</FONT> </H1>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The following table sets forth information for our current directors: </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"></P>

<DIV style="text-align: center"><TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="554" STYLE="vertical-align: text-top; text-indent:0px; text-align: left; font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: -15pt; *margin-top: -20pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR>

          <TD><IMG HEIGHT="1" SRC="spacer.gif" WIDTH="258"></TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none"><!-- GUTTER -->&nbsp;</TD>

          <TD><IMG HEIGHT="1" SRC="spacer.gif" WIDTH="32"></TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none"><!-- GUTTER -->&nbsp;</TD>

          <TD><IMG HEIGHT="1" SRC="spacer.gif" WIDTH="232"></TD>

</TR>

<TR STYLE="vertical-align: top">

          <TD STYLE="line-height: normal; vertical-align: bottom; font-weight: bold; font-size: 8pt; text-align: left; border-bottom: 1pt solid black" ROWSPAN=1 COLSPAN=1>Name</TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="line-height: normal; vertical-align: bottom; font-weight: bold; font-size: 8pt; text-align: center; border-bottom: 1pt solid black" ROWSPAN=1 COLSPAN=1>Age</TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="line-height: normal; vertical-align: bottom; font-weight: bold; font-size: 8pt; text-align: center; border-bottom: 1pt solid black" ROWSPAN=1 COLSPAN=1>Position</TD>

</TR>

<TR STYLE="vertical-align: top">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt" ROWSPAN=1 COLSPAN=1>M. Scott Salka</TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD ROWSPAN=1 COLSPAN=1 STYLE="text-align: center">54</TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD ROWSPAN=1 COLSPAN=1 STYLE="text-align: left">Chief Executive Officer, Director</TD>

</TR>

<TR STYLE="vertical-align: top">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt" ROWSPAN=1 COLSPAN=1>Wendy S. Johnson</TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD ROWSPAN=1 COLSPAN=1 STYLE="text-align: center">64</TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD ROWSPAN=1 COLSPAN=1 STYLE="text-align: left">Interim Chief Operating Officer, Director</TD>

</TR>

<TR STYLE="vertical-align: top">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt" ROWSPAN=1 COLSPAN=1>Jeremy Curnock Cook<sup>&#040;2&#041;</sup><sup>&#040;3&#041;</sup></TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD ROWSPAN=1 COLSPAN=1 STYLE="text-align: center">66</TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD ROWSPAN=1 COLSPAN=1 STYLE="text-align: left">Chairman of the Board</TD>

</TR>

<TR STYLE="vertical-align: top">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt" ROWSPAN=1 COLSPAN=1>Louis Drapeau<sup>&#040;1&#041;</sup><sup>&#040;3&#041;</sup></TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD ROWSPAN=1 COLSPAN=1 STYLE="text-align: center">72</TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD ROWSPAN=1 COLSPAN=1 STYLE="text-align: left">Director</TD>

</TR>

<TR STYLE="vertical-align: top">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt" ROWSPAN=1 COLSPAN=1>Michael S. Perry, Ph.D.<sup>&#040;1&#041;</sup><sup>&#040;2&#041;</sup><sup>&#040;3&#041;</sup></TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD ROWSPAN=1 COLSPAN=1 STYLE="text-align: center">56</TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD ROWSPAN=1 COLSPAN=1 STYLE="text-align: left">Director</TD>

</TR>

<TR STYLE="vertical-align: top">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt" ROWSPAN=1 COLSPAN=1>Vijay B. Samant<sup>&#040;1&#041;</sup></TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD ROWSPAN=1 COLSPAN=1 STYLE="text-align: center">63</TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD ROWSPAN=1 COLSPAN=1 STYLE="text-align: left">Director</TD>

</TR>

<TR STYLE="vertical-align: top">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt" ROWSPAN=1 COLSPAN=1>Paul C. Grint, M.D.<sup>&#040;2&#041;</sup></TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD ROWSPAN=1 COLSPAN=1 STYLE="text-align: center">58</TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD ROWSPAN=1 COLSPAN=1 STYLE="text-align: left">Director</TD>

</TR>

</TABLE></DIV>


<P STYLE="text-align: left; text-indent: 1px"><IMG SRC="line.gif" STYLE="width: 72px; height: 1pt"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 1px"></TD>

          <TD STYLE="width: 20px; text-align: left">(1)</TD>

          <TD STYLE="text-align: justify">Member of the Audit Committee. </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 1px"></TD>

          <TD STYLE="width: 20px; text-align: left">(2)</TD>

          <TD STYLE="text-align: justify">Member of the Compensation Committee. </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 1px"></TD>

          <TD STYLE="width: 20px; text-align: left">(3)</TD>

          <TD STYLE="text-align: justify">Member of the Nominating and Corporate Governance Committee. </TD>

</TR>

</TABLE>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">7</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The Nominating and Corporate Governance Committee seeks to assemble a Board of Directors that, as a whole, possesses the appropriate balance of professional and industry knowledge, financial expertise and high-level management experience necessary to oversee and direct the Company&#146;s business. To that end, the Nominating and Corporate Governance Committee has identified and evaluated nominees in the broader context of the Board of Directors&#146; overall composition, with the goal of recruiting members who complement and strengthen the skills of other members and who also exhibit integrity, collegiality, sound business
judgment and other qualities that the Nominating and Corporate Governance Committee views as critical to effective functioning of the Board of Directors. The brief biographies below include information regarding the specific and particular experience, qualifications, attributes or skills of each nominee that led the Nominating and Corporate Governance Committee to recommend that person as a nominee. However, each of the members of the Nominating and Corporate Governance Committee may have a variety of reasons why he believes a particular person would be an appropriate nominee for the Board of Directors, and these views may differ from the views of other members. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><FONT STYLE="font-variant: small-caps">Nominees for Election for a Three-year Term Expiring at the 2019 Annual Meeting</FONT> </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B><I>Louis Drapeau </I></B>has served as a member of our Board of Directors since March 2011. Since October 2007 through February 2016, Mr. Drapeau has served in various management positions of InSite Vision, a traded ophthalmology drug development company that was acquired in October 2015, including Vice President and Chief Financial Officer and Chief Executive Officer from November 2008 to December 2010. Prior to InSite Vision, he served as Chief Financial Officer, Senior Vice President, Finance, at Nektar Therapeutics, a biopharmaceutical company, from January 2006 to August 2007. Prior to Nektar, he served as Acting Chief
Executive Officer from August 2004 to May 2005 and as Senior Vice President and Chief Financial Officer from August 2002 to August 2005 for BioMarin Pharmaceutical Inc. Previously, Mr. Drapeau spent 30 years at Arthur Andersen, including 19 years as an Audit Partner in Arthur Andersen&#146;s Northern California Audit and Business Consulting practice, which included 12 years as Managing Partner. Since February 2007, Mr. Drapeau has served as a member of the board of Bio-Rad Laboratories, Inc., a publicly traded pharmaceutical company. Mr. Drapeau received a B.S. in mechanical engineering and an M.B.A. from Stanford University. The Nominating and Corporate Governance Committee and the Board of Directors believe that Mr. Drapeau&#146;s experience with respect to accounting and financial matters qualifies him to serve on our Board of Directors. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B><I>Michael S. Perry, D.V.M., Ph.D. </I></B>has served as a member of our Board of Directors since November 2005. Since January of 2016 Dr. Perry has served as Senior Vice President and Chief Scientific Officer of Business Development and Licensing for Novartis AG. From September 2014 to January 2016 he served as Chief Scientific Officer for the Cell and Gene Therapy Unit of Novartis Pharmaceuticals Corporation and from October 2012 to September 2014, he served as Global Head of Stem Cell Therapy and Vice President of the Integrated Hospital Care Franchise for Novartis Pharmaceuticals Corporation. Prior to rejoining Novartis
in October 2012, he was a Venture Partner with Bay City Capital, a venture capital firm, from 2005 to September 2012. While serving in this capacity, he concurrently served as President and Chief Medical Officer at Poniard Pharmaceuticals, Inc., a publicly held drug development company, from 2009 to 2011. Dr. Perry also previously served as Chief Development Officer of VIA Pharmaceuticals, Inc., a publicly held biotechnology company, from 2005 to 2009. Dr. Perry served as Chairman and Chief Executive Officer of Extropy Pharmaceuticals, Inc., a privately held pediatric specialty pharmaceutical company, from 2003 to 2005. From 2002 to 2003, Dr. Perry served as President and Chief Executive Officer of Pharsight Corporation, a publicly held software and consulting services firm. From 2000 to 2002, Dr. Perry served as Global Head of Research and Development for Baxter Healthcare&#146;s BioScience Division (now Baxalta). From 1997 to 2000, Dr. Perry served as President and Chief Executive
Officer of SyStemix Inc. and Genetic Therapy Inc., two wholly-owned subsidiaries of Novartis Pharma. Dr. Perry served as Vice President of Regulatory Affairs for Novartis from 1994 to 1997. Prior to 1994, Dr. Perry held various management positions with Syntex Corporation (now Roche), Schering-Plough Corporation (now Merck) and BioResearch Laboratories, Inc. Dr. Perry received a Doctor of Veterinary Medicine (DVM), a Ph.D. in biomedical science-pharmacology specialty and an Honours B.Sc. in physics from the University of Guelph in Ontario, Canada. He is also a graduate of the Harvard Business School International Management Forum. Dr. Perry has served as Adjunct Professor in the Gates Center for Regenerative Medicine at the University of Colorado School of Medicine, Anschutz Medical Campus since November 2013. He has served as a member of the board of directors of </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">8</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Arrowhead Research Corporation since December 2011 and as a member of the board of directors of Avita Medical Ltd since February 2013. The Nominating and Corporate Governance Committee and the Board of Directors believe that Dr. Perry&#146;s substantial scientific and medical knowledge, as well as his operational and investing experience, qualifies him to serve on our Board of Directors. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><FONT STYLE="font-variant: small-caps">Nominee for Election for a One-year Term Expiring at the 2017 Annual Meeting</FONT> </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B><I>Vijay B. Samant </I></B>has served as a member of our Board of Directors since November 2015. Since November 2000, Mr. Samant has served as President and Chief Executive Officer of Vical, Inc., a developer of biopharmaceutical products for the prevention and treatment of chronic life-threatening infectious diseases. Prior to joining Vical, he had 23 years of diverse U.S. and international sales, marketing, operations, and business development experience with Merck. From 1998 to 2000, he was Chief Operating Officer of the Merck Vaccine Division. From 1990 to 1998, he served in the Merck Manufacturing Division as Vice
President of Vaccine Operations, Vice President of Business Affairs and Executive Director of Materials Management. Mr. Samant holds a master&#146;s degree in management studies from the Sloan School of Management at the Massachusetts Institute of Technology, a master&#146;s degree in chemical engineering from Columbia University, and a bachelor&#146;s degree in chemical engineering from the University of Bombay, University Department of Chemical Technology. Mr. Samant has been a member of the board of directors of Vical since 2000, and was a member of the board of directors of Raptor Pharmaceutical Corporation from 2011 to 2014, and was a member of the board of directors for BioMarin Pharmaceutical Inc. from 2002 to 2004. Mr. Samant was a Director of the Aeras Global TB Vaccine Foundation from 2001 to 2010, a member of the Board of Trustees for the National Foundation for Infectious Diseases from 2003 to 2012, and a member of the Board of Trustees for the International Vaccine
Institute in Seoul, Korea from 2008 to 2012. The Nominating and Corporate Governance Committee and the Board of Directors believe that Mr. Samant&#146;s significant experience leading biopharmaceutical product development companies, as well his significant sales, marketing, operations, and business development expertise within the biotechnology and pharmaceutical industries, qualifies him to serve on our Board of Directors. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><FONT STYLE="font-variant: small-caps">Nominee for Election for a Two-year Term Expiring at the 2018 Annual Meeting</FONT> </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B><I>Paul C. Grint, M.D. </I></B>has served as a member of our Board of Directors since November 2015. Since June 2015, Dr. Grint has served as President and Chief Executive Officer of Regulus Therapeutics Inc., a company focused on the discovery and development of microRNA therapeutics. From June 2014 until his appointment as President and Chief Executive Officer, Dr. Grint served as Regulus Therapeutics&#146; Chief Medical Officer. From February 2011 to June 2014, Dr. Grint served as the President of Cerexa, Inc., a wholly-owned subsidiary of Forest Laboratories, Inc., a pharmaceutical company, where he was responsible for
the oversight of anti-infective product development. Before that, Dr. Grint served as Senior Vice President of Research at Forest Research Institute, Inc., the scientific development subsidiary of Forest Laboratories, Inc., from January 2009 to February 2011, as Chief Medical Officer of Kalypsys, Inc., a biopharmaceutical company, from 2006 to 2008, and as Senior Vice President and Chief Medical Officer of Zephyr Sciences, Inc., a biopharmaceutical company, during 2006. Dr. Grint also previously served in similar executive level positions at Pfizer Inc., IDEC Pharmaceuticals Corporation, and Schering-Plough Corporation. Dr. Grint has served on the board of directors of Synedgen, a privately-held bio-pharmaceutical company, since December 2014. Dr. Grint also served on the board of directors of Illumina Inc. from April 2005 to May 2013. Dr. Grint received a B.S. in Medical Science from St. Mary&#146;s Hospital in London and his medical degree from St. Bartholomew&#146;s Hospital Medical
College at the University of London. Dr. Grint is a Fellow of the Royal College of Pathologists, a member of numerous professional and medical societies, and the author or co-author of over 50 scientific publications. The Nominating and Corporate Governance Committee and the Board of Directors believe that Dr. Grint&#146;s significant experience in leading biotechnology and pharmaceutical companies, as well his significant experience in drug development and in the biotechnology industry, qualifies him to serve on our Board of Directors. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The following is a brief biography, and a discussion of the specific experience, qualifications, attributes or skills of each director whose term will continue after the 2016 Annual Meeting of Shareholders. </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">9</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><FONT STYLE="font-variant: small-caps">Class II Directors Continuing in Office Until the 2017 Annual Meeting</FONT> </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B><I>Wendy S. Johnson </I></B>has served as our Interim Chief Operating Officer since September 2014 and has served as a member of our Board of Directors since May 2014. From 2005 to January 2014, Ms. Johnson served as a venture partner at ProQuest Investments, a venture capital firm. From 2006 to January 2014, Ms. Johnson served as the President and Chief Executive Officer of Aires Pharmaceuticals, a ProQuest portfolio company. Prior to joining ProQuest, she served as Senior Vice President, Corporate Development, at Salmedix Inc., and she held senior business and corporate development positions at WomenFirst Healthcare, Prizm
Pharmaceuticals (Selective Genetics Inc.), Cytel Corp., Synbiotics Corp., and Murex Corp. (Cambridge U.K.). Additionally, Ms. Johnson served as Assistant Director with the Center for Devices and Radiological Health at the U.S. Food and Drug Administration. Ms. Johnson received an M.B.A. from Loyola University, an M.S. in clinical microbiology from the Hahnemann Medical School and a B.S. in microbiology from the University of Maryland. The Nominating and Corporate Governance Committee and the Board of Directors believe that Ms. Johnson&#146;s significant experience in pharmaceutical drug development and business development, as well her strong background in microbiology, qualifies her to serve on our Board of Directors. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><FONT STYLE="font-variant: small-caps">Class III Directors Continuing in Office Until the 2018 Annual Meeting</FONT> </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B><I>M.</I></B> <B><I>Scott Salka </I></B>has served as our Chief Executive Officer and a member of our Board of Directors since May 18, 2015. Mr. Salka served as the Chief Executive Officer of Aspyrian Therapeutics Inc., a company focused on developing near-infrared photoimmunotherapy therapies, from March 2010 to May 2015. Prior to that, Mr. Salka served as the Chief Executive Officer of Ambit Biosciences Corporation, a publicly traded company that developed a novel platform for discovering small molecule drugs for oncology, autoimmune and inflammatory diseases, that was acquired by Daiichi Sankyo in 2014. During Mr.
Salka&#146;s tenure at Ambit, he was responsible for transforming the company from a service contract business to a fully-capable drug discovery and development enterprise. Prior to joining Ambit in 2001, Mr. Salka served as the President and Chief executive officer of two privately-held genomics companies, Arcaris, Inc. and 454 Corporation that was sold to Roche in 2007. He also previously co-founded one of the first commercial genomics companies, Sequana Therapeutics, Inc., a pioneer in the effort to commercialize the international Human Genome Project. From February 2012 to March 2014, Mr. Salka served on the board of directors of Sorrento Therapeutics, Inc. and since 2009, Mr. Salka has served on the board of directors of San Diego State University College of Business Administration. He received his M.B.A. from Carnegie Mellon University and his B.S. in finance from San Diego State University. The Nominating and Corporate Governance Committee and the Board of Directors believe that
Mr. Salka&#146;s significant experience leading drug development companies, as well as his service as our Chief Executive Officer, qualifies him to serve on our Board of Directors. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B><I>Jeremy Curnock Cook </I></B>has served as a member of our Board of Directors since July 1995 and as Chairman of the board of directors since February 1998. From September 2014 to May 2015, he served as our Interim Chief Executive Officer. Mr. Curnock Cook has served as Chairman of International Bioscience Managers Limited, a corporate and investment advisory firm, since 2000, and also currently serves as Managing Director of Bioscience Managers Pty Ltd, a medical sciences fund manager. From 1987 to 2000, Mr. Curnock Cook was a director of Rothschild Asset Management Limited, a corporate and investment advisory company,
and was responsible for the Rothschild Bioscience Unit. Mr. Curnock Cook founded the International Biochemicals Group in 1975, which was sold in 1985 to Royal Dutch Shell, where he served as Managing Director until 1987. He also serves as a member of the board of directors of Avita Medical Ltd, Nexus6 Ltd and SeaDragon Ltd, all private companies. Mr. Curnock Cook received an M.A. in natural sciences from Trinity College, Dublin. The Nominating and Corporate Governance Committee and the Board of Directors believe that Mr. Curnock Cook&#146;s significant experience as a board member of multiple biotechnology companies qualifies him to serve on our Board of Directors. </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">10</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<H1 STYLE="text-indent:0pt; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 9pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">INFORMATION REGARDING THE BOARD OF DIRECTORS AND CORPORATE GOVERNANCE </H1>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><FONT STYLE="font-variant: small-caps">Independence of The Board of Directors</FONT> </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">As required under the NYSE MKT listing standards, a majority of the members of a listed company&#146;s Board of Directors must qualify as &#147;independent,&#148; as affirmatively determined by the Board of Directors. Our Board of Directors consults with the Company&#146;s counsel to ensure that the Board&#146;s determinations are consistent with relevant securities and other laws and regulations regarding the definition of &#147;independent,&#148; including those set forth in pertinent listing standards of NYSE MKT, as in effect from time to time. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Consistent with these considerations, after review of all relevant identified transactions or relationships between each director, or any of his or her family members, and the Company, its senior management and its independent auditors, the Board has affirmatively determined that all of our directors are independent directors within the meaning of the applicable NYSE MKT listing standards, other than Mr. Salka and Ms. Johnson. In making this determination, the Board found that none of these directors or nominees for director had a material or other disqualifying relationship with the Company. The Board concluded that Mr. Salka
and Ms. Johnson are not independent directors within the meaning of the applicable NYSE MKT listing standards rules given their roles as Chief Executive Officer and Interim Chief Operating Officer, respectively. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><FONT STYLE="font-variant: small-caps">Board Leadership Structure</FONT> </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Our Board of Directors has a Chairman, Jeremy Curnock Cook, who has authority, among other things, to call and preside over board meetings, to set meeting agendas and to determine materials to be distributed to the Board. Accordingly, the Chairman has substantial ability to shape the work of the Board of Directors. We have a separate chair for each committee of the Board. As a general policy, the Board believes that separation of the positions of Chairman and Chief Executive Officer reinforces the independence of the Board of Directors from management, creates an environment that encourages objective oversight of
management&#146;s performance and enhances the effectiveness of the Board of Directors as a whole. As such, Mr. Salka serves as our Chief Executive Officer while Mr. Cook serves as our Chairman of the Board of Directors but is not an officer. We expect and intend the positions of Chairman of the Board of Directors and Chief Executive Officer to continue to be held by separate individuals in the future. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><FONT STYLE="font-variant: small-caps">Role of the Board in Risk Oversight</FONT> </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The Audit Committee of our Board of Directors is primarily responsible for overseeing our financial risk management processes on behalf of the Board. Going forward, we expect that the Audit Committee will receive reports from management at least quarterly regarding our assessment of risks. In addition, the audit Committee reports regularly to the full Board, which also considers our risk profile. The Audit Committee and the Board focus on the most significant risks we face and our general risk management strategies. While the Board oversees our risk management, our management is responsible for day-to-day risk management
processes. The Board expects management to consider risk and risk management in each business decision, to proactively develop and monitor risk management strategies and processes for day-to-day activities and to effectively implement risk management strategies adopted by the Audit Committee and the Board. We believe this division of responsibilities is the most effective approach for addressing the risks we face and that our board of directors leadership structure, which also emphasizes the independence of our board of directors in its oversight of its business and affairs, supports this approach. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><FONT STYLE="font-variant: small-caps">Meetings of The Board of Directors</FONT> </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The Board of Directors met eight times during the last fiscal year. Each Board member attended 75% or more of the total number of meetings of the Board and of the committees on which he or she served, held during the portion of the last fiscal year for which he or she was a director or committee member. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">As required under applicable NYSE MKT listing standards, during 2015, the Company&#146;s independent directors met on a regular basis in executive session without the presence of non-independent directors and management. </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">11</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><FONT STYLE="font-variant: small-caps">Information Regarding Committees of the Board of Directors</FONT> </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The Board of Directors has an Audit Committee, a Compensation Committee and a Nominating and Corporate Governance Committee. The following table provides membership and meeting information during 2015 for each of the Board committees: </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"></P>

<DIV style="text-align: center"><TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="554" STYLE="vertical-align: text-top; text-indent:0px; text-align: left; font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: -15pt; *margin-top: -20pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR>

          <TD><IMG HEIGHT="1" SRC="spacer.gif" WIDTH="302"></TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none"><!-- GUTTER -->&nbsp;</TD>

          <TD><IMG HEIGHT="1" SRC="spacer.gif" WIDTH="54"></TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none"><!-- GUTTER -->&nbsp;</TD>

          <TD><IMG HEIGHT="1" SRC="spacer.gif" WIDTH="70"></TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none"><!-- GUTTER -->&nbsp;</TD>

          <TD><IMG HEIGHT="1" SRC="spacer.gif" WIDTH="78"></TD>

</TR>

<TR STYLE="vertical-align: top">

          <TD STYLE="line-height: normal; vertical-align: bottom; font-weight: bold; font-size: 8pt; text-align: left; border-bottom: 1pt solid black" ROWSPAN=1 COLSPAN=1>Name</TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="line-height: normal; vertical-align: bottom; font-weight: bold; font-size: 8pt; text-align: center; border-bottom: 1pt solid black" ROWSPAN=1 COLSPAN=1>Audit</TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="line-height: normal; vertical-align: bottom; font-weight: bold; font-size: 8pt; text-align: center; border-bottom: 1pt solid black" ROWSPAN=1 COLSPAN=1>Compensation</TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="line-height: normal; vertical-align: bottom; font-weight: bold; font-size: 8pt; text-align: center; border-bottom: 1pt solid black" ROWSPAN=1 COLSPAN=1>Nominating<BR> and Corporate<BR> Governance</TD>

</TR>

<TR STYLE="vertical-align: top">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt" ROWSPAN=1 COLSPAN=1>Jeremy Curnock Cook<sup>&#040;1&#041;</sup></TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD ROWSPAN=1 COLSPAN=1 STYLE="text-align: center">X</TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD ROWSPAN=1 COLSPAN=1 STYLE="text-align: center">X</TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD ROWSPAN=1 COLSPAN=1 STYLE="text-align: center">&nbsp;X*</TD>

</TR>

<TR STYLE="vertical-align: top">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt" ROWSPAN=1 COLSPAN=1>Louis Drapeau<sup>&#040;2&#041;</sup></TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD ROWSPAN=1 COLSPAN=1 STYLE="text-align: center">&nbsp;X*</TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD ROWSPAN=1 COLSPAN=1 STYLE="text-align: center">X</TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD ROWSPAN=1 COLSPAN=1 STYLE="text-align: center">X</TD>

</TR>

<TR STYLE="vertical-align: top">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt" ROWSPAN=1 COLSPAN=1>Michael S. Perry, Ph.D.</TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD ROWSPAN=1 COLSPAN=1 STYLE="text-align: center">X</TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD ROWSPAN=1 COLSPAN=1 STYLE="text-align: center">&nbsp;X*</TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD ROWSPAN=1 COLSPAN=1 STYLE="text-align: center">X</TD>

</TR>

<TR STYLE="vertical-align: top">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt" ROWSPAN=1 COLSPAN=1>Julian P. Kirk<sup>&#040;3&#041;</sup></TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD ROWSPAN=1 COLSPAN=1 STYLE="text-align: center">&nbsp;&nbsp;</TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD ROWSPAN=1 COLSPAN=1 STYLE="text-align: center">&nbsp;&nbsp;</TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD ROWSPAN=1 COLSPAN=1 STYLE="text-align: center">&nbsp;&nbsp;</TD>

</TR>

<TR STYLE="vertical-align: top">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt" ROWSPAN=1 COLSPAN=1>Vijay B. Samant<sup>&#040;4&#041;</sup></TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD ROWSPAN=1 COLSPAN=1 STYLE="text-align: center">X</TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD ROWSPAN=1 COLSPAN=1 STYLE="text-align: center">&nbsp;&nbsp;</TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD ROWSPAN=1 COLSPAN=1 STYLE="text-align: center">&nbsp;&nbsp;</TD>

</TR>

<TR STYLE="vertical-align: top">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt" ROWSPAN=1 COLSPAN=1>Paul C. Grint, M.D.<sup>&#040;5&#041;</sup></TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD ROWSPAN=1 COLSPAN=1 STYLE="text-align: center">&nbsp;&nbsp;</TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD ROWSPAN=1 COLSPAN=1 STYLE="text-align: center">X</TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD ROWSPAN=1 COLSPAN=1 STYLE="text-align: center">&nbsp;&nbsp;</TD>

</TR>

<TR STYLE="vertical-align: top">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt" ROWSPAN=1 COLSPAN=1>M. Scott Salka</TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD ROWSPAN=1 COLSPAN=1 STYLE="text-align: center">&nbsp;&nbsp;</TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD ROWSPAN=1 COLSPAN=1 STYLE="text-align: center">&nbsp;&nbsp;</TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD ROWSPAN=1 COLSPAN=1 STYLE="text-align: center">&nbsp;&nbsp;</TD>

</TR>

<TR STYLE="vertical-align: top">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt" ROWSPAN=1 COLSPAN=1>Wendy S. Johnson</TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD ROWSPAN=1 COLSPAN=1 STYLE="text-align: center">&nbsp;&nbsp;</TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD ROWSPAN=1 COLSPAN=1 STYLE="text-align: center">&nbsp;&nbsp;</TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD ROWSPAN=1 COLSPAN=1 STYLE="text-align: center">&nbsp;&nbsp;</TD>

</TR>

<TR STYLE="vertical-align: top">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt" ROWSPAN=1 COLSPAN=1>Total meetings during 2015</TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD ROWSPAN=1 COLSPAN=1 STYLE="text-align: center">5</TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD ROWSPAN=1 COLSPAN=1 STYLE="text-align: center">2</TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD ROWSPAN=1 COLSPAN=1 STYLE="text-align: center">0</TD>

</TR>

</TABLE></DIV>


<P STYLE="text-align: left; text-indent: 1px"><IMG SRC="line.gif" STYLE="width: 72px; height: 1pt"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 1px"></TD>

          <TD STYLE="width: 20px; text-align: left">*</TD>

          <TD STYLE="text-align: justify">Committee Chairperson </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 1px"></TD>

          <TD STYLE="width: 20px; text-align: left">(1)</TD>

          <TD STYLE="text-align: justify">Mr. Curnock Cook resigned from the Audit Committee in January 2016. </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 1px"></TD>

          <TD STYLE="width: 20px; text-align: left">(2)</TD>

          <TD STYLE="text-align: justify">Mr. Drapeau resigned from the Compensation Committee in January 2016. </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 1px"></TD>

          <TD STYLE="width: 20px; text-align: left">(3)</TD>

          <TD STYLE="text-align: justify">Mr. Kirk resigned from the Board in April 2016. </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 1px"></TD>

          <TD STYLE="width: 20px; text-align: left">(4)</TD>

          <TD STYLE="text-align: justify">Mr. Samant was appointed to the Audit Committee in November 2015. </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 1px"></TD>

          <TD STYLE="width: 20px; text-align: left">(5)</TD>

          <TD STYLE="text-align: justify">Dr. Grint was appointed to the Compensation Committee in November 2015. </TD>

</TR>

</TABLE>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Below is a description of each committee of the Board of Directors. The Board of Directors has determined that each member of each committee meets the applicable NYSE MKT rules and regulations regarding &#147;independence&#148; and each member is free of any relationship that would impair his or her individual exercise of independent judgment with regard to the Company. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Audit Committee </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The Audit Committee of the Board of Directors was established by the Board in accordance with Section 3(a)(58)(A) of the Securities Exchange Act of 1934, as amended, or the Exchange Act, to oversee the Company&#146;s corporate accounting and financial reporting processes and audits of its financial statements. The functions of this Audit Committee include, among other things: </P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">evaluating the performance, independence and qualifications of our independent auditors and determining whether to retain our existing independent auditors or engage new independent auditors and to present the committee&#146;s conclusion to our Board of Directors; </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">reviewing and approving the engagement of our independent auditors to perform audit services and any permissible non-audit services; </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">monitoring the rotation of partners of our independent auditors on our audit engagement team as required by law; </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">prior to engagement of any independent auditor, and at least annually thereafter, reviewing relationships that may reasonably be thought to bear on their independence, and assessing and otherwise taking the appropriate action to oversee the independence of our independent auditor; </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">reviewing our annual and quarterly financial statements and reports, including the disclosures contained under the caption &#147;Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations,&#148; and discussing the statements and reports with our independent auditors and management; </TD>

</TR>

</TABLE>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">12</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">reviewing with our independent auditors and management significant issues that arise regarding accounting principles and financial statement presentation and matters concerning the scope, adequacy and effectiveness of our internal control over financial reporting; </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">reviewing with management and our auditors any earnings announcements and other public announcements regarding material developments; </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">establishing procedures for the receipt, retention and treatment of complaints received by us regarding internal accounting controls, accounting or auditing matters and other matters; </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">preparing the report that the SEC requires in our annual proxy statement; </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">reviewing and providing oversight of any related-person transactions in accordance with our related-person transactions policy and reviewing and monitoring compliance with legal and regulatory responsibilities, including our code of business conduct and ethics; </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">reviewing on a periodic basis our investment policy; and </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">reviewing and evaluating on an annual basis its own performance, including its compliance with its charter. </TD>

</TR>

</TABLE>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Our Audit Committee consists of Louis Drapeau, Michael S. Perry and Vijay Samant. The Board of Directors reviews the NYSE MKT listing standards definition of independence for Audit Committee members on an annual basis and has determined that each of the members of our Audit Committee satisfies the NYSE MKT listing requirements and SEC independence requirements. Mr. Drapeau serves as the chair of our Audit Committee. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Our Board of Directors has determined that Mr. Drapeau qualifies as an Audit Committee financial expert within the meaning of SEC regulations. In making this determination, our Board of Directors has considered Mr. Drapeau&#146;s formal education and previous and current experience in financial roles. Both our independent registered public accounting firm and management periodically meet privately with our Audit Committee. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The Audit Committee charter can be found on our website at <I>www.ampliphibio.com/corporate-governance.htm</I>. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Report of the Audit Committee of the Board of Directors </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><I>The material in this report is not &#147;soliciting material,&#148; is not deemed &#147;filed&#148; with the SEC and is not to be incorporated by reference in any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof and irrespective of any general incorporation language in any such filing.</I> </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The Audit Committee has reviewed and discussed the audited financial statements for the fiscal year ended December 31, 2015 with management of the Company. The Audit Committee has discussed with the independent registered public accounting firm the matters required to be discussed by Auditing Standard No. 16, <I>Communications with Audit Committees,</I> as adopted by the Public Company Accounting Oversight Board, or the PCAOB. The Audit Committee has also received the written disclosures and the letter from the independent registered public accounting firm required by applicable requirements of the PCAOB regarding the
independent accountants&#146; communications with the Audit Committee concerning independence, and has discussed with the independent registered public accounting firm the accounting firm&#146;s independence. Based on the foregoing, the Audit Committee has recommended to the Board of Directors that the audited financial statements be included in the Company&#146;s Annual Report on Form 10-K for the fiscal year ended December 31, 2015. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Mr. Louis Drapeau<BR> Dr. Michael S. Perry<BR> Mr. Vijay Samant </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">13</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Compensation Committee </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Our Compensation Committee consists of Jeremy Curnock Cook, Paul C. Grint and Michael S. Perry. Dr. Perry serves as the chair of our Compensation Committee. Our Board of Directors has determined that each of the members of our Compensation Committee is a non-employee director, as defined in Rule 16b-3 promulgated under the Exchange Act, as defined pursuant to Section 162(m) of the Code, and satisfies the NYSE MKT listing independence requirements. The functions of this committee include, among other things: </P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">reviewing, modifying and approving (or if it deems appropriate, making recommendations to the full Board of Directors regarding) our overall compensation strategy and policies; </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">reviewing and approving (or if it deems appropriate, making recommendations to the full Board of Directors regarding) the compensation and other terms of employment of our executive officers; </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">reviewing and approving (or if it deems appropriate, making recommendations to the full Board of Directors regarding) performance goals and objectives relevant to the compensation of our executive officers and assessing their performance against these goals and objectives; </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">reviewing and approving (or if it deems it appropriate, making recommendations to the full Board of Directors regarding) the equity incentive plans, compensation plans and similar programs advisable for us, as well as modifying, amending or terminating existing plans and programs; </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">evaluating risks associated with our compensation policies and practices and assessing whether risks arising from our compensation policies and practices for our employees are reasonably likely to have a material adverse effect on us; </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">reviewing making recommendations to the full Board of Directors regarding the type and amount of compensation to be paid or awarded to our non-employee board members; </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">establishing policies with respect to votes by our shareholders to approve executive compensation as required by Section 14A of the Exchange Act and determining our recommendations regarding the frequency of advisory votes on executive compensation, to the extent required by law; </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">reviewing and assessing the independence of compensation consultants, legal counsel and other advisors as required by Section 10C of the Exchange Act; </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">administering our equity incentive plans; </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">establishing policies with respect to equity compensation arrangements; </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">reviewing the competitiveness of our executive compensation programs and evaluating the effectiveness of our compensation policy and strategy in achieving expected benefits to us; </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">reviewing and approving (or if it deems appropriate, making recommendations to the full Board of Directors regarding) the terms of any employment agreements, severance arrangements, change-of-control protections and any other compensatory arrangements for our executive officers; </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">reviewing the adequacy of its charter on a periodic basis; </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">reviewing with management and approving our disclosures, if any, under the caption &#147;Compensation Discussion and Analysis&#148; and related tables in our periodic reports or proxy statements to be filed with the SEC; </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">preparing the report that the SEC requires in our annual proxy statement; and </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">reviewing and assessing on an annual basis its own performance. </TD>

</TR>

</TABLE>

<H4 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: italic; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Compensation Committee Processes and Procedures </H4>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Typically, the Compensation Committee meets quarterly and with greater frequency if necessary. The agenda for each meeting is usually developed by the Chair of the Compensation Committee, in consultation with the Chief Executive Officer<B>. </B>The Compensation Committee meets regularly in executive session. However, from time to time, various members of management and other employees as well as outside advisors or consultants may be invited by the Compensation Committee to make presentations, to provide financial or other </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">14</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">background information or advice or to otherwise participate in Compensation Committee meetings. The Chief Executive Officer and Interim Chief Operating Officer may not participate in, or be present during, any deliberations or determinations of the Compensation Committee regarding his or her compensation or individual performance objectives. The charter of the Compensation Committee grants the Compensation Committee full access to all books, records, facilities and personnel of the Company. In addition, under the charter, the Compensation Committee has the authority to obtain, at the expense of the Company, advice and
assistance from compensation consultants and internal and external legal, accounting or other advisors and other external resources that the Compensation Committee considers necessary or appropriate in the performance of its duties. The Compensation Committee has direct responsibility for the oversight of the work of any consultants or advisers engaged for the purpose of advising the Committee. In particular, the Compensation Committee has the sole authority to retain, in its sole discretion, compensation consultants to assist in its evaluation of executive and director compensation, including the authority to approve the consultant&#146;s reasonable fees and other retention terms. Under the charter, the Compensation Committee may select, or receive advice from, a compensation consultant, legal counsel or other adviser to the compensation committee, other than in-house legal counsel and certain other types of advisers, only after taking into consideration six factors, prescribed by the
SEC and NYSE MKT, that bear upon the adviser&#146;s independence; however, there is no requirement that any adviser be independent. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Historically, the Compensation Committee has made most of the significant adjustments to annual compensation, determined bonus and equity awards and established new performance objectives at one or more meetings held during the first quarter of the year. However, the Compensation Committee also considers matters related to individual compensation, such as compensation for new executive hires, as well as high-level strategic issues, such as the efficacy of the Company&#146;s compensation strategy, potential modifications to that strategy and new trends, plans or approaches to compensation, at various meetings throughout the
year. Generally, the Compensation Committee&#146;s process comprises two related elements: the determination of compensation levels and the establishment of performance objectives for the current year. For executives other than the Chief Executive Officer, the Compensation Committee solicits and considers evaluations and recommendations submitted to the Committee by the Chief Executive Officer. In the case of the Chief Executive Officer, the evaluation of his performance is conducted by the Compensation Committee, which determines any adjustments to his compensation as well as awards to be granted. For all executives and directors as part of its deliberations, the Compensation Committee may review and consider, as appropriate, materials such as financial reports and projections, operational data, tax and accounting information, tally sheets that set forth the total compensation that may become payable to executives in various hypothetical scenarios, executive and director stock
ownership information, company stock performance data, analyses of historical executive compensation levels and current Company-wide compensation levels and recommendations of the Compensation Committee&#146;s compensation consultant, if any, including analyses of executive and director compensation paid at other companies identified by the consultant. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The Compensation Committee charter can be found on our website at <I>www.ampliphibio.com/corporate-governance.htm</I>. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Nominating and Corporate Governance Committee </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The Nominating and Corporate Governance Committee of the Board of Directors is responsible for, among other things: </P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">identifying, reviewing and evaluating candidates to serve on our Board of Directors consistent with criteria approved by our Board of Directors; </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">evaluating director performance on management and the board and applicable committees of the board and determining whether continued service on our Board of Directors is appropriate; </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">evaluating, nominating and recommending individuals for membership on our Board of Directors; </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">evaluating nominations by shareholders of candidates for election to our Board of Directors; </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">considering and assessing the independence of members of our Board of Directors; </TD>

</TR>

</TABLE>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">15</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">developing a set of corporate governance policies and principles, periodically reviewing and assessing these policies and principles and their application and recommending to our Board of Directors any changes to such policies and principles; </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">reviewing the adequacy of its charter on an annual basis; and </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">annually evaluating the performance of the Nominating and Corporate Governance Committee. </TD>

</TR>

</TABLE>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Our Nominating and Corporate Governance Committee consists of Jeremy Curnock Cook, Louis Drapeau and Michael S. Perry. Our Board of Directors has determined that each of the members of this committee satisfies the NYSE MKT listing independence requirements. Mr. Curnock Cook serves as the chair of our Nominating and Corporate Governance Committee. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The Nominating and Corporate Governance Committee believes that candidates for director should, both individually and collectively, have the integrity, experience, judgment, commitment (including having sufficient time to devote to us and a sufficient level of participation), skills, diversity and expertise appropriate for our company. In assessing the directors, both individually and collectively, the Nominating and Corporate Governance Committee may consider our current needs and the needs of our Board of Directors, to maintain a balance of knowledge, experience and capability in various areas. However, the Nominating and
Corporate Governance Committee retains the right to modify these qualifications from time to time. In the case of new director candidates, the Nominating and Corporate Governance Committee also determines whether the nominee is independent for NYSE MKT purposes, which determination is based upon applicable NYSE MKT listing standards, applicable SEC rules and regulations and the advice of counsel, if necessary. The Nominating and Corporate Governance Committee then uses its network of contacts to compile a list of potential candidates, but may also engage, if it deems appropriate, a professional search firm. The Nominating and Corporate Governance Committee conducts any appropriate and necessary inquiries into the backgrounds and qualifications of possible candidates after considering the function and needs of the Board of Directors. The Nominating and Corporate Governance Committee meets to discuss and consider the candidates&#146; qualifications and then selects a nominee for
recommendation to the Board of Directors by majority vote. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The Nominating and Corporate Governance Committee will consider director candidates recommended by shareholders. The Nominating and Corporate Governance Committee does not intend to alter the manner in which it evaluates candidates, including the criteria set forth above, based on whether or not the candidate was recommended by a shareholder. Shareholders who wish to recommend individuals for consideration by the Nominating and Corporate Governance Committee to become nominees for election to the Board may do so by delivering a written recommendation to the Secretary of the Company at 3579 Valley Centre Drive, San Diego,
California 92130, no later than the close of business on the 90<sup>th</sup> day and no earlier than the 120<sup>th</sup> day prior to the one year anniversary of the preceding year&#146;s annual meeting of shareholders. Submissions must include the full name of the proposed nominee, a description of the proposed nominee&#146;s business experience for at least the previous five years, complete biographical information, a description of the proposed nominee&#146;s qualifications as a director and the number of shares of the Company&#146;s stock that are owned beneficially by such nominating shareholder as of the date the submission is made. Any such submission must be accompanied by the written consent of the proposed nominee to be named as a nominee and to serve as a director if elected. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The Nominating and Corporate Governance Committee charter can be found on our website at <I>www.ampliphibio.com/corporate-governance.html</I>. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><FONT STYLE="font-variant: small-caps">Shareholder Communications With The Board Of Directors</FONT> </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The Company&#146;s Board has adopted a formal process by which shareholders may communicate with the Board or any of its directors. Shareholders who wish to communicate with the Board may do so by sending written communications addressed to the Secretary of the Company at AmpliPhi Biosciences Corporation, 3579 Valley Centre Drive, Suite 100, San Diego, California 92130. All communications will be compiled by the Secretary of the Company and submitted to the Board of Directors or the individual directors on a periodic basis. These communications will be reviewed by the Company&#146;s Secretary, who will determine whether the
communication should be presented to the Board. The purpose of this screening is to allow the Board to avoid having to consider irrelevant or inappropriate communications (such as advertisements, solicitations and </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">16</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">hostile communications). All communications directed to the Audit Committee in accordance with the Company&#146;s Open Door Policy for Reporting Complaints Regarding Accounting and Auditing Matters, discussed below, will be treated in accordance with that policy. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Any interested person may, however, communicate directly with the presiding director or the independent directors as a group. Persons interested in communicating directly with the independent directors regarding their concerns or issues may do so by addressing correspondence to a particular director, or to the independent directors generally, in care of AmpliPhi Biosciences Corporation at 3579 Valley Centre Drive, Suite 100, San Diego, California 92130. If no particular director is named, letters will be forwarded, depending upon the subject matter, to the Chair of the Audit, Compensation, or Nominating and Corporate Governance
Committee. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><FONT STYLE="font-variant: small-caps">Code of Ethics</FONT> </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">We have adopted a code of ethics for directors, officers (including our principal executive officer, principal financial officer and principal accounting officer) and employees, known as the Code of Business Conduct and Ethics. The Code of Business Conduct and Ethics is available on our website at <I>http://www.ampliphibio.com</I> under the Corporate Governance section of our Investor Relations page. We will promptly disclose on our website (i) the nature of any amendment to the policy that applies to our principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing
similar functions and (ii) the nature of any waiver, including an implicit waiver, from a provision of the policy that is granted to one of these specified individuals that is required to be disclosed pursuant to SEC rules and regulations, the name of such person who is granted the waiver and the date of the waiver. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><FONT STYLE="font-variant: small-caps">Open Door Policy for Reporting Complaints Regarding Accounting and Auditing Matters</FONT> </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">We have adopted an Open Door Policy for Reporting Complaints Regarding Accounting and Auditing Matters to facilitate the receipt, retention and treatment of complaints regarding accounting, internal accounting controls or auditing matters, as well as the confidential, anonymous submission by our employees of concerns regarding these matters. The Open Door Policy is available on our website at <I>http://www.ampliphibio.com/corporate-governance.html.</I> </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">17</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<H1 STYLE="text-indent:0pt; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 9pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><FONT STYLE="font-variant: small-caps">Proposal 2<BR>&nbsp;<BR> Approval of the<BR> AmpliPhi Biosciences Corporation 2016 Equity Incentive Plan</FONT> </H1>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Overview </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">On April 21, 2016, our Board of Directors approved our AmpliPhi Bioscience Corporation 2016 Equity Incentive Plan, or the 2016 Plan, subject to approval by our shareholders at the Annual Meeting. The 2016 Plan is intended as the successor plan to our 2013 Stock Incentive Plan, or 2013 Plan. If this Proposal 2 is approved, no additional equity grants may be made under the 2013 Plan. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Requested Shares </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Subject to adjustment for certain changes in our capitalization, the aggregate number of shares of our common stock that may be issued under the 2016 Plan will not exceed the sum of (i) the number of unallocated shares remaining available for the grant of new awards under the 2013 Plan as of the effective date of the 2016 Plan (which is equal to 514,340 shares as of May 20, 2016), (ii) 1,000,000 new shares, and (iii) any Prior Plans&#146; Returning Shares (as defined below in &#147;Description of the 2016 Plan&nbsp;&#151;&nbsp;Share Reserve&#148;), as such shares become available from time to time. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Approval of the 2016 Plan by our shareholders will allow us to grant stock options and other equity awards at levels determined appropriate by our Board of Directors or Compensation Committee. The 2016 Plan will also allow us to utilize a broad array of equity incentives and performance cash incentives in order to secure and retain the services of our employees, directors and consultants, and to provide long-term incentives that align the interests of our employees, directors and consultants with the interests of our shareholders. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Why You Should Vote For the 2016 Plan </H2>

<H3 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: italic; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Key Plan Features </H3>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The 2016 Plan includes provisions that are designed to protect our shareholders&#146; interests including: </P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify"><I>No single trigger accelerated vesting upon change in control</I>.&nbsp;&nbsp;The 2016 Plan does not provide for any automatic mandatory vesting of awards upon a change in control. </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify"><I>Awards subject to forfeiture/clawback</I>.&nbsp;&nbsp;Awards granted under the 2016 Plan will be subject to recoupment in accordance with any clawback policy that we are required to adopt pursuant to the listing standards of any national securities exchange or association on which our securities are listed or as is otherwise required by the Dodd-Frank Wall Street Reform and Consumer Protection Act or other applicable law. In addition, we may impose other clawback, recovery or recoupment provisions in an award agreement, including a reacquisition right in respect of previously acquired shares or other cash or property upon the occurrence of cause. </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify"><I>No discounted stock options or stock appreciation rights</I>.&nbsp;&nbsp;All stock options and stock appreciation rights granted under the 2016 Plan must have an exercise or strike price equal to or greater than the fair market value of our common stock on the date the stock option or stock appreciation right is granted. </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify"><I>Administration by independent committee</I>.&nbsp;&nbsp;The 2016 Plan will be administered by the members of our Compensation Committee, all of whom are &#147;non-employee directors&#148; within the meaning of Rule 16b-3 under the Exchange Act and &#147;outside directors&#148; within the meaning of Section 162(m) of the Code. </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify"><I>Material amendments require shareholder approval</I>.&nbsp;&nbsp;The 2016 Plan requires shareholder approval of any material revisions to the 2016 Plan. </TD>

</TR>

</TABLE>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">18</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify"><I>Limit on non-employee director awards and other awards</I>.&nbsp;&nbsp;As further described below, except in extraordinary circumstances, the maximum number of shares subject to stock awards granted during any calendar year to any of our non-employee directors, taken together with any cash fees paid by the Company to such non-employee director during such calendar year, may not generally exceed $375,000 in total value (calculating the value of any such stock awards based on the grant date fair value of such stock awards for financial reporting purposes), or with respect to the calendar year in which the non-employee director is first appointed or elected, $783,000 in total value. The 2016 Plan also contains other annual per-participant limits on stock options, stock appreciation rights and performance-based stock and cash awards. </TD>

</TR>

</TABLE>

<H3 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: italic; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">We Intend to Recruit Additional Personnel to Facilitate the Growth of Our Business and Equity Awards Are an Important Part of Our Compensation Philosophy </H3>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The Board of Directors believes that the future success of the Company depends, in large part, upon the ability of the Company to implement our plans for future expansion and growth in light of our anticipated recruiting and retention needs and is necessary to maintain a competitive position in recruiting, retaining and motivating key personnel, consultants and advisors. The Board of Directors believes that the issuance of equity awards is a key element underlying our ability to recruit, retain and motivate key personnel, consultants and advisors, better aligns the interests of such persons with those of our shareholders, and
is a substantial contributing factor to our success and the future growth of our business. Therefore, the Board of Directors believes that the approval of the 2016 Plan is in the best interests of the Company and its shareholders and recommends a vote in favor of this proposal. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">If this Proposal 2 is adopted by our shareholders, the 2016 Plan will become effective upon the date of the Annual Meeting and no additional equity grants maybe made under our 2013 Plan. In the event that our shareholders do not approve this Proposal 2, the 2016 Plan will not become effective and our 2013 Plan will continue in its current form. However, we believe that the shares available for grant under the 2013 Plan will be insufficient to meet our anticipated recruiting and retention needs. </P>

<H3 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: italic; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">We Manage Our Equity Award Use Carefully and Our Dilution Is Reasonable </H3>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">We manage our long-term shareholder dilution by limiting the number of equity awards granted annually. The Compensation Committee monitors our annual burn rate, dilution, and equity expense to ensure that we maximize shareholders&#146; value by granting only the appropriate number of equity awards necessary to recruit, reward, and retain key personnel, consultants and advisors. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The following table provides certain additional information regarding our equity award program. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"></P>

<DIV style="text-align: center"><TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="608" STYLE="vertical-align: bottom; text-indent:0px; text-align: left; font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: -15pt; *margin-top: -20pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR>

          <TD><IMG HEIGHT="1" SRC="spacer.gif" WIDTH="516"></TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none"><!-- GUTTER -->&nbsp;</TD>

          <TD COLSPAN="3"><IMG HEIGHT="1" SRC="spacer.gif" WIDTH="76"></TD>

</TR>

<TR>

          <TD STYLE="line-height: normal; vertical-align: bottom; font-weight: bold; font-size: 8pt; text-align: left" ROWSPAN=1 COLSPAN=1></TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="line-height: normal; vertical-align: bottom; font-weight: bold; font-size: 8pt; text-align: center; border-bottom: 1pt solid black" ROWSPAN=1 COLSPAN=3>As of<BR> December 31,<BR> 2015</TD>

</TR>

<TR STYLE="background-color: #cceeff">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt; vertical-align: text-bottom" ROWSPAN=1 COLSPAN=1>Total shares subject to outstanding stock options</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>669,769</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

</TR>

<TR STYLE="background-color: white">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt; vertical-align: text-bottom" ROWSPAN=1 COLSPAN=1>Total shares subject to full value awards</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>&#151;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

</TR>

<TR STYLE="background-color: #cceeff">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt; vertical-align: text-bottom" ROWSPAN=1 COLSPAN=1>Weighted-average exercise price per share of outstanding stock options</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->$</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>8.68</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

</TR>

<TR STYLE="background-color: white">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt; vertical-align: text-bottom" ROWSPAN=1 COLSPAN=1>Weighted-average remaining term of outstanding stock options</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>9.29 yrs</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

</TR>

<TR STYLE="background-color: #cceeff">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt; vertical-align: text-bottom" ROWSPAN=1 COLSPAN=1>Total shares available for grant under the 2013 Plan</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>723,431</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

</TR>

<TR STYLE="background-color: white">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt; vertical-align: text-bottom" ROWSPAN=1 COLSPAN=1>Total shares available for grant under other equity plans</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>&#151;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

</TR>

</TABLE></DIV>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"></P>

<DIV style="text-align: center"><TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="608" STYLE="vertical-align: bottom; text-indent:0px; text-align: left; font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: -15pt; *margin-top: -20pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR>

          <TD><IMG HEIGHT="1" SRC="spacer.gif" WIDTH="513"></TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none"><!-- GUTTER -->&nbsp;</TD>

          <TD COLSPAN="3"><IMG HEIGHT="1" SRC="spacer.gif" WIDTH="78"></TD>

</TR>

<TR>

          <TD STYLE="line-height: normal; vertical-align: bottom; font-weight: bold; font-size: 8pt; text-align: left" ROWSPAN=1 COLSPAN=1></TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="line-height: normal; vertical-align: bottom; font-weight: bold; font-size: 8pt; text-align: center; border-bottom: 1pt solid black" ROWSPAN=1 COLSPAN=3>As of<BR> May 20, 2016<BR> (Record Date)</TD>

</TR>

<TR STYLE="background-color: #cceeff">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt; vertical-align: text-bottom" ROWSPAN=1 COLSPAN=1>Total common stock outstanding</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>8,242,528</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

</TR>

<TR STYLE="background-color: white">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt; vertical-align: text-bottom" ROWSPAN=1 COLSPAN=1>Closing price of common stock as reported on The NYSE MKT</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->$</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>1.57</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

</TR>

</TABLE></DIV>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Common measures of an equity incentive plan&#146;s cost include burn rate, dilution and overhang. The burn rate, or run rate, refers to how fast a company uses the supply of shares authorized for issuance under its equity incentive plan. Over the last three years, the Company has maintained an average equity run rate of 5.6% of shares of common stock outstanding per year, including shares of preferred stock on an as-converted basis. Our run rate in 2015 was unusually high due primarily to the equity grant that we made to Mr. Salka in </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">19</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">connection with his commencement of our Chief Executive Officer, which the Compensation Committee believed was consistent with the level of options granted to chief executive officers in our industry. Excluding the special hiring grant we made to our Chief Executive Officer, in 2015 our three-year average equity run rate was 3.7%. Dilution measures the degree to which our stockholders' ownership has been diluted by stock-based compensation awarded under our equity incentive plans and also includes shares that may be awarded under our equity incentive plans in the future (&#147;overhang&#148;). </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The following table shows how our key equity metrics have changed over the past three years: </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"></P>

<DIV style="text-align: center"><TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="554" STYLE="vertical-align: bottom; text-indent:0px; text-align: left; font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: -15pt; *margin-top: -20pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR>

          <TD><IMG HEIGHT="1" SRC="spacer.gif" WIDTH="306"></TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none"><!-- GUTTER -->&nbsp;</TD>

          <TD COLSPAN="3"><IMG HEIGHT="1" SRC="spacer.gif" WIDTH="64"></TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none"><!-- GUTTER -->&nbsp;</TD>

          <TD COLSPAN="3"><IMG HEIGHT="1" SRC="spacer.gif" WIDTH="64"></TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none"><!-- GUTTER -->&nbsp;</TD>

          <TD COLSPAN="3"><IMG HEIGHT="1" SRC="spacer.gif" WIDTH="72"></TD>

</TR>

<TR>

          <TD STYLE="line-height: normal; vertical-align: bottom; font-weight: bold; font-size: 8pt; text-align: left; border-bottom: 1pt solid black" ROWSPAN=1 COLSPAN=1>Key Equity Metrics</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="line-height: normal; vertical-align: bottom; font-weight: bold; font-size: 8pt; text-align: center; border-bottom: 1pt solid black" ROWSPAN=1 COLSPAN=3>2013</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="line-height: normal; vertical-align: bottom; font-weight: bold; font-size: 8pt; text-align: center; border-bottom: 1pt solid black" ROWSPAN=1 COLSPAN=3>2014</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="line-height: normal; vertical-align: bottom; font-weight: bold; font-size: 8pt; text-align: center; border-bottom: 1pt solid black" ROWSPAN=1 COLSPAN=3>2015<sup>&#040;4&#041;</sup></TD>

</TR>

<TR STYLE="background-color: #cceeff">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt; vertical-align: text-bottom" ROWSPAN=1 COLSPAN=1>Equity Run Rate<sup>&#040;1&#041;</sup></TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>7.9</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left">%<!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>0.3</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left">%<!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>8.5</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left">%<!-- PERCENT -->&nbsp;</TD>

</TR>

<TR STYLE="background-color: white">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt; vertical-align: text-bottom" ROWSPAN=1 COLSPAN=1>Overhang<sup>&#040;2&#041;</sup></TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>24.0</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left">%<!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>21.6</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left">%<!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>18.9</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left">%<!-- PERCENT -->&nbsp;</TD>

</TR>

<TR STYLE="background-color: #cceeff">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt; vertical-align: text-bottom" ROWSPAN=1 COLSPAN=1>Dilution<sup>&#040;3&#041;</sup></TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>9.2</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left">%<!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>7.7</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left">%<!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>9.1</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left">%<!-- PERCENT -->&nbsp;</TD>

</TR>

</TABLE></DIV>


<P STYLE="text-align: left; text-indent: 1px"><IMG SRC="line.gif" STYLE="width: 72px; height: 1pt"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 1px"></TD>

          <TD STYLE="width: 20px; text-align: left">(1)</TD>

          <TD STYLE="text-align: justify">Equity run rate is calculated by dividing the number of shares subject to equity awards granted during the year by the weighted-average number of common shares and as-converted preferred shares outstanding during the year. </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 1px"></TD>

          <TD STYLE="width: 20px; text-align: left">(2)</TD>

          <TD STYLE="text-align: justify">Overhang is calculated by dividing (a) the sum of (x) the number of shares subject to equity awards outstanding at the end of the year and (y) the number of shares available for future grants, by (b) the number of common shares and as-converted preferred shares outstanding at the end of the year. </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 1px"></TD>

          <TD STYLE="width: 20px; text-align: left">(3)</TD>

          <TD STYLE="text-align: justify">Dilution is calculated by dividing the number of shares subject to equity awards outstanding at the end of the fiscal year by the number of common shares and as-converted preferred shares outstanding at the end of the fiscal year. </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 1px"></TD>

          <TD STYLE="width: 20px; text-align: left">(4)</TD>

          <TD STYLE="text-align: justify">Excluding the special stock option grant we made to Mr. Salka in connection with his commencement of employment with us, the 2015 Equity Run Rate was 2.8%, Overhang was 13.4% and Dilution was 3.7%. </TD>

</TR>

</TABLE>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">In evaluating whether to approve the 2016 Plan our Board of Directors and Compensation Committee reviewed our historical issuances under our 2013 Plan and considered our future needs for equity awards under the 2016 Plan, based on our plans for future expansion and growth in light of our anticipated recruiting and retention needs and potential changes in company capitalization and dilution. We intend to grant future equity awards under the 2016 Plan in amounts that are reasonable and based on market data prepared by the independent compensation consultant to the Compensation Committee. If this Proposal 2 is approved by our
shareholders, we expect the initial share reserve to last for approximately 2 to 3 years of awards. While we believe this is a reasonable estimate of how long the share reserve could last, because there are a number of uncertain factors that could impact our future share usage, we are not able to presently forecast the share amounts and rate at which we will utilize equity as a tool for attracting and retaining talent. </P>

<H3 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: italic; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Continued Ability to Grant Performance-Based Awards </H3>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Approval of the 2016 Plan by our shareholders will also constitute approval of terms and conditions set forth therein that will permit us to grant stock options, stock appreciation rights and performance-based stock and cash awards under the 2016 Plan that may qualify as &#147;performance-based compensation&#148; within the meaning of Section 162(m) of the Code. Section 162(m) of the U.S. Internal Revenue Code of 1986, as amended, or the Code, disallows a deduction to any publicly held corporation and its affiliates for certain compensation paid to &#147;covered employees&#148; in a taxable year to the extent that compensation
to a covered employee exceeds $1 million. However, some kinds of compensation, including qualified &#147;performance-based compensation,&#148; are not subject to this deduction limitation. For compensation awarded under a plan to qualify as &#147;performance-based compensation&#148; under Section 162(m) of the Code, among other things, the following terms must be disclosed to and approved by the shareholders before the compensation is paid: (i) a description of the employees eligible to receive such awards; (ii) a per-person limit on the number of shares subject to stock options, stock appreciation rights and performance-based stock awards, and the amount of cash subject to performance-based cash awards, that may be granted to any employee under the plan in any year; and (iii) a description of the business criteria upon which the performance goals for performance-based awards may be granted (or become vested or exercisable). Accordingly, we are requesting that our shareholders approve
the 2016 Plan, which includes terms and conditions regarding eligibility for awards, annual </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">20</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">per-person limits on awards and the business criteria for performance-based awards granted under the 2016 Plan (as described in the summary below). </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">We believe it is in the best interests of our Company and our shareholders to preserve the ability to grant &#147;performance-based compensation&#148; under Section 162(m) of the Code. However, in certain circumstances, we may determine to grant compensation to covered employees that is not intended to qualify as &#147;performance-based compensation&#148; for purposes of Section 162(m) of the Code. Moreover, even if we grant compensation that is intended to qualify as &#147;performance-based compensation&#148; for purposes of Section 162(m) of the Code, we cannot guarantee that such compensation ultimately will be deductible by
us. </P>

<H3 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: italic; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Description of 2016 Plan </H3>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The material features of the 2016 Plan are outlined below. This summary is qualified in its entirety by reference to the complete text of the 2016 Plan. Shareholders are encouraged to read the actual text of the 2016 Plan, which is appended to this proxy statement as Appendix A and may be accessed from the SEC&#146;s website at <I>www.sec.gov.</I> </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><I>Purpose</I>.&nbsp;&nbsp;The 2016 Plan is critical to our ongoing effort to build shareholder value through recruiting, retaining and motivating employees, directors and consultants. We are seeking to approval of the 2016 Plan to provide for the shares necessary so that we can ensure that we have the most qualified, motivated employees possible to help us move the Company&#146;s programs forward and implement our recruiting plans to facilitate the future growth of our business. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><I>Awards</I>.&nbsp;&nbsp;The 2016 Plan provides for the grant of incentive stock options, or ISOs, nonstatutory stock options, or NSOs, stock appreciation rights, restricted stock awards, restricted stock unit awards, performance-based stock awards, and other forms of equity compensation, or collectively, stock awards, all of which may be granted to employees, including officers, non-employee directors and consultants of us and our affiliates. Additionally, the 2016 Plan provides for the grant of performance cash awards. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><I>Eligibility.</I>&nbsp;&nbsp;As of May 20, 2016, all of our approximately 30 employees, six non-employee directors and one consultant are eligible to participate in the 2016 Plan and may receive all types of awards other than ISOs. ISOs may be granted only to our employees (including officers) and employees of our affiliates. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><I>Share Reserve</I>.&nbsp;&nbsp;The aggregate number of shares of our common stock that initially may be issued pursuant to stock awards under the 2016 Plan will not exceed 2,373,000 shares, which is the sum of (i) 1,000,000 shares, plus (ii) the number of shares reserved for issuance under our 2013 Plan at the time our 2016 Plan became effective, plus (iii) any shares subject to stock options or other stock awards granted under our Prior Plans that would have otherwise returned to the share reserve of our Prior Plans (such as upon the expiration or termination of an option prior to exercise), such shares are referred to as
our &#147;Prior Plans&#146; Returning Shares.&#148; Collectively, our 2013 Plan, 2009 Targeted Genetics Stock Incentive Plan and the AmpliPhi Biosciences Corporation 2012 Stock Incentive Plan are our &#147;Prior Plans.&#148; </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Additionally, the number of shares of our common stock reserved for issuance under our 2016 Plan automatically increases on January 1 of each year, beginning on January 1, 2017 and continuing through and including January 1, 2026, by 5% of the total number of shares of our capital stock outstanding on December 31 of the preceding calendar year, or a lesser number of shares determined by our Board of Directors. The maximum number of shares that may be issued upon the exercise of ISOs under our 2016 Plan is 4,746,000 shares. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">If a stock award granted under the 2016 Plan expires or otherwise terminates without being exercised in full, or is settled in cash, the shares of our common stock not acquired pursuant to the stock award again will become available for subsequent issuance under the 2016 Plan. In addition, the following types of shares under the 2016 Plan may become available for the grant of new stock awards under the 2016 Plan: (1) shares that are forfeited to or repurchased by us prior to becoming fully vested; (2) shares withheld to satisfy income or employment withholding taxes; or (3) shares used to pay the exercise or purchase price of a
stock award. Shares issued under the 2016 Plan may be previously unissued shares or reacquired shares bought by us on the open market. </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">21</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><I>Section 162(m) Limits</I>.&nbsp;&nbsp;No person may be granted stock awards covering more than 1,000,000 shares of our common stock under our 2016 Plan during any calendar year pursuant to stock options, stock appreciation rights and other stock awards whose value is determined by reference to an increase over an exercise or strike price of at least 100% of the fair market value on the date the stock award is granted. Additionally, no person may be granted in a calendar year a performance stock award covering more than 1,000,000 shares or a performance cash award having a maximum value in excess of $2,000,000. Such
limitations are designed to help assure that any deductions to which we would otherwise be entitled with respect to such awards will not be subject to the $1,000,000 limitation on the income tax deductibility of compensation paid to any covered executive officer imposed by Section 162(m) of the Code. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><I>Non-Employee Director Compensation Limit.&nbsp;&nbsp;</I>The aggregate value of all compensation paid or granted, as applicable, to any individual for service as a non-employee director of our Board of Directors with respect to any calendar year commencing with the 2016 calendar year, including awards granted under the 2016 Plan and cash fees paid by us to such non-employee director, will not exceed (i) $375,000 in total value or (ii) in the event such non-employee director is first appointed or elected to our Board of Directors during such calendar year, $783,000 in total value, in each case calculating the value of any
awards granted under the 2016 Plan based on the grant date fair value of such awards for financial reporting purposes. However, the Board of Directors may make exceptions to the applicable limit for individual non-employee directors in extraordinary circumstances (for example, to compensate such individual for interim service in the capacity of an officer of the Company), as the Board of Directors may determine in its discretion, provided that the non-employee director receiving such additional compensation may not participate in the decision to award such compensation. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><I>Administration.</I>&nbsp;&nbsp;Our Board of Directors, or a duly authorized committee thereof, has the authority to administer the 2016 Plan. Our Board of Directors has delegated authority to administer the 2016 Plan to our Compensation Committee. Subject to the terms of the 2016 Plan, the Compensation Committee, referred to herein as the plan administrator, determines recipients, dates of grant, the numbers and types of stock awards to be granted and the terms and conditions of the stock awards, including the period of their exercisability and vesting schedule applicable to a stock award. Subject to the limitations set
forth below, the plan administrator will also determine the exercise price, strike price or purchase price of awards granted and the types of consideration to be paid for the award. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The plan administrator has the authority to modify outstanding awards under our 2016 Plan. Subject to the terms of our 2016 Plan, the plan administrator has the authority to reduce the exercise, purchase or strike price of any outstanding stock award, cancel any outstanding stock award in exchange for new stock awards, cash or other consideration, or take any other action that is treated as a repricing under generally accepted accounting principles, with the consent of any adversely affected participant. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><I>Stock Options</I>.&nbsp;&nbsp;ISOs and NSOs are granted pursuant to stock option agreements adopted by the plan administrator. The plan administrator determines the exercise price for a stock option, within the terms and conditions of the 2016 Plan, provided that the exercise price of a stock option generally cannot be less than 100% of the fair market value of our common stock on the date of grant. Options granted under the 2016 Plan vest at the rate specified by the plan administrator. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The plan administrator determines the term of stock options granted under the 2016 Plan, up to a maximum of 10 years. Unless the terms of an option holder&#146;s stock option agreement provide otherwise, if an option holder&#146;s service relationship with us, or any of our affiliates, ceases for any reason other than disability, death or cause, the option holder may generally exercise any vested options for a period of three months following the cessation of service. The option term may be extended in the event that exercise of the option following such a termination of service is prohibited by applicable securities laws or
our insider trading policy. If an optionholder&#146;s service relationship with us or any of our affiliates ceases due to disability or death, or an optionholder dies within a certain period following cessation of service, the optionholder or a beneficiary may generally exercise any vested options for a period of 12 months in the event of disability and 18 months in the event of death. In the event of a termination for cause, options generally terminate immediately upon the termination of the individual for cause. In no event may an option be exercised beyond the expiration of its term. </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">22</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Acceptable consideration for the purchase of common stock issued upon the exercise of a stock option will be determined by the plan administrator and may include (1) cash, check, bank draft or money order, (2) a broker-assisted cashless exercise, (3) the tender of shares of our common stock previously owned by the optionholder, (4) a net exercise of the option if it is an NSO, and (5) other legal consideration approved by the plan administrator. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Unless the plan administrator provides otherwise, options generally are not transferable except by will, the laws of descent and distribution, or pursuant to a domestic relations order. An optionholder may designate a beneficiary, however, who may exercise the option following the optionholder&#146;s death. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><I>Tax Limitations on Incentive Stock Options</I>.&nbsp;&nbsp;The aggregate fair market value, determined at the time of grant, of our common stock with respect to ISOs that are exercisable for the first time by an optionholder during any calendar year under all of our stock plans may not exceed $100,000. Options or portions thereof that exceed such limit will generally be treated as NSOs. No ISO may be granted to any person who, at the time of the grant, owns or is deemed to own stock possessing more than 10% of our total combined voting power or that of any of our affiliates unless (1) the option exercise price is at least
110% of the fair market value of the stock subject to the option on the date of grant, and (2) the term of the ISO does not exceed five years from the date of grant. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><I>Restricted Stock Awards</I>.&nbsp;&nbsp;Restricted stock awards are granted pursuant to restricted stock award agreements adopted by the plan administrator. Restricted stock awards may be granted in consideration for (1) cash, check, bank draft or money order, (2) services rendered to us or our affiliates, or (3) any other form of legal consideration. Common stock acquired under a restricted stock award may, but need not, be subject to a share repurchase option in our favor in accordance with a vesting schedule to be determined by the plan administrator. Rights to acquire shares under a restricted stock award may be
transferred only upon such terms and conditions as set by the plan administrator. Except as otherwise provided in the applicable award agreement, restricted stock unit awards that have not vested will be forfeited upon the participant&#146;s cessation of continuous service for any reason. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><I>Restricted Stock Unit Awards</I>.&nbsp;&nbsp;Restricted stock unit awards are granted pursuant to restricted stock unit award agreements adopted by the plan administrator. Restricted stock unit awards may be granted in consideration for any form of legal consideration. A restricted stock unit award may be settled by cash, delivery of stock, a combination of cash and stock as deemed appropriate by the plan administrator, or in any other form of consideration set forth in the restricted stock unit award agreement. Additionally, dividend equivalents may be credited in respect of shares covered by a restricted stock unit award.
Except as otherwise provided in the applicable award agreement, restricted stock units that have not vested will be forfeited upon the participant&#146;s cessation of continuous service for any reason. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><I>Stock Appreciation Rights</I>.&nbsp;&nbsp;Stock appreciation rights are granted pursuant to stock appreciation grant agreements adopted by the plan administrator. The plan administrator determines the strike price for a stock appreciation unit, which generally cannot be less than 100% of the fair market value of our common stock on the date of grant. Upon the exercise of a stock appreciation unit, we will pay the participant an amount equal to the product of (1) the excess of the per share fair market value of our common stock on the date of exercise over the strike price, multiplied by (2) the number of shares of common
stock with respect to which the stock appreciation unit is exercised. A stock appreciation unit granted under the 2016 Plan vests at the rate specified in the stock appreciation grant agreement as determined by the plan administrator. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The plan administrator determines the term of stock appreciation rights granted under the 2016 Plan, up to a maximum of ten years. Unless the terms of a participant&#146;s stock appreciation right agreement provides otherwise, if a participant&#146;s service relationship with us or any of our affiliates ceases for any reason other than cause, disability or death, the participant may generally exercise any vested stock appreciation right for a period of three months following the cessation of service. The stock appreciation right term may be further extended in the event that exercise of the stock appreciation right following
such a termination of service is prohibited by applicable securities laws. If a participant&#146;s service relationship with us, or any of our affiliates, ceases due to disability or death, or a participant dies within a certain period following cessation of service, the participant or a beneficiary may generally exercise any vested stock appreciation right for a period of 12 months in the event of disability and 18 months in the event of death. In the event of a termination for </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">23</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">cause, stock appreciation rights generally terminate immediately upon the occurrence of the event giving rise to the termination of the individual for cause. In no event may a stock appreciation right be exercised beyond the expiration of its term. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><I>Performance Awards</I>.&nbsp;&nbsp;The 2016 Plan permits the grant of performance-based stock and cash awards that may qualify as performance-based compensation that is not subject to the $1,000,000 limitation on the income tax deductibility of compensation paid to a covered executive officer imposed by Section 162(m) of the Code. To help assure that the compensation attributable to performance-based awards will so qualify, our Compensation Committee can structure such awards so that stock or cash will be issued or paid pursuant to such award only after the achievement of certain pre-established performance goals during a
designated performance period. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">A performance stock award is a stock award that is payable (including that may be granted, may vest, or may be exercised) contingent upon the achievement of pre-determined performance goals during a performance period. A performance stock award may require the completion of a specified period of continuous service. The length of any performance period, the performance goals to be achieved during the performance period, and the measure of whether and to what degree such performance goals have been attained will generally be determined by our Compensation Committee, except that the plan administrator also may make any such
determinations to the extent that the award is not intended to comply with Section 162(m) of the Code. In addition, to the extent permitted by applicable law and the performance stock award agreement, the plan administrator may determine that cash may be used in payment of performance stock awards. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">A performance cash award is a cash award that is payable contingent upon the achievement of pre-determined performance goals during a performance period. A performance cash award may require the completion of a specified period of continuous service. The length of any performance period, the performance goals to be achieved during the performance period, and the measure of whether and to what degree such performance goals have been attained will generally be determined by our Compensation Committee, except that the plan administrator also may make any such determinations to the extent that the award is not intended to comply
with Section 162(m) of the Code. The plan administrator may specify the form of payment of performance cash awards, which may be cash or other property, or may provide for a participant to have the option for his or her performance cash award, or such portion thereof as the plan administrator may specify, to be paid in whole or in part in cash or other property. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">In granting a performance award intended to qualify as &#147;performance-based compensation&#148; under Section 162(m) of the Code, our Compensation Committee will set a period of time, or a performance period, over which the attainment of one or more goals, or performance goals, will be measured. Within the time period prescribed by Section 162(m) of the Code (no later than the earlier of the 90<sup>th</sup> day of a performance period and the date on which 25% of the performance period has elapsed, and in any event at a time when the achievement of the performance goals remains substantially uncertain), our Compensation
Committee will establish the performance goals, based upon one or more criteria, or performance criteria, enumerated in the 2016 Plan and described below. As soon as administratively practicable following the end of the performance period, our Compensation Committee will certify in writing whether the performance goals have been satisfied. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Performance goals under the 2016 Plan will be based on any one or more of the following performance criteria: (1) earnings (including earnings per share and net earnings); (2) earnings before interest, taxes and depreciation; (3) earnings before interest, taxes, depreciation and amortization; (4) earnings before interest, taxes, depreciation, amortization and legal settlements; (5) earnings before interest, taxes, depreciation, amortization, legal settlements and other income (expense); (6) earnings before interest, taxes, depreciation, amortization, legal settlements, other income (expense) and stock-based compensation; (7)
earnings before interest, taxes, depreciation, amortization, legal settlements, other income (expense), stock-based compensation and changes in deferred revenue; (8) earnings before interest, taxes, depreciation, amortization, legal settlements, other income (expense), stock-based compensation, other non-cash expenses and changes in deferred revenue; (9) total shareholder return; (10) return on equity or average shareholder&#146;s equity; (11) return on assets, investment, or capital employed; (12) stock price; (13) margin (including gross margin); (14) income (before or after taxes); (15) operating income; (16) operating income after taxes; (17) pre-tax profit; (18) operating cash flow; (19) sales or revenue targets; (20) increases in revenue or product revenue; </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">24</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(21) expenses and cost reduction goals; (22) improvement in or attainment of working capital levels; (23) economic value added (or an equivalent metric); (24) market share; (25) cash flow; (26) cash flow per share; (27) cash balance; (28) cash burn; (29) cash collections; (30) share price performance; (31) debt reduction; (32) implementation or completion of projects or processes (including, without limitation, clinical trial initiation, clinical trial enrollment and dates, clinical trial results, regulatory filing submissions, regulatory filing acceptances, regulatory or advisory committee interactions, regulatory approvals,
and product supply); (33) shareholders&#146; equity; (34) capital expenditures; (35) debt levels; (36) operating profit or net operating profit; (37) workforce diversity; (38) growth of net income or operating income; (39) billings; (40) bookings; (41) employee retention; (42) initiation of studies by specific dates; (43) budget management; (44) submission to, or approval by, a regulatory body (including, but not limited to the U.S. Food and Drug Administration) of an applicable filing or a product; (45) regulatory milestones; (46) progress of internal research or development programs; (47) acquisition of new customers; (48) customer retention and/or repeat order rate; (49) improvements in sample and test processing times; (50) progress of partnered programs; (51) partner satisfaction; (52) timely completion of clinical trials; (53) submission of 510(k)s or pre-market approvals and other regulatory achievements; (54) milestones related to research development (including, but not
limited to, preclinical and clinical studies), product development and manufacturing; (55) expansion of sales in additional geographies or markets; (56) research progress, including the development of programs; (57) strategic partnerships or transactions (including in-licensing and out-licensing of intellectual property; and (58) and to the extent that an award is not intended to comply with Section 162(m) of the Code, other measures of performance selected by the plan administrator. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Performance goals may be based on a company-wide basis, with respect to one or more business units, divisions, affiliates or business segments, and in either absolute terms or relative to the performance of one or more comparable companies or the performance of one or more relevant indices. Under the 2016 Plan, unless specified otherwise by our Compensation Committee (or, if not required for compliance with Section 162(m) of the Code, the plan administrator) (i) in the award agreement at the time the award is granted or (ii) in such other document setting forth the performance goals at the time the performance goals are
established, our compensation committee (or, if not required for compliance with Section 162(m) of the Code, the plan administrator) will appropriately make adjustments in the method of calculating the attainment of performance goals for a performance period: (1) to exclude restructuring and/or other nonrecurring charges; (2) to exclude exchange rate effects; (3) to exclude the effects of changes to generally accepted accounting principles; (4) to exclude the effects of any statutory adjustments to corporate tax rates; (5) to exclude the effects of any items that are &#147;unusual&#148; in nature or occur &#147;infrequently&#148; as determined under generally accepted accounting principles; (6) to exclude the dilutive effects of acquisitions or joint ventures; (7) to assume that any business divested by the Company achieved performance objectives at targeted levels during the balance of a performance period following such divestiture; (8) to exclude the effect of any change in the
outstanding shares of common stock of the Company by reason of any stock dividend or split, stock repurchase, reorganization, recapitalization, merger, consolidation, spin-off, combination or exchange of shares or other similar corporate change, or any distributions to common shareholders other than regular cash dividends; (9) to exclude the effects of stock based compensation and the award of bonuses under the Company&#146;s bonus plans; (10) to exclude costs incurred in connection with potential acquisitions or divestitures that are required to be expensed under generally accepted accounting principles; (11) to exclude the goodwill and intangible asset impairment charges that are required to be recorded under generally accepted accounting principles; and (12) to exclude the effects of the timing of acceptance for review and/or approval of submissions to the U.S. Food and Drug Administration or any other regulatory body. In addition, our Compensation Committee (or, if not required for
compliance with Section 162(m) of the Code, the plan administrator) retains the discretion to reduce or eliminate the compensation or economic benefit due upon the attainment of any performance goals and to define the manner of calculating the performance criteria it selects to use for a performance period. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><I>Other Stock Awards</I>.&nbsp;&nbsp;The plan administrator may grant other awards based in whole or in part by reference to our common stock. The plan administrator will set the number of shares under the stock award and all other terms and conditions of such awards. </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">25</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><I>Changes to Capital Structure</I>.&nbsp;&nbsp;In the event that there is a specified type of change in our capital structure, such as a stock split or recapitalization, appropriate adjustments will be made to (a) the class and maximum number of shares reserved for issuance under the 2016 Plan, (b) the class and maximum number of shares by which the share reserve may increase automatically each year, (c) the class and maximum number of shares that may be issued upon the exercise of ISOs, (d) the class and maximum number of shares subject to stock awards that can be granted in a calendar year (as established under the 2016 Plan
pursuant to Section 162(m) of the Code) and (e) the class and number of shares and exercise price, strike price, or purchase price, if applicable, of all outstanding stock awards. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><I>Corporate Transactions</I>.&nbsp;&nbsp;In the event of certain specified significant corporate transactions, the plan administrator has the discretion to take any of the following actions with respect to stock awards: </P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">arrange for the assumption, continuation or substitution of a stock award by a surviving or acquiring entity or parent company; </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">arrange for the assignment of any reacquisition or repurchase rights held by us to the surviving or acquiring entity or parent company; </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">accelerate the vesting of the stock award and provide for its termination prior to the effective time of the corporate transaction; </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">arrange for the lapse of any reacquisition or repurchase right held by us; </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">cancel or arrange for the cancellation of the stock award in exchange for such cash consideration, if any, as our plan administrator may deem appropriate; or </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">make a payment equal to the excess of (a) the value of the property the participant would have received upon exercise of the stock award over (b) the exercise price otherwise payable in connection with the stock award. </TD>

</TR>

</TABLE>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Our plan administrator is not obligated to treat all stock awards, even those that are of the same type, in the same manner. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Under the 2016 Plan, a corporate transaction is generally the consummation of (i) a sale or other disposition of all or substantially all of our consolidated assets, (ii) a sale or other disposition of at least 50% of our outstanding securities, (iii) a merger, consolidation or similar transaction following which we are not the surviving corporation, or (iv) a merger, consolidation or similar transaction following which we are the surviving corporation but the shares of our common stock outstanding immediately prior to such transaction are converted or exchanged into other property by virtue of the transaction. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><I>Change of Control</I>.&nbsp;&nbsp;The plan administrator may provide, in an individual award agreement or in any other written agreement between a participant and us that the stock award will be subject to additional acceleration of vesting and exercisability in the event of a change of control. Under the 2016 Plan, a change of control is generally (i) the acquisition by a person or entity of more than 50% of our combined voting power other than by merger, consolidation or similar transaction; (ii) a consummated merger, consolidation or similar transaction immediately after which our shareholders cease to own more than 50%
of the combined voting power of the surviving entity; (iii) a consummated sale, lease or exclusive license or other disposition of all or substantially of our consolidated assets; (iv) a complete dissolution or liquidation; or (v) when a majority of the Board of Directors becomes comprised of individuals whose nomination, appointment, or election was not approved by a majority of the Board of Directors members or their approved successors. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><I>Amendment and Termination</I>.&nbsp;&nbsp;Our Board of Directors has the authority to amend, suspend, or terminate our 2016 Plan, provided that such action does not materially impair the existing rights of any participant without such participant&#146;s written consent. No ISOs may be granted after the tenth anniversary of the date our Board of Directors adopted our 2016 Plan. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">U.S. Federal Income Tax Consequences </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The following is a summary of the principal United States federal income tax consequences to participants and us with respect to participation in the 2016 Plan. This summary is not intended to be exhaustive and does not discuss the income tax laws of any local, state or foreign jurisdiction in which a participant may reside. </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">26</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The information is based upon current federal income tax rules and therefore is subject to change when those rules change. Because the tax consequences to any participant may depend on his or her particular situation, each participant should consult the participant&#146;s tax adviser regarding the federal, state, local and other tax consequences of the grant or exercise of an award or the disposition of stock acquired the 2016 Plan. The 2016 Plan is not qualified under the provisions of Section 401(a) of the Code and is not subject to any of the provisions of the Employee Retirement Income Security Act of 1974. Our ability to
realize the benefit of any tax deductions described below depends on our generation of taxable income as well as the requirement of reasonableness, the provisions of Section 162(m) of the Code and the satisfaction of our tax reporting obligations. </P>

<H4 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: italic; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Nonstatutory Stock Options </H4>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Generally, there is no taxation upon the grant of an NSO if the stock option is granted with an exercise price equal to the fair market value of the underlying stock on the grant date. Upon exercise, a participant will recognize ordinary income equal to the excess, if any, of the fair market value of the underlying stock on the date of exercise of the stock option over the exercise price. If the participant is employed by us or one of our affiliates, that income will be subject to withholding taxes. The participant&#146;s tax basis in those shares will be equal to their fair market value on the date of exercise of the stock
option, and the participant&#146;s capital gain holding period for those shares will begin on that date. Subject to the requirement of reasonableness, the provisions of Section 162(m) of the Code and the satisfaction of a tax reporting obligation, we will generally be entitled to a tax deduction equal to the taxable ordinary income realized by the participant. </P>

<H4 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: italic; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Incentive Stock Options </H4>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The 2016 Plan provides for the grant of stock options that are intended to qualify as &#147;incentive stock options,&#148; as defined in Section 422 of the Code. Under the Code, a participant generally is not subject to ordinary income tax upon the grant or exercise of an ISO. If the participant holds a share received upon exercise of an ISO for more than two years from the date the stock option was granted and more than one year from the date the stock option was exercised, which is referred to as the required holding period, the difference, if any, between the amount realized on a sale or other taxable disposition of that
share and the participant&#146;s tax basis in that share will be long-term capital gain or loss. If, however, a participant disposes of a share acquired upon exercise of an ISO before the end of the required holding period, which is referred to as a disqualifying disposition, the participant generally will recognize ordinary income in the year of the disqualifying disposition equal to the excess, if any, of the fair market value of the share on the date of exercise of the stock option over the exercise price. However, if the sales proceeds are less than the fair market value of the share on the date of exercise of the stock option, the amount of ordinary income recognized by the participant will not exceed the gain, if any, realized on the sale. If the amount realized on a disqualifying disposition exceeds the fair market value of the share on the date of exercise of the stock option, that excess will be short-term or long-term capital gain, depending on whether the holding period for
the share exceeds one year. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">For purposes of the alternative minimum tax, the amount by which the fair market value of a share of stock acquired upon exercise of an ISO exceeds the exercise price of the stock option generally will be an adjustment included in the participant&#146;s alternative minimum taxable income for the year in which the stock option is exercised. If, however, there is a disqualifying disposition of the share in the year in which the stock option is exercised, there will be no adjustment for alternative minimum tax purposes with respect to that share. In computing alternative minimum taxable income, the tax basis of a share acquired
upon exercise of an ISO is increased by the amount of the adjustment taken into account with respect to that share for alternative minimum tax purposes in the year the stock option is exercised. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">We are not allowed an income tax deduction with respect to the grant or exercise of an ISO or the disposition of a share acquired upon exercise of an ISO after the required holding period. If there is a disqualifying disposition of a share, however, we will generally be entitled to a tax deduction equal to the taxable ordinary income realized by the participant, subject to the requirement of reasonableness and the provisions of Section 162(m) of the Code, and provided that either the employee includes that amount in income or we timely satisfy our reporting requirements with respect to that amount. </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">27</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<H4 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: italic; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Restricted Stock Awards </H4>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Generally, the recipient of a restricted stock award will recognize ordinary income at the time the stock is received equal to the excess, if any, of the fair market value of the stock received over any amount paid by the recipient in exchange for the stock. If, however, the stock is not vested when it is received (for example, if the employee is required to work for a period of time in order to have the right to sell the stock), the recipient generally will not recognize income until the stock becomes vested, at which time the recipient will recognize ordinary income equal to the excess, if any, of the fair market value of the
stock on the date it becomes vested over any amount paid by the recipient in exchange for the stock. A recipient may, however, file an election with the Internal Revenue Service, within 30 days following his or her receipt of the stock award, to recognize ordinary income, as of the date the recipient receives the award, equal to the excess, if any, of the fair market value of the stock on the date the award is granted over any amount paid by the recipient for the stock. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The recipient&#146;s basis for the determination of gain or loss upon the subsequent disposition of shares acquired from a restricted stock award will be the amount paid for such shares plus any ordinary income recognized either when the stock is received or when the stock becomes vested. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Subject to the requirement of reasonableness, the provisions of Section 162(m) of the Code and the satisfaction of a tax reporting obligation, we will generally be entitled to a tax deduction equal to the taxable ordinary income realized by the recipient of the stock award. </P>

<H4 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: italic; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Restricted Stock Unit Awards </H4>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Generally, the recipient of a restricted stock unit award structured to conform to the requirements of Section 409A of the Code or an exception to Section 409A of the Code will recognize ordinary income at the time the stock is delivered equal to the excess, if any, of the fair market value of the stock received over any amount paid by the recipient in exchange for the stock. To conform to the requirements of Section 409A of the Code, the stock subject to a restricted stock unit award may generally only be delivered upon one of the following events: a fixed calendar date (or dates), separation from service, death, disability or
a change in control. If delivery occurs on another date, unless the restricted stock unit award otherwise complies with or qualifies for an exception to the requirements of Section 409A of the Code, in addition to the tax treatment described above, the recipient will owe an additional 20% federal tax and interest on any taxes owed. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The recipient&#146;s basis for the determination of gain or loss upon the subsequent disposition of shares acquired from a restricted stock unit award will be the amount paid for such shares plus any ordinary income recognized when the stock is delivered. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Subject to the requirement of reasonableness, the provisions of Section 162(m) of the Code and the satisfaction of a tax reporting obligation, we will generally be entitled to a tax deduction equal to the taxable ordinary income realized by the recipient of the restricted stock unit award. </P>

<H4 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: italic; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Stock Appreciation Rights </H4>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Generally, if a stock appreciation right is granted with an exercise price equal to the fair market value of the underlying stock on the grant date, the recipient will recognize ordinary income equal to the fair market value of the stock or cash received upon such exercise. Subject to the requirement of reasonableness, the provisions of Section 162(m) of the Code, and the satisfaction of a tax reporting obligation, we will generally be entitled to a tax deduction equal to the taxable ordinary income realized by the recipient of the stock appreciation right. </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">28</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><FONT STYLE="font-variant: small-caps">New Plan Benefits</FONT> </H2>

<H1 STYLE="text-indent:0pt; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 9pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">2016 Plan </H1>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"></P>

<DIV style="text-align: center"><TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="608" STYLE="vertical-align: bottom; text-indent:0px; text-align: left; font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: -15pt; *margin-top: -20pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR>

          <TD><IMG HEIGHT="1" SRC="spacer.gif" WIDTH="488"></TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none"><!-- GUTTER -->&nbsp;</TD>

          <TD COLSPAN="3"><IMG HEIGHT="1" SRC="spacer.gif" WIDTH="40"></TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none"><!-- GUTTER -->&nbsp;</TD>

          <TD COLSPAN="3"><IMG HEIGHT="1" SRC="spacer.gif" WIDTH="48"></TD>

</TR>

<TR>

          <TD STYLE="line-height: normal; vertical-align: bottom; font-weight: bold; font-size: 8pt; text-align: left; border-bottom: 1pt solid black" ROWSPAN=1 COLSPAN=1>Name and position</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="line-height: normal; vertical-align: bottom; font-weight: bold; font-size: 8pt; text-align: center; border-bottom: 1pt solid black" ROWSPAN=1 COLSPAN=3>Dollar<BR> value</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="line-height: normal; vertical-align: bottom; font-weight: bold; font-size: 8pt; text-align: center; border-bottom: 1pt solid black" ROWSPAN=1 COLSPAN=3>Number<BR> of shares</TD>

</TR>

<TR STYLE="background-color: #cceeff">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt; vertical-align: text-bottom" ROWSPAN=1 COLSPAN=1>M. Scott Salka, Chief Executive Officer</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1><sup>&#040;1&#041;</sup></TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1><sup>&#040;1&#041;</sup></TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

</TR>

<TR STYLE="background-color: white">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt; vertical-align: text-bottom" ROWSPAN=1 COLSPAN=1>Steve R. Martin, Chief Financial Officer</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1><sup>&#040;1&#041;</sup></TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1><sup>&#040;1&#041;</sup></TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

</TR>

<TR STYLE="background-color: #cceeff">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt; vertical-align: text-bottom" ROWSPAN=1 COLSPAN=1>Wendy S. Johnson, Interim Chief Operating Officer</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1><sup>&#040;1&#041;</sup></TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1><sup>&#040;1&#041;</sup></TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

</TR>

<TR STYLE="background-color: white">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt; vertical-align: text-bottom" ROWSPAN=1 COLSPAN=1>All current executive officers as a group</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1><sup>&#040;1&#041;</sup></TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1><sup>&#040;1&#041;</sup></TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

</TR>

<TR STYLE="background-color: #cceeff">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt; vertical-align: text-bottom" ROWSPAN=1 COLSPAN=1>All current directors who are not executive officers as a group</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1><sup>&#040;2&#041;</sup></TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1><sup>&#040;2&#041;</sup></TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

</TR>

<TR STYLE="background-color: white">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt; vertical-align: text-bottom" ROWSPAN=1 COLSPAN=1>All employees, including all current officers who are not executive officers, as a group</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1><sup>&#040;1&#041;</sup></TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1><sup>&#040;1&#041;</sup></TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

</TR>

</TABLE></DIV>


<P STYLE="text-align: left; text-indent: 1px"><IMG SRC="line.gif" STYLE="width: 72px; height: 1pt"></P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 1px"></TD>

          <TD STYLE="width: 20px; text-align: left">(1)</TD>

          <TD STYLE="text-align: justify">Awards granted under the 2016 Plan to our executive officers and other employees are discretionary and are not subject to set benefits or amounts under the terms of the 2016 Plan, and our Board of Directors and our Compensation Committee have not granted any awards under the 2016 Plan subject to shareholder approval of this Proposal 2. Accordingly, the benefits or amounts that will be received by or allocated to our executive officers and other employees under the 2016 Plan, as well as the benefits or amounts which would have been received by or allocated to our executive officers and other employees for fiscal year 2015 if the 2016 Plan had been in effect, are not determinable. </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 1px"></TD>

          <TD STYLE="width: 20px; text-align: left">(2)</TD>

          <TD STYLE="text-align: justify">Awards granted under the 2016 Plan to our non-employee directors are currently discretionary and not subject to set benefits or amounts under the terms of the 2016 Plan. </TD>

</TR>

</TABLE>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Vote Required; Recommendation of the Board of Directors </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">In order for Proposal 2 to be approved, the number of shares that vote &#147;For&#148; the proposal must exceed the number of shares that vote &#147;Against&#148; the proposal. Abstentions will be counted towards the vote total for Proposal 2 and will have the same effect as &#147;Against&#148; votes. Broker non-votes are counted towards a quorum, but are not counted for any purpose in determining whether this matter has been approved. </P>

<H1 STYLE="text-indent:0pt; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 9pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><FONT STYLE="font-variant: small-caps">The Board of Directors Recommends<BR> a Vote &#147;For&#148; Proposal 2.</FONT> </H1>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">29</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<H1 STYLE="text-indent:0pt; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 9pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><FONT STYLE="font-variant: small-caps">Proposal 3<BR> &nbsp;<BR>Approval of the<BR> AmpliPhi Biosciences Corporation 2016 Employee Stock Purchase Plan</FONT> </H1>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Overview </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">On April 21, 2016, the Board of Directors adopted the AmpliPhi Bioscience Corporation 2016 Employee Stock Purchase Plan, or the ESPP, subject to shareholder approval at the annual meeting. There are 120,000 shares of common stock initially reserved for issuance under the ESPP. In this Proposal 3, we are requesting approval by our shareholders of the ESPP. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The material features of the ESPP are outlined below. This summary is qualified in its entirety by reference to the complete text of the ESPP. Shareholders are encouraged to read the actual text of the ESPP, which is appended to this proxy statement as Appendix B and may be accessed from the SEC&#146;s website at <I>www.sec.gov</I>. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">If this Proposal 3 is approved by our shareholders, the ESPP will become effective as of the date of the annual meeting. In the event that our shareholders do not approve this Proposal 3, the ESPP will not become effective. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Forecasted Utilization Rates and Dilution </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">We manage our long-term shareholder dilution by limiting the number of equity incentive awards granted annually. The Compensation Committee carefully monitors our annual burn rate, dilution, and equity expense to ensure that we maximize shareholders&#146; value by granting only the appropriate number of equity incentive awards necessary to attract, reward, and retain employees. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">We cannot determine at this time the participants who will be granted options to purchase shares under the ESPP, the amount of any such options or purchases, or the potential value of such options or purchases to participants as the election to participate and the amount of any purchases under the ESPP will be determined by the individual employees in their sole discretion and the purchase price has not yet been determined; however, all participants are subject to the purchase limitations set forth in the ESPP. Under the terms of the proposed ESPP and the anticipated terms of the offerings, the number of shares of our common
stock which a participant could purchase during any six month purchase period is limited to 7,000 shares, and the number of shares of our common stock which all participants could purchase during any six month purchase period is limited to 45,000 shares. In addition, the fair market value of shares purchased by an individual participant in the ESPP may not exceed $25,000 in any calendar year. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Purpose; General </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The purpose of the ESPP is to provide a means by which our employees may be given an opportunity to purchase shares of our common stock through payroll deductions, to assist us in retaining the services of our employees, to secure and retain the services of new employees, and to provide incentives for such persons to exert maximum efforts for our success. If the ESPP is approved by our shareholders, approximately eight of our employees will initially be eligible to participate in the ESPP. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The rights to purchase common stock granted under the ESPP are intended to qualify as options issued under an &#147;employee stock purchase plan,&#148; as that term is defined in Section 423(b) of the Internal Revenue Code of 1986, as amended, or the Code. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Administration </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The Board of Directors administers the ESPP and has the final power to construe and interpret both the ESPP and the rights granted under it. The Board of Directors has the power, subject to the provisions of the ESPP, to determine when and how rights to purchase common stock will be granted, the provisions of each offering of such rights (which need not be identical), and whether employees of any subsidiary of AmpliPhi will be eligible to participate in the ESPP. </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">30</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The Board of Directors has the power to delegate administration of the ESPP to a committee comprised of one or more members of the Board of Directors. The Board of Directors has delegated administration of the ESPP to the Compensation Committee. As used herein with respect to the ESPP, the &#147;Board of Directors&#148; refers both to the Board of Directors and to any committee the Board of Directors appoints, including the Compensation Committee. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Stock Subject to ESPP </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Subject to approval of this Proposal 3, an aggregate of 120,000 shares of our common stock has been initially reserved for issuance under the ESPP. Additionally, the number of shares of our common stock reserved for issuance under the ESPP will automatically increase on January 1 of each year, beginning on January 1, 2017 and including January 1, 2026, by the lesser of (i) 1% of the total number of shares of our common stock outstanding on December 31 of the preceding calendar year, (ii) 300,000 shares of common stock, or (iii) such lesser number of shares of common stock as determined by the Board of Directors. If purchase
rights granted under the ESPP terminate without being exercised, the shares of common stock not purchased under such rights again become available for purchase under the ESPP. The shares of common stock purchasable under the ESPP will be shares of authorized but unissued or reacquired common stock, including shares that may be repurchased by us on the open market. The closing price of our common stock as reported on The NYSE MKT on May 20, 2016 was $1.57 per share. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Offerings </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The ESPP is implemented by offerings of rights to all eligible employees from time to time. The Board of Directors determines the terms and conditions of offerings The maximum length for an offering under the ESPP is twenty-seven (27) months. The provisions of separate offerings need not be identical. When an eligible employee elects to join an offering period, he or she is granted a purchase right to acquire shares of common stock on each purchase date within the offering period. On the purchase date, all payroll deductions collected from the participant during the purchase period are automatically applied to the purchase of
common stock, subject to certain limitations (which are described further below under &#147;Eligibility&#148;). </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The Board of Directors currently anticipates that each offering under the ESPP will be 24 months long, consisting of four separate six month &#147;purchase periods.&#148; The first day of an offering is referred to as an &#147;offering date,&#148; and the last day of an offering and purchase period is referred to as a &#147;purchase date.&#148; Subsequent 24 month offerings will commence following the expiration of each offering, unless longer or shorter offerings and/or purchase periods are established and approved by the Board of Directors. If any offering date is not a trading day (<I>i.e.</I>, a day on which the NYSE MKT,
or any other exchange or market on which shares of our common stock are listed, is not open for trading), then the offering date will fall on the next subsequent trading day, and if the last day of an offering and purchase period falls on a day that is not a trading day, then the purchase date for that offering and purchase period will instead fall on the immediately preceding trading day. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Eligibility </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The Board of Directors has the power to exclude certain part-time employees and certain highly compensated employees under applicable tax laws. No employee is eligible to participate in the ESPP if, immediately after the grant of purchase rights, the employee would own, directly or indirectly, stock possessing 5% or more of the total combined voting power or value of all classes of stock or of any parent or subsidiary of AmpliPhi. In addition, no employee may purchase more than $25,000 worth of common stock (determined based on the fair market value of the shares at the time such rights are granted) under all employee stock
purchase plans of AmpliPhi and our subsidiary corporations in any calendar year; provided, that any unused limit in one year may be carried over to a future year to the extent permitted by applicable tax laws. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Participation in the ESPP </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Eligible employees will generally enroll in the ESPP by delivering to us, prior to the date selected by the Board of Directors as the offering date for the applicable offering, an agreement authorizing payroll deductions. However, for the initial offering under the ESPP which will commence on the date of the annual meeting, we anticipate that each eligible employee will be automatically enrolled in such offering and will </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">31</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">have a two week period after the date of the annual meeting to elect to either authorize payroll deductions or withdraw from such offering. Currently, such payroll deductions are limited to 15% of an employee&#146;s base salary or base wages earned during the offering and other compensation, such as overtime pay, bonuses and commissions, and the spread on the exercise of an option, is excluded from such calculation. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Purchase Price </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The purchase price per share at which shares of common stock are sold in an offering under the ESPP may not be less than the lower of (i) 85% of the fair market value of a share of common stock on the first day of the offering period and (ii) 85% of the fair market value of a share of common stock on the purchase date (<I>i.e.</I>, the last day of the applicable purchase period). If the scheduled purchase date is not a trading day, the purchase will occur on the immediately preceding trading day. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Payment of Purchase Price; Payroll Deductions </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The purchase price of the shares is funded by accumulated payroll deductions during the offering. All payroll deductions made on behalf of a participant are credited to his or her account under the ESPP and deposited with our general funds. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Purchase of Shares </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">In connection with offerings made under the ESPP, the Board of Directors may specify a maximum number of shares of common stock an employee may be granted the right to purchase and the maximum aggregate number of shares of common stock that may be purchased pursuant to such offering by all participants. The Board of Directors currently anticipates that the terms of offerings will provide maximum number of shares that may be purchased during any six month purchase period by any single eligible employee will be 7,000 shares and the number purchasable during such six month period by all eligible employees will be 45,000 shares.
</P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">If the aggregate number of shares to be purchased upon exercise of all outstanding purchase rights would exceed the number of shares of common stock remaining available under the ESPP, or the maximum number of shares that may be purchased on a single purchase date across all offerings, the Board of Directors would make a pro rata allocation (based on each participant&#146;s accumulated payroll deductions) of available shares. Unless the employee&#146;s participation is discontinued, his or her right to purchase shares is exercised automatically at the end of the purchase period at the applicable price. See
&#147;Withdrawal&#148; below. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Withdrawal </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Although each participant in the ESPP is required to sign an agreement authorizing payroll deductions, the participant may withdraw from a given offering by terminating his or her payroll deductions and by delivering to us a notice of withdrawal from the ESPP. Such withdrawal may be elected at any time prior to the end of the applicable offering, except as otherwise provided in the offering document. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Upon any withdrawal from an offering by an employee, we will distribute to the employee his or her accumulated payroll deductions without interest (unless otherwise required by applicable local law) and such employee&#146;s rights in the offering will be automatically terminated. The employee is not entitled to again participate in that offering. However, an employee&#146;s withdrawal from an offering will not prevent such employee from participating in subsequent offerings under the ESPP. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Reset Feature </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The Board of Directors has the authority to provide that if the fair market value of a share of our common stock on the first day of any purchase period within a particular offering period is less than or equal to the fair market value on the start date of that offering period, then the participants in that offering period will automatically be transferred and enrolled in a new offering period which will begin on the first day of that purchase period and the participants&#146; purchase rights in the original offering period will terminate. The Board of Directors currently anticipates that the terms of offering periods will
include such a reset feature. </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">32</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Termination of Employment </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Unless otherwise specified by the Board of Directors, a participant&#146;s rights under any offering under the ESPP terminate immediately upon cessation of an employee&#146;s employment for any reason (subject to any post-employment participation period required by law), and we will distribute to such employee all of his or her accumulated payroll deductions, without interest (unless otherwise required by applicable law). </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Capitalization Adjustment Provisions </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Upon certain transactions by AmpliPhi, such as a merger, consolidation, reorganization, recapitalization, reincorporation, stock dividend, dividend in property other than cash, stock split, liquidating dividend, combination of shares, exchange of shares, change in corporate structure or other similar transaction, the ESPP share reserve, the number and class of shares by which the ESPP share reserve may increase each year pursuant to the &#147;evergreen&#148; provision, the outstanding purchase rights thereunder, and any purchase limits will be appropriately adjusted as to the type, class, maximum number of shares and purchase
price subject thereto. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Effect of Certain Corporate Transactions </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">In the event of a corporate transaction (as defined in the ESPP and described below), then any surviving or acquiring corporation may assume or continue outstanding purchase rights under the ESPP or may substitute similar rights for outstanding purchase rights. If any surviving or acquiring corporation does not assume or continue such rights or substitute similar rights, then the participants&#146; accumulated payroll deductions will be used to purchase shares of common stock within ten business days prior to the corporate transaction under the ongoing offering and the participants&#146; rights under the ongoing offering will
terminate immediately after such purchase. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">A &#147;corporate transaction&#148; generally means the occurrence, in a single transaction or in a series of related transactions, of any one or more of the following events: </P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">the consummation of a sale or other disposition of all or substantially all, as determined by the Board of Directors in its sole discretion, of the consolidated assets of the Company and its subsidiaries; </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">the consummation of a sale or other disposition of at least 50% of our outstanding securities; or </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">the consummation of certain specified types of mergers, consolidations or similar transactions. </TD>

</TR>

</TABLE>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Duration, Amendment and Termination </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The Board of Directors may amend, suspend or terminate the ESPP at any time. However, except in regard to capitalization adjustments (as described above), to the extent shareholder approval is required by applicable law or listing requirements, then any amendment to the ESPP must be approved by our shareholders if the amendment would: </P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">materially increase the number of shares of common stock available for issuance under the ESPP; </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">materially expand the class of individuals eligible to participate under the ESPP; </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">materially increase the benefits accruing to participants under the ESPP or materially reduce the price at which shares of common stock may be purchased under the ESPP; </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">materially extend the term of the ESPP; or </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">expand the types of awards available for issuance under the ESPP. </TD>

</TR>

</TABLE>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The Board of Directors may amend outstanding purchase rights without a participant&#146;s consent if such amendment is necessary to ensure that the purchase right complies with the requirements of Section 423 of the Code. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Rights granted before amendment or termination of the ESPP will not be impaired by any amendment or termination of the ESPP without the consent of the participant to whom such rights were granted, except as necessary to comply with applicable laws, or as necessary to obtain or maintain favorable tax, listing or regulatory treatment. </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">33</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">U.S. Federal Income Tax Information </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The following is a summary of the principal United States federal income taxation consequences to participants and us with respect to participation in the ESPP. This summary is not intended to be exhaustive and does not discuss the income tax laws of any local, state or foreign jurisdiction in which a participant may reside. The information is based upon current federal income tax rules and therefore is subject to change when those rules change. Because the tax consequences to any participant may depend on his or her particular situation, each participant should consult the participant&#146;s tax adviser regarding the federal,
state, local, and other tax consequences of the grant or exercise of an option or the disposition of common stock acquired under the ESPP. The ESPP is not qualified under the provisions of Section 401(a) of the Code and is not subject to any of the provisions of the Employee Retirement Income Security Act of 1974, as amended. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Purchase rights granted under the ESPP are intended to qualify for favorable federal income tax treatment associated with rights granted under an employee stock purchase plan that qualifies under provisions of Section 423 of the Code. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">A participant will be taxed on amounts withheld for the purchase of shares of common stock as if such amounts were actually received. Otherwise, no income will be taxable to a participant as a result of the granting or exercise of a purchase right until disposition of the acquired shares. The taxation upon disposition will depend upon the holding period of the acquired shares. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">If the stock is disposed of more than two years after the beginning of the offering period and more than one year after the stock is transferred to the participant, then the lesser of: </P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 20px; text-align: left">(1)</TD>

          <TD STYLE="text-align: justify">the excess of the fair market value of the stock at the time of such disposition over the purchase price, or </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 20px; text-align: left">(2)</TD>

          <TD STYLE="text-align: justify">the excess of the fair market value of the stock as of the beginning of the offering period over the purchase price (determined as of the beginning of the offering period) will be treated as ordinary income. </TD>

</TR>

</TABLE>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Any further gain or any loss will be taxed as a long-term capital gain or loss. At present, such capital gains generally are subject to lower tax rates than ordinary income. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">If the stock is sold or disposed of before the expiration of either of the holding periods described above, then the excess of the fair market value of the stock on the purchase date over the purchase price will be treated as ordinary income at the time of such disposition. The balance of any gain will be treated as capital gain. Even if the stock is later disposed of for less than its fair market value on the purchase date, the same amount of ordinary income is attributed to the participant, and a capital loss is recognized equal to the difference between the sales price and the fair market value of the stock on such purchase
date. Any capital gain or loss will be short-term or long-term, depending on how long the stock has been held. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">There are no federal income tax consequences to us by reason of the grant or exercise of rights under the ESPP. We are entitled to a deduction to the extent amounts are taxed as ordinary income to a participant (subject to the requirement of reasonableness and the satisfaction of tax reporting obligations). </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">New Plan Benefits </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Participation in the ESPP is voluntary and each eligible employee will make his or her own decision regarding whether and to what extent to participate in the ESPP. It is, therefore, not possible to determine the benefits or amounts that will be received in the future by individual employees or groups of employees under the ESPP. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Vote Required; Recommendation of the Board of Directors </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">In order for Proposal 3 to be approved, the number of shares that vote &#147;For&#148; the proposal must exceed the number of shares that vote &#147;Against&#148; the proposal. Abstentions will be counted towards the vote total for Proposal 3 and will have the same effect as &#147;Against&#148; votes. Broker non-votes are counted towards a quorum, but are not counted for any purpose in determining whether this matter has been approved. </P>

<H1 STYLE="text-indent:0pt; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 9pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><FONT STYLE="font-variant: small-caps">The Board of Directors Recommends<BR> a Vote &#147;For&#148; Proposal 3.</FONT> </H1>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">34</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<H1 STYLE="text-indent:0pt; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 9pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><FONT STYLE="font-variant: small-caps">Proposal 4<BR>&nbsp;<BR> Approval of the reincorporation of the Company in the State of Delaware, to be effected through a<BR> merger with and into a newly formed and wholly owned Delaware subsidiary</FONT> </H1>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">What is the Reincorporation Proposal? </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">On April 21, 2016, the Board of Directors, which we refer to, for purposes of this Proposal 4, as the &#147;Board&#148; or the &#147;AmpliPhi Board,&#148; of AmpliPhi Biosciences Corporation, which we refer to, for the purposes of this Proposal 4, as the &#147;Company,&#148; &#147;AmpliPhi&#148; or &#147;AmpliPhi Washington,&#148; approved a proposal, or the Reincorporation Proposal, to change the state of incorporation of AmpliPhi from Washington to Delaware, or the Reincorporation. The Board believes that the Reincorporation can improve corporate governance, reduce administrative costs, and enhance long-term shareholder
value. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The choice of state of domicile is important because state corporate law governs the internal affairs of a corporation. Management and boards of directors of corporations look to state law and judicial interpretations of state law to guide their decision-making on many key issues, including determining appropriate governance policies and procedures, ensuring that boards satisfy their fiduciary obligations to shareholders, and evaluating key strategic alternatives for the corporation, including mergers, acquisitions, and divestitures. After careful consideration of these and other factors as discussed more fully below, the
AmpliPhi Board believed that it is in the best interest of AmpliPhi and its shareholders to complete the Reincorporation. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Where can I find information on the Reincorporation Proposal? </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Shareholders are urged to read this proxy statement carefully for information regarding the Reincorporation Proposal, including the related appendices referenced below and attached to this proxy statement, before voting on the Reincorporation. The following discussion summarizes material provisions of the Reincorporation. This summary is subject to and qualified in its entirety by the following reincorporation documents attached as appendices to this proxy statement: the Agreement and Plan of Merger to be executed in connection with the Reincorporation in substantially the form attached hereto as Appendix C, the Delaware
Certificate of Incorporation to be effective after the Reincorporation, in the form attached hereto as Appendix D (the &#147;Delaware Charter&#148;) and the Delaware Bylaws to be effective after the Reincorporation, in the form attached hereto as Appendix E (the &#147;Delaware Bylaws&#148;). Copies of our Amended and Restated Washington Articles of Incorporation, as amended (&#147;Washington Charter&#148;) and our Washington Amended and Restated Bylaws (the &#147;Washington Bylaws&#148;) are filed publicly as exhibits to our periodic reports and are also available for inspection at our principal office. Copies will be sent to shareholders free of charge upon written request to our Secretary at AmpliPhi Biosciences Corporation at 3579 Valley Centre Drive, Suite 100, San Diego, California 92130. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Why did our Board of Directors choose Delaware over other jurisdictions? </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">It is well established that the State of Delaware has been a leader in adopting a comprehensive and coherent set of corporate laws that are responsive to the evolving legal and business needs of corporations. Our Board of Directors believes that the most important criterion in comparing jurisdictions is the existence of a highly developed and predictable corporate law that will guide management and our Board of Directors in addressing the complex and varied decisions faced by public companies. We believe that no other jurisdiction in the United States satisfies this criterion to the same extent as Delaware. In particular,
relative to our current domicile in Washington or a domicile in any other state, we believe Delaware will offer us greater predictability and clarity due to characteristics that are unique to the state, which are further discussed below. </P>

<H4 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: italic; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Predictability, Flexibility and Responsiveness of Delaware Law </H4>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Delaware courts have established a jurisprudence that is significantly more thorough and broadly applied with respect to principles of corporate governance than any other state&#146;s courts, including the courts in Washington. As a result, corporations domiciled in Delaware have an advantage over companies organized under the laws of other states, because Delaware corporations can draw upon these firmly established and consistently interpreted principles when making business and legal decisions. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">We believe that Delaware is the preferred domicile for most major American corporations. According to the Delaware Secretary of State, over 50 percent of all public companies and approximately 64 percent of all Fortune 500 corporations are incorporated in Delaware. </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">35</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Because of the large number of major corporations domiciled in Delaware, Delaware courts often take the lead in reviewing and deciding important new issues relating to corporate governance and rights and obligations of shareholders and corporations. As Delaware courts were among the first and most influential to address these issues, many corporations in Washington and other states have looked to Delaware laws for guidance on these issues. The Board believes that the clarity provided on these issues is ultimately beneficial to AmpliPhi and our shareholders because it establishes more reliable guidance for corporate governance
decisions. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Delaware&#146;s court system also provides swift and efficient resolutions in corporate litigation. Delaware has a specialized Court of Chancery that reviews and decides corporate law cases, and appeals to Delaware&#146;s Supreme Court can be decided quickly. In addition, Delaware passed the Delaware Rapid Arbitration Act, which became effective on May 4, 2015, and which provides a streamlined arbitration process that will allow for prompt, cost-effective resolution of business disputes. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">We have identified the following key benefits of Delaware&#146;s corporate legal framework that are available to AmpliPhi after the Reincorporation: </P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">The Delaware General Corporate Law, as amended (the &#147;DGCL&#148;), is generally acknowledged to be the most advanced and flexible state corporate statute in the United States; </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">The Delaware Court of Chancery routinely handles cases involving complex corporate issues with a level of experience and a degree of sophistication and understanding unmatched by other courts in the country; </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">The Delaware Supreme Court is well regarded and is timely and highly responsive in cases involving complex corporate issues; </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">The well-established body of case law construing Delaware law has developed over the last century and provides businesses with a greater predictability on numerous issues than the case law of most, if not all, other jurisdictions, including, but not limited to, Washington; </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">The Delaware legislature each year considers and adopts statutory amendments in an effort to ensure that the Delaware corporate statute continues to be responsive to the changing needs of businesses; </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">Delaware has a user-friendly Office of Secretary of State that facilitates filings and interactions and reduces (as compared to other states) complications and delays that can arise in time sensitive transactions. </TD>

</TR>

</TABLE>

<H3 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: italic; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Ability to Have the Delaware Courts Serve as the Exclusive Forum for the Adjudication of Certain Legal Matters </H3>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">To ensure that we get the full benefits of Delaware&#146;s corporate legal framework, the Board has decided to include in the Delaware Charter a provision providing that the Delaware Courts are the exclusive forum for the adjudication of certain legal actions. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Under the exclusive forum provision contained in the Delaware Charter, the state courts of the State of Delaware (or if no state court has jurisdiction, the federal district court for the District of Delaware) will be the exclusive forum for certain actions involving AmpliPhi, unless AmpliPhi consents to an alternative forum. Based on the proposed language in the Delaware Charter, the Delaware courts would be the exclusive forum for (i) derivative actions or proceedings brought on behalf of AmpliPhi; (ii) any action asserting a claim of breach of a fiduciary duty owed by any director, officer or other employee to AmpliPhi or
its stockholders; (3) any action asserting a claim against AmpliPhi or any director or officer or other employee arising pursuant to any provision of the DGCL, the Delaware Charter or the Delaware Bylaws; and (4) any action asserting a claim against AmpliPhi or any director or officer or other employee governed by the internal affairs doctrine. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The exclusive forum provision contained in the Delaware Charter is intended to assist AmpliPhi in avoiding multiple lawsuits in multiple jurisdictions on matters relating to the corporate law of Delaware, which will be our state of incorporation if the Reincorporation Proposal is approved. AmpliPhi believes that the exclusive forum provision in the Delaware Charter will reduce the risk that AmpliPhi could become subject to duplicative litigation in multiple forums, as well as the risk that the outcome of cases in multiple forums </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">36</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">could be inconsistent, even though each forum purports to follow Delaware law. Any of these could expose AmpliPhi to increased expenses or losses. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The exclusive forum provision contained in the Delaware Charter would only regulate the forum where our shareholders may file claims relating to the specified intra-corporate disputes. The exclusive forum provision does not contain any restrictions on the ability of our shareholders to bring such claims, nor the remedies available if such claims are ultimately successful; rather it attempts to prevent AmpliPhi from being forced to waste corporate assets defending against duplicative suits. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Although the Board of Directors believes that the designation of the Delaware Court of Chancery as the exclusive forum for intra-corporate disputes serves the best interests of AmpliPhi and our shareholders as a whole, the Board of Directors also believes that we should retain the ability to consent to an alternative forum on a case-by-case basis. Specifically, where the Board of Directors determines that AmpliPhi&#146;s interests and those of our shareholders are best served by permitting a dispute to proceed in a forum other than the Delaware Court of Chancery, the exclusive forum provision in the Delaware Charter permits
AmpliPhi to consent to the selection of such alternative forum. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The Board of Directors believes that our shareholders will benefit from having intra-corporate disputes litigated in the Delaware Court of Chancery. Although some plaintiffs might prefer to litigate such matters in a forum outside of Delaware because they perceive another court as more convenient or more favorable to their claims (among other reasons), the Board of Directors believes that the substantial benefits to us and our shareholders as a whole from designating the Delaware Court of Chancery as the exclusive forum for intra-corporate disputes outweigh these concerns. The Delaware Court of Chancery is widely regarded as
the preeminent court for the determination of disputes involving a corporation&#146;s internal affairs in terms of precedent, experience and focus. The Court&#146;s considerable expertise has led to the development of a substantial and influential body of case law interpreting Delaware&#146;s corporate law. This provides us and our shareholders with more predictability regarding the outcome of intra-corporate disputes. In addition, the Delaware Court of Chancery has developed streamlined procedures and processes that help provide decisions for litigating parties on a relatively expedited basis. This accelerated schedule can limit the time, cost, and uncertainty of litigation for all parties. Furthermore, there is a significant risk that allowing shareholders to bring such highly sophisticated matters in forums with little familiarity or experience in corporate governance leaves shareholders at risk that foreign jurisdictions may misapply Delaware law. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Without the exclusive forum provision in the Delaware Charter, AmpliPhi remains exposed to the possibility of plaintiffs using AmpliPhi&#146;s more diverse operational base to bring claims against AmpliPhi in multiple jurisdictions or choosing a forum state for litigation that may not apply Delaware law to AmpliPhi&#146;s internal affairs in the same manner as the Delaware courts would be expected to do so. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">What are the consequences of the Reincorporation? </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">At the effective time of the Reincorporation, we will be governed by the Delaware Charter, the Delaware Bylaws and the DGCL. Although the Delaware Charter and the Delaware Bylaws contain many similar provisions from our existing Amended and Restated Articles of Incorporation, as amended, or the Washington Articles, and Amended and Restated Bylaws, or the Washington Bylaws, there are important differences that are discussed below. See &#147;What are the differences between the charters and bylaws of AmpliPhi Washington and AmpliPhi Delaware? What are the material differences between Delaware law and Washington law?&#148; below.
</P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">After the Reincorporation, our name will remain AmpliPhi Biosciences Corporation. Other than the change in corporate domicile (and certain related changes of a legal nature in our organizational documents, which are described in this proxy statement), the Reincorporation will not result in any change in our name, business operations, management, board composition, fiscal year, assets, liabilities or net worth, or physical location, nor will it result in any change in location of our current employees, including management. Upon consummation of the Reincorporation, our daily business operations will continue as they are
presently conducted. In addition, the Reincorporation will not, we believe, significantly affect any of our material contracts with any third parties and our rights and obligations under these contractual arrangements will continue and be assumed by AmpliPhi Delaware. In addition, upon the effectiveness of the Merger, the directors who are elected at the annual meeting as directors of AmpliPhi will become directors of AmpliPhi </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">37</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Delaware, and the individuals serving as executive officers of AmpliPhi immediately prior to the Reincorporation will continue to serve as executive officers of AmpliPhi Delaware, without a change in title or responsibilities. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Upon consummation of the Reincorporation, our daily business operations will continue as they are presently conducted at our current principal executive office located at 3579 Valley Centre Drive, Suite 100, San Diego, California 92130. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">What are the differences between the charters and bylaws of AmpliPhi Washington and AmpliPhi Delaware? What are the material differences between Delaware law and Washington law? </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Because of differences between the Revised Code of Washington (the &#147;RCW&#148;) and the DGCL, as well as differences between the Company&#146;s charter and bylaws before and after the Reincorporation, the Reincorporation will effect some changes to the rights of the Company&#146;s shareholders. Summarized below are the most significant differences between the rights of the shareholders of the Company before and after the Reincorporation, as a result of the differences among the RCW and the DGCL, the Washington Charter and the Delaware Charter, and the Washington Bylaws and the Delaware Bylaws. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The summary below is not intended to be relied upon as an exhaustive list of all differences or a complete description of the differences between the DGCL and the Delaware Charter and Bylaws, on the one hand, and the RCW and the Washington Charter and Bylaws on the other hand. The summary below is qualified in its entirety by reference to the RCW, the Washington Charter, the Washington Bylaws, the DGCL, the Delaware Charter and the Delaware Bylaws. </P>

<H5 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><U>Authorized Capital Stock</U> </H5>

<H4 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: italic; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Delaware Provisions </H4>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">AmpliPhi Delaware&#146;s authorized capital stock will consist of 150,000,000 authorized shares of common stock, $0.01 par value, and 10,000,000 authorized shares of preferred stock, $0.01 par value. All of the shares of AmpliPhi Delaware common stock issued in connection with the Reincorporation will be validly issued, fully paid and non-assessable. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The holders of AmpliPhi Delaware common stock will be entitled to one vote for each share on all matters voted on by shareholders, including the election of directors. The holders of AmpliPhi Delaware common stock will not have any cumulative voting, conversion, redemption or preemptive rights. The holders of AmpliPhi Delaware common stock will be entitled to such dividends as may be declared from time to time by the AmpliPhi Delaware Board of Directors from funds available therefor, and upon liquidation will be entitled to receive pro rata all assets of AmpliPhi Delaware available for distribution to such holders. </P>

<H4 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: italic; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Washington Provisions </H4>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The holders of the Company&#146;s common stock are entitled to one vote for each share on all matters voted on by shareholders, including the election of directors. The Company&#146;s authorized capital stock consists of (i) 670,000,000 authorized shares of common stock, par value $0.01 per share, and (ii) 10,000,000 authorized shares of preferred stock, par value $0.01 per share. The holders of the Company&#146;s common stock do not have any cumulative voting, conversion, redemption or preemptive rights. </P>

<H5 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><U>Number of Directors; Election; Removal; Filling Vacancies; Independent Directors</U> </H5>

<H4 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: italic; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Delaware Provisions </H4>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The Delaware Charter and Delaware Bylaws will provide that the number of directors will be fixed from time to time by action of the Board of Directors. Delaware law permits corporations to classify their board of directors so that less than all of the directors are elected each year to overlapping terms. The Delaware Charter will provide for directors to be divided into three classes designated as Class I, Class II and Class III, respectively. The classes correspond to the current classification of the Board. Accordingly, if this proposal is approved at the annual meeting, the term of office of the Class I directors will expire
at our 2019 Annual Meeting of Shareholders, the term of office of the Class II directors will expire at our 2017 Annual Meeting of Shareholders and the term of office of the Class III directors will expire at our 2018 annual meeting of shareholders. The term of each class will be three years, beginning on the date of the annual meeting at which </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">38</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">such directors are elected and ending on the date of the third annual meeting thereafter. At the second annual meeting of stockholders following such initial classification, the term of office of the Class II directors shall expire and Class II directors shall be elected for a full term of three years. At the third annual meeting of stockholders following such initial classification, the term of office of the Class III directors shall expire and Class III directors shall be elected for a full term of three years. At each succeeding annual meeting of stockholders, directors shall be elected for a full term of three years to
succeed the directors of the class whose terms expire at such annual meeting. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The Delaware Charter and Bylaws provide that the stockholders may remove one or more directors with cause at a special meeting called for the purpose of removing the director, or at an annual meeting, upon the affirmative vote of the holders of at least 66&nbsp;2/3% of the voting power of all then outstanding shares of capital stock of the corporation entitled to vote generally at an election of the directors. A vacancy on the Board of Directors, whether created as a result of the removal of a director or resulting from an enlargement of the Board of Directors, may only be filled by the affirmative vote of a majority of the
directors then in office. </P>

<H4 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: italic; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Washington Provisions </H4>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The Washington Bylaws provide that the number of directors shall not be less than one nor more than nine. Under the Washington Charter and Bylaws, the specific number of directors must be set by a resolution of the Board of Directors or the shareholders. The Board is divided into three classes. At each annual meeting of shareholders, the number of directors equal to the number of directors in the class whose term expires at the time of such meeting shall be elected to serve until the third ensuing annual meeting of shareholders. Directors shall serve until their successors are elected and qualified or until their earlier death,
resignation or removal from office or until there is a decrease in the number of directors. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The Washington Charter and Bylaws provide that the shareholders may remove one or more directors for cause at a special meeting called for the purpose of removing the director upon the affirmative vote of the holders of at least two-thirds of the shares entitled to elect the director or directors whose removal is sought. A vacancy on the Board of Directors created by the removal of a director shall be filled only by a vote of the holders of at least two-thirds of the shares then entitled to elect the director removed. Any other vacancy may be filled by the shareholders or by the affirmative vote of a majority of the remaining
directors. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Under the RCW, shareholders may remove one or more directors with or without cause unless the articles of incorporation provide that directors may be removed only for cause. A director may be removed by the shareholders only at a special meeting called for that purpose. If a vacancy occurs on the Board of Directors either the shareholders or the directors shall fill the vacancy. </P>

<H5 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><U>Cumulative Voting for Directors</U> </H5>

<H4 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: italic; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Delaware Provisions </H4>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Delaware law permits cumulative voting if provided in the certificate of incorporation. The Delaware Charter does not provide for cumulative voting. </P>

<H4 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: italic; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Washington Provisions </H4>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Under Washington law, unless the articles of incorporation provide otherwise, shareholders are entitled to use cumulative voting in the election of directors. The Washington Charter expressly prohibits cumulative voting. </P>

<H5 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><U>Business Combinations; Interested Transactions</U> </H5>

<H4 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: italic; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Delaware Provisions </H4>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Section 203 of the DGCL provides that, subject to certain exceptions specified therein, a corporation shall not engage in any business combination with any &#147;interested stockholder&#148; for a three-year period following the date that such stockholder becomes an interested stockholder unless (i) prior to such date, the board of directors of the corporation approved either the business combination or the transaction which resulted in the stockholder becoming an interested stockholder, (ii) upon consummation of the transaction which resulted in the stockholder becoming an interested stockholder, the interested stockholder
owned at least 85% of the voting stock of the corporation outstanding at the time the transaction commenced (excluding shares held by directors who are also officers and employee stock purchase plans in which employee participants do not have </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">39</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">the right to determine confidentially whether plan shares will be tendered in a tender or exchange offer), or (iii) on or subsequent to such date, the business combination is approved by the board of directors of the corporation and by the affirmative vote at an annual or special meeting, and not by written consent, of at least 66-&nbsp;2/3% of the outstanding voting stock which is not owned by the interested stockholder. Except as specified in Section 203 of the DGCL, an interested stockholder is defined to include (a) any person that is the owner of 15% or more of the outstanding voting stock of the corporation or is an
affiliate or associate of the corporation and was the owner of 15% or more of the outstanding voting stock of the corporation, at any time within three years immediately prior to the relevant date, and (b) the affiliates and associates of any such person. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Under certain circumstances, Section 203 of the DGCL may make it more difficult for a person who would be an &#147;interested stockholder&#148; to effect various business combinations with a corporation for a three-year period, although the corporation&#146;s certificate of incorporation or stockholders may elect to exclude a corporation from the restrictions imposed thereunder. The Delaware Charter does not exclude AmpliPhi Delaware from the restrictions imposed under Section 203 of the DGCL. It is anticipated that the provisions of Section 203 of the DGCL may encourage companies interested in acquiring AmpliPhi Delaware to
negotiate in advance with AmpliPhi Delaware&#146;s Board of Directors, since the stockholder approval requirement would be avoided if a majority of the directors then in office approve either the business combination or the transaction which results in the stockholder becoming an interested stockholder. </P>

<H4 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: italic; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Washington Provisions </H4>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Section 23B.19.040 of the RCW provides that a Washington public company may not, for a period of five years following the date on which a shareholder becomes the beneficial owner of ten percent or more of the corporation&#146;s outstanding shares, without the prior approval of the corporation&#146;s board of directors of the transaction or of the acquisition by the shareholder resulting in the shareholder&#146;s ownership of ten percent or more of the corporation&#146;s outstanding shares, engage in (i) a merger, share exchange, or consolidation with such shareholder or an affiliate of such shareholder, (ii) a sale or other
disposition to such shareholder of assets with a value equal to five percent or more of the aggregate market value of all the corporation&#146;s assets, or having an aggregate value equal to five percent or more of the aggregate market value of all the outstanding shares of the corporation, or representing five percent or more of the earning power of the corporation, (iii) a termination, as a result of such shareholder&#146;s acquisition of ten percent or more of the shares of the corporation, of five percent or more of the employees of the corporation employed in Washington whether at one time or over the five-year period following the date that the shareholder acquires ten percent of the corporation&#146;s voting securities, (iv) an issuance, transfer or redemption by the corporation of shares, options or warrants to such shareholder, (v) a liquidation or dissolution proposed by or pursuant to an agreement with such shareholder, (vi) a reclassification of securities, including any
share splits, share dividend or other distribution of shares in respect of stock, proposed by or pursuant to any agreement with such shareholder that has the effect of increasing the proportionate share of the outstanding shares of a class of shares owned by such shareholder, or (vii) a transaction with such shareholder in which the corporation makes any loans or advances to such shareholder or provides other financial assistance or tax credits or other tax advantages to such shareholder through the target corporation. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The Company is not aware of any specific effort by any party to assume control of the Company. Because the RCW includes provisions affecting acquisitions and business combinations, the possibility that Section 203 of the DGCL may impede the accomplishment of mergers with, or the assumption of control of, the Company is not among the principal reasons for the Reincorporation. </P>

<H5 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><U>Limitation of Liability of Directors</U> </H5>

<H4 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: italic; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Delaware Provisions </H4>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The DGCL permits a corporation to include a provision in its certificate of incorporation eliminating or limiting the personal liability of a director to the corporation or its stockholders for damages for certain breaches of the director&#146;s fiduciary duty. However, no such provision may eliminate or limit the liability of a director: (i) for any breach of the director&#146;s duty of loyalty to the corporation or its stockholders; (ii) for acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law; (iii) for declaration of unlawful dividends or illegal redemptions or stock
repurchases; or (iv) for any transaction from which the director derived an improper personal benefit. </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">40</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The Delaware Charter provides that the liability of the directors for monetary damages shall be eliminated to the fullest extent allowed under applicable law. While these provisions provide directors with protection from awards for monetary damages for breaches of their duty of care, they do not eliminate such duty. Accordingly, these provisions will have no effect on the availability of equitable remedies such as an injunction or rescission based on a director&#146;s breach of his or her duty of care. </P>

<H4 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: italic; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Washington Provisions </H4>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The RCW permits a corporation to include in its articles of incorporation provisions that eliminate or limit the personal liability of a director to the corporation or its shareholders for monetary damages for conduct as a director, provided that such provisions may not eliminate or limit the liability of a director for acts or omissions that involve (i) intentional misconduct by the director or a knowing violation of law by a director, (ii) liability for unlawful distributions, or (iii) for any transaction from which the director will personally receive a benefit in money, property or services to which the director is not
legally entitled. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The Washington Charter provides that a director of the Company will not be liable to the corporation or its shareholders for monetary damages for any conduct as a director to the fullest extent permitted by the RCW. </P>

<H5 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><U>Indemnification of Officers and Directors</U> </H5>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Both the RCW and the DGCL permit a corporation to indemnify officers, directors, employees and agents for actions taken in good faith and in a manner they reasonably believed to be in, or not opposed to, the best interests of the corporation, and with respect to any criminal action, which they had no reasonable cause to believe was unlawful. Both states&#146; laws provide that a corporation may advance expenses of defense (upon receipt of a written undertaking to reimburse the corporation if indemnification is not appropriate), and both states permit a corporation to purchase and maintain liability insurance for its directors
and officers. </P>

<H4 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: italic; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Delaware Provisions </H4>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The DGCL provides that indemnification may not be made for any matter as to which a person has been adjudged by a court of competent jurisdiction to be liable to the corporation, unless and only to the extent a court determines that the person is entitled to indemnity for such expenses as the court deems proper. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The Delaware Bylaws provide that AmpliPhi Delaware shall indemnify directors, officers and agents to the fullest extent permitted by the DGCL or other applicable law and that AmpliPhi Delaware may purchase and maintain insurance on behalf of any person who is or was serving as a director, officer, employee or agent of the Company. The Delaware Charter provides that AmpliPhi Delaware is authorized to indemnify its directors, officers and agents to the maximum extent permitted by applicable law through bylaw provisions or agreements with such persons. </P>

<H4 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: italic; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Washington Provisions </H4>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The RCW provides that a corporation may not indemnify a director in connection with a proceeding in which the director was adjudged liable to the corporation or in connection with any other proceeding charging improper personal benefit to the director in which the director was adjudged liable on the basis that personal benefit was improperly received by the director. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The Washington Bylaws provide that each person who was, is or is threatened to be made a named party to or is otherwise involved (including, without limitation, as a witness) in any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative and whether formal or informal, by reason of the fact that he or she is or was a director or officer of the corporation or, that being or having been such a director or officer or an employee of the corporation, he or she is or was serving at the request of the corporation as a director, officer, partner, trustee, employee or agent
of another corporation or of a partnership, joint venture, trust, employee benefit plan or other enterprise, whether the basis of a proceeding is alleged action in an official capacity as such a director, officer, partner, trustee, employee or agent or in any other capacity while serving as such a director, officer, partner, trustee, employee or agent, shall be indemnified and held harmless by the corporation against all expense, liability and loss actually and reasonably incurred or suffered by such indemnitee in connection therewith, and such indemnification shall continue as to an indemnitee who has ceased to be a director, officer, partner, trustee, employee or agent and shall inure to the benefit of the indemnitee's heirs, executors and administrators. </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">41</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<H5 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><U>Special Meetings of Shareholders</U> </H5>

<H4 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: italic; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Delaware Provisions </H4>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Under the DGCL, a special meeting of stockholders may be called by the corporation&#146;s board of directors or by such persons as may be authorized by the corporation&#146;s certificate of incorporation or bylaws. The Delaware Bylaws provide that a special meeting may be called at any time by (i) the Chairman of the Board, (ii) the Chief Executive Officer, or (iii) the Board of Directors pursuant to a resolution adopted by a majority of the total number of authorized directors. </P>

<H4 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: italic; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Washington Provisions </H4>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Under the RCW, a corporation must hold a special meeting of shareholders upon request by the board of directors or by such persons authorized to do so by the articles of incorporation or bylaws. A corporation must also hold a special meeting of shareholders if the holders of at least ten percent of all votes entitled to be cast at a special meeting deliver to the corporation a demand for a special meeting. However, a corporation that is a public company may in its articles of incorporation limit or deny the right of shareholders to call a special meeting. A corporation other than a public company may require that shareholders
who hold a greater amount than ten percent of the outstanding shares may call a special meeting of shareholders provided that the amount is not greater than twenty-five percent. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The Washington Charter and Bylaws provide that special meetings of shareholders may be called by (i) the Board, (ii) the Chairman of the Board, (iii) the President of the Company or (iv) upon written demand by the holders of at least 30% of all the votes entitled to be cast on any issue proposed to be considered at such meeting. </P>

<H5 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><U>Amendment or Repeal of the Certificate of Incorporation</U> </H5>

<H4 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: italic; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Delaware Provisions </H4>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Under the DGCL, unless the certificate of incorporation otherwise provides, amendments to the certificate of incorporation generally require the approval of the holders of a majority of the outstanding stock entitled to vote thereon, and if the amendment would increase or decrease the number of authorized shares of any class or series or the par value of such shares, or would adversely affect the rights, powers or preferences of such class or series, a majority of the outstanding stock of such class or series also would have to approve the amendment. The Delaware Charter provides that the affirmative vote of the holders of at
least 66&nbsp;2/3% of the voting power of all of the then-outstanding shares of capital stock of the Company entitled to vote generally in the election of directors, voting as a single class, is required to amend certain provisions of the Delaware Charter, including those related to the Board, indemnification of directors and officers, forum selection, and amendment of the Delaware Charter. </P>

<H4 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: italic; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Washington Provisions </H4>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Under the RCW, the board of directors may amend the Company&#146;s articles of incorporation without shareholder approval (i) to change any provisions with respect to the par value of any class of shares, (ii) to delete the names and addresses of the initial directors, (iii) to delete the name and address of the initial registered agent or registered officer, (iv) if the corporation has only one class of shares outstanding, solely to effect a forward or reverse stock split, or (v) to change the corporate name. Other amendments to the articles of incorporation must be approved, in the case of a public company, by a majority of
the votes entitled to be cast on the proposed amendment. The Washington Charter provides that the Company reserves the right to amend or repeal any provision by the affirmative vote of the holders of a majority of the outstanding shares, except that certain provisions relating to the bylaws, the board of directors, amendments of the charter, special meetings of shareholders and special voting requirements may only be amended by the affirmative vote of the holders of two-thirds of the outstanding shares. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><U>Amendment to Bylaws</U> </P>

<H4 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: italic; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Delaware Provisions </H4>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Under the DGCL, directors may amend the bylaws of a corporation only if such right is expressly conferred upon the directors in its certificate of incorporation. The Delaware Bylaws provide that the Delaware Bylaws may be amended by the Board of Directors or upon the affirmative vote of the holders of at least 66&nbsp;2/3% of </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">42</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">the voting power of all of the then-outstanding shares of the capital stock of the corporation entitled to vote generally in the election of directors, voting together as a single class. </P>

<H4 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: italic; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Washington Provisions </H4>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The RCW provides that the board of directors may amend or repeal the corporation&#146;s bylaws unless the articles of incorporation reserve this power exclusively to the shareholders or the shareholders, in amending or repealing a particular bylaw, provide expressly that the board of directors may not amend or repeal that bylaw. The shareholders may also amend or repeal the corporation&#146;s bylaws, or adopt new bylaws, even though the bylaws may also be amended or repealed by the board of directors. The Washington Charter and Bylaws provide that the Board of Directors has the power to adopt, amend or repeal the bylaws of the
Company subject to approval by a majority of the Continuing Directors (defined as any member of the Board of Directors who was a member of the Board of Directors on January 1, 1994 or who is elected to the Board of Directors after January 1, 1994 upon the recommendation of a majority of the Continuing Directors voting separately and as a subclass of Directors on such recommendation), other than any bylaw that the shareholders have expressly provided may not be amended or repealed by the Board. The Washington Bylaws may also be amended by the affirmative vote of the holders of at least two-thirds of the outstanding shares. </P>

<H5 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><U>Merger with Subsidiary</U> </H5>

<H4 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: italic; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Delaware Provisions </H4>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The DGCL provides that a parent corporation may merge into a subsidiary and a subsidiary may merge into its parent, without stockholder approval, where such parent corporation owns at least 90% of the outstanding shares of each class of capital stock of its subsidiary. </P>

<H4 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: italic; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Washington Provisions </H4>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The RCW provides that a parent corporation may merge a subsidiary into itself without shareholder approval if the parent corporation owns at least 90% of the outstanding shares of each class of capital stock of its subsidiary. </P>

<H5 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><U>Committees of the Board of Directors</U> </H5>

<H4 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: italic; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Delaware Provisions </H4>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The DGCL provides that the board of directors may delegate certain of its duties to one or more committees elected by a majority of the board of directors. A Delaware corporation can delegate to a committee of the board of directors, among other things, the responsibility of nominating candidates for election to the office of director, to fill vacancies on the board of directors, to reduce earned or capital surplus, and to authorize the acquisition of the corporation&#146;s own stock. Moreover, if the corporation&#146;s certificate of incorporation or bylaws, or the resolution of the board of directors creating the committee so
permits, a committee of the board of directors may declare dividends and authorize the issuance of stock. </P>

<H4 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: italic; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Washington Provisions </H4>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The RCW also provides that the board of directors may delegate certain of its duties to one or more committees elected by a majority of the board of directors. Under the RCW, each committee may exercise such powers of the board of directors specified by the board of directors; however, a committee may not (i) authorize or approve a distribution except in accordance with a general formula or method prescribed by the board of directors, (ii) approve or propose to shareholders any action that the RCW requires be approved by shareholders, (iii) fill vacancies on the board of directors or on any of its committees, (iv) amend the
articles of incorporation, (v) adopt, amend or repeal bylaws, (vi) approve a plan of merger not requiring shareholder approval, or (vii) approve the issuance or sale of shares or determine the designation and relative rights, preferences and limitations of a class or series of shares. </P>

<H5 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><U>Mergers, Acquisitions and Transactions with Controlling Shareholder</U> </H5>

<H4 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: italic; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Delaware Provisions </H4>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Under the DGCL, a merger, consolidation, sale of all or substantially all of a corporation&#146;s assets other than in the regular course of business or dissolution of a corporation must be approved by a majority of the outstanding shares entitled to vote. No vote of stockholders of a constituent corporation surviving a merger, </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">43</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">however, is required (unless the corporation provides otherwise in its certificate of incorporation) if (i) the merger agreement does not amend the certificate of incorporation of the surviving corporation; (ii) each share of stock of the surviving corporation outstanding before the merger is an identical outstanding or treasury share after the merger; and (iii) the number of shares to be issued by the surviving corporation in the merger does not exceed twenty percent (20%) of the shares outstanding immediately prior to the merger. The Delaware Charter does not make any provision with respect to such mergers. </P>

<H4 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: italic; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Washington Provisions </H4>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Under the RCW, a merger, share exchange, consolidation, sale of substantially all of a corporation&#146;s assets other than in the regular course of business, or dissolution of a public corporation must be approved by the affirmative vote of a majority of directors when a quorum is present, and by two-thirds of all votes entitled to be cast by each voting group entitled to vote as a separate group, unless a higher or lower proportion is specified in the articles of incorporation. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The Washington Charter provides that if a merger is approved by a majority of the Continuing Directors (as defined in the Washington Charter), and is otherwise required to be approved by the Company&#146;s shareholders, such merger shall require the affirmative vote of not less than fifty-one percent (51%) of the outstanding shares entitled to vote thereon. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The RCW also provides that certain mergers need not be approved by the shareholders of the surviving corporation if (i) the articles of incorporation will not change in the merger, except for specified permitted amendments; (ii) no change occurs in the number, designations, preferences, limitations and relative rights of shares held by those shareholders who were shareholders prior to the merger; (iii) the number of voting shares outstanding immediately after the merger, plus the voting shares issuable as a result of the merger, will not exceed the authorized voting shares specified in the surviving corporation&#146;s articles
of incorporation immediately prior to the merger; and (iv) the number of participating shares outstanding immediately after the merger, plus the number of participating shares issuable as a result of the merger, will not exceed the authorized participating shares specified in the corporation&#146;s articles of incorporation immediately prior to the merger. </P>

<H5 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><U>Class Voting</U> </H5>

<H4 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: italic; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Delaware Provisions </H4>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The DGCL requires voting by separate classes only with respect to amendments to the certificate of incorporation that adversely affect the holders of those classes or that increase or decrease the aggregate number of authorized shares or the par value of the shares of any of those classes. </P>

<H4 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: italic; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Washington Provisions </H4>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Under the RCW, a corporation&#146;s articles of incorporation may authorize one or more classes of shares that have special, conditional or limited voting rights, including the right to vote on certain matters as a group. Under the RCW, a corporation&#146;s articles of incorporation may not limit the rights of holders of a class to vote as a group with respect to certain amendments to the articles of incorporation and certain mergers that adversely affect the rights of holders of that class. </P>

<H5 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><U>Preemptive Rights</U> </H5>

<H4 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: italic; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Delaware Provisions </H4>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Under Delaware law, a stockholder does not have preemptive rights unless such rights are specifically granted in the certificate of incorporation. The Delaware Charter does not specifically grant any preemptive rights. </P>

<H4 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: italic; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Washington Provisions </H4>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Under Washington law, a shareholder has preemptive rights unless such rights are specifically denied in the articles of incorporation. The Washington Charter states that shareholders do not have any preemptive rights. </P>

<H5 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><U>Transactions with Officers and Directors</U> </H5>

<H4 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: italic; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Delaware Provisions </H4>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The DGCL provides that contracts or transactions between a corporation and one or more of its officers or directors or an entity in which they have an interest are not void or voidable solely because of such interest or </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">44</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">the participation of the director or officer in a meeting of the board of directors or a committee which authorizes the contract or transaction if (i) the material facts as to the relationship or interest and as to the contract or transaction are disclosed or are known to the board of directors or the committee, and the board of directors or committee in good faith authorizes the contract or transaction by the affirmative votes of a majority of disinterested directors, even though the disinterested directors are less than a quorum; (ii) the material facts as to the relationship or interest and as to the contract or transaction
are disclosed or are known to the stockholders entitled to vote thereon, and the contract or transaction is specifically approved in good faith by vote of the stockholders; or (iii) the contract or transaction is fair as to the corporation as of the time it is authorized, approved or ratified by the board of directors, a committee thereof or the stockholders. </P>

<H4 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: italic; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Washington Provisions </H4>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The RCW sets forth a safe harbor for transactions between a corporation and one or more of its directors. A conflicting interest transaction may not be enjoined, set aside or give rise to damages if (i) it is approved by a majority of the qualified directors on the board of directors or an authorized committee, but in either case no fewer than two qualified directors; (ii) it is approved by a majority of all qualified shares; or (iii) at the time of commitment, the transaction was fair to the corporation. For purposes of this provision, &#147;qualified director&#148; is one who does not have (a) a conflicting interest
respecting the transaction; or (b) a familial, financial, professional or employment relationship with a non-qualified director which relationship would reasonably be expected to exert an influence on the qualified director&#146;s judgment when voting on the transaction. &#147;Qualified shares&#148; are defined generally as shares other than those beneficially owned, or the voting of which is controlled, by a director who has a conflicting interest respecting the transaction. </P>

<H5 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><U>Stock Redemptions and Repurchases</U> </H5>

<H4 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: italic; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Delaware Provisions </H4>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Under the DGCL, a Delaware corporation may purchase or redeem its own shares of capital stock, except when the capital of the corporation is impaired or when such purchase or redemption would cause any impairment of the capital of the corporation. </P>

<H4 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: italic; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Washington Provisions </H4>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">A Washington corporation may acquire its own shares. </P>

<H5 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><U>Proxies</U> </H5>

<H4 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: italic; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Delaware Provisions </H4>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Under the DGCL, a proxy executed by a stockholder will remain valid for a period of three years unless the proxy provides for a longer period. </P>

<H4 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: italic; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Washington Provisions </H4>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Under the RCW, a proxy executed by a shareholder will remain valid for eleven months unless a longer period is expressly provided in the appointment. </P>

<H5 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><U>Consideration for Stock</U> </H5>

<H4 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: italic; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Delaware Provisions </H4>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Under the DGCL, a corporation may accept as consideration for its stock a combination of cash, property or past services in an amount not less than the par value of the shares being issued, and a secured promissory note or other binding obligation executed by the subscriber for any balance, the total of which must equal at least the par value of the issued stock, as determined by the board of directors. </P>

<H4 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: italic; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Washington Provisions </H4>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Under the RCW, a corporation may issue its capital stock in return for consideration consisting of any tangible or intangible property or benefit to the corporation, including cash, promissory notes, services performed, contracts for services to be performed, or other securities of the corporation. </P>

<H5 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><U>Shareholders Rights to Examine Books and Records</U> </H5>

<H4 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: italic; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Delaware Provisions </H4>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The DGCL provides that any stockholder of record may demand to examine the corporation&#146;s books and records for any proper purpose. If management of the corporation refuses, the stockholder can compel release of the books by court order. </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">45</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<H4 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: italic; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Washington Provisions </H4>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The RCW provides that upon five business days&#146; notice to the corporation a shareholder is entitled to inspect and copy, during regular business hours at the corporation&#146;s principal office, the corporation&#146;s articles of incorporation, bylaws, minutes of all shareholders&#146; meetings for the past three years, certain financial statements for the past three years, communications to shareholders within the past three years, list of the names and business addresses of the current directors and officers and the corporation&#146;s most recent annual report delivered to the secretary of state. Upon five business
days&#146; notice, so long as the shareholder&#146;s demand is made in good faith and for a proper purpose, the shareholder describes with reasonable particularity the shareholder&#146;s purpose and the records the shareholder desires to inspect, and the records are directly connected with the shareholder&#146;s purpose, a shareholder may inspect and copy excerpts from minutes of any meeting of the board of directors or other records of actions of the board of directors, accounting records of the corporation and the record of shareholders. </P>

<H5 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><U>Appraisal and Dissenters&#146; Rights</U> </H5>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Under the DGCL and the RCW, shareholders have appraisal or dissenter&#146;s rights, respectively, in the event of certain corporate actions such as a merger. These rights include the right to dissent from voting to approve such corporate action, and demand fair value for the shares of the dissenting shareholder. If a proposed corporate action creating dissenters&#146; rights is submitted to a vote at a shareholders meeting, a shareholder who wishes to assert dissenters&#146; rights must (i) deliver to the corporation, before the vote is taken, written notice of his intent to demand payment for his shares if the proposed action
is effected, and (ii) not vote his shares in favor of the proposed action. If fair value is unsettled, the DGCL and the RCW provide for the dissenter and the company to petition the Court of Chancery or a superior court of the county in Washington where a corporation&#146;s principal office or registered office is located, respectively. Although appraisal or dissenter&#146;s rights are substantially similar in Delaware and Washington, this discussion is qualified in its entirety by reference to the DGCL and the RCW, which provide more specific provisions and requirements for dissenting shareholders. </P>

<H5 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><U>Dividends</U> </H5>

<H4 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: italic; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Delaware Provisions </H4>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The DGCL provides that the corporation may pay dividends out of surplus, out of the corporation&#146;s net profits for the preceding fiscal year, or both, provided that there remains in the stated capital account an amount equal to the par value represented by all shares of the corporation&#146;s stock having a distribution preference. </P>

<H4 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: italic; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Washington Provisions </H4>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The RCW provides that shares may be issued pro rata and without consideration to the corporation&#146;s shareholders as a share dividend. The board of directors may authorize distributions to its shareholders provided that no distribution may be made if after giving it effect, the corporation would not be able to pay its liabilities as they become due in the usual course of business or the corporation&#146;s total assets would be less than the sum of its total liabilities plus the amount that would be needed if the corporation were to be dissolved at the time of the distribution, to satisfy the preferential rights upon
dissolution of shareholders whose preferential rights are superior to those receiving the distribution. </P>

<H5 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><U>Corporate Action Without a Shareholder Meeting</U> </H5>

<H4 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: italic; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Delaware Provisions </H4>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The DGCL permits corporate action without a meeting of stockholders upon the written consent of the holders of that number of shares necessary to authorize the proposed corporate action being taken, unless the certificate of incorporation or articles of incorporation expressly provide otherwise. The Delaware Charter provides that no action may be taken by the stockholders of the Company except at an annual or special meeting. </P>

<H4 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: italic; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Washington Provisions </H4>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">If the corporation is a public company, the RCW only permits action by shareholders without a meeting if the action is taken by all shareholders entitled to vote on the action. The Washington Bylaws provide that any action which could be taken at a meeting of the shareholders may be taken without a meeting if one or more written consents setting forth the action so taken are signed by all shareholders entitled to vote. </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">46</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Will I have dissenters&#146; rights as a result of the Reincorporation? </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Under the RCW, shareholders of the Company are or may be entitled to assert dissenters&#146; rights as a result of the proposed Reincorporation. Shareholders who oppose the Reincorporation may be entitled to assert the right to receive payment for the value of their shares as set forth in Chapter 23B.13 of the RCW. A copy of this section is attached hereto as Appendix C to this Proxy Statement. These provisions are very technical in nature and should be carefully reviewed by any shareholder wishing to assert such rights. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">A shareholder who wishes to assert dissenters&#146; rights must (a) deliver to the Company before the vote is taken written notice of the shareholder&#146;s intent to demand payment for the shareholder&#146;s shares if the Reincorporation is effected, and (b) not vote such shares in favor of the Reincorporation. The Company will not treat a vote against this proposal as a notice sufficient to meet such requirements. A vote for this proposal will serve as a waiver of dissenters&#146; rights pursuant to Chapter 23B.13 of the RCW. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">How will the Reincorporation be implemented? </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Subject to shareholder approval at the annual meeting and certain other conditions, the Reincorporation will be effected by means of a merger pursuant to the terms of the Agreement and Plan of Merger, or the Merger Agreement, between AmpliPhi and AmpliPhi Biosciences Corporation, a Delaware corporation, or AmpliPhi Delaware, recently formed solely for the purpose of effecting the Reincorporation. Under the Merger Agreement, AmpliPhi will merge with and into AmpliPhi Delaware and, following the effectiveness of the merger, which we refer to as the Merger, AmpliPhi will cease to exist and AmpliPhi Delaware will become the
surviving entity. Upon effectiveness of the Reincorporation, AmpliPhi Delaware will be the successor in interest to AmpliPhi and the shareholders of AmpliPhi will become stockholders of AmpliPhi Delaware. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">What is the timing of the Reincorporation? </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">If shareholders approve the Reincorporation at the annual meeting, we intend to cause the Reincorporation to become effective as soon as practicable, subject to the completion of certain legal formalities, including obtaining certain consents and approval by third parties. The Reincorporation will become effective upon the filing of a Certificate of Merger or similar document with the Secretary of State of Delaware. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Does AmpliPhi have the right to abandon the Reincorporation? </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Pursuant to the Merger Agreement, AmpliPhi and AmpliPhi Delaware agree to take all actions that Delaware law and Washington law require for AmpliPhi and AmpliPhi Delaware to effect the Reincorporation, subject to the approval of the Reincorporation by the shareholders of AmpliPhi and the sole shareholder of AmpliPhi Delaware. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Notwithstanding the foregoing, the Merger Agreement provides that the Board of Directors may abandon the Reincorporation at any time prior to its consummation if the Board of Directors determines that the Reincorporation is inadvisable for any reason. For example, Delaware or Washington law may be changed to reduce the benefits that we hope to achieve through the Reincorporation, or the costs of operating as a Delaware corporation may be increased, although we do not know of any such changes under consideration. The Merger Agreement may be amended at any time prior to its consummation, either before or after the shareholders
have voted to adopt the proposal, subject to applicable law. We will re-solicit shareholder approval of the Reincorporation if the terms of the Merger Agreement are changed in any material respect. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">What will happen to my shares of common stock as a result of the Reincorporation? </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">On the effective date of the Merger, each outstanding share of common stock of AmpliPhi will be automatically converted into one share of common stock of AmpliPhi Delaware. Any stock certificate representing issued and outstanding shares of common stock of AmpliPhi will continue to represent the same number of shares of common stock of AmpliPhi Delaware. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>ANY SHARE CERTIFICATES CURRENTLY ISSUED FOR OUR SHARES WILL AUTOMATICALLY REPRESENT SHARES IN AMPLIPHI DELAWARE UPON COMPLETION OF THE MERGER, AND SHAREHOLDERS WILL NOT BE REQUIRED TO SURRENDER OR EXCHANGE ANY SHARE CERTIFICATES AS A RESULT OF THE REINCORPORATION.</B> </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">47</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Will the common stock continue to be listed for trading after the Reincorporation? </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Our common stock is listed for trading on the NYSE MKT under the ticker symbol &#147;APHB.&#148; After the Reincorporation, AmpliPhi Delaware&#146;s common stock would continue to be traded on the NYSE MKT without interruption, under the same symbol. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Will the reincorporation impact AmpliPhi Washington&#146;s registration statements with the SEC? </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">No. The registration statements of AmpliPhi Washington on file with the SEC immediately prior to the Reincorporation will be assumed by AmpliPhi Delaware. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">What will be the impact of the Reincorporation on AmpliPhi&#146;s Employee Benefit and Incentive Compensation Plans? </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Each outstanding option and restricted stock unit to purchase or receive shares of our common stock will be converted into an option and restricted stock unit, respectively, to purchase or receive the same number of shares of AmpliPhi Delaware common stock with no other changes in the terms and conditions of such award. Shareholders should note that approval of this proposal would also constitute approval of the assumption by AmpliPhi Delaware of the 2009 Stock Incentive Plan, 2012 Stock Incentive Plan, 2013 Stock Incentive Plan, and, if approved by shareholders at the annual meeting, the 2016 Equity Incentive Plan and the 2016
Employee Stock Purchase Plan. Up to 723,431 shares of common stock remain available for issuance under the 2013 Stock Incentive Plan, and, if approved by shareholders at the annual meeting, up to 2,373,000 shares of common stock may be issued under the 2016 Equity Incentive Plan and up to 120,000 shares of common stock may be issued under the 2016 Employee Stock Purchase Plan. AmpliPhi&#146;s other employee benefit arrangements would also be continued by AmpliPhi Delaware upon the terms and subject to the conditions in effect prior to the Reincorporation. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Interest of AmpliPhi&#146;s Directors and Executive Officers in the Reincorporation </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Our shareholders should be aware that certain of our directors and executive officers may have interests in the transaction that are different from, or in addition to, the interests of the shareholders generally. For example, the Reincorporation may be of benefit to our directors and officers by reducing their potential personal liability and increasing the scope of permitted indemnification, by strengthening directors&#146; ability to resist a takeover bid, and in other respects. The Board of Directors was aware of these interests and considered them, among other matters, in reaching its decision to approve the Reincorporation
and to recommend that our shareholders vote in favor of this proposal. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Accounting Consequences Associated with the Reincorporation </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The consolidated financial condition and results of operations of AmpliPhi Delaware immediately after consummation of the Reincorporation will be substantially identical as those of AmpliPhi immediately prior to the consummation of the Reincorporation. We believe that there will be no material accounting impact as a result of the Reincorporation. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Certain U.S. Federal Income Tax Consequences </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The following discussion summarizes certain U.S. federal income tax consequences of the Reincorporation to holders of our common stock. The discussion is based on the Internal Revenue Code of 1986, as amended, or the Code, regulations promulgated under the Code by the U.S. Treasury Department (including proposed and temporary regulations), rulings, current administrative interpretations and official pronouncements of the Internal Revenue Service, or the IRS, and judicial decisions, all as currently in effect and all of which are subject to differing interpretations or to change, possibly with retroactive effect. Such change
could materially and adversely affect the tax consequences described below. No assurance can be given that the IRS would not assert, or that a court would not sustain, a position contrary to any of the tax consequences described herein. No ruling from the IRS has been or will be sought with respect to any aspect of the transactions described herein. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">This discussion is for general information only, and does not purport to discuss all potential tax effects of the Reincorporation. For example, it does not consider the effect of any applicable state, local, or non-U.S. tax laws, or any non-income tax laws (such as estate and gift tax laws). In addition, it does not address all aspects </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">48</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">of U.S. federal income taxation that may affect particular holders in light of their particular investment or tax circumstances, including, without limitation, holders subject to special tax rules, such as partnerships, subchapter S corporations or other entities that are fiscally transparent for U.S. federal income tax purposes, banks, financial institutions, tax-exempt entities, insurance companies, regulated investment companies, real estate investment trusts, trusts and estates, dealers in stocks, securities or currencies, traders in securities that have elected to use the mark-to-market method of accounting for their
securities, persons holding our common stock as part of an integrated transaction, including a &#147;straddle,&#148; &#147;hedge,&#148; &#147;constructive sale,&#148; or &#147;conversion transaction,&#148; persons whose functional currency for tax purposes is not the U.S. dollar, persons who acquired our common stock pursuant to the exercise of stock options or otherwise as compensation, persons whose common stock constitutes qualified business stock with the meaning of Section 1202 of the Code, and persons who are not &#147;U.S. persons&#148; as defined below. This summary also does not consider any alternative minimum or Medicare &#147;net investment income&#148; tax considerations. Furthermore, this discussion does not address the tax consequences of transactions occurring prior to or after the Reincorporation (whether or not such transactions are in connection with the Reincorporation). </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">This discussion is directed solely to holders that hold our common stock as capital assets within the meaning of Section 1221 of the Code, which generally means as property held for investment. In addition, the following discussion only addresses &#147;U.S. persons&#148; for U.S. federal income tax purposes, generally defined as beneficial owners of our common stock who are: </P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">Individuals who are citizens or residents of the United States for U.S. federal income tax purposes; </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">Corporations (including an entity treated as a corporation for U.S. federal income tax purposes) created or organized in or under the laws of the United States or of any state of the United States or the District of Columbia; </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">Estates the income of which is subject to U.S. federal income taxation regardless of its source; </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">Trusts if a court within the United States is able to exercise primary supervision over the administration of any such trust and one or more U.S. persons have the authority to control all substantial decisions of such trust; or </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">Trusts in existence on August 20, 1996 that have valid elections in effect under applicable Treasury regulations to be treated as U.S. persons. </TD>

</TR>

</TABLE>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Holders of our common stock who are not covered by this summary, including partners of partnerships and owners of other pass-through entities holding our capital stock, should consult their own tax advisors. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>This discussion does not purport to be a complete analysis of all of the Reincorporation&#146;s tax consequences that may be relevant to holders. We urge you to consult your own tax advisor regarding your particular circumstances and the U.S. federal income and other federal tax consequences to you of the Reincorporation, as well as any tax consequences arising under the laws of any state, local, foreign or other tax jurisdiction and the possible effects of changes in U.S. federal or other tax laws.</B> </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Subject to the caveats and qualifications noted above, we believe: </P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">The Reincorporation will constitute a tax-free reorganization under Section 368(a) of the Code; </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">No gain or loss will be recognized by holders on the exchange of their AmpliPhi Washington common stock on receipt of AmpliPhi Delaware common stock pursuant to the Reincorporation; </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">The aggregate tax basis of AmpliPhi Delaware common stock received by each holder will equal the aggregate tax basis of the AmpliPhi Washington common stock surrendered by such holder in exchange therefor; and </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">The holding period of the AmpliPhi Delaware common stock received by each holder will include the period during which such holder held the AmpliPhi Washington common stock surrendered in exchange therefor. </TD>

</TR>

</TABLE>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">49</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Vote Required </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Votes &#147;For&#148; the proposal by at least 51% of the outstanding shares of common stock on the record date is required to approve the Reincorporation Proposal. Approval of this Reincorporation Proposal will constitute approval of the Merger Agreement and therefore the Reincorporation itself. A vote in favor of the Reincorporation Proposal is also effectively a vote to approve the form of the Delaware Charter and the Delaware Bylaws. If the shareholders approve the Merger Agreement and the Reincorporation is effected, the Delaware Charter and the Delaware Bylaws will become the certificate of incorporation and bylaws of the
surviving corporation. </P>

<H1 STYLE="text-indent:0pt; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 9pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><FONT STYLE="font-variant: small-caps">The Board of Directors Recommends<BR> a Vote &#147;For&#148; Proposal 4.</FONT> </H1>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">50</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<H1 STYLE="text-indent:0pt; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 9pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><FONT STYLE="font-variant: small-caps">PROPOSAL 5<BR>&nbsp;<BR> Approval of the issuance of up to an aggregate of 1,037,053 shares of common stock<BR> as and to the extent required to be issued pursuant to the terms of that certain<BR> Common Stock Issuance Agreement, dated April 8, 2016, by and among the Company and certain<BR> former holders of the Company&#146;s Series B convertible preferred stock</FONT> </H1>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Background </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">On April 8, 2016, certain holders (the &#147;Holders&#148;) of over two-thirds of the Company&#146;s then-outstanding shares of Series B convertible preferred stock (&#147;Series B Preferred&#148;) elected to automatically convert all outstanding shares of Series B Preferred into shares of common stock in accordance with Section 4.4.4(b)(ii) of the Company&#146;s Amended and Restated Articles of Incorporation, as amended (the &#147;Conversion&#148;). On April 8, 2016, the Company entered into a Common Stock Issuance Agreement (the &#147;Agreement&#148;) with the Holders, pursuant to which the Holders waived their right to
receive approximately $2.2 million in aggregate cash payments to which they were entitled upon the Conversion in respect of accrued dividends on their former shares of Series B Preferred and waived their registration rights with respect to certain future registration statements that may be filed, and certain future public offerings that may be conducted, by the Company. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">As consideration for the foregoing waivers by the Holders, the Company issued the Holders an aggregate of 853,465 shares of common stock (the &#147;Transaction Shares&#148;) in a transaction constituting a private placement, at an effective price per share (taking into consideration the waiver of the accrued dividends) that was less than the greater of the Company&#146;s book or market value per share. Immediately prior to such issuance on April 8, 2016, there were 5,883,503 shares of common stock outstanding. The number of Transaction Shares represented approximately 14.5% of the shares outstanding prior to the issuance of
such shares. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Pursuant to Section 713(a) of the NYSE MKT Company Guide, shareholder approval is generally required prior to the issuance of securities in connection with a transaction other than a public offering involving the sale, issuance, or potential issuance by the issuer of common stock (or securities convertible into common stock) equal to 20% or more of presently outstanding stock for less than the greater of book or market value of the stock. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Pursuant to the Agreement, as further consideration for the waivers provided by the Holders described above, the Company agreed that if in the future it conducts one or more bona fide equity financings in which it sells shares of its common stock or preferred stock at a price of less than $4.05 per share (each, a &#147;Dilutive Financing&#148;), the Company will, to the extent permitted by NYSE MKT rules, issue to the Holders, for no additional consideration, a number of additional shares of common stock (&#147;Additional Shares&#148;) based on a specified formula, as described further below. We refer to the foregoing rights as
the &#147;Additional Issuance Rights&#148;. Any Additional Shares that the Company issues pursuant to the Additional Issuance Rights would be aggregated with the Transaction Shares for purposes of determining whether the total number of Additional Shares issued equals or exceeds 20% of the Company&#146;s outstanding stock as of immediately prior to the issuance of the Transaction Shares (the &#147;NYSE 20% Cap&#148;). Accordingly, absent shareholder approval, the maximum number of Additional Shares that the Company can issue pursuant to Section 713(a) of the NYSE MKT Company Guide without shareholder approval is 323,235 shares. If the shareholders do not approve this proposal at the annual meeting, the Company could be required to make cash payments to the Holders in lieu of issuing Additional Shares, as described further below. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">If the Company conducts a Dilutive Financing, the Holders will be entitled to receive (absent consideration of the NYSE 20% Cap) in the aggregate a number of Additional Shares equal to (A) the product of (x) 1,037,053 multiplied by (y) a fraction, the numerator of which is $4.05 and the denominator of which is the lowest price per share paid by investors in such Dilutive Financing (the &#147;Effective Price&#148;) less (B) 1,037,053 and all Additional Shares issued previously to the Holders pursuant to the Additional Issuance Rights. The Agreement includes a provision intended to limit the Company&#146;s obligation to issue
Additional Shares to the extent such Additional Shares would exceed the 20% limit on the number of shares that can be issued without shareholder approval pursuant to Section 713(a) of the NYSE MKT Company Guide. The Company&#146;s obligation to issue Additional Shares as a result of one or more Dilutive Financings may be </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">51</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">waived by the Holders of at least 95% of the then-outstanding Transaction Shares, but there can be no assurance that the Holders will elect to do so. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The Company&#146;s obligation to issue Additional Shares in the event of a Dilutive Financing only applies to the lowest priced financing conducted after the date of the Agreement. For example, if the Company completes a Dilutive Financing priced at $3.50 a share followed by a Dilutive Financing priced at $3.75 a share, the obligation to issue Additional Shares would be triggered by the first Dilutive Financing but not the second Dilutive Financing. In addition, the Company&#146;s obligation to issue Additional Shares will expire on June 30, 2018 or at such earlier time as the Company has raised at least $10.0 million in gross
proceeds from the sale of its common stock and/or preferred stock in one or more bona fide financings. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Reason for Seeking Shareholder Approval </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Pursuant to the Agreement, the Company agreed to use its commercially reasonable efforts to obtain shareholder approval of the issuance of up to 1,037,053 Additional Shares to the Holders as and to the extent required by the Agreement in connection with one or more Dilutive Financings. If the shareholders approve this proposal, such number of Additional Shares may be issued to the Holders even if the issuance of such shares would, when aggregated with the Transaction Shares, exceed the NYSE 20% Cap. If the shareholders do not approve this proposal, the maximum number of Additional Shares that the Company may issue in
satisfaction of the Additional Issuance Rights in accordance with Section 713(a) of the NYSE MKT Company Guide will be 323,235 shares. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">If the Company&#146;s shareholders do not approve this proposal at the annual meeting, then in lieu of issuing any Additional Shares that would have been required to be issued to a Holder pursuant to the operation of the Additional Issuance Rights but for the limitations imposed by NYSE 20% Cap (the &#147;Excess Shares&#148;), the Company will, to the extent legally permitted, become obligated to pay to such Holder a cash amount per Excess Share equal to the difference between the lowest price per share paid by investors in such Dilutive Financing and $4.05, less any cash payment per share previously made or obligated to be
made to such Holder pursuant to the Agreement (the &#147;Cash Make-Whole&#148;). </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Certain Consequences if the Proposal is Approved or Not Approved </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The Company believes the approval of this proposal will provide the Company with increased flexibility to raise financing through the sale of its capital stock at market or negotiated prices in one or more Dilutive Financing transactions by reducing or eliminating the application of the Cash Make-Whole provision. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">If the proposal is not approved, the Company may be required to make cash payments to the Holders pursuant to the Cash Make-Whole in connection with one or more Dilutive Financing transactions. If the Cash Make-Whole would be triggered by a proposed Dilutive Financing, the potential payment obligations could make such Dilutive Financing less feasible and financially viable for the Company, particularly if the proceeds to be received by the Company in such financing would not significantly exceed the Cash Make-Whole payments, and thereby jeopardize the Company&#146;s ability to raise capital in a Dilutive Financing that could
otherwise provide needed cash resources to the Company. Even if the Company is able to complete a Dilutive Financing, any Cash Make-Whole payments would deplete the Company&#146;s cash resources at a time when the Company&#146;s cash resources may be extremely limited. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The Company&#146;s shareholders will incur dilution of their percentage ownership interest in the Company to the extent the Company issues Additional Shares to the Holders pursuant to the Additional Issuance Rights. The Company&#146;s shareholders will incur greater ownership interest dilution to the extent this proposal is approved and the Company becomes required to issue some or all of the 1,037,053 Additional Shares that are the subject to this proposal, which shares the Company would not otherwise have been permitted to issue pursuant to the NYSE 20% Cap. In addition, because the Additional Shares will be issued for no
additional consideration, any such issuance would reduce the net tangible book value per share of the Company. However, to the extent Additional Shares are not issued when otherwise required by the Agreement due to the NYSE 20% Cap, the payments by the Company in satisfaction of the Cash Make-Whole will also reduce the net tangible book value per share of the Company, as well as the overall net tangible book value. </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">52</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Interest of Certain Persons in the Proposal </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">One Fund Management Limited as Trustee for Asia Pacific Healthcare Fund II (&#147;One Funds&#148;), an entity affiliated with Jeremy Curnock Cook, the Chairman of the Company&#146;s Board of Directors, is a party to the Agreement as a Holder. The Agreement was approved by the Company&#146;s Audit Committee and no special terms were given to Mr. Cook or One Funds. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Vote Required </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">In order for Proposal 5 to be approved, the number of shares that vote &#147;For&#148; the proposal must exceed the number of shares that vote &#147;Against&#148; the proposal. Abstentions will be counted towards the vote total for Proposal 5 and will have the same effect as &#147;Against&#148; votes. Broker non-votes are counted towards a quorum, but are not counted for any purpose in determining whether this matter has been approved. </P>

<P STYLE="text-indent:0pt; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B><FONT STYLE="font-variant: small-caps">The Board of Directors Recommends<BR> a Vote &#147;For&#148; Proposal 5.</FONT></B> </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">53</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<H1 STYLE="text-indent:0pt; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 9pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><FONT STYLE="font-variant: small-caps">Proposal 6<BR> &nbsp;<BR>Approval of the issuance by the Company of up to an aggregate of 4,706,000 shares of common stock and/or warrants to purchase common stock in a financing that does not constitute a public offering under NYSE MKT rules, for gross sale proceeds of up to $12,000,000 and at a discount to the then-current market value of the Company&#146;s Common Stock not to exceed 15%</FONT> </H1>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Pursuant to Section 713(a) of the NYSE MKT Company Guide, shareholder approval is generally required prior to the issuance of securities in connection with a transaction other than a public offering involving (each of the following, a &#147;Discounted Private Placement&#148;): (i) the sale, issuance, or potential issuance by the issuer of common stock (or securities convertible into common stock) at a price less than the greater of book or market value which together with sales by officers, directors or principal shareholders of the issuer equals 20% or more of presently outstanding common stock; or (ii) the sale, issuance, or
potential issuance by the issuer of common stock (or securities convertible into common stock) equal to 20% or more of presently outstanding stock for less than the greater of book or market value of the stock. The foregoing 20% limitations are referred to in this proposal as the &#147;NYSE 20% Cap&#148;. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The Company is seeking shareholder approval of the potential issuance by the Company in one or more Discounted Private Placement transactions of up to an aggregate of 4,706,000 shares of the Company&#146;s common stock and/or warrants exercisable for common stock, for aggregate proceeds of up to $12 million, at a price per share that is equal to or greater than 85% of the market price per share of common stock as most recently reported on the NYSE MKT prior to the entry into a definitive transaction agreement for the financing, without further shareholder approval. Approval of this proposal at the annual meeting will permit the
Company to complete one or more Discounted Private Placements only if the definitive agreement for any such Discounted Private Placement is entered into no later than 90 days following the date of the annual meeting. . Any definitive agreement for a Discounted Private Placement entered into more than 90 days following the date of the annual meeting would again be subject to any shareholder approval required under Section 713(a) of the NYSE MKT Company Guide. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The Company currently anticipates using the proceeds of any Discounted Private Placement approved by the shareholders pursuant to this proposal for general corporate purposes, including manufacturing expenses, clinical trial expenses, research and development expenses and general and administrative expenses. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">If the Company issues shares of its common stock or common stock warrants in one or more Discounted Private Placement transactions, existing shareholders will incur dilution of their percentage ownership interest in the Company and may also incur dilution in the value of their investment in the Company depending on the price per share sold in such transaction. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The Company believes that the approval of this proposal will provide the Company with increased flexibility to raise financing through the sale of its capital stock at negotiated prices. The Company currently anticipates that its existing cash resources will be sufficient to fund its planned operations into the third quarter of 2016. As a result, it is critical for the Company to raise additional capital within the next several months. The Company&#146;s ability to raise significant cash proceeds from a registered public offering is limited as a result of the aggregate market value of the Company&#146;s outstanding common stock
held by non-affiliates, or public float, being less than $75.0 million as of the date of this proxy statement. The rules of the Securities and Exchange Commission limit the dollar amount of securities the Company may sell under a registration statement on Form S-3 to one-third of the Company&#146;s public float (based on the trading price of the common stock as of a date within 60 days prior to the relevant offering) during any 12-month period for so long as the Company&#146;s public float remains below $75.0 million. In addition, certain registered offerings are not considered to be &#147;public offerings&#148; under the rules of the NYSE MKT, and consequently the NYSE 20% Cap may further limit the Company&#146;s ability to raise capital, even if the offering is registered on Form S-3, so that the Company may not be permitted to raise the amounts otherwise permitted under Form S-3. In addition, completing a registered offering on Form S-1 is a significantly lengthier and generally
more expensive process than both a private placement and an offering pursuant to a Form S-3 registration statement. Consequently, the Company is seeking approval of this proposal to provide it with increased financing flexibility and enable it to potentially raise up to an aggregate of $12 million through one or more Discounted Private Placement </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">54</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">transactions, which would be in excess of what it could currently raise on Form S-3 or in any offering subject to the NYSE 20% Cap based on the current market value of the common stock as of the date of this proxy statement. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">In order for Proposal 6 to be approved, the number of shares that vote &#147;For&#148; the proposal must exceed the number of shares that vote &#147;Against&#148; the proposal. Abstentions will be counted towards the vote total for Proposal 6 and will have the same effect as &#147;Against&#148; votes. Broker non-votes are counted towards a quorum, but are not counted for any purpose in determining whether this matter has been approved. </P>

<P STYLE="text-indent:0pt; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><FONT STYLE="font-variant: small-caps"><B>The Board of Directors Recommends<BR> a Vote &#147;For&#148; Proposal 6.</FONT> </B></P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>This proxy statement shall not constitute an offer to sell or the solicitation of an offer to buy any securities of the Company, nor shall there be any offer, solicitation, or sale of any securities of the Company in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state.</B> </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">55</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<H1 STYLE="text-indent:0pt; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 9pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><FONT STYLE="font-variant: small-caps">Proposal 7<BR> &nbsp;<BR>Ratification of Selection of Independent Registered Public Accounting Firm</FONT> </H1>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The Audit Committee of the Board of Directors has selected Ernst &amp; Young LLP as the Company&#146;s independent registered public accounting firm for the fiscal year ending December 31, 2016 and has further directed that management submit the selection of its independent registered public accounting firm for ratification by the shareholders at the annual meeting. Ernst &amp; Young LLP was selected as our independent accountant as of January 20, 2015. Prior to selecting Ernst &amp; Young LLP, PBMares, LLP served as our independent registered public accounting firm, including for the fiscal year ended December 31, 2014.
Representatives of Ernst &amp; Young LLP are expected to be present at the annual meeting. They will have an opportunity to make a statement if they so desire and will be available to respond to appropriate questions. Representatives of PBMares, LLP are not expected to be present at the annual meeting. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Neither the Company&#146;s Bylaws nor other governing documents or law require shareholder ratification of the selection of Ernst &amp; Young LLP as the Company&#146;s independent registered public accounting firm. However, the Audit Committee of the Board is submitting the selection of Ernst &amp; Young LLP to the shareholders for ratification as a matter of good corporate practice. If the shareholders fail to ratify the selection, the Audit Committee of the Board will reconsider whether or not to retain that firm. Even if the selection is ratified, the Audit Committee of the Board in its discretion may direct the appointment
of different independent auditors at any time during the year if they determine that such a change would be in the best interests of the Company and its shareholders. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">In order for Proposal 7 to be approved, the number of shares that vote &#147;For&#148; the proposal must exceed the number of shares that vote &#147;Against&#148; the proposal. Abstentions will be counted towards the vote total for Proposal 7 and will have the same effect as &#147;Against&#148; votes. Broker non-votes, if any, are counted towards a quorum, but are not counted for any purpose in determining whether this matter has been approved. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><FONT STYLE="font-variant: small-caps">Principal Accountant Fees and Services</FONT> </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The following table represents aggregate fees billed to us for the fiscal years ended December 31, 2015 and December 31, 2014 by Ernst &amp; Young LLP, our current principal accountant. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"></P>

<DIV style="text-align: center"><TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="608" STYLE="vertical-align: bottom; text-indent:0px; text-align: left; font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: -15pt; *margin-top: -20pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR>

          <TD><IMG HEIGHT="1" SRC="spacer.gif" WIDTH="424"></TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none"><!-- GUTTER -->&nbsp;</TD>

          <TD COLSPAN="3"><IMG HEIGHT="1" SRC="spacer.gif" WIDTH="72"></TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none"><!-- GUTTER -->&nbsp;</TD>

          <TD COLSPAN="3"><IMG HEIGHT="1" SRC="spacer.gif" WIDTH="80"></TD>

</TR>

<TR>

          <TD STYLE="line-height: normal; vertical-align: bottom; font-weight: bold; font-size: 8pt; text-align: left" ROWSPAN=1 COLSPAN=1></TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="line-height: normal; vertical-align: bottom; font-weight: bold; font-size: 8pt; text-align: center; border-bottom: 1pt solid black" ROWSPAN=1 COLSPAN=3>Fiscal Year<BR> Ended<BR> December 31,<BR> 2015</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="line-height: normal; vertical-align: bottom; font-weight: bold; font-size: 8pt; text-align: center; border-bottom: 1pt solid black" ROWSPAN=1 COLSPAN=3>Fiscal Year<BR> Ended<BR> December 31,<BR> 2014</TD>

</TR>

<TR STYLE="background-color: #cceeff">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt; vertical-align: text-bottom" ROWSPAN=1 COLSPAN=1>Audit Fees</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->$</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>534,000</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->$</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>382,000</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

</TR>

<TR STYLE="background-color: white">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt; vertical-align: text-bottom" ROWSPAN=1 COLSPAN=1>Audit Related Fees</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>&#151;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>&#151;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

</TR>

<TR STYLE="background-color: #cceeff">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt; vertical-align: text-bottom" ROWSPAN=1 COLSPAN=1>Tax Fees</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>&#151;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>&#151;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

</TR>

<TR STYLE="background-color: white">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt; vertical-align: bottom; border-bottom: 1pt solid white" ROWSPAN=1 COLSPAN=1>All Other Fees</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center; border-bottom: 1pt solid white" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left; border-bottom: 1pt solid black" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right; border-bottom: 1pt solid black" ROWSPAN=1 COLSPAN=1>&#151;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left; border-bottom: 1pt solid white"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center; border-bottom: 1pt solid white" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left; border-bottom: 1pt solid black" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right; border-bottom: 1pt solid black" ROWSPAN=1 COLSPAN=1>&#151;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left; border-bottom: 1pt solid white"><!-- PERCENT -->&nbsp;</TD>

</TR>

<TR STYLE="background-color: #cceeff">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt; vertical-align: bottom; border-bottom: 3pt double white" ROWSPAN=1 COLSPAN=1>Total</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center; border-bottom: 3pt double white" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left; border-bottom: 3pt double black" ROWSPAN=1><!-- $ -->$</TD>

          <TD STYLE="vertical-align: bottom; text-align: right; border-bottom: 3pt double black" ROWSPAN=1 COLSPAN=1>534,000</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left; border-bottom: 3pt double white"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center; border-bottom: 3pt double white" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left; border-bottom: 3pt double black" ROWSPAN=1><!-- $ -->$</TD>

          <TD STYLE="vertical-align: bottom; text-align: right; border-bottom: 3pt double black" ROWSPAN=1 COLSPAN=1>382,000</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left; border-bottom: 3pt double white"><!-- PERCENT -->&nbsp;</TD>

</TR>

</TABLE></DIV>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The following table represents aggregate fees billed to us for the fiscal years ended December 31, 2015 and December 31, 2014 by PBMares, LLP, our former principal accountant. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"></P>

<DIV style="text-align: center"><TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="608" STYLE="vertical-align: bottom; text-indent:0px; text-align: left; font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: -15pt; *margin-top: -20pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR>

          <TD><IMG HEIGHT="1" SRC="spacer.gif" WIDTH="424"></TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none"><!-- GUTTER -->&nbsp;</TD>

          <TD COLSPAN="3"><IMG HEIGHT="1" SRC="spacer.gif" WIDTH="72"></TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none"><!-- GUTTER -->&nbsp;</TD>

          <TD COLSPAN="3"><IMG HEIGHT="1" SRC="spacer.gif" WIDTH="80"></TD>

</TR>

<TR>

          <TD STYLE="line-height: normal; vertical-align: bottom; font-weight: bold; font-size: 8pt; text-align: left" ROWSPAN=1 COLSPAN=1></TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="line-height: normal; vertical-align: bottom; font-weight: bold; font-size: 8pt; text-align: center; border-bottom: 1pt solid black" ROWSPAN=1 COLSPAN=3>Fiscal Year<BR> Ended<BR> December 31,<BR> 2015</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="line-height: normal; vertical-align: bottom; font-weight: bold; font-size: 8pt; text-align: center; border-bottom: 1pt solid black" ROWSPAN=1 COLSPAN=3>Fiscal Year<BR> Ended<BR> December 31,<BR> 2014</TD>

</TR>

<TR STYLE="background-color: #cceeff">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt; vertical-align: text-bottom" ROWSPAN=1 COLSPAN=1>Audit Fees</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->$</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>51,551</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->$</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>132,775</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

</TR>

<TR STYLE="background-color: white">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt; vertical-align: text-bottom" ROWSPAN=1 COLSPAN=1>Audit Related Fees</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>&#151;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>118,950</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

</TR>

<TR STYLE="background-color: #cceeff">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt; vertical-align: text-bottom" ROWSPAN=1 COLSPAN=1>Tax Fees</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>&#151;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>&#151;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

</TR>

<TR STYLE="background-color: white">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt; vertical-align: bottom; border-bottom: 1pt solid white" ROWSPAN=1 COLSPAN=1>All Other Fees</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center; border-bottom: 1pt solid white" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left; border-bottom: 1pt solid black" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right; border-bottom: 1pt solid black" ROWSPAN=1 COLSPAN=1>&#151;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left; border-bottom: 1pt solid white"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center; border-bottom: 1pt solid white" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left; border-bottom: 1pt solid black" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right; border-bottom: 1pt solid black" ROWSPAN=1 COLSPAN=1>69,947</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left; border-bottom: 1pt solid white"><!-- PERCENT -->&nbsp;</TD>

</TR>

<TR STYLE="background-color: #cceeff">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt; vertical-align: bottom; border-bottom: 3pt double white" ROWSPAN=1 COLSPAN=1>Total</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center; border-bottom: 3pt double white" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left; border-bottom: 3pt double black" ROWSPAN=1><!-- $ -->$</TD>

          <TD STYLE="vertical-align: bottom; text-align: right; border-bottom: 3pt double black" ROWSPAN=1 COLSPAN=1>51,551</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left; border-bottom: 3pt double white"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center; border-bottom: 3pt double white" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left; border-bottom: 3pt double black" ROWSPAN=1><!-- $ -->$</TD>

          <TD STYLE="vertical-align: bottom; text-align: right; border-bottom: 3pt double black" ROWSPAN=1 COLSPAN=1>321,672</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left; border-bottom: 3pt double white"><!-- PERCENT -->&nbsp;</TD>

</TR>

</TABLE></DIV>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Representatives of Ernst &amp; Young LLP attended all of the meetings of the Audit Committee occurring between and including the dates of January 20, 2015 and December 31, 2015. Representatives of PBMares, LLP attended all of the meetings of the Audit Committee during the period commencing on January 1, 2014 and ending on January 20, 2015. </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">56</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><FONT STYLE="font-variant: small-caps">Pre-Approval Policies and Procedures</FONT> </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The Audit Committee approves in advance the engagement and fees of the independent registered public accounting firm for all audit services and non-audit services, based upon independence, qualifications and, if applicable, performance. The Audit Committee may form and delegate to subcommittees of one or more members of the Audit Committee the authority to grant pre-approvals for audit and permitted non-audit services, up to specific amounts. All audit services provided by Ernst &amp; Young LLP and PBMares, LLP for the periods presented were pre-approved by the Audit Committee. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><FONT STYLE="font-variant: small-caps">Change in Independent Registered Public Accounting Firm</FONT> </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">On January 20, 2015, we dismissed PBMares, LLP as our independent registered public accounting firm. The reports of PBMares, LLP on our financial statements for the year ended December 31, 2014 did not contain an adverse opinion or a disclaimer of opinion, nor were they qualified or modified as to audit scope or accounting principles. The decision to change auditors was approved by the Audit Committee. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">During our two most recent fiscal years, and in the interim period ending on the date of our dismissal of PBMares, LLP, we have not had any disagreements with PBMares, LLP on any matter of accounting principles or practices, financial statement disclosure or auditing scope or procedure, which disagreements, if not resolved to PBMares LLP&#146;s satisfaction, would have caused them to make reference thereto in their reports on our financial statements for such periods. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">During our two most recent fiscal years, and in the interim period ending on the date of our dismissal of PBMares, LLP, there were no reportable events, as defined in Item 304(a)(1)(v) of Regulation S-K. PBMares, LLP provided us with a letter addressed to the SEC confirming PBMares, LLP&#146;s agreement with the foregoing disclosures. A copy of the letter from PBMares, LLP, dated January 22, 2015, is included as Exhibit 16.1 to our Current Report on Form 8-K filed with the SEC on January 23, 2015. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><FONT STYLE="font-variant: small-caps">Ability to Continue as a Going Concern</FONT> </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The report of Ernst &amp; Young LLP on the consolidated financial statements of the Company for the fiscal year ended December 31, 2015, included in the Form 10-K filed with the Securities and Exchange Commission on March 30, 2016 states that the Company has incurred net losses since its inception, has negative operating cash flows and has an accumulated deficit of $362.5 million as of December 31, 2015, $47.0 million of which has been accumulated since January of 2011, when the Company began its focus on bacteriophage development, which raise substantial doubts about the Company&#146;s ability to continue as a going concern.
Other than the foregoing, Ernst &amp; Young LLP&#146;s report on the financial statements for the past two years contained no adverse opinion or disclaimer of opinion and was not qualified as to audit scope or accounting principles. </P>

<P STYLE="text-indent:0pt; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><FONT STYLE="font-variant: small-caps"><B>The Board Of Directors Recommends<BR> A Vote &#147;For&#148; Proposal 7.</FONT> </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">57</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"></B></P>

<H1 STYLE="text-indent:0pt; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 9pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><FONT STYLE="font-variant: small-caps">Executive Officers</FONT> </H1>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The following table sets forth information regarding our executive officers as of the date of this proxy statement. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"></P>

<DIV style="text-align: center"><TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="608" STYLE="vertical-align: text-top; text-indent:0px; text-align: left; font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: -15pt; *margin-top: -20pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR>

          <TD><IMG HEIGHT="1" SRC="spacer.gif" WIDTH="216"></TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none"><!-- GUTTER -->&nbsp;</TD>

          <TD><IMG HEIGHT="1" SRC="spacer.gif" WIDTH="48"></TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none"><!-- GUTTER -->&nbsp;</TD>

          <TD><IMG HEIGHT="1" SRC="spacer.gif" WIDTH="312"></TD>

</TR>

<TR STYLE="vertical-align: top">

          <TD STYLE="line-height: normal; vertical-align: bottom; font-weight: bold; font-size: 8pt; text-align: left; border-bottom: 1pt solid black" ROWSPAN=1 COLSPAN=1>Name</TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="line-height: normal; vertical-align: bottom; font-weight: bold; font-size: 8pt; text-align: center; border-bottom: 1pt solid black" ROWSPAN=1 COLSPAN=1>Age</TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="line-height: normal; vertical-align: bottom; font-weight: bold; font-size: 8pt; text-align: center; border-bottom: 1pt solid black" ROWSPAN=1 COLSPAN=1>Position</TD>

</TR>

<TR STYLE="vertical-align: top">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt" ROWSPAN=1 COLSPAN=1>M. Scott Salka</TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD ROWSPAN=1 COLSPAN=1 STYLE="text-align: center">54</TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD ROWSPAN=1 COLSPAN=1 STYLE="text-align: left">Chief Executive Officer, Director</TD>

</TR>

<TR STYLE="vertical-align: top">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt" ROWSPAN=1 COLSPAN=1>Steve R. Martin</TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD ROWSPAN=1 COLSPAN=1 STYLE="text-align: center">55</TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD ROWSPAN=1 COLSPAN=1 STYLE="text-align: left">Chief Financial Officer</TD>

</TR>

<TR STYLE="vertical-align: top">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt" ROWSPAN=1 COLSPAN=1>Wendy S. Johnson</TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD ROWSPAN=1 COLSPAN=1 STYLE="text-align: center">64</TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD ROWSPAN=1 COLSPAN=1 STYLE="text-align: left">Interim Chief Operating Officer, Director</TD>

</TR>

</TABLE></DIV>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The following is biographical information for Steve R. Martin, our Chief Financial Officer. The biographical information for our other executive officers, Mr. Salka and Ms. Johnson, is included under Proposal 1. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B><I>Steve R. Martin</I></B> has served as our Chief Financial Officer since January 2016. Mr. Martin served as Senior Vice President and Chief Financial Officer of Applied Proteomics, Inc., a molecular diagnostics company, from December 2014 to August 2015. From June 2011 to December 2014, Mr. Martin served as Senior Vice President and Chief Financial Officer of Apricus Biosciences, Inc., a publicly traded pharmaceutical company, and served as the Interim Chief Executive Officer of Apricus from November 2012 through March 2013. From 2008 to January 2011, Mr. Martin served as Senior Vice President and Chief Financial Officer
of BakBone Software, a publicly traded software company. During his final 10 months with BakBone until the company&#146;s acquisition in January 2011, Mr. Martin also served as BakBone&#146;s Interim Chief Executive Officer. From 2005 to 2007, Mr. Martin served as Chief Financial Officer of Stratagene Corporation, a publicly traded research products and clinical diagnostics company. Mr. Martin&#146;s previous experience also includes serving as Controller with Gen-Probe Incorporated, a publicly traded molecular diagnostics company, as well as 10 years with Deloitte &amp; Touche LLP, a public accounting firm. Mr. Martin holds a B.S. degree from San Diego State University and is a certified public accountant. </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">58</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<H1 STYLE="text-indent:0pt; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 9pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><FONT STYLE="font-variant: small-caps">Security Ownership of Certain Beneficial Owners and Management</FONT> </H1>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The following table sets forth information regarding beneficial ownership of our capital stock by: </P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">each person, or group of affiliated persons, known by us to beneficially own more than 5% of our common stock; </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">each of our directors; </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">each of our named executive officers; and </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">all of our current executive officers and directors as a group. </TD>

</TR>

</TABLE>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The percentage ownership information in the table below is based on 8,242,528 shares of common stock outstanding as of April 30, 2016. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Information with respect to beneficial ownership has been furnished by each director, officer or beneficial owner of more than 5% of our common stock, unless otherwise indicated. We have determined beneficial ownership in accordance with the rules of the SEC. These rules generally attribute beneficial ownership of securities to persons who possess sole or shared voting power or investment power with respect to those securities. In addition, the rules include shares of common stock issuable pursuant to the exercise of stock options or warrants that are either immediately exercisable or exercisable on or before June 29, 2016,
which is 60 days after April 30, 2016. These shares are deemed to be outstanding and beneficially owned by the person holding those options or warrants for the purpose of computing the percentage ownership of that person, but they are not treated as outstanding for the purpose of computing the percentage ownership of any other person. Unless otherwise indicated, the persons or entities identified in this table have sole voting and investment power with respect to all shares shown as beneficially owned by them, subject to applicable community property laws. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Except as otherwise noted below, the address for each person or entity listed in the table is c/o AmpliPhi Biosciences Corporation, 3579 Valley Centre Drive, Suite 100, San Diego, California 92130. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"></P>

<DIV style="text-align: center"><TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="608" STYLE="vertical-align: bottom; text-indent:0px; text-align: left; font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: -15pt; *margin-top: -20pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR>

          <TD><IMG HEIGHT="1" SRC="spacer.gif" WIDTH="429"></TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none"><!-- GUTTER -->&nbsp;</TD>

          <TD COLSPAN="3"><IMG HEIGHT="1" SRC="spacer.gif" WIDTH="69"></TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none"><!-- GUTTER -->&nbsp;</TD>

          <TD COLSPAN="3"><IMG HEIGHT="1" SRC="spacer.gif" WIDTH="77"></TD>

</TR>

<TR>

          <TD STYLE="line-height: normal; vertical-align: bottom; font-weight: bold; font-size: 8pt; text-align: left" ROWSPAN=1 COLSPAN=1></TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="line-height: normal; vertical-align: bottom; font-weight: bold; font-size: 8pt; text-align: center; border-bottom: 1pt solid black" ROWSPAN=1 COLSPAN=7>Beneficial Ownership</TD>

</TR>

<TR>

          <TD STYLE="line-height: normal; vertical-align: bottom; font-weight: bold; font-size: 8pt; text-align: left; border-bottom: 1pt solid black"  ROWSPAN=1 COLSPAN=1>Beneficial Owner</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="line-height: normal; vertical-align: bottom; font-weight: bold; font-size: 8pt; text-align: center; border-bottom: 1pt solid black" ROWSPAN=1 COLSPAN=3>Number of<BR> Shares</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="line-height: normal; vertical-align: bottom; font-weight: bold; font-size: 8pt; text-align: center; border-bottom: 1pt solid black" ROWSPAN=1 COLSPAN=3>Percent of<BR> Total</TD>

</TR>

<TR STYLE="background-color: white">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt; vertical-align: bottom; font-weight: bold" ROWSPAN=1 COLSPAN=1>5% or Greater Shareholders<BR></TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>&nbsp;&nbsp;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>&nbsp;&nbsp;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

</TR>

<TR STYLE="background-color: #cceeff">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt; vertical-align: text-bottom" ROWSPAN=1 COLSPAN=1>Randal J. Kirk<sup>&#040;1&#041;</sup><BR>c/o Third Security, LLC<BR>1881 Grove Avenue<BR>Radford, Virginia 24141</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>1,764,197</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>21.0</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left">%<!-- PERCENT -->&nbsp;</TD>

</TR>

<TR STYLE="background-color: white">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt; vertical-align: text-bottom" ROWSPAN=1 COLSPAN=1>Pendinas Limited<sup>&#040;2&#041;</sup><BR>Ballacarrick, Pooilvaaish Road<BR>Isle of Man, IM9 4PJ</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>1,630,905</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>19.0</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left">%<!-- PERCENT -->&nbsp;</TD>

</TR>

<TR STYLE="background-color: #cceeff">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt; vertical-align: text-bottom" ROWSPAN=1 COLSPAN=1>Phillip Asset Management Limited<sup>&#040;3&#041;</sup><BR>Level 12, 15 William Street<BR>Melbourne VIC Australia</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>654,914</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>7.9</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left">%<!-- PERCENT -->&nbsp;</TD>

</TR>

<TR STYLE="background-color: white">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt; vertical-align: text-bottom" ROWSPAN=1 COLSPAN=1>Broadfin Healthcare Master Fund, LTD<sup>&#040;4&#041;</sup><BR>20 Genesis Close<BR>Ansbacher House, Second Floor<BR>Grand Cayman KY1-1108<BR>Cayman Islands</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>620,000</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>7.5</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left">%<!-- PERCENT -->&nbsp;</TD>

</TR>

<TR STYLE="background-color: #cceeff">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt; vertical-align: text-bottom" ROWSPAN=1 COLSPAN=1>Dr. Anthony M. Smithyman and Margaret Smithyman<sup>&#040;5&#041;</sup><BR>14 Norfolk Avenue<BR>Collaroy, NSW 2097<BR>Australia</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>507,412</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>6.2% </TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

</TR>

</TABLE></DIV>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">59</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<DIV style="text-align: center"><TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="608" STYLE="vertical-align: bottom; text-indent:0px; text-align: left; font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: -15pt; *margin-top: -20pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR>

          <TD><IMG HEIGHT="1" SRC="spacer.gif" WIDTH="429"></TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none"><!-- GUTTER -->&nbsp;</TD>

          <TD COLSPAN="3"><IMG HEIGHT="1" SRC="spacer.gif" WIDTH="69"></TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none"><!-- GUTTER -->&nbsp;</TD>

          <TD COLSPAN="3"><IMG HEIGHT="1" SRC="spacer.gif" WIDTH="77"></TD>

</TR>

<TR>

          <TD STYLE="line-height: normal; vertical-align: bottom; font-weight: bold; font-size: 8pt; text-align: left" ROWSPAN=1 COLSPAN=1></TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="line-height: normal; vertical-align: bottom; font-weight: bold; font-size: 8pt; text-align: center; border-bottom: 1pt solid black" ROWSPAN=1 COLSPAN=7>Beneficial Ownership</TD>

</TR>

<TR>

          <TD STYLE="line-height: normal; vertical-align: bottom; font-weight: bold; font-size: 8pt; text-align: left; border-bottom: 1pt solid black"  ROWSPAN=1 COLSPAN=1>Beneficial Owner</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="line-height: normal; vertical-align: bottom; font-weight: bold; font-size: 8pt; text-align: center; border-bottom: 1pt solid black" ROWSPAN=1 COLSPAN=3>Number of<BR> Shares</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="line-height: normal; vertical-align: bottom; font-weight: bold; font-size: 8pt; text-align: center; border-bottom: 1pt solid black" ROWSPAN=1 COLSPAN=3>Percent of<BR> Total</TD>

</TR>

<TR STYLE="background-color: white">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt; vertical-align: bottom; font-weight: bold" ROWSPAN=1 COLSPAN=1>Directors and Named Executive Officers<BR></TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>&nbsp;&nbsp;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>&nbsp;&nbsp;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

</TR>

<TR STYLE="background-color: #cceeff">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt; vertical-align: text-bottom" ROWSPAN=1 COLSPAN=1>M. Scott Salka<sup>&#040;6&#041;</sup></TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>40,285</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1></TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->*&nbsp;</TD>

</TR>

<TR STYLE="background-color: white">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt; vertical-align: text-bottom" ROWSPAN=1 COLSPAN=1>Jeremy Curnock Cook<sup>&#040;7&#041;</sup></TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>677,550</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>8.1</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left">%<!-- PERCENT -->&nbsp;</TD>

</TR>

<TR STYLE="background-color: #cceeff">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt; vertical-align: text-bottom" ROWSPAN=1 COLSPAN=1>Louis Drapeau<sup>&#040;8&#041;</sup></TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>13,454</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1></TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->*&nbsp;</TD>

</TR>

<TR STYLE="background-color: white">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt; vertical-align: text-bottom" ROWSPAN=1 COLSPAN=1>Michael S. Perry, Ph.D.<sup>(9)</sup></TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>7,869</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1></TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->*&nbsp;</TD>

</TR>

<TR STYLE="background-color: #cceeff">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt; vertical-align: text-bottom" ROWSPAN=1 COLSPAN=1>Vijay B. Samant</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>&#151;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>&#151;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

</TR>

<TR STYLE="background-color: white">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt; vertical-align: text-bottom" ROWSPAN=1 COLSPAN=1>Paul C. Grint, M.D.</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>&#151;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>&#151;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

</TR>

<TR STYLE="background-color: #cceeff">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt; vertical-align: text-bottom" ROWSPAN=1 COLSPAN=1>Wendy Johnson<sup>&#040;10&#041;</sup></TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>25,254</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1></TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->*&nbsp;</TD>

</TR>

<TR STYLE="background-color: white">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt; vertical-align: text-bottom" ROWSPAN=1 COLSPAN=1>David E. Bosher</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>&#151;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>&#151;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

</TR>

<TR STYLE="background-color: #cceeff">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt; vertical-align: bottom; font-weight: bold" ROWSPAN=1 COLSPAN=1>All current executive officers and directors as a group (8 persons)<sup>&#040;11&#041;</sup></TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>764,412</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>9.1</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left">%<!-- PERCENT -->&nbsp;</TD>

</TR>

</TABLE></DIV>


<P STYLE="text-align: left; text-indent: 1px"><IMG SRC="line.gif" STYLE="width: 72px; height: 1pt"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 1px"></TD>

          <TD STYLE="width: 20px; text-align: left">*</TD>

          <TD STYLE="text-align: justify">Represents beneficial ownership of less than 1%. </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 1px"></TD>

          <TD STYLE="width: 20px; text-align: left">(1)</TD>

          <TD STYLE="text-align: justify">Based solely upon a Schedule 13D filed with the SEC on March 16, 2015. According to the Schedule 13D and giving effect to the 1-for-50 reverse stock split of the Company&#146;s common stock effected on August 3, 2015, or the Reverse Stock Split, and the conversion of all outstanding shares of Series B redeemable convertible preferred stock into shares of common stock on April 8, 2016, or the Series B Conversion, consists of (a) 828,571 shares of common stock held by NRM VII Holdings I, LLC, which we refer to as NRM VII Holdings, (b) 107,142 shares of common stock issuable upon exercise of warrants held by NRM VII Holdings, (c) 758,788 shares of common stock held by Intrexon Corporation, and (d) 69,696 shares of common stock issuable upon exercise of warrants held Intrexon Corporation. Third Security, LLC is the Manager of Third Security Capital Partners VII, LLC, which is the Manager of NRM VII Holdings. Third Security, LLC has sole voting and
investment power over the shares beneficially owned by NRM VII Holdings listed in the foregoing clauses (a) and (b), and consequently Third Security beneficially owns approximately 11.2% of our common stock. Randal J. Kirk is the Manager of Third Security, LLC. Shares held by this entity may be deemed to be indirectly beneficially owned (as defined under Rule 13d-3 promulgated under the Exchange Act) by Mr. Kirk. Mr. Kirk disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein. Randal J. Kirk, directly and through certain affiliates, has voting and dispositive power over a majority of the outstanding capital stock of Intrexon Corporation. Mr. Kirk may therefore be deemed to have voting and dispositive power over the shares of the issuer owned by Intrexon Corporation. Shares held by Intrexon Corporation may be deemed to be indirectly beneficially owned (as defined under Rule 13d-3 promulgated under the Exchange Act) by Mr. Kirk. Mr. Kirk
disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein. </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 1px"></TD>

          <TD STYLE="width: 20px; text-align: left">(2)</TD>

          <TD STYLE="text-align: justify">Based in part upon a Form 4 filed with the SEC on February 24, 2014 filed by Gwynn Williams, who may be deemed to control Pendinas Limited. After giving effect to the Reverse Stock Split and Series B Conversion, consists of 1,294,861 shares of common stock and 336,044 shares of common stock issuable upon exercise of warrants. </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 1px"></TD>

          <TD STYLE="width: 20px; text-align: left">(3)</TD>

          <TD STYLE="text-align: justify">Consists of (a) 567,903 shares of common stock held by One Fund Management Limited as Trustee for Asia Pacific Healthcare Fund II, which is also known as Phillip Asset Management Limited as Trustee for Asia Pacific Healthcare Fund II (&#147;Phillip Asset Management&#148;), and (b) an aggregate of 87,011 shares of common stock issuable upon exercise of warrants held by Phillip Asset Management. Phillip Asset Management holds all securities in its capacity as trustee for Bioscience Managers Pty Ltd. Jeremy Curnock Cook, the Chairman of our Board of Directors, is a Managing Director and holds an ownership interest in Bioscience Managers Pty Ltd. </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 1px"></TD>

          <TD STYLE="width: 20px; text-align: left">(4)</TD>

          <TD STYLE="text-align: justify">Based solely upon a Schedule 13G filed with the SEC on February 12, 2016. According to the Schedule 13G, this amount consists of 552,000 shares of our common stock and 68,000 shares of common stock issuable upon the exercise of warrants. Broadfin Capital, LLC serves as investment adviser to Broadfin Healthcare Master Fund, LTD with the power to direct investments and/or sole power to vote the shares owned by Broadfin Healthcare Master Fund, LTD. Kevin Kotler is the Managing Member of Broadfin Capital, LLC. Mr. Kotler has voting and dispositive power over the shares held by Broadfin Healthcare Master Fund, LTD. Mr. Kotler disclaims beneficial ownership of all shares beneficially owned, except to the extent of his pecuniary interests in such shares. </TD>

</TR>

</TABLE>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">60</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 1px"></TD>

          <TD STYLE="width: 20px; text-align: left">(5)</TD>

          <TD STYLE="text-align: justify">Based solely upon a Schedule 13G filed with the SEC on April 27, 2015. According to the Schedule 13G and giving effect to the Reverse Stock Split, consists of (a) 211,966 shares of common stock held by Dr. Anthony M. Smithyman, (b) 237,829 shares of common held by Margaret Smithyman, (c) 17,617 shares of common stock held jointly, and (d) 40,000 shares of common stock held by Cellabs Pty Ltd., an Australian biotechnology company controlled by Dr. Smithyman. Dr. Smithyman disclaims beneficial ownership over the shares held by Ms. Smithyman. </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 1px"></TD>

          <TD STYLE="width: 20px; text-align: left">(6)</TD>

          <TD STYLE="text-align: justify">Includes 36,085 shares of common stock that Mr. Salka has the right to acquire from us within 60 days of April 30, 2016, pursuant to the exercise of stock options. </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 1px"></TD>

          <TD STYLE="width: 20px; text-align: left">(7)</TD>

          <TD STYLE="text-align: justify">Includes the shares reference in Footnote 3 above and 19,336 shares of common stock that Mr. Cook has the right to acquire from us within 60 days of April 30, 2016, pursuant to the exercise of stock options. </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 1px"></TD>

          <TD STYLE="width: 20px; text-align: left">(8)</TD>

          <TD STYLE="text-align: justify">Includes 3,454 shares of common stock that Mr. Drapeau has the right to acquire from us within 60 days of April 30, 2016, pursuant to the exercise of stock options. </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 1px"></TD>

          <TD STYLE="width: 20px; text-align: left">(9)</TD>

          <TD STYLE="text-align: justify">Includes 5,569 shares of common stock that Dr. Perry has the right to acquire from us within 60 days of April 30, 2016, pursuant to the exercise of stock options. </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 1px"></TD>

          <TD STYLE="width: 20px; text-align: left">(10)</TD>

          <TD STYLE="text-align: justify">Includes 24,254 shares of common stock that Ms. Johnson has the right to acquire from us within 60 days of April 30, 2016, pursuant to the exercise of stock options. </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 1px"></TD>

          <TD STYLE="width: 20px; text-align: left">(11)</TD>

          <TD STYLE="text-align: justify">Consists of (a) 588,703 shares of common stock, (b) 87,011 shares of common stock issuable upon exercise of warrants, and (d) 88,698 shares of common stock exercisable within 60 days of April 30, 2016. </TD>

</TR>

</TABLE>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">61</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<H1 STYLE="text-indent:0pt; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 9pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><FONT STYLE="font-variant: small-caps">Section 16(a) Beneficial Ownership Reporting Compliance</FONT> </H1>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Section 16(a) of the Exchange Act requires the Company&#146;s directors and executive officers, and persons who own more than ten percent of a registered class of the Company&#146;s equity securities, to file with the SEC initial reports of ownership and reports of changes in ownership of common stock and other equity securities of the Company. Officers, directors and greater than ten percent shareholders are required by SEC regulation to furnish the Company with copies of all Section 16(a) forms they file. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">To the Company&#146;s knowledge, based solely on a review of the copies of such reports furnished to the Company and written representations that no other reports were required, during the fiscal year ended December 31, 2015, all Section 16(a) filing requirements applicable to its officers, directors and greater than ten percent beneficial owners were complied with; except an initial report of ownership was filed late on behalf of Mr. Salka and a report of the acquisition of securities was filed late on behalf of Mr. Curnock Cook related to his indirect ownership in One Fund Management Limited as Trustee for Asia Pacific
Healthcare Fund II. </P>

<H1 STYLE="text-indent:0pt; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 9pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><FONT STYLE="font-variant: small-caps">Equity Compensation Plan Information</FONT> </H1>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">In March 2009, our Board of Directors and shareholders adopted the 2009 Stock Incentive Plan, which we refer to as the 2009 Stock Incentive Plan. There are no shares of common stock remaining for future awards under the 2009 Stock Incentive Plan. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">In October 2012, our Board of Directors approved and adopted the 2012 Stock Incentive Plan, which we refer to as the 2012 Stock Incentive Plan. There are no shares of common stock remaining for future awards under the 2012 Stock Incentive Plan. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">In December 2013, our Board of Directors adopted the 2013 Stock Incentive Plan, or the 2013 Plan. Under the 2013 Plan, we are authorized to issue up to 1,320,000 shares of our common stock in stock option and other stock incentive awards to employees, directors and consultants. Our shareholders approved the 2013 Plan in February 2014 and an amendment to the plan in August 2015. The 2013 Plan replaces the 2012 Stock Incentive Plan. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The following table provides information as of December 31, 2015 with respect to our equity compensation plans: </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"></P>

<DIV style="text-align: center"><TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="608" STYLE="vertical-align: bottom; text-indent:0px; text-align: left; font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: -15pt; *margin-top: -20pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR>

          <TD><IMG HEIGHT="1" SRC="spacer.gif" WIDTH="264"></TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none"><!-- GUTTER -->&nbsp;</TD>

          <TD COLSPAN="3"><IMG HEIGHT="1" SRC="spacer.gif" WIDTH="96"></TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none"><!-- GUTTER -->&nbsp;</TD>

          <TD COLSPAN="3"><IMG HEIGHT="1" SRC="spacer.gif" WIDTH="96"></TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none"><!-- GUTTER -->&nbsp;</TD>

          <TD COLSPAN="3"><IMG HEIGHT="1" SRC="spacer.gif" WIDTH="104"></TD>

</TR>

<TR>

          <TD STYLE="line-height: normal; vertical-align: bottom; font-weight: bold; font-size: 8pt; text-align: left; border-bottom: 1pt solid black" ROWSPAN=1 COLSPAN=1>Plan Category</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="line-height: normal; vertical-align: bottom; font-weight: bold; font-size: 8pt; text-align: center; border-bottom: 1pt solid black" ROWSPAN=1 COLSPAN=3>Number of<BR> securities to be<BR> issued upon exercise<BR> of outstanding<BR> options, warrants<BR> and rights</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="line-height: normal; vertical-align: bottom; font-weight: bold; font-size: 8pt; text-align: center; border-bottom: 1pt solid black" ROWSPAN=1 COLSPAN=3>Weighted-average<BR> exercise price of<BR> outstanding options,<BR> warrants and rights</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="line-height: normal; vertical-align: bottom; font-weight: bold; font-size: 8pt; text-align: center; border-bottom: 1pt solid black" ROWSPAN=1 COLSPAN=3>Number of securities<BR> remaining available<BR> for future issuance<BR> under equity<BR> compensation Plans<BR> (excluding securities<BR> reflected in column<BR> (a))</TD>

</TR>

<TR>

          <TD STYLE="line-height: normal; vertical-align: bottom; font-weight: bold; font-size: 8pt; text-align: left"  ROWSPAN=1 COLSPAN=1>&nbsp;&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="line-height: normal; vertical-align: bottom; font-weight: bold; font-size: 8pt; text-align: center" ROWSPAN=1 COLSPAN=3>(a)</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="line-height: normal; vertical-align: bottom; font-weight: bold; font-size: 8pt; text-align: center" ROWSPAN=1 COLSPAN=3>(b)</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="line-height: normal; vertical-align: bottom; font-weight: bold; font-size: 8pt; text-align: center" ROWSPAN=1 COLSPAN=3>(c)</TD>

</TR>

<TR STYLE="background-color: white">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt; vertical-align: text-bottom" ROWSPAN=1 COLSPAN=1>Equity compensation plans approved by security holders<sup>&#040;1&#041;</sup></TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>599,669</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->$</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>8.52</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>723,431</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

</TR>

<TR STYLE="background-color: #cceeff">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt; vertical-align: bottom; border-bottom: 1pt solid white" ROWSPAN=1 COLSPAN=1>Equity compensation plans not approved by security holders<sup>&#040;2&#041;</sup></TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center; border-bottom: 1pt solid white" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left; border-bottom: 1pt solid black" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right; border-bottom: 1pt solid black" ROWSPAN=1 COLSPAN=1>70,100</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left; border-bottom: 1pt solid white"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center; border-bottom: 1pt solid white" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left; border-bottom: 1pt solid black" ROWSPAN=1><!-- $ -->$</TD>

          <TD STYLE="vertical-align: bottom; text-align: right; border-bottom: 1pt solid black" ROWSPAN=1 COLSPAN=1>10.00</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left; border-bottom: 1pt solid white"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center; border-bottom: 1pt solid white" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left; border-bottom: 1pt solid black" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right; border-bottom: 1pt solid black" ROWSPAN=1 COLSPAN=1>&#151;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left; border-bottom: 1pt solid white"><!-- PERCENT -->&nbsp;</TD>

</TR>

<TR STYLE="background-color: white">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt; vertical-align: bottom; border-bottom: 3pt double white" ROWSPAN=1 COLSPAN=1>Total</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center; border-bottom: 3pt double white" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left; border-bottom: 3pt double black" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right; border-bottom: 3pt double black" ROWSPAN=1 COLSPAN=1>669,769</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left; border-bottom: 3pt double white"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center; border-bottom: 3pt double white" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left; border-bottom: 3pt double black" ROWSPAN=1><!-- $ -->$</TD>

          <TD STYLE="vertical-align: bottom; text-align: right; border-bottom: 3pt double black" ROWSPAN=1 COLSPAN=1>8.68</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left; border-bottom: 3pt double white"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center; border-bottom: 3pt double white" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left; border-bottom: 3pt double black" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right; border-bottom: 3pt double black" ROWSPAN=1 COLSPAN=1>723,431</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left; border-bottom: 3pt double white"><!-- PERCENT -->&nbsp;</TD>

</TR>

</TABLE></DIV>


<P STYLE="text-align: left; text-indent: 1px"><IMG SRC="line.gif" STYLE="width: 72px; height: 1pt"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 1px"></TD>

          <TD STYLE="width: 20px; text-align: left">(1)</TD>

          <TD STYLE="text-align: justify">The 2009 Stock Incentive Plan and 2013 Plan. </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 1px"></TD>

          <TD STYLE="width: 20px; text-align: left">(2)</TD>

          <TD STYLE="text-align: justify">The 2012 Stock Incentive Plan. </TD>

</TR>

</TABLE>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">62</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<H1 STYLE="text-indent:0pt; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 9pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><FONT STYLE="font-variant: small-caps">Executive Compensation</FONT> </H1>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Our named executive officers for the year ended December 31, 2015, which consist of all individuals who served as our principal executive officer during 2015, our two most highly compensated executive officers other than our principal executive officer who were serving as executive officers as of December 31, 2015 and one former executive officer who would have been among the most highly compensated executive officers if such individual had been serving as of December 31, 2015, are: </P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">M. Scott Salka, our Chief Executive Officer and Director; </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">Jeremy Curnock Cook, our former interim Chief Executive Officer and President and current Chairman of the Board; </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">David E. Bosher, our former Interim Chief Financial Officer and current consultant; and </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">Wendy S. Johnson, our Interim Chief Operating Officer and Director. </TD>

</TR>

</TABLE>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">In January 2016, Steve Martin commenced employment with us as our Senior Vice President and Chief Financial Officer. Although Mr. Martin is not one of our named executive officers for the year ended December 31, 2015, we have included information regarding Mr. Martin&#146;s compensation in this report where it may be material to an understanding of our executive compensation program. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Summary Compensation Table </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The following table provides information regarding the compensation paid during the last two fiscal years to our named executive officers for the year ended December 31, 2015. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"></P>

<DIV style="text-align: center"><TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="608" STYLE="vertical-align: bottom; text-indent:0px; text-align: left; font-family: Times New Roman, Times, Serif; font-size: 9pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: -15pt; *margin-top: -20pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR>

          <TD><IMG HEIGHT="1" SRC="spacer.gif" WIDTH="120"></TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none"><!-- GUTTER -->&nbsp;</TD>

          <TD COLSPAN="3"><IMG HEIGHT="1" SRC="spacer.gif" WIDTH="32"></TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none"><!-- GUTTER -->&nbsp;</TD>

          <TD COLSPAN="3"><IMG HEIGHT="1" SRC="spacer.gif" WIDTH="48"></TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none"><!-- GUTTER -->&nbsp;</TD>

          <TD COLSPAN="3"><IMG HEIGHT="1" SRC="spacer.gif" WIDTH="50"></TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none"><!-- GUTTER -->&nbsp;</TD>

          <TD COLSPAN="3"><IMG HEIGHT="1" SRC="spacer.gif" WIDTH="56"></TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none"><!-- GUTTER -->&nbsp;</TD>

          <TD COLSPAN="3"><IMG HEIGHT="1" SRC="spacer.gif" WIDTH="66"></TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none"><!-- GUTTER -->&nbsp;</TD>

          <TD COLSPAN="3"><IMG HEIGHT="1" SRC="spacer.gif" WIDTH="66"></TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none"><!-- GUTTER -->&nbsp;</TD>

          <TD COLSPAN="3"><IMG HEIGHT="1" SRC="spacer.gif" WIDTH="56"></TD>

</TR>

<TR>

          <TD STYLE="line-height: normal; vertical-align: bottom; font-weight: bold; font-size: 8pt; text-align: left; border-bottom: 1pt solid black" ROWSPAN=1 COLSPAN=1>Name and Principal Position</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="line-height: normal; vertical-align: bottom; font-weight: bold; font-size: 8pt; text-align: center; border-bottom: 1pt solid black" ROWSPAN=1 COLSPAN=3>Year</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="line-height: normal; vertical-align: bottom; font-weight: bold; font-size: 8pt; text-align: center; border-bottom: 1pt solid black" ROWSPAN=1 COLSPAN=3>Salary</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="line-height: normal; vertical-align: bottom; font-weight: bold; font-size: 8pt; text-align: center; border-bottom: 1pt solid black" ROWSPAN=1 COLSPAN=3>Bonus</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="line-height: normal; vertical-align: bottom; font-weight: bold; font-size: 8pt; text-align: center; border-bottom: 1pt solid black" ROWSPAN=1 COLSPAN=3>Option Awards<sup>&#040;1&#041;</sup></TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="line-height: normal; vertical-align: bottom; font-weight: bold; font-size: 8pt; text-align: center; border-bottom: 1pt solid black" ROWSPAN=1 COLSPAN=3>Non-Equity<BR> Incentive Plan<BR> Compensation</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="line-height: normal; vertical-align: bottom; font-weight: bold; font-size: 8pt; text-align: center; border-bottom: 1pt solid black" ROWSPAN=1 COLSPAN=3>All Other<BR> Compensation</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="line-height: normal; vertical-align: bottom; font-weight: bold; font-size: 8pt; text-align: center; border-bottom: 1pt solid black" ROWSPAN=1 COLSPAN=3>Total</TD>

</TR>

<TR STYLE="background-color: white">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt; vertical-align: text-top" ROWSPAN=2 COLSPAN=1>Michael Scott Salka, Chief Executive Officer<sup>&#040;2&#041;</sup></TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: center" ROWSPAN=1 COLSPAN=1>2015</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->$</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>264,263</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->$</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>&#151;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->$</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>3,469,919</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->$</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>85,000</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->$</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>4,925</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->$</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>3,824,107</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

</TR>

<TR STYLE="background-color: white">

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="padding-left: 10pt; text-indent: -10pt; vertical-align: text-top" ROWSPAN=1 COLSPAN=1>&nbsp;&nbsp;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>&nbsp;&nbsp;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>&nbsp;&nbsp;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>&nbsp;&nbsp;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>&nbsp;&nbsp;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>&nbsp;&nbsp;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>&nbsp;&nbsp;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

</TR>

<TR STYLE="background-color: white">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt; vertical-align: text-top" ROWSPAN=3 COLSPAN=1>Jeremy Curnock Cook, Former Interim Chief Executive Officer and President and Current Chairman of our Board of Directors<sup>&#040;3&#041;</sup></TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: center" ROWSPAN=1 COLSPAN=1>2015</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->$</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>&#151;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->$</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>100,000</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->$</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>223,949</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->$</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>&#151;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->$</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>58,250</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><sup>&#040;6&#041;</sup><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->$</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>382,199</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

</TR>

<TR STYLE="background-color: white">

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="text-align: center; vertical-align: text-bottom" ROWSPAN=1 COLSPAN=1>2014</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->$</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>&#151;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->$</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>&#151;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->$</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>&#151;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->$</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>&#151;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->$</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>50,325</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->$</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>50,325</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

</TR>

<TR STYLE="background-color: white">

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="padding-left: 10pt; text-indent: -10pt; vertical-align: text-top" ROWSPAN=1 COLSPAN=1>&nbsp;&nbsp;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>&nbsp;&nbsp;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>&nbsp;&nbsp;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>&nbsp;&nbsp;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>&nbsp;&nbsp;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>&nbsp;&nbsp;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

</TR>

<TR STYLE="background-color: white">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt; vertical-align: text-top" ROWSPAN=3 COLSPAN=1>David E. Bosher, Former Interim Chief Financial Officer<sup>&#040;4&#041;</sup></TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: center" ROWSPAN=1 COLSPAN=1>2015</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->$</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>308,650</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->$</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>&#151;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->$</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>&#151;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->$</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>&#151;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->$</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>&#151;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->$</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>308,650</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

</TR>

<TR STYLE="background-color: white">

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="text-align: center; vertical-align: text-bottom" ROWSPAN=1 COLSPAN=1>2014</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->$</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>127,125</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->$</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>&#151;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->$</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>&#151;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->$</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>&#151;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->$</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>&#151;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->$</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>127,125</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

</TR>

<TR STYLE="background-color: white">

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="padding-left: 10pt; text-indent: -10pt; vertical-align: text-top" ROWSPAN=1 COLSPAN=1>&nbsp;&nbsp;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>&nbsp;&nbsp;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>&nbsp;&nbsp;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>&nbsp;&nbsp;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>&nbsp;&nbsp;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>&nbsp;&nbsp;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>&nbsp;&nbsp;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

</TR>

<TR STYLE="background-color: white">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt; vertical-align: text-top" ROWSPAN=3 COLSPAN=1>Wendy S. Johnson, Interim Chief Operating Officer and Director<sup>&#040;5&#041;</sup></TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: center" ROWSPAN=1 COLSPAN=1>2015</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->$</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>270,000</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->$</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>25,000</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->$</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>289,373</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->$</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>&#151;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->$</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>30,000</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><sup>&#040;6&#041;</sup><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->$</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>614,373</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

</TR>

<TR STYLE="background-color: white">

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="text-align: center; vertical-align: text-bottom" ROWSPAN=1 COLSPAN=1>2014</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->$</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>60,000</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->$</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>&#151;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->$</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>&#151;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->$</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>&#151;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->$</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>7,324</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->$</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>67,324</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

</TR>

<TR STYLE="background-color: white">

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="padding-left: 10pt; text-indent: -10pt; vertical-align: text-top" ROWSPAN=1 COLSPAN=1>&nbsp;&nbsp;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>&nbsp;&nbsp;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>&nbsp;&nbsp;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>&nbsp;&nbsp;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>&nbsp;&nbsp;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>&nbsp;&nbsp;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>&nbsp;&nbsp;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

</TR>

</TABLE></DIV>


<P STYLE="text-align: left; text-indent: 1px"><IMG SRC="line.gif" STYLE="width: 72px; height: 1pt"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 1px"></TD>

          <TD STYLE="width: 20px; text-align: left">(1)</TD>

          <TD STYLE="text-align: justify">In accordance with SEC rules, this column represents the aggregate grant date fair value of the option awards granted during 2015 and 2014 (if any) computed in accordance with Financial Accounting Standard Board Accounting Standards Codification Topic 718 for stock-based compensation transactions (ASC 718). Assumptions used in the calculation of these amounts are included in the notes to our audited financial statements incorporated herein by reference. These amounts do not reflect the actual economic value that will be realized by the named executive officer upon the vesting of the stock options, the exercise of the stock options, or the sale of the common stock underlying such stock options. </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 1px"></TD>

          <TD STYLE="width: 20px; text-align: left">(2)</TD>

          <TD STYLE="text-align: justify">Mr. Salka commenced employment with us as Chief Executive Officer on May 18, 2015. </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 1px"></TD>

          <TD STYLE="width: 20px; text-align: left">(3)</TD>

          <TD STYLE="text-align: justify">Mr. Curnock Cook served as interim Chief Executive Officer and President from September 15, 2014 until May 18, 2015. Mr. Curnock Cook did not receive or earn any compensation in 2014 or 2015 for his role as interim Chief Executive Officer, except that in September 2015, he was paid a discretionary lump sum cash payment of $100,000 and awarded an option grant to purchase 31,000 shares of common stock </TD>

</TR>

</TABLE>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">63</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 1px; text-align: left"></TD>

          <TD STYLE="width: 20px; text-align: left"></TD>

          <TD STYLE="text-align: justify">in recognition of his services as interim Chief Executive Officer. Mr. Salka has served as our Chief Executive Officer since May 18, 2015. Mr. Curnock Cook continues to serve as Chairman of our Board of Directors. </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 1px"></TD>

          <TD STYLE="width: 20px; text-align: left">(4)</TD>

          <TD STYLE="text-align: justify">Mr. Bosher served as interim Chief Financial Officer from July 1, 2014 to January 18, 2016. </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 1px"></TD>

          <TD STYLE="width: 20px; text-align: left">(5)</TD>

          <TD STYLE="text-align: justify">Ms. Johnson has served as interim Chief Operating Officer since her appointment on September 15, 2014. Ms. Johnson joined our Board of Directors on May 19, 2014. </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 1px"></TD>

          <TD STYLE="width: 20px; text-align: left">(6)</TD>

          <TD STYLE="text-align: justify">Represents Board of Director retainers paid to Mr. Curnock Cook and Ms. Johnson in 2015. </TD>

</TR>

</TABLE>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Base Salary </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The base salary or consulting compensation of our named executive officers, as applicable, is generally determined and approved by our Board of Directors, based on the recommendation of the Compensation Committee. The Board of Directors approved an annual base salary of $425,000 for Mr. Salka, which became effective on May 18, 2015 in connection with his commencement of employment with us. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Mr. Curnock Cook did not receive or earn any base salary or consulting fees in 2015 for his role as interim Chief Executive Officer and President. In September 2015, upon recommendation from the Compensation Committee, the Board of Directors approved a discretionary $100,000 cash payment to Mr. Curnock Cook in recognition of his service as interim Chief Executive Officer from September 2014 to May 2015. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Ms. Johnson was paid monthly consulting fees for her interim officer role during 2015. Ms. Johnson was compensated at a rate of $20,000 per month for her consulting services as Interim Chief Operating Officer from January 1, 2015 until June 30, 2015, which rate was increased to $25,000 per month effective on July 1, 2015. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Mr. Bosher was also paid monthly consulting fees for his interim officer role during 2015. During all of 2015, Mr. Bosher was compensated for services provided as an independent contractor on an interim basis as our Interim Chief Financial Officer pursuant to a services agreement between us and The Fahrenheit Group, LLC (of which Mr. Bosher is a managing director) dated June 30, 2014. Under this services agreement, we paid $5,000 per month to The Fahrenheit Group, LLC for Mr. Bosher&#146;s services, up to 20 hours per month, and $300 per hour for any additional services in excess of 20 hours per month. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Bonus Opportunity </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">In addition to base salaries, certain of our named executive officers are eligible to receive annual performance-based cash bonuses, which are designed to provide appropriate incentives to our executives to achieve defined annual corporate goals and to reward our executives for individual achievement towards these goals. The performance-based bonus a named executive officer may be eligible to receive is generally based on the extent to which we achieve the specified corporate goals that our Board of Directors or Compensation Committee establishes. At the end of the year, the Board of Directors and/or Compensation Committee
reviews our performance against the established corporate goals and approves the extent to which we achieved such goals. In addition, we may award a named executive officer a discretionary cash or equity bonus, if our Board of Directors or Compensation Committee determines appropriate based on the circumstances. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The Board of Directors and/or Compensation Committee generally will consider each executive officer&#146;s individual contributions towards reaching our corporate goals and may also establish specific individual goals for our executive officers as it determines appropriate. There is no minimum bonus percentage or amount established for the named executive officers and, as a result, the bonus amounts vary based on corporate and individual performance, as applicable. Under the terms of his offer letter agreement described below, Mr. Salka is eligible to receive an annual performance-based bonus for 2015 equal to, at target, 40%
of his annual salary based on our achievement of certain performance goals, pro-rated for Mr. Salka&#146;s services during 2015. Under the terms of her consulting agreement described below, Ms. Johnson is eligible to receive up to $200,000 in cash bonus payments upon achievement of specific goals relating to dosing the first patient in the first and second clinical trials utilizing our drug product. Mr. Bosher is not entitled to any specific target or maximum bonus for company or individual performance in 2015. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Mr. Salka&#146;s 2015 bonus was based entirely on corporate goals relating to our clinical trial progress, manufacturing capabilities being established, certain organizational achievements and for listing our company on a major stock exchange. </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">64</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">No specific corporate or individual goals were established for Mr. Bosher for 2015. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Ms. Johnson was eligible to earn a bonus of $175,000 upon dosing of the first patient in the first clinical trial utilizing our drug product in 2015 (or alternatively, a bonus of $75,000 if such milestone was met after 2015 and prior to March 31, 2016) and a bonus of $25,000 upon dosing of the first patient in the second clinical trial utilizing our drug product before March 31, 2016. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">In January 2016, the Compensation Committee reviewed the corporate performance goals for Mr. Salka and determined that on an overall basis, we had achieved 50% of such goals for 2015, based on the evaluation of the results by the Compensation Committee and considering the importance of each goal to us. The Compensation Committee assessed the goals established for Ms. Johnson&#146;s bonus and determined that she had not met the goals in 2015 because no patients were dosed in 2015. However, the Compensation Committee awarded Ms. Johnson a discretionary bonus of $25,000, in recognition of significant progress towards the goal
which was supported by the patient screenings which occurred in 2015, although no patients were dosed until January 2016. Ms. Johnson has earned performance bonuses in 2016 based on the achievement of the established goals and additional achievements in the first quarter of 2016. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Equity-Based Awards </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Our equity-based incentive awards are designed to align our interests with those of our employees and consultants, including our named executive officers. Our Board of Directors or our Compensation Committee approves equity grants. Vesting of equity awards is generally tied to continuous service with us and serves as an additional retention measure. Our executives may be awarded an initial new hire grant upon commencement of service and may receive additional grants, as the Board of Directors or Compensation Committee determines appropriate, in order to incentivize and/or reward such executives. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">We have traditionally granted stock options to our named executive officers under our equity incentive plans, the terms of which are described below under &#147;&#151;&nbsp;Equity Benefit Plans.&#148; </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">In August 2015, our Board of Directors granted an option to purchase 399,716 shares of common stock to Mr. Salka at a per share exercise price of $9.45. One-third of the shares underlying the option vest over a four-year period, subject to Mr. Salka&#146;s continued service with us, and two-thirds of the shares underlying the option vest upon satisfaction of certain business goals relating to a $20 million capital raise and human clinical trial milestones for our phage products. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">In September 2015, in recognition of his service as interim Chief Executive Officer from September 2014 to May 2015, our Board of Directors granted an option to purchase 31,100 shares of common stock to Mr. Curnock Cook at a per share exercise price of $6.38. The option vests over a four-year period, subject to Mr. Cook&#146;s continued service with us. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">In September 2015, pursuant to her consulting agreement, our Board of Directors granted Ms. Johnson an option for 49,965 shares at an exercise price per share of $7.46, half of which vests monthly over a one-year period and half of which vests upon the achievement of certain clinical trial milestones for our drug product, in each case subject to Ms. Johnson&#146;s continued service with us. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Our Board of Directors also granted each of Mr. Curnock Cook and Ms. Johnson stock options for an aggregate of 7,400 shares and 16,200 shares, respectively, in September 2015 for services on our Board of Directors, which is described below under &#147;&#151;&nbsp;Non-Employee Director Compensation&#148;. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">In January 2016, pursuant to his offer letter agreement, our Board of Directors granted Mr. Martin an option to purchase 99,919 shares of common stock at a per share exercise price of $2.85. Twenty-five percent of the shares subject to the option vest on the one-year anniversary of Mr. Martin&#146;s commencement of employment with us and the remainder vest in equal monthly installments thereafter, subject to Mr. Martin&#146;s continued service with us. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Agreements with our Named Executive Officers </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Below are descriptions of our employment and consulting agreements with our named executive officers governing the terms of their service with us. For a discussion of the severance pay and other benefits that may </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">65</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">be provided in connection with a termination of service and/or a change in control under the arrangements with our named executive officers, please see &#147;&#151;&nbsp;Potential Payments and Benefits upon Termination or Change in Control&#148; below. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><I>Mr. Salka.&nbsp;&nbsp;</I>In April 2015, we entered into an offer letter agreement with Mr. Salka, our Chief Executive Officer. Mr. Salka&#146;s employment under the agreement is at will and may be terminated at any time by us or Mr. Salka. Under the terms of the agreement, Mr. Salka is entitled to receive an initial annual base salary of $425,000, an annual target performance bonus of 40% of his annual salary based on our achievement of certain performance objectives and an option to purchase a number of shares of our common stock under our 2013 Plan equal to 4% of the number of shares of common stock outstanding on a
fully-diluted basis, which was granted in August 2015 and is described above under &#147;&#151;&nbsp;Equity-Based Awards&#148;. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><I>Mr. Bosher.&nbsp;&nbsp;</I>Mr. Bosher provided services as an independent contractor on an interim basis as our Interim Chief Financial Officer pursuant to a services agreement between us and The Fahrenheit Group, LLC (of which Mr. Bosher is a managing director) dated June 30, 2014. Under this services agreement, we paid $5,000 per month to The Fahrenheit Group, LLC for Mr. Bosher&#146;s services, up to 20 hours per month, and $300 per hour for any additional services in excess of 20 hours per month. The services agreement was terminated by mutual agreement on March 30, 2016. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><I>Ms. Johnson.&nbsp;&nbsp;</I>We entered into an agreement with Ms. Johnson in September 2014 which provided for Ms. Johnson&#146;s services as an independent contractor on an interim basis as our Chief Operating Officer. The agreement had an original term until December 31, 2014, which was further extended in January 2015 to March 31, 2015. Under the agreement, Ms. Johnson was entitled to compensation at the rate of $20,000 per month. In September 2015, we entered into a consulting agreement with Ms. Johnson, which supersedes her prior agreement, effective July 1, 2015. Under the terms of her consulting agreement, Ms. Johnson
is entitled to receive monthly compensation of $25,000 for consulting services of at least 120 hours per month, cash bonus payments up to an aggregate of $200,000 upon the achievement of certain Company milestones and an option to purchase a number of shares of our common stock under our 2013 Plan equal to 0.5% of the number of shares of common stock outstanding on a fully-diluted basis, which was granted in September 2015 and is described above under &#147;&#151;&nbsp;Equity-Based Awards&#148;. The consulting agreement will terminate on July 1, 2016, unless earlier terminated pursuant to its terms. We can terminate the consulting agreement at any time for cause, or for any other reason upon 90 days written notice to Ms. Johnson, provided that no such termination can be effective before March 31, 2016. Ms. Johnson can terminate the agreement upon our material breach upon 30 days written notice, or for any other reason upon 45 days written notice. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Agreements with our Chief Financial Officer </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><I>Mr. Martin</I>.&nbsp;&nbsp;In January 2016, we entered into an offer letter agreement with Mr. Martin, our Senior Vice President and Chief Financial Officer. Mr. Martin&#146;s employment under the agreement is at will and may be terminated by us or Mr. Martin at any time. Under the terms of the agreement, Mr. Martin is entitled to receive an initial annual base salary of $320,000, an annual target performance bonus of 35% of his annual salary based on our achievement of certain performance objectives and an option to purchase a number of shares of our common stock equal to 1% of the number of shares of common stock
outstanding on a fully-diluted basis, which was granted in January 2016 and is described above under &#147;&#151;&nbsp;Equity-Based Awards&#148;. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Potential Payments and Benefits upon Termination or Change in Control </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><I>Mr. Salka</I>.&nbsp;&nbsp;Under the terms of his offer letter agreement, Mr. Salka is entitled to receive 12 months of continued base salary if his employment with us is terminated without cause or if he resigns for good reason, provided that Mr. Salka executes an effective release of claims against us. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><I>Mr. Martin</I>.&nbsp;&nbsp;Under the terms of his offer letter agreement, Mr. Martin is entitled to receive 12 months of continued base salary if his employment with us is terminated without cause or if he resigns for good reason, and additionally, if such termination or resignation occurs in connection with a change in control, full acceleration of his equity awards, provided that in either case Mr. Martin executes an effective release of claims against us. </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">66</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">All of named executive officers hold stock options under our equity incentive plans that were granted subject to the general terms of our equity incentive plans and form of stock option agreements. A description of the termination and change in control provisions in such equity incentive plans and stock options granted thereunder is provided below under &#147;&#151;&nbsp;Equity Benefit Plans&#148; and the specific vesting terms of each named executive officer&#146;s stock options are described below under &#147;&#151;&nbsp;Outstanding Equity Awards at Fiscal Year End.&#148; </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Outstanding Equity Awards at Fiscal Year End </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The following table sets forth certain information regarding all outstanding equity awards held by our named executive officers as of December 31, 2015. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"></P>

<DIV style="text-align: center"><TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="608" STYLE="vertical-align: bottom; text-indent:0px; text-align: left; font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: -15pt; *margin-top: -20pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR>

          <TD><IMG HEIGHT="1" SRC="spacer.gif" WIDTH="202"></TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none"><!-- GUTTER -->&nbsp;</TD>

          <TD COLSPAN="3"><IMG HEIGHT="1" SRC="spacer.gif" WIDTH="69"></TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none"><!-- GUTTER -->&nbsp;</TD>

          <TD COLSPAN="3"><IMG HEIGHT="1" SRC="spacer.gif" WIDTH="69"></TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none"><!-- GUTTER -->&nbsp;</TD>

          <TD COLSPAN="3"><IMG HEIGHT="1" SRC="spacer.gif" WIDTH="69"></TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none"><!-- GUTTER -->&nbsp;</TD>

          <TD COLSPAN="3"><IMG HEIGHT="1" SRC="spacer.gif" WIDTH="53"></TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none"><!-- GUTTER -->&nbsp;</TD>

          <TD COLSPAN="3"><IMG HEIGHT="1" SRC="spacer.gif" WIDTH="64"></TD>

</TR>

<TR>

          <TD STYLE="line-height: normal; vertical-align: bottom; font-weight: bold; font-size: 8pt; text-align: left; border-bottom: 1pt solid black" ROWSPAN=1 COLSPAN=1>Name</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="line-height: normal; vertical-align: bottom; font-weight: bold; font-size: 8pt; text-align: center; border-bottom: 1pt solid black" ROWSPAN=1 COLSPAN=3>Number of<BR> Securities<BR> Underlying<BR> Unexercised<BR> Options (#)<BR> Exercisable</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="line-height: normal; vertical-align: bottom; font-weight: bold; font-size: 8pt; text-align: center; border-bottom: 1pt solid black" ROWSPAN=1 COLSPAN=3>Number of<BR> Securities<BR> Underlying<BR> Unexercised<BR> Options (#)<BR> Unexercisable</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="line-height: normal; vertical-align: bottom; font-weight: bold; font-size: 8pt; text-align: center; border-bottom: 1pt solid black" ROWSPAN=1 COLSPAN=3>Equity<BR> Incentive<BR> Plan Awards:<BR> Number of<BR> Securities<BR> Underlying<BR> Unexercised<BR> Unearned<BR> Options (#)</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="line-height: normal; vertical-align: bottom; font-weight: bold; font-size: 8pt; text-align: center; border-bottom: 1pt solid black" ROWSPAN=1 COLSPAN=3>Option<BR> Exercise<BR> Price<BR> ($)</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="line-height: normal; vertical-align: bottom; font-weight: bold; font-size: 8pt; text-align: center; border-bottom: 1pt solid black" ROWSPAN=1 COLSPAN=3>Option<BR> Expiration<BR> Date</TD>

</TR>

<TR STYLE="background-color: #cceeff">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt; vertical-align: text-bottom" ROWSPAN=1 COLSPAN=1>Mr. Salka</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>&#151;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>133,238</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><sup>&#040;1&#041;</sup><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>266,478</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><sup>&#040;1&#041;</sup><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->$</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>9.45</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>8/5/2025</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

</TR>

<TR STYLE="background-color: white">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt; vertical-align: text-bottom" ROWSPAN=1 COLSPAN=1>Mr. Curnock Cook</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>541</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>5,959</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><sup>&#040;2&#041;</sup><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>&#151;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->$</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>6.38</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>9/20/2025</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

</TR>

<TR STYLE="background-color: #cceeff">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt; vertical-align: text-bottom" ROWSPAN=1 COLSPAN=1>&nbsp;&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>&#151;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>&#151;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>900</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><sup>&#040;3&#041;</sup><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->$</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>6.38</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>9/20/2025</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

</TR>

<TR STYLE="background-color: white">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt; vertical-align: text-bottom" ROWSPAN=1 COLSPAN=1>&nbsp;&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>&#151;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>31,100</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><sup>&#040;4&#041;</sup><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>&#151;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->$</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>6.38</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>9/20/2025</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

</TR>

<TR STYLE="background-color: #cceeff">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt; vertical-align: text-bottom" ROWSPAN=1 COLSPAN=1>&nbsp;&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>6,600</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>2,200</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><sup>&#040;5&#041;</sup><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>&#151;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->$</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>10.00</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>10/23/2022</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

</TR>

<TR STYLE="background-color: white">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt; vertical-align: text-bottom" ROWSPAN=1 COLSPAN=1>&nbsp;&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>60</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>&#151;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><sup>&#040;6&#041;</sup><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>&#151;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->$</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>190.00</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>5/8/2016</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

</TR>

<TR STYLE="background-color: #cceeff">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt; vertical-align: text-bottom" ROWSPAN=1 COLSPAN=1>&nbsp;&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>1,800</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>&#151;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><sup>&#040;7&#041;</sup><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>&#151;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->$</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>13.50</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>5/29/2019</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

</TR>

<TR STYLE="background-color: white">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt; vertical-align: text-bottom" ROWSPAN=1 COLSPAN=1>Mr. Bosher</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>&#151;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>&#151;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>&#151;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->$</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>&#151;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>&#151;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

</TR>

<TR STYLE="background-color: #cceeff">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt; vertical-align: text-bottom" ROWSPAN=1 COLSPAN=1>Ms. Johnson</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>10,409</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>14,574</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><sup>&#040;8&#041;</sup><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>24,982</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><sup>&#040;8&#041;</sup><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->$</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>7.46</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>9/8/2025</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

</TR>

<TR STYLE="background-color: white">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt; vertical-align: text-bottom" ROWSPAN=1 COLSPAN=1>&nbsp;&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>541</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>5,959</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><sup>&#040;9&#041;</sup><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>&#151;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->$</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>6.38</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>9/20/2025</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

</TR>

<TR STYLE="background-color: #cceeff">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt; vertical-align: text-bottom" ROWSPAN=1 COLSPAN=1>&nbsp;&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>&#151;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>&#151;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>9,700</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><sup>&#040;10&#041;</sup><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->$</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>6.38</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>9/20/2025</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

</TR>

</TABLE></DIV>


<P STYLE="text-align: left; text-indent: 1px"><IMG SRC="line.gif" STYLE="width: 72px; height: 1pt"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 1px"></TD>

          <TD STYLE="width: 20px; text-align: left">(1)</TD>

          <TD STYLE="text-align: justify">One-third of the shares underlying the 399,716 share option grant vest over a four-year period commencing on May 18, 2015 (with 25% vesting on the one-year anniversary of the commencement of Mr. Salka&#146;s employment and the balance vesting in monthly installments thereafter), subject to Mr. Salka&#146;s continued service with us, and two-thirds of the shares underlying the 399,716 share option grant vest upon satisfaction of certain business goals relating to a $20 million capital raise and human clinical trial milestones for our phage products. </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 1px"></TD>

          <TD STYLE="width: 20px; text-align: left">(2)</TD>

          <TD STYLE="text-align: justify">The shares underlying this option will vest on an equal monthly basis over a four year period commencing on August 3, 2015, the date of our most recent annual meeting of shareholders. This option was granted to Mr. Cook for his services as a non-employee director and is described below under &#147;&#151;&nbsp;Non-Employee Director Compensation.&#148; </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 1px"></TD>

          <TD STYLE="width: 20px; text-align: left">(3)</TD>

          <TD STYLE="text-align: justify">The shares underlying this option will vest on the date that the market price of our common stock reaches $25.00 per share before the option expires. This option was granted to Mr. Cook for his services as a non-employee director and is described below under &#147;&#151;&nbsp;Non-Employee Director Compensation.&#148; </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 1px"></TD>

          <TD STYLE="width: 20px; text-align: left">(4)</TD>

          <TD STYLE="text-align: justify">The shares underlying this option will vest on an equal monthly basis over a four-year period commencing on May 1, 2015. </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 1px"></TD>

          <TD STYLE="width: 20px; text-align: left">(5)</TD>

          <TD STYLE="text-align: justify">6.25% of the total shares underlying this option vested and became exercisable on January 23, 2013. 6.25% of the total shares underlying this option vests and becomes exercisable on the first business day of each three (3) month period thereafter, subject to continued service through each vesting date. </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 1px"></TD>

          <TD STYLE="width: 20px; text-align: left">(6)</TD>

          <TD STYLE="text-align: justify">100.00% of the total shares underlying this option vested and became exercisable on May 8, 2007. </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 1px"></TD>

          <TD STYLE="width: 20px; text-align: left">(7)</TD>

          <TD STYLE="text-align: justify">25.00% of the total shares underlying this option vested and became exercisable on May 29, 2009. 37.50% of the total shares underlying this option vests and became exercisable on the first business day of each twelve (12) month period thereafter. </TD>

</TR>

</TABLE>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">67</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 1px"></TD>

          <TD STYLE="width: 20px; text-align: left">(8)</TD>

          <TD STYLE="text-align: justify">One-half of the shares underlying this option will vest and become exercisable upon the achievement of certain clinical trial milestones for our drug product, and one-half of the shares will vest on an equal monthly basis over the 12 months following July 1, 2015, in each case subject to Ms. Johnson&#146;s continued service through each vesting date. </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 1px"></TD>

          <TD STYLE="width: 20px; text-align: left">(9)</TD>

          <TD STYLE="text-align: justify">The shares underlying this option will vest on an equal monthly basis over a four year period commencing on August 3, 2015, the date of our most recent annual meeting of shareholders. This option was granted to Ms. Johnson for her services as a non-employee director and is described below under &#147;&#151;&nbsp;Non-Employee Director Compensation.&#148; </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 1px"></TD>

          <TD STYLE="width: 20px; text-align: left">(10)</TD>

          <TD STYLE="text-align: justify">The shares underlying this option will vest on the date that the market price of our common stock reaches $25.00 per share before the option expires. This option was granted to Ms. Johnson for her services as a non-employee director and is described below under &#147;&#151;&nbsp;Non-Employee Director Compensation.&#148; </TD>

</TR>

</TABLE>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">All of the stock options held by our named executive officers listed in the table above were granted under and subject to the terms of our 2013 Stock Incentive Plan, our 2009 Targeted Genetics Stock Incentive Plan, or our 2012 Stock Incentive Plan, the terms of which are described below under &#147;&#151;&nbsp;Equity Benefit Plans.&#148; </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Option Exercises and Stock Vested </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Our named executive officers did not exercise any stock option awards during the year ended December 31, 2015. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Pension Benefits </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">None of our named executive officers participate in or have account balances in qualified or non-qualified defined benefit plans sponsored by us. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Non-Qualified Deferred Compensation </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">None of our named executive officers participate in or have account balances in qualified or non-qualified defined contribution plans or other non-qualified compensation plans sponsored by us. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Equity Benefit Plans </H2>

<H3 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: italic; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">2013 Stock Incentive Plan </H3>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Our 2013 Stock Incentive Plan, or the 2013 Plan, was first approved by our Board of Directors in December 2013 and approved by our shareholders in February 2014, and subsequently amended by our Board of Directors and shareholders effective in August 2015. The 2013 Plan replaces the Targeted Genetics Corporation Stock Incentive Plan and the 2012 Stock Incentive Plan. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">As of December 31, 2015, there were outstanding options to purchase 673,169 shares of common stock and 723,431 shares of common stock remaining available for the grant of new awards under the 2013 Plan, subject to adjustment in the event of a stock split, stock dividend or other change in our capitalization. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The 2013 Plan permits the granting of stock options (both options to purchase common stock intended to qualify as incentive stock options under Section 422 of the Code and options that do not so qualify), restricted stock, restricted stock units, and performance-based awards. The exercise price of each stock option will be determined by our plan administrator but may not be less than 100% of the fair market value of our common stock on the date of grant or, in the case of an incentive stock option granted to a 10% owner, less than 110% of the fair market value of our common stock on the date of grant. The term of each stock
option will be fixed by the plan administrator and may not exceed 10 years from the date of grant. The plan administrator will determine at what time or times each option may be exercised. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Under the terms of the 2013 Plan, an option may be exercised following the cessation of a participant&#146;s service with us only to the extent provided in the applicable option agreement. If a participant&#146;s service relationship with us or any of our affiliates ceases for any reason other than disability or death, the participant may generally exercise any vested options for a period of three months following the cessation of service. If a participant&#146;s service relationship with us or any of our affiliates ceases due to disability or death, or a participant dies within a certain period following cessation of service,
the participant or a beneficiary may generally exercise any vested options for a period of 12 months. In no event may an option be exercised beyond the expiration of its term. </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">68</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The 2013 Plan provides that upon the effectiveness of a corporate transaction (as such term is defined in the 2013 Plan) in the event that all awards are not affirmed by us or assumed by the successor entity, all awards granted under the 2013 Plan shall terminate. In addition, in connection with a corporate transaction or change in control (as such term is defined in the 2013 Plan) the plan administrator may provide the full or partial automatic vesting and exercisability of one or more outstanding unvested awards under the 2013 Plan and the release from restrictions on transfer or forfeiture rights of such awards in connection
with such transaction, on such terms and conditions as the plan administrator may specify. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Our Board of Directors may amend or terminate the 2013 Plan at any time. The plan administrator may amend the terms of any outstanding award granted under the 2013 Plan, but no such action may adversely affect the holder&#146;s rights under an outstanding award without the holder&#146;s consent. Certain amendments to the 2013 Plan require the approval of our shareholders. No awards may be granted under the 2013 Plan after the date that is 10 years from the date of adoption by our Board of Directors. </P>

<H3 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: italic; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">2009 Targeted Genetics Stock Incentive Plan and 2012 Stock Incentive Plan </H3>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Our Board of Directors and shareholders adopted the 2009 Targeted Genetics Stock Incentive Plan in March 2009. Our Board of Directors adopted our 2012 Stock Incentive Plan in October 2012. There are no shares of common stock remaining for future awards under the 2009 Targeted Genetics Stock Incentive Plan and the 2012 Stock Incentive Plan. We refer to the 2009 Targeted Genetics Stock Incentive Plan and the 2012 Stock Incentive Plan together as the Former Plans. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The Former Plans provide that upon the effectiveness of a corporate transaction (as such term is defined in each of the Former Plans) in the event that all awards are not assumed or continued or substituted by the successor entity, all awards granted under the Former Plans shall terminate. In addition, in connection with a corporate transaction, the plan administrator may provide the full automatic vesting and exercisability of one or more outstanding unvested awards under the Former Plans in connection with a corporate transaction, on such terms and conditions as the plan administrator may specify. Furthermore, in connection
with a change in control (as such term is defined in each of the Former Plans), the Former Plans provide for the full automatic vesting and exercisability of any outstanding unvested awards held by certain &#147;key service providers,&#148; which under the terms of the Former Plans is defined as any employee, director or consultant who has been designated as a key service provider by the plan administrator, in the event that any such awards are not assumed or continued or substituted by the successor entity. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Our Board of Directors may amend or terminate the Former Plans at any time. Our Board of Directors may also amend the terms of any outstanding award, provided that no amendment to an award may materially impair any of the rights of a participant under any awards previously granted without his or her written consent. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Non-Employee Director Compensation </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The following table and related footnotes show the compensation paid during the year ended December 31, 2015 to our non-employee directors. The only type of stock awards held by any of our non-employee directors as of December 31, 2015 were stock option awards. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"></P>

<DIV style="text-align: center"><TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="608" STYLE="vertical-align: bottom; text-indent:0px; text-align: left; font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: -15pt; *margin-top: -20pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR>

          <TD><IMG HEIGHT="1" SRC="spacer.gif" WIDTH="288"></TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none"><!-- GUTTER -->&nbsp;</TD>

          <TD COLSPAN="3"><IMG HEIGHT="1" SRC="spacer.gif" WIDTH="64"></TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none"><!-- GUTTER -->&nbsp;</TD>

          <TD COLSPAN="3"><IMG HEIGHT="1" SRC="spacer.gif" WIDTH="64"></TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none"><!-- GUTTER -->&nbsp;</TD>

          <TD COLSPAN="3"><IMG HEIGHT="1" SRC="spacer.gif" WIDTH="66"></TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none"><!-- GUTTER -->&nbsp;</TD>

          <TD COLSPAN="3"><IMG HEIGHT="1" SRC="spacer.gif" WIDTH="61"></TD>

</TR>

<TR>

          <TD STYLE="line-height: normal; vertical-align: bottom; font-weight: bold; font-size: 8pt; text-align: left; border-bottom: 1pt solid black" ROWSPAN=1 COLSPAN=1>Name</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="line-height: normal; vertical-align: bottom; font-weight: bold; font-size: 8pt; text-align: center; border-bottom: 1pt solid black" ROWSPAN=1 COLSPAN=3>Fees Earned<BR> or Paid in<BR> Cash</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="line-height: normal; vertical-align: bottom; font-weight: bold; font-size: 8pt; text-align: center; border-bottom: 1pt solid black" ROWSPAN=1 COLSPAN=3>Option<BR> Awards</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="line-height: normal; vertical-align: bottom; font-weight: bold; font-size: 8pt; text-align: center; border-bottom: 1pt solid black" ROWSPAN=1 COLSPAN=3>All Other<BR> Compensation</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="line-height: normal; vertical-align: bottom; font-weight: bold; font-size: 8pt; text-align: center; border-bottom: 1pt solid black" ROWSPAN=1 COLSPAN=3>Total</TD>

</TR>

<TR STYLE="background-color: #cceeff">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt; vertical-align: text-bottom" ROWSPAN=1 COLSPAN=1>Louis Drapeau<sup>&#040;1&#041;</sup></TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->$</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>47,750</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->$</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>73,306</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->$</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>&#151;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->$</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>121,056</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

</TR>

<TR STYLE="background-color: white">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt; vertical-align: text-bottom" ROWSPAN=1 COLSPAN=1>Michael S. Perry, Ph.D.<sup>&#040;2&#041;</sup></TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->$</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>44,750</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->$</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>68,465</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->$</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>&#151;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->$</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>113,215</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

</TR>

<TR STYLE="background-color: #cceeff">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt; vertical-align: text-bottom" ROWSPAN=1 COLSPAN=1>Anthony Smithyman, Ph.D.<sup>&#040;3&#041;</sup></TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->$</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>10,000</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->$</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>&#151;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->$</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>&#151;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->$</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>10,000</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

</TR>

<TR STYLE="background-color: white">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt; vertical-align: text-bottom" ROWSPAN=1 COLSPAN=1>Julian P. Kirk<sup>&#040;4&#041;</sup></TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->$</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>30,000</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->$</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>84,927</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->$</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>&#151;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->$</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>114,927</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

</TR>

<TR STYLE="background-color: #cceeff">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt; vertical-align: text-bottom" ROWSPAN=1 COLSPAN=1>Vijay Samant<sup>&#040;5&#041;</sup></TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->$</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>7,028</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->$</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>83,866</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->$</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>&#151;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->$</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>90,894</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

</TR>

<TR STYLE="background-color: white">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt; vertical-align: text-bottom" ROWSPAN=1 COLSPAN=1>Paul C. Grint<sup>&#040;6&#041;</sup></TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->$</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>6,875</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->$</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>83,866</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->$</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>&#151;</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->$</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>90,741</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

</TR>

</TABLE></DIV>


<P STYLE="text-align: left; text-indent: 1px"><IMG SRC="line.gif" STYLE="width: 72px; height: 1pt"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 1px"></TD>

          <TD STYLE="width: 20px; text-align: left">(1)</TD>

          <TD STYLE="text-align: justify">As of December 31, 2015, Mr. Drapeau held stock options for an aggregate of 16,200 shares, of which 2,641 shares were vested and exercisable. </TD>

</TR>

</TABLE>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">69</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 1px"></TD>

          <TD STYLE="width: 20px; text-align: left">(2)</TD>

          <TD STYLE="text-align: justify">As of December 31, 2015, Dr. Perry held stock options for an aggregate of 18,840 shares, of which 6,156 shares were vested and exercisable. </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 1px"></TD>

          <TD STYLE="width: 20px; text-align: left">(3)</TD>

          <TD STYLE="text-align: justify">Dr. Smithyman resigned from our Board of Directors on April 16, 2015. As of December 31, 2015, Mr. Smithyman did not hold any stock options. </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 1px"></TD>

          <TD STYLE="width: 20px; text-align: left">(4)</TD>

          <TD STYLE="text-align: justify">As of December 31, 2015, Mr. Kirk held stock options for an aggregate of 16,200 shares, of which 541 shares were vested and exercisable. Mr. Kirk resigned from our Board of Directors on April 15, 2016. </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 1px"></TD>

          <TD STYLE="width: 20px; text-align: left">(5)</TD>

          <TD STYLE="text-align: justify">Mr. Samant joined our Board of Directors in November 2015. As of December 31, 2015, Mr. Samant held stock options for an aggregate of 16,200 shares, of which no shares were vested and exercisable. </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 1px"></TD>

          <TD STYLE="width: 20px; text-align: left">(6)</TD>

          <TD STYLE="text-align: justify">Dr. Grint joined our Board of Directors in November 2015. As of December 31, 2015, Dr. Grint held stock options for an aggregate of 16,200 shares, of which no shares were vested and exercisable. </TD>

</TR>

</TABLE>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">From January until September 2015, our non-employee directors were paid annual cash retainers for their service on the Board of Directors and committees. The chairman of the Board of Directors received an annual cash retainer of $30,000 and each other non-employee director received an annual cash retainer of $20,000. For the Audit Committee, the committee chair received an additional annual cash retainer of $7,500 and each member received an additional annual cash retainer of $4,000. For the Compensation Committee and Nominating and Corporate Governance Committee, each chair received an additional annual cash retainer of $4,000
and each member received an additional annual cash retainer of $2,500. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">During 2015, Mr. Curnock Cook, Mr. Salka and Ms. Johnson served on our Board of Directors. As an employee, Mr. Salka did not receive cash or equity compensation for his services as a director during 2015. Mr. Curnock Cook and Ms. Johnson were compensated for their services as non-employee directors in 2015. As named executive officers, the compensation of each of Messrs. Cook and Salka and Ms. Johnson for services on the Board of Directors and with respect to Mr. Curnock Cook, as Chairman of the Board of Directors, are reflected in the Summary Compensation Table above. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">In September 2015, the Board of Directors approved a revised compensation structure for our non-employee directors. Effective as of July 1, 2015, the chairman of the Board will receive an annual cash retainer of $60,000 and each other non-employee director will receive an annual cash retainer of $40,000. For the Audit Committee, the committee chair will receive an additional annual cash retainer of $15,000 and each member will receive an additional annual cash retainer of $6,000. For the Compensation Committee, the committee chair will receive an additional annual cash retainer of $10,000 and each member will receive an
additional annual cash retainer of $5,000. For the Nominating and Corporate Governance Committee, the committee chair will receive an additional annual cash retainer of $5,000 and each member will receive an additional annual cash retainer of $3,000. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">On September 21, 2015, our Board of Directors granted options to purchase shares of common stock to each of the following members of our Board of Directors as follows: </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"></P>

<DIV style="text-align: center"><TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="554" STYLE="vertical-align: bottom; text-indent:0px; text-align: left; font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: -15pt; *margin-top: -20pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR>

          <TD><IMG HEIGHT="1" SRC="spacer.gif" WIDTH="376"></TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none"><!-- GUTTER -->&nbsp;</TD>

          <TD COLSPAN="3"><IMG HEIGHT="1" SRC="spacer.gif" WIDTH="69"></TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none"><!-- GUTTER -->&nbsp;</TD>

          <TD COLSPAN="3"><IMG HEIGHT="1" SRC="spacer.gif" WIDTH="77"></TD>

</TR>

<TR>

          <TD STYLE="line-height: normal; vertical-align: bottom; font-weight: bold; font-size: 8pt; text-align: left; border-bottom: 1pt solid black" ROWSPAN=1 COLSPAN=1>Name</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="line-height: normal; vertical-align: bottom; font-weight: bold; font-size: 8pt; text-align: center; border-bottom: 1pt solid black" ROWSPAN=1 COLSPAN=3>Shares<BR> Subjected to<BR> Standard<BR> Vesting<sup>&#040;1&#041;</sup></TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="line-height: normal; vertical-align: bottom; font-weight: bold; font-size: 8pt; text-align: center; border-bottom: 1pt solid black" ROWSPAN=1 COLSPAN=3>Shares<BR> Subjected to<BR> Performance<BR> Vesting<sup>&#040;2&#041;</sup></TD>

</TR>

<TR STYLE="background-color: #cceeff">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt; vertical-align: text-bottom" ROWSPAN=1 COLSPAN=1>Mr. Curnock Cook</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>6,500</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>900</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

</TR>

<TR STYLE="background-color: white">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt; vertical-align: text-bottom" ROWSPAN=1 COLSPAN=1>Dr. Perry</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>6,500</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>6,300</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

</TR>

<TR STYLE="background-color: #cceeff">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt; vertical-align: text-bottom" ROWSPAN=1 COLSPAN=1>Mr. Drapeau</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>6,500</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>7,300</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

</TR>

<TR STYLE="background-color: white">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt; vertical-align: text-bottom" ROWSPAN=1 COLSPAN=1>Mr. Kirk</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>6,500</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>9,700</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

</TR>

<TR STYLE="background-color: #cceeff">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt; vertical-align: text-bottom" ROWSPAN=1 COLSPAN=1>Ms. Johnson</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>6,500</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>9,700</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

</TR>

</TABLE></DIV>


<P STYLE="text-align: left; text-indent: 1px"><IMG SRC="line.gif" STYLE="width: 72px; height: 1pt"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 1px"></TD>

          <TD STYLE="width: 20px; text-align: left">(1)</TD>

          <TD STYLE="text-align: justify">The shares vest on an equal monthly basis over a four year period commencing on August 3, 2015. </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 1px"></TD>

          <TD STYLE="width: 20px; text-align: left">(2)</TD>

          <TD STYLE="text-align: justify">All of the shares will vest upon the market price of our common stock reaching $25.00 per share during the term of the option. </TD>

</TR>

</TABLE>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">70</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">On November 5, 2015, our Board of Directors granted options to purchase shares of common stock to each of the following new members of our Board of Directors, who each commenced services in November 2015, as follows: </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"></P>

<DIV style="text-align: center"><TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="554" STYLE="vertical-align: bottom; text-indent:0px; text-align: left; font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: -15pt; *margin-top: -20pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR>

          <TD><IMG HEIGHT="1" SRC="spacer.gif" WIDTH="466"></TD>

          <TD STYLE="width: 12px; vertical-align: bottom; text-align: center; border-bottom: none"><!-- GUTTER -->&nbsp;</TD>

          <TD COLSPAN="3"><IMG HEIGHT="1" SRC="spacer.gif" WIDTH="72"></TD>

</TR>

<TR>

          <TD STYLE="line-height: normal; vertical-align: bottom; font-weight: bold; font-size: 8pt; text-align: left; border-bottom: 1pt solid black" ROWSPAN=1 COLSPAN=1>Name</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="line-height: normal; vertical-align: bottom; font-weight: bold; font-size: 8pt; text-align: center; border-bottom: 1pt solid black" ROWSPAN=1 COLSPAN=3>Options<sup>&#040;1&#041;</sup></TD>

</TR>

<TR STYLE="background-color: #cceeff">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt; vertical-align: text-bottom" ROWSPAN=1 COLSPAN=1>Mr. Samant</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>16,200</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

</TR>

<TR STYLE="background-color: white">

          <TD STYLE="padding-left: 10pt; text-indent: -10pt; vertical-align: text-bottom" ROWSPAN=1 COLSPAN=1>Dr. Grint</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: center" ROWSPAN=1><!-- GUTTER -->&nbsp;</TD>

          <TD STYLE="width: 6px; vertical-align: bottom; text-align: left" ROWSPAN=1><!-- $ -->&nbsp;</TD>

          <TD STYLE="vertical-align: bottom; text-align: right" ROWSPAN=1 COLSPAN=1>16,200</TD>

          <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left"><!-- PERCENT -->&nbsp;</TD>

</TR>

</TABLE></DIV>


<P STYLE="text-align: left; text-indent: 1px"><IMG SRC="line.gif" STYLE="width: 72px; height: 1pt"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 1px"></TD>

          <TD STYLE="width: 20px; text-align: left">(1)</TD>

          <TD STYLE="text-align: justify">25% of the shares subject to the option will vest one year following the date of grant, and the remaining shares will vest in 36 equal monthly installments thereafter. </TD>

</TR>

</TABLE>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">71</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<H1 STYLE="text-indent:0pt; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 9pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><FONT STYLE="font-variant: small-caps">Transactions With Related Persons</FONT> </H1>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><FONT STYLE="font-variant: small-caps">Related-Person Transactions policy and Procedures</FONT> </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">We have adopted a written related-person transactions policy that sets forth our policies and procedures regarding the identification, review, consideration and oversight of &#147;related-person transactions.&#148; For purposes of our policy only, a &#147;related-person transaction&#148; is a transaction, arrangement or relationship (or any series of similar transactions, arrangements or relationships) in which we and any &#147;related person&#148; are participants involving an amount that exceeds $120,000 (or such lower threshold as may be applicable to us from time to time pursuant to the rules and regulations of the SEC or
the NYSE MKT). </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Transactions involving compensation for services provided to us by an employee, consultant or director are not considered related-person transactions under this policy. A related person is any executive officer, director or a holder of more than five percent of our common stock, including any of their immediate family members and any entity owned or controlled by such persons. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Under the policy, where a transaction has been identified as a related-person transaction, management must present information regarding the proposed related-person transaction to our Audit Committee (or, where review by our Audit Committee would be inappropriate, to another independent body of our Board of Directors) for approval. The presentation must include a description of, among other things, the material facts, the direct and indirect interests of the related persons, the benefits of the transaction to us and whether any alternative transactions are available. To identify related-person transactions in advance, we rely
on information supplied by our executive officers, directors and certain significant shareholders. In considering related-person transactions, our Audit Committee or other independent body of our Board of Directors takes into account the relevant available facts and circumstances including, but not limited to: </P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">the risks, costs and benefits to us; </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">the impact on a director&#146;s independence in the event the related person is a director, immediate family member of a director or an entity with which a director is affiliated; </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">the terms of the transaction; </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">the availability of other sources for comparable services or products; and </TD>

</TR>

</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" STYLE="text-indent:0px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">

<TR STYLE="font-weight: normal; font-style: normal; line-height: 12pt; font-size: 10pt; vertical-align: top; text-align: left">

          <TD STYLE="width: 21px"></TD>

          <TD STYLE="width: 24px; text-align: left">&#149;</TD>

          <TD STYLE="text-align: justify">the terms available to or from, as the case may be, unrelated third parties. </TD>

</TR>

</TABLE>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">In the event a director has an interest in the proposed transaction, the director must recuse himself or herself from the deliberations and approval. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><FONT STYLE="font-variant: small-caps">Certain Related-Person Transactions</FONT> </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The following includes a summary of transactions since January 1, 2014 to which we have been a party, in which the amount involved in the transaction exceeded the lesser of $120,000 or one percent of the average of our total assets at year end for the last two completed fiscal years, and in which any of our directors, executive officers or, to our knowledge, beneficial owners of more than 5% of our capital stock or any member of the immediate family of any of the foregoing persons had or will have a direct or indirect material interest, other than equity and other compensation, termination, change in control and other
arrangements, which are described in the sections above entitled &#147;Executive Compensation&#148; and &#147;Non-Employee Director Compensation.&#148; </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Sale of Common Stock </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">In March 2015, in connection with a private placement of our common stock, we sold an aggregate of 68,455 shares and 17,113 shares underlying warrants to One Fund Management Limited as Trustee for Asia Pacific Healthcare Fund II (&#147;One Funds&#148;), which is also known as Phillip Asset Management Limited as Trustee for Asia Pacific Healthcare Fund II, or Phillip Asset Management. Jeremy Curnock Cook, our then-interim Chief Executive Officer and the current chairman of our Board of Directors, is a Managing Director and holds an ownership interest in Bioscience Managers Pty Ltd. Phillip Asset Management Limited is 100% owned
by Phillip Capital Holdings Ltd., an Australian stockbroker. Phillip Asset Management holds all shares in its capacity as trustee for Bioscience Managers Pty Ltd. </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">72</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">In addition, in connection with the March 2015 private placement, we sold an aggregate of 278,788 shares and 69,697 shares underlying warrants to Intrexon Corporation. Randal J. Kirk, directly and through certain affiliates, has voting and dispositive power over a majority of the outstanding capital stock of Intrexon Corporation. Randal J. Kirk is also deemed a holder of more than five percent of the shares of our common stock, as described in the section entitled &#147;Security Ownership of Certain Beneficial Owners and Management and Related Shareholder Matters&#148;. In connection with the March 2015 private placement, we
entered into a registration rights agreement with Intrexon and certain other purchasers in the private placement, pursuant to which we registered for resale on Form S-1 (File No. 333-203454) 824,848 shares of common stock (on a post-August 2015 reverse split basis) held or issuable upon exercise of warrants by Intrexon. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Exclusive Channel Collaboration </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Pursuant to the that certain Exclusive Channel Collaboration Agreement, dated as of March 29, 2013 with Intrexon Corporation, which we refer to as the ECC Agreement, we agreed to pay Intrexon Corporation royalties as a percentage in the upper-single digits of the net product sales of a product developed under the collaboration, and may also pay up to $7.5 million in aggregate milestone payments for each product developed. Intrexon Corporation owns more than five percent of our common stock. On April 13, 2016, we provided written notice to Intrexon Corporation of our election to voluntarily terminate the ECC Agreement. The
effective date of termination will be 90 days following delivery of the termination notice. We will not incur any early termination penalties as a result of the termination of the ECC Agreement. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Common Stock Issuance </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">On April 8, 2016, we entered into a Common Stock Issuance Agreement, or the Stock Issuance Agreement, with certain former holders of our Series B convertible preferred stock, pursuant to which we agreed to issue the former holders an aggregate of 853,465 shares of our Common Stock. Pursuant to the Stock Issuance Agreement, the Company and the holders party thereto also agreed to amend certain warrants to purchase Common Stock issued to such holders in the private placement of Series B convertible preferred stock in June 2013 and/or July 2013, in order to reduce the exercise price of such warrants from $7.00 per share to $4.05
per share and extend the expiration date thereof from June 26, 2018 to March 31, 2021. As consideration for the transactions described above, such holders waived their right to receive approximately $2.2 million in aggregate cash payments to which they were entitled upon the conversion of all outstanding shares of Series B redeemable convertible preferred stock into shares of common stock on April 8, 2016, or the Series B Conversion, in respect of accrued dividends on their former shares of Series B convertible preferred stock. Such holders also waived their registration rights with respect to certain future registration statements that may be filed, and certain future public offerings that may be conducted, by us. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Pursuant to the Stock Issuance Agreement, we agreed to seek shareholder approval of the issuance of up to 1,037,053 shares of Common Stock to the holders in the future in connection with one or more dilutive financings, as set forth in further detail in Proposal 5 to this proxy statement. To the extent we are not permitted by applicable NYSE MKT rules to issue any additional shares of Common Stock that would otherwise be required to be issued pursuant to the terms of the Stock Issuance Agreement as a result of a dilutive financing, including without limitation if Proposal 5 detailed under this proxy statement is not approved,
we have agreed to pay the holders a cash payment equal to the difference between the price per share in such dilutive financing and $4.05 for each share issued to the holders pursuant to the Series B Conversion. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Pendinas Limited and One Funds, each beneficial owners of more than 5% of our capital stock, participated in this transaction and are parties to the Stock Issuance Agreement. One Funds is affiliated with Jeremy Curnock Cook, the Chairman of our Board of Directors. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Employment Agreements </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">We have entered into compensatory arrangements with our executive officers, as more fully described in the section above entitled &#147;Executive Compensation.&#148; </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Stock Options Granted to Executive Officers and Directors </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">We have granted stock options to our executive officers and directors, as more fully described in the sections above entitled &#147;Executive Compensation&#148; and &#147;Non-Employee Director Compensation.&#148; </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">73</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Indemnification Agreements </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">We have entered, and intend to continue to enter, into separate indemnification agreements with each of our directors and executive officers, as described in the sections above entitled &#147;Executive Compensation&#148; and &#147;Non-Employee Director Compensation.&#148; </P>

<H1 STYLE="text-indent:0pt; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 9pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><FONT STYLE="font-variant: small-caps">Householding of Proxy Materials</FONT> </H1>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The SEC has adopted rules that permit companies and intermediaries (e.g., brokers) to satisfy the delivery requirements for annual meeting materials with respect to two or more shareholders sharing the same address by delivering a single set of annual meeting materials addressed to those shareholders. This process, which is commonly referred to as &#147;householding,&#148; potentially means extra convenience for shareholders and cost savings for companies. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">This year, a number of brokers with account holders who are AmpliPhi shareholders will be &#147;householding&#148; the Company&#146;s proxy materials. A single set of annual meeting materials will be delivered to multiple shareholders sharing an address unless contrary instructions have been received from the affected shareholders. Once you have received notice from your broker that they will be &#147;householding&#148; communications to your address, &#147;householding&#148; will continue until you are notified otherwise or until you revoke your consent. If, at any time, you no longer wish to participate in
&#147;householding&#148; and would prefer to receive a separate set of annual meeting materials, please notify your broker or AmpliPhi. Direct your written request to AmpliPhi Biosciences Corporation, Attn: Investor Relations, 3579 Valley Centre Drive, Suite 100, San Diego, California 92130 or contact Matt Dansey at (858) 800-4869. Shareholders who currently receive multiple copies of the annual meeting materials at their addresses and would like to request &#147;householding&#148; of their communications should contact their brokers. </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">74</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<H1 STYLE="text-indent:0pt; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 9pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><FONT STYLE="font-variant: small-caps">Other Matters</FONT> </H1>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The Board of Directors knows of no other matters that will be presented for consideration at the annual meeting. If any other matters are properly brought before the meeting, it is the intention of the persons named in the accompanying proxy to vote on such matters in accordance with their best judgment. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 224px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">By Order of the Board of Directors, </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 224px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><IMG SRC="sig_jcook.jpg" WIDTH="146" ALIGN="MIDDLE" ALT="[GRAPHIC MISSING]"></P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 224px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Jeremy Curnock Cook<BR> <I>Chairman of the Board of Directors</I> </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">San Diego, California<BR> May 20, 2016 </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>A copy of the Company&#146;s Annual Report to the Securities and Exchange Commission on Form 10-K for the fiscal year ended December 31, 2015 is available without charge upon written request to: Secretary, AmpliPhi Biosciences Corporation, 3579 Valley Centre Drive, Suite 100, San Diego, California 92130. We will furnish a copy of any exhibit to such report upon written request and payment of reasonable expenses in furnishing such exhibit.</B></P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">75</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:0pt; text-align: right; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>APPENDIX A</B> </P>

<H1 STYLE="text-indent:0pt; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 9pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><FONT STYLE="font-variant: small-caps">AmpliPhi Biosciences Corporation<BR>&nbsp;<BR>2016 Equity Incentive Plan<BR>&nbsp;<BR> Adopted by the Board of Directors: April 21, 2016<BR>Approved by the Shareholders: [June 20, 2016]</FONT> </H1>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">1. <FONT STYLE="font-variant: small-caps">General.</FONT> </H2>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(a) Successor to and Continuation of Prior Plan.</B>&nbsp;&nbsp;The Plan is intended as the successor to and continuation of the AmpliPhi Biosciences Corporation 2013 Stock Incentive Plan (the &#147;<B><I>2013 Plan</I></B>&#148;). From and after 12:01 a.m. Pacific Time on the Effective Date, no additional stock awards will be granted under the 2013 Plan. All Awards granted on or after 12:01 a.m. Pacific Time on the Effective Date will be granted under this Plan. All stock awards granted under the 2013 Plan or under the 2009 Targeted Genetics Stock Incentive Plan or the AmpliPhi Biosciences Corporation 2012 Stock Incentive
Plan (collectively, with the 2013 Plan, the &#147;<B><I>Prior Plans</I></B>&#148;), will remain subject to the terms of the Prior Plans. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(i)</B> Any shares that would otherwise remain available for future grants under the 2013 Plan as of 12:01 a.m. Pacific Time on the Effective Date (the &#147;<B><I>2013 Plan&#146;s Available Reserve</I></B>&#148;) will cease to be available under the 2013 Plan at such time. Instead, that number of shares of Common Stock equal to the 2013 Plan&#146;s Available Reserve will be added to the Share Reserve (as further described in Section 3(a) below) and will be immediately available for grants and issuance pursuant to Stock Awards hereunder, up to the maximum number set forth in Section 3(a) below. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(ii)</B> In addition, from and after 12:01 a.m. Pacific Time on the Effective Date, any shares subject, at such time, to outstanding stock awards granted under the Prior Plans that (i) expire or terminate for any reason prior to exercise or settlement; (ii) are forfeited because of the failure to meet a contingency or condition required to vest such shares or otherwise return to the Company; or (iii) are reacquired, withheld (or not issued) to satisfy a tax withholding obligation in connection with an award or to satisfy the purchase price or exercise price of a stock award (such shares the &#147;<B><I>Returning Shares</I>
</B>&#148;) will immediately be added to the Share Reserve (as further described in Section 3(a) below) as and when such shares become Returning Shares, up to the maximum number set forth in Section 3(a) below. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(b) Eligible Award Recipients.</B>&nbsp;&nbsp;Employees, Directors and Consultants are eligible to receive Awards. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(c) Available Awards.</B>&nbsp;&nbsp;The Plan provides for the grant of the following Awards: (i) Incentive Stock Options, (ii) Nonstatutory Stock Options, (iii) Stock Appreciation Rights, (iv) Restricted Stock Awards, (v) Restricted Stock Unit Awards, (vi) Performance Stock Awards, (vii) Performance Cash Awards, and (viii) Other Stock Awards. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(d) Purpose.</B>&nbsp;&nbsp;The Plan, through the grant of Awards, is intended to help the Company secure and retain the services of eligible award recipients, provide incentives for such persons to exert maximum efforts for the success of the Company and any Affiliate, and provide a means by which the eligible recipients may benefit from increases in value of the Common Stock. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">2. <FONT STYLE="font-variant: small-caps">Administration.</FONT> </H2>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(a) Administration by Board.</B>&nbsp;&nbsp;The Board will administer the Plan. The Board may delegate administration of the Plan to a Committee or Committees, as provided in Section 2(c). </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(b) Powers of Board.</B>&nbsp;&nbsp;The Board will have the power, subject to, and within the limitations of, the express provisions of the Plan: </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(i) </B>To determine: (A) who will be granted Awards; (B) when and how each Award will be granted; (C) what type of Award will be granted; (D) the provisions of each Award (which need not be identical), including when a person will be permitted to exercise or otherwise receive cash or Common Stock under the Award; (E) the number of shares of Common Stock subject to, or the cash value of, an Award; and (F) the Fair Market Value applicable to a Stock Award. </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">A-1</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(ii) </B>To construe and interpret the Plan and Awards granted under it, and to establish, amend and revoke rules and regulations for administration of the Plan and Awards. The Board, in the exercise of these powers, may correct any defect, omission or inconsistency in the Plan or in any Award Agreement or in the written terms of a Performance Cash Award, in a manner and to the extent it will deem necessary or expedient to make the Plan or Award fully effective. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(iii) </B>To settle all controversies regarding the Plan and Awards granted under it. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(iv) </B>To accelerate, in whole or in part, the time at which an Award may be exercised or vest (or the time at which cash or shares of Common Stock may be issued in settlement thereof). </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(v) </B>To suspend or terminate the Plan at any time. Except as otherwise provided in the Plan or an Award Agreement, suspension or termination of the Plan will not materially impair a Participant&#146;s rights under the Participant&#146;s then-outstanding Award without the Participant&#146;s written consent, except as provided in subsection (viii) below. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(vi) </B>To amend the Plan in any respect the Board deems necessary or advisable, including, without limitation, by adopting amendments relating to Incentive Stock Options and certain nonqualified deferred compensation under Section 409A of the Code and/or bringing the Plan or Awards granted under the Plan into compliance with the requirements for Incentive Stock Options or ensuring that they are exempt from, or compliant with, the requirements for nonqualified deferred compensation under Section 409A of the Code, subject to the limitations, if any, of applicable law. If required by applicable law or listing requirements,
and except as provided in Section 9(a) relating to Capitalization Adjustments, the Company will seek shareholder approval of any amendment of the Plan that (A) materially increases the number of shares of Common Stock available for issuance under the Plan, (B) materially expands the class of individuals eligible to receive Awards under the Plan, (C) materially increases the benefits accruing to Participants under the Plan, (D) materially reduces the price at which shares of Common Stock may be issued or purchased under the Plan, (E) materially extends the term of the Plan, or (F) materially expands the types of Awards available for issuance under the Plan. Except as otherwise provided in the Plan or an Award Agreement, no amendment of the Plan will materially impair a Participant&#146;s rights under an outstanding Award without the Participant&#146;s written consent. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(vii) </B>To submit any amendment to the Plan for shareholder approval, including, but not limited to, amendments to the Plan intended to satisfy the requirements of (A) Section 162(m) of the Code regarding the exclusion of performance-based compensation from the limit on corporate deductibility of compensation paid to Covered Employees, (B) Section 422 of the Code regarding &#147;incentive stock options&#148; or (C) Rule 16b-3. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(viii) </B>To approve forms of Award Agreements for use under the Plan and to amend the terms of any one or more Awards, including, but not limited to, amendments to provide terms more favorable to the Participant than previously provided in the Award Agreement, subject to any specified limits in the Plan that are not subject to Board discretion; <I>provided, however,</I> that a Participant&#146;s rights under any Award will not be impaired by any such amendment unless (A) the Company requests the consent of the affected Participant, and (B) such Participant consents in writing. Notwithstanding the foregoing, (1) a
Participant&#146;s rights will not be deemed to have been impaired by any such amendment if the Board, in its sole discretion, determines that the amendment, taken as a whole, does not materially impair the Participant&#146;s rights, and (2) subject to the limitations of applicable law, if any, the Board may amend the terms of any one or more Awards without the affected Participant&#146;s consent (A) to maintain the qualified status of the Award as an Incentive Stock Option under Section 422 of the Code; (B) to change the terms of an Incentive Stock Option, if such change results in impairment of the Award solely because it impairs the qualified status of the Award as an Incentive Stock Option under Section 422 of the Code; (C) to clarify the manner of exemption from, or to bring the Award into compliance with, Section 409A of the Code; or (D) to comply with other applicable laws or listing requirements. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(ix) </B>Generally, to exercise such powers and to perform such acts as the Board deems necessary or expedient to promote the best interests of the Company and that are not in conflict with the provisions of the Plan or Awards. </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">A-2</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(x) </B>To adopt such procedures and sub-plans as are necessary or appropriate to permit participation in the Plan by Employees, Directors or Consultants who are foreign nationals or employed outside the United States (provided that Board approval will not be necessary for immaterial modifications to the Plan or any Award Agreement that are required for compliance with the laws of the relevant foreign jurisdiction). </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(xi) </B>To effect, with the consent of any adversely affected Participant, (A) the reduction of the exercise, purchase or strike price of any outstanding Stock Award; (B) the cancellation of any outstanding Stock Award and the grant in substitution therefor of a new (1) Option or SAR, (2) Restricted Stock Award, (3) Restricted Stock Unit Award, (4) Other Stock Award, (5) cash and/or (6) other valuable consideration determined by the Board, in its sole discretion, with any such substituted award (x) covering the same or a different number of shares of Common Stock as the cancelled Stock Award and (y) granted under the Plan
or another equity or compensatory plan of the Company; or (C) any other action that is treated as a repricing under generally accepted accounting principles. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(c) Delegation to Committee.</B> </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(i) General.</B>&nbsp;&nbsp;The Board may delegate some or all of the administration of the Plan to a Committee or Committees. If administration of the Plan is delegated to a Committee, the Committee will have, in connection with the administration of the Plan, the powers theretofore possessed by the Board that have been delegated to the Committee, including the power to delegate to a subcommittee of the Committee any of the administrative powers the Committee is authorized to exercise (and references in this Plan to the Board will thereafter be to the Committee or subcommittee, as applicable). Any delegation of
administrative powers will be reflected in resolutions, not inconsistent with the provisions of the Plan, adopted from time to time by the Board or Committee (as applicable). The Board may retain the authority to concurrently administer the Plan with the Committee and may, at any time, revest in the Board some or all of the powers previously delegated. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(ii) Section 162(m) and Rule 16b-3 Compliance.</B>&nbsp;&nbsp;The Committee may consist solely of two or more Outside Directors, in accordance with Section 162(m) of the Code, or solely of two or more Non-Employee Directors, in accordance with Rule 16b-3. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(d) Delegation to an Officer.</B>&nbsp;&nbsp;To the extent permissible under applicable law, the Board may delegate to one (1) or more Officers the authority to do one or both of the following (i) designate Employees who are not Officers to be recipients of Options and SARs (and, to the extent permitted by applicable law, other Stock Awards) and, to the extent permitted by applicable law, the terms of such Awards, and (ii) determine the number of shares of Common Stock to be subject to such Stock Awards granted to such Employees; <I>provided, however</I>, that the Board resolutions regarding such delegation will specify the
total number of shares of Common Stock that may be subject to the Stock Awards granted by such Officer and that such Officer may not grant a Stock Award to himself or herself. Any such Stock Awards will be granted on the form of Stock Award Agreement most recently approved for use by the Committee or the Board, unless otherwise provided in the resolutions approving the delegation authority. The Board may not delegate authority to an Officer who is acting solely in the capacity of an Officer (and not also as a Director) to determine the Fair Market Value pursuant to Section 13(y)(iii) below. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(e) Effect of Board&#146;s Decision.</B>&nbsp;&nbsp;All determinations, interpretations and constructions made by the Board in good faith will not be subject to review by any person and will be final, binding and conclusive on all persons. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">3. <FONT STYLE="font-variant: small-caps">Shares Subject to the Plan.</FONT> </H2>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(a) Share Reserve.</B>&nbsp;&nbsp;Subject to Section 9(a) relating to Capitalization Adjustments, and the following sentence regarding the annual increase, the aggregate number of shares of Common Stock that may be issued pursuant to Stock Awards will not exceed 2,373,000 shares (the &#147;<B><I>Share Reserve</I></B>&#148;), which number is the sum of (i) 1,000,000 new shares, <I>plus</I> (ii) the number of shares subject to the 2013 Plan&#146;s Available Reserve, <I>plus</I> (iii) the number of shares that are Returning Shares, as such shares become available from time to time. </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">A-3</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">In addition, the Share Reserve will automatically increase on January 1<sup>st</sup> of each year, for a period of not more than ten years, commencing on January 1<sup>st</sup> of the year following the year in which the Effective Date occurs and ending on (and including) January 1, 2026, in an amount equal to 5% of the total number of shares of Capital Stock outstanding on December 31<sup>st</sup> of the preceding calendar year. Notwithstanding the foregoing, the Board may act prior to January 1<sup>st</sup> of a given year to provide that there will be no January 1<sup>st</sup> increase in the Share Reserve for such year or
that the increase in the Share Reserve for such year will be a lesser number of shares of Common Stock than would otherwise occur pursuant to the preceding sentence. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">For clarity, the Share Reserve in this Section 3(a) is a limitation on the number of shares of Common Stock that may be issued pursuant to the Plan. Accordingly, this Section 3(a) does not limit the granting of Stock Awards except as provided in Section 7(a). Shares may be issued in connection with a merger or acquisition as permitted by NASDAQ Listing Rule 5635(c), NYSE Listed Company Manual Section 303A.08, AMEX Company Guide Section 711 or other applicable rule, and such issuance will not reduce the number of shares available for issuance under the Plan. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(b) Reversion of Shares to the Share Reserve.</B>&nbsp;&nbsp;If a Stock Award or any portion thereof (i) expires or otherwise terminates without all of the shares covered by such Stock Award having been issued or (ii) is settled in cash (<I>i.e.</I>, the Participant receives cash rather than stock), such expiration, termination or settlement will not reduce (or otherwise offset) the number of shares of Common Stock that may be available for issuance under the Plan. If any shares of Common Stock issued pursuant to a Stock Award are forfeited back to or repurchased by the Company because of the failure to meet a contingency
or condition required to vest such shares in the Participant, then the shares that are forfeited or repurchased will revert to and again become available for issuance under the Plan. Any shares reacquired by the Company in satisfaction of tax withholding obligations on a Stock Award or as consideration for the exercise or purchase price of a Stock Award will again become available for issuance under the Plan. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(c) Incentive Stock Option Limit.</B>&nbsp;&nbsp;Subject to the provisions of Section 9(a) relating to Capitalization Adjustments, the aggregate maximum number of shares of Common Stock that may be issued pursuant to the exercise of Incentive Stock Options will be 4,746,000 shares of Common Stock. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(d) Section 162(m) Limitations.</B>&nbsp;&nbsp;Subject to the provisions of Section 9(a) relating to Capitalization Adjustments, at such time as the Company may be subject to the applicable provisions of Section 162(m) of the Code, the following limitations shall apply. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(i) </B>A maximum of 1,000,000 shares of Common Stock subject to Options, SARs and Other Stock Awards whose value is determined by reference to an increase over an exercise or strike price of at least 100% of the Fair Market Value on the date the Stock Award is granted may be granted to any one Participant during any one calendar year. Notwithstanding the foregoing, if any additional Options, SARs or Other Stock Awards whose value is determined by reference to an increase over an exercise or strike price of at least 100% of the Fair Market Value on the date the Stock Award are granted to any Participant during any calendar
year, compensation attributable to the exercise of such additional Stock Awards will not satisfy the requirements to be considered &#147;qualified performance-based compensation&#148; under Section 162(m) of the Code unless such additional Stock Award is approved by the Company&#146;s shareholders. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(ii) </B>A maximum of 1,000,000 shares of Common Stock subject to Performance Stock Awards may be granted to any one Participant during any one calendar year (whether the grant, vesting or exercise is contingent upon the attainment during the Performance Period of the Performance Goals). </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(iii) </B>A maximum of $2,000,000 may be granted as a Performance Cash Award to any one Participant during any one calendar year. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(e) Limitation on Grants to Non-Employee Directors.</B>&nbsp;&nbsp;The (i) maximum number of shares of Common Stock subject to Stock Awards granted under the Plan or otherwise during any one calendar year (beginning with the 2016 calendar year) to any Non-Employee Director, taken together with the (ii) cash fees paid by the Company to such Non-Employee Director during such calendar year, and in both cases for service on the Board, will not exceed $375,000 in total value (calculating the value of any such Stock Awards based on the grant date fair value of such Stock Awards for financial reporting purposes), or, with respect
to the </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">A-4</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">calendar year in which a Non-Employee Director is first appointed or elected to the Board, $783,000. The Board may make exceptions to the applicable limit in this Section 3(e) for individual Non-Employee Directors in extraordinary circumstances (for example, to compensate such individual for interim service in the capacity of an officer of the Company), as the Board may determine in its discretion, provided that the Non-Employee Director receiving such additional compensation may not participate in the decision to award such compensation. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(f) Source of Shares.</B>&nbsp;&nbsp;The stock issuable under the Plan will be shares of authorized but unissued or reacquired Common Stock, including shares repurchased by the Company on the open market or otherwise. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">4. <FONT STYLE="font-variant: small-caps">Eligibility.</FONT> </H2>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(a) Eligibility for Specific Stock Awards.</B>&nbsp;&nbsp;Incentive Stock Options may be granted only to employees of the Company or a &#147;parent corporation&#148; or &#147;subsidiary corporation&#148; thereof (as such terms are defined in Sections 424(e) and 424(f) of the Code). Stock Awards other than Incentive Stock Options may be granted to Employees, Directors and Consultants; <I>provided, however</I>, that Stock Awards may not be granted to Employees, Directors and Consultants who are providing Continuous Service only to any &#147;parent&#148; of the Company, as such term is defined in Rule 405 of the Securities
Act, unless (i) the stock underlying such Stock Awards is treated as &#147;service recipient stock&#148; under Section 409A of the Code (for example, because the Stock Awards are granted pursuant to a corporate transaction such as a spin off transaction), (ii) the Company, in consultation with its legal counsel, has determined that such Stock Awards are otherwise exempt from Section 409A of the Code, or (iii) the Company, in consultation with its legal counsel, has determined that such Stock Awards comply with the distribution requirements of Section 409A of the Code. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(b) Ten Percent Shareholders.</B>&nbsp;&nbsp;A Ten Percent Shareholder will not be granted an Incentive Stock Option unless the exercise price of such Option is at least 110% of the Fair Market Value on the date of grant and the Option is not exercisable after the expiration of five years from the date of grant. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">5. <FONT STYLE="font-variant: small-caps">Provisions Relating to Options and Stock Appreciation Rights.</FONT> </H2>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Each Option or SAR will be in such form and will contain such terms and conditions as the Board deems appropriate. All Options will be separately designated Incentive Stock Options or Nonstatutory Stock Options at the time of grant, and, if certificates are issued, a separate certificate or certificates will be issued for shares of Common Stock purchased on exercise of each type of Option. If an Option is not specifically designated as an Incentive Stock Option, or if an Option is designated as an Incentive Stock Option but some portion or all of the Option fails to qualify as an Incentive Stock Option under the applicable
rules, then the Option (or portion thereof) will be a Nonstatutory Stock Option. The provisions of separate Options or SARs need not be identical; <I>provided, however</I>, that each Award Agreement will conform to (through incorporation of provisions hereof by reference in the applicable Award Agreement or otherwise) the substance of each of the following provisions: </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(a) Term.</B>&nbsp;&nbsp;Subject to the provisions of Section 4(b) regarding Ten Percent Shareholders, no Option or SAR will be exercisable after the expiration of ten years from the date of its grant or such shorter period specified in the Award Agreement. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(b) Exercise Price.</B>&nbsp;&nbsp;Subject to the provisions of Section 4(b) regarding Ten Percent Shareholders, the exercise or strike price of each Option or SAR will be not less than 100% of the Fair Market Value of the Common Stock subject to the Option or SAR on the date the Award is granted. Notwithstanding the foregoing, an Option or SAR may be granted with an exercise or strike price lower than 100% of the Fair Market Value of the Common Stock subject to the Award if such Award is granted pursuant to an assumption of or substitution for another option or stock appreciation right pursuant to a Corporate Transaction
and in a manner consistent with the provisions of Section 409A of the Code and, if applicable, Section 424(a) of the Code. Each SAR will be denominated in shares of Common Stock equivalents. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(c) Purchase Price for Options.</B>&nbsp;&nbsp;The purchase price of Common Stock acquired pursuant to the exercise of an Option may be paid, to the extent permitted by applicable law and as determined by the Board in its sole discretion, by any combination of the methods of payment set forth below. The Board will have the authority to grant Options that do not permit all of the following methods of payment </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">A-5</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(or otherwise restrict the ability to use certain methods) and to grant Options that require the consent of the Company to use a particular method of payment. The permitted methods of payment are as follows: </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 44px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(i) </B>by cash, check, bank draft or money order payable to the Company; </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 44px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(ii) </B>pursuant to a program developed under Regulation T as promulgated by the Federal Reserve Board that, prior to the issuance of the stock subject to the Option, results in either the receipt of cash (or check) by the Company or the receipt of irrevocable instructions to pay the aggregate exercise price to the Company from the sales proceeds; </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 44px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(iii) </B>by delivery to the Company (either by actual delivery or attestation) of shares of Common Stock; </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 44px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(iv) </B>if an Option is a Nonstatutory Stock Option, by a &#147;net exercise&#148; arrangement pursuant to which the Company will reduce the number of shares of Common Stock issuable upon exercise by the largest whole number of shares with a Fair Market Value that does not exceed the aggregate exercise price; <I>provided, however</I>, that the Company will accept a cash or other payment from the Participant to the extent of any remaining balance of the aggregate exercise price not satisfied by such reduction in the number of whole shares to be issued. Shares of Common Stock will no longer be subject to an Option and will
not be exercisable thereafter to the extent that (A) shares issuable upon exercise are used to pay the exercise price pursuant to the &#147;net exercise,&#148; (B) shares are delivered to the Participant as a result of such exercise, and (C) shares are withheld to satisfy tax withholding obligations; or </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 44px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(v) </B>in any other form of legal consideration that may be acceptable to the Board and specified in the applicable Award Agreement. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(d) Exercise and Payment of a SAR.</B>&nbsp;&nbsp;To exercise any outstanding SAR, the Participant must provide written notice of exercise to the Company in compliance with the provisions of the Stock Appreciation Right Agreement evidencing such SAR. The appreciation distribution payable on the exercise of a SAR will be not greater than an amount equal to the excess of (A) the aggregate Fair Market Value (on the date of the exercise of the SAR) of a number of shares of Common Stock equal to the number of Common Stock equivalents in which the Participant is vested under such SAR, and with respect to which the Participant is
exercising the SAR on such date, over (B) the aggregate strike price of the number of Common Stock equivalents with respect to which the Participant is exercising the SAR on such date. The appreciation distribution may be paid in Common Stock, in cash, in any combination of the two or in any other form of consideration, as determined by the Board and contained in the Award Agreement evidencing such SAR. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(e) Transferability of Options and SARs.</B>&nbsp;&nbsp;The Board may, in its sole discretion, impose such limitations on the transferability of Options and SARs as the Board will determine. In the absence of such a determination by the Board to the contrary, the following restrictions on the transferability of Options and SARs will apply: </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 44px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(i) Restrictions on Transfer.</B>&nbsp;&nbsp;An Option or SAR will not be transferable except by will or by the laws of descent and distribution (or pursuant to subsections (ii) and (iii) below), and will be exercisable during the lifetime of the Participant only by the Participant. The Board may permit transfer of the Option or SAR in a manner that is not prohibited by applicable tax and securities laws. Except as explicitly provided in the Plan, neither an Option nor a SAR may be transferred for consideration. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 44px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(ii) Domestic Relations Orders.</B>&nbsp;&nbsp;Subject to the approval of the Board or a duly authorized Officer, an Option or SAR may be transferred pursuant to the terms of a domestic relations order, official marital settlement agreement or other divorce or separation instrument as permitted by Treasury Regulations Section 1.421-1(b)(2). If an Option is an Incentive Stock Option, such Option may be deemed to be a Nonstatutory Stock Option as a result of such transfer. </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">A-6</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 44px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(iii) Beneficiary Designation.</B>&nbsp;&nbsp;Subject to the approval of the Board or a duly authorized Officer, a Participant may, by delivering written notice to the Company, in a form approved by the Company (or the designated broker), designate a third party who, on the death of the Participant, will thereafter be entitled to exercise the Option or SAR and receive the Common Stock or other consideration resulting from such exercise. In the absence of such a designation, upon the death of the Participant, the executor or administrator of the Participant&#146;s estate will be entitled to exercise the Option or SAR and
receive the Common Stock or other consideration resulting from such exercise. However, the Company may prohibit designation of a beneficiary at any time, including due to any conclusion by the Company that such designation would be inconsistent with the provisions of applicable laws. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(f) Vesting Generally.</B>&nbsp;&nbsp;The total number of shares of Common Stock subject to an Option or SAR may vest and become exercisable in periodic installments that may or may not be equal. The Option or SAR may be subject to such other terms and conditions on the time or times when it may or may not be exercised (which may be based on the satisfaction of Performance Goals or other criteria) as the Board may deem appropriate. The vesting provisions of individual Options or SARs may vary. The provisions of this Section 5(f) are subject to any Option or SAR provisions governing the minimum number of shares of Common
Stock as to which an Option or SAR may be exercised. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(g) Termination of Continuous Service.</B>&nbsp;&nbsp;Except as otherwise provided in the applicable Award Agreement or other agreement between the Participant and the Company, if a Participant&#146;s Continuous Service terminates (other than for Cause and other than upon the Participant&#146;s death or Disability), the Participant may exercise his or her Option or SAR (to the extent that the Participant was entitled to exercise such Award as of the date of termination of Continuous Service) within the period of time ending on the earlier of (i) the date three months following the termination of the Participant&#146;s
Continuous Service (or such longer or shorter period specified in the applicable Award Agreement), and (ii) the expiration of the term of the Option or SAR as set forth in the Award Agreement. If, after termination of Continuous Service, the Participant does not exercise his or her Option or SAR (as applicable) within the applicable time frame, the Option or SAR will terminate. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(h) Extension of Termination Date.</B>&nbsp;&nbsp;If the exercise of an Option or SAR following the termination of the Participant&#146;s Continuous Service (other than for Cause and other than upon the Participant&#146;s death or Disability) would be prohibited at any time solely because the issuance of shares of Common Stock would violate the registration requirements under the Securities Act, then the Option or SAR will terminate on the earlier of (i) the expiration of a total period of time (that need not be consecutive) equal to the applicable post termination exercise period after the termination of the
Participant&#146;s Continuous Service during which the exercise of the Option or SAR would not be in violation of such registration requirements, and (ii) the expiration of the term of the Option or SAR as set forth in the applicable Award Agreement. In addition, unless otherwise provided in a Participant&#146;s Award Agreement, if the sale of any Common Stock received on exercise of an Option or SAR following the termination of the Participant&#146;s Continuous Service (other than for Cause) would violate the Company&#146;s insider trading policy, then the Option or SAR will terminate on the earlier of (i) the expiration of a period of months (that need not be consecutive) equal to the applicable post-termination exercise period after the termination of the Participant&#146;s Continuous Service during which the sale of the Common Stock received upon exercise of the Option or SAR would not be in violation of the Company&#146;s insider trading policy, or (ii) the expiration of the term
of the Option or SAR as set forth in the applicable Award Agreement. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(i) Disability of Participant.</B>&nbsp;&nbsp;Except as otherwise provided in the applicable Award Agreement or other agreement between the Participant and the Company, if a Participant&#146;s Continuous Service terminates as a result of the Participant&#146;s Disability, the Participant may exercise his or her Option or SAR (to the extent that the Participant was entitled to exercise such Option or SAR as of the date of termination of Continuous Service), but only within such period of time ending on the earlier of (i) the date 12 months following such termination of Continuous Service (or such longer or shorter period
specified in the Award Agreement), and (ii) the expiration of the term of the Option or SAR as set forth in the Award Agreement. If, after termination of Continuous Service, the Participant does not exercise his or her Option or SAR within the applicable time frame, the Option or SAR (as applicable) will terminate. </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">A-7</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(j) Death of Participant.</B>&nbsp;&nbsp;Except as otherwise provided in the applicable Award Agreement or other agreement between the Participant and the Company, if (i) a Participant&#146;s Continuous Service terminates as a result of the Participant&#146;s death, or (ii) the Participant dies within the period (if any) specified in the Award Agreement for exercisability after the termination of the Participant&#146;s Continuous Service for a reason other than death, then the Option or SAR may be exercised (to the extent the Participant was entitled to exercise such Option or SAR as of the date of death) by the
Participant&#146;s estate, by a person who acquired the right to exercise the Option or SAR by bequest or inheritance or by a person designated to exercise the Option or SAR upon the Participant&#146;s death, but only within the period ending on the earlier of (i) the date 18 months following the date of death (or such longer or shorter period specified in the Award Agreement), and (ii) the expiration of the term of such Option or SAR as set forth in the Award Agreement. If, after the Participant&#146;s death, the Option or SAR is not exercised within the applicable time frame, the Option or SAR (as applicable) will terminate. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(k) Termination for Cause.</B>&nbsp;&nbsp;Except as explicitly provided otherwise in a Participant&#146;s Award Agreement or other individual written agreement between the Company or any Affiliate and the Participant, if a Participant&#146;s Continuous Service is terminated for Cause, the Option or SAR will terminate immediately upon such Participant&#146;s termination of Continuous Service, and the Participant will be prohibited from exercising his or her Option or SAR from and after the time of such termination of Continuous Service. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(l) Non-Exempt Employees.</B>&nbsp;&nbsp;If an Option or SAR is granted to an Employee who is a non-exempt employee for purposes of the Fair Labor Standards Act of 1938, as amended, the Option or SAR will not be first exercisable for any shares of Common Stock until at least six months following the date of grant of the Option or SAR (although the Award may vest prior to such date). Consistent with the provisions of the Worker Economic Opportunity Act, (i) if such non-exempt Employee dies or suffers a Disability, (ii) upon a Corporate Transaction in which such Option or SAR is not assumed, continued, or substituted, (iii)
upon a Change in Control, or (iv) upon the Participant&#146;s retirement (as such term may be defined in the Participant&#146;s Award Agreement in another agreement between the Participant and the Company, or, if no such definition, in accordance with the Company&#146;s then current employment policies and guidelines), the vested portion of any Options and SARs may be exercised earlier than six months following the date of grant. The foregoing provision is intended to operate so that any income derived by a non-exempt employee in connection with the exercise or vesting of an Option or SAR will be exempt from his or her regular rate of pay. To the extent permitted and/or required for compliance with the Worker Economic Opportunity Act to ensure that any income derived by a non-exempt employee in connection with the exercise, vesting or issuance of any shares under any other Stock Award will be exempt from the employee&#146;s regular rate of pay, the provisions of this Section 5(l) will
apply to all Stock Awards and are hereby incorporated by reference into such Stock Award Agreements. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">6. <FONT STYLE="font-variant: small-caps">Provisions of Stock Awards other than Options and SARs.</FONT> </H2>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(a) Restricted Stock Awards.</B>&nbsp;&nbsp;Each Restricted Stock Award Agreement will be in such form and will contain such terms and conditions as the Board will deem appropriate. To the extent consistent with the Company&#146;s bylaws, at the Board&#146;s election, shares of Common Stock may be (x) held in book entry form subject to the Company&#146;s instructions until any restrictions relating to the Restricted Stock Award lapse; or (y) evidenced by a certificate, which certificate will be held in such form and manner as determined by the Board. The terms and conditions of Restricted Stock Award Agreements may change
from time to time, and the terms and conditions of separate Restricted Stock Award Agreements need not be identical. Each Restricted Stock Award Agreement will conform to (through incorporation of the provisions hereof by reference in the agreement or otherwise) the substance of each of the following provisions: </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(i) Consideration.</B>&nbsp;&nbsp;A Restricted Stock Award may be awarded in consideration for (A) cash, check, bank draft or money order payable to the Company, (B) past services to the Company or an Affiliate, or (C) any other form of legal consideration that may be acceptable to the Board, in its sole discretion, and permissible under applicable law. </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">A-8</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(ii) Vesting.</B>&nbsp;&nbsp;Shares of Common Stock awarded under the Restricted Stock Award Agreement may be subject to forfeiture to the Company in accordance with a vesting schedule to be determined by the Board. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(iii) Termination of Participant&#146;s Continuous Service.</B>&nbsp;&nbsp;If a Participant&#146;s Continuous Service terminates, the Company may receive through a forfeiture condition or a repurchase right any or all of the shares of Common Stock held by the Participant that have not vested as of the date of termination of Continuous Service under the terms of the Restricted Stock Award Agreement. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(iv) Transferability.</B>&nbsp;&nbsp;Rights to acquire shares of Common Stock under the Restricted Stock Award Agreement will be transferable by the Participant only upon such terms and conditions as are set forth in the Restricted Stock Award Agreement, as the Board will determine in its sole discretion, so long as Common Stock awarded under the Restricted Stock Award Agreement remains subject to the terms of the Restricted Stock Award Agreement. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(v) Dividends.</B>&nbsp;&nbsp;A Restricted Stock Award Agreement may provide that any dividends paid on Restricted Stock will be subject to the same vesting and forfeiture restrictions as apply to the shares subject to the Restricted Stock Award to which they relate. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(b) Restricted Stock Unit Awards.</B>&nbsp;&nbsp;Each Restricted Stock Unit Award Agreement will be in such form and will contain such terms and conditions as the Board will deem appropriate. The terms and conditions of Restricted Stock Unit Award Agreements may change from time to time, and the terms and conditions of separate Restricted Stock Unit Award Agreements need not be identical. Each Restricted Stock Unit Award Agreement will conform to (through incorporation of the provisions hereof by reference in the Agreement or otherwise) the substance of each of the following provisions: </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(i) Consideration.</B>&nbsp;&nbsp;At the time of grant of a Restricted Stock Unit Award, the Board will determine the consideration, if any, to be paid by the Participant upon delivery of each share of Common Stock subject to the Restricted Stock Unit Award. The consideration to be paid (if any) by the Participant for each share of Common Stock subject to a Restricted Stock Unit Award may be paid in any form of legal consideration that may be acceptable to the Board, in its sole discretion, and permissible under applicable law. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(ii) Vesting.</B>&nbsp;&nbsp;At the time of the grant of a Restricted Stock Unit Award, the Board may impose such restrictions on or conditions to the vesting of the Restricted Stock Unit Award as it, in its sole discretion, deems appropriate. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(iii) Payment.</B>&nbsp;&nbsp;A Restricted Stock Unit Award may be settled by the delivery of shares of Common Stock, their cash equivalent, any combination thereof or in any other form of consideration, as determined by the Board and contained in the Restricted Stock Unit Award Agreement. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(iv) Additional Restrictions.</B>&nbsp;&nbsp;At the time of the grant of a Restricted Stock Unit Award, the Board, as it deems appropriate, may impose such restrictions or conditions that delay the delivery of the shares of Common Stock (or their cash equivalent) subject to a Restricted Stock Unit Award to a time after the vesting of such Restricted Stock Unit Award. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(v) Dividend Equivalents.</B>&nbsp;&nbsp;Dividend equivalents may be credited in respect of shares of Common Stock covered by a Restricted Stock Unit Award, as determined by the Board and contained in the Restricted Stock Unit Award Agreement. At the sole discretion of the Board, such dividend equivalents may be converted into additional shares of Common Stock covered by the Restricted Stock Unit Award in such manner as determined by the Board. Any additional shares covered by the Restricted Stock Unit Award credited by reason of such dividend equivalents will be subject to all of the same terms and conditions of the
underlying Restricted Stock Unit Award Agreement to which they relate. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(vi) Termination of Participant&#146;s Continuous Service.</B>&nbsp;&nbsp;Except as otherwise provided in the applicable Restricted Stock Unit Award Agreement, such portion of the Restricted Stock Unit Award that has not vested will be forfeited upon the Participant&#146;s termination of Continuous Service. </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">A-9</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(c) Performance Awards</B>. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(i) Performance Stock Awards.</B>&nbsp;&nbsp;A Performance Stock Award is a Stock Award (covering a number of shares not in excess of that set forth in Section 3(d) above) that is payable (including that may be granted, may vest or may be exercised) contingent upon the attainment during a Performance Period of certain Performance Goals. A Performance Stock Award may, but need not, require the Participant&#146;s completion of a specified period of Continuous Service. The length of any Performance Period, the Performance Goals to be achieved during the Performance Period, and the measure of whether and to what degree such
Performance Goals have been attained will be conclusively determined by the Committee (or, if not required for compliance with Section 162(m) of the Code, the Board), in its sole discretion. In addition, to the extent permitted by applicable law and the applicable Award Agreement, the Board may determine that cash may be used in payment of Performance Stock Awards. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(ii) Performance Cash Awards.</B>&nbsp;&nbsp;A Performance Cash Award is a cash award (for a dollar value not in excess of that set forth in Section 3(d) above) that is payable contingent upon the attainment during a Performance Period of certain Performance Goals. A Performance Cash Award may also require the completion of a specified period of Continuous Service. At the time of grant of a Performance Cash Award, the length of any Performance Period, the Performance Goals to be achieved during the Performance Period, and the measure of whether and to what degree such Performance Goals have been attained will be
conclusively determined by the Committee (or, if not required for compliance with Section 162(m) of the Code, the Board), in its sole discretion. The Board may specify the form of payment of Performance Cash Awards, which may be cash or other property, or may provide for a Participant to have the option for his or her Performance Cash Award, or such portion thereof as the Board may specify, to be paid in whole or in part in cash or other property. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(iii) Board Discretion.</B>&nbsp;&nbsp;The Board retains the discretion to reduce or eliminate the compensation or economic benefit due upon attainment of Performance Goals and to define the manner of calculating the Performance Criteria it selects to use for a Performance Period. Partial achievement of the specified criteria may result in the payment or vesting corresponding to the degree of achievement as specified in the Stock Award Agreement or the written terms of a Performance Cash Award. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(iv) Section 162(m) Compliance.</B>&nbsp;&nbsp;Unless otherwise permitted in compliance with the requirements of Section 162(m) of the Code with respect to an Award intended to qualify as &#147;performance-based compensation&#148; thereunder, the Committee will establish the Performance Goals applicable to, and the formula for calculating the amount payable under, the Award no later than the earlier of (a) the date 90 days after the commencement of the applicable Performance Period, and (b) the date on which 25% of the Performance Period has elapsed, and in any event at a time when the achievement of the applicable
Performance Goals remains substantially uncertain. Prior to the payment of any compensation under an Award intended to qualify as &#147;performance-based compensation&#148; under Section 162(m) of the Code, the Committee will certify the extent to which any Performance Goals and any other material terms under such Award have been satisfied (other than in cases where such Performance Goals relate solely to the increase in the value of the Common Stock). Notwithstanding satisfaction of, or completion of any Performance Goals, the number of shares of Common Stock, Options, cash or other benefits granted, issued, retainable and/or vested under an Award on account of satisfaction of such Performance Goals may be reduced by the Committee on the basis of such further considerations as the Committee, in its sole discretion, will determine. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(d) Other Stock Awards.</B>&nbsp;&nbsp;Other forms of Stock Awards valued in whole or in part by reference to, or otherwise based on, Common Stock, including the appreciation in value thereof (e.g., options or stock rights with an exercise price or strike price less than 100% of the Fair Market Value of the Common Stock at the time of grant) may be granted either alone or in addition to Stock Awards provided for under Section 5 and the preceding provisions of this Section 6. Subject to the provisions of the Plan, the Board will have sole and complete authority to determine the persons to whom and the time or times at which
such Other Stock Awards will be granted, the number of shares of Common Stock (or the cash equivalent thereof) to be granted pursuant to such Other Stock Awards and all other terms and conditions of such Other Stock Awards. </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">A-10</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">7. <FONT STYLE="font-variant: small-caps">Covenants of the Company.</FONT> </H2>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(a) Availability of Shares.</B>&nbsp;&nbsp;The Company will keep available at all times the number of shares of Common Stock reasonably required to satisfy then-outstanding Awards. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(b) Securities Law Compliance.</B>&nbsp;&nbsp;The Company will seek to obtain from each regulatory commission or agency having jurisdiction over the Plan such authority as may be required to grant Stock Awards and to issue and sell shares of Common Stock upon exercise of the Stock Awards; <I>provided, however</I>, that this undertaking will not require the Company to register under the Securities Act the Plan, any Stock Award or any Common Stock issued or issuable pursuant to any such Stock Award. If, after reasonable efforts and at a reasonable cost, the Company is unable to obtain from any such regulatory commission or
agency the authority that counsel for the Company deems necessary for the lawful issuance and sale of Common Stock under the Plan, the Company will be relieved from any liability for failure to issue and sell Common Stock upon exercise of such Stock Awards unless and until such authority is obtained. A Participant will not be eligible for the grant of an Award or the subsequent issuance of cash or Common Stock pursuant to the Award if such grant or issuance would be in violation of any applicable securities law. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(c) No Obligation to Notify or Minimize Taxes.</B>&nbsp;&nbsp;The Company will have no duty or obligation to any Participant to advise such holder as to the time or manner of exercising such Stock Award. Furthermore, the Company will have no duty or obligation to warn or otherwise advise such holder of a pending termination or expiration of an Award or a possible period in which the Award may not be exercised. The Company has no duty or obligation to minimize the tax consequences of an Award to the holder of such Award. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">8. <FONT STYLE="font-variant: small-caps">Miscellaneous.</FONT> </H2>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(a) Use of Proceeds from Sales of Common Stock.</B>&nbsp;&nbsp;Proceeds from the sale of shares of Common Stock pursuant to Awards will constitute general funds of the Company. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(b) Corporate Action Constituting Grant of Awards.</B>&nbsp;&nbsp;Corporate action constituting a grant by the Company of an Award to any Participant will be deemed completed as of the date of such corporate action, unless otherwise determined by the Board, regardless of when the instrument, certificate, or letter evidencing the Award is communicated to, or actually received or accepted by, the Participant. In the event that the corporate records (e.g., Board consents, resolutions or minutes) documenting the corporate action constituting the grant contain terms (e.g., exercise price, vesting schedule or number of shares)
that are inconsistent with those in the Award Agreement or related grant documents as a result of a clerical error in the papering of the Award Agreement or related grant documents, the corporate records will control and the Participant will have no legally binding right to the incorrect term in the Award Agreement or related grant documents. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(c) Shareholder Rights.</B>&nbsp;&nbsp;No Participant will be deemed to be the holder of, or to have any of the rights of a holder with respect to, any shares of Common Stock subject to an Award unless and until (i) such Participant has satisfied all requirements for exercise of, or the issuance of shares of Common Stock under, the Award pursuant to its terms, and (ii) the issuance of the Common Stock subject to such Award has been entered into the books and records of the Company. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(d) No Employment or Other Service Rights.</B>&nbsp;&nbsp;Nothing in the Plan, any Award Agreement or any other instrument executed thereunder or in connection with any Award granted pursuant thereto will confer upon any Participant any right to continue to serve the Company or an Affiliate in the capacity in effect at the time the Award was granted or will affect the right of the Company or an Affiliate to terminate (i) the employment of an Employee with or without notice and with or without cause, (ii) the service of a Consultant pursuant to the terms of such Consultant&#146;s agreement with the Company or an Affiliate,
or (iii) the service of a Director pursuant to the bylaws of the Company or an Affiliate, and any applicable provisions of the corporate law of the state in which the Company or the Affiliate is incorporated, as the case may be. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(e) Change in Time Commitment.</B> In the event a Participant&#146;s regular level of time commitment in the performance of his or her services for the Company and any Affiliates is reduced (for example, and without limitation, if the Participant is an Employee of the Company and the Employee has a change in status from a full-time Employee to a part-time Employee or takes an extended leave of absence) after the date of grant of any Award to the Participant, the Board has the right in its sole discretion to (x) make a corresponding reduction in the number of shares or cash amount subject to any portion of such Award that is
scheduled to </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">A-11</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">vest or become payable after the date of such change in time commitment, and (y) in lieu of or in combination with such a reduction, extend the vesting or payment schedule applicable to such Award. In the event of any such reduction, the Participant will have no right with respect to any portion of the Award that is so reduced or extended. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(f) Incentive Stock Option Limitations.</B>&nbsp;&nbsp;To the extent that the aggregate Fair Market Value (determined at the time of grant) of Common Stock with respect to which Incentive Stock Options are exercisable for the first time by any Optionholder during any calendar year (under all plans of the Company and any Affiliates) exceeds $100,000 (or such other limit established in the Code) or otherwise does not comply with the rules governing Incentive Stock Options, the Options or portions thereof that exceed such limit (according to the order in which they were granted) or otherwise do not comply with such rules will
be treated as Nonstatutory Stock Options, notwithstanding any contrary provision of the applicable Option Agreement(s). </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(g) Investment Assurances.</B>&nbsp;&nbsp;The Company may require a Participant, as a condition of exercising or acquiring Common Stock under any Award, (i) to give written assurances satisfactory to the Company as to the Participant&#146;s knowledge and experience in financial and business matters and/or to employ a purchaser representative reasonably satisfactory to the Company who is knowledgeable and experienced in financial and business matters and that such Participant is capable of evaluating, alone or together with the purchaser representative, the merits and risks of exercising the Award; and (ii) to give written
assurances satisfactory to the Company stating that the Participant is acquiring Common Stock subject to the Award for the Participant&#146;s own account and not with any present intention of selling or otherwise distributing the Common Stock. The foregoing requirements, and any assurances given pursuant to such requirements, will be inoperative if (A) the issuance of the shares upon the exercise or acquisition of Common Stock under the Award has been registered under a then currently effective registration statement under the Securities Act, or (B) as to any particular requirement, a determination is made by counsel for the Company that such requirement need not be met in the circumstances under the then applicable securities laws. The Company may, upon advice of counsel to the Company, place legends on stock certificates issued under the Plan as such counsel deems necessary or appropriate in order to comply with applicable securities laws, including, but not limited to, legends
restricting the transfer of the Common Stock. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(h) Withholding Obligations.</B>&nbsp;&nbsp;Unless prohibited by the terms of an Award Agreement, the Company may, in its sole discretion, satisfy any federal, state or local tax withholding obligation relating to an Award by any of the following means or by a combination of such means: (i) causing the Participant to tender a cash payment; (ii) withholding shares of Common Stock from the shares of Common Stock issued or otherwise issuable to the Participant in connection with the Award; <I>provided, however, </I>that no shares of Common Stock are withheld with a value exceeding the minimum amount of tax required to be
withheld by law (or such lesser amount as may be necessary to avoid classification of the Stock Award as a liability for financial accounting purposes); (iii) withholding cash from an Award settled in cash; (iv) withholding payment from any amounts otherwise payable to the Participant; or (v) by such other method as may be set forth in the Award Agreement. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(i) Electronic Delivery.</B>&nbsp;&nbsp;Any reference herein to a &#147;written&#148; agreement or document will include any agreement or document delivered electronically, filed publicly at <I>www.sec.gov</I> (or any successor website thereto) or posted on the Company&#146;s intranet (or other shared electronic medium controlled by the Company to which the Participant has access). </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(j) Deferrals.</B>&nbsp;&nbsp;To the extent permitted by applicable law, the Board, in its sole discretion, may determine that the delivery of Common Stock or the payment of cash, upon the exercise, vesting or settlement of all or a portion of any Award may be deferred and may establish programs and procedures for deferral elections to be made by Participants. Deferrals by Participants will be made in accordance with Section 409A of the Code. Consistent with Section 409A of the Code, the Board may provide for distributions while a Participant is still an employee or otherwise providing services to the Company. The Board is
authorized to make deferrals of Awards and determine when, and in what annual percentages, Participants may receive </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">A-12</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">payments, including lump sum payments, following the Participant&#146;s termination of Continuous Service, and implement such other terms and conditions consistent with the provisions of the Plan and in accordance with applicable law. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(k) Compliance with Section 409A of the Code.</B>&nbsp;&nbsp;Unless otherwise expressly provided for in an Award Agreement, the Plan and Award Agreements will be interpreted to the greatest extent possible in a manner that makes the Plan and the Awards granted hereunder exempt from Section 409A of the Code, and, to the extent not so exempt, in compliance with Section 409A of the Code. If the Board determines that any Award granted hereunder is not exempt from and is therefore subject to Section 409A of the Code, the Award Agreement evidencing such Award will incorporate the terms and conditions necessary to avoid the
consequences specified in Section 409A(a)(1) of the Code, and to the extent an Award Agreement is silent on terms necessary for compliance, such terms are hereby incorporated by reference into the Award Agreement. Notwithstanding anything to the contrary in this Plan (and unless the Award Agreement specifically provides otherwise), if the shares of Common Stock are publicly traded, and if a Participant holding an Award that constitutes &#147;deferred compensation&#148; under Section 409A of the Code is a &#147;specified employee&#148; for purposes of Section 409A of the Code, no distribution or payment of any amount that is due because of a &#147;separation from service&#148; (as defined in Section 409A of the Code without regard to alternative definitions thereunder) will be issued or paid before the date that is six months following the date of such Participant&#146;s &#147;separation from service&#148; (as defined in Section 409A of the Code without regard to alternative definitions
thereunder) or, if earlier, the date of the Participant&#146;s death, unless such distribution or payment can be made in a manner that complies with Section 409A of the Code, and any amounts so deferred will be paid in a lump sum on the day after such six month period elapses, with the balance paid thereafter on the original schedule. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(l) Clawback/Recovery.</B>&nbsp;&nbsp;All Awards granted under the Plan will be subject to recoupment in accordance with any clawback policy that the Company is required to adopt pursuant to the listing standards of any national securities exchange or association on which the Company&#146;s securities are listed or as is otherwise required by the Dodd-Frank Wall Street Reform and Consumer Protection Act or other applicable law. In addition, the Board may impose such other clawback, recovery or recoupment provisions in an Award Agreement as the Board determines necessary or appropriate, including but not limited to a
reacquisition right in respect of previously acquired shares of Common Stock or other cash or property upon the occurrence of an event constituting Cause. No recovery of compensation under such a clawback policy will be an event giving rise to a right to resign for &#147;good reason&#148; or &#147;constructive termination&#148; (or similar term) under any agreement with the Company. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">9. <FONT STYLE="font-variant: small-caps">Adjustments upon Changes in Common Stock; Other Corporate Events.</FONT> </H2>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(a) Capitalization Adjustments.</B>&nbsp;&nbsp;In the event of a Capitalization Adjustment, the Board will appropriately and proportionately adjust: (i) the class(es) and maximum number of securities subject to the Plan pursuant to Section 3(a), (ii) the class(es) and maximum number of securities that may be issued pursuant to the exercise of Incentive Stock Options pursuant to Section 3(c), (iii) the class(es) and maximum number of securities that may be awarded to any person pursuant to Sections 3(d), and (iv) the class(es) and number of securities and price per share of stock subject to outstanding Stock Awards. The
Board will make such adjustments, and its determination will be final, binding and conclusive. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(b) Dissolution.</B>&nbsp;&nbsp;Except as otherwise provided in the Stock Award Agreement, in the event of a Dissolution of the Company, all outstanding Stock Awards (other than Stock Awards consisting of vested and outstanding shares of Common Stock not subject to a forfeiture condition or the Company&#146;s right of repurchase) will terminate immediately prior to the completion of such Dissolution, and the shares of Common Stock subject to the Company&#146;s repurchase rights or subject to a forfeiture condition may be repurchased or reacquired by the Company notwithstanding the fact that the holder of such Stock Award is
providing Continuous Service; <I>provided, however</I>, that the Board may, in its sole discretion, cause some or all Stock Awards to become fully vested, exercisable and/or no longer subject to repurchase or forfeiture (to the extent such Stock Awards have not previously expired or terminated) before the Dissolution is completed but contingent on its completion. </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">A-13</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(c) Transactions.</B>&nbsp;&nbsp;The following provisions shall apply to Stock Awards in the event of a Transaction unless otherwise provided in the instrument evidencing the Stock Award or any other written agreement between the Company or any Affiliate and the Participant or unless otherwise expressly provided by the Board at the time of grant of a Stock Award. In the event of a Transaction, then, notwithstanding any other provision of the Plan, the Board shall take one or more of the following actions with respect to Stock Awards, contingent upon the closing or completion of the Transaction: </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(i) </B>arrange for the surviving corporation or acquiring corporation (or the surviving or acquiring corporation&#146;s parent company) to assume or continue the Stock Award or to substitute a similar stock award for the Stock Award (including, but not limited to, an award to acquire the same consideration paid to the shareholders of the Company pursuant to the Transaction); </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(ii) </B>arrange for the assignment of any reacquisition or repurchase rights held by the Company in respect of Common Stock issued pursuant to the Stock Award to the surviving corporation or acquiring corporation (or the surviving or acquiring corporation&#146;s parent company); </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(iii) </B>accelerate the vesting, in whole or in part, of the Stock Award (and, if applicable, the time at which the Stock Award may be exercised) to a date prior to the effective time of such Transaction as the Board shall determine (or, if the Board shall not determine such a date, to the date that is five days prior to the effective date of the Transaction), with such Stock Award terminating if not exercised (if applicable) at or prior to the effective time of the Transaction; </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(iv) </B>arrange for the lapse, in whole or in part, of any reacquisition or repurchase rights held by the Company with respect to the Stock Award; </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(v) </B>cancel or arrange for the cancellation of the Stock Award, to the extent not vested or not exercised prior to the effective time of the Transaction, in exchange for such cash consideration, if any, as the Board, in its sole discretion, may consider appropriate; and </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(vi) </B>make a payment, in such form as may be determined by the Board equal to the excess, if any, of (A) the value of the property the Participant would have received upon the exercise of the Stock Award immediately prior to the effective time of the Transaction, over (B) any exercise price payable by such holder in connection with such exercise. For clarity, this payment may be zero ($0) if the value of the property is equal to or less than the exercise price. Payments under this provision may be delayed to the same extent that payment of consideration to the holders of Common Stock in connection with the Transaction
is delayed as a result of escrows, earn outs, holdbacks or other contingencies. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The Board need not take the same action or actions with respect to all Stock Awards or portions thereof or with respect to all Participants. The Board may take different actions with respect to the vested and unvested portions of a Stock Award. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(d) Change in Control.</B>&nbsp;&nbsp;A Stock Award may be subject to additional acceleration of vesting and exercisability upon or after a Change in Control as may be provided in the Stock Award Agreement for such Stock Award or as may be provided in any other written agreement between the Company or any Affiliate and the Participant, but in the absence of such provision, no such acceleration will occur. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">10. <FONT STYLE="font-variant: small-caps">Plan Term; Earlier Termination or Suspension of the Plan.</FONT> </H2>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The Board may suspend or terminate the Plan at any time. No Incentive Stock Options may be granted after the tenth anniversary of the earlier of (i) the date the Plan is adopted by the Board (the &#147;<B><I>Adoption Date</I></B>&#148;), or (ii) the date the Plan is approved by the shareholders of the Company. No Awards may be granted under the Plan while the Plan is suspended or after it is terminated. Suspension or termination of the Plan will not impair rights and obligations under any Award granted while the Plan is in effect except with the written consent of the affected Participant or as otherwise permitted in the Plan.
</P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">11. <FONT STYLE="font-variant: small-caps">Existence of the Plan.</FONT> </H2>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The Plan will become effective on the Effective Date. </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">A-14</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">12. <FONT STYLE="font-variant: small-caps">Choice of Law.</FONT> </H2>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The law of the State of Delaware will govern all questions concerning the construction, validity and interpretation of this Plan, without regard to that state&#146;s conflict of laws rules. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>13. </B><FONT STYLE="font-variant: small-caps"><B>Definitions.</FONT>&nbsp;&nbsp;</B>As used in the Plan, the following definitions will apply to the capitalized terms indicated below: </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(a) </B>&#147;<B><I>Affiliate</I></B>&#148; means, at the time of determination, any &#147;parent&#148; or &#147;subsidiary&#148; of the Company as such terms are defined in Rule 405 of the Securities Act. The Board will have the authority to determine the time or times at which &#147;parent&#148; or &#147;subsidiary&#148; status is determined within the foregoing definition. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(b) </B>&#147;<B><I>Award</I></B>&#148; means a Stock Award or a Performance Cash Award. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(c) </B>&#147;<B><I>Award Agreement</I></B>&#148; means a written agreement between the Company and a Participant evidencing the terms and conditions of an Award. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(d) </B>&#147;<B><I>Board</I></B>&#148; means the Board of Directors of the Company. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(e) </B>&#147;<B><I>Capital Stock</I></B>&#148; means each and every class of common stock of the Company, regardless of the number of votes per share. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(f) </B>&#147;<B><I>Capitalization Adjustment</I></B>&#148; means any change that is made in, or other events that occur with respect to, the Common Stock subject to the Plan or subject to any Stock Award after the Adoption Date without the receipt of consideration by the Company through merger, consolidation, reorganization, recapitalization, reincorporation, stock dividend, dividend in property other than cash, large nonrecurring cash dividend, stock split, reverse stock split, liquidating dividend, combination of shares, exchange of shares, change in corporate structure or any similar equity restructuring transaction, as
that term is used in Statement of Financial Accounting Standards Board Accounting Standards Codification Topic 718 (or any successor thereto). Notwithstanding the foregoing, the conversion of any convertible securities of the Company will not be treated as a Capitalization Adjustment. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(g) </B>&#147;<B><I>Cause</I></B>&#148; shall have the meaning ascribed to such term in any written agreement between the Participant and the Company defining such term and, in the absence of such agreement, such term means, with respect to a Participant, the occurrence of any of the following events: (i) such Participant&#146;s commission of any felony or any crime involving fraud, dishonesty or moral turpitude under the laws of the United States or any state thereof; (ii) such Participant&#146;s attempted commission of, or participation in, a fraud or act of dishonesty against the Company; (iii) such Participant&#146;s
intentional, material violation of any contract or agreement between the Participant and the Company or of any statutory duty owed to the Company; (iv) such Participant&#146;s unauthorized use or disclosure of the Company&#146;s confidential information or trade secrets; or (v) such Participant&#146;s gross misconduct. The determination that a termination of the Participant&#146;s Continuous Service is either for Cause or without Cause shall be made by the Company, in its sole discretion. Any determination by the Company that the Continuous Service of a Participant was terminated with or without Cause for the purposes of outstanding Awards held by such Participant shall have no effect upon any determination of the rights or obligations of the Company or such Participant for any other purpose. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(h) </B>&#147;<B><I>Change in Control</I></B>&#148; means the occurrence, in a single transaction or in a series of related transactions, of any one or more of the following events: </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(i) </B>any Exchange Act Person becomes the Owner, directly or indirectly, of securities of the Company representing more than 50% of the combined voting power of the Company&#146;s then outstanding securities other than by virtue of a merger, consolidation or similar transaction. Notwithstanding the foregoing, a Change in Control will not be deemed to occur (A) on account of the acquisition of securities of the Company directly from the Company, (B) on account of the acquisition of securities of the Company by an investor, any affiliate thereof or any other Exchange Act Person that acquires the Company&#146;s securities
in a transaction or series of related transactions the primary purpose of which is to obtain financing for the Company through the issuance of equity securities, (C) on account of the acquisition of securities of the Company by any individual who is, on the Adoption Date, either an executive officer or a Director (either, a &#147;<B><I>Legacy Investor</I></B>&#148;) and/or any entity in which a Legacy Investor has a direct or indirect interest (whether in the form of voting rights or participation in profits or capital contributions) of more </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">A-15</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">than 50% (collectively, the &#147;<B><I>Legacy Entities</I></B>&#148;) or on account of the Legacy Entities continuing to hold shares that come to represent more than 50% of the combined voting power of the Company&#146;s then outstanding securities as a result of the conversion of any class of the Company&#146;s securities into another class of the Company&#146;s securities having a different number of votes per share pursuant to the conversion provisions set forth in the Company&#146;s Amended and Restated Certificate of Incorporation; or (D) solely because the level of Ownership held by any Exchange Act Person (the &#147;<B>
<I>Subject Person</I></B>&#148;) exceeds the designated percentage threshold of the outstanding voting securities as a result of a repurchase or other acquisition of voting securities by the Company reducing the number of shares outstanding, provided that if a Change in Control would occur (but for the operation of this sentence) as a result of the acquisition of voting securities by the Company, and after such share acquisition, the Subject Person becomes the Owner of any additional voting securities that, assuming the repurchase or other acquisition had not occurred, increases the percentage of the then outstanding voting securities Owned by the Subject Person over the designated percentage threshold, then a Change in Control will be deemed to occur; </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(ii) </B>there is consummated a merger, consolidation or similar transaction involving (directly or indirectly) the Company and, immediately after the consummation of such merger, consolidation or similar transaction, the shareholders of the Company immediately prior thereto do not Own, directly or indirectly, either (A) outstanding voting securities representing more than 50% of the combined outstanding voting power of the surviving Entity in such merger, consolidation or similar transaction or (B) more than 50% of the combined outstanding voting power of the parent of the surviving Entity in such merger, consolidation or
similar transaction, in each case in substantially the same proportions as their Ownership of the outstanding voting securities of the Company immediately prior to such transaction; <I>provided, however</I>, that a merger, consolidation or similar transaction will not constitute a Change in Control under this prong of the definition if the outstanding voting securities representing more than 50% of the combined voting power of the surviving Entity or its parent are owned by the Legacy Entities; </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(iii) </B>there is consummated a sale, lease, exclusive license or other disposition of all or substantially all of the consolidated assets of the Company and its Subsidiaries, other than a sale, lease, license or other disposition of all or substantially all of the consolidated assets of the Company and its Subsidiaries to an Entity, more than 50% of the combined voting power of the voting securities of which are Owned by shareholders of the Company in substantially the same proportions as their Ownership of the outstanding voting securities of the Company immediately prior to such sale, lease, license or other
disposition; <I>provided, however</I>, that a sale, lease, exclusive license or other disposition of all or substantially all of the consolidated assets of the Company and its Subsidiaries will not constitute a Change in Control under this prong of the definition if the outstanding voting securities representing more than 50% of the combined voting power of the acquiring Entity or its parent are owned by the Legacy Entities; </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(iv) </B>the shareholders of the Company approve or the Board approves a plan of complete dissolution or liquidation of the Company, or a complete dissolution or liquidation of the Company will otherwise occur, except for a liquidation into a parent corporation; or </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(v) </B>individuals who, on the date the Plan is adopted by the Board, are members of the Board (the &#147;<B><I>Incumbent Board</I></B>&#148;) cease for any reason to constitute at least a majority of the members of the Board; <I>provided, however,</I> that if the appointment or election (or nomination for election) of any new Board member was approved or recommended by a majority vote of the members of the Incumbent Board then still in office, such new member will, for purposes of this Plan, be considered as a member of the Incumbent Board. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Notwithstanding the foregoing definition or any other provision of the Plan, the term Change in Control will not include a sale of assets, merger or other transaction effected exclusively for the purpose of changing the domicile of the Company and the definition of Change in Control (or any analogous term) in an individual written agreement between the Company or any Affiliate and the Participant will supersede the foregoing </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">A-16</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">definition with respect to Awards subject to such agreement; <I>provided, however</I>, that if no definition of Change in Control or any analogous term is set forth in such an individual written agreement, the foregoing definition will apply. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(i) </B>&#147;<B><I>Code</I></B>&#148; means the Internal Revenue Code of 1986, as amended, including any applicable regulations and guidance thereunder. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(j) </B>&#147;<B><I>Committee</I></B>&#148; means a committee of one or more Directors to whom authority has been delegated by the Board in accordance with Section 2(c). </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(k) </B>&#147;<B><I>Common Stock</I></B>&#148; means the common stock of the Company, having one vote per share. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(l) </B>&#147;<B><I>Company</I></B>&#148; means AmpliPhi Biosciences Corporation. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(m) </B>&#147;<B><I>Consultant</I></B>&#148; means any person, including an advisor, who is (i) engaged by the Company or an Affiliate to render consulting or advisory services and is compensated for such services, or (ii) serving as a member of the board of directors of an Affiliate and is compensated for such services. However, service solely as a Director, or payment of a fee for such service, will not cause a Director to be considered a &#147;Consultant&#148; for purposes of the Plan. Notwithstanding the foregoing, a person is treated as a Consultant under this Plan only if a Form S-8 Registration Statement under the
Securities Act is available to register either the offer or the sale of the Company&#146;s securities to such person. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(n) </B>&#147;<B><I>Continuous Service</I></B>&#148; means that the Participant&#146;s service with the Company or an Affiliate, whether as an Employee, Director or Consultant, is not interrupted or terminated. A change in the capacity in which the Participant renders service to the Company or an Affiliate as an Employee, Consultant or Director or a change in the entity for which the Participant renders such service, provided that there is no interruption or termination of the Participant&#146;s service with the Company or an Affiliate, will not terminate a Participant&#146;s Continuous Service; <I>provided, however</I>,
that if the Entity for which a Participant is rendering services ceases to qualify as an Affiliate, as determined by the Board, in its sole discretion, such Participant&#146;s Continuous Service will be considered to have terminated on the date such Entity ceases to qualify as an Affiliate. To the extent permitted by law, the Board or the chief executive officer of the Company, in that party&#146;s sole discretion, may determine whether Continuous Service will be considered interrupted in the case of (i) any leave of absence approved by the Board or chief executive officer, including sick leave, military leave or any other personal leave, or (ii) transfers between the Company, an Affiliate, or their successors. Notwithstanding the foregoing, a leave of absence will be treated as Continuous Service for purposes of vesting in an Award only to such extent as may be provided in the Company&#146;s leave of absence policy, in the written terms of any leave of absence agreement or policy
applicable to the Participant, or as otherwise required by law. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(o) </B>&#147;<B><I>Corporate Transaction</I></B>&#148; means the consummation, in a single transaction or in a series of related transactions, of any one or more of the following events: </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(i) </B>a sale or other disposition of all or substantially all, as determined by the Board, in its sole discretion, of the consolidated assets of the Company and its Subsidiaries; </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(ii) </B>a sale or other disposition of more than 50% of the outstanding securities of the Company; </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(iii) </B>a merger, consolidation or similar transaction following which the Company is not the surviving corporation; or </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(iv) </B>a merger, consolidation or similar transaction following which the Company is the surviving corporation but the shares of Common Stock outstanding immediately preceding the merger, consolidation or similar transaction are converted or exchanged by virtue of the merger, consolidation or similar transaction into other property, whether in the form of securities, cash or otherwise. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(p) </B>&#147;<B><I>Covered Employee</I></B>&#148; will have the meaning provided in Section 162(m)(3) of the Code. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(q) </B>&#147;<B><I>Director</I></B>&#148; means a member of the Board. </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">A-17</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(r) </B>&#147;<B><I>Disability</I></B>&#148; means, with respect to a Participant, the inability of such Participant to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment that can be expected to result in death or that has lasted or can be expected to last for a continuous period of not less than 12 months, as provided in Sections 22(e)(3) and 409A(a)(2)(c)(i) of the Code, and will be determined by the Board on the basis of such medical evidence as the Board deems warranted under the circumstances. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(s) </B>&#147;<B><I>Dissolution</I></B>&#148; means when the Company, after having executed a certificate of dissolution with the State of Delaware (or other applicable state), has completely wound up its affairs. Conversion of the Company into a Limited Liability Company (or any other pass-through entity) will not be considered a &#147;Dissolution&#148; for purposes of the Plan. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(t) </B>&#147;<B><I>Effective Date</I></B>&#148; means the date of the Company shareholders approve this Plan, which is the date of the annual meeting of shareholders of the Company held on [June 20, 2016] provided this Plan is approved by the Company&#146;s shareholders at such meeting. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(u) </B>&#147;<B><I>Employee</I></B>&#148; means any person employed by the Company or an Affiliate. However, service solely as a Director, or payment of a fee for such services, will not cause a Director to be considered an &#147;Employee&#148; for purposes of the Plan. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(v) </B>&#147;<B><I>Entity</I></B>&#148; means a corporation, partnership, limited liability company or other entity. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(w) </B>&#147;<B><I>Exchange Act</I></B>&#148; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(x) </B>&#147;<B><I>Exchange Act Person</I></B>&#148; means any natural person, Entity or &#147;group&#148; (within the meaning of Section 13(d) or 14(d) of the Exchange Act), except that &#147;Exchange Act Person&#148; will not include (i) the Company or any Subsidiary of the Company, (ii) any employee benefit plan of the Company or any Subsidiary of the Company or any trustee or other fiduciary holding securities under an employee benefit plan of the Company or any Subsidiary of the Company, (iii) an underwriter temporarily holding securities pursuant to a registered public offering of such securities, (iv) an Entity
Owned, directly or indirectly, by the shareholders of the Company in substantially the same proportions as their Ownership of stock of the Company; or (v) any natural person, Entity or &#147;group&#148; (within the meaning of Section 13(d) or 14(d) of the Exchange Act) that, as of the Effective Date, is the Owner, directly or indirectly, of securities of the Company representing more than 50% of the combined voting power of the Company&#146;s then outstanding securities. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(y) </B>&#147;<B><I>Fair Market Value</I></B>&#148; means, as of any date, the value of the Common Stock determined as follows: </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(i) </B>If the Common Stock is listed on any established stock exchange or traded on any established market, the Fair Market Value of a share of Common Stock will be, unless otherwise determined by the Board, the closing sales price for such stock as quoted on such exchange or market (or the exchange or market with the greatest volume of trading in the Common Stock) on the date of determination, as reported in a source the Board deems reliable. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(ii) </B>Unless otherwise provided by the Board, if there is no closing sales price for the Common Stock on the date of determination, then the Fair Market Value will be the closing selling price on the last preceding date for which such quotation exists. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(iii) </B>In the absence of such markets for the Common Stock, the Fair Market Value will be determined by the Board in good faith and in a manner that complies with Sections 409A and 422 of the Code. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(z) </B>&#147;<B><I>Incentive Stock Option</I></B>&#148; means an option granted pursuant to Section 5 of the Plan that is intended to be, and qualifies as, an &#147;incentive stock option&#148; within the meaning of Section 422 of the Code. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(aa) </B>&#147;<B><I>Non-Employee Director</I></B>&#148; means a Director who either (i) is not a current employee or officer of the Company or an Affiliate, does not receive compensation, either directly or indirectly, from the Company or an Affiliate for services rendered as a consultant or in any capacity other than as a Director (except for an amount as to which disclosure would not be required under Item 404(a) of Regulation S-K promulgated pursuant to the Securities Act (&#147;<B><I>Regulation S-K</I></B>&#148;)), does not possess an interest in any other transaction for </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">A-18</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">which disclosure would be required under Item 404(a) of Regulation S-K, and is not engaged in a business relationship for which disclosure would be required pursuant to Item 404(b) of Regulation S-K; or (ii) is otherwise considered a &#147;non-employee director&#148; for purposes of Rule 16b-3. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(bb) </B>&#147;<B><I>Nonstatutory Stock Option</I></B>&#148; means any Option granted pursuant to Section 5 of the Plan that does not qualify as an Incentive Stock Option. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(cc) </B>&#147;<B><I>Officer</I></B>&#148; means a person who is an officer of the Company within the meaning of Section 16 of the Exchange Act. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(dd) </B>&#147;<B><I>Option</I></B>&#148; means an Incentive Stock Option or a Nonstatutory Stock Option to purchase shares of Common Stock granted pursuant to the Plan. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(ee) </B>&#147;<B><I>Option Agreement</I></B>&#148; means a written agreement between the Company and an Optionholder evidencing the terms and conditions of an Option grant. Each Option Agreement will be subject to the terms and conditions of the Plan. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(ff) </B>&#147;<B><I>Optionholder</I></B>&#148; means a person to whom an Option is granted pursuant to the Plan or, if applicable, such other person who holds an outstanding Option. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(gg) </B>&#147;<B><I>Other Stock Award</I></B>&#148; means an award based in whole or in part by reference to the Common Stock which is granted pursuant to the terms and conditions of Section 6(d). </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(hh) </B>&#147;<B><I>Other Stock Award Agreement</I></B>&#148; means a written agreement between the Company and a holder of an Other Stock Award evidencing the terms and conditions of an Other Stock Award grant. Each Other Stock Award Agreement will be subject to the terms and conditions of the Plan. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(ii) </B>&#147;<B><I>Outside Director</I></B>&#148; means a Director who either (i) is not a current employee of the Company or an &#147;affiliated corporation&#148; (within the meaning of Treasury Regulations promulgated under Section 162(m) of the Code), is not a former employee of the Company or an &#147;affiliated corporation&#148; who receives compensation for prior services (other than benefits under a tax-qualified retirement plan) during the taxable year, has not been an officer of the Company or an &#147;affiliated corporation,&#148; and does not receive remuneration from the Company or an &#147;affiliated
corporation,&#148; either directly or indirectly, in any capacity other than as a Director, or (ii) is otherwise considered an &#147;outside director&#148; for purposes of Section 162(m) of the Code. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(jj) </B>&#147;<B><I>Own,</I></B>&#148; &#147;<B><I>Owned,</I></B>&#148; &#147;<B><I>Owner,</I></B>&#148; &#147;<B><I>Ownership</I></B>&#148; means a person or Entity will be deemed to &#147;Own,&#148; to have &#147;Owned,&#148; to be the &#147;Owner&#148; of, or to have acquired &#147;Ownership&#148; of securities if such person or Entity, directly or indirectly, through any contract, arrangement, understanding, relationship or otherwise, has or shares voting power, which includes the power to vote or to direct the voting, with respect to such securities. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(kk) </B>&#147;<B><I>Participant</I></B>&#148; means a person to whom an Award is granted pursuant to the Plan or, if applicable, such other person who holds an outstanding Stock Award. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(ll) </B>&#147;<B><I>Performance Cash Award</I></B>&#148; means an award of cash granted pursuant to the terms and conditions of Section 6(c)(ii). </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(mm) </B>&#147;<B><I>Performance Criteria</I></B>&#148; means the one or more criteria that the Board will select for purposes of establishing the Performance Goals for a Performance Period. The Performance Criteria that will be used to establish such Performance Goals may be based on any one of, or combination of, the following as determined by the Board: (i) earnings (including earnings per share and net earnings); (ii) earnings before interest, taxes and depreciation; (iii) earnings before interest, taxes, depreciation and amortization; (iv) earnings before interest, taxes, depreciation, amortization and legal
settlements; (v) earnings before interest, taxes, depreciation, amortization, legal settlements and other income (expense); (vi) earnings before interest, taxes, depreciation, amortization, legal settlements, other income (expense) and stock-based compensation; (vii) earnings before interest, taxes, depreciation, amortization, legal settlements, other income (expense), stock-based compensation and changes in deferred revenue; (viii) earnings before interest, taxes, depreciation, amortization, legal settlements, other income (expense), stock-based compensation, other non-cash expenses and changes in deferred revenue; (ix) total shareholder return; (x) return on equity or average shareholder&#146;s equity; (xi) return on assets, investment, or capital employed; (xii) stock price; </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">A-19</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(xiii) margin (including gross margin); (xiv) income (before or after taxes); (xv) operating income; (xvi) operating income after taxes; (xvii) pre-tax profit; (xviii) operating cash flow; (xix) sales or revenue targets; (xx) increases in revenue or product revenue; (xxi) expenses and cost reduction goals; (xxii) improvement in or attainment of working capital levels; (xxiii) economic value added (or an equivalent metric); (xxiv) market share; (xxv) cash flow; (xxvi) cash flow per share; (xxvii) cash balance; (xxviii) cash burn; (xxix) cash collections; (xxx) share price performance; (xxxi) debt reduction; (xxxii)
implementation or completion of projects or processes (including, without limitation, clinical trial initiation, clinical trial enrollment and dates, clinical trial results, regulatory filing submissions, regulatory filing acceptances, regulatory or advisory committee interactions, regulatory approvals, and product supply); (xxxiii) shareholders&#146; equity; (xxxiv) capital expenditures; (xxxv) debt levels; (xxxvi) operating profit or net operating profit; (xxxvii) workforce diversity; (xxxviii) growth of net income or operating income; (xxxix) billings; (xl) bookings; (xli) employee retention; (xlii) initiation of studies by specific dates; (xliii) budget management; (xliv) submission to, or approval by, a regulatory body (including, but not limited to the U.S. Food and Drug Administration) of an applicable filing or a product; (xlv) regulatory milestones; (xlvi) progress of internal research or development programs; (xlvii) acquisition of new customers; (xlviii) customer retention
and/or repeat order rate; (xlix) improvements in sample and test processing times; (l) progress of partnered programs; (li) partner satisfaction; (lii) timely completion of clinical trials; (liii) submission of 510(k)s or pre-market approvals and other regulatory achievements; (liv) milestones related to research development (including, but not limited to, preclinical and clinical studies), product development and manufacturing; (lv) expansion of sales in additional geographies or markets; (lvi) research progress, including the development of programs; (lvii) strategic partnerships or transactions (including in-licensing and out-licensing of intellectual property; and (lviii) and to the extent that an Award is not intended to comply with Section 162(m) of the Code, other measures of performance selected by the Board. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(nn) </B>&#147;<B><I>Performance Goals</I></B>&#148; means, for a Performance Period, the one or more goals established by the Board for the Performance Period based upon the Performance Criteria. Performance Goals may be based on a Company-wide basis, with respect to one or more business units, divisions, Affiliates, or business segments, and in either absolute terms or relative to the performance of one or more comparable companies or the performance of one or more relevant indices. Unless specified otherwise by the Board (i) in the Award Agreement at the time the Award is granted or (ii) in such other document setting
forth the Performance Goals at the time the Performance Goals are established, the Board will appropriately make adjustments in the method of calculating the attainment of Performance Goals for a Performance Period as follows: (1) to exclude restructuring and/or other nonrecurring charges; (2) to exclude exchange rate effects; (3) to exclude the effects of changes to generally accepted accounting principles; (4) to exclude the effects of any statutory adjustments to corporate tax rates; (5) to exclude the effects of any items that are &#147;unusual&#148; in nature or occur &#147;infrequently&#148; as determined under generally accepted accounting principles; (6) to exclude the dilutive effects of acquisitions or joint ventures; (7) to assume that any business divested by the Company achieved performance objectives at targeted levels during the balance of a Performance Period following such divestiture; (8) to exclude the effect of any change in the outstanding shares of common stock of
the Company by reason of any stock dividend or split, stock repurchase, reorganization, recapitalization, merger, consolidation, spin-off, combination or exchange of shares or other similar corporate change, or any distributions to common shareholders other than regular cash dividends; (9) to exclude the effects of stock based compensation and the award of bonuses under the Company&#146;s bonus plans; (10) to exclude costs incurred in connection with potential acquisitions or divestitures that are required to be expensed under generally accepted accounting principles; (11) to exclude the goodwill and intangible asset impairment charges that are required to be recorded under generally accepted accounting principles; and (12) to exclude the effects of the timing of acceptance for review and/or approval of submissions to the U.S. Food and Drug Administration or any other regulatory body. In addition, the Board retains the discretion to reduce or eliminate the compensation or economic
benefit due upon attainment of Performance Goals and to define the manner of calculating the Performance Criteria it selects to use for such Performance Period. Partial achievement of the specified criteria may result in the payment or vesting corresponding to the degree of achievement as specified in the Stock Award Agreement or the written terms of a Performance Cash Award. </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">A-20</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(oo) </B>&#147;<B><I>Performance Period</I></B>&#148; means the period of time selected by the Board over which the attainment of one or more Performance Goals will be measured for the purpose of determining a Participant&#146;s right to and the payment of a Stock Award or a Performance Cash Award. Performance Periods may be of varying and overlapping duration, at the sole discretion of the Board. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(pp) </B>&#147;<B><I>Performance Stock Award</I></B>&#148; means a Stock Award granted under the terms and conditions of Section 6(c)(i). </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(qq) </B>&#147;<B><I>Plan</I></B>&#148; means this AmpliPhi Biosciences Corporation 2016 Equity Incentive Plan. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(rr) </B>&#147;<B><I>Restricted Stock Award</I></B>&#148; means an award of shares of Common Stock which is granted pursuant to the terms and conditions of Section 6(a). </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(ss) </B>&#147;<B><I>Restricted Stock Award Agreement</I></B>&#148; means a written agreement between the Company and a holder of a Restricted Stock Award evidencing the terms and conditions of a Restricted Stock Award grant. Each Restricted Stock Award Agreement will be subject to the terms and conditions of the Plan. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(tt) </B>&#147;<B><I>Restricted Stock Unit Award</I></B>&#148; means a right to receive shares of Common Stock which is granted pursuant to the terms and conditions of Section 6(b). </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(uu) </B>&#147;<B><I>Restricted Stock Unit Award Agreement</I></B>&#148; means a written agreement between the Company and a holder of a Restricted Stock Unit Award evidencing the terms and conditions of a Restricted Stock Unit Award grant. Each Restricted Stock Unit Award Agreement will be subject to the terms and conditions of the Plan. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(vv) </B>&#147;<B><I>Rule 16b-3</I></B>&#148; means Rule 16b-3 promulgated under the Exchange Act or any successor to Rule 16b-3, as in effect from time to time. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(ww) </B>&#147;<B><I>Securities Act</I></B>&#148; means the Securities Act of 1933, as amended. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(xx) </B>&#147;<B><I>Stock Appreciation Right</I></B>&#148; or &#147;<B><I>SAR</I></B>&#148; means a right to receive the appreciation on Common Stock that is granted pursuant to the terms and conditions of Section 5. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(yy) </B>&#147;<B><I>Stock Appreciation Right Agreement</I></B>&#148; means a written agreement between the Company and a holder of a Stock Appreciation Right evidencing the terms and conditions of a Stock Appreciation Right grant. Each Stock Appreciation Right Agreement will be subject to the terms and conditions of the Plan. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(zz) </B>&#147;<B><I>Stock Award</I></B>&#148; means any right to receive Common Stock granted under the Plan, including an Incentive Stock Option, a Nonstatutory Stock Option, a Restricted Stock Award, a Restricted Stock Unit Award, a Stock Appreciation Right, a Performance Stock Award or any Other Stock Award. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(aaa) </B>&#147;<B><I>Stock Award Agreement</I></B>&#148; means a written agreement between the Company and a Participant evidencing the terms and conditions of a Stock Award grant. Each Stock Award Agreement will be subject to the terms and conditions of the Plan. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(bbb) </B>&#147;<B><I>Subsidiary</I></B>&#148; means, with respect to the Company, (i) any corporation of which more than 50% of the outstanding capital stock having ordinary voting power to elect a majority of the board of directors of such corporation (irrespective of whether, at the time, stock of any other class or classes of such corporation will have or might have voting power by reason of the happening of any contingency) is at the time, directly or indirectly, Owned by the Company, and (ii) any partnership, limited liability company or other entity in which the Company has a direct or indirect interest (whether in
the form of voting or participation in profits or capital contribution) of more than 50%. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(ccc) </B>&#147;<B><I>Ten Percent Shareholder</I></B>&#148; means a person who Owns (or is deemed to Own pursuant to Section 424(d) of the Code) stock possessing more than 10% of the total combined voting power of all classes of stock of the Company or any Affiliate. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(ddd) </B>&#147;<B><I>Transaction</I></B>&#148; means a Corporate Transaction or a Change in Control. </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">A-21</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:0pt; text-align: right; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>APPENDIX B</B> </P>

<H1 STYLE="text-indent:0pt; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 9pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><FONT STYLE="font-variant: small-caps">AmpliPhi Biosciences Corporation<BR>&nbsp;<BR>2016 Employee Stock Purchase Plan<BR>&nbsp;<BR> Adopted by the Board of Directors: April 21, 2016<BR>Approved by the Shareholders: [June 20, 2016]</FONT> </H1>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">1. <FONT STYLE="font-variant: small-caps">General; Purpose</FONT>. </H2>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(a) </B>The Plan provides a means by which Eligible Employees of the Company and certain designated Related Corporations may be given an opportunity to purchase shares of Common Stock. The Plan permits the Company to grant a series of Purchase Rights to Eligible Employees under an Employee Stock Purchase Plan. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(b) </B>The Company, by means of the Plan, seeks to retain the services of such Employees, to secure and retain the services of new Employees and to provide incentives for such persons to exert maximum efforts for the success of the Company and its Related Corporations. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><FONT STYLE="font-variant: small-caps">2. Administration.</FONT> </H2>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(a) </B>The Board will administer the Plan unless and until the Board delegates administration of the Plan to a Committee or Committees, as provided in Section 2(c). </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(b) </B>The Board will have the power, subject to, and within the limitations of, the express provisions of the Plan: </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(i) </B>To determine how and when Purchase Rights will be granted and the provisions of each Offering (which need not be identical). </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(ii) </B>To designate from time to time which Related Corporations of the Company will be eligible to participate in the Plan. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(iii) </B>To construe and interpret the Plan and Purchase Rights, and to establish, amend and revoke rules and regulations for its administration. The Board, in the exercise of this power, may correct any defect, omission or inconsistency in the Plan, in a manner and to the extent it deems necessary or expedient to make the Plan fully effective. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(iv) </B>To settle all controversies regarding the Plan and Purchase Rights granted under the Plan. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(v) </B>To suspend or terminate the Plan at any time as provided in Section 12. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(vi) </B>To amend the Plan at any time as provided in Section 12. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(vii) </B>Generally, to exercise such powers and to perform such acts as it deems necessary or expedient to promote the best interests of the Company and its Related Corporations and to carry out the intent that the Plan be treated as an Employee Stock Purchase Plan. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(viii) </B>To adopt such procedures and sub-plans as are necessary or appropriate to permit participation in the Plan by Employees who are foreign nationals or employed outside the United States. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(c) </B>The Board may delegate some or all of the administration of the Plan to a Committee or Committees. If administration is delegated to a Committee, the Committee will have, in connection with the administration of the Plan, the powers theretofore possessed by the Board that have been delegated to the Committee, including the power to delegate to a subcommittee any of the administrative powers the Committee is authorized to exercise (and references in this Plan to the Board will thereafter be to the Committee or subcommittee), subject, however, to such resolutions, not inconsistent with the provisions of the Plan, as
may be adopted from time to time by the Board. The Board may retain the authority to concurrently administer the Plan with the Committee and may, at any time, revest in the Board some or all of the powers previously delegated. Whether or not the Board has delegated administration of the Plan to a Committee, the Board will have the final power to determine all questions of policy and expediency that may arise in the administration of the Plan. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(d) </B>All determinations, interpretations and constructions made by the Board in good faith will not be subject to review by any person and will be final, binding and conclusive on all persons. </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">B-1</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">3. <FONT STYLE="font-variant: small-caps">Shares of Common Stock Subject to the Plan</FONT>. </H2>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(a) </B>Subject to the provisions of Section 11(a) relating to Capitalization Adjustments, the maximum number of shares of Common Stock that may be issued under the Plan will not exceed 120,000<FONT STYLE="font-variant: small-caps"> </FONT>shares of Common Stock, plus the number of shares of Common Stock that are automatically added on January 1<sup>st</sup> of each year for a period of up to ten years, commencing on the first January 1 following the Effective Date and ending on (and including) January 1, 2026, in an amount equal to the lesser of (i) 1% of the total number of shares of Capital Stock outstanding on December
31<sup>st</sup> of the preceding calendar year, and (ii)<FONT STYLE="font-variant: small-caps"> </FONT>300,000 shares of Common Stock. Notwithstanding the foregoing, the Board may act prior to the first day of any calendar year to provide that there will be no January 1<sup>st</sup> increase in the share reserve for such calendar year or that the increase in the share reserve for such calendar year will be a lesser number of shares of Common Stock than would otherwise occur pursuant to the preceding sentence. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(b) </B>If any Purchase Right granted under the Plan terminates without having been exercised in full, the shares of Common Stock not purchased under such Purchase Right will again become available for issuance under the Plan. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(c) </B>The stock purchasable under the Plan will be shares of authorized but unissued or reacquired Common Stock, including shares repurchased by the Company on the open market. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">4. <FONT STYLE="font-variant: small-caps">Grant of Purchase Rights; Offering</FONT>. </H2>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(a) </B>The Board may from time to time grant or provide for the grant of Purchase Rights to Eligible Employees under an Offering (consisting of one or more Purchase Periods) on an Offering Date or Offering Dates selected by the Board. Each Offering will be in such form and will contain such terms and conditions as the Board will deem appropriate, and will comply with the requirement of Section 423(b)(5) of the Code that all Employees granted Purchase Rights will have the same rights and privileges. The terms and conditions of an Offering shall be incorporated by reference into the Plan and treated as part of the Plan. The
provisions of separate Offerings need not be identical, but each Offering will include (through incorporation of the provisions of this Plan by reference in the document comprising the Offering or otherwise) the period during which the Offering will be effective, which period will not exceed 27 months beginning with the Offering Date, and the substance of the provisions contained in Sections 5 through 8, inclusive. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(b) </B>If a Participant has more than one Purchase Right outstanding under the Plan, unless he or she otherwise indicates in forms delivered to the Company: (i) each form will apply to all of his or her Purchase Rights under the Plan, and (ii) a Purchase Right with a lower exercise price (or an earlier-granted Purchase Right, if different Purchase Rights have identical exercise prices) will be exercised to the fullest possible extent before a Purchase Right with a higher exercise price (or a later-granted Purchase Right if different Purchase Rights have identical exercise prices) will be exercised. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(c) </B>The Board will have the discretion to structure an Offering so that if the Fair Market Value of a share of Common Stock on the first Trading Day of a new Purchase Period within that Offering is less than or equal to the Fair Market Value of a share of Common Stock on the Offering Date for that Offering, then (i) that Offering will terminate immediately as of that first Trading Day, and (ii) the Participants in such terminated Offering will be automatically enrolled in a new Offering beginning on the first Trading Day of such new Purchase Period. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><FONT STYLE="font-variant: small-caps">5. Eligibility.</FONT> </H2>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(a) </B>Purchase Rights may be granted only to Employees of the Company or, as the Board may designate in accordance with Section 2(b), to Employees of a Related Corporation. Except as provided in Section 5(b), an Employee will not be eligible to be granted Purchase Rights unless, on the Offering Date, the Employee has been in the employ of the Company or the Related Corporation, as the case may be, for such continuous period preceding such Offering Date as the Board may require, but in no event will the required period of continuous employment be equal to or greater than two years. In addition, the Board may provide that
no Employee will be eligible to be granted Purchase Rights under the Plan unless, on the Offering Date, such Employee&#146;s customary employment with the Company or the Related Corporation is more than 20 hours per week and more than five months per calendar year or such other criteria as the Board may determine consistent with Section 423 of the Code. </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">B-2</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(b) </B>The Board may provide that each person who, during the course of an Offering, first becomes an Eligible Employee will, on a date or dates specified in the Offering which coincides with the day on which such person becomes an Eligible Employee or which occurs thereafter, receive a Purchase Right under that Offering, which Purchase Right will thereafter be deemed to be a part of that Offering. Such Purchase Right will have the same characteristics as any Purchase Rights originally granted under that Offering, as described herein, except that: </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(i) </B>the date on which such Purchase Right is granted will be the &#147;Offering Date&#148; of such Purchase Right for all purposes, including determination of the exercise price of such Purchase Right; </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(ii) </B>the period of the Offering with respect to such Purchase Right will begin on its Offering Date and end coincident with the end of such Offering; and </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(iii) </B>the Board may provide that if such person first becomes an Eligible Employee within a specified period of time before the end of the Offering, he or she will not receive any Purchase Right under that Offering. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(c) </B>No Employee will be eligible for the grant of any Purchase Rights if, immediately after any such Purchase Rights are granted, such Employee owns stock possessing five percent or more of the total combined voting power or value of all classes of stock of the Company or of any Related Corporation. For purposes of this Section 5(c), the rules of Section 424(d) of the Code will apply in determining the stock ownership of any Employee, and stock which such Employee may purchase under all outstanding Purchase Rights and options will be treated as stock owned by such Employee. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(d) </B>As specified by Section 423(b)(8) of the Code, an Eligible Employee may be granted Purchase Rights only if such Purchase Rights, together with any other rights granted under all Employee Stock Purchase Plans of the Company and any Related Corporations, do not permit such Eligible Employee&#146;s rights to purchase stock of the Company or any Related Corporation to accrue at a rate which exceeds $25,000 of Fair Market Value of such stock (determined at the time such rights are granted, and which, with respect to the Plan, will be determined as of their respective Offering Dates) for each calendar year in which such
rights are outstanding at any time. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(e) </B>Officers of the Company and any designated Related Corporation, if they are otherwise Eligible Employees, will be eligible to participate in Offerings under the Plan. Notwithstanding the foregoing, the Board may provide in an Offering that Employees who are highly compensated Employees within the meaning of Section 423(b)(4)(D) of the Code will not be eligible to participate. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">6. <FONT STYLE="font-variant: small-caps">Purchase Rights; Purchase Price</FONT>. </H2>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(a) </B>On each Offering Date, each Eligible Employee, pursuant to an Offering made under the Plan, will be granted a Purchase Right to purchase up to that number of shares of Common Stock purchasable either with a percentage or with a maximum dollar amount, as designated by the Board, but in either case not exceeding 15% of such Employee&#146;s earnings (as defined by the Board in each Offering) during the period that begins on the Offering Date (or such later date as the Board determines for a particular Offering) and ends on the date stated in the Offering, which date will be no later than the end of the Offering. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(b) </B>The Board will establish one or more Purchase Dates during an Offering on which Purchase Rights granted for that Offering will be exercised and shares of Common Stock will be purchased in accordance with such Offering. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(c) </B>In connection with each Offering made under the Plan, the Board may specify (i) a maximum number of shares of Common Stock that may be purchased by any Participant on any Purchase Date during such Offering, (ii) a maximum aggregate number of shares of Common Stock that may be purchased by all Participants pursuant to such Offering and/or (iii) a maximum aggregate number of shares of Common Stock that may be purchased by all Participants on any Purchase Date under the Offering. If the aggregate purchase of shares of Common Stock issuable upon exercise of Purchase Rights granted under the Offering would exceed any
such maximum aggregate number, then, in the absence of any Board action otherwise, a pro rata (based on each Participant&#146;s accumulated Contributions) allocation of the shares of Common Stock available will be made in as nearly a uniform manner as will be practicable and equitable. </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">B-3</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(d) </B>The purchase price of shares of Common Stock acquired pursuant to Purchase Rights will be not less than the lesser of: </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(i) </B>an amount equal to 85% of the Fair Market Value of the shares of Common Stock on the Offering Date; or </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(ii) </B>an amount equal to 85% of the Fair Market Value of the shares of Common Stock on the applicable Purchase Date. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">7. <FONT STYLE="font-variant: small-caps">Participation; Withdrawal; Termination</FONT>. </H2>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(a) </B>An Eligible Employee may elect to authorize payroll deductions as the means of making Contributions by completing and delivering to the Company, within the time specified in the Offering, an enrollment form provided by the Company. The enrollment form will specify the amount of Contributions not to exceed the maximum amount specified by the Board. Each Participant&#146;s Contributions will be credited to a bookkeeping account for such Participant under the Plan and will be deposited with the general funds of the Company except where applicable law requires that Contributions be deposited with a third party. If
permitted in the Offering, a Participant may begin such Contributions with the first payroll occurring on or after the Offering Date (or, in the case of a payroll date that occurs after the end of the prior Offering but before the Offering Date of the next new Offering, Contributions from such payroll will be included in the new Offering). If permitted in the Offering, a Participant may thereafter reduce (including to zero) or increase his or her Contributions. If specifically provided in the Offering, in addition to making Contributions by payroll deductions, a Participant may make Contributions through the payment by cash or check prior to a Purchase Date. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(b) </B>During an Offering, a Participant may cease making Contributions and withdraw from the Offering by delivering to the Company a withdrawal form provided by the Company. The Company may impose a deadline before a Purchase Date for withdrawing. Upon such withdrawal, such Participant&#146;s Purchase Right in that Offering will immediately terminate and the Company will distribute to such Participant all of his or her accumulated but unused Contributions and such Participant&#146;s Purchase Right in that Offering shall thereupon terminate. A Participant&#146;s withdrawal from that Offering will have no effect upon his or
her eligibility to participate in any other Offerings under the Plan, but such Participant will be required to deliver a new enrollment form to participate in subsequent Offerings. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(c) </B>Purchase Rights granted pursuant to any Offering under the Plan will terminate immediately if the Participant either (i) is no longer an Employee for any reason or for no reason (subject to any post-employment participation period required by law) or (ii) is otherwise no longer eligible to participate. The Company will distribute to such individual all of his or her accumulated but unused Contributions. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(d) </B>During a Participant&#146;s lifetime, Purchase Rights will be exercisable only by such Participant. Purchase Rights are not transferable by a Participant, except by will, by the laws of descent and distribution, or, if permitted by the Company, by a beneficiary designation as described in Section 10. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(e) </B>Unless otherwise specified in the Offering, the Company will have no obligation to pay interest on Contributions. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">8. <FONT STYLE="font-variant: small-caps">Exercise of Purchase Rights.</FONT> </H2>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(a) </B>On each Purchase Date, each Participant&#146;s accumulated Contributions will be applied to the purchase of shares of Common Stock, up to the maximum number of shares of Common Stock permitted by the Plan and the applicable Offering, at the purchase price specified in the Offering. No fractional shares will be issued unless specifically provided for in the Offering. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(b) </B>If any amount of accumulated Contributions remains in a Participant&#146;s account after the purchase of shares of Common Stock and such remaining amount is less than the amount required to purchase one share of Common Stock on the final Purchase Date of an Offering, then such remaining amount will be held in such Participant&#146;s account for the purchase of shares of Common Stock under the next Offering under the Plan, unless such Participant withdraws from or is not eligible to participate in such Offering, in which case such amount will be distributed to such Participant after the final Purchase Date, without
interest. If the amount of Contributions remaining in a Participant&#146;s account after the purchase of shares of Common Stock is at least </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">B-4</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">equal to the amount required to purchase one whole share of Common Stock on the final Purchase Date of an Offering, then such remaining amount will not roll over to the next Offering and will instead be distributed in full to such Participant after the final Purchase Date of such Offering without interest. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(c) </B>No Purchase Rights may be exercised to any extent unless the shares of Common Stock to be issued upon such exercise under the Plan are covered by an effective registration statement pursuant to the Securities Act and the Plan is in material compliance with all applicable federal, state, foreign and other securities and other laws applicable to the Plan. If on a Purchase Date the shares of Common Stock are not so registered or the Plan is not in such compliance, no Purchase Rights will be exercised on such Purchase Date, and the Purchase Date will be delayed until the shares of Common Stock are subject to such an
effective registration statement and the Plan is in material compliance, except that the Purchase Date will in no event be more than six months from the Offering Date. If, on the Purchase Date, as delayed to the maximum extent permissible, the shares of Common Stock are not registered and the Plan is not in material compliance with all applicable laws, no Purchase Rights will be exercised and all accumulated but unused Contributions will be distributed to the Participants without interest. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">9. <FONT STYLE="font-variant: small-caps">Covenants of the Company</FONT>. </H2>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The Company will seek to obtain from each federal, state, foreign or other regulatory commission or agency having jurisdiction over the Plan such authority as may be required to grant Purchase Rights and issue and sell shares of Common Stock thereunder. If, after commercially reasonable efforts, the Company is unable to obtain the authority that counsel for the Company deems necessary for the grant of Purchase Rights or the lawful issuance and sale of Common Stock under the Plan, and at a commercially reasonable cost, the Company will be relieved from any liability for failure to grant Purchase Rights and/or to issue and sell
Common Stock upon exercise of such Purchase Rights. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">10. <FONT STYLE="font-variant: small-caps">Designation of Beneficiary</FONT>. </H2>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(a) </B>The Company may, but is not obligated to, permit a Participant to submit a form designating a beneficiary who will receive any shares of Common Stock and/or Contributions from the Participant&#146;s account under the Plan if the Participant dies before such shares and/or Contributions are delivered to the Participant. The Company may, but is not obligated to, permit the Participant to change such designation of beneficiary. Any such designation and/or change must be on a form approved by the Company. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(b) </B>If a Participant dies, and in the absence of a valid beneficiary designation, the Company will deliver any shares of Common Stock and/or Contributions to the executor or administrator of the estate of the Participant. If no executor or administrator has been appointed (to the knowledge of the Company), the Company, in its sole discretion, may deliver such shares of Common Stock and/or Contributions to the Participant&#146;s spouse, dependents or relatives, or if no spouse, dependent or relative is known to the Company, then to such other person as the Company may designate. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">11. <FONT STYLE="font-variant: small-caps">Adjustments upon Changes in Common Stock; Corporate Transactions</FONT>. </H2>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(a) </B>In the event of a Capitalization Adjustment, the Board will appropriately and proportionately adjust: (i) the class(es) and maximum number of securities subject to the Plan pursuant to Section 3(a), (ii) the class(es) and maximum number of securities by which the share reserve is to increase automatically each year pursuant to Section 3(a), (iii) the class(es) and number of securities subject to, and the purchase price applicable to outstanding Offerings and Purchase Rights, and (iv) the class(es) and number of securities that are the subject of the purchase limits under each ongoing Offering. The Board will make
these adjustments, and its determination will be final, binding and conclusive. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(b) </B>In the event of a Corporate Transaction, then: (i) any surviving corporation or acquiring corporation (or the surviving or acquiring corporation&#146;s parent company) may assume or continue outstanding Purchase Rights or may substitute similar rights (including a right to acquire the same consideration paid to the shareholders in the Corporate Transaction) for outstanding Purchase Rights, or (ii) if any surviving or acquiring corporation (or its parent company) does not assume or continue such Purchase Rights or does not substitute similar rights for such Purchase Rights, then the Participants&#146; accumulated
Contributions will be used to purchase shares of Common Stock within ten business days prior to the Corporate Transaction under the outstanding Purchase Rights, and the Purchase Rights will terminate immediately after such purchase. </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">B-5</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">12. <FONT STYLE="font-variant: small-caps">Amendment, Termination or Suspension of the Plan</FONT>. </H2>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(a) </B>The Board may amend the Plan at any time in any respect the Board deems necessary or advisable. However, except as provided in Section 11(a) relating to Capitalization Adjustments, shareholder approval will be required for any amendment of the Plan for which shareholder approval is required by applicable law or listing requirements, including any amendment that either (i) materially increases the number of shares of Common Stock available for issuance under the Plan, (ii) materially expands the class of individuals eligible to become Participants and receive Purchase Rights, (iii) materially increases the benefits
accruing to Participants under the Plan or materially reduces the price at which shares of Common Stock may be purchased under the Plan, (iv) materially extends the term of the Plan, or (v) expands the types of awards available for issuance under the Plan, but in each of (i) through (v) above only to the extent shareholder approval is required by applicable law or listing requirements. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(b) </B>The Board may suspend or terminate the Plan at any time. No Purchase Rights may be granted under the Plan while the Plan is suspended or after it is terminated. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(c) </B>Any benefits, privileges, entitlements and obligations under any outstanding Purchase Rights granted before an amendment, suspension or termination of the Plan will not be materially impaired by any such amendment, suspension or termination except (i) with the consent of the person to whom such Purchase Rights were granted, (ii) as necessary to comply with any laws, listing requirements, or governmental regulations (including, without limitation, the provisions of Section 423 of the Code and the regulations and other interpretive guidance issued thereunder relating to Employee Stock Purchase Plans) including without
limitation any such regulations or other guidance that may be issued or amended after the date the Plan is adopted by the Board, or (iii) as necessary to obtain or maintain favorable tax, listing, or regulatory treatment. To be clear, the Board may amend outstanding Purchase Rights without a Participant&#146;s consent if such amendment is necessary to ensure that the Purchase Right and/or the Plan complies with the requirements of Section 423 of the Code. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">13. <FONT STYLE="font-variant: small-caps">Effective Date of Plan</FONT>. </H2>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The Plan will become effective immediately prior to and contingent upon the Effective Date. No Purchase Rights will be exercised unless and until the Plan has been approved by the shareholders of the Company, which approval must be within 12 months before or after the date the Plan is adopted (or if required under Section 12(a) above, materially amended) by the Board. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">14. <FONT STYLE="font-variant: small-caps">Miscellaneous Provisions</FONT>. </H2>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(a) </B>Proceeds from the sale of shares of Common Stock pursuant to Purchase Rights will constitute general funds of the Company. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(b) </B>A Participant will not be deemed to be the holder of, or to have any of the rights of a holder with respect to, shares of Common Stock subject to Purchase Rights unless and until the Participant&#146;s shares of Common Stock acquired upon exercise of Purchase Rights are recorded in the books of the Company (or its transfer agent). </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(c) </B>The Plan and Offering do not constitute an employment contract. Nothing in the Plan or in the Offering will in any way alter the at will nature of a Participant&#146;s employment or be deemed to create in any way whatsoever any obligation on the part of any Participant to continue in the employ of the Company or a Related Corporation, or on the part of the Company or a Related Corporation to continue the employment of a Participant. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(d) </B>The provisions of the Plan will be governed by the laws of the State of Delaware without resort to that state&#146;s conflicts of laws rules. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><FONT STYLE="font-variant: small-caps">15. Definitions.</FONT> </H2>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">As used in the Plan, the following definitions will apply to the capitalized terms indicated below: </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(a) </B>&#147;<B><I>Board</I></B>&#148; means the Board of Directors of the Company. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(b) </B>&#147;<B><I>Capital Stock</I></B>&#148; means each and every class of common stock of the Company, regardless of the number of votes per share. </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">B-6</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(c) </B>&#147;<B><I>Capitalization Adjustment</I></B>&#148; means any change that is made in, or other events that occur with respect to, the Common Stock subject to the Plan or subject to any Purchase Right after the date the Plan is adopted by the Board without the receipt of consideration by the Company through merger, consolidation, reorganization, recapitalization, reincorporation, stock dividend, dividend in property other than cash, large nonrecurring cash dividend, stock split, liquidating dividend, combination of shares, exchange of shares, change in corporate structure or other similar equity restructuring
transaction, as that term is used in Financial Accounting Standards Board Accounting Standards Codification Topic 718 (or any successor thereto). Notwithstanding the foregoing, the conversion of any convertible securities of the Company will not be treated as a Capitalization Adjustment. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(d) </B>&#147;<B><I>Code</I></B>&#148; means the Internal Revenue Code of 1986, as amended, including any applicable regulations and guidance thereunder<I>.</I> </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(a) </B>&#147;<B><I>Committee</I></B>&#148; means a committee of one or more members of the Board to whom authority has been delegated by the Board in accordance with Section 2(c). </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(e) </B>&#147;<B><I>Common Stock</I></B>&#148; means the common stock of the Company, having one vote per share. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(f) </B>&#147;<B><I>Company</I></B>&#148; means AmpliPhi Biosciences Corporation. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(g) </B>&#147;<B><I>Contributions</I></B>&#148; means the payroll deductions and other additional payments specifically provided for in the Offering that a Participant contributes to fund the exercise of a Purchase Right. A Participant may make additional payments into his or her account if specifically provided for in the Offering, and then only if the Participant has not already had the maximum permitted amount withheld during the Offering through payroll deductions. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(h) </B>&#147;<B><I>Corporate Transaction</I></B>&#148; means the consummation, in a single transaction or in a series of related transactions, of any one or more of the following events: </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 44px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(i) </B>a sale or other disposition of all or substantially all, as determined by the Board in its sole discretion, of the consolidated assets of the Company and its Subsidiaries; </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 44px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(ii) </B>a sale or other disposition of more than 50% of the outstanding securities of the Company; </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 44px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(iii) </B>a merger, consolidation or similar transaction following which the Company is not the surviving corporation; or </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 44px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(iv) </B>a merger, consolidation or similar transaction following which the Company is the surviving corporation but the shares of Common Stock outstanding immediately preceding the merger, consolidation or similar transaction are converted or exchanged by virtue of the merger, consolidation or similar transaction into other property, whether in the form of securities, cash or otherwise. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(i) </B>&#147;<B><I>Director</I></B>&#148; means a member of the Board. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(j) </B>&#147;<B><I>Effective Date</I></B>&#148; means the date of the Company shareholders approve this Plan, which is the date of the annual meeting of shareholders of the Company held on [June 20, 2016] provided this Plan is approved by the Company&#146;s shareholders at such meeting. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(k) </B>&#147;<B><I>Eligible Employee</I></B>&#148; means an Employee who meets the requirements set forth in the document(s) governing the Offering for eligibility to participate in the Offering, provided that such Employee also meets the requirements for eligibility to participate set forth in the Plan. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(l) </B>&#147;<B><I>Employee</I></B>&#148; means any person, including an Officer or Director, who is &#147;employed&#148; for purposes of Section 423(b)(4) of the Code by the Company or a Related Corporation. However, service solely as a Director, or payment of a fee for such services, will not cause a Director to be considered an &#147;Employee&#148; for purposes of the Plan. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(m) </B>&#147;<B><I>Employee Stock Purchase Plan</I></B>&#148; means a plan that grants Purchase Rights intended to be options issued under an &#147;employee stock purchase plan,&#148; as that term is defined in Section 423(b) of the Code. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(n) </B>&#147;<B><I>Exchange Act</I></B>&#148; means the Securities Exchange Act of 1934, as amended and the rules and regulations promulgated thereunder. </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">B-7</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(o) </B>&#147;<B><I>Fair Market Value</I></B>&#148; means, as of any date, the value of the Common Stock determined as follows: </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 44px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(i) </B>If the Common Stock is listed on any established stock exchange or traded on any established market, the Fair Market Value of a share of Common Stock will be the <B><U>closing sales price</U></B> for such stock as quoted on such exchange or market (or the exchange or market with the greatest volume of trading in the Common Stock) <B><U>on the date of determination</U></B>, as reported in such source as the Board deems reliable. Unless otherwise provided by the Board, if there is no closing sales price for the Common Stock on the date of determination, then the Fair Market Value will be the closing sales price on
the last preceding date for which such quotation exists. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 44px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(ii) </B>In the absence of such markets for the Common Stock, the Fair Market Value will be determined by the Board in good faith in compliance with applicable laws and in a manner that complies with Sections 409A of the Code. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(p) </B>&#147;<B><I>Offering</I></B>&#148; means the grant to Eligible Employees of Purchase Rights, with the exercise of those Purchase Rights automatically occurring at the end of one or more Purchase Periods. The terms and conditions of an Offering will generally be set forth in the &#147;<B><I>Offering Document</I></B>&#148; approved by the Board for that Offering. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(q) </B>&#147;<B><I>Offering Date</I></B>&#148; means a date selected by the Board for an Offering to commence. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(r) </B>&#147;<B><I>Officer</I></B>&#148; means a person who is an officer of the Company or a Related Corporation within the meaning of Section 16 of the Exchange Act. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(s) </B>&#147;<B><I>Participant</I></B>&#148; means an Eligible Employee who holds an outstanding Purchase Right. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(t) </B>&#147;<B><I>Plan</I></B>&#148; means this AmpliPhi Biosciences Corporation 2016 Employee Stock Purchase Plan. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(u) </B>&#147;<B><I>Purchase Date</I></B>&#148; means one or more dates during an Offering selected by the Board on which Purchase Rights will be exercised and on which purchases of shares of Common Stock will be carried out in accordance with such Offering. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(v) </B>&#147;<B><I>Purchase Period</I></B>&#148; means a period of time specified within an Offering, generally beginning on the Offering Date or on the first Trading Day following a Purchase Date, and ending on a Purchase Date. An Offering may consist of one or more Purchase Periods. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(w) </B>&#147;<B><I>Purchase Right</I></B>&#148; means an option to purchase shares of Common Stock granted pursuant to the Plan. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(x) </B>&#147;<B><I>Related Corporation</I></B>&#148; means any &#147;parent corporation&#148; or &#147;subsidiary corporation&#148; of the Company whether now or subsequently established, as those terms are defined in Sections 424(e) and (f), respectively, of the Code. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(y) </B>&#147;<B><I>Securities Act</I></B>&#148; means the Securities Act of 1933, as amended. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(z) </B>&#147;<B><I>Trading Day</I></B>&#148; means any day on which the exchange(s) or market(s) on which shares of Common Stock are listed, including but not limited to the NYSE, Nasdaq Global Select Market, the Nasdaq Global Market, the Nasdaq Capital Market or any successors thereto, is open for trading. </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">B-8</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:0pt; text-align: right; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>APPENDIX C</B> </P>

<H1 STYLE="text-indent:0pt; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 9pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">WASHINGTON BUSINESS CORPORATION ACT<BR> CHAPTER 23B.13&nbsp;&#151;&nbsp;DISSENTERS&#146; RIGHTS </H1>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">RCW 23B.13.010<BR> Definitions. </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">As used in this chapter: </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(1) &#147;Corporation&#148; means the issuer of the shares held by a dissenter before the corporate action, or the surviving or acquiring corporation by merger or share exchange of that issuer. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(2) &#147;Dissenter&#148; means a shareholder who is entitled to dissent from corporate action under RCW 23B.13.020 and who exercises that right when and in the manner required by RCW 23B.13.200 through 23B.13.280. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(3) &#147;Fair value,&#148; with respect to a dissenter&#146;s shares, means the value of the shares immediately before the effective date of the corporate action to which the dissenter objects, excluding any appreciation or depreciation in anticipation of the corporate action unless exclusion would be inequitable. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(4) &#147;Interest&#148; means interest from the effective date of the corporate action until the date of payment, at the average rate currently paid by the corporation on its principal bank loans or, if none, at a rate that is fair and equitable under all the circumstances. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(5) &#147;Record shareholder&#148; means the person in whose name shares are registered in the records of a corporation or the beneficial owner of shares to the extent of the rights granted by a nominee certificate on file with a corporation. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(6) &#147;Beneficial shareholder&#148; means the person who is a beneficial owner of shares held in a voting trust or by a nominee as the record shareholder. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(7) &#147;Shareholder&#148; means the record shareholder or the beneficial shareholder. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">[1989 c 165 &sect;140.] </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">RCW 23B.13.020<BR> Right to dissent. </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(1) A shareholder is entitled to dissent from, and obtain payment of the fair value of the shareholder&#146;s shares in the event of, any of the following corporate actions: </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(a) A plan of merger, which has become effective, to which the corporation is a party (i) if shareholder approval was required for the merger by RCW 23B.11.030, 23B.11.080, or the articles of incorporation, and the shareholder was entitled to vote on the merger, or (ii) if the corporation was a subsidiary and the plan of merger provided for the merger of the subsidiary with its parent under RCW 23B.11.040; </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(b) A plan of share exchange, which has become effective, to which the corporation is a party as the corporation whose shares have been acquired, if the shareholder was entitled to vote on the plan; </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(c) A sale or exchange, which has become effective, of all, or substantially all, of the property of the corporation other than in the usual and regular course of business, if the shareholder was entitled to vote on the sale or exchange, including a sale in dissolution, but not including a sale pursuant to court order or a sale for cash pursuant to a plan by which all or substantially all of the net proceeds of the sale will be distributed to the shareholders within one year after the date of sale; </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(d) An amendment of the articles of incorporation, whether or not the shareholder was entitled to vote on the amendment, if the amendment effects a redemption or cancellation of all of the shareholder&#146;s shares in exchange for cash or other consideration other than shares of the corporation; </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(e) Any action described in RCW 23B.25.120; </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(f) Any corporate action approved pursuant to a shareholder vote to the extent the articles of incorporation, bylaws, or a resolution of the board of directors provides that voting or nonvoting shareholders are entitled to dissent and obtain payment for their shares; or </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">C-1</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(g) A plan of entity conversion in the case of a conversion of a domestic corporation to a foreign corporation, which has become effective, to which the domestic corporation is a party as the converting entity, if: (i) The shareholder was entitled to vote on the plan; and (ii) the shareholder does not receive shares in the surviving entity that have terms as favorable to the shareholder in all material respects and that represent at least the same percentage interest of the total voting rights of the outstanding shares of the surviving entity as the shares held by the shareholder before the conversion. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(2) A shareholder entitled to dissent and obtain payment for the shareholder&#146;s shares under this chapter may not challenge the corporate action creating the shareholder&#146;s entitlement unless the action fails to comply with the procedural requirements imposed by this title, RCW 25.10.831 through 25.10.886, the articles of incorporation, or the bylaws, or is fraudulent with respect to the shareholder or the corporation. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(3) The right of a dissenting shareholder to obtain payment of the fair value of the shareholder&#146;s shares shall terminate upon the occurrence of any one of the following events: </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(a) The proposed corporate action is abandoned or rescinded; </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(b) A court having jurisdiction permanently enjoins or sets aside the corporate action; or </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(c) The shareholder&#146;s demand for payment is withdrawn with the written consent of the corporation. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">[2014 c 83 &sect;15; 2013 c 97 &sect;1. Prior: 2009 c 189 &sect;41; 2009 c 188 &sect;1404; 2003 c 35 &sect;9; 1991 c 269 &sect;37; 1989 c 165 &sect;141.] </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">RCW 23B.13.030<BR> Dissent by nominees and beneficial owners. </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(1) A record shareholder may assert dissenters&#146; rights as to fewer than all the shares registered in the shareholder&#146;s name only if the shareholder dissents with respect to all shares beneficially owned by any one person and delivers to the corporation a notice of the name and address of each person on whose behalf the shareholder asserts dissenters&#146; rights. The rights of a partial dissenter under this subsection are determined as if the shares as to which the dissenter dissents and the dissenter&#146;s other shares were registered in the names of different shareholders. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(2) A beneficial shareholder may assert dissenters&#146; rights as to shares held on the beneficial shareholder&#146;s behalf only if: </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(a) The beneficial shareholder submits to the corporation the record shareholder&#146;s consent to the dissent not later than the time the beneficial shareholder asserts dissenters&#146; rights, which consent shall be set forth either (i) in a record or (ii) if the corporation has designated an address, location, or system to which the consent may be electronically transmitted and the consent is electronically transmitted to the designated address, location, or system, in an electronically transmitted record; and </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(b) The beneficial shareholder does so with respect to all shares of which such shareholder is the beneficial shareholder or over which such shareholder has power to direct the vote. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">[2002 c 297 &sect;35; 1989 c 165 &sect;142.] </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">RCW 23B.13.200<BR> Notice of dissenters&#146; rights. </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(1) If proposed corporate action creating dissenters&#146; rights under RCW 23B.13.020 is submitted for approval by a vote at a shareholders&#146; meeting, the meeting notice must state that shareholders are or may be entitled to assert dissenters&#146; rights under this chapter and be accompanied by a copy of this chapter. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(2) If corporate action creating dissenters&#146; rights under RCW 23B.13.020 is submitted for approval without a vote of shareholders in accordance with RCW 23B.07.040, the shareholder consent described in RCW 23B.07.040(1)(b) and the notice described in RCW 23B.07.040(3)(a) must include a statement that shareholders are or may be entitled to assert dissenters&#146; rights under this chapter and be accompanied by a copy of this chapter. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">[2009 c 189 &sect;42; 2002 c 297 &sect;36; 1989 c 165 &sect;143.] </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">C-2</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">RCW 23B.13.210<BR> Notice of intent to demand payment. </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(1) If proposed corporate action creating dissenters&#146; rights under RCW 23B.13.020 is submitted to a vote at a shareholders&#146; meeting, a shareholder who wishes to assert dissenters&#146; rights must (a) deliver to the corporation before the vote is taken notice of the shareholder&#146;s intent to demand payment for the shareholder&#146;s shares if the proposed corporate action is effected, and (b) not vote such shares in favor of the proposed corporate action. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(2) If proposed corporate action creating dissenters&#146; rights under RCW 23B.13.020 is submitted for approval without a vote of shareholders in accordance with RCW 23B.07.040, a shareholder who wishes to assert dissenters&#146; rights must not execute the consent or otherwise vote such shares in favor of the proposed corporate action. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(3) A shareholder who does not satisfy the requirements of subsection (1) or (2) of this section is not entitled to payment for the shareholder&#146;s shares under this chapter. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">[2009 c 189 &sect;43; 2002 c 297 &sect;37; 1989 c 165 &sect;144.] </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">RCW 23B.13.220<BR> Dissenters&#146; rights&nbsp;&#151;&nbsp;Notice. </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(1) If proposed corporate action creating dissenters&#146; rights under RCW 23B.13.020 is approved at a shareholders&#146; meeting, the corporation shall within ten days after the effective date of the corporate action deliver to all shareholders who satisfied the requirements of RCW 23B.13.210(1) a notice in compliance with subsection (5) of this section. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(2) If proposed corporate action creating dissenters&#146; rights under RCW 23B.13.020 is approved without a vote of shareholders in accordance with RCW 23B.07.040, the notice delivered pursuant to RCW 23B.07.040(3)(b) to shareholders who satisfied the requirements of RCW 23B.13.210(2) shall comply with subsection (5) of this section. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(3) In the case of proposed corporate action creating dissenters&#146; rights under RCW 23B.13.020(1)(a)(ii), the corporation shall within ten days after the effective date of the corporate action deliver to all shareholders of the subsidiary other than the parent a notice in compliance with subsection (5) of this section. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(4) In the case of proposed corporate action creating dissenters&#146; rights under RCW 23B.13.020(1)(d) that, pursuant to RCW 23B.10.020(4)(b), is not required to be approved by the shareholders of the corporation, the corporation shall within ten days after the effective date of the corporate action deliver to all shareholders entitled to dissent under RCW 23B.13.020(1)(d) a notice in compliance with subsection (5) of this section. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(5) Any notice under subsection (1), (2), (3), or (4) of this section must: </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(a) State where the payment demand must be sent and where and when certificates for certificated shares must be deposited; </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(b) Inform holders of uncertificated shares to what extent transfer of the shares will be restricted after the payment demand is received; </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(c) Supply a form for demanding payment that includes the date of the first announcement to news media or to shareholders of the terms of the proposed corporate action and requires that the person asserting dissenters&#146; rights certify whether or not the person acquired beneficial ownership of the shares before that date; </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(d) Set a date by which the corporation must receive the payment demand, which date may not be fewer than thirty nor more than sixty days after the date the notice in subsection (1), (2), (3), or (4) of this section is delivered; and </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(e) Be accompanied by a copy of this chapter. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">[2013 c 97 &sect;2; 2009 c 189 &sect;44; 2002 c 297 &sect;38; 1989 c 165 &sect;145.] </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">C-3</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">RCW 23B.13.230<BR> Duty to demand payment. </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(1) A shareholder sent a notice described in RCW 23B.13.220 must demand payment, certify whether the shareholder acquired beneficial ownership of the shares before the date required to be set forth in the notice pursuant to RCW 23B.13.220(5)(c), and deposit the shareholder&#146;s certificates, all in accordance with the terms of the notice. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(2) The shareholder who demands payment and deposits the shareholder&#146;s share certificates under subsection (1) of this section retains all other rights of a shareholder until the proposed corporate action is effected. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(3) A shareholder who does not demand payment or deposit the shareholder&#146;s share certificates where required, each by the date set in the notice, is not entitled to payment for the shareholder&#146;s shares under this chapter. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">[2013 c 97 &sect;3; 2002 c 297 &sect;39; 1989 c 165 &sect;146.] </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">RCW 23B.13.240<BR> Share restrictions. </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(1) The corporation may restrict the transfer of uncertificated shares from the date the demand for payment under RCW 23B.13.230 is received until the proposed corporate action is effected or the restriction is released under RCW 23B.13.260. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(2) The person for whom dissenters&#146; rights are asserted as to uncertificated shares retains all other rights of a shareholder until the effective date of the proposed corporate action. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">[2009 c 189 &sect;45; 1989 c 165 &sect;147.] </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">RCW 23B.13.250<BR> Payment. </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(1) Except as provided in RCW 23B.13.270, within thirty days of the later of the effective date of the proposed corporate action, or the date the payment demand is received, the corporation shall pay each dissenter who complied with RCW 23B.13.230 the amount the corporation estimates to be the fair value of the shareholder&#146;s shares, plus accrued interest. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(2) The payment must be accompanied by: </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(a) The corporation&#146;s balance sheet as of the end of a fiscal year ending not more than sixteen months before the date of payment, an income statement for that year, a statement of changes in shareholders&#146; equity for that year, and the latest available interim financial statements, if any; </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(b) An explanation of how the corporation estimated the fair value of the shares; </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(c) An explanation of how the interest was calculated; </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(d) A statement of the dissenter&#146;s right to demand payment under RCW 23B.13.280; and </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(e) A copy of this chapter. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">[1989 c 165 &sect;148.] </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">RCW 23B.13.260<BR> Failure to take corporate action. </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(1) If the corporation does not effect the proposed corporate action within sixty days after the date set for demanding payment and depositing share certificates, the corporation shall return the deposited certificates and release any transfer restrictions imposed on uncertificated shares. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(2) If after returning deposited certificates and releasing transfer restrictions, the corporation wishes to effect the proposed corporate action, it must send a new dissenters&#146; notice under RCW 23B.13.220 and repeat the payment demand procedure. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">[2009 c 189 &sect;46; 1989 c 165 &sect;149.] </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">C-4</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">RCW 23B.13.270<BR> After-acquired shares. </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(1) A corporation may elect to withhold payment required by RCW 23B.13.250 from a dissenter unless the dissenter was the beneficial owner of the shares before the date set forth in the dissenters&#146; notice as the date of the first announcement to news media or to shareholders of the terms of the proposed corporate action. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(2) To the extent the corporation elects to withhold payment under subsection (1) of this section, after the effective date of the proposed corporate action, it shall estimate the fair value of the shares, plus accrued interest, and shall pay this amount to each dissenter who agrees to accept it in full satisfaction of the dissenter&#146;s demand. The corporation shall send with its offer an explanation of how it estimated the fair value of the shares, an explanation of how the interest was calculated, and a statement of the dissenter&#146;s right to demand payment under RCW 23B.13.280. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">[2009 c 189 &sect;47; 1989 c 165 &sect;150.] </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">RCW 23B.13.280<BR> Procedure if shareholder dissatisfied with payment or offer. </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(1) A dissenter may deliver a notice to the corporation informing the corporation of the dissenter&#146;s own estimate of the fair value of the dissenter&#146;s shares and amount of interest due, and demand payment of the dissenter&#146;s estimate, less any payment under RCW 23B.13.250, or reject the corporation&#146;s offer under RCW 23B.13.270 and demand payment of the dissenter&#146;s estimate of the fair value of the dissenter&#146;s shares and interest due, if: </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(a) The dissenter believes that the amount paid under RCW 23B.13.250 or offered under RCW 23B.13.270 is less than the fair value of the dissenter&#146;s shares or that the interest due is incorrectly calculated; </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(b) The corporation fails to make payment under RCW 23B.13.250 within sixty days after the date set for demanding payment; or </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(c) The corporation does not effect the proposed corporate action and does not return the deposited certificates or release the transfer restrictions imposed on uncertificated shares within sixty days after the date set for demanding payment. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(2) A dissenter waives the right to demand payment under this section unless the dissenter notifies the corporation of the dissenter&#146;s demand under subsection (1) of this section within thirty days after the corporation made or offered payment for the dissenter&#146;s shares. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">[2009 c 189 &sect;48; 2002 c 297 &sect;40; 1989 c 165 &sect;151.] </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">RCW 23B.13.300<BR> Court action. </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(1) If a demand for payment under RCW 23B.13.280 remains unsettled, the corporation shall commence a proceeding within sixty days after receiving the payment demand and petition the court to determine the fair value of the shares and accrued interest. If the corporation does not commence the proceeding within the sixty-day period, it shall pay each dissenter whose demand remains unsettled the amount demanded. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(2) The corporation shall commence the proceeding in the superior court of the county where a corporation&#146;s principal office, or, if none in this state, its registered office, is located. If the corporation is a foreign corporation without a registered office in this state, it shall commence the proceeding in the county in this state where the registered office of the domestic corporation merged with or whose shares were acquired by the foreign corporation was located. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(3) The corporation shall make all dissenters, whether or not residents of this state, whose demands remain unsettled, parties to the proceeding as in an action against their shares and all parties must be served with a copy of the petition. Nonresidents may be served by registered or certified mail or by publication as provided by law. </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">C-5</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(4) The corporation may join as a party to the proceeding any shareholder who claims to be a dissenter but who has not, in the opinion of the corporation, complied with the provisions of this chapter. If the court determines that such shareholder has not complied with the provisions of this chapter, the shareholder shall be dismissed as a party. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(5) The jurisdiction of the court in which the proceeding is commenced under subsection (2) of this section is plenary and exclusive. The court may appoint one or more persons as appraisers to receive evidence and recommend decision on the question of fair value. The appraisers have the powers described in the order appointing them, or in any amendment to it. The dissenters are entitled to the same discovery rights as parties in other civil proceedings. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(6) Each dissenter made a party to the proceeding is entitled to judgment (a) for the amount, if any, by which the court finds the fair value of the dissenter&#146;s shares, plus interest, exceeds the amount paid by the corporation, or (b) for the fair value, plus accrued interest, of the dissenter&#146;s after-acquired shares for which the corporation elected to withhold payment under RCW 23B.13.270. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">[1989 c 165 &sect;152.] </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">RCW 23B.13.310<BR> Court costs and counsel fees. </H2>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(1) The court in a proceeding commenced under RCW 23B.13.300 shall determine all costs of the proceeding, including the reasonable compensation and expenses of appraisers appointed by the court. The court shall assess the costs against the corporation, except that the court may assess the costs against all or some of the dissenters, in amounts the court finds equitable, to the extent the court finds the dissenters acted arbitrarily, vexatiously, or not in good faith in demanding payment under RCW 23B.13.280. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(2) The court may also assess the fees and expenses of counsel and experts for the respective parties, in amounts the court finds equitable: </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(a) Against the corporation and in favor of any or all dissenters if the court finds the corporation did not substantially comply with the requirements of RCW 23B.13.200 through 23B.13.280; or </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(b) Against either the corporation or a dissenter, in favor of any other party, if the court finds that the party against whom the fees and expenses are assessed acted arbitrarily, vexatiously, or not in good faith with respect to the rights provided by chapter 23B.13 RCW. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(3) If the court finds that the services of counsel for any dissenter were of substantial benefit to other dissenters similarly situated, and that the fees for those services should not be assessed against the corporation, the court may award to these counsel reasonable fees to be paid out of the amounts awarded the dissenters who were benefited. </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">[1989 c 165 &sect;153.]  </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">C-6</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:0pt; text-align: right; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>APPENDIX D</B> </P>

<H1 STYLE="text-indent:0pt; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 9pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">FORM OF<BR>AGREEMENT AND PLAN OF MERGER OF<BR>AMPLIPHI BIOSCIENCES CORPORATION,<BR>A DELAWARE CORPORATION,<BR>AND<BR>AMPLIPHI BIOSCIENCES CORPORATION,<BR>A WASHINGTON CORPORATION </H1>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">This AGREEMENT AND PLAN OF MERGER, dated as of [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;], 2016 (the &#147;<B><I>Merger Agreement</I></B>&#148;), is made by and between AmpliPhi Biosciences Corporation, a Delaware corporation (&#147;<B><I>AmpliPhi Delaware</I></B>&#148;), and AmpliPhi Biosciences Corporation, a Washington corporation (&#147;<B><I>AmpliPhi Washington</I></B>&#148;). AmpliPhi Delaware and AmpliPhi Washington are sometimes referred to herein as the &#147;<B><I>Constituent Corporations</I></B>.&#148; AmpliPhi Delaware is a wholly-owned subsidiary of AmpliPhi Washington. </P>

<H1 STYLE="text-indent:0pt; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 9pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">RECITALS </H1>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">A. AmpliPhi Delaware is a corporation duly incorporated and existing under the laws of the State of Delaware and has a total authorized capital stock of 100 shares, all of which are designated common stock, par value $0.01 per share (the &#147;<B><I>AmpliPhi Delaware Common Stock</I></B>&#148;). As of the date hereof, and before giving effect to the transactions contemplated hereby, 100 shares of AmpliPhi Delaware Common Stock are issued and outstanding, all of which are held by AmpliPhi Washington. AmpliPhi Delaware was formed solely for the purposes contemplated by the Merger Agreement, and prior to becoming the Surviving
Corporation (as defined below) shall have had no operations, assets or liabilities. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">B. AmpliPhi Washington is a corporation duly incorporated and existing under the laws of the State of Washington and has a total authorized capital stock of 455,000,000 shares, 445,000,000 of which are designated common stock, par value $0.01 per share (the &#147;<B><I>AmpliPhi Washington Common Stock</I></B>&#148;) and 10,000,000 of which are designated Preferred Stock, par value $0.01 per share (the &#147;<B><I>AmpliPhi Washington Preferred Stock</I></B>&#148;). As of the date hereof, and before giving effect to the transactions contemplated hereby, [&nbsp;&nbsp;&nbsp;&nbsp;] shares of AmpliPhi Washington Common Stock are
issued and outstanding and no shares of AmpliPhi Washington Preferred Stock are issued and outstanding. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">C. The Board of Directors of AmpliPhi Washington has determined that, for the purpose of effecting the reincorporation of AmpliPhi Washington in the State of Delaware, it is advisable and in the best interests of AmpliPhi Washington and its shareholders that AmpliPhi Washington merge with and into AmpliPhi Delaware upon the terms and conditions herein provided. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">D. The respective Boards of Directors of the Constituent Corporations, the shareholders of AmpliPhi Washington and the stockholders of AmpliPhi Delaware have approved this Merger Agreement and have directed that this Merger Agreement be executed by the undersigned officers. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>NOW, THEREFORE,</B> in consideration of the mutual agreements and covenants set forth herein, AmpliPhi Delaware and AmpliPhi Washington hereby agree, intending to be legally bound hereby, subject to the terms and conditions hereinafter set forth, as follows: </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">1. MERGER </H2>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">1.1 <U>Merger</U>.&nbsp;&nbsp;In accordance with the provisions of this Merger Agreement, the General Corporation Law of the State of Delaware (the &#147;<B><I>DGCL</I></B>&#148;) and the Washington Business Corporation Act, AmpliPhi Washington shall be merged with and into AmpliPhi Delaware (the &#147;<B><I>Merger</I></B>&#148;), the separate existence of AmpliPhi Washington shall cease, and AmpliPhi Delaware shall be the surviving corporation (AmpliPhi Delaware is herein sometimes referred to as the &#147;<B><I>Surviving Corporation</I></B>&#148;). </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">1.2 <U>Filing and Effectiveness</U>.&nbsp;&nbsp;The Merger shall become effective upon completion of the following actions: </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 44px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(a) Adoption and approval of this Agreement and the Merger by the stockholders and shareholders, respectively, of each Constituent Corporation in accordance with the applicable requirements of the Delaware General Corporation Law and the Washington Business Corporation Act; </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">D-1</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 44px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(b) The satisfaction or waiver of all of the conditions precedent to the consummation of the Merger as specified in this Agreement; </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 44px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(c) The filing with the Secretary of State of Delaware of an executed certificate of merger (the &#147;<B><I>Certificate of Merger</I></B>&#148;) or an executed counterpart of this Agreement meeting the requirements of the Delaware General Corporation Law; and </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 44px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(d) The filing with the Secretary of State of Washington of executed Articles of Merger (the &#147;<B><I>Articles of Merger</I></B>&#148;) meeting the requirements of 23B.11.050 of the Washington Business Corporation Act. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The date and time when the Merger becomes effective is referred to in this Agreement as the &#147;<B><I>Effective Time</I></B>.&#148; </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">1.3 <U>Effect of the Merger</U>.&nbsp;&nbsp;Upon the Effective Time, the separate existence of AmpliPhi Washington shall cease, and AmpliPhi Delaware, as the Surviving Corporation, shall: (i) continue to possess all of its assets, rights, powers and property as constituted immediately prior to the Effective Time, (ii) be subject to all actions previously taken by its and AmpliPhi Washington&#146;s Boards of Directors, (iii) succeed, without other transfer, to all of the assets, rights, powers and property of AmpliPhi Washington in the manner as more fully set forth in Section 259 of the DGCL, (iv) continue to be subject to
all of its debts, liabilities and obligations as constituted immediately prior to the Effective Time, and (v) succeed, without other transfer, to all of the debts, liabilities and obligations of AmpliPhi Washington in the same manner as if AmpliPhi Delaware had itself incurred them, all as more fully provided under the applicable provisions of the DGCL and the Washington Business Corporation Act. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">2. CHARTER DOCUMENTS, DIRECTORS AND OFFICERS </H2>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">2.1 <U>Certificate of Incorporation</U>.&nbsp;&nbsp;The Amended and Restated Certificate of Incorporation attached as an exhibit to the Certificate of Merger shall continue in full force and effect as the Certificate of Incorporation of the Surviving Corporation until duly amended in accordance with the provisions thereof and applicable law. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">2.2 <U>Bylaws</U>.&nbsp;&nbsp;The Amended and Restated Bylaws of AmpliPhi Delaware as in effect at the Effective Time shall continue in full force and effect as the Bylaws of the Surviving Corporation until duly amended in accordance with the provisions thereof and applicable law. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">2.3 <U>Directors and Officers</U>.&nbsp;&nbsp;The directors and officers of AmpliPhi Washington immediately prior to the Effective Time shall be the directors and officers of the Surviving Corporation until their successors shall have been duly elected and qualified or until as otherwise provided by law, the Certificate of Incorporation of the Surviving Corporation or the Bylaws of the Surviving Corporation. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">3. MANNER OF CONVERSION OF STOCK </H2>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">3.1 <U>AmpliPhi Washington Common Stock</U>.&nbsp;&nbsp;Upon the Effective Time, each share of AmpliPhi Washington Common Stock issued and outstanding immediately prior thereto shall, by virtue of the Merger and without any action by the Constituent Corporations, the holder of such shares or any other person, be converted into and exchanged for one (1) legally issued, fully paid and nonassessable share of AmpliPhi Delaware Common Stock. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">3.2 <U>AmpliPhi Delaware Common Stock</U>.&nbsp;&nbsp;Upon the Effective Time, each share of AmpliPhi Delaware Common Stock issued and outstanding immediately prior thereto shall, by virtue of the Merger and without any action by AmpliPhi Delaware, or the holder of such shares or any other person, be cancelled and returned to the status of authorized and unissued shares of AmpliPhi Delaware Common Stock, without any consideration being delivered in respect thereof. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">3.3 <U>AmpliPhi Washington Convertible Securities</U>.&nbsp;&nbsp;Upon the Effective Time, AmpliPhi Delaware shall assume the obligations of AmpliPhi Washington pursuant to any outstanding securities convertible into AmpliPhi Washington Common Stock outstanding immediately prior thereto. Each such outstanding and unexercised security convertible into AmpliPhi Washington Common Stock as of immediately prior to the Effective Time (each, a &#147;<B><I>Right</I></B>&#148;) shall upon the Effective Time become a security convertible into </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">D-2</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">AmpliPhi Delaware Common Stock on the same terms and conditions. A number of shares of AmpliPhi Delaware Common Stock shall upon the Effective Time be reserved for issuance upon the exercise or conversion of Rights equal to the number of shares of AmpliPhi Washington Common Stock so reserved immediately prior to the Effective Time. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">3.4 <U>Exchange of Certificates</U>.&nbsp;&nbsp;After the Effective Time, each holder of an outstanding certificate representing shares of AmpliPhi Washington Common Stock may, at such shareholder&#146;s option, surrender the same for cancellation to an exchange agent designated by the Surviving Corporation (the &#147;<B><I>Exchange Agent</I></B>&#148;), and each such holder shall be entitled to receive in exchange therefor a certificate or certificates representing the number of shares of AmpliPhi Delaware Common Stock into which the shares formerly represented by the surrendered certificate were converted as herein
provided. Until so surrendered, each certificate representing shares of AmpliPhi Washington Common Stock outstanding immediately prior to the Effective Time shall be deemed for all purposes, from and after the Effective Time, to represent the number of shares of AmpliPhi Delaware Common Stock into which such shares of AmpliPhi Washington Common Stock were converted in the Merger. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The registered owner on the books and records of the Surviving Corporation or the Exchange Agent of any shares of stock represented by such certificate shall, until such certificate shall have been surrendered for transfer or conversion or otherwise accounted for to the Surviving Corporation or the Exchange Agent, have and be entitled to exercise any voting and other rights with respect to and to receive dividends and other distributions upon the shares of AmpliPhi Delaware Common Stock represented by such certificate as provided above. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Each certificate representing shares of AmpliPhi Delaware Common Stock so issued in the Merger shall bear the same legends, if any, with respect to the restrictions on transferability as the certificate of AmpliPhi Washington Common Stock so converted and given in exchange therefor (and such legends shall continue to be reflected for any such shares held in book entry), unless otherwise determined by the Board of Directors of the Surviving Corporation in compliance with applicable laws. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">If any certificate for shares of the Surviving Corporation&#146;s stock is to be issued in a name other than that in which the certificate surrendered in exchange therefor is registered, it shall be a condition of issuance thereof that the certificate so surrendered shall be properly endorsed and otherwise in proper form for transfer, that such transfer otherwise be proper and comply with applicable securities laws and that the person requesting such transfer pay to the Exchange Agent any transfer or other taxes payable by reason of the issuance of such new certificate in a name other than that of the registered holder of the
certificate surrendered or establish to the satisfaction of the Surviving Corporation that such tax has been paid or is not payable. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">3.5 <U>Shareholder Agreements</U>.&nbsp;&nbsp;In the event any outstanding shares of capital stock of AmpliPhi Washington are subject to any agreements between AmpliPhi Washington and one or more shareholders, or among shareholders, such agreements shall remain in full force and effect following the Effective Time, substituting the applicable shares of capital stock of AmpliPhi Delaware, including without limitation any outstanding restricted stock purchase agreements or stock option agreements issued under the Plans. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">3.6 <U>AmpliPhi Washington Equity Incentive Plans and Equity Awards</U>. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 44px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(a) Upon the Effective Time, AmpliPhi Delaware shall assume and continue any and all stock option, stock incentive, stock purchase and other equity-based award plans heretofore adopted by AmpliPhi Washington, including its 2009 Stock Incentive Plan, 2012 Stock Incentive Plan, 2013 Stock Incentive Plan, [2016 Equity Incentive Plan and 2016 Employee Stock Purchase Plan] (collectively, the &#147;<B><I>Plans</I></B>&#148;) for its employees and other service providers. Each option, restricted stock unit, stock appreciation right or right to purchase or receive, or security convertible into, AmpliPhi Washington Common Stock that
is outstanding and unexercised (as applicable) immediately prior to the Effective Time shall become an option, restricted stock unit, stock appreciation right or right to purchase or receive, or security convertible into, AmpliPhi Delaware Common Stock, on the basis of one (1) share of AmpliPhi Delaware Common Stock for each share </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">D-3</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 44px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">of AmpliPhi Washington Common Stock issuable pursuant to such option, restricted stock unit, stock appreciation right or right to purchase or receive, or convertible security, on all of the same terms and conditions and at an exercise, conversion or purchase price (as applicable) per share equal to the exercise, conversion or purchase price (as applicable) per share applicable to any such option, restricted stock unit, stock appreciation right or right to purchase or receive, or security convertible into, AmpliPhi Washington Common Stock as in effect immediately prior to the Effective Time. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 44px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(b) Upon the Effective Time, a number of shares of AmpliPhi Delaware Common Stock shall be reserved for issuance under the Plans equal to the number of shares of AmpliPhi Washington Common Stock so reserved immediately prior to the Effective Time. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">3.7 <U>Benefit Plans</U>.&nbsp;&nbsp;Upon the Effective Time, the Surviving Corporation shall assume and be subject to all of the duties, liabilities, obligations and restrictions of every kind and description of AmpliPhi Washington under each employee benefit plan sponsored by AmpliPhi Washington or its subsidiaries in effect as of immediately prior to the Effective Time or with respect to which employee rights or accrued benefits are outstanding as of the Effective Time. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">4. CONDITIONS </H2>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">4.1 <U>Conditions to AmpliPhi Washington&#146;s Obligations</U>.&nbsp;&nbsp;The obligations of AmpliPhi Washington under this Merger Agreement shall be conditioned upon the occurrence of the following events: </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 44px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(a) The principal terms of this Merger Agreement shall have been duly approved by the shareholders of AmpliPhi Washington; </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 44px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(b) Any consents, approvals or authorizations that AmpliPhi Washington deems necessary or appropriate to be obtained in connection with the consummation of the Merger shall have been obtained, including, but not limited to, approvals with respect to federal and state securities laws; and </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 44px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(c) The AmpliPhi Delaware Common Stock to be issued and reserved for issuance in connection with the Merger shall have been approved for listing on the NYSE MKT stock exchange. </P>

<H2 STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 5pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">5. GENERAL </H2>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">5.1 <U>Covenants of AmpliPhi Delaware</U>.&nbsp;&nbsp;AmpliPhi Delaware covenants and agrees that it will, at or before the Effective Time: </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 44px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(a) Irrevocably appoint an agent for service of process in the State of Washington; and </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 44px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(b) Take such other actions as may be required by the Washington Business Corporation Act. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">5.2 <U>FIRPTA Notification</U>.&nbsp;&nbsp;If any shareholder believes that it, or its direct or indirect beneficial owners, could potentially be subject to tax in connection with the Merger under Section 897 of the Internal Revenue Code of 1986, as amended (the &#147;<B><I>Code</I></B>&#148;) by reason of (i) being a nonresident alien individual or foreign corporation within the meaning of Section 897(a)(1) of the Code, and (ii) not qualifying for the exemption in Section 897(c)(3) of the Code, such shareholder may provide the Surviving Corporation with a statement on the date hereof in accordance with Notice 89-57, 1989-1
C.B. 698, and Section 1.1445-2(d)(2)(iii) of the Treasury Regulations, which statement the Surviving Corporation shall file with the Internal Revenue Service within 20 days in accordance with Section 1.1445-2(d)(2)(i)(V) of the Treasury Regulations. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">5.3 <U>Reorganization for Tax Purposes</U>.&nbsp;&nbsp;The Merger is intended to be treated for U.S. federal income tax purposes as a &#147;reorganization&#148; described in Section 368(a)(1)(F) of the Code, and by executing this agreement the parties intend to adopt a &#147;plan of reorganization&#148; within the meaning of Sections 1.368-2(g) and 1.368-3(a) of the Treasury Regulations. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">5.4 <U>Further Assurances</U>.&nbsp;&nbsp;From time to time, as and when required by AmpliPhi Delaware or by its successors or assigns, there shall be executed and delivered on behalf of AmpliPhi Washington such deeds and other instruments, and there shall be taken or caused to be taken by AmpliPhi Delaware and AmpliPhi Washington such further and other actions, as shall be appropriate or necessary in order to vest </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">D-4</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">or perfect in or conform of record or otherwise by AmpliPhi Delaware the title to and possession of all the property, interests, assets, rights, privileges, immunities, powers, franchises and authority of AmpliPhi Washington and otherwise to carry out the purposes of this Merger Agreement, and the officers and directors of AmpliPhi Delaware are fully authorized in the name and on behalf of AmpliPhi Washington or otherwise to take any and all such action and to execute and deliver any and all such deeds and other instruments. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">5.5 <U>Abandonment</U>.&nbsp;&nbsp;At any time before the Effective Time, this Merger Agreement may be terminated and the Merger may be abandoned for any reason whatsoever by the Board of Directors of either or both of the Constituent Corporations, notwithstanding the approval of this Merger Agreement by the shareholders of AmpliPhi Washington or by the stockholders of AmpliPhi Delaware, or by both. In the event of the termination of this Merger Agreement, this Merger Agreement shall become void and of no effect and there shall be no obligations on either Constituent Corporation or their respective Board of Directors,
shareholders or stockholders (as applicable) with respect thereto. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">5.6 <U>Amendment</U>.&nbsp;&nbsp;The Boards of Directors of the Constituent Corporations may amend this Merger Agreement at any time prior to the filing of this Merger Agreement with the Secretaries of State of the States of Delaware and Washington, provided that an amendment made subsequent to the adoption of this Merger Agreement by the stockholders or shareholders (as applicable) of either Constituent Corporation shall not, unless approved by such stockholders or shareholders (as applicable) as required by law: </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 44px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(a) Alter or change the amount or kind of shares, securities, cash, property and/or rights to be received in exchange for or on conversion of all or any of the shares of any class or series thereof of such Constituent Corporation; </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 44px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(b) Alter or change any term of the Certificate of Incorporation or Bylaws of the Surviving Corporation to be effected by the Merger; or </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 44px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(c) Alter or change any of the terms and conditions of this Merger Agreement if such alteration or change would adversely affect the holders of any class or series of capital stock of any Constituent Corporation. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">5.7 <U>Registered Office</U>.&nbsp;&nbsp;The registered office of the Surviving Corporation in the State of Delaware is 160 Greentree Drive, Suite 101, in the City of Dover, County of Kent, 19904, and National Registered Agents, Inc. is the registered agent of the Surviving Corporation at such address. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">5.8 <U>Governing Law</U>.&nbsp;&nbsp;This Merger Agreement shall in all respects be construed, interpreted and enforced in accordance with and governed by the laws of the State of Delaware and, so far as applicable, the merger provisions of the Washington Business Corporation Act. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">5.9 <U>Counterparts</U>.&nbsp;&nbsp;In order to facilitate the filing and recording of this Merger Agreement, the same may be executed in any number of counterparts, each of which shall be deemed to be an original and all of which together shall constitute one and the same instrument. </P>

<P STYLE="text-indent:0pt; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B><I>[BALANCE OF PAGE INTENTIONALLY LEFT BLANK]</I></B> </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">D-5</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:0pt; text-align: right; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>APPENDIX E</B> </P>

<H1 STYLE="text-indent:0pt; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 9pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">AMENDED AND RESTATED CERTIFICATE OF INCORPORATION<BR> OF<BR> AMPLIPHI BIOSCIENCES CORPORATION </H1>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The undersigned, M. Scott Salka, in accordance with the provisions of Sections 242 and 245 of the Delaware General Corporation Law (<B><I>&#147;DGCL&#148;</I></B>) hereby certifies that: </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>FIRST:</B>&nbsp;&nbsp;He is the duly elected and acting President and Chief Executive Officer of AmpliPhi Biosciences Corporation, a Delaware corporation. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>SECOND:</B>&nbsp;&nbsp;The date of filing of the original Certificate of Incorporation of this corporation with the Secretary of State of the State of Delaware was [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;], 2016. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>THIRD:</B>&nbsp;&nbsp;This Amended and Restated Certificate of Incorporation (this <B><I>&#147;Certificate of Incorporation&#148;</I></B>) has been duly approved and adopted by the Board of Directors of this corporation (the <B><I>&#147;Board&#148;</I></B>) in accordance with the applicable provisions of Sections 242 and 245 of the DGCL. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>FOURTH:</B>&nbsp;&nbsp;This Certificate of Incorporation has been duly approved and adopted by the stockholders of the Corporation in accordance with the applicable provisions of Sections 211, 242 and 245 of the DGCL. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>FIFTH:</B>&nbsp;&nbsp;The text of this Certificate of Incorporation, as heretofore amended or supplemented, is hereby amended and restated in its entirety to read as follows: </P>

<H1 STYLE="text-indent:0pt; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 9pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">I. </H1>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The name of this corporation is AmpliPhi Biosciences Corporation. </P>

<H1 STYLE="text-indent:0pt; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 9pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">II. </H1>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The address of the registered office of the corporation in the State of Delaware is 160 Greentree Drive, Suite 101, City of Dover, County of Kent, 19904, and the name of the registered agent of the corporation in the State of Delaware at such address is the National Registered Agents, Inc. </P>

<H1 STYLE="text-indent:0pt; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 9pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">III. </H1>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The purpose of this corporation is to engage in any lawful act or activity for which a corporation may be organized under the DGCL. </P>

<H1 STYLE="text-indent:0pt; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 9pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">IV. </H1>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>A. </B>This corporation is authorized to issue two classes of stock to be designated, respectively, &#147;<B><I>Common Stock</I></B>&#148; and &#147;<B><I>Preferred Stock</I></B>.&#148; The total number of shares which the corporation is authorized to issue is one hundred sixty million (160,000,000) shares. One hundred fifty million (150,000,000) shares shall be Common Stock, each having a par value of one cent ($0.01). Ten million (10,000,000) shares shall be Preferred Stock, each having a par value of one cent ($0.01). </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">The number of authorized shares of Common Stock may be increased or decreased (but not below the number of shares of Common Stock then outstanding) by the affirmative vote of the holders of the stock of the corporation entitled to vote, voting together as a single class, irrespective of Section 242(b)(2) of the DGCL. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>B. </B>The Preferred Stock may be issued from time to time in one or more series. The Board of Directors is hereby expressly authorized to provide for the issue of all of any of the remaining shares of the Preferred Stock in one or more series, and to fix the number of shares and to determine or alter for each such series, such voting powers, full or limited, or no voting powers, and such designation, preferences, and relative, participating, optional, or other rights and such qualifications, limitations, or restrictions thereof, as shall be stated and expressed in the resolution or resolutions adopted by the Board of
Directors providing for the issuance of such shares and as may be permitted by the DGCL. The Board of Directors is also expressly </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">E-1</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">authorized to increase or decrease the number of shares of any series subsequent to the issuance of shares of that series, but not below the number of shares of such series then outstanding. In case the number of shares of any series shall be decreased in accordance with the foregoing sentence, the shares constituting such decrease shall resume the status that they had prior to the adoption of the resolution originally fixing the number of shares of such series. The number of authorized shares of Preferred Stock may be increased or decreased (but not below the number of shares thereof then outstanding) by the affirmative vote
of the holders of a majority of the voting power of the stock of the corporation entitled to vote thereon, without a separate vote of the holders of the Preferred Stock, or of any series thereof, unless a vote of any such holders is required pursuant to the terms of any certificate of designation filed with respect to any series of Preferred Stock. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>C. </B>Each outstanding share of Common Stock shall entitle the holder thereof to one vote on each matter properly submitted to the stockholders of the corporation for their vote; <I>provided, however</I>, that, except as otherwise required by law, holders of Common Stock shall not be entitled to vote on any amendment to this Certificate of Incorporation (including any certificate of designation filed with respect to any series of Preferred Stock) that relates solely to the terms of one or more outstanding series of Preferred Stock if the holders of such affected series are entitled, either separately or together as a class
with the holders of one or more other such series, to vote thereon by law or pursuant to this Certificate of Incorporation (including any certificate of designation filed with respect to any series of Preferred Stock). </P>

<H1 STYLE="text-indent:0pt; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 9pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">V. </H1>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">For the management of the business and for the conduct of the affairs of the corporation, and in further definition, limitation and regulation of the powers of the corporation, of its directors and of its stockholders or any class thereof, as the case may be, it is further provided that: </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>A. </B>The management of the business and the conduct of the affairs of the corporation shall be vested in its Board of Directors. The number of directors which shall constitute the Board of Directors shall be fixed exclusively by resolutions adopted by a majority of the authorized number of directors constituting the Board of Directors. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>B. </B>Subject to the rights of the holders of any series of Preferred Stock to elect additional directors under specified circumstances, the directors shall be divided into three classes designated as Class I, Class II and Class III, respectively. The Board of Directors is authorized to assign members of the Board of Directors already in office to such classes at the time the classification becomes effective. At the first annual meeting of stockholders following the initial classification of the Board of Directors, the term of office of the Class II directors shall expire and Class II directors shall be elected for a full
term of three years. At the second annual meeting of stockholders following such initial classification, the term of office of the Class III directors shall expire and Class III directors shall be elected for a full term of three years. At the third annual meeting of stockholders following such initial classification, the term of office of the Class I directors shall expire and Class I directors shall be elected for a full term of three years. At each succeeding annual meeting of stockholders, directors shall be elected for a full term of three years to succeed the directors of the class whose terms expire at such annual meeting. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Notwithstanding the foregoing provisions of this section, each director shall serve until his successor is duly elected and qualified or until his earlier death, resignation or removal. No decrease in the number of directors constituting the Board of Directors shall shorten the term of any incumbent director. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>C. </B>Subject to the rights of any series of Preferred Stock to elect additional directors under specified circumstances, neither the Board of Directors nor any individual director may be removed without cause. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>D. </B>Subject to any limitations imposed by applicable law, any individual director or directors may be removed with cause by the affirmative vote of the holders of sixty-six and two-thirds percent (66&nbsp;2/3%) of the voting power of all then-outstanding shares of capital stock of the corporation entitled to vote generally at an election of directors. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>E. </B>Subject to any limitations imposed by applicable law and subject to the rights of the holders of any series of Preferred Stock, any vacancies on the Board of Directors resulting from death, resignation, disqualification, removal or other causes and any newly created directorships resulting from any increase in </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">E-2</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">the number of directors, shall, unless the Board of Directors determines by resolution that any such vacancies or newly created directorships shall be filled by the stockholders and except as otherwise provided by applicable law, be filled only by the affirmative vote of a majority of the directors then in office, even though less than a quorum of the Board of Directors, and not by the stockholders. Any director elected in accordance with the preceding sentence shall hold office for the remainder of the full term of the director for which the vacancy was created or occurred and until such director&#146;s successor shall have
been elected and qualified. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>F. </B>The Board of Directors is expressly empowered to adopt, amend or repeal the Bylaws of the corporation. Any adoption, amendment or repeal of the Bylaws of the corporation by the Board of Directors shall require the approval of a majority of the authorized number of directors. The stockholders shall also have power to adopt, amend or repeal the Bylaws of the corporation; <I>provided, however, </I>that, in addition to any vote of the holders of any class or series of stock of the corporation required by law or by this Certificate of Incorporation, such action by stockholders shall require the affirmative vote of the
holders of at least sixty-six and two-thirds percent (66&nbsp;2/3%) of the voting power of all of the then-outstanding shares of the capital stock of the corporation entitled to vote generally in the election of directors, voting together as a single class. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>G. </B>The directors of the corporation need not be elected by written ballot unless the Bylaws so provide. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>H. </B>No action shall be taken by the stockholders of the corporation except at an annual or special meeting of stockholders called in accordance with the Bylaws. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>I. </B>Advance notice of stockholder nominations for the election of directors and of business to be brought by stockholders before any meeting of the stockholders of the corporation shall be given in the manner provided in the Bylaws of the corporation. </P>

<H1 STYLE="text-indent:0pt; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 9pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">VI. </H1>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>A. </B>The liability of the directors for monetary damages shall be eliminated to the fullest extent under applicable law. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>B. </B>To the fullest extent permitted by applicable law, the corporation is authorized to provide indemnification of (and advancement of expenses to) directors, officers and agents of the corporation (and any other persons to which applicable law permits the corporation to provide indemnification) through Bylaw provisions, agreements with such agents or other persons, vote of stockholders or disinterested directors or otherwise in excess of the indemnification and advancement otherwise permitted by such applicable law. If applicable law is amended after approval by the stockholders of this Article VI to authorize corporate
action further eliminating or limiting the personal liability of directors, then the liability of a director to the corporation shall be eliminated or limited to the fullest extent permitted by applicable law as so amended. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>C. </B>Any repeal or modification of this Article VI shall only be prospective and shall not affect the rights or protections or increase the liability of any director under this Article VI in effect at the time of the alleged occurrence of any act or omission to act giving rise to liability or indemnification. </P>

<H1 STYLE="text-indent:0pt; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 9pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">VII. </H1>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Unless the corporation consents in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware shall, to the fullest extent permitted by law, be the sole and exclusive forum for (1) any derivative action or proceeding brought on behalf of the corporation; (2) any action asserting a claim of breach of a fiduciary duty owed by any director, officer or other employee of the corporation to the corporation or the corporation&#146;s stockholders; (3) any action asserting a claim against the corporation or any director or officer or other employee of the corporation arising pursuant to any
provision of the DGCL, this Certificate of Incorporation or the Bylaws of the corporation; and (4) any action asserting a claim against the corporation or any director or officer or other employee of the corporation governed by the internal affairs doctrine. </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">E-3</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<H1 STYLE="text-indent:0pt; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 9pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">VIII. </H1>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>A. </B>The corporation reserves the right to amend, alter, change or repeal any provision contained in this Certificate of Incorporation, in the manner now or hereafter prescribed by statute, except as provided in paragraph B. of this Article VIII, and all rights conferred upon the stockholders herein are granted subject to this reservation. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>B. </B>Notwithstanding any other provisions of this Certificate of Incorporation or any provision of law which might otherwise permit a lesser vote or no vote, but in addition to any affirmative vote of the holders of any particular class or series of the corporation required by law or by this Certificate of Incorporation or any certificate of designation filed with respect to a series of Preferred Stock, the affirmative vote of the holders of at least sixty-six and two-thirds percent (66-&nbsp;2/3%) of the voting power of all of the then-outstanding shares of capital stock of the corporation entitled to vote generally in
the election of directors, voting together as a single class, shall be required to alter, amend or repeal Articles V, VI, VII and VIII of this Certificate of Incorporation. </P>

<P STYLE="text-indent:0pt; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">* * * *</P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">E-4</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:0pt; text-align: right; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>APPENDIX F</B> </P>

<H1 STYLE="text-indent:0pt; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 9pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">AMPLIPHI BIOSCIENCES CORPORATION<BR>&nbsp;<BR> AMENDED AND RESTATED BYLAWS<BR>&nbsp;<BR> AMENDED AND RESTATED<BR> BYLAWS<BR> OF<BR> AMPLIPHI BIOSCIENCES CORPORATION<BR>&nbsp;<BR> </H1>

<H1 STYLE="text-indent:0pt; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 9pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">ARTICLE I<BR>&nbsp;<BR> OFFICES </H1>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>Section 1. Registered Office.</B>&nbsp;&nbsp;The registered office of the corporation in the State of Delaware shall be in the City of Dover, County of Kent. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>Section 2. Other Offices.</B>&nbsp;&nbsp;The corporation shall also have and maintain an office or principal place of business at such place as may be fixed by the corporation&#146;s Board of Directors (the &#147;<B><I>Board of Directors</I></B>&#148;), and may also have offices at such other places, both within and without the State of Delaware as the Board of Directors may from time to time determine or the business of the corporation may require. </P>

<H1 STYLE="text-indent:0pt; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 9pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">ARTICLE II<BR>&nbsp;<BR> CORPORATE SEAL </H1>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>Section 3. Corporate Seal.</B>&nbsp;&nbsp;The Board of Directors may adopt a corporate seal. The corporate seal shall consist of a die bearing the name of the corporation and the inscription, &#147;Corporate Seal-Delaware.&#148; Said seal may be used by causing it or a facsimile thereof to be impressed or affixed or reproduced or otherwise. </P>

<H1 STYLE="text-indent:0pt; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 9pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">ARTICLE III<BR>&nbsp;<BR> STOCKHOLDERS&#146; MEETINGS </H1>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>Section 4. Place of Meetings.</B>&nbsp;&nbsp;Meetings of the stockholders of the corporation may be held at such place, either within or without the State of Delaware, as may be determined from time to time by the Board of Directors. The Board of Directors may, in its sole discretion, determine that the meeting shall not be held at any place, but may instead be held solely by means of remote communication as provided under the Delaware General Corporation Law (the &#147;<B><I>DGCL</I></B>&#148;). </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>Section 5. Annual Meetings.</B> </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(a) </B>The annual meeting of the stockholders of the corporation, for the purpose of election of directors and for such other business as may properly come before it, shall be held on such date and at such time as may be designated from time to time by the Board of Directors. Nominations of persons for election to the Board of Directors of the corporation and the proposal of business to be considered by the stockholders may be made at an annual meeting of stockholders: (i) pursuant to the corporation&#146;s notice of meeting of stockholders (with respect to business other than nominations); (ii) brought specifically by or
at the direction of the Board of Directors; or (iii) by any stockholder of the corporation who was a stockholder of record at the time of giving the stockholder&#146;s notice provided for in Section 5(b) of these Amended and Restated Bylaws (the &#147;<B><I>Bylaws</I></B>&#148;), who is entitled to vote at the meeting and who complied with the notice procedures set forth in this Section 5. For the avoidance of doubt, clause (iii) above shall be the exclusive means for a stockholder to make nominations and submit other business (other than matters properly included in the corporation&#146;s notice of meeting of stockholders and proxy statement under Rule 14a-8 under the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder (the &#147;<B><I>1934 Act</I></B>&#148;)) before an annual meeting of stockholders. </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">F-1</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(b) </B>At an annual meeting of the stockholders, only such business shall be conducted as is a proper matter for stockholder action under Delaware law and as shall have been properly brought before the meeting. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 44px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>i. </B>For nominations for the election to the Board of Directors to be properly brought before an annual meeting by a stockholder pursuant to clause (iii) of Section 5(a) of these Bylaws, the stockholder must deliver written notice to the Secretary at the principal executive offices of the corporation on a timely basis as set forth in Section 5(b)(iii) of these Bylaws and must update and supplement such written notice on a timely basis as set forth in Section 5(c) of these Bylaws. Such stockholder&#146;s notice shall set forth: (A) as to each nominee such stockholder proposes to nominate at the meeting: (1) the name, age,
business address and residence address of such nominee; (2) the principal occupation or employment of such nominee; (3) the class and number of shares of each class of capital stock of the corporation which are owned of record and beneficially by such nominee; (4) the date or dates on which such shares were acquired and the investment intent of such acquisition; (5) with respect to each nominee for election or re-election to the Board of Directors, include a completed and signed questionnaire, representation and agreement required by Section 5(e) of these Bylaws; and (6) such other information concerning such nominee as would be required to be disclosed in a proxy statement soliciting proxies for the election of such nominee as a director in an election contest (even if an election contest is not involved), or that is otherwise required to be disclosed pursuant to Section 14 of the 1934 Act and the rules and regulations promulgated thereunder (including such person&#146;s written
consent to being named as a nominee and to serving as a director if elected); and (B) the information required by Section 5(b)(iv) of these Bylaws. The corporation may require any proposed nominee to furnish such other information as it may reasonably require to determine the eligibility of such proposed nominee to serve as an independent director of the corporation or that could be material to a reasonable stockholder&#146;s understanding of the independence, or lack thereof, of such proposed nominee. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 44px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>ii. </B>Other than proposals sought to be included in the corporation&#146;s proxy materials pursuant to Rule 14(a)-8 under the 1934 Act, for business other than nominations for the election to the Board of Directors to be properly brought before an annual meeting by a stockholder pursuant to clause (iii) of Section 5(a) of these Bylaws, the stockholder must deliver written notice to the Secretary at the principal executive offices of the corporation on a timely basis as set forth in Section 5(b)(iii) of these Bylaws, and must update and supplement such written notice on a timely basis as set forth in Section 5(c) of these
Bylaws. Such stockholder&#146;s notice shall set forth: (A) as to each matter such stockholder proposes to bring before the meeting, a brief description of the business desired to be brought before the meeting, the reasons for conducting such business at the meeting, and any material interest (including any anticipated benefit of such business to any Proponent (as defined below) other than solely as a result of its ownership of the corporation&#146;s capital stock, that is material to any Proponent individually, or to the Proponents in the aggregate) in such business of any Proponent; and (B) the information required by Section 5(b)(iv) of these Bylaws. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 44px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>iii. </B>To be timely, the written notice required by Section 5(b)(i) or 5(b)(ii) of these Bylaws must be received by the Secretary at the principal executive offices of the corporation not later than the close of business on the 90<sup>th</sup> day nor earlier than the close of business on the 120<sup>th</sup> day prior to the first anniversary of the preceding year&#146;s annual meeting; <I>provided, however,</I> that, subject to the last sentence of this Section 5(b)(iii), in the event that the date of the annual meeting is advanced more than 30 days prior to or delayed by more than 30 days after the anniversary of the
preceding year&#146;s annual meeting, notice by the stockholder to be timely must be so received not earlier than the close of business on the 120<sup>th</sup> day prior to such annual meeting and not later than the close of business on the later of the 90<sup>th</sup> day prior to such annual meeting or the 10<sup>th</sup> day following the day on which public announcement of the date of such meeting is first made. In no event shall an adjournment or a postponement of an annual meeting for which notice has been given, or the public announcement thereof has been made, commence a new time period for the giving of a stockholder&#146;s notice as described above. </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">F-2</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 44px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>iv. </B>The written notice required by Section 5(b)(i) or 5(b)(ii) of these Bylaws shall also set forth, as of the date of the notice and as to the stockholder giving the notice and the beneficial owner, if any, on whose behalf the nomination or proposal is made (each, a &#147;<B><I>Proponent</I></B>&#148; and collectively, the &#147;<B><I>Proponents</I></B>&#148;): (A) the name and address of each Proponent, as they appear on the corporation&#146;s books; (B) the class, series and number of shares of the corporation that are owned beneficially and of record by each Proponent; (C) a description of any agreement,
arrangement or understanding (whether oral or in writing) with respect to such nomination or proposal between or among any Proponent and any of its affiliates or associates, and any others (including their names) acting in concert, or otherwise under the agreement, arrangement or understanding, with any of the foregoing; (D) a representation that the Proponents are holders of record or beneficial owners, as the case may be, of shares of the corporation entitled to vote at the meeting and intend to appear in person or by proxy at the meeting to nominate the person or persons specified in the notice (with respect to a notice under Section 5(b)(i) of these Bylaws) or to propose the business that is specified in the notice (with respect to a notice under Section 5(b)(ii) of these Bylaws); (E) a representation as to whether the Proponents intend to deliver a proxy statement and form of proxy to holders of a sufficient number of holders of the corporation&#146;s voting shares to elect such
nominee or nominees (with respect to a notice under Section 5(b)(i) of these Bylaws) or to carry such proposal (with respect to a notice under Section 5(b)(ii) of these Bylaws); (F) to the extent known by any Proponent, the name and address of any other stockholder supporting the proposal on the date of such stockholder&#146;s notice; and (G) a description of all Derivative Transactions (as defined below) by each Proponent during the previous 12-month period, including the date of the transactions and the class, series and number of securities involved in, and the material economic terms of, such Derivative Transactions. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 44px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">For purposes of Sections 5 and 6 of these Bylaws, a &#147;<B><I>Derivative Transaction</I></B>&#148; means any agreement, arrangement, interest or understanding entered into by, or on behalf or for the benefit of, any Proponent or any of its affiliates or associates, whether record or beneficial: </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 64px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(w) the value of which is derived in whole or in part from the value of any class or series of shares or other securities of the corporation; </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 64px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(x) which otherwise provides any direct or indirect opportunity to gain or share in any gain derived from a change in the value of securities of the corporation; </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 64px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(y) the effect or intent of which is to mitigate loss, manage risk or benefit of security value or price changes; or </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 64px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">(z) which provides the right to vote or increase or decrease the voting power of, such Proponent, or any of its affiliates or associates, with respect to any securities of the corporation, </P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">which agreement, arrangement, interest or understanding may include, without limitation, any option, warrant, debt position, note, bond, convertible security, swap, stock appreciation right, short position, profit interest, hedge, right to dividends, voting agreement, performance-related fee or arrangement to borrow or lend shares (whether or not subject to payment, settlement, exercise or conversion in any such class or series), and any proportionate interest of such Proponent in the securities of the corporation held by any general or limited partnership, or any limited liability company, of which such Proponent is, directly
or indirectly, a general partner or managing member. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(c) </B>A stockholder providing written notice required by Section 5(b)(i) or (ii) of these Bylaws shall update and supplement such notice in writing, if necessary, so that the information provided or required to be provided in such notice is true and correct in all material respects as of (i) the record date for the meeting and (ii) the date that is five business days prior to the meeting and, in the event of any adjournment or postponement thereof, five business days prior to such adjourned or postponed meeting. In the case of an update and supplement pursuant to clause (i) of this Section 5(c), such update and
supplement shall be received by the Secretary at the principal executive offices of the corporation not later than five business days after the record date for the meeting. In the case of an update and supplement pursuant to clause (ii) of this Section 5(c), such update and supplement shall be received by </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">F-3</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">the Secretary at the principal executive offices of the corporation not later than two business days prior to the date for the meeting, and, in the event of any adjournment or postponement thereof, two business days prior to such adjourned or postponed meeting. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(d) </B>Notwithstanding anything in Section 5(b)(iii) of these Bylaws to the contrary, in the event that the number of directors in an Expiring Class (as defined below) is increased and there is no public announcement of the appointment of a director to such class, or, if no appointment was made, of the vacancy in such class, made by the corporation at least 10 days before the last day a stockholder may deliver a notice of nomination in accordance with Section 5(b)(iii) of these Bylaws, a stockholder&#146;s notice required by this Section 5 and which complies with the requirements in Section 5(b)(i) of these Bylaws, other
than the timing requirements in Section 5(b)(iii) of these Bylaws, shall also be considered timely, but only with respect to nominees for any new positions in such Expiring Class created by such increase, if it shall be received by the Secretary at the principal executive offices of the corporation not later than the close of business on the 10<sup>th</sup> day following the day on which such public announcement is first made by the corporation. For purposes of this Section 5, an &#147;<B><I>Expiring Class</I></B>&#148; shall mean a class of directors whose term shall expire at the next annual meeting of stockholders. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(e) </B>To be eligible to be a nominee for election or re-election as a director of the corporation pursuant to a nomination under clause (iii) of Section 5(a) of these Bylaws, such proposed nominee or a person on such proposed nominee&#146;s behalf must deliver (in accordance with the time periods prescribed for delivery of notice under Section 5(b)(iii) or 5(d) of these Bylaws, as applicable) to the Secretary at the principal executive offices of the corporation a written questionnaire with respect to the background and qualification of such proposed nominee and the background of any other person or entity on whose
behalf the nomination is being made (which questionnaire shall be provided by the Secretary upon written request) and a written representation and agreement (in the form provided by the Secretary upon written request) that such person: (i) is not and will not become a party to (A) any agreement, arrangement or understanding with, and has not given any commitment or assurance to, any person or entity as to how such person, if elected as a director of the corporation, will act or vote on any issue or question (a &#147;<B><I>Voting Commitment</I></B>&#148;) that has not been disclosed to the corporation in the questionnaire or (B) any Voting Commitment that could limit or interfere with such person&#146;s ability to comply, if elected as a director of the corporation, with such person&#146;s fiduciary duties under applicable law; (ii) is not and will not become a party to any agreement, arrangement or understanding with any person or entity other than the corporation with respect to any
direct or indirect compensation, reimbursement or indemnification in connection with service or action as a director of the corporation that has not been disclosed therein; and (iii) in such person&#146;s individual capacity and on behalf of any person or entity on whose behalf the nomination is being made, would be in compliance, if elected as a director of the corporation, and will comply with, all applicable publicly disclosed corporate governance, conflict of interest, confidentiality and stock ownership and trading policies and guidelines of the corporation. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(f) </B>A person shall not be eligible for election or re-election as a director unless the person is nominated either in accordance with clause (ii) of Section 5(a) of these Bylaws, or in accordance with clause (iii) of Section 5(a) of these Bylaws. Except as otherwise required by law, the chairman of the meeting shall have the power and duty to determine whether a nomination or any business proposed to be brought before the meeting was made, or proposed, as the case may be, in accordance with the procedures set forth in these Bylaws and, if any proposed nomination or business is not in compliance with these Bylaws, or
the Proponent does not act in accordance with the representations in Sections 5(b)(iv)(D) and 5(b)(iv)(E) of these Bylaws, to declare that such proposal or nomination shall not be presented for stockholder action at the meeting and shall be disregarded, notwithstanding that proxies in respect of such nominations or such business may have been solicited or received. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(g) </B>Notwithstanding the foregoing provisions of this Section 5, in order to include information with respect to a stockholder proposal in the proxy statement and form of proxy for a stockholders&#146; meeting, a stockholder must also comply with all applicable requirements of the 1934 Act and the rules and regulations thereunder. Nothing in these Bylaws shall be deemed to affect any rights of stockholders to request inclusion of proposals in the corporation&#146;s proxy statement pursuant to Rule 14a-8 under the 1934 Act; <I>provided, however, </I>that any references in these Bylaws to the 1934 Act or the rules and
regulations </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">F-4</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">thereunder are not intended to and shall not limit the requirements applicable to proposals and/or nominations to be considered pursuant to Section 5(a)(iii) of these Bylaws. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(h) </B>For purposes of Sections 5 and 6 of these Bylaws, </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 44px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>i. </B>&#147;<B><I>public announcement</I></B>&#148; shall mean disclosure in a press release reported by the Dow Jones News Service, Associated Press or comparable national news service or in a document publicly filed by the corporation with the Securities and Exchange Commission pursuant to Section 13, 14 or 15(d) of the 1934 Act; and </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 44px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>ii. </B>&#147;<B><I>affiliates</I></B>&#148; and &#147;<B><I>associates</I></B>&#148; shall have the meanings set forth in Rule 405 under the Securities Act of 1933, as amended. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>Section 6. Special Meetings.</B> </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(a) </B>Special meetings of the stockholders of the corporation may be called, for any purpose as is a proper matter for stockholder action under Delaware law, by (i) the Chairman of the Board of Directors, (ii) the Chief Executive Officer, or (iii) the Board of Directors pursuant to a resolution adopted by a majority of the total number of authorized directors (whether or not there exist any vacancies in previously authorized directorships at the time any such resolution is presented to the Board of Directors for adoption). </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(b) </B>The Board of Directors shall determine the time and place, if any, of such special meeting. Upon determination of the time and place, if any, of the meeting, the Secretary shall cause a notice of meeting to be given to the stockholders entitled to vote, in accordance with the provisions of Section 7 of these Bylaws. No business may be transacted at such special meeting otherwise than specified in the notice of meeting. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(c) </B>Nominations of persons for election to the Board of Directors may be made at a special meeting of stockholders at which directors are to be elected (i) by or at the direction of the Board of Directors or (ii) by any stockholder of the corporation who is a stockholder of record at the time of giving notice provided for in this paragraph, who shall be entitled to vote at the meeting and who delivers written notice to the Secretary of the corporation setting forth the information required by Section 5(b)(i) of these Bylaws. In the event the corporation calls a special meeting of stockholders for the purpose of
electing one or more directors to the Board of Directors, any such stockholder of record may nominate a person or persons (as the case may be), for election to such position(s) as specified in the corporation&#146;s notice of meeting, if written notice setting forth the information required by Section 5(b)(i) of these Bylaws shall be received by the Secretary at the principal executive offices of the corporation not later than the close of business on the later of the 90<sup>th</sup> day prior to such meeting or the 10<sup>th</sup> day following the day on which public announcement is first made of the date of the special meeting and of the nominees proposed by the Board of Directors to be elected at such meeting. The stockholder shall also update and supplement such information as required under Section 5(c) of these Bylaws. In no event shall an adjournment or a postponement of a special meeting for which notice has been given, or the public announcement thereof has been made,
commence a new time period for the giving of a stockholder&#146;s notice as described above. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(d) </B>Notwithstanding the foregoing provisions of this Section 6, a stockholder must also comply with all applicable requirements of the 1934 Act and the rules and regulations thereunder with respect to matters set forth in this Section 6. Nothing in these Bylaws shall be deemed to affect any rights of stockholders to request inclusion of proposals in the corporation&#146;s proxy statement pursuant to Rule 14a-8 under the 1934 Act; <I>provided, however, </I>that any references in these Bylaws to the 1934 Act or the rules and regulations thereunder are not intended to and shall not limit the requirements applicable to
nominations for the election to the Board of Directors to be considered pursuant to Section 6(c) of these Bylaws. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>Section 7. Notice of Meetings.</B>&nbsp;&nbsp;Except as otherwise provided by law, notice, given in writing or by electronic transmission, of each meeting of stockholders shall be given not less than 10 nor more than 60 days before the date of the meeting to each stockholder entitled to vote at such meeting, such notice to specify the place, if any, date and hour, in the case of special meetings, the purpose or purposes of the meeting, and the </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">F-5</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">means of remote communications, if any, by which stockholders and proxy holders may be deemed to be present in person and vote at any such meeting. If mailed, notice is deemed given when deposited in the United States mail, postage prepaid, directed to the stockholder at such stockholder&#146;s address as it appears on the records of the corporation. If sent via electronic transmission, notice is deemed given as of the sending time recorded at the time of transmission. Notice of the time, place, if any, and purpose of any meeting of stockholders may be waived in writing, signed by the person entitled to notice thereof, or by
electronic transmission by such person, either before or after such meeting, and will be waived by any stockholder by his attendance thereat in person, by remote communication, if applicable, or by proxy, except when the stockholder attends a meeting for the express purpose of objecting, at the beginning of the meeting, to the transaction of any business because the meeting is not lawfully called or convened. Any stockholder so waiving notice of such meeting shall be bound by the proceedings of any such meeting in all respects as if due notice thereof had been given. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>Section 8. Quorum.</B>&nbsp;&nbsp;At all meetings of stockholders, except where otherwise provided by statute or by the corporation&#146;s Certificate of Incorporation (&#147;<B><I>Certificate of Incorporation</I></B>&#148;), or by these Bylaws, the presence, in person, by remote communication, if applicable, or by proxy duly authorized, of the holders of a majority of the outstanding shares of stock entitled to vote shall constitute a quorum for the transaction of business. In the absence of a quorum, any meeting of stockholders may be adjourned, from time to time, either by the chairman of the meeting or by vote of the
holders of a majority of the shares represented thereat, but no other business shall be transacted at such meeting. The stockholders present at a duly called or convened meeting, at which a quorum is present, may continue to transact business until adjournment, notwithstanding the withdrawal of enough stockholders to leave less than a quorum. Except as otherwise provided by statute or by applicable stock exchange rules, or by the Certificate of Incorporation or these Bylaws, in all matters other than the election of directors, the affirmative vote of the majority of shares present in person, by remote communication, if applicable, or represented by proxy at the meeting and entitled to vote generally on the subject matter shall be the act of the stockholders. Except as otherwise provided by statute, the Certificate of Incorporation or these Bylaws, directors shall be elected by a plurality of the votes of the shares present in person, by remote communication, if applicable, or
represented by proxy at the meeting and entitled to vote generally on the election of directors. Where a separate vote by a class or classes or series is required, except where otherwise provided by the statute or by the Certificate of Incorporation or these Bylaws, a majority of the outstanding shares of such class or classes or series, present in person, by remote communication, if applicable, or represented by proxy duly authorized, shall constitute a quorum entitled to take action with respect to that vote on that matter. Except where otherwise provided by statute or by the Certificate of Incorporation or these Bylaws, the affirmative vote of the majority (plurality, in the case of the election of directors) of shares of such class or classes or series present in person, by remote communication, if applicable, or represented by proxy at the meeting shall be the act of such class or classes or series. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>Section 9. Adjournment and Notice of Adjourned Meetings.</B>&nbsp;&nbsp;Any meeting of stockholders, whether annual or special, may be adjourned from time to time either by the chairman of the meeting or by the vote of a majority of the shares present in person, by remote communication, if applicable, or represented by proxy at the meeting. When a meeting is adjourned to another time or place, if any, notice need not be given of the adjourned meeting if the time and place, if any, thereof are announced at the meeting at which the adjournment is taken. At the adjourned meeting, the corporation may transact any business which
might have been transacted at the original meeting. If the adjournment is for more than 30 days or if after the adjournment a new record date is fixed for the adjourned meeting, a notice of the adjourned meeting shall be given to each stockholder of record entitled to vote at the meeting. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>Section 10. Voting Rights.</B>&nbsp;&nbsp;For the purpose of determining those stockholders entitled to vote at any meeting of the stockholders, except as otherwise provided by law, only persons in whose names shares stand on the stock records of the corporation on the record date, as provided in Section 12 of these Bylaws, shall be entitled to vote at any meeting of stockholders. Every person entitled to vote shall have the right to do so either in person, by remote communication, if applicable, or by an agent or agents authorized by a proxy granted in accordance with Delaware law. An agent so appointed need not be a
stockholder. No proxy shall be voted after three years from its date of creation unless the proxy provides for a longer period. </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">F-6</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>Section 11. Joint Owners of Stock.</B>&nbsp;&nbsp;If shares or other securities having voting power stand of record in the names of two or more persons, whether fiduciaries, members of a partnership, joint tenants, tenants in common, tenants by the entirety, or otherwise, or if two or more persons have the same fiduciary relationship respecting the same shares, unless the Secretary is given written notice to the contrary and is furnished with a copy of the instrument or order appointing them or creating the relationship wherein it is so provided, their acts with respect to voting shall have the following effect: (a) if only
one votes, his act binds all; (b) if more than one votes, the act of the majority so voting binds all; or (c) if more than one votes, but the vote is evenly split on any particular matter, each faction may vote the securities in question proportionally, or may apply to the Delaware Court of Chancery for relief as provided in the DGCL, Section 217(b). If the instrument filed with the Secretary shows that any such tenancy is held in unequal interests, a majority or even-split for the purpose of clause (c) of this Section 11 shall be a majority or even-split in interest. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>Section 12. List of Stockholders.</B>&nbsp;&nbsp;The Secretary shall prepare and make, at least 10 days before every meeting of stockholders, a complete list of the stockholders entitled to vote at said meeting, arranged in alphabetical order, showing the address of each stockholder and the number of shares registered in the name of each stockholder. Such list shall be open to the examination of any stockholder, for any purpose germane to the meeting, (a) on a reasonably accessible electronic network, provided that the information required to gain access to such list is provided with the notice of the meeting, or (b) during
ordinary business hours, at the principal place of business of the corporation. In the event that the corporation determines to make the list available on an electronic network, the corporation may take reasonable steps to ensure that such information is available only to stockholders of the corporation. The list shall be open to examination of any stockholder during the time of the meeting as provided by law. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>Section 13. Action Without Meeting.</B>&nbsp;&nbsp;No action shall be taken by the stockholders except at an annual or special meeting of stockholders called in accordance with these Bylaws, and no action shall be taken by the stockholders by written consent or electronic transmission. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>Section 14. Organization.</B> </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(a) </B>At every meeting of stockholders, the Chairman of the Board of Directors, or, if a Chairman has not been appointed or is absent, the President, or, if the President is absent, a chairman of the meeting chosen by a majority in interest of the stockholders entitled to vote, present in person or by proxy, shall act as chairman. The Secretary, or, in his or her absence, an Assistant Secretary directed to do so by the President, shall act as secretary of the meeting. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(b) </B>The Board of Directors of the corporation shall be entitled to make such rules or regulations for the conduct of meetings of stockholders as it shall deem necessary, appropriate or convenient. Subject to such rules and regulations of the Board of Directors, if any, the chairman of the meeting shall have the right and authority to prescribe such rules, regulations and procedures and to do all such acts as, in the judgment of such chairman, are necessary, appropriate or convenient for the proper conduct of the meeting, including, without limitation, establishing an agenda or order of business for the meeting, rules
and procedures for maintaining order at the meeting and the safety of those present, limitations on participation in such meeting to stockholders of record of the corporation and their duly authorized and constituted proxies and such other persons as the chairman shall permit, restrictions on entry to the meeting after the time fixed for the commencement thereof, limitations on the time allotted to questions or comments by participants and regulation of the opening and closing of the polls for balloting on matters which are to be voted on by ballot. The date and time of the opening and closing of the polls for each matter upon which the stockholders will vote at the meeting shall be announced at the meeting. Unless and to the extent determined by the Board of Directors or the chairman of the meeting, meetings of stockholders shall not be required to be held in accordance with rules of parliamentary procedure. </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">F-7</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<H1 STYLE="text-indent:0pt; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 9pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">ARTICLE IV<BR>&nbsp;<BR> DIRECTORS </H1>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>Section 15. Number and Term of Office.</B>&nbsp;&nbsp;The authorized number of directors of the corporation shall be fixed in accordance with the Certificate of Incorporation. Directors need not be stockholders unless so required by the Certificate of Incorporation. If for any cause, the directors shall not have been elected at an annual meeting, they may be elected as soon thereafter as convenient at a special meeting of the stockholders called for that purpose in the manner provided in these Bylaws. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>Section 16. Powers.</B>&nbsp;&nbsp;The business and affairs of the corporation shall be managed by or under the direction of the Board of Directors, except as may be otherwise provided by statute or by the Certificate of Incorporation. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>Section 17. Classes of Directors.</B> </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Subject to the rights of the holders of any series of Preferred Stock to elect additional directors under specified circumstances, the directors shall be divided into three classes designated as Class I, Class II and Class III, respectively. Initially, directors shall be assigned to each class in accordance with a resolution or resolutions adopted by the Board of Directors. At the first annual meeting of stockholders following the adoption of these Bylaws, the term of office of the Class II directors shall expire and Class II directors shall be elected for a full term of three years. At the second annual meeting of
stockholders following the adoption of these Bylaws, the term of office of the Class III directors shall expire and Class III directors shall be elected for a full term of three years. At the third annual meeting of stockholders following the adoption of these Bylaws, the term of office of the Class I directors shall expire and Class I directors shall be elected for a full term of three years. At each succeeding annual meeting of stockholders, directors shall be elected for a full term of three years to succeed the directors of the class whose terms expire at such annual meeting. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Notwithstanding the foregoing provisions of this Section 17, each director shall serve until his successor is duly elected and qualified or until his earlier death, resignation or removal. No decrease in the number of directors constituting the Board of Directors shall shorten the term of any incumbent director. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>Section 18. Vacancies.</B> </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(a) </B>Unless otherwise provided in the Certificate of Incorporation, and subject to the rights of the holders of any series of Preferred Stock, any vacancies on the Board of Directors resulting from death, resignation, disqualification, removal or other causes and any newly created directorships resulting from any increase in the number of directors shall, unless the Board of Directors determines by resolution that any such vacancies or newly created directorships shall be filled by stockholders, be filled only by the affirmative vote of a majority of the directors then in office, even though less than a quorum of the
Board of Directors, or by a sole remaining director, and not by the stockholders, <I>provided, however</I>, that whenever the holders of any class or classes of stock or series thereof are entitled to elect one or more directors by the provisions of the Certificate of Incorporation, vacancies and newly created directorships of such class or classes or series shall, unless the Board of Directors determines by resolution that any such vacancies or newly created directorships shall be filled by stockholders, be filled by a majority of the directors elected by such class or classes or series thereof then in office, or by a sole remaining director so elected, and not by the stockholders. Any director elected in accordance with the preceding sentence shall hold office for the remainder of the full term of the director for which the vacancy was created or occurred and until such director&#146;s successor shall have been elected and qualified. A vacancy in the Board of Directors shall be
deemed to exist under this Bylaw in the case of the death, removal or resignation of any director. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>Section 19. Resignation.</B>&nbsp;&nbsp;Any director may resign at any time by delivering his or her notice in writing or by electronic transmission to the Secretary, such resignation to specify whether it will be effective at a particular time. If no such specification is made, it shall be deemed effective at the time of delivery to the Secretary. When one or more directors shall resign from the Board of Directors, effective at a future date, a majority of the directors then in office, including those who have so resigned, shall have power to fill such vacancy or vacancies, the vote thereon to take effect when such
resignation or resignations shall become </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">F-8</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">effective, and each director so chosen shall hold office for the unexpired portion of the term of the director whose place shall be vacated and until his successor shall have been duly elected and qualified. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>Section 20. Removal.</B> </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(a) </B>Subject to the rights of any series of Preferred Stock to elect additional directors under specified circumstances, neither the Board of Directors nor any individual director may be removed without cause. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(b) </B>Subject to any limitation imposed by law, any individual director or directors may be removed with cause by the affirmative vote of the holders of at least 66&nbsp;2/3% of the voting power of all then outstanding shares of capital stock of the corporation entitled to vote generally at an election of directors. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>Section 21. Duties of Chairman of the Board of Directors.</B>&nbsp;&nbsp;The Chairman of the Board of Directors, when present, shall preside at all meetings of the stockholders and the Board of Directors. The Chairman of the Board of Directors shall perform other duties commonly incident to the office and shall also perform such other duties and have such other powers, as the Board of Directors shall designate from time to time. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>Section 22. Meetings.</B> </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(a) Regular Meetings.</B>&nbsp;&nbsp;Unless otherwise restricted by the Certificate of Incorporation, regular meetings of the Board of Directors may be held at any time or date and at any place within or without the State of Delaware which has been designated by the Board of Directors and publicized among all directors, either orally or in writing, by telephone, including a voice-messaging system or other system designed to record and communicate messages, facsimile, telegraph or telex, or by electronic mail or other electronic means. No further notice shall be required for regular meetings of the Board of Directors. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(b) Special Meetings.</B>&nbsp;&nbsp;Unless otherwise restricted by the Certificate of Incorporation, special meetings of the Board of Directors may be held at any time and place within or without the State of Delaware whenever called by the Chairman of the Board of Directors, the Chief Executive Officer or a majority of the authorized number of directors. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(c) Meetings by Electronic Communications Equipment.</B>&nbsp;&nbsp;Any member of the Board of Directors, or of any committee thereof, may participate in a meeting by means of conference telephone or other communications equipment by means of which all persons participating in the meeting can hear each other, and participation in a meeting by such means shall constitute presence in person at such meeting. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(d) Notice of Special Meetings.</B>&nbsp;&nbsp;Notice of the time and place of all special meetings of the Board of Directors shall be orally or in writing, by telephone, including a voice messaging system or other system or technology designed to record and communicate messages, facsimile, telegraph or telex, or by electronic mail or other electronic means, during normal business hours, at least 24 hours before the date and time of the meeting. If notice is sent by U.S. mail, it shall be sent by first class mail, charges prepaid, at least three days before the date of the meeting. Notice of any meeting may be waived in
writing, or by electronic transmission, at any time before or after the meeting and will be waived by any director by attendance thereat, except when the director attends the meeting for the express purpose of objecting, at the beginning of the meeting, to the transaction of any business because the meeting is not lawfully called or convened. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(e) Waiver of Notice.</B>&nbsp;&nbsp;The transaction of all business at any meeting of the Board of Directors, or any committee thereof, however called or noticed, or wherever held, shall be as valid as though it had been transacted at a meeting duly held after regular call and notice, if a quorum be present and if, either before or after the meeting, each of the directors not present who did not receive notice shall sign a written waiver of notice or shall waive notice by electronic transmission. All such waivers shall be filed with the corporate records or made a part of the minutes of the meeting. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>Section 23. Quorum and Voting.</B> </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(a) </B>Unless the Certificate of Incorporation requires a greater number, and except with respect to questions related to indemnification arising under Section 45 of these Bylaws for which a quorum shall be one-third of the exact number of directors fixed from time to time, a quorum of the Board of </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">F-9</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Directors shall consist of a majority of the exact number of directors fixed from time to time by the Board of Directors in accordance with the Certificate of Incorporation; <I>provided, however,</I> at any meeting whether a quorum be present or otherwise, a majority of the directors present may adjourn from time to time until the time fixed for the next regular meeting of the Board of Directors, without notice other than by announcement at the meeting. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(b) </B>At each meeting of the Board of Directors at which a quorum is present, all questions and business shall be determined by the affirmative vote of a majority of the directors present, unless a different vote be required by law, the Certificate of Incorporation or these Bylaws. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>Section 24. Action without Meeting.</B>&nbsp;&nbsp;Unless otherwise restricted by the Certificate of Incorporation or these Bylaws, any action required or permitted to be taken at any meeting of the Board of Directors or of any committee thereof may be taken without a meeting, if all members of the Board of Directors or committee, as the case may be, consent thereto in writing or by electronic transmission, and such writing or writings or transmission or transmissions are filed with the minutes of proceedings of the Board of Directors or committee. Such filing shall be in paper form if the minutes are maintained in paper
form and shall be in electronic form if the minutes are maintained in electronic form. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>Section 25. Fees and Compensation.</B>&nbsp;&nbsp;Directors shall be entitled to such compensation for their services as may be approved by the Board of Directors, including, if so approved, by resolution of the Board of Directors, a fixed sum and expenses of attendance, if any, for attendance at each regular or special meeting of the Board of Directors and at any meeting of a committee of the Board of Directors. Nothing herein contained shall be construed to preclude any director from serving the corporation in any other capacity as an officer, agent, employee, or otherwise and receiving compensation therefor. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>Section 26. Committees.</B> </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(a) Executive Committee.</B>&nbsp;&nbsp;The Board of Directors may appoint an Executive Committee to consist of one or more members of the Board of Directors. The Executive Committee, to the extent permitted by law and provided in the resolution of the Board of Directors shall have and may exercise all the powers and authority of the Board of Directors in the management of the business and affairs of the corporation, and may authorize the seal of the corporation to be affixed to all papers which may require it; but no such committee shall have the power or authority in reference to (i) approving or adopting, or
recommending to the stockholders, any action or matter (other than the election or removal of directors) expressly required by the DGCL to be submitted to stockholders for approval, or (ii) adopting, amending or repealing any Bylaw of the corporation. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(b) Other Committees.</B>&nbsp;&nbsp;The Board of Directors may, from time to time, appoint such other committees as may be permitted by law. Such other committees appointed by the Board of Directors shall consist of one or more members of the Board of Directors and shall have such powers and perform such duties as may be prescribed by the resolution or resolutions creating such committees, but in no event shall any such committee have the powers denied to the Executive Committee in these Bylaws. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(c) Term.</B>&nbsp;&nbsp;The Board of Directors, subject to any requirements of any outstanding series of Preferred Stock and the provisions of subsections (a) or (b) of this Section 26, may at any time increase or decrease the number of members of a committee or terminate the existence of a committee. The membership of a committee member shall terminate on the date of his death or voluntary resignation from the committee or from the Board of Directors. The Board of Directors may at any time for any reason remove any individual committee member and the Board of Directors may fill any committee vacancy created by death,
resignation, removal or increase in the number of members of the committee. The Board of Directors may designate one or more directors as alternate members of any committee, who may replace any absent or disqualified member at any meeting of the committee, and, in addition, in the absence or disqualification of any member of a committee, the member or members thereof present at any meeting and not disqualified from voting, whether or not he or they constitute a quorum, may unanimously appoint another member of the Board of Directors to act at the meeting in the place of any such absent or disqualified member. </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">F-10</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(d) Meetings.</B>&nbsp;&nbsp;Unless the Board of Directors shall otherwise provide, regular meetings of the Executive Committee or any other committee appointed pursuant to this Section 26 shall be held at such times and places as are determined by the Board of Directors, or by any such committee, and when notice thereof has been given to each member of such committee, no further notice of such regular meetings need be given thereafter. Special meetings of any such committee may be held at any place which has been determined from time to time by such committee, and may be called by any director who is a member of such
committee, upon notice to the members of such committee of the time and place of such special meeting given in the manner provided for the giving of notice to members of the Board of Directors of the time and place of special meetings of the Board of Directors. Notice of any special meeting of any committee may be waived in writing or by electronic transmission at any time before or after the meeting and will be waived by any director by attendance thereat, except when the director attends such special meeting for the express purpose of objecting, at the beginning of the meeting, to the transaction of any business because the meeting is not lawfully called or convened. Unless otherwise provided by the Board of Directors in the resolutions authorizing the creation of the committee, a majority of the authorized number of members of any such committee shall constitute a quorum for the transaction of business, and the act of a majority of those present at any meeting at which a quorum is
present shall be the act of such committee. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>Section 27. Lead Independent Director.</B>&nbsp;&nbsp;The Chairman of the Board of Directors, or if the Chairman is not an independent director, one of the independent directors, may be designated by the Board of Directors as lead independent director (&#147;<B><I>Lead Independent Director</I></B>&#148;) to serve until replaced by the Board of Directors. The Lead Independent Director will: with the Chairman of the Board of Directors, establish the agenda for regular Board meetings and serve as chairman of Board of Directors meetings in the absence of the Chairman of the Board of Directors; establish the agenda for meetings
of the independent directors; coordinate with the committee chairs regarding meeting agendas and informational requirements; preside over meetings of the independent directors; preside over any portions of meetings of the Board of Directors at which the evaluation or compensation of the Chief Executive Officer is presented or discussed; preside over any portions of meetings of the Board of Directors at which the performance of the Board of Directors is presented or discussed; and perform such other duties as may be established or delegated by the Chairman of the Board of Directors<B>.</B> </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>Section 28. Organization.</B>&nbsp;&nbsp;At every meeting of the directors, the Chairman of the Board of Directors, or, if a Chairman has not been appointed or is absent, the Lead Independent Director, or if the Lead Independent Director is absent, the Chief Executive Officer (if a director), or, if a Chief Executive Officer is absent, the President (if a director), or if the President is absent, the most senior Vice President (if a director), or, in the absence of any such person, a chairman of the meeting chosen by a majority of the directors present, shall preside over the meeting. The Secretary, or in his absence, any
Assistant Secretary or other officer or director directed to do so by the President, shall act as secretary of the meeting. </P>

<H1 STYLE="text-indent:0pt; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 9pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">ARTICLE V<BR>&nbsp;<BR> OFFICERS </H1>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>Section 29. Officers Designated.</B>&nbsp;&nbsp;The officers of the corporation shall include, if and when designated by the Board of Directors, the Chairman of the Board of Directors, the Chief Executive Officer, the President, one or more Vice Presidents, the Secretary, the Chief Financial Officer and the Treasurer. The Board of Directors may also appoint one or more Assistant Secretaries and Assistant Treasurers and such other officers and agents with such powers and duties as it shall deem necessary. The Board of Directors may assign such additional titles to one or more of the officers as it shall deem appropriate. Any
one person may hold any number of offices of the corporation at any one time unless specifically prohibited therefrom by law. The salaries and other compensation of the officers of the corporation shall be fixed by or in the manner designated by the Board of Directors. </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">F-11</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>Section 30. Tenure and Duties of Officers.</B> </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(a) General.</B>&nbsp;&nbsp;All officers shall hold office at the pleasure of the Board of Directors and until their successors shall have been duly elected and qualified, unless sooner removed. Any officer elected or appointed by the Board of Directors may be removed at any time by the Board of Directors. If the office of any officer becomes vacant for any reason, the vacancy may be filled by the Board of Directors. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(b) Duties of Chief Executive Officer.</B>&nbsp;&nbsp;The Chief Executive Officer shall preside at all meetings of the stockholders and at all meetings of the Board of Directors, unless the Chairman of the Board of Directors or the Lead Independent Director has been appointed and is present. Unless an officer has been appointed Chief Executive Officer of the corporation, the President shall be the chief executive officer of the corporation and shall, subject to the control of the Board of Directors, have general supervision, direction and control of the business and officers of the corporation. To the extent that a Chief
Executive Officer has been appointed and no President has been appointed, all references in these Bylaws to the President shall be deemed references to the Chief Executive Officer. The Chief Executive Officer shall perform other duties commonly incident to the office and shall also perform such other duties and have such other powers, as the Board of Directors shall designate from time to time. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(c) Duties of President.</B>&nbsp;&nbsp;The President shall preside at all meetings of the stockholders and at all meetings of the Board of Directors, unless the Chairman of the Board of Directors, the Lead Independent Director, or the Chief Executive Officer has been appointed and is present. Unless another officer has been appointed Chief Executive Officer of the corporation, the President shall be the chief executive officer of the corporation and shall, subject to the control of the Board of Directors, have general supervision, direction and control of the business and officers of the corporation. The President shall
perform other duties commonly incident to the office and shall also perform such other duties and have such other powers, as the Board of Directors shall designate from time to time. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(d) Duties of Vice Presidents.</B>&nbsp;&nbsp;The Vice Presidents may assume and perform the duties of the President in the absence or disability of the President or whenever the office of President is vacant. The Vice Presidents shall perform other duties commonly incident to their office and shall also perform such other duties and have such other powers as the Board of Directors or the Chief Executive Officer, or, if the Chief Executive Officer has not been appointed or is absent, the President shall designate from time to time. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(e) Duties of Secretary.</B>&nbsp;&nbsp;The Secretary shall attend all meetings of the stockholders and of the Board of Directors and shall record all acts and proceedings thereof in the minute book of the corporation. The Secretary shall give notice in conformity with these Bylaws of all meetings of the stockholders and of all meetings of the Board of Directors and any committee thereof requiring notice. The Secretary shall perform all other duties provided for in these Bylaws and other duties commonly incident to the office and shall also perform such other duties and have such other powers, as the Board of Directors
shall designate from time to time. The President may direct any Assistant Secretary or other officer to assume and perform the duties of the Secretary in the absence or disability of the Secretary, and each Assistant Secretary shall perform other duties commonly incident to the office and shall also perform such other duties and have such other powers as the Board of Directors or the President shall designate from time to time. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(f) Duties of Chief Financial Officer.</B>&nbsp;&nbsp;The Chief Financial Officer shall keep or cause to be kept the books of account of the corporation in a thorough and proper manner and shall render statements of the financial affairs of the corporation in such form and as often as required by the Board of Directors or the President. The Chief Financial Officer, subject to the order of the Board of Directors, shall have the custody of all funds and securities of the corporation. The Chief Financial Officer shall perform other duties commonly incident to the office and shall also perform such other duties and have such
other powers as the Board of Directors or the President shall designate from time to time. To the extent that a Chief Financial Officer has been appointed and no Treasurer has been appointed, all references in these Bylaws to the Treasurer shall be deemed references to the Chief Financial Officer. The President may direct the Treasurer, if any, or any Assistant Treasurer, or the Controller or any Assistant Controller to assume and perform the duties of the Chief Financial Officer in the absence or disability of the Chief </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">F-12</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Financial Officer, and each Treasurer and Assistant Treasurer and each Controller and Assistant Controller shall perform other duties commonly incident to the office and shall also perform such other duties and have such other powers as the Board of Directors or the President shall designate from time to time. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(g) Duties of Treasurer.</B>&nbsp;&nbsp;Unless another officer has been appointed Chief Financial Officer of the corporation, the Treasurer shall be the chief financial officer of the corporation and shall keep or cause to be kept the books of account of the corporation in a thorough and proper manner and shall render statements of the financial affairs of the corporation in such form and as often as required by the Board of Directors or the President, and, subject to the order of the Board of Directors, shall have the custody of all funds and securities of the corporation. The Treasurer shall perform other duties commonly
incident to the office and shall also perform such other duties and have such other powers as the Board of Directors or the President shall designate from time to time. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>Section 31. Delegation of Authority.</B>&nbsp;&nbsp;The Board of Directors may from time to time delegate the powers or duties of any officer to any other officer or agent, notwithstanding any provision hereof. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>Section 32. Resignations.</B>&nbsp;&nbsp;Any officer may resign at any time by giving notice in writing or by electronic transmission to the Board of Directors or to the President or to the Secretary. Any such resignation shall be effective when received by the person or persons to whom such notice is given, unless a later time is specified therein, in which event the resignation shall become effective at such later time. Unless otherwise specified in such notice, the acceptance of any such resignation shall not be necessary to make it effective. Any resignation shall be without prejudice to the rights, if any, of the
corporation under any contract with the resigning officer. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>Section 33. Removal.</B>&nbsp;&nbsp;Any officer may be removed from office at any time, either with or without cause, by the affirmative vote of a majority of the directors in office at the time, or by the unanimous written consent of the directors in office at the time, or by any committee or by the Chief Executive Officer or by other superior officers upon whom such power of removal may have been conferred by the Board of Directors. </P>

<H1 STYLE="text-indent:0pt; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 9pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">ARTICLE VI<BR>&nbsp;<BR> EXECUTION OF CORPORATE INSTRUMENTS AND VOTING OF SECURITIES OWNED<BR> BY THE CORPORATION </H1>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>Section 34. Execution of Corporate Instruments.</B>&nbsp;&nbsp;The Board of Directors may, in its discretion, determine the method and designate the signatory officer or officers, or other person or persons, to execute on behalf of the corporation any corporate instrument or document, or to sign on behalf of the corporation the corporate name without limitation, or to enter into contracts on behalf of the corporation, except where otherwise provided by law or these Bylaws, and such execution or signature shall be binding upon the corporation. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">All checks and drafts drawn on banks or other depositaries on funds to the credit of the corporation or in special accounts of the corporation shall be signed by such person or persons as the Board of Directors shall authorize so to do. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Unless authorized or ratified by the Board of Directors or within the agency power of an officer, no officer, agent or employee shall have any power or authority to bind the corporation by any contract or engagement or to pledge its credit or to render it liable for any purpose or for any amount. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>Section 35. Voting of Securities Owned by the Corporation.</B>&nbsp;&nbsp;All stock and other securities of other corporations owned or held by the corporation for itself, or for other parties in any capacity, shall be voted, and all proxies with respect thereto shall be executed, by the person authorized so to do by resolution of the Board of Directors, or, in the absence of such authorization, by the Chairman of the Board of Directors, the Chief Executive Officer, the President, or any Vice President. </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">F-13</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<H1 STYLE="text-indent:0pt; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 9pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">ARTICLE VII<BR>&nbsp;<BR> SHARES OF STOCK </H1>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>Section 36. Form and Execution of Certificates.</B>&nbsp;&nbsp;The shares of the corporation shall be represented by certificates, or shall be uncertificated if so provided by resolution or resolutions of the Board of Directors. Certificates for the shares of stock of the corporation, if any, shall be in such form as is consistent with the Certificate of Incorporation and applicable law. Every holder of stock represented by certificate in the corporation shall be entitled to have a certificate signed by or in the name of the corporation by the Chairman of the Board of Directors, the Chief Executive Officer, or the President
or any Vice President and by the Chief Financial Officer, Treasurer or Assistant Treasurer or the Secretary or Assistant Secretary, certifying the number of shares owned by him in the corporation. Any or all of the signatures on the certificate may be facsimiles. In case any officer, transfer agent, or registrar who has signed or whose facsimile signature has been placed upon a certificate shall have ceased to be such officer, transfer agent, or registrar before such certificate is issued, it may be issued with the same effect as if he were such officer, transfer agent, or registrar at the date of issue. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>Section 37. Lost Certificates.</B>&nbsp;&nbsp;A new certificate or certificates shall be issued in place of any certificate or certificates theretofore issued by the corporation alleged to have been lost, stolen, or destroyed, upon the making of an affidavit of that fact by the person claiming the certificate of stock to be lost, stolen, or destroyed. The corporation may require, as a condition precedent to the issuance of a new certificate or certificates, the owner of such lost, stolen, or destroyed certificate or certificates, or the owner&#146;s legal representative, to agree to indemnify the corporation in such manner
as it shall require or to give the corporation a surety bond in such form and amount as it may direct as indemnity against any claim that may be made against the corporation with respect to the certificate alleged to have been lost, stolen, or destroyed. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>Section 38. Transfers.</B> </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(a) </B>Transfers of record of shares of stock of the corporation shall be made only upon its books by the holders thereof, in person or by attorney duly authorized, and, in the case of stock represented by certificate, upon the surrender of a properly endorsed certificate or certificates for a like number of shares. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(b) </B>The corporation shall have power to enter into and perform any agreement with any number of stockholders of any one or more classes of stock of the corporation to restrict the transfer of shares of stock of the corporation of any one or more classes owned by such stockholders in any manner not prohibited by the DGCL. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>Section 39. Fixing Record Dates.</B> </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(a) </B>In order that the corporation may determine the stockholders entitled to notice of or to vote at any meeting of stockholders or any adjournment thereof, the Board of Directors may fix a record date, which record date shall not precede the date upon which the resolution fixing the record date is adopted by the Board of Directors, and which record date shall, subject to applicable law, not be more than 60 nor less than 10 days before the date of such meeting. If no record date is fixed by the Board of Directors, the record date for determining stockholders entitled to notice of or to vote at a meeting of stockholders
shall be at the close of business on the day next preceding the day on which notice is given, or if notice is waived, at the close of business on the day next preceding the day on which the meeting is held. A determination of stockholders of record entitled to notice of or to vote at a meeting of stockholders shall apply to any adjournment of the meeting; <I>provided, however,</I> that the Board of Directors may fix a new record date for the adjourned meeting. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(b) </B>In order that the corporation may determine the stockholders entitled to receive payment of any dividend or other distribution or allotment of any rights or the stockholders entitled to exercise any rights in respect of any change, conversion or exchange of stock, or for the purpose of any other lawful action, the Board of Directors may fix, in advance, a record date, which record date shall not precede the date upon which the resolution fixing the record date is adopted, and which record date shall be not more than </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">F-14</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">60 days prior to such action. If no record date is fixed, the record date for determining stockholders for any such purpose shall be at the close of business on the day on which the Board of Directors adopts the resolution relating thereto. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>Section 40. Registered Stockholders.</B>&nbsp;&nbsp;The corporation shall be entitled to recognize the exclusive right of a person registered on its books as the owner of shares to receive dividends, and to vote as such owner, and shall not be bound to recognize any equitable or other claim to or interest in such share or shares on the part of any other person whether or not it shall have express or other notice thereof, except as otherwise provided by the laws of Delaware. </P>

<H1 STYLE="text-indent:0pt; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 9pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">ARTICLE VIII<BR>&nbsp;<BR> OTHER SECURITIES OF THE CORPORATION </H1>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>Section 41. Execution of Other Securities.</B>&nbsp;&nbsp;All bonds, debentures and other corporate securities of the corporation, other than stock certificates (covered in Section 36 of these Bylaws), may be signed by the Chairman of the Board of Directors, the Chief Executive Officer, President or any Vice President, or such other person as may be authorized by the Board of Directors, and the corporate seal impressed thereon or a facsimile of such seal imprinted thereon and attested by the signature of the Secretary or an Assistant Secretary, or the Chief Financial Officer or Treasurer or an Assistant Treasurer; <I>
provided, however,</I> that where any such bond, debenture or other corporate security shall be authenticated by the manual signature, or where permissible facsimile signature, of a trustee under an indenture pursuant to which such bond, debenture or other corporate security shall be issued, the signatures of the persons signing and attesting the corporate seal on such bond, debenture or other corporate security may be the imprinted facsimile of the signatures of such persons. Interest coupons appertaining to any such bond, debenture or other corporate security, authenticated by a trustee as aforesaid, shall be signed by the Treasurer or an Assistant Treasurer of the corporation or such other person as may be authorized by the Board of Directors, or bear imprinted thereon the facsimile signature of such person. In case any officer who shall have signed or attested any bond, debenture or other corporate security, or whose facsimile signature shall appear thereon or on any such interest
coupon, shall have ceased to be such officer before the bond, debenture or other corporate security so signed or attested shall have been delivered, such bond, debenture or other corporate security nevertheless may be adopted by the corporation and issued and delivered as though the person who signed the same or whose facsimile signature shall have been used thereon had not ceased to be such officer of the corporation. </P>

<H1 STYLE="text-indent:0pt; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 9pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">ARTICLE IX<BR>&nbsp;<BR> DIVIDENDS </H1>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>Section 42. Declaration of Dividends.</B>&nbsp;&nbsp;Dividends upon the capital stock of the corporation, subject to the provisions of the Certificate of Incorporation and applicable law, if any, may be declared by the Board of Directors pursuant to law at any regular or special meeting. Dividends may be paid in cash, in property, or in shares of the capital stock, subject to the provisions of the Certificate of Incorporation and applicable law. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>Section 43. Dividend Reserve.</B>&nbsp;&nbsp;Before payment of any dividend, there may be set aside out of any funds of the corporation available for dividends such sum or sums as the Board of Directors from time to time, in their absolute discretion, think proper as a reserve or reserves to meet contingencies, or for equalizing dividends, or for repairing or maintaining any property of the corporation, or for such other purpose as the Board of Directors shall think conducive to the interests of the corporation, and the Board of Directors may modify or abolish any such reserve in the manner in which it was created. </P>

<H1 STYLE="text-indent:0pt; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 9pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">ARTICLE X<BR>&nbsp;<BR> FISCAL YEAR </H1>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>Section 44. Fiscal Year.</B>&nbsp;&nbsp;The fiscal year of the corporation shall be fixed by resolution of the Board of Directors. </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">F-15</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<H1 STYLE="text-indent:0pt; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 9pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">ARTICLE XI<BR>&nbsp;<BR> INDEMNIFICATION </H1>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>Section 45. Indemnification of Directors, Officers, Employees and Other Agents.</B> </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(a) Directors and Officers.</B>&nbsp;&nbsp;The corporation shall indemnify its directors and officers to the extent not prohibited by the DGCL or any other applicable law; <I>provided, however,</I> that the corporation may modify the extent of such indemnification by individual contracts with its directors and officers; and, <I>provided, further,</I> that the corporation shall not be required to indemnify any director or officer in connection with any proceeding (or part thereof) initiated by such person unless (i) such indemnification is expressly required to be made by law, (ii) the proceeding was authorized by the Board
of Directors of the corporation, (iii) such indemnification is provided by the corporation, in its sole discretion, pursuant to the powers vested in the corporation under the DGCL or any other applicable law or (iv) such indemnification is required to be made under subsection (d). </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(b) Employees and Other Agents.</B>&nbsp;&nbsp;The corporation shall have power to indemnify its employees and other agents as set forth in the DGCL or any other applicable law. The Board of Directors shall have the power to delegate the determination of whether to indemnify any such employee or other agent to such officers or other persons as the Board of Directors so determines. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(c) Expenses.</B>&nbsp;&nbsp;The corporation shall advance to any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative, by reason of the fact that he is or was a director or officer, of the corporation, or is or was serving at the request of the corporation as a director or officer of another corporation, partnership, joint venture, trust or other enterprise, prior to the final disposition of the proceeding, promptly following request therefor, all expenses incurred by any director or
officer in connection with such proceeding provided, however, that if the DGCL requires, an advancement of expenses incurred by a director or officer in his or her capacity as a director or officer (and not in any other capacity in which service was or is rendered by such indemnitee, including, without limitation, service to an employee benefit plan) shall be made only upon delivery to the corporation of an undertaking, by or on behalf of such indemnitee, to repay all amounts so advanced if it shall ultimately be determined by final judicial decision from which there is no further right to appeal that such indemnitee is not entitled to be indemnified for such expenses under this Section 45 or otherwise. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">Notwithstanding the foregoing, unless otherwise determined pursuant to paragraph (e) of this Section 45, no advance shall be made by the corporation to an officer of the corporation (except by reason of the fact that such officer is or was a director of the corporation in which event this paragraph shall not apply) in any action, suit or proceeding, whether civil, criminal, administrative or investigative, if a determination is reasonably and promptly made (i) by a majority vote of directors who were not parties to the proceeding, even if not a quorum, or (ii) by a committee of such directors designated by a majority vote of
such directors, even though less than a quorum, or (iii) if there are no such directors, or such directors so direct, by independent legal counsel in a written opinion, that the facts known to the decision-making party at the time such determination is made demonstrate clearly and convincingly that such person acted in bad faith or in a manner that such person did not believe to be in or not opposed to the best interests of the corporation. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(d) Enforcement.</B>&nbsp;&nbsp;Without the necessity of entering into an express contract, all rights to indemnification and advances to directors and officers under this Section 45 shall be deemed to be contractual rights and be effective to the same extent and as if provided for in a contract between the corporation and the director or officer. Any right to indemnification or advances granted by this Section 45 to a director or officer shall be enforceable by or on behalf of the person holding such right in any court of competent jurisdiction if (i) the claim for indemnification or advances is denied, in whole or in
part, or (ii) no disposition of such claim is made within 90 days of request therefor. To the extent permitted by law, the claimant in such enforcement action, if successful in whole or in part, shall be entitled to be paid also the expense of prosecuting the claim. In connection with any claim for indemnification, the corporation shall be entitled to raise as a defense to any such action that the claimant </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">F-16</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">has not met the standards of conduct that make it permissible under the DGCL or any other applicable law for the corporation to indemnify the claimant for the amount claimed. In connection with any claim by an officer of the corporation (except in any action, suit or proceeding, whether civil, criminal, administrative or investigative, by reason of the fact that such officer is or was a director of the corporation) for advances, the corporation shall be entitled to raise a defense as to any such action clear and convincing evidence that such person acted in bad faith or in a manner that such person did not believe to be in or
not opposed to the best interests of the corporation, or with respect to any criminal action or proceeding that such person acted without reasonable cause to believe that his conduct was lawful. Neither the failure of the corporation (including its Board of Directors, independent legal counsel or its stockholders) to have made a determination prior to the commencement of such action that indemnification of the claimant is proper in the circumstances because the officer or director has met the applicable standard of conduct set forth in the DGCL or any other applicable law, nor an actual determination by the corporation (including its Board of Directors, independent legal counsel or its stockholders) that the claimant has not met such applicable standard of conduct, shall be a defense to the action or create a presumption that claimant has not met the applicable standard of conduct. In any suit brought by a director or officer to enforce a right to indemnification or to an advancement
of expenses hereunder, the burden of proving that the director or officer is not entitled to be indemnified, or to such advancement of expenses, under this Section 45 or otherwise shall be on the corporation. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(e) Non-Exclusivity of Rights.</B>&nbsp;&nbsp;The rights conferred on any person by this Bylaw shall not be exclusive of any other right which such person may have or hereafter acquire under any applicable statute, provision of the Certificate of Incorporation, Bylaws, agreement, vote of stockholders or disinterested directors or otherwise, both as to action in such person&#146;s official capacity and as to action in another capacity while holding office. The corporation is specifically authorized to enter into individual contracts with any or all of its directors, officers, employees or agents respecting indemnification
and advances, to the fullest extent not prohibited by the DGCL, or by any other applicable law. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(f) Survival of Rights.</B>&nbsp;&nbsp;The rights conferred on any person by this Bylaw shall continue as to a person who has ceased to be a director or officer, or, if applicable, employee or other agent, and shall inure to the benefit of the heirs, executors and administrators of such a person. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(g) Insurance.</B>&nbsp;&nbsp;To the fullest extent permitted by the DGCL or any other applicable law, the corporation, upon approval by the Board of Directors, may purchase insurance on behalf of any person required or permitted to be indemnified pursuant to this Section 45. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(h) Amendments.</B>&nbsp;&nbsp;Any repeal or modification of this Section 45 shall only be prospective and shall not affect the rights under this Bylaw in effect at the time of the alleged occurrence of any action or omission to act that is the cause of any proceeding against any agent of the corporation. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(i) Saving Clause.</B>&nbsp;&nbsp;If this Bylaw or any portion hereof shall be invalidated on any ground by any court of competent jurisdiction, then the corporation shall nevertheless indemnify each director and officer to the full extent not prohibited by any applicable portion of this Section 45 that shall not have been invalidated, or by any other applicable law. If this Section 45 shall be invalid due to the application of the indemnification provisions of another jurisdiction, then the corporation shall indemnify each director and officer to the full extent under any other applicable law. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(j) Certain Definitions.</B>&nbsp;&nbsp;For the purposes of this Bylaw, the following definitions shall apply: </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 44px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>i. </B>The term &#147;<B><I>proceeding</I></B>&#148; shall be broadly construed and shall include, without limitation, the investigation, preparation, prosecution, defense, settlement, arbitration and appeal of, and the giving of testimony in, any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 44px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>ii. </B>The term &#147;<B><I>expenses</I></B>&#148; shall be broadly construed and shall include, without limitation, court costs, attorneys&#146; fees, witness fees, fines, amounts paid in settlement or judgment and any other costs and expenses of any nature or kind incurred in connection with any proceeding. </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">F-17</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 44px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>iii. </B>The term the &#147;<B><I>corporation</I></B>&#148; shall include, in addition to the resulting corporation, any constituent corporation (including any constituent of a constituent) absorbed in a consolidation or merger which, if its separate existence had continued, would have had power and authority to indemnify its directors, officers, and employees or agents, so that any person who is or was a director, officer, employee or agent of such constituent corporation, or is or was serving at the request of such constituent corporation as a director, officer, employee or agent of another corporation, partnership,
joint venture, trust or other enterprise, shall stand in the same position under the provisions of this Section 45 with respect to the resulting or surviving corporation as he would have with respect to such constituent corporation if its separate existence had continued. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 44px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>iv. </B>References to a &#147;<B><I>director</I></B>,&#148; &#147;<B><I>officer</I></B>,&#148; &#147;<B><I>employee</I></B>,&#148; or &#147;<B><I>agent</I></B>&#148; of the corporation shall include, without limitation, situations where such person is serving at the request of the corporation as, respectively, a director, officer, employee, trustee or agent of another corporation, partnership, joint venture, trust or other enterprise. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 44px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>v. </B>References to &#147;<B><I>other enterprise</I></B>&#148; shall include employee benefit plans; references to &#147;<B><I>fines</I></B>&#148; shall include any excise taxes assessed on a person with respect to an employee benefit plan; and references to &#147;<B><I>serving at the request of the corporation</I></B>&#148; shall include any service as a director, officer, employee or agent of the corporation which imposes duties on, or involves services by, such director, officer, employee, or agent with respect to an employee benefit plan, its participants, or beneficiaries; and a person who acted in good faith and in
a manner such person reasonably believed to be in the interest of the participants and beneficiaries of an employee benefit plan shall be deemed to have acted in a manner &#147;<B><I>not opposed to the best interests of the corporation</I></B>&#148; as referred to in this Section 45. </P>

<H1 STYLE="text-indent:0pt; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 9pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">ARTICLE XII<BR>&nbsp;<BR> NOTICES </H1>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>Section 46. Notices.</B> </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(a) Notice to Stockholders.</B>&nbsp;&nbsp;Written notice to stockholders of stockholder meetings shall be given as provided in Section 7 of these Bylaws. Without limiting the manner by which notice may otherwise be given effectively to stockholders under any agreement or contract with such stockholder, and except as otherwise required by law, written notice to stockholders for purposes other than stockholder meetings may be sent by U.S. mail or nationally recognized overnight courier, or by facsimile, telegraph or telex or by electronic mail or other electronic means. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(b) Notice to Directors.</B>&nbsp;&nbsp;Any notice required to be given to any director may be given by the method stated in subsection (a), as otherwise provided in these Bylaws, or by overnight delivery service, facsimile, telex or telegram, except that such notice other than one which is delivered personally shall be sent to such address as such director shall have filed in writing with the Secretary, or, in the absence of such filing, to the last known post office address of such director. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(c) Affidavit of Mailing.</B>&nbsp;&nbsp;An affidavit of mailing, executed by a duly authorized and competent employee of the corporation or its transfer agent appointed with respect to the class of stock affected, or other agent, specifying the name and address or the names and addresses of the stockholder or stockholders, or director or directors, to whom any such notice or notices was or were given, and the time and method of giving the same, shall in the absence of fraud, be prima facie evidence of the facts therein contained. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(d) Methods of Notice.</B>&nbsp;&nbsp;It shall not be necessary that the same method of giving notice be employed in respect of all recipients of notice, but one permissible method may be employed in respect of any one or more, and any other permissible method or methods may be employed in respect of any other or others. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(e) Notice to Person with whom Communication is Unlawful.</B>&nbsp;&nbsp;Whenever notice is required to be given, under any provision of law or of the Certificate of Incorporation or Bylaws of the corporation, to any person with whom communication is unlawful, the giving of such notice to such person shall not be </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">F-18</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">required and there shall be no duty to apply to any governmental authority or agency for a license or permit to give such notice to such person. Any action or meeting which shall be taken or held without notice to any such person with whom communication is unlawful shall have the same force and effect as if such notice had been duly given. In the event that the action taken by the corporation is such as to require the filing of a certificate under any provision of the DGCL, the certificate shall state, if such is the fact and if notice is required, that notice was given to all persons entitled to receive notice except such
persons with whom communication is unlawful. </P>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 24px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>(f) Notice to Stockholders Sharing an Address.</B>&nbsp;&nbsp;Except as otherwise prohibited under the DGCL, any notice given under the provisions of the DGCL, the Certificate of Incorporation or the Bylaws shall be effective if given by a single written notice to stockholders who share an address if consented to by the stockholders at that address to whom such notice is given. Such consent shall have been deemed to have been given if such stockholder fails to object in writing to the corporation within 60 days of having been given notice by the corporation of its intention to send the single notice. Any consent shall be
revocable by the stockholder by written notice to the corporation. </P>

<H1 STYLE="text-indent:0pt; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 9pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">ARTICLE XIII<BR>&nbsp;<BR> AMENDMENTS </H1>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>Section 47. Amendments.</B>&nbsp;&nbsp;Subject to the limitations set forth in Section 45(h) of these Bylaws or the provisions of the Certificate of Incorporation, the Board of Directors is expressly empowered to adopt, amend or repeal the Bylaws of the corporation. Any adoption, amendment or repeal of the Bylaws of the corporation by the Board of Directors shall require the approval of a majority of the authorized number of directors. The stockholders also shall have power to adopt, amend or repeal the Bylaws of the corporation; provided, ho<I>wever, </I>that, in addition to any vote of the holders of any class or series
of stock of the corporation required by law or by the Certificate of Incorporation, such action by stockholders shall require the affirmative vote of the holders of at least 66&nbsp;2/3% of the voting power of all of the then-outstanding shares of the capital stock of the corporation entitled to vote generally in the election of directors, voting together as a single class. </P>

<H1 STYLE="text-indent:0pt; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 9pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">ARTICLE XIV<BR>&nbsp;<BR> LOANS TO OFFICERS OR EMPLOYEES </H1>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>Section 48. Loans to Officers or Employees.</B>&nbsp;&nbsp;Except as otherwise prohibited by applicable law, the corporation may lend money to, or guarantee any obligation of, or otherwise assist any officer or other employee of the corporation or of its subsidiaries, including any officer or employee who is a director of the corporation or its subsidiaries, whenever, in the judgment of the Board of Directors, such loan, guarantee or assistance may reasonably be expected to benefit the corporation. The loan, guarantee or other assistance may be with or without interest and may be unsecured, or secured in such manner as the
Board of Directors shall approve, including, without limitation, a pledge of shares of stock of the corporation. Nothing in these Bylaws shall be deemed to deny, limit or restrict the powers of guaranty or warranty of the corporation at common law or under any statute. </P>

<H1 STYLE="text-indent:0pt; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; padding-top: 9pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">ARTICLE XV<BR>&nbsp;<BR> FORUM FOR ADJUDICATION OF DISPUTES </H1>

<P STYLE="text-indent:20px; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><B>Section 49. Forum for Adjudication of Disputes.</B>&nbsp;&nbsp;Unless the corporation consents in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware shall be the sole and exclusive forum for (a) any derivative action or proceeding brought on behalf of the corporation, (b) any action asserting a claim of breach of a fiduciary duty owed by any director, officer or other employee of the corporation to the corporation or the corporation&#146;s stockholders, (c) any action asserting a claim against the corporation or any director or officer or other employee of the corporation
arising pursuant to any provision of the DGCL, the Certificate of Incorporation or the Bylaws, and (d) any action asserting a claim against the corporation or any director or officer or other employee of the corporation governed by the internal affairs doctrine. </P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt">F-19</P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:0pt; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><IMG SRC="v439550_proxycard-1.jpg" WIDTH="652" ALIGN="MIDDLE" ALT="[GRAPHIC MISSING]"></P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"></P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">

<div id="PN" style="PAGE-BREAK-AFTER: always">&nbsp;</div>

<div id="HDR">&nbsp;</div>

<DIV STYLE="width: 708px; border-top: 1pt white solid; border-bottom: 1pt white solid; border-right: 1pt white solid; border-left: 1pt white solid; padding-top: 9pt; padding-bottom: 9pt; padding-right: 3pt; padding-left:6pt; margin-top:6pt; margin-right: 0pt; margin-left:0pt; margin-bottom:6pt" ALIGN="CENTER">

<P STYLE="text-align: left; font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-variant: normal; font-weight: bold"></P>

<P STYLE="text-indent:0pt; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; text-transform: none; padding-top: 3pt; padding-right: 0pt; padding-left: 4px; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"><IMG SRC="v439550_proxycard-2.jpg" WIDTH="652" ALIGN="MIDDLE" ALT="[GRAPHIC MISSING]"></P>

</DIV>

<P STYLE="width: 708px; text-indent:0px; text-align: center; font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 12pt; font-style: normal; font-variant: normal; font-weight: normal; color: black; text-transform: none; text-decoration: none; padding-top: 12pt; padding-right: 0pt; padding-left: 0pt; padding-bottom: 3pt; margin-top: 0pt; margin-right: 0pt; margin-left: 0pt; margin-bottom: 0pt"></P>

<HR align="left" STYLE="width: 708px; height: 2px; text-align: center">



</DIV>

</B></B></B></B></B></B></B></B></B></B></B></B></B></B></B></B></B></B>

</I></I></I></I></I></I></I></I></I></I></I></I></I></I></I></I></I></I>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"></P></DIV>

<!-- Field: Page; Sequence: 46 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Washington, DC 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM 8-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>CURRENT REPORT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Pursuant to Section&nbsp;13 or 15(d)
of the</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Securities Exchange Act of 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Date of report (Date of earliest event
reported): May 31, 2016</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Commission File Number: 001-37544 </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>AmpliPhi
Biosciences Corporation</B> </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Exact name of Registrant as specified
in its charter)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>Washington</B></FONT></TD>
    <TD STYLE="width: 50%; font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>91-1549568</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>(State or other jurisdiction of incorporation or organization)</B></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>(IRS Employer Identification No.)</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>3579 Valley Centre
Drive, Suite 100</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>San Diego, California
92130</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>(Address of principal
executive offices)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>(858) 829-0829</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>(Registrant&rsquo;s Telephone number)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>N/A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>(Former Name or Former
Address, if Changed Since Last Report)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><B>&nbsp;&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions (see General Instruction
A.2. below):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; font-size: 10pt"><FONT STYLE="font: 10pt Wingdings">&uml;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; font-size: 10pt"><FONT STYLE="font: 10pt Wingdings">&uml;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; font-size: 10pt"><FONT STYLE="font: 10pt Wingdings">&uml;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; font-size: 10pt"><FONT STYLE="font: 10pt Wingdings">&uml;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;<B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 47 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Item 1.01 Entry into a Material Definitive Agreement. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On May 31, 2016, AmpliPhi Biosciences Corporation
(the &ldquo;Company&rdquo;) entered into a securities purchase agreement (the &ldquo;Purchase Agreement&rdquo;) with certain institutional
purchasers (the &ldquo;Purchasers&rdquo;). Pursuant to the terms of the Purchase Agreement, the Company has agreed to sell an aggregate
of 2,127,660 shares of common stock together with warrants to purchase up to an aggregate of 1,063,830 shares of common stock.
Each share of common stock is being sold together with a warrant to purchase 0.50 of a share of common stock at a combined purchase
price of $2.35. The net proceeds to the Company from the offering are expected to be approximately $4.5 million, after deducting
placement agent fees and estimated offering expenses payable by the Company, but excluding the proceeds, if any, from the exercise
of the warrants issued in the offering. The offering is expected to close on or about June 3, 2016, subject to customary closing
conditions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The warrants will have an exercise price
of $2.25 per share, will be immediately exercisable and will expire five years following the date of issuance.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to an agreement dated May 31,
2016 (the &ldquo;Placement Agency Agreement&rdquo;), the Company engaged Roth Capital Partners, LLC and Griffin Securities, Inc.
(the &ldquo;Co-Placement Agents&rdquo;) to act as co-placement agents in connection with the issuance and sale of the shares and
warrants. The Company has agreed to pay the Co-Placement Agents 7.0% of the aggregate gross proceeds from the offering, excluding
the proceeds, if any, from the exercise of the warrants. The Company also agreed to reimburse the Co-Placement Agents for their
out of pocket and legal expenses in connection with the offering in an amount not to exceed $75,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The offering is being made pursuant to
the Company&rsquo;s effective registration statement on Form S-3 (File No. 333-210974) previously filed with the Securities and
Exchange Commission (&ldquo;SEC&rdquo;) and a prospectus supplement thereunder. A copy of the opinion of Cooley LLP relating to
the legality of the issuance and sale of the securities in the offering is attached as Exhibit 5.1 hereto. On May 31, 2016, the
Company also issued a press release announcing the pricing of the offering. A copy of the press release is attached as Exhibit
99.1 hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Purchase Agreement contains customary
representations, warranties and agreements by the Company, customary conditions to closing, indemnification obligations of the
Company, including for liabilities under the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;), termination
provisions, and other obligations and rights of the parties. The representations, warranties and covenants contained in the Purchase
Agreement were made only for purposes of such agreement and as of specific dates, were solely for the benefit of the parties to
such agreement, and may be subject to limitations agreed upon by the contracting parties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The foregoing descriptions of the Placement
Agency Agreement, Purchase Agreement and the warrants are not complete and are qualified in their entireties by reference to the
full text of the Placement Agency Agreement, the form of Purchase Agreement and form of warrant, copies of which are attached to
this report as Exhibit 99.2, Exhibit 99.3 and Exhibit 4.1, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Item 3.02 Unregistered Sales of Equity
Securities.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As previously disclosed, on April 8, 2016
the Company entered into a Common Stock Issuance Agreement (the &ldquo;CSIA&rdquo;) with certain former holders of the Company&rsquo;s
Series B convertible preferred stock (the &ldquo;Holders&rdquo;). Pursuant to Section 3 of the CSIA, in the event the Company conducts
one or more bona fide equity financings in which it sells shares of its common stock at a price of less than $4.05 per share, the
Company will, subject to the provisions of Section 3 of the CSIA and to the extent permitted by NYSE MKT rules, issue to the Holders,
for no additional consideration, a number of shares of common stock based on a specified formula. In connection with the offering
described above under Item 1.01 and pursuant to the terms of the CSIA, the Company will be required to issue to the Holders within
15 business days following the closing of the offering up to an aggregate of 750,210 shares of common stock as a result of the
price per share in the offering being less than $4.05 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The maximum number of shares of common
stock the Company is currently permitted to issue to the Holders pursuant to the Company&rsquo;s obligations under Section 3 of
the CSIA without shareholder approval is 323,235 shares. The Company is seeking, pursuant to Proposal 5 set forth in the Company&rsquo;s
Definitive Proxy Statement on Schedule 14A filed with the SEC on May 20, 2016, shareholder approval at its 2016 Annual Meeting
of Shareholders (the &ldquo;Annual Meeting&rdquo;) of the issuance of up to an aggregate of 1,037,053 shares of common stock as
and to the extent required pursuant to the terms of the CSIA. In the event that such Proposal 5 is not approved by the Company&rsquo;s
shareholders at the Annual Meeting, then the Company will be obligated to pay to the Holders $1.70 (representing the difference
between $4.05 and the price per share in the offering of $2.35) for each of the remaining 426,975 shares that the Holders would
otherwise have been entitled to receive pursuant to the CSIA in connection with the closing of the offering described above under
Item&nbsp;1.01.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 48 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">None of the Holders are Purchasers in the
offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The shares of common stock to be issued to the Holders pursuant
to the CSIA will be issued in a private placement transaction exempt from registration pursuant to Section&nbsp;4(a)(2) of the
Securities Act. The Holders have represented to the Company that the shares will be acquired for investment only and not with a
view to or for sale in connection with any distribution thereof and appropriate legends will be affixed to the shares. Each of
the Holders has represented to being an &ldquo;accredited investor&rdquo; under Rule 506 of Regulation D of the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Forward-Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Statements in this report that are not statements of historical
fact are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking
statements include, without limitation, statements with respect to the completion, timing and size of the offering, the expected
proceeds from the offering, the anticipated use of the proceeds from the offering and the issuance of shares or payment of cash
to the Holders in connection with the closing of the offering. Because such statements are subject to risks and uncertainties,
actual results may differ materially from those expressed or implied by such forward-looking statements. Words such as &ldquo;believes,&rdquo;
&ldquo;anticipates,&rdquo; &ldquo;plans,&rdquo; &ldquo;expects,&rdquo; &ldquo;intends,&rdquo; &ldquo;will,&rdquo; &ldquo;goal,&rdquo;
&ldquo;potential&rdquo; and similar expressions are intended to identify forward-looking statements, though not all forward-looking
statements necessarily contain these identifying words. These forward-looking statements are based upon the Company&rsquo;s current
expectations and involve a number of risks and uncertainties, including the risks and uncertainties described in the Company&rsquo;s
Quarterly Report on Form 10-Q for the quarter ended March 31, 2016, as filed with the SEC. Actual results and the timing of events
could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties.
You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this report.
All forward-looking statements are qualified in their entirety by this cautionary statement, and the Company undertakes no obligation
to revise or update any forward-looking statements to reflect events or circumstances after the date of this report.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Item 9.01 Financial Statements and Exhibits. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>(d) Exhibits. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: black 1pt solid"><B>Exhibit<BR>
        No.</B></P></TD>
    <TD>&nbsp;</TD>
    <TD NOWRAP>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; border-bottom: black 1pt solid"><B>Description</B></P></TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR>
    <TD NOWRAP STYLE="vertical-align: top; font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">4.1</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">Form of Warrant to Purchase Common Stock</FONT></TD></TR>
<TR>
    <TD NOWRAP STYLE="vertical-align: top; padding-top: 3pt; font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">5.1</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-top: 3pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-top: 3pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">Opinion of Cooley LLP</FONT></TD></TR>
<TR>
    <TD NOWRAP STYLE="vertical-align: top; padding-top: 3pt; font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">23.1</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-top: 3pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-top: 3pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">Consent of Cooley LLP (included in Exhibit 5.1)</FONT></TD></TR>
<TR>
    <TD NOWRAP STYLE="vertical-align: top; padding-top: 3pt; font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">99.1</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-top: 3pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-top: 3pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">Press release </FONT></TD></TR>
<TR>
    <TD NOWRAP STYLE="vertical-align: top; padding-top: 3pt; font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">99.2</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-top: 3pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-top: 3pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">Placement Agency Agreement, dated May 31, 2016, by and among AmpliPhi Biosciences Corporation, Roth Capital Partners, LLC and Griffin Securities, Inc.</FONT></TD></TR>
<TR>
    <TD NOWRAP STYLE="vertical-align: top; padding-top: 3pt; font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">99.3</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-top: 3pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-top: 3pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">Form of Securities Purchase Agreement</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 49 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Date: June 1, 2016</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt"><B>AmpliPhi Biosciences Corporation</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-size: 10pt">By: </FONT></TD>
    <TD STYLE="width: 45%; border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ Steve R. Martin</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD NOWRAP><FONT STYLE="font-size: 10pt">Name:&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Steve R. Martin</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Title: </FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Chief Financial Officer</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 50 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT INDEX</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: black 1pt solid"><B>Exhibit<BR>
        No.</B></P></TD>
    <TD>&nbsp;</TD>
    <TD NOWRAP>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; border-bottom: black 1pt solid"><B>Description</B></P></TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR>
    <TD NOWRAP STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">4.1</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Form of Warrant to Purchase Common Stock</FONT></TD></TR>
<TR>
    <TD NOWRAP STYLE="vertical-align: top; padding-top: 3pt; text-align: center"><FONT STYLE="font-size: 10pt">5.1</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-top: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-top: 3pt"><FONT STYLE="font-size: 10pt">Opinion of Cooley LLP</FONT></TD></TR>
<TR>
    <TD NOWRAP STYLE="vertical-align: top; padding-top: 3pt; text-align: center"><FONT STYLE="font-size: 10pt">23.1</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-top: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-top: 3pt"><FONT STYLE="font-size: 10pt">Consent of Cooley LLP (included in Exhibit 5.1)</FONT></TD></TR>
<TR>
    <TD NOWRAP STYLE="vertical-align: top; padding-top: 3pt; text-align: center"><FONT STYLE="font-size: 10pt">99.1</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-top: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-top: 3pt"><FONT STYLE="font-size: 10pt">Press release </FONT></TD></TR>
<TR>
    <TD NOWRAP STYLE="vertical-align: top; padding-top: 3pt; text-align: center"><FONT STYLE="font-size: 10pt">99.2</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-top: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-top: 3pt"><FONT STYLE="font-size: 10pt">Placement Agency Agreement, dated May 31, 2016, by and among AmpliPhi Biosciences Corporation, Roth Capital Partners, LLC and Griffin Securities, Inc.</FONT></TD></TR>
<TR>
    <TD NOWRAP STYLE="vertical-align: top; padding-top: 3pt; text-align: center"><FONT STYLE="font-size: 10pt">99.3</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-top: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-top: 3pt"><FONT STYLE="font-size: 10pt">Form of Securities Purchase Agreement</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 51 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 4.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: right"><B>EXHIBIT A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>COMMON STOCK PURCHASE WARRANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>AMPLIPHI
BIOSCIENCES CORPORATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 40%; text-align: left; font-size: 10pt">Warrant Shares: _______</TD>
    <TD STYLE="width: 60%; padding-right: 0.5in; text-align: right; font-size: 10pt">Initial Exercise Date: June ____, 2016</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">THIS COMMON STOCK PURCHASE
WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, _____________ or its assigns (the &ldquo;<U>Holder</U>&rdquo;)
is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on
or after the date hereof (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) and on or prior to the close of business on the five
year anniversary of the Initial Exercise Date (the &ldquo;<U>Termination Date</U>&rdquo;) but not thereafter, to subscribe for
and purchase from Ampliphi Biosciences Corporation, a Washington corporation (the &ldquo;<U>Company</U>&rdquo;), up to ______ shares
(as subject to adjustment hereunder, the &ldquo;<U>Warrant Shares</U>&rdquo;) of Common Stock. The purchase price of one share
of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 1</U>.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Definitions</U>.
Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Securities Purchase Agreement
(the &ldquo;<U>Purchase Agreement</U>&rdquo;), dated May 31, 2016, among the Company and the purchasers signatory thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 2</U>.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Exercise
of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on or after the Initial
Exercise Date and on or before the Termination Date by delivery to the Company (or such other office or agency of the Company as
it may designate by notice in writing to the registered Holder at the address of the Holder appearing on the books of the Company)
of a duly executed facsimile copy (or e-mail attachment) of the Notice of Exercise in the form annexed hereto and , within one
(1) Trading Day of the date said Notice of Exercise is delivered to the Company, payment of the aggregate Exercise Price of the
shares thereby purchased by wire transfer or cashier&rsquo;s check drawn on a United States bank or, if available, pursuant to
the cashless exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise. No ink-original
Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice
of Exercise form be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender
this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been
exercised in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation within three (3) Trading
Days of the date the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases
of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number
of Warrant Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and
the Company shall maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall
deliver any objection to any Notice of Exercise within one (1) Business Day of receipt of such notice. <B>The Holder and any assignee,
by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase
of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may
be less than the amount stated on the face hereof.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 52; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Exercise
Price</U>. The exercise price per share of the Common Stock under this Warrant shall be <B>$2.25</B>, subject to adjustment hereunder
(the &ldquo;<U>Exercise Price</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Cashless
Exercise</U>. If at the time of exercise hereof there is no effective registration statement registering, or the prospectus contained
therein is not available for the issuance of the Warrant Shares to the Holder, then this Warrant may also be exercised, in whole
or in part, at such time by means of a &ldquo;cashless exercise&rdquo; in which the Holder shall be entitled to receive a number
of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99pt; text-align: justify; text-indent: -27pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.35in; text-align: left">(A) =</TD><TD STYLE="text-align: justify">the last VWAP immediately preceding the time of delivery
of the Notice of Exercise giving rise to the applicable &ldquo;cashless exercise&rdquo;, as set forth in the applicable Notice
of Exercise (to clarify, the &ldquo;last VWAP&rdquo; will be the last VWAP as calculated over an entire Trading Day such that,
in the event that this Warrant is exercised at a time that the Trading Market is open, the prior Trading Day&rsquo;s VWAP shall
be used in this calculation);</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.35in; text-align: left">(B) =</TD><TD STYLE="text-align: justify">the Exercise Price of this Warrant, as adjusted hereunder;
and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.35in; text-align: left">(X) =</TD><TD STYLE="text-align: justify">the number of Warrant Shares that would be issuable upon
exercise of this Warrant in accordance with the terms of this Warrant if such exercise were by means of a cash exercise rather
than a cashless exercise.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.5pt; text-align: justify; text-indent: -31.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="background-color: white">If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9)
of the Securities Act, the Warrant Shares shall take on the registered characteristics of the Warrants being exercised.&nbsp;&nbsp;The
Company agrees not to take any position contrary to this Section 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed
or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding
date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading
Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b)&nbsp; if OTCQB or OTCQX is not a Trading Market,
the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable,
(c) if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then
reported in the &ldquo;Pink Sheets&rdquo; published by OTC Markets Group, Inc. (or a similar organization or agency succeeding
to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported, or (d)&nbsp;in all
other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith
by the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees
and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 53; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left">d)</TD><TD STYLE="text-align: justify"><U>Mechanics of Exercise</U>.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">i.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Delivery
of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Transfer
Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository
Trust Company through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant
in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or
resale of the Warrant Shares by Holder or (B) this Warrant is being exercised via cashless exercise, and otherwise by physical
delivery of a certificate, registered in the Company&rsquo;s share register in the name of the Holder or its designee, for the
number of Warrant Shares to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the
Notice of Exercise by the date that is one (1) Trading Day after the delivery to the Company of the Notice of Exercise (such date,
the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;). Upon delivery of the Notice of Exercise the Holder shall be deemed for all
corporate purposes to have become the holder of record of the Warrant Shares with respect to which this Warrant has been exercised,
irrespective of the date of delivery of the Warrant Shares; provided payment of the aggregate Exercise Price (other than in the
case of a Cashless Exercise) is received within three Trading Days of delivery of the Notice of Exercise. The Company agrees to
maintain a transfer agent that is a participant in the FAST program so long as this Warrant remains outstanding and exercisable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">ii.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Delivery
of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder
and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant
evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall
in all other respects be identical with this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">iii.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Rescission
Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section 2(d)(i)
by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 54; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">iv.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Compensation
for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to the Holder,
if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions
of Section 2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder
is required by its broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise
purchases, shares of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated
receiving upon such exercise (a &ldquo;<U>Buy-In</U>&rdquo;), then the Company shall (A) pay in cash to the Holder the amount,
if any, by which (x) the Holder&rsquo;s total purchase price (including brokerage commissions, if any) for the shares of Common
Stock so purchased exceeds (y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required
to deliver to the Holder in connection with the exercise at issue times (2) the price at which the sell order giving rise to such
purchase obligation was executed, and (B) at the option of the Holder, either reinstate the portion of the Warrant and equivalent
number of Warrant Shares for which such exercise was not honored (in which case such exercise shall be deemed rescinded) or deliver
to the Holder the number of shares of Common Stock that would have been issued had the Company timely complied with its exercise
and delivery obligations hereunder. For example, if the Holder purchases Common Stock having a total purchase price of $11,000
to cover a Buy-In with respect to an attempted exercise of shares of Common Stock with an aggregate sale price giving rise to such
purchase obligation of $10,000, under clause (A) of the immediately preceding sentence the Company shall be required to pay the
Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable to the Holder in respect of the
Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing herein shall limit a Holder&rsquo;s right
to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific
performance and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares of Common Stock upon
exercise of the Warrant as required pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">v.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No
Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise
of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the
Company shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction
multiplied by the Exercise Price or round up to the next whole share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 55; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">vi.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Charges,
Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or
other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the
Company, and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder;
<U>provided</U>, <U>however</U>, that in the event that Warrant Shares are to be issued in a name other than the name of the Holder,
this Warrant when surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder
and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental
thereto. The Company shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees
to the Depository Trust Company (or another established clearing corporation performing similar functions) required for same-day
electronic delivery of the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">vii.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Closing
of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this
Warrant, pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Holder&rsquo;s
Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise
any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after
exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other
Persons acting as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;Attribution Parties&rdquo;)),
would beneficially own in excess of the Beneficial Ownership Limitation (as defined below).&nbsp; For purposes of the foregoing
sentence, the number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall
include the number of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is
being made, but shall exclude the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining,
nonexercised portion of this Warrant beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii)
exercise or conversion of the unexercised or nonconverted portion of any other securities of the Company (including, without limitation,
any other Common Stock Equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained herein
beneficially owned by the Holder or any of its Affiliates or Attribution Parties.&nbsp; Except as set forth in the preceding sentence,
for purposes of this Section 2(e), beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act
and the rules and regulations promulgated thereunder, it being acknowledged by the Holder that the Company is not representing
to the Holder that such calculation is in compliance with Section 13(d) of the Exchange Act and the Holder is solely responsible
for any schedules required to be filed in accordance therewith. To the extent that the limitation contained in this Section 2(e)
applies, the determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together
with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable shall be in the sole discretion
of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s determination of whether this
Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties)
and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company
shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any group
status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations
promulgated thereunder. For purposes of this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder
may rely on the number of outstanding shares of Common Stock as reflected in (A) the Company&rsquo;s most recent periodic or annual
report filed with the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent
written notice by the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding.&nbsp; Upon
the written or oral request of a Holder, the Company shall within two Trading Days confirm orally and in writing to the Holder
the number of shares of Common Stock then outstanding.&nbsp; In any case, the number of outstanding shares of Common Stock shall
be determined after giving effect to the conversion or exercise of securities of the Company, including this Warrant, by the Holder
or its Affiliates or Attribution Parties since the date as of which such number of outstanding shares of Common Stock was reported.
The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall be 4.99% of the number of shares of the Common Stock outstanding
immediately after giving effect to the issuance of shares of Common Stock issuable upon exercise of this Warrant. The Holder, upon
notice to the Company, may increase or decrease the Beneficial Ownership Limitation provisions of this Section 2(e), provided that
the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares of the Common Stock outstanding immediately
after giving effect to the issuance of shares of Common Stock upon exercise of this Warrant held by the Holder and the provisions
of this Section 2(e) shall continue to apply. Any increase in the Beneficial Ownership Limitation will not be effective until the
61<SUP>st</SUP> day after such notice is delivered to the Company. The provisions of this paragraph shall be construed and implemented
in a manner otherwise than in strict conformity with the terms of this Section 2(e) to correct this paragraph (or any portion hereof)
which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make changes or
supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph shall
apply to a successor holder of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 56; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 3</U>.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Certain
Adjustments</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Stock
Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise
makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable
in shares of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon
exercise of this Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including
by way of reverse stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification
of shares of the Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied
by a fraction of which the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding
immediately before such event and of which the denominator shall be the number of shares of Common Stock outstanding immediately
after such event, and the number of shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the
aggregate Exercise Price of this Warrant shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become
effective immediately after the record date for the determination of stockholders entitled to receive such dividend or distribution
and shall become effective immediately after the effective date in the case of a subdivision, combination or re-classification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 57; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[RESERVED]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Subsequent
Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants, issues
or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record
holders of any class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to
acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired
if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to
any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date
on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as
of which the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights
(provided, however, to the extent that the Holder&rsquo;s right to participate in any such Purchase Right would result in the Holder
exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such
extent (or beneficial ownership of such shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase
Right to such extent shall be held in abeyance for the Holder until such time, if ever, as its right thereto would not result in
the Holder exceeding the Beneficial Ownership Limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Pro
Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other
distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital
or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way of
a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &quot;<U>Distribution</U>&quot;),
at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution
to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock
acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation,
the Beneficial Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such
record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the participation in
such Distribution (<U>provided</U>, <U>however</U>, to the extent that the Holder's right to participate in any such Distribution
would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate
in such Distribution to such extent (or in the beneficial ownership of any shares of Common Stock as a result of such Distribution
to such extent) and the portion of such Distribution shall be held in abeyance for the benefit of the Holder until such time, if
ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 58; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Fundamental
Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related
transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company, directly or indirectly,
effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets
in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether
by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange
their shares for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding Common
Stock, (iv) the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization
or recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted
into or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly, in one or more related transactions
consummates a stock or share purchase agreement or other business combination (including, without limitation, a reorganization,
recapitalization, spin-off or scheme of arrangement) with another Person or group of Persons whereby such other Person or group
acquires more than 50% of the outstanding shares of Common Stock (not including any shares of Common Stock held by the other Person
or other Persons making or party to, or associated or affiliated with the other Persons making or party to, such stock or share
purchase agreement or other business combination) (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then, upon any subsequent
exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been issuable upon
such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without regard
to any limitation in Section 2(e) on the exercise of this Warrant), the number of shares of Common Stock of the successor or acquiring
corporation or of the Company, if it is the surviving corporation, and any additional consideration (the &ldquo;<U>Alternate Consideration</U>&rdquo;)
receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant
is exercisable immediately prior to such Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise
of this Warrant). For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to
apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common
Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration in
a reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Common
Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder
shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental
Transaction. Notwithstanding anything to the contrary, in the event of a Fundamental Transaction, concurrently with, the consummation
of the Fundamental Transaction, the Company shall purchase this Warrant from the Holder by paying to the Holder an amount of cash
equal to the Black Scholes Value of the remaining unexercised portion of this Warrant on the date of the consummation of such Fundamental
Transaction. The Company shall be required to give at least 20 days prior written notice of the occurrence of such Fundamental
Transaction. &ldquo;<U>Black Scholes Value</U>&rdquo; means the value of this Warrant based on the Black and Scholes Option Pricing
Model obtained from the &ldquo;OV&rdquo; function on Bloomberg, L.P. (&ldquo;<U>Bloomberg</U>&rdquo;) determined as of the day
of consummation of the applicable Fundamental Transaction for pricing purposes and reflecting (A) a risk-free interest rate corresponding
to the U.S. Treasury rate for a period equal to the time between the date of the public announcement of the applicable Fundamental
Transaction and the Termination Date, (B) an expected volatility equal to the greater of 100% and the 100 day volatility obtained
from the HVT function on Bloomberg as of the Trading Day immediately following the public announcement of the applicable Fundamental
Transaction, (C) the underlying price per share used in such calculation shall be the sum of the price per share being offered
in cash, if any, plus the value of any non-cash consideration, if any, being offered in such Fundamental Transaction and (D) a
remaining option time equal to the time between the date of the public announcement of the applicable Fundamental Transaction and
the Termination Date. The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the
survivor (the &ldquo;<U>Successor Entity</U>&rdquo;) to assume in writing all of the obligations of the Company under this Warrant
and the other Transaction Documents in accordance with the provisions of this Section 3(e) pursuant to written agreements in form
and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental
Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor
Entity evidenced by a written instrument substantially similar in form and substance to this Warrant which is exercisable for a
corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the shares of Common
Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant)
prior to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such shares of
capital stock (but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction
and the value of such shares of capital stock, such number of shares of capital stock and such exercise price being for the purpose
of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and which
is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor
Entity shall succeed to, and be substituted for (so that from and after the date of such Fundamental Transaction, the provisions
of this Warrant and the other Transaction Documents referring to the &ldquo;Company&rdquo; shall refer instead to the Successor
Entity), and may exercise every right and power of the Company and shall assume all of the obligations of the Company under this
Warrant and the other Transaction Documents with the same effect as if such Successor Entity had been named as the Company herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 59; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Calculations</U>.
All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be.
For purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall
be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Notice
to Holder</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">i.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Adjustment
to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly
deliver to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment
to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">ii.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Notice
to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the
Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the
Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares
of capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection
with any reclassification of the Common Stock, any consolidation or merger to which the Company is a party, any sale or transfer
of all or substantially all of the assets of the Company, or any compulsory share exchange whereby the Common Stock is converted
into other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation
or winding up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by facsimile or email
to the Holder at its last facsimile number or email address as it shall appear upon the Warrant Register of the Company, at least
10 calendar days prior to the applicable record or effective date hereinafter specified, a notice stating (x) the date on which
a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to
be taken, the date as of which the holders of the Common Stock of record to be entitled to such dividend, distributions, redemption,
rights or warrants are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer or
share exchange is expected to become effective or close, and the date as of which it is expected that holders of the Common Stock
of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable upon
such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to deliver such notice
or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to be specified
in such notice. To the extent that any notice provided in this Warrant constitutes, or contains, material, non-public information
regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant
to a Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the
date of such notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 60; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 4</U>.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Transfer
of Warrant</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Transferability</U>.
Subject to applicable laws and compliance with the Purchas Agreement, this Warrant and all rights hereunder (including, without
limitation, any registration rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office
of the Company or its designated agent, together with a written assignment of this Warrant substantially in the form attached
hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making
of such transfer. Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants
in the name of the assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument
of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this
Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically
surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall surrender
this Warrant to the Company within three (3) Trading Days of the date the Holder delivers an assignment form to the Company assigning
this Warrant full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase
of Warrant Shares without having a new Warrant issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>New
Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the
Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by
the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such
division or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants
to be divided or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the initial
issuance date of this Warrant and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant
thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Warrant
Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the &ldquo;<U>Warrant
Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered
Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and
for all other purposes, absent actual notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 5</U>.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No
Rights as Stockholder Until Exercise</U>. This Warrant does not entitle the Holder to any voting rights, dividends or other rights
as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set forth in
Section 3.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 61; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Loss,
Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant
Shares, and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of
the Warrant, shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate,
if mutilated, the Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation,
in lieu of such Warrant or stock certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Saturdays,
Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required or
granted herein shall not be a Business Day, then, such action may be taken or such right may be exercised on the next succeeding
Business Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Authorized
Shares</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.48in">The Company covenants
that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a sufficient
number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant.
The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged
with the duty of executing stock certificates to execute and issue the necessary Warrant Shares upon the exercise of the purchase
rights under this Warrant. The Company will take all such reasonable action as may be necessary to assure that such Warrant Shares
may be issued as provided herein without violation of any applicable law or regulation, or of any requirements of the Trading Market
upon which the Common Stock may be listed. The Company covenants that all Warrant Shares which may be issued upon the exercise
of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented by this Warrant and payment
for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable and free from
all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any transfer
occurring contemporaneously with such issue).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 62; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">Except and
to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending
its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or
sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this
Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions
as may be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting
the generality of the foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable
therefor upon such exercise immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate
in order that the Company may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant
and (iii) use commercially reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory
body having jurisdiction thereof, as may be, necessary to enable the Company to perform its obligations under this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">Before taking
any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the
Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary
from any public regulatory body or bodies having jurisdiction thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Jurisdiction</U>.
All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined in accordance
with the provisions of the Purchase Agreement, including, without limitation, that all questions concerning the construction, validity,
enforcement and interpretation of this Warrant shall be governed by and construed and enforced in accordance with the internal
laws of the State of New York, without regard to the principles of conflicts of law thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Restrictions</U>.
The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does
not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Nonwaiver
and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate
as a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision
of this Warrant or the Purchase Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant,
which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to
cover any costs and expenses including, but not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings,
incurred by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies
hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Notices</U>.
Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall be delivered
in accordance with the notice provisions of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Limitation
of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase
Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder
for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company
or by creditors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 63; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Remedies</U>.
The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled
to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation
for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert
the defense in any action for specific performance that a remedy at law would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">k)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Successors
and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure
to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns
of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and
shall be enforceable by the Holder or holder of Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">l)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Amendment</U>.
This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and the Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">m)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Severability</U>.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable
law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective
to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions
of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">n)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Headings</U>.
The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of
this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">********************</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(Signature Page Follows)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>


<!-- Field: Page; Sequence: 64; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">IN WITNESS WHEREOF, the
Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase"><B>AMPLIPHI BIOSCIENCES CORPORATION</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 46%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Name:</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Title:</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>


<!-- Field: Page; Sequence: 65; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTICE OF EXERCISE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="text-transform: uppercase">To:</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase">AMPLIPHI BIOSCIENCES CORPORATION</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(1)&nbsp;&nbsp;&nbsp;&nbsp;The
undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only
if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes,
if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(2)&nbsp;&nbsp;&nbsp;&nbsp;Payment
shall take the form of (check applicable box):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Wingdings">&uml;</FONT> in lawful
money of the United States; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Wingdings">&uml;</FONT> [if permitted
the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 2(c),
to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure
set forth in subsection 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(3)&nbsp;&nbsp;&nbsp;&nbsp;Please
issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: left">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Warrant Shares shall be delivered to
the following DWAC Account Number:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: left">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: left">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: left">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="text-transform: uppercase">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Name of Investing Entity: ________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><I>Signature of Authorized Signatory of Investing
Entity</I>: _________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Name of Authorized Signatory: ___________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Title of Authorized Signatory: ____________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Date: ________________________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>


<!-- Field: Page; Sequence: 66 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>EXHIBIT B</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-weight: normal">ASSIGNMENT
FORM</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt"><I>(To assign the
foregoing Warrant, execute this form and supply required information. Do not use this form to purchase shares.)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt">FOR VALUE RECEIVED,
the foregoing Warrant and all rights evidenced thereby are hereby assigned to</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; text-align: left">Name:</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 49%; border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">(Please Print)</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">Address:</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="text-underline-style: double; color: blue">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">(Please Print)</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">Phone Number:</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="border-top: Black 1pt solid; border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="text-underline-style: double; color: blue">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="text-underline-style: double; color: blue">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">Email Address:</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">Dated: _______________ __, ______</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="border-top: Black 1pt solid; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; text-decoration: none">Holder&rsquo;s Signature: ________________________</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; text-decoration: none">Holder&rsquo;s Address: _________________________</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 67 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 5.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><IMG SRC="tex5-1logo.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Matthew T. Browne</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">+1 858 550 6045</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">mbrowne@cooley.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">June 1, 2016</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">AmpliPhi Biosciences Corporation</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">3579 Valley Centre Drive</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Suite 100</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">San Diego, CA 92130</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You have requested our opinion with respect
to certain matters in connection with the offering by AmpliPhi Biosciences Corporation, a Washington corporation (the &ldquo;<B><I>Company</I></B>&rdquo;),
of 2,127,660 shares (the &ldquo;<B><I>Shares</I></B>&rdquo;) of the Company&rsquo;s common stock, par value $0.01 (the &ldquo;<B><I>Common
Stock</I></B>&rdquo;), plus warrants (the &ldquo;<B><I>Warrants</I></B>&rdquo;) to purchase an additional 1,063,830 shares of the
Company&rsquo;s common stock (the &ldquo;<B><I>Warrant Shares</I></B>&rdquo;) pursuant to a Registration Statement on Form S-3
(Registration Statement No. 333-210974) (the <I>&ldquo;<B>Registration Statement</B>&rdquo;</I>), filed with the Securities and
Exchange Commission (the <I>&ldquo;<B>Commission</B>&rdquo;</I>) under the Securities Act of 1933, as amended (the &ldquo;<B><I>Act</I></B><I>&rdquo;</I>),
the prospectus included within the Registration Statement (the &ldquo;<B><I>Base Prospectus</I></B>&rdquo;), and the prospectus
supplement dated May 31, 2016, filed with the Commission pursuant to Rule 424(b) of the Rules and Regulations of the Act (the &ldquo;<B><I>Prospectus
Supplement</I></B>&rdquo;)<FONT STYLE="font: 10pt Times New Roman, Times, Serif">. </FONT>The Base Prospectus
and the Prospectus Supplement are collectively referred to as the &ldquo;<B><I>Prospectus</I></B>.&rdquo; The Shares, the Warrants
and the Warrant Shares are to be sold by the Company as described in the Registration Statement and the Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with this opinion, we have
examined and relied upon the Registration Statement, the Prospectus, the Company&rsquo;s articles of incorporation and bylaws,
as currently in effect, and the originals or copies certified to our satisfaction of such records, documents, certificates, memoranda
and other instruments as in our judgment are necessary or appropriate to enable us to render the opinion expressed below. We have
assumed the genuineness and authenticity of all documents submitted to us as originals, and the conformity to originals of all
documents submitted to us as copies thereof and the due execution and delivery of all documents where due execution and delivery
are a prerequisite to the effectiveness thereof. With regard to our opinion regarding the Warrants and the Warrant Shares, (i)
we have assumed that the exercise price of the Warrants at the time of exercise is equal to or greater than the par value of the
Common Stock, and (ii) we express no opinion to the extent that, notwithstanding its current reservation of shares of Common Stock,
future issuances of securities, including the Warrant Shares, of the Company and/or antidilution adjustments to outstanding securities,
including the Warrants, of the Company cause the Warrants to be exercisable for more shares of Common Stock than the number that
then remain authorized but unissued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">With regard to our opinion concerning the
Warrants constituting valid and binding obligations of the Company:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">Cooley LLP 4401
Eastgate Mall San Diego, CA 92121<BR>
t: (858) 550-6000 f: (858) 550-6420 cooley.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 68 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><IMG SRC="tex5-1logo.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">AmpliPhi Biosciences Corporation</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">June 1, 2016</P>

<P STYLE="margin: 0pt 0">Page <FONT STYLE="font: 10pt Times New Roman, Times, Serif">Two</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
opinion is subject to, and may be limited by, (a) applicable bankruptcy, reorganization, insolvency, moratorium, fraudulent conveyance,
debtor and creditor, and similar laws which relate to or affect creditors&rsquo; rights generally, and (b) general principles of
equity (including, without limitation, concepts of materiality, reasonableness, good faith and fair dealing) regardless of whether
considered in a proceeding in equity or at law;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
opinion is subject to the qualification that (a) the enforceability of provisions for indemnification or limitations on liability
may be limited by applicable law and by public policy considerations, and (b) the availability of specific performance, an injunction
or other equitable remedies is subject to the discretion of the court before which the request is brought;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
express no opinion with respect to any provision of the Warrants that: (a) relates to the subject matter jurisdiction of any federal
court of the United States of America or any federal appellate court to adjudicate any controversy related to the Warrants; (b)
specifies provisions may be waived in writing, to the extent that an oral agreement or implied agreement by trade practice or course
of conduct has been created that modifies such provision; (c) contains a waiver of an inconvenient forum; (d) provides for liquidated
damages, default interest, late charges, monetary penalties, prepayment or make-whole payments or other economic remedies; (e)
relates to advance waivers of claims, defenses, rights granted by law, or notice, opportunity for hearing, evidentiary requirements,
statutes of limitations, trial by jury, service of process or procedural rights; (f) restricts non-written modifications and waivers;
(g) provides for the payment of legal and other professional fees where such payment is contrary to law or public policy; (h) relates
to exclusivity, election or accumulation of rights or remedies; or (i) provides that provisions of the Warrants are severable to
the extent an essential part of the agreed exchange is determined to be invalid and unenforceable; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
express no opinion as to whether a state court outside of the State of New York or a federal court of the United States would give
effect to the choice of New York law provided for in the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our opinion herein is expressed solely
with respect to the Washington Business Corporation Act and, as to the Warrants constituting valid and legally binding obligations
of the Company, with respect to the laws of the State of New York. Our opinion is based on these laws as in effect on the date
hereof. We express no opinion as to whether the laws of any particular jurisdiction are applicable to the subject matter hereof.
We are not rendering any opinion as to compliance with any federal or state antifraud law, rule or regulation relating to securities,
or to the sale or issuance thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 10pt"><FONT STYLE="text-transform: uppercase">Cooley LLP 4401 Eastgate
Mall San Diego, CA 92121<BR>
t: (858) 550-6000 f: (858) 550-6420 cooley.com</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>


<!-- Field: Page; Sequence: 69 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><IMG SRC="tex5-1logo.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">AmpliPhi Biosciences Corporation</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">June 1, 2016</P>

<P STYLE="margin: 0pt 0">Page <FONT STYLE="font: 10pt Times New Roman, Times, Serif">Three</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On the basis of the foregoing, and in reliance
thereon, we are of the opinion that (i) the Shares, when sold in accordance with the Registration Statement and the Prospectus,
will be validly issued, fully paid and nonassessable, (ii) provided that the Warrants have been duly executed and delivered by
the Company and duly delivered to the purchasers thereof against payment therefor, the Warrants, when issued and sold as contemplated
in the Registration Statement and the Prospectus will be valid and legally binding obligations of the Company, enforceable against
the Company in accordance with their terms, and (iii) the Warrant Shares, when issued and paid for in accordance with the terms
of the Warrants, will be validly issued, fully paid and nonassessable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We consent to the reference to our firm
under the caption &ldquo;Legal Matters&rdquo; in the Prospectus, the filing of this opinion as an exhibit to a current report on
Form 8-K of the Company and the incorporation by reference of this opinion in the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Very truly yours,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Cooley <FONT STYLE="font-variant: small-caps">llp</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">By:</FONT></TD>
    <TD STYLE="width: 46%; border-bottom: Black 1pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">/s/ Matthew T. Browne</FONT></TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Matthew T. Browne, Esq. </TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 10pt"><FONT STYLE="text-transform: uppercase">Cooley LLP 4401 Eastgate
Mall San Diego, CA 92121<BR>
t: (858) 550-6000 f: (858) 550-6420 cooley.com</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 70 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9pt; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9pt; text-align: right">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 45%; font-size: 10pt"><IMG SRC="tex99-1logo.jpg" ALT="">&nbsp;</TD>
    <TD STYLE="width: 55%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9pt; text-align: right">AmpliPhi Biosciences Corporation</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">3579 Valley Centre Drive, Suite 100</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">San Diego, CA 92130</P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; border-bottom: Black 1pt solid; text-indent: 0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Press Release</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AmpliPhi Biosciences Announces Pricing
of Registered Direct Public Offering<BR>
 of Common Stock and Warrants</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>SAN DIEGO &ndash; May 31, 2016 &ndash;
AmpliPhi Biosciences Corporation </B><I>(</I>NYSEMKT:APHB),<I> </I>a global leader in the development of bacteriophage-based antibacterial
therapies to treat drug-resistant infections,<I> </I>today announced the pricing of a registered direct offering of 2,127,660 shares
of common stock and warrants to purchase up to an aggregate of 1,063,830 shares of common stock. Each share of common stock is
being sold together with a warrant to purchase one-half of a share of common stock of AmpliPhi at a combined purchase price of
$2.35. The warrants will be immediately exercisable at a price of $2.25 per full share of common stock for a period of five years
from closing, which is expected to occur on June 3, 2016.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Roth Capital Partners and Griffin Securities,
Inc. acted as co-placement agents for the offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">AmpliPhi expects to receive net proceeds of approximately $4.5
million after deducting placement agent fees and estimated offering expenses payable by AmpliPhi. The offering is expected to close
on or about June 3, 2016, subject to customary closing conditions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">AmpliPhi intends to use the net proceeds from the offering for
general corporate purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The securities described above are being offered by AmpliPhi
pursuant to a registration statement on Form S-3 previously filed with and subsequently declared effective by the Securities and
Exchange Commission (SEC) on May 13, 2016. A prospectus supplement relating to the offering will be filed with the SEC and will
be available on the SEC&rsquo;s website at http://www.sec.gov.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This press release shall not constitute an offer to sell or
a solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities in any
state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under
the securities laws of any such state or jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">###</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>About AmpliPhi Biosciences</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">AmpliPhi Biosciences Corporation (NYSEMKT: APHB) is a biotechnology
company focused on the development and commercialization of novel bacteriophage-based antibacterial therapeutics. AmpliPhi's product
development programs target infections that are often resistant to existing antibiotic treatments. AmpliPhi is currently conducting
a Phase 1 clinical trial of AB-SA01 for the treatment of <I>Staphylococcus aureus (S. aureus) </I> in chronic rhinosinusitis patients
and another Phase 1 clinical trial to evaluate the safety of AB-SA01 when administered topically to the intact skin of healthy
adults. AmpliPhi expects to report final data for both trials in the second half of 2016. AmpliPhi is also developing bacteriophage
therapeutics targeting <I>Pseudomonas aeruginosa</I> and <I>Clostridium difficile</I> in collaboration with a number of leading
organizations focused on the advancement of bacteriophage-based therapies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>About Bacteriophage</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Bacteriophage are naturally occurring viruses that are highly
specific for the bacterial hosts they infect. They can rapidly kill their host, amplifying themselves in the process. Bacteriophage
are unaffected by antibiotic resistance and are able to disrupt bacterial biofilms. Such biofilms are a major line of defense for
bacteria, contributing to antibiotic resistance. Bacteriophage are able to penetrate biofilms and replicate locally to high levels,
to produce strong local therapeutic effects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 71 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 45%; font-size: 10pt"><IMG SRC="tex99-1logo.jpg" ALT="">&nbsp;</TD>
    <TD STYLE="width: 55%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9pt; text-align: right">AmpliPhi Biosciences Corporation</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">3579 Valley Centre Drive, Suite 100</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">San Diego, CA 92130</P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; border-bottom: Black 1pt solid; text-indent: 0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Press Release</B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Forward Looking Statements</B><BR>
Statements in this press release that are not statements of historical fact are forward-looking statements within the meaning of
the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include, without limitation, statements with
respect to the completion, timing and size of the offering, the expected proceeds from the offering and the anticipated use of
the proceeds from the offering. Because such statements are subject to risks and uncertainties, actual results may differ materially
from those expressed or implied by such forward-looking statements. Words such as &ldquo;believes,&rdquo; &ldquo;anticipates,&rdquo;
&ldquo;plans,&rdquo; &ldquo;expects,&rdquo; &ldquo;intends,&rdquo; &ldquo;will,&rdquo; &ldquo;goal,&rdquo; &ldquo;potential&rdquo;
and similar expressions are intended to identify forward-looking statements, though not all forward-looking statements necessarily
contain these identifying words. These forward-looking statements are based upon AmpliPhi&rsquo;s current expectations and involve
a number of risks and uncertainties, including the risks and uncertainties described in AmpliPhi&rsquo;s Quarterly Report on Form
10-Q for the quarter ended March 31, 2016, as filed with the Securities and Exchange Commission. Actual results and the timing
of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties.
You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press
release. All forward-looking statements are qualified in their entirety by this cautionary statement, and AmpliPhi undertakes no
obligation to revise or update any forward-looking statements to reflect events or circumstances after the date of this press release.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="border: Black 1pt solid; padding: 3pt; font-size: 10pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>For further information please contact</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 33%; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding: 3pt; font-size: 10pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Company and Investor relations:</B></FONT></TD>
    <TD STYLE="width: 27%; border-bottom: Black 1pt solid; padding: 3pt; border-right: Black 1pt solid; font-size: 10pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Media relations (USA)</B></FONT></TD>
    <TD STYLE="width: 40%; border-bottom: Black 1pt solid; padding: 3pt; border-right: Black 1pt solid; font-size: 10pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Media Relations (Europe and ROW)</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding: 3pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Matt Dansey</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">AmpliPhi Biosciences</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">+1 858-800-4869</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>md@ampliphibio.com</U></P></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding: 3pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Danielle Lewis/Glenn Silver</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Lazar Partners</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">+ 1 212-867-1762</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>ampliphi@lazarpartners.com</U></P></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding: 3pt; font-size: 10pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Gemma
    Howe/Sue Charles </FONT><BR>
    <FONT STYLE="font: 10pt Times New Roman, Times, Serif">Instinctif Partners</FONT><BR>
    <FONT STYLE="font: 10pt Times New Roman, Times, Serif">+44 (0)20 7866 7860</FONT><BR>
    <FONT STYLE="font: 10pt Times New Roman, Times, Serif"><U>ampliphi@instinctif.com</U></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 72 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 99.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PLACEMENT AGENCY AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">May 31, 2016</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Roth Capital Partners, LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">888 San Clemente Drive</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Newport Beach, CA 92660</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Griffin Securities, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">17 State Street, 3<SUP>rd</SUP> Floor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">New York, NY 10004</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">AmpliPhi BioSciences
Corp., a Washington corporation (the &ldquo;<U>Company</U>&rdquo;), proposes, subject to the terms and conditions stated herein,
to issue and sell, through Roth Capital Partners, LLC (&ldquo;<U>Roth</U>&rdquo;) and Griffin Securities, Inc. (&ldquo;Co-<U>Placement
Agents</U>&rdquo;) as co-placement agents, securities of the Company consisting of shares (&ldquo;<U>Shares</U>&rdquo;) of the
Company&rsquo;s common stock (&ldquo;<U>Common Stock</U>&rdquo;), $0.01 par value per share, and warrants to purchase shares of
Common Stock (&ldquo;<U>Warrants</U>&rdquo;, and collectively with the Shares, the &ldquo;<U>Securities</U>&rdquo;), directly to
various investors (the &ldquo;<U>Investors</U>&rdquo;) as set forth on <U>Schedule I</U> hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company and the
Co-Placement Agents hereby confirm their agreement as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B><I>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Agreement
to Act as Co-Placement Agents</I></B><I>. </I>On the basis of the representations, warranties and agreements of the Company herein
contained, and subject to all the terms and conditions of this Agreement, the Co-Placement Agents shall serve as the exclusive
placement agents in connection with the issuance and sale by the Company from the Registration Statement (as defined in Section
2 below), as to the Shares and Warrants, with the terms of such offering (the &ldquo;<U>Offering</U>&rdquo;) to be subject to market
conditions and negotiations between the Company, the Co-Placement Agents and the Investors. The Co-Placement Agents shall act on
a best efforts basis and the Co-Placement Agents do not guarantee that they will be able to sell the Securities in the prospective
Offering. As compensation for services rendered, on the Closing Date (as defined below), the Company shall pay to the Co-Placement
Agents an aggregate amount equal to 7% of the gross proceeds received by the Company. The per Share and Warrant combination purchase
price to the Investors shall be mutually agreed to between the Company and the Co-Placement Agents (the &ldquo;<U>Offering Price</U>&rdquo;).
The Co-Placement Agents may retain other brokers or dealers to act as sub-agents on their behalf in connection with the Offering;
<U>provided</U>, <U>however</U>, to the extent that such other brokers or dealers are retained, the commissions paid to such brokers
or dealers shall reduce by equal amounts from the compensation paid to the Co-Placement Agents. The term of the Co-Placement Agents&rsquo;
exclusive engagement will be thirty (30) days from the date hereof (the &ldquo;<U>Exclusive Term</U>&rdquo;). The Co-Placement
Agents shall be entitled to collect all fees earned through termination. The Company also agrees to reimburse the out of pocket
and legal expenses of the Co-Placement Agents in an amount&nbsp;up to $75,000; out of pocket and legal expenses exceeding $75,000
shall require prior approval by the Company, such approval not to be unreasonably withheld. Such reimbursement shall be payable
immediately upon (but only in the event of) a Closing of the Offering. Roth shall also be entitled to a &ldquo;tail fee&rdquo;
of 7% on any investment made by a purchaser in the Offering if such purchaser purchases additional securities from the Company
within three (3) months of the Closing Date.</FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 73 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Registration
Statement and Final Prospectus</I></B>. The Company has prepared and filed with the Securities and Exchange Commission (the &ldquo;<U>Commission</U>&rdquo;)
a registration statement on Form S-3 (File No. 333-210974) under the Securities Act of 1933 (the &ldquo;<U>Securities Act</U>&rdquo;)
and the rules and regulations (the &ldquo;<U>Rules and Regulations</U>&rdquo;) of the Commission thereunder, and such amendments
to such registration statement (including post effective amendments) as may have been required to the date of this Agreement. Such
registration statement, as amended (including any post effective amendments), has been declared effective by the Commission. Such
registration statement, as amended (including post effective amendments thereto), the exhibits and any schedules thereto and the
documents and information otherwise deemed to be a part thereof or included therein by the Securities Act or otherwise pursuant
to the Rules and Regulations, is herein called the &ldquo;<U>Registration Statement</U>.&rdquo; If the Company has filed or files
an abbreviated registration statement pursuant to Rule 462(b) under the Securities Act (the &ldquo;<U>Rule 462 Registration Statement</U>&rdquo;),
then any reference herein to the term Registration Statement shall include such Rule 462 Registration Statement. The Company will
file with the Commission pursuant to Rule 424 under the Securities Act a prospectus supplement relating to the Securities to the
form of prospectus included in the Registration Statement. Such prospectus in the form in which it appears in the Registration
Statement is hereinafter called the &ldquo;<U>Base Prospectus</U>,&rdquo; and the final prospectus supplement as filed, along with
the Base Prospectus, is hereinafter called the &ldquo;<U>Final Prospectus</U>.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For purposes of this
Agreement, all references to the Registration Statement, the Rule 462 Registration Statement, the Base Prospectus, the Final Prospectus,
or any amendment or supplement to any of the foregoing shall be deemed to include the copy filed with the Commission pursuant to
its Interactive Data Electronic Applications system. All references in this Agreement to amendments or supplements to the Registration
Statement, the Rule 462 Registration Statement, the Base Prospectus, or the Final Prospectus shall be deemed to mean and include
the subsequent filing of any document under the Securities Exchange Act of 1934, as amended (the &ldquo;<U>Exchange Act</U>&rdquo;),
that is deemed to be incorporated therein by reference therein or otherwise deemed by the Rules and Regulations to be a part thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Representations
and Warranties Regarding the Offering.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company represents and warrants to, and agrees with, the Co-Placement Agents, as of the date hereof and as of the Closing Date,
except as otherwise indicated, as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;At
each time of effectiveness, at the date hereof and at the Closing Date, the Registration Statement and any post-effective amendment
thereto, complied or will comply in all material respects with the requirements of the Securities Act and the Rules and Regulations
and did not and will not contain any untrue statement of a material fact or omit to state a material fact required to be stated
therein or necessary to make the statements therein not misleading. The Time of Sale Disclosure Package (as defined below) as of
the date hereof and at the Closing Date, and the Final Prospectus, as amended or supplemented, at the time of filing pursuant to
Rule 424(b) under the Securities Act and at the Closing Date, did not and will not contain any untrue statement of a material fact
or omit to state a material fact required to be stated therein or necessary to make the statements therein, in the light of the
circumstances under which they were made, not misleading. The representations and warranties set forth in the two immediately preceding
sentences shall not apply to statements in or omissions from the Registration Statement or any post-effective amendment thereto
or the Final Prospectus in reliance upon, and in conformity with, written information furnished to the Company by the Co-Placement
Agents specifically for use in the preparation thereof. The Registration Statement contains all exhibits and schedules required
to be filed by the Securities Act or the Rules and Regulations. No order preventing or suspending the effectiveness or use of the
Registration Statement or the Final Prospectus is in effect and no proceedings for such purpose have been instituted or are pending,
or, to the Knowledge of the Company, are contemplated or threatened by the Commission. The term &ldquo;Knowledge&rdquo; as used
in this Agreement shall mean actual knowledge of the Company&rsquo;s officers after due and reasonable inquiry.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;&nbsp;</P>


<!-- Field: Page; Sequence: 74; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
documents incorporated by reference in the Registration Statement, the Time of Sale Disclosure Package and the Final Prospectus,
when they became effective or were filed with the Commission, as the case may be, conformed in all material respects to the requirements
of the Securities Act or the Exchange Act, as applicable, were filed on a timely basis with the Commission and none of such documents,
when they were filed (or, if amendments to such documents were filed, when such amendments were filed), contained an untrue statement
of a material fact or omitted to state a material fact necessary to make the statements therein, in the light of the circumstances
under which they were made, not misleading. Any further documents so filed and incorporated by reference in the Registration Statement,
the Time of Sale Disclosure Package or the Final Prospectus, when such documents are filed with the Commission, will conform in
all material respects to the requirements of the Exchange Act, and will not contain an untrue statement of a material fact or omit
to state a material fact necessary to make the statements therein, in the light of the circumstances under which they were made,
not misleading. As used in this paragraph and elsewhere in this Agreement, &ldquo;<U>Time of Sale Disclosure Package</U>&rdquo;
means the Base Prospectus, the Final Prospectus most recently filed with the Commission before the time of this Agreement, any
subscription agreement between the Company and the Investors, and any issuer free writing prospectus as defined in Rule 433 of
the Act (each, an &ldquo;<U>Issuer Free Writing Prospectus</U>&rdquo;), if any, that the parties hereto shall hereafter expressly
agree in writing to treat as part of the Disclosure Package.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
financial statements of the Company, together with the related notes, included or incorporated by reference in the Registration
Statement, the Time of Sale Disclosure Package and the Final Prospectus comply in all material respects with the requirements of
the Securities Act and the Exchange Act and fairly present the financial condition of the Company as of the dates indicated and
the results of operations and changes in cash flows for the periods therein specified in conformity with generally accepted accounting
principles consistently applied throughout the periods involved; and the supporting schedules included in the Registration Statement
present fairly the information required to be stated therein. No other financial statements or schedules are required to be included
in the Registration Statement, the Time of Sale Disclosure Package or the Final Prospectus. To the Company&rsquo;s Knowledge, Ernst
&amp; Young LLP is an independent public accounting firms with respect to the Company within the meaning of the Securities Act
and the Rules and Regulations. The interactive data in eXtensible Business Reporting Language included or incorporated by reference
in the Registration Statement, the Time of Sale Disclosure Package and the Final Prospectus fairly presents the information called
for in all material respects and has been prepared in accordance with the Commission&rsquo;s rules and guidelines applicable thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;&nbsp;</P>


<!-- Field: Page; Sequence: 75; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company had a reasonable basis for, and made in good faith, each &ldquo;forward-looking statement&rdquo; (within the meaning of
Section 27A of the Act or Section 21E of the Exchange Act) contained or incorporated by reference in the Registration Statement,
the Time of Sale Disclosure Package or the Final Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(v)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All
statistical or market-related data included or incorporated by reference in the Registration Statement, the Time of Sale Disclosure
Package or the Final Prospectus are based on or derived from sources that the Company reasonably believes to be reliable and accurate,
and the Company has obtained the written consent to the use of such data from such sources, to the extent required.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(vi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;There
is no action pending to delist the Common Stock from NYSE MKT (&ldquo;<U>NYSE</U>&rdquo;), nor has the Company received any notification
that NYSE is currently contemplating terminating such listing. When issued, the Shares and shares underlying the Warrants will
be listed on NYSE.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(vii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Securities have been or will be qualified for sale under the securities laws of such jurisdictions (United States and foreign)
as the Co-Placement Agents determine, or are or will be exempt from the qualification and broker-dealer requirements of such jurisdictions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(viii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company has not taken, directly or indirectly, any action that is designed to or that has constituted or that would reasonably
be expected to cause or result in the stabilization or manipulation of the price of any security of the Company to facilitate the
sale or resale of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(ix)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company is not an &ldquo;<U>ineligible issuer</U>,&rdquo; as defined in Rule 405 of the Securities Act. Subject to Section 6(d)
below, the Company represents and warrants that it has not prepared or had prepared on its behalf or used or referred to any Issuer
Free Writing Prospectus in connection with the Offering. Subject to Section 6(d) below, the Company has not distributed and the
Company will not distribute, prior to the completion of the distribution of the Securities, any offering material in connection
with the Offering other than subscription agreements between the Company and the Investors and the Base Prospectus, the Final Prospectus,
the Registration Statement, and copies of the documents, if any, incorporated by reference therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(x)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company is not and, after giving effect to the offering and sale of the Securities, will not be an &ldquo;investment company,&rdquo;
as such term is defined in the Investment Company Act of 1940, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(xi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
issuance and sale of the Securities hereunder does not contravene the rules and regulations of the Trading Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any
certificate signed by any officer of the Company and delivered to the Co-Placement Agents or to the Co-Placement Agents&rsquo;
counsel shall be deemed a representation and warranty by the Company to the Co-Placement Agents as to the matters covered thereby.</FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 76; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Representations
and Warranties Regarding the Company. </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company represents and warrants to and agrees with, the Co-Placement Agents, except as set forth in the Registration Statement,
the Time of Sale Disclosure Package and the Final Prospectus, as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company and each of its subsidiaries has been duly organized and is validly existing as a corporation or other entity in good standing
under the laws of its jurisdiction of incorporation or organization. The Company and each of its subsidiaries has the corporate
power and authority to own its properties and conduct its business as currently being carried on and as described in the Registration
Statement, the Time of Sale Disclosure Package and the Final Prospectus, and is duly qualified to do business as a foreign corporation
in good standing in each jurisdiction in which it owns or leases real property or in which the conduct of its business makes such
qualification necessary and in which the failure to so qualify would have or is reasonably likely to result in a material adverse
effect upon the business, properties, operations, condition (financial or otherwise) or results of operations of the Company and
its subsidiaries, taken as a whole, or in its ability to perform its obligations under this Agreement (&ldquo;<U>Material Adverse
Effect</U>&rdquo;); provided that none of the following alone shall be deemed, in and of itself, to constitute a Material Adverse
Effect: (x) a change in the market price or trading volume of the Company&rsquo;s common stock or (y) changes in general economic
conditions or changes affecting the industry in which the Company operates generally (as opposed to Company-specific changes) so
long as such changes do not have a materially disproportionate effect on the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company has the power and authority to enter into this Agreement. This Agreement has been duly authorized, executed and delivered
by the Company, and constitutes a valid, legal and binding obligation of the Company, enforceable in accordance with its terms,
except as rights to indemnity hereunder may be limited by federal or state securities laws and except as such enforceability may
be limited by bankruptcy, insolvency, reorganization or similar laws affecting the rights of creditors generally and subject to
general principles of equity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
execution, delivery and performance of this Agreement and the consummation of the transactions herein contemplated will not (A)
result in a breach or violation of any of the terms and provisions of, or constitute a default under, any law, rule or regulation
to which the Company or any subsidiary is subject, or by which any property or asset of the Company or any subsidiary is bound
or affected, (B) conflict with, result in any violation or breach of, or constitute a default (or an event that with notice or
lapse of time or both would become a default) under, or give to others any right of termination, amendment, acceleration or cancellation
(with or without notice, lapse of time or both) of, any agreement, lease, credit facility, debt, note, bond, mortgage, indenture
or other instrument (the &ldquo;<U>Contracts</U>&rdquo;) or obligation or other understanding to which the Company or any subsidiary
is a party of by which any property or asset of the Company or any subsidiary is bound or affected, or (C) result in a breach or
violation of any of the terms and provisions of, or constitute a default under, the Company&rsquo;s charter or bylaws, except in
the case of each of clauses (i) and (ii), such as would not have or reasonably be expected to result in a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All
consents, approvals, orders, authorizations and filings required on the part of the Company and its subsidiaries in connection
with the execution, delivery or performance of this Agreement have been obtained or made, other than such consents, approvals,
orders and authorizations the failure of which to make or obtain is not reasonably likely to result in a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 77; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(v)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All
of the issued and outstanding shares of capital stock of the Company are duly authorized and validly issued, fully paid and nonassessable,
and have been issued in compliance with all applicable securities laws, and conform to the description thereof in the Registration
Statement, the Time of Sale Disclosure Package and the Final Prospectus. Except for the issuances of options, restricted stock
units or restricted stock in the ordinary course of business, since the respective dates as of which information is provided in
the Registration Statement, the Time of Sale Disclosure Package or the Final Prospectus or otherwise as disclosed therein, the
Company has not entered into or granted any convertible or exchangeable securities, options, warrants, agreements, contracts or
other rights in existence to purchase or acquire from the Company any shares of the capital stock of the Company. The Securities,
when issued, will be duly authorized and validly issued, and the Shares, when issued, will be fully paid and nonassessable, issued
in compliance with all applicable securities laws, and free of preemptive, registration or similar rights. The shares of Common
Stock underlying the Warrants, when issued, will be duly authorized and validly issued, fully paid and nonassessable, issued in
compliance with all applicable securities laws, and free of preemptive, registration or similar rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(vi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except
as described in the Registration Statement, the Time of Sale Disclosure Package and the Final Prospectus, the Company does not
own, directly or indirectly, any capital stock or other ownership interest in any partnership, corporation, business trust, limited
liability company, limited liability partnership, joint stock company, trust, unincorporated association, joint venture or other
entity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(vii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except
for matters that would not, individually or in the aggregate, have or reasonably be expected to result in a Material Adverse Effect,
(a) each of the Company and its subsidiaries has filed all foreign, federal, state and local returns (as hereinafter defined) required
to be filed with taxing authorities prior to the date hereof or has duly obtained extensions of time for the filing thereof, (b)
each of the Company and its subsidiaries has paid all taxes (as hereinafter defined) shown as due on such returns that were filed
and has paid all taxes imposed on or assessed against the Company or such respective subsidiary, and (c) the provisions for taxes
payable, if any, shown on the financial statements filed with or as part of the Registration Statement are sufficient for all accrued
and unpaid taxes, whether or not disputed, and for all periods to and including the dates of such consolidated financial statements.
Except as disclosed in writing to the Co-Placement Agents, (i) no issues have been raised (and are currently pending) by any taxing
authority in connection with any of the returns or taxes asserted as due from the Company or its subsidiaries, and (ii) no waivers
of statutes of limitation with respect to the returns or collection of taxes have been given by or requested from the Company or
its subsidiaries. The term &ldquo;<U>taxes</U>&rdquo; mean all federal, state, local, foreign, and other net income, gross income,
gross receipts, sales, use, ad valorem, transfer, franchise, profits, license, lease, service, service use, withholding, payroll,
employment, excise, severance, stamp, occupation, premium, property, windfall profits, customs, duties or other taxes, fees, assessments,
or charges of any kind whatever, together with any interest and any penalties, additions to tax, or additional amounts with respect
thereto. The term &ldquo;<U>returns</U>&rdquo; means all returns, declarations, reports, statements, and other documents required
to be filed in respect to taxes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;&nbsp;</P>


<!-- Field: Page; Sequence: 78; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(viii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Since
the respective dates as of which information is given in the Registration Statement, the Time of Sale Disclosure Package or the
Final Prospectus or otherwise disclosure therein, (a) neither the Company nor any of its subsidiaries has incurred any material
liabilities or obligations, direct or contingent, or entered into any material transactions other than in the ordinary course of
business, (b) the Company has not declared or paid any dividends or made any distribution of any kind with respect to its capital
stock; (c) there has not been any change in the capital stock of the Company or any of its subsidiaries (other than a change in
the number of outstanding shares of Common Stock due to the issuance of shares upon the exercise of outstanding options or warrants
or the issuance of restricted stock awards or restricted stock units under the Company&rsquo;s existing stock awards plan, or any
new grants thereof in the ordinary course of business), (d) there has not been any material change in the Company&rsquo;s long-term
or short-term debt, and (e) there has not been the occurrence of any Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(ix)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;There
is not pending or, to the Knowledge of the Company, threatened, any action, suit or proceeding to which the Company or any of its
subsidiaries is a party or of which any property or assets of the Company is the subject before or by any court or governmental
agency, authority or body, or any arbitrator or mediator, which is reasonably likely to result in a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(x)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company and each of its subsidiaries holds, and is in compliance with, all franchises, grants, authorizations, licenses, permits,
easements, consents, certificates and orders (&ldquo;<U>Permits</U>&rdquo;) of any governmental or self-regulatory agency, authority
or body required for the conduct of its business, and all such Permits are in full force and effect, in each case except where
the failure to hold, or comply with, any of them is not reasonably likely to result in a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(xi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company and its subsidiaries have good and valid title to all property (whether real or personal) described in the Registration
Statement, the Time of Sale Disclosure Package and the Final Prospectus as being owned by them that are material to the business
of the Company, in each case free and clear of all liens, claims, security interests, other encumbrances or defects, except those
that are not reasonably likely to result in a Material Adverse Effect. The property held under lease by the Company and its subsidiaries
is held by them under valid, subsisting and enforceable leases with only such exceptions with respect to any particular lease as
do not interfere in any material respect with the conduct of the business of the Company or its subsidiaries or which would not
reasonably be expected to have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(xii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company and each of its subsidiaries owns or possesses or has valid right to use all patents, patent applications, trademarks,
service marks, trade names, trademark registrations, service mark registrations, copyrights, licenses, inventions, trade secrets
and similar rights (&ldquo;<U>Intellectual Property</U>&rdquo;) necessary for the conduct of the business of the Company and its
subsidiaries as currently carried on and as described in the Registration Statement, the Time of Sale Disclosure Package and the
Final Prospectus. To the Knowledge of the Company, no action or use by the Company or any of its subsidiaries will involve or give
rise to any infringement of, or license or similar fees for, any Intellectual Property of others, except where such action, use,
license or fee is not reasonably likely to result in a Material Adverse Effect. Neither the Company nor any of its subsidiaries
has received any notice alleging any such infringement or fee where such infringement or fee would reasonably be expected to result
in a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 79; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(xiii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company and each of its subsidiaries has complied with, is not in violation of, and has not received any notice of violation relating
to any law, rule or regulation relating to the conduct of its business, or the ownership or operation of its property and assets,
including, without limitation, (A) the Currency and Foreign Transactions Reporting Act of 1970, as amended, or any money laundering
laws, rules or regulations, (B) any laws, rules or regulations related to health, safety or the environment, including those relating
to the regulation of hazardous substances, (C) the Sarbanes-Oxley Act and the rules and regulations of the Commission thereunder,
(D) the Foreign Corrupt Practices Act of 1977 and the rules and regulations thereunder, and (E) the Employment Retirement Income
Security Act of 1974 and the rules and regulations thereunder, in each case except where the failure to be in compliance is not
reasonably likely to result in a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(xiv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Neither
the Company nor any of its subsidiaries nor, to the Knowledge of the Company, any director, officer, employee, representative,
agent or affiliate of the Company or any of its subsidiaries is currently subject to any U.S. sanctions administered by the Office
of Foreign Assets Control of the U.S. Treasury Department (&ldquo;<U>OFAC</U>&rdquo;); and the Company will not directly or indirectly
use the proceeds of the Offering of the Securities contemplated hereby, or lend, contribute or otherwise make available such proceeds
to any person or entity, for the purpose of financing the activities of any person currently subject to any U.S. sanctions administered
by OFAC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(xv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company and each of its subsidiaries carries, or is covered by, insurance in such amounts and covering such risks as is adequate
for the conduct of its business and the value of its properties and as is customary for companies engaged in similar businesses
in similar industries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(xvi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No
labor dispute with the employees of the Company or any of its subsidiaries exists or, to the Knowledge of the Company, is imminent
that is reasonably likely to result in a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(xvii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Neither
the Company nor any of its subsidiaries is in violation, breach or default under its certificate of incorporation, bylaws or other
equivalent organizational or governing documents, except where the violation is not reasonably likely to result in a Material Adverse
Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(xviii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Neither
the Company, its subsidiaries nor, to its Knowledge, any other party&nbsp;is in violation, breach or default of any Contract that
is reasonably likely to result in a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(xix)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
No supplier, customer,&nbsp;distributor or sales agent of the Company has&nbsp;notified the Company&nbsp;that it intends to&nbsp;discontinue
or&nbsp;decrease the rate of business done&nbsp;with&nbsp;the Company, except where such decrease is not reasonably likely to result
in a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(xx)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;There
are no claims, payments, issuances, arrangements or understandings for services in the nature of a finder&rsquo;s, consulting or
origination fee with respect to the introduction of the Company to the Co-Placement Agents or the sale of the Securities hereunder
or any other arrangements, agreements, understandings, payments or issuances with respect to the Company that may affect the Co-Placement
Agents&rsquo; compensation, as determined by FINRA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 80; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(xxi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except
as disclosed to the Co-Placement Agents in writing, the Company has not made any direct or indirect payments (in cash, securities
or otherwise) to (i) any person, as a finder&rsquo;s fee, investing fee or otherwise, in consideration of such person raising capital
for the Company or introducing to the Company persons who provided capital to the Company, (ii) any FINRA member, or (iii) any
person or entity that has any direct or indirect affiliation or association with any FINRA member within the 12-month period prior
to the date on which the Registration Statement was filed with the Commission (&ldquo;<U>Filing Date</U>&rdquo;) or thereafter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(xxii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To
the Company&rsquo;s Knowledge, no (i) officer or director of the Company or its subsidiaries, (ii) owner of 5% or more of the Company&rsquo;s
unregistered securities or that of its subsidiaries or (iii) owner of any amount of the Company&rsquo;s unregistered securities
acquired within the 180-day period prior to the Filing Date, has any direct or indirect affiliation or association with any FINRA
member. The Company will advise the Co-Placement Agents and their respective counsel if it becomes aware that any officer, director
or stockholder of the Company or its subsidiaries is or becomes an affiliate or associated person of a FINRA member participating
in the Offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(xxiii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other
than the Co-Placement Agents, no person has the right to act as a placement agent, underwriter or as a financial advisor in connection
with the sale of the Securities contemplated hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Closing
and Settlement</I>. </B>Subject to the terms and conditions hereof, payment of the purchase price for, and delivery of, the Securities
shall be made at one or more closings (each a &ldquo;<U>Closing</U>&rdquo; and the date on which each Closing occurs, a &ldquo;<U>Closing
Date</U>&rdquo;) at the offices of the Roth Capital Partners, LLC (or at such other place as shall be agreed upon by the Co-Placement
Agents and the Company), the first such Closing to take place at 4:00 p.m., Eastern Standard time, on June 3, 2016 (unless another
time shall be agreed to by and among the Co-Placement Agents and the Company). Payment of the purchase price at each Closing shall
be made by the Investors directly to the Company by Federal Funds wire transfer, against delivery of such Shares (through the DWAC
facilities of the Depository Trust Company) and Warrants, and such Securities shall be registered in such name or names and shall
be in such denominations, as the Co-Placement Agents may request and as set forth in the applicable subscription agreement executed
by each Investor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Covenants.
</I></B>The Company covenants and agrees with the Co-Placement Agents as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;During
the period beginning on the date hereof and ending on the later of the Closing Date or such date as determined by the Co-Placement
Agents, the Final Prospectus is no longer required by law to be delivered in connection with sales by an underwriter or dealer
(the &ldquo;<U>Prospectus Delivery Period</U>&rdquo;), prior to amending or supplementing the Registration Statement, including
any Rule 462 Registration Statement, the Time of Sale Disclosure Package or the Final Prospectus, the Company shall furnish to
the Co-Placement Agents for review and comment a copy of each such proposed amendment or supplement, and the Company shall not
file any such proposed amendment or supplement to which the Co-Placement Agents reasonably object.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 81; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;From
the date of this Agreement until the end of the Prospectus Delivery Period, the Company shall promptly advise the Co-Placement
Agents in writing (A) of the receipt of any comments of, or requests for additional or supplemental information from, the Commission,
(B) of the time and date of any filing of any post-effective amendment to the Registration Statement or any amendment or supplement
to the Time of Sale Disclosure Package or the Final Prospectus, (C) of the time and date that any post-effective amendment to the
Registration Statement becomes effective and (D) of the issuance by the Commission of any stop order suspending the effectiveness
of the Registration Statement or of any order preventing or suspending its use or the use of the Time of Sale Disclosure Package,
or of any proceedings to remove, suspend or terminate from listing or quotation the Common Stock from any securities exchange upon
which it is listed for trading or included or designated for quotation, or of the threatening or initiation of any proceedings
for any of such purposes. If the Commission shall enter any such stop order at any time during the Prospectus Delivery Period,
the Company will use its reasonable efforts to obtain the lifting of such order at the earliest possible moment. Additionally,
the Company agrees that it shall comply with the provisions of Rules 424(b), 430A and 430B, as applicable, under the Securities
Act and will use its reasonable efforts to confirm that any filings made by the Company under Rule 424(b) or Rule 433 were received
in a timely manner by the Commission (without reliance on Rule 424(b)(8) or Rule 164(b) of the Securities Act).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;During
the Prospectus Delivery Period, the Company will comply with all requirements imposed upon it by the Securities Act, as now and
hereafter amended, and by the Rules and Regulations, as from time to time in force, and by the Exchange Act, as now and hereafter
amended, so far as necessary to permit the continuance of sales of or dealings in the Securities as contemplated by the provisions
hereof, the Registration Statement, the Time of Sale Disclosure Package and the Final Prospectus. If during such period any event
occurs the result of which the Final Prospectus would include an untrue statement of a material fact or omit to state a material
fact necessary to make the statements therein, in the light of the circumstances then existing, not misleading, or if during such
period it is necessary or appropriate in the opinion of the Company or its counsel or the Co-Placement Agents or their respective
counsel to amend the Registration Statement or supplement the Final Prospectus to comply with the Securities Act, the Company will
promptly notify the Co-Placement Agents and will amend the Registration Statement or supplement the Final Prospectus so as to correct
such statement or omission or effect such compliance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company covenants that it will not, unless it obtains the prior written consent of the Co-Placement Agents, make any offer relating
to the Securities that would constitute an Issuer Free Writing Prospectus or that would otherwise constitute a &ldquo;<U>free writing
prospectus</U>&rdquo; (as defined in Rule 405 of the Act) required to be filed by the Company with the Commission or retained by
the Company under Rule 433 of the Act. In the event that the Co-Placement Agents expressly consent in writing to any such free
writing prospectus (a &ldquo;<U>Permitted Free Writing Prospectus</U>&rdquo;), the Company covenants that it shall (i) treat each
Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, and (ii) comply with the requirements of Rule 164 and 433
of the Act applicable to such Permitted Free Writing Prospectus, including in respect of timely filing with the Commission, legending
and record keeping.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company will furnish to the Co-Placement Agents and counsel for the Co-Placement Agents copies of the Registration Statement, the
Final Prospectus and all amendments and supplements to such documents, in each case as soon as available and in such quantities
as the Co-Placement Agents may from time to time reasonably request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 82; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company will make generally available to its security holders as soon as practicable, but in any event not later than 15 months
after the end of the Company&rsquo;s current fiscal quarter, an earnings statement (which need not be audited) covering a 12-month
period that shall satisfy the provisions of Section 11(a) of the Securities Act and Rule 158 of the Rules and Regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company will not take, directly or indirectly, during the Prospectus Delivery Period, any action designed to or which might reasonably
be expected to cause or result in, or that has constituted, the stabilization or manipulation of the price of any security of the
Company to facilitate the sale or resale of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company, whether or not the transactions contemplated hereunder are consummated or this Agreement is terminated, will pay or cause
to be paid (A) all expenses (including transfer taxes allocated to the respective transferees) incurred in connection with the
delivery of the Securities, (B) all expenses and fees (including, without limitation, fees and expenses of the Company&rsquo;s
counsel) in connection with the preparation, printing, filing, delivery, and shipping of the Registration Statement (including
the financial statements therein and all amendments, schedules, and exhibits thereto), the Securities, the Time of Sale Disclosure
Package, the Final Prospectus, any Issuer Free Writing Prospectus and any amendment thereof or supplement thereto, (C) all reasonable
filing fees and reasonable fees and disbursements of the Co-Placement Agents&rsquo; counsel incurred in connection with the qualification
of the Securities for offering and sale by the Co-Placement Agents or by dealers under the securities or blue sky laws of the states
and other jurisdictions that the Co-Placement Agents shall designate, (D) the fees and expenses of any transfer agent or registrar,
(E)</FONT> <FONT STYLE="font-size: 10pt">the reasonable filing fees and reasonable fees and disbursements of the Co-Placement Agents&rsquo;
counsel incident to any required review and approval by FINRA, of the terms of the sale of the Securities, (F) listing fees, if
any, and (F) all other costs and expenses incident to the performance of its obligations hereunder that are not otherwise specifically
provided for herein. In addition to the foregoing, the Company will reimburse the Co-Placement Agents for their reasonable, documented
out-of-pocket legal fees, costs and other expenses incurred in connection with the purchase and sale of the Securities contemplated
hereby, provided that such out-of-pocket legal fees, costs and other expenses shall not exceed $75,000 in the aggregate (including
amounts payable pursuant to clauses (C) and (E) above) without prior written approval from the Company, such approval not to be
unreasonably withheld.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company will not issue or sell any Common Stock or other equity or equity-linked securities (other than under existing stock option
plans or warrants to purchase securities of the Company) during the 45 calendar day period following the date hereof at less than
the Offering Price or equivalent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Conditions
to the Co-Placement Agents&rsquo; Obligations.</I></B> The obligations of the Co-Placement Agents hereunder are subject to the
accuracy, as of the date hereof and at the applicable Closing Date (as if made at the Closing Date), of and compliance with all
representations, warranties and agreements of the Company contained herein, the performance by the Company of its obligations hereunder
and the following additional conditions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
filing of the Final Prospectus, or any amendment or supplement thereto, is required under the Securities Act or the Rules and Regulations,
the Company shall have filed the Final Prospectus (or such amendment or supplement) with the Commission in the manner and within
the time period so required (without reliance on Rule 424(b)(8) or Rule 164(b) under the Securities Act); the Registration Statement
shall remain effective; no stop order suspending the effectiveness of the Registration Statement or any part thereof, any Rule
462 Registration Statement, or any amendment thereof, nor suspending or preventing the use of the Time of Sale Disclosure Package
or the Final Prospectus shall have been issued; no proceedings for the issuance of such an order shall have been initiated or threatened;
any request of the Commission for additional information (to be included in the Registration Statement, the Time of Sale Disclosure
Package, the Final Prospectus, or otherwise) shall have been complied with to the Co-Placement Agents&rsquo; satisfaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 83; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Co-Placement Agents shall not have reasonably determined and advised the Company that the Registration Statement, the Time of Sale
Disclosure Package or the Final Prospectus, or any amendment thereof or supplement thereto, contains an untrue statement of fact
which, in the Co-Placement Agents&rsquo; reasonable opinion, is material, or omits to state a fact which, in the Co-Placement Agents&rsquo;
reasonable opinion, is material and is required to be stated therein or necessary to make the statements therein not misleading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Co-Placement Agents shall have received a letter from Ernst &amp; Young LLP, on the Closing Date addressed to the Co-Placement
Agents, confirming that they are independent public accountants within the meaning of the Securities Act and are in compliance
with the applicable requirements relating to the qualifications of accountants under Rule 2-01 of Regulation S-X of the Commission,
and confirming, as of the date of such letter (or, with respect to matters involving changes or developments since the respective
dates as of which specified financial information is given in the Time of Sale Disclosure Package, as of a date not more than five
days prior to the date of such letter), the conclusions and findings of said firms with respect to the financial information, including
any financial information contained in Exchange Act Reports filed by the Company, and other matters required by the Co-Placement
Agents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On
the applicable Closing Date, there shall have been furnished to the Co-Placement Agents a certificate, dated the applicable Closing
Date and addressed to the Co-Placement Agents, signed by the chief executive officer and the chief financial officer of the Company,
in their capacity as officers of the Company, to the effect that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
representations and warranties of the Company in this Agreement are true and correct, in all material respects, as if made at and
as of the applicable Closing Date, and the Company has complied with all the agreements and satisfied all the conditions on its
part to be performed or satisfied at or prior to the applicable Closing Date;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Disclosure Package does not contain any material misrepresentation or omit to state any material information;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No
stop order or other order (A) suspending the effectiveness of the Registration Statement or any part thereof or any amendment thereof,
(B) suspending the qualification of the Securities for offering or sale, or (C) suspending or preventing the use of the Time of
Sale Disclosure Package or the Final Prospectus has been issued, and no proceeding for that purpose has been instituted or, to
their Knowledge, is contemplated by the Commission or any state or regulatory body; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;There
has been no occurrence of any event resulting or reasonably likely to result in a Material Adverse Effect during the period from
and after the date of this Agreement and prior to the applicable Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 84; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Common Stock shall be registered under the Exchange Act and shall be listed on NYSE, and the Company shall not have taken any action
designed to terminate, or likely to have the effect of terminating,&nbsp;the registration of the Common Stock under the Exchange
Act or delisting or suspending from trading the Common Stock from NYSE, nor shall the Company have received any information suggesting
that the Commission is contemplating terminating such registration or listing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;FINRA
shall have raised no objection to the Co-Placement Agents&rsquo; compensation provided for hereby. The Company shall pay any filing
fees due FINRA in connection with such review.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company shall have furnished to the Co-Placement Agents and counsel for the Co-Placement Agents such additional documents, certificates
and evidence as the Co-Placement Agents or counsel for the Co-Placement Agents may have reasonably requested.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If any condition specified
in this Section 7 shall not have been fulfilled when and as required to be fulfilled, this Agreement may be terminated by the Co-Placement
Agents by notice to the Company at any time at or prior to the applicable Closing Date and such termination shall be without liability
of any party to any other party, except that Section 1(b), Section 6(h), Section 8 and Section 9 shall survive any such termination
and remain in full force and effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Indemnification
and Contribution</I></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company agrees to indemnify, defend and hold harmless the Co-Placement Agents, their affiliates, directors and officers and employees,
and each person, if any, who controls the Co-Placement Agents within the meaning of Section 15 of the Securities Act or Section
20 of the Exchange Act, from and against any losses, claims, damages or liabilities to which the Co-Placement Agents or such person
may become subject, under the Securities Act or otherwise (including in settlement of any litigation if such settlement is effected
with the written consent of the Company), insofar as such losses, claims, damages or liabilities (or actions in respect thereof)
arise out of or are based upon (i) an untrue statement or alleged untrue statement of a material fact contained in the Registration
Statement, including the information deemed to be a part of the Registration Statement at the time of effectiveness and at any
subsequent time pursuant to Rules 430A and 430B of the Rules and Regulations, the Time of Sale Disclosure Package, the Final Prospectus,
or any amendment or supplement thereto (including any documents filed under the Exchange Act and deemed to be incorporated by reference
into the Registration Statement or the Final Prospectus), or any Issuer Free Writing Prospectus or in any materials or information
provided to Investors by, or with the written approval of, the Company in connection with the marketing of the Offering of the
Securities, including any roadshow or investor presentations (whether in person or electronically) (&ldquo;<U>Marketing Materials</U>&rdquo;),
or arise out of or are based upon the omission or alleged omission to state therein a material fact required to be stated therein
or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading, (ii) in
whole or in part, any inaccuracy in the representations and warranties of the Company contained herein, or (iii) in whole or in
part, any failure of the Company to perform its obligations hereunder or under law, and will reimburse the Co-Placement Agents
for any legal or other expenses reasonably incurred by it in connection with evaluating, investigating or defending against such
loss, claim, damage, liability or action; <I>provided, however</I>, that the Company shall not be liable in any such case to the
extent that any such loss, claim, damage, liability or action arises out of or is based upon an untrue statement or alleged untrue
statement or omission or alleged omission made in the Registration Statement, the Time of Sale Disclosure Package, the Final Prospectus,
or any amendment or supplement thereto, any Issuer Free Writing Prospectus or any Marketing Materials, in reliance upon and in
conformity with written information furnished to the Company by the Co-Placement Agents specifically for use in the preparation
thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 85; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Co-Placement Agents will indemnify and hold harmless the Company, its affiliates, directors, officers and employees, and each person,
if any, who controls the Company within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act, from
and against any losses, claims, damages or liabilities to which the Company may become subject, under the Securities Act or otherwise
(including in settlement of any litigation, if such settlement is effected with the written consent of the Co-Placement Agents),
insofar as such losses, claims, damages or liabilities (or actions in respect thereof) arise out of or are based upon an untrue
statement or alleged untrue statement of a material fact contained in the Registration Statement, the Time of Sale Disclosure Package,
the Final Prospectus, or any amendment or supplement thereto, any Issuer Free Writing Prospectus or any Marketing Materials, or
arise out of or are based upon the omission or alleged omission to state therein a material fact required to be stated therein
or necessary to make the statements therein not misleading, in each case to the extent, but only to the extent, that such untrue
statement or alleged untrue statement or omission or alleged omission was made in the Registration Statement, the Time of Sale
Disclosure Package, the Final Prospectus, or any amendment or supplement thereto, any Issuer Free Writing Prospectus or any Marketing
Materials, in reliance upon and in conformity with written information furnished to the Company by the Co-Placement Agents specifically
for use in the preparation thereof, and will reimburse the Company for any legal or other expenses reasonably incurred by the Company
in connection with defending against any such loss, claim, damage, liability or action.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Promptly
after receipt by an indemnified party under subsection (a) or (b), above of notice of the commencement of any action, such indemnified
party shall, if a claim in respect thereof is to be made against the indemnifying party under such subsection, notify the indemnifying
party in writing of the commencement thereof; but the failure to notify the indemnifying party shall not relieve the indemnifying
party from any liability that it may have to any indemnified party except to the extent such indemnifying party has been materially
prejudiced by such failure. In case any such action shall be brought against any indemnified party, and it shall notify the indemnifying
party of the commencement thereof, the indemnifying party shall be entitled to participate in, and, to the extent that it shall
wish, jointly with any other indemnifying party similarly notified, to assume the defense thereof, with counsel satisfactory to
such indemnified party, and after notice from the indemnifying party to such indemnified party of the indemnifying party&rsquo;s
election so to assume the defense thereof, the indemnifying party shall not be liable to such indemnified party under such subsection
for any legal or other expenses subsequently incurred by such indemnified party in connection with the defense thereof other than
reasonable costs of investigation; <I>provided</I>, <I>however</I>, that if (i) the indemnified party has reasonably concluded
(based on advice of counsel) that there may be legal defenses available to it or other indemnified parties that are different from
or in addition to those available to the indemnifying party, (ii) a conflict or potential conflict exists (based on the reasonable
advice of counsel to the indemnified party) between the indemnified party and the indemnifying party (in which case the indemnifying
party will not have the right to direct the defense of such action on behalf of the indemnified party), or (iii) the indemnifying
party has not in fact employed counsel reasonably satisfactory to the indemnified party to assume the defense of such action within
a reasonable time after receiving notice of the commencement of the action, the indemnified party shall have the right to employ
a single counsel to represent it in any claim in respect of which indemnity may be sought under subsection (a) or (b) of this Section
8, in which event the reasonable and documented fees and expenses of such separate counsel shall be borne by the indemnifying party
or parties and reimbursed to the indemnified party as incurred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 86; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">The indemnifying party
under this Section 8 shall not be liable for any settlement of any proceeding effected without its written consent, but if settled
with such consent or if there be a final judgment for the plaintiff, the indemnifying party agrees to indemnify the indemnified
party against any loss, claim, damage, liability or expense by reason of such settlement or judgment. No indemnifying party shall,
without the prior written consent of the indemnified party, effect any settlement, compromise or consent to the entry of judgment
in any pending or threatened action, suit or proceeding in respect of which any indemnified party is a party or could be named
and indemnity was or would be sought hereunder by such indemnified party, unless such settlement, compromise or consent (a) includes
an unconditional release of such indemnified party from all liability for claims that are the subject matter of such action, suit
or proceeding and (b) does not include a statement as to or an admission of fault, culpability or a failure to act by or on behalf
of any indemnified party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
the indemnification provided for in this Section 8 is unavailable or insufficient to hold harmless an indemnified party under subsection
(a) or (b), above, then each indemnifying party shall contribute to the amount paid or payable by such indemnified party as a result
of the losses, claims, damages or liabilities referred to in subsection (a) or (b) above, (i) in such proportion as is appropriate
to reflect the relative benefits received by the Company, on the one hand, and the Co-Placement Agents, on the other hand, from
the Offering of the Securities or (ii) if the allocation provided by clause (i) above is not permitted by applicable law, in such
proportion as is appropriate to reflect not only the relative benefits referred to in clause (i) above but also the relative fault
of the Company, on the one hand, and the Co-Placement Agents, on the other hand, in connection with the statements or omissions
that resulted in such losses, claims, damages or liabilities, as well as any other relevant equitable considerations. The relative
benefits received by the Company, on the one hand, and the Co-Placement Agents, on the other hand, shall be deemed to be in the
same proportion as the total net proceeds from the Offering (before deducting expenses) received by the Company, and the total
placement agent fees received by the Co-Placement Agents, in each case as set forth on the cover page of the Final Prospectus,
bear to the aggregate offering price of the Securities set forth on such cover. The relative fault shall be determined by reference
to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to
state a material fact relates to information supplied by the Company or the Co-Placement Agents and the parties&rsquo; relevant
intent, knowledge, access to information and opportunity to correct or prevent such untrue statement or omission. The Company and
the Co-Placement Agents agree that it would not be just and equitable if contributions pursuant to this subsection (d) were to
be determined by pro rata allocation or by any other method of allocation that does not take account of the equitable considerations
referred to in the first sentence of this subsection (d). The amount paid by an indemnified party as a result of the losses, claims,
damages or liabilities referred to in the first sentence of this subsection (d) shall be deemed to include any legal or other expenses
reasonably incurred by such indemnified party in connection with investigating or defending against any action or claim that is
the subject of this subsection (d). Notwithstanding the provisions of this subsection (d),the Co-Placement Agents shall not be
required to contribute any amount in excess of the amount of the Co-Placement Agents&rsquo; placement agent fees actually received
by the Co-Placement Agents from the Offering of the Securities. No person guilty of fraudulent misrepresentation (within the meaning
of Section 11(f) of the Securities Act) shall be entitled to contribution from any person who was not guilty of such fraudulent
misrepresentation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 87; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
obligations of the Company under this Section 8 shall be in addition to any liability that the Company may otherwise have and the
benefits of such obligations shall extend, upon the same terms and conditions, to each person, if any, who controls the Co-Placement
Agents within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act; and the obligations of the Co-Placement
Agents under this Section 8 shall be in addition to any liability that the Co-Placement Agents may otherwise have and the benefits
of such obligations shall extend, upon the same terms and conditions, to the Company, and its officers, directors and each person
who controls the Company within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For
purposes of this Agreement, the Co-Placement Agents confirm, and the Company acknowledges, that there is no information concerning
the Co-Placement Agents furnished in writing to the Company by the Co-Placement Agents specifically for preparation of or inclusion
in the Registration Statement, the Time of Sale Disclosure Package or the Final Prospectus, other than the statements regarding
the Co-Placement Agents set forth in the &ldquo;Plan of Distribution&rdquo; section of the Final Prospectus and Time of Sale Disclosure
Package, only insofar as such statement relate to the amount of selling concession and related activities that may be undertaken
by the Co-Placement Agents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Representations
and Agreements to Survive Delivery</I></B>. All representations, warranties, and agreements of the Company herein or in certificates
delivered pursuant hereto including, but not limited to, the agreements of the Co-Placement Agents and the Company contained in
Section 1(b), Section 6(h) and Section 8 hereof, shall remain operative and in full force and effect regardless of any investigation
made by or on behalf of the Co-Placement Agents or any controlling person thereof, or the Company or any of its officers, directors,
or controlling persons, and shall survive delivery of, and payment for, the Securities to and by the Co-Placement Agents hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notices</I></B>.
Except as otherwise provided herein, all communications hereunder shall be in writing and, if to the Co-Placement Agents, shall
be mailed, delivered or telecopied to the Roth Capital Partners, LLC, 888 San Clemente, Newport Beach, CA, telecopy number: (949)
720-7227, Attention: Managing Director and if to the Company, shall be mailed, delivered or telecopied to it at 3579 Valley Centre
Drive, Suite 100, San Diego, California 92130, telecopy number: (858) 350-0300, Attention: Chief Executive Officer; or in each
case to such other address as the person to be notified may have requested in writing. Any party to this Agreement may change such
address for notices by sending to the parties to this Agreement written notice of a new address for such purpose.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>11.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Persons
Entitled to Benefit of Agreement</I></B>. This Agreement shall inure to the benefit of and be binding upon the parties hereto and
their respective successors and assigns and the controlling persons, officers and directors referred to in Section 8. Nothing in
this Agreement is intended or shall be construed to give to any other person, firm or corporation any legal or equitable remedy
or claim under or in respect of this Agreement or any provision herein contained. The term &ldquo;successors and assigns&rdquo;
as herein used shall not include any purchaser, as such purchaser, of any of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 88; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B><I>12.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Absence
of Fiduciary Relationship</I></B>. The Company acknowledges and agrees that: (a) the Co-Placement Agents have been retained solely
to act as placement agents in connection with the sale of the Securities and that no fiduciary, advisory or agency relationship
between the Company and the Co-Placement Agents has been created in respect of any of the transactions contemplated by this Agreement,
irrespective of whether the Co-Placement Agents has advised or is advising the Company on other matters; (b) the price and other
terms of the Securities set forth in this Agreement were established by the Co-Placement Agents and the Investors following discussions
and arms-length negotiations and the Company is capable of evaluating and understanding and understands and accepts the terms,
risks and conditions of the transactions contemplated by this Agreement; (c) it has been advised that the Co-Placement Agents and
their affiliates are engaged in a broad range of transactions that may involve interests that differ from those of the Company
and that the Co-Placement Agents do not have any obligation to disclose such interest and transactions to the Company by virtue
of any fiduciary, advisory or agency relationship; (d) it has been advised that the Co-Placement Agents are acting, in respect
of the transactions contemplated by this Agreement, solely for the benefit of the Co-Placement Agents, and not on behalf of the
Company.</FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>13.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No
Limitations</I></B>. Nothing in this Agreement shall be construed to limit the ability of the Co-Placement Agents or thier affiliates
to (a) trade in the Company&rsquo;s or any other company&rsquo;s securities or publish research on the Company or any other company,
subject to applicable law, or (b) pursue or engage in investment banking, financial advisory or other business relationships with
entities that may be engaged in or contemplate engaging in, or acquiring or disposing of, businesses that are similar to or competitive
with the business of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>14.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amendments
and Waivers</I></B>. No supplement, modification or waiver of this Agreement shall be binding unless executed in writing by the
party to be bound thereby. The failure of a party to exercise any right or remedy shall not be deemed or constitute a waiver of
such right or remedy in the future. No waiver of any of the provisions of this Agreement shall be deemed or shall constitute a
waiver of any other provision hereof (regardless of whether similar), nor shall any such waiver be deemed or constitute a continuing
waiver unless otherwise expressly provided.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>15.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Partial
Unenforceability</I></B><I>; <B>Engagement Agreement</B>. </I>The invalidity or unenforceability of any section, paragraph, clause
or provision of this Agreement shall not affect the validity or enforceability of any other section, paragraph, clause or provision.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>16.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Governing
Law</I></B>. This Agreement shall be governed by and construed in accordance with the laws of the State of New York.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>17.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Counterparts.</I></B>
This Agreement may be executed and delivered (including by facsimile transmission and electronic mail attaching a portable document
file (.pdf)) in one or more counterparts and, if executed and delivered in more than one counterpart, the executed counterparts
shall each be deemed to be an original and all such counterparts shall together constitute one and the same instrument.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">***********************</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 89; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Please sign and return
to the Company the enclosed duplicates of this letter whereupon this letter will become a binding agreement between the Company
and the Co-Placement Agents in accordance with its terms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Very truly yours,</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>AMPLIPHI BIOSCIENCES CORPORATION</B></P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 45%">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD NOWRAP STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">By: </FONT></TD>
    <TD NOWRAP STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ M. Scott Salka</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Name: &nbsp;M. Scott Salka</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Title: Chief Executive Officer</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 197.65pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Confirmed as of the date first above-</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">mentioned.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-variant: small-caps"><B>ROTH
CAPITAL PARTNERS, LLC</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="width: 7%"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="width: 43%; border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ Michael Margolis</FONT></TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
<TR>
    <TD><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt">Michael Margolis, Rh.P.</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR>
    <TD><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt">Managing Director</FONT></TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-variant: small-caps"><B>GRIFFIN
SECURITIES, INC. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="width: 7%"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="width: 43%; border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ Adrian Z. Stecyk</FONT></TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
<TR>
    <TD><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt">Adrian Z. Stecyk</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR>
    <TD><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt">Chairman and CEO</FONT></TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 90; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>Schedule I</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: right">Shares of Common<BR>
 Stock</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: right">Warrants to Purchase<BR> Common Stock</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; text-align: left">Roth Capital Partners, LLC</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 15%; text-align: right">1,489,362</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 15%; text-align: right">744,681</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Griffin Securities, Inc.</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">638,298</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">319,149</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold">Total</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">2,127,660</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">1,063,830</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 91 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 99.3</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-transform: uppercase; text-align: center; text-indent: -0.5in"><B>SECURITIES
PURCHASE AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Securities Purchase
Agreement (this &ldquo;<U>Agreement</U>&rdquo;) is dated as of May 31, 2016, between AmpliPhi Biosciences Corporation, a Washington
corporation (the &ldquo;<U>Company</U>&rdquo;), and each purchaser identified on the signature pages hereto (each, including its
successors and assigns, a &ldquo;<U>Purchaser</U>&rdquo; and collectively the &ldquo;<U>Purchasers</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, subject to
the terms and conditions set forth in this Agreement and pursuant to an effective registration statement under the Securities Act
of 1933, as amended (the &ldquo;<U>Securities Act</U>&rdquo;), the Company desires to issue and sell to each Purchaser, and each
Purchaser, severally and not jointly, desires to purchase from the Company, securities of the Company as more fully described in
this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NOW, THEREFORE, IN
CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt and
adequacy of which are hereby acknowledged, the Company and each Purchaser agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>ARTICLE I.</B><BR>
DEFINITIONS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Definitions</U>.
In addition to the terms defined elsewhere in this Agreement, for all purposes of this Agreement, the following terms have the
meanings set forth in this Section 1.1:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Acquiring
Person</U>&rdquo; shall have the meaning ascribed to such term in Section 4.5.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Action</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(j).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common
control with a Person as such terms are used in and construed under Rule 405 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Board
of Directors</U>&rdquo; means the board of directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Business
Day</U>&rdquo; means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States or
any day on which banking institutions in the State of New York are authorized or required by law or other governmental action to
close.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Closing</U>&rdquo;
means the closing of the purchase and sale of the Securities pursuant to Section 2.1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Closing
Date</U>&rdquo; means the Trading Day on which all of the Transaction Documents have been executed and delivered by the applicable
parties thereto, and all conditions precedent to (i) the Purchasers&rsquo; obligations to pay the Subscription Amount and (ii)
the Company&rsquo;s obligations to deliver the Securities, in each case, have been satisfied or waived, but in no event later than
the third Trading Day following the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 92 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common
Stock</U>&rdquo; means the common stock of the Company, par value $0.01 per share, and any other class of securities into which
such securities may hereafter be reclassified or changed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common
Stock Equivalents</U>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to
acquire at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument
that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common
Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Company
Counsel</U>&rdquo; means Cooley LLP.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Disclosure
Schedules</U>&rdquo; means the Disclosure Schedules of the Company delivered concurrently herewith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Evaluation
Date</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(s).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Exempt
Issuance</U>&rdquo; means the issuance of (a) shares of Common Stock or options to employees, officers or directors of the Company
pursuant to any stock or option plan duly adopted for such purpose, by a majority of the non-employee members of the Board of Directors
or a majority of the members of a committee of non-employee directors established for such purpose for services rendered to the
Company, (b) securities upon the exercise or exchange of or conversion of any Securities issued hereunder and/or other securities
exercisable or exchangeable for or convertible into shares of Common Stock issued and outstanding on the date of this Agreement,
provided that such securities have not been amended since the date of this Agreement to increase the number of such securities
or to decrease the exercise price, exchange price or conversion price of such securities (other than in connection with stock splits
or combinations) or to extend the term of such securities, and (c) securities issued pursuant to acquisitions or strategic transactions
approved by a majority of the disinterested directors of the Company, provided that any such issuance shall only be to a Person
(or to the equityholders of a Person) which is, itself or through its subsidiaries, an operating company or an owner of an asset
in a business synergistic with the business of the Company and shall provide to the Company additional benefits in addition to
the investment of funds, but shall not include a transaction in which the Company is issuing securities primarily for the purpose
of raising capital or to an entity whose primary business is investing in securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>FCPA</U>&rdquo;
means the Foreign Corrupt Practices Act of 1977, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>FDA</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(hh).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>FDCA</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(hh).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 93; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>GAAP</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(h).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Indebtedness</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(aa).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Intellectual
Property Rights</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(p).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Liens</U>&rdquo;
means a lien, charge, pledge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Lock-Up
Agreement</U>&rdquo; means the Lock-Up Agreement by and among the Roth Capital Partners, LLC and each of Phillips Capital and Pendinas
Limited, in the form reasonably acceptable to the Roth Capital Partners, LLC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Material
Adverse Effect</U>&rdquo; shall have the meaning assigned to such term in Section 3.1(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Material
Permits</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(n).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>ML</U>&rdquo;
means Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., with offices located at 666 Third Avenue, New York, New York 10017.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Per
Share Purchase Price</U>&rdquo; equals $2.35, subject to adjustment for reverse and forward stock splits, stock dividends, stock
combinations and other similar transactions of the Common Stock that occur after the date of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Pharmaceutical
Product</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(hh).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Placement
Agents</U>&rdquo; means Roth Capital Partners, LLC and Griffin Securities, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Proceeding</U>&rdquo;
means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial
proceeding, such as a deposition), whether commenced or threatened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Prospectus</U>&rdquo;
means the final prospectus filed for the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Prospectus
Supplement</U>&rdquo; means the supplement to the Prospectus complying with Rule 424(b) of the Securities Act that is filed with
the Commission and delivered by the Company to each Purchaser at the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Purchaser
Party</U>&rdquo; shall have the meaning ascribed to such term in Section 4.8.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 94; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Registration
Statement</U>&rdquo; means the effective registration statement with Commission file No. 333-210974 which registers the sale of
the Shares, the Warrants and the Warrant Shares to the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Required
Approvals</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(e).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Rule
144</U>&rdquo; means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted
from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose
and effect as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Rule
424</U>&rdquo; means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted
from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose
and effect as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>SEC
Reports</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(h).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Securities</U>&rdquo;
means the Shares, the Warrants and the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Shares</U>&rdquo;
means the shares of Common Stock issued or issuable to each Purchaser pursuant to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Short
Sales</U>&rdquo; means all &ldquo;short sales&rdquo; as defined in Rule 200 of Regulation SHO under the Exchange Act (but shall
not be deemed to include the location and/or reservation of borrowable shares of Common Stock).&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Subscription
Amount</U>&rdquo; means, as to each Purchaser, the aggregate amount to be paid for Shares and Warrants purchased hereunder as specified
below such Purchaser&rsquo;s name on the signature page of this Agreement and next to the heading &ldquo;Subscription Amount,&rdquo;
in United States dollars and in immediately available funds.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Subsidiary</U>&rdquo;
means any subsidiary of the Company and shall, where applicable, also include any direct or indirect subsidiary of the Company
formed or acquired after the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the principal Trading Market is open for trading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on
the date in question: the NYSE MKT, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New
York Stock Exchange, OTCQB or OTCQX (or any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 95; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Transaction
Documents</U>&rdquo; means this Agreement, the Warrants, the Lock-Up Agreements and any other documents or agreements executed
in connection with the transactions contemplated hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Transfer
Agent</U>&rdquo; means the current transfer agent of the Company and any successor transfer agent of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Variable
Rate Transaction</U>&rdquo; shall have the meaning ascribed to such term in Section 4.12(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Warrants</U>&rdquo;
means, collectively, the Common Stock purchase warrants delivered to the Purchasers at the Closing in accordance with Section 2.2(a)
hereof, which Warrants shall be exercisable immediately and have a term of exercise equal to five years, in the form of <U>Exhibit
A</U> attached hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Warrant
Shares</U>&rdquo; means the shares of Common Stock issuable upon exercise of the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>ARTICLE II.</B><BR>
PURCHASE AND SALE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Closing</U>.
On the Closing Date, upon the terms and subject to the conditions set forth herein, substantially concurrent with the execution
and delivery of this Agreement by the parties hereto, the Company agrees to sell, and the Purchasers, severally and not jointly,
agree to purchase, up to an aggregate of $5,000,000 of Shares and Warrants. Each Purchaser&rsquo;s Subscription Amount as set forth
on the signature page hereto executed by such Purchaser shall be made available for &ldquo;Delivery Versus Payment&rdquo; settlement
with the Company. The Company shall deliver to each Purchaser its respective Shares and a Warrant as determined pursuant to Section
2.2(a), and the Company and each Purchaser shall deliver the other items set forth in Section 2.2 deliverable at the Closing. Upon
satisfaction of the covenants and conditions set forth in Sections 2.2 and 2.3, the Closing shall occur at the offices of ML or
such other location as the parties shall mutually agree. Unless otherwise directed by the Placement Agents, settlement of the Shares
shall occur via &ldquo;Delivery Versus Payment&rdquo; (&ldquo;<U>DVP</U>&rdquo;)<I> </I>(i.e., on the Closing Date, the Company
shall issue the Shares registered in the Purchasers&rsquo; names and addresses and released by the Transfer Agent directly to the
account(s) at the Placement Agents identified by each Purchaser; upon receipt of such Shares, the Placement Agents shall promptly
electronically deliver such Shares to the applicable Purchaser, and payment therefor shall be made by the Placement Agents (or
their clearing firm) by wire transfer to the Company).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">2.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Deliveries</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On
or prior to the Closing Date, the Company shall deliver or cause to be delivered to each Purchaser the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;this
Agreement duly executed by the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a
legal opinion of Company Counsel, substantially in form and substance reasonably acceptable to the Purchasers;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 96; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;subject
to the last sentence of Section 2.1, a copy of the irrevocable instructions to the Transfer Agent instructing the Transfer Agent
to deliver on an expedited basis via The Depository Trust Company Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;)
Shares equal to such Purchaser&rsquo;s Subscription Amount divided by the Per Share Purchase Price, registered in the name of such
Purchaser;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a
Warrant registered in the name of such Purchaser to purchase up to a number of shares of Common Stock equal to 50% of such Purchaser&rsquo;s
Shares, with an exercise price equal to $2.25, subject to adjustment therein (such Warrant certificate may be delivered within
three Trading Days of the Closing Date);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(v)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
Lock-Up Agreements; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(vi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
Prospectus and Prospectus Supplement (which may be delivered in accordance with Rule 172 under the Securities Act).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On
or prior to the Closing Date, each Purchaser shall deliver or cause to be delivered to the Company, as applicable, the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;this
Agreement duly executed by such Purchaser; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;such
Purchaser&rsquo;s Subscription Amount, which shall be made available for &ldquo;Delivery Versus Payment&rdquo; settlement with
the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Closing
Conditions</U>.<U> </U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
obligations of the Company hereunder in connection with the Closing are subject to the following conditions being met:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse
Effect, in all respects) on the Closing Date of the representations and warranties of the Purchasers contained herein (unless as
of a specific date therein in which case they shall be accurate as of such date);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;all
obligations, covenants and agreements of each Purchaser required to be performed at or prior to the Closing Date shall have been
performed; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
delivery by each Purchaser of the items set forth in Section 2.2(b) of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
respective obligations of the Purchasers hereunder in connection with the Closing are subject to the following conditions being
met:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 97; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse
Effect, in all respects) when made and on the Closing Date of the representations and warranties of the Company contained herein
(unless as of a specific date therein in which case they shall be accurate as of such date);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;all
obligations, covenants and agreements of the Company required to be performed at or prior to the Closing Date shall have been performed;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
delivery by the Company of the items set forth in Section 2.2(a) of this Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;there
shall have been no Material Adverse Effect with respect to the Company since the date hereof; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(v)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;from
the date hereof to the Closing Date, trading in the Common Stock shall not have been suspended by the Commission or the Company&rsquo;s
principal Trading Market, and, at any time prior to the Closing Date, trading in securities generally as reported by Bloomberg
L.P. shall not have been suspended or limited, or minimum prices shall not have been established on securities whose trades are
reported by such service, or on any Trading Market, nor shall a banking moratorium have been declared either by the United States
or New York State authorities nor shall there have occurred any material outbreak or escalation of hostilities or other national
or international calamity of such magnitude in its effect on, or any material adverse change in, any financial market which, in
each case, in the reasonable judgment of such Purchaser, makes it impracticable or inadvisable to purchase the Securities at the
Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>ARTICLE III.</B><BR>
REPRESENTATIONS AND WARRANTIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Representations
and Warranties of the Company</U>. Except as set forth in the Disclosure Schedules, which Disclosure Schedules shall be deemed
a part hereof and shall qualify any representation or otherwise made herein to the extent of the disclosure contained in the corresponding
section of the Disclosure Schedules, the Company hereby makes the following representations and warranties to each Purchaser:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Subsidiaries</U>.
All of the direct and indirect subsidiaries of the Company are set forth in last Annual Report on Form 10-K in the SEC Reports.
The Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear
of any Liens other than Liens securing the Indebtedness disclosed in the SEC Reports, and all of the issued and outstanding shares
of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights
to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of
them in the Transaction Documents shall be disregarded.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 98; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Organization
and Qualification</U>. The Company and each of the Subsidiaries is an entity duly incorporated or otherwise organized, validly
existing and in good standing under the laws of the jurisdiction of its incorporation or organization, with the requisite power
and authority to own and use its properties and assets and to carry on its business as currently conducted. Neither the Company
nor any Subsidiary is in violation nor default of any of the provisions of its respective certificate or articles of incorporation,
bylaws or other organizational or charter documents. Each of the Company and the Subsidiaries is duly qualified to conduct business
and is in good standing as a foreign corporation or other entity in each jurisdiction in which the nature of the business conducted
or property owned by it makes such qualification necessary, except where the failure to be so qualified or in good standing, as
the case may be, could not have or reasonably be expected to result in: (i) a material adverse effect on the legality, validity
or enforceability of any Transaction Document, (ii) a material adverse effect on the results of operations, assets, business, prospects
or condition (financial or otherwise) of the Company and the Subsidiaries, taken as a whole, or (iii) a material adverse effect
on the Company&rsquo;s ability to perform in any material respect on a timely basis its obligations under any Transaction Document
(any of (i), (ii) or (iii), a &ldquo;<U>Material Adverse Effect</U>&rdquo;) and no Proceeding has been instituted in any such jurisdiction
revoking, limiting or curtailing or seeking to revoke, limit or curtail such power and authority or qualification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Authorization;
Enforcement</U>. The Company has the requisite corporate power and authority to enter into and to consummate the transactions contemplated
by this Agreement and each of the other Transaction Documents and otherwise to carry out its obligations hereunder and thereunder.
The execution and delivery of this Agreement and each of the other Transaction Documents by the Company and the consummation by
it of the transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part of the Company
and no further action is required by the Company, the Board of Directors or the Company&rsquo;s stockholders in connection herewith
or therewith other than in connection with the Required Approvals. This Agreement and each other Transaction Document to which
it is a party has been (or upon delivery will have been) duly executed by the Company and, when delivered in accordance with the
terms hereof and thereof, will constitute the valid and binding obligation of the Company enforceable against the Company in accordance
with its terms, except (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium
and other laws of general application affecting enforcement of creditors&rsquo; rights generally, (ii) as limited by laws relating
to the availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification
and contribution provisions may be limited by applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 99; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No
Conflicts</U>. The execution, delivery and performance by the Company of this Agreement and the other Transaction Documents to
which it is a party, the issuance and sale of the Securities and the consummation by it of the transactions contemplated hereby
and thereby do not and will not (i) conflict with or violate any provision of the Company&rsquo;s or any Subsidiary&rsquo;s certificate
or articles of incorporation, bylaws or other organizational or charter documents, or (ii) conflict with, or constitute a default
(or an event that with notice or lapse of time or both would become a default) under, result in the creation of any Lien upon any
of the properties or assets of the Company or any Subsidiary, or give to others any rights of termination, amendment, acceleration
or cancellation (with or without notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument (evidencing
a Company or Subsidiary debt or otherwise) or other understanding to which the Company or any Subsidiary is a party or by which
any property or asset of the Company or any Subsidiary is bound or affected, or (iii) subject to the Required Approvals, conflict
with or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court
or governmental authority to which the Company or a Subsidiary is subject (including federal and state securities laws and regulations),
or by which any property or asset of the Company or a Subsidiary is bound or affected; except in the case of each of clauses (ii)
and (iii), such as could not have or reasonably be expected to result in a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Filings,
Consents and Approvals</U>. The Company is not required to obtain any consent, waiver, authorization or order of, give any notice
to, or make any filing or registration with, any court or other federal, state, local or other governmental authority or other
Person in connection with the execution, delivery and performance by the Company of the Transaction Documents, other than: (i)
the filings required pursuant to Section 4.4 of this Agreement, (ii) the filing with the Commission of the Prospectus Supplement,
(iii) application(s) to each applicable Trading Market for the listing of the Shares and Warrant Shares for trading thereon in
the time and manner required thereby and (iv) such filings as are required to be made under applicable state securities laws (collectively,
the &ldquo;<U>Required Approvals</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Issuance
of the Securities; Registration</U>. The Securities are duly authorized and, when issued and paid for in accordance with the applicable
Transaction Documents, will be duly and validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the
Company. The Warrant Shares, when issued in accordance with the terms of the Warrants, will be validly issued, fully paid and nonassessable,
free and clear of all Liens imposed by the Company. The Company has reserved from its duly authorized capital stock the maximum
number of shares of Common Stock issuable pursuant to this Agreement and the Warrants. The Company has prepared and filed the Registration
Statement in conformity with the requirements of the Securities Act, which became effective on&nbsp;May 13, 2016 (the &ldquo;<U>Effective
Date</U>&rdquo;), including the Prospectus, and such amendments and supplements thereto as may have been required to the date of
this Agreement. The Registration Statement is effective under the Securities Act and no stop order preventing or suspending the
effectiveness of the Registration Statement or suspending or preventing the use of the Prospectus has been issued by the Commission
and no proceedings for that purpose have been instituted or, to the knowledge of the Company, are threatened by the Commission.
The Company, if required by the rules and regulations of the Commission, shall file the Prospectus with the Commission pursuant
to Rule 424(b). At the time the Registration Statement and any amendments thereto became effective, at the date of this Agreement
and at the Closing Date, the Registration Statement and any amendments thereto conformed and will conform in all material respects
to the requirements of the Securities Act and did not and will not contain any untrue statement of a material fact or omit to state
any material fact required to be stated therein or necessary to make the statements therein not misleading; and the Prospectus
and any amendments or supplements thereto, at time the Prospectus or any amendment or supplement thereto was issued and at the
Closing Date, conformed and will conform in all material respects to the requirements of the Securities Act and did not and will
not contain an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein,
in light of the circumstances under which they were made, not misleading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 100; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Capitalization</U>.
The capitalization of the Company is as set forth on <U>Schedule 3.1(g)</U>. The Company has not issued any capital stock since
its most recently filed periodic report under the Exchange Act, other than pursuant to the exercise of employee stock options under
the Company&rsquo;s stock option plans, the issuance of shares of Common Stock to employees pursuant to the Company&rsquo;s employee
stock purchase plans and pursuant to the conversion and/or exercise of Common Stock Equivalents outstanding as of the date of the
most recently filed periodic report under the Exchange Act. No Person has any right of first refusal, preemptive right, right of
participation, or any similar right to participate in the transactions contemplated by the Transaction Documents. Except as a result
of the purchase and sale of the Securities, there are no outstanding options, warrants, scrip rights to subscribe to, calls or
commitments of any character whatsoever relating to, or securities, rights or obligations convertible into or exercisable or exchangeable
for, or giving any Person any right to subscribe for or acquire, any shares of Common Stock or the capital stock of any Subsidiary,
or contracts, commitments, understandings or arrangements by which the Company or any Subsidiary is or may become bound to issue
additional shares of Common Stock or Common Stock Equivalents or capital stock of any Subsidiary. The issuance and sale of the
Securities will not obligate the Company or any Subsidiary to issue shares of Common Stock or other securities to any Person (other
than the Purchasers) and will not result in a right of any holder of Company securities to adjust the exercise, conversion, exchange
or reset price under any of such securities. There are no outstanding securities or instruments of the Company or any Subsidiary
that contain any redemption or similar provisions, and there are no contracts, commitments, understandings or arrangements by which
the Company or any Subsidiary is or may become bound to redeem a security of the Company or such Subsidiary. The Company does not
have any stock appreciation rights or &ldquo;phantom stock&rdquo; plans or agreements or any similar plan or agreement. All of
the outstanding shares of capital stock of the Company are duly authorized, validly issued, fully paid and nonassessable, have
been issued in compliance with all federal and state securities laws, and none of such outstanding shares was issued in violation
of any preemptive rights or similar rights to subscribe for or purchase securities. No further approval or authorization of any
stockholder, the Board of Directors or others is required for the issuance and sale of the Securities. There are no stockholders
agreements, voting agreements or other similar agreements with respect to the Company&rsquo;s capital stock to which the Company
is a party or, to the knowledge of the Company, between or among any of the Company&rsquo;s stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 101; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>SEC
Reports; Financial Statements</U>. The Company has filed all reports, schedules, forms, statements and other documents required
to be filed by the Company under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof,
for the two years preceding the date hereof (or such shorter period as the Company was required by law or regulation to file such
material) (the foregoing materials, including the exhibits thereto and documents incorporated by reference therein, together with
the Prospectus and the Prospectus Supplement, being collectively referred to herein as the &ldquo;<U>SEC Reports</U>&rdquo;) on
a timely basis or has received a valid extension of such time of filing and has filed any such SEC Reports prior to the expiration
of any such extension. As of their respective dates, the SEC Reports complied in all material respects with the requirements of
the Securities Act and the Exchange Act, as applicable, and none of the SEC Reports, when filed, contained any untrue statement
of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements
therein, in the light of the circumstances under which they were made, not misleading. The Company has never been an issuer subject
to Rule 144(i) under the Securities Act. The financial statements of the Company included in the SEC Reports comply in all material
respects with applicable accounting requirements and the rules and regulations of the Commission with respect thereto as in effect
at the time of filing. Such financial statements have been prepared in accordance with United States generally accepted accounting
principles applied on a consistent basis during the periods involved (&ldquo;<U>GAAP</U>&rdquo;), except as may be otherwise specified
in such financial statements or the notes thereto and except that unaudited financial statements may not contain all footnotes
required by GAAP, and fairly present in all material respects the financial position of the Company and its consolidated Subsidiaries
as of and for the dates thereof and the results of operations and cash flows for the periods then ended, subject, in the case of
unaudited statements, to normal, immaterial, year-end audit adjustments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Material
Changes; Undisclosed Events, Liabilities or Developments</U>. Since the date of the latest audited financial statements included
within the SEC Reports, except as specifically disclosed in a subsequent SEC Report filed prior to the date hereof, (i) there has
been no event, occurrence or development that has had or that could reasonably be expected to result in a Material Adverse Effect,
(ii) the Company has not incurred any liabilities (contingent or otherwise) other than (A) trade payables and accrued expenses
incurred in the ordinary course of business consistent with past practice and (B) liabilities not required to be reflected in the
Company&rsquo;s financial statements pursuant to GAAP or disclosed in filings made with the Commission, (iii) the Company has not
altered its method of accounting, (iv) the Company has not declared or made any dividend or distribution of cash or other property
to its stockholders or purchased, redeemed or made any agreements to purchase or redeem any shares of its capital stock and (v)
the Company has not issued any equity securities to any officer, director or Affiliate, except pursuant to existing Company stock
option plans. The Company does not have pending before the Commission any request for confidential treatment of information. Except
for the issuance of the Securities contemplated by this Agreement, no event, liability, fact, circumstance, occurrence or development
has occurred or exists or is reasonably expected to occur or exist with respect to the Company or its Subsidiaries or their respective
businesses, prospects, properties, operations, assets or financial condition that would be required to be disclosed by the Company
under applicable securities laws at the time this representation is made or deemed made that has not been publicly disclosed at
least 1 Trading Day prior to the date that this representation is made.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 102; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Litigation</U>.
There is no action, suit, inquiry, notice of violation, proceeding or investigation pending or, to the knowledge of the Company,
threatened against or affecting the Company, any Subsidiary or any of their respective properties before or by any court, arbitrator,
governmental or administrative agency or regulatory authority (federal, state, county, local or foreign) (collectively, an &ldquo;<U>Action</U>&rdquo;)
which (i) adversely affects or challenges the legality, validity or enforceability of any of the Transaction Documents or the Securities
or (ii) could, if there were an unfavorable decision, have or reasonably be expected to result in a Material Adverse Effect. Neither
the Company nor any Subsidiary, nor any director or officer thereof, is or has been the subject of any Action involving a claim
of violation of or liability under federal or state securities laws or a claim of breach of fiduciary duty. There has not been,
and to the knowledge of the Company, there is not pending or contemplated, any investigation by the Commission involving the Company
or any current or former director or officer of the Company. The Commission has not issued any stop order or other order suspending
the effectiveness of any registration statement filed by the Company or any Subsidiary under the Exchange Act or the Securities
Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(k)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Labor
Relations</U>. No labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees of
the Company, which could reasonably be expected to result in a Material Adverse Effect. None of the Company&rsquo;s or its Subsidiaries&rsquo;
employees is a member of a union that relates to such employee&rsquo;s relationship with the Company or such Subsidiary, and neither
the Company nor any of its Subsidiaries is a party to a collective bargaining agreement, and the Company and its Subsidiaries believe
that their relationships with their employees are good. To the knowledge of the Company, no executive officer of the Company or
any Subsidiary, is, or is now expected to be, in violation of any material term of any employment contract, confidentiality, disclosure
or proprietary information agreement or non-competition agreement, or any other contract or agreement or any restrictive covenant
in favor of any third party, and the continued employment of each such executive officer does not subject the Company or any of
its Subsidiaries to any liability with respect to any of the foregoing matters. The Company and its Subsidiaries are in compliance
with all U.S. federal, state, local and foreign laws and regulations relating to employment and employment practices, terms and
conditions of employment and wages and hours, except where the failure to be in compliance could not, individually or in the aggregate,
reasonably be expected to have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(l)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Compliance</U>.
Neither the Company nor any Subsidiary: (i) is in default under or in violation of (and no event has occurred that has not been
waived that, with notice or lapse of time or both, would result in a default by the Company or any Subsidiary under), nor has the
Company or any Subsidiary received notice of a claim that it is in default under or that it is in violation of, any indenture,
loan or credit agreement or any other agreement or instrument to which it is a party or by which it or any of its properties is
bound (whether or not such default or violation has been waived), (ii) is in violation of any judgment, decree or order of any
court, arbitrator or other governmental authority or (iii) is or has been in violation of any statute, rule, ordinance or regulation
of any governmental authority, including without limitation all foreign, federal, state and local laws relating to taxes, environmental
protection, occupational health and safety, product quality and safety and employment and labor matters, except in each case as
could not have or reasonably be expected to result in a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 103; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(m)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Environmental
Laws</U>.&nbsp;&nbsp;The Company and its Subsidiaries (i) are in compliance with all
federal, state, local and foreign laws relating to pollution or protection of human health or the environment (including ambient
air, surface water, groundwater, land surface or subsurface strata), including laws relating to emissions, discharges, releases
or threatened releases of chemicals, pollutants, contaminants, or toxic or hazardous substances or wastes (collectively, &ldquo;<U>Hazardous
Materials</U>&rdquo;) into the environment, or otherwise relating to the manufacture, processing, distribution, use, treatment,
storage, disposal, transport or handling of Hazardous Materials, as well as all authorizations, codes, decrees, demands, or demand
letters, injunctions, judgments, licenses, notices or notice letters, orders, permits, plans or regulations, issued, entered,
promulgated or approved thereunder (&ldquo;<U>Environmental Laws</U>&rdquo;); (ii) have received all permits licenses or other
approvals required of them under applicable Environmental Laws to conduct their respective businesses; and (iii) are in compliance
with all terms and conditions of any such permit, license or approval where in each clause (i), (ii) and (iii), the failure to
so comply could be reasonably expected to have, individually or in the aggregate, a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(n)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Regulatory
Permits</U>. The Company and the Subsidiaries possess all certificates, authorizations and permits issued by the appropriate federal,
state, local or foreign regulatory authorities necessary to conduct their respective businesses as described in the SEC Reports,
except where the failure to possess such permits could not reasonably be expected to result in a Material Adverse Effect (&ldquo;<U>Material
Permits</U>&rdquo;), and neither the Company nor any Subsidiary has received any notice of proceedings relating to the revocation
or modification of any Material Permit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(o)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Title
to Assets</U>. The Company and the Subsidiaries have good and marketable title in fee simple to all real property owned by them
and good and marketable title in all personal property owned by them that is material to the business of the Company and the Subsidiaries,
in each case free and clear of all Liens, except for (i) Liens as do not materially affect the value of such property and do not
materially interfere with the use made and proposed to be made of such property by the Company and the Subsidiaries, and (ii) Liens
for the payment of federal, state or other taxes, for which appropriate reserves have been made therefor in accordance with GAAP
and, the payment of which is neither delinquent nor subject to penalties. Any real property and facilities held under lease by
the Company and the Subsidiaries are held by them under valid, subsisting and enforceable leases with which the Company and the
Subsidiaries are in compliance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(p)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Intellectual
Property</U>. The Company and the Subsidiaries have, or have rights to use, all patents, patent applications, trademarks, trademark
applications, service marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property rights
and similar rights necessary or required for use in connection with their respective businesses as described in the SEC Reports
and which the failure to so have could have a Material Adverse Effect (collectively, the &ldquo;<U>Intellectual Property Rights</U>&rdquo;).
None of, and neither the Company nor any Subsidiary has received a notice (written or otherwise) that any of, the Intellectual
Property Rights has expired, terminated or been abandoned, or is expected to expire or terminate or be abandoned, within two (2)
years from the date of this Agreement. Neither the Company nor any Subsidiary has received, since the date of the latest audited
financial statements included within the SEC Reports, a written notice of a claim or otherwise has any knowledge that the Intellectual
Property Rights violate or infringe upon the rights of any Person, except as could not have or reasonably be expected to not have
a Material Adverse Effect. To the knowledge of the Company, all such Intellectual Property Rights are enforceable and there is
no existing infringement by another Person of any of the Intellectual Property Rights. The Company and its Subsidiaries have taken
reasonable security measures to protect the secrecy, confidentiality and value of all of their intellectual properties, except
where failure to do so could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 104; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(q)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Insurance</U>.
The Company and the Subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks and
in such amounts as are prudent and customary in the businesses in which the Company and the Subsidiaries are engaged, including,
but not limited to, directors and officers insurance coverage at least equal to the aggregate Subscription Amount. Neither the
Company nor any Subsidiary has any reason to believe that it will not be able to renew its existing insurance coverage as and when
such coverage expires or to obtain similar coverage from similar insurers as may be necessary to continue its business without
a significant increase in cost.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(r)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Transactions
With Affiliates and Employees</U>. Except as set forth in the SEC Reports, none of the officers or directors of the Company or
any Subsidiary and, to the knowledge of the Company, none of the employees of the Company or any Subsidiary is presently a party
to any transaction with the Company or any Subsidiary (other than for services or separation from service as employees, officers
and directors), including any contract, agreement or other arrangement providing for the furnishing of services to or by, providing
for rental of real or personal property to or from, providing for the borrowing of money from or lending of money to or otherwise
requiring payments to or from any officer, director or such employee or, to the knowledge of the Company, any entity in which any
officer, director, or any such employee has a substantial interest or is an officer, director, trustee, stockholder, member or
partner, in each case in excess of $120,000 other than for (i) payment of salary or consulting fees for services rendered, (ii)
reimbursement for expenses incurred on behalf of the Company and (iii) other employee benefits, including stock option agreements
under any stock option plan of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 105; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(s)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Sarbanes-Oxley;
Internal Accounting Controls</U>. The Company and the Subsidiaries are in compliance with any and all applicable requirements of
the Sarbanes-Oxley Act of 2002 that are effective as of the date hereof, and any and all applicable rules and regulations promulgated
by the Commission thereunder that are effective as of the date hereof and as of the Closing Date. The Company and the Subsidiaries
maintain a system of internal accounting controls sufficient to provide reasonable assurance that: (i) transactions are executed
in accordance with management&rsquo;s general or specific authorizations, (ii) transactions are recorded as necessary to permit
preparation of financial statements in conformity with GAAP and to maintain asset accountability, (iii) access to assets is permitted
only in accordance with management&rsquo;s general or specific authorization, and (iv) the recorded accountability for assets is
compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences. The
Company and the Subsidiaries have established disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and
15d-15(e)) for the Company and the Subsidiaries and designed such disclosure controls and procedures to ensure that information
required to be disclosed by the Company in the reports it files or submits under the Exchange Act is recorded, processed, summarized
and reported, within the time periods specified in the Commission&rsquo;s rules and forms. The Company&rsquo;s certifying officers
have evaluated the effectiveness of the disclosure controls and procedures of the Company and the Subsidiaries as of the end of
the period covered by the most recently filed periodic report under the Exchange Act (such date, the &ldquo;<U>Evaluation Date</U>&rdquo;).
The Company presented in its most recently filed periodic report under the Exchange Act the conclusions of the certifying officers
about the effectiveness of the disclosure controls and procedures based on their evaluations as of the Evaluation Date. Since the
Evaluation Date, there have been no changes in the internal control over financial reporting (as such term is defined in the Exchange
Act) of the Company and its Subsidiaries that have materially affected, or is reasonably likely to materially affect, the internal
control over financial reporting of the Company and its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(t)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Certain
Fees</U>. Except as set forth in the Prospectus Supplement, no brokerage or finder&rsquo;s fees or commissions are or will be payable
by the Company or any Subsidiary to any broker, financial advisor or consultant, finder, placement agent, investment banker, bank
or other Person with respect to the transactions contemplated by the Transaction Documents. The Purchasers shall have no obligation
with respect to any fees or with respect to any claims made by or on behalf of other Persons for fees of a type contemplated in
this Section that may be due in connection with the transactions contemplated by the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(u)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Investment
Company</U>. The Company is not, and is not an Affiliate of, and immediately after receipt of payment for the Securities, will
not be or be an Affiliate of, an &ldquo;investment company&rdquo; within the meaning of the Investment Company Act of 1940, as
amended. The Company shall conduct its business in a manner so that it will not become an &ldquo;investment company&rdquo; subject
to registration under the Investment Company Act of 1940, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(v)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Registration
Rights</U>. No Person has any right to cause the Company or any Subsidiary to effect the registration under the Securities Act
of any securities of the Company or any Subsidiary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 106; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(w)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Listing
and Maintenance Requirements</U>. The Common Stock is registered pursuant to Section 12(b) or 12(g) of the Exchange Act, and the
Company has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration
of the Common Stock under the Exchange Act nor has the Company received any notification that the Commission is contemplating terminating
such registration. Except as disclosed in the SEC Reports, the Company has not, in the 12 months preceding the date hereof, received
notice from any Trading Market on which the Common Stock is or has been listed or quoted to the effect that the Company is not
in compliance with the listing or maintenance requirements of such Trading Market. The Company is, and has no reason to believe
that it will not in the foreseeable future continue to be, in compliance with all such listing and maintenance requirements. The
Common Stock is currently eligible for electronic transfer through the Depository Trust Company or another established clearing
corporation and the Company is current in payment of the fees to the Depository Trust Company (or such other established clearing
corporation) in connection with such electronic transfer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(x)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Application
of Takeover Protections</U>. The Company and the Board of Directors have taken all necessary action, if any, in order to render
inapplicable any control share acquisition, business combination, poison pill (including any distribution under a rights agreement)
or other similar anti-takeover provision under the Company&rsquo;s certificate of incorporation (or similar charter documents)
or the laws of its state of incorporation that is or could become applicable to the Purchasers as a result of the Purchasers and
the Company fulfilling their obligations or exercising their rights under the Transaction Documents, including without limitation
as a result of the Company&rsquo;s issuance of the Securities and the Purchasers&rsquo; ownership of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(y)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Disclosure</U>.
Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents, the Company
confirms that neither it nor any other Person acting on its behalf has provided any of the Purchasers or their agents or counsel
with any information that it believes constitutes or might constitute material, non-public information which is not otherwise disclosed
in the Prospectus Supplement. The Company understands and confirms that the Purchasers will rely on the foregoing representation
in effecting transactions in securities of the Company. All of the disclosure furnished by or on behalf of the Company to the Purchasers
regarding the Company and its Subsidiaries, their respective businesses and the transactions contemplated hereby, including the
Disclosure Schedules to this Agreement, is true and correct and does not contain any untrue statement of a material fact or omit
to state any material fact necessary in order to make the statements made therein, in light of the circumstances under which they
were made, not misleading. The press releases disseminated by the Company during the twelve months preceding the date of this Agreement
taken as a whole do not contain any untrue statement of a material fact or omit to state a material fact required to be stated
therein or necessary in order to make the statements therein, in light of the circumstances under which they were made and when
made, not misleading. The Company acknowledges and agrees that no Purchaser makes or has made any representations or warranties
with respect to the transactions contemplated hereby other than those specifically set forth in Section 3.2 hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(z)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No
Integrated Offering</U>. Assuming the accuracy of the Purchasers&rsquo; representations and warranties set forth in Section 3.2,
neither the Company, nor any of its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly, made
any offers or sales of any security or solicited any offers to buy any security, under circumstances that would cause this offering
of the Securities to be integrated with prior offerings by the Company for purposes of any applicable shareholder approval provisions
of any Trading Market on which any of the securities of the Company are listed or designated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 107; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(aa)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Solvency</U>.
Based on the consolidated financial condition of the Company as of the Closing Date, after giving effect to the receipt by the
Company of the proceeds from the sale of the Securities hereunder, (i) the fair saleable value of the Company&rsquo;s assets exceeds
the amount that will be required to be paid on or in respect of the Company&rsquo;s existing debts and other liabilities (including
known contingent liabilities) as they mature, (ii) the Company&rsquo;s assets do not constitute unreasonably small capital to carry
on its business as now conducted and as proposed to be conducted including its capital needs taking into account the particular
capital requirements of the business conducted by the Company, consolidated and projected capital requirements and capital availability
thereof, and (iii) the current cash flow of the Company, together with the proceeds the Company would receive, were it to liquidate
all of its assets, after taking into account all anticipated uses of the cash, would be sufficient to pay all amounts on or in
respect of its liabilities when such amounts are required to be paid. The Company does not intend to incur debts beyond its ability
to pay such debts as they mature (taking into account the timing and amounts of cash to be payable on or in respect of its debt).
The Company has no knowledge of any facts or circumstances which lead it to believe that it will file for reorganization or liquidation
under the bankruptcy or reorganization laws of any jurisdiction within one year from the Closing Date. The SEC Reports sets forth
as of the date hereof all outstanding secured and unsecured Indebtedness of the Company or any Subsidiary, or for which the Company
or any Subsidiary has commitments. For the purposes of this Agreement, &ldquo;<U>Indebtedness</U>&rdquo; means (x) any liabilities
for borrowed money or amounts owed in excess of $50,000 (other than trade accounts payable incurred in the ordinary course of business),
(y) all guaranties, endorsements and other contingent obligations in respect of indebtedness of others, whether or not the same
are or should be reflected in the Company&rsquo;s consolidated balance sheet (or the notes thereto), except guaranties by endorsement
of negotiable instruments for deposit or collection or similar transactions in the ordinary course of business; and (z) the present
value of any lease payments in excess of $50,000 due under leases required to be capitalized in accordance with GAAP. Neither the
Company nor any Subsidiary is in default with respect to any Indebtedness.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(bb)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Tax
Status</U>. Except for matters that would not, individually or in the aggregate, have or reasonably be expected to result in a
Material Adverse Effect, the Company and its Subsidiaries each (i) has made or filed all United States federal, state and local
income and all foreign income and franchise tax returns, reports and declarations required by any jurisdiction to which it is subject,
(ii) has paid all taxes and other governmental assessments and charges that are material in amount, shown or determined to be due
on such returns, reports and declarations and (iii) has set aside on its books provision reasonably adequate for the payment of
all material taxes for periods subsequent to the periods to which such returns, reports or declarations apply. There are no unpaid
taxes in any material amount claimed to be due by the taxing authority of any jurisdiction, and the officers of the Company or
of any Subsidiary know of no basis for any such claim.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 108; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(cc)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Foreign
Corrupt Practices</U>. Neither the Company nor any Subsidiary, nor to the knowledge of the Company or any Subsidiary, any agent
or other person acting on behalf of the Company or any Subsidiary, has (i) directly or indirectly, used any funds for unlawful
contributions, gifts, entertainment or other unlawful expenses related to foreign or domestic political activity, (ii) made any
unlawful payment to foreign or domestic government officials or employees or to any foreign or domestic political parties or campaigns
from corporate funds, (iii) failed to disclose fully any contribution made by the Company or any Subsidiary (or made by any person
acting on its behalf of which the Company is aware) which is in violation of law, or (iv) violated in any material respect any
provision of FCPA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(dd)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Accountants</U>.
The Company&rsquo;s accounting firm is Ernst &amp; Young LLP. To the knowledge and belief of the Company, such accounting firm
(i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the
financial statements to be included in the Company&rsquo;s Annual Report for the fiscal year ending December 31, 2016.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ee)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Acknowledgment
Regarding Purchasers&rsquo; Purchase of Securities</U>. The Company acknowledges and agrees that each of the Purchasers is acting
solely in the capacity of an arm&rsquo;s length purchaser with respect to the Transaction Documents and the transactions contemplated
thereby. The Company further acknowledges that no Purchaser is acting as a financial advisor or fiduciary of the Company (or in
any similar capacity) with respect to the Transaction Documents and the transactions contemplated thereby and any advice given
by any Purchaser or any of their respective representatives or agents in connection with the Transaction Documents and the transactions
contemplated thereby is merely incidental to the Purchasers&rsquo; purchase of the Securities. The Company further represents to
each Purchaser that the Company&rsquo;s decision to enter into this Agreement and the other Transaction Documents has been based
solely on the independent evaluation of the transactions contemplated hereby by the Company and its representatives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ff)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Acknowledgement
Regarding Purchaser&rsquo;s Trading Activity</U>. Anything in this Agreement or elsewhere herein to the contrary notwithstanding
(except for Sections 3.2(f) and 4.14 hereof), it is understood and acknowledged by the Company that: (i) none of the Purchasers
has been asked by the Company to agree, nor has any Purchaser agreed, to desist from purchasing or selling, long and/or short,
securities of the Company, or &ldquo;derivative&rdquo; securities based on securities issued by the Company or to hold the Securities
for any specified term; (ii) past or future open market or other transactions by any Purchaser, specifically including, without
limitation, Short Sales or &ldquo;derivative&rdquo; transactions, before or after the closing of this or future private placement
transactions, may negatively impact the market price of the Company&rsquo;s publicly-traded securities; (iii) any Purchaser, and
counter-parties in &ldquo;derivative&rdquo; transactions to which any such Purchaser is a party, directly or indirectly, presently
may have a &ldquo;short&rdquo; position in the Common Stock, and (iv) each Purchaser shall not be deemed to have any affiliation
with or control over any arm&rsquo;s length counter-party in any &ldquo;derivative&rdquo; transaction. The Company further understands
and acknowledges that (y) one or more Purchasers may engage in hedging activities at various times during the period that the
Securities are outstanding, including, without limitation, during the periods that the value of the Warrant Shares deliverable
with respect to Securities are being determined, and (z) such hedging activities (if any) could reduce the value of the existing
stockholders' equity interests in the Company at and after the time that the hedging activities are being conducted.&nbsp; The
Company acknowledges that such aforementioned hedging activities do not constitute a breach of any of the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 109; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(gg)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Regulation
M Compliance</U>.&nbsp; The Company has not, and to its knowledge no one acting on its behalf has, (i) taken, directly or indirectly,
any action designed to cause or to result in the stabilization or manipulation of the price of any security of the Company to facilitate
the sale or resale of any of the Securities, (ii) sold, bid for, purchased, or, paid any compensation for soliciting purchases
of, any of the Securities, or (iii) paid or agreed to pay to any Person any compensation for soliciting another to purchase any
other securities of the Company, other than, in the case of clauses (ii) and (iii), compensation paid to the Company&rsquo;s placement
agent in connection with the placement of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(hh)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>FDA</U>.
As to each product subject to the jurisdiction of the U.S. Food and Drug Administration (&ldquo;<U>FDA</U>&rdquo;) under the Federal
Food, Drug and Cosmetic Act, as amended, and the regulations thereunder (&ldquo;<U>FDCA</U>&rdquo;) that is manufactured, packaged,
labeled, tested, distributed, sold, and/or marketed by the Company or any of its Subsidiaries (each such product, a &ldquo;<U>Pharmaceutical
Product</U>&rdquo;), such Pharmaceutical Product is being manufactured, packaged, labeled, tested, distributed, sold and/or marketed
by the Company in compliance with all applicable requirements under FDCA and similar laws, rules and regulations relating to registration,
investigational use, premarket clearance, licensure, or application approval, good manufacturing practices, good laboratory practices,
good clinical practices, product listing, quotas, labeling, advertising, record keeping and filing of reports, except where the
failure to be in compliance would not have a Material Adverse Effect. There is no pending, completed or, to the Company's knowledge,
threatened, action (including any lawsuit, arbitration, or legal or administrative or regulatory proceeding, charge, complaint,
or investigation) against the Company or any of its Subsidiaries, and none of the Company or any of its Subsidiaries has received
any notice, warning letter or other communication from the FDA or any other governmental entity, which (i) contests the premarket
clearance, licensure, registration, or approval of, the uses of, the distribution of, the manufacturing or packaging of, the testing
of, the sale of, or the labeling and promotion of any Pharmaceutical Product, (ii) withdraws its approval of, requests the recall,
suspension, or seizure of, or withdraws or orders the withdrawal of advertising or sales promotional materials relating to, any
Pharmaceutical Product, (iii) imposes a clinical hold on any clinical investigation by the Company or any of its Subsidiaries,
(iv) enjoins production at any facility of the Company or any of its Subsidiaries, (v) enters or proposes to enter into a consent
decree of permanent injunction with the Company or any of its Subsidiaries, or (vi) otherwise alleges any violation of any laws,
rules or regulations by the Company or any of its Subsidiaries, and which, either individually or in the aggregate, would have
a Material Adverse Effect. The properties, business and operations of the Company have been and are being conducted in all material
respects in accordance with all applicable laws, rules and regulations of the FDA.&nbsp; The Company has not been informed by the
FDA that the FDA will prohibit the marketing, sale, license or use in the United States of any product proposed to be developed,
produced or marketed by the Company nor has the FDA expressed any concern as to approving or clearing for marketing any product
being developed or proposed to be developed by the Company.<U> </U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 110; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Office
of Foreign Assets Control</U>. Neither the Company nor any Subsidiary nor, to the Company's knowledge, any director, officer, agent,
employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of
Foreign Assets Control of the U.S. Treasury Department (&ldquo;<U>OFAC</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(jj)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>U.S.
Real Property Holding Corporation</U>. The Company is not and has never been a U.S. real property holding corporation within the
meaning of Section 897 of the Internal Revenue Code of 1986, as amended, and the Company shall so certify upon Purchaser&rsquo;s
request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(kk)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Bank
Holding Company Act</U>. Neither the Company nor any of its Subsidiaries or Affiliates is subject to the Bank Holding Company Act
of 1956, as amended (the &ldquo;<U>BHCA</U>&rdquo;) and to regulation by the Board of Governors of the Federal Reserve System (the
&ldquo;<U>Federal Reserve</U>&rdquo;). Neither the Company nor any of its Subsidiaries or Affiliates owns or controls, directly
or indirectly, five percent (5%) or more of the outstanding shares of any class of voting securities or twenty-five percent or
more of the total equity of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve. Neither
the Company nor any of its Subsidiaries or Affiliates exercises a controlling influence over the management or policies of a bank
or any entity that is subject to the BHCA and to regulation by the Federal Reserve.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ll)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Money
Laundering</U>. The operations of the Company and its Subsidiaries are and have been conducted at all times in compliance with
applicable financial record-keeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970,
as amended, applicable money laundering statutes and applicable rules and regulations thereunder (collectively, the &ldquo;<U>Money
Laundering Laws</U>&rdquo;), and no Action or Proceeding by or before any court or governmental agency, authority or body or any
arbitrator involving the Company or any Subsidiary with respect to the Money Laundering Laws is pending or, to the knowledge of
the Company or any Subsidiary, threatened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Representations
and Warranties of the Purchasers</U>. Each Purchaser, for itself and for no other Purchaser, hereby represents and warrants as
of the date hereof and as of the Closing Date to the Company as follows (unless as of a specific date therein, in which case they
shall be accurate as of such date):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify; text-indent: 51pt">&nbsp;</P>


<!-- Field: Page; Sequence: 111; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify; text-indent: 51pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify; text-indent: 51pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Organization;
Authority</U>. Such Purchaser is either an individual or an entity duly incorporated or formed, validly existing and in good standing
under the laws of the jurisdiction of its incorporation or formation with full right, corporate, partnership, limited liability
company or similar power and authority to enter into and to consummate the transactions contemplated by the Transaction Documents
and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of the Transaction Documents and
performance by such Purchaser of the transactions contemplated by the Transaction Documents have been duly authorized by all necessary
corporate, partnership, limited liability company or similar action, as applicable, on the part of such Purchaser. Each Transaction
Document to which it is a party has been duly executed by such Purchaser, and when delivered by such Purchaser in accordance with
the terms hereof, will constitute the valid and legally binding obligation of such Purchaser, enforceable against it in accordance
with its terms, except: (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium
and other laws of general application affecting enforcement of creditors&rsquo; rights generally, (ii) as limited by laws relating
to the availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification
and contribution provisions may be limited by applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify; text-indent: 51pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify; text-indent: 51pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Understandings
or Arrangements</U>. Such Purchaser is acquiring the Securities as principal for its own account and has no direct or indirect
arrangement or understandings with any other persons to distribute or regarding the distribution of such Securities (this representation
and warranty not limiting such Purchaser&rsquo;s right to sell the Securities pursuant to the Registration Statement or otherwise
in compliance with applicable federal and state securities laws). Such Purchaser is acquiring the Securities hereunder in the ordinary
course of its business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify; text-indent: 51pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify; text-indent: 51pt">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Purchaser
Status</U>. At the time such Purchaser was offered the Securities, it was, and as of the date hereof it is, and on each date on
which it exercises any Warrants, it will be either: (i) an &ldquo;accredited investor&rdquo; as defined in Rule 501(a)(1), (a)(2),
(a)(3), (a)(7) or (a)(8) under the Securities Act or (ii) a &ldquo;qualified institutional buyer&rdquo; as defined in Rule 144A(a)
under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify; text-indent: 51pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify; text-indent: 51pt">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Experience
of Such Purchaser</U>. Such Purchaser, either alone or together with its representatives, has such knowledge, sophistication and
experience in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment
in the Securities, and has so evaluated the merits and risks of such investment. Such Purchaser is able to bear the economic risk
of an investment in the Securities and, at the present time, is able to afford a complete loss of such investment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify; text-indent: 51pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify; text-indent: 51pt">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Access
to Information</U>. Such Purchaser acknowledges that it has had the opportunity to review the Transaction Documents (including
all exhibits and schedules thereto) and the SEC Reports and has been afforded, (i) the opportunity to ask such questions as it
has deemed necessary of, and to receive answers from, representatives of the Company concerning the terms and conditions of the
offering of the Securities and the merits and risks of investing in the Securities; (ii) access to information about the Company
and its financial condition, results of operations, business, properties, management and prospects sufficient to enable it to evaluate
its investment; and (iii) the opportunity to obtain such additional information that the Company possesses or can acquire without
unreasonable effort or expense that is necessary to make an informed investment decision with respect to the investment.&nbsp;
Such Purchaser acknowledges and agrees that neither the Placement Agents nor any Affiliate of the Placement Agents have provided
such Purchaser with any information or advice with respect to the Securities nor is such information or advice necessary or desired.&nbsp;
Neither the Placement Agents nor any of their Affiliates have made or make any representation as to the Company or the quality
of the Securities and the Placement Agents and any Affiliate may have acquired non-public information with respect to the Company
which such Purchaser agrees need not be provided to it.&nbsp; In connection with the issuance of the Securities to such Purchaser,
neither the Placement Agents nor any of their Affiliates have acted as a financial advisor or fiduciary to such Purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify; text-indent: 51pt">&nbsp;</P>


<!-- Field: Page; Sequence: 112; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify; text-indent: 51pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify; text-indent: 51pt">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Certain
Transactions and Confidentiality</U>. Other than consummating the transactions contemplated hereunder, such Purchaser has not,
nor has any Person acting on behalf of or pursuant to any understanding with such Purchaser, directly or indirectly executed any
purchases or sales, including Short Sales,&nbsp;of the securities of the Company during the period commencing as of the time that
such Purchaser first received a term sheet (written or oral) from the Company or any other Person representing the Company setting
forth the material pricing terms of the transactions contemplated hereunder and ending immediately prior to the execution hereof.
Notwithstanding the foregoing, in the case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio
managers manage separate portions of such Purchaser&rsquo;s assets and the portfolio managers have no direct knowledge of the investment
decisions made by the portfolio managers managing other portions of such Purchaser&rsquo;s assets, the representation set forth
above shall only apply with respect to the portion of assets managed by the portfolio manager that made the investment decision
to purchase the Securities covered by this Agreement. Other than to other Persons party to this Agreement or to such Purchaser&rsquo;s
representatives, including, without limitation, its officers, directors, partners, legal and other advisors, employees, agents
and Affiliates, such Purchaser has maintained the confidentiality of all disclosures made to it in connection with this transaction
(including the existence and terms of this transaction). Notwithstanding the foregoing, for the avoidance of doubt, nothing contained
herein shall constitute a representation or warranty, or preclude any actions, with respect to the identification of the availability
of, or securing of, available shares to borrow in order to effect Short Sales or similar transactions in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">The Company acknowledges
and agrees that the representations contained in this Section 3.2 shall not modify, amend or affect such Purchaser&rsquo;s right
to rely on the Company&rsquo;s representations and warranties contained in this Agreement or any representations and warranties
contained in any other Transaction Document or any other document or instrument executed and/or delivered in connection with this
Agreement or the consummation of the transactions contemplated hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>ARTICLE IV.</B><BR>
OTHER AGREEMENTS OF THE PARTIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Warrant
Shares</U>. If all or any portion of a Warrant is exercised at a time when there is an effective registration statement to cover
the issuance or resale of the Warrant Shares or if the Warrant is exercised via cashless exercise, the Warrant Shares issued pursuant
to any such exercise shall be issued free of all legends. If at any time following the date hereof the Registration Statement (or
any subsequent registration statement registering the sale or resale of the Warrant Shares) is not effective or is not otherwise
available for the sale or resale of the Warrant Shares, the Company shall promptly (but in no event later than one Trading Day)
notify the holders of the Warrants in writing that such registration statement is not then effective and thereafter shall promptly
notify such holders when the registration statement is effective again and available for the sale or resale of the Warrant Shares
(it being understood and agreed that the foregoing shall not limit the ability of the Company to issue, or any Purchaser to sell,
any of the Warrant Shares in compliance with applicable federal and state securities laws). The Company shall use best efforts
to keep a registration statement (including the Registration Statement) registering the issuance or resale of the Warrant Shares
effective during the term of the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 113; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Furnishing
of Information</U>. Until the earliest of the time that (i) no Purchaser owns Securities or (ii) the Warrants have expired, the
Company covenants to timely file (or obtain extensions in respect thereof and file within the applicable grace period) all reports
required to be filed by the Company after the date hereof pursuant to the Exchange Act even if the Company is not then subject
to the reporting requirements of the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Integration</U>.
The Company shall not sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security (as defined
in Section 2 of the Securities Act) that would be integrated with the offer or sale of the Securities for purposes of the rules
and regulations of any Trading Market such that it would require shareholder approval prior to the closing of such other transaction
unless shareholder approval is obtained before the closing of such subsequent transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Securities
Laws Disclosure; Publicity</U>. The Company shall (a) by 9:00 a.m. (New York City time) on the Trading Day immediately following
the date hereof, issue a press release disclosing the material terms of the transactions contemplated hereby, and (b) file a Current
Report on Form 8-K, including the Transaction Documents as exhibits thereto, with the Commission within the time required by the
Exchange Act. From and after the issuance of such press release, the Company represents to the Purchasers that it shall have publicly
disclosed all material, non-public information delivered to any of the Purchasers by the Company or any of its Subsidiaries, or
any of their respective officers, directors, employees or agents in connection with the transactions contemplated by the Transaction
Documents. In addition, effective upon the issuance of such press release, the Company acknowledges and agrees that any and all
confidentiality or similar obligations under any agreement, whether written or oral, between the Company, any of its Subsidiaries
or any of their respective officers, directors, agents, employees or Affiliates on the one hand, and any of the Purchasers or any
of their Affiliates on the other hand, shall terminate. The Company and each Purchaser shall consult with each other in issuing
any other press releases with respect to the transactions contemplated hereby, and neither the Company nor any Purchaser shall
issue any such press release nor otherwise make any such public statement without the prior consent of the Company, with respect
to any press release of any Purchaser, or without the prior consent of each Purchaser, with respect to any press release of the
Company, which consent shall not unreasonably be withheld or delayed, except if such disclosure is required by law, in which case
the disclosing party shall promptly provide the other party with prior notice of such public statement or communication. Notwithstanding
the foregoing, the Company shall not publicly disclose the name of any Purchaser, or include the name of any Purchaser in any filing
with the Commission or any regulatory agency or Trading Market, without the prior written consent of such Purchaser, except (a)
as required by federal securities law in connection with the filing of final Transaction Documents with the Commission and (b)
to the extent such disclosure is required by law or Trading Market regulations, in which case the Company shall provide the Purchasers
with prior notice of such disclosure permitted under this clause (b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 114; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Shareholder
Rights Plan</U>. No claim will be made or enforced by the Company or, with the consent of the Company, any other Person, that any
Purchaser is an &ldquo;<U>Acquiring Person</U>&rdquo; under any control share acquisition, business combination, poison pill (including
any distribution under a rights agreement) or similar anti-takeover plan or arrangement in effect or hereafter adopted by the Company,
or that any Purchaser could be deemed to trigger the provisions of any such plan or arrangement, by virtue of receiving Securities
under the Transaction Documents or under any other agreement between the Company and the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Non-Public
Information</U>. Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents,
which shall be disclosed pursuant to Section 4.4, the Company covenants and agrees that neither it, nor any other Person acting
on its behalf will provide any Purchaser or its agents or counsel with any information that constitutes, or the Company reasonably
believes constitutes, material non-public information, unless prior thereto such Purchaser shall have consented to the receipt
of such information and agreed with the Company to keep such information confidential. The Company understands and confirms that
each Purchaser shall be relying on the foregoing covenant in effecting transactions in securities of the Company. To the extent
that the Company delivers any material, non-public information to a Purchaser without such Purchaser&rsquo;s consent, the Company
hereby covenants and agrees that such Purchaser shall not have any duty of confidentiality to the Company, any of its Subsidiaries,
or any of their respective officers, directors, agents, employees or Affiliates, or a duty to the Company, any of its Subsidiaries
or any of their respective officers, directors, agents, employees or Affiliates not to trade on the basis of, such material, non-public
information, provided that the Purchaser shall remain subject to applicable law. To the extent that any notice provided pursuant
to any Transaction Document constitutes, or contains, material, non-public information regarding the Company or any Subsidiaries,
the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K. The Company understands
and confirms that each Purchaser shall be relying on the foregoing covenant in effecting transactions in securities of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Use
of Proceeds</U>. The Company shall use the net proceeds from the sale of the Securities hereunder for working capital purposes
and shall not use such proceeds: (a) for the satisfaction of any portion of the Company&rsquo;s debt (other than payment of trade
payables in the ordinary course of the Company&rsquo;s business and prior practices), (b) for the redemption of any Common Stock
or Common Stock Equivalents, (c) for the settlement of any outstanding litigation or (d) in violation of FCPA or OFAC regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 115; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Indemnification
of Purchasers</U>. Subject to the provisions of this Section 4.8, the Company will indemnify and hold each Purchaser and its directors,
officers, shareholders, members, partners, employees and agents (and any other Persons with a functionally equivalent role of a
Person holding such titles notwithstanding a lack of such title or any other title), each Person who controls such Purchaser (within
the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers, shareholders,
agents, members, partners or employees (and any other Persons with a functionally equivalent role of a Person holding such titles
notwithstanding a lack of such title or any other title) of such controlling persons (each, a &ldquo;<U>Purchaser Party</U>&rdquo;)
harmless from any and all losses, liabilities, obligations, claims, contingencies, damages, costs and expenses, including all judgments,
amounts paid in settlements, court costs and reasonable attorneys&rsquo; fees and costs of investigation that any such Purchaser
Party may suffer or incur as a result of or relating to (a) any breach of any of the representations, warranties, covenants or
agreements made by the Company in this Agreement or in the other Transaction Documents or (b) any action instituted against the
Purchaser Parties in any capacity, or any of them or their respective Affiliates, by any stockholder of the Company who is not
an Affiliate of such Purchaser Party, with respect to any of the transactions contemplated by the Transaction Documents (unless
such action is based upon a breach of such Purchaser Party&rsquo;s representations, warranties or covenants under the Transaction
Documents or any agreements or understandings such Purchaser Party may have with any such stockholder or any violations by such
Purchaser Party of state or federal securities laws or any conduct by such Purchaser Party which constitutes fraud, gross negligence,
willful misconduct or malfeasance). If any action shall be brought against any Purchaser Party in respect of which indemnity may
be sought pursuant to this Agreement, such Purchaser Party shall promptly notify the Company in writing, and the Company shall
have the right to assume the defense thereof with counsel of its own choosing reasonably acceptable to the Purchaser Party. Any
Purchaser Party shall have the right to employ separate counsel in any such action and participate in the defense thereof, but
the fees and expenses of such counsel shall be at the expense of such Purchaser Party except to the extent that (i) the employment
thereof has been specifically authorized by the Company in writing, (ii) the Company has failed after a reasonable period of time
to assume such defense and to employ counsel or (iii) in such action there is, in the reasonable opinion of counsel, a material
conflict on any material issue between the position of the Company and the position of such Purchaser Party, in which case the
Company shall be responsible for the reasonable fees and expenses of no more than one such separate counsel. The Company will not
be liable to any Purchaser Party under this Agreement (y) for any settlement by a Purchaser Party effected without the Company&rsquo;s
prior written consent, which shall not be unreasonably withheld or delayed; or (z) to the extent, but only to the extent that a
loss, claim, damage or liability is attributable to any Purchaser Party&rsquo;s breach of any of the representations, warranties,
covenants or agreements made by such Purchaser Party in this Agreement or in the other Transaction Documents. The indemnification
required by this Section 4.8 shall be made by periodic payments of the amount thereof during the course of the investigation or
defense, as and when bills are received or are incurred. The indemnity agreements contained herein shall be in addition to any
cause of action or similar right of any Purchaser Party against the Company or others and any liabilities the Company may be subject
to pursuant to law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.9&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Reservation
of Common Stock</U>. As of the date hereof, the Company has reserved and the Company shall continue to reserve and keep available
at all times, free of preemptive rights, a sufficient number of shares of Common Stock for the purpose of enabling the Company
to issue Shares pursuant to this Agreement and Warrant Shares pursuant to any exercise of the Warrants.<U> </U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.10&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Listing
of Common Stock</U>. The Company hereby agrees to use best efforts to maintain the listing or quotation of the Common Stock on
the Trading Market on which it is currently listed, and concurrently with the Closing, the Company shall apply to list or quote
all of the Shares and Warrant Shares on such Trading Market and promptly secure the listing of all of the Shares and Warrant Shares
on such Trading Market. The Company further agrees, if the Company applies to have the Common Stock traded on any other Trading
Market, it will then include in such application all of the Shares and Warrant Shares, and will take such other action as is necessary
to cause all of the Shares and Warrant Shares to be listed or quoted on such other Trading Market as promptly as possible. The
Company will then take all action reasonably necessary to continue the listing and trading of its Common Stock on a Trading Market
and will comply in all respects with the Company&rsquo;s reporting, filing and other obligations under the bylaws or rules of the
Trading Market. The Company agrees to maintain the eligibility of the Common Stock for electronic transfer through the Depository
Trust Company or another established clearing corporation, including, without limitation, by timely payment of fees to the Depository
Trust Company or such other established clearing corporation in connection with such electronic transfer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 116; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.11&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[RESERVED]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.12&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Subsequent
Equity Sales</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;From
the date hereof until 90 days after the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement
to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;From
the date hereof until the second anniversary of the Closing Date, the Company shall be prohibited from effecting or entering into
an agreement to effect any issuance by the Company or any of its Subsidiaries of Common Stock or Common Stock Equivalents (or a
combination of units thereof) involving a Variable Rate Transaction. &ldquo;<U>Variable Rate Transaction</U>&rdquo; means a transaction
in which the Company (i) issues or sells any debt or equity securities that are convertible into, exchangeable or exercisable for,
or include the right to receive additional shares of Common Stock either (A) at a conversion price, exercise price or exchange
rate or other price that is based upon and/or varies with the trading prices of or quotations for the shares of Common Stock at
any time after the initial issuance of such debt or equity securities, or (B) with a conversion, exercise or exchange price that
is subject to being reset at some future date after the initial issuance of such debt or equity security or upon the occurrence
of specified or contingent events directly or indirectly related to the business of the Company or the market for the Common Stock
or (ii) enters into, or effects a transaction under, any agreement, including, but not limited to, an equity line of credit, whereby
the Company may issue securities at a future determined price. Any Purchaser shall be entitled to obtain injunctive relief against
the Company to preclude any such issuance, which remedy shall be in addition to any right to collect damages.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding
the foregoing, this Section 4.12 shall not apply in respect of an Exempt Issuance, except that no Variable Rate Transaction shall
be an Exempt Issuance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.13&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Equal
Treatment of Purchasers</U>. No consideration (including any modification of any Transaction Document) shall be offered or paid
to any Person to amend or consent to a waiver or modification of any provision of the Transaction Documents unless the same consideration
is also offered to all of the parties to the Transaction Documents. For clarification purposes, this provision constitutes a separate
right granted to each Purchaser by the Company and negotiated separately by each Purchaser, and is intended for the Company to
treat the Purchasers as a class and shall not in any way be construed as the Purchasers acting in concert or as a group with respect
to the purchase, disposition or voting of Securities or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 117; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.14&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Certain
Transactions and Confidentiality</U>. Each Purchaser, severally and not jointly with the other Purchasers, covenants that neither
it nor any Affiliate acting on its behalf or pursuant to any understanding with it will execute any purchases or sales, including
Short Sales of any of the Company&rsquo;s securities during the period commencing with the execution of this Agreement and ending
at such time that the transactions contemplated by this Agreement are first publicly announced pursuant to the initial press release
as described in Section 4.4.<FONT STYLE="color: windowtext">&nbsp; </FONT>Each Purchaser, severally and not jointly with the other
Purchasers, covenants that until such time as the transactions contemplated by this Agreement are publicly disclosed by the Company
pursuant to the initial press release as described in Section 4.4, such Purchaser will maintain the confidentiality of the existence
and terms of this transaction and the information included in the Disclosure Schedules.&nbsp; N<FONT STYLE="color: windowtext">otwithstanding
the foregoing and notwithstanding anything contained in this Agreement to the contrary, the Company expressly acknowledges and
agrees that (i) no Purchaser makes any representation, warranty or covenant hereby that it will not engage in effecting transactions
in any securities of the Company after the time that the transactions contemplated by this Agreement are first publicly announced
pursuant to the initial press release as described in Section 4.4, (ii) no Purchaser shall be restricted or prohibited from effecting
any transactions in any securities of the Company in accordance with applicable securities laws from and after the time that the
transactions contemplated by this Agreement are first publicly announced pursuant to the initial press release as described in
Section 4.4 and (iii) no Purchaser shall have any duty of confidentiality or duty not to trade in the securities of the Company
to the Company or its Subsidiaries after the issuance of the initial press release as described in Section 4.4.&nbsp; </FONT>Notwithstanding
the foregoing, in the case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage
separate portions of such Purchaser&rsquo;s assets and the portfolio managers have no direct knowledge of the investment decisions
made by the portfolio managers managing other portions of such Purchaser&rsquo;s assets, the covenant set forth above shall only
apply with respect to the portion of assets managed by the portfolio manager that made the investment decision to purchase the
Securities covered by this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.15&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Capital
Changes</U>. Until the one year anniversary of the Closing Date, the Company shall not undertake a reverse or forward stock split
or reclassification of the Common Stock without the prior written consent of the Purchasers holding a majority in interest of the
Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.16&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="color: windowtext"><U>Exercise
Procedures</U>. The form of Notice of Exercise included in the Warrants set forth the totality of the procedures required of the
Purchasers in order to exercise the Warrants. No additional legal opinion, other information or instructions shall be required
of the Purchasers to exercise their Warrants. Without limiting the preceding sentences, no ink-original Notice of Exercise shall
be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise form be required
in order to exercise the Warrants. The Company shall honor exercises of the Warrants and shall deliver Warrant Shares in accordance
with the terms, conditions and time periods set forth in the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 118; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>ARTICLE V.</B><BR>
MISCELLANEOUS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Termination</U>.&nbsp;
This Agreement may be terminated by any Purchaser, as to such Purchaser&rsquo;s obligations hereunder only and without any effect
whatsoever on the obligations between the Company and the other Purchasers, by written notice to the other parties, if the Closing
has not been consummated on or before June 30, 2016; <U>provided</U>, <U>however</U>, that no such termination will affect the
right of any party to sue for any breach by any other party (or parties).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Fees
and Expenses</U>. Except as expressly set forth in the Transaction Documents to the contrary, each party shall pay the fees and
expenses of its advisers, counsel, accountants and other experts, if any, and all other expenses incurred by such party incident
to the negotiation, preparation, execution, delivery and performance of this Agreement. The Company shall pay all Transfer Agent
fees (including, without limitation, any fees required for same-day processing of any instruction letter delivered by the Company
and any exercise notice delivered by a Purchaser), stamp taxes and other taxes and duties levied in connection with the delivery
of any Securities to the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Entire
Agreement</U>. The Transaction Documents, together with the exhibits and schedules thereto, the Prospectus and the Prospectus Supplement,
contain the entire understanding of the parties with respect to the subject matter hereof and thereof and supersede all prior agreements
and understandings, oral or written, with respect to such matters, which the parties acknowledge have been merged into such documents,
exhibits and schedules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Notices</U>.
Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and
shall be deemed given and effective on the earliest of: (a) the date of transmission, if such notice or communication is delivered
via facsimile or email attachment at the facsimile number or email address as set forth on the signature pages attached hereto
at or prior to 5:30 p.m. (New York City time) on a Trading Day, (b) the next Trading Day after the date of transmission, if such
notice or communication is delivered via facsimile or email attachment at the facsimile number or email address as set forth on
the signature pages attached hereto on a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading
Day, (c) the second (2<SUP>nd</SUP>) Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight
courier service or (d) upon actual receipt by the party to whom such notice is required to be given. The address for such notices
and communications shall be as set forth on the signature pages attached hereto. To the extent that any notice provided pursuant
to any Transaction Document constitutes, or contains, material, non-public information regarding the Company or any Subsidiaries,
the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 119; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Amendments;
Waivers</U>. No provision of this Agreement may be waived, modified, supplemented or amended except in a written instrument signed,
in the case of an amendment, by the Company and Purchasers which purchased at least 50.1% in interest of the Shares based on the
initial Subscription Amounts hereunder or, in the case of a waiver, by the party against whom enforcement of any such waived provision
is sought, provided that if any amendment, modification or waiver disproportionately and adversely impacts a Purchaser (or group
of Purchasers), the consent of such disproportionately impacted Purchaser (or group of Purchasers) shall also be required. No waiver
of any default with respect to any provision, condition or requirement of this Agreement shall be deemed to be a continuing waiver
in the future or a waiver of any subsequent default or a waiver of any other provision, condition or requirement hereof, nor shall
any delay or omission of any party to exercise any right hereunder in any manner impair the exercise of any such right. Any proposed
amendment or waiver that disproportionately, materially and adversely affects the rights and obligations of any Purchaser relative
to the comparable rights and obligations of the other Purchasers shall require the prior written consent of such adversely affected
Purchaser, Any amendment effected in accordance with accordance with this Section 5.5 shall be binding upon each Purchaser and
holder of Securities and the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Headings</U>.
The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to limit or affect
any of the provisions hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Successors
and Assigns</U>. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and permitted
assigns. The Company may not assign this Agreement or any rights or obligations hereunder without the prior written consent of
each Purchaser (other than by merger). Any Purchaser may assign any or all of its rights under this Agreement to any Person to
whom such Purchaser assigns or transfers any Securities, provided that such transferee agrees in writing to be bound, with respect
to the transferred Securities, by the provisions of the Transaction Documents that apply to the &ldquo;Purchasers.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No
Third-Party Beneficiaries</U>. The Placement Agents shall be the third party beneficiary of the representations and warranties
of the Company in Section 3.1 and the representations and warranties of the Purchasers in Section 3.2. This Agreement is intended
for the benefit of the parties hereto and their respective successors and permitted assigns and is not for the benefit of, nor
may any provision hereof be enforced by, any other Person, except as otherwise set forth in Section 4.8 and this Section 5.8.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.9&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Governing
Law</U>. All questions concerning the construction, validity, enforcement and interpretation of the Transaction Documents shall
be governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the
principles of conflicts of law thereof. Each party agrees that all legal Proceedings concerning the interpretations, enforcement
and defense of the transactions contemplated by this Agreement and any other Transaction Documents (whether brought against a party
hereto or its respective affiliates, directors, officers, shareholders, partners, members, employees or agents) shall be commenced
exclusively in the state and federal courts sitting in the City of New York. Each party hereby irrevocably submits to the exclusive
jurisdiction of the state and federal courts sitting in the City of New York, Borough of Manhattan for the adjudication of any
dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein (including with respect
to the enforcement of any of the Transaction Documents), and hereby irrevocably waives, and agrees not to assert in any Action
or Proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such Action or Proceeding
is improper or is an inconvenient venue for such Proceeding. Each party hereby irrevocably waives personal service of process and
consents to process being served in any such Action or Proceeding by mailing a copy thereof via registered or certified mail or
overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Agreement and
agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall
be deemed to limit in any way any right to serve process in any other manner permitted by law. If any party shall commence an Action
or Proceeding to enforce any provisions of the Transaction Documents, then, in addition to the obligations of the Company under
Section 4.8, the prevailing party in such Action or Proceeding shall be reimbursed by the non-prevailing party for its reasonable
attorneys&rsquo; fees and other costs and expenses incurred with the investigation, preparation and prosecution of such Action
or Proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 120; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.10&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Survival</U>.
The representations and warranties contained herein shall survive the Closing and the delivery of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.11&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Execution</U>.
This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same
agreement and shall become effective when counterparts have been signed by each party and delivered to each other party, it being
understood that the parties need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission
or by e-mail delivery of a &ldquo;.pdf&rdquo; format data file, such signature shall create a valid and binding obligation of the
party executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile or &ldquo;.pdf&rdquo;
signature page were an original thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.12&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Severability</U>.
If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal,
void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full
force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially
reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated
by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that
they would have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be
hereafter declared invalid, illegal, void or unenforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.13&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Rescission
and Withdrawal Right</U>. Notwithstanding anything to the contrary contained in (and without limiting any similar provisions of)
any of the other Transaction Documents, whenever any Purchaser exercises a right, election, demand or option under a Transaction
Document and the Company does not timely perform its related obligations within the periods therein provided, then such Purchaser
may rescind or withdraw, in its sole discretion from time to time upon written notice to the Company, any relevant notice, demand
or election in whole or in part without prejudice to its future actions and rights; <U>provided</U>, <U>however</U>, that in the
case of a rescission of an exercise of a Warrant, the applicable Purchaser shall be required to return any shares of Common Stock
subject to any such rescinded exercise notice concurrently with the return to such Purchaser of the aggregate exercise price paid
to the Company for such shares and the restoration of such Purchaser&rsquo;s right to acquire such shares pursuant to such Purchaser&rsquo;s
Warrant (including, issuance of a replacement warrant certificate evidencing such restored right).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 121; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.14&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Replacement
of Securities</U>. If any certificate or instrument evidencing any Securities is mutilated, lost, stolen or destroyed, the Company
shall issue or cause to be issued in exchange and substitution for and upon cancellation thereof (in the case of mutilation), or
in lieu of and substitution therefor, a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory
to the Company of such loss, theft or destruction. The applicant for a new certificate or instrument under such circumstances shall
also pay any reasonable third-party costs (including customary indemnity) associated with the issuance of such replacement Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.15&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Remedies</U>.
In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages, each of
the Purchasers and the Company will be entitled to specific performance under the Transaction Documents. The parties agree that
monetary damages may not be adequate compensation for any loss incurred by reason of any breach of obligations contained in the
Transaction Documents and hereby agree to waive and not to assert in any Action for specific performance of any such obligation
the defense that a remedy at law would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.16&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Payment
Set Aside</U>. To the extent that the Company makes a payment or payments to any Purchaser pursuant to any Transaction Document
or a Purchaser enforces or exercises its rights thereunder, and such payment or payments or the proceeds of such enforcement or
exercise or any part thereof are subsequently invalidated, declared to be fraudulent or preferential, set aside, recovered from,
disgorged by or are required to be refunded, repaid or otherwise restored to the Company, a trustee, receiver or any other Person
under any law (including, without limitation, any bankruptcy law, state or federal law, common law or equitable cause of action),
then to the extent of any such restoration the obligation or part thereof originally intended to be satisfied shall be revived
and continued in full force and effect as if such payment had not been made or such enforcement or setoff had not occurred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.17&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Independent
Nature of Purchasers&rsquo; Obligations and Rights</U>. The obligations of each Purchaser under any Transaction Document are several
and not joint with the obligations of any other Purchaser, and no Purchaser shall be responsible in any way for the performance
or non-performance of the obligations of any other Purchaser under any Transaction Document. Nothing contained herein or in any
other Transaction Document, and no action taken by any Purchaser pursuant hereto or thereto, shall be deemed to constitute the
Purchasers as a partnership, an association, a joint venture or any other kind of entity, or create a presumption that the Purchasers
are in any way acting in concert or as a group with respect to such obligations or the transactions contemplated by the Transaction
Documents. Each Purchaser shall be entitled to independently protect and enforce its rights including, without limitation, the
rights arising out of this Agreement or out of the other Transaction Documents, and it shall not be necessary for any other Purchaser
to be joined as an additional party in any Proceeding for such purpose. Each Purchaser has been represented by its own separate
legal counsel in its review and negotiation of the Transaction Documents. For reasons of administrative convenience only, each
Purchaser and its respective counsel have chosen to communicate with the Company through ML. ML does not represent any of the Purchasers
and only represents the Placement Agents. The Company has elected to provide all Purchasers with the same terms and Transaction
Documents for the convenience of the Company and not because it was required or requested to do so by any of the Purchasers. It
is expressly understood and agreed that each provision contained in this Agreement and in each other Transaction Document is between
the Company and a Purchaser, solely, and not between the Company and the Purchasers collectively and not between and among the
Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 122; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.18&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Liquidated
Damages</U>. The Company&rsquo;s obligations to pay any partial liquidated damages or other amounts owing under the Transaction
Documents is a continuing obligation of the Company and shall not terminate until all unpaid partial liquidated damages and other
amounts have been paid notwithstanding the fact that the instrument or security pursuant to which such partial liquidated damages
or other amounts are due and payable shall have been canceled.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.19&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Saturdays,
Sundays, Holidays, etc.</U>&nbsp;&nbsp;&nbsp;&nbsp;If the last or appointed day for the taking of
any action or the expiration of any right required or granted herein shall not be a Business Day, then such action may be taken
or such right may be exercised on the next succeeding Business Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.20&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Construction</U>.
The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to revise the Transaction
Documents and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against the drafting
party shall not be employed in the interpretation of the Transaction Documents or any amendments thereto. In addition, each and
every reference to share prices and shares of Common Stock in any Transaction Document shall be subject to adjustment for reverse
and forward stock splits, stock dividends, stock combinations and other similar transactions of the Common Stock that occur after
the date of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.21&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>WAIVER
OF JURY TRIAL</U>. <U>IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY, THE
PARTIES EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY,
IRREVOCABLY AND EXPRESSLY WAIVES FOREVER TRIAL BY JURY. </U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(Signature Pages Follow)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 123; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF,
the parties hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories
as of the date first indicated above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase"><B>AmpliPhi Biosciences Corporation</B></FONT></TD>
    <TD STYLE="layout-grid-mode: line">&nbsp;</TD>
    <TD STYLE="text-decoration: underline; layout-grid-mode: line"><U>Address for Notice:</U></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; layout-grid-mode: line">&nbsp;</TD>
    <TD STYLE="width: 45%; layout-grid-mode: line">&nbsp;</TD>
    <TD STYLE="width: 2%; layout-grid-mode: line">&nbsp;</TD>
    <TD STYLE="width: 49%; layout-grid-mode: line">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="layout-grid-mode: line">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; layout-grid-mode: line">&nbsp;</TD>
    <TD STYLE="layout-grid-mode: line">&nbsp;</TD>
    <TD STYLE="layout-grid-mode: line">Fax:</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="layout-grid-mode: line">&nbsp;</TD>
    <TD STYLE="layout-grid-mode: line">Name:</TD>
    <TD STYLE="layout-grid-mode: line">&nbsp;</TD>
    <TD STYLE="layout-grid-mode: line">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="layout-grid-mode: line">&nbsp;</TD>
    <TD STYLE="layout-grid-mode: line">Title:</TD>
    <TD STYLE="layout-grid-mode: line">&nbsp;</TD>
    <TD STYLE="layout-grid-mode: line">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="layout-grid-mode: line">&nbsp;</TD>
    <TD STYLE="layout-grid-mode: line">&nbsp;</TD>
    <TD STYLE="layout-grid-mode: line">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="layout-grid-mode: line">With a copy to (which shall not constitute notice):</TD>
    <TD STYLE="layout-grid-mode: line">&nbsp;</TD>
    <TD STYLE="layout-grid-mode: line">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SIGNATURE PAGE FOR PURCHASER FOLLOWS]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 124; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[PURCHASER SIGNATURE PAGES TO APHB SECURITIES
PURCHASE AGREEMENT]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF,
the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as
of the date first indicated above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Purchaser: ________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Signature of Authorized Signatory of
Purchaser</I>: _________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Authorized Signatory: _______________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Title of Authorized Signatory: ________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Email Address of Authorized Signatory:_________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Facsimile Number of Authorized Signatory: __________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Address for Notice to Purchaser:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Address for Delivery of Securities to Purchaser (if not same
as address for notice):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Subscription Amount: $_________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Shares: _________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Warrant Shares: __________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">EIN Number: _______________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Wingdings">o</FONT>
Notwithstanding anything contained in this Agreement to the contrary, by checking this box (i) the obligations of the above-signed
to purchase the securities set forth in this Agreement to be purchased from the Company by the above-signed, and the obligations
of the Company to sell such securities to the above-signed, shall be unconditional and all conditions to Closing shall be disregarded,
(ii) the Closing shall occur on the third (3<SUP>rd</SUP>) Trading Day following the date of this Agreement and (iii) any condition
to Closing contemplated by this Agreement (but prior to being disregarded by clause (i) above) that required delivery by the Company
or the above-signed of any agreement, instrument, certificate or the like or purchase price (as applicable) shall no longer be
a condition and shall instead be an unconditional obligation of the Company or the above-signed (as applicable) to deliver such
agreement, instrument, certificate or the like or purchase price (as applicable) to such other party on the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[SIGNATURE PAGES CONTINUE]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 125 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>



<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Washington, DC 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>FORM 8-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>CURRENT REPORT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Pursuant to Section&nbsp;13 or 15(d)
of the</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Securities Exchange Act of 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Date of report (Date of earliest event
reported): June 20, 2016</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Commission File Number: 001-37544 </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="text-transform: uppercase"><B>AmpliPhi
Biosciences Corporation</B> </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>(Exact name of Registrant as specified
in its charter)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>Washington</B></FONT></TD>
    <TD STYLE="width: 50%; font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>91-1549568</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>(State or other jurisdiction of incorporation or organization)</B></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>(IRS Employer Identification No.)</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>3579 Valley Centre
Drive, Suite 100</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>San Diego, California
92130</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>(Address of principal
executive offices)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>(858) 829-0829</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>(Registrant&rsquo;s Telephone number)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>N/A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>(Former Name or Former
Address, if Changed Since Last Report)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><B>&nbsp;&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions (see General Instruction
A.2. below):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; font-size: 10pt"><FONT STYLE="font: 10pt Wingdings">&uml;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; font-size: 10pt"><FONT STYLE="font: 10pt Wingdings">&uml;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; font-size: 10pt"><FONT STYLE="font: 10pt Wingdings">&uml;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; font-size: 10pt"><FONT STYLE="font: 10pt Wingdings">&uml;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Item 5.02 Departure of Directors or
Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(e)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At the 2016 Annual Meeting of Shareholders
(the &ldquo;<B><I>Annual Meeting</I></B>&rdquo;) of AmpliPhi Biosciences Corporation (the &ldquo;<B><I>Company</I></B>&rdquo;),
the Company&rsquo;s shareholders approved the Company&rsquo;s 2016 Equity Incentive Plan (the &ldquo;<B><I>2016 Plan</I></B>&rdquo;)
and the Company&rsquo;s 2016 Employee Stock Purchase Plan (the &ldquo;<B><I>ESPP</I></B>&rdquo;), each of which had been previously
approved by the Company&rsquo;s Board of Directors (the &ldquo;<B><I>Board</I></B>&rdquo;) subject to shareholder approval.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Detailed summaries of the material terms
of the 2016 Plan and the ESPP are set forth under the captions &ldquo;Proposal&nbsp;2&rdquo; and &ldquo;Proposal 3,&rdquo; respectively,
in the Company&rsquo;s definitive proxy statement for the Annual Meeting, filed with the Securities and Exchange Commission on
May 20, 2016 (the &ldquo;<B><I>Proxy Statement</I></B>&rdquo;). Those summaries are qualified in their entirety by reference to
the text of the 2016 Plan and the ESPP, which are attached as Exhibit&nbsp;99.1 and Exhibit 99.3, respectively, to our Registration
Statement on Form S-8 (No.&nbsp;333-212183), filed with the SEC on June&nbsp;22, 2016.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>Item 5.07 Submission of Matters to a Vote of Security Holders.
</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 20, 2016, the Company held its
Annual Meeting. As of May 20, 2016, the record date for the Annual Meeting, 8,242,528 shares of the Company&rsquo;s common stock
(&ldquo;<B><I>Common Stock</I></B>&rdquo;) were outstanding and entitled to vote at the Annual Meeting. A summary of the matters
voted upon by shareholders at the Annual Meeting is set forth below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A total of 6,718,122 shares of Common Stock
were present at the meeting in person or by proxy, which represents approximately 81.5% of the shares of Common Stock outstanding
as of the record date for the Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Proposal 1. Election of Directors.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&rsquo;s shareholders elected
Louis Drapeau and Michael S. Perry, Ph.D. as Class I Directors to serve until the Company&rsquo;s 2019 Annual Meeting of Shareholders,
Vijay B. Samant as a Class II Director to serve until the Company&rsquo;s 2017 Annual Meeting of Shareholders, and Paul C. Grint,
M.D. as a Class III Director to serve until the Company&rsquo;s 2018 Annual Meeting of Shareholders, in each case until their respective
successors are duly elected and qualified. The final tabulation of voting results in the election was as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-decoration: underline; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><U>Name</U></FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-decoration: underline; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><U>Votes For</U></FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-decoration: underline; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><U>Votes Withheld</U></FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-decoration: underline; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><U>Broker Non-Votes</U></FONT></TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: bottom; text-align: justify; width: 24%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Louis Drapeau</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; width: 2%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify; width: 22%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">3,575,954</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify; width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; width: 2%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify; width: 22%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">1,908,800</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify; width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; width: 2%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify; width: 22%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">1,233,368</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify; width: 1%">&nbsp;</TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: bottom; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Michael S. Perry, Ph.D.</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">3,509,880</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">1,974,874</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">1,233,368</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: bottom; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Vijay B. Samant</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">3,750,926</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">1,733,828</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">1,233,368</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: bottom; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Paul C. Grint, M.D.</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">3,841,261</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">1,643,493</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">1,233,368</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Proposal 2. Approval of the AmpliPhi
Biosciences Corporation 2016 Equity Incentive Plan.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&rsquo;s shareholders approved
the 2016 Plan. The final tabulation of voting results on this matter was as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="padding-right: 3pt; text-decoration: underline; text-align: justify"><FONT STYLE="font-size: 10pt"><U>Votes For</U></FONT></TD>
    <TD STYLE="padding-right: 3pt; text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 3pt; text-decoration: underline; text-align: justify"><FONT STYLE="font-size: 10pt"><U>Votes Against</U></FONT></TD>
    <TD STYLE="padding-right: 3pt; text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 3pt; text-decoration: underline; text-align: justify"><FONT STYLE="font-size: 10pt"><U>Abstentions</U></FONT></TD>
    <TD STYLE="padding-right: 3pt; text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 3pt; text-decoration: underline; text-align: justify"><FONT STYLE="font-size: 10pt"><U>Broker Non-Votes</U></FONT></TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: bottom; width: 24%; text-align: justify"><FONT STYLE="font-size: 10pt">3,360,379</FONT></TD>
    <TD STYLE="vertical-align: top; width: 1%; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 2%; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 22%; text-align: justify"><FONT STYLE="font-size: 10pt">2,074,152</FONT></TD>
    <TD STYLE="vertical-align: top; width: 1%; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 2%; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 22%; text-align: justify"><FONT STYLE="font-size: 10pt">50,223</FONT></TD>
    <TD STYLE="vertical-align: top; width: 1%; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 2%; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 22%; text-align: justify"><FONT STYLE="font-size: 10pt">1,233,368</FONT></TD>
    <TD STYLE="vertical-align: top; width: 1%; text-align: justify">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Proposal 3. Approval of the AmpliPhi
Biosciences Corporation 2016 Employee Stock Purchase Plan.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&rsquo;s shareholders approved
the ESPP. The final tabulation of voting results on this matter was as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="padding-right: 3pt; text-decoration: underline; text-align: justify"><FONT STYLE="font-size: 10pt"><U>Votes For</U></FONT></TD>
    <TD STYLE="padding-right: 3pt; text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 3pt; text-decoration: underline; text-align: justify"><FONT STYLE="font-size: 10pt"><U>Votes Against</U></FONT></TD>
    <TD STYLE="padding-right: 3pt; text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 3pt; text-decoration: underline; text-align: justify"><FONT STYLE="font-size: 10pt"><U>Abstentions</U></FONT></TD>
    <TD STYLE="padding-right: 3pt; text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 3pt; text-decoration: underline; text-align: justify"><FONT STYLE="font-size: 10pt"><U>Broker Non-Votes</U></FONT></TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: bottom; width: 24%; text-align: justify"><FONT STYLE="font-size: 10pt">3,556,423</FONT></TD>
    <TD STYLE="vertical-align: top; width: 1%; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 2%; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 22%; text-align: justify"><FONT STYLE="font-size: 10pt">1,877,789</FONT></TD>
    <TD STYLE="vertical-align: top; width: 1%; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 2%; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 22%; text-align: justify"><FONT STYLE="font-size: 10pt">50,542</FONT></TD>
    <TD STYLE="vertical-align: top; width: 1%; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 2%; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 22%; text-align: justify"><FONT STYLE="font-size: 10pt">1,233,368</FONT></TD>
    <TD STYLE="vertical-align: top; width: 1%; text-align: justify">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Proposal 4. Approval of the Company&rsquo;s
reincorporation in the State of Delaware, to be effected through a merger with and into a newly formed and wholly owned Delaware
subsidiary.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The proposed reincorporation of the Company
in the State of Delaware, as detailed under the caption &ldquo;Proposal 4&rdquo; in the Proxy Statement, was not approved at the
Annual Meeting, as the requisite number of votes needed for shareholder approval was not obtained. The final tabulation of voting
results on this matter was follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="padding-right: 3pt; text-decoration: underline; text-align: justify"><FONT STYLE="font-size: 10pt"><U>Votes For</U></FONT></TD>
    <TD STYLE="padding-right: 3pt; text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 3pt; text-decoration: underline; text-align: justify"><FONT STYLE="font-size: 10pt"><U>Votes Against</U></FONT></TD>
    <TD STYLE="padding-right: 3pt; text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 3pt; text-decoration: underline; text-align: justify"><FONT STYLE="font-size: 10pt"><U>Abstentions</U></FONT></TD>
    <TD STYLE="padding-right: 3pt; text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 3pt; text-decoration: underline; text-align: justify"><FONT STYLE="font-size: 10pt"><U>Broker Non-Votes</U></FONT></TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: bottom; width: 24%; text-align: justify"><FONT STYLE="font-size: 10pt">3,655,570</FONT></TD>
    <TD STYLE="vertical-align: top; width: 1%; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 2%; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 22%; text-align: justify"><FONT STYLE="font-size: 10pt">1,791,938</FONT></TD>
    <TD STYLE="vertical-align: top; width: 1%; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 2%; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 22%; text-align: justify"><FONT STYLE="font-size: 10pt">37,246</FONT></TD>
    <TD STYLE="vertical-align: top; width: 1%; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 2%; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 22%; text-align: justify"><FONT STYLE="font-size: 10pt">1,233,368</FONT></TD>
    <TD STYLE="vertical-align: top; width: 1%; text-align: justify">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Proposal 5. Approval of the issuance
by the Company of up to an aggregate of 1,037,053 shares of common stock as and to the extent required to be issued pursuant to
the terms and conditions of that certain Common Stock Issuance Agreement, dated April 8, 2016, by and among the Company and certain
former holders of the Company&rsquo;s Series B Convertible Preferred Stock</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&rsquo;s shareholders approved
the issuance by the Company of up to an aggregate of 1,037,053 shares of Common Stock as and to the extent required pursuant to
the terms of a Common Stock Issuance Agreement. The final tabulation of voting results on this matter was as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="padding-right: 3pt; text-decoration: underline; text-align: justify"><FONT STYLE="font-size: 10pt"><U>Votes For</U></FONT></TD>
    <TD STYLE="padding-right: 3pt; text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 3pt; text-decoration: underline; text-align: justify"><FONT STYLE="font-size: 10pt"><U>Votes Against</U></FONT></TD>
    <TD STYLE="padding-right: 3pt; text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 3pt; text-decoration: underline; text-align: justify"><FONT STYLE="font-size: 10pt"><U>Abstentions</U></FONT></TD>
    <TD STYLE="padding-right: 3pt; text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 3pt; text-decoration: underline; text-align: justify"><FONT STYLE="font-size: 10pt"><U>Broker Non-Votes</U></FONT></TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: bottom; width: 24%; text-align: justify"><FONT STYLE="font-size: 10pt">3,707,601</FONT></TD>
    <TD STYLE="vertical-align: top; width: 1%; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 2%; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 22%; text-align: justify"><FONT STYLE="font-size: 10pt">1,636,714</FONT></TD>
    <TD STYLE="vertical-align: top; width: 1%; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 2%; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 22%; text-align: justify"><FONT STYLE="font-size: 10pt">140,439</FONT></TD>
    <TD STYLE="vertical-align: top; width: 1%; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 2%; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 22%; text-align: justify"><FONT STYLE="font-size: 10pt">1,233,368</FONT></TD>
    <TD STYLE="vertical-align: top; width: 1%; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Proposal 6. Approval of the issuance
by the Company of up to an aggregate of 4,706,000 shares of common stock and/or warrants to purchase common stock in a financing
that does not constitute a public offering under NYSE MKT rules, for gross sale proceeds of up to $12,000,000 and at a discount
to the then-current market value of the Company&rsquo;s Common Stock not to exceed 15%.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&rsquo;s shareholders approved
the issuance of up to an aggregate of 4,706,000 shares of Common Stock and/or warrants to purchase Common Stock in a financing
that does not constitute a public offering, as detailed under the caption &ldquo;Proposal 6&rdquo; in the Proxy Statement. The
final tabulation of voting results on this matter was as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="padding-right: 3pt; text-decoration: underline; text-align: justify"><FONT STYLE="font-size: 10pt"><U>Votes For</U></FONT></TD>
    <TD STYLE="padding-right: 3pt; text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 3pt; text-decoration: underline; text-align: justify"><FONT STYLE="font-size: 10pt"><U>Votes Against</U></FONT></TD>
    <TD STYLE="padding-right: 3pt; text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 3pt; text-decoration: underline; text-align: justify"><FONT STYLE="font-size: 10pt"><U>Abstention</U></FONT></TD>
    <TD STYLE="padding-right: 3pt; text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 3pt; text-decoration: underline; text-align: justify"><FONT STYLE="font-size: 10pt"><U>Broker Non-Votes</U></FONT></TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: bottom; width: 24%; text-align: justify"><FONT STYLE="font-size: 10pt">3,709,098</FONT></TD>
    <TD STYLE="vertical-align: top; width: 1%; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 2%; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 22%; text-align: justify"><FONT STYLE="font-size: 10pt">1,726,320</FONT></TD>
    <TD STYLE="vertical-align: top; width: 1%; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 2%; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 22%; text-align: justify"><FONT STYLE="font-size: 10pt">49,336</FONT></TD>
    <TD STYLE="vertical-align: top; width: 1%; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 2%; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 22%; text-align: justify"><FONT STYLE="font-size: 10pt">1,233,368</FONT></TD>
    <TD STYLE="vertical-align: top; width: 1%; text-align: justify">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Proposal 7. Ratification of the Selection
of Independent Registered Public Accounting Firm.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&rsquo;s shareholders ratified
the selection by the Audit Committee of the Board of Ernst&nbsp;&amp; Young LLP as the Company&rsquo;s independent registered public
accounting firm for the fiscal year ending December&nbsp;31, 2016. The final tabulation of voting results on this matter was as
follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="padding-right: 3pt; text-decoration: underline; text-align: justify"><FONT STYLE="font-size: 10pt"><U>Votes For</U></FONT></TD>
    <TD STYLE="padding-right: 3pt; text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 3pt; text-decoration: underline; text-align: justify"><FONT STYLE="font-size: 10pt"><U>Votes Against</U></FONT></TD>
    <TD STYLE="padding-right: 3pt; text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 3pt; text-decoration: underline; text-align: justify"><FONT STYLE="font-size: 10pt"><U>Abstentions</U></FONT></TD>
    <TD STYLE="padding-right: 3pt; text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 3pt; text-decoration: underline; text-align: justify"><FONT STYLE="font-size: 10pt"><U>Broker Non-Votes</U></FONT></TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: bottom; width: 24%; text-align: justify"><FONT STYLE="font-size: 10pt">6,650,930</FONT></TD>
    <TD STYLE="vertical-align: top; width: 1%; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 2%; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 22%; text-align: justify"><FONT STYLE="font-size: 10pt">12,967</FONT></TD>
    <TD STYLE="vertical-align: top; width: 1%; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 2%; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 22%; text-align: justify"><FONT STYLE="font-size: 10pt">54,225</FONT></TD>
    <TD STYLE="vertical-align: top; width: 1%; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 2%; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 22%; text-align: left"><FONT STYLE="font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="vertical-align: top; width: 1%; text-align: justify">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; text-align: left">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Date: June 23, 2016</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt"><B>AmpliPhi Biosciences Corporation</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 6%"><FONT STYLE="font-size: 10pt">By: </FONT></TD>
    <TD STYLE="width: 44%; border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ Steve R. Martin</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD NOWRAP><FONT STYLE="font-size: 10pt">Name:&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Steve R. Martin</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Title: </FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Chief Financial Officer</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->
















</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>line.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 line.gif
K1TE&.#EA 0 ! (       /___R'Y!       +      !  $   ("1 $ .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 logo.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  M *0# 2(  A$! Q$!_\0
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=DC 9XHLAR><].N" ?I17N&!Z45?M%V*]HNQ__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>sig_jcook.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 sig_jcook.jpg
M_]C_X  02D9)1@ ! 0$ KP"O  #_X@H@24-#7U!23T9)3$4  0$   H0
M  (0  !M;G1R4D="(%A96B                !A8W-P05!03
M                        ]M4  0    #3+
M                                              ID97-C    _
M 'QC<')T   !>    "AW='!T   !H    !1B:W!T   !M    !1R6%E:   !
MR    !1G6%E:   !W    !1B6%E:   !\    !1R5%)#   "!   " QG5%)#
M   "!   " QB5%)#   "!   " QD97-C         ")!<G1I9F5X(%-O9G1W
M87)E('-21T(@24-#(%!R;V9I;&4              ")!<G1I9F5X(%-O9G1W
M87)E('-21T(@24-#(%!R;V9I;&4
M            =&5X=     !#;W!Y<FEG:'0@07)T:69E>"!3;V9T=V%R92 R
M,#$Q %A96B        #S40 !     1;,6%E:(                     !8
M65H@        ;Z(  #CU   #D%A96B        !BF0  MX4  !C:6%E:(
M     "2@   /A   ML]C=7)V        !      %  H #P 4 !D '@ C "@
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M 0$! 0$! ?_  !$( )P!"P,!(@ "$0$#$0'_Q  ?   !!0$! 0$! 0
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M=1U#PGJVK6MA?F$B=;.[EAN&@99EC,3*Y_"7]@3]C[Q)_P %-/!?AW_@H?\
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MUDC_ $[[_P 4^&=*UG1/#FJ>(M"TWQ#XF^W?\(YH-_J^GV>L^(/[+@6YU/\
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M6>U\-^)_'7B6\\/^$M/N!/+!;ZX=!OO%6I>'"+N"_P!&?5K1M(D_<ROYG/\
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M\%.?%WCG4M*F^(G[1?[??Q@^,=KI$6K:9?>(-+^"&OZWJMY\%[C7M.M=3O\
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M&C?"+5-3M=<\/&ZO)/A^^C3VL]CJ]SXFU.^U+PC?W]]X#%TZ'3O"FGP-<07
M7'WK1;LU?E>ZUU:?;75/UT/[;]5U73-#TS4=;UO4;#1]&T>PO-5U?5]5O+?3
M],TO3-/MY+N_U'4;^[DAM;&PL;6&6YO+RYEBM[:WBDFFD2-&88NGW/A7QYIG
M@OQIH.M6GB70)8[/QKX+\1>%_$<MUX<U_3]>\-ZA9:9K5I>Z#J/]C>+?#VJ^
M'_$<]]I7VIM6T*Y>?3/$-C$VH:?H^HVG\W7[(_A#Q'_P6_\ V3OV2?%_[<OQ
M?^+-YX-USX8^,O&OQ,^!?P:US0?@_P#!_P",_B;P!^T%XR^&FG7WQ1M?#7A@
M_$'5[34M#\+:5?ZCH&A_$/P[X;M/$ GU7PUH_A]I%AC_ *2_!WA#PQ\/O"/A
M;P%X)T/3O#'@SP1X<T/PAX1\-:1;K::3X>\,>&M,M=&T#0]+M4^2VT[2=*LK
M2PLK=?EAMK>*->%%!+5M+ZIM/LK:;]?NM\SHZ***!!1110 4444 %%%% !11
E10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>spacer.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 spacer.gif
K1TE&.#EA 0 ! (           "'Y! $     +      !  $   ("1 $ .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>tex5-1logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tex5-1logo.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ +@". P$1  (1 0,1 ?_$ +$   (" P$!
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M2>S=8:]JR!F'W%5!_$:Z_P S])K/P8LS8/>=K-E@A(2YQTMO"[4X#SH[BX=
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MR\:LDZ&R*SQ2=DD<@97!-1WZB]X!\UC5]M\K8+K\S)OL:93I-BM$"PESM4I
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..S&%,;%.4GM74AI>Z_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>tex99-1logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tex99-1logo.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ /0#F P$1  (1 0,1 ?_$ +L   (" P # 0
M       *" D$!@<"!0L# 0 " @,! 0$             !P4& P0( @$)$
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M9MB(AE8)7$6'\CY+C8*1<KLX^9?4BHR]D:1;YVV(HY;-'Z\:5)11,ICD(81
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M2-(:KE:NKW-,J5"6)Q6Z(W<&]!YJ1*UC ,!@]_LINOEIB\A?)*K5I2DI,B:
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M2!J0HM!"QQ]11$^<C658F'=VVKQN&G4*4PJU*&5$#4VI324+3Q]12A/B9$3
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M7'(V!4\;G?8Y.O -#2K!U;P4='!Z5B=%HI\ .</3S03>V;#%];,!?AOE'AS
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#(__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>v439550_proxycard-1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 v439550_proxycard-1.jpg
M_]C_X  02D9)1@ ! 0$ KP"O  #_X@H@24-#7U!23T9)3$4  0$   H0
M  (0  !M;G1R4D="(%A96B                !A8W-P05!03
M                        ]M4  0    #3+
M                                              ID97-C    _
M 'QC<')T   !>    "AW='!T   !H    !1B:W!T   !M    !1R6%E:   !
MR    !1G6%E:   !W    !1B6%E:   !\    !1R5%)#   "!   " QG5%)#
M   "!   " QB5%)#   "!   " QD97-C         ")!<G1I9F5X(%-O9G1W
M87)E('-21T(@24-#(%!R;V9I;&4              ")!<G1I9F5X(%-O9G1W
M87)E('-21T(@24-#(%!R;V9I;&4
M            =&5X=     !#;W!Y<FEG:'0@07)T:69E>"!3;V9T=V%R92 R
M,#$Q %A96B        #S40 !     1;,6%E:(                     !8
M65H@        ;Z(  #CU   #D%A96B        !BF0  MX4  !C:6%E:(
M     "2@   /A   ML]C=7)V        !      %  H #P 4 !D '@ C "@
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M 0$! 0$! ?_  !$(!X4%T ,!(@ "$0$#$0'_Q  ?   !!0$! 0$! 0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **S=&UK1_$>E:?KWA[5M,UW0]7M(;_2M9T:_M=4T
MK4[&Y026][I^HV,L]G>VEQ&RR0W-M-+#*A#1NRD&M*@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH ***_,CXK_\ !4;X1_"2^_;*L-9^'OQ&U.3]BS_A
M4/\ PG;Z8/#.SQ7_ ,+B\1>'_#>B?\(E]JURW8_V7=>(;:?5?[8&F_Z/!/\
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M?S+A]9@:W^S+.NV*7S&0[ W/>,/^"JOP@\&?M@^ _P!C6^^'/Q)N_''C^_\
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M3'8Z'-EN?8/%97B+U(IXFC-T95Z/+B)E%%%<)\<%%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110!B^'/#?AWP?H.D^%O".@:+X6\,:!86^E:%X<\.:78Z)H.BZ9:1B
M*TT[2=(TR"UT_3;"UB58[>SL[>&W@C 2*-5 %;5%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_P"SL_V8_P#U([VOTD_8G_Y2X_MX_P#9O'[*/_JE_@S7SN:?\DUFO_8EJ_\
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M_P :Z7]D7_DT;_@FS_VF?^'G_I-X&I/CC_R3O_@HM_VF>TK_ -2?XUUZ<O\
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MQ_Y)9^QK_P!I[8?_ %(?#=+\:O\ E8\T;_LK7P"_]9S^'%)\,?\ DEG[&O\
MVGMA_P#4A\-USU/^1?P[_P!DGPY_ZK^,CP\=_P D+X"_]HQ^ ?\ ZPWTLS]
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M&&63S*<HP?9_MA?\DM_X+>?]G9_LQ_\ J1WM?I)^Q/\ \I<?V\?^S>/V4?\
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MBXYO/"O$QRF6%Q4<UEE<L+B8X?JOV1?^31O^";/_ &F?^'G_ *3>!J3XX_\
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MZAJO@R2P@U:;POHVJQZ;->QVMU):1WC0O<I;3M"KK#(5\Y^,_P"SK^T%JO\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M ,"_V9/VF_C-X4^&?[7/_!07]JZ^MOC3_P %,_BI:?"+7/A-X'_8PT/]BSP
M_P 0/VG/V1/A/\,_@Q\2/A_X+_97^#WP)@\*?"7PW\ ?VB)3PW^S]\+9_C/J
MC_M,_#SP/^T;X,^$GP/^#7PJ^%7PX^ MQ\7OBKH/@WQ/X3\*:/\ &;X$>.?V
M2OB_^UC\9/VS;/X\>!S\//BOJW@KX5?LG:?J$G['7QQ^)/[9/_!'/X8?M%_
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M/PN^*WC7]L#P[IUYJ_PBMXOZ+:#&?Q/Y?DOUN%%%%! 5XA\9?VF_V;?V<_\
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M3)X=_P"%U^7_ ,+-%W\&O W[*^@?'GQ7\?/%>FZ/X(\&V]G_ ,)OX9\1W/\
M+%\2/^"AWCS]LO\ :GUGX^?L^?M(?VE^TE\,_P!EC3K/X"7FH?L]?LVZ%\?'
M^.GBCXX6/QBLOA=^R6NOZK^SOKE]X'70_"_@G]G'QA\!O&_Q-_;V_:%M;G]H
M;]I'X#_L^>!/^"A/PE^(?Q*_:2UON/VH/A1^S)^T-\2?A_\ $SX':G_PVO\
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M%?@G5-1T+6OB[XGC\0:##HGANYMM$TK5IOB!XN\ ^&O$O\3_ .PO_P %]/\
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MTNQL?[1UG4]1U6]\C[3J-]=WDLUQ)_I)U_CS?\%-?^4D?_!0;_L]_P#:O_\
M5\^/J_V&:#2JDE"R2NM;*U](A11108G^;9^PO_P7T_X*T_&/]MO]CKX1?$?]
MK#_A(_AY\5/VI_V?/AOX]\/?\**_9JTC^WO!?CCXM^$?#'BG1O[6T'X-Z7KF
ME_VIH>J7UC_:.C:GIVJV7G_:=.OK2\BAN(_]).O\>;_@F5_RDC_X)\_]GO\
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M<?%_P/\ "GX-?$\%O/R<O)[OY+^EY(W/^":G[6_[7_[2/QVM7^*/CCX5ZM\
M;_X5_%+6?"VB:3\3_!WBOXL:K?Z9\,/^"9OB#X/>,O$^BS_LJ_LH>)-8T/XC
M?#/XO>+/VL[?Q?\ #?P<_AOPG#^VEX>^"/QW^'_P ^(_PV^'GPLM?W:K^6+_
M ((>>'_BEJ_[25IXH3]E7P/\/?V;?A%^Q!;_  .^"_QA\&^/OA#\8-!\)Z4_
MCSX2V=Q\$-#_ &D?@)\'/@M\*_VLO''Q3^*GPF^/W[6G[1_Q*\'^(/VE/!?P
MU^)/Q.\._#;2M7_9C^+4W[0O@+XP?U.T!-)2LK;+:WGVZ]S\L?\ @KA^U/\
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M?&?]GK]E;_@HU_1=^T5_P00\%^$?&GCS]J;_ ()R?M'_ +4_[&7[2_B'P/\
M$G1OB1<^ O&VJ_'_ %7X_P"E>/M*\<:G\0K&:^_:'^-?@CQ.GQP^)GB?6/"V
MH:#\2/&'[2&A>"_!WC3P=X6^(-GIWA'XD6-K\7?#WX@_&WX1_MQ_LV?%+]F'
M]C;]H_P=^RQXV_M'P/\ M._$G3_CK^S5IGAW_@E;XB\,W/[,7PA^*?[5:?LZ
M_"3]KCP5\*/AEX'D^!_P4\<>(O@;^WGHGCCQG^SC:? .7]N.]'A7XA^/+C_A
M1OQ/USPF'0I1E9JSMT>CM;735/7L^O<^5_"_A?X0ZQ^S;\7V^,GQ0_X:+T/0
M/ _[%7[&G@/XG_#O]JWX6_$#]GKX/>-/&O@,:?\ !GXQ?#;P5^WQ^U=\&_%G
MA?\ X1[X"?M!?M#6'B;]G7XK?L>W6E?!'XZ>!OVC/&/[-_[7O_!/K0_#?Q'?
M]F?W#3?V5/CA\0_B]^T=XXUKP'\</!7AC7?^%H_'K3/AA??L%_LL?MZ:K9_'
MSX4?%+X@_LJ_%WPQIW@>Q_;#E\4?\%$_''[/WB?X?6O[,NC?M+?''X/_ !WN
M;/QI^UO\2/VS/CQ\._V4/$_[15M^UO\ $/Z+;XG?%CX;^+?VO?AQ\1?"&N:#
MH!^%?@+5OAA:_#']F>&Q^,MI\=IO@E^PA\%?V>OV2O@IH7AG]EC0/B9^SO\
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M?PEJ6C^)/"]A;^)[6;5CX$\1>/= \0_8?_!,G_@@I\?/VSO^$.^-W[1FI?\
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M:6NFZ3I.FVMM8:=86UO9V=O#;PQQK_D!?\$RO^4D?_!/G_L]_P#90_\ 5\^
M:!PDY^UD^VB[*TK+^NI_L,U_+%_P=U_\HW/@E_V>_P##;_U0W[2M?U.U_+%_
MP=U_\HW/@E_V>_\ #;_U0W[2M!C3^./K^C/XG_\ @G/_ ,%&/C;_ ,$QOC;X
MI^/7P%\+?"OQ=XP\6_"O6_A%J6F_%W1/%NO>&X/#>O>+? _C.\OK&S\&>./
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MF_X*:_\ *2/_ (*#?]GO_M7_ /J^?'U?ZG7_  \U_P"";G_20;]B#_Q*_P"
MW_S?4&]5-JG9-Z=$WTCV3/M^BO$/@U^TW^S;^T9_PDG_  SW^T'\#_CO_P (
M=_8__"7?\*:^+'@/XG_\(K_PD/\ :G]@?\))_P (1K^N?V'_ &Y_8>M?V/\
MVG]E_M/^Q]4^Q>?_ &?=^3[?0<^VY_CS?\$RO^4D?_!/G_L]_P#90_\ 5\^
M:_V&:_QYO^"97_*2/_@GS_V>_P#LH?\ J^? -?[#-!O7WCZ/\SYT_:[UOPWH
M/[+WQ\NO%_@_XJ?$'PWJ'PK\8^&-5\#?!'X.6'[07Q8\70^,M'N?",?A[P+\
M&]=\%_$/P?X]US5;C6X;.+2?B/X,UWX3PPRSZE\6[>#X9V/BN]MOXNOV'?\
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MOB?8^%?%'BZ7X4_#'[?_ ."QGQM_X5)^Q+XZ\(Z-\(OCA\</B?\ M'?\)/\
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MSU[3O!=YX$\,:_-\4?#UE;ZYXP_X0_0[BR_L'PC\2O\ A./AM-<^'O"W]O\
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M]H_\(]X\^)7C?_A)/[?_ .%R_#S[']L_X6'_ &9_8_\ 8MU]G_L?[;_:D_\
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ML?$&[^&OQAU/XW_LB^)O@?\ "[]GVW_9"\%^-]-TK]ICXM_"'6?CHV@?M(>
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M"> =%^&OPP\-^ 9O%_Q/\":VOC(^%_ ^NQ[G@OX)?\/Y?^"H7_!17PC^UO\
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M_#%QKNA:3XD\.^&]&TG2O$WB'XA:^^I>+[[Y7^-W_!'7]HOX6_M0^.OVL?\
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M>_[$G[9W['/_  C/@CXR_P#!1;_AJC]GCX<_ _1?@U\*?@?_ ,,B_"KX'_\
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M6]\C[3J-]=WDLUQ(!-IJ-GJE9I7M:RMHTK/NE==;W9^+O_!Q7^VG\6/V)O\
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M]@;_ (8&_P"&./\ A2/P/_X6?_PH_P#X03_AKO\ X4SIO_"Y_P#A<_\ 9O\
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MEM_B7X;MO%/AP:#J4>HSW.H2)IEW$NI+<:=8"UN@\437" 2G"ID^:4:,Z]7
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M9I+6\V%&_LG+%5N7#V>1J2I2RK&QJQJ2HR@Z2YE5CB'A94VO:_$L3&5!J_\
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MIX:7/22M7JXQY?3I/]Z_?GC8O"Q76LG"Z7O&&;^"WBSD$:LLZ\/.*<KC0S?
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MXE^"?[-G[.GCKQ]?_$[PW^R-^SIX(^#O@/X5_M7W_P"R\OBOXK^-M<^(VO\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M3A+_ -C&\0S]4OV)/^4K/_!5;_NW[_U$;FOYM_V4/^1._P""JO\ V;#XM_\
M5[> *_I(_8D_Y2L_\%5O^[?O_41N:_FW_90_Y$[_ (*J_P#9L/BW_P!7MX K
MS,@_B9__ -B3PP_]XA^>>"'^_>-__9H?V<_Y^$!T?P&_Y1T^!_\ M+C\#?\
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M?^]4KR<__P"19F7_ &&T?_6VX=/S#QN_Y-WXA?\ 96Y7_P"Q@^ Q^"?[)O\
MRC(_X*V_]V%_^M ^)*^R/V./^2#_ /!)/_M))XY_]"\)5\;_ +)O_*,C_@K;
M_P!V%_\ K0/B2OLC]CC_ )(/_P $D_\ M))XY_\ 0O"5?69[\.?_ /93S_\
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M5?\ U)_@I7J'_!<?_E*%^RC_ -DE^!?_ *T+\6Z\O^!W_)._^"=/_:9[5?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M)'D*!%)'JG[-7PT^(]E^QA^RKIMY\/\ QM::C8_\%AO"OB&^L+GPIKL%[9Z
MGPI^$D#ZY=6LM@D]OHZ3V]Q"VIS1I9++!-&9P\3JOW^:UZ#Q&=6KT'?B#)&K
M5J+NEPIG<6U:L[I2:BVKI2:BVI-)_P!P^)F=9-/._%QPSG)YJIXY^#]6FX9O
ME,U4I4_HR^+]&I5@X9I-3ITZU2G1J5(.=.G6J4Z,ZD*M2%*?HGQ6_P"24?\
M!47_ +2^:#_ZM3XAUZW_ ,'*O_(]_LF?]BE\6O\ T\>!*Y3XH_#WQ]/\+/\
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MU]C_ +-\G[5_HWF?:=GVC]SN\SY:\S^"GP[^(%O\/O\ @GU%<>!?&,$FD?\
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M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7QYXG_X*'_L
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ME?\  ;_YOJ/^'FO_  3<_P"D@W[$'_B5_P !O_F^KY<_X<%?\$@_^C)O ?\
MX6?Q<_\ GAT?\."O^"0?_1DW@/\ \+/XN?\ SPZ->WX_\ /<[S^Z/^9]1_\
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M  2#_P"C)O ?_A9_%S_YX=&O;\?^ 'N=Y_='_,^H_P#AYK_P3<_Z2#?L0?\
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MS_I(-^Q!_P")7_ ;_P";ZC_AYK_P3<_Z2#?L0?\ B5_P&_\ F^KY<_X<%?\
M!(/_ *,F\!_^%G\7/_GAT?\ #@K_ ()!_P#1DW@/_P +/XN?_/#HU[?C_P
M/<[S^Z/^9]1_\/-?^";G_20;]B#_ ,2O^ W_ ,WU'_#S7_@FY_TD&_8@_P#$
MK_@-_P#-]7RY_P ."O\ @D'_ -&3> __  L_BY_\\.C_ (<%?\$@_P#HR;P'
M_P"%G\7/_GAT:]OQ_P" 'N=Y_='_ #/J/_AYK_P3<_Z2#?L0?^)7_ ;_ .;Z
MC_AYK_P3<_Z2#?L0?^)7_ ;_ .;ZOES_ (<%?\$@_P#HR;P'_P"%G\7/_GAT
M?\."O^"0?_1DW@/_ ,+/XN?_ #PZ->WX_P# #W.\_NC_ )GU'_P\U_X)N?\
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M:SW^COX@\(:KK&DIJEE!?64UWI[78N[:*\M9)H42XB9_S)_X<%?\$@_^C)O
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ K^9[_@@Y_R>K_P7S_[2-^./_5L?M%U_3#7\SW_  0<_P"3U?\
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MAXE\,_"FR\!>%/BO\,]/T[]DW]F^2UO(?$FM:IXV\4^,]*TK5M>C\-Z?X?\
M NC:=X*UOQ5K^B#2_#?B:&.74(=5L=*"?=>ONJ\;+;XI2=VUTY5U?E8\V_:$
M_P""QO[8OBW_ (*,?#'XL? KQOJ/A+_@EAX#_;H^!W["_B74[/2/"DVB_'+Q
MCJFIZCJ_Q?\ $L&L:UX:U'5GLK70;36%L)-,\0Z18_\ ",67@G5-.-OJ>OZ]
M<Z=^KG[;/[5_[0L?_!9K_@F9^PO\$/B3J?@;P-XK\)?$'XZ_M&Z/HUEHEXOC
MGP)I0\1ZIH6A>([K5M)U&[TG3%_X4QXITBTET2\TF]O)?&-S;W,\I.FF'\H_
MVL/^#;/XZ_#7]A_PQX+_ &3?VI?VI?VB/BC\+O&7P_\ 'W@S]F3Q1\5?!/A+
M]G*#XA2:F]OX\^(7@/P9XVU+PSX+\(:YI<?B+Q9KNC7^H:ZNMS:??:KIEQ?:
MS?ZM<QW_ +S\3/@__P %=_ O_!83XG_\%$OAE_P3ATS]H#PQ??L\^!_@E\+M
M%\1?M2?L\?#6#PK)<^"_AQ?>.M:MA??$K5=8:XL?&5K\2?#MI976FP6MSIWB
M&?48KRZ5;6YN0=H.S7+I&2ULKO11;N]]6[^6FQ_6;7\>/[2?_!3W]L*'_@O_
M .!?V8_A-\:]5T7]DCP;^T)^RY\ ?B1X&MM%\&SZ#KNO_$CPD/%/C"VN=2U'
MPW/XEAEEGC\4Z)=SPZS;&TN_"[/9,L'E2O\ TN_L:_$K]J[XK?"6]\4_MC?L
MUZ'^RI\5E\9:QIFG_"_0?BQX5^,L$O@RTT[1)-(\3WGBWP;<7>APWNK:I<Z[
M;'1H;F:>SM--L[BY*27IBC_D _:?_P"".'_!3GXU_!GXZ?$/0O@3_9O[4'QR
M_P""LOC7]I.WT./XR?!*QN_ ?P&M/!/B6'X:^,(O&J?$A-,C_L_Q1XSU&PM_
M#>CZG>>+M,LM#TO4&T/?(%@"8)7:E;:RO9I-WU^5MT>S_#'_ (*Z?M:?M<?\
M%LM$\+_"OXQ>(/ W_!.7PYKGQ9U@:58:'X/D\/\ Q ^$7[,7P^\3:OXX^(L^
MKZGH$WBNYT/XC>-]"6TTZ_L+^RM[>RUG3]!26*_T/7IK?Y;_ &4/^"BO[0_[
M4?P_\3?%SX\_\'"FA_L*^*-8^)GC*V\/? +5?V8_A[\4;S2?!$4MC>:%JQU^
M#4O!ILK:>XO]2T>PTB?3KRYCL-#MM2EU.X.J""U^T-'_ ."/O[8GP*\2?MMV
MOP8^":ZYX?\ !7_!++0_V"OV,-?A^('P?T34?BWXY^+,7AW5_P!H[XG6-KJ'
MQ!L+CX;ZC+\0/%'QK\26]]XX;PA/-9>)C)I N]2N$ME@_9.^ '_!2+]F+]G;
MX5_ ?4O^#=?]E+XS:I\.O#\VE:K\4_B#^T7^Q;J'C'QSJM]JVI:WJ>O:W<:K
M?Z_?+-=7^J7"VUI-K&H)I]C':Z?;SFVMH54+]RVBCM%+6"=K-MOFNKO1/K?3
MH<Q^VA^V_P#M+_!_]JS]BW]B!?\ @L%)\%_!,/[*%S\7OV@/VY_$7P.\ W<7
MCGQ1\1=:^(7C#X<O=?!^Z<SZ==W?AG3_  %X?T;0]/\ &%B-/T'Q+'KU\+RZ
MTZ[MKO[S_8_^'W[5W[5?@#X\']G_ /X.'IOVC[Z'2_!_A"T\=^'/V+/ -G;?
M!?Q#<^,-"\93ZQ#IDWQ%M+?Q#KGB;PKX4UGP;%;W=XEGI.B>)-8U!K>?4&TN
M2W^1_B)^R1_P4K\)_P#!4K]KK]KZW_X)(_![]LWX9?$CPMX0^#WP<\._$KX]
M_LMZ+X!\(^!? .A> M!L_$'A#PGXZ\1ZEJ.F_P!KCP'#-I<6I>$_"FL:=8:K
MJBW6GV<^JWME'^WG['0_:FT7]EW]HCQ%XA_X)S?!7]A?X]PP^,F^$WP/^#WC
M3X(>)[/XJ:WHOP\COO OB+Q!XE\ 2Z-\/[";6/&=]+X0L;3Q7K-F^G1:9=7^
MLW.FZ)>VUW($R:25N79:^X]6[NZMS:7MVT['X0_\$W]0_P""J/[;.L?M;>.M
M>_X+$^// ?P*_8__ &AM>^%Q\53_ ++OPHUN7XS>%? -UJFL>*?$5Q:PZOI,
M?PT^U>#K+0]1;3[:^^(LVFMXFDC-U=KI,$VL_'WC#_@KG_P4JU/_ ()N:'\;
MO WQT\<'XZ_M>?\ !1[X@^"?V>=,LO"'P\U'Q!X;_9Q^&W@.*[U'P?X9TN+P
MI-;7\]U\2/&GA_0K[4;JSU::PLO#2Q?VH&U>1X?VA_8A_8*_;#_9&_X(0_'_
M /9VTSX3[OVY/CCH/[1^IZA\.5^(/PVEOXO'OQ<,WPIT'6)_B*GC-_AS<ZOI
MWPRTCPSXRCO;CQG+;+-:6^D7LQU*&;3AX%^R=_P24_:G\ ?'7_@B;H/Q&^$Z
MZ'\ _P!A3]G[XQ?%#XSZZ/B!\,]:M](_:L^./B+Q_P"+M7\ 1Z/IOC#4/$>N
MZCHOB-/AK<:KXK\/Z)KW@:ZT?2K?1-'\3S0V"S605>-Y/W;)Z*RU48M]%KS2
MM^1J^(O^"MOQ9_:E7_@A)H?[//QCD^&OB?\ :U\>:MXE_;&@T:P\)22VGA/X
M!R^&=.^.'AO45US0M5@\.Z+XBO-*^*5_X=U&S@TYH-%TFSUB\%K8FW5N8^'/
M[07[=/\ P5AE^-7[5VB_\%%=#_X)=?\ !//P+\5_$?PB_9^O;'P[X)@\6?$S
M5]$CLHX/%7CCQ1XU\0^#S'#JUM?P7+Z:?%QL!K"W?AO0_#<=QHVH>)[NK^PA
M_P $//C7^S;_ ,%A_C?\4O$W@N2R_86\*^&OVA=5_9A\7VOCGP5=QZ?JGQ_T
M[1O#4O@CP]X+L_$E[X\\*7_AKP1XW\>>&+K7]4\(Z3I5^?!ZW,5]=#6-,-]X
MO\.OV/O^"GG[)O[.OBC_ ()E>,/^"5_P>_X*/?L[^'_C)XE^(OP*^+.N?'7P
MK\-_!UP-5U'4)]*UOQIX4O\ Q?8ZM%<027VJZFVB:EJOA&XT>XUBZL$U+7[:
MWT[5[D%[GV7&]DTWRZ*3;>^EXJRUV5S]\?\ @D7\3OVO/'/P4^)'A;]K_P"+
M'P*_:$\3_"OXJ:KX,\ _M!? SXA?#/QI9_%/X>PVL,FB:IXWTOX8ZC>Z9X6\
M7QQHNH"WU6TT37=0\/:WH;:YI)U^SUC5=5_-']KK_@I!^T/X!_X*E?MM^"_!
MOQ7U'P[^SK^P3_P30\<_&CQ;\.[2R\,R:%XJ^/6I>";/4?AN^J:KJ6@WFJQZ
MYJ&N?&KX?6NG:5%JG]E3-X6M);C3YB-1BF_0K_@AW_P3_P#B)_P3H_8AM/@_
M\9/^$.'Q@\<?$[QC\7?B'!X(N_[3T;2M1\26>@:#HV@_VNMAIMM?W>D>&/"N
MBPZA_9EJ-$L]2EO;+1KG4K&"+5;_ /#SXZ?\$Q_^"F/Q$\$?\%JO&^D?LXS3
M?&/]OK]I;X2>%/@[H]Q\7?@'!J,7[*?@#XF^*O&]]KUQKLWQ1_L71X=5T'0O
MA?X9U;PWJ>J6/B686X%KH4EM#>26P)<KE*[C;1+9+5I-I=+)-^5^AQG[&G_!
M<+]I^7_@E;_P4@O?VB_B;J=U^V)\ ? ?@;QY\&/'FOZ#X>TGQ/>^!_VHK7P?
MX.^%GB73]#T_1++P]J<G@?Q-XNT3QAIU]<:3);7NC^-/"KWME?V,%U)+5^/W
M_!0_]L'1_CA_P3Z_99\=_P#!3>X_8DCU?_@G]\./C?\ M6_M$>*OACX$^(8F
M^-7Q1TGQ)X\L_#T_A!M.T:VU"_M[.3PAX6LTT;5_#FGVMG?ZAJC1:@=,BM[[
MVO\ X*Z?\$%_CC\:_BS^Q9K/['OA*/6?!%K\%_A%^RA^U6FF>-_"'@5=.^&G
MP8U3P-:>#O'E]8>+O$_AZ7Q=:0^&]-6*XT3P[#JVKVDOPU\'RV>AW=\T$L?W
M5^SO_P $N==^*?\ P5._X*+_ +5?[=W[*7PF\8?!'Q38?##X8_LC:)\6](^"
MWQF\+:QX'\&Z;:>$W\5>'/ <NI^.W\ 7>G^'?AOX2D5O$VA^$]?F3QSJ<=M9
MF:?Q+;6H5>G\5EJF[:73TBDD].\K;=3X7\1?\%#_ -H;]E3]GJ[\0? /_@IW
M9?\ !7/X^?M<_&[P-^R3^RU:'X >%?A+X.^#'Q1E@CU3QGXAO=.TW7];;XB>
M([JU\=?"_2= T/4+C3M(TG5M>TB]U:VUW2[R_P!.6_\ M>>(?^"N_P#P1O\
M ?P-_;>^-/\ P43;]L3PCKWQC\'^!?VD_P!G/6OA7X>\/^$HK/Q;9:[K^HVO
MPP\0K,DZ16]MH.KZ5I>KZ5HGPUGT_56T#4)-"U#P\^J>';;[L_X*F_\ !*GQ
MCJWAC]D7XS_\$OO@U\!/AS\7/V'?V@M3_:#\,? #POX1\#?!_P"'?Q9U?7Y/
MAK<:W<36.BP>$O!,OC0S?"'P/IXO_$5SHD]_X;BO[.W\6Z3>6.E17'@'CO\
M9E_X*=_\%D_B]^SUH_[>O[-WA/\ 89_8B_9]\>:;\6_%WPKM_BCX=^*?CO\
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M-TV;X@:9HVIQ^)=2T6!);O\ MC4M%UOP^(?T!_91_P""*>J_'VP_X*M^._\
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M&E'**_ \J-','4PWU:K5J<-<.X:G2A)8N4Y3GB*-6C&*H\SJTYPM='^H&?\
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MK-+BXFN]#TOPSK=Q=6\"2OBPF"AL9KY4^'O_  6M_9Z\'?L[^!_A!JOP"_;
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MWI\MU' EU8W%M?PEK.Y@GD_-#_@GI_P4]^&7[#7[,/A?]FOXU_L^_M:-\2/
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M?^"DFH:1\)O^$&TWP]\:+/X>?"S5;CP]J.G0VWPXFO?$&MWGASPIJFI19O-
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MK%X=\6W6OV5U?V4 AO\ [)I>KWUG;:7!<VEG9V/A_P#'K]NS]GK]H/\ 9P\
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MNFZ594L/6<'?^'BL/1Q-)W<(7;I5X<R2:C-3IMN5.:7J\8<&\0\!YW+A[BC
M3RW-HY9D6;RPT_:.V"XBR/*^(<LFIU,-A5.4LNSC!_6(PA..'QD<7@IU98C
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M*VMKVT%H/L2 7MI86TMT=#T[G?!G[0?[?'[/GQ:_95E_;-\1_"#Q=\+/VO\
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M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5_$3^R]^VU\<?\
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MAV_X*&?^$#K_ /\ ,'7].%% <T?Y%_X%(_F/_P"(BGXF?](=O^"AG_A Z_\
M_,'1_P 1%/Q,_P"D.W_!0S_P@=?_ /F#K^G"B@.:/\B_\"D?S'_\1%/Q,_Z0
M[?\ !0S_ ,('7_\ Y@Z/^(BGXF?](=O^"AG_ (0.O_\ S!U_3A10'-'^1?\
M@4C^8_\ XB*?B9_TAV_X*&?^$#K_ /\ ,'1_Q$4_$S_I#M_P4,_\('7_ /Y@
MZ_IPHH#FC_(O_ I'\Q__ !$4_$S_ *0[?\%#/_"!U_\ ^8.C_B(I^)G_ $AV
M_P""AG_A Z__ /,'7].%% <T?Y%_X%(_F/\ ^(BGXF?](=O^"AG_ (0.O_\
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M?69>''B/PFK>&^#^C_BO%?):6 RS Y1Q#6\3\/P[QS/AC&YM3\:,ZXXSKAK
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M^TOV9OV,/B)\.OC/XC_::_:7_:"N_P!I7X^ZOX!M?A9X<UU/ .A_#?PC\//
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MFJ3WFN6&M7&E:J(O]$GFFM5DA%KYDGZ/_MWIJ^L_\% _V&-*\&I"GBWP_P#
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M#C#$9-5P_!%7!8VJ\5B)XC(*-7_@E9=0VGA[]O*#6;A;?Q/8?\%'_P!J>_\
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MK6PN01R#%YOA9\+X3#9AB<3@JM6&7P_G_P#C/JOB7XD_\%2?VKQK_P"P_/\
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MX=BNKF/0]*N+B2QTF.YG2P@MUFD#?55A^Q=I_@W]L30_VJ_A)XUM/AKI5_\
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M#X2T#XHV>@>%YI-06[\*1Z5IWC"UTV73=)_LV.S>V>U^RVXB\B/ZV_9PM_\
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MD=\XUVYN)-UQR_FOB[]DGXM?M"_M&_LY_#OXF^+OCU\/_A[^R'^R5HA'QO\
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M'Q,<-2A1CB7#%TJSJOZLH3E&*^C+E&!J8S 8GCS'U,XXEGQ?B/!ZCA>%:53
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MBPV,Q'"ZR3.XYK7Q^:9GDLEDE#BO#9AD^68?#U>(\(LKJ5EEV8*K^FFO>(=
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M&LVL>'['6M-N];TJ)W6-9=2TJWN9+^QC9W1%>Z@B5G=5!)8 _P \&K>.)O\
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M3JK,EO$SRL 2J$ UNR21PQO+*Z111(TDDDC*D<<:*6=W=B%1$4%F9B%5022
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M+/6?%'C>QO;K4K"XOM-U;0+OQ% ;2ULXXM6O=,2S@3^QM 72YOA'^R3\(_\
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M%",V^:HX)_%Y?X.8'+.-/%W(?$#B/&91P]X*5,QH\5YQPMD^&S_-,TQ-/C;
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M Y=3<^&\]KYGEV45Z>>4W7R^A5RN<>7]#:*_/;]H[]N?Q%\,/C)9_LZ?L_\
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MZMYD$D,]O/&T4T,J,"KQRQNR.C AE8@C!KXQ_P"'</[!?_1HWP$_\-SX?_\
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M/VOM*M18;&3PF(E637-";Q/.USRG*HI.KS>\[]_$?!W$F29%P9QEGCH5<O\
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MV&9=/M=)D_91^!;Z997M_J-I8M\/=!-M;WVJ0:=;:C=PQ&TVI/>V^D:7#<2
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M$$2 +'$BHH  %7J_/W]JC]JWXB? []JC]@[X'>$]&\%ZAX3_ &HO&'Q6\/\
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MZYXO\-:YX(TRPT[QUI^M:GX;E@\2^+-*T*_>[L_#_B#PQJ<DT5I?2R6C0ZQ
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M+Q>*Q%2=;$8G%8K$U:^(Q.(KUJDZM>O7KUJU:K.=2K5J5)RG(HHHJ3 ****
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M9V;_  XUOQ!HO@KP"\UNNG)<))<ZMIFJ:;#*EJWGI';-.RRK+M_33XR?LU?
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MT74/AE'=Z1X=\*:FMO+!%*)[F72=7AN9Q)+#<"UA>-8I!-O^1_V]_#6H6O\
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M;CQ%]#%R2CA<5)M*EF+JMI1;2I+VK:2I?O'3/[A****_FX_Y_ HHHH ****
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MQ>'XGA*M6I4XX2JL-4G3S)2R^-;X0_MA^-/V<?@A_P $7O@_X;\+>&-?T/\
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MI"'X+:7X77_A+&\(7&AS:;X)U/\ M:_C/B :S+JRIXFO+;%OJUK9EX+:?[.
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M'QEHO_!1[P%^QE%X;\,S^ _%W[,5Y\;KGQ3(-57Q=:>)+;QIXS\.KI<#K?\
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M?_"[O"7_  D'_#3W_"_O^$T_X1+6/[&_LS_A'O\ A'?^$=_LS^U/MOV_RO\
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M&X2P<\;GF4X3'9IA<'E> PN?9A&E@L.GBLR>44\76IY?1QE'&_2_C_\ ;O\
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MZ>"Q,ZZHQJ8/V]7%UY8VCA(RIQA3H4\/*FYU)OFS3PB\&J>$X]XTROA3/O\
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M:?<PO-O2TLQ'J=@+:6W@:A\/Y,YXZ"P^)2X<K2IYDUC:K>;QAP]7S67+>C;
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MH]9TQ]6$GQY_9XEC.F)>P-?AXH/B*\TJ&U$NZ.%'E=<K&K.0#Z!_PVK\4_\
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MO-3DL[:\O$T^VO-2AGO7M;2ZN5MDE:"VGE"1-Z]17H/,\6Z>5TG*GR9/.K/
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M_8P^(_P6_;B_;)_:<\2>)/!.I>"/VB?^$?\ ^$-T71+O79O%6D_V9-#/>?\
M"3VM_H&GZ1:<Q%+;^RM9UCS@=\OV<C97Z5T5CA<PQ."H9AAZ$H*EF>%C@\6I
MTXSE*A#$T<7%4Y-ITI^VH4VYQ4FXJ4+6DVO'X:XYXAX3R?CG(LEK82EEWB)P
MWA^$^)X8G T<76KY-A>(,IXGHT\#7J5(3R[$K-LEP%26+H1JU)X>-;#.FJ=:
M52'YU?MK?L??$#]I7XV?L+_$OP;XB\':+HW[+_QWM?BCXWLO$UUK=OJ>MZ%!
MK_@'6&LO"L>E:)JMK<ZN8_"-W"L.KW>CV>^ZMF-\%$H7PO2_^"=WQ<LOC/\
M\%.?B+-XP^')T3]M?X0^*OA[\,[6*^\3-JGAO5?$/A+5-"BO/'4+^&([2QT^
MVO;Z*21] O?$5S):K)(MLLH6!_V)HKT,/Q)FN%PE'!4:E!4*&%>#IJ6&IRFJ
M#SC#9ZTYN:<I?VCA*,^=J_L5*A;DFY+[O(OI ^)7#?#66<)97CLFIY+E'#M3
MA; TJ^08+$XF&45/%?A_QIE3J8NIBH5*V(_U\X8RG%K%3IJHLJIXC)N1X7%5
M,33^2?V$_@#XK_9;_9-^#?P$\<:MX>USQ7\.]&URPUG5?"D^I7/AZ[N-6\7^
M(?$<9TRXU?3-&U*:&*VUB"!WNM,LW:>*7;%Y>QF\*_9H_8P^(_P6_;B_;)_:
M<\2>)/!.I>"/VB?^$?\ ^$-T71+O79O%6D_V9-#/>?\ "3VM_H&GZ1:<Q%+;
M^RM9UCS@=\OV<C97Z5T5SO.L>ZF=57.ESY_&I#,G[&%IQJXZ&83]BN:U!O$T
MXM.'-:%Z:T?,>#4\7>-:F.\6LQGBLM>*\;</CL-Q])93AE#%TLQXPP?'6*64
MT_;\N2REQ#@,/5A+"/$NG@U/ Q3I5'57P]^UE^RYXN_:!^*G[&_CWPWXA\.:
M+IW[-WQWM/BMXIL]<.I_;==T>WAL8VTW0/L%C=P'4F-JY7^T9K*UPRYGSG'W
M#117'7QE?$8?!86K*+HY?3Q%+#)0C&488G$O%UE.2=ZC==N47*SC'W%IJ?+9
MOQ9G6>9%PCPYF-:A4RK@?!9WE_#U*EA:5"MA\+Q#Q!4XGS2.)Q$).IC9U<WJ
MSJT:E>,98>@UAJ:=)*05^71_84^(1\3_ /!537?^$P\&_9_V]OAMH7@KX=0Y
MUOSO!M_I7P@^(OPZFN_&O_$KV"TDU/QE8WT7]A/JLWV"UN]\2W'DPR?J+16N
M!S+%Y=[?ZK.$?K,<-&KSTXU+K"8_"9G0Y>9KEY<7@</.37QPC*F[1G)KT.#N
M/^)>!/[9_P!7,3A,/_;]'A[#YE]:P&'QWM*7"W&W"WB%DZI>WG#V#H\3\&Y#
MB:\J=WBL)0Q&7U>7#XRM./@/[*WPDUKX"_LW_!'X+^(M3TO6==^&'PV\+>"M
M6U71?M?]DZA?Z#ID%C<7>G?;K>TO/LDTD1>'[3;03;"/,B1LBOS\^'W_  3R
M^+/A;4_^"MD^J>,/AW):?M_:5XET_P"%<EA>>)9[GPD^OZ#\;]+23X@6]QX:
MLXK-;:X^)^C.R^'+KQ&98;#4V!1TM8[K]@:*Z*&>9AAJN8UJ4Z2J9K6H5\8Y
M4(24JF&S6EG5)TTY)4DL?1A.48\RE2O1=H/F7O9-XQ\<Y!F/'N:9=C,MAC?$
MK-,FSGBJI6R?"5XXC,,@\2\N\6\MJX"E.M"&6PAQKE>$Q=:C0]M3KY=&IE,^
M7"U95H^ _LK?"36O@+^S?\$?@OXBU/2]9UWX8?#;PMX*U;5=%^U_V3J%_H.F
M06-Q=Z=]NM[2\^R321%X?M-M!-L(\R)&R*\!_97_ &2?&?P%_:;_ &Y_CAXB
M\2^&-9T#]J?QK\.?$_A#2-%.JG6/#MIX,A\?Q7UOXD^W:?:60N+L^+;(VG]F
M75]%BVNO.DC/E>9]^45C_:N,_P"%;WX?\+2MF'[J'[S_ &]9G^[U_<_[6E/W
M+^Y^[^'4\G_B)/%?_&S?]JP?_&W8N/&__"=AO]M3XVI^(3_L_P!__A)_XR>E
M#$WPGM/]D3R__=VYA7@/[5/PDUKX]?LW_&[X+^'=3TO1M=^)_P -O%/@K2=5
MUK[7_9.GW^O:9/8V]WJ/V&WN[S[)#)*'F^S6T\VP'RXG; KWZBN3#UZF%Q%#
M$T6E6PU>CB*3E%2BJM"K3K4W*+TDE4I0;B]))-/1L^7R/.,=P[G>3<0Y7.G2
MS/(,WRO/,MJUJ,,11IYCDV98#-<!4JX>HXTZ]*&-RW"3J4*DE"M3A.E-J%23
M7XV:_P#\$X_BUJ-O_P $HK6S\:?#HI^P5?VEQ\3Y;FZ\2P-XL@M?^%8MGP%%
M%X<N1=2N_@:_7R_$,OA]%6\M'\YB)DC^LOV7OV7/%WP+^/'[:7Q7\0^(?#FL
M:/\ M,?%#PQXZ\*Z;HQU,ZGH&GZ'I6M6%Q9^(?MUC:VHO9I-3B>'^S9[V#9'
M)OE5MH;[AHKUL3Q%FF+PU3"5ZE%T:M*O1J*.'IPDX8G.:F?55SJ3:;S*K.I&
M25XT;4$G!<S_ %#B'QY\1^*,@S#AK-\?E-3*LSRW.<IQM/#Y%@<+7JX//_%G
M'>-F91CB:=>=2G4GQ_F.*QM&K3@I4,LE3R6$98.G&M(K\;- _P""<?Q:TZW_
M ."KMK>>-/AT$_;UO[NX^&$MM=>)9V\)P77_  LYL^/8I?#EL+65'\<V"^7X
M>E\0(RV=V_G*3"DG[)T5RY?FV-RN.)C@YTXK%?4G6]I2C5;>7YAA\SPW*Y-<
MG+B\-2E.U_:4U*E*T9-KYO@7Q.XM\.:6?T>%L3@<-#B5\(2S7Z[EF'S&4Y<#
M<<9)XA\//#RQ%6G]6=#B?A_+,1BN15%CL%3K9?65.AB*E6/CG[.OPWU3X-_L
M^_ KX0ZY?V&J:U\*O@Y\,?AOK&IZ5]H_LO4=4\#>"=$\,:A?Z;]LAMKO[!>7
M>ES7%G]JMX+C[/)'Y\,4NY%]CHHKBK59XBM6Q%5IU:]:M7J-)13J5ZM6M4:B
MM(IU*U1J*TBFHK1(^/S;,\9G>;9MG>83A4S#.LUS3.<PJ4J4:-*IC\XS/,<W
MQU2G1@W"C3GCLUQLZ=&#<*-.=.E!N%*#97XZWW_!.;XJR>#/^"HF@6OC;X?2
M:C^W-XJF\1?#AKB;Q'!9>%(S<^(KB.U\;3QZ!<SPNW]L6Z/)H5IK2IY<S*LF
M$5_V*HKMR[-<;E;K/!SIQ]O+!3J>TI1JIO+\?1S+#6YFN51Q5"G*:7\2"=.3
M49-KZ_@3Q,XM\.)9K+A7%8'#/.L1PAB<P6-RW#9C&K5X&XTRGC_AWD6(J4W1
MA0XER7 8C%QIR_V["0JX"M*G0K3J1_)O5/V"OBMJ&O\ _!)C54\4_#V.V_8)
M\"R^&?BPCZAXD,_BC4&^&GPH\&I+\/%'ACR]1LSJO@/5)WD\2R^%ITT^[L)A
M;/<O<6EMYQXU_P""9_Q<U_X=_P#!3OPIIGCKX<#5?VW_ (E^%_'/PZDOI_$U
MMI_A6ST'QI<>)I['QK/;^';VYAN9[69;>)]#L]:B6X!WD1X<_M717HT^*\YI
M2IRA5PZ=*4)1OA:;5X9]6XDC=.>J6:UZE2UU>@XX9_NXJ;^^P/TE_%C+:N!K
M83,<CIRR^MAJ^'4N&\OJ0=3">->:_2"H>UC/%7J1CXEYSCL=*/-3Y\FE1R"3
M^I48XF?C'[-_PXUKX._L\? 7X1^([O2]0\0_"SX+_"[X<:]?Z)+=SZ+>ZUX'
M\#Z%X9U2[TB>_L].OIM+N;[2YYK"6\T^QNY+1XGN+.VF+P)QO[9/P1U_]I']
MF#XS? SPMJVCZ%X@^)7A&3P]I6KZ^;T:-87+ZA878GU#^SK6]O?("6KJ?LUK
M-)O9?DQDCZ9HKR(8[$4\?',XR@L7'&_VA&7)%P6)^M2QG-[)OE</;R;]FWR\
MMH7LKGY7A.,<]P7&]#Q"PU;#0XGPW%_^O-'$/!TIX./$*XDK<5JN\OE-T)81
M9SB*E58&51T?J_+A74=*/._QQOO^"='Q;E^,/_!,'Q];^,OAT^A_L0_!SPC\
M-_B5!->>)H=6\3ZIX9\'Z3X?DO\ P-:IX:GL[NPN[RPEE3^W]1T"XAMGC=H9
M)2T*^\_$']C[X@>+?^"EOP*_;1L/$7@ZW^''PN^!'B'X7:WX;N[K6U\;7VNZ
MK)\4#:WNE6D.B3:%)I"IX[L#/-=Z_9WB-97:QV,P,+/^BM%>E/B7-:DHSE4H
M.4<MS3*4UAJ:_P!CSC$XG%XZ+2G9U9UL77=*KI*C%QA",E!-_H>,^D%XEX[$
M4,5B<?DTJV&X \1_#.G*.08*"_U4\5>(.(>)^,:$XQQ/++,,5FW%&;U,OS/W
M:^54*F'PV&H5J>%ISG^ NC?\$G?CG8_\$Z/CO^QU<_$#X3_\)]\5/VDW^,FB
M>)8+_P 82>#]/\-K=?#F:/3]4GD\(0ZTFN/'X+O=\%IH]U81O=VJKJ,JB9T_
M=[PQID^B^&_#VC73Q27.DZ'I.F7$D!=H))["PM[65X6D2*1HFDB9HR\<;E""
MR(V5&Y16.:9[F.<*2QTZ,^;'8K,7[*A"C_M6,H8+#UY>[*5H2I9?AE&G\,)1
MG)-NI)+R/$;QGX[\58UH\8XS*\3&OQEQ)Q[467Y-A,K_ .,CXLR?A'(LZKQ>
M&KUG'"5<NX'X>AA\ KT<+6H8JO2J3GC:T:?PS^P#^R[XT_9-^%/Q#\!^.M=\
M+^(-4\7_ !Y^)GQ6L+OPG/JT]A;:+XWET>73]/NWUC2M(N!JEH=/G6\6&WEM
M,-$T%U+N=8_N:BBN''8VOF.+Q&.Q4HRQ&)J>UK2A!4X.?)2IWC"+<8KEHPT3
M:NF^K/C^,>+<ZX[XISSC'B*KAZ^><18[^T<TK83"4L#AJF*^J9=@N:C@Z,ZE
M+#P^KY5@X^SISE'FA4G?FJR2^ O^"EO[*/CW]L_]EG7?@=\-M=\(>'?%6I>+
MO!OB&VU+QQ=ZS8^'UM?#NIF[O89[G0=$\0ZC'<2P.WV41Z7-&\JA)9(48RK]
M^T44ZF.Q%7 X7+YN#PV#KXS$T(J"4U5QRPT<0Y5$^:<6L)1Y(M)0M*S?.[7C
MN,<\S'@_AS@7%5<++A[A7.^*>(,GHPP=*GC*69<8TN'Z.>3Q&.C4=;%4*L.&
M,I^JX>I2A#!RIXATIU/K514RO@+Q)^RCX]UK_@I/\/\ ]LNWUWPA%\-_"/[+
MU[\$K[P]-=ZR/&]SXIN?&GC;Q$FHVMBFB/H)\/K8>)[.-KJ;Q#%J/VNWN8AI
M9A$5Q)]^T48/'8C RQ,L.X1>*P6+R^MSP52^&QL*=.O&*;7)-QI04*BO*#NT
MG?0X5XQSS@RMG]?(JN%I5.)>$.)>!LU>*P=+&*IP_P 6X7+\'G5'#QJU*:PV
M+JT,LPL<-CH<]7"252=.E4=62B4445R'RX4444 %%%% !1110 4444 %%%%
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M^TRSNGU"/1[RX1XM.UP6S:/J;*W]GWUR 37YA_\ !.O1?VC[#_@H1_P4,O\
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MW=U_:9TNT\5KJ+#3F\,7-_%KPOPUD=/^U(\2@6?9Z;Z/_(^V:*_F<_X+_?\
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M_P"65</_ ,+[^,O_ $F>_8J_\19^&/\ \X&C_A??QE_Z3/?L5?\ B+/PQ_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MU72KFRU'3=*\4:CX-T[P[J5_87EGJ-I:ZH]QI=W;:I'93)ZGX;_8K_X+#?\
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MV6+_ .-5]H$^L>([K5?$.NZ#;^,_!5EJ>G0:YJVH:C;W46G23:E=#3H]Z_\
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M3PKXA\5^*K&_U.PLSIMSI^E.##J;VWE@0DE%W>L&Y1\VU:R^>H[X^_ +PO\
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MWDEGTCXSZRC6SR/&+7Q'^T;\8/$-C&QEBA87$5EJEO%=($,:723)#+/$J3R
MIWY'>2E^\TL[V5G9?\#H?C-_P=J_\E/_ ."3O_8^?M'_ /J0_LG5X7_P60^
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M/&UI:>";[PQX7MM$N-0A/@"3P_;^'+#6=$FTK5=*O?Z,_P!M']A']K3XE_\
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M;GTW4/ GAWXD_#W6])T^/PU/?2:#97<%]96K/J5E8V]Y/%%Y<TKAY"_ZC?\
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M\NM:[X8C\>>!HK.VTO\ M"]UKP[X8N]&M8(8='T[4I[+#_X*%_LR_P#!4_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MI 3K.;PN*4%1A/BUPE6<G%4HS3A*JZ49IPE-/^M>BBBOYO/\  HHHH ****
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MEEU?.*JEDT*%7'IT\IPV)S.I^X?)E]"MBY<M"G.:]MHKQOXH_M _![X*Z_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M"WC[X@Z3\/M6T_7?!'@_XA_$BVUO4+[4]'TC5-*TF35;Y;6?4?$G]CVUY/\
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MMA\.?$5C\-[GQ#'JAM6BE;2Y'TNR2ZB%Q:B<F. S?O!%)^E?_!6OPCX+M?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M!Q7*FUHH*TKZW4[);VU7EYG??L _\%,O^';7_!!_]D76?!OPS;XU_'WX\_M
M_&KX6? WX5&^OM-M-<U^;XL>)GU+6=4N=/LKR]NM.T>6^T/38M$TTV^JZ]K?
MB/1=.M;JPMI;_5=._7K_ ()O_P#!5C]HCX[?M3?$_P#8/_;\_9ET+]E+]J[P
M9X#M/BKX0T;P]XAN-5\-?$'P3-)8+J$&D"74?%&G3ZEI%MJ5IJD6HZ%XZ\16
M.MV<?B*%;+2+OP=J\<O\BOC?X3>)KS_@C'_P2%_:BEM_BA'\&_V:_P!K']IV
MQ^-?B;X-:K:Z)\2O NA?$[XZ>"=1TGQ=X0UZYAOHO"OB>T;X7:MIG@_QA?Z7
M>:+H7CC5O"\>HD3ZCI]GJ'Z^?\$;-&_8C^,O_!5K6/B3^RAXL_X*3_M)O\#?
M@SJ9N?VIOVHOC!X/\3?#Z72/&7AZX\/R>!?$7A:_^!'A+X@6%['J_B&_A\"Z
M7)X\@&JWNA^*/$]OHC:-H-Q)?,)1C:;M=WG=ZZ-2T5[I)6Z6;=]#^D7_ (*@
M_L9^/_V_?V/?'?[+GP^^-<?P)N_'^M>$9O$7BN;PQ?\ BJWUCPIX?URWUO4_
M"%U9:;XE\+W=M::W=6>G2W=RMY>P7%M82Z1=Z;-::I-<6O\ +SKG[)G[,7[(
M7_!=3_@E;^S?_P $];2>R^+_ ,,O#H?]L2]\.^)?%.KPW^F6_A*]N?$VK^,3
MK&NZGI^@^)?%/PQA\:ZMXH\/Z;<V6GFR\2>%+3^R%EO].M;K^D#_ (+)?M]7
MW_!.3]A7XA?'?PM#87/Q4\0:MI'PF^"L&JPPW6F1_$WQI9ZO=6&LWUE.&AU&
MW\)>&]!\3^-#I4T<EOJ[^'$TNZ"6MY/+'_*W_P &]W[?W[!OP<^-.CZ/\1_#
M'[4_Q<_X*0?MO?%)/ WC;X\^(_#'PZU3P#H)\=^,4N+/1-/\4ZG\9V\<76F:
M[JPL?%GQ$\6W'@@>(-9UHP:?%I$^G>'M/EOPF"ER2>KC:2275M6;?DEZZ[%O
M_@Y6_:E^(G[8GC[XM? WX+O]L_9A_P"";4G@[6/VA_%D%U<'1->_:1^*?BK3
M_AIH7@]#%;/;W&O> [+6/$6DV%I-+%Y%WIGQ=6>83:5IUO=_VB?L._\ )E7[
M'_\ V:Y^S_\ ^JG\)5_!U^WK_P $BO\ @HW_ ,$[?^"?OQ_\0?$;]KGX.^.?
MV>/&_P 5/A_XT^,GPY\'Z9KM[XO^)'Q#U[QIH.EZ!XHUGQ9XJ^'&G^(+^;2=
M<EM-6DBN?%\5LC_VC/#9R7.I7PN_[+_^"//@7]H;X?\ _!/?]GG2_P!I+XIZ
M/\6_%NK^!?"OBGP7KFBV@L[?P_\ "'Q%X.\,ZA\,_ ES&- \/>9J/@_PZ\.D
MWMQ]EO#-+%O.JZCGSRNO]=PG;DCRM-)M*U[O17>JWO\ A;<_G&_:D^./[2_P
M'_X.3_VAM>_9"_9U7]IWX_>+?V5O!7@?P3\.[W7K?PUX=L#>_#;X3^(M7\7^
M+-7O+[1[2'P_H>D>&;R)X+CQ#X<2^U34-+L8]9M[BXA@N?U9_8J_X+MZ-\5_
MV(/VPOVF?VM/A.OP0^(G[#'B.?PG\9_ 'ARYO#9Z[XAU>ZN=)\">'?#%IXFG
M;5-#\5^(_&5O-\.KC0-<O[Z.P\1P17TFK"ROWM-,^>_A=_RM@?M'_P#9D&A?
M^H;\!J_(;X3?LZ?$#]J#]CO_ (.2OAM\*]$U'Q/\0=,_;+\*_$GP[X7TF&2[
MU/Q)'\,?CM\5?&OB/1M,L+>"YO=4UB[\(:/XA.@:/I\37^KZ_'I>F6BR2W0A
MD.WK^K':+232TC3]Z[O9MI^5K?YW/T;\"?\ !QS^UYX,F^"_[07[8?\ P3W;
MX0_L ?M$^,D\+_#SXW^%]8\0:AX@T:TO1J<UAK%Y+K$@TSQ>JV&EW^M169T#
MX?3^)_#>D:]KW@\ZS%IAM)_URM?^"F?C"^_X+$6W_!-BQ^'W@N\^&MY\ (?C
M-9_%BUUK5+CQ+=7-QX67Q';V5M90L^@3Z3.'1(;N)FDEMV69';<,_P J/[6'
M_!3SP-_P45_X)D_L/?\ !+7]G7X)?$C6_P!L!M4^ /PT\6>"T\,0V'ACPIJG
MP3\*S^ #=>&K\7=S+);>*+V"RU6".>VL['P/X-FUX^+M8LI='87WV;^T+\9/
M 7_!+'_@OE\#OC'^U5<^*]+^#EI^P/X'^&.F_$G0/!^K^(++Q!JWAWX:S?#^
M[U&RT^Q-QJ%Q#_PDWAJ2RU"TLAJ.HZ1)JVD7.I6\6G7@U!6-P3^S:5IVC=N]
MFN5[^OD]['Z7Z%_P6W^*^K>&_P#@MOKDOP3^'D4O_!*[XACP9\/((]=\2&/X
MIVI^*_QL^'GVWQFS$MI-P++X6:=J/EZ'B,W6J7L7$44&/F+X-?\ !PS^U[XC
M^"7Q4_;0^+/[ D'A;]BOP+\")/$OA+XC:5K7B:PD^)?QXMOB+\-/@JO@'P[X
MQU1-3\/?V#J?Q6\:ZU!A?#MSK>C>#?"?B76_,U[4_"^KZ+)^4'[-?Q#C^+W[
M,'_!U9\7[?PWXC\'67Q=\1?#;XKZ9X6\8:?)I7BG0='^)?QG_:D\;Z-IFOZ?
M*%:UU2VTO7;-+R,9C\T,T+O$R.W[9_"N\\$>%/\ @V'^&$_CG]F3Q'^U;\,6
M_9SL;SXB?!?P;XFN?"7B.]T"[^)VHZWJGCG3-?M=)\0:CIDWP]US[+\1KK4]
M.TF^GT&WT*Y\0"W-GI$Z4"<8K[-[RC'=Z7A%NVMKWOOIJ=1^Q;_P5R_X*7?%
M3XU?LS:1^TK_ ,$Z=.L/V;OVN+;[5\-_CC^S)K6H_&&R\ Z=>K8MIGB;XK7'
M@WQ-\2]'\,:!9S:YX>MO%J>-I?AEJOAC3K[4?$-S9S#0-5T*'^COQ=XDMO!O
MA/Q/XOO-/UK5K/PKX>UKQ)=Z5X;TNXUOQ%J=MH>FW.ISZ?H.BVF;K5]:O8K5
M[;2]+M@;B_OI8+2']Y*M?YL/['^M?"WX2?MU?\$_KS_@CK^TS^U)XPUKX[_$
MKP.W[2G[+WCGPQK5FGPM\+_\)!X5/CCPC\2_'&C:1X0^'GQD\+6_AFY\7SZE
MXDTKP0-+\*Z)X;M/%HU^SUJ2VATC_1!_:O\ %_Q(^'O[+7[2OC[X.:=)K'Q>
M\#_ 'XQ^+_A7I,6F+K<NJ?$CPU\._$>M>!].CT9DD75Y+WQ/9:7;)IC(ZW[2
MBU*,)<$)G%)JR2OTU76VJ;=O5.S2NC^7/QS_ ,'"?_!2'X1^%_#_ .UC\7_^
M"8%G\/\ ]A+Q3\7]0^&.CZUXD\5ZOH'QF$MA?ZK;SV-W9:OJ,%W9:Y%;Z%K:
M6]_J_P *M&\':QKFD:AH-AX@6>VGN8OZ^]*U.QUO2]-UG3)_M.FZO86>IZ?<
M^5-#]HL;^WCNK2?R;B.*XB\VWECD\J>**:/=LEC1PRC_ "?_ -HKXP?!O]HO
M]B'PU\4_B?\ M(?M@_M+_P#!2+4?BMJ6I_%WP_\ $O5/%6M_!'X"_!RQUSQ+
MX?TN\T:YU/3'TF*?QA+J?PYM+(:?KC6&D:CJ=YX8M]!\-1V&GGQ+_JC?!K4;
M'6/A!\*=6TRZAOM-U3X;>!M1T^]MVWP7EC>^&-+N;2Z@?C?#<6\L<L;?Q(ZG
MO0.I%1M96UDG:]M+6W;OUUTOV/Y7OVDO^"Y7[6?QL\3_ +=O@?\ 8^_84_X7
MG^QG^S%X>^)7PW^/?QO;Q#?:9XMM])_L?Q!X3\2>/?"UO)=6VE-8Z3+::[XH
MT[PO9Z+XN\0WO@C2%\2>($\(V%S>S:/XC_P2K_;=^*'["W_!!_P)\0O@G^SE
MXV_::^+7CG]K?XB_#7P1X(\,Z'XIU#P]I.I:]>V4W_"2>/=6\,:1JDVE:' U
MI%I6G63S:==>(/$&JZ9IUI>VEN-1U"Q^7/V0_P!N#P=_P2;\-?\ !6[_ ()[
M?M"_#'XH7/[0WQ!^*/Q.7X!:#X3\&7VLM\6]7\?>&=4^'O@^RCU!%MKRUT#7
M+67PKXW\-:VNBSV^L>&->U6YTJWNM:&G:#J7S=X"_:7_ &B/V>O^"%/['>G?
M";XG_%#X$_"3XJ_MW_&7PE^T9\:O@Z+ZT\?>%/!MM_PB]WI^BZ-K>EW>G:KI
MLVMV4WBK6X[+2]6T6[\1W/@^WT";58]+OM2LK\+Y5:RBK.4+-M^\N5N^C[]K
M7V/Z*?V;?^"P7_!0G7_VB?CO^Q'^UC^Q)\.O@_\ M=^'?V8?'GQ_^ OAGPMX
MOO=?\)^-M<\+>'7USP[X(\4SZ!XJ^(-N^G>-/*O+>U\4>%O%5S-I&H:;<:'>
M^'IM1D9K7HO!'_!>L>)/^",WQ#_X*7:E\-?!MK\6O 'Q)N_@Q<?!VQUS5I?"
MM_\ $Z\\;^&+/P]I,6ISLFLQVP^&GC70O'NLH\@NDMK35?L/F V=O)^*'_!)
MW5/V0-*_X+__  XMOV/O'_QJ^*'P<\3_ +.WQ+TCP]\9?V@;C79_'GQT\=Z?
MX+\0ZAXO\:VTGB;PYX.U9]'6/POJF@64<WA?1#%+X+U16TZ%XIC7RO\ &;]E
MCXF:1_P5=\;?\$7])@6S_9M^.W_!17X8?M0V6C64+Q0Z9\,+[PCXN\5:K_98
M@4/J-EX;^"WCG6](N;66X@M3KOPYM1*UM+&]W: N2-[6MI&;W6BOS*S;MTTN
MVC_06_90^)GQ"^-/[,WP'^,'Q6\(Z3X!^(7Q4^%7@KXB>)_!.AW-[>:;X5O?
M&>A6?B*'08[C42;U[C3++4;6UOUN"SQZA'=1!F1%)\R_;9_8"_9D_P""A/@+
MPG\-?VHO!^L>,O"7@GQ</'/AZQT7QAXF\&SVOB,:-J>@?:Y;[POJ6F7=U#_9
MFKWT/V2XEDM]\BS>7YL:,/,OV:_^"CGPF_:(_;&_:G_8>\&?#WQSX8\9_L@0
MV-OXJ\1ZQ#X:@\%:[ ^H6FCV\'A*+2M8N]5BAMVN(MD>HZ5IR);QE44$*A]L
M_;Q^+>H_ ;]B7]K?XS:+.UMX@^&?[.'QF\8^&9E,ZE?%>B_#_7[OPL#);*T\
M"R>(4TV-[F, VR.UPS*L3, RU4E]EMIKROM;Y,_E/_X(S?L"?LL_$O\ X*W_
M +5/[2_[-G@K6/!'[*/[!?B>3X0_ NTN?&?BKQ)>?$?XUW^E:]X/\4>/]0UO
MQ#J6HZC>Z!9:7;>+-9L="#:5:)8>+/AO)+;74]EXA2^_K3_:Z_:9\"_L;_LT
M_&7]IWXD17=WX1^#G@N^\4WFE:>\<6H^(=3::WTKPSX5TR>=6MK?4_%OBC4=
M&\-:=<W>+.VO=5@GO'2VCE=?RQ_X-NO@GHWP>_X)+_ '5K.QCM?$'QMUKXC_
M !G\97"1+&VHZIK?C75O"GARZ9C!#-)Y?PZ\&^";/=,9OGMI#;S-:M %^@/^
M"X?P,^('[1W_  2K_;!^%'PNT34?$OCK4/!O@WQCHOAW1[*34]9UZ/X4?%?P
M#\6=7T?1M,@=+G4M8U+0_!&I6>E:=9+<7]]J$UM:Z?9WU[+!93A4GS5+-Z)J
M-WV3LW?S=W\S^0/_ (*T_P#!4#]NC]MC_@GC\/M0_:-_8<TWX$_L[_''XR>&
MO'G[._QJ\-^)M0U"TUR3P+I7C*SO?#/B+2M7N;O4Y9/$.F:Q=:UX5\176F>"
M;77M/\/ZE>^'M(\0:6USJ.E?TC?M8?\ !1O]OOX6?%GX,_LB?\$^_P!@V]_:
M.\<0_L[^&/BEXU^(?Q*DU+PC\+ETU- TMWT#P=XCOM>\">%]6U72+6?3WUB:
M?QO]JFU?7--\,Z1H-[JT<V_^73]OS_@JG\&?VJ_^",/[$G[%/PV\$^.KOXM_
MLZ67P,M/CMJ.J^$+S_A%/ASI7P)^%^K_  1T35+7Q*DLEJ;WXDZQK^CSZ5=K
MB&QLY-8\/:E';:IJ6G1O]M_\%%/VF-#U;_@II=?LV?\ !1;]I;]K#]G_ /X)
MZ^"/V3OA#XI^$W@+]G6X\1:39_''Q7J/PI^'>M-IWB&R\-Z5JBZ[9>(_&FI_
M%/PA)XHU?2]0.EW_ (3T_P +Q:SX0T^[O_$.FAHX[+E2M[1\NKV<4G9.[;6M
MKKOHC[VN?^#BSXWZA_P38B_;F\-_LL>"O^$N^&'[6$7[,G[2/PXU;Q-XH_LW
MPY:ZGX/B\4^'_B+X0OXK:TN(=.O]0NK+P9?Z%KEQ>:GI?B:YB#-<Z7+%J#_I
M!^UG_P %5_$WPP_:[_X)M_LK?LX_#CPE\6+[]NJ/3/'&OZ]XGU;6-.G\"?!;
M6+_0;BQ\;:1IFB+,]_.WA*#XB^(YQJ#QV<*>$(H$,ZW-W+9_S^?\$2_V;]#_
M &O/^"/7_!6O]D2QTK4;3Q9XA^+'B"^\)^$-;MIH?$'A_P 9:+X!\+^(_@S%
MKD-PD1AO8/B-\-[2QU.W\U+I)=*U&&80[T9Z/_!M-IGQ&_;&_;=G_:7^+L,U
MUI?_  3_ /V,/AK^RE\+FEBNMVDW=_%J_@_P? UQ>EQ'-IOP_P!+^*EE>Z;9
MPV[6YU_3S(\2QRKJ82XQ7.[)<CEIKKS)<O7HV_\ @GW-J/\ P7R_X*!?%_Q3
M^T'\1OV)?^">'@WX\?LJ?LV?$S4O /C*[;XHV6H?'[6['3-1LM+@\0V'PU\,
M>))?&MG9>(6O(-1L[SPU\+/B3H>CVLUS;7>MZC+H.MW%O_45\%_B)>?%SX1_
M#/XHZCX#\;?"W4?B#X%\+^,-2^&GQ)T.]\-^/_A_J6OZ/::EJ'@WQEH6HV]I
M>:;XC\-7EQ-H^K6\MO&/MEG*\(:%XV;_ #8/VR;W]@34/B;^UW\:O!.H_M.?
M\$M/^"@_PK^+OBQ_#/[,=G)XD^)?A_XB^-+BYLKO6M5\&>/O _A;P/=_ *_U
MKQ)J?BE)=-G\8Z[X-L= @T/6_ INM*UN+PSIO]_W_!,7Q1^T%XV_8 _91\7?
MM3/JTOQX\1?"+0=5\=W/B'3WTKQ)>F[ENY/#.H>*-/E@M9[;Q3J/@X^'[[Q,
MES:VUVVNW&H27D$-T\L:@JD4DFE;6W6^R?=IKS5M['YG?MR_\%3/^"B_@+]J
M7XM?LV_L%_\ !/"[^-NF?L^_#RP^(GQ/^+GQ;;Q#X2\+>(=+N]#L]<U#_A6%
MIJ&K?#JT\3VFA_;ET>*;1/$GBC7/%NNZ?K]GX;\+RV.CQ:KJ?Z%_\$LOV](/
M^"D/['/@7]IM_ G_  K;7M6UKQ1X.\7^$(=4?6M+T[Q3X/U+[!?W&A:K-;6=
MS=Z+JEM+8ZI9)>6L=W8?;)-+N);V2Q-_=_R/?\%"_P!I?PS\5_\ @I1^WS\#
M_P#@IE\>/VN/!'P?^#NCG1/V._V0_@)<^*M(\'?'C7=1TNSC\":3XCL=!T#6
MK*\E^(FEZO8^(SK^N6UA-J;>(KK2K?QOIFF:+IOAC5/V1_X-1+O3IO\ @F#X
M@LK2=7U#2_VI?BQ::[:FX@EFL-1D\*?#*\A@FMX@)[%GTNYT^<6]X//?S3<J
M?L\\ 4"44H)V2?NZJ^MT[ZMV?R22>FI]G:C_ ,%1]?\ AY_P56^,'[ _QD^'
MWAKPQ\)_#/[+>H?M*_"[XMZ5>:W<>*O%5AX;\-:)XC\6:7K>AW8&D1VFGV^E
M_%E;>_TNX+._@K3X)(?.U.[%A^;'P$_X.0]?^*?_  3I_;<_;'\6?!7X?>&O
MB=^R]XV^$WA3PA\+-*\2^(;_ $7Q?'\:=8M="\'2ZQJETD.I0RPW=AXTO=0>
MQBMHY-,\,3RV\8G9H:^?_P#@Z^\%>,OA'XC_ &3/VUOAG-)HVN:CX'_:#_8Y
M\>>((;:0.WA?XN_#CQ38Z5HAOH/*=9+_ ,&^,OCM%:1SW'^CSW!OK.%VBO,_
MBO\ &O\ X)^^._A%^VG^QG_P3JT$W>A_#[]O7X<?\$W_ (D_%O2[#[1:PW7B
M#0?"FJ^ ?BKJZ21M!<1V>E>+1\8/'M_97,;ZHE_<VMW";=5MH90J,8.*;ZI/
M_P  OS]>JM_P#^F3XQ?\%N?VU;GQA^S%^R]^R/\ L6^#?CA^VM\4?V7? W[3
MWQQ\#:AXFU;3?!GPBT[QUX2M?'-GX#M4U+6/",MYKFE>&-2TB]UK5]6\8V%A
M#J&LZ'X>TBTUW6]8%I8^O?#_ /X. _AG>_\ !,?XN_MQ?%3X57'@GXU? KXA
MS? /QU^S-#KUY#JMW\>KF6"+PSH%GJFM:'::CH?A[7[.2]\1ZI<ZEI%_?>%-
M.\,^-M'3_A)M<\+F+4_Q*_X*G?#GX3_LW_\ !<[XD?%?]K_XH_M?_LO?LO?M
M+_ +P7_PK3XU_L:>)%\#>)+35_AW\-OA/X$N_!5]>67A+QH^L>#;;5?AC/#K
M_@G2M&M=5T[5_$/PY\47)M?#]N)=0^9?&/[+7AGXU?\ !#O]J/\ : _9&^&G
M[9MEX*M/VU/A[\;_ !K=_M+?$WP5\3]?^)WAOX9^%?BMX"\9_$WP@? GPD^&
M5QJV@Z;<?&+3M:^(VI7]MXA$.N>%->G?7Y8?A[K5S< <D&HNUDW'57ZMW5V[
M=DDE=6UW/Z'?V(O^"TW[6OB_]J_X'_LM_P#!1+]C71_V7+G]K;P3/XV_9C\<
M^'=7UA['7T73;C6-,T#Q+HVJ:EXGDCO=?LX&LXI9-5\.ZWX?UR71-,USP?'%
MXEMK[3_Q7_8U_P""H7A?_@F?K7_!8;7-)\+0_%?]HKXQ?\%!AX,^ 'P0BEOQ
M>>-M5B^(_P 9H_$FLW\>CQ7.LKH'AVSU6QM=NE6EUJ.K^*M=\*^'+.*(:O<Z
MCIL?["%K^P/^TK_P4,_8!TC]G?Q[_P %7_VKOB1\.E\+?&G5_%'QK^.7P[U/
MX=?LU:OX2N]'\0>*_#7B?P[XI_9[NKR^\!0'1+/1M?U;P9XZ\-V^N7]UX8\-
M>%-<O?$&I:7>67P-)^Q!\1_BQXB_X*[?M^?!?QIKFC_&#_@GM^VS-\4/"?AC
M1M/,TE_HEO\ &SXI^)_&'C"&_@#WMGK'PZA\+Z+XVT]XC!:1Z/H'B=KMI;F7
M36ME_7YC48IM-634;JS2OSM+=MI/2^O=K<_>C_@N'HO[0_Q<\!_\$1O%W[1?
M@[PI\,?C7XN_:]T/0?'7@+P-)JWB'PK\/O$'Q-UKX=7NA^%KGQ'=W-PVH^(-
M"TO05M==6S,UAJ&N0:ZGA^ZO=*TN#4=0_L1K^5#]MC_@H%^RU^T_^R__ ,$4
MOVOO'UE\3K6?Q+^W!\&/C#H.B?"?3O"^LC1/C-\&+J\T?QU\*_%H\7^*]!?3
M/"0^(5SY">)+2'6-?G\/Z%;W=CI<<?B".ZB_JOIF4KVBFK6<_3XNGIL%%%%!
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %?EC_P6)C^ TO[&6JI^T==_%RR^&O_  L;P&9Y_@EIW@W5/'(U
MH7.H?V2L-KX[U32- .EL_G#47>\6[1?*-M'(2X'ZG5\3_M_^-/V5_ 7[/-_X
M@_;&\(OXV^#">+?#%I=Z%'HEYX@>3Q)<SW(T&Y&GV-[I\Y^SR)<,9A<JD08[
ME?<!7L\/5)T<]RBK"EC:\Z>/P\XT<NE"./J24IVA@Y3C.$<1*_[MRC**:E=,
M_5_ G'XG*_&?POS'!Y=Q=F^*P/&V1XG#Y7P#6PV'XVS"K2K8IPPG"M?&4,3A
M*6>57)K 5,1AZU&,XU>>G)-6_BZ^Q_\ !(/_ *&/_@I'_P"$5^S#_P#-]1]C
M_P""0?\ T,?_  4C_P#"*_9A_P#F^K]<?^&H_P#@WM_Z-MO/_#6>)O\ YK:/
M^&H_^#>W_HVV\_\ #6>)O_FMK^@O[:S#_H0>*/\ X59?_P#,9_NE_P 1<XX_
MZ,E^TB_\27@;_P"A8_([['_P2#_Z&/\ X*1_^$5^S#_\WU=%X/L_^"1X\6^%
MSIWB+_@HRVHCQ%HGV 7O@S]F=;(WO]IVOV47;0>/7G6U,_EBX:%&E$6\QJSA
M0?U/_P"&H_\ @WM_Z-MO/_#6>)O_ )K:UM _:=_X-_KC7=%@T?\ 9QO(=7FU
M;3HM+F_X5?XEC\K49+R%+&7S&\6,L?EW+1/O8$+C<00,5-3.L>Z=1?V#XH*\
M)J\L5E_*KPFKR_V3X5>\O[JD<N-\6^-Y8+&Q?@I^T=@I8/&1<Z_$G SH04L)
MBHN5=+A=-T(J3E62:;HQJI--IK^I:BBBOYF/^> **** "BBB@ HHHH ****
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M]_%+X3?'#XK^'[CQQII_9P\*Z]XO^,WPU\7>"]2\(_%GP5IN@^&-5\7M#?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M]G3X=7/_  3J\.?$O]DSX2?#+Q1^TSJ'[0WQ?\8_#K0/BQ\7_B-X1C^(-O\
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M5X:\--J<=[H&AZ9J<4MA:BZNNP_92_X)WZK^P?I7[4G[(WBGQ7IWBS_@E_\
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M:*WA/PBMO^W]X<\5ZS\1Y0-9\[P7/H'[(FO_ +0]M%X))U/8(9O$ND0Z'/\
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MA?XA\6W/B6W\$ZQ\1OB5X3\2:[!IGQ3M_#.C>-DGMM4@N=&)C@BM_MM7QO\
M\$M/VB?@1\3A\1_#7[&7[&/_  5*U#XL?LK?LN?"+X@ZK^U3/X TWQ5\*OVA
M?V;O@[HWP5O?C%H^K_%CX>>-[WQ3\-_B5X?T#P]K7BCPMI.LZ5XKU?7=)+W#
MZ4]M%J.L@[0TVZV6GEJ]5TZ.VNS:L?O/^Q]^U1X2_:Z_9,^#/[6&B:=-X/\
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MA:W).]O#S/(NW).]I/*4HNU[2;23LVTDV<^,J?2*^IXOGX;^C<H?5,7SNG]
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M[?7[7/Q1\>?M+_M+_!_X(_&+X5_$KXK:KXP^!&O_  ?^)UQ\0/#ECI]M\/\
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MOVM+S]CK_@F_K6J?\%&/VTM1^)G_  5:^+7P^^$OQ0\:^)OC%>:S8_!/X/\
M@'1?BWXNU>Q_9[DU[2[F3P!\8OB'X>\(>#_#6I_$>\\0ZIXNUS7(-7U6UM=7
MNM5O8K<'RW^UILM'_>OZ)<K]=+;Z?V;45_,=XP\"?M(^!O%O_!17_@GQX7_;
MJ_:'6T^%'[,OPD_;R_98_:-^*WQJ\1:A\6OA#K^GZWXRM/&'PS^+7Q8LM4TO
M5_'GP<\3ZO\ #_9J6D>.+74--T#P9KFIW$^CZW/;Z?=2_,?PX_:*_;)_;6_X
M)]_M9?\ !77P]\>/B+X0^)/PS\=?"CQC\,/V4?@U\9O'^C_"7X=_#+]D/4?"
M?C+XW^&?'/@RTO+32O$7B#X]^&+OQQXI\36OB31M>@U?P<W@6QD,VA7\V@60
M')UNK72Z_:V^_6_:VO0_L-HK\AOV./CMX@_; _;Z_:N^-_@?XC^+]2_93^#/
MP1_9Z^ ?PM\)VFN:S%\-?%OQ/^)'AZU_:.^*/Q"N?#$>I2>&[OQ[X4\-^+_A
MAX"'B%[*;5;'3+G4]'L;BVTV>YN-=_7F@EJVGDGZ7UL%%%% @HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH P?%/A;PUXX\->(/!GC/P_HOBSPAXLT74_#
M?BGPMXDTRRUOP]XC\/:W93:=K&AZYH^HPW.GZKI.JZ?<W%EJ&GWMO/:7EI/+
M;W$4D4C*?F;]F;]@S]CO]C:Z\3ZA^S%^SU\.O@YJGC.&"U\4:SX6TN=M=UBQ
MM;J:]MM+N-<U6ZU+5TT>"\G>YAT>"]ATN.989%M UM;F+ZWHH'=[7=GNKZ,*
M***!!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7PS_P %
M#_$_B#PC^SAJ&L>&?VA/AY^S)JB>,/"MNOQ0^)_@K1O'WA6"">>Z6;0Y/#VO
M>&/%UA)?:N $L[LZ-)-:M [1W$&YF/W-7Y8_\%B9/@-%^QEJK_M'6GQ<O?AK
M_P +&\!B>#X):CX-TOQR=:-SJ']DM#=>.]+U?0!I:OYQU%'LVNW7RA;21D.3
M[/#M*-;/LHHRA4J1J9AAX.%+#4<95FI2G>-/"8F4,/B).VE&M.-.>JDU9'ZU
MX#9=1S?QI\+<KQ&%QV-H8_C?(L+5PF6</91Q9F.)IU:V*4J."X9S_$87),^Q
M,U%*GE>:XFA@<4U*->K%4X-_CI_POOXR_P#29[]BK_Q%GX8__.!H_P"%]_&7
M_I,]^Q5_XBS\,?\ YP-?EW]L_P""0?\ T+G_  4C_P#"U_9A_P#F!H^V?\$@
M_P#H7/\ @I'_ .%K^S#_ /,#7]#?V#A?^A=G/_B#<+__ #:?[N_\06X;_P"B
M"\6?_&,OHW__ $7GZB?\+[^,O_29[]BK_P 19^&/_P X&M?P_P#'?XQ2Z_H<
M4O\ P60_8QU..75]-CDTVU_9>^&D%SJ"/>P*]C;SQ_ 2*2&>[4FWBE26-XY)
M%=9$90P_*3[9_P $@_\ H7/^"D?_ (6O[,/_ ,P-=%X/O/\ @D>?%OA<:=X=
M_P""C*ZB?$6B?8#>^,_V9VLA>_VG:_93=K!X"2=K43^6;A8764Q;Q&RN5(BI
MD6%5.H_[.SG2$WKP/PNEI";U:QMTM-6M4KM:I'+C?!CAR&"QLUP'XL1<,%C)
M)R^AK]'*E%..$Q<DY5:?%[G2BG%.56"<Z<5*I!.=."?]_=%%%?S&?\Z04444
M %%%% !1110 4444 %%%% 'Y_?';]OKPO\#?VN/@!^RUJ/@F?6X?C&='M_%'
MQ&A\2QZ?9?##4O'6H>(_#_PHTZ_T%M!O8];G\?\ BGPOJ>CQB;Q#X>DTN%8;
MZ.+5I+BVL9YOVC_VNOC%\+?V@/A[^SK\#_V9[#]H#QIXZ^%_B;XIR-J/QOT?
MX/6^CZ+X7\16'AZ^A$FN>!O$]EJ,AGU.RF5AJ-E,1(R1VDJQO*/Q>^*FG?M.
M_M2:5_P4&^-/PE_9GM/B)X/^)OQ4T*T^$/[0$7QH\(>$M9\ Z#^Q3KTUEX8U
M?P5\.]9\.ZGK/B2'6-=T#Q!K-]##K&C'6[O6KG34MVN;*"4??WPC^,NE_M#?
MMU_L2?&W2?+2W^)?_!.OXB^*+FUB!5=-UF]^(/@)?$.C$&27$FB:]'J6D3;9
MID\VR?9-*FV1OT>MP]E^!H87$RPN&Q4\%D^9QS6A+&RK0GF]'+,%FV&GBJ>#
MQ5/$8)QCC<1@GA93P\ISRV51PO.:?]^9IX%\#\'Y/P[Q!6X;R#B7%<'^%?B%
MA_$G)<1QAB<VPN*\4LI\/.$O$W(,7Q%@.%.),%G?"4L/1XNSSA&IPUB,9D=?
M$XOP^KXVKAG+$XJ,_;_!G_!0S5KOP)^UFGQ:_9]USX,?M#?LD_"CQ3\8O%/P
M(UGQ[I7B;3_%_@O2/!^L^*O#VM>$/BIH7A_^R-2T;Q!/HTNB7^J6GAV]_P"$
M=O;FV:2TU-V:V7S,_P#!2;X^^ _!WP[^-?[0W["VH_"W]FCQS#X.OM3^-/A#
M]HCP=\6G\":+X_&D?\(KXC\5^ [#P3X5UZUT"X;6K+^T[U;CS=*!:&6VFU"6
MRL+SQ']L36-(\;?M1_M_:AX/>UU>S^$?_!&3X[?#?XHZQICP36^B>//&>N^(
M/&7@_P (:O/ 68ZQ%X7T37M7BM9R3907EQ''LFDO8T]J_:@\4^&O#7_!&?[-
MXAFM7NO&/[(GPI\!^$M'D6*YU'Q#XW\8>!O"6A^%-)T'3"'NM5U@ZQ=VU]!;
M:?!/>6\-E/J2(D=C+-%,,MRE/*6\EIS>>YADV'JX=XG,56RVGF64NO6C@9K$
MJ47"I;,*#Q]/%N%"<*=5SH?O998/P^\,(S\,Y5?"/ XN?C-QQX3Y)F&1RXAX
M[AFGA_@/$#PPEG&;4>#,33S^G6HSPF8>RXZR:IQME_$TL-D^+PV S.6+R6V8
M5OU1\<^-]!^'W@+QA\2-?EG?PQX(\(>(/&^M3:;$M[<MH/AK1KO7M1EL(%D1
M;N=M/LIGM8EE1;B0QH)%#[A\!? +]O'XD?$3XH_!SP'\:OV8M2^ VA_M.^"/
M$WC[]G#Q4WQ/T/Q_+XMT[PKH5EXMO_#WC;0M-T#19O OBN?P1=Q^,[;3GO=8
MVV4LVCR[;[1]2N:^O-(\1Z5\"?V<M$\4_%G4)/#^C_"3X-Z-JOQ'U5;34_$#
MZ+9>"O!MK-XJOVM-!L]5U755TZ/3KZXE72[*^NKA(7>"&9B ?S,^(%K<^%?V
M_P#]B']IFQ^+VH_'WP3^TS-\2/ 'PP\!:[:P6ME\(O"'C/X;VGC,?$'X.QZ;
M+I4:V,^E:'HUGX]N_$^DZGK5YHVHA7O(KJ6Q@T_P<GP6#Q%/-,/7PJK3]CF?
MU''REC(J6(P& Q.*I8;"RHM8*G7G&@\?7GCI5:<\#!X:E3IU:U+$+\3\*^$.
M%,\P'B/DN<\-TLVQ*RGQ#_U,XUK8CBJA2Q&>\%<$\0\2Y;D'#57*94N$L#F^
M+I9+/C;.,9QG7S# XO@S"U,ARW!8+,LVRW/8_M%1117S!_.@4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ KY#_;>\8_LX^!?@7>:]^U/\/7^)WPH3Q1X=M+CPM'X&/Q#>77
MKF6Y&C7H\.!6W_8W2=S><?90Q.?GP?KROAS_ (*%^/[?X:?LYWWB>Y_:HOOV
M.HH_&'A:Q/QGT[X2ZG\:KFT:[FNP/#@\$:3%->2IKVSRWU,)Y>GBW#.0)17I
MY-3=;-LNI+VZ=3%T8+ZM/%4L1JY?P:F!HXG&0J:>[+"X>M76O)3D[V_0O";
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MV?M?_L/_ !C^*'Q_^*_CC]CW]HKP3XC\*ZOIGB[5/%7B32OV@_ OPX^(MO\
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M?!OB*'XLZI)IFLSZ_P"(=8G\:7?B:RD6;3K3PQ!K'B+XB_8/^+<O[*/[1_\
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M<!&KB?K%3BFAE,HYG6R2,7!XZG@)1Q4H.E[)IJ1_.G_PO;_@NO\ ]&U^(_\
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MJ'#'C&J[F\+B5!4'+&<JK.;@J+E[JK.DY>ZI']<-%%%?SL?X,A1110 4444
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MK.*F*@LAGF_%-:MG&-_U0RW-?J61U5E&72J8ZC''59OB1IOQ\^'7[&U]X<^
MWAFP\8?M#>&/@SX<\'^!M$EUG0])T]_&EOHFD>&I=535?$M]I6@F/P]NO?$5
MM!JE_9VFJ-I<6GO*IO%!_'']CFR^./P;_;_^ GPMU3]CSQ!\.;K0_P!ACQ#X
M+\7G6/CG\)?&.M7F@:U\?_"_B?QW^TCXBUCPWJ5Y;Z]J&L_$%GLM5\(6US<^
M,+R_\0?VI;*^CV$KI_1]7#M\-? K_$J#XPMX9TYOB9;>![KX:P>,2)O[6B\"
MWNOVGBBZ\,JWG?9_[.G\06%GJC@P&8W-O&1,$!0^7EN?QP>#S;!U\#A\1',Z
M./;KIXFG6CBL70A1HJ?L\32I3PM!NO5A"=.<Z=2?-3;<ZM_SK@#QOH<*\*^)
MW"F<\&9'G=+Q$ROC>K4SB-7/\%F]+B+B7*,'E>60Q2R_B'+\LQ7#F43GG&88
M;"8G 8S&8''XQ8G!SG+%9@ZG<4445\V?S^%%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 5\+_''_ ()Y_L_?M _M;_LR_MG^//\ A,D^+'[*\.MP^"M-
MT35]&L_!7BU+\7]QX=/Q%TJ\\.:CK6LM\.]=U75?%/@,Z%XB\,C3O$&I7D^K
M#6[&7^SU^Z**!IM;:;K[]&?,/[/_ .R?\//V=?''[2_Q(\+:YXV\4^,_VJOC
M-<_&GXD:WXYU#0-0N;"_3P[I'A7P[X&\*?V!X:\-+8_#[P5H>CQV?A73=9&O
M^(+9;W4&U/Q-JQFA^S_#/Q9_X(L_L]_$[QA\0/&^B_'7]K'X*ZYX\_:IL_VS
M()?@E\0/AOX3_P"$"^/(^'NI_#GQ'XG^']UK/P?\3ZIHR^.M-U+^VO%_]H:A
MK.H7?B*QL;K2]2TC3HY]+N?V$HH"[6M^WX;=#\H+S_@DSX1\5?!/XR? 3XO?
MMJ_M_?M >!_C/<_"&]U&7XW?&CX=^-=9\$7?P;^*?A_XN:)<?#R9?@OIFF:)
M-XC\0^&-(TSQ@^IZ3KK:EX>@^R::='OUBU.*;XY?\$G?!GQC_:%^,7[2?A?]
MLO\ ;Y_9G\<_'C0?AWX=^)FE_LN_&SP/\+O#.O6/PL\,7GA3P9,RW/PB\2^)
MUO\ 2M.U/5Y[:]?Q/+-9:AK&I7.EG3Q.L4?ZLT460<S[_@O+I:W1=.A^8'A+
M_@D?^RGX&^'/[-_PJ\,7?Q5L?!W[.'[4%G^V1#;7?C+3M<U7XU_M#Z<E\VG_
M ! ^/?B#Q!X:U77?&]_9WUZFJ01Z/J'A2,7FF:-$^_3=*L["+Z1_:B_8]^&O
M[5]]^S[K?C;7_'G@[Q5^S-\>_!W[0_PN\7_#?4O#VE>(+3Q=X/AU"V/AW5YO
M$OA?Q;8:EX#\56>H-9^,?#HT^VEUJUM;.)=1M! 2_P!744!=WO=WU_'?[SYN
M^%G[+O@#X1_'W]J3]HSPWK'C"]\;_M;ZO\(-9^(^EZYJ&BW/A71+KX*_#.Q^
M%7A:/P18V'A_3=7TVWO_  ]80WGB!->USQ))=:RTMQITNE6+)IR>-P?\$WOV
M9;SX4?M@?!#QQH_B7XH?#']MSX]>._VBOC)X9\<ZQ9&.S\<^/=.\!V5U:>!=
M1\)Z/X4U7PWHOAVZ^''AK7?"4TU]JGBG1M>AFU ^)[K%I%:?>M% 7?=]/PV^
MX_(#X3?\$</A/X*^)_P@^(WQ@_:;_;%_:YL/V<=6M-?_ &=/AO\ M,?%O2_&
M/P[^$_B/2XHH= \80:)H'A#PM-XL\:>%X8EM_#6O^*KS45TJW2#9I\EW965Y
M;_</PA_9-^&GP9^*/[4WQ8\/ZAXKUW6_VN_&WAGQW\4-%\6W6@:IX7L-1\+>
M ].^'=IIGA/3;+PWI=W:Z'?:#ID,FJV7B'4O$L]S?S7+Q7EO9R+8Q_3U% -M
M[OR_&_YZ^I\1?L(?L _ K_@G7\.?B9\)_P!GJX\;?\(+\3/CCXS^/%QHWC35
M]%UE?"6N>,]"\'^&YO"'@Z;1_#GAV:V\"Z#H_@C1+3P]9:\WB'Q%"/M3ZIXG
MU9I8C!\[?&/_ ()(^#?BG^T+\>OVD?"7[:__  4&_9L\8?M(MX D^*/A[]F7
MXY>!?AAX.U*?X:?#;0_A9X7NK.WF^#OB'Q/;WMKX;T))_MUQXIO+NVU;4=3N
M],GTZ":VM+3]9J* YG=N^KW>COMW3[(_+C6_^"1/[*U[^Q/>_L*>%]6^,/PY
M^'&L?$?0OC'XC^)7@_QOIEW\=O%7Q<T7QEHGCN?XE^)?B#XY\+^,[76/&&NZ
M_P"'M);5]3N?#I6+3K*TTO0X-%L;#38;.Y\(O^":>M?";XE^#/B/<?\ !2'_
M (*=_%:#P?K4&LR?#KXN_M#_  _\3_#3Q<L"2)_8_C/P_I?P2\/:AJVBS&0/
M/:6NM:;*[QQD7*A2K?IW10',^^]WT>^^Z9\RZG^RMX%U']K&#]LJ/Q)XZTSX
MLVG[,OB+]E:QL;"]\,OX,L_ OB/XDZ%\5+CQ)%H^I>%-1U*7QU8^)?#UA#I]
M[=ZY<^&1I37%K?>%+ZXD6\C;^RG^R9\+?V0?V=/"7[,?P\F\2^*_ 7A>/Q@U
MYJWQ-O=)\3^,/&VH>/\ Q5X@\9>,=9\=:E8:'H6E:]J>OZWXFU9[]TT.RM'L
MY8K%;1;:!(Z^G** N]KZ:?A>WW7?WGY7_ G_ ()%?LZ_L^7/P%D\'?$/X^ZQ
M9?LV^ ?VD_AA\*M(\8>+? VKV&D^!OVH-;AU_P 9:#>2VGPUTO5;ZV\)WL<D
M?P\9M2BET>SN);37'\2Q1V@MO.O@/_P1I\/_ +.5K\,?#_PR_P""B?\ P5 T
M[X=_"?4M!N_#/PDN/VA/A@GPPFTG0M8BUG_A$-4\,Z5\ M*,WA+6)$FLM;TN
MQO=/EO-/O;V&&\M99A.G[*T4!S2[[^GGY>;^\_%WXD?\$4_AAXD\9_%G5/A!
M^UM^VK^RS\+?C_XGUCQA\;/V>OV??BYI/A3X.^+?$'BDQ#QOJ>A:%J/A+6+[
MP1=>/8EG@\7IH>H&PU&VG73[:PL=)MXM.'W1XZ_8J^#WBW]B[6OV#O#MSXP^
M$OP+U;X/1? J _"_5M+T_P 8Z)\.O[-@T34-,TO6O%6A>+M/EN]=T2.[TK7]
M0UO1=8N-6M]6U:>Y+7]X;Q/KJB@.9Z:[:KU77;7YW/F'XO?LB_!OXT?LD^*/
MV*O$VG:KI?P3\2_""S^"L5KX<N[*TU_PUX6T?1++1?#%_P"&K[4M-U?3+;Q!
MX3_LO2=5T"ZU+1M5TZ'5=+LI;_2M0M%FLIN8_9D_8I^'/[+7CGXS_$?PCXU^
M*7C?Q;\>="_9WT/Q_J?Q*UCPIJK7#_LU_!?0_@;X0UJP7PQX+\(_9]:\3^&M
M!M]=\=37+7MEJ/BRZOKW0+#PUI$D&AVWV+10%W:U]&?D-\2O^",/[./Q"M?V
MC-*TOXN?M+?"GPY^TG^T?\/?VM=>\,?"GQA\,] T?X=?M ^ &2Y?XC?"9]9^
M$/B35O#&L>-M6AM=>\;MJVJ>(X[_ %BQT^XT5= AL;:WB[[X1?\ !-/6OA-\
M2_!GQ'N/^"D/_!3OXK0>#]:@UF3X=?%W]H?X?^)_AIXN6!)$_L?QGX?TOX)>
M'M0U;19C('GM+76M-E=XXR+E0I5OT[HH#F??\O3MY(^,?VW/V(_ O[='@7X7
M^"O&OQ0^-WP=N_@[\;O"O[0'@'Q]^S_XJ\,^#?B%HGQ"\&^&?&OA;0KFVUWQ
M3X*\=V=O96]GX[U:](LM)M-374[32YX-4@@@NK6\\[^$7_!.7PKX"T'XM>"_
MB]^T_P#MB_MH_#GXS^!+GX=^+OAI^V+\5O"GQ0\$6^A7TK-J-QH&F^&_AMX!
MO-*UJ^@<VDFJC49[BVA6*;3_ +%?0PWD?Z)44!=VM?3Y>N]K_B?BYX"_X(D?
M!CPWXE^'%O\ $3]J#]M#]H;X"_!;Q+I7BSX0?LJ?'/XQ:=XM^!7A35?#Y$WA
M.#6=%M/".D:UXWT7P'=QVTG@70_$>M3Z=I%G96VFZM#XAM'O4O/HO]KG_@F[
MX _:B^*W@?\ :'\*?&?X\?LK?M)^ _"MW\/;/XX?LX^+=*\+^)_%'PTO=2?6
M7^'7C[3M>T'Q%H?BSPI9:S/=ZUI%I<V5M<Z?JUR]P;NXM@MG7Z,44!S.][_E
MUWTM;7KIJ?DSX#_X(X?LQ>"_!'P\\)7WC3XZ^.M7\,_M8>"/VU?B;\0O'GCG
M1O%/C[]I7X[_  ]L[N#PK>?'OQ%K/A*^O/$O@G1[R\.KV/@CP\_A;3$U2WAO
MKB6ZNKC59M2^N_VK/V0?AM^UYIGP7M/'VO>._".K_ #X_?#K]I'X9>+OAMJF
M@Z/XGT7XB?#234SH\4UUXB\,^*].O/#6K6NKWVG^)-%ETL?VI9R1JEU:SP07
M$?U710%WO=W7Z[GS=\./V7? 'PP_:._:7_:?T#6/&%YX^_:HTCX&:-\0M(UC
M4-%N/"&CVO[/WASQ9X8\&R>#;"R\/Z?K6GW&IV'C'4YO$SZWX@\0QWMY!82:
M5%HL,5Q;W7P#+_P1L\*Z7XZ^,_C7X9?\% ?^"E_P,M/CG\;OBA^T!XP\ _!C
MX^?#'P=\/;+XA?%SQ-=^*?%MSH&A2_ ?5+RULFO+F.RL1J6K:MJ::986$%]J
ME_/"]U+^Q]% 7:Z]ETZ;;I['Y(_$7_@D5X0^)4?[.6L:K^V]_P %"M&^*O[,
M_ACXM>#_  E\?O#GQL^'%E\</%^A?&3Q9#XJ\26GQ$\:WOP2U*/65TR.ST[P
MMX=31-)\-PV?A/3-/TS48=5N;?[>WOO[&G_!/'X+_L5ZM\3O&WA?QE\;/C=\
M9_C+/HQ^)O[0/[2_Q%?XL?&GQ7I7AN*>'PWX9N?%1TC0+&P\-:&MS-]CTK1]
M$TZ.<BS&I27ZZ3HZZ?\ >-% <SM:^GR[W[=^FWD? /[9O_!/7P3^V?X\^ 7Q
M1U3X^?M/?L\_$7]F^V^+5E\._&G[,/C_ ,'_  ^\1FT^--AX*TOQI;ZSJGBC
MX<^/KF:&73O NFV5DFDOHZK;ZAK$6H#45N;467B/@[_@C?\ L[^'O O[5OAO
MQA\8_P!JOXX>/_VQOA;+\%OBQ^T'\=/BQH?Q!^.5C\,?L=S:V?A#P/KT_@+3
M_!_AO2=-EN6U"SMG\#ZC')>P6/\ :"WUIIUA:6WZV44!S.UKZ?+O?M??7<_(
M'P-_P2,N?A_+X/BT3_@I[_P5AFT#P3)X?CTCP=J'[2OPSD\)RZ1X;:T6P\-7
MNEVGP LG?P])9646EW.GVMS:,VFE[>&> E9$CUC_ ((\>%/^%E_&WXE?#7]O
M7_@I%\ ?^%_?&'Q=\=/'G@/X%_'?X:>"?AY_PL/QLFFV^N:KI6AW'P+UJ_C\
MRPT71M,BEU/6=5U#^S]*L+>XO[C[.CU^P5%%D/FEW_!?Y'YE_M$?\$O?AI\>
M?$/P;^*ND?'C]ICX&_M,?!/X<V7PIT7]J7X.?$'1= ^,?C_P-9VR++X?^,]U
M?^$]3\,_$C3-0U8WGB>]M;OP]I@7Q'JFIWFGO86E]<6#^R?L9_L+_"/]B;0/
M'T7@?Q!\2OB=\2OC!XEM_&7QL^/7QO\ %S>/?C-\7O$FGP7-GHMWXS\5"QTJ
MUEL/#6G7=SI?AC1=,TK3M,T>QGN"EO-?WVI7][]H44"N[6OI_3_/I>WD?GW^
MS#_P32_9L_9-_9I^-G[*/PUA\8:E\*_V@/$OQ<\3_$4>+]0\.:AKM[-\9?#M
MKX1\2Z59W.C>%/#^DPZ+IGA:QL- \.V=UHM[+9Z=90)J-UJLQFFF]P_8_P#V
M5?AE^Q)^S?\ "[]ESX.S^);SX<_";3-8T[P_?>,;[2]2\4ZE)XA\4:YXQUS5
M->O]$T7PYI%SJ>I^(?$6K7]S)I^AZ7:[[DK%:1@<_2E% -MWN]W=^NU_N/@3
MXN?\$Y_@E\9_BY^TG\9_%'BGXJ6'BC]J3]C'Q#^PS\0+#0-;\)6N@:/\)?$L
MFN27WB'P=:ZCX'U74=/^(L3:_>"TU;6]5\0^&HQ%;>=X1G*2F;/_ &GO^"9?
M[-O[7'[%_@G]AOXNOX[G^&7PWT7X7Z7X$\:Z%K'A^P^*OA:_^$^BVGAG0/$^
MF:Y?>%=4\+#Q%J?AJ+4O#_B&2X\&7&DWVF>(M<CM-(T^>6QGT_\ 0NB@+O35
MZ;>5M#)T#1K7PYH6B^'K&2XELM!TC3=&LY;IXWNI+72[.&QMY+EX8H(GN'B@
M1IGB@AC:0L4BC4A!X)\+/V7? 'PC^/O[4G[1GAO6/&%[XW_:WU?X0:S\1]+U
MS4-%N?"NB77P5^&=C\*O"T?@BQL/#^FZOIMO?^'K"&\\0)KVN>))+K66EN-.
METJQ9-.3Z1HH%^O_  Y\T_LM_LK_  ]_9'\&>.O WPWUCQEK>D_$'XT_%;X[
M:S<>-]0T34M1MO%WQ@\3W'BSQ-IVF3:#X>\-6T/ARQU&X>'0K2[M+W4[:R"1
MZAJ^IS@W+?#>O?\ !&;X#7_P+_9@^!?A/X^_M;?"BW_9&^(_QE^*7PA^*/PM
M^(?PY\-?%ZU\3?'/Q1XV\4^,EU;Q/<?"#5-(:PMY_'^OZ3HB:'X;T*]M]$:W
MM-2OM5N!<WEU^O5% [O>_P#5K=NQ\ _LT?L&ZK^S?\1I?B'>_MT_M_?M%PR^
M'-3\/#X?_M+_ !M\%_$#X<Q/J5SIUROB"+0= ^$_@J^7Q'IHT]K?3+\ZPT%O
M;:AJ,<EG.T\;P^_?M4?LX>!_VO/V>OBM^S5\2=5\5Z)X%^,'AB3PGXFU;P/?
M:1IOBRQTZ6]L[YIM"O\ 7M#\2Z/;7HFLHE$FH:#J< C:0&V+%73Z HH"[O?K
M\NGHE^1\I?M)?L??#3]J/X#Z%^SS\0-<\=:/X+\/^)_A%XLLM4\':GH&G^*)
M=1^"_BSP]XQ\+PW5[K7AGQ#I+V5_J?AJP@U^.+1(9[JPENXM.N=*N)(;J#7^
M/G[*_P /?VBO&?[-OCGQMK'C+2]6_9<^--G\=OA_;^%M0T2RT[6/%UEX8\0>
M$XM.\8PZMX>URYU#PXVG>)+Z:2TT6[\/ZF;V*TD75T@CFMI_I:B@+OOM?\=&
M?G+^UI_P3:\$_M8?&WX>?M"_\-(_M;?LW_%3X:_#GQ#\*]$\1_LO?$CP3\.[
MJ_\ !WBC7[3Q)K-AK5WXD^&'CO4KG[3J6GV+,EEJ&GV;QVD FM)98Q-7EGCW
M_@D7X0^)G@+X+>%/&/[;W_!0G5_&GP!^*GC3XM?#;X^W'QL^'$_QZTC6?'/A
M*S\%ZGH/_";W7P2N+"+PI8:-;W8TC3]-\/:=J%M<:UK)N=6O+>[2V@_6VB@.
M9Z:[;;>?EYL^ ?V:/V#=5_9O^(TOQ#O?VZ?V_OVBX9?#FI^'A\/_ -I?XV^"
M_B!\.8GU*YTZY7Q!%H.@?"?P5?+XCTT:>UOIE^=8:"WMM0U&.2SG:>-X:'[8
M/_!.;P1^V!\5O@]\;+O]H;]JG]G7XF_!'PQX]\'^#O%G[,'Q#\%_#W5Y]"^)
M$^@3^)[36+_Q-\-/'M],LX\.6$$2:;=:7"8)+F.[ANR\30_H;10%W>]]?1?Y
M6_ _&FW_ ."'_P"S%?>"OBUX7^(?QG_:X^-?B7X]>-O@[XF^-/Q=^-'Q=\.^
M/OBI\2O"?P-\4V?C+P+\%O$&L:A\.X?#UO\ !Q->L+*YU;PUH/A?1M8OXK+3
MK5?$EO!I6E)8_=_[9/[(GPT_;?\ @9JOP'^*6L^./"NBWGBGP+XWT7QK\,]5
MT;0_B'X*\7_#SQ9I7B[PYXB\(:OXA\/>+-$L=2CN]+;3;F74/#FJ1OI&IZG!
M!';W<MO?6OU/10',]'=Z:KR_JQ\T_LY_LL?#_P#9EE_:#F\$ZWXR\0R_M*?M
M%^//VG/'[>-KWP_J"V7C_P"(OA[P9X;U[2O#,6@^&O#<-CX1CLO ^E3:?INI
MQZSJD-W=:DUQK=W;36MM9_//P2_X)G_"_P#9S\%^'OAI\%_CC^U#\/?AGX4_
M:XO_ -K;P]\/O"_Q+\.Z%X9L)M6BU\ZO^SG<1:-X"T_4=;_9:U;4?$$VO:E\
M+_$6HZOJEWKVGZ9J4GB\RPW NOT<HH"[[[VO\M%^ 4444""BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ K\]/^"G7CO1_AS^RWJ/B77/C[\4?V;+"+QQX
M/LS\3/@_H$_B3QG!+=SWJQZ)#IEOKOAV1M.U8J5OYSJ2K"D"$PRE@!^A=?%7
M[??Q$UKX7_L^7OBG0/VG-#_9'U"/Q;X9L%^,'B'X:VOQ7TVUBO)KI9?#S>$K
MS1M=@DFUP((XM0-@S61MR5EC,F3ZN1*^<Y6E#VE\;07)RN?/K/W>2. S24K]
MEEV-;Z8:KM'],\&(.IXM>',(X7ZZY<7Y/%83ZO5Q?UENKB?W/U:AP7XC5J_/
MM[*EP%QA.5O=X?S!IPH_S%?\->_#/_I,/_P4"_\ #/ZK_P#/<H_X:]^&?_28
M?_@H%_X9_5?_ )[E?5/_  VK\4_^D]OPF_\ $&/#W_SL:/\ AM7XI_\ 2>WX
M3?\ B#'A[_YV-?N7LI?]"Y?^$.)_^E&?[*_V=6_Z(./_ (AW$/\ ]:W/E;_A
MKWX9_P#28?\ X*!?^&?U7_Y[E;GAC]KCX:W'B3P];I_P5Z_;ZU)Y]<TF%-.O
M/A%J<=IJ#RW]NBV5U(WQ9E6.WNBP@G=HY D4C,4<#:?HW_AM7XI_])[?A-_X
M@QX>_P#G8UK:!^V=\4+K7=%MG_X+N_"G5DN-6TZ!]*C_ &(/#]H^II->0QMI
MZ70^&<9MGO0QMEN Z&$RB0.I7(F=*7)/_A.7P3_Y@L3_ "3_ .K2Q_\ 2H_X
MH_%'FQ>7UOJF+_XP2*_V3%:_ZG\0JW^RXG6[_9>X=*V]WB,.E:[KT$G7H_U%
MT445_/1_A.%%%% !1110 4444 %%%% !113))(X8WEE=(HHD:2221E2..-%+
M.[NQ"HB*"S,Q"JH)) % TFVDDVVTDDFVVVDDDDVVVTDDFVVDDVTG^2_[3_[=
MOC[X.?MO?!?X2^&XM$NO@1HD_P --&_:<U2XTWS;_P -ZS^T7KGBKP=\)9#K
M<K(NB6NA:IX?T[Q!JIB5EO-+UN**5G5)39=)^U?\3_VOM0_:Z^$W[-7[+WQ*
M^&OPS'BOX%^-_BOKFK?$3P(?&5K<W/A7QCHWA\6=N8)%N[0RVVL1NGEH\1>!
M_,&75D_-G3/V?OVO?VZ/@[^V;\=OAEXK^">G?"G]LWXA:_KN@:!XS\(^*M1^
M*6M>$?V>M>N/"/P2/AOQ/I.L66EZ%/;OX$LIM DN["ZCAU.:XU8[[+4$#>H_
M#3]MCX5>)?VF/V$/VF_C+\1?"GP[TSQC^P)\3- \6:_XOU:ST'2H?BGI?Q.\
M+^'_ !AHGGWKPQPW3^*?#/B1K.TD"3O:6XD\L"OU/^Q<+AXT)8+"Y?C\=E&5
M9I@,PPM.A+,)2S>.68;,L/5QV#E0C&>*IXJKFN!A3A[>+CE]-<SG"48_Z2_\
M0BX;R2CDV(X0X;X&XVXQ\+?#;Q&X)XYX;P635^.L3B/%&AX=\/<?Y%F'&/"M
M?**5+&<28/B3,/$S@S"8+"+.*$\-P+@(?6)XS!UZ%'Z6M?VPOVH/A=X:_;6^
M"'[0]I\.3^TG^SY^RCX__:=^#WQ-^'FDZG!X ^*/@/2_#'B.+3=>OO"NOS23
MV&K^%/'FF66CZ_912+I6IM<36EO;6\>FG4=;\RF^/W_!2_X _ OP-^V+\6O%
MOP ^//P%NO#_ ,.O'OQ1^'WA3P+K'@GXF^&?AMXXM-*NK_7?"NJ17<6BZCK?
MAB/7;.XU"RU".YM+BVM+AX4CB$US#P'QG^)OAG]JGXE?\%$?C]\&;]/%WP.^
M"_\ P2I^/'[.,WQ+T^WNF\+>,/BAXQAUGXH:II_A+6)HX+76K3PMH.A6EMJM
MQIPNH4N]2MIS<"ROM)GO]#XR?MI_L]^,/^":7A?]FOX2?$?PW\8/VA_BW^SW
M\,/@#X1^#_PZOD\5>,I?&_B;P7X>\,:I;ZGIVEM*=%M_#47]J7FJW>J26L$$
MFG-9J9KN6&VEJEERO@8QX>P52>/S')J>?8>672E'+*6*R5U\<H5>?GR*,8<N
M8R;K4HX2M)WY81^KQWRS@.ES<'T*'@7PACL9QKQ[X48#QLR*MP%B*]'PZR[B
M3PCJ9SQG2PN8/%K%^#5##X;V7'M>57-\LI<+YI7DJGU?!X=9%1_<[6?'F@:5
M\.]6^)T-U'J7A;3?!=]X\BOK5F\F_P! L]#E\01W5N_EL_EW6G1B:%O)9MLB
MGRR?E/Y=?L&_&K]NK]H&Y^$_Q'^)WQ?_ &--6^%_BCP7;^.?&_PM^'.G^*8_
MC?X>TGQ7X/O+_P %Q7UM-K.IZ7H=TNM:CX9OM474 8I=(:[M[65[J:W8_;OQ
M*T'2OA[^QSXV\*>,] \1_$70/!O[..N>%_&/AWP!<R:9XJ\7Z!HGPXN-&\3V
M7@^Y-_IEU9:UJNEV]_\ V(T&H6NHQ7<MN+*47P@!_';P#IG[%,?Q_P#^"8^J
M_P#!//3?!V@>-M>;Q#J'Q(T[P%JD%YXFA_9ZD^&^KZEXOLOV@WL[^_O[KQ39
M^)9=,TVUNO'4UQK3>);1M.@NG%AI45O\[DN#PM?+<YA'"NK4G6Q<,/F=7+J&
M-PF$P^#RK,,;RUJ\\31JY=4Q2I4Y4\33H3:J2H6Y^6>'/P;PBX5X=SCP_P#%
MG"T>'*N9X[%9KQ/@\B\1,SX!R;B[AKAK).$_#/CCBU4<USG&<195F' 68<14
M\NP6(P/$. R7$SAC:V3>R>+='$Y%+^B6BBBOC#^2PHHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "OXM5_;F_X+B?%?P)_P %)/VG?@C^TY^SGHWP5_8*
M^/GQ_P#".I_#3Q[\*?!]MXNUOP/\';J\\33P:'J\/@*ZL]3NH/!0BM+:#5/$
MFE:SKNIVDEG:W:ZC>V<DW]I5?PV?\$Z_^"0/[/\ _P %)?&__!2CQA\=?B_^
MU!X5TOP=_P %'OCOX2D^&WPA^)?ACPG\,_%VG6OB6W\4?:O&'AW7/AYXMNM1
MU:>[O?L,NI6&K:5/'IUI8):&UO+2.]H+A;WF[67+NN;[6JM=;K2_0_<7X>_\
M%Z?V*_"G[*/[+_QE_;!^)EE\%/BO\>?V?M,^,DOPYT;P#\5O$T&I"S\5:E\.
M/$MUX0N](\(ZQIYLKKQOX?UN;1/#^HZ])K\6@(-0=]3TJTDUVX^@OC7_ ,%J
M?^"9O[//CSP#\-OBU^T[H?AGQ;\0_#GA/Q=IVGQ^#/B1K(\-^&_'FB6/B'P;
MJ?Q$ET3P?J ^'+:_I&J:5J$6F>,UT76=,T[4K36-=T[2M%:74HORQ^-?[,WP
M%\*_\%Z/^"5G[.^G_"WPC?\ P6^%W[ GQ1\/>#?AWXCTJW\4^&['3O"FF?&W
M3]"-]I_B)=2AUR]LU)O3J&MKJ%[-K)&N33R:NJ7J_FA\5?C1^R;^Q/\ &W_@
MX%^!?[=GPWN+OXR?M/WGB?7/V3KK6OA3<^*;;Q]X$\6Z#XYN?@OX0\!Z[INB
M7VD^!K#P'>>(O E[9^)'U/1-/M;CPJD1OH_&G@.RT:E?\"E&+V4M5S636SDT
MK:?96K_IG]=GB+_@H]^Q/X2^-/A[]GWQ-\>O#^A_$_QA\(+OX^>#K+4O#_C>
MU\'^,?@]8^%M8\;W?CSPA\5)/"X^%7BG1X?"?A[7M=9-!\::A?FQT7576S9]
M/NDB^+O&W_!27PG\<OB'_P $T_&?['G[5?P\TGX ?M)_'[XH?#KQ3IOQ#^"_
MQVTCQ)^T/9^!++0K6_\ "GPCGU_X :@OAV_\-ZY/J5OJ7B;Q9K7PR\,7MR9M
M-TWQ7JE_I6IV6G?RO_\ !0+X6^.OB;^PM_P25_X)[^'OA!X@^('_  42^%/[
M-GQ&^/GCJST^1;3QG\(_V:5\*>,/%-G\+?%EC.MJZZYK_A72=%FL_!^I7,.O
MZ/>^"-.\,V.D7>J?$?2[?4?TDT'X\? G]H.V_P"#8SQ3^SWH>G>#_!GA/XV^
M/?AAKGP_T\/GX??$#P'\._ASI/C;PQ=O,6NKR9]8\SQ!::U?,U_XFTG7=-\3
MWQ-UK,M'^:#D22>KOS+I;13L_25M/1[Z'[]V_P#P6#_X)S7?[6/_  Q1;?M+
M>&)?V@/^$KF^'W]A+HGBY?"9^)4-\NFGX;)\2'T!? $WC9M39M'31X/$<H/B
M2*3P@;@>+@N@MS7Q@_X+8_\ !,KX#_M!W?[,7Q1_:=T/PY\6-(UQ/#/BBT7P
MA\0=5\*>#/$<WDK%HOBWQ[I'A2^\&Z+>I-.MOJ1FUI[?P[<)-'XGN-$,,A7^
M'WX*>&YM0^&WA_\ 8:^./[5'C+X=_M-:=_P49\R7]E'P!_P3OT+XO_':#XW6
MMZZZ?\=Y/COJ'QF^!VLW/@R[N?,T+5K*TU^R\2Z=I$ZSZ7H.H>&%_M6W]M_;
MS^*?A;]G?]J__@H1JO[-?QQU;PCXCUS]K:R\7?&+_@FK^V]^R_I'Q.\-_M$_
M%+5/B =:G^(7PAM_LGQB^'OBWP?JWB+5K[QOX(U/Q OPF\9V_@:^TR;PYKUT
MNH>'+:X8_9QO:[V^_5*][:)W[-=Y=3_1<O=2T[3=.N]8U&_LK#2;"RGU*^U2
M]NH+73K+3K6![JZO[N]GDCMK:RMK:-[B>ZFE2"&!'FDD6-2P_,#]GO\ X+3?
M\$U/VI?CTG[-?P2_:4TKQ7\5]0N=1LO"^F7?@KXB^&="\=7FC6=W?:Q:>"O%
MOBCPEH_AK7;FR@L;J2V@BU.*7Q!#$][X437M/1[Q?L'Q-=?\)7^R5XAO?B+\
M-?%T8\2?LZ:M=>._@_\ #^PA;QY'_;'PTN)O$_PU\$:9>W6G6[>+E^T7WA?P
MW87=]8PG6196]Q=6R;YD_@]_X)P_'6Z^&/[7W_!.+X4?LY_'KPY^VY\'=>^-
MNM^!]"_9G_:(_9GM;+]I+]B#P;XA\<0WOCSQWIGBF_T;QAX?^'NL:'92ZMXY
MU#5?A-\99--U5=&=+SPTT,MQ;Z*$1BI*5[W6W;9O5V:Z=;)][V1_:C!_P5$_
M86NOV<?C9^UK!\<M_P"SY^SI\4I?@M\9/B!_PK/XPK_PAWQ,@UOP+X=E\-?\
M(H_P_7QMXAVZS\2_!-G_ &SX6\-ZYH#?VU]H753:Z;JT]A^6/Q&_X+:>"/V5
M_P#@J=^TW\(/VL_CKI'@C]CSPQ^SS\%?%GP5TVV^&.KZ_P")M0^(_P 0]%^'
MOB&Z>&7P7X1UCQ_J-O<:+JWB34YX-8B72M)@"1S&UNA8V\G\W?Q*_:P^%/P*
M_P""6'_!6[_@G/X\U'5M(_:M\>_\%-?%'BVW^'=QX2\6,D'@#2OB7\ =1O/%
MLGB:/1_^$8LK2WUCX+:KI+6^IZK:WUP=:\/RV-G=1:Q;3)^CWC?]J/\ 8V_9
M*_X+7_M4?$/]M_PM'K/PH\3?\$\_@=\-='U:\^&>I_$W38/%WB?X,_":^'@J
M6PTS1M:?1;_XF>$M"\6>&;#5[B.RL#$+[3M6U/3M#OM6O8$^G]="^1*^C=U*
MRTNTN1IK3^\]>Q_2M\6_^"MO_!.[X&_#GX#_ !<^)G[3'AK0_AO^TWX6\<^,
M?@9XOL?"WQ%\3:-X\T7X;6&BW_C1(KKPMX.UI?#NM:*WB+1])?PSXO\ ^$?\
M1W?B:[?PE8:5=>)[.^TFV^=;+_@X4_X)$WVF?#K4U_:WT6V_X63KTGA_3]/O
M? 7Q.M-3\+W$-XFGS:C\1;2;P<O_  K_ $%+N:V$>N^*)-/TR\LYWUBPN;O1
M=/U;4M/_ )=/V//A%XM\.:-_P;*:%\8_"K'2_&_[5'[<WQ#\'>&/&&G"[C/@
M/6O%'[.^K>$]4?1-7MFCM;+6-6T^Z\:^'6,#17=GJ>E>)[&0KJ5O.>@^,OP3
M^&FE?\$X?^#D_P :V/A#P_:ZQX3_ ."K"^#O!T]MI-I;3^%=#\&_M>^"M(TC
M3]'NX42X@TZ'1?B3XDTJ+3-QL(+>Z=XH!,XD1A[..S<GK:Z:MK-P[>5_P/WU
M_:V_X*G^+?V-/VF?^"AE_P"+OC[\%_&_PR_9]_91^'WCCX0?LK1>!?BU:?$G
M2/C+X[/P\T?P=J'COXBZ9\#T\%WW@OQWXI\4QV-O'H7Q@\2W>DVOB"QFUK3?
M"UM9ZAJ&B_&!_P"#G/X6:;X8_P"":EMJ_CCX?-K7QCAC\1_\%!_%\/PP^-,5
MG\!-'T5=/L+[1?AYX83PS=OXGE\5>,%\6:-!JOAK4OB+)X?T;P7<[K&^N/%.
MA^)+/YT_:.T&?Q)^V/\ \%N]-M=*_MFZC_X(@_#[5+>S6V2[E5]%^%'P6U=[
MRWA=7/GZ?!92WL4D0\^-H-\'[T+7SK=_M+?LH:5\&_\ @V]_:7U#Q+H-O\'/
MV5?%/Q:^!_[5'B-/AYXLO9_#WQ%T+X9_L\:WK/A[6=%T[P?=ZMXO^Q6;SW2S
MZ99ZS;:FFK_:M&?4K5]3N;5+]6"C%I7BV]-M-Z;:Z=6M.[^Y_P!9_P 7?^"P
M?_!.;X%?M+:;^R1\4/VEO#'AKXVWFJ:7H6J:,^B>+K[PQX/UO78[:31-'\<_
M$+3] N? ?A+4=1%W );;6/$5N^A+)#-XG_L.VNK.>XP/V]?^"M'[%_[$U[KW
MP8^)?[0WA[P'^T?XA^&OB+7?A[X5/AGQ5XN&CZY?:%JP\!7OC6]T#PWKWAGP
M;::QXAM[%+)?'%]I-O<6DT>K7L<7AS[1JD7\57QT?1-!\;_\%6?V:_VD_P!J
M'6_A+XG^.W[=\?C33O@1X._8-T#]IKXQ_M)Z#X_^*!\3?"?XI_!;XL:O\2OA
M1/X>TZRT75T\1:1X:AU[PXVH^&?$#V/ALZIJOC6_\+#] _B'\1O@Q^PQ^W[_
M ,%0/#G_  4$T+Q#XQ\7_M0?L!_!+P/^S3XM\3_"+5_&FM?%[48OV?\ PC\-
MM9\$:-I-I+X]BT;Q%XM\<Z/8Z'J:WWBO4?#FG^(? FH6FK>/;OR+'5M48>S6
MF[TO96U^':ZM9<SNM=%OO;^F'_@C-^TW\7_VQO\ @FQ^S?\ M'_'K7;#Q-\6
M/B-_PN#_ (2O6],T+2/#-C>_\(A\>OBEX$T+R-$T&TL=*LOLWAOPOH]I+]EM
M8OM,UO)=S[[FXFD?\T/@]_P7B^$OP4_:\_X*(_!G_@H-^T3H?@GPS\,/VJ6^
M%?[,6B6/PMU_5-0L/ ^EWGBZT\0SZ[>?#+P7K5_/IVF20>&(KCQ!XPE65I)9
M!937!74/)^L/^#</_E#'^QM_W<-_ZU7\<J_FQ^(?[4?['WP#^*?_  <H_#7]
MHKPSYOQ:_:5\6?%WX>?LUZU=?#?5/%\7B+QS;1_$W3;7PMHWB>VTB_L/!VI^
M%/&GC3X=_$/4);Z_T>WN+73;'4C<W.JZ'H%E<+JOF)13E-6;L]$K77OVT]%O
MY(_MA\"?MN_LM?$W]H'Q!^RYX$^+6F>)/C=X:^$WA[X[7WA:RT#QA'I%]\(/
M%=MX6N_#_P 0?"_Q N_#MO\ #CQKX=U&W\:^&72Z\'>+==>%M2,5U%!+9:BE
MIT'[+W[67[/_ .V?\,7^,O[-/CUOB5\,U\3Z[X.C\5KX3\;^$;2[U_PTULFM
M6^G6GCSPWX7U/4[*TENX85UK3K&ZT2[G$\%EJ-S+:720_P 1?[;7A+]H#_@F
MO^R3_P $HOVUX/#VH:/\4-<_8(^+/[!_Q?TO78KVVU/PP?BG\*_&WB3X%VNM
M23[+JV\1^!(/&>OZP?#NH103:1=?#&Q\,LLEG:RP6/\ 85_P2]_9H7]D+_@G
M]^RI\ 9[+^S]?\(?";0M5\<6Q@E@DC^(_CMKCQ_\1HI%N MRWV;QMXGUVTA:
MY2*<6MO!&UO:A%M863**233O=V6W2_-^EO7J?B/K'_!P /B1XF_X*]_#OX8^
M+O"'A#Q'^S'\%=8U[]B"6V\!>,]:U3XAZO\ "30OBI>?'+X@>,+KQ5X73PW8
MKHVL67@"WTSPGXILO#T$EB)(]$3Q7,^K:BOW%_P3$_X+3_LK_M=>'/V;OV>_
M%O[0>C^)_P!N/QE\%?#'B/XA^&;;P+XC\,Z'K'Q%@\&+XK\<^']!UZ'PQIOP
M\G\0:+80WVHZAX>T'5'6U2RU*QM4EO\ 1]5LK'\'/'?Q)^%GPS_:#_X.C?@1
MXQ5=!^,'QB^$Y\5?!SP[+X3U1I[_ ,'^ _A/\8O$GCK5+36X-*?2/#NG?V+X
M[\!WT$%_J6G3>);;6;";1[;5(+*]ELNQT?P3X<\,:S_P:47W@G0?#GA3Q#XG
M\(?%6;4]>T_0+-+K4M2OO"OP%UP7FO/9MI][KD2>(/%7B+6'M+K48Q)=:YK3
M0S6TFJ74SA;C&UK-:)I_]PN;MJFU]]W?H?TF:1_P6&_X)QZ]^U7'^Q=H_P"T
MQX:O_C]-XLG^'MOH$'A[QJ?"UU\1H+Y]-?X?6?Q';PVOP_O/%KZC&VEV^GVO
MB26*ZUT#PU:W4WB5ET<^S?\ !1#XQ>//V>_V%_VL/CA\+M3MM&^(OPJ^!7Q"
M\<^"]5O=,L-9M-/\1^']!NK_ $N[N-*U2"YT[4(8;F)'>TO;>:WF4%)8V4D5
M_GR_LW>&=+OO 'PA_8V^,W[4?CGP-^TMX7_X*0)*W[)7P\_X)^^'?BU^T1HW
MQHTC43IP^+'B']H7Q7\7_A#?7WA2^OK3_A'_ !'I3ZQJ^KZ.UI9:C<^%]7T3
M2AJ%K_>5_P %?/\ E%W^WM_V:Y\7/_45OZ"914912N[M;]=8JZT6COY^K/E7
MX2?\%HOV5?@Y^R#^R%XW_;T_:'TCP1\>/C7^R3X%_:'U>Q3X<^-ISXPM=8":
M1J>H>'+;P%X*U'PJNIWOB2.[MK/PA87=OK*V]O<ZE'I,>B6=UJ$'A_\ P4"_
MX. _V?O@W^R=^S3\>_V2?'_@_P"),O[3?QP?P!IVI^)_"/Q%C7P+\./AT=)N
M?VA/%^H^&3X?T^[C\8?#T>*/ &A6'A'7;C3[W5Y?']AXL\.:9XST#0]0@N/S
M:_8P\-^'O$W_  4&_P"#>RU\1Z'I.OVNG_\ !)"[UJQM=9TZTU.VM-7T[PG\
M8)-.U."WO(IH8[^PF8SV-VJ">TN EQ;O',B.OYJZE:Z#X6_X)->(O%]YI=M8
M>#OA)_P<I:IK.NW]EHS7%KX,^'>G_ 72H-3\BRTRSN+FVT-;G^Q;8Z5I=JZW
M5T-,MH;.:=;6,)?DRE"-UH]]5I;5U$EM?3E77R/[-/C1_P %K?\ @F;^S^?@
MF/BA^TUI6B/^T#\.O GQ>^',-GX#^*&N7;?"SXEZ1#KG@GQUXNT_1_!5[J'@
M#2M>TVZM+JUT[QM:Z#XE6"X-S-H4=K9:G/8]7^U'_P %=O\ @GG^QKX@T;PE
M^T#^T/IGA/Q/XG^$WAKXY>$M(TGP5\1_&J>+_A?XP\3W_A#PWXF\+:YX,\(:
M]X8US^U=8TK5)(-'L=<EUY=$TV]\33:9'X<@;5:_C=_;)^,/PO@_;K_X*1?$
M+QI^U%#^SY\!/VSOV//@EXV^ FK7G[%ME^TCJG[3/[.7C7X*>#-.\.>!?@TG
MC7Q9\+;SX(^($,4-GHUU=:GX/CT+Q5X3O+?7=9\&:UX M9:^\_V8_P!GOX?W
M?_!6W_@DE\)_B7H.J_%[PIX0_P""*FAWOA^R_:"^%.D>%/$4VG?\)K^TQ;^$
MF\:?"&^\4_$K1_#.L:/X0UV+24\-7OB?Q,=#\J$-<0ZC:HMFQ<D4DWS?"VUZ
M*]D[6TV>_?38_<SXC_\ !?+_ ()0_"K5K_0/&/[4T-GXAT;QF/ _B#P]!\)?
MC=/KWA[5$M+2^N[_ %71C\.(]17P_8VU];F?7+.VO+">Z^TZ;ITE]JEC?65M
M[S^U7_P5:_8'_8N\.?"[Q1\?OV@=!T#3_C3H.G^+?A=;^%]#\5?$75/&'@O4
MX;:ZL_&^G:9X"T/Q%=P^#Y[2[BN;7Q%?QVFF:EA[72I[_4%%F?YE8OAE\//$
MG@W_ (.QO$^O^"_#FL>(M%\;>*;?1=;U'2K2ZU318-!;XN>+=+@T>]EC:?2H
M8/$NE:3K,L=@]NEY?:3I,MZMS_9EBMO\?_$#Q%KG[/WQ_P#V#/C#\6_V@M)_
M97^%/Q/_ ."#_P"S%X'^%OQC\9_LH:7^U]X/\21Z'\&O!<OCWX)67@?6=5T"
MQ\/^)?$DG_"1&;7;6^OM2LK?Q7HWAZ^M(-"^)DM[9I/0%"+[Z;JZU?+&5E9/
MN^CV/Z'_ /@H!_P7F^ _[+'QP_X)_>"_ OQ)^'FO?!?]I&T3XV_''XPP:#X]
M\;1>"_V:+K4I_#_@G7/!=GX1T&_AUK5OB#XKT+Q]H^HV^GIK_BOP0O@#4+/6
MO!NG7?B/1M3MOZ!-?U_0_"NA:UXH\3:QIGA[PWX;TG4M?\0Z_K5[;:9H^AZ'
MH]G-J.K:QJVI7DD-II^F:;86]Q>W][=2Q6UI:P2SSR)%&S#^ 6Z'PA_8Z^$_
M_!N1\</B5XJ^)6K?LR>"/BK^V=XQU/XB?&3X"S^ _&=A\-?&?B?X7^*O#>C:
MU\+/"/Q"^/US/HM_>W'C+5O!$6D>(M1L?$?AZ_;Q-I^D6EEJLU[>?UP?\%A_
MAS\0OC-_P2__ &R? GP>T[5O$GC?Q%\&KR^T'1O"\<NH:SXET_0]8T7Q1KNB
MZ):63_:-7N]>\+Z3JVFVFEV N;O66O%TZRM;ZXNX;2=BE%+D2TNVG+O:5OO2
M_KJ2_LK_ /!7[_@G=^VE\6]5^!?[.?[1FC^-OBCI]MJE_8>&-0\)>/\ P3-X
MMT[0[<76L7W@B\\<^%O#FG^+ETVW6ZN[JRT2ZNM572].U#7DT]_#]J^JU'\!
M?^"O_P#P3V_:?^._AO\ 9L^ GQXF^(_Q<\4:=XVU*S\/:;\,?BYI-MIT?P_.
MJ?\ "26_B/5_$W@71-,\-7,,>BZG/8)K=S8Q:I!%8O82S_V]X<&K_P NWP9^
M._[+G[97QY_X-]?@[^P+X#N=)^.7[*-UX7\1?M3ZOHOPSU7P;_PK?P1X,\/>
M!7^+_A7Q?XDETW1[7QJOC2]\/>-[Z/Q-;:QKFEM?>)D-Q<7/B;QMJNA-^J7_
M  ;&_"GX<6O[)/QS^*R^"O#$WQ*U7]M;X^Z?-X\N="TJX\76^D6.B^ =-M=#
ML/$<MHVL6.AQ0O>3#2K>\2S-WJFJW)B,E_<;E?6P2@HIOWEM9.UTVVKO39VN
MOZ9]4_\ !4G_ (+ ^ ?^"=O[0O[&7P9\3:_X:\/:!\8?%L_BW]H3Q5KGA+XA
M>*-2^'/P"TNYETVVUWPQI_A'1-1@U75O%7B:PU;1)8K*/Q!KFC:?I%U<+X90
MZMI>L6GTA\9_^"P'_!.K]GW]I/2_V2_BS^TCX>\+_&Z_O]&TK4M#/A_QEJ?A
M[P?JWB2*TF\.Z7XY\=:5X>O?!7A*_P!6BOK68VVLZ];/HMK<6NH>)1HFG7UA
M=W7YH_\ !>3XG?"CX _M5?\ !'3X^?&UX='^$WP]_:/^*UU\2O%+^%M2\4QZ
M=X9/A7P8!#?Z7HFE:OJ^KVRF:^NH]'L["_NKB)-0EL["X=)E/\VOQYU#0-#\
M?_\ !6CX"_M+_M2Z[\)_$/QV_;4MO&UA\%_#'[!7AS]H_P"-/[2OA+QY\2I?
M%/PA^(7P;^)/BKXF_!V;P;IFB:)JMCX@TSPI'KWAD-X8UTVOA8ZIJ/B"[\,Q
MG^8XP4E'=:.]NKYK=GLM6OO:W/Z^_ O[=GQ-L_\ @K]^W1^S5\5?B'X6\/?L
MG_LW_L@^ OCK8?VUI/AO0H/!E[=:=\.=5\9>*O$/CA[6WU631;/3]<U^]NH]
M6U)].T^V_>JD:VT93WW]F#_@K]_P3S_;%O/BOIOP _:!M/%VI_!CP?KOQ&\<
M:3J'@;XC^$]8C^''AH0#6O'N@Z-XK\):-JOB?P[I\UU;6M[_ &#9W^K6%U=Z
M=!J&EVCZQHPU#^6#]M#X4_%O7?VD?^"QOPN\!KXA\5?$S0_^"1?[',>K>=HD
M]EXI\0:3\.]5_9-UWXIRW/ARUU_Q/<6FM:EX(\-^+I;O1(/$OB>6"[EEL(]5
M\0,HN+WD?V'-4^%WQJ^._P &O%'@+]L+6_CIXO\ @7_P2O\ CQI6O> ?AE_P
M3]\)? OX=?"OX>WGP \>>%3\%?C-\8[#XTQ:UJ?BOP-XXUW1]2TCQ3;?#+Q[
MHGBW5HX;:+Q+IEQXEN+RW%^K#D35]=EMM\*=WH]_5?/8_J5^%/\ P7)_X)9_
M&[XN_#;X'_#+]J_P[X@^('Q<^P6W@*SNO!'Q1\,Z1JVNZM=3V>C^$;WQ!XL\
M$:'H_AWQCK%S;M;:5X:\27FD:I?WL^FZ7;P/JVM:+8ZA^>/PF_X+S?"CX&_M
M;?\ !1'X0?\ !03]H'2/"7A?X7_M7Q_"?]F;0=)^%VL:KJVE^!-/O/&-KXCO
M]=E^&_A+5=4O=(T9K7PTM[KWB9IKQWE,6FB]G:[B3^<;X/?&G]G#XU?\$QO^
M":W["7P)\%R7?_!1BR_X*":7XPN6T7X9:O:>)3H5W\1OB?J,7Q0?XDV^@)I>
ML>'K;PSK/@7POJEM_P )#=W&E0?#NZU/7-.L-'\#V.HQ?I;/\+_ GC#P1_P=
MC^(]>\-:1?>)-(^(>N2Z5XAN--T^[UG3(?"M]\6/&^G66FWM_:W<FFVDWB'2
M+"\U!; 6TUXUK9R/.MSI^FW%D=4-PBKIJ7;6U_C44UIL[]NEO3^G_P#:N_X*
MC_L)_L4^%?AKXO\ VAOCYH/A;3?C%I-KXB^&%IH.B^*?'VM^,_"]TFFSKXLT
MO1/ NA^(=2C\++9ZI:WB^(-0M[+2[Q-]IIMS>ZF$L7C\8?\ !5/_ ()^> _@
M;\&_VEO%'[3'@^R^!'Q\\86_@#X7_$RST7QOK?AW5O&$T6H33Z)K[:%X6U.]
M^'\^D+I.IKXDG^(=IX5L_"LUA=V_B6XTJ>"2-?Y6?A[\2_@=^Q?^V-_P2Y_:
MJ_;]\/W.I?LI_$?_ ((?_LR?##X-_$77OA]K'Q%\%_#3XI:7\)_!DGB#21X?
MT#0_%FJ:AJ-QH4WB>PNH+/09+BWB^,EI?3HNDVVHWT'QSH'P[O-0_8K_ &0?
M$>I> KWPK^S;^T=_P<"V?CW]GSX:>*=(:SLA\!?%.DZ=X;MX;31ITDM(O"FI
MIIM[X>@L[2XN=+N7T/4[FVWP7OVJ]8O9K35^;TL_CNEYKEUWWZ:']LG[,W_!
M57]@K]KKP#\:OB=\$?V@-!UCP5^SO87&M_&35_%&B^*?A[_P@_A:&QU?5(O&
M6J6?CK1/#]XWA*\T[0=8N[;7;:">T']G7=I=-;:A!):+:_8V_P""I'["_P"W
MYXE\<>#?V5OCC9?$7Q9\/;+^V?$/AN]\)>.O ^MMX9:_M]*3Q9I&F^//#7AN
M[UOPY_:5W9V%UJ&F17#:5=W^F6^LP:;)JVEK>?R>?\%#?AMXHUK]K3_@Y:\'
M?!3PO<1ZPO[,'[#OB^?0?!.FBRFD\-Z/<_LG_$?XP:D+#1X(S+'=>#['QSX@
M\4NL+/J<,NLW.H-,]W=2/[!_P1KU?X8?'3_@HY^RW\1? W[6'B7]H'QK\'?V
M%?\ A%O%6@?#/]@#PG^SS\*OA?X%O/#UYH>G_!SXM_%/2?C*+W5/&/@+Q/>:
M>-%UFT^%?BC1_%DZV5IIWBNWBCN1I8#A&S:;V376WNJ6NG6]D]/GL?U>?M6_
MMM?LO?L0>&_!/C#]J;XK67PD\+_$3QM:?#OPGKNI>&O&OB#3KWQ;>V%[JD-A
MJ%QX.\-^(E\/62:=IU[>76O^(_[)\/6$%O(]]JMN-N?SY'_!Q#_P2%_X06Q\
M?M^UE8)IVH>,;CP7%H!^&WQ8?QU#>6L=G<S:Y?>!8O!,GBG3_!QL+V&\M_%U
M[ID&A7TD=YHUA>7/B2POM%M_$_\ @OKX4T#QWXC_ ."0G@?Q7IEIK7A;QE_P
M5A_9H\*>)=&O[>"[L=6T#Q%?7ND:SIE[:744]M=6E_IUY<VMS;W$,T$T,KQS
M121LR'\?_P!H/X/_  ZL_'/_  =9>)[?PKHZ:IX*\"_LLV'A>1M,TV8:)%\3
M+#6?&WBUM+DFLY+K36O_ !'X2T2_":=<6ENKVD7F02M:V+V@*,8M*][OLU;X
MXQ[?WK_(_KRT_P#;:_9=U;X^_#7]F'2/BQIVL?&OXP_!&Q_:/^&?A;2/#WC'
M5-)\7_!/4Y];M]-\?:7X]L/#MQ\.QIVH/X=U>2RL+KQ9;ZW=6UM%>0:8]I>V
M$]S\Y>)/^"QG_!.+PK^SM?\ [5&K_M'Z=!\%[/XH:_\ !6VUQ_ 'Q4M?$&N_
M%7PQ8P:CK?@SPWX$U#P19>.-=NK"TNK6>[UK3_#\WA:S@G6ZO=>MK-)KB+^:
M_P (?M'_  D_8I_;L_X(J_M+_M):]J?P^^"<G_! ']GSP-9^.!X4\5>);'4_
M&EEX.\<:C-X5TNU\*Z-K6H7VM+#K_AQ'M8+1A;S>(]"6\DMDU.VD?X*^'+?"
MF?\ X)??L^?$'X@_$G]H;]E+QUX;_P""K7[0VO?!_P#:<\%_#F+Q=X'_ &?O
M&]YX<^%%Z;7]H#2;+Q9HGC;P[_:2VEO>:)=>!],\8:S97?@KQ/!/HE_:J]E?
MKJA^S6F]G;7SO-/I_=6UVKO?1']-/[<O_!>[]G+X??\ !.3Q#^V!^Q9\1O!O
MQ?\ &/B3Q[I_P3^&>D^*?#'Q TV'2/BC?Z;;^(-=M/&/AJ\T+1M4TR]\'>"9
M;[QA;6GB"XT+P_XI_L^&RTC7M1%Y!'=?LO\ LN_'_P"'_P"U+^S]\*OC[\+_
M !-'XQ\$_$GPM;ZMI?B2+0]>\-Q:E>6-S<Z'X@:/1/$^EZ+KEA':^(]*U:R2
M.]TVV$JVPN+4SV<MO<3?P4^+OB]\2/C?_P $6?\ @J=8^,]&^$'Q9TKX3?M8
M_L\'P]^VE\(O@EI_PO7]IC4/$/Q4'_"7>)_%UU:^"? FK>*/$?AF.30+J]\6
M^*/#EKXCDMOB=!I^J:MK2S07MQ_=O^QG\6_A-\=/V6O@?\4_@;JMMK?PM\4>
M!=.'A;5;/P]J_A6VNQH4USX;UIXM!UW2=#U:P5/$.CZM"?MFE6CW+1M>1K)#
M<132,4XJ*T3^)J][Z6BTMEW\GO='X*_\$R?^#@#X$^+/!DGPZ_X* _M0^$-
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M;/V>/B"/^"M?P\_X(_:GH4I_9R_8T_;^^-W_  4"M%OA/+:-\+YO ?PY\7?
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M_P#SMJ_<O_AH;_@C]_TC5^)__B'.D?\ R\H_X:&_X(_?](U?B?\ ^(<Z1_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !69INBZ-HWVS^R-)TS2O[0NY=0O_P"S;"UL?MU_/CSKV\^RQ1?:;N;
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MFV>D:1IMJK,ZVUAINGPV]E9P!G9A#;P1QAF8A<DDZU% '%K\-_AVFJ:)KB>
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MX*Q_MN_MK?L=_M"_ME?L]^'/V5M=_P"">OP9^*WA:X^*&N^+/!WBZ/\ :/\
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MH'[4O[4?@[3O^"8/@3]L&Y_:$_:5O?C)\"/VN_B3^TC\4/A]\,?A1\+/&OC
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M_7E10)2:5DEOO;7=.WI=+SZ;'\=O[.7P*_X*H_&O]M/_ ((Y?$[]HC]A^]^
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MO?17X(?\1%/[$_\ T2_]J7_PB?A-_P#/NKWS]F#_ (+/?LN_M8_'+P/^S_\
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M"I6P].6(Q>*K4J%&-3$4(.I.*E6IQO->^45^1G[,'_!9[]EW]K'XY>!_V?\
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MX@TO4-$UK2KV,2V>IZ3JMI-8:EI]W$<"6VO+.XFMIXR</%(ZGK7\(7_!/O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** /Y+?V /A3\+OC!_P %E/\
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M9\:/V9_B5\-/V=?B+_PJ?XR>)/\ A#?^$.\?_P#"7>+? G]@?V/X_P#"NO\
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M^V-0UZ[\+ZICPIJFHZN/QB\%>.?&W_!.;_@JOIGC7]L_QCXI^.7C+X.?;/\
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M .TO^#>G]F_X]_L\_P##Q'_A>?PA\?\ PH_X6+^UA>^+O G_  G?AO4?#O\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MXR<,RH1PU:^,IU?PZ_X*[?\ !13X)_M]?\,^?\*=\+_%/PW_ ,*G_P"%L?\
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M57CU)+;3+E+>]U'38;O^?S_@I5^V'X@_:$^&_P#P;P_ME?#WX2R_'_Q]XO\
MBAJ_C<_!#3=0T_1)/B)\5-"L?A5H_C?X;6&IG1M?T_3UN?B%HWB'P]:W;^'K
MZ*..%))-'4EK*/ TC]FW]L'XC>+/^"R__!2GX]_L<:=^P'\/?%__  2C_:J^
M"WA?X,V.K>';O6O&GB"^^$46HWVN^(6T73]"N]<:TM_ ;:AK?B;4_"'A2/5M
M3N_"UKI,.HC0M7G5=P4%;71[;K=34;);[7=]M#^G#QC_ ,%)OV2_ G[%_A_]
MO_Q)XXURT_9C\3V7AK4-'\8P^!_%EWK-Q;>+?$D?A/1'D\'VVE2>)H&N-;D6
MWE2;34:WCS<3!(!OKP']J+_@N!_P3L_8Y^)\7P?^//Q6\5^&O'<WA#PIXY33
M=+^%7Q#\36Q\.>-=-75_#UV=2T+P_>V(FNK%EEEM#/\ :;5CY5Q''("H_C^^
M.WQ,_P""F]]_P0"^&7@/QQ^SA\"M%_8+MO#_ ,)8_#/QQTKQZMW\7-1L;7XK
MVUUX5GOO!_\ PG%TT$VJ>*@FF:@G_")0?9M/9KC;!C[17Z-_$_5_VP=%_P""
MZOCBZ_8H_9^^"O[2'Q4D_P""8_P6M]?\#_'?6K'0O".E?#][[X+2:KXKTZ[O
M_$?AB&3Q'8^(XO"FD6=LM_-*^F:[K$JV<B0O-;L.1:W>W/M)+X>6UW9V>NOR
M/ZK?V0_VU/V:?V[?A8WQC_9>^)EA\2?!-MK5WX:UF1-,UKP]KWAKQ)8PV]S=
M:%XF\,>)=/TG7]%OQ:W=K>VIO-/2TU33[FVU/2;J_P!.N(+J3ZGK^7W_ (-N
M=1?1=9_X*9_#?XO>&Y/AC^V;;?M=:A\2/VCO@UI>C>'M$^&WP^C\>MXAD\,Z
M1\)QX?\ $?B>RU/PU8:YIWC>VE:QU2YTS1])?PA8V$]]I]QI^MZU_4%01)*,
MFEMI;YI/Y[[]=PHHHH)"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _GG_X*G?\
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M3W_%G/\ L?/^%@_\D,^%?_8D?\C1_P!P3_F+U_4I7\8W_!<']BO]F?\ 8_\
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MW\.ZEX9U=/(E_=3;M/U.X7RI?W<F=C_*37?T4 VW:[V_X&NG71:[Z'\R*_\
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M6/AW^Q?8_L<P_#@^&;5--U72['Q[K/CH>.Y?$@UEKJTOY)M8;3CH*:1/;K%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M'1XIPF05J<\-A(5:DZ:Y;XU?!7XF?L[_ +#7B7_@I+\8O#7_  A__!6#P?\
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M6IV?]FVFC_VSI\%I>7G]H6VJW4E]\$?\%"/V;?\ @CSX!_9 ^+OBW]ECQ%\
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MXP?M[7OC2']J[4-;U_Q7\9_B7\1O&^L7WA[7HY[#Q#XG\016^A:M:VOAF_\
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MXGATJSTG6GUBZF"(Q3775VTV6SN_+7RZ^A_19\!/VY_V._VI/%7BSP/^SO\
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MT+XF^!?B+^T9\!+;1/"6M^-OB=IGCOQGH]KX8AL/#GBS0=5T'Q9X<31X-/\
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M?^%Q?&'X6?"?_A)/[2_X1W_A9?Q!\)>!/[?_ +'^P?VO_8O_  E.KZ5_:O\
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M44 ?G=_P3X_95^+_ , =._:#^+'[3FN_"_Q/^U1^UC\:KSXN?&+4O@POB?\
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MAV5CKUOXCU;4M<AOTU.^NKJ7RV^_8*_8>U3Q=X^\>ZM^Q]^S'K/C3XI_:?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M#KP=XI\?>,M:_P"%4?V/X2\%>']6\5>)M6_L[XW_  UU;4/[,T'0K2_U6_\
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MC<PS'B3*,BS;&9KD>/I570I4/P0^)?\ P6V_X*A_!?\ L7_A<7[)WPL^$_\
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MOA-\$=!\?:_;7]M\0/%=]IWBNTCB\(>'K?X?,\L^H276K66G7B^2WG_!/O\
M:9\2? S]BJX^/7_!.B3XY6W_  3Y^*7[5WPU^)O[-^M?$+X>7EU^TM\&?VB_
M%+^+_#/QE^"6NV?BR'1;/5OACKVF:%>3>%_$&H:1K6OQSZG;6Q>VD58%K?\
MKR_X)5HWMI;1[Z_:M]JSOILUI:_+<_2KQM_P6.^+7@_X%:KJ#?L;7-[^V-\/
MOVV?AM^P]\3/V58?BM:26,_CWXJ^';SQ#\//%?P^^*\/A-]*U?PC\0[)]$N_
M#MYJV@Z=-I=M?:DVM1?9M,M-0UA_C/\ X+)_$#]GOX<?M<:;^UE^RYHWPP_:
M@_9AMO@7J^B?##PS\:=/\2?"WXN^$OVD?%]K\/\ X<>.M)^+NI>$]$'A'PIX
M<\9RWNE?%&^UWPS.?#-MIPNM/&L7]\-&LOSC\?\ P-^,W[,7[/7PL^*OPV_8
M'^$_[,GBOQU_P5U_9.\5_L_?LB>%/$-E'X[\3>"OAYX<\=P>&-+^,_Q D\;>
M(O UG\2?B'J-QXE@T]-+N+'1O!<&I:<FK7E^N^.P^L?&OP0_;L_:.U#]N7]M
M:?\ 8N\$Z3XC^*/PD_9Z_9R^%_[#W[36L>!_$VJ?&/X#_#+Q_K7CGXV1^,]2
MT/Q)_P (7X"\=>,I_$M_%\)KK4]9U&+0K[1K;4-0$,UQI6I6AU?R_(+1[*U]
M^;6]XZ;M6WUUMWTU_5O]BO\ ::_:3^..K_%3PA^TI^R_:? W6? <'@/7O!/Q
M'^'/Q#D^,G[/WQM\)>/=)O[];SX<?$Y?"WA2"]U[P;>:>VF>,=#-E.MH=0TB
M]LKVYANYH[7R3]IW]O+]H/PO^TO??LE?L5?LI:5^U-\6O 'PDTCXX?&R\\6?
M&32_@OX+\ ^%?$^J:SI'@?P5::WJ'AKQ&VK_ !(\=3:+>:CI&GO#::=I^CQ1
MW]Y-<02WLND?*O\ P2!_95^)7P-^/?[4/Q#\)?LQ?%3]A?\ 8X^(7A'X=:=\
M//V6/BU\7[;XDZH?C-INJ>(-3^(7Q/\ "_ANP\3^-K3X<^&+VRU.TT"/3)/$
M*W&M30Q7MO:+I%IIFF>'_3_CKHW[7?[(/[>OQI_:X^ _[*OB+]LKX6_M3_ 3
MX.?#CQ)X-^'WCKP#X'^('PX^,OP0U3QS:>"9=2'CJ\LH)_A;XLT'QO.FN^*-
M*?4;KPSJ23WFJZ+)8Z?IYU%DV7,]MM%>ROIHW=^?VK7ZGJO[,/\ P5"\/_M5
M_$7]DCPQX)^&E_X=T+]I3X _M&?%7Q-'XIU@P>-?A+X__9R^)G@/X5^+OA7K
M>@0Z:(+R\M_$WB?7(;C5+BYTJ8VVCZ=?P:6;?6$\C\W?VNO^"@/[7GQCU']G
M9_V>?@KX;'_"KO\ @MI\;?V0]3T:X^.NJ^![#XL:[^SGX5\?6_PI\+^,)(O"
MTR+X0^*OE^+O'GB:*[M]6TGP9XE^%G@JV5-5N-<MM4T;+^'?[)/[<?[  _X)
M\?M$Z%^SSK'[4WCKP;X8_;?TK]JKX.?!KQIX'T;5O!_BS]L+XG^'?C'X;A\(
MW_C"_M[#Q-X4\)^(;"/PQXEO;"]EDL;G1AXAAU"^T/4C!:87A3]FC_@H/X&_
M9P\*_%[Q!^R!>^)?CWX2_P""Z7Q#_P""A'C7]G7P;\4/AY%?7GPM^)/@3XD:
M9JA\#>--7UP^&];71?$WQ,@TZTCEO%N[^STF]U#RTT]&OP%)13NK6V5W_C7?
MMRZNW1F'^RYXG^'>B?M2^"='\7_"_P#X3CQ3XI_X."?^"M&G_#CQC_PFVN>&
MO^%5ZY9^$];OM4\0_P#"/:7;RZ=XX_M?1HKC0O[)UZ6WL]/^T_VG;NUU"B'Z
MK^!?_!9?]J+XCQ?LS?%GQ]^P18>"/V2?VC_VH-)_9#T7XT:-\>M-\2^*[;XE
M>)OB7XB^%/AWQ@OPR?P=INH6_P .)O'.B2>%;R^U+5;>^CO[#4K^$O;WFA6F
MH>7_  ?_ &)_VJ='_:=^"7Q"UGX,^(-)\*:!_P %JO\ @I-^U!KNI7FJ^$R=
M(^!?QO\  FM:=\+_ !]=V]MXAN+A[+Q5?W<%G;Z=:QW.M6<SYU+3;.,&2O8_
M!O[(G[1VG?\ !.;_ ()N?!N]^%VKV_Q,^"W_  4+_9S^,'Q/\)OJ?ATWOA+X
M;>#?VSO$OQ)\3>*KRZ366TV[M-)\#WMKX@FM=+O;[4I;:806UE/>J]JJ_P"#
M^8GRMZV=_/;?S\EY?>=I\1?^"O?Q<\,W'QS^.W@S]CP>-O\ @G[^S'\:]7^!
MOQD_:'?XQZ5H?Q/N-3\&>)=/\%?%#Q_\._@G=^%Y7\2^ _AYXLU--.GDN?%E
MAJ/B:RT[4M4TE8(8+F*Q\Z_;Y_X*0?&KQ;X"_P""B7P\_9I_91M?CE^SA^S3
M\$?&7P^_:2^/C_&#2?"&L:7XB^(/P5U+Q!XE;X4> +GPWJ3>.M.^#7A#Q+I'
MBOQ[<ZAKN@?VC;QZKIFA@-;66I:E^>WC+_@E3XT^&WB7]H3X#^'_ /@D[\*?
MVF?B=\2OVB?&'CS]G?\ ;D^(/BG0)/@GX8^"_P 4O'MMXKO+3XZ>&5^(7AWX
MCMXI^#VFZOK_ (<MM'T^TO=3\:&VLK[1WETVPMTU;Z^^-_PA_P""@/[+%M_P
M4M_9O_9G_9 U']I#X;_MZPZUXY^"/Q;\+^/_ (?^$] ^#WB[XB? 3PY\&/BW
MH'Q-\/\ CCQ!%X@BB\)V7@NR\0?#6.VGUZV\5#^R-!N=4FUC4-7%@QVC=6L]
MMW9-7C=O7=:]O\+MK^S?[*OC/P[\.?\ @GK^S?\ $+Q???V7X3\!_L9_!_QG
MXHU/R9KC^SO#OA?X(^'=<UJ^^SVZ27$_V33;&YN/)@CDFE\O9$C.RJ?S^^"7
M_!6;X]>+/$O[*GCCX\_L0W?P-_9'_;K\::)X!_9H^-4?QET7QIXULO$7Q TR
MZUKX'Q?&3X:6?AG38_"=I\<-(M&NO"UYHGB?78=(NKG3["\.HQ7\.HC[T\$_
M #7/&7_!.3PC^RSXZ2;P9XD\5?L3:!\ /&,=PL5_/X4US7/@5:?#KQ"DZV%Y
MY%[-H5_=7BR+9:AY5R]JPMKS8Z3U^.OPV^%/_!1+]H#1_P#@FG^QG\=_V0)?
M@CX/_8%^-7P#^+/QO_:=G^)'@#7OA]\3XOV0-'GT[X16/P8\/>'M2;Q+J%S\
M6=3L=(U/Q4-2T#1;?P=;K=0/9V<=U!;VZ6R]%^A*2?->V[W=FE:6J5U=WMW]
M-;G:>"/^"UO[2&K^'?!GQY\8_L*:5X=_8[OOVK9_V3?'7QJLOCWIU]XJT7Q%
M=_&'4_A/I/Q$\/\ PVN/!MK=:KX"L-2E\.Z?KLM]K&G:BWB7_A(].T^$Z?8Z
M=J>H?9O_  7"\??%WX:?\$O?VK?%7P8-S9>)8/ O]GZSXDTSQIJ'@77O!O@[
M5;ZVL/$?B?P[JVEV\U_>:Q:P3PV$6BVTVGMJ=KJ-W$VHVB(S'X8\1?L4_M,W
M/_!&SP'^SA8_"#56^..G_ML7GQ1UGP%'J?A:/4X_!;_\%(_&?QCB\2W&HG6T
MT6>$_"F^TKQ0L:ZI+J TUX+'[,-0A:PC_53_ (*B? SXB?M+?\$^?VLO@9\)
M=+@UWXE?$3X1:YI/@O0KB_L]+37=>M+BRUBST2+4=1FMM.L[O5SIK:=8SZC=
M6>GQWMS;F^O+2U\ZYB8_=4HVLDI6>MU9.-F[OU\ON/Q/\&_M$_MV?#_]O;Q_
M+\)/V-?!_P 9?VA?%O\ P3._8_\ %7Q$\"2?'JR\+^!/ GA_P'XR^.\4@TWQ
MM>^%+S4_&_BGQ;<>)?#EOX:T"RT'3C+))KMQ?7]NFD)'??>-M_P5F^(OQP\)
M_L>Z1^Q9^RPOQA^/O[5O[.^J?M0ZOX!^(GQ6L?AIX%^!OPG\-:QI?@W7=3\8
M?$!?#&MS^);G4OB5J#^!?!MOH7ARUFUAK9_$&KP>'K9X-.G[#]AGP!^T!J'[
M77Q-_:*^+GP"\6_ G0O'_P"Q!^R7\,+;0/%WB#P=K^I:;X_^%'COX_P>+/#=
MQ<^$M:U6WFN+72-:\,>(4NHD6QDL/$EC!'<27L%];VWXQZ=_P2X^)_@3X;?\
M$V_C#\>O^">;?MKZ=\,_V+-:_96_:*_9B7Q5X0L?B;\*?$6E?%#Q/\4_AG\3
MO!0U/QUHGA+Q1,EWXJ\4>$O$^GZ;KQN+;2==@O6AU9H[:30 %RO=*Z2Z[NST
MW2LGHM5TUU/Z8?V(/VLK?]L;X)S_ !'O?A]K'P@^(?@SXB_$/X*_&KX0:_JU
MAXAU3X7?&7X3^([GPQXZ\'2>(]*B@TSQ%96UW#;ZGHVN65O:IJ6BZIIUS-96
M%V]S8V_P-IW_  5,_:"\;_'WXK^'O@Y^QK9?%[]GCX#_ +6%S^R7\6M=\$_&
M:TUO]I_P_JVB^(['P9XN^,4?[-FE^#[Z\C^%'A_Q-J FAN]1\66FI:OX/L9_
M&48LM)EE.G_1_P#P2G_9^\7?L\?LLS:+XX_9Y^$W[*FO_$+XJ_$'XJ+\ _A#
M=7NJZ9\./#WB6XT[2_!GA[QAX@G\0>(M-\3?$>P\&>'O#]KXPU[P[<6.@WEY
M!$EKIEO=07LMQ^*W[5/[$O[4_P 7?VI?%6J^$_V A\-/VPT_:QT+QK\%/^"G
MO[/7Q0T/X4?"7_AFVR\?^']:N-2^//@BW\<3^(?%'Q(L_AOI]WX)\2^'=5\+
MZSKWBSQ!'%K.C:I-H<4FC>(@24>:6UNEWHOQ5_DVUO:1^A/Q=_X*T_&GPCKG
M[3'Q1^%O[&K_ !/_ &)_V+?BSKWP:_:+^.5U\8=,\)_$B;Q-\/;FPT_XUZQ\
M*?A#<^%=0;Q7X:^#-]JD0UN\U'Q-I4OBD:7K4&@+%+93/;]/\<?^"GGQZ_X6
MI\;O!O[#W['UK^UUX'_93^'W@;XB_M!^/7^,%G\/O[1_X6#X*L?BGX>^'?P,
MT2'PEXLOOB3X^N?AA=+XD>VC%M#%?7FF^'EMI]:O+&RU'\BOBS_P2[^(/P^^
M(_[7/PZT7_@DS\)?VOOB1\=OVD/B'\7_ -F7]L3QCXYT.T^$W@3X>?&7Q>GB
MK4/"_P ?O#^H^.O#'CE=6^"QO]?M[&'1;*Z?QY&]C;Z7+BU$VI_>^J?#S]N[
M]@;XX_MDI^RW^R9-^T3I?[:/@WX+ZK\$OB%\/O%7@/PCX+^ 7Q[^'GP2T[X+
MZKIWQ8\,?$;Q.FH6?PGL+W0]'^(/AJ]LVUC&C1R>";Z^U;5+E]1TT':.EK/3
M2[T?PW;UO_-VVV=M?LSP%_P4DO\ X@2?\%&;JQ^$%[H.F_L0_!GX,?%[PO9>
M++[5/#_BWQS%\7OV2K?]IM?#GCKPS?:+'=_#K7/#L]U'X,U33]VL7EK/%<SW
M4%O=P/8CYNL/^"KG[5?Q*^+_ .Q_\'?V=?V(?#_Q?UO]HC]@C]E_]O3XD7]Y
M\=M+\ :9\(/ GQN\3ZQX;\;:7'>>)O#<=MXJF\&S0:*_AZ.UFM=;\3+=ZI(F
MAQ+I9CF^:/BG\(?^"EWP/^)'_!0/PYX=_9;;]KKQ)_P4G_9B_9_\*7'Q[\&>
M./ 'PX^&WPY^-OP\_93;]G?XN:CX\\*:Y?Z?K=EX8N=76;XA>%-,T.UAFU;3
MY[3PCI-S=ZO/=2Z-]8_L%_LE?&CX=_&CX!:M\7/ACJ.@>#]!_P""&G[$?[)7
MC6]O-3T:1=/^-'P^\5_$2Y^)OPQD?1M9GU$:CH6EZSITM[J>G;M&F%S"=,UF
MYGB/E+7^O7_(+12;T>FFO]U>=_BOO;[C)\(?\%B/BEK]O\-OVD=9_9!7P[_P
M3?\ C)\==-^!/P]_:9N/C'I<OQ,C3Q+X^F^&'@WXU>+_ ((GPM#)H/PH\3>.
M+2;28T3Q9=^)-/TZ]TWQ%+:3V5Q!;7?Z)_MN?M5ZC^R!X)^#?Q&_X0RR\5^#
M/&7[3WP+^"/Q1U:^UJ?1D^&O@'XR>*&\#S_$V,Q:=?Q:FWAKQ/J7A>";2;R7
M3+:ZLM3NY5U)+JWMK6[_ )GO@5_P2J^(7PGF^#'[+LG_  2=^#GB7XN_##X\
MZ3'XQ_X*.^.O$VDZI\'_ !?^SWH/CR\\16?Q-TCP?X<^)/AKXB6WQFO?!PTO
MP]:^$VTZ&72_$>G_ -MW=R([W;8?TM?\%&_V>]7_ &J/V&/VG_@1X9A:X\:^
M-OA1K\_PYA66"W9_BEX/-OXY^%FVZNGB@LF7XA^&?#++?O)']@*B\21'@5@P
MDHIQMLWKKTO9/1OO?IMLC\^O%?\ P6Q\,^'M>_X*R>';;X66NH:I_P $Y8?A
M]I_P^L1XJNDN?C]XJ\<:E?\ PYDT<JF@R#PTND?'*+2?A]*+#^WKFY76[.2U
MBEU)+BQBF^*G_!5_]I/PQ??M*^-OA5^PU!\7?V<OV%M2'A7]KKXHV_QTT;PK
MXEM_&WA+P3H'CKX]:+\#_ ^K^$Y!XZM/@1HNN&ZUW4O$.M^%H?%1M)H-$^SQ
MF*]E_-;PA_P2@_:YU?X@_P#!+OQ[XV\!7":A\5/$OQ#^('_!4F.ZU+PW#!I^
MJZ3^UU_PW?X TOQ1#8^(9H->^W>/-5UGX>V,7A^+6K>RMHYEE6TGU=M4M;7[
M0W_!-#QAX'^//[<=AI__  2?\ _MQ>,?VI/CKXM^./[+W[5/BCQSX<TSP)\,
M-2^-L>GW_C'P=^T!X>U7QWX>\66'AOX1^.SXE\7Z0^A6VICQII.L)HFG76BA
MK>QTD':%^CT[]FD]6UV<EKL[V=K'K.C_ +6?[3/A'_@I_P#\%,_'_P"Q%^RC
M8_M>:#\0_P!G/_@G]\;M;U/4OBE%\*K/2OA_X:^!7C;6O#&A^'([GPKXCNO$
MOQ%^*MGX\EN/!&@E=/B$7A'7ENVEDE@$/UOKG_!8[QS\6=9_9Y\'?L-_L[^!
M_C1XX^.'['5G^V?)X?\ C!\>M,^"]VGA:[\5>(O ;?"3X?V$?A+Q9JGQ&^+-
MAXQ\'>+-*UJWTZTL- T>/2K&]FU">SUN"XM? ]%\,?\ !0K]@W]L']KOQ+\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M=; 9CA/K.#X;H8O#_6,)7JTO;8:O1Q%+FYZ-6G4C&2_+7_AVI_QLQ_X>*?\
M"Z?^Z/?\*Y_ZH#_PHW_DH/\ PGG_ '-'_(D?]03_ *B]'_#M3_C9C_P\4_X7
M3_W1[_A7/_5 ?^%&_P#)0?\ A//^YH_Y$C_J"?\ 47K]2J*Y?[1QG_/[_F#^
MH?PZ?^Z?\^O@_P#)_P")_>/S#_B8;Q?_ .BM_P";/?\ $ _^1'P]_P FG_Z)
M7_D5?^9K_D?_ /4S/RU_X=J?\;,?^'BG_"Z?^Z/?\*Y_ZH#_ ,*-_P"2@_\
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M%% !1110 4444 %%%% !1110 4444 %%%% 'EWQ0^"WPT^,__"N_^%E>&O\
MA)/^%4?%+PE\:? '_$YU_1_[ ^)?@7^T/^$5\2_\2#5=+_M3^R_[4O\ _B3:
MU_:.@7WG_P#$QTJ\\J'R_4:** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH K7M[9Z;9W>HZC=VUAI]A;3WM]?7L\5K9V5G:Q//=7=W
M=3O'!;6UM!&\T\\SI%#$CR2.J*2/,?A#\>?@;^T'X?U'Q9\!/C/\*/C?X6TC
M6)?#NK>)?A#\1?"'Q*\/Z7X@@LK+4IM#U'6?!FL:UIUEK$.G:GIM_+IES<Q7
ML=EJ%E=/ (+N"23U5T2161U5T=61T=0RNC AE92"&5@2&4@@@D$8K^/7_@B1
MKVC?\$^O^"F7_!6G_@GAXSU*W\-?#[PW=ZA^T5\-SJ"SV5GHW@#P3='68IK:
MR\HR37>K_!?XJ?#[7KN&TCN&?3/!5Q=:<MQ90O,P4HW4GUBD[=U>S^ZZ/ZK_
M  W^T#\!O&/Q0\5_!'PC\;?A%XJ^-'@.PFU7QQ\(O#?Q)\&ZY\4/!FF6\^E6
ML^I>*_ .F:U=>*_#MA!=:]H=M->:OI-G;QSZSI4+R+)J-FLWKM?P*?\ !.7]
MOWPK^QK\(?\ @H;_ ,%G/C/X&UOXB?%3]M;]K+4_@Q^SO\+K2]30]1\2ZLL^
MM_&+QC9_VRUEK;:#X TI?%GA?1]0UFQL-?ALKWP/8>&-,L;G4+FW0?LG^R3_
M ,%T/V@_$7[2_@O]D7]OO]ACQ)^R5\7?CAX0O?$W[.U]-?ZY;:%X[U5-+UJ\
MT7PGK.E>*M.@U'2;KQ1J.BS>'-&U2PU+5)H_%5S9>'=8T#2I[J.\H*E3:O;5
M+?:]TDY65[M*]FS^DF/5=,FU.\T2+4;"76=/L-.U6_TB.\MWU.QTS6+C5;32
M-1O+!9#=6UAJEUH>MVVG7DT26]]<:/JL-M)+)I]VL-^OX>/^"(/[;?[4\O\
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MQ$?^$;\+Z5HV=?ET,#19=:/V+.J2:0!I;WWGMIX%H8:_A4_X)Y_\%3OV>?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MCP=XQ_:+^.EM\6];^*7['/[3VN_#[PAX9T&?PU\.O@C\)=(^-/PZTKP'\/\
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MG7#W%NL%[<VD=M*T\*QRL94#?S!:3^S]\)O^"</B?_@CE^T7\!?#,?AWQ?\
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MOBE+^QQ\<CX0N?B?=Z7X5@N?'\GC@7(\/GPW-XKD?Q$_BL(-'_LMCJX467%
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M)R*&?X<CQSX8/CM%,*W(9_" U3_A(%4V[I< G3P/)99<^6P8_E3^TY%?3?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M.EZ-\1/AK\1?']SX;L&N->\0ZA!IUDFK7T4%GH4<SQ6'RG^U#_P2Z_:X\?\
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MI80?\)-X:NM<U/2[";6KO35EOO+?#G_!)W]K7P-I'P#CO[?P?X^\;P_L>_\
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MPEKGCOPZ-*\.:5X<FN-*O_:/A5\0_P!I'X>^._\ @E3>_'G1/%<GCO\ 9O\
MC=_P66T/X<:)\6/B3X5^+'Q.?X9_#K]C3QGXH^&'A/XO^-O &MZS8ZEXY\+6
M%TOP^\2J;JTUJ)?#D1N+*SD>$%?YE<B[][+K]JW5]8ZZ+U[?V.45_#W^QQK'
M[8-P_P"P9^V3X7^ /[7-M\7_ (N?'7X7ZW^TA^UQ\3_VM? .H? []I3X(_%[
MQ3)%\0OAU8? _P 1?%NVT?PWIVB:!?F\^#^F>&_"5AXHT;4/"=L;S1M0O3!;
M:5U&L_ Z7P;^P3^W#_P5)TOX_P#QJM?VLOV<?VY/VAM?^"?B"3XY?$&3P5X
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 5S'C;P7X4^(_@WQ7\/?'6@Z=XI\$^.?#
MFM^$/%WAK5X!<Z7X@\,^(]-N=(US1M1@)7SK+4],O+FSN8PRLT,SA65L,.GH
MH _%WX=?\$,/V5_ GB7X82:[\9_VROC+\&_@CXNLO''P;_92^-O[0,_CW]F+
MX;^(=%G@N/"TNA?#M_"VFZGJ.G>$)( /#VB^*O%/B'1X(I[^WOK&_M]3U**[
MZOXM?\$8?V;?C#XP_:#U76_C#^UMX9^%W[4OBFZ^('QT_9I\ _&Z/PG^S_X[
M^)%[I=AI]W\0=0\-V7A)_&$7B&]NM'T+6]3M;?QU'X9UK5= T1-;\/:CI&FV
M^E+^N]%!7-+>[_IW[;WUOOYGQ1\'?V"?@E\$?%_CGQQX2U'Q_?>(/B'^SS\%
MOV9_$D_B'Q!IE_#+\/?@/X4U/P?X+O;6&S\/Z:+?Q3=:7J]Y-X@U3=)9:A?L
MDUKI6GPI]G/RX/\ @C%^SUH5K\#/^%2_'3]KW]G_ %_X%? B7]F73_&OP2^,
M.@^$?&'Q!^!C^--5^(,7@'XCZK>_#[7(;ZTL?%6NZSJFFZQX4L_!_B33KC4'
MN+/68;JVT^XM/UZHH%=]W_6GY'Y(0_\ !%W]DO0?@GX!^"?PT\5_M#?!R#X.
M?&_Q]\>?@3\4?AG\66TWXT?!#Q-\3()K'QCX<\!?$#7_  _XCN;GP1K6EW$N
ME:GHOCFR\9WNLVC+)K^K:M?1QWB8.F?\$1/V6- ^&6H>!/#?Q3_:K\/^,+O]
MI31?VO++]H*R^,5A>_'_ $;]H/3_  O!X3UOX@V/C;7/!>K:3?7?CJP&J77C
M;3?$7A?7-(U6_P#$&L/9V.F6K:=9Z=^QM% ^:7=]_P"M/Z['P5^R;_P3O^#G
M['WQ,^+OQE\"^//CO\0?BA\?M!\$Z7\;/&OQJ^)DOQ$UKXE:S\/[GQ WAKQK
MKDL^CZ;#8^);+2_$5SX:@MO#<.A^$-/\.6>G:=H_A73##//<Y/[5_P#P3<^$
MG[5GQ+T'XU_\+8_:1_9Q^,VD^ -1^$FK_%/]EGXIP?"WQ?XZ^$VHZC<:PWPW
M\<SZCX:\6Z7K?AJQUF\O]7TEX=+L-=TK4;Z>YL=:@9+46_Z%T4"N[WOK_7E;
M\#X1^%7_  3E_9D^"7BO]E;Q5\+M"\0^$1^QU\)?B-\&_@_X>L-<CE\._P#"
M,?%:?2K[QQJ7BR"\T^YU/Q!XIUG5]*_MVYUPZK9R7&M:EJU_>074EZ0GM7[/
M7[-'PY_9FM/C%9?#B7Q'+#\<?VA/BU^TOXT/B34[;5'C^(WQHUN'7_&$6BM;
M:=IPL?#D=]"@T?3)UO+FR@S'-J-XQ\P?0E% 7;W?]7;_ #;?S/Q_^*__  14
M_9B^+VN?M"+K?Q9_:P\.?"/]I[QEXH^*7Q=_9H\#?&J'PO\  #7?C%XOL8$U
MKXMCPO:^$I/%#^+KGQ!9Z=XWGT[4?&>H^!-1\7Z5I5]K/@W4[#3;/2X?TXTC
MX5^$]+^$.F?!&>*]UKP-IWPWLOA7-#J]Q&VHZMX3M/#$7A&2+4[O3H-.B:]O
M]'C*WMQ8VMA&9Y99+6"U79&GI%% -M[O8_&S1?\ @B3^SOX6^%7P9^'?@[]H
M3]M7P=XN_9VU_P :WGP+_:"\.?'/2;/X^?"_P)X_L-+TSQ!\#O#?BJ;X?W/A
ME_@B+/1[./2? NL^"]5717DU&;3-1MI]7U:2][KQ%_P1V_93U7]FSX1?LX^&
M/$OQ[^%TWP0^+-]\>? /[0?PX^*;Z7^TU:_&C7I=7E\9_$O5OBIK>A>(5USQ
M+X\;7-03Q4=2T"?3)[<:;:Z5INDVNA:%#IOZLT4#YI=WO?Y_=YORU>FK/R3\
M._\ !%[]D+0_@K\?O@EJ.N?'OQK9?M'^./ GQ7\>_$GQM\6+K6?C)8?&7X=V
M5HGA[XQ>$_B)%H]CJFB?$/\ MNU?Q7?:G)%?Z;/K=[?VD6D6_ABZ;PZ-/P5_
MP1__ &;O#,ECX@\6_$?]I'XV?%9/VE/@!^U'KWQU^-7Q/TOQC\7/&7C?]F&[
MU*Z^"WA3Q)K=IX-T30A\-?"*:QJEI!X5T#PUH,L]K?3";53.L5Q'^K-% N:7
M=GA7A_\ 9X\ ^&_VBOB1^T]ITOB!OB3\4_AG\./A/XFAN=1MI?#2>%OA;K/C
M77?#+Z9I:V$=U::H]]X]UP:G=RZE<Q74"V,<5K;-;N\WB_QX_8+^$_[0'[1O
MP3_:>\1^-?C%X1\>?!?PQXI^'\^@_#WQK8Z%\/\ XQ?"_P 9ZA8:IXB^%/QP
M\*ZCX=UM/''P[U34-/ANK_PY:WNA1:G*(CJLU_\ 8-*&G_;M% 7:Z]+?+8_*
M+X%?\$>?V:?@+\4_A9\0])^)'[3GQ$\*_L^ZGXCUG]FOX!?%_P",LWCWX#?L
MZZKXEL;K2KG4/A=X1N_#]IKPN]+TR^O++PU-XW\6^-'\,K<&ZT,V5_#;7<'K
M^H?\$V_V>=3_ &3M"_8SN;SXBCX0^'OBY-\:K"YC\2Z8OC!O&,_[0&L?M)NE
MQK1\/-92:/\ \+%UR]B6Q71XYAX=$&F&[-Q&VH/]_44!S-]7_P -_P ._OZG
MY'?&[_@C%^S%\</B5\5O&][\3OVIOAQX)_:"\5Z-XX_:._9V^$OQJ?P=^SU\
M?_%FD"T6;7?B5X'D\-:KJQO?$$=A8+XJ/@_Q3X2B\12V5O>ZE'-J"&[;]._$
M_P ._"'BWX<^(?A/JVC6P\ ^)O!.K?#O4_#]DB65F/"&M:%<>&KW1K2.%1':
M6W]BW,EE D2!((MBQJ @%=M10#;=KO;8_'32O^"*OP$\.?#/X&^"/"?[27[<
M/A'QU^S?;>+O#OP;_:,\/?'K2[/X_>#_ (7^,DT>"]^"$'B6;X?W/A"^^#.C
M6.@Z7I_A'P)J7@6[LO"-I#-_8$UA<WM]<7/NOPA_X)=?LN?!)OV3)O!<'C^6
M_P#V/M>^.GB_P5J_B/Q9%XAUCXB^./VD/!6J^!OB_P"-_C1J6H:0]UXX\2^*
M=/UF_P!1:ZMI-!M++4VMXK2RBT6SL]&@_1:B@.:3ZO\ X>_EYO[WW9^1GPR_
MX(O_ ++7PL^)WPS\8Z+\0_VG-:^%7P/^*NH_&[X%_LD^*_C'_;/[*OP9^*-W
M>7^IZ9XM\!?#P>&;7Q';W?A/5]4U36/!]IKGCC7=-\/ZEJ>IW%I98U&^2X^.
M_P!A[_@D'X1\6:?X[^)/[2.M?M4^';;6OVY/VB?C=KW[)6M_$.YT#]FCXF:Y
MX;_:-\;:U\%_BSXQ^$]UX=;5=:FN_#%CX%UJR2T\56'A'Q39Z!X8OM:T#5A#
M*UU_1O10/FEW_K5]O/??S/BJW_8*^!UMX*_;?\!1W7CHZ'_P4 U3XCZO\=F;
M7[ WUK=?%'X9V_PG\2CP'<#0UC\/0IX6MHGTQ-0@UUK75-UW*]S$?LP^?_C;
M_P $A_V?OC#XDT+QCH/Q>_:G_9[\40?!/PK^SM\0M;_9P^,%I\-KSXY_![P7
M:V]AX=\(?&);CPCXAMM?^PZ=%/IBZ[H%OX7\2G2K^ZTH:PNFI8VMG^JM% N9
MKJ_Z27Y)?<CXS^$?[!?[.WP*^+/PO^+GPJT'6O".I_!W]E'_ (8T\!>%;/63
M<>#=,^#0\>>'OB+_ *59WUI=:YJGC!_$?AJQENO%&H>(+BZU&.XU&?4X;W4K
MZ74*\1\:_P#!)S]FSQ;\.?!O@?2O%OQU^&?BGX9?'7XR?M$_"GXY?"WXC6OA
M+XW_  O^(?Q\\3^(?%'Q17PAXL7PW>Z.OACQ+-XEO](O?#.O>&-<TV[T.#3[
M._2]GLH[L_IU10%WO=W_ .'_ ,W][/D_]D+]C?X4_L7^ _$W@WX<:M\0?&VO
M?$+QUK/Q.^*_Q<^,/BL^._B_\6_B)KT5I:ZAXN^('B[[!I-OJ&H_V?I]AI]I
M9Z5I&C:+8VUKOL]*AN[S4;J\^L***!-WU84444 %%%% !1110 4444 %%%%
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MO#=YXUL/AQXGN_#EG\4/!T,Q)U?X:_$&&V7Q!X#\11XAUO0KFWO8@$<5[!0
M4444 %%%?#'[$G[>7P[_ &YO^&CO^%?^#O&GA#_AFK]H;QK^SGXI_P"$Q&AC
M^WO$_@?[/]OUWP__ &)JNJ?\2&\^TK]C_M'[%J'RMYUG'QD"V[[;_/8^YZ*^
M,-,_;9\!:I^WWXB_X)\0^$_%T?Q*\-_LPP?M2W7C:4:-_P (//X1G^(>A?#E
M?#MN5U-M?_X2,:GKUM?-YFD)IGV"&?%\;CRX7^SZ M;YJ_R8445\,?L2?MY?
M#O\ ;F_X:._X5_X.\:>$/^&:OVAO&O[.?BG_ (3$:&/[>\3^!_L_V_7?#_\
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MQ31 :G#=I;?@OXJ\&6_Q8\-_ME_M8_"[]H;]H+_@H/X!^"?Q1_X)Z>-_C?\
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M*Z/I-HT5OX?L-2<>'?[(NH[:[M^#O==^)WPU\1?%?_@EAX:^/?QOTO\ 9_\
M%7_!8/\ 9_\ V:;+XAZY\2?$&J_%;P5^SK\8/@)=?'+QO\#O"?Q5U*^/B#1/
M^$J\0>'(O"WA*[^V7&HKI^M>*5N(M9N=7OH[G^B+P1_P3A^"'@'XI?#WXMZ/
MXJ^*MSXD^&O[4_[6?[7>A66I:YX1FT2[^)/[9'AWQGX9^)VB:M;6O@:SOY_
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MX%B/B?QAI?@!M;T?PU#XDO;:Q\)ZK)JN@>$8M0\.:/J\?Y=_LR_%/XA^*O\
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MCGX*?L\_$.Y^+?[.?[)7Q"^*MKXA_9Z^"7Q);4M7U30_$OA714\-6/C#5/\
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M OQC\<6/@V[T^XN+W0_]/\3Z?X*O?-T.RUCQ+?0ZEIUQ_9\5L:'[(]Y\2?\
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MU$6T(OY+"&:6YALGO GVAK2*XGGGCMFD,,<TTLJH'D=C;HHH$%%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>*_M ?
MM!_"O]F+X;7GQ8^,6OS>'?!MIX@\'^%$N[73-0UB]O?$OC[Q3I/@SPCHUCI^
MF6]S<RW.L>(];TVP69UBLK))I+[4KNST^VNKJ'VJOPS_ .#@WP!9^-_V$_#L
MUWXE\>>'SH7[4O[+8BC\%^--=\(PZE_PDWQK\'^$I_[<CT2[M5U@Z1;:U-K7
MAO[;YG]@>*[#1_$VF^3JVDV5Q$#2NTGU=C]0_A!^T]\-OC;\4_VC_A!X-A\2
MQ^+/V6_''A?X??$R36M+M;'2)M>\7>#-.\=:4WAB\@U*]FU6P71-4M5N[BZM
M-,DAO?,MT@E1/.;L](^+>E:Q\9?&OP4A\*>/[36? _@?P7X[O?&6H^%;FT^&
MNM6/C?4_$^EV6B>&/&+3M:ZUXIT:7PK=7/B;1(K>.;1K+4M#N9I)%U.,)_*)
M?_L>^)O&?Q>_X+L?$#PY^UI^UI\*]0_9/C\!>(/@_'\-?C=XG\+2:]\6/AO^
MQ]X=\4:7\2_CAJ-B5U?XO:PY\(>&]/)U_4D9(]2\<:A&T6L^)%U*S^A?'GQ@
M_;K^.7AO]K>Q^ GQ.^(MS\:O$7_!)G_@FM\7_!_AWPSX[/A"'3O&OQ(\9?$3
M6?CWK_PJMM2OHO"'P_\ BAXZ^'NG:]I&A>*-,L;74(M=MO"FQ[J32-+MXS_A
MRG%='T6]U9M1?W:_+\3^HRBOY\/^"-OQ,\&WWQG_ &BOA9X?^+W[>/A?5],\
M"?#_ ,5:]^PU_P %$]%\6ZS\8O@WK<6M:[HOB#XJ_#OXN>+?%6LS^)_ACX\N
MKC3[&XT"QTNQCL]8M[+Q#=/ ^OP6$/D'_!3/X\_$+QQ_P49L/V5K[1O^"E_B
M?X$?"K]E;PQ\8+SP-_P3$N[70_B;K_Q:^(/Q&\0:1I/C'XJ^*H_'7@#5;;P%
MX,T/PC:Q^%/#T5YJUI<>-[I=:N(K?[&D-R"Y=;7Z7O;I]_ZV\S^FZBOY OB_
M^UI^W;^RO_P3R_94_P""B?Q+\8?&CPW\:?V:?C#\2_V<O'/[/?[1NMZ]\.+/
M]LKX3^.M3\4>&_A+XL^('POTO6=<\/:C\=_!.C0>'?&<^OZ-#>ZI>'PY\2;Z
M?7]0T_3;=9/4OBO/?>!_V=_^"=7PN^-O[=_[<7[0^O\ Q^\%?$KX^_$GX=?L
M02_%/Q_^TC^UCXD^(.A^&_%^DWO@+QWHFOV<_P ,OV7_ (,2:\=.T/PS;CP;
MX8UW2Y--O9;'28;+7+:P!\GFMVM$WMJ_PL]^O2S/ZJZ*_BC^%_Q?_:;^,/P3
M_9O_ &<=._:*_;6^!-C#_P %N_B]^Q;>ZYXY^*=U#^U)I7[-T?P%A\:CX5_$
MWQ1HVH:A8WWC;PMI7C+4?#NG7VH7GB>'P=XJTK1O$^@FWNO#NAVFEZOCSX)?
M'+P3\.?^"Q-QX<_;Y_;BMK7_ ();>+M)\6?LA6,_QY\0W)T.\U3X=Z)\</$5
MM\3M0NEN;_XO:9<QS1>"=$T?QE+<Z5H6A3:^\%I--XDNQ; <G>27R?=+IYM'
M]H]>%6O[0W@&[_:9US]E"*+Q!_PM'P_\"O"O[0U_.^G6R^%CX!\8>/\ QC\-
MM(B@U87YNY/$ \0^!M;>[TYM+2VATXV5RM_++.]O#_.[<_!GXT_MN_ME_P#!
M5_5?$G[:_P"UQ\(/#W[.7PZ_9"\4? #P#\&OCMXW\"?#SX?_ !;\?_L5^%OB
M+J7CEO"]KJ-QIQT>T\1V;WL_A6Q6QTO6YO$GBS4=:%QJUW;:C#\H>)O^"@_Q
M]TKX:?$O]O?3S';_ +1VL_\ ! K]D*Z37K30[>:.V^(OCG]N/XV?"2X^)5IH
M*VO]E6WV?4->E^(EM:364GAK3&2,WEI/H%K-!( H7ZWT7=6;46O7?6Q_:-17
M\P7_  3K\1?M)_#O]M_X+>"/!WP\_P""P#_L^?%/X2?$G1_VG]:_X*9:2=<\
M.V?Q=\&:#8^*?A_\9?AAKEI\1?B3+X(UCQSJ=OXD\'^/-"DOM"\)3?VQX*LK
M.TUC6&TV;2/Z?:"9*SM>_7^M7^9^-/B[_@MO\ O"WB/XWZ39?LO?\%!O'WA?
M]G?XJ?$_X/\ Q4^+GPQ_90\1>//@UX>\5_![Q!>^'O'TD_Q$T+7KC1X=+T2:
MQ?4KF>_-C>6^C7%G?7EA:BYCB/V-\'_V^/V<_CW\5_AA\)?A-K^M>,-1^,/[
M*DO[8_@/Q59Z*UKX.U/X/0_$#0?AI(+J\U"ZM-<TOQA%XH\0V=O=>&-0\/V]
MQI\=MJ,6HSVFHV4E@?P:_8[^*?\ P4]T76_^"F'P]_8U_9%^!OQ,\ ZW_P %
M1?\ @H$MG\<OB[\>M/\ "%CX8\<:K\4)[.^M-5^%L.BZCKWB'1] @32=0/V>
M>.+6OM<]EE%@DW^#^+?"_P 0/^"0/C&V\->$O$^F>+?BU^RQ_P &[OQN&F>,
M(+-6T&/XI^)?VX/A[?2Z_I>GZK9?\3+P]X4\:>,IKW1+/6=/AFUO1]&LH=8M
M+6:]NHHE_G_F7RK9;]/>O?2.K5M-7_5C^RVBOY)OV+_BE^TY\+?VBOV=O$'A
M[0O^"NNG_#3XA_"CXKG]MGQ]_P %'-"@\2_L^1>(]-^#EQXQ\%_M!?#A;7XL
M^*&^&VG:/\1= M-,\2:5I<6BZ=<_"_6M-T:WNTO-'LH;SP;X)?'KQ;X:_:$_
MX)R?&;X5?&C_ (*E?&B^^._[7/@_X*?'C]IO]H*T\5?#W]A;]I?PS\5](\>-
M>:9\$?A1XVUF6:TM["ZT.'5/AM!X>\':=X>\-^'_  MJL,FJQ^([6R6T=Q<F
M^JVO^?GIMW;VTWM_:E17\A'P,\??&3X/?MU?"R']M_XU?\%#?V=_VC_&G[8?
MC?PC8_$?Q?JTGQ;_ .";7[6/PS\2>-O&^F^"OV??A[H6D^(['P'\$M<O=)N_
M!FG^'(H[77-2\%>(]/O+^]L;#6-=M]/\+?-'@/\ :P_;8^,'A2']MWX9>!?^
M"PWQ!_:CUC]IG6O$_A&R\!>'[+5_^";%Y\"_#OQWN/ 6K_LWVG@6'XB'^V-%
MM_AKH&KZ3J7B23X9V_CR#XWPR13ZC]OTS_A+G Y'W5K+7H[]G>UM-^G5=#^X
MZOG;6OVGOAMH/[4G@;]D.^A\2GXK_$'X/^,/C=H-Q!I=K)X37P9X(\2:-X5U
MJ._UAM22\M]:;4]=L6L[&/29X)[7SI7O87C$3_,/_!73XW_%']G_ /8!^-GC
MKX+>(IO!7Q/UC4?A-\*_"?Q 2UCN8OAW=_&KXR> ?A)>^.IGDREE+X:TKQG?
MZAI%\59K?Q!'I&SRW=9HOPN_:)^%7B'_ ()7?MN>*_BQ\,/CU\=?CA?>$_\
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MH_G7BS]J+]LWXW>(OVJ?VEOA=X6_X*\>+/VDOA[^U3\4?"/[+$'P&T2PO/\
M@GGX0\ ?![XB67A'3?A1\3OAU+X[TYO%]SXLTOPYJ$/Q?O\ 5?A[-KMSKM[H
MMW%#+-I*O= ^3S6C:;Z7O;JUIOK\[=#^T#XC?$'P=\)?A[X[^*OQ#UN'PUX
M^&?@WQ/\0?'/B.XMKZ]@T#P=X,T2^\1^)M;GL],M;[4KN'2M%TV]OI;;3K*\
MOIT@:*TM;BX>.)_$/AU^UW\(_BG\4/ GPF\)'Q/<>(_B-^R]X8_:[\,WM[HL
M=CHD_P (_%_B&Q\-:*;NYEOC?6GB>2_U"VEGT6333';VC/(]]YR&"OG?_@IY
MI4OQ5_X)-_MJSZS+XX^'UY?_ +%?Q;^(E[8>']=U;P=XHTS4_"GPMU/XC_\
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MY_'WQ!:/0->TO7]=O?&/@K4$L] U#Q9I>E7J6,T.I7[6/T-X:_9 \0?LT?\
M!2;_ ((>^+;_ /:?_:+^/TWQ?TO]KO7?B+:?'GXH:S\3M/7XMI^Q-XFU/7_B
M%\/CK@DG\'67C"+6Y]/U?PWI]P=+6P\/^%!$DES9W-S,"Y+;OH[>;46^C=K>
M;/ZGJ*_'W_@L)\1M(\(_#K]GWP=K_P"T#^T%\(M#^)GQOM]$UKX9_L@^$?&7
MB?\ :O\ VF]+T[POK5[+\&_@]?\ @2X@U_PC'=WDECJ_C'Q!;F'SM&LHM!BO
MK:YUJ"&\_GZN?CM^U#H_P(_:Y_9W^%'QA_;O_9]7P'_P4@_X)X^!_@E<_M/?
M$B_'[4OPG\%_M0:'::GKGA'QQK.D:SXCN9_".H:IY7BK3?!>LZ[XGTJY\*ZS
MI]CXAT>;49M<@O6"A=7O;Y/O;Y_)?.^A_</17\?/QY@\:_"[]K&__P""?5OX
MS_X+4_'_ . 7[*GP"\,^.-"U/]C;XBQ^+?VAM8^+GQW^(7C;QQIOC7X\_%6?
MQE\,M1OO"/PT\.6ND^#?@UX4CL[O3[6?P])J-^KW5I/+JW0^*/C]\8?B3\ /
M^"?/PS_;7^)G_!0W0?BOK/A3]H2'QI^R#^R+\,?%WAG]M/\ :=@\ >-Y?"7P
MH^-/Q'\0^!?%EC;^"? ND>!++2?$7BNRU+6--\/^)_'>IZYK<FLZMHV@3WFD
M <FVN_ETLW>U[[+7:UU=G]<M%?QC^"/'_P"W/\6?V"?!6E6D?_!0#XL?"/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MF1V?Z]T4#YI=]M.GIKIKI;>^R['XW:[_ ,$;OAWX0T?]GIOV0/VBOCG^QO\
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MXR\+W7@OQOH>K^%O&^CZWX9\2^'/%?AF[?3M5TO4+1%F2*.*62;3IM0TZ_\
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M\,?!K]IG]H_X:_%7X9_M'_$_]I?X._M&/JO@_P 7?%WP1XH^-G@?0_ ?Q?\
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M_P "7^1^57_$4Q_P2C_Z&7X[?^&9U'_Y<T?\13'_  2C_P"AE^.W_AF=1_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M .CV? ?_ (1GQ<_^=Y1_P_U_X)!_]'L^ _\ PC/BY_\ .\HNNX<LOY9?<_\
M(_8*BOQ]_P"'^O\ P2#_ .CV? ?_ (1GQ<_^=Y1_P_U_X)!_]'L^ _\ PC/B
MY_\ .\HNNX<LOY9?<_\ (_8*BOQ]_P"'^O\ P2#_ .CV? ?_ (1GQ<_^=Y1_
MP_U_X)!_]'L^ _\ PC/BY_\ .\HNNX<LOY9?<_\ (_8*BOQ]_P"'^O\ P2#_
M .CV? ?_ (1GQ<_^=Y1_P_U_X)!_]'L^ _\ PC/BY_\ .\HNNX<LOY9?<_\
M(_8*BOQ]_P"'^O\ P2#_ .CV? ?_ (1GQ<_^=Y1_P_U_X)!_]'L^ _\ PC/B
MY_\ .\HNNX<LOY9?<_\ (_8*BOQ]_P"'^O\ P2#_ .CV? ?_ (1GQ<_^=Y1_
MP_U_X)!_]'L^ _\ PC/BY_\ .\HNNX<LOY9?<_\ (_8*BOQ]_P"'^O\ P2#_
M .CV? ?_ (1GQ<_^=Y1_P_U_X)!_]'L^ _\ PC/BY_\ .\HNNX<LOY9?<_\
M(_8*BOQ]_P"'^O\ P2#_ .CV? ?_ (1GQ<_^=Y1_P_U_X)!_]'L^ _\ PC/B
MY_\ .\HNNX<LOY9?<_\ (_8*BOQ]_P"'^O\ P2#_ .CV? ?_ (1GQ<_^=Y1_
MP_U_X)!_]'L^ _\ PC/BY_\ .\HNNX<LOY9?<_\ (_8*BOQ]_P"'^O\ P2#_
M .CV? ?_ (1GQ<_^=Y1_P_U_X)!_]'L^ _\ PC/BY_\ .\HNNX<LOY9?<_\
M(_8*BOQ]_P"'^O\ P2#_ .CV? ?_ (1GQ<_^=Y1_P_U_X)!_]'L^ _\ PC/B
MY_\ .\HNNX<LOY9?<_\ (_8*BOQ]_P"'^O\ P2#_ .CV? ?_ (1GQ<_^=Y1_
MP_U_X)!_]'L^ _\ PC/BY_\ .\HNNX<LOY9?<_\ (_8*BOQ]_P"'^O\ P2#_
M .CV? ?_ (1GQ<_^=Y1_P_U_X)!_]'L^ _\ PC/BY_\ .\HNNX<LOY9?<_\
M(_8*BOQ]_P"'^O\ P2#_ .CV? ?_ (1GQ<_^=Y1_P_U_X)!_]'L^ _\ PC/B
MY_\ .\HNNX<LOY9?<_\ (_8*BOQ]_P"'^O\ P2#_ .CV? ?_ (1GQ<_^=Y1_
MP_U_X)!_]'L^ _\ PC/BY_\ .\HNNX<LOY9?<_\ (_8*BOQ]_P"'^O\ P2#_
M .CV? ?_ (1GQ<_^=Y1_P_U_X)!_]'L^ _\ PC/BY_\ .\HNNX<LOY9?<_\
M(_8*BOQ]_P"'^O\ P2#_ .CV? ?_ (1GQ<_^=Y1_P_U_X)!_]'L^ _\ PC/B
MY_\ .\HNNX<LOY9?<_\ (_8*BOQ]_P"'^O\ P2#_ .CV? ?_ (1GQ<_^=Y1_
MP_U_X)!_]'L^ _\ PC/BY_\ .\HNNX<LOY9?<_\ (_8*BOQ]_P"'^O\ P2#_
M .CV? ?_ (1GQ<_^=Y1_P_U_X)!_]'L^ _\ PC/BY_\ .\HNNX<LOY9?<_\
M(_8*BOQ]_P"'^O\ P2#_ .CV? ?_ (1GQ<_^=Y1_P_U_X)!_]'L^ _\ PC/B
MY_\ .\HNNX<LOY9?<_\ (_8*BOQ]_P"'^O\ P2#_ .CV? ?_ (1GQ<_^=Y1_
MP_U_X)!_]'L^ _\ PC/BY_\ .\HNNX<LOY9?<_\ (_8*BOQ]_P"'^O\ P2#_
M .CV? ?_ (1GQ<_^=Y1_P_U_X)!_]'L^ _\ PC/BY_\ .\HNNX<LOY9?<_\
M(_8*BOQ]_P"'^O\ P2#_ .CV? ?_ (1GQ<_^=Y1_P_U_X)!_]'L^ _\ PC/B
MY_\ .\HNNX<LOY9?<_\ (_8*BOQ]_P"'^O\ P2#_ .CV? ?_ (1GQ<_^=Y1_
MP_U_X)!_]'L^ _\ PC/BY_\ .\HNNX<LOY9?<_\ (_8*BOQ]_P"'^O\ P2#_
M .CV? ?_ (1GQ<_^=Y1_P_U_X)!_]'L^ _\ PC/BY_\ .\HNNX<LOY9?<_\
M(_8*BOQ]_P"'^O\ P2#_ .CV? ?_ (1GQ<_^=Y1_P_U_X)!_]'L^ _\ PC/B
MY_\ .\HNNX<LOY9?<_\ (_8*BOQ]_P"'^O\ P2#_ .CV? ?_ (1GQ<_^=Y1_
MP_U_X)!_]'L^ _\ PC/BY_\ .\HNNX<LOY9?<_\ (_8*BOQ]_P"'^O\ P2#_
M .CV? ?_ (1GQ<_^=Y1_P_U_X)!_]'L^ _\ PC/BY_\ .\HNNX<LOY9?<_\
M(_8*BOQ]_P"'^O\ P2#_ .CV? ?_ (1GQ<_^=Y1_P_U_X)!_]'L^ _\ PC/B
MY_\ .\HNNX<LOY9?<_\ (_8*BOQ]_P"'^O\ P2#_ .CV? ?_ (1GQ<_^=Y1_
MP_U_X)!_]'L^ _\ PC/BY_\ .\HNNX<LOY9?<_\ (_8*BOQ]_P"'^O\ P2#_
M .CV? ?_ (1GQ<_^=Y1_P_U_X)!_]'L^ _\ PC/BY_\ .\HNNX<LOY9?<_\
M(_8*BOQ]_P"'^O\ P2#_ .CV? ?_ (1GQ<_^=Y1_P_U_X)!_]'L^ _\ PC/B
MY_\ .\HNNX<LOY9?<_\ (_8*BOQ]_P"'^O\ P2#_ .CV? ?_ (1GQ<_^=Y1_
MP_U_X)!_]'L^ _\ PC/BY_\ .\HNNX<LOY9?<_\ (_8*BOQ]_P"'^O\ P2#_
M .CV? ?_ (1GQ<_^=Y1_P_U_X)!_]'L^ _\ PC/BY_\ .\HNNX<LOY9?<_\
M(_8*BOQ]_P"'^O\ P2#_ .CV? ?_ (1GQ<_^=Y1_P_U_X)!_]'L^ _\ PC/B
MY_\ .\HNNX<LOY9?<_\ (_8*BOQ]_P"'^O\ P2#_ .CV? ?_ (1GQ<_^=Y1_
MP_U_X)!_]'L^ _\ PC/BY_\ .\HNNX<LOY9?<_\ (_8*BOQ]_P"'^O\ P2#_
M .CV? ?_ (1GQ<_^=Y1_P_U_X)!_]'L^ _\ PC/BY_\ .\HNNX<LOY9?<_\
M(_8*BOQ]_P"'^O\ P2#_ .CV? ?_ (1GQ<_^=Y1_P_U_X)!_]'L^ _\ PC/B
MY_\ .\HNNX<LOY9?<_\ (_8*BOQ]_P"'^O\ P2#_ .CV? ?_ (1GQ<_^=Y1_
MP_U_X)!_]'L^ _\ PC/BY_\ .\HNNX<LOY9?<_\ (_8*BOQ]_P"'^O\ P2#_
M .CV? ?_ (1GQ<_^=Y1_P_U_X)!_]'L^ _\ PC/BY_\ .\HNNX<LOY9?<_\
M(_8*BOQ]_P"'^O\ P2#_ .CV? ?_ (1GQ<_^=Y1_P_U_X)!_]'L^ _\ PC/B
MY_\ .\HNNX<LOY9?<_\ (_8*BOQ]_P"'^O\ P2#_ .CV? ?_ (1GQ<_^=Y1_
MP_U_X)!_]'L^ _\ PC/BY_\ .\HNNX<LOY9?<_\ (_8*BOQ]_P"'^O\ P2#_
M .CV? ?_ (1GQ<_^=Y1_P_U_X)!_]'L^ _\ PC/BY_\ .\HNNX<LOY9?<_\
M(_8*BOQ]_P"'^O\ P2#_ .CV? ?_ (1GQ<_^=Y1_P_U_X)!_]'L^ _\ PC/B
MY_\ .\HNNX<LOY9?<_\ (_8*BOQ]_P"'^O\ P2#_ .CV? ?_ (1GQ<_^=Y1_
MP_U_X)!_]'L^ _\ PC/BY_\ .\HNNX<LOY9?<_\ (_8*BOQ]_P"'^O\ P2#_
M .CV? ?_ (1GQ<_^=Y1_P_U_X)!_]'L^ _\ PC/BY_\ .\HNNX<LOY9?<_\
M(_8*BOQ]_P"'^O\ P2#_ .CV? ?_ (1GQ<_^=Y1_P_U_X)!_]'L^ _\ PC/B
MY_\ .\HNNX<LOY9?<_\ (_8*BOQ]_P"'^O\ P2#_ .CV? ?_ (1GQ<_^=Y1_
MP_U_X)!_]'L^ _\ PC/BY_\ .\HNNX<LOY9?<_\ (_8*BOQ]_P"'^O\ P2#_
M .CV? ?_ (1GQ<_^=Y1_P_U_X)!_]'L^ _\ PC/BY_\ .\HNNX<LOY9?<_\
M(_8*BOQ]_P"'^O\ P2#_ .CV? ?_ (1GQ<_^=Y1_P_U_X)!_]'L^ _\ PC/B
MY_\ .\HNNX<LOY9?<_\ (_8*BOQ]_P"'^O\ P2#_ .CV? ?_ (1GQ<_^=Y1_
MP_U_X)!_]'L^ _\ PC/BY_\ .\HNNX<LOY9?<_\ (_8*BOQ]_P"'^O\ P2#_
M .CV? ?_ (1GQ<_^=Y1_P_U_X)!_]'L^ _\ PC/BY_\ .\HNNX<LOY9?<_\
M(_8*BOQ]_P"'^O\ P2#_ .CV? ?_ (1GQ<_^=Y1_P_U_X)!_]'L^ _\ PC/B
MY_\ .\HNNX<LOY9?<_\ (_8*BOQ]_P"'^O\ P2#_ .CV? ?_ (1GQ<_^=Y1_
MP_U_X)!_]'L^ _\ PC/BY_\ .\HNNX<LOY9?<_\ (_8*BOQ]_P"'^O\ P2#_
M .CV? ?_ (1GQ<_^=Y1_P_U_X)!_]'L^ _\ PC/BY_\ .\HNNX<LOY9?<_\
M(_8*BOQ]_P"'^O\ P2#_ .CV? ?_ (1GQ<_^=Y1_P_U_X)!_]'L^ _\ PC/B
MY_\ .\HNNX<LOY9?<_\ (_8*BOQ]_P"'^O\ P2#_ .CV? ?_ (1GQ<_^=Y1_
MP_U_X)!_]'L^ _\ PC/BY_\ .\HNNX<LOY9?<_\ (_8*BOQ]_P"'^O\ P2#_
M .CV? ?_ (1GQ<_^=Y1_P_U_X)!_]'L^ _\ PC/BY_\ .\HNNX<LOY9?<_\
M(_8*BOQ]_P"'^O\ P2#_ .CV? ?_ (1GQ<_^=Y1_P_U_X)!_]'L^ _\ PC/B
MY_\ .\HNNX<LOY9?<_\ (_8*BOQ]_P"'^O\ P2#_ .CV? ?_ (1GQ<_^=Y1_
MP_U_X)!_]'L^ _\ PC/BY_\ .\HNNX<LOY9?<_\ (_8*BOQ]_P"'^O\ P2#_
M .CV? ?_ (1GQ<_^=Y1_P_U_X)!_]'L^ _\ PC/BY_\ .\HNNX<LOY9?<_\
M(_8*BOQ]_P"'^O\ P2#_ .CV? ?_ (1GQ<_^=Y1_P_U_X)!_]'L^ _\ PC/B
MY_\ .\HNNX<LOY9?<_\ (_8*BOQ]_P"'^O\ P2#_ .CV? ?_ (1GQ<_^=Y1_
MP_U_X)!_]'L^ _\ PC/BY_\ .\HNNX<LOY9?<_\ (_8*BOQ]_P"'^O\ P2#_
M .CV? ?_ (1GQ<_^=Y1_P_U_X)!_]'L^ _\ PC/BY_\ .\HNNX<LOY9?<_\
M(_8*BOQ]_P"'^O\ P2#_ .CV? ?_ (1GQ<_^=Y1_P_U_X)!_]'L^ _\ PC/B
MY_\ .\HNNX<LOY9?<_\ (_8*BOQ]_P"'^O\ P2#_ .CV? ?_ (1GQ<_^=Y1_
MP_U_X)!_]'L^ _\ PC/BY_\ .\HNNX<LOY9?<_\ (_8*BOQ]_P"'^O\ P2#_
M .CV? ?_ (1GQ<_^=Y1_P_U_X)!_]'L^ _\ PC/BY_\ .\HNNX<LOY9?<_\
M(_8*BOQ]_P"'^O\ P2#_ .CV? ?_ (1GQ<_^=Y1_P_U_X)!_]'L^ _\ PC/B
MY_\ .\HNNX<LOY9?<_\ (_8*BOQ]_P"'^O\ P2#_ .CV? ?_ (1GQ<_^=Y1_
MP_U_X)!_]'L^ _\ PC/BY_\ .\HNNX<LOY9?<_\ (_8*BOQ]_P"'^O\ P2#_
M .CV? ?_ (1GQ<_^=Y1_P_U_X)!_]'L^ _\ PC/BY_\ .\HNNX<LOY9?<_\
M(_8*BOQ]_P"'^O\ P2#_ .CV? ?_ (1GQ<_^=Y1_P_U_X)!_]'L^ _\ PC/B
MY_\ .\HNNX<LOY9?<_\ (_8*BOQ]_P"'^O\ P2#_ .CV? ?_ (1GQ<_^=Y1_
MP_U_X)!_]'L^ _\ PC/BY_\ .\HNNX<LOY9?<_\ (_8*BOQ]_P"'^O\ P2#_
M .CV? ?_ (1GQ<_^=Y1_P_U_X)!_]'L^ _\ PC/BY_\ .\HNNX<LOY9?<_\
M(_8*BOQ]_P"'^O\ P2#_ .CV? ?_ (1GQ<_^=Y1_P_U_X)!_]'L^ _\ PC/B
MY_\ .\HNNX<LOY9?<_\ (_8*BOQ]_P"'^O\ P2#_ .CV? ?_ (1GQ<_^=Y1_
MP_U_X)!_]'L^ _\ PC/BY_\ .\HNNX<LOY9?<_\ (_8*BOQ]_P"'^O\ P2#_
M .CV? ?_ (1GQ<_^=Y1_P_U_X)!_]'L^ _\ PC/BY_\ .\HNNX<LOY9?<_\
M(_8*BOQ]_P"'^O\ P2#_ .CV? ?_ (1GQ<_^=Y1_P_U_X)!_]'L^ _\ PC/B
MY_\ .\HNNX<LOY9?<_\ (_8*BOQ]_P"'^O\ P2#_ .CV? ?_ (1GQ<_^=Y1_
MP_U_X)!_]'L^ _\ PC/BY_\ .\HNNX<LOY9?<_\ (_8*BOQ]_P"'^O\ P2#_
M .CV? ?_ (1GQ<_^=Y1_P_U_X)!_]'L^ _\ PC/BY_\ .\HNNX<LOY9?<_\
M(_8*BOQ]_P"'^O\ P2#_ .CV? ?_ (1GQ<_^=Y1_P_U_X)!_]'L^ _\ PC/B
MY_\ .\HNNX<LOY9?<_\ (_8*BOQ]_P"'^O\ P2#_ .CV? ?_ (1GQ<_^=Y1_
MP_U_X)!_]'L^ _\ PC/BY_\ .\HNNX<LOY9?<_\ (_8*BOQ]_P"'^O\ P2#_
M .CV? ?_ (1GQ<_^=Y1_P_U_X)!_]'L^ _\ PC/BY_\ .\HNNX<LOY9?<_\
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MH?@U_P"$KXW_ /C=?VLT4<D?/[P^L5?YE_X#'_(_BF_XA;OVA/\ HZ'X-?\
MA*^-_P#XW1_Q"W?M"?\ 1T/P:_\ "5\;_P#QNO[6:*.2/G]X?6*O\R_\!C_D
M?Q3?\0MW[0G_ $=#\&O_  E?&_\ \;H_XA;OVA/^CH?@U_X2OC?_ .-U_:S1
M1R1\_O#ZQ5_F7_@,?\C^*;_B%N_:$_Z.A^#7_A*^-_\ XW1_Q"W?M"?]'0_!
MK_PE?&__ ,;K^UFBCDCY_>'UBK_,O_ 8_P"1_%-_Q"W?M"?]'0_!K_PE?&__
M ,;H_P"(6[]H3_HZ'X-?^$KXW_\ C=?VLT4<D?/[P^L5?YE_X#'_ "/XIO\
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M=#\&O_"5\;__ !NC_B%N_:$_Z.A^#7_A*^-__C=?VLT4<D?/[P^L5?YE_P"
MQ_R/XIO^(6[]H3_HZ'X-?^$KXW_^-T?\0MW[0G_1T/P:_P#"5\;_ /QNO[6:
M*.2/G]X?6*O\R_\  8_Y'\4W_$+=^T)_T=#\&O\ PE?&_P#\;H_XA;OVA/\
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ML5?YE_X#'_(_BF_XA;OVA/\ HZ'X-?\ A*^-_P#XW1_Q"W?M"?\ 1T/P:_\
M"5\;_P#QNO[6:*.2/G]X?6*O\R_\!C_D?Q3?\0MW[0G_ $=#\&O_  E?&_\
M\;H_XA;OVA/^CH?@U_X2OC?_ .-U_:S11R1\_O#ZQ5_F7_@,?\C^*;_B%N_:
M$_Z.A^#7_A*^-_\ XW1_Q"W?M"?]'0_!K_PE?&__ ,;K^UFBCDCY_>'UBK_,
MO_ 8_P"1_%-_Q"W?M"?]'0_!K_PE?&__ ,;H_P"(6[]H3_HZ'X-?^$KXW_\
MC=?VLT4<D?/[P^L5?YE_X#'_ "/XIO\ B%N_:$_Z.A^#7_A*^-__ (W1_P 0
MMW[0G_1T/P:_\)7QO_\ &Z_M9HHY(^?WA]8J_P R_P# 8_Y'\4W_ !"W?M"?
M]'0_!K_PE?&__P ;H_XA;OVA/^CH?@U_X2OC?_XW7]K-%')'S^\/K%7^9?\
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M (W7]K-%')'S^\/K%7^9?^ Q_P C^*;_ (A;OVA/^CH?@U_X2OC?_P"-T?\
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MH.7XJ-OS]3\W?^(6[]H3_HZ'X-?^$KXW_P#C='_$+=^T)_T=#\&O_"5\;_\
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M ,;K](O^'+'[>_\ TG/_ &O?_ /XS?\ T7E'_#EC]O?_ *3G_M>_^ ?QF_\
MHO*.5?RO_P "0>UE_P!!$/\ P5+_ "/S=_XA;OVA/^CH?@U_X2OC?_XW1_Q"
MW?M"?]'0_!K_ ,)7QO\ _&Z_2+_ARQ^WO_TG/_:]_P# /XS?_1>4?\.6/V]_
M^DY_[7O_ (!_&;_Z+RCE7\K_ / D'M9?]!$/_!4O\C\W?^(6[]H3_HZ'X-?^
M$KXW_P#C='_$+=^T)_T=#\&O_"5\;_\ QNOTB_X<L?M[_P#2<_\ :]_\ _C-
M_P#1>4?\.6/V]_\ I.?^U[_X!_&;_P"B\HY5_*__  )![67_ $$0_P#!4O\
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M;^W[?0-W@;0]*UGX4>,;KPM!J6L>']&M9(-!6[TW4(?$&@75WIE[IT'ZT_\
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MDO4K1_ $MKJ$NI>#_A)>_&F^MI/#_P#Q7LEO=ZU-X,GA?X@?Z*\<BMX-_P!
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M+[0[KQUX+\+VGAA?$>D^'O!FLS2/;Z_9P7]O/-H<M_XGT?Q-X6LM3GD_6_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MUW5FL]2DT[2;6:>WM;9(=.N[O5;Z0VUM'%!;ZA?V'Y2_\%HO$GA'Q_\ %WX
M_ [P!IECKGQ7T"#4=/U6#1X8FU"T'CZ]\-6?@7P3(;=!NN[F:TN=4M=*F??I
MMMJUA=6\$4>NN\WZY_%S]B_X(_%/QC\-/C7\6$\2:GXM^"NB>&GM39ZXS^&=
M0LO ][/XF^R:OX>U&RO+/4+&[U.2\GU$HEE?ZE;/':W5WY4,*1:9C@.$J#X5
MSS%93C<LP&;X;-*V)R+#XBMB9UY8.:IY;.%6I.GB*.&Q]6<(U:L6O<M.G'63
MGZ''W!'T6,FG]&+QJXE\+>+_  XX(\5>'?$C-^(/!3(L_P UXBQF=5^%,5'
M>'F,P69YAB\!GF5</<<YCBL%A\TS&A.G%X1TL5@<.G5Q-3$_(W[(G_!6;1_C
MW\5M+^#/Q1^&)^%GBKQ1<36GA#5['7+G5]&U'56B:[L?#VK66H:3IM_H]]?6
MJ,FFZ@)[ZUU.^>"T-MIS7%N9OV*9E52S$*J@LS,0%50,DDG@ #DD\ <FOY?Y
M/'ND_P#!13_@IE\&_&WP@T*]\$^&/ /_  @6L:QJOB&XT;1?%&LZ3\*O%%YX
MQU+7VL['4[IGUZ_2ZM/#.B6VG7FL:A9Z?8:;JU[';V-A?Q:?^G/_  51_:AN
M?@I\$XOA5X'N9I/BW\>1>>$-#M=,9I-6TGPI<^5I_B76;>*UF6]M[_4EOHO#
M?AZ6-%DEU#4+R\L7:?19D7#B+A;#UL\X=RW*<!+*,=G6 HXC,<HJ5YXJ.3U'
M6JJI4J5IRDU2C@Z57%U8NHU#V5N:#J.*\3Q]^C-D>:>-/@#X>>%G ^(\*N-/
M%_@;*L_X_P#"G'YWC.)L/X28ZIF^8T\=F&/SC%5\15I991X2RO,>)\QPU7,*
MD,*LN]FJV#K8^6&I\_\ !'_@IBWQY_;2O?V=_!?@_0+CX6BY\9VNB?$,:CJ$
MNM:Y%X.\/WUZ^KVMF FGKI>LZGIT[Z863SSHT]I-,$NGDC3]:*_E7_X)^_"3
M6O@5_P %-/#/PI\2W$%QXB\)^$_$<6OFV(>VMM:U?X.?V_JFG6\RDK<P:5?:
MK/IL5XNP7D=HMT(XA-Y:?U45YO'N595E&:9?A\F@HX*KD>7XF-52G-XJ=5XB
M+Q<I3E+W\3&G"J^10I^^N2G&/*C\]^G)X9>%_A7XE< Y%X18.C1X/S3P7X#X
MBHYE2Q.+Q4^)\5F57/*%3BO$UL77K<V*X@PV7X7,:OU6G@\%;$TWA,%AL.Z,
M65\:_MO_ +7MG^QE\+- ^(TW@<_$.\\1>.=/\%V7AM/%">$V47>A^(-;N=7?
M4VT'Q(YM[&/0EM7@CTMS)<:C:[IH4#$_95?SV?\ !=KQ>H@_9U\ P2@N\OQ"
M\7ZG#\FY%C3POHNARCDR8E,OB%#D(F8EP9#N\KS^#,JP^=\395EV+I.MA*U6
MM4Q5)3G3YZ&'PV(K3BYTY1J04I1I+FA*,MDFN9GP7T0?"_(O&/Z1GAEP!Q3E
MT\VX6S3,LTQO$N70Q.,P7US),CX=SS-\7AYXW+Z^&QN$A6K4,MINOA<10K)N
M-.%6/MI7NZ/_ ,%UO[6U?2M*_P"&6OL_]IZE8Z?Y_P#PN[S?(^VW45MYWE?\
M*AC\SR_,W^7YD>_;MWIG</T\_;0_;2\ _L:>!-+\0^(]+NO%OC#Q9=7EAX'\
M":=?0:9<ZU-IT,4VIZEJ6J3PW8T?P_I0N;&"^U&'3]4N_MFI:=;6NFW FN)[
M3\K_ -F__@H/^R;XR^)/A3X7?$3]C7X9_">RUG4=&T#PEXU;2/!?B7[#=7WV
M*V\-'Q:EWX \-W-BEXTEM+/XHM;JXMXY+N"ZGL+:Q2?4E\=_X*A_$'PNW_!0
MWX96_P 48+W5/A=\+=!^&4WB/P_IT<.HSZKH;ZY?>,_$EA!IUQ):VOV_Q#:7
M<.BR)<W,44MM'927%U#;A3#]]+A/+,9Q-EV6RX5Q^186AEV9YKB\/_::S"><
MT<+&F\-0PN(I5ZT*4Y5W##58PJPJ1=91DXW59?W3B/HN^''%GTC> /#[$?1B
MXX\%.&\EX!\1?$[BC(5XCTN.L5XN95PU0P$N'\CX9S[+<[S;"9;B<3G=7"Y!
MFF'PF987'T*N;0H5JN&]K2S6G]N?LJ_\%=]*^-?Q<\.?"#XJ?"K_ (5?J7CF
M^@TOP9XBT_Q!<ZQI=QK6IEWT#1=9T_4-'TN]L_[<WVFFZ5J]E-?PWFKWEG'+
M86%C=/>6D?[2_P#P5]_X9W^.7Q!^#'_#//\ PF'_  @FI6&G_P#"2?\ "V?^
M$?\ [5^W:'I>L^=_8_\ PK/6_L/E?VE]F\O^U;S?Y/G;T\SRH_)OAW^U=^PY
M^W=^TI\-E^+_ ,%_%/@;XG:0^F>'_@_X@NO'&H6NAWVHZ9JUSKGAS2=0O/!M
MWX7O;'6CK$V_PW9WO]J:7)J4BZ9#<QSWRV^H_M5XZ\)_!W3-+\4?$+QYX*\!
M36FAZ-J?B7Q1XCUOPGH-_=1:5H.F2WNH7]]>W>GS7,RV6FV3L6DD=EA@5%(5
M5 \;-J/#N2YQA5F/!69T'B\M2JY)/,:D*$,=+%QA1Q.78ZE7K5,72J4;4*M)
MN/)BIJ,::EI+\A\4LH\ ?!_Q:X9I<?\ T//$7)I\3^'=*GF7@WBN/\;ALGP?
M&N)XKHX3*.(^ >-LLSO.,;Q3EV.RCDR3-,KJ2H+"\2XJ%*E@:-9^SQ'XV?#G
M_@MPWQ ^(7@3P&O[,9TMO&WC+PQX174U^,YU!M.;Q)K=CHPOA8#X3V9O3:&]
M^T"T%W:FY,?DBY@W^:OU'^VY_P %+_#7[*7C/3/A/X2\ W'Q4^*=_IUCJ6HZ
M8-9;1M&\-1:PQ&AVMY):Z9K&HZMKFIHJW46AVEM8E+"ZL+MM1W7D%L_QE_P3
M3^'-M^U%^TU\8OVV/%WA/2]%\-^%O$3:+\*/"MA86UEH6A:_=64:6HLK.SBA
ML&N? _@S^S(994@1+S7_ !*?$2I'J4 E7E_VLM7_ .&-?^"HOA[]J?XC^&K[
MQI\-/'6FQ:OI*Z3)H]UX@LY;'X:VGPTU>+3;+4KVRA.K>&KR&SU73UO9--L[
MK2]0M+*WU9+V*ZN;;VJN1<*5>*7E.%R67M\MX?Q6-Q&30S/$3699[[+#XJEE
M,<74JN5\)AZLHUI4IT8UJO,E[M/WOV',O!'Z,&9_2:EX6<->$&)CG7AYX#\1
M\8Y]X0X3Q'SS%T_$/QK_ +-R+B7+?"[#\58[-*E55>%LCS&M1S6KE>*RK#9O
MF*JTJ25# REB?OS]B/\ X*5^&/VL/%VK?"OQ1X#NOA7\5-,L+_4['2)-8.M:
M-XCLM)DBCU>"RN;G3=&U'3=>TPRM-=:!=V5RQL+:ZOH=1D-M=VMI^GE?SF_L
M;:LO[77_  5 \;?M5?#GPZ_@GX9^#],OM4U+3M3DTNSUW5)=<^'%S\-=+_M;
M2M-U2\A?6->U&2^\5:I+IIO]+L9-.6"^U"XU2ZM[_4?Z,J^(XVRS 95F]"A@
M<-+ .OE> QF-RN=>6)EE>.Q-.<ZV"]M)RE)0BJ=1)SJ<G/R\]FE'^,/ID^&_
M _ACXJY-DW!/#V(X'EG/AKP-Q;Q?X;8K.ZO$5;PUXSXBP&)Q><<'O-Z]3$5L
M1'"4:>"QT:=3&8UX98QT5B90E&G1*_-#]N/_ (*1>#OV0]9T?X?:%X2?XF_%
M;6+"WU>Y\/)J[:+I'AG1[R62'3[G6]1AT[5+B?4]5>&9M.T&SMEN3:(-0OKJ
MQM[G3%U/]+Z_G0M_['3_ (+EZE_PL3[,5.KP?\(K_;?[RU_MB3X$Z=_PA/V/
M.ZU%R)&M_P"Q/-QY>KBT\C9K"V^%P=EF7YAC,SQ&9X>IC<+DV2X[-W@*56=&
M6.J87V<:="52G>I&E>;J573][ECJ^524H^B1X<<"\=\6>(^>^(N1X_B_AKPD
M\'>-?%:KP-EN98G*<1QIC>&U@J&!R2MF.!4L?ALN57&SQN8SP*]NZ&'BI2CA
MZ=>-?[G_ &&_^"F7AC]K/Q7??"[Q7X)/PR^*%KIEUJVE6,.LOK6@^++73/FU
MB+39;G3]-OM*U?38&%W)HMTE^9M/@O;Z'46^R7%M#O\ [=?_  48\,_L>ZEX
M=\"Z+X-;XD_%+Q+IJZX-";6&T72/#N@SW-S8V&HZO>0:?J=W=WVJ7UG=0Z=H
MEI;P2RV]M<7MU?V49L(]1_++]IOQ%X7^'O\ P6(^'GB+P)-964Q^)'P4@\>_
MV*B1HFM>*6TGP_XSCECM+AHWU+4?"^J(^KA8[62ZU"]NS?P2WDUY=77?>'C#
M\5?^"X&J2>)$^V6?@KQ!K8TFQN466&&;X>?"26TT)X5W!8/LFO6L7B.!U#,+
M^,2,HDD9E^SEPKD/U^AGCR^O3R.IP=7XIGDLL3636*H2CAU@5B7:NL/4K5:=
M9.ZER-6:IR43^P:WT8O!#_7?)O&>? ><X#P5QOT2<[^DSC/!ZOQ%FT:M+B3)
ML1A\CAP7'B2;CG,<@Q^:YA@LUA4]I&M]2E3Y:L,!B8X8_0?]A;_@H]X:_:]U
MSQ!\._$/@M_AG\5/#VF3ZY'HHU9M7T;Q)HUG=P66I3Z3=7-CIE[9:KI%Q=VH
MU#0;R"><VDIU&RO+N&WU.+2_KO\ :2^/G@_]FKX/^+_BQXQN[5(M#TZXC\/:
M--<I;W?BOQ7<03?V#X8TQ#F::ZU.\11.\$4IT_38K_5KE5LK"YEC_#SQZD?P
MM_X+=^%;_P /QQZ/;^-?$/A-[^!6@@LKV3Q_\,1X:U^01*@2235=4GO-0=9Q
M)//KTKW<3K,UL8O1_P!O?]C'X[?'/XI?M+_&[Q[XZO="_9[^"WPHUOQ=\)/#
MDNKC5I]:UCPO\%=+U_5+7P_X<BGDT_PSI.H>.;#5H_$^O:FD.N:C]D^QV%A=
M6<ECJNF>;BN&N':N?Y)7EB(Y-D6<9-EV=O!U*E7$UG6KXO#X*IE&"J/FJ5*F
M(Q-:FH3DY>QH/$U+KDA[/\\XC^CKX!9CXY>#F<UL_H^$'@GXL>$?A_XR2X3Q
M^.S/B#-JN:YWQ5D/"&/\*N#L;+VN88W&9YQ#FV!IX3%XB=>64Y)/B#'\U)8+
M"/ _H=^P!^U?XC_;#^#GB7XF>)_"FB>#[_0_B9K/@6'3-!N[^\LY[/3/"W@S
MQ!'?22Z@3,MS+-XGN+=XU/E"*UA9?G9Z^7/VN_\ @K-H/P$^*.J_!CX6?#1O
MBMXQ\-SC3O%6K7>NRZ5H.E:\T$4[Z!IEGIFF:KJ/B#4+ 2^1K3"?2(M,OX9M
M-3[;<QW1LZG_  0^_P"34/B#_P!G#>+/_5;?":OIGX)_L*_"G]FWXV?%/]I?
M_A-O$'B37/&5EXPU35[[Q\GAO[/X5/B/7Y/%?BC7;35[+3=*6S,D,3VMW=R0
MPF/3FOUDG%O=S0CDQ>'X6R?BKBFEF. J8G#9?5E2R3):$\33H8K%2^I)4J^)
MIRG6I4J4*M2I%2E-U:D^7WFH0?R?%>0_1E\)OI/?28RWQ X(S#B#AS@3,<1E
MG@YX/Y-BN(\!DW$G$F(_U.A2RS.>(\OQ.,S3+,LRW!YECL;AXXBOBY9ACL7]
M7_?SA@\)4P?V&?\ @HCX)_;*DU[PK/X6G^'7Q/\ #6F_VY=>%I-777M,UKPZ
MMU;V$^MZ!J_]GZ5,_P!AO;NRAU33+S3X9K(ZA9/;76IPM<S6WZ+U_-I^P+-I
MOQ?_ ."HOQM^+OPMT\V7PPL4^*/B(W-M9PZ?87.F>(]1M]#T=S;QVIC@N/$F
MI7,GB2WL0UI=O%;7L\KL;2\@E_I+KR>-LJP.49U"AE]&IA*.(RW+L?4P%6JZ
MU3+J^,P_M:N#E4DW-^R=FE-N<4W%MKEM^7?3+\+^"?"CQAPN2<!Y3CN%\IS_
M ,/> ..<;P-F>95<VQ_ .=\79'_:>9\)8C'XB4\75_LZJHSI4\;.>*P\:E6C
M4G*FJ"I%?E)^VM_P4_T']F#X@I\&_ 7P^D^*GQ-M[&PO?$<,NL/I6A^&&U>S
M^WZ3I<J6%CJFJZQKMQ82V6JW&FQ0:;;V^EZA83+J4UQ<26UM^K=?GI\3O@I^
MS%^R?XZ^)_\ P4)\6:?XWOO$VG:?/+KT-O>V/B&"/4/&>J^'O"D5]X8T;5Q8
M/8ZY,UU;Z#9$>([+3;72]8U2V:$1/ ;;AX:_LC^T)?VM@<5FKE0E3RW*\,YT
MUF&:5:E*EA</B*U.I3J4J+<Y/F@WS5.6,DH[_&?1T7A2^.\0O%+@KB;Q,G6R
M:M@/#OPUX<K8K PXZ\2LTQ^79;PUD.>9M@,=@<=E>4598K$3=;#2J>WQOU:A
M7C&@O?J?L,_\%#O!O[9$GB'PI=>%IOAS\4?"]@=:O/"LNK+K>G:SX>6\BL)M
M9T'5&L=+N7.GWEU96^L:=>:=#+8OJ%B]O<ZA%+.]K]O_ !*^(7ACX3^ ?%_Q
M)\97HT_PQX*T'4/$&L7/RF4VMA THMK6-V03W]]-Y5CI]J&#W5]<6]M'\\J@
M_@-_P3(T._\ CU^V_P#'?]K30M"L/!/P\BNO&TMMX?BO+![XZU\0K^&>QTR2
MQMY8Y6,6E_;=9UO58K5-.;67A@M=QN6%MZ[_ ,%,?B9XG_:)^-'PK_X)Z_!V
M[\W4_$6OZ-K_ ,6[ZV8RV^G*(/[9TG3-4$4BL-/\*>'8[SXB>(K5TD,ZKX8:
MS87MG+!)]1FG"F7U.,H93@5+ 9?# 87-<ZISKNNLCHQPL<9FM"6)ES<WL()4
MJ+E*;]MB*<%*I[L3^EO$KZ+W N8?2YPGA=P7"OP-P%@N">&/$SQCP.,SB6=4
M?!;)\-PS1XK\3,EK\15O;K$O)<+"EEN53K5\9-9MG^ PE*MCE'#T3ZJ_X)Z_
MMU>)OVU+GXTG7_ FA>";3X;3^ SHRZ1J6H:C<ZA;>,I/'.]=3DO52(3V,7A6
MT"/:QQQRR75PQ156)1Y3^UW_ ,%8+3]EKXY>(O@M;?!!/B)-X:TSPY>ZAKZ?
M%$>%VCN_$.B6>O)ITNCCX>^)#"]O8:A92B5M38SQW,<ODPJR@_,W_!!G_FZO
M_NAO_O8:^)OB?^T;H'@?_@HU^T-\6_$'PIT?X[6^F^+O'W@K2/!OB&2RGT2Y
MG\+QV_@>TUBY6Z\/>(XKNSTC1O#EU/9QP:>KA1;SK?Q0PR2R?0T>$<GJ\;\4
M8"&3_6\NRC*<-B,+E=+&5<(JF+Q%' 1IP6+J8B/LW.<L3-RK5G33<I2CRJ,5
M^]Y1]%7PFS3Z9OTD^"<+X3OBKP^\*O"WAO/^&O#3+.*\QX7CF'$^>Y3P+1R[
M#0XHQV>X=X&>+Q>)XAQE7$YOFTLOIU*M:M7HNC3HT8_M%^P__P %,/\ ALOX
ML>(?AA_PI3_A7']@_#S5O'O]N?\ "Q_^$P^U?V7XD\)>'O[*_LS_ (0/PMY'
MG_\ "4?;/MW]H3>5]A^S_8Y/M7GV_P"I]?F'_P $]OVJ?V<OVE7\4M\/O@GX
M+^!OQ<\,Z1$?$/A_0M&\+1W.J>$[^^ME?4-$\2:+H/A_4-6T2+5K;38]:L;O
M3;0:;J$NB&47?VBSN3^GE?G'%>&H8/.L1AL/DN(R"%&EAX2R[$XKZY4C4]G*
M4Z\<2IU(U:6)4H5*3A4E#EBU%I\T8_YZ_2@X>R3A3QCSWAS(?!_// O"91EN
M0X7$>'W$'$G^MV-PV8?4,17Q>=T.(88S,,/F66<01KX/'9=5P6-Q.#5##U(T
M9PE[>C1_*;_@JY_P35\!_M__  *UDZ9HVE:5^T?\/]$U/5?@UX\2"WM+^_O[
M2WGO%^&WB;4<1O=>#O%=ROV-6O'F'A?5[F'Q%IR$)JEAJV7_ ,$?/^"@U_\
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M[1YDWUT6O3O:WS/X>?\ @G%\./\ @L1\/? _B3XT_P#!//P-XAL_!7Q:EM]
MUSQG8^'?@#XBC\1'P!J6LVJ6-DOQ@M-7U'3;?2]5U35H;QM&M=/MM2NEC%\]
M\VEV7V3O?V _%G[0'_!/O_@KK\,A^U=X7NOAEXO^.FLWOA+XJZ9J,?AO3;2\
MT;]H+4Y?[&U^.'P1*_A'2]#B^)L'AS7I;73(8-$TFVT2ZLTL]*AM$>Q_N)_9
M-_9T\,_LE?LY?"3]G3PCJ4VM:)\*_"T>A+KMS86^EW'B#5;J^O=;\1>(;C3;
M22>"QFU[Q%JFJZO+:I<W;027K1R7EY*KW4OY^_\ !23_ () ^"?^"AWQ.^%?
MQ>F^,GB#X*^.?AIX6N/"+:OX?\'V'BBXUW2K?Q#)XG\+YGN=?\/W&ES>&-7U
M+Q)=6KQRWBS/KCNBVCVS-=5R-)--W6MM+>9I[>,I34HQ4)*4>9)\S7V;]_T/
MQX_;.T^/4_\ @Y,_9EMI7>-8]<_9VU -'MW&32=)O-5A0[@1LEELDBDP-WEN
M^TAL$7_^#JK3[.+4?V&-52';?WME^TEI]S<>9*?-L],G^!%S8P^47,*>1-J^
MH/YD<:2R_:-LSR)% L7[#^/O^"4%A\1_V_?A'^W[XB^/6K-XS^&5G\.DO_!5
MI\/--M]'\5ZGX$T&;1[K46U1/%'FZ(FOW%Q/J!L;?3;V/2]ZVD4MTB"4[7_!
M3_\ X)7^'O\ @IA_PH_^WOC)K7PD_P"%*?\ "R_LG]D>#;'Q=_PD'_"Q_P#A
M7_G_ &C[;XAT'^S_ .RO^$"A\KR_M7VO^TI=_D?9D\Y\KM+3=W6Q,:D5.BV]
M(0<9:/1^]]^Z/PV_X.3XHYOVPOV)H9HTEAE\%2Q2Q2HLD<L<GQ1ME>.1&!5T
M=25=&!5E)!!!(K[O_P"#GJ.,_L&?""8QH94_:Z\"QI*44R)'+\&OCTTL:.1N
M5)&AA:1 0KM%&6!**1]A?\%$O^"3/AS_ (*"?%WX,?%C6OC7K?PQN/@[HYTF
MUT32_!-AXGAUU3XGC\2F>XOKOQ'HSV!WQBT\N.VN1L)FWY_=U[A_P4G_ & ]
M&_X*,_ SPI\$=<^)>I_"NT\+?%C0OBI'XATKPS:^*KB\N-$\'^._"2:,^G7F
MLZ'%##<1>.)KYKU;N22.33HX!;NMPTL)9^_Y["C4BO87?P.7-H]+MV]?D?S;
M_P#!8RSNG_X)$_\ !'W4$@=K*U^$?P9L[BY 'EQ75_\ LR>"I[.!SG(>XBTZ
M^DC !!6VDR1@9_0#_@J!\2O#-C_P0%^%FGVOB;0G'Q2^$_['/ACP]&EY;W#^
M(Y]&;X<>-;^RT8Q2-YUUI]MX,O+Z^,>3;6^G7D,_ER'8?T;_ &A_^"8OPR_:
M1_8)^$_[#OC/QIK-HGP3\#?"CP_\//BUI^BV1UG2_%GPE\"P> =,\77'AF:^
M:SN[+7='.J6VO>&1K$ EL=7N(++6K._MK'5K;\E_AM_P;)>$;+P=XJT3XR?M
M6^)_'FL'0;[1?A0-#\"3Z-X3^%M[JNM6>HZQXG3P[J7CS5CXBU'4K."\M8],
MBN_#VE65]J4VL7::WJ-KI\UHFI7=ENDM]K)#C.FU'FDTX5932Y6^92E=>GG?
M_(\F\ _MW_$C]@O_ (-]/V0/&?P;@TZ+XJ?$WXB?%_X;>%O$>L:=::QIW@N"
M7XZ?'[Q)K7B<:/J"3:?J^JP66@KIFCV&IV]QI:7FJ#4]0MKZWTUM,O\ X>_;
MA_93_:FN?^"?/@G]NK]L3]O#Q3\7M;^+/_"KM5^%7P)BUJ]UWP9;K\2[>#Q-
M#,M_-XFL?"L.K:5X,CU'4-2T?P'X#>RM=2M6\K7[[3K22[D_I2UC_@CO\*/%
M7_!-GP)_P3L\7?$GQ#J]C\,->\0^,_ 7QDM/#FG:;K^A>-M8\=^/O&=GK3>%
M9-3U#3[NQM[+XAZYX2U723K$+ZMH=S=2VNI:+JDUI?:=^>'A#_@V<\/W'@G6
MO#/QF_;+^(GQ!N].TBZT?X01:3X-N-%\)?"U[G7]/U&ZUF#POK'Q!\1KJTNI
MZ;:7EI/HEA?^'-+M;K5Y;R:36+BPM+AAJ6UKZ)+6R3Z^I4:E--R4E%^UE)OD
MYI2BWHD_L^>S/DC]JG_E6K_8Q_[*OX>_]2OX]5_2W_P2]_Y1V?L7_P#9NOPQ
M_P#4;LZ^3?&O_!'K3O'?_!.?X9?\$\]:_:(UUM"^%OQ";QKH?Q1C^'6G?VS<
MZ>NL>-]:MO#=YX;/BW[&4M)_'-[;0:G'JZN+&QL8&LBZR3-^F7[-/P4M/V</
MV?\ X/? 6Q\07'BNS^$?P_\ #?@*V\27>GQZ3<ZY#X<TZ'3X]2GTV&[OHK&6
MZ6(2O;1WERD18JLS@9II-._]U+YF4YQ<+)W?M9RV?PRV?_ W/R0_X.-/^4;&
MO?\ 99?A3_Z6ZO7\UG[8VE>*?@9^S[_P1N_:_P#A[.^C^+3^SWJOA6UUBW,Z
M1Q:S\(OB5J/BO2$U#[+-;2'^TK+XFZC8R,DT%W>Z993VBW"QV<7D?VI?\%!_
MV*M*_;Z_9VOOV?-9^(&H?#2RO?%_A?Q:WB?3/#]MXFNHY/#,UW-'8C2[K5=&
MA9+LW1#SF]#0A/EBD+<?''Q\_P"",O@;X\?L/?LS_L9:C\:M;T _LTZQ'J&A
M_%2W\#:?J&JZ_82:5XGT_4])N?#4OB6UMM,BU.?7-+OI9X=9O#')X?@B$,@N
MV>W)1;;?DK>J95*I&$8)O:<G)6;]V4.7YZ]#^4'6?A-#X._X(3^'?BA<0NNK
M?&/_ (*5Z%-#<$,L<OA7P#^S_P#&3POI$*JPP[P>)6\;227$;%'6YB@V+):R
M,_T]_P %G-+UX_L2_P#!$[6GBO9/#"_L6>'M+@G#2R:=:Z\_PE_9WN[N)T!:
M"SO=0T]+-XV<1RZC!IL@C,R:7*(/Z*/C'_P1L\#?%;_@GO\ L_?\$_[/XRZU
MX/\ #GP&\?VGQ#@^(5EX'L=3U'Q3K'V+XJ)K N_#<WB6TMM+_MK5OBKJVM3R
MPZQ>>1/:) D;I<L\'T%\:?\ @F?\%OV@_P!AOX4?L3?%+5=8U33_ (+_  X^
M&OA#P!\4]*M;72O%>@^*_ACX"M/ >D^.;/3I);^Q"ZK8P7(UWPQ=7%WI][I^
MHW-BMW#>P:=K%DN5V:\E]Z;;+]O'FC+5VJU&U9Z1E%13_#;<_FX_; _8>_:.
M'P4^%NL?ME_\%D_!VO? SXP^(=!U+X8/\03\:O&'A7Q-K4_AC4O$>AZ_:V%C
MINL-I]I;^')[R8^)-6M=/TC36U.RTV\U"VU'6M,L[SYN_P""M_P[UOX46W_!
M*?PY'\4M$UKPKX;_ &3?!7ASP?\ '/PE:ZY#X,OHM \<R7=MX[\.QW6_5I(K
M#PMJ_@K7I_(Q=2QO9S6MM;Q3V<(_5;X:?\&RGAZP\>>%)OCG^V#XO^+GP:\#
M:@MSHWPRTCX?W7@N[U+3IYH=0O\ 0VUV^^)'C&T\'Z3J-_!';:XGAG16U'6[
M RW%EJGAK4VM[FT_:#]NG_@G+\!OV[?@5X>^"?C:WNO Q^'CP77PB\8>#K6T
MBU'X;W-MI<6BI8Z?IDHCL-1\+7FE6]II^K>&)VM[2\@L--GMKC3]2TK2]0LC
ME;3TMMN[W_KH'M8QE#WN9)RNU!12YE9-))-NV_3\C^8S]N3]@?X]Z/X6^$VD
M_MW?\%A_A_J_@WQ[JVH>(/A'!\23\8_''A[5M1TK1[;[=XCT:;2]/UZPL;6#
M1O$EG$-?NY;/3IH-9M[>"]E>\CC?3_X.&?#-UX*_9S_X)(>#;WQ+I/C.\\)?
M!3XF^&;OQAH$<T6A>*[K0? O[+.E7'B718KG_2(])UV6T?5-.CG_ 'R6=U"L
MOSAJ^V_@5_P;4^$O"WQ4\'>+/VC_ -J37OV@OAQ\/+BP_P"$?^%T/@"Z\(6.
MN:;I5PE]8>']=U/5?B%XW.D^#GNQ)%JWA3P]90MJ5E--%;Z_I;32$_IG_P %
M2?\ @E_X4_X*2_#;X=>'3\0)OA-X\^$&K:]J'@'Q5'X;A\4:(NF>*K31K7Q/
MX;UCP^FIZ#<FRU3_ (1OP[-:W^GZO;R:5<:5%(UCJ4#O:$Y7:6F]M+W>C!58
MJ=/W^:,7)MJ"BES)I622?:_X'P=_P<V7]AJ7[ 7PBN-.O;2_MS^UW\.V$]E<
MPW4)6Y^!_P =[VW82P/(A6>RNK6[A(;$MK<P7"%HIHW;\Y_^"HO_ "@X_P""
M5?\ W3#_ -4CXKK]0]/_ ."#%G>?\$_/#W[#7BS]I[4)_P"Q_P!IV7]IAOB%
MH?PJL[9(;R?X;:I\/6\#6GAV]\;3R3:?&=6N=;/B*[UK[9/<$V@TFUMO*6#Z
M'_:7_P""07AG]I#]BO\ 9@_8UOOCEKOA32_V:/\ A&OL'CRT\#:?JU_XM_X1
MSP9JG@Z/[9H,WB:QM](^U1:FU^_DZI?^5)"L"[U<RJ--W=MXK[[BC.G!4X\U
MU"K.3=G\+C9/YOIN>!_M46EI<?\ !N%X8AGMK>>%?V%_V.;M8IH8Y(UN[:Q^
M!]_;7(1U91<6]]%%>03 >9%=QQW$;+,BN/Q=^(7A?6O$'_!M3\"M6THZ@+'P
M/^UUJ_BCQ*+*.9[9M%N_%WQC\%P#5FB94BT__A(O%^@&.2Y#PG51ID2J+B2!
MT_J]^)G[#6D?$C_@GMIO[ <_Q$U'2=&T[X'_  F^"B_$N+PY;7>IRVGPJM/!
MEI;^(#X9?5H+5+C61X/B>?3QK+1V1OI%CNK@0*9?C?QM\(OV=?\ @E7_ ,$I
M_$7P4_:%T[XC?M-?L[VNIZUX2^(K^$/"^AZ-XMNM(^,_C*^>"^BTN]\<Z-9:
M5_8FOZSIEG8:S:>+[+5+'4VTS5--DAU"*%4;3]%RVOYBA425E=R==32MO%\R
MTOI?79GA7P&_;#_9ITC_ (((/J%_\0/!-A-X6_9/\>? K7/!7]KZ0GB6;XKW
M/A3Q%X(L_"C>&9)(+^76?&>LWUIKEK')9LEWHNM?\)'//+I0NM2'B/\ P:U?
M\D,_:K_[*QX&_P#4/OJ_-#P+^Q3_ ,$@6^ 7QD_:VT[]M#7O%6B^&?!?Q7MO
MAI^S9\6Y? /P_P#BU+\3+;PKKL'P[TC7- T+Q/=>)/&\L^NRZ1K&ACPWI.CZ
M+K2VIN-:F70['Q'80?K7_P &P'@^[TO]D7X[^-+G3YK:'Q;^T#+I.GWTKL$U
M*T\)^ /"3.UM S8\FTO_ !#>V[7:(%GN!<6QD=[%DB2OS1VT3V=].Y4U%4ZM
MN;6I%OFBXV;;=E?>UW=^A^_?[1G_ ";W\=_^R-?$_P#]0C7*_B3_ ."(/_!,
M7]FO_@H)X7_:!U[X^3_$=+KX6^)?AUIOAR#P-XIL/#EK<6GB;3_%5YJD>K+=
M>']8GN6:31;-('M;BR>&-IP"7='C_NB^(7A*/Q]X!\<>!)KY],B\:^$/$OA*
M74HX%NI-/C\1Z+>Z.]]';-+ MP]HMX9U@::%9FC$9EC#%Q^<O_!,;_@F-H'_
M  35T#XO:#H/Q>UCXLI\6=8\(:O<W.K^$++PDVB-X2LM?LXX(([/7]=%ZMZ-
M=>1WD>V,!ME55E$A*4U>2TNK.YC"IR4ZB4FI-QY;>5[Z]-#TK]CS_@F+^QQ^
MPSJNL>)_@+\-)K/QWKVGRZ-J7Q"\7Z_JOB_QA_84MPET^AZ9>ZI.=/\ #^F3
M3Q0/?1>'M,TJ76#:V7]MSZD;"Q-O_/UJ>EV6K_\ !UE':7\7G01:AI.J1IN9
M-M[HG_!/*RUK39<J03Y&HZ?:S[2=K^7L<%&8'^P2OR?_ .'5_A[_ (>C?\/-
MO^%R:U_;_P#T2+_A#;'^Q_\ DWC_ (9__P"1O_X2'[;_ ,>7_%3?\@'_ (^O
M^)9_JO\ 3:&MDEHFF$*EG4<Y-N5.44W=MMVLOZT/RD_X.G?#FOW7PU_8[\76
MQNO^$6T3QS\7O#FL!+,O9'7_ !3H'@;4_#1N-0SBUNAIW@_Q6+2S()OHFO9P
M0-..?T>_:R_:*_9\U#_@BAX^^)%EX@\,W?PZ^(O[(2> /AY90ZI'*9?'7BWP
M'!X,\(>%;*W8"_G\1^$/%]Q:?VOI#VJ:CH[^'-5EUBWL8-,U&6V_1/\ :K_9
M;^$O[9'P0\7? /XT:7>ZAX-\5I;3QWVD74>G^(O#.OZ9+]IT3Q3X9U*6WNX;
M'7-&NOWMLUS9WNGWD$EUIFK6&HZ1?W]A<_S8Z!_P:T:'#X]BD\5?MB:SJ?PF
MM-3-X-"T3X36VD^.=0L)A )].&NWWCK6/#NB:@RQI#)K\?AO6H[I+2&0Z#;&
M98K)-.[LK\RMZ%PE3<(*<G%TY.2LF^9-IVTV=U8]E_X-]/$>D_LZ?\$P/V@O
MC]\8=7?P]\*;7XT?$CX@B6[2)K9_#7A'X=?#W0=8U;3(Y+I5OM0UW7=&OO"U
MGI@BAN;[5=#M+*%[F2]MTC_EC^&?QB\&_#_]L?P=^V'?_ "$_L]V?[3NJ>-=
M,^&<-A=2>#[+2=,\2VGBZ3X>Z#J-\TVEWNN>!/#WB'P]?V&DW5U-:+,NAMJ5
MH-&O1#)_>3^UC_P3'\-?'[]D7X<?L2?"/XJ:E^S1\!_ EQI O_#_ (9\)Q^-
M;OQ;I/AS-YH.C:OJ.L^)])O6MU\12S>+M>O+J?4=1\2>)H['5-0NUGM[@WWF
M_BW_ ((O?L]^)O\ @GMX/_8*MM?OM%3P7XAM/B!IGQJMO#>F7'BV?XI2WMQ+
MXF\;7^CR7J172^)-'U#4?"LFCRZTRZ=X:_L73;?4)!X>TV1$XO1=E][W_K_@
ME1JP3G)WO4E9I7]V%FK^;VVU_7V__@H+\+?"W[=?_!-WXR:/\/+ZR\86'Q ^
M#MG\7O@[K6EK]K37-8\-6MA\3_ ,ND2JC31?\)2^E6FAO)&@G&GZY>6TD9$L
MT+?PSV7Q\\<?M8_LS?L'_P#!-SP\=0;6O"G[1WCW3+.:XADO;2YA^+7B'PK:
M?#.>$12PM)'X:U7QK\65U&*Z9VM=,N-/$%W8V,;1G^X3]F#X?_#'_@E!^S+H
M?P?_ &@?VP_".H_#S2/$/B*;X9>+?C))X=^$\VF:=>0_V]J'P\T2;5/%^I6_
MB>6UOCK&O:'HVGL==6#4-0LK&RO+"QMHK+^83_@BG\#O GQ]_P""N'Q3^,/P
M]T6;_A0WP+USXS?%KP FIVR1I;6/BKQ5J_A+X,:1=V\,$44&LVVB>))_$UC$
ML%M;V]QX-N9$\J2WM[:4DKN/1O1H=)J,:CU<8/GA)II7LXK=;NZNC^X3P)X,
MT'X<>!_!OP\\*VS67ACP'X4\/>#/#=FQ1FM-!\+Z19Z'H]LS1QQ1LT&GV-O$
M2D42$H2L:+A1^*/_  <4_"+7?BC_ ,$Y-7U[0K>ZNV^"?Q?^'_Q=U:VM/*9W
MT*'3_%?PWU.XEB<&66UTV+XD+JMW]F_>P6]C)=RD6=M=&OW8K'\0^']$\6:!
MKGA7Q-I5CKOAOQ+H^I^'_$&B:I;QW>FZSHFLV4^G:KI6HVDRM%=6.H6%S<6E
MW;RJT<]O-)$ZE6(JVKIKR.:,G&<9;M23]==?ONS\4_\ @B#^VC\&OB=^P!\*
M? VL_$/PCX;^(?[/N@WWP\\>>&_$GBC1M*U*PT/P[?WDGA7Q3%!J5U9W#^&-
M0\(SZ2G]JF%;&SU:RUC2&N)&TTSS>3_L[?\ !:+QM^TK_P %0?$O[(OP?^'O
M@+XF?LVWNL:U8^%/BSINJ:WHGB#1M#\!>"C>^,O'5Q?B/6]#\6^&-8\6:9J%
MGX.M8-(\/OJ%OK.@,?$+0W:RCYG^.G_!KW\/_%/Q!O\ 7_@%^TIJ/PL\!:QJ
M4UV? ?C3X?R_$*X\*6]Q*DK6?A_Q-:^-/#%YJ^G6@>:+3K+7K0ZE%;16T5_X
MCU*X::]/ZW?\$W?^"4WP-_X)QZ)XAOO"6MZQ\3OB[XVL;33/&/Q6\3:9I^D7
M#Z39S?:4\/>#_#]E+?CPGX;N+Q8=0U"QEUO7M1U._M[274=9NK?3]+M;"5S:
M+9+=]T;2=%<\DW*4[\L6FN1MW;;\GL?B'K_[2_\ P4!_X*K_ /!0GX]_L@?
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MGC#2K;Q RVVA:%_:MKIDTDWAS53XXTNYE$KZ%Y6JWD&G6.G_ +,U^6'[>/\
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MO_"]?^"P'_18_P#@I-_X<+]I_P#^6]'_  O7_@L!_P!%C_X*3?\ APOVG_\
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M>_\ "]?^"P'_ $6/_@I-_P"'"_:?_P#EO1_PO7_@L!_T6/\ X*3?^'"_:?\
M_EO1[1=G^ ?57_S\A]S_ ,S_ $PJ*_S/?^%Z_P#!8#_HL?\ P4F_\.%^T_\
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M*VC;[BI4*DK*5922V3O_ )G^F%17^9[_ ,+U_P""P'_18_\ @I-_X<+]I_\
M^6]'_"]?^"P'_18_^"DW_APOVG__ );T_:+L_P "?JK_ .?D/N?^9_IA45_F
M>_\ "]?^"P'_ $6/_@I-_P"'"_:?_P#EO1_PO7_@L!_T6/\ X*3?^'"_:?\
M_EO1[1=G^ ?57_S\A]S_ ,S_ $PJ*_S/?^%Z_P#!8#_HL?\ P4F_\.%^T_\
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M_P#_ "WH]HNS_ /JK_Y^0^Y_YG^F%17^9[_PO7_@L!_T6/\ X*3?^'"_:?\
M_EO1_P +U_X+ ?\ 18_^"DW_ (<+]I__ .6]'M%V?X!]5?\ S\A]S_S/],*B
MO\SW_A>O_!8#_HL?_!2;_P .%^T__P#+>C_A>O\ P6 _Z+'_ ,%)O_#A?M/_
M /RWH]HNS_ /JK_Y^0^Y_P"9_IA45_F>_P#"]?\ @L!_T6/_ (*3?^'"_:?_
M /EO1_PO7_@L!_T6/_@I-_X<+]I__P"6]'M%V?X!]5?_ #\A]S_S/],*BO\
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M_P#_ "WH]HNS_ /JK_Y^0^Y_YG^F%17^9[_PO7_@L!_T6/\ X*3?^'"_:?\
M_EO1_P +U_X+ ?\ 18_^"DW_ (<+]I__ .6]'M%V?X!]5?\ S\A]S_S/],*B
MO\SW_A>O_!8#_HL?_!2;_P .%^T__P#+>C_A>O\ P6 _Z+'_ ,%)O_#A?M/_
M /RWH]HNS_ /JK_Y^0^Y_P"9_IA45_F>_P#"]?\ @L!_T6/_ (*3?^'"_:?_
M /EO1_PO7_@L!_T6/_@I-_X<+]I__P"6]'M%V?X!]5?_ #\A]S_S/],*BO\
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M_P#_ "WH]HNS_ /JK_Y^0^Y_YG^F%17^9[_PO7_@L!_T6/\ X*3?^'"_:?\
M_EO1_P +U_X+ ?\ 18_^"DW_ (<+]I__ .6]'M%V?X!]5?\ S\A]S_S/],*B
MO\SW_A>O_!8#_HL?_!2;_P .%^T__P#+>C_A>O\ P6 _Z+'_ ,%)O_#A?M/_
M /RWH]HNS_ /JK_Y^0^Y_P"9_IA45_F>_P#"]?\ @L!_T6/_ (*3?^'"_:?_
M /EO1_PO7_@L!_T6/_@I-_X<+]I__P"6]'M%V?X!]5?_ #\A]S_S/],*BO\
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M_P#_ "WH]HNS_ /JK_Y^0^Y_YG^F%17^9[_PO7_@L!_T6/\ X*3?^'"_:?\
M_EO1_P +U_X+ ?\ 18_^"DW_ (<+]I__ .6]'M%V?X!]5?\ S\A]S_S/],*B
MO\SW_A>O_!8#_HL?_!2;_P .%^T__P#+>C_A>O\ P6 _Z+'_ ,%)O_#A?M/_
M /RWH]HNS_ /JK_Y^0^Y_P"9_IA45_F>_P#"]?\ @L!_T6/_ (*3?^'"_:?_
M /EO1_PO7_@L!_T6/_@I-_X<+]I__P"6]'M%V?X!]5?_ #\A]S_S/],*BO\
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M_P#_ "WH]HNS_ /JK_Y^0^Y_YG^F%17^9[_PO7_@L!_T6/\ X*3?^'"_:?\
M_EO1_P +U_X+ ?\ 18_^"DW_ (<+]I__ .6]'M%V?X!]5?\ S\A]S_S/],*B
MO\SW_A>O_!8#_HL?_!2;_P .%^T__P#+>C_A>O\ P6 _Z+'_ ,%)O_#A?M/_
M /RWH]HNS_ /JK_Y^0^Y_P"9_IA45_F>_P#"]?\ @L!_T6/_ (*3?^'"_:?_
M /EO1_PO7_@L!_T6/_@I-_X<+]I__P"6]'M%V?X!]5?_ #\A]S_S/],*BO\
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M"P'_ $6/_@I-_P"'"_:?_P#EO2YUV?X L-).ZJ136S7,G^9_4YH/_!!SX@?
M3Q%'<_L0_P#!3']IG]F[P;<:.D.N>$/$6A6'Q,75_$<EYJ+7NM/_ ,(IXO\
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M_F?TL?\ #%W_  <<_P#213]G7_P9ZQ_]"31_PQ=_P<<_])%/V=?_  9ZQ_\
M0DU_-/\ \+U_X+ ?]%C_ ."DW_APOVG_ /Y;T?\ "]?^"P'_ $6/_@I-_P"'
M"_:?_P#EO1>/:7_@0>SG_-0_\%+_ #/Z6/\ AB[_ (..?^DBG[.O_@SUC_Z$
MFC_AB[_@XY_Z2*?LZ_\ @SUC_P"A)K^:?_A>O_!8#_HL?_!2;_PX7[3_ /\
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MT?\ "]?^"P'_ $6/_@I-_P"'"_:?_P#EO1>/:7_@0>SG_-0_\%+_ #/Z6/\
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M=$MAFYUC76T'7+\:1I=N.9]0U V]I$.9)E% 6/9J*^7/^&XOV*O^CP/V7/\
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M?L;?&[]FC]JK_@J=\6OBEIOA^R\'?M8_M-:9\4O@_<:/XAM-8OK_ ,)VL_Q
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MAU+4="T7QUXE\36.D^.C=QO/H6H:#H.LZ?HM]JM\SPZSJ5A<W]LL<%PBJO\
M@@I1LKM75M5L[U+M?*UUY,\1_P""447_  3B\3>)OV M"_X<V?M:Z/\ 'RVT
MS]G_ %?_ (;#U;P7\1;;X/3?%_PGX;\.>)?^%\Q:]_PL Z"W@_7/&>C?\)EH
MM[_87]D75GJ%@?[*%E-]D'J_QR_X)2?\$^/"W_!=']BG]EG0/V:?"VF_ 'XF
M_LH?%KQ_XZ^&\7B3X@2:7XA\8>'D^*IT;6[G49_%TNO6]Q8G0=(,<-CJUK9R
M?8H_.MY-\OF?5O[(WA'_ (.0/@9HW[,7P'U[X<_L/P_L\_!W3/@M\(]:OHM:
M?4O'47P8^'UKX:\&ZC=QWL'C2*"_\6IX'TB:9+J'2HX;K6 )8]/1)!;#]!_C
M)^QM\;O&O_!9K]D+]MG0M-\/R_ GX-_LR_%#X6^-]3N/$-I;>(K;Q9XK3XF#
M2(-/\..IO-0LG/B?21/>Q.(X/-FW ^0^!KMW_P"')<FI/WM'&5K3<N]NUGV7
MW'T/^V1XB3]BC_@FO^T#K'[/^E6G@^+]FK]DGQAIGP6TJ&>]N;+P9;_#SX:S
MZ!\/(H)KZXN]1O;?PG#I^D20+>WLUW?)IJ1W5\99I+H?R_>"/^",7[)6O_\
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MB.Y>=XM0M+"X!-U)&X"N9*_-)2=I=;^Z^73;=ZM+I8_G2^*G[6VM^#?V:_\
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M9":4I-O[+VDW=^[HI6O?Y>1_&9J_A?Q!X3_X)(?LG7WQ,^%_Q.\1?LV^*/\
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MMM;7U];'[(?\$S'2/_@FS_P3[=V5$3]A[]E%W=V"HB+\!? 19F8D!54 EF)
M !).*_BG\'_M+>,=/_X*>^&/^"W=QXRTW_A17Q3_ ."E/C+]BZ]TLZE;>:?V
M=Y?AQX?^'?@SQ[+;+*J3^&;;X?)>ZH;I@NGR>,O JR07"W*-,_\ 8"GP._:<
M^'?_  2#\(?LR?"K3O#I_:O\)?L'?#7]GK1[>X\1V=IX=T;XHZ;\%_#?POUW
M5K7Q/*T=@]OX7OTU76])U!E>VOIM+LV^S7,=P+:7\/=:_P"#6_X"'_@G7'H>
MB^#K@?\ !1=?@OHFHR^,Y/BWXK7P%)\;8FT_7=<\/1Z=/=R^#O\ A'9W74/
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M]5U2'2'UWP.;G4C<WXM-2\#ZMIAMG\ 6$EO\7^"_V2_^"]?['_[3'[?/C/\
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M4CL]%L/$FNZNTWB35XHY]+T?3["2RM[J_O;>$Q@LK+^\W_!:S]D7XR_MQ_\
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MF^&-MXPU[2?"'BKQ-\8/!GPH^(,WCZ4^"M5T1)K:\E\>ZS+JK:9?*OB--+\
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MB[X!?MF^,)?BAX@\!_'+4;QM9^#?Q1U>.\N/$OB?08M6U'3+.[DDUS6=9O\
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MAM=<NK[X>^*/%GC76-)N]<MK:-&T34Y++7;!IM,N"\\$C2QNV8R3\)_LT_\
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M]E;_ (*Q_M=>#_V!/$O[87A']GS2_C!^S'_P59^#W[1'BJT^%7B2'2_#%O\
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M_P!..LU@_!/]@K_@JA^UG^V5^S#^U)_P55\9_L\^&/ '[&NI>(_''P=^"OP
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MWXCUC1+""ZTNY\PWDK0&&YCAGC^ZO^#93_E$'\"?^Q\^.W_JW/%=,_9PO/\
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M-?B5#X5B$?C;Q5XSU73+*[\>S?"C9H\6J:7I5UJVC:;=:%H42Z1K=]=_(O\
MP3$N/^"=]Y^S-\,M _:$_P"".W[6?[6GQ1U+Q?XHT[6?VB/AEX+^(6J_#C6+
M+4?&M_;Z-!'J_A_Q[H6E[?"&ES6VD:TT.EQ/;7&G7*S--*C2-_HL^)O"EO)\
M._%7@_PKIFF:4FH^%O$NDZ1IMC;VVEZ9#>:QIU_&BK#;116UM'/?7;37$B1
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MQ?T T&M2IS1BEUUEZ]OU^X****#$**** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !52#3["UN;V]MK*TM[S4Y()=1NX+:&&YU"6VMX[
M2VDO9XT66[DM[6**V@>=Y&BMXXX8RL:*HMT4 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M;W?;<ONGI?\ $=/$?_6[_7CZYPK_ *Q?V'_JY[;_ (AGX6?V7_97UGZW[/\
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MU;42=4G*W5M&"+C/F#S/]DW]D;XW?L\^,O$GB7XH?ML?&3]IS2=;\,G0M/\
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M@98G#Q;2Y(8:O0A26E*%.+:?C8/Q7XUP/#7$?".&Q.01R/BO&YMF&=4JO _
M.)S&IBL[K0Q&82R_/L5P;B.(<CHSJTXO"X7(,ZR;"9;#FI99AL!1G.E+\N?C
MK^P5^TE\6/BSXS^(7@O_ (*/?M"?!GPOXFOK.[TCX8^$-/N)O#?A*&VTJPT^
M6STJ1/'.EJ\-U=6<^IRD6%L!<WTPV-CS'^G/%O[/_P 3/$/[*=K^S]I?[2OQ
M%\,?$VW\,^"M#E_:6TVWD;XBW.H^&->T'5]8\0R6XUZWD%_XNL=)O=%U5?[>
M8I9ZU>$S7(4PR_55%54SO,:L,#3G/"N.75*57"\N6Y9!QG0A&%-UIT\OA/%Q
M481YH8R6*A4=Y585)2E*71C_ !AX[S+"<'8'%XKAR6&X"QN69APTJ' 'AU@Z
MM'%91A</@\#+-L3@N",)BN**,:&&HK$83BO$<1X/'U%/$9AAL;B:U>O5_-_]
MF?\ 8G_:!^!OQ3L?'WQ$_;]^.G[0OAJUT?6=-F^&WCZQG@\.WEWJ=L(+3599
M'\9:THNM)D!N+4&P?+DXDC/S5C_M"_L*_M%_&3XP>+_B1X#_ ."B7Q^^!7A3
MQ'_8']E?"OP383S^&/"W]C^%]$T&^_LR5/&VD*W]MZEI=YXCO<:=;[=0U>[4
M^:09Y?TXHK5<0YHL;+,%/!_6I8=85R_LG*'1]BI\Z2PKRQX15.9?QEAE7:]U
MUG'W3T8>.OB/#BVKQQ'&<*_ZQ5\CAPY4K/PS\+)96\JIXJ.,A3CPW+P\EPO3
MQOMXIRS>EP_3SF=.^'GFDL.W0?RK>?L__$RY_933]GZ+]I7XBVOQ-7PS8Z&?
MVEXK>0_$5]1M=>M]7F\0FW.NB3[?>6,,FB3+_;V19SNPG('E'Y__ &;_ -A_
M]H7X)_%G1/B%\0/^"@OQY^/WA?2K'6[2\^&/CJPG@\-ZQ-JNDW6GV=Y=R2>,
M]943:/=7$6IV@^P2$W-M& \6=X_2JBL:>=9A3H8S#0GAE2Q]2M5Q*EEV6SG*
M==6JNC6G@)UL+%KX(82KAH4GK2A3>IY6"\6^.,OR;BS(<+B>'HY9QMC<US#B
M&%;@/P^Q6+K8K.J;I9A+*\TQ?!>)S;ARC.#:PN$X8S+(,'ETO?RS#8":4U^:
MO[2'[#_[0OQL^+.M_$+X?_\ !07X\_ 'POJMCHEI9_#'P+83S^&]'FTK2;73
M[R\M)(_&>C*9M8NK>74[L?8(R+FYD!>7&\^Y:'^SK\4M*_9,G_9XO?VH?B5K
M/Q0ET?Q#IJ?M.WEM*/B1#=ZSXQU/Q)8:JEM_PD$DGVK0M)OK?PK8C^WQNTS3
MK=O,B4_9D^N**<\ZS"IA\'A9SPOL<#4H5<,HY=ED)QGADU2=6M# 1KXF*3]^
M&*JXBG6WK0JNS*QGB]QSC\DX5X=Q.*X=EE7!F.R;,L@A2X"\/,+C*6+R&$J>
M6RS/-L+P3A\XXBHPA)_6\'Q+F>>X+-)6GFV%S&<8R7YC_L]?L*_M%_!OXP>$
M/B1X\_X*)?'[XZ^%/#G]O_VK\*_&UA/!X8\4_P!L>%];T&Q_M.5_&VKJO]B:
MEJEGXCLLZ=<;M0TBT4>42)XMC]IC]B?]H'XY?%.^\??#O]OWXZ?L]>&KK1]&
MTV'X;> ;&>?P[9W>F6S07>JQ2)XRT53=:M(1<70%@F' S)(?FK](**U?$.:/
M&QS!SP?UJ.'>%4O[)RA4?8N?.T\*LL6$=3F?\9X9UTO=591]T].?CKXCSXMI
M<<2QG"O^L5#(Y\.4ZR\,_"R.5K*JF*EC)TY<-Q\/(\+U,;[>3<<WJ\/U,YA3
MMAX9I'#I4%\C^!_V=?BEX5_9;U[X":S^U#\2O&/Q)U?1_&.FV7[2&KVTJ?$+
M1;OQ+>7MSI.JV=N?$%U(;KPI%=0VNE@:Y%NBLX2)+?.U?G'X%?L%?M)?"?XL
M^#/B%XT_X*/?M"?&;POX9OKR[U?X8^+]/N(?#?BV&YTJ_P!/BL]5D?QSJBI#
M:W5Y!J<1-A<@W-C"-BY\Q/U&HK.&>9C3ACH0GA>7,9U:F+YLMRN;E.M3=.I[
M&4\OE+"1<)-1A@Y86%.5ITXPFE-<.#\8^/,!A>,L'AL5PW&AQ[C,PQ_$JJ^'
MWAQBJE;$YI@JN7XR64XC%\#8G$\+TI86M.-#"\)U^',)@JSCBL#A\'BZ=/$P
M_/O]J[]CSXZ?M!_$31O&?PQ_;D^-/[,V@Z9X+T[PQ=^ _AS937.B:MJ]EKGB
M/5;CQ==/'XMT%1JM_9:UI^C3H;.0BTT&Q/VEPPBA],^%G[.OQ2\ ?LU>-O@?
MXE_:A^)7Q)^(?BC1_B!INC_M!>(K:6/QYX0N_&&C7&F:%JNE0-X@OW>Z\#W<
MT>K:*%UJUWW4" 26A/FCZXHJ)9QCYX/#8&4\-]6PE2C5H)9?ET:JG0J2J4G4
MQ,<#'%5XJ<GSPQ&(K0JQM"K"I!*"Y*_BOQKB>%N'^#:V)R!Y!POC<JS#)Z4.
M!N :.94\5DN,JX_+Y8[B&AP;2XDSJC#$UZDL5A<\SW-\)F-%QPN9X;'X2G2P
MU/\ *OX-_L ?M,?#3XH^"/'OBW_@I5^T3\6/#?A;7+?5=8^''BG3KB+P]XPL
MH4D631M6D;QWJ*I:3EU=R;&Z&8US$W;U[]K+]D;XW?M#>,O#?B7X7_ML?&3]
MF/2=$\,_V%J'A/X;V<MSI?B#4?[5O[__ (2*_>/Q5H 74#;7D&F[3;SG[/8P
MGSN=B_>U%;3X@S2>,I8^4\']9H4:E"G)95E$:*IU'>:EA8Y;'"5)M_#5JX:I
M5AM"I!:'KXGQR\1L7Q9EG&U?&<+/B')\JQN2X&M3\-/"[#Y7'+\PFZF*AB>&
M\/X>T.&,?B92;]CF.8Y!CLRPJM'"8_#02BODOX(_L\?%'X6? +QG\(?&/[3W
MQ)^,/CCQ-_PF?]D?&[Q;;21>,_"7_"3:#;Z1I']E0OKVIN__  B5]#)K>E?\
M36WWWL[J/LW^M/RK\)O^"?'[3GP\^)G@;QSXH_X*9_M'?$[P[X4\3:5KNM?#
MWQ)IUQ'H/C+3M/NDGNO#NKR/X\U!4T_4XD:VN6-E= 1NQ\E^E?J]14T\]S*D
M\<X3PB>8RE/%\V695/FE.E*C+V*GETUA%[.32C@UA8QE:I&*J1C-<V!\9^/\
MNJ<95,+B^&8SX^Q%?%<3>V\//#7%QK5L3EU?*JKRF&,X$Q4.%Z;P6(JQA1X3
MCPY0HXAPQU&C2Q]*CC*7PG^UK^R=\:OVB/$OA/7/A=^V?\7_ -F'3O#VAW>E
M:IX?^&UI-<V'B>]N+]KR+6=2:/Q3H 6[M8"+*(&"<F$ ^:HP@[3]GC]G7XI?
M!KX+>._AAX\_:A^)7QW\7^+-8\3ZEHOQ<\;VTL'BKP9::[X4T3P]INE:1$_B
M#5W>U\.ZGI=YXFT\KJ=INU+6+M1' 0;B7ZXHK*6;XZ6!I9<Y8?ZI0G3J4XK
M9>JRE2JRK0YL7'!+&5$ISDY1JXJI"<;4ZD9TXQA'S:WBEQE7X-RS@&KB,A?#
M.3XO 8W T8<%<"TLVCB,MS"OFF$>)XHI<(4^+,?2CC,36E7PV8\1X["XR@X8
M+&X?%X&C0P=+\D_AO_P3N_:C\$_$3P%XS\0?\%/_ -I/Q_H/A'QIX6\3ZWX#
MUW3;B/1/&VD:!KECJNI>$=9=O']ZJ:5XDLK2;1M1<V=V%M+V8FVG \I_H[]K
MG]ECXQ_M%:GX(OOA9^V'\6OV7;?PM8ZY::SI_P -+26Y@\83:K<:;-9WFK&/
MQ/X?"3:.EC<06@,=R2FH3_/%C:_V]16]3B#-*N+P^.G/!O$X6G5I47'*LHA2
M4*W\15,-3RV&%K2=_=G7P]:=/_EW.![>.\<O$;,N*<CXRQ>,X6EG_#F!S'+L
MJJT?#3PNP>6T\+FCD\9'&\/8+P]PO#>;UI.3]AB\YR+-,9@M%@,5@THI?(_[
M,/[.OQ2^!'P[\:^#/B/^U#\2OVB]>\4:Q=ZEH_CSX@6TMOKGA&TN=#M-*BTK
M2DD\0:VSVMK>V\NLQ%;RUS=W4H\M2/-;X]\%?\$X_P!JGPQXR\)>)=8_X*E_
MM,^+M)\/>)M!US5/">JZ;<II?B?3M)U6UO[WP]J3GXA7(6PUJVMY=-O&-O<!
M;>YD)AEQY;?KU12IY_F=*KC:T)X15,P:>*<LKRF<9-4Y4E[&G4RV=/"^Y)IK
M"0PR<K5&G4C&:SP'C;XAY9F/%V:X3%\+QQO'$Z=3B*5?PX\,<9AZTJ6 KY9#
M^R\#C> ,7@.&DL'B*L91X7P?#\)UW#&3C/'4J.+I?%_[7O[,?Q=_:-_X5[_P
MJO\ :V^*G[+7_"&_\)9_;W_"L[66Y_X3K_A(?^$9_LO^V_+\2>'MG_",?V'J
M/]F[OM>[_A(;_'V?:?/V/V2?V=?BE^SMH'C#2/BC^U#\2OVG[[Q)K&GZEI6M
M_$JVEMKWPK:6=E+:SZ5IBR>(/$&ZUOIG6[F(EML2QJ#&_##ZXHK!YMC7ERRM
MRP_U.+YE'ZC@%7NJLJVN-6#6/:]I)NSQC7+:G;V:5->)/Q,XOJ<"4O#>>(R/
M_5.C5C6IT(\&\$0SI5(YE5S9.7%\.$X\:5(_7J]23IU.*9TWAW' NF\OITL%
M3_'?P]_P39_:OT;7]#U>_P#^"K'[3VNV.E:QIFI7NB7VF7*V6LVEC>P75QI5
MXW_"Q)<6NHPQ/:7!\J3$4SGRW^Z?L;]KG]FWXK_M%Z;X(L?A9^U5\3_V7;CP
MM?:Y=ZSJ'PTM9+F?QC#JMOIL-E9ZL(_$/A\I#HSV-Q/:$R7(+ZA<?)'C<_V%
M1715X@S2OBL+C*D\&Z^#514''*LHITU[5<L_:8>EEM/#8BZ^%XBA7=-ZT^1Z
MGOYGXY>(V<<1\.\5X_&<+2SKA6.80R6IAO#3PNR_ 4XYG3=+&?7\CR[P]P.0
MYXY0;5"6?9/G$L%*T\#+"5$IKX]_9&_9M^*_[.FF^-['XI_M5?$_]J*X\4WV
MAW>C:A\2[62VG\'0Z5;ZE#>V>DB3Q#X@+PZR]];SW9$EL ^GV_R29W)\>_\
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M+EE7]ERK/$.#X97AZN%I8SVK;6;2X>EG"A^Z69JBE27R/H?[.OQ2TK]DR?\
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M+EL,'FLXSQL<7P_A/#S#<.9I7E**^KXW-LCS+'X%7C@,9@XMQ?RK^S)^S_\
M$SX%_"GQ5\/OB+^TK\1?VB/$^O\ B;7-<TSXF>/[>2W\1^&M.U7PWH&B67A[
M3HWU[6F:PT;4-(OM?M&%_ #?:W>J(8BIFE^+_!7_  3C_:I\,>,O"7B76/\
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M^UK_ .M_^JG^N?)]=][V7^M/LOJ_^P^S^H?[&?COXA_X)L_M7ZSK^N:O8?\
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M7P(\7^$]8\,:EK7Q<\$6TL_BKQG::%X4UOP]J6E:Q$GB#2'2U\1:GJEGXFU
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MEC:$)X54\PG6J8I2R[+)RE/$1<*OL:E3 3JX2+C)\D,'4PT*3M*E&G)*2\W
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MXRMY(?%OAV/Q!HUKIFF6VGQ-KNJNT?AF[MY=6TXC5("UU<R "WQYA^/?AO\
M\$[OVH_!/Q$\!>,_$'_!3_\ :3\?Z#X1\:>%O$^M^ ]=TVXCT3QMI&@:Y8ZK
MJ7A'67;Q_>JFE>)+*TFT;47-G=A;2]F)MIP/*?\ 6RBHI9[F5&6.G3GA%+,9
M2EBN;+,JJ*4I4YT7[&-3+IQPBY)R2C@XX6*E:HDJD8SCRY=XT<?Y5B.,<5@L
M7PS&MQY7K8GB5XCP[\-<=3K5:^7XK*ZCRFAC^ \90X8@\'C*\84>%*/#M&E7
M=/&TJ5/'8?#8NA\)_M:_LG?&K]HCQ+X3USX7?MG_ !?_ &8=.\/:'=Z5JGA_
MX;6DUS8>)[VXOVO(M9U)H_%.@!;NU@(LH@8)R80#YJC"#T+]F3]G_P")GP+^
M%/BKX??$7]I7XB_M$>)]?\3:YKFF?$SQ_;R6_B/PUIVJ^&] T2R\/:=&^O:T
MS6&C:AI%]K]HPOX ;[6[U1#$5,TOU516,\VQT\!2RV4L/]4HRA.$5@,OC74J
M=2=6'-C(X*.-J+GG)RC4Q<XSC:$XRA&,(^7B?$_C#%\%9?X?5\1D3X7RO$8/
M%8.A3X+X'H9Q&M@,=BLQPSK\5X?A*AQ?C:<<5C*\JM''<38NABJ+IX3%T<3@
M\/AL+0_(7P5_P3C_ &J?#'C+PEXEUC_@J7^TSXNTGP]XFT'7-4\)ZKIMRFE^
M)].TG5;6_O?#VI.?B%<A;#6K:WETV\8V]P%M[F0F&7'EM].?M<_LL?&/]HK4
M_!%]\+/VP_BU^R[;^%K'7+36=/\ AI:2W,'C";5;C39K.\U8Q^)_#X2;1TL;
MB"T!CN24U"?YXL;7^WJ*Z:G$.:5<7A\;.>#>(PL*M.BXY3E$*2C65JGM,-3R
MR&&KM_9E7P]:=/\ Y=2IGOX_QU\1\RXFR+B[%XSA66><-X3,L%E-6AX9^%F#
MRZGA\VCRXY8W(<%X>87A[-ZLDO\ 9\3G629KBL"]<OQ&"EJ?(_[)/[.OQ2_9
MVT#QAI'Q1_:A^)7[3]]XDUC3]2TK6_B5;2VU[X5M+.REM9]*TQ9/$'B#=:WT
MSK=S$2VV)8U!C?AA\6^&_P#@FO\ M8:)KF@:KJ'_  59_:>U^RTC5M+U"^T6
M^TR\%EK5K87D%S<Z7>,_Q'N7%KJ,43VEPSK.PBF<L)3D-^Q5%*EQ!F=&OC,1
M">#57'\GUERRK**D)>SIRIQ]E2J9;.CA?<D^;ZK2P_/*TY\TXQDL\O\ ''Q%
MRO-^*L\P>+X6CF/&CPCX@G7\-?"_&X6K]1P=? 8;^S,LQWA_C,KX=MAL15C5
M_P!6LOR'ZS6<,5BOK&+I4<32****\4_) HHHH **** "BBO\Q3_@X:^-OQG\
M(?\ !83]KWP[X3^+OQ/\+^']/_X4#]@T+P[X^\5Z+H]C]K_9>^"E]=?8],TW
M5K:RMOM-[<W-Y<>3 GG75Q/<2;II9'8+A#G=KVTOM?M_F?Z==%?Y+G[ /[/O
M_!17_@I-\5?%'PB_9Q^./CL:_P"#/ MW\0?$FL^/?C?\1?#7A73-#MM;T7P_
M#;RZM92ZY,^L:EJ.NVPTS3(K%YKNVM-4NPR6VFW4B?,_QQ\6_MB?L[_&/XH?
M GXG_&KXR:5\0?A%XZ\2_#[Q?96OQ9\=W5BNN>%M5N=)O+C2[UM8@&HZ/?/;
M?;M&U-(DAU/2[FSOX%\FX2@T]CJUSJZ5VK.]G\S_ &.Z*_S3/^#;GXT?&+QG
M_P %9?@AH'C#XL?$OQ7H5SX'^-\MQHOB7QWXIUW2;B6U^%'BF>VEGT[5-5NK
M.62WG1)H'DA9HI462,JZ@C_2SH,YPY':]]$^VX45^:G[;/\ P5N_8?\ ^">W
MCWPG\-?VHOB+XD\&^+?&WA$>.?#UCHOPY\;>,H+KPX=9U/0/M<M]X7T;4[2U
MF_M/2+Z'[)<2QW&R-9O+\J1&.E^QI_P5D_8&_;Y\1ZGX(_9D^/6G>,/B%HVC
MW'B#4OA[K_A;QKX!\8)HEK>+9W&J:;IGCCP]H,7B2RM6EM)=0G\+7>N)I,-_
M8_VN;"6X6(!/+*U[.W>SM]Y^C-%%% @HHHH **** "BBB@ HKY!\9?MT?LX^
M OVR/A/^P7XE\6:O9_M+?&OP!J7Q-^'OA&'PGXCO-'U3P?I5C\2M1O;^Z\76
MVGR>&]+N([3X2>.'6PU#4;>\D;3K9$B9]1L1-]?4!9KYZKS7<**** "BBB@
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M;^'[/2[[7/#JZO:>9IU_>Z1#K.GQZBVFW-Y;6EY+-ITTZ:A9WMK;@'J%%%%
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MZG#Y5G!=%Q;WMK))]?? #X[?#;]IOX-?#[X]_!_5[O7OAG\4-!C\2^#M8O\
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MK02Q_,?[*7B_]E']J?\ X.+_ -F7XF_\$KO@Y-\-/V>_AQ\*_$VJ?&6?P?\
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MT=KK]\=+T^T\266@:/K=W';>)+)@?U^9JU%R=TKJ<DO/W;J^NNOIVN?TE_\
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M5(/%6JZ==RZ/H@$8QOJH_9YEH[-IWM[R26U[7=]$?U.?\%#?^"J/_!270_\
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M;4)=1NKJ1([VV!0ORQL[6J-MWM96COJM-^YZ=J'[8WC77/V#_P#@W!\6>*O
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M"_BK5= UC3]$UFVOO&/AR[O(=%U:[M8=,U19CIEI.YLYKA@MJ&4JF_<E^O\
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MJ!U'P=K/Q L],\2>/_ =MIMW+X;TFVFL=)US0&MXX%O_ .@3_@NQH&N^*/\
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M+^PK_P %%?\ @ISH/_!5%O\ @G=_P4@\._ ^;5?BE\'M1^,'@>7X.:<+.Q\
MM;Z!?^*[/2-/UF"\NV\0:%]BT'Q3X:U6WUY]6U>U\1:5;76G^*M2TH-+JGYT
M_MX_"SXDZS_P3,_X-Z-!T[X<^.-5U;PIXK^#1\7Z-9>$->OM1\-0P^%O!,5R
M?$FG0:?+<Z-'$T<L<_\ :<-LJ&.1),%6 _1?XF^"/&<W_!TM^SQXYA\(^)Y?
M!-I^Q;K>FW7C&/0-5?PM;:BWA#XYQKI]QXA6T.DPWK27-NBVLEVLY>XA41[I
M8PQ_7XB?*T_=BKJIMNN5^[U_X?T/S?\ V:/^"D'QQ^ G_!(7_@HC^T_\$/ _
M[/OPD^)WPQ_;G\+^!M$'P^^"_AGPQX6U73_$FH?#?1=7U?Q5X:TTPV7B#Q+<
MZ;J]U;'7+P_:E1+8<BW0#V)O^"P__!7_ .!GQ$_8!^/W[5'PQ^ .D_L8_MW^
M(O 6F>$_!7A:T;4_&V@^!O%O_"(M#XGUGQ#974.JZ9X[U+PKXNL?B%H]@]K=
M^']4ABN]&F\/>&[F.:RL/SA\"?!_XMQ_\$&O^"H?A:3X7?$6/Q/KG_!0KX?:
MQHGAQ_!/B9=>UC28?$7PH>75-*TAM,&H:AIT203/)>VEO-;(L,K-*!&Y'Z;_
M /!7_P"'7Q!\1_L;?\$&-.\/>!/&6NZAX5\6_L[2>)['1O#&MZI>>'$M/A9\
M*X+I]>M;&QGGT=+:>WGAN&U!+<0RPS1R%7C<*ET]/\AVC>S2=Y25WT2A%JVO
M<]P_;'_X*C?\%(/B[^WA^T#^R#_P3'L?@1X9\/\ [&_@\:O\7/&OQL&D17_Q
M&\=):6=W?>"/"Q\37JVJ2&_N7\)^&=)T[2+6]U76M&\1:SJ7BRQT";2&AH>,
MO^#ASQIJW_!);X,_M1?"_P"'7@]OVS_CA\:+K]E73O EY;:G/\,_#WQ>T."U
MU/Q/XRM$O];LYI?#TWA36?"&L^'-#USQ.C:9K_CC2]-UB_\ $.C>'-:OK_\
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M0!L=;T>Y*^7>Z;=@P74):*0%6-?V,?LNZ!\4?"G[,W[.OA?XX:M+KWQJ\-_
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MZ!X1>:W\#>.DT'3;:VT?2_%'A6YUG3[1$C2RB_-C]D#]M/\ X)<_LG?M3?\
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M37PKO3I'A;0]3\0:F+.#PO\ $I)[LV&DVMW="VA>:%99S%Y4;2QJ[J74$?\
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MHU;P7J_A7Q%X235)=7LM$OYOB78>+;;1=<\.1ZW8ZCK'ACQ!;^/_ +''PO\
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M]9);?"S3M<-EIVO^.H#!XSLH#K"QV4%[K'Z3T$M-.S\OQ5_R84444""BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K^37_@IC
M_P &UOCO]O[]MSXU_M;Z-^UEX2^&>F_%G_A6_P!F\$:G\)M8\37VB?\ "!_"
M3P%\,YO/URU\=:-;WO\ :5QX,EU>+R]-MOLT-_':-YSV[3R_UE44%1DXN\79
MVMT?YG\(_P#Q!S_$[_H^WP'_ .&(\0__ #SJ/^(.?XG?]'V^ _\ PQ'B'_YY
MU?W*^&_&/A'QBFM2>$/%/ASQ5'X;\1ZQX.\12>&]<TS7$T#Q=X=G%KX@\+:T
MVF75TNE>(]"NF6VUC0[XP:GID["&]M8)"%K=N+B"T@GNKJ>&VM;:&2XN;FXD
M2&"W@A1I)IYYI&6.*&*-6DDDD94C169F"@F@KVM3^;\%_D?RM_\ !+7_ (-R
M/''_  3L_;+\ ?M4:W^U3X4^*6G>"_#_ (_T27P;I7PJU?PK>W[^-/!VK^%H
MKB/6;OQOK<%NNGR:FMY)&VGRFX2%H5>)G$B_U55\N?\ #<7[%7_1X'[+G_B0
M'PG_ /FMKZ T?QCX1\0ZIK6AZ!XI\.:YK7AR'1;CQ#I&CZYIFIZIH,'B2Q;5
M/#L^M:?974]WI<.O:8K:CHLE]# FJ6*M=V+3VX,E&A,G*3O+5VMM;3[D='11
M37=(U9W941%9W=V"JB*"69F) 55 )9B0  23B@D=17+6WCGP5>^)U\$V?C#P
MM=^,G\+6GCE/"5MX@TF?Q._@J_U";2;'Q@N@Q7;ZJWA:]U6VN-,M/$ M#I-S
MJ$$UE#=O<Q/&O4T ?DU_P4N_X)K:[^WW\2/V&O'FC?%G2/AI#^R#\=XOC'J>
MFZGX2O/$TOCFUCU[X>ZS_8-A<VNNZ,FAW!3P3-!]ON(M2C#:A')]E(MV67]9
M:**!W;2717M\W=_B%%9>N:YHGAC1-8\2^)=8TOP]X<\/:7J&N:_K^N:A::3H
MFAZ)I-I-?ZKK&L:K?S6]CIFEZ98V\][J&H7L\%I96D$US<S1PQNZ\3X!^,_P
M>^*W@%?BM\+OBQ\-?B3\+FCUB5?B3X!\=^%_&/@%HO#TUS;Z_(OC'P[JNH^'
M3'H<]G=P:PXU$KILUK<QWI@>"55!'I5%?/\ X2_:Q_98\?>(=-\)>!/VEOV?
M_&OBO69C;Z1X9\)?&7X=>(_$.JSJC2M!INBZ/XCO-2OIEC1Y#':VTKA$9RNU
M21["GBSPM)XIG\#)XE\/OXVM?#]IXLNO!Z:SIS>*;;PM?ZC>Z/8^)9_#XN3J
MT/A^]U;3=1TNTUF2T73KG4;"]LH;E[FUGBC -^BBB@ HJM=7MG8I%)>W=M9Q
MSW-K90R74\5NDUY?3QVME:1-,Z+)<WEU+%;6L"$RW$\D<,2/(ZJ;- !1110
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MG2/$=_\ #;XC?$_PQJO@3QO:Z7=QW,WAKQ;IUKX4M+B]T'540VNHV\-S!))
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M*L$:>0C<?I>BB@-]>X4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M3X/B?\'M%^)ECHOP U+0?!4<GQ2^!?CRU\0_$&75/$WBS7?A/J?B^#X/^/\
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M>-O"/BC6+.VURPTZ:\TS7+71YDN=-MC=W]NR7RMK9*\KVVW?+?Y6OY'XC?\
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MS:]>>)]+MXK=_#ZRZ!!\,]NA2R37%RYU.WN/LITR)KOQG]DS_@B)^U]\%O\
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MA_X*"ZI\3_VVO&7[#?[)GP1^+'[&O_!.OQ7K?@_]H7QU\1_$7B.V^(OC;4/
M)OW^*&H?#-]"\::-I>G:/X5MM$\0:FUZ_A+QY$/"FG6GBR21SJ]MX?B3PY_P
M2?\ VN]-_P""5_\ P2C_ &3KO0/ H^,O[(O_  4)\)_M%_&*S7QOIDFB:;\,
M-*^,/[2GC34+K0-?$/V?7-5_L7XF>$)ET>T5)YKF2Z@SOL')XSXZ_P#!,C_@
MJU\)/&W_  42^!O[#-_^SAXE_9$_X*<^-O%WC?QIXA^*.L:AX7\8_ *^^,O]
MM6?Q>TK1=(TI1;R:/?:)K.I>%8;C2_#_ (WN'\*KX8N-+TS1]?T_5!* ^1R;
M]V]WNVDUSK7UY;M=^QSGBG]LGX5^-O\ @M5^R7^WAI_V^+X1W'_!"[QC^T?J
M%HS6S:SI'AG0=>_:7\;^)]!NV>2"R.N^'4TS5=#U#]^ED-6TZX"W'V<"8_"?
M[6?[:?\ P4!_;=\._P#!*+XZ?M*?L\? _P"%/[-'Q?\ ^"C/P>\:_LYZY\,_
M$GB;4/'NGVOA_P ;7?AJ+P[\5;'Q!K6JV>IS^*-+N[S6O"_B70].\(1W5MX6
MU6>^\+V,>L:5'!^M5I_P1,\>Z'^U;^SWH>GWVF7_ .R;X$_X(^>-/^">_P 0
MOB#+KELOC6]\?>/S\=+'Q;X@TWP9/(+M[#4Q\4EUZU"7D=E8->/I,4B16 :O
MB?1?^"67_!9[Q!X&_8)_9D^*FA?LMS?L^?\ !/7]K+X<^.?"/B?PCXTNK7QU
M\4O >E^+[K7KGQC?"^EDL5M/ FA+J.A:9HEQH7@[Q3K4GB:S:]T[6)=)N]:<
M&G#1W6BMJ]4K5-O.[5_)G]HE%%%!@%%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %?B#_P<>?\ *&/]LG_NWG_UJOX&U^WU?F7_ ,%B_P!EOXL_MI?\$XOV
MB_V:/@;8Z+J7Q2^)7_"HO^$7LO$6M6_AW1YO^$.^.WPP\?ZW]LUB[1[>S\OP
M[X5U>6W\Q3]HNHX+5,/.I 5'246]E)?F?SQ_\$A[S_@C3:_$#X)>// ?_!/+
M]L?X-_M*?!#]G_5?C)XI_:9^)D7Q2M/@R^M^!/A')+\5/%>B"X_:6\7>'=2M
MO%=I=^)+OPGI\OPSM].NK:_@:UTW1)([6.V]Q\+?\%[?V^-.\(?#G]O'XO\
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MI:/XCUFVU&\TS2Q;>&](UK41-=VVDZC*DILQ;HMJXEF1FC5P-]CZ$HK\??\
MA_K_ ,$@_P#H]GP'_P"$9\7/_G>4?\/]?^"0?_1[/@/_ ,(SXN?_ #O*5UW*
MY9?RR^Y_Y'[!45^/O_#_ %_X)!_]'L^ _P#PC/BY_P#.\H_X?Z_\$@_^CV?
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M]G^)/#^L:5+]JL+?S)K&26#S;9X9I/8*9(4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%?!W[47_!3G]A+]BWQ_H_PM_:?_ &B/#/PD\?:_X/T_
MQ_I'AO6?#_CK5;J]\'ZIK7B#P[8:W'<>&/"NN6"6]SK7A7Q!8+#-=QWBR:;+
M));I#);RS TF]DWZ:GWC17X^_P##_7_@D'_T>SX#_P#",^+G_P [RC_A_K_P
M2#_Z/9\!_P#A&?%S_P"=Y2NNX^67\LON?^1^P5%?C[_P_P!?^"0?_1[/@/\
M\(SXN?\ SO*]W_9R_P""K?\ P3X_:W^)MG\&_P!G3]I;PM\4/B9J&DZOKMGX
M4TGPW\0--O)])T&W6ZU:]%UXB\(Z/IBQV4#+)(DEZLK@A88Y&^6G="Y9?RO[
MG_D?H71110(***^;OVHOVO/V<?V+? &C_%+]I_XI:1\)/ .O^,-/\ :1XDUG
M3/$>JVM[XPU31?$'B*PT2.W\,:-KE^EQ<Z+X5\07ZS36D=FL>FRQR7"326\4
MP&^VI](T5^/O_#_7_@D'_P!'L^ __",^+G_SO*/^'^O_  2#_P"CV? ?_A&?
M%S_YWE*Z[E<LOY9?<_\ (_8*BOQ]_P"'^O\ P2#_ .CV? ?_ (1GQ<_^=Y5W
M3?\ @O)_P20UC4;#2=-_;2\"W6HZI>VNG6%JG@[XLH]S>WL\=M:P*\OP_2-6
MFGECC5I'1%+ NRJ"077<.67\LON?^1^NM%%%,D**** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBOR3U__ (+L?\$FO"^NZUX9U_\ ;,\#Z;KOAW5M
M2T+6M.E\'_%>26PU;2+R;3]1LI7@\ 2P/):WEO- [PRR1,T9,<CH0Q!I-[)O
MT3?Y'ZV45^/O_#_7_@D'_P!'L^ __",^+G_SO*/^'^O_  2#_P"CV? ?_A&?
M%S_YWE*Z[CY9?RR^Y_Y'[!45^/O_  _U_P""0?\ T>SX#_\ ",^+G_SO*^Y/
MV6OVS?V9/VUO"/B+QY^R[\6='^+OA+PGXC_X1'Q#K6BZ5XFTF#3/$?\ 9ECK
M/]ERP^*-$T*[EF_LS4K&[\VWMYK?9<*OG>:KHKN)IK=->J:_0^GJ***!!117
MP#^TO_P5*_8%_8[^(T7PD_:5_:/\,?"KXBS^'-,\71>&-8\.^/=4NW\.:S<Z
MC9Z9J@N?#?A/6M.$-W<Z3J,21&\%PC6KF6%%:-G!I-[)OTU/OZBOQ]_X?Z_\
M$@_^CV? ?_A&?%S_ .=Y1_P_U_X)!_\ 1[/@/_PC/BY_\[RE==Q\LOY9?<_\
MC]@J*_'W_A_K_P $@_\ H]GP'_X1GQ<_^=Y7N_[.7_!5O_@GQ^UO\3;/X-_L
MZ?M+>%OBA\3-0TG5]=L_"FD^&_B!IMY/I.@VZW6K7HNO$7A'1],6.R@99)$D
MO5E<$+#'(WRT[H7++^5_<_\ (_0NBBB@04444 %%%% !1110 4444 %?%%U_
MP4K_ ."<MC=7-C??M^_L3V=[9W$UK>6=U^U3\"K>ZM;JWD:&XMKFWF\>)+!<
M02H\4T,J+)%(K(ZJRD#[7K_./\;_ /!JW_P4Y\0^-/%VOV&L?LQ+8ZYXGU_6
M+(7'Q6\4QSBTU/5;N]MA/&OPTD6.80SH)461U5]RAV W$+A&+OS2Y>WF?T?_
M /!;;]O+]AOXK_\ !+/]K[X>_"W]L[]E#XE>/O$W@KPG:^&_ _@#]HGX0>,?
M&'B"ZMOBCX%U"XMM$\->'?&&HZUJMQ;V%G=WTT-A97$D5G:W%RZK#!*Z_P V
MW_!K'\?O@1^SW^UU^T1XE^/OQK^$GP/\.:W^S@VAZ-K_ ,7_ (D>#OAIHFKZ
MW_PLWP-?_P!CZ7JOC36=%L;_ %3[#:7=[_9]I/+=_9+6XN?)\F&1U^7OVJ_^
M#=O]O[]CO]GWXE?M*_%O5/V?Y_AU\*M*T[6/$\7A'XC>(=9\1O::IK^D>&[8
M:7IEYX"TFVNYAJ.M69E274;54MQ-*'9D$;_#?_!/K_@G#^T)_P %*_B3XU^%
MG[.EW\/+3Q/X"\#GX@:X_P 1O$FI>&=,;01KVD^'"MC=Z;X?\0RW%_\ VAK5
MF?L\EM!']G$TGG[D$;K_ (!O&,%"24[Q;UEVV\C_ %(/^'FO_!-S_I(-^Q!_
MXE?\!O\ YOJ^D_A/\:O@W\>?"S^./@;\6OAG\9_!4>J7>AR>,/A/X\\+?$7P
MM'K=A%:SW^COX@\(:KK&DIJEE!?64UWI[78N[:*\M9)H42XB9_\ .T_XA0_^
M"HG_ $&?V7/_  [/BK_YV-?V#?\ !#+]A#XW_P#!.W]BK4?@!\?[GP/=>.[K
MXV>._B!%+\/]?OO$>@_V#XCT/P7I^GJVH:AHF@7 OQ<:!??:+?["8XXS RSR
M&1E1F,HP2O&?,[[:;=]C]D:***#,**** "BBB@ HHHH **** "BBB@ HHHH
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M\'=6^%CV$.BV=CK.G:?J&NZG=0^,4GTV745TNWD3P_:1Z@5M?JC]B[]IB_\
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M5W."Y)>7S:Z6U]-5KYH_H,HK\D?AQ_P5#C^,/@#_ ()<Z_\ #?X76NK^-/\
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MAYM0%O9KJ<>B:Y!J.EP:LEG9QZK;VL6HQVELERL$?\OO_!/C_@CK^Q7^T/\
M\$;?A!^T!9_#R_\ AK^U[K/P>^)?CGPG^TUX$\>_$?PUX\\)?%#PAXQ^(,7@
MKQ9!%I/BR#0Y(--;1-)LM1TZ/1XQ=Z5'.;.73]:^Q:S9A*2UNVK-+:^NN^JV
MMT/[$Z*^"O\ @EW^T#XM_:F_X)[_ +)7QX\?7?\ :/COQY\'O#[>-M7,;0OK
MOB[PU)=^#_$OB*:$VME'!<>(=9\/WNMW$-K;)80SW\D>G--8+;S2?>M FK-K
MLVON"BBB@04444 %?P\?\%SOA)\/OCU_P<+?\$VO@O\ %CP__P )7\-/B?\
M!K]G'P7XY\-?VKK>A?VYX9U[]IG]HJQU73?[8\-ZEH^OZ9]JM97B^V:/JNGZ
MA!NWVUU#( X_N'K^+_\ X*W_ /*S/_P2=_[$/]EK_P!:C_:&H>S-*?Q/_!/\
MC]@O^(</_@C'_P!&;?\ FPW[5?\ \_*C_B'#_P"",?\ T9M_YL-^U7_\_*OV
M^HH)YY_S2^]GX@_\0X?_  1C_P"C-O\ S8;]JO\ ^?E7X'?\$Z?@'\)OV7O^
M#H#XV? 7X%^%/^$'^$_PY\!_$/3/!OA3^W?$OB;^QK'4/@QX#UZ\@_MWQAK/
MB#Q)J'G:KJM_=>;JNL7TT?VCR(I$MHH88_[KZ_BP_9F_Y6W_ -J+_L4O&W_J
M@?AG07&4FIIMOW'NV^J/[3Z***#(*_EB_P"#NO\ Y1N?!+_L]_X;?^J&_:5K
M^IVOY8O^#NO_ )1N?!+_ +/?^&W_ *H;]I6@NG\<?7]&=Q^PO_P0+_X)+?&/
M]B7]CKXN_$?]D_\ X2/XA_%3]EC]GSXD>/?$/_"]?VE=(_M[QIXX^$GA'Q/X
MIUG^R=!^,FEZ'I?]J:YJE]??V=HVF:=I5EY_V;3K&TLXH;>/ZG_XAP_^",?_
M $9M_P";#?M5_P#S\J^W_P#@F5_RC<_X)\_]F0?LH?\ JAO -?;] .<KOWI;
MOJ^[/Q!_XAP_^",?_1FW_FPW[5?_ ,_*OYGO^#@O_@G#^QC_ ,$_/B?_ ,$Y
M/^&1/@W_ ,*D_P"%M^//B_\ \+"_XN'\5?'O_"0?\(%XA_9V_P"$3_Y*;XY\
M:?V5_97_  FGB7_D"?V;]N_M+_B9?;/L=A]E_P!!^OXO_P#@[5_Y*?\ \$G?
M^Q\_:/\ _4A_9.I/9^C_ "95.4G))R;5I:-M_99_:!1113,@HHHH **** "B
MBB@ HHKX@_X*5?''Q+^S;^P)^UW\;_!5_)I/C7P!\"/'VH^"M7BC,LNC>,K_
M $:;1/"FLQQCAI-(\0:IIVHH'S%NM0908@XH&E=I=VE]Y]L0W5K<274-O<V\
M\MC<+:WT4,T<LEG=/:VU\EM=(C,UO<-97EG>+#,$D:UNK:X"F*>)V$NK62XG
MLX[FWDN[6."6YM4FC:XMXKHS"VDG@5C+#'<&WG$#R*JS&"81EO+?;_-#\.OV
M4/A__P $ZOVL?^"5M[^SKJ=_X#UO]LGX5?'3X _M1>)M7UOQEXZC^,/Q&M/@
M"/C?\._B_P"*_#^N:S=V^K^-;'XN>']4:?5#<Z4ZZ#XKN/#T=QIF@1,+3P?3
M?@?\&_V+/^"FO_!.;X#?"+Q-\3+G]LK4OB1\0]6_;1_;$^)3>*_ /A#]K/PC
MXZ^&NI^,O$O@;5=0\9^*];\*_%+X@Z_KNJ>$;SPEX"\(S^([KP%J-G8O:SV.
MJ(]U:!7*GL^C:T[7O?71::;O5:;G];M%%>(?M+_ WPU^TS^SU\:_V>_%XC'A
M[XR_#'QG\.M0N7B$S:8?%.A7NEV6MVR'!%_H-_<6NM:=*I$D%_86TT;+)&I
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M>"/'%IXGN_$.K_#[6?"VK7OA^VLK^^TGQ'JEUI&CZNUUJVFV.HVBZ>WZR?\
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M.BWEG0O^"07[16C?LZ_L[:[\7?V%_AG\:M;_ &7_ -M+]LWQ?XH_8FTCXH^
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M/L],O_%-_HGAC]I/]HS4K^UT"RUK6/#^DW6J300LEG!J.MZ5:22E5FOK="9
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M_#ZUM[![0&.&6RO=0N&N/DDM8X_WM!K33<:B2NVEI\S_ $JZ*_EB_P"(NO\
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MLO\ B+K_ .";G_1$OVW_ /PVWP&_^B5K\O/^"57[47@#]M+_ (.4?BC^T_\
M"W1_&&@> ?BW\._B3K/AO2/'^GZ+I?C"RM=*^$G@SPQ<1ZW8>'?$'BK1;:X>
M_P!#NYH4L/$&I1M9R6\CRQS/+;PA482BIMQ:7(UKZKS/[X****#(**** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "N(^('PR^&WQ9T%?"WQ3^'W
M@?XE^&$O[?54\.?$#PGH/C+04U.TCGBM-172/$=AJ6GK?VL5U<QV]X+<7$,=
MQ.D<BK-(&[>B@#Y<_P"&'?V*O^C/_P!ES_Q'_P"$_P#\R5'_  P[^Q5_T9_^
MRY_XC_\ "?\ ^9*OJ.BE9=E]R_R'=]W][_S/ES_AAW]BK_HS_P#9<_\ $?\
MX3__ #)4?\,._L5?]&?_ ++G_B/_ ,)__F2KZCHHLNR^Y?Y!=]W][_S"BBBF
M(*J:A86&JV%[I>J65IJ6F:E:7-AJ.G:A;0WEA?V%Y"]O=V5[:7"26]U:75O)
M)!<VT\<D,\,CQ2HR,RFW10!\N?\ ##O[%7_1G_[+G_B/_P )_P#YDJ/^&'?V
M*O\ HS_]ES_Q'_X3_P#S)5]1T4K+LON7^0[ON_O?^9\N?\,._L5?]&?_ ++G
M_B/_ ,)__F2H_P"&'?V*O^C/_P!ES_Q'_P"$_P#\R5?4=%%EV7W+_(+ON_O?
M^9RW@OP-X*^&_AG3?!?P[\'^%O 7@[1?MG]C^$_!?A_2?"WAG2?[1U"ZU;4/
M[-T'0[2QTNQ^W:I?7VI7GV6UB^U:A>75Y/ON;B:1^IHHIB"BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ KQGXB?LY?L]?%_6[7Q+\6?@/\&?BAXCL
M=+@T.RU_XB?"_P $>-M;L]$MKN^O[;1[75?$NAZG?6^EV]]J>I7L&GQ3I:17
M>H7US'"LUW.\GLU% 'RY_P ,._L5?]&?_LN?^(__  G_ /F2H_X8=_8J_P"C
M/_V7/_$?_A/_ /,E7U'12LNR^Y?Y#N^[^]_YGRY_PP[^Q5_T9_\ LN?^(_\
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M679?<O\ (+ON_O?^84444Q!1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 5\RWO[%7[&VI7EWJ.H_LE?LRW^H7]S/>WU]>_ ;X675Y>WEU*\]U=W=U
M/X5DGN;FYGD>:>>9WEFE=Y)'9V)/TU10!\N?\,._L5?]&?\ [+G_ (C_ /"?
M_P"9*C_AAW]BK_HS_P#9<_\ $?\ X3__ #)5]1T4K+LON7^0[ON_O?\ F?+G
M_##O[%7_ $9_^RY_XC_\)_\ YDJ]@^'/PB^%'P>TR^T3X2?##X>?"W1M4O\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@_\ X59\9/ 7_"KOB/\ '>T_X2GXD^!_^$7\'?$7_A/?VBOC-\0/M/PLUO\
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MA)K_ (CG\&GQGX)^)'@*.QTC6[31_%D46@ZND>FI!;:A<K9K>2ZA9ZK9:?\
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MX7GX9?%+]L7_ ()E>/?V8/V2/BGXR\(>"H_CC-\?? _Q*\:?":X^(FM6^@^
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MU+4KF\N-'TDV7ZL44#YI:ZO7?7^NYY%\"/@=\.OV;OA3X5^"WPFTJ[T3X?\
M@S^W/[ TN^U74=;NK7_A(O$FL>*]5\W5-5N+J_NO.UO7=2N$\^=_)CE2WBVP
MPQHOPI^TO_P1P_82_:K^*_B#XU_$7P%XV\._$+QU966E?%/5?A/\5_B!\*[/
MXOZ1I^FMH]GIWQ-TCP=KNFZ7XD6+2V_L^341:V>MW=DL=G>ZI<VL4<*?J110
M";3NFT^Y\B:M^PI^R[J4?[*UI:_#*R\-:/\ L6>(T\5?LY^'O"&HZKX8\/\
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ME=F/744!=O=M]0HHHH$%%%% !1110 4444 %?S/?\'7G_*+O1O\ LZ/X3?\
MJ*_$ZOZ8:_(+_@MK^P!\9/\ @I+^QKI_[._P-\2_#/PIXUM/C-X'^(DFJ?%C
M6?%.A>%FT3PUHOC'3;^U2]\(>#/'6K'5)9_$-D]I VB+:2117337T#I%'./^
MOO14&E.+>B35V?3W_!,K_E&Y_P $^?\ LR#]E#_U0W@&OM^OXG/!W_!&'_@X
M_P#A[X1\*^ ? _\ P5$^%_A3P5X'\.:'X/\ !_A?0_VF?VGM/T3PWX6\-:9:
MZ+X?T#1["#]G=(+'2]'TFRM-.T^SA58K:TMH88U"(H'1_P##I#_@YG_Z2Q>
M_P#Q*7]J/_Z'FEKV_'_@%.,6V_:0U;?VNK;[>9_:!7\0?_!Y1_SCC_[N^_\
M?7J[S_ATA_P<S_\ 26+P'_XE+^U'_P#0\U\Y?M ?\&Z7_!<7]JS_ (1+_AI/
M]N?]G'XW_P#"!_V]_P (7_PLKX[_ +1WBK_A&/\ A*/[%_X2/^Q?[3_9RG^P
M?VU_PCNA?VCY&W[5_9-AYN[[/'AZ_P!/_@%048R4G4@TK[7[-=C^\VBBB@Q"
MO"?VI/\ DV7]HO\ [(3\7?\ U7_B&O=J\U^,W@[4_B+\'_BO\/M$GL+76?'7
MPU\=>#M(N=5EN(-,MM3\3^%]4T2PGU&:TM;ZZAL(;J^BDO);:RO+B.W61X;6
MXD"Q. MUZK\S^7#_ (-!/^3*OVG/^SHV_P#53_#ZOZV:_A,^ W_!OK_P7C_9
M<\.ZSX1_9T_;^^ 'P6\,>(=:/B/7-"^'/Q__ &DO#&F:MKQL;33#JU]::;^S
MG#%<7_\ 9]C9V?VB13)]GMH8L[4 KW/_ (=(?\',_P#TEB\!_P#B4O[4?_T/
M-&O]/_@&LHQE)R52&KOU\O(_M K\??\ @OK_ ,H@_P!MG_L0_!G_ *MSX>5^
M(/\ PZ0_X.9_^DL7@/\ \2E_:C_^AYK@OBA_P0^_X.(?C7X#\1_"[XM_\%+?
MA!\1?AUXNMK>R\3^"_%W[2/[36M>'->M+2_M-4MK?5-+O/V=I+:[A@U&QL[V
M-)495N+:&4#<@(6O]/\ X E&*:?M(:-/KT?H?M__ ,&X?_*&/]C;_NX;_P!:
MK^.5?M]7YT?\$FOV1/B3^PA_P3]^ /[*7Q=UOP/XC^(?PK_X6I_PD.L_#C4M
M>U?P7>?\)Q\:_B/\2-)_L;4?$_AKP?KEQ]GT/QAIEKJ/V[P[IWDZK!?06WVN
MSBM[ZZ_1>F3)WE)K9R;7WA11102%%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MK7:WEGI\_B[3+?1/B-K^M&WO6TWPYJ>IZK!HU[J%K'H$WSO\>/\ @D-\>/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MTW3[>QT37+7Q"^BR>*/!]QH%C)<ED;-QE)K>RT3DE%OW=FDK:7ZZL]+^-?\
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MINN>)(+ZYU?0_&]GB*QO9/"@.T-4N7>+U?2TM/B[VV=M5=J^GV/^V%_P5/\
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M+Z#)VN[;7=O2[L%%%% @HHHH **** "BBB@ HHHH ***^>_VHOVGOA+^Q_\
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MO7K3/VV]T_[/;>1IX-SYS_<K[\H!IIV?Z?HW^8445\8_!_\ ;F^$_P 6[/\
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MOV6(_A4_CW7$_:SO?CGHO@V2]\,6FA3^ /%'[.VAPZY\3/"/Q;TC6M;L=?\
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M-!*B]A0(**** "BBB@ HHHH **^#/VOO^"A7PJ_8^\6_#;X9ZI\,OV@/C_\
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M)N?])!OV(/\ Q*_X#?\ S?4%/F>K4F_--_H?;]%?$'_#S7_@FY_TD&_8@_\
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M[0'QI_; _:(T3P!\4- _X*;?$'X??";]@S]CKQ]9>'O^";GB'P[\.K]_CO\
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M?A?1=7%[/?:LL'B;4X7L=,UE],7]$OVS/^"55I^UW^TWX!_:KT[]K_\ :?\
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MB!HL7QX\$6WB6Y^(7Q \0P>(? >AR/XO\-:=\,HFT@7]_P"?;FR]C\ ?#_\
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M-[66FJ=E\M7=Z7^1_.]^RWX'\0?M>:[_ ,$#_BK\>?C-\<_$_P 24D_;_P#
MFL>+M*^*7B?P[J'B:Q_9+^)/Q M/A[JOB V-XTFJ:]XGTSPSI.A_%/5[V:XO
MOB+H-O\ V5XAGN87D9NE_8C_ &C?B!^SYX _X)<?MD_&;XR?$K6O@I\88/\
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M?L??"?6/@9H7BSQYX\^)?C;XZZOX5_:5^,^B_!7P9H>O:=I5O^T+XC\'^*?
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M+Z?@?C3\>/#_ (-_:S^+_P .O^"2?[$7@/0_!_[+7[,7QG\#?&W]N?XJ>$+
M6WP]^&-UX2^)]U\9-._9B^'DJ!["\^-7Q!^(R#Q)XP-M)<6OP^M);I[RSU'4
M+3Q%H6D_&WB);.7_ (-V_P#@HY?>+7ME\:7O[3W[6>J>+9K2>*XU)OC%'^W
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MZ9K6EVFN6FEZU=3Z3<ZEH^K6$%_';RWFF7]NDEK+_>A7\0?_  6V_P"5D?\
MX)&?]V#_ /K>/Q7H-*7Q/_#/\C[?_P"(13_@FY_T6W]M_P#\.3\!O_H:J/\
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M$G_E9'_X*Y_]W\?^MX_"BOV"_P"(FO\ X)!_]%V\>?\ AB?BY_\ ,I7X??\
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MU^P5?C[_ ,$"O^40?[$W_8A^,_\ U;GQ#K]@J2V1,OBE_B?YL****9(4444
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M0U&YM#H_B"X.J:0=-T+4(K?5]736M#DTJRO$UK2VN_P!_:$\-_\ !/#XZ_\
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M ,$@_P#HNWCS_P ,3\7/_F4K^:O_ (.-_P#@J5^QI_P43\#_ +*VB?LK^/\
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MX)!_]&3> _\ PL_BY_\ /#K]@J*5EV*YI?S2^]_YGX^_\."O^"0?_1DW@/\
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MVC:UJ[K*'U*]:?TT_L]? 3_A3LW[/"?!/X30? .?2+C09/@G:_#OPE:?"?\
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MOV"HI678KFE_-+[W_F?C[_PX*_X)!_\ 1DW@/_PL_BY_\\.C_AP5_P $@_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MQOWUC1-?\66_ASPWXLTZ_P 6\7A*^U34$@U*ZLX=/NOSL^'_ .T_^WY^SO\
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M>$_%'AS7]8\&^-_"5UJ=O;VEOJDWA;QIX=U_P^VIP6EK#J/]G?;8K:WCG6)
M332N_P#@Z[772]G8]U\0>.?!7A.\T;3_ !5XP\+>&;_Q'=_8/#UCX@\0:3HU
MYKM]@'[%HUMJ-W;3:I=X(/V:Q2>;!!V<UU-?S/?L'?L _LR_\%1/A)\8?V\_
MVY?A['\>OB;^U7\8?COHWA"'Q5XF\1O:? 7X,?##XI>.O@[X"^&_PMM-+U.P
MC\&R:+;^$[[5I=8LWFU?4+V[M-4GOC<M,TOTLWQ)_:I_8&\ _L;?\$U_@C=Z
M'^W-^U_XS\/_ !2U/0?B5\<=6UGX8>"? '[.OPNUR.XLO%'QEUC2+KQMXE\0
M7WAW3/%/A+X3^&;CP[:VUWXKN-(;5[O3=+N8(M)U@&XK9.[6]U9;7;3[+9WM
MY=C]RZ*_GF\4?\%C_P!HK3_ ?PN\*:#^R3X8G_;#U/\ ;H\0_L ?%?X':G\1
M]13P7H7Q3A^&VK>,_!_C[PG\1HM @^V_"_Q''/X2\67FI7VC2WFE>"KCQ#"@
MOKZPL-4O?.=;_P""OO\ P4:\(^%?VI-6\1?L+_ JZN_^">?B>WC_ &SM4T3X
M]ZR="UKPGJVFZ!XNTH?L^V%WX9_MR^\06G@*^U;7_$$_C58-'LX8](DT\ZE?
M75[H-B!R2\OO7=+\6TEWNC^E^BOPM^+W_!17]O&__:+_ &J/A5^R)^R5\(/B
MS\//V5/A'\(?C7XG\8_$WXG^*_ &N>+-*^)WPS@^(=I\+_!^EZ+X9\36.H?$
M_5[6'7IM%>[N;#PUI5CH8CUV[-_K6B17W1>*/^"CW[5'QK\'_ _QW^PK^SA\
M,[SX9_$?]F'0_P!IWQK\>_VNO'_BGX5? [PE)K=]+IT?[/NC>+/#7A?5;/7?
MC-:75E?C6;F;4['PGH$ L;K4;O[+<7<U@!RO3;7S6FEU?M='[845_.MHO_!9
M#]IGX\:!^P#I_P"R=^RQ\-?%WQ2_;E^$O[1/B<Z'\0?BGJNF>!OA/XT_9M^(
MUGX$\<W&M>,]%T)WU[P!$^C>-EL+S2M+&I:WJDOA"VTJ>:WOYKBX]A^$7_!5
M;XS:_J'[*^G_ !J_9\\+?"Z3QW^W'\>/^">'[34NE^,;[Q)IWPZ_:$\">&+W
M4_@_??#C5IK73+?Q!X/^*FNZ9-I#_P!LPI=6HOK8Z->ZQ)%:'6@.5^772ZOI
M?I\FC]N[G4M.LKBQM+R_LK2ZU.:2WTVVN;J""XU">*)IY8+&&61)+N:*!'FD
MCMUD=(D:1E"*6%VOQATC6=4_;R_:6UKXSS^&M T#X0?\$NOVUOBAX6^'7BG3
M%\1:K\0OB_K?@[]F[5O!/QHT32K)/$=CX0M;*P^*_C>'1HM1O=&U5[FV\"W.
MC:9=Z5K%WK5U9<G^P)_P4V_:B_;(\7?!CQK<_L]? [4/V6_V@++Q_/I_BKX#
M_&_4_BG\5?V9+[PW;7NH^$]*_:O\.77A30-$\,WOC$:=/X;MH/#5U=W-IXDN
MK=[RVM;"UOA$!RO[EKY7U2\W;7\-S]RJ*_,?_@I7^VI\;_V0+']E_1/V?/@Q
MX6^./Q/_ &GOV@K/]G[PSX6\6^)K_P ):58ZWXA\$^*]9T'7;O6;*"X6UTC2
M];T?3[OQ-+<1;(O"\.L2P2V]TL%Q%\9^+_\ @J'^W2NO_$GP%\-OV5OV;M<^
M(7[(GPU^'_B3]LG1O&'[1MYX5LM0^*?C'PM9_$'4/@A^S3>IX9OX_&/B7P[X
M$N(=2U7Q#X@D7P[:ZUJ4/AR*>^U.RM8?$("BWKIKW:76WYM+U/WW&I:<=1;1
MQ?V1U9;)=2;2Q=0?VBNG/.]JE^UCYGVD63W,;VZW1B\AIT>$2&12HNU_,[\9
MO^"F?PT\+_%KXD_MR_!;X">'/%'C5/\ @B'\(?VH/"7C[QAXO\<V'B#4? GB
MW]J7Q1IMG\!_%/A'2=?N/ &GVWA;Q%>:IKFI^)M(T67Q=)XA>]T4^(KKP[:V
M5NOTQ\*O^"H_[17@_P",UOX,_;P_9K\"_ 7X?_$W]D[XJ?MB?!C7?AE\1=1^
M)'B?1? GP9TO3O%GCWP%\7=,U+1] M+;Q[I7@C6+;59KOP^8=!CU:S;1K9]1
M.H/=:,!R/^K7\]/(_<JBOPK^%?\ P4Y_;(LM \!?M%?M1?L16GPZ_8O^,GP7
M^,7QY\+_ !!^%'BOQ=\3_B1\"O GPU^&FL_&?PM<?M/Z%_PANF>&/"4?Q2^'
MNBR0^&=5TO6TT_3_ !??:1X<\1?V3J6HFQM;7P3_ ."FG[6L_P 0/V/]=_:K
M_9-^'WP=_9D_X* ZI:^&_P!G?Q]X'^*VL>-O'?P\\9^,?"6I_$+X/>"/CWH&
MI^$]!TNVUSXI>$=*NAI<G@^XNH-+U:*2'58[<6^H0:>!ROR^]=+W2[M6=UY=
M>O[E45_+MI7_  6L_P""@4W[.VF?M=W?[#/PBO\ X#>,OC1X8^ OPF32/B]J
MT7C_ .*GQ!N/CK-\'_$%AINBW%I<IX;L+VYTCQ5I?AS5-5CNX(/$6@)/J$=U
MI^I1VMM]8:E_P5F^,W[+ME^UCX0_X*"?L\^"?!OQE_9Z_9_\#?M*_#FQ_9X^
M(&N>./ 7Q]\$_$KQY:?!SPYX3\/ZAXK\+Z3XC\->+]*^-NL^%OAKK\]WI.K6
M\EYXA.M:=I;Z1::3-XH Y)>7HFK]$_NNK]C]V:*_#&R_X*4?MC_!7Q3XG^%_
M[<?[+?PH^$?Q#\8?LA_';]J/]FS4_A;\4M<^(?@KQ9K_ .S_ .#(O&/Q$^ _
MQ"DO- TJ]TCQ[X3TK4M(U;6M:\/W>H>$+K3Y9X=$U:^GFL)[CD_@[_P46_X*
MA?%KX%?"SXGV7_!/WX;66I_M3:C\/-8_9SU^;XH>+I/A'X'^#>N> ?%'C_Q?
M\8?VI/%FA^%?$NH_#?1TTO2O"1\#Z1%IUM/XGE\=PV%EJ%[JN@?8=> Y7Y>M
MU9[[?<[^FQ^_55(-0L+JYO;*VO;2XO-,D@BU&T@N89KG3Y;FWCN[:.]@C=I;
M22XM98KF!)TC:6WDCFC#1NK'^1[]N3_@H3^UI^T1^PQ\>O 3> ?@SX*^,?[.
M?[>/[-/P)^.FJ_"GXV^*=>^$OC'PUXL\7> O%/@:_P# /B:PT&#6M5T/Q=XH
MN].\&_$7PGXALR=)\-/J5_-]MU=;CPM8?:FN?MTWW[+OQ*_;WU'2?V7?"GB#
M]LKQY^TA_P $^_V<-*\)^#/B7XP.@_M ?M1_'#]CWX8ZOX?M=9UKQC<WV@^
M_!/PQT"TU_3EU;PWX?\ #MMK?@WP-%J_B:.T\0:KJ7B"W!\C^?;3RU]-;G]#
M%%?S\_%/_@KA^TI^S!\.?VT?#7[4_P"S=\,/"G[47[*OP=^%?[1OA/2/AO\
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MOV7P*^#7B.ST*\B\4^-K&RM[^XU+5=:UBP\-Z!'J>A0^)-1TN=O^)AXG8_\
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MP7:?MW>%/VV]+_8%\.?!CPQ\0[N+X/\ C#XK^*?!FD_$CPY\2)_B!KNG)?\
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MF0WRZ9X3TV]G%RFGV=IIXNQ:K(;F28*C%R=E9:-Z[66K/[):*_BP_P"&9O\
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MO"E_XTUFTOM0L+6>RT.&W\/Z;=W,=WJTUK;7$J+:PR/.ZH0#W&BBB@ HHHH
M**** "OX@_CM_P K>_P;_P"Z>?\ K(VL5_;Y7\0?QV_Y6]_@W_W3S_UD;6*7
M;Y_D:4_M_P""7Y']OE%%%,S"OX@_^")/_*R/_P %<_\ N_C_ -;Q^%%?V^5_
M$'_P1)_Y61_^"N?_ '?Q_P"MX_"B@TA\-3_ O_2D?V^4444&85_'9_P>%_\
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M5_ V@4/CC_B7YG>?\$"O^40?[$W_ &(?C/\ ]6Y\0Z_8*OQ]_P""!7_*(/\
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M.GP_VYX5US2]4_LZ>[BU73/M7V'6+'3]1@N+.'\E_B%^RG_P4E\$_!;]LO\
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MAX[O_A9XDT[7/%?A0Z9H/CI?$MCJXM-)M-,U"%;?2/0?CW^RO_P4I^&6N_\
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M@M_B;\,-;UF_L_B!X>U_QM';>*]1\0>!O#WCQK^PT>3P_I$EU<>((!:^]_\
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M;P[H>H>)O"G@*>_T.X:^L["PL;R;XD_!'_@HM^WQXYTWXI?'[]D[0/V6+/\
M9S_8Q_;%\ ?#KX>-\;_A=\5/$/QR_:=_:@^#,GPEN;KP]J'A75KSP]X'^&>@
M:3;W]IH.L^-?$&@>(FN-?":A;2Z-?ZC>:3^Z7P+^,7A_X_\ PG\&?&'PMX?\
M=^%O#_CBPN]1TS0?B;X/U7P#XZT^"TU6_P!)9/$'A#7$CU71;B>;3Y+JU@O$
M5Y]/GM+Q!Y5S&3ZS1N',UT2MMIMHD[:^6M[N]W<_&/X,_LG_ !_\)S_\$,7\
M0> ?L"_L=?LL>+OAO^T<?^$I\%77_"NO&FJ?LC_#?X86.C8LO$=R?%WG^.=
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M7/A:S26YT9I[W])/^"GWPP_:!\?_  O_ &>O%O[-?PEMOCI\1?V??VQO@/\
MM#S_  GE^('A3X8W?C;PO\.I_$L>O:1I'C+QQ<6GA;2=5>/7+>:"35KF.$01
M7,D45Y<QPV%U]5?$;XB?!?\ 8O\ V>SXM\4F;P1\$O@MX<\#^$;6#2=.UGQ$
M_A[PXNH^'OAWX/TNSL;5=2UJ_AMKC4-$TP2L;JX2#-W>3,L<\U?0%+R_K^M
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MDP_;M_['SX$?^H]\3J_M I+]6:5?XDO7]$%?G)_P5\_Y1=_M[?\ 9KGQ<_\
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M)=_+N?@Q_P +P_;@_P"&$_\ A^-_PV;\3OM7_"W?^%D_\,8_V=X?_P"&7/\
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MT*VT/X5?%!;76?#4WP]U'4]5'A(P6ERGB*]^SV<=U^X?Q2_X)@_"SXU^*_\
M@HCJWQ+\9>(-6\,_\%"OA]^SCX'\2>&]+TVSTC4/A;>_LUZ'XJL_!GC'PGXB
MDN]175/$$?B37]+\9:?_ &CHUO::1K'AFPBDAU6UN)E7S?X7?\$O/B/JOB[Q
M%XK_ &Y_VU?'_P"VU#-^SS\0?V7O!/A6Z^&OAWX&^$_#WPO^*VCKX=^(NJ^+
M=)\(^)/$9^)/Q2\5>'D.CW_C_69]//V6XNY$T/[5]@GTX_X/YAS1:UL]%?3?
M1;671WZK>^NQ\>VG[)/[=R_LRP?&;Q=_P4B^,WQ,T#X]?L5?%_QK^UMX)\87
MG@NS@T'Q7XC^#L?CGP'J'[(&B:7\+/[+^'.CZ!XLN4\'^-M,U]Y]+USP'J5]
M/9V.FZQ>Z58Z+^8OP\_:+^(?PH_9[_X)5_L@/^T)^WMX2^#?CK]A=OVM/BEX
MI_9"\"Z=\2OVE97U?4="\ _#KX0^ M3\.?#K69OAS\%? FHKJ>HW.I:EX9UJ
M]N4N](\/ZSXDU'4]2TV[M_W+^$G_  2#\4:%XB^%%M^T1^VE\1_VE_A'^S)\
M*OB/\(OV4?ACJWPN\!_#N]^%NA?$GX:R_!N^U_QWXW\-W5_=?&/QIX>^&-S=
M^&/"NO:OH?AV/2&F.KII\FI&>:XY'X?_ /!'/XQ?"+X??LW3?"O_ (*!>*_"
M'[2W[*GA3Q_\%OA9\?S^SO\ #S5=!U+]EWQA+I%SH?P#^)7P:N?$\6C^/++P
M)J&B66M:!XUNO%>GZ]+K\UYJUY \T>BIHC'S+JT];_#9;-+IT]/OM<^%?@]^
MU=^VY^U?H?[$O[#GB;XQ_M%_ ;4/C#^TM^VGX-\9_M2ZG\,7^ _[5'Q+_9D_
M9'\ ?#CXI?#G6=&T;Q;X2;3/!GCKXCV'Q?\ "?A/Q3XNTSPY?6OVWP1K\\]]
MK5\_B'3_ !!]K?\ !&WP!XX^%G[3'_!73X>?$7XI^(?C7XI\)?M0_"+2)/BC
MXP@TN#QAXNT*#X%Z$_@Z]\7OHNG:3I=_XLM/!TF@Z7XFUFSTVRCUW7+&_P!:
M:!)+]\^LS_\ !([4]-^#?P:L_!7[87Q9T+]L7X*_'?XF?M+:+^V=XA\+>'_&
MVM^(OBO\;-,U'0OB_:>)_A%J&I6/A"?X6^-O#]Y9>'YOASI.KZ3'IVD:%I5M
M;:\[R:S-J_O/_!/W]@;Q)^Q5JO[2WC#QW^T=XG_:9^)'[4OQ,T;XL_$/QQXH
M\#Z-X$N$\56.@-HVHQ:;H^A:SJ^FVFAW$LC'0]%M%M+3PQHT&G^'[,75M81W
M+@FU9I6UZ6Z\U[WMM;I?Y'X*_MQ_"K4K']I__@X$\6/\8/B[J%KI?_!-GX>Z
M_)X,O]8\)R>#M6A\>^"_BE;V7AW5K.#P9;:S/X=^';:=-<_#RUMM<M+[3;G5
MM3;7M1\21-916/T38S?M;?L-?%S]F3PWXH_;7^.OQZMOVQ_V ?VQ_&7C3PC\
M2O\ A#;GPC\)_CA^SI\%_ 'Q.T+Q-\#K/PYH7A\> /#%HOBJ?P]IGAU?[=C$
M&GR7.I7&IRZCITOAK] _VH_^"5FK?M#?'7]I3XK>&_VGO$'PI\&?M<?LG3?L
MQ?'7X56_PK\,>-+7Q-<:1I/B?2?AY\0M,\8ZMKNFZWX:F\%)XIN[N?PQHUM;
MP^)KJW@74-;M[-[BTF]V^/W[ NC_ !X^(G[,GQ!O/B7J?AN?]FOX'_M2_!6P
MTRV\,VNI0^++7]IWX3^#_A7?^(+RYEUFS?29_"%OX2CUFSTZ&*^CUB:^>RFN
M]/2!;B4#F6BT:LKZ=HI+IW73_@'X._ +4OV^O$7P*_X)P>&];_X*%_'G5_B7
M_P %<=9\*:MXP^(4]EX5W?LY?"'X'?!GX@_%[QIH/P.:[\.7&E:'\2/BMX-L
MO!NA:QXJU9)KF;Q+H&M^(K72-<NM;U*:T]5\>_M%_M4_LJ>)_P!IK]BR]_:;
M^*_Q?/P._:=_X)=^)/@_\=?B#<>&[GXRW?P2_:J^.WAWPI\2?A%\4/$FA>'_
M  ]9>+)K*;2-6L;+Q(='-_K7A_Q3J%K=R:3!IVE:7;_IWXH_X)<Z1J?['O[(
M?[.O@[XY^*?AW\9/V&O^%?:O^SO^U#H7A#1+WQ%X;\8>!O#\WA.]U'6? &J:
MC/HOB+PGXV\-7NHZ1XO\!7VMKI>K0S6;7%[(=.A5_,M4_P""/LWCWX#_ +4W
MA;XS_M8?$'XC?M3_ +5WC/X*?$;Q=^UC9> ?"_@F;P?XO_9JU#2]5^ 5KX"^
M#NC:E<^&=(\"^ ;ZPO9)O"5SXAOKK6QXE\2W+>(]/U>]LM5TT#FB][;O3E7\
MVCT6RCI:_P GN>'_ /!33]N3]H']E'XY_MF7'PO\6SBV\%?\$R_V;?$_PL\*
M:LEM>^$_#/QY^//[;OQ&_9RT[XI2:9<VMQ#=:EH]MK7A:ZN(;V.\TV\M?#%G
M:WNG7=L9X)_&OBG\-?VKOV/OVF_A[\#O%_[=W[0'[3OP7^/W[!G[>_C+Q7X4
M^-FK>%=8U&T^+WPN^$WA4>(=7TZ]T+PYH%[;?#Z\E\6:->?#_P )7Z78\(3V
MWB2&#5]5DU*]F7UCXS?\$T/&'PX^$?[?'[1W[6WQH^+?_!2?QW\;?V0+#X1?
M$'X?>!/A1X)^!WB6_P##WPX\23^+='OO@EX>\'7?B?2=#\0>&(%A\3:!X:ET
MGQ')K/C?2;W5;J;59/$+:'#\._L<^!-9_;-_;\\!:WX._;*_:!_;2^&'PT_8
M,^/_ ,)/&WQX^*_[.\7P1\._!V'XO:=HG@?X=_"C3-.B\)^"X/'?Q?MX+_7_
M !%\0]:U2YU/7==_L 0ZKK8N-#N;>T!JUM+62U=MW96U:NK/TOTOT[3]C.U_
M:L_9-\%?\$*OBQKO[7WQD^)O@S]K_2/AA\!/'/[-OBG_ (0R+X&^$_A7XH_9
MLU/Q%\!3\-M!\.^'-*U+P]XB^'?ACP]X6_X2/Q!JFLZ]KWCG6X9;[5KVQCFU
M73-1_9G_ (*Q?%B]^$G[,OA_4XOVKH/V.M$\3_&SX:^#_''Q1T;0=7\5?&/6
M/ FJ7&J77B+X>?LY>&M#\'^/-1U7XY^,1I]I8^%W3PMJ-OI.C1^)-;NGLH=-
M:]@U;K_@G5HEU\-O^"9_PZ_X6GJJ0?\ !-[6_@]K6AZK_P (K:-+\5V^$?P6
MN_@W;6^K6O\ ;BIX377+2[;7IY+.?738W""QC2YC)N:[O]NK]C/4_P!K[PY\
M&;SP/\9M4_9_^,W[.GQJ\/?'?X,_%.S\%:+\2])T7QAHFCZYX=N;#Q7\._$&
MHZ+IWB[PYK&A^(M1MKJP37-"OH+M+*[MM42**ZL[T);3DGYROITNVM+=FNC^
M=C\[O^",?QU\?>/?C;^WE\';SXR?M@_&3X)_"FP_94\;_!#5_P!NGP:_A3]H
M.PM_C+H7QF'C8:C<7OAGPAK.N^"]4U'X<Z1?^"[V_P##FC6RV)N6TZP\NXGO
M]0K?MM>'_P!J#X_?\%)O'G[/?P\_;(^/G[,'P2^'/_!,GP_^TA=V?P*U;PUH
MVL:Q\;3\<?CIX.\)7%]J&M:+JU_'X<O=-TB*;QIIND26$OB33_"FC:*VIZ1)
M+!J=O]H?L=?\$^O&7[-/[1GQ_P#VI/B9^U+XO_:4^+'[2_@GX<>'/B9J/BGX
M>^&/ >FV>K_#*]\01>'KCP#HWA'4FTKPCX-MO#&KV/A^V\%R6>LWD5SI3^(+
MSQ=J6HZMJ*R>[ZU^R;IVL?M6?$?]J-O&U[!J'Q$_9#\.?LFS^#ET2"2STO3O
M#OQ'^)?Q$C\;1:R=22>ZO;J?XD7&EOHCZ?!!%%I4-TNI.]T\$(#:YFU;X=-+
MZV7=>NMOS/YY/V7OVA/VQ/!?A_\ X)+?MT_&W]L[XO?%VW_;F\>:Q\*/C=\!
M=0TCPAIGP.TCP9'\(?B+/X,\1>"?"&AZ/IM[HWQ!TC4/AY8>*?&'B2#4W7Q?
MXAU._P#)TW2=)672=3^9_@+_ ,%(?VNOB%<?L_?M<:)\1_\ @HI\0/C/\4OV
M@/"UY\3?V7+;]F'7=1_8%3]F?QAX_N?"UUX-^&'BO3/ -N]GXK\#_#_4+'Q-
M;_&*?Q)<QZ[KNCW,.JV$TOFZE>_T)^"/^"6OA_P7\&/^";WP=B^,>L:A;?\
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MM=7'B#3'U/4;BZU=O#Q\/RPV=M%;P+J(U621S:+[/XV_8;T'QS^T7^S=\?\
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MOBO2].GT_P 'PKX=N8=*LQK?B.:ZTY-%^WV_\^'@_P#X*,_M&_"#P'_P4?\
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M4_8T_:V\3_&?XW^%/$GQ=_X(\Z+^T)XL\!>'-<\):?\ #^/6_#_QQ^$OPO\
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M!+]L']N'XI_#KQM\<_C1\._^"AG[57Q4_: ^$'[6VB>'(_A+^SQ\)_$6K?\
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MW\9>!-<TX^&=9UKQ)I>@ZQ>PMX=T"[\(G^E_]M?]C9?VM="^$^J^%/BQXC^
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M"F@Z"^N2*\CWNN)J.H2R2/=ES^+>C?M/_'_P3_P4(M_#_P"U+^V)^US^R?\
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M"^CV+V-_XGM_&6O6&G:-I$5M865JRZA!QZ_"#X.^/_'_ ,+/V8+3PYH_C/\
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MYJ^IZQ;S>)M3_:%^./BKX4:WH^L1V95+6P\/:;H$&JZ5-9$7%Q?7$L5WF!4
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M"Z\0Z+I%]?V7B#PW8ZI=>(M#M].U/5$TSS-;L+.03&&&;;<2!#UWA_\ :#^
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MVQ\,]%^-U[IO_!O]\%]2L-*^+&AVNN6ZMK/[3WQC\%>&_&,NF:E;O!<>)?\
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M=(N;WP[J>MWEO<ZQ%H^D>Z_MX_%'X.^'_P!J;_@MG%\0]%\3_%+POK/[-?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M,\(:1XF\<^+;)=/LI/!FC^"_!^D^(/"MCX8U W,__"0:Y?ZSI-W<Z?=R3O\
MJ_10";7W->E]';Y:>ADZ_H&A>*]"UKPOXHT72?$GAGQ)I.I:!XB\.Z_IMGK&
MA:_H6L6<VG:OHNM:1J,-SI^JZ3JNGW-Q8ZEIM];SV=]9SS6MU#+!*Z-\A_LQ
M_P#!.W]BG]C7Q+XH\9?LS_L\^"?A7XL\8:<-&USQ)I<FO:UK9T'[>-5;PWI&
MI>*M9UV[\->&)=26"_N/#/AN72=!N;NST^XN-.DDTZP:W^TJ*!7>U]'N?&]Y
M_P $^?V,M0^&GC3X.WG[/_@N;X9_$3XYW7[2OC+P@9-=33-;^.-[J^FZY=?$
M&5H]82[M=3EO]'TT&QL+FTT1=/M5T=-,71WEL9/?H?@_\-K?XPZE\?H?"UI'
M\7]7^&NB_!_4?&PNM2-_=?#;P[XHU_QIHOA9[(WIT=;2P\3^*-?U:*ZCTY-2
M>;4I89KV2UC@@B]*HH'=]W]_I_DON1\-^+O^":O[#/CSX%>"_P!FOQ;^SIX-
MUGX-?#?Q/XC\:?#SPQ-?>*;?4_ GBOQ=XKUKQOXFU[P?XXLO$%MX^\-:CK?B
MCQ#J^JW\^C>*+(S-=BU(%C;6EK!M7O\ P3T_8HU#]F:U_8YN/V;_ (;#]FNR
MN;;4;+X6VVFW5CIMGKEK?'48O%-KK=C>V_BJW\9->M+/<^-(=>3Q7>-<7:7>
ML3QWETDWV510%WW>]]WOWWW/E;]F']B/]E7]C&T\86'[,'P9\-_!^S\?MX6D
M\96_AR\\074?B&X\&:3<:+X>O=0&NZQJQ;4;>QN[QK[4HS'?ZYJ%[>ZOKMQJ
M6KW=S?2^0_M$?\$J?^"?7[6/Q2N/C5^T1^S1X2^*/Q.N],T71KKQ5KFO>.[2
M>XTOP]";?1[&;3M$\5Z7HTEO9PDQ!&TX^>C,+DS;CG]!Z* N[WN[][N_WGSW
MX9_9._9G\&? C4?V8/"OP*^%^@?L]ZQH^K:#K'P@TSPAI%MX&UG3M?#?VXNL
M:*EMY&JWNKR,;G4M5O\ [1JM[>A;^XO9+U$G7P7X6_\ !+/_ ()__!;P#\8_
MAE\,OV9?!/A?P=^T!X8D\$_%^RBU+Q?J>J^-/!CV\UHOA&Z\4ZWXDU+Q7IGA
MBWMIWALM T+6]+TJP1(!8VEN;6V,7W]10%WW>NKU>K^\^!?B%_P2W_X)^?%C
MX@>%_BA\2/V6OAMXS\9^$?#'@WP987VNQZ[>:5J_A?X?1:=;^"M'\<^%3K*^
M$_B5;>&[32-+L=,;XB:'XIFATZPM=.:5[&%+<>C:5^PK^R;HWA;]G'P5I_P7
M\/IX9_9&\3CQE^SEIEQJGBB_'PK\2J]W)'J>AW>H:[=7]ZT+WLSV]KKMUJUE
M;,EHT%M&;"Q-O]:44!=]W][/FFR_8Y_9AL-(_:)T"#X+^#7T7]K/7-:\2?M&
M:7>6UWJ-C\5]:\0Z5_8NKWWB.WU"\NHT:[L"X$.EC3[:VNYKC4[2&#4KF>[D
M\!^&?_!)C_@G=\'=5TO7_AK^S#X0\+>(M'LO&VEV?B6V\0^/[WQ,VB_$/P9?
M_#WQ7H%_XCU7Q=?ZWJWAR\\&:I?Z#IWAW5;^]T/PY:W#2^&[#2+I([A/T4HH
M"[[O[V?+_B?]BW]EGQI^S;HW[(/B_P""G@[Q/^S?X=\/:#X6\/\ PLUZ+4-5
MT?0]'\+QQQ^'%TC4KV_F\1:=J>AI&G]EZ]9ZS#KUFVYX-21W=FT?V9_V1?V;
M_P!CKP=K'@/]FOX4>'_A9X;\1^(+CQ5XECTNYUK6-9\3^)+J&*WFUOQ/XI\4
M:IKGBGQ'J)@A2&.YUK6;Z2"/>D!C620/]'T4!=[7=M[7/A[]I7_@FU^P]^V!
MX[T#XF_M'?L\>$/B7X]\-Z&/"]AXHO-1\5^']2O?#"75S?0^&?$S>$?$/A^'
MQEX<M;V\N[RRT'Q?%KFDV5W=7%Q:6<,TLCLGQR_X)J?L(?M)^)/A=XM^-_[,
M'PQ\?:Y\&/#NC^#OAO-?Z=?Z;8Z!X+\.W,MYH'@BXT70=0TK1?$/@?1+NXN;
MC2/!OB;3]9\,:=-=7<EGI4+7=P9?N*B@+ON]-M7I^)^=/CK_ ()+?\$[?B7X
M.^&_@'QQ^S#X2U_PK\'_  !<?"_X7Z?-XC^(-I<^!? ]UXDA\73Z1X;UC3O%
M]GK>G3R:_"+LZW%J(U];>6[TQ-472KV\LI^_^(G_  3E_8@^*GP.^'/[-WC3
M]G#P!=?!CX07!O/A7X/T./6/!LGP[OI%N_M>H^#?$W@S5?#_ (O\.ZGJDU_>
M7NMZEI>OVU]KNIW$FJZS<7VI8NA]KT4!=]WIMJSY+^''["?[(OPA7X#+\,?@
M3X-\$#]F34?B%K/P0_X1X:M8GP5K7Q8\,W/@[XCZXS)J9;Q-KGC'PW>7&F:W
MK/C ^(-3N5<7(NTO(XKA/*-#_P""4/\ P3L\,?&N']HGPU^RC\-/#WQBM/'=
MA\3M.\7Z&/$.DKHWCW3M0CU6'Q-H/AVPURW\*:!?W.HQ17>JC1=#L+;7)8T.
MLP7ZJ%'Z%T4!=]WKYO\ S/@;Q]_P2\_8*^)_@W3_  %XX_9Q\+:UX;TCXL^.
MOCEH\:Z]XYTK6='^*7Q.U&/5OB%XHTCQ5HWBK3O%6E_\)EJ$%M<^(-$L-:M_
M#NI-9V*7&D-%96B0]-X _P""=?[%'PIM[.R^&O[/7@OP+IFG?$[X8?&?3]$\
M+3^(=&\/V'Q3^#GAIO"'P\\<V7AZRUJ+1+37M&T!WM;^YM["-?%%RS:KXLCU
MS5R;ZOM.B@+ON_O9^3WQ[_9P_:&_:=_X*(?LO:_\0/AE\,='_8U_8TU[5_C[
MX+^(;>+(-;^)?Q3^-VK> CX5\*^&3X1&FQWO@C2?AQXGU&^\9W-ZU[<:=XFE
MT+PM,MP+VU-C;?H5X"^!WPI^&'C7XM_$7P)X.LO#OC3X[>)-%\7?%G7;:\U6
MXN/&?B/P]X?M/"NC:I?6]_?W=E9S6/A^QM--CCTFVT^WDB@62:&6<M*WJ]%
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MO%?P+\-_"2SGNM1N?B+KWQUB\402:'9:MJ.GWVHF\UJSUA_#[#4JW_C_ /\
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M/B+PWX8TK6KK&9;YFYK[OHH"[[OMN]NVX4444""BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MK?\ !:KX9_##Q7\2K.V_98_:O^(7PP_9TD\(:9^UK\;_  %X)\-:QX"_9O\
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M[TNR\/:9INDR&QN-,DU+7=4\6^'='TBTEE?5;C2]3]G/_@LU\&?VDOC+\"/
M'A[X#?M(^!_A5^U18>*X/V;/VC?B1X+TGPW\,_BQXT\ >&;SQ3XY\$V%LNOW
MNOZ1=Z+:Z5KNDZ=J^HV(TKQ/K^@:I::#->:>VFZMJ0/EE:]M/E_G?H^G1]F?
ML517\]'A+_@X@^#/BKPI\)_B?'^QG^VO;_!CXYZG>_#KX1?%&T^'GA76]*^)
M'[0D-AK,^G? CP7I&D>,;G6=>\0Z]KFAW_@/2?$%M;KH$GCFVOK&YFM_#FDZ
MMXIL?I'0_P#@LS\$4^ ?Q:^*OQ+^#/QZ^%'Q9^#WQS\*_LT:U^RAX@\,:1JG
MQW\4?'3XC:=IVK_"OP%X!T[1]:G\.^);OXBZ9J+7^@W/]MV,<=EI.MW]Y'%8
M6UC=ZD!R273\O3OWT?;K8_8:BOQPC_X+-?"3P_\ !K]JKX@?&7X"?'SX#_%/
M]C?2OAWXF^,W[.OQ'TCPM;?$<^"/BGX@TK0/!_C[P-J&E^(]0\+>-/"-W/J<
M@O=1T[58KG3;W3KG3;RRCGN]'?5/6?V2_P#@IEX=_:<^.NK_ +//BK]FW]HO
M]F'XB77PDC^/WPOL/C_X8T/P\OQ;^##>(K#PO<>*_#JZ/KVL2:7K&EZGK&BG
M6O!NM+;Z[IEKJD<T\>ZTU&*T Y9:Z;;[?YZ[K:Y^FU%%%!(4444 %%%% !11
M7\CW_!3/_@N+_P %%_V9_P#@I5XG_8/_ &/_ -GSX!?&N=-#^'U[X$T+Q!\-
M_B_XS^*7B75?$WPVT_QWKMG%'X)^,_@_3M06Q634Y[6&R\.6\T&EV9-S)=21
M27#A48N3LK;-ZNRLO,_KAHK^+_\ X>W_ /!S/_TB=\!_^(M?M1__ $0U'_#V
M_P#X.9_^D3O@/_Q%K]J/_P"B&I77<KV;[P_\#B?V@45_%_\ \/;_ /@YG_Z1
M.^ __$6OVH__ *(:OJO_ ((N_P#!:/\ ;?\ V]_VY/C;^R/^UE\'/@1\)Y?@
MU\%_B3XNU[2?A]X&^*/A'Q_H/Q-^'?Q?^%GPSU3PGXF3QU\6_'EE;6^EMXQ\
M1VVLZ4-$M-4AUK3;(#4;>*VO+2\8G3DDW>+25W:2?Y']2M%%%! 445^"?_!>
M?_@J3^T#_P $N?A3\ ?'7P \'_!WQ?JWQ4^(7BGPGXAM_C#X?\:^(-.L].T/
MPW:ZQ:3:-#X*^(7P^N;>]DN9GCN)+Z[U&!X JQ6T,@,I!I.326[/WLHK^*W1
M?^"Q'_!REXCT?2?$.@_\$K?AQJ^AZ[IEAK.C:K8?LP_M07-CJ>E:I:Q7VG:A
M97$?[0[1W%I>V<\-S;31L4EAE21258&M+_A[?_P<S_\ 2)WP'_XBU^U'_P#1
M#4KHOV;[P_\  XG]H%%?Q?\ _#V__@YG_P"D3O@/_P 1:_:C_P#HAJ\]TO\
MX.#/^"QOP[_:G_9O_9X_:O\ V./V=_@1)\<?B9\+O#SZ?XJ^"_Q_\'>+KKP/
MXV^(NF^!]5\0>&5\0_M WMKYUNTNIP:??W.F:C81:G9XN;.[CBDMW=T'LY=X
MO1O22;TU/[@J***#,***^=/VP?B[XD_9]_9)_:D^/7@RQT/4_&'P1_9T^-WQ
M=\*:;XGMK^]\-ZAXD^&WPS\3^,]"L?$-GI6IZ+JEWH=WJFBVL&K6VFZQI-_/
M827$5GJ=A</'=1 ;Z=]/O/HNBOX5?@1_P7]_X+W?M/\ A'4?'W[._P#P3Y^
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MJNZZ[=-^J3[/2Y^TE%?@]+_P7+MHO%?BKX3M_P $Z?V]U_:!TCP;I7QC\.?
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MW_V"/VY/@E^R/^R;\'/@1\6)?C+\%_AMXNT'2?B#X&^*/B[Q_KWQ-^(GQ?\
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MULI-7UB:UN[V'2=+2YEB:_U.6RL+Z[CL+02W3VME=W"Q&*VF=#]!<_\ =7_
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MD+]E'4?V>OACK_Q1?_@G9^T/^RC\=O"WPB\':4^K>.?&'PQ^ ,<_P]\4>&?
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MBWUMJFC:UIUEJ^DZG92K/9ZCIFI6T5Y87UI.A*36UW:S17$$J$K)%(CJ2"*
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M=V6EW%Y'?75K;S7$$$D44CK^ME%/K<3EY65FEJ]FDOT"BBB@D**** "BBB@
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MM]7ECU:^TVS&GLMRTT7N-% [Z)=K_C_2/Q__ ."U7POU;XO_ +-7P+\$Z?\
M#O4?BCIE[^W7^Q]<>,O"-GX2N?&UC=^ X/BK9)XPF\3:!!I^IV]QX1AT2:Y7
MQ+)JMH^C1Z7+.-486CR _-G[1G[+OAS_ ()G_MG?LW_MX?L8?L]6'AWX)?$C
M5K/]E_\ ;D^"O[/_ ,)89=+TWX?^+76;X??M#>%/AUX!T0_\(Y>?#;Q+9(OQ
M$O?".AM=^(="N+.U.GF\U?Q#J=[^XOCWXT_";X6:]\.?"_Q'^(?A/P1XA^+W
MBE? _P +])\3:S::3>>//&+Q)-%X7\,1W<D8U77IXI$>VTNV9[RY!/D12%6
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M1?AMJF@);MH7@[6HO#WAN?5/#_@R*\CN1X0M[74;&Q33$!B^8O#WPB^)MO\
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MC/\ NP?_ -;Q^*]?V^5_$'_P6V_Y61_^"1G_ '8/_P"MX_%>@TI?$_\ !/\
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MO=/_ ."5_P"UMX3\%^$/VD/#GQ4^!%]_P4BT/]N+XB_MP^)9IK;Q[I7[-7B
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M\_;N?X.ZG_P36C^(O[-EU_P34U3XZR^-Q\0M0G^($O[4VG_LZW?QCM?CG?\
M[.D?A >&&^'5QKC>+GU#PM9?$*?Q5+IT?@27(\/V;Q6?A2$'>+;UC:]]>S;;
MMYV2M^'4^E_V7/C_ /\ !0;]I#]O/]J#1_\ A*OV??#/[%7[)O[2GCGX&:]X
M:/@7Q1-\9?B-O^%6B^)- 6P\2'5I_#^FS^$?$&O^&-0O-13['_:FFZSJ]I=:
M1*UGI32:W[9?_!0SQ]^QU^T7\=O"/C,>#_\ A3^G?\$UOBK^U?\ !"[N]%OH
M/$>K_'CX*>*[G0?%7PRN-2&JC3];L-;TOQ)\/=6TNU%IIUU:S7>J1W6H06:0
MSS?7'['?[.'CC]GOQ)^VMK'C/5?"FIVW[1_[:OQ _:/\#Q^&+[5[V?2O _BO
MX4_!7P+IVE>*UU70]%CL?%<.K?#C7+B]L=(EUW2(].NM*F@URYN9[RTL?EG_
M (*L_P#!-_QG^W]J'['FH^ _&/A;P=/\$?CW97?Q</BB]UBP;Q3^S%XVNO#E
MW\;?!WAIM'\->)1JOBS6I_ /@:31?#FNIH7A?5Y+*9]8\3:2;&T^TA/N\VMN
M6UOP3OZW37S/E;]G7_@J9^U=\??"'[$>C>%OAOX&U_\ :&\8? []O7XJ?M7?
M"%K-?!DUGXI_9)U&_P#A#X&^'VB:WXC\5OH?PPF^)'Q]O_"^DWOB#Q5J6J:1
MI&A-J#WLVD^?;SV_#?LD_P#!2?\ :IU/]NW]E+]G'XQ?M:?L&_M-C]J/2?B]
M'\4_A#^R];VUWXA_9$\:^ /@[XH^+]CX?7Q]X;\?>.-%\?6$5_X6U3X=ZM+J
MEY+=1W=G)>I/YJQ7%_ZSX>_X(W?$"Q^)7_!83Q=<_%CPMH-A^WK\//&_PV_9
MHOO#EQXFN=4^#&A_&:;QQX]^-*^--%DTK1+.U@\6?&#Q3IVJW%AX3\0:N-8T
M/3+VXU"\L[O4;?2M,XG]FK_@F[^WMX0^.?\ P3V^)'CGPM_P3V^!?PT_8?O?
M&&A:S\,_V;(/B3!K'Q=L?&WP-\8_!CQ'\5]?\0ZA\/-$L+_QE%'JEE?^%/"V
MI6<6V/Q/XSUS7_&Z:O/%H5P%>YKMM\[M-Z7[-I:=M78^5O W_!23_@L9KW[$
M_P"SM^VC<:G^Q]?']M#X]?!C]G#X#?"-?AYXUM[CPWXJ\<^-?'?PO_X2[QCK
M=EXGNF&D^*?$?AJU\0_V39W6MW^EZ7<VEC FGW:WUN_U!^T_^U+_ ,%)_P!G
M.WT+X??&K]M7_@G1^RUJ'@/X+W'C74/CK\4+3P[=WO[67Q0U7QAXV73/!?PQ
M^!=W\1;'QWX"\'^#/!VF>%]*\7^*IO"&ISZMXSO+^Z\*1:II<5YI^D>P_#K_
M ()>?'[PC_P3]_X)A_LI:EXO^#T_Q#_8L_;,_9Z_:)^*6LV.O^-)?!>O^"OA
M-\:_&GQ(\1Z7X U&X^']MKFJ^*;W0_$=C:Z)9>(O#OA72;G58KJ"_P!;TVS2
M&^G;^TG_ ,$^OVNM6_;M^.'[3GP"\/\ [%7C_3?VC?A/\)OAQ9>/OVI=-\=:
MY\1OV1K_ .&&C^)-&O\ Q#\$] T'PYJVG:ROB>37;/Q>;"/Q)X0DO?&.A:;!
MJ-]I%A%<:MJ"5_Z] O&_V5K+IV:4=[K:[U3OZV/!O!O_  47_P""AO[86M_\
M$]?AQ^S7J'[.OP4\3?M<_L.>+_VC/BMXS\=> O$WCW3?A_XF\ ^.-,\*:OJ?
M@+0!XPTZ2^TW7M2V:7I?AC7KC5I-(LO$K7]YK>ISZ )KWPS7_P!H;]L[]L:3
M_@DUXMOO&'P.^'OQN^&O_!13]IW]G+XC7T'PU\2^)? >N?&+X,?#CXW>&V^(
MGAO3V\>:-J<7A'7?AKI/B"QN_#ES)9W0\;Z_;:[93:?H6C1^';W[W_8-_P""
M9'[0O[,7Q,_83\9?$KQ?\&=9TS]E?]B+XU?LM^,T\#ZYXWN[_7O$GC/XW6/C
MCP3K_ABTU_P)HMO/H?\ PA>EVJ^*9=5U+2;_ $[Q1-<6&DZ9K&DQQZN_ V?_
M  3*_;1^&'P^^$NJ_"'Q3^S/J_QG^#W_  4__:*_;3T72/'_ (A^)T'PUU[X
M6?'BV^)/AR/P_JVN:%X!7Q-IWCC1?#WQ!^V7UC9:#>Z+'?VDR67B#4D@@CU!
MA>-].7R=N_.G?Y<OIIYGF_[./_!2[]LGX\?MH:AX&MOB_P#LCZ"NB_M<>,?@
M3\0O^">'Q!\/ZA\+OVE?A]\"O#/B#6M+/QL\+?$'Q?XRTY_BUXYLO#.D:;XX
MO_"W@OPYKNBZK8:OJ4-AINEQ00R:1^J?_!3/XES?"G]GWP+XE@\#_#3X@/J'
M[5_['W@XZ)\5?!EAXZ\-V<?C;]H[X=>&)?$FGZ-J,D<%IXP\,)J;:[X*\0HQ
MNO#?B>QTS6[16N+*,'\T_'?_  3,_;M^-WQK^%N@?'?5_P!C[Q]\,_@G^UUH
M'[1?@;]MZ[T?Q-%^W7/\*O"WQ,NOB1H/P'FM;'PAI_ANPO(?/M_ MQJMOXO'
M@Z#P5I6B74&@7NL:39V,7ZQ?MZ_LW^./VI/@OX1^'/P_U7PIH^MZ!^T7^S-\
M7;RZ\8WVKZ?I4OAOX,?''P1\3/%%C;3Z)H7B&[?7+_0?#5]::!;2V,-A=:O+
M:0:CJ>E6<DU_ $OEO&UK=;=/GI^.JV=]S\6/C;^W[_P5+\/>'?\ @H%^U;\/
M]:_9ETS]FG_@GM^UAX_^$4GPG\5?#7Q<_CKX_>!O!&N>#G\4[O'D/B62U\,7
MOAWPWXNTJS\/ZOHNDB#7?$W_  D,>K&VATBWLI/Z(/BMX\\5Z%\"OB%\2_@]
MX4M/B9XVTSX6^)?&?PP\&ZCKFD^#-,\;^)8/"]YK'@[1-5\2>+=1\/:1X6TG
M6]2&GVVJZSKNHZ9!HNGSW-Y=21-;%*_+OXH?\$Z/C;XV_8A_X*<_LU:5XI^%
MEOXZ_;2_:*^//Q=^%NK:AK?BV+PGH'AOXHZKX$OO#]CX_O[;P/=ZQI>N6</A
M?4%UBV\.Z#XJL+>2:S%EJ6H+),]O]G_M9?LP>*?VC_V#_B]^R9H?C>U\!^+O
MB5\!KKX5VGC*(:C<Z/8ZM+X?M=.D2_6S-EJ=QX8UF6UDT?7%BA^TS>']2O@V
MG73,VGS);:_UN#L[;+6STZ6COWUYO/==C\DOV-?^"B7[4&L_MW? ;]F+XQ?M
M>?L*_M9P?'[X>?%37_B+X(_9:TQ4US]E+XA?#SPBGC:/PBWC+P]XX\;>'?&V
M@W%Q_;?@N:36+^7Q";GP^FH3#39(Y?[<^^/^"E_[1/[5/P8O_P!CGX:_LBO\
M+;/XD_M3?M(R? N[USXM>&]>\4>'/"FA7GPM\?>++OQC%IOAW5M*OIKOPB_A
MM/$HM)&GL]5ATJ32;T6MI?37UM\5?LS_ /!.W]NGPS^TE^P+\9_B+X7_ &!?
M@#\+?V/-.^+W@[Q'\$_V5[?Q]IUW\1=.^(_P4UGX9-\1]5\0ZE\.-)L-6\1Q
M^(K3PEJNF>#+Z&V@L-$&NZM>>.KC7]4ET"W_ %&_:D_9O\<?&[XT?L+?$;PI
MJOA33]$_9C_:+U_XN^/;7Q#?:O::KJ_AO5?@=\4OAG;V/A"#3="U:TO]<37O
M&^DW<UMK-]H%@ND6^HSIJ<EY%;6%VP?+S)JS5G?M?WK7MIV_"[W/R6/_  4E
M_;D^#OAC]HS]EOXDQ? 3XL?MT^ OVV/V:?V-O@C\1-,T/6O _P )?%TO[7GP
M^MOBQ\._B%\0_!$.M37]G_PA7@"S\7:SKVB>&-<1KV72+72-C-87^N:S#\9O
M^"@O[?G[$?@_]M[X,_M%^(/@'\7/CY\&/V/-)_;+_9R^-/@KP'JWA#PKXS\&
M2?%'3OA-XX\+_$CX72^*II;?6/!GB[5M*33+SP_J]I9:GH6JV-SJ#IJ+&-O8
MOVAO^"6/Q^^*?QE_;D^//P[^*/PI\"_$OXA?M(_L*_M8?L9ZWK=MX@\3:?X6
M^*7['OP,@^%VH:3\;M";PO;#3/#7C::\\3Z%'=^"-5\77T'AG71J][933P77
MA#4?.?B[_P $U?V[_P!L;PE^W!\4OVF?%'[,?@_]HSX^?LH:'^Q[^SQ\.?AM
MK/C[4OA%\)_AO9_$+3/BCXQU?QW\1]7\ MXUU?7?'OCG2[74F@T3P??VNBZ3
MIFEV4\^K2-!#X?!KETORVTOWO[NWE\5_GY'K7P;_ &N_VVOV>OVI](^&'_!1
M[X@?LTO\(_BQ^R/\1_VK;;QAX&\-:Y\,HOV<=5^%/B;P)9>/?AMXFU/Q)KNI
MQ>*?!OA_1_B#8"/QGK,6G:U>WE@UQ-%8Q0W5K<T_VN_^"F'C;XA>(/V./A]_
MP2O^-/[,?Q;UG]I;X]^/?@/XP\>ZO+-\2O"/P[GT3X4R^/9M=8>%?$&G;=:\
M':*\GC0:%="\3Q#%8V6C210P:D\X^Z_BY^R7JWQ7_;>^"/Q_U^U^'7B/X+>!
MOV9?VBO@;\0/ GBZ"YUC5?$^H_&/Q7\']:TB./PO>^&]1\*:UX433OA_K=MX
MB36M9M)UFN]-AM=(U2">[ELOR]_X*E?![6OA%^T-_P $FM&_81^'G[/_ ,(O
MBI=_M7?%_P 2>%M%N_!]MX!^%7B;7]-^ &LRZKIGCN/X:Z'!JD5MXK\*:;?^
M$+CQ!8Z=?:KI4%_;7<,<RV*0T"5FUHKV?^'12W6_1?KU-C1_^"BO[8?PI\3>
M*/V6_CE<_"+QC^T-\$?^"A__  3Y_9X\;_%7PGX/UC0O!OQ6_9N_;G\6HWA[
MQCIG@N369$\$_$:Q\/6'BG0+ZVM];UG2])UG2+>Y^PZA;M'?:OYS_P %L_V@
MOB'XK^"/_!6#]EJZM=#E^'GPR_8T_9 ^*7A/[#I=V/%5QXM^*W[2'B/P_P"(
MK>_U 7TT%]IQM/ F@KI-C;Z9;SV]R]ZSW-T+F..'U'Q;_P $R/VS?B?\*_VA
M/CGXT^)GP$T/_@H/\7_VH_V6OVJO!NE>&[7QA??LY^ C^Q?=Z8/@3\&=3\17
M^DVOCSQ#IATZ+7[_ ,6>,8?#UBY\3>(I(['2+NPLKC5M9\\^)O\ P3(_X*,?
MM3>&?^"C'BCX^^-OV5/!?Q2_;8^ _P"S)\*/AOX;^'/BSXNZAX-^#G_"C?BC
MJ?BW4=/UO6=:\!3ZM?P76D7;Z];ZSH,4_P!O\:ZUJ^G?V-HND6EKKM\GL/W;
MIWCHU?UO#5:;?%^.FQ:^+?[1G_!0#X0P_%S]EW]OC5?@5XXL/VN_^"=W[8_Q
M6^$FN_!?PKJO@U_A-\3_ (-_"B?5?B?\#]3&IZ[KD?C[PYI7A;QCIE[H_CSS
MK/5;R]LF\VQEL[V1[#BO#G[>.M_LB?"?XB^,/#OP;^%?B[Q7\(O^"4G_  2N
MU+X=WEOX4MM)^)?Q)^)'QYU_Q+\(/ _@CQ[X^LKF'7O$7PZ\/>*;_1M7TSPU
M"UO)H5M?^,;S3+B*YU:6:+Z='["W_!0+]I;Q9XT^*/[;OC?]FFT\:_#S]C']
MH7]E?]FGPS\$-0^($_A'6OB%^T3X3M_"WQ'^/WQ5U3Q'X/TR^\,KXDM/#GA:
MPM/!?A/0]>MM(TR2\N5C2]TFWM=9QO%O_!(CXL?$GP'\:O 7B;XG^ _"#>/_
M /@G_P#L#_LY^!O&'A.Y\2:[K'@[]H+]B[Q=X@^(UGXWN=*U+PUX>M[KP!)X
MX7PA-I,T&JC7]7TF#6K?5/#^BMY$5X=?E^H7CI>W2]KVZ;?+?Y]3[*_9#D_X
M*?>#OC-XA^'G[:UQ\$?C/\*=>^%>F_$#PS\>/@IX?B^&UM\._BD-<@TK7/@1
MK?@C7O%%]XB\7Z/<Z5+<>(_"?Q"TO2CY$.CWEIXM:QN]>T.QMORX_P""A/A?
MXR7O_!8;X<>(TU3X ^*?!7@C_@GC^T/\4_#W@7XJ_!.?X@V:>"/ VM^"[KQQ
MX;U#^T/&4&E7?C#Q/XJMQ>>&O%T&C64/A?0)+G1KS2]>EN5O;;].OV3?A9_P
M4>U;X\7GQR_;I^)/P;\.Z/X7^#:_![P=\!/V7_%OQ.UCX4>,O%MSXFL]=\2_
MM!^.K7Q[I7AU8/%-S;::GA_P/H5MIEVVA^&]6U$:E=QZDL<=5_VEOV)OBK\9
M/VRM._:(\,>(/A]8>"K3]@;]I+]EB32]>U7Q':^*6^(/QAUK1-2\,ZPEEI_A
M35-)/@VQ@TV=-=U!M;76[65XET_P]J:,\D;$FE)_#\+6FUW;\?30_+?X"_M>
M_P#!1']H'6/V._V5_P!CC_AD/]F_1?&W_!*3X'_MC^)_$UY\&;U_"'PSUS6?
MB3\0_A]-X$^%_P ,_#WB6QT73_#'B"?1O!FE:7ICV%U8^"M!M?%6I0OJ&I3:
M'IX]6_X>*_MK?%O]B;]C#XS6?CK]D/\ 8HF^*=S^T#H7[5O[3WQ_UWPJ?AK\
M+?%_[/OQ(\1?";2/"GPL^&'C7XG^$/$GB[Q!\:?%_A#6[R&T'_"16W@K0XFT
M^>YGUB^TJZ'TI^P/_P $Y_C;^RS\<?@'\3/B#XI^%>L:#\+/^"5'P9_89\06
MG@W6_%NH:O>?%KX=_&CQ7\1M;\0Z-!K?@?P]9W'PZNM$UVTM=+U:]O\ 3O$L
M^JQW,%WX1L;1(KZ;XXE_X)'?M=?#JW_8J\:^$-%_8M_:,\9_LX:E^VAHWB/X
M-_M(ZC\0;[X&V=G^T[^T_P".?C=X-^+/@;48?AOJ]_!\1?"'A[Q)I&A^+/M?
M@..>(V5S;^&K_6S9:;>RA5XW^SIJM-_CO>__ &[OHM-]3B/ 7_!6_P#;6^+/
M[/O[/6G?!OQ7^RI\2_CIX^_X*6_$3_@GMK'QHT_PMXT/P0\::!HOPLN/&WA7
MXZZ'H(U[3=4M-NE:[X9\:ZEHNEWUU8:]#IEYH6F0Z--K'V;2/8I?^"D_[;OP
M,\'?MB_LZ?%)/@=\:_VU?@Q^U;^R-^RG\ ?B!HWAK5_AY\)/B+XF_;A\.^&?
M$GPLU7Q_X/3Q'/JVGMX(TS5=8U#Q-9^&M2B&H"TLM*@=(K;4?$\\WP'_ ."2
M?[77@'7OA=X@^)GQ*_9V\3:SX9_X*W^,O^"B/C34O!,GCSPII-SX"\>? +0_
MAQJ'@7P5X+N? U_;Z)K7AKQ;IT]KX;T"Z\22Z W@B'3KB;Q19ZI')HR^Q_'_
M /X)9_&SXM_%/_@H'\7?"?Q)^&?@OQQ\9?V@?V!OVH/V/=?OAXBUZ/P/\6/V
M*?AGX9\-1CXQZ&?#%FMEH?B/7]'U;3[1_!6M^)+Y/#VK1ZQ=+'=VT_AB] ]R
M_P!FV_XK\+7T72_D<)\<?BE_P45^ 7P_U[PE^V?X(_9?_:5\'0_M(_L%Q?"#
M]H"#X6Z#9>"M<N_BE^TEX1\'>//"6N_!/7?'6OZWH/Q*^$LL^F^+/A=\1[#3
MX=*M;J33=9-_+XBTY+*+Q+XV_M^_\%2_#WAW_@H%^U;\/]:_9ETS]FG_ ()[
M?M8>/_A%)\)_%7PU\7/XZ^/W@;P1KG@Y_%.[QY#XEDM?#%[X=\-^+M*L_#^K
MZ+I(@UWQ-_PD,>K&VATBWLI/I#QW^Q!_P4J_:H/BWQY^TW\5_@5X2URY^*G[
M%]_\-OV=?A;\0OBYJ_P"\#> _P!F[]H;1_C1\2_'6H7FO^"+>YUGXW?$B&SN
M]*T._@\(6T4.B6/A[PWK?BJWTZ-!H/IGQ0_X)T?&WQM^Q#_P4Y_9JTKQ3\++
M?QU^VE^T5\>?B[\+=6U#6_%L7A/0/#?Q1U7P)?>'['Q_?VW@>[UC2]<LX?"^
MH+K%MX=T'Q586\DUF++4M0629[==5\Q7BFK\KU5[;6;5[?*^J^1X7\:?VUO^
M"A_QF\>?MO>//V#];_9[\/? ;_@G[I>EZ=J/A/XM^!O$_B;QC^T_\0+?X6:9
M\8?B/HMGK%CJVB'X967A;PWJ]GX>\'>5!=R:[XJ'G:W=P:/J!.A?L%^QG\6/
M%/QY_8__ &4OCEXX32X_&OQG_9L^!GQ8\81Z':2Z?HD?BGXB_"_PMXO\0)H]
MA/=7T]EI::MK%VNGVDU[>2VUH(89+JX=&E?^8S]K7Q%XU_92UG_@K!X-_9Q_
M;!_9/^$VB^,/A!X%U3]JWX7_ +1EM\0/#OQ@\ ?$_5/V;K#PU/XL_8\M-)6T
MTKXNR_'?PG!HD.F7VI*3HGQ'N[6U%LMQI8T:Y_63]@OQS^TMX(NO^"9O[,=Q
MH/ARW^"-G_P2*^$WC/XN6EUX;\2#X@_#_P",_@30?@UX#T/2];\4.L'@VQTO
MQ5;:WKMEH/AFSN=6\47]_P" /'6I7MII.CZ197>JL&O=327Y.W*F[]]7_2T/
M./\ @K_\-_C%\2_VE_\ @E;X<\'^)?@M!X-UC]JGQ!86_A?XN?"&Z^*&F-X_
ML/@7\8->7Q#K=D_BW1=-UCPY%X0TW6-,L/#SV,-Y9>+KG1?%*:RT.D-I5UX+
MJ'_!1G_@H;:_ CQ?_P %2=#TWX##_@GQX%^-7B+PK:?LOCP3X@3XY:]^S#X*
M^+\OP.\0_&V+XEQZ^ECI'Q$M-;TO6?%5GX";PQ_PC4'A;3WVSZHXLI-1_8W]
MJ3]F_P <?&[XT?L+?$;PIJOA33]$_9C_ &B]?^+OCVU\0WVKVFJZOX;U7X'?
M%+X9V]CX0@TW0M6M+_7$U[QOI-W-;:S?:!8+I%OJ,Z:G)>16UA=_DIK'_!+?
M]O2;X->+?^";.D_%']G!/^";WC7XXZ_X[N_B-=2_$:V_:FT+X!^+?C)+\;?%
M'[/EAX8LM$'@2]UR^\4W^IZ/;_$>3Q;:(?#&H7\ATNQN/L.AP )JR3Y=._;F
M;=O.UK=>Q]'_ +*_[1_[?_[37[>_[4.@6?BS]GGP[^Q9^R5^T;XG^#>NZ+_P
MA?B.^^+GQ.T_5/A9:>(_#O\ 9/B&+69M$TV[\(>(;_PQJ$VL!K2VUS2?$NL0
MRZ5-)HFG17_I'[:'[0?[7GB#]KKX*?L%_L1^)OA7\+?B)XL^!WQ$_:@^+_QI
M^+G@R]^(.G>#/A3X.\6^'?AOX7T;P=X,MM:T2VU[Q!XL^(/B&+3];DOKDMHF
MB1PZC9Q2LUP8?;_V,/V5_B%^SK\5?V\_'/C;6/!NJ:3^U'^UAJGQV^']OX6U
M#6[W4='\(WOP]\$^$XM.\8PZMX>T.VT_Q&NH^&[Z:2TT6[\0:8+*6TD75WGD
MFMH/AO\ X*)ZM?\ PH_X* _LN_&?X$?M"?L\_ _]J_4_V<OC1\,O^$5_;*M_
M&WAO]FWXW? "'Q?X2\6^(]&M?BIX3MU?PY\3OAIXWCT+QI:>&X+M;SQ)H]W$
M]U+I^F6$T>K@M'+1+2.FFE^5:OOK>_\ D?'.C_\ !37_ (*C^./"GP/^$NG:
M;^S+X-_:I^*/_!1+]JK]A3QG?W7@[Q?JGPT\%1? [X=:5=2^-] MX_$FH:IJ
MC>&]?D\0^+K1KQ;_ $_Q3IFG:3I%U#9V5W<ZG7NMQ^U#_P %</B5'^T[?_!/
MQ;^RI:6G_!.KP[H'P\^,,/B;X6^-=3'[7?[3/@KX.:'\4?CMH?@FXC\4:-_P
MJGP);2Z]IOA[P+=A9]5U34+NTUO5HO#^DZI_9&A?-W_!+3]D_P"-O[0.@_LZ
M_M2CXE?#7QYX?^%O_!6+_@H/^TAXS^)20^*/#-E\=O#'Q$T#5_A''\1/@[HD
M/AW6["XTWQ7X^LM8U^TL=6U_3-/T_0&>WCUN^U6SFT\?='QG_8A_X*'> ?BG
M^VE9?L/^/?V88O@=_P %!=13Q5\0KCX^W'Q*A\??LY_$S7_AW:_#/XF>.?AM
MIGA/0M=T#XA6OBGPYHNFZOHNC^)KS2HM+\8Q:-IMQ:)X4T_4;R]7]?F4^5.U
MHIKNM+\RNM?[M[?YVM\>?'7_ (+$_M"_$+X@?!ZP^!7QH_9?_8E\/_$C]C/X
M.?M2_!O2_P!L+PCKVIZ7^U/\0?B?:ZUJ&L_!JS^+TVN^#_AQ\-="\"ZGI&F>
M -6UJ[U?3]=OM<UJZUK2KJ\THQ_V!W?[8/\ P4O_ &R?!?[17A[X Z5\9_V-
MOV'/'.F_LJ?"'XZ>&?#O[2FE:KXM\"_M1_&+QUIVOW/C/X1>$_CM/XF\(_#C
MP7X$\&>*/#2?#^W\5MJMOJ^NW^LR:MINH7,0$&A]Y\=O^"97[8_A_P"'WAO]
MFCX#)^R%^U#^RD_[*/PJ_9PTWP#^VKIGB*RO?@!\0?AOX6U/PE>_'WX6)X3\
M&^,UN;_QTEY:>+_%=@-0L-=M?%>C:#;Z'>1Z7I=I):9'Q4_X)E_MX>'O@]X)
M_9D^'NL?L??MB_L^R_LD_"+]G:Y\,?MHZ3XET^7]G_XG_#CP?J'@_5/C9\%$
M\,>#/&5Q/IGBE+JPU^^TG4M3C\6:7JWAGPK9:1JPL=,6>)A[FGP]=_S=UOY/
MSL]C]SW^('Q$TO\ 9P;XIZS\/H=1^+&G?!(_$#5?A3X.UB'Q%;WWQ$M/ A\1
M7WP^\+:_9&XM]=ANO$L<OAS0]8M#-#JB/:WL!D2=-WX3_P#!,?\ X*+_ +8G
M[57BGPUXGU'XY_L:?M0^'_&WP=\?>-OB5^S?\+[5O@+^T'^RO\6-#TBPU?PE
M\+Y_#WQ%\77_ (A\>^&-9\0W.I?#75?'%[HTVBZ3JEA!XB;Q/-HZK/KG[*_
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MQ:V5K=W7WK09NUW;;^OUN%%%% @HHHH **** "OX@_CM_P K>_P;_P"Z>?\
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M$95X?W;.VG6]V_\ P';R_$\.N/\ @M'^U/9_!WXS_#[X6?$K]D#]J_\ :/\
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M[VNU9']=U%?Q!_\ "B?^#O?_ *+)_P"9#_9&_P#E11_PHG_@[W_Z+)_YD/\
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MYGL[RS^"'Q7NK2[M9I+>ZM;JW\!Z_+!<VUQ"R2P3P2HDL,T3K)%(JNC*R@@
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M(@JJ_P"/_ _S"R;=M%S67W2?_MOXG];->??%KXG^$/@E\*OB;\9_B#>7.G>
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M7]QIP_M<_IQXC^'/P]\8:]X+\5>+O G@WQ3XH^&VJW^N_#OQ)XC\,:)K>O>
M=;U33)]%U/6/!>L:G8W6H>%M5U'1[FXTF_U#0[BQN[S3+B>PN)I+662)OY1[
MZ2V/_!M;\<XHQX=;XI2?M'?%VUU>-HKADF^.\O\ P4_U!O":2IJ"'4)]6\UO
M!C:<TP>_CL$T\SLKP3;/Z!O^"EGQ!T;X7?L)?M,^-->^.?BO]FS3;+X=3:0?
MC5X#\+2>-/'G@R^\6:QI/A'21X%\-PZUX;GU#QMXCU;7;'PGX1>W\1:#<Z?X
MBU[3=3M]:TN:SCOH 32NDKK5QZN^VMOF]$?<E%?Q>?#BYU3X(?'[XY>$OA)\
M#OVV_P!CKX4_%C_@D_\ MJ>++SP-^UU\=;CQMXX^,'CSX6:'X9'A[XU3_#Z_
M^)7Q(\0?"CQ_IT6KZI#?S)J>B6UP;F]M_"6F:;IMEKT$WI?[/7PSUK]DG6?^
M"'?[4G@7XO?'WQU\6?VV/@[KR_M*VOQ$^+GCCQMX3^*NC^(?V/;KXV>%_#$_
M@W6M4U'3-%MOAWXACT32O R^&(=*CM+/0=.EN[*^O#*[@.'GTNM-]&^C:6SZ
ML_IM_:1_:2\+?LSZ1\(]8\5Z#K^OP?&#]HOX'?LVZ)%X>&G&73/%/QV\<6'@
M3P]KVJ_VE>V2#0-'U#4([S63:-<ZC]C1_L-E=3[8C]%U_%QX1_9NL/&O[+__
M  24_P""D?C+XW?&CQC^TW^TA_P4L_8H\6?&_4/$'Q4\9ZM\._B!8^._VGX)
M]*^'UG\+]3U<>#O#.F?".?1M+_X0;_A'-&@FTFWTO7;)VO\ 3;S39-#_ *)/
M^"L_CKPYX%_8>^)9\2_&CXO_  ,M/&/B#X;_  _M/%/[/GA6X\8_'CQ+?>*_
M'_AZR'PN^$.D6NO>&I8O&WQ2LDO? ]GK UFR_L*PUK4=765'LT= '%)I)W;;
M3T>Z:6BZ]?7R/N3XL?$WP?\ !3X6?$KXR_$*_N-+\ _"3P!XR^)OCC4[6PO-
M4NM.\'^ O#NI>*O$M_;:9I\5Q?ZC<6>BZ5>W$-A8P37EY)&MO;1232(C2?"W
MXAZ'\7?AE\.?BOX9@U.U\-_$_P ">$/B'X>M=:@MK76+;0_&GA_3_$FDP:M;
M6=WJ%I;ZG#8:E;QW\%K?WMM#=++'!=W,2K,_\8>M_#NTMM+_ ."K_P  M.^!
MW[77[)7[/GB7_@CS\1?VH]$_9V_:(_:*U7X@>+[_ .*/P@\>>(-8\+_&:.QA
M^*7Q)\5?#[3_ !9K_A:71_%O@W7_ !4UKXX33?%.G:K87WA34(=+M?Z>?^";
M7PS\$_ 3_@GC^S#HOA6_U73O#S_L_P#@+XDZIJ7C3Q/KOBPZ?JWC?P1I7CCQ
M1>S:GXBU6XO;;P_::KJE_/8Z-#?VNF:'I$<6EZ6EA86L$<2_K\O\PE%);W=_
MP:OW>OS9]_45_#AX1\:/I_Q1_P"">G[2WP.T;_@HEXQ\0?%;_@I/\"OA_P#$
M[_@HY\?_ !_JOPQ^%/[4GP\^,7Q=\0^$-3^'G@K]FS5/C%XWMKCX;ZMX1NK[
M3/!L^B^!O"2Z#HGAYY+O[)!>6FEP?T6_\%E/&7CC1/V4O _PX\#_ !!\0?"3
M_AIC]JS]F#]E[QK\4_"FJ1:%XE\ ?#3XT_%+2?#OC[7=&UR2>.31[F?P\EWH
MDNHVL%[<VUEJ]TR00IYFH63!PLTK[WZ;6>NEW]V_DCW3XR_MV^'?A+\<_BS^
MSSIGP;^,/Q7^)7PL_8S7]L^+P_\ "[0K'Q-K'C[PQ/\ $GQ-\,++X;^!?#]O
M?_V_K/Q&U#6_#%S<66GKIRZ?<VMW:1Q7SW;26Z?;ND7[ZKI.EZH]C>Z8^I:=
M97[Z;J4)MM1T][RVBN&L;^W.3!>VAD-O=0DYBGCD0\K7\='[4?[+?@W]A7]H
M'_@IUX4^!'CWXF)X=NO^"%7B3QWX4T_Q=\5O'?CWQ;\,-0_X7EK^CWUAX9\5
M^+=<UCQ-I.@:QK>B7_CJRM(M96*U\6>)_%]Q86FGVLUNCV?V^]#\:>'_ (Z_
M&+XZ?'CPM^V+\2O@'I/P>_9JU3X+_M1?L5_'_6]8\1_\$ZM3\*?"K06^(VI_
M$3]FG0?'OA:SN;C6?%@UGXG:UXQ\<P7&EGP9K)>R>[N+748]-/Z_(.5.UGT7
M35NRZ77?OZ7T1_8_17\R]G\&?"W_  5'_:&_;W\1_%[]IOXT>%_!_P"R]\+O
MV:_"W[)WCKP7\2?%WP5T+X53_%7]E_P]\=-4_:^U3PKX.\6^#M(U/Q+XCU;Q
M1:^(["T\5'3M T[P7I*Z)J5G%(D<^@<K\.O@1:_\%(OBK^V_J?QH_;&^)OC=
M?V,OAU^SC\+/V6?C)\$/B]XP^&/@73/$5]^S1X:^*GB+]LNRTOX6>*+_ ,*^
M)M;^+?C'5Y/%5I-]L\7Z+9>#(4T*P;6XK70M;C Y>[V2;T>E[6]=]=GOHS^A
MOXA?LM?LR?%OQKH'Q)^*W[.?P(^)OQ%\*?8_^$7\??$+X1?#_P :>-?#?]G7
M2WVG_P!@>*?$GA[4M=T?[!>JMY9_V=?VWV6Z5;B#9, X]WK^9O\ X)3?M&?%
MG]H[]L[]F_X@?%'Q;JVN:YXU_P""%?P6\5>+(GU"[72==\=6'[8?Q6\'ZGX[
MNM&$PTM/%/B2ST*"YUG4K>TBDDEGEMH?*L8X+:/XK_9@^%VH?MD^!O\ @A_\
M(/B=\7?C1:?#KQ[;_P#!:C7/BS:^!OBUXZ\&:[\4M!\ _M,Z/'X4\)^(?%OA
MO7;'79]!L[V723L6]:1-#L;C1M/FL8;TS1']?E_F'+NF]O5])/17_N^6Y_5]
M\=_VD/AI^SHWP7A^(T^M)=_'[X]_#[]F_P"&UGH>DOJDVI?$OXCQ:Y?:-!J$
MAFMK32=%L=%\,>(M=UC5KZYC2&QTB:UL(=1UJ\TO2;^_^T?\?_AY^RO\"_BC
M^T1\5[C5K?X>?"/PEJ'C#Q0V@:7)K.N3V-CY<<5CI&F)) MWJ>HWD]KI]DES
M=65BES<QRZA?V%C'<7D'\BOQ7_9G\+?$#X;_ +)/P+^)7CWXT^/_  E\!_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MT+38-3\17T$NI:E?K?ZE-+!/J-Q;1?-7PS\->)?VH/BM^Q+\!/&/QB^,FA^
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MFC3[?:^)?$+2W*37LTDI_7X7'RII/;1-O5W;\KVZH_KTHK^++X-?L01-=?\
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MK;6-C;6]G96=O#:V=G:PQV]K:VMO&L-O;6UO"J106\$2)%##$BQQ1JJ(JJH
M_B+TGX&Z=\)/B1^V%\-/@U\0OC1\*V_:4_X+3?!S_@G5XT\?^'OBIXWU#Q-X
M<_9U^)'@#0/BKXV31;_7-;OX-,\=^+=7\'6G@B'XA3))XA@T?Q&OAF*XN='>
M'1)O;/V\_ _B3]B!/^"@G[%O[-'Q<^+-E\'_ !]^P5\"/VGO WASQG\6_'/C
MG4_@)\7X_P!L[P1\#KN;PAXW\4^)-=\?Z!X>^(VBW<>L7M@ESJL<^H>&]6D2
M6S@M["PO5>PW%723MMT?]V[>NGQ;=E]_]A]?G/\ #_\ X*:_ ;XK^)/V+=(^
M'.B^/=?T/]N3QU^UCX$^%GBN[TG3]#LM*N_V0XOB ?'.L>)M+U'5%UJTT?Q3
M<?#G6D\&>193:M-;W>EW'B#2]!FFN[2R]*_9P_8;^%7[-/[.?C#]F?PWXN^,
M7CCP=\09?&EYXT\3_$WXG>(?%?Q%U;4_B'X>L_#WB_4+3QF\UIJVA3:C':R:
MI:_V/+:-I>M7M[JEA)%=W#2U_(C^Q]^QI\-/B3\._P#@AA\-G\3_ !8\*:1^
MT#^TW_P5>UKXFZGX3^*?CG1?$-YI?PQL?BSX;E\*^&=>L==M]5\#:'XY\!_"
M_3_!?C6/PA>:/-K5IX@\5:O<R2:WKNH7LY_7XB44[ZO3;3I:3O:_EL?V\_#[
MX1?"?X2Q^)XOA5\,/AY\,HO&_BG4_'/C./X?>"O#?@R/Q=XUUID;6?&'B=/#
MFF::NO\ BG5FCC;4_$&JB[U:_:-#=7<I5<>AU_$3XV\?_%OX1^%O'?\ P39^
M%^J?M->//@:__!8?Q?\  72_#?PX^*5O:_'[4?V<M"^ /ASXP7?[,_@[XO\
MQ \3>'HM$T?Q+XHN)7L[F_\ $VG>(9O#MOXDT4:UJPU&2PN?VE_X)&Z=\:/A
MM\8/VOO@OK'P?^._P._9ET^/X1?$7]GOX3?M*?&OP;\8OB?\*=7\5VGBVP^*
MGA+3=1T;XI?%?Q;%\-=:U+2?#WBGP@OB[75GM-0N_$OEW6L7.I7ES;L'&RO?
MT\UHN][Z[6V6^Q]!_M5?\%-Y_P!GO]H74?V</AI^R%^TE^UAXV\&?!.R^/GQ
M4'P'T71-6N/!'@K7]<UWPSX0L--\/WVH0^(?'7BOQ'K?A^Z@30?#.G2M:6=U
M:7_VJZCMM=31/T]TB_?5=)TO5'L;W3'U+3K*_?3=2A-MJ.GO>6T5PUC?VYR8
M+VT,AM[J$G,4\<B'E:_CF_X*@?LW^!/!_P"TE_P6"^/'A?7OBMH/Q(^'?[!/
MP+^,7A35-)^+WQ%L+#3_ !M\7_&'QT^&_C"9M%M?$46EW.BIX:MP/#?AV>V?
M1?">KW%YKGAZRT_5;RXNI,[]M'2_'O@;XW_&/]H;]HS2?VQ_$?P?L;+]G+4/
MV?\ ]N[]CCXV:SXYM_V"K+P?\/\ P)<>-_"/Q0_9AT3QGX>\/6++XN;4O$OB
MO6O'6D:U%JVD>,X]8@M]4U:\N;&8'RIVL[::]V]':S?GTUTV;/[.Z*_E_P!*
M^!GAS_@I1XW_ ."F7[2GQ9_;$^(OP7U+]F7XMK\*OV4OBOX-^+_BWX>?#?\
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MB2-[7Q1X)\ V&C>"O!<5C!XFTLQ:%KNMZX=?\37VA0+I)UI+.>]BNL+X!?\
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M\T!]/?X8V'A70&\"6]SK.N^";KP9X=\,RW?B;Q%K6J_$7_A8 EL[:R^DK/\
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M_"OC'P]XS^&GB,>$OB+X \<^"-;M?$'A+QMX'\12V&K6FE^(]!U.U2:RGO\
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M_P#"1V]Y:6VK+=WVE7VG76H1'^T=+O;&:XLIOH"B@+O37;5>6W^2/R(\;?\
M!'#X-^,_^$8UB+]J+]NKP;\2+3X/0? ;XI?&;P3\?M,T?XJ?M)?"^SU35=3L
M-"_:!UVZ^'^I:7XPO]-&M:CI6F^)]!T+PEXIT_07MM$L]9AT[3]/@M?TK^#/
MP?\ AW^S]\*/A]\$OA+X<MO"7PV^%_A31_!G@WP_:R33KI^B:):):VPN+RZD
MFO-1U&Y*/>:KJU_/<:CJVIW%WJ>HW-S?7=Q/)Z910#;>C?\ 7]?=TL?EI\*?
M^"27[/\ \'?B1X=\?^$_BE^TC<Z3X)_:<\4_M6_#WX3^(?B)X;UOX2_#GQ_X
MV\+?%3PMXM\/>!?#-QX"74?#O@3Q"/B[XCU_5=)M->_MJ]\1:=X>O)_$3V=A
M<Z??]C\5O^"7/[,GQKU7]L?5OB++\1]9N?VU?$7P&\9^.6M/%.GZ%=?#'QO^
MS;X&TGP+\*O&GP0UO0?#VF^)/!?B72+;1;'6[R_UC6O%27VL&\MF@C\,ZC?^
M'+C]&J* YGO=W_X-_P SX*_9*_X)[?##]DSQY\1OB_%\5OVAOVB_C?\ %'P[
MX4\%>)?C9^U%\1]/^)GQ'M_ '@H32>'O 6@ZAH_A;P;HNA^%H+^XFUG4+6QT
M)+[7-;==5UW4-2O(8)(MS]H_]A+X9?M*_&GX$?'W7/B%\;OAI\1/@)9>,] T
MB[^#WCJP\(Z;X_\  _C^;P]<^*?AS\4=/U'PWXA7Q-X&U2Z\-:=/=:/8RZ'+
M=L9XKZ]NK8PPP?;-% 7=[WUV^5K6]+>1\"1?\$Y_@E#\$OV'O@*OBGXJ'P?^
MP)\5/@_\7?@[J3:WX2/B3Q+XD^"GA+Q;X,\*V/Q+O!X'&EZQH>H:7XRU2?Q!
M;>%M'\&W]U?P6$NG:GI5O%<6MUX'K_\ P1:_99U_XG:KXM?XB?M.:7\'/$7Q
MPM/VCO%/[&>C?&%+/]D'Q/\ &.VU@^)YO%6K?#!_"]QX@CM-1\7K;>+=1\(Z
M5XZTWP5<ZWI^F >'(]+T^UTV/]=Z* YGW?7\7=_B[_E8^%=9_P""?7P9USX-
M_MN? ^[\3?$Z/PG^WM\0_B3\2_C!J%OK/A5/$/AO7?BC\// OPT\06GPVNY?
M!<VFZ/I-GH7P^T:[T>#Q1I/C&\M]7NM3GO;_ %"SFM+"R^OO 7@[3/AUX%\%
M_#[1)[^ZT;P+X3\.>#M(N=5EMY]3N=,\,:/9Z)83ZC-:6MC:S7\UK8Q27DMM
M96=O)<-(\-K;QE8DZRB@+M]?/\+?DD@HHHH$%%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% 'Y _P#!9C]FSQ9^U;\&?V4?A'X=\*^/_$^A7_\ P4+_
M &3M2^*=U\-7U*S\4>"_@]%XCU[3/B+\0(-<TE&O?"L'A+0M6DU%O%<>S_A'
M[@6VHB1'A0UV&@?\$A_V98?A!^TW\+/B;XS^/W[0^N_M=:9X5T;XT_'3X[_$
MJR\6_'35-+^'3P7?PLL-"\6:-X6\,:!X;M/A=K-K;>(O!MKI?A**WCUVWM[W
M7HM=6"&&/1_X*S_M$?'S]F[]FWP)XB_9J\2>%/"/Q5^(_P"TU\ /@9I/B3QI
MX7B\8>']'M/B[XS3PG=ZA>Z%+-!]J6S>ZM[D^5(LXCAD2$B1PP^7=*_:0_X*
M9?L3?'[]E[P5^WUXF_9G^/W[._[5OQ9TG]G'1_B]\$?!?BKX<>/?A=\>?&UO
MK5Y\+=,\2^']5U*;0-=\)>.;K39?#J76GV$-U97<:W-Q>64UK!9>+ M<W*K-
M+5M*^KLTWTZ6[Z]F>@Z)_P $/OV=[6Z^-.N^-?VBOVU?C/X\^/G[+7C[]C_X
M@?$SXT_&?PK\0?'4GP@\=Z]X'\0+!HFH:C\+X=,T76/!]WX%M8O"+6FC_P!@
M1KK_ (IOO$?A_P 2:UJL>JVG8?"7_@C7^SA\+8/$D.H_%S]JGXQM<?L]_$#]
MESX5S?'#XNZ9X^'[-_P7^)VD2Z%XN\,_ 6R/@G2M+\-W-[HXTS2;?7/%=AXU
MUFST70M)\/P7J^'Q?Z7?_2NH_P#!1_\ 86TG]I"#]D34OVG_ (5V?[1EQK%O
MX;C^&4VM3#45\47D,4UIX3GUD6A\+VOBZ[,\%O:^%+G7(?$5Q?S0Z;#IKZA*
MELS?BK_P4A_85^"'QUT#]FCXL?M/?"WP-\<?$EQHEI8> =:U>X2]L[OQ)Y1\
M/V?B35;>SN/#W@^[UI)[6?3+7Q;J^B3WMM>V%U;QO;W]G+."O/;757VZ+MIM
MZ:'A5K_P1[_9&E\->(?!?BQ_B9\0_!WBG]B+X&?L%:WX9\8>)/#IT^Z^$O[/
M,D=W\._%T5QX:\'>&]6LOBO;ZM;6&NWOB:QU*VT)-9TVPO=&\*:.8-C>F?LE
M?\$Y_A?^R;\1?%GQC3XO_M(_M&_&/Q1\//#/P?M_BG^U%\2],^)'C'PC\(?"
M=VNJ:9\,_!USH7A'P3IFE^%KC78XO$>L&ZTO4=;UKQ!'_:NIZS<W,D[2]7\1
M/^"D'["OPF^/6E?LP?$?]J'X3^$/CQK%[HFF6_P[U?7FCU.TU7Q*+%O#VD:[
MJ,5M+H/AK6-<CU/39])TGQ'JNE:C?VVH6-U:VLMM=V\LG._%[_@J5_P3V^ G
MQ%N/A+\8?VL/A/X ^)%CXNB\#:KX1UW5+]-5T'Q'/I/A[78H?$BVNG7,'AK2
MY-)\4Z%>+XDUZ;3O#92[EC_M?SK#48[0#WWI[VNNSU7W;>AQ7QY_X):_!KX[
M_'3XA_'=_C1^U/\ "#5/C;X'\(_#G]H7P+\"_B]:?#_X?_M >#_ ]GJVD>']
M*^)5L?"6L>+HOLWAS7-4\+O=^ _&/@B\;0KZ]MTGCN;_ %"[NO-E_P"",O[/
MNC_"W]G/X?\ PY^.O[7GP9\7_LN^#?B#\,?AE^T!\(_BYX:\'_'6;X3_ !)\
M4:AXLUOX6^+?$,?PYO/!_B/P;IVIWEDOAF*X\"PZWX?30M)N[#6DU@ZKJFJ=
M)\6O^"I/[,GC+]GW]OB__8^_:-^%OQ._: _9+_9?_: ^+DF@:++)KL.BZ[\-
M? 'B?4-(UX6U[:VND^-?"VF>,-/TBPUF_P##=]K&AQS7UAI]]?P-J]@+GT3]
MBW_@I1^R5^UY%X<^&GPZ_:.^%_Q%_:&T;X9^%_$WQ,\!^&+^2WU"VUDZ'H[>
M,KC0H;BVM]-\0:=HFOW[VFJ2^$[[6[+19)8(+V>#?&6!^_:^MEY;::7TVL^O
MH>4>(O\ @C9^S'_PC'P5T?X+_$;]IC]E'Q9\#OAKXM^#V@_%W]FGXMV_@KXK
M>+_AKX\\0:GXT\9>%OB7XA\2^%?&NF>-(/$'Q"UK5_B1<:E?:#%K=CX]U&Z\
M2Z/J>FWK(4I>)?\ @BW^RLWAOX.Z+\%O'_[2W[)NN_!KX.ZE\ ;#XB_LQ_%V
M+P'\0/'?PDUK6=4\4ZQX0^)NK^(/"_C/3?%<.H>--?\ $?CAM5&C:=KEGXL\
M0:EJNF:G8D64-G]/?"?_ (*._L+_ !U^.&N?LW?"']I_X4^/_C;X?DUJ&\\!
M>']<>XO[Z;PVMU)XA@\-ZE):PZ%XPN-#@L;Z[U:#PGJNM3:?8V5W?W216=M/
M.FM\"?V_?V-_VG/B7XB^#WP"^/\ X'^*?Q*\)>$V\<^)?"OA9]6N;S1?"\>L
MV/A^74;^YN-+MM-AD@U?4]-M+C3OMIU2W&HV%Q/91VMY;SR KS\]-=5W[W6W
MK==CYG\>_P#!'O\ 9EU_P7^R]X2^%'CW]HW]E/4?V0_"WC/P/\(?B'^S'\5X
M_ ?Q'7PA\1S;77Q!T'Q7XB\0^&O&D/B6W\9:W;'Q/K=]=:;%K#^([K4-3L]2
MLVO[N*6_^S[_ ,$B_P!F?]FG7?V;-<^'?B[XWW3?LK_%W]IKXR_#6P\6^,_#
M7B.WO_$'[5/@>[^'_CW2/&>H3^!H?$7B'0= T*\>7P;+_;EEXGBU.-+[Q;XE
M\7L]Q'/XO^W3^T5_P4J\ >*_VJ/B!\ M.^!'P;_9K_8E^#>@?%VZ\1?M">"?
M%.O?\->Z\_@WQ!X]\:>!_ WBW2?%OAS2/ _AKPKIFDVG@V;4UB;Q!_PL2^M(
M);Q=$OM]AY)_P4H_X+(>-_V<_P!AOX:_%;]GSX+^,M7_ &A?CM^SA\//VBK.
MVUCPCJFK_#_]FSX;>.;/PW+?>,OB_K%S9Z;IIU'3]:\01>!_"_A2[:PO=<\6
MRK->VL-I9'2]4!KG=DG>[[K2^NKMVDWN]WUT/LCXF?\ !);]GCXG^&OC]H-]
M\0_V@/">K?'W]K#PC^VE+X^\!>.O#'ACQ_\ "3X[^!=,T#2O"VO_  :U^'P%
M<1>&[;2+?P_!+9CQ%8>+M5MKR]O;RVU>&X73WT_;\&?\$MO@5X+\<_"GXBQ_
M$3XZ^(_%7PD_:>^+G[6NDZAXI\4^"=1D\2_%+XU?#FS^&?C*'QC+;?#JPNM3
M\-_V19KJVG6VGW.DZZGB&>YO-1\0:E92+IR?I57P)^W1\3OVPO#<W[/_ ,(O
MV+? VAW?Q&^/?Q,U7PQXI^-_Q!\$>+O&WPB_9U^'GA/P=K'C+Q)XX\<V7A:?
M3+<:QKHTVV\*_#[3_$7B'0])U_Q3J$.D)/=7]Q:6S DV]+_?MMKT[+_@7/C7
M_@I-^Q;X-L? 'Q[^+FA_L_\ QH_:LN/VD?VE?V:?BE\>/ WPQ\4II/QE^$6D
M?!7X66GP?T/XR?L?+X9TO1/$*?%GP%9^'O"OB"'0-8USQ"WB5[_Q=9Q7&FZ1
M?II]IYK_ ,$:_P!FKQ3X0_:*_;?_ &I9_AW^V#\/?AM\9M(^ _@#P%J'[>VI
MZO>_M6?%O7/AWI_C+4/B'\3?B+I?B&^N-:\-:2+OQ)X<\*>!].EM;"TN= T3
M=;Z?ILUG<V@Q8O\ @I9^VI\/?!GQQ_9?\;:%\$/B)^WGX#_;8_9]_8@^$_Q.
MT'0O%NB_ #QUJ/[3'P_C^+'@_P"*GCCPQI^IZKK.C7?P[^&&D^-?%'Q.\):!
MK*06=YHECIMK]G:X>&?Z3^!G[=_Q@^!EU^VY\(O^"@^H^&/&OQ#_ &+_  _\
M,?BQ9_$K]GWX;>*[.#XV?!GXUVNJV_@DZ%\,6N=;N[3XBZ?XWT#5O =]HMCJ
MS:??ZC<:6;2:2UM-3UR<*][E:WO;J]5>.J5K6^%7T].J^LOC=^P!\&_CW\4/
MCI\6?&'B7XF:;XC_ &@OV&_$_P"P!XSLO#6L^%K/1-,^#?BSQ#XV\2ZCXE\,
M6VJ>#-8OK+XF0WWCW6(K+6=5U+6O"T=I;:;'/X,N9H;J>\B^''_!/OX,_##6
M_P!I?7M \3?$Z\O/VJ/@A\#/@'\0H]8UGPK<6VC^#_V?OA9XL^$?@W4O!J67
M@O3Y=/\ $NI^&_&.IWOB:\UN;Q#I=[KD%A<Z5HVBV$5QIMU^?W[,/_!6;XD>
M)OV%_P#@HY^V[^TE\)KOX=3?LK?M&_&7P-X%^ ^H0KHWC'0_#_A'X5?!36/A
MS\+O'.H)!<NOC_Q!X[^(#:1XFU26P)T?5-=>R331;:/#:5[5^QK\7/\ @I?+
M\>]$\$_M7M^S1\8/AMX]^&VO^(_&?B']FRPN="O/V/?CAH'_  C=P?@+\2(-
M7\=>)=0\1Z=K6FZIJD&B:W=:?;>()/$.BZI]I9-(AC0 K22>NUEOO9)Z::V5
MNOI<^G/#O[ 'P;\-:A_P3YU*P\2_$R6?_@FUX"UWX=_ U+O6?"TD7BO1/$/P
M&M?V=[VZ^+"P^#('US5(O!5I'JEK/X0D\"VB>*6>]EL9])*Z(OJ?[.O[+O@#
M]F6\_:%OO >L>,-6E_:4_:1\??M1>.E\7:AHM_'I/C_XBZ%X-\/:WH_A,:-X
M?T!K'P?:V7@?29=*T_6'U[6H+JXU%[OQ!?136T%I](T4$W??^KM_FVS\VO&7
M_!*[]F+X@^"OVK_ OC"[^)VKZ=^US\>M/_:7\4ZO%XKTS1?%/PM^,.AZ3X9T
MKPSXK^"7B/P]X:TC4O!MWX7?PIINI:/-J\OBF\-Y/J=KJ=WJ6B:C<:0W!:/_
M ,$>OV>8?A]^T-X4\;_%O]I[XR^/?VGK+X9:)\4OVAOC%\2O#'C3XZR^$_A#
MXITGQ?X&\%>&]=?X>V/@OPUX4T_5](A:]TW3O :2:RLSSZK=7>HVFE7VG?K%
M10',^[_JW^2^Y7N%?E-\"_\ @D)^S[^SY\7?@_\ %CP9\6?VF-6M?@#\5OC_
M /%GX,_"?QC\1/"FO_"+X;ZA^TGX0\5>$OB1X2\(^&O^%=V>L:'X'D;QGKOB
MG3=)T[Q);:DWB^X&KZYK.N1-<65Q^K-% )M7L]]_Z^;/S$\>_P#!)G]F3XC:
M-\?]/U[Q!\9+/7OCQ^T_H_[8=I\0O#?C31_#7Q$^!GQ[\/>'=%\+Z%XP^ WB
MC1O"5I/X2DTK2-&,%O'XD@\9RR_VMJR7EQ<V\]M!9^U_LB_L-?##]CZY^+/B
M?P]XW^,'QG^+?QV\1:-XA^+_ ,>/V@O&6G^._BYX\'A73[G2?!.@:IK.B^'?
M"'A^R\+>!=*O;_3O">@Z'X8TFSTRUOKI&%PSHZ?:%% 7=K7T_P"&_P E]Q^?
M_P"T-_P3A^!_[2NI?M2ZIXZ\5?%;2;C]KGX"?#7]G;XD)X2USPC80Z)X)^%O
MBGQ?XM\/ZIX(76/ VO/IOBF\U+QIJD&LWNO2>)=)N+&WT^.RT33YXKBYNO O
MBU_P1@_9W^*OC/XD:_;_ !K_ &L/A=X(^.MEX*L_VCO@?\)OBWI/A3X/_M R
M>!M$L?#5IJ/Q$\/S^"-5UBVU'Q'X?TVST;QO/X)\0^$8_%%C$1=PQ74T]U+^
MOM% *36S?]?\,C\F_CO_ ,$;_P!F#XZ>._&_BR+Q]^TC\%O"OQ@T7P)X=_:!
M^"7P#^+$'P\^"G[0VB_#BSTO1O"MC\5/!S^%]:O9/LWAC1[+PC>W?@C7?!5_
MJGAL7%CJ%W<2WEW<S<?\3O\ @A]^RU\2IOCEH$/Q<_:R^&GP._:(U[5/&OQ+
M_9;^$GQCTOP-^SMJ/Q&U3PYI^A-\0;;P;:>!KG74UJVO=$\.^*TT&\\67WP^
MOO$OAKP^^M^"]5T/2[?0Q^RE% ^:7=_U\OQW\SY/_9T_8^^'?[-'BOXC>-/!
M_BCX@^)]?^*7@G]GSP-XIN/&^H>%;J%K']F_X9K\+/!NJ:?;>%_!_A2&SUC7
MM##:GXQ;;+I=WKLC3>']*\-Z8$TE/SL_:K^#.K?MD_\ !5C]A[0[_P#9H^+>
MD?#O_@G[KGC3]H+Q7^TYXN\,:7I/PE\<:SXG\'^#=1^%OP[^#_B<:W=W'C#5
M-+^)^EZ%KGCRWN=(T_4/"]WX!F@M;*2RU6+7A^X=% DVG?K9K[U;\KGY>?M-
M_P#!)_X(?M+?%CXA_&./XT_M7?L^>*/C7X+\/?#S]H*P_9K^,L/PZ\-?'_P?
MX5LVTC1-'^*>BZMX3\71W_V/PS)/X1_M#PW-X9U23PM=WVCR7S0:A?&XPO&O
M_!'7]F?6_%MEXB^&?Q(_:<_9FT.Z^"_P\_9[^(GPX_9N^,;_  \\!_&3X1?"
MO39- \">%?B5#?>'/$GBF:30O"UQ?>%8O$'@WQ5X-\3SZ)JFK1W.LRWVIWM]
M-^L%% <TN[T_KM_G;I8_.[]E+_@F?\"/V/?$_P )O$_PP\6?%O5Y?@K\ _BQ
M^S;X$TGQOKW@[5-)M/AG\7/CMI'[0.JV]\-$\!>'-3OM8\->*=$L?#WA/47U
M-$M_!RO9:]:^(==9?$*>\_M:_LF?"/\ ;2^#FH?!7XR0^);?0WU[P_XR\,>+
M/ OB*Z\(?$/X<_$#PC>_VEX1^(?P]\5V233^'O&'AF^+SZ7J#6U[:O'-<V6H
M6%_IUW=V<WTQ10%W>]W?O_7J?D8__!&C]G76/A9^T)\/OB%\8_VI_B_XQ_:=
MU/X*W7Q4_:#^*_Q-\*>+_CM=:)\ /B/X<^*'PV\$^']<F^&]KX(\.>"]-\1>
M&H(;W1M-\ 1OJ&G7]^);M=2CTK4],^H_BW^P9\ OCK\<_%'QT^*UCXA\87OC
M;]D7QI^Q5XL^'6H7^E+\-=<^#_CSX@Z+\2-=O9[&WT.'Q=:^.(];T*SMM*\0
MZ;XRL;;2;$O<66DQZY#8ZU:?:%% <S[O_A[?Y+[C\9/ G_!$+]GSP;XQ3QSK
M7[1W[:_Q8UZP_9]^+/[+OAJ3XQ?&;PCXZM_!OP2^+/@\^"[CP;X3ANOA9:'2
MH/!&G3ZC>^"KII+BY&IZK=2^,9/&%G;:39:;]C_LT?L)?"/]E?Q5IGB[X>^(
M_B/K&I:5^RQ^S?\ LB6\'C+5_#.H6+_#;]E[3O$>F> -;FBT3PAX>N&\<:O;
M^)[]_&&I1W,>@ZA-#9MHOAKP^D<T=Q]J44 Y-[O^ON/Y>?VI?V&_AY^R(G['
M/PA\*?L^_P#!27XD_!7X"_ OXF^ OA]^UE^P-XNDU#]LGP]X@\;?$:[\0^)O
M@S\6M'^'FF^";#4_@_XSTG7GU'3/%-KX?TT>'==LYK>*:QAOM>UJ']+?^"+_
M .R[XP_9+_8.\$_#_P ?>!+OX7>*_%WC_P"+/Q>N_AGJ?B"X\4:Y\/M%^)7C
MS5]<\$>#?$NN7,UQ)>^*?#_@$^%M.\3%II9HM=@OX;V6?4([R>7]6:*!N3:M
M\V[[[OY;O;[D%%%%!(4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MWWB&/6;&S@U%-<O+O5EN1?W$UP]+XJ_ GX'_ !VL-(TKXW_!OX5?&32] O\
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MRYUZ S]A^TCH7C+X@1_\%._'M[^UU\-/VU_$&E?LS_L9R_M6W7[(_P !=/\
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M:3X<FU$P:'>7CZGH.AWFD6-QI6CP?98[K]KOVI/^39?VB_\ LA/Q=_\ 5?\
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M'QE^(_[07P5^'7B]M.T[0D_:,O\ X"?%;XI>#K/QQX8T?P];1Z7:7'BCX?\
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MZ?=_!+Q1\/=2/Q3T;Q+XWOY?#T_A"Z^$NI>"8KW0O"":+<2:=JD-M8:C=/\
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MHNDVUIINGVPEDDD$%I;0Q"21WV;G8G?ID!1110 4444 %%%% !1110 4444
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M?6XDEUC38+8SW&H6D4O]M'B?]F3]GOQI\:_!?[1_BWX-_#SQ%\>OAUHJ>'/
MGQ<U?PSIM[X]\):#')XBFCTG0?$<T+:AIU@DOB[Q/(MO;RI&'U[5& S=R[N
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %>&?M+?M&_"C]DGX%_$
M?]HKXW:_)X;^&7PNT$Z[XCU"WM)-0U&X:>\M=*T?1-&TZ)D?4->\1Z[J&FZ!
MH=B9((KG5=2M(KBYM+=I;F'W.OYU/^#I'2_$VH?\$H/%]QH%M<W&FZ/\;?@U
MJGC)K>VNKA+;PR=7U+3(+F[>V!BM+8>+-2\+Q&YO<6OGS06X(N[BUR%15Y13
MV;2&_LV?\'#7@GXN?''X$_"KXX_L6_M*_LF>"_VJM3L=%_9H^-GQ5TV8^ OB
MGJFMW5G:>&5MKFZ\.>'+;^S/$5SJNAZ?9:WX3U3QOI=MJ/B#13J-Q9Z+?+KB
M?J?^R=^VYX8_:O\ BE^V+\+M!\#:]X2O_P!CSX[WGP*\1ZKJ^IZ??V?C+5+.
M&]F.OZ)#91QS:?82+9.!:7QDN%+K\Y ->(_M%?M??\$U_ =O^P(/B]I?P^^(
M]A^T!XZ\&Z?^Q0NE?"[2_BO_ &%J^O:1I&E^$?&_@S1;73-6U;PGIT4>O>&O
M"EEXA\,:5+JFFWWB#3=,B@A@^WRV?\GG[0_['7@_XR1?\'#O[4OBOQG\2]-\
M5_LF?M;:CXQ^ FC^$_'&J>'_  UX:^)8\6WEWKWCS5- M(A;:GXBN-#CT7P]
MHFL"YAOM&LO[6DM##>/87=LNOWE*,9='':V[UYN739];/L]C_0/HK^"?]N[6
MO!?[=&D?LT6WB?PC^UE^V7^T5X-_X)$?!?X\_$/X<^&OBWX0^"G[.7[-NK>,
M?A#X6^(=[^TKX[^(WBJUU*^U_P >01^*-4\2:_I>JV%Y%XITR\\(Z"-=GFA?
M2K"CX;\/^)_VQ[7_ (-MOA!\7/B[\8TT/XW?"#]K;P5\3?$'ACXAZ]HGC3Q1
MX)\-ZWK.C_\ "+7WB:.XFOIM/U7P5H$?@'4'N#/<GPI?7UA#+&THD5A[/1-R
MMO?3:RD^]W?E?1>5T?WS45_G9>(?B)\1OV8OV"/^"C'[%OP[^,'Q%\(? ?PM
M_P %I]*_8UT[Q5>>)KF75OA;^SY=WGQ;;Q3(WB-VM3H>AZPGP<\+Q^*8+6YT
M30M4N=7UZ*[B2'Q7K=OJ7T1XR\ :'_P2M_X*'?MC^!/V+_BQ\1?$GA?X-_\
M!&WXO_$SX=:1XE^(4WC]_A%XZU6;2;Q9]/%W)8:+:+IMQ/'\8[?3[:S^RQR^
M+;FYL[*XBOTTR0#V>^O>VFZ7+N[Z?&M/4_O%HK^"'_@D=\/_ -H3X3?M7?\
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MW%*+=[MN-GJM&F]N^GGY'9_M9_\ !8_X!_LC_MX?LX?L'>,O#&N:WXQ^/[>
MTO\ QWI^MZ18>%OA:_Q,\9ZCX(\&KXNAOHS,[:AJ.G&^NUAN;<Z7HUW8ZI>B
M.SNX)9/U]K_, _;:_:=\(_M<?%__ (*@?'^+X0?'WQ]X[\=_&KX60?L<_'+P
M%X177?AQ\(O /[,^OW>AZAJFM>)8+D7GA^Y\9_#>PTC55'A=Y[;1]3NKG5-5
M>^%XUZ/W4_:"^,VF_P#!7[]H'_@AE\#/BC\0_%?A7]F/]JO]G_XF_&KXS>%?
M!/BFY\&)X^^.?P[\*>*(-=\&RZIH9FM+B;PK\3OA??Z'HJWMGI#:=9ZOKO\
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M4>&M)BN_BS\*_#WQ6\.V]OH_C75=*UB6;^RM;N-/*6B7S37>DW+J$%Q;1O\
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M?B6Y\;16VHV< W3?892VG1SV%T![-=9>:TW5HOO_ 'EH?WGT5_G.CXN?&O\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!\)_\
M!2']N'2?^"=G[)WC?]JC6_AYJ/Q2T[P7KG@C1)?!NE>(K;PK>W[^-/%>E^%H
MKB/6;O2=;@MUT^34UO)(VT^4W"0M"KQ,XD7\[?CS_P %^?A!\$O^"<O[+/\
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M_P#I+%X#_P#$I?VH_P#Z'FC_ (=(?\',_P#TEB\!_P#B4O[4?_T/-&O;\?\
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M-!?:1KVDM<7"V\Z-+:7=I=7NDZM9:CHVHZCIUW_*O_PZ0_X.9_\ I+%X#_\
M$I?VH_\ Z'FC_ATA_P ',_\ TEB\!_\ B4O[4?\ ]#S1KV_'_@":N[NK&ZV=
MY7_(_>']FK_@B_\ L/\ [*_P>_:/^#WPY\.>/=5@_:N^'7BCX3_&GXB>.?&\
M_B3XHZ]\/_%?AW6?#%[X;TSQ,NGV%GX>LK73M>U":U.CZ+:RSZC]BOM6DU2?
M3-.-K]J?!W]E[X9_ ?\ 9F\-_LG_  TE\5Z'\+?"/P^U7X;>';D^(9;CQEI>
M@ZM!J4,MW;>)6MUF77+5M5N;BPU/[-NM;E()5B;R@I_E*_X=(?\ !S/_ -)8
MO ?_ (E+^U'_ /0\T?\ #I#_ (.9_P#I+%X#_P#$I?VH_P#Z'FC7M^/_   <
M;[U8O6^\M]OY>VA_45^RO^Q'^SW^QU^S;:?LH_!WPM=K\'8O^$U_M+2O%>I/
MXCU3Q)_PL#4-2OO$W_"2ZK-#;OJOVNWU)M%C\R&/R=#L]/TX;DM5=O@S7O\
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MIOAF$6?A77_%7@.2&6SU#Q9X5TS?I/A[6(KNVCTVQN+X161NM2U&YNOY>?\
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M )A/^'2'_!S/_P!)8O ?_B4O[4?_ -#S1_PZ0_X.9_\ I+%X#_\ $I?VH_\
MZ'FC7M^/_ #E_P"GL=;]9=;7Z=;+[C^L+]EW]F[X=_LB_ OP-^SS\*;CQ;=^
M ?A]_P )-_8-QXY\2WGC#Q3)_P )9XP\0>.-4_M3Q%J"I=ZCLUKQ+J*67G*/
MLFG+:6,>8K5"??J_B_\ ^'2'_!S/_P!)8O ?_B4O[4?_ -#S1_PZ0_X.9_\
MI+%X#_\ $I?VH_\ Z'FC7M^/_ %R)_\ +R'_ )-_D?V@45_%_P#\.D/^#F?_
M *2Q> __ !*7]J/_ .AYH_X=(?\ !S/_ -)8O ?_ (E+^U'_ /0\T:]OQ_X
M<B_Y^0_\F_R/[0**_B__ .'2'_!S/_TEB\!_^)2_M1__ $/-'_#I#_@YG_Z2
MQ> __$I?VH__ *'FC7M^/_ #D7_/R'_DW^1_:!17\7__  Z0_P"#F?\ Z2Q>
M _\ Q*7]J/\ ^AYH_P"'2'_!S/\ ])8O ?\ XE+^U'_]#S1KV_'_ ( <B_Y^
M0_\ )O\ (_M HK^+_P#X=(?\',__ $EB\!_^)2_M1_\ T/-'_#I#_@YG_P"D
ML7@/_P 2E_:C_P#H>:->WX_\ .1?\_(?^3?Y']H%%?Q?_P##I#_@YG_Z2Q>
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M3XNOIY1ID\=LBV&RR$NU=Y_G^_X=(?\ !S/_ -)8O ?_ (E+^U'_ /0\T?\
M#I#_ (.9_P#I+%X#_P#$I?VH_P#Z'FC7M^/_   M_P!/8_?+LUV[-KYL_>[X
MF_\ !'']B[XMVO[9-GXOTCXC2P_MV>./A/\ $+X^#3_'MW8M>^(_@OK&O:YX
M)D\*LMC)_P (W:17_B34VU.UA^TKJ$3PQLT0A4GZ-\2_L+_ 7Q7^TE\1OVK-
M7L?%+_%KXI?LP:Q^R'XLN;?Q)/!H$WP=USQ!9^);^TL=%%N8[+Q"VIV-N8M=
M2=I8X T(@.XM7\PG_#I#_@YG_P"DL7@/_P 2E_:C_P#H>:/^'2'_  <S_P#2
M6+P'_P")2_M1_P#T/-&O;\?^ %O^GL?OEY+MV2^Y'[>>-O\ @AI^P5XY_9C_
M &??V6+[P]\3-&\*?LM:YXW\0? GXA^&OB-J&C_&/P%>_$;QOJ?Q!\916'CF
M.RE2[LM8\3:DMXUKJ.D7<=FVEZ--8?9;W3HKL]/X>_X(N_L*>%/@C^S]\ ?#
MO@WQII/@?]G']H+2_P!J+P=<V_CG46\3>(_C;I:11?\ "8^/];G@E?Q))?6]
MM8V=WIT<&FZ='I^G:=IVGVUA8V5O;I^#G_#I#_@YG_Z2Q> __$I?VH__ *'F
MC_ATA_P<S_\ 26+P'_XE+^U'_P#0\T:]OQ_X 6_Z>QW;WEN[W>WF_O9_2/XW
M_P"":_[+?Q&^,7[4/QP\8Z!XIUCQC^U_\ 6_9J^--M)XJO+?0-2^&#:-HVAB
MVT#3K6&&?P]KT5GH6GRV^O6-[]MMKV,WEN8IQ&T?Q0O_  ;R?\$^(O@W\/OA
M#9M\>]+O?A7XP\6>+_ /QCT7XMRZ)\;/#O\ PFVF:'H_B'PO;>,M)T"SL)_!
M]QI_AW38++1+WP_<_P!D!M0;2+FQ;5=3-W^1_P#PZ0_X.9_^DL7@/_Q*7]J/
M_P"AYH_X=(?\',__ $EB\!_^)2_M1_\ T/-'R_'_ ( 6MM5CTZRZ*R^SVT/Z
MF?V._P!C3X"?L)_!JU^!?[._AF_\/>#1XBUGQEK=[KFM7_B3Q3XP\:>(5LXM
M;\7^+?$&I.UUJVO:A;:;I=B\X2WMK;3M+T[3K&TM;*RMX$^IZ_B__P"'2'_!
MS/\ ])8O ?\ XE+^U'_]#S1_PZ0_X.9_^DL7@/\ \2E_:C_^AYHU[?C_ , 3
MBGJZD&_^WO\ (_M KQ3]HWX ?#S]J?X'_$G]GOXL6^K77PZ^*WAV3PQXMM]"
MU231=7ETN6ZM;QEL-4BCFDLI_/M(2)EB<A0RE2&-?R5?\.D/^#F?_I+%X#_\
M2E_:C_\ H>:/^'2'_!S/_P!)8O ?_B4O[4?_ -#S1KV_'_@!R+_GY#_R;_(_
MLMT72;/0-&TG0M/61=/T73+#2;%99#+*MGIMK%9VRR2D R2"&% \A +MEB 3
M7Y^?$;_@EM^RE\3OAIXB^&^M:=\0]&DU?]J#X@?MC>'/B/X,^(>N>#_BW\,/
MV@?B7XKU'Q?XG\:_"[Q_H9M=5\)[]1U;4+:STM%O-.M[&6#?;S7VG:9?67\Z
MO_#I#_@YG_Z2Q> __$I?VH__ *'FC_ATA_P<S_\ 26+P'_XE+^U'_P#0\T:]
MOQ_X **6U2"_\"_R/WM7_@CK^R#_ ,*)U7X)RWGQQN]<USXX^'_VF=5_:0U#
MXS>*=2_:HN_V@_"EK<:;X9^+K?&O4#<ZS'XOT+1+W4-"TJ2&SCTNRT_5-6E@
MTQ-4U74=1NJ6D_\ !&#]BJVT_P"/%IXJM?C)\4]1_:=^&NC?#CX\^*OBQ\9/
M&'CKQE\2'\+^.U^(G@_Q]JOB?5;@ZKIWQ#\&>(+/05\*:QX?GT?2M%T_PKX;
MM;;0@VG--/\ @_\ \.D/^#F?_I+%X#_\2E_:C_\ H>:/^'2'_!S/_P!)8O ?
M_B4O[4?_ -#S1KV_'_@#M_T]C]\O+^[Y+[MC^@;X8?\ !)+]DWP+X9^.7A[Q
M[=?&[]I[4/VBOAMIWP;^*/CK]JCXU>-/C'\0]0^$NCW5]J.C?#O0?%NHW>G7
MW@_PYI&LZA/K^FCPJND:G:Z]#INKQZE]MT;1YK#K_P!D_P#X)H?L_P#[(OQ#
MU7XN>&/%?QZ^,'Q0N? EK\)_#7CS]I#XS^*?C1XA^&WPCL]0@U:'X5_#2X\1
M,D'A+P.-2M+*[;3;2VENF:RMX3?_ &8202?SE?\ #I#_ (.9_P#I+%X#_P#$
MI?VH_P#Z'FC_ (=(?\',_P#TEB\!_P#B4O[4?_T/-&O;\?\ @!;?]['7??\
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MGJ]Y<WESJ%S"D%T+2*PBL]-L++3K?^</_ATA_P ',_\ TEB\!_\ B4O[4?\
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MO[4?_P!#S1KV_'_@!R+_ )^0_P#)O\C^T"BOXO\ _ATA_P ',_\ TEB\!_\
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M-U>^T[5+74K"ZT9;%=+@TW2].'A[PZ=)W9?^".?[&5P/VB/M.F_$JXE_:A^
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M.GW/@S3K>\OS;PN+>WFOK2.63"M/&#N!KV_'_@!R+_GY#_R;_(_O=HK^?_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110!\0?\ !37_ )1N?\%!O^S(/VK_ /U0WCZOQ!_X-%/^4;GQM_[/
M?^)/_JAOV:J_;[_@IK_RC<_X*#?]F0?M7_\ JAO'U?B#_P &BG_*-SXV_P#9
M[_Q)_P#5#?LU4&B_A3_QQ_)G]3M?G)_P5\_Y1=_M[?\ 9KGQ<_\ 45OZ_1NO
MSD_X*^?\HN_V]O\ LUSXN?\ J*W]!"W7JOS1^7/_  :A_P#*+O6?^SH_BS_Z
MBOPQK^F&OYGO^#4/_E%WK/\ V='\6?\ U%?AC7],-)?Y_FRI_'+_ !,****9
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?Q!_\'8O_ "<[
M_P $S/\ NI'_ *L'X0U_;Y7\0?\ P=B_\G._\$S/^ZD?^K!^$-)[/T?Y,TI_
M&O27_I+/[?****9F?C#_ ,%Z]-T_6?\ @GY=:1JUE;:EI6J_M,?L@Z;J>G7L
M,=S9W^GWW[1WP[M;RRN[>56BGMKJVED@GAD5HY8I'1U*L0?P_P!>U'4_B%^R
MQX+_ ."6>L7<VH:A_P $\O%?_!3#QK\9(7C:YU%OA=^Q!\.O$DG[)&M:IYUH
M8!I'B?7OVB_@7JVCZ@$ABN9_!)N(Y+#68(;)?ZU?VHOV8?AM^UU\+%^$'Q6F
M\2V_A-?''P[^((D\)ZI:Z/J_]O?#'QGH_CKPTOVR\TW58?L#:WH=DNI6_P!D
M\RZLC-;QSV[R"9/%Y?\ @G'^S5)\:_VPOV@(]+\4VOQ'_;@^$6G_  4^--_:
M:Y:PV$/@VR\%Q^!+F3P98#22NA:UK.CVFEW&M:A>2:O'>ZMH]AJ"VL+F]2\&
M7&22L[W3;7KHORO^!_/=\4K#X8?M!7_[*OP.U/X1_MI?MV^./A__ ,$T?V5[
M[2OV7_V??B#/^SI\#OV=]7\8>![&]MOC7\3OCG-\7OA_I5Q\3/&ME'IMEX8T
MO6]!\1^&].\-^'A+?6EW,LEL>!_9G^%>O?\ !2'PQ_P15^%W[1/QA^-FH>#_
M !/^PQ^V/XJ^*$WA7XL^+/!_B;Q]_P *M^,/@#P1\/O^$AU[39+B]\07?A^X
MD\,Z@D^JS"YNI=#2XO+ZZ#75CJ7[P>-O^"//[.?BSQ?H7B[0/BS^U7\(V3X
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M?%,OA^*P\,G4QH.FV&GVX4DN5M_+?^9+^OQ/W0HK^:G]M[]JKXF_L$_M&?\
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M;^Y)O]/F?VUT5_%UX[^+W[1GPZ^$'PM_8#TCQ1^UQ\:_ :_\%4/VWOV?KH?
MSQS(_P"UCX\_9I_9G\,6OQ1\#?!W2_BQXEUS0+VVFN8?$\$OB_5HM8TS5!X,
M\(:CHWA^Z32K./1M1_7[_@C/J_Q^TG5OVP?@]\0OAM^U#\-?@)\//&7PF\1_
MLR>'/VP?%FD>.?C9X2T3XB>$-=?XB?#:^\46'BCQ7J.I^$?"GB?PM9>(/ XU
MW46U&R\.>.[/3WDN_LKW<QN#A97NO^!=*^^^NUN^I^X]%%%! 4444 ?Q?_\
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M8Z;\0-8UOXO>&_"%]XPT6VCC?0HOA]JR&&^%OJ+V/T;^U1_P2Q^'W[2?Q?\
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MX*\2Z3XQ\'>+?"VJSVE_;6VKZ#XDT33KZ);JRN[6ZACGL[B%H;AR/CKX<?\
M!)+X9^&?BUXA^/GQ4_:2_:K_ &C/C'XV_9]^)/[,'CSQ1\7_ !OX&O-'\3_!
MCXDOIDUQX07PEX?^'&B:3X?L/#5WITVK>'H?#ITV&XU[6]>UCQ3%XDN;NS&G
M_HC\%/BQH7QV^$GPZ^,OAC1_%?A_P[\3/".B^,]%T3QUHC>&O&.EZ=KMG'>V
MMEXET![B[?1]8@BE5+W3VN9S;3!HS(V,UZA0*[6E[;Z?GT\N_0_'?X<_\$<O
MAY\-8OV+KG3/VI?VK-:\1?L0ZQXFTSX?>)/$OC#P9J]YXQ^!?BN3P9!J7[-?
MCRRF\#C3;KX01>'_  'H?A*QTG0+70;FR\.7>OV%M/']MTI]#B^&O_!%OX%_
M#?XA_"R_'QR_:4\9_L[? /XJWWQO^ G[&OC;QQH6L_L^?";XGOJ&HZOX=UC0
MK!?"UMXOU32? &JZWK>I^ ="\0^*-4BT"^OC/)=W_FZFFJ?L;10/FEW_ "\_
M+S?WONS\V-3_ ."6W[/VJ_LG_&O]CNX\8?&)/AE\=_V@-2_:/\7Z[#X@\%+X
M[T[QQJGQT\+?M W&E>&]3?X>R>'[/PHGC+PCINF0V.I^&-8U=?#$]]9/KDFJ
MRV^M6WE'[3W_  1I^"/[3'CKXX^)/^%]_M3_  0\$_M26&F#]ICX-? [XB^'
M/#7PS^,/BCP[H\.B^&_'VIZ-XA\$^*WT7Q;!;V>D'Q*^D31:%XZ&@:/'XJT/
M4%;7#KGZ_44"YI+9O^K>7DON."\,_#GP_P"%_A?X?^$=L^HZAX5\.^ M)^'-
MO)J5S$=6O?#^D>'K?PS$]_>:?;Z?"=1N=.MU:ZN;*TLHC<O)+;6]LFR)/SE_
M90_X)+?"/]E'Q;\!/&.E?'/]H_XJ7W[,.A?&CP-\$=/^*GBOP7K.D^%?AC\9
M[/P58W7P_N4TSP!I.I7>C^#(_!%K/X._L[4]$ALKO6==:]LKVUGL+/3OU7HH
M"[UUWW_'_-GYC?$__@E-\ OB3X.\6Z)#X]^-W@3QSJ_[7?BW]M_P+\:? WBS
MPYHGQ2^#7QU\90V%IK$GPYU9/!SZ2/ MWIM@='O_  AXNT;Q4FJZ7>7*ZEJ5
MSJ-MHVIZ3[!^QI^PWX#_ &.8/BQKUC\0/BA\;?C-\?/%>E>,/C?\>?C/KMEK
MOQ&^(VH>&=+DT#P7I]^=%TS0_#VE>'_!/AZ631O#6D:/HUG%9VDUP)9)P\2P
M?;-% 7=K7T_K_+O;R"BBB@04444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %?Q!_P#.YQ_G_I%37]OE?Q!_\[G'^?\ I%30:4_M_P#7
MN7Z']OE%%%!F%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M 4444 %%%% !1110 4444 %%%% !1110 4444 %?Q!_\'8O_ "<[_P $S/\
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MM4?LE:#^U=JW[-;>,/&.L:+X2_9X_:+\$?M)S>"].TS3;S3OB1XM^&UIJ_\
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MM^T__P %+_B1XFNO^"=7[-WC/2_V:_\ @FC!\0(?C+HGQ6\9>&;+5+S]H?\
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MV739J*79]4]4OS;/S5_X)A?&KXD?M#_M6_\ !)_XO_%WQ+?^,OB/XK_X)/\
M[34'BGQ7JLBS:MXBN_#'[3GAOPA;:OJ]R$0WFK7VG:!9SZI?2@SW]^]Q>7+R
M3SR2-ZQ_P<%? ?4_VE?BW_P3M^#_ (>>YC\8ZWH__!1/Q-\/)+,-]KC^*/PR
M_8^U;XH?"U[=HR)(ID^(?@WPRT<\0>6W8">**62-8G_0G]D3_@E-X#_9%\;?
MLU^+_#GQ;\8>,(OV8/@#\:OV=?!>E:[H.AV1U?P9\7_C*WQ?BOO$%_IT@,NM
M>$I3'X8L[BRM+6#5M.@BO[Z"/4#.\WUE\8?V5M"^,'[2G['W[26H^+-6T;6?
MV0-:^.&M>'O#-E86=QIGC*7XW_"74/A-J<&M7L\BW6G1Z%I^H/J]@UC'(UU>
M1I!<;("6H_X <RYKK9)VT_Q67XI'\NW[77QTL/\ @HGXJ_9'_:7T^4:EX._9
MJ\"_\$N]<N8/*LXK3P]^TQ^W3^US\%/%'CO2[>*+SB-9\&?#+X/V6@ZI]FN7
MBL%\92VL9%I>0W&IW?BU^T#^U]^T%\3_ -OSXQ_"K6/^"J\GQS_9^_:I^+OP
M/_8[\'?LL^%=0UC]B+1=-_9LUZR\.V'AKXV^$8+ZRMO'VM_&+Q!I.H:K\5K7
MQIH6J77AVPUOP]!IL<VFZ;!92?LW\,?^",GP)^$'P&^(WP$\"^.?%>FZ'\0_
MVV? W[9=QKDFDZ++JVDS?#7XD> _'?@?X264,?D61\&>'M/\ Z?X5L;E(K>X
M@M-0U&_@LX9I5MUI_&G_ ((Z>'OB?XU_: 7P7^UE^T-\$?V>?VO?&$7C[]JS
M]F3P"O@2Y\$_%3Q;?-91^.-6T'Q5XA\-:EXR^&,GQ/LM-L;3XAKX3U%6\2JM
MQ%?2/IKVFF6 Q\T=NBVNGM=-]'OJOEJU>Y^4WQL_:/\ VCOVL/VI?VH-/U9?
M^"KOPSN/V<_AE\ ?"WP4^''[ OA[5K/PO\/?C[X[^">@?&'QUXG_ &D+2VUV
MS'C*_MO&'BFU\#:5X$\56NHZ7+\.]*UN.[MK74M:F^R7++P1\=?BC^UY\&OV
MC_CU\0/VI_@9^TTG_!$KXV_'#XC?#W0OB?XH^'&DZ#\5_A-XW^$GPWOO#)\#
M6D%J?#GPY\<ZI<-\5?%?PYMGAL[[X@P^'/$WVL7NAVDK_KA\>O\ @DWI?CSX
MC>.?B#^SA^U)\;OV*U^-7PK\$?!;]H;PK\$['P3J?A[XL^ ?AMX8E\"^!)8H
M_&>BZO>^!?'/A;P#(O@?1_'7ABZBU2Q\-6EG9VL,,PO;F^T?%G_!)CX;IK'[
M-]Y\$OC)\3O@-H/[/?[,'C3]CN?PIX;MO#/B/2OBC\!_&=KI,E_X=\;S:[IO
MVUM6E\1Z+8>+=4U[3YX;K5]=MXKMXK6=#.S%S1MVTMMMHM-NK]>[:V/QO_9:
M\,_M"_MY?&;]C'X+>//VZ?VTOAA\.]4_X(B?LY_M$_$)O@W\>?%GA3QM\0_C
M+??'7XJ>"X/&NN^,]0GUS41K%U8ZA'<>+=6CC.L^-O\ A'_"NG>(]0O=-T2S
M@AV_V3_BW^TE_P %#] _X)J_LF_%+]J/XX_#WPUJ/[/'[8_QH^._Q,^#WQ%U
M+X8?'#X]3_LY?M2:[^RS\)_#NI_$K28CK\#0:;8VOC7Q[_9][<7GCB\&H7VO
MJ)[:TU*/]LOV4/\ @FWX,_92^*'PG^)^@?$SQ/XMO?A1^P9\-_V#[#2M8T;2
MK&UU?PK\./B3KWQ)LO'UW/93/-;^(-2O=>FTRZTJ%6TZ&U@BFBE,K.*_)?\
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MOXA^)6E36$4[C61<PVD\%Y#+)_0?3(E\3_RMLEVTUUV"BBB@D**** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O
MX@_^=SC_ #_TBIK^WROY1/\ @H]_P;A?$[]N/]NKXR?ME>#?VP]!^#O_  M#
M_A7G]F^&?^%8^(=7USPY_P (5\'O WPKO/\ BIM*\?:#]H_M?_A$KK4/W%C:
M>59ZI_9\OG^5)-,&E-I.5W9.+5[-ZNW8_J[HK^(/_B$Z_:=_Z29_^8W^(/\
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M;_$'_P">]1KY?C_D'+#_ )^+_P !D?V^45_$'_Q"=?M._P#23/\ \QO\0?\
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M_D'+#_GXO_ 9']OE%?Q!_P#$)U^T[_TDS_\ ,;_$'_Y[U'_$)U^T[_TDS_\
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MM._]),__ #&_Q!_^>]1KY?C_ )!RP_Y^+_P&1_;Y17\0?_$)U^T[_P!),_\
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M/^0<L/\ GXO_  &1_;Y17\0?_$)U^T[_ -),_P#S&_Q!_P#GO4?\0G7[3O\
MTDS_ /,;_$'_ .>]1KY?C_D'+#_GXO\ P&1_;Y17\0?_ !"=?M._]),__,;_
M !!_^>]1_P 0G7[3O_23/_S&_P 0?_GO4:^7X_Y!RP_Y^+_P&1_;Y17\0?\
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MOVG?^DF?_F-_B#_\]ZC7R_'_ "#EA_S\7_@,C^WRBOX@_P#B$Z_:=_Z29_\
MF-_B#_\ />H_XA.OVG?^DF?_ )C?X@__ #WJ-?+\?\@Y8?\ /Q?^ R/[?**_
MB#_XA.OVG?\ I)G_ .8W^(/_ ,]ZC_B$Z_:=_P"DF?\ YC?X@_\ SWJ-?+\?
M\@Y8?\_%_P" R/[?**_B#_XA.OVG?^DF?_F-_B#_ //>H_XA.OVG?^DF?_F-
M_B#_ //>HU\OQ_R#EA_S\7_@,C^WRBOX@_\ B$Z_:=_Z29_^8W^(/_SWJ/\
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M R/[?**_B#_XA.OVG?\ I)G_ .8W^(/_ ,]ZC_B$Z_:=_P"DF?\ YC?X@_\
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M?X@__/>H_P"(3K]IW_I)G_YC?X@__/>HU\OQ_P @Y8?\_%_X#(_M\HK^(/\
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M8?\ /Q?^ R/[?**_B#_XA.OVG?\ I)G_ .8W^(/_ ,]ZC_B$Z_:=_P"DF?\
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MEM"\4^,O&'A.+Q%9:;J5W9:9#IHAU4_4W[4__!?G]F[]GO\ 97_9'_;%\%^
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MN6*WT_3+:WLKR>>_NY(;6&&TN99)52"5D_FG_9P_X.*]8^)7QD\$?"#]H?\
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MXE1HS\ZD#^5T?\'4%UJOPVT#X[^$O^":'[0'B']GWP_KFG^&?V@OC##XU/\
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M+;2[?7-"U2PU+Q%!<74=K\.:G_P=,7D7P_\ A[\?-)_X)K_'N[_9AU'Q39>
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M?]F?3M0M)!+:WUA\8O&%G>6TH! DM[FW^&D<T,@!(#QNK $C.":@E_X-2?\
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MBK97<26\"QS*L,85C]HKWL[MWEJMU%K3LM;Z^A_-A_P<]?\ .+K_ +/2T_\
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M/_PSOBK_ .BOH_X<I_\ !43_ *6$OVH__#.^*O\ Z*^OZ8:*5EV#GE_=_P#
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M*<:OJPFM=&U2R@E&IZCOC;[;<^:#4DDE9Z*:_P# MON/X7OV>+_X V7[,/\
MP<91?M0?#;XU?$OX):C^VEX=LO%UK\ +7PS/\2?!]TOQF^,-_P"%/B'IUSXM
MU/3=&TK3O"'C&QT"^U;4[N/6+6&R=X=5T'5M#N-5MCXI^Q=\;/''[%7[9G_!
M/SX=_P#!/'_@H[XK_;)^!_[4?Q,^'F@_$?\ 9:UKPYXKT"Z^%?A+Q!JW@^R\
M0>'/'GA/7;SQAX$\,>(]*\/>)/$<Y\;> KW2+W1+KP+?ZEJ]@/#=K$EY_?\
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M5]6$UKHVJ64$HU/4=\;?;;GS:VC_ +/WP&\.^(OB9XO\/_!+X1:%XM^-5O\
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MVUU2=M(TH273+IMD( KVB=[IWO-K5?;5M?3R/X+_ -K,?L?Z=^TO^WI^TO\
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ME\0O!_B'X=6%Y?"$7&LV6C6UYJD:7<1'['?L$Z7^S[\8_P#@LI^RCXD\&_\
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MN=5UC6M>TZ[TB73+S^P6OF/X=_L4_L>_"+XDZM\8_A7^RW^S[\.?BMK?VO\
MM+XB>"/A#X#\,>,)CJ+2R:L\.O:-H5GJ%E)K<LSSZ_)8SVTFOW.RYUEKZ>*.
M1 E27+9INS;5G;5JVO6VSTU/Y1OV-OVO?V??^"2W_!6__@LUX9_;OUO4?AC=
M_M ?%,_&SX1_$6]\%^(/$\6N^"[_ ,;_ !=^*=EX?TR7P?X?UG43<^-O#GQ6
M\,3VJV5M:^'KCQ#X&U#P]?2VFNZ?INFI^0EQX,\37G_!$?\ X*"_M(KX4O\
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MKRW\'N_@-X=^)G_!&O\ X*8_'#]FCXD?M-?'[P]J'[7'P4^(GQ3\7_&SX/\
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MS/X/TGP1XB\6>-VTJ#5=$L(?"VAG1M:U/^U&C.I\#_B7X)\"_P#!:C_@MK\
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M?AB_AYO!-O<-XKO+SQ.TT.B)(WB&ZN=:+'4IY;E@IU$VG9_%"6Z^S&SVMO\
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MZ'>:9)8>&/[)TE?[)TTZ%#IYLM*9],MS'8R26[7? _[-G[.OPQ\8M\1/AM\
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MQ75/&'B6\7[5:Z_??;/[_O''P&^!OQ.\8> OB'\2?@Q\*/B%X_\ A5J*ZO\
M"_QSXX^'7A#Q9XP^&^K)?6.J+JG@+Q-KVCW^M>#]174]+TS45O?#U[IUR+[3
MK&[$HN+2WDC=I?P(^!^A_%GQ)\>]$^#7PIT?XZ>,M%@\-^+_ (TZ7\//".G_
M !9\5>';6VT"SMM \2?$:TT>'QAKFBVUIX5\+VL&EZIK-U8PVWAO0((X%BT?
M3EMP%4]VUOLM7\]D_E'0]5HHHH,@HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "N>\4^+O"?@;1KCQ'XU\3^'O!_AZTD
MMXKO7O%.M:;X?T:UENYDMK6.XU35KFTL89+FXDCM[=))U:::1(HPTCJIZ&OQ
M%_X.$KWPKIO_  37\5ZCX[2TD\#Z?\?/V5[WQE'J&GRZM82>%;7X_P#@*?Q"
ME[I=O;7D^I6CZ1'>+<Z?#9W4MY"7MH[:=Y%B<&E=I=VE]Y^NWA#XO_";X@OJ
M:> OBA\._&[Z+;)>ZRGA#QMX:\2OI-G(9!'=ZFNC:G>FPMI#%*$GNA%$QBD"
MN2C8[+1M:T?Q'I6GZ]X>U;3-=T/5[2&_TK6=&O[75-*U.QN4$EO>Z?J-C+/9
MWMI<1LLD-S;32PRH0T;LI!K^-K^W/^":WQU_;!_9'\7?\$5_AI>VGBGX?:I\
M:]2_:M^(OP7^#/Q5^#/PCT7]G2Y^#FNZ;XC\-?%!OB!X3\#^'=4U'6];N_#2
M>%[2TTF_N#J$[1Q74&N:CHJS>W_LN?\ !27XM_#;]F3]@_\ 8_\ V9=3_8Q\
M'^.?!7_!/;X'_&SXH_$S]M[XN:K\-OAS$OB?39-+\$_"3P3IWAZ]TK7-7\>^
M)+;1[K7+_7);V;0O"VA7=C?7FGZA.PLI@IP[7\U+1K???Y=[[']9%%?@CI7_
M  4]_:Q_:5^!/[.'Q7_9/^%'[,WPET;XD?#GXE^*?CI\;_VQ?B?K:_LY?!?X
MC?#/X@W?PINO@CI?B/X<7&D:CXU\8>(_%VB^(-=T/4Q?:-ITOPYM-/\ %MM;
M:C%J201>$6'_  6R^/7Q.^'/[%^E^ -&_8H^"7QA_:5N_P!J/2/%OQ-_:7^+
M?BJ+]E+3O$'[,GCZU^'2Z%\,O%WA">QU'QE?_%S5+VVU?P@LGB!!IVE/'':C
MQ>]W8W5R"Y)?YZ[;[[]GW]-4?TRT5_/W\2_^"J?[5.B#]E_X#'X7?LH_LS?M
M??%WX1?$3XT_%[4_VP/C<VA_LR_#;P1X!\<O\.O#VH>#O%7@O4VUCXCW?QIU
M@1^(O ^AZ5K$>K^&_"TR7/B"#4HX-3U#3?T1_P""<G[9[_MR_LZ2?%+6/#GA
M_P )_$+P-\3/B-\#OBYH7@SQ+!XV^'T/Q,^%>N'1]=U+X<>-K4M:^+? 7B.Q
MGTGQ-X8UJWDN8C8:PE@M_JIL3JMZ"<6E?IZ^J7R=G8^\ZR="U_0O%&E6NN^&
MM:TGQ%HE]Y_V+6-"U*SU;2KS[-<S6=S]EU"PFN+2X^SW=O/:S^5,_E7,$T$F
MV6)U7\#_ -D7_@J'^V!^U;\;/#^I>#/AU^R)XM_9\U;X^_$'X->/_@EX*^*F
MOVW[=O[-7A'PEXJ\:^$-+^-WQP\&^,=3T;PR_A2_OO#>DZEJ?AKPUX9;7;31
M_$.ES:==:I<3ZC!H7E?[,7[='[2_C+X;?LN?LK?\$[/V;?V9?"OQ'U'X#?%?
M]I_XC6WQ=\3_ !8LO@5\-/AC9_M._%+X6>&_"7A@Z/J/B#Q[JGCWXL>,_"WB
M>Z2]U+7;W3?"#R3:Y=:1J>B^5IUL7'RORNM]59>O;^MS^EJBOYKO!'_!5S_@
MHE\<M _8C\%_!S]F[]FSP_\ M$?M8>-O^"@'@KQIH?Q8\0_$F+X<_ N7]C3Q
MOX-\.Q:IKNH^%;VZ\1>(88[76]8TSQ)8Z;:0W&O^)_[$30Y?#MC-=(?U<_X)
MW_M0_%G]J/X._$#4/CY\/O"?PV^.7P._:"^+W[-OQ:T7X?:KJFL?#S4?&?PG
MUFTM;CQ)X#N]=SKO_"+:WIFJZ9<Z?'K+O?EQ<3,P@F@C0!Q:WM]Z;W:^ZZ9]
MZT5_,O\ $?\ X+G_ !3\.ZY\:OCKX4T3]B^Y_8V_9]^/>K_!CQ'\.O$_Q]FT
M[]N/XL>$_!_C&U\">/OCI\)O UM<_P#"*Q>%M$U6>[UKPUX'UK2;WQ/XY\.Z
M+JTUCJ.ER?V=)J'MGQ1_X*O?M)^ ?VAO'?["ND? SP!XM_;#\?\ QO\ AA#^
MQA<V$/C?_A3/Q-_9%^)VGZMXEU3]HGQW=6^HW>K6MO\ !'P]X+\;:?\ %:WT
M?7--2Y\1)IS>%=/O=+L-2FF Y)>7??;:]_2Z;['[^45_.C^V+_P52_;?_90N
M/C-\;_%7PL_9 \!_LR?!3XQ67P]L/A)\8OB'XR\*_MH?M%^ +;Q%X7\-:M\9
M/@EX=358?!EKH&NG4M:\1^"?#VLZ;K&NWGAO3K^>_$=WH+0:_P"T_$+]OO\
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MM_$EEXK@\2V6Z#14THK^H/@7_@J?\6/'7[,G[)6MVWP]^&^F?M>_'W]N"_\
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MZ5I/C-O"VN:K;Z/X>M(O#"66KZ3>:AK%J(0%%OM]Z\O\U_5S^CNBOYVO!_\
MP5Y_:D^'/B#X6_$[]L[X%_ CX;?LP_M2?L@_M$_MA?L[:?\ ##QOXY\1?'+P
MEX4^ 'PZ\+_&*X\%_&:;Q)I&F>#-2\8^+/AUXMT232[;PGIFC0P>(=2BT:8M
MJMK/I#R?LR?\%A_C+XE^,W[,N@_M-VO[$%C\+OVRK/Q.WP]T_P#9N^/MU\1_
MC)^S?XAT_P $7/Q$\*>#/VEM"N;B]TW4[_Q5H.GWVCOKO@JTTC3=#\7J=$U6
MT@>*!M1 Y)>7W^M[>:L[^A_0+I_B?PWJVL>(/#VE>(=#U/7_  G-IMOXJT/3
M]6L+W6/#4^LZ?'JVD0>(-,MKB6]T:;5=*FBU/38]1@MGOM/ECO+59;9UD)<>
M)_#=IXBTWPA=>(=#MO%FLZ7JNN:/X7N-6L(?$6K:)H5QIEIK>L:;HLEPNI7V
MEZ/=ZUH]KJNH6MM+::?<:MID-W-#)?VJR_S&?#/]O#XF?L\_L4?LI_&_PT_[
M/?A;X^_\%:/VFOC?\7/%_P </VK]8\1>!/V;_A1'J]KXKUOX?V_C_4?"S6>K
MLVD_!SP-\*/A#X \/R>+-/CU6^T>2=?$TEBDMV/?OV@_C?\ M&)^RQ^SU^W?
M^T#\.?AO\)_C?^QK^W+\/M U?Q)\+?',GBSX/?&7]FSXU_$3PO\ LY>.O&?P
MPUE[VZU&7X7_ !6\(_%S0O$>E:7XND?6]+\1?#_2O$-_;6EQI=K91@^1W^;2
M[W5UMVNFOQL?T(T5\R_M>_%?XQ_!GX$^)_&7[/\ \'V^.'Q@?4?#7AWP3X)N
M]2.B>%K:_P#$FOV&DWGC'X@Z_&3<:'\/O VDW.H>*_%=_9Q2WC:=I365M]GE
MO%O;;\-?&'_!9C]J+X$Z!^W#X1^*V@_L2?&_XQ_LQ? #X7?M&^ _$/[)WQ \
M?>*/A-XG\/\ CKXVZ-\(M<^''CK3M6U+5_$WA?XA^&I-9M+M8FURTN;^SOM$
M\0IX932M:MK9 2BWM;[_ #2_5?\ !U/Z9**_G?\ B;_P5"_;R_9)L/BOX:_;
M)^ _[.FD?$K5OV+?BW^US^S5=_!W5_B5K/@9]:^#-II5[X\^!/QC'B:[M=5G
M\7^%[+Q#H]_?>*?!][IOAK4H6,%@(KB^L]NUX:_X*F_M>? +Q#\)O$W_  43
M^"'P*^'_ ,#_ -I/]FSXW_M"_"?5O@'K_CW7_'/PVU'X#?!NX^/WBCX0?%ZT
M\7!])U[Q=JWPNTG6=4T;6O"4>B:5-XB@3PE:VFIWD+WLX'*_+RUW].Y_0-17
M\Y/[-7_!9/XY^*/BM^S#;?M!>'?V.=4^&'[:&G>((_A=X(_92^-=W\5?VC_@
M;XR_X0V]^(G@#P3\?/"E]J9TS5=0\;Z!IL_AK[=X2L-%M- \=W=MI/B%=*2%
MDN=KPM_P5$_;=\'?'[]D;P]^T[\-/V-?A]X#_:]^.,/P4MOV<O"/Q3\5ZO\
MMM_L^7GB:U\67/@77/BWH5WJ$WA?6M.E.DZ)#XLN= \*Z38>';S5=-TV\OK:
M_P#$FGP:<!R/RZ]>U[V]+/\ SU5_Z'**_E:TC_@L]_P4-?X >$?VJO&7P/\
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M2T\-VVB^"]*\5:9X2L-1\8S>,[J_UBQ1KZ5#J^GK+\T>-/VWOVT_V./VJO\
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M?6-OJ4EW<^=*@#BTF]++S7FK+N]'<_82BOS[_;[_ &N/B1^S;I_P!^''P"\
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MM0L]6N8;YYM,T[Y!^+__  4D_;ENM5_;.^,?[+?[.WP$\<?LA_\ !/\ \?\
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M^K']+--#H79 REU579 PWJCEPC,N<A7,;A6(PQ1P"2IQXO\ LZWOQ_U'X+^
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M A,LTA"1HS$"G^@G*]]-.GI=O]3^5+4/^"4?[27PVU+XU_L]_#+]@7_@G?\
M%W0_BA^T=XI^(_PK_P""A_QY\&? _P"(?CWX.?"+XD^-1XZ\0^$?B+\'OB+\
M)_%7C'XJ^,/!,%QKGA#PE>6_B(Z#=VVHZ7(\>F6>G VOM?Q5_8)_;_\ ''QS
M\=?\%&_#4-AH'[5W[/WQL^'_ (+_ &)/V=KCXC>'M-^'6N_L1^ TU3PK\1?
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MBVEP?#SPUX(\&:]J7CNR\-^);^7Q-9^-;_3[7S-5L!=_V1_1?X]\$?#CXW>
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MG):7_B'7O"^K:HG@_4TCT6.XUK4M.OO$>E:0WAZZLV;8T_\ 8Z_X*L0>"/\
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M86<,NI2O$_\ 6S\5/A-\%/VGOA9K7PT^+7@OP/\ &;X1^-8($U;PWXBL]/\
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MP8T?4+/21J=[JDMU=307<USX@O+Y3_5)10/G?EO%_P#@*LO^"?AC_P %)?\
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M%?B#J6J>+_'>@^([RU0:_KNG^+=.TR[NO^$<U:.V^[/C?^S1^S5\:_%/P?\
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M-:K\8/V!O O[,OP6^#^B?M%>#_B1)IWBCPE^U+X'^+NMR^*O&;Z9X,T**_\
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MDJRD,I((-"5M YW=/32_XG\K7[8'_!.?]MCXV^$_$/P6\2?L9?LP_M-VNO\
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M]TNIP3QW"(/@SQ;^SO\ \%8_&_QG^%O_  4:UWPM\+;KXS_!#XN_$2V^%O\
MP3XN/BYHJ>%?#W[+_P 5/A9X5^&OQ#\*I^T-8>#H-'N/C#XK\4>#])^*#ZCJ
MVGZQX1TV:WM8;"ZLT6X\(2?T0T4 I-=%U6JZ/=>GX^9_.CX6_8*_;4^(/QE\
M#_MD?'+P/\/O"?QI^*/_  4Y_9S_ &BOB7\(_!/Q$T[Q7HOP*_9<_9Q_9>^.
M7P.\!:'-XVU&RT&'QWXY@UCXB'4_$T'A*"YTS4;GQ"^MZ)I^G//KFEZ;Y?XS
MD_X* ZS^WA_P6S^%7[(/P8^#WQ0\*?'"X_9H^&6M>-OB)\5%^'MU\!_&GB#]
MA[X1:'_PL#5/#\N@:K/\1_"5QX3\07LT/A[P].FMV_B'PW;M/'_9U\\-]_3]
M7GWA?X5?#OP7XT^)OQ%\+>$]+T3QO\9=4\,ZW\4/$EFDRZCXTU7P;X3TSP-X
M7O=8:2:2)YM%\):-I>A6?D10*ME91!U>7=(P/GWND]+)=%JGWZ6T_$_!'X=_
ML8_M_?\ !,OQ/XZL_P!A#X7?"O\ :J\"?'+]G#]F#X;:G)\2?C"GPBU7X,_'
MW]FKX,:7\"+?XM7FE:OHNLV/CKX=>-O#>CZ+XH\0>$=!O=-\1SZUIK:/IT_A
MW2[.WEUCT_\ 8R_X)I?'+]E+Q_9Z!:>+K:?1M*_X)2>"/V7HOCE8:R'NV_:=
MN/V@/VA_B]X\UW3=&FNK;QB-'TO5OBU9>(M#UZ^M;26^A:*&6YBUF"\BA_>"
MB@7,_+7=VU?KZ>GJ?R$? W_@EM^V)X MOV!].B_X)_?LR_#/QM^RQ^UQ\&_B
MW^TQ^T[H?QK\(>./CI^U7IGA?Q5KFF>)_%NA:YJGA[2_$>F>')M#\1ZM\3/$
M'A+QQXSMM2U[Q79^%=)T7PYIJZ7*T?>ZM_P3,_;,O+W0M:\9_L>?LS?M!:?^
MR!^VO^UO\6/A-\*_C!X_\!^(O '[87[/W[;7C+QKXE^(.F7NG>+/!_BO2/A1
M\1OAEJ5A\,O$7@Z_\9Z.UI/?17$H#2Z3-I^L_P!75% ^=[Z?CU;;Z^;6^BVM
M9'YB?\$T?V=OBE\%M$^.GC7XI?LY?LM_LB2_&+XAZ9JG@?\ 9N_9@\#?"W2M
M/^&'P_\ "6C-HVC6?Q%^)WPS\$>"8?BWXXUS4;K6=?N=3O;>^TW0+74([/P_
M_9,5]?Z)I_PS\5?V6/\ @I#\)K/_ (*#?LN_LL?"+X-_$3X'?\% OBK\5_BO
MX8_:*\8?&.T\"ZQ^S7JW[4&AV&C?'RS\:_"V?PKK.L_$>/2]2_M[7OA]<^$M
M1WVZZC:2ZM%J+(WAVQ_HAHH%S.[=D[VT>VFW6^GJ[];G\Z'Q+_X)B?'?1OAW
M^WY\)/A/X=TS7_"OQ&_9B_X)2_ ;]GS4K_Q%X6T";Q:/V-=5\467Q"DU33Y-
M2CB\)_V;X?N-&N[5-2^R6>I37$EIHKW?V=@-K]HS_@GY^UEX@_:=_:7_ &M/
M@SX<\&ZEX]\'?MN_L=?M7_LY>$_%WCNT\.:!\</"?PC_ &0_#OP ^,WPXUK6
MM.M]:O/AYJNN&Y\3Z;X9UKQ!I*6:ZGIVG7=S%)H&H7%P/Z%:*+!SOR_JW^7X
MG\T'[1/[$_\ P46_:]\0^&?VPOCU\"OV<_'?B7X)_'72=>^"W_!,3XL^,O 7
MQ2^$5W\!M0^%^J?#CXOZ1XH^+>I_#N3P7>?%_P")7B'5=/\ B'H&J:]X>\1^
M$_ DG@CPI/I2VVO075M<]1\-?V /VF+RZ\$_$>?]DC]DG]D6SE_X*+?LD_&J
MT_9Q_9N\/?!3P[-\-?V?_P!GW1_B/8Z[XB^)7Q8^'W@SP&OQF\<:WKGCJ_UK
M3=#/]L6_A>PO);7PG::;)K'B"R']&]%*W]?UZ!S.UM+?/;[[?.S?F?(7[/G[
M07CKXM_'7]LOX7^)/"/AK1_"O[.'Q2\!^ ? _BKPYK4FMR^+K?Q1\*_#7Q"U
MF+Q,4DFL=&\4^'[CQ'9V][H$#I=V&FW^D7&HV\,M]%O_ "0_;7_8R_;B^(OQ
MS_;OT?X6?!OP7XU^"G[7=Y_P3N\>Z#\1W^*?AKPWXC\(^*OV1_C-\(=7\8>%
M-5\&Z_-93WMIK/@[0/%>OV6L6ETL5O-H^G:7$NI7VO&'2/Z)8+6UMFN'MK:W
MMWO+@W5VT$,<375TT44!N;AHU4SW!A@@A,TI:0Q0Q1EMD: 3TQ)V=TET_"VO
MWJY^.'[57PQ_;T^&O[>\'[77['?P1^$_[0FC_$C]CG0OV5/$WASXA?&&#X.R
M_"SQ;X0^,/C[XF>%_BKJ-U=>'_$4OC7P:J_$2>UUKP?X=M+?Q)>QZ-<+::C9
M2W-F[_G3H_\ P3^_;H\#?LE?LB_ +XO_ +%?[-G_  4#^&'@?X'?%+PA\2_V
M?_B/\2OA]\/?&WPT_:%UCXR^/_&FC?'3P!\>M3\.ZWJR:5XT\#Z]H7A;Q%I'
MA3Q!IFL6/V=[\1QWANHY?ZI:*!J35M%IUUOHFEJFMK]+'\HOA_\ X)%_ML>#
M_"7[./PIUV#P?\5-!\<?\$R_C[_P3L_:)\=#XLSP7W[/-G\7?CG<?&OP?XL\
M(6_BK2O[9^*7AKX4:8?#WPR\/>'+)X+FYT7PRH=[:QMK$:CVWP"_X)D_M!^+
M]5^#_P '?B]_P3Y_X)X_LD^ ?AG\(/'_ (!^.G[4OP=\!_ /XA_&']I37M6^
M'&I_#'PQKGPG:'X4:/XY^!][=7&I?\)_XL\1:MK2^)K^9K_2;#4=,><1S?U"
M44#YWY?CY^=NO5/[S^8#]C[_ ()O_M0?#/QE^Q]\)?&/_!/G_@G#\*=&_93\
M<:!J_P 4?V^?#G@+X$_$3XM?M(^%_A#$B_#:;P%X8U+X2P_$;X7_ !2\9:G:
MZ!K7C;XG^(?$ \8V6KZ/?^,-#\2:1XAN4TO4OVM_80_:-^(_[4?P:\4?$GXE
M^"_"/@K5-(^.OQT^%FBP>!?$9\6>%_$'AWX0_$C7/AU;>*--\0)/=6FIKJFI
M^'=6BFN=-N;C2Y9K.1]/FDMF1S]I5!:VMK90):V5M;VEM%N\NWM88[>"/>[2
M/LAB5(TWR.[MM4;G9F.68D@G*^ZU[Z]VWNWO?Y=#^)']H\_M-?"O_@FW\0OV
M6/@CX@_9L^*?["K?MO6/ACX8?'/1OBAK>E?''7D\7?MN:5XXNOV7;CX-:OX1
MT[48_BUX1^*.O:CJ'C+7M0\0V^EW/PW\->(9H+>>TU#3E/W=^U?^QA_P5%O/
MAU_P4V_8]^ OP3^#'Q$^"7[;OQQ\>_M&^#OV@/%7QRT_PMK?@JS\?Z+X&U/Q
M?\%S\*+S0EN[WQ'JOB'P$=&\,>*[GQ#IGA71W\23ZYK-Y>0L;?1_VHMO^":_
M[!EI^T0W[6%O^RI\'HOV@SXB?QB/B0/#,9OT\:27'VU_&\6CM*WAF'QP=1)U
M8>,HM$3Q.NM%M:751JK->'[?I6*<]K)=W==;IWT>ZMOI?L?R-?&O_@E%^USX
ME\1_MZ:4_P"Q;^S1^T7\0_VH-*:#X+_MI_&[XN>'=1US]GSX>ZC\%M'\"S_"
MCPA\+=<\)ZWJ.C^.? <^G:OI/PR\8^&;[P[ID6K:UI/B#6O&%O8^&[;/VQ^S
M-_P37^-6J>%_^"@OPZ^/_AJV^'/A;]KO_@G[^P-^S+H&IV7BGPSXHU#1?'?P
M<_96^)'PA^*ER8/#NI:FBKX&\:^)=(N]%OKI/[-\310I<V27=HMU"O\ 0;11
M8GG=K:=._2WG_=6RMOIJ?S#_ /#,O_!6?XR_%?\ X)S:!\<OV=/@?X'^%W["
MVD_$?PQXN^(W@3XZZ'XLOOC#KFL?L_>)OA)X;^(NA^$]0TSP]J?@SPU,D6D0
MW/A6[;4=<35_$=WJ$RP:18)!8>/^!O\ @EQ^U_\ #O7/V;M=^(_[$W[.7[;_
M /PAW[ 7P+_9_P#!'A7]H+XQ^'+/X??L@_'3X>'58?&&KZCX+U/0?'GA[XD>
M"_%%WJ=AXEU+5?!&CZGXDO9]'ETBR_LO9:ZGJ'];%%,?.^R6EM+];OO?KW\M
MC^?+_@E?^P;^U=^S-\1/V3M8^/'@[PYHUI\$/V#/VI?V;/&.M>'O%'A74M-O
M?'7CC]N/PI\8/AY-HFE:-J=Q>G2_$7PKT5]=N[@:?86NB:LL^AW5K83_ &2V
MDW?V3S^TW^P5XJ^!_P"SAXL^%W@F_MOVTO\ @HI^WIXIU^Z/C?3=4\5^$_A;
MJUAXL^.'@'QWH&B^']1N?MFG7FF:)<6/C&?4H?L_A*]U/PUI.K-8ZQXET6VO
MOWPJ![6UDN(+R2VMY+NUCGBMKIX8VN+>*Z,)N8X)V4RPQW!MX#.D;*LQ@A,@
M;RTV@G)N]TM?TNU^+N?F;_P4 ^ 7[0OB3XH?L=_M>_LJ>%_"'Q,^,_['GC;X
MHBX^#'C7Q99?#W3?BU\)/CQX(M/!7Q+\-Z-\0M0T?7;+PCXNL9M"\)ZYX>OM
M1L5TISI][]NFF,4&E:I^=ES_ ,$_?VUOB[\:/ G[9/Q;^'?@'P1\8/B/_P %
M2/V-OVA/B)\&?"GQ&T'Q7IOP._93_9,^!OQJ^%OABWO?B!-9>'+7XB^/9]8^
M)>H:UKMGX;L;E)SKD$NC0Q01WFDZ-_29118%)I6T[7ZVUTW\_P"D?&__  4&
M_9CU?]LC]C+]H#]FWPWXCM/"'BSXE>"XX?!7B74$G;3M&\=^%M=TCQMX&O-2
M>UBN+RUTU/%WAK1EU&_L;:ZU#3K)Y[^PM+N\MH+>7\AOVF/V>?\ @KW_ ,%$
M?@K\6OAW\9? OP@_99\.^&_@'H=IX2^$^B?%S0?BII'[2G[4WA'XK_#+XK>'
M?'NM>(-(\+Z;>_#3X;Z5-\+9]-\.>&;_ %@:E8ZGXRA?7[O7M*M]1FLOZ0:*
M 4FNBWNKK;;_ "_RL?S@7OP._P""OW[0O[3/Q=_:A\2_!SX'_LA^,'_X)N_$
M;]F+X(:#<?%CP=^T=X=3XMWGQU^#OQ2E/Q%LKWPI)H+^%OB[I'A[Q9X7N1;>
M$->B\*>';&V_M:[U#6_[,DN?E^[_ ."2/[3WQET_]MGQ3X7_ &0/@7_P3DF^
M,G[#FM? J/X%?"/XUZ=XV^'G[0OQ[O\ QUH7Q"TWQ_JFA^$M,TCX?_"_PUX;
MC\-:EX2\,P+HT>M6$GC5;NYO[C2K35X)OZWZ*!\[6R2V6E^GSU^=_*Q_.+\-
M?A1_P5N_9I\8?&KXX_!S]D_X#>+?$_[;'PS^$#^/OA7K/[1GA[PX/V5?VB/@
MOX _X4A9>.6UN/P9=:#\8?AOXS\%Z%X3^(6NZ'HMY!XJN/%<FKZ,;[3(;?\
MM#7<+X!_\$^/VZO^"5MWX7U#]BKP!\*_VK8?B9^R/\*_@7\<-$\7_%M?@O%X
M,_:!^%&K>/=9\.?'#1Y=;\+:RGC'X61'XE>(]*N_!1>T\<3VZPO8WNF6SBQB
M_I7HH%S/LK/=6>MM%?7ITM;SN?Q_V'_!(#_@H5<? '3_ (=6DGAWP9\1XO\
M@DG\9/V5=4\7Q?$?14M]4^,WBC_@H#X>_:&G\!S7NB7-UJ4>@_%7X/Z5KV@Z
MEXDAM4T6Q'B:;2M6O]-N#/Y.IXA_X);_ +4_BKQ3JWB7X4?\$Z?V;/V*O %]
M^P!^W=^RYI_PO^%GQ@^'GB_QWK'Q5^-7P N?#_@GQQ\5_B!;:/X1M/%6C^*/
M%KZ?X$\-74^I>+/$?AF"PO\ Q-XROM-TS7Y$TK^NRBE:P^=^7X_Y_G>W0_':
M/]D#XZK\5_\ @A[XJ/AO3/[%_8E^&OQ:\-_M#7'_  DFA^9X6U;Q9^Q=#\&M
M$ATJW^V^=XICN/'R-IDD_A]+^*WM<:G,R6!\^OM#]@_]H#QM^U-^R;\'OCW\
M1O"OAKP7XS^(>F>)+S6?#W@S6)O$/A"W.C>-O$OAFPOO"WB&66<>(/#VN:7H
MMEKNC:]:SW&G:SIVI6^I:7<7&G75K,_US4-O;P6D$%K:P0VUK;0QV]M;6\:0
MP6\$*+'#!!#&JQQ0Q1JL<<<:JD:*JJH4 4[?U]W^1+=U^7WMO\7^!_(=^Q'\
M$_V_?VQOV)?V4_V5/$7PG^$_A3]BO3?VE[CXV>(OVGH/BM#=^-_%7PB^%G[2
M/B;XF6?P<T[X,VNAVVM:/\0;WXC:/-H<GCJZU>3PW%X:LK6Z^QSZ@)+S4?4M
M8_X)1_M#^&-4^"_[0%Y^R?\ LZ_M>>(_AQ\<_P!O>R^(G[)GQ_U_X;W/A?QY
M\%?VDOVB/%7Q9^%?C_P+XI\8>%_'O@3PQ\0_"AO+35;R/7-.-^VF:S<Z"K6%
MRFH1S?TS?"[X6?#[X*^!=#^&?PK\*Z9X)\!^&O[3_L+PQHXG73M,_MG6-0\0
M:I]G%S-<3C[;K.JZCJ$V^9_W]W+MVIM5>_I+1)%<[OHDEK^.]];W]&MM#^4G
MQ7_P2Z_:LU?PM^R]\0_''[$?[&WQ!\)^%OVC?VD?B]\7/^":WP8O/AA^SQ\(
MK#PQ\3_ G@WP5^S]'K7BWPSX+\-_#WXV?$?X"P>&O$=SKGB_QSI6JR:XOC:7
M0]"=M)LI+@Z7PR_8%_X*(?"?P;^T5;0_L@_L7^*/AG\4OVNO#WQL\7_L&P:K
M\+Y/@!\7/@3XL^!V@^%$^$O@CQ5XI^'4\7PP\:?LX^+_  [X;GT[7_\ A!_!
MWA_Q3XATS5-:T!+WPY!I6FZK_5)13#G?9?CWOW_'?ST1_(=X?_X(P_M"^%_"
MG@[X^Z=^RA^SCXEU/X<?M>_&'XM^!/\ @EA\5_B/HGQ5^ ?A_P#9Y^-'PT\+
M?#WQGX#TSXE^/O"WBGP7I?Q1O_%7@S0?B?97UMH+^"M*O+#2[FS$%]IJ>&7_
M &L_X)G?LW_$[X*V7[0/C[XH?LU?LK?LA3_&7X@Z)=> _P!GG]F#P!\*-'C^
M'?PT\$Z-<Z9X?M/B;\4OAAX+\&Q_%KQEJNK:OXCUUKB_BU'3/#$6ISP^')-,
M@UK4-$T[]1:*!.;:L_U_SM\[7\S^.C]MC5_VB_V?OV<O^"V/P]_9E\5?LW?$
M;]E/XE?&3XX^//C'\1?%/Q'\1^!/C+^S=\3?CAH.ES_'[X!WWPSNO#!G^(FI
M_$N^O[>Q^$.N:=K=OX;>U\9RB:_U>PCFTKP]]J^%_P#@FK\;_BA\&/\ @J-X
M9\5Z#;^%!^US\ OV!KG]FS6)=>TF/5;?XN?LT?L@_#S1M)U#6+2&[;4_!UQX
M1^/?@G1(&GU2/3KI[>SEU+3I/)$=R/UC^)?_  38_8/^,?QUT[]I?XG_ ++7
MPF\:?''3+O1-13Q_K6@O+?ZCJ7AO["- U/Q%ID5S#H'BK4]'BTS3K73]1\3:
M3JU[:V-A:6$4ZV5O% OV_0-ST5EKHV[=5R^>OP^6FEMV?S*Z[_P28^/EU^P[
M^R!K/B'X8_ KX_\ [9'P:_:7^)W[87[1'P+^.#^&M5^#7[1'B[]I#5_%][\;
M?A]K>JZAH_BSPG;>(],TGQ%X;L?!/BF[M-3\+6&L>![/5)X-0D-E=Q_H/_P3
M2_9G^*_PC\3_ +1GQ7^*'[*?[(_[%>E_%36/!6C?"C]G?]F+P)\(8-9\&>"?
M!>FZFFI:G\6OC'\,O '@MOB9X@\6^(-5EU72M*=[G0_!UG#.FG007.L7<-O^
ML=% G)M-/KZ]7?O;\+VTN?S]?M6?\$\/VH/C/XT_X+#:W\/[/PAHMQ^U!X<_
MX)I>)/V9M9\2Z_I[Z5XL\<_L7>(M3^)'BGPWXBL;&>?4_#%KJ6OZ/H7A>SU+
M6K6TLIVUP:C'*]A8WLT/SE^T9^R-_P %2?VVKW]M'XD_%S]FSX7_  7U7XO?
M\$YK;]E;X,_";PO^T!X2^(\MOXWTSX^>'?B-J-QXL\:3:=X2TRWN?%<8\0:O
M92V]O)H>B>'[#P]HMYJEQXB.H27/]25%*P*;5M%I:VFUK>?]U'YO_L)?LZ?%
M;X&_&'_@HOXO^(^B66DZ%^T/^V5J_P 8?A9<VFMZ5JTNM> [OX:> O#4&IWM
MMIMU<SZ+<OJV@ZE"=,U1+6_6.))V@$4T;-^=OQ0_8K_;?U;]K_XP0:'\'?!N
ML_L[>/O^"F7[!O[=^A_&.W^*GAFRUVUT7X'WGP(\/?$_P=JGP]U26SUI;K2/
M#O@CQ#XAT^\M3.=4FTS^S=/AO)]3L0O]&5%,.9IMZ:_I_P ,?S1:'_P3\_;-
M\1_'C5/A[\2OA#X5TW]G'2?^"H'[6O[5NB?&'PQ\6/#%YKOBGX+_ +7OPR_:
M?T+7(+SP3=FWUSP]XD\":EX_\ :5% MOJ,FKW/B#5KF&T33O#3:AJOGW[*__
M  3#_:A^%.L?LL? #Q!^P%_P3B\*Z%^SK\6](UWXE?\ !12/X?\ P'^(OQ5^
M.OPB^'>L7.J^%-*\+?#[Q#\))_B#X%^-7B^(Z#:ZU\3=<\1WEYX>O]%O/$FE
MZFNJS6R7']3U% ^=^6OKVM??\[KR/ ?V>?$_[0WBK0/'UU^T=\,O"7PM\0Z9
M\7/'NA_#W2_"'BJ#Q;:^)?@[IE[:Q_#[QQJ]W;WEXNE^(?$MD]U<:MH+O#+I
M<D4<3VT)?!]^HHH("BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K\6/\
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M+'?M8_"+6_VR?B'X3_8P\!^,/V4_V!OVA=*^$'QW^(MW\9[O2_B)XLT369?
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M:WQ1_P""C?\ P2Z\0?M>_LL^"?@;H6N_#+]L;XQ?"=OA3\2-:^+&L3:-K_P
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M#_B[\.](UZU\6VMWX9N9_&Z:!?/X?\6WW@O5O$-OX6GBT5[E[K3UO?&?#_\
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M#4M6@U3QE8^'M5U#1);?<UO9?(7[0G[!G[7OQG_:FMM;/[!/@KP?^T[X?_;
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M_P %HOV6_CQ^U%^QL+']E71(?$'[3?P@^*_@#XN?!?27UOPWX8FU'5[274_
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M[$OAW7OB)^T=_P %>_V_OV=+CPS=?'/Q;!IWBGXU^#)DU;5?CYX@UCQ?IGB
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MJ%[8Z'J,VLZB-&?3[6?4/9KNT_X*3_M#?M!>$_VU?&_[!L?P4\0_L4?LO_M
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M5XF\)Z=K)M+B"+5HM>D\2:\GBFQU.@UM=+IHNBL]);/>_P#,G?RMH?LU=_\
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MQM\/T^%]_>:+<:+XB^'UQH>KIXVD\0ZII.AZ+':0W/\ ;-S:ZMH<^I\]K?\
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M^#_^$UN?'^A!_&FIV>JZ3XOTR#5;+P<EM=M>S:WH.LZ5XCM?#4]K%]H_&?\
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MB[5M9\:?$2WOO[:UK2]!\6V.L17-_:3V.CV'WE^T/_P4N_9N_9B\6?'KP?\
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MTN6ZOK;N^KNK^5EY]]+'I'B#_@K1^R;X3^#W@;XU>*I?B+X<\-^._P!K^_\
MV'[;1=6\+:=!XL\/?'32/%?BGPGK5IXITI/$4MIIOAC1KCPAJNJZEKMMJ5^U
MOH\EC-]A:^NAIZ87[0/[;WPFN?COX(^"FB?$#XZ^#/%OP9_;9^ OPC\:Q?#7
MPCX=UGPQ\7/&_P 6/V;_ (Q?&+0_@;K6HZAXA@NY/",GA+2+7Q%XUO=/L(]4
MTCQ?8>"M$LX+[[;JTNF_@C^VC^P]\:?C+^V_^W[^R_X?\,:Y:_!;PO\ "_\
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M6QZ]J6AQ:!J>EZE;^'&UBWU?2;^\M-.BN?#]]-=6XUK1Y+GZ\_;+\!^+K_\
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M\=QC][_CAX7\0^*/V OB_P""_#^CW^J^*_$7['WQ \+Z)X?M8&;5-2\0ZO\
M!;5M*TW1[:U;:[7]YJ5Q!90P,%8W$BQG!S@Z?+_,EI*UNZ3UWTB_ENT?A9\$
MO^"NOQ-TKXB_L">+OBWX'_;!^(X^-'_!+&;6M0^!/P^^"=OK/Q#_ &@?VG[+
MQG\!+[4?C-\/O 6D7VD:!/X2USP4OQ2\5>&?&5]K'A#PK)X+EO6@M;"YN]+T
MN?\ 4V7_ (*[_LJS?LR_ _\ :8\-Z/\ &SQRG[1OC36_AG\'O@+X)^&<VO\
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M%?\ Y.H_X>^?\$N_^C]OV7/_  [GA7_Y.K\N?^(4/_@EW_T&?VH__#L^%?\
MYV-'_$*'_P $N_\ H,_M1_\ AV?"O_SL:/E^*"U/^:?_ ("O\S]1O^'OG_!+
MO_H_;]ES_P .YX5_^3J/^'OG_!+O_H_;]ES_ ,.YX5_^3J_+G_B%#_X)=_\
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MN>%?_DZC_A[Y_P $N_\ H_;]ES_P[GA7_P"3J_+G_B%#_P""7?\ T&?VH_\
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M9_:C_P##L^%?_G8T?\0H?_!+O_H,_M1_^'9\*_\ SL:/E^*"U/\ FG_X"O\
M,_4;_A[Y_P $N_\ H_;]ES_P[GA7_P"3J/\ A[Y_P2[_ .C]OV7/_#N>%?\
MY.K\N?\ B%#_ ."7?_09_:C_ /#L^%?_ )V-'_$*'_P2[_Z#/[4?_AV?"O\
M\[&CY?B@M3_FG_X"O\S]1O\ A[Y_P2[_ .C]OV7/_#N>%?\ Y.H_X>^?\$N_
M^C]OV7/_  [GA7_Y.K\N?^(4/_@EW_T&?VH__#L^%?\ YV-'_$*'_P $N_\
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MG_!+O_H_;]ES_P .YX5_^3J_+G_B%#_X)=_]!G]J/_P[/A7_ .=C1_Q"A_\
M!+O_ *#/[4?_ (=GPK_\[&CY?B@M3_FG_P" K_,_4;_A[Y_P2[_Z/V_9<_\
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M  [GA7_Y.K\N?^(4/_@EW_T&?VH__#L^%?\ YV-'_$*'_P $N_\ H,_M1_\
MAV?"O_SL:/E^*"U/^:?_ ("O\S]1O^'OG_!+O_H_;]ES_P .YX5_^3J/^'OG
M_!+O_H_;]ES_ ,.YX5_^3J_+G_B%#_X)=_\ 09_:C_\ #L^%?_G8T?\ $*'_
M ,$N_P#H,_M1_P#AV?"O_P [&CY?B@M3_FG_ . K_,_4;_A[Y_P2[_Z/V_9<
M_P##N>%?_DZC_A[Y_P $N_\ H_;]ES_P[GA7_P"3J_+G_B%#_P""7?\ T&?V
MH_\ P[/A7_YV-'_$*'_P2[_Z#/[4?_AV?"O_ ,[&CY?B@M3_ )I_^ K_ #/U
M&_X>^?\ !+O_ */V_9<_\.YX5_\ DZC_ (>^?\$N_P#H_;]ES_P[GA7_ .3J
M_+G_ (A0_P#@EW_T&?VH_P#P[/A7_P"=C1_Q"A_\$N_^@S^U'_X=GPK_ /.Q
MH^7XH+4_YI_^ K_,_4;_ (>^?\$N_P#H_;]ES_P[GA7_ .3J/^'OG_!+O_H_
M;]ES_P .YX5_^3J_+G_B%#_X)=_]!G]J/_P[/A7_ .=C1_Q"A_\ !+O_ *#/
M[4?_ (=GPK_\[&CY?B@M3_FG_P" K_,_4;_A[Y_P2[_Z/V_9<_\ #N>%?_DZ
MC_A[Y_P2[_Z/V_9<_P##N>%?_DZORY_XA0_^"7?_ $&?VH__  [/A7_YV-'_
M !"A_P#!+O\ Z#/[4?\ X=GPK_\ .QH^7XH+4_YI_P#@*_S/U&_X>^?\$N_^
MC]OV7/\ P[GA7_Y.H_X>^?\ !+O_ */V_9<_\.YX5_\ DZORY_XA0_\ @EW_
M -!G]J/_ ,.SX5_^=C1_Q"A_\$N_^@S^U'_X=GPK_P#.QH^7XH+4_P":?_@*
M_P S]1O^'OG_  2[_P"C]OV7/_#N>%?_ ).H_P"'OG_!+O\ Z/V_9<_\.YX5
M_P#DZORY_P"(4/\ X)=_]!G]J/\ \.SX5_\ G8T?\0H?_!+O_H,_M1_^'9\*
M_P#SL:/E^*"U/^:?_@*_S/U&_P"'OG_!+O\ Z/V_9<_\.YX5_P#DZC_A[Y_P
M2[_Z/V_9<_\ #N>%?_DZORY_XA0_^"7?_09_:C_\.SX5_P#G8T?\0H?_  2[
M_P"@S^U'_P"'9\*__.QH^7XH+4_YI_\ @*_S/U&_X>^?\$N_^C]OV7/_  [G
MA7_Y.H_X>^?\$N_^C]OV7/\ P[GA7_Y.K\N?^(4/_@EW_P!!G]J/_P .SX5_
M^=C1_P 0H?\ P2[_ .@S^U'_ .'9\*__ #L:/E^*"U/^:?\ X"O\S]1O^'OG
M_!+O_H_;]ES_ ,.YX5_^3J/^'OG_  2[_P"C]OV7/_#N>%?_ ).K\N?^(4/_
M ()=_P#09_:C_P##L^%?_G8T?\0H?_!+O_H,_M1_^'9\*_\ SL:/E^*"U/\
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M'<\*_P#R=7Y<_P#$*'_P2[_Z#/[4?_AV?"O_ ,[&C_B%#_X)=_\ 09_:C_\
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M:C_\.SX5_P#G8T?+\4%J?\T__ 5_F?J-_P /?/\ @EW_ -'[?LN?^'<\*_\
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MOC-_Z<=&K^C2OYR_^#6?_E%'X:_[+M\9O_3CHU?T:4%3^.7^)A11100%%%%
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MPHHHH("BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH _F>_P"#KS_E%WHW_9T?PF_]17XG5^HW_!(/_E%W^P3_ -FN?"/_ -16
MPK\N?^#KS_E%WHW_ &='\)O_ %%?B=7ZC?\ !(/_ )1=_L$_]FN?"/\ ]16P
MI=_E^1H_X<?\<OR1^C=%%%,S/X@_^=SC_/\ TBIK^WROX@_^=SC_ #_TBIK^
MWR@TJ?8_Z]Q_4****#,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M(>NKW>H4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !7RY^W%_P F5?M@?]FN?M ?^JG\6U]1U\N?MQ?\
MF5?M@?\ 9KG[0'_JI_%M)[/T?Y,:W7JOS1_.3_P:"?\ )E7[3G_9T;?^JG^'
MU?ULU_)-_P &@G_)E7[3G_9T;?\ JI_A]7];-,JI\<O7]$%%%%! 4444 %%%
M% !1110 4444 %%%% !7\7_A#_E<8^*?_8AZ=_Z[X^'%?V@5_%_X0_Y7&/BG
M_P!B'IW_ *[X^'%)_P"7YHTA]O\ P/\ -']H%%%%,S"BBB@ HHHH **** "B
MBB@ HHHH *R]<US1_#.B:QXD\0ZG9:+H'A_2]0US7-8U*XCM-.TG1])M)K_4
M]3O[J9EBMK*PLK>>ZNKB5ECA@BDD=@JDC4K\8?\ @NY;_M8^-/V%M9_9_P#V
M0/A1XV^(_CO]IKQSX2^"7C;6_".G2ZC;?#GX4^*[X1>,]?\ $B6!NM6M- UR
M-+'P?X@U.WT74=-T;PCKWBG6M8N=+@TV&>4&E=I7M=[OIYGP?_P1/T+6?V]?
MVU/VV?\ @LQ\1])NUT#QAXMU+]G+]C_3]<M&BG\.?";PFFG6VK:SIUL[I;VM
MW)X=L_"?AV\U.RM,S^);_P"*EK]L\V\U:.;^HZOF[]C_ /9I\%_L=?LQ?!/]
MF7P D9\-_![P'I7A87Z0FW;7]>/FZIXP\6W-N9)1#?\ C+QAJ.N^*]2B1S''
M?ZS<K$%B"*/I&@<G=NVVR]%HO\_5A11102%%%% !1110 4444 %%%% !1110
M 4444 ?BW_P7F_;1O_V/_P!@+QYIO@.ZNV^//[3%W%^SE\$-)TB&:ZUZ77?B
M!;S6/BS7M*MK0/>1W?AWP2VMR:+?01/Y'C34/"%GQ-J, /U)_P $O/V+]._8
M%_8>^!?[."PVG_"8>'_#4?B3XL:C9RBYAU?XN>,2NO>/KB&\621+VPTS6+IO
M#>AW2%%E\.Z'I&(HR"@_-+XF?LR?M ?MJ_\ !=_X>>/?C9\)/&GA;]B__@GC
M\,=,\:_ _7_$.G3Q>!_C#\</%+Z=JL/B+P]J<1O]*U'4M$\5&QOM1T^VOK+4
MM*MO@[X1DUS3K5/$:6^H?T6T%O2*BNOO2]7HE\E^+"BBB@@**** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _F>_X.O/^
M47>C?]G1_";_ -17XG5^HW_!(/\ Y1=_L$_]FN?"/_U%;"ORY_X.O/\ E%WH
MW_9T?PF_]17XG5^HW_!(/_E%W^P3_P!FN?"/_P!16PI=_E^1H_X<?\<OR1^C
M=%%%,S/X@_\ G<X_S_TBIK^WROX@_P#G<X_S_P!(J:_M\H-*GV/^O<?U"BBB
M@S"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** /XL/\ @H7_ ,K4'_!/S_L4O@1_Z>OC'7]I]?Q8?\%"_P#E:@_X
M)^?]BE\"/_3U\8Z_M/H-)[4_\'_MS"OSD_X*^?\ *+O]O;_LUSXN?^HK?U^C
M=?G)_P %?/\ E%W^WM_V:Y\7/_45OZ"%NO5?FC\YO^#6?_E%'X:_[+M\9O\
MTXZ-7]&E?SE_\&L__**/PU_V7;XS?^G'1J_HTH*G\<O\3"BBB@@**** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MS_PQ/Q<_^92O>/\ AP5_P2#_ .C)O ?_ (6?Q<_^>'1_PX*_X)!_]&3> _\
MPL_BY_\ /#HU[?C_ , /W7:?WQ_R/!_^(FO_ ()!_P#1=O'G_AB?BY_\RE'_
M !$U_P#!(/\ Z+MX\_\ #$_%S_YE*]X_X<%?\$@_^C)O ?\ X6?Q<_\ GAT?
M\."O^"0?_1DW@/\ \+/XN?\ SPZ->WX_\ /W7:?WQ_R/!_\ B)K_ ."0?_1=
MO'G_ (8GXN?_ #*4?\1-?_!(/_HNWCS_ ,,3\7/_ )E*]X_X<%?\$@_^C)O
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M)K_X)!_]%V\>?^&)^+G_ ,RE'_$37_P2#_Z+MX\_\,3\7/\ YE*]X_X<%?\
M!(/_ *,F\!_^%G\7/_GAT?\ #@K_ ()!_P#1DW@/_P +/XN?_/#HU[?C_P
M/W7:?WQ_R/!_^(FO_@D'_P!%V\>?^&)^+G_S*4?\1-?_  2#_P"B[>//_#$_
M%S_YE*]X_P"'!7_!(/\ Z,F\!_\ A9_%S_YX='_#@K_@D'_T9-X#_P#"S^+G
M_P \.C7M^/\ P _==I_?'_(\'_XB:_\ @D'_ -%V\>?^&)^+G_S*4?\ $37_
M ,$@_P#HNWCS_P ,3\7/_F4KWC_AP5_P2#_Z,F\!_P#A9_%S_P">'1_PX*_X
M)!_]&3> _P#PL_BY_P#/#HU[?C_P _==I_?'_(\'_P"(FO\ X)!_]%V\>?\
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M^(CS_@C'_P!'D_\ FO/[5?\ \XVC_B(\_P"",?\ T>3_ .:\_M5__.-KO/\
MAP5_P2#_ .C)O ?_ (6?Q<_^>'1_PX*_X)!_]&3> _\ PL_BY_\ /#I:]OQ_
MX OW7:?WQ_R.#_XB//\ @C'_ -'D_P#FO/[5?_SC:/\ B(\_X(Q_]'D_^:\_
MM5__ #C:[S_AP5_P2#_Z,F\!_P#A9_%S_P">'1_PX*_X)!_]&3> _P#PL_BY
M_P#/#HU[?C_P _==I_?'_(X/_B(\_P"",?\ T>3_ .:\_M5__.-H_P"(CS_@
MC'_T>3_YKS^U7_\ .-KO/^'!7_!(/_HR;P'_ .%G\7/_ )X='_#@K_@D'_T9
M-X#_ /"S^+G_ ,\.C7M^/_ #]UVG]\?\C@_^(CS_ ((Q_P#1Y/\ YKS^U7_\
MXVC_ (B//^",?_1Y/_FO/[5?_P XVN\_X<%?\$@_^C)O ?\ X6?Q<_\ GAT?
M\."O^"0?_1DW@/\ \+/XN?\ SPZ->WX_\ /W7:?WQ_R.#_XB//\ @C'_ -'D
M_P#FO/[5?_SC:/\ B(\_X(Q_]'D_^:\_M5__ #C:[S_AP5_P2#_Z,F\!_P#A
M9_%S_P">'1_PX*_X)!_]&3> _P#PL_BY_P#/#HU[?C_P _==I_?'_(X/_B(\
M_P"",?\ T>3_ .:\_M5__.-H_P"(CS_@C'_T>3_YKS^U7_\ .-KO/^'!7_!(
M/_HR;P'_ .%G\7/_ )X='_#@K_@D'_T9-X#_ /"S^+G_ ,\.C7M^/_ #]UVG
M]\?\C@_^(CS_ ((Q_P#1Y/\ YKS^U7_\XVC_ (B//^",?_1Y/_FO/[5?_P X
MVN\_X<%?\$@_^C)O ?\ X6?Q<_\ GAT?\."O^"0?_1DW@/\ \+/XN?\ SPZ-
M>WX_\ /W7:?WQ_R.#_XB//\ @C'_ -'D_P#FO/[5?_SC:/\ B(\_X(Q_]'D_
M^:\_M5__ #C:[S_AP5_P2#_Z,F\!_P#A9_%S_P">'1_PX*_X)!_]&3> _P#P
ML_BY_P#/#HU[?C_P _==I_?'_(X/_B(\_P"",?\ T>3_ .:\_M5__.-H_P"(
MCS_@C'_T>3_YKS^U7_\ .-KO/^'!7_!(/_HR;P'_ .%G\7/_ )X='_#@K_@D
M'_T9-X#_ /"S^+G_ ,\.C7M^/_ #]UVG]\?\C@_^(CS_ ((Q_P#1Y/\ YKS^
MU7_\XVC_ (B//^",?_1Y/_FO/[5?_P XVN\_X<%?\$@_^C)O ?\ X6?Q<_\
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M_P XVN\_X<%?\$@_^C)O ?\ X6?Q<_\ GAT?\."O^"0?_1DW@/\ \+/XN?\
MSPZ->WX_\ /W7:?WQ_R.#_XB//\ @C'_ -'D_P#FO/[5?_SC:/\ B(\_X(Q_
M]'D_^:\_M5__ #C:[S_AP5_P2#_Z,F\!_P#A9_%S_P">'1_PX*_X)!_]&3>
M_P#PL_BY_P#/#HU[?C_P _==I_?'_(X/_B(\_P"",?\ T>3_ .:\_M5__.-H
M_P"(CS_@C'_T>3_YKS^U7_\ .-KO/^'!7_!(/_HR;P'_ .%G\7/_ )X='_#@
MK_@D'_T9-X#_ /"S^+G_ ,\.C7M^/_ #]UVG]\?\C@_^(CS_ ((Q_P#1Y/\
MYKS^U7_\XVC_ (B//^",?_1Y/_FO/[5?_P XVN\_X<%?\$@_^C)O ?\ X6?Q
M<_\ GAT?\."O^"0?_1DW@/\ \+/XN?\ SPZ->WX_\ /W7:?WQ_R.#_XB//\
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MY/\ YKS^U7_\XVC_ (B//^",?_1Y/_FO/[5?_P XVN\_X<%?\$@_^C)O ?\
MX6?Q<_\ GAT?\."O^"0?_1DW@/\ \+/XN?\ SPZ->WX_\ /W7:?WQ_R.#_XB
M//\ @C'_ -'D_P#FO/[5?_SC:/\ B(\_X(Q_]'D_^:\_M5__ #C:[S_AP5_P
M2#_Z,F\!_P#A9_%S_P">'1_PX*_X)!_]&3> _P#PL_BY_P#/#HU[?C_P _==
MI_?'_(X/_B(\_P"",?\ T>3_ .:\_M5__.-H_P"(CS_@C'_T>3_YKS^U7_\
M.-KO/^'!7_!(/_HR;P'_ .%G\7/_ )X='_#@K_@D'_T9-X#_ /"S^+G_ ,\.
MC7M^/_ #]UVG]\?\C@_^(CS_ ((Q_P#1Y/\ YKS^U7_\XVC_ (B//^",?_1Y
M/_FO/[5?_P XVN\_X<%?\$@_^C)O ?\ X6?Q<_\ GAT?\."O^"0?_1DW@/\
M\+/XN?\ SPZ->WX_\ /W7:?WQ_R/YFOBY^V'^SE^W!_P<G_L!_&C]EWXB_\
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MK_@D'_T9-X#_ /"S^+G_ ,\.C7M^/_ #]UVG]\?\C@_^(CS_ ((Q_P#1Y/\
MYKS^U7_\XVC_ (B//^",?_1Y/_FO/[5?_P XVN\_X<%?\$@_^C)O ?\ X6?Q
M<_\ GAT?\."O^"0?_1DW@/\ \+/XN?\ SPZ->WX_\ /W7:?WQ_R.#_XB//\
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MY/\ YKS^U7_\XVC_ (B//^",?_1Y/_FO/[5?_P XVN\_X<%?\$@_^C)O ?\
MX6?Q<_\ GAT?\."O^"0?_1DW@/\ \+/XN?\ SPZ->WX_\ /W7:?WQ_R.#_XB
M//\ @C'_ -'D_P#FO/[5?_SC:/\ B(\_X(Q_]'D_^:\_M5__ #C:[S_AP5_P
M2#_Z,F\!_P#A9_%S_P">'1_PX*_X)!_]&3> _P#PL_BY_P#/#HU[?C_P _==
MI_?'_(X/_B(\_P"",?\ T>3_ .:\_M5__.-H_P"(CS_@C'_T>3_YKS^U7_\
M.-KO/^'!7_!(/_HR;P'_ .%G\7/_ )X='_#@K_@D'_T9-X#_ /"S^+G_ ,\.
MC7M^/_ #]UVG]\?\C@_^(CS_ ((Q_P#1Y/\ YKS^U7_\XVC_ (B//^",?_1Y
M/_FO/[5?_P XVN\_X<%?\$@_^C)O ?\ X6?Q<_\ GAT?\."O^"0?_1DW@/\
M\+/XN?\ SPZ->WX_\ /W7:?WQ_R.#_XB//\ @C'_ -'D_P#FO/[5?_SC:/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M*7#,,HK86MD#X:AF$Y8BKFTL?7I9BL9]0:C3IX'".A[5.4ZO(^;ZBHK^*?\
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M?$.,R^&8X+@CB/Q1H4X<$Y'Q=7A6PV#KX>K2QF297FN)I99FF?T,1[2I2_I
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M?%VUT?0M3LK5-4T^ZU1XIK>"YT,ZIJGAF75;8:?:ZM:S+\,^/?\ @GK^V/\
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M'7BO4O@AXX7]M#X-_!SQ)#X-\;:[XBO_ ![I?AKXA:%XX@O[[0+C7]0BFOM
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MW_VB]Q=_Z7Q&>M?\''__ "=%\"_^R!I_ZL/QG7]87P"_Y(3\%?\ LDOPX_\
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M_P#ZD5Y7]#7_  ;9_P#)&?VF?^RG>#/_ %%;VOYY?^"CO_)^?[77_9?/B/\
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M &0-_P#U8?@ROGG_ (+V?\I#/%?_ &3'X7_^F2:OH;_@W _Y.B^.G_9 W_\
M5A^#*_2\=_R:"/\ V3.!_P#3^%/]"^,_^55='_M'?@S_ -7'#1^:/_!47_E(
M-^UA_P!E:UC_ -)+"OW6_P"#:K_D1?VL_P#L;/A)_P"F?QY7X4_\%1?^4@W[
M6'_96M8_])+"OW6_X-JO^1%_:S_[&SX2?^F?QY1QE_R:VC_V+>&O_>:'TL?^
M5;.5?]F^^CU^?A^?#_\ P1__ .4N7C'_ +N-_P#3AJ%<]^TC_P I^O#O_9ZO
M[*G_ *=?@]70_P#!'_\ Y2Y>,?\ NXW_ -.&H5SW[2/_ "GZ\._]GJ_LJ?\
MIU^#U.K_ ,E?G/\ V;&/_J/BS3,O^4J?%G_M710_]4G$Q[W_ ,')'_)=OV</
M^R2^)?\ U,9*_I2_86_Y,C_8Y_[-7_9[_P#52>$:_FM_X.2/^2[?LX?]DE\2
M_P#J8R5_2E^PM_R9'^QS_P!FK_L]_P#JI/"-?F_$W_)MN ?^PG,O_36*/\_O
MI$_\J^_H1_\ 90\?_P#JNXC/Y!?^"]G_ "D,\5_]DQ^%_P#Z9)J^AO\ @W _
MY.B^.G_9 W_]6'X,KYY_X+V?\I#/%?\ V3'X7_\ IDFKZ&_X-P/^3HOCI_V0
M-_\ U8?@ROT?'?\ )H(_]DS@?_3^%/[]XS_Y55T?^T=^#/\ U<<-'YH_\%1?
M^4@W[6'_ &5K6/\ TDL*_=;_ (-JO^1%_:S_ .QL^$G_ *9_'E?A3_P5%_Y2
M#?M8?]E:UC_TDL*_=;_@VJ_Y$7]K/_L;/A)_Z9_'E'&7_)K:/_8MX:_]YH?2
MQ_Y5LY5_V;[Z/7Y^'Y^?O_!)K_E,*W_8Q?M+?^F+QQ2_M(_\I^O#O_9ZO[*G
M_IU^#U)_P2:_Y3"M_P!C%^TM_P"F+QQ2_M(_\I^O#O\ V>K^RI_Z=?@]6E?_
M )*W-?\ LU[_ /2,8=V<_P#*4'B5_P!JXI_^H?%9]4?\'*O_ "/?[)G_ &*7
MQ:_]/'@2OZ)?V%O^3(_V.?\ LU?]GO\ ]5)X1K^=K_@Y5_Y'O]DS_L4OBU_Z
M>/ E?T2_L+?\F1_L<_\ 9J_[/?\ ZJ3PC7YAQ%_R;7@3_L.S?_TG$G^<WCS_
M ,J]_H6_]EIXI?\ IGB$_DR_X.#_ /D_33/^R"?#S_U(/'=>L_\ !N!_R=%\
M=/\ L@;_ /JP_!E>3?\ !P?_ ,GZ:9_V03X>?^I!X[KUG_@W _Y.B^.G_9 W
M_P#5A^#*_1\3_P F=C_V3>%_]3*1_?O$/_*J##_]H_\ #G_K69<?G]_P5Z_Y
M2/?M2?\ 8V^&/_5<^#:_:G_@VJ_Y$7]K/_L;/A)_Z9_'E?BM_P %>O\ E(]^
MU)_V-OAC_P!5SX-K]J?^#:K_ )$7]K/_ +&SX2?^F?QY1Q9_R:C#?]BOAG\\
M 'TG?^59'#O_ &;?Z/'_ *=X)/BK_@FQ_P IO_&__93_ -KK_P!%?$2O)OVS
M_P#E-_J?_9U'[/'_ *!\*Z]9_P"";'_*;_QO_P!E/_:Z_P#17Q$KR;]L_P#Y
M3?ZG_P!G4?L\?^@?"NNBG_R5N*_[-?AO_2)GN8#_ )2@XD_[5P\/?^H6,/M7
M_@Y5_P"1[_9,_P"Q2^+7_IX\"5_1+^PM_P F1_L<_P#9J_[/?_JI/"-?SM?\
M'*O_ "/?[)G_ &*7Q:_]/'@2OZ)?V%O^3(_V.?\ LU?]GO\ ]5)X1K\PXB_Y
M-KP)_P!AV;_^DXD_SF\>?^5>_P!"W_LM/%+_ -,\0GU11117Y@?YRA1110 5
M\V?MF:?J^K_L?_M6Z5X?@NKG7M3_ &;/CII^B6UBQ2]N-7O?A?XIMM-@M'5D
M*74M[+#';L'0K*R$,I&1])U'-##<0RV]Q%'/!/&\,\$R++#-#*I22*6-PR21
MR(S(Z.I5U)5@02*WPM9X;$X;$J*F\-B</B%!Z*;P^(H5U!O6RFZ"BW;129['
M#N;RX?XAX>S^-"&*ED.?Y#GL<+4?+3Q4LCSS)<ZCAJDK2Y:>)EDT</4ERRY8
M8B<N65K/\@_^"%=SX;G_ ."<7PJBT,(-4LO&'Q8MO&140@MXD?XA:[>6ID,3
M%V?_ (1"[\*J#<A9MBH%4VXMV;]3OB#\0_ _PH\':W\0?B3XIT;P5X)\-PVT
M^O>*/$-Y'I^CZ3#>7UKIEK+>WDI$<"7&H7MI9Q%C\T]Q%&.6%?@GH/[*O_!0
M'_@F?\5_B9K'[#G@SP=^TG^RK\4_%#^*Y_@9K_B.Q\->*O >IW;0PJVE3:KJ
M.B1Q7&G6OV;P]:ZYHE]XB&M>';"P?Q3X5CNM%T_4[;/^+7PN_P""HO\ P5 7
MP[\(OC7\(_#'[%'[+$?B+0_$/Q"#>+K+Q-X_\;1Z1=)=QZ7!9V5_>7VHO8M)
M!J6C:5K7ASPKX9AUVUMM6U/5=8U#1+#3K7[[,\EP&;Y[B\[_ +?RFEP_F.+G
MF6(Q53,,/',\)1Q%J]?!/*9IXZIF-&?M,-1I0HU*%62I35?V*DU_;GB'X1\%
M^*?C1Q/XP?\ $;?#'+O WCWBC&>(.=\18SCK(J7B+PSE6>^RSK.N$JGAAC(S
MXQQO'>5XJ6-X>RC+,'E./R;,*\,LQE+.5E,:U2/]!WA3Q;X6\=^'-'\8>"?$
MF@^+_"?B"RCU'0?$WAC5K#7= UFPE+".]TO5]+N+JPO[5V5E6>UN)8RRLN[<
MK =!7(_#_P #>&_ACX%\&_#CP=8C3/"?@+PMH/@[PUIX*M]CT/PWI=KI&EP.
MZI&))([.SA$LNQ3-+OE8;G-==7Y]5]DJM547-T54J*BZJBJKI*<U2=10O!5'
M35-U%!N*FYJ+<4F_X8S*.7QS',(Y14QE7*8X_&QRJKF,,/2S"KED<9BHY=5Q
M]+".6$I8ZK@(X*KC*6%E+#4L75Q-*A.=&E2G/\F?^"RN@:%X<_X)?_M/67A[
M1-(T&SN;[X3ZG<6FC:;9Z7;3ZEJ7[0_PKNM1U&:"QA@BEOK^Y=[B]NW1KBZG
M=I9Y))&+'[J_93_Y-=_9M_[('\'?_5>>':^?_P#@J'\$_B=^T5^PM\<O@W\'
M/#/_  F/Q(\8_P#"L_\ A'/#G]L^'_#_ /:/_"/_ !@^'_BG5_\ B;^*=5T3
M0;3[)H.AZI?_ .GZI:_:/LOV6U\Z\GM[>;Z?_9^\+Z[X(^ OP2\%^*+'^S/$
MOA#X1?#;POXBTW[39WO]GZ[H'@W1=)U>Q^V:=<7>GW?V34+2XM_M-C=7-G/Y
M?FVUQ-"Z2-]#7Q-*?". P[KPGBH\2YKB*E%U5+$1HU,HRNE3KS@Y2J*G.I2G
M3A4E[LITY04FX-+]VSK/LLQ?T7."<DGG.#Q7$E#Z0OB7GF.RF>8T\1G=+*<?
MX6>&^6X+-\7@ZF(K8^. QF.R_%8#"X^NG0Q&*P-?#4JTJF&E3I^ ?MN_MY?!
MG]AOX?)XD\?74GB/Q]XBCGMOAK\)- N+=O&/CK5@1!$T<#&1](\,VEW)"FM^
M)[FWFM[%'%MI]IK&N3Z=HM_\6_\ !.S]DWXZ^*OC7XU_X*.?MJ6PT?X^?%/1
MVT;X:_"M+2XTR/X0> +BV@T^"+4-,DF:33-8N=!MK;1]-T&\,^IZ3I4VJ:CX
MJN;SQ?XCU*+1OSE\/?L\_P#!7+3_ -L#QO\ MF^-_P!AKP#\:/B7K%]<'X=V
M7Q1^-/P@O_#OPBTA+FY31;'P;HNC_&W2[2*X\/Z-)!I6CWMY]JDL9?[0UQ _
MB/4[G6*_6_\ 9L^-G_!6+Q=\:O!?A[]I?]C;X1?"GX):A_PD?_":^/O"_P 2
MO".OZ[H/V3PGKM]X;^PZ1I?QF\67UW_:GBVVT'1;GR/#]_Y%GJ-Q<R_9889+
MVV^GQ664\DR3$87)\SX>Q.)QN YL]S3^W\L>+J4.6.(JY)E&"C4E6C0YX0AB
M:UWBLSJTU2I*CA5&-7^C.)?#O ^$'@]GO#GA1XA>!7$'$/%O!,<1XS>(R\</
M#JIQ/C,G6'P^=YEX0>%G"%'&XC-:63K$X/"X3B'-5.?$GB)F>!I99EU+*^'(
MT,-F/Z._%'P]XQ\6_#GQOX7^'OC=OAIXW\0>&=7T?PM\04T2U\2R>"]:U"SE
MM;'Q+#H%[<6EIJ\^D2R"]@L+FZMX;B:%$DFC4EQ_,]JGPX^*W_!,S_@H;\ O
MCG^U+XV@_;,T/]H"]/PCT'X^>*;?Q)H?Q ^$>J7K6/A^\ETKPW<^+O$7AW2;
M6UL/%*L;82:R+_PO_P )-!X>?PYJ,FHQ:G]Q?M!_LX?MA_LY?MQZY^W7^QQX
M*T;X]^'/BQX2TWP?\;_V?]6\6Z7X-UAH]-MM.C.J>$=6UYXM,M+:ZN]"TO74
MNK$ZAK5CXDO?$&_P]J^CZ]>_9?-)O@'^V]_P4B_:4^!/Q,_:T^"FE_LK_LO_
M +/?B*'Q]X>^%%SXSTSQAXW\?>)X[S3=1%IK,^F+;7GDWEQHVEZ=JEUK.A^$
M!I7AQM4L] LKG5]7O=1A7#T*&5X>O5J9MDU?AS,\EQ+S>,IX/#YW3Q=7 5Z?
M]E8:BI/.5B(8Z&%]E]7G_9N,HN5?$ITG4IQGP*P>2^'.0YQF&/\ %#PGSKP#
M\1/"3B&7BG2KXSA3(_&' <39CP7G. 7AID&4PQ$O%NEG>#XRPG#2RQY)BUX?
M<595.OG?$%.IE\L=E]'F_P#@JA^UGX"^*?[0_@__ ()U^(OBS8? _P"#FG77
MAWQQ^U_\3M6U&YTB>]\-R6&E^+/#OPE\+^3;74VH7^N:7J.C:O>&.PU&T>^U
M;P_/<"/3?#7B>"X\/^(?[5W[%&A?\%4?V O'OPM^*_P]T[]G+X%_L_\ CSX=
MW^O:(=2C\*^!$'@'XTZ!X9\/2B6Q^VJSG7/#]E;L(KEY9-0@>>=I'FD']#GC
M;]E#]EKXE^)]3\;?$;]FOX ^/_&>M?8O[9\7>-O@Y\._%7B?5O[-T^TTG3O[
M3U_7?#E_JM_]@TJPL=,LOM5W+]ET^RM+*#R[:WAC3\MOBU_P32\,ZK_P4G_9
M8^(W@;]DGX(1?LB^&/ACX]TWXU:?IO@OX+Z-X$N?&-]X9^*MMX8D\1?"V06-
M[XNU!-8U3P2UGJUOX1UJ/3KB+3KM[RU71Y)K+7(L\X:>%I8"K3S7 PP?#>?T
MZZ^N913PF-Q^.RUPQ^(@ZM+V]3,<9&-/"9;"M*5.A3I4L/[-P=7VOH^#'C)]
M'NIPUEO!&8Y?XF\&8;A/Z/\ XWY?F]+_ %J\+L%PQQAQMQEP!/"<:9]A)9CE
M\<ZQO'G%E*E@N&/#[#9M7KX/*,!EF69"L#4PU3-/[0^I?^"A/[*FN_\ !13]
MF7P1\/OA5\6O#_@GPYKGC'P7\5&\3:AH6HZ[I_BWPBOA_5SI5I;1VMYI\]O!
M<KXCL/$UL\D3-<W&DV%G(UE%<3W$?Y_?M*_\$9O WPO^"?C+X\_!#X^?M#:?
M^T]\(?!6O?$.W^*7B;XC7&H:CXUO/".F77B35M.OYK#3[+5=%FU.*QNH=!GT
MG58EL+N6U&L'6H_M-P_WC_P4A_8H\7?M,? +P3H'[/.NZ=\,_BI\"?$.D^*_
MA#96;Q^'?"ES9:181Z;)X">*QMFT[1],>TM=)N-#1]/ET:UO] TO3;RWMM(N
M;JYM/BSXJ_$__@L-^TU\)=5_9?'[%'A;X&^)/'.@W/@7XL?'[4_BYX;O?!B^
M&]9@ET?Q)?>%-%TZZO+K2!JMF+ZVN#HNL?$C4X-.U!I-*T^*9[34(L>'<9FE
M/ Y9#*N(\MP67X;-<94S/+LPJY;@:N'PE7$8:=2KC'B:<YYSA,9@J<X2H86,
M_9XB#H+#-SH5:?D> _%GB/@.#/#K#>&WC]X?<(<#9#XF<58_Q#X"XYS+P_X/
MS'(>&,SSWA_%8W,N*9\0X/&8SQ:X8XLX0P&)PE?)^',/BU@L[PU7)8</U)XS
M)\PP7SS^U;^TA\0_VJ_^"#?AGXN>, )/&-QXZ\$^$_B9J4=O:6T/B"7P3\1[
MKPU'XF2)HH(EG\17^G^&M7U2+18(8+76KO4K.TAATJVFB3UKX.?\$G?&W[2G
M[./PW^-WQK_;$_:,TS]H'QM\-O"OC#X=CPCXLM]+^&GPBTK5/"MC=^ /"MOX
M/_LP:E)#H>DSZ8OB(>&O$/A'S-02YAT^0317.LZS^D6E?\$\_A_IW_!.^3]@
M-]9DN-$N?AU<Z'?>,A8Q)-<_$2ZUUO'K>.AILYN]D%O\2?*U^QTJ6YN)[/2[
M6STB+4=]K#>+^?GPI^(?_!87]ESX-Z+^RA9_L9^&/C3XE\$Z,G@/X2?M$:?\
M5O#L?@BU\+:= -.\+W/B7P_?RZ?/J$7AFS>ST_3_ .W=5^'UW)I&DVT&HZ5=
MRQW&HW?H8?./;X#'X/A3&Y7E-;#\6YGCZ,<?5R[ RJ9'CX4U1>&JYI1J4EAZ
M57#M8[!T^7$2PD\/3]G5I0E27W.1^*CSG@GC3A7Z,W%_AQX8YGDGTG_$3C7*
M:/&N8\!\'U\;X-\;87+XY75R#,O$C*\PRRED.6YCD-2'&/"V E1SNOPQBLAP
M"P>9Y=@ZV60^G/\ @CM^TW\7/CQ\#/B/\/OCSJEUXG^+'[-OQ2U?X4:]XUO9
M9KC4/%FFVZO-I=WK5W=16UW?:]IEW;ZQHEWJ%U9V]YJ.G:=I&H:HUQK=UJMQ
M)XC_ ,%F_&7BSXN>)OV5?^"=7PVU(V&O?M1?$33M9^(E];37 N-'^'/AO5K:
MVL9M0M(25N]!DU >(/%]^K1RNI^&:)%&YE93]G?\$S/V,-<_8P^ >H^'_B#K
M.G>)?C1\4O&6J?$_XN:[ICFXL%\1:O#;6UIX?T^_>VM)+^QT.SMC+-=-;117
M&OZIK]U9*+"XM5'C]G^RW\<O$O\ P6,U;]JOQIX+6/X#?#W]GV/P9\)/'-QX
MD\)7)G\57ND:;I^I:/8^&+37[[QC8,)?''Q.9[_4_#VCZ8ZPWGEWDOVW3SJO
MD4L7DM'C'/<YP<\'#!Y7ALRS+*H)0HX;%YM2PE##X3ZE0J**E2EFF)Q&/PV'
MC!/V%"+C34(\L/R_+N*?"/*?I7^,OBSPKB^$\)PIX<Y!XA>(/AK@X1PN5\/<
M2^)F7<,Y+D?#*X2R?&0PT:V7U?$GB'/>-,@R/#X13_LC)<-5H9?2P=%4,+^H
MOP\\ ^%?A9X$\'_#;P/I4&B>#_ OAS2/"OAO2K=56.RT?1+&&PLHV953SIVA
M@62ZN7'FW5R\US.SS2NS?S,^ ?AG\7_^"C_[<W[1O[17[)/C^#]AGP3\--8N
MOA!XG^+_ (*3Q'XC\;_''7-/>6"'5/$/@NV\4>%_"=_'>V6C:7JM[%+-I(TJ
MVN?#LUXWC'Q!#+J-A_4O7\^/A;X+_MT_\$Q_C=\=M6_9K^ MA^UW^RI\<?&-
MY\1K+P-I'CC3/!7C[X<^)K^6\E:P5M0L]3U"86]M+_8\MSI_A[Q98:UH^D>&
M[J:Z\.ZS]NLKGCX2QDJ<>(9T<5@H9]C,%2IY?+-ZU".#Q4:V.]IFM.I_:$GE
MU?&5*/LZF'CF2G1<U6G3MB5"2^3^C#Q35P5'QTQ64<1<)8/QLXIX2RS \"U_
M%'-<EH\)\1T,VXQ68>)F"Q_^O%:7 .;\5YAE2P./R*AX@0Q655,5#-L9@O9\
M00P=>/GO[$_A7Q;^P9_P4V\1_ #]I%=)^,OQ._:O\&:GXE^'O[75SJ'BJX\<
M^*+#3X+K5[KPAXBTO6]?UW3=%L;NZ\#:I#<VMJD>K0:MIGAR*?6M=\/76@Q:
M+ZK^TO\ "[]JW]BW_@H#XF_;O_9L^".O_M*_"OX[>#=,\+?&WX7^#4N+OQIH
M^HZ1I_A_3VN-%T[3[+6M?;[8?">C>(M*U;3-#URU6_E\2>']7M-*MK_1;R;M
M/V>OV9_VP?VD?VY?#7[>'[:?@7P_\"M'^#GA34/"OP+^!FB^)M*\5ZQ$^IV.
MN6+:MXDU;0KJ\M7@MCXHU_5+BYOKBPUG4M9.D6RZ%IF@Z5'%=^A_M6>!OV\_
M@G^U[I'[7G[+NDZ]^TI\*M=\ 6_@3XG_ ++NJ_%2]\.V>D36DMF&\2^ M(\0
MZA<>&-(GU!-+T:X%_P"&]#U'6K+6?^$BNKW0M3T_Q)JUPOT%?,*=7/H*6,R+
M$XW&<)QP&?X:OB90R',L=3=X97AL?AJM+"Y=56'H8*=+$86I2R[#9CAY4Z"A
M&K)'[AG/'.!S/QKP=*MQ9X+\0\6\6?1BP_!'C;D&<\05<)X*\?\ &67S4\)X
M;</<:\/9GEW#G >91R')^#\5E>>\-8[+N N'^.\BQ&!R>.%P^958O\A_^"E7
MQG_:M_::\4_L@>-OB'^SMXF_9;^%>F_';0O"_P ,?!WQ$G>[^*?C;QQXBO\
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MQ&-RO+<MQ&78;BG.>%LKSGB?))9GPGEN#QG!65XO/L#2Q/"2I8N>'PWEDO\
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MOXB?"_\ RGYNO^SUO%__ *=];K]/\-?X?&O_ &26-_/%'^C7[/?_ '/Z7?\
MVB]Q=_Z7Q&>M?\''_P#R=%\"_P#L@:?^K#\9U_6%\ O^2$_!7_LDOPX_]0[1
MJ_D]_P"#C_\ Y.B^!?\ V0-/_5A^,Z_K"^ 7_)"?@K_V27X<?^H=HU'%?_)
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M?]GO_P!5)X1K^=K_ (.5?^1[_9,_[%+XM?\ IX\"5_1+^PM_R9'^QS_V:O\
ML]_^JD\(U^8<1?\ )M>!/^P[-_\ TG$G^<WCS_RKW^A;_P!EIXI?^F>(3^3+
M_@X/_P"3]-,_[()\//\ U(/'=>L_\&X'_)T7QT_[(&__ *L/P97DW_!P?_R?
MIIG_ &03X>?^I!X[KUG_ (-P/^3HOCI_V0-__5A^#*_1\3_R9V/_ &3>%_\
M4RD?W[Q#_P JH,/_ -H_\.?^M9EQ^?W_  5Z_P"4CW[4G_8V^&/_ %7/@VOV
MI_X-JO\ D1?VL_\ L;/A)_Z9_'E?BM_P5Z_Y2/?M2?\ 8V^&/_5<^#:_:G_@
MVJ_Y$7]K/_L;/A)_Z9_'E'%G_)J,-_V*^&?SP ?2=_Y5D<._]FW^CQ_Z=X)/
MBK_@FQ_RF_\ &_\ V4_]KK_T5\1*\F_;/_Y3?ZG_ -G4?L\?^@?"NO6?^";'
M_*;_ ,;_ /93_P!KK_T5\1*\F_;/_P"4W^I_]G4?L\?^@?"NNBG_ ,E;BO\
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M_A[Q%NBUO5+C4+<"TMX/ ?CS^Q7XH^&_Q>^-GPM_98^&_P 4-'\#?M,?LQ_
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M2O\ 7]!TJ^TS3-4UO2--U+6OM_\ 8VGW^I6=G?:M_95FVH:I_9EI<31SW_\
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M*I0Q,?R]_8=\,_ WP3\0M/3X?_LG_MK_  A\<:M\/;KP_P"(/'/QSD^,]_\
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M\ W_ (?N)/"7PDU?43X?\,:SI4&IZAI>D6D5@T>B_:V&GP6\\-K+!\^3Z_\
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M44 %%%% !1110 4444 %%%% !1110 4444 ?FK_P4X_X*<?"C_@EQ\*/A_\
M%OXM_#_XA_$/1OB'\0Q\.=,TSX<CPV=3L=3/AO6_$WVZ^_X2;6]#M?L'V30[
MBW_T>XFN/M$T/[GR][K^*'_$7W^Q5_T;'^U'_P!\_"?_ .>#1_P=]_\ )E7[
M,?\ V=&O_JI_B#7^?!0=%.G&4;N][M:.VQ_H/_\ $7W^Q5_T;'^U'_WS\)__
M )X-'_$7W^Q5_P!&Q_M1_P#?/PG_ /G@U_GP44%^QAV?_@3_ ,C_ $2O ?\
MP=G?L;>/_''@SP)IW[-O[35EJ'C7Q7X=\)6-Y>K\+/L=I>>(]7L]'M;F[\CQ
M]+/]F@GO$EG\F*27RD?RXW?"G^JZO\7#]FW_ ).)^ ?_ &6GX6?^ISH5?[1]
M!C5A&#CRWUO>[N%%%%!D%?Q$^%_^4_-U_P!GK>+_ /T[ZW7]NU?Q$^%_^4_-
MU_V>MXO_ /3OK=?I_AK_  ^-?^R2QOYXH_T:_9[_ .Y_2[_[1>XN_P#2^(SU
MK_@X_P#^3HO@7_V0-/\ U8?C.OZPO@%_R0GX*_\ 9)?AQ_ZAVC5_)[_P<?\
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M  <?_P#)T7P+_P"R!I_ZL/QG7]87P"_Y(3\%?^R2_#C_ -0[1J_D]_X./_\
MDZ+X%_\ 9 T_]6'XSK^L+X!?\D)^"O\ V27X<?\ J':-7YIQ7_R0/A[_ ->\
MR_.H?YZ?28_Y0@^@E_V ^(/_ *<QQ_$K_P %T?\ E(_\6O\ L4_A-_ZKCP[7
MV5_P;;_\EV_:/_[)+X:_]3&.OC7_ (+H_P#*1_XM?]BG\)O_ %7'AVOLK_@V
MW_Y+M^T?_P!DE\-?^IC'7Z7FO_)H8?\ 9-Y3_P"G<"?Z%^)G_*K#"?\ :/\
MX9?^K+@X_(W_ (*._P#)^?[77_9?/B/_ .I%>5_0U_P;9_\ )&?VF?\ LIW@
MS_U%;VOYY?\ @H[_ ,GY_M=?]E\^(_\ ZD5Y7]#7_!MG_P D9_:9_P"RG>#/
M_45O:../^38T/^P+AG_TC+P^F1_RKIR?_LDOH[_^HG Y\$?\$+?^4EOQ'_[)
MA\9O_4X\(5R7BC_E/S:_]GK>$/\ T[Z)76_\$+?^4EOQ'_[)A\9O_4X\(5R7
MBC_E/S:_]GK>$/\ T[Z)1BO^2MXK_P"S;T/_ $QCPXE_Y2@^DS_VK]R;_P!4
MG&A[Y_P<D?\ )=OV</\ LDOB7_U,9*_I^_93_P"37?V;?^R!_!W_ -5YX=K^
M8'_@Y(_Y+M^SA_V27Q+_ .IC)7]/W[*?_)KO[-O_ &0/X._^J\\.U^:<3_\
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M/]CG_LU?]GO_ -5)X1K\WXF_Y-MP#_V$YE_Z:Q1_G]](G_E7W]"/_LH>/_\
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MG;FZ7MZ/S72_3N?>M%?A/^Q-_P %./VA?^"B7[=/QIT+]F?P3\)8_P#@F?\
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MO_D@?#W_ *]YE^=0_P ]/I,?\H0?02_[ ?$'_P!.8X_B5_X+H_\ *1_XM?\
M8I_";_U7'AVOLK_@VW_Y+M^T?_V27PU_ZF,=?&O_  71_P"4C_Q:_P"Q3^$W
M_JN/#M?97_!MO_R7;]H__LDOAK_U,8Z_2\U_Y-##_LF\I_\ 3N!/]"_$S_E5
MAA/^T?\ PR_]67!Q^1O_  4=_P"3\_VNO^R^?$?_ -2*\K^AK_@VS_Y(S^TS
M_P!E.\&?^HK>U_/+_P %'?\ D_/]KK_LOGQ'_P#4BO*_H:_X-L_^2,_M,_\
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M^%__ *9)J^J/^#;?_DNW[1__ &27PU_ZF,=?*_\ P7L_Y2&>*_\ LF/PO_\
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M#/%?_9,?A?\ ^F2:OH;_ (-P/^3HOCI_V0-__5A^#*_2\=_R:"/_ &3.!_\
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M])W_ )5D<._]FW^CQ_Z=X)/BK_@FQ_RF_P#&_P#V4_\ :Z_]%?$2O)OVS_\
ME-_J?_9U'[/'_H'PKKUG_@FQ_P IO_&__93_ -KK_P!%?$2O)OVS_P#E-_J?
M_9U'[/'_ *!\*ZZ*?_)6XK_LU^&_](F>Y@/^4H.)/^U</#W_ *A8P^U?^#E7
M_D>_V3/^Q2^+7_IX\"5_1+^PM_R9'^QS_P!FK_L]_P#JI/"-?SM?\'*O_(]_
MLF?]BE\6O_3QX$K^B7]A;_DR/]CG_LU?]GO_ -5)X1K\PXB_Y-KP)_V'9O\
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M77_LC'@[_P!%_L]U_4[7\>O[6OQ'\7?\$;/^"X'Q%_X*!?$3X6_$'QA^Q/\
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M\,:C-I]Q=Z?=:GI%[=V-Y=VMQ%<2 -.,+-6;DFD][).[MVU/TZK^ '_@D?\
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MJM_P4E^$?QE^&&C:QI_['W["^JZI=:9\2]5M+BPC^(OQ&FN+/53%X>MKI8I
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M33-2TYHO$^C#Q?X8?0YM2^WZ45.I?:-*OVC18O$O G["=Y^SWXL_8O\ CE\
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MJBP^1X.6;Y9Q3E\N(>"\JXCQ/"^+R'*N*>#\YCQ#BLNXKJ<-\7Y;PU6J]_\
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M?L$?'WX=^-/!>M^)+32M7M_AY\:?B;X+\(WD/B#3F;3_ -E/P5^RU\?OA/\
MLZAH[K5;FY6_NO%OQBU!+W0(<3:#%J\EQ<0):V]U=GT'0X3E2J8A3RY.4<SQ
M=&@IU*3:S+ TJ6#PDJ-2O.I2_L?,,/C*U"E5J.HJ-?"^TG74D?<3R;Z,>(RW
M&Y[2Q7 <:N)H^(?%&4Y/#%9AETY0X_X.RS+.%>&*^4X[.,7C\L7A7QQDG%>;
MY+EN98VKF$,KSKAQX[%9O3Q%.*V]-_;A_;,\!?#O]F?XP?&:Q_94\3>#/VJ?
M G]L^#O#'PNT+XI>'/B-X,U[7O@/XA^-/A;5-;TOQ3\0/%-CXK\&:4VA1^'_
M !W-I$NAS:2=2L;VVU0FXA@D^H?B)^UC\2_"_P#P38\+?M@:/I?@!?BGX@^!
M?P'^),VEZUINOR_#FS\1_%2/X??VY$VEVOB>R\1+X?TY_%NH/IUNWBMKZWAM
M[3[9J=\8YVN.'_9^_P""=7P<^"_[,OA_^Q?@%\._#W[5-U^RW;^ O%WBZVAL
M-1UUOBAK7PE7PWXV-CXHNKN]L-/DUOQ)=ZK9ZEK.B7%G:ZA8WES&UP^EW+QO
MX5K/PR_;3\?_ + ,/[&7B#]D33/#^H^$/@#\&_A[IGBN[^/OPP\0:3XXUWX3
M:E\,K.ZTV30;>&,Z-:>)]*\-ZSJ"3ZEJ-S9V*1+I]P]W+<1%\JL.'<=B\.\)
M1RZC0P?$5*GCIUIX/+H8K*?;8I<U'"/,:T:N%IT_849U:55U\4E'%5H8=2<3
MSLPPW@/QAQ-D57AK*. <HRCA3QZR_ \9XS-,3PGP'A.)/#%YMQ)'VV5<-2X[
MS:AF?#N!P2R;*\5F67YG4SCB.,,/Q'FN#R2-:K17WA^S3XZ_:&\6^)_$%O\
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M8=>TB.32_P!D7X?? OXS^!/@''*;K46N)-5/B'XL:M'J.APJ+G3/MS7$MO\
M9H9;IN/*Z/#$\+.>)EA?:4,3GWL8XFI*%;%8;$TZF&RCVT>>*YL#*C#&134&
MYXBTO:+W%\KX;Y7]';%<-8K%\0UN&UCLFX@\;/[)P_$&/KX7-N(\AS_ X_A_
MPM>:45BZ$%6X/Q&587BO#QE'"3JXG.^6M]?I?[+2]#^#_P"WA^TU??\ #'_B
MSXF^+?V*O'7A7]JCQ%\+O#%S\,_@LGQ T;XU_#Z?XK>#+GQ7;:MJ-MX@^)GC
MG3KNT\"2P+I_C2QDT2S>(R,\>HV31A)/JC]OO]K_ ,7_ +)_A_X87?P]\):-
MXV\1>)/$GB3Q5XTTC6H-1G32OV??@_X5O/&WQR\6Z4-*U73+F+Q%H^C'0M-\
M/SW*:AI,.K:]:2:G874*I;S?.?PV_8)UG]GS2OV$/C5\$?A#\//#GQ_^%?@3
MX;?"S]JGPQH5KX-T6+XE>$/$W@7P[X=^+?B.774DL]&U/XF>"O%&G3^*='\5
M6U]!J?C".?Q!I>IZQJEGJ\<$GNOQ9_8]U[]I/]J#QSXX^*7B#Q]X%^%'A7X'
MZ#\(/A6?AC\01X9U?QHOC[4]=U_XZ2^)ETX7-[:Z'>1V/P^\+C1]0@2'6H]&
MGO JV\*F[O$OAB6;X;%*&$658:EFT\50ITH4I8FK1S*OA<)A?J>#Q4W-?5Z]
M"MAL52Q$9XS#0ABJ\:<\-7I3Z<_G]'7$>*/#_$E+"<+4_#7(,N\3<5Q'DV"R
M["Y=B.(<QRGQ!SGAOA?AV/"G"?$>,GBJ4LCS?)\VX=XDR[.Z.*XJX>PF%XDS
M>E@<7D&=9?B_;_VMOV@]1^!'[,GB_P".O@*R\.>)[NQ@\#KX>O\ Q#<Z@/ F
MGVOC[Q?X9\*V_CKQ==Z+G5/^$&\*6/B3_A+_ !%+I;17,NA:7<K'=V"2-J%K
MY'\)/VE?BWH7P_\ CQ\1/V@=2^!7Q#^%WPL^'L?Q5\&?M!?LXZLX^&OCW0[;
M1?$FK^+/!DVCZGXR\=:GI7B[PB^AV#P7EKJ^HZ7XATGQ1HTEO%;:C;SPWN%X
M(^%?[7W@O]A/P;\(]#N/"9^.OP9NK#P?8:9XPF\,Z]X'^.OPA^'/C.72-+\(
M>)=0N=.\1CP[9?%CX+V=CHVH:B;2S\1:!KUPS3SZ=$)[H?%UW^Q#\=_B1J/Q
M1M=&_9K\%?L??"']HOQ%^SW\._C+\(/AU\4_"FMF[\"^!O'_ (B^('Q7^,T4
M/A6ST7P3HVO^(-"M]#^%FAZ5X<TZZUZ]LM>U+7M8T^ PW22XX' 9*\-C,)BL
M5EBC2S2K'^T76H2Q-7!4<3@W#ZO3E6HXJG+$8&GBJF%GA:6+P=6I6JX?,%A<
M12P<WY/!G!GA%/A[BGAKB/B3P]C2RSQ&S*@^/IYKE%?/\RX2RGB#A:KA%DF!
MK9ME?$F KYWP=@^)<;PWB^',NXHX6S+,,WS+(^.J7#F>Y;PKBZOHGB;_ (*-
M_M#^&_\ @GUXX^/EY\-_AM:_M4_"SXQ>&_@_X]^&,VD>+Y?!,>M>*O%GA670
M5TW1O^$NM/%T3ZS\.O'7A:_L9+KQ%,O]OSWC&&6VA;38_;?C'^WYKF@_%?\
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MB\M_%OQ!\7:/XG\,Z/=>'H=*\6#3%TZZLTU73IX+I7NT2/ZO\5_M1_$;2/\
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MH>Z\6>"O%OA>UN_A7X<M[6Y\1>'-8T2"YG7Q<DC06\VI6=M'-,L8,C1QLSA
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MEZSHFB^(]-N=&\0Z1I>NZ1>H([S2M9L+35--NXP0P2YL;Z*>UG0, P66)UR
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M;G"5.;ISG!SIS24Z<^2<.:G-)*=.7-":24H22211112("BBB@ HHHH ****
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M1FO[MJ*"U.T)0M\3WOMM_D%%%%! 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MXNN=+L(IK_4+'PY+JE[9V,,UY/;QVT,LJ>>>+/\ @LQ_P3C\"^,O'O@;Q?\
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M0%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MS:A/>27<LC,[S,Q)/OE%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
0% !1110 4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>v439550_proxycard-2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 v439550_proxycard-2.jpg
M_]C_X  02D9)1@ ! 0$ KP"O  #_X@H@24-#7U!23T9)3$4  0$   H0
M  (0  !M;G1R4D="(%A96B                !A8W-P05!03
M                        ]M4  0    #3+
M                                              ID97-C    _
M 'QC<')T   !>    "AW='!T   !H    !1B:W!T   !M    !1R6%E:   !
MR    !1G6%E:   !W    !1B6%E:   !\    !1R5%)#   "!   " QG5%)#
M   "!   " QB5%)#   "!   " QD97-C         ")!<G1I9F5X(%-O9G1W
M87)E('-21T(@24-#(%!R;V9I;&4              ")!<G1I9F5X(%-O9G1W
M87)E('-21T(@24-#(%!R;V9I;&4
M            =&5X=     !#;W!Y<FEG:'0@07)T:69E>"!3;V9T=V%R92 R
M,#$Q %A96B        #S40 !     1;,6%E:(                     !8
M65H@        ;Z(  #CU   #D%A96B        !BF0  MX4  !C:6%E:(
M     "2@   /A   ML]C=7)V        !      %  H #P 4 !D '@ C "@
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M 0$! 0$! ?_  !$(!X4%T ,!(@ "$0$#$0'_Q  ?   !!0$! 0$! 0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **S=&UK1_$>E:?KWA[5M,UW0]7M(;_2M9T:_M=4T
MK4[&Y026][I^HV,L]G>VEQ&RR0W-M-+#*A#1NRD&M*@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ,7PYX;
M\.^#]!TGPMX1T#1?"WAC0+"WTK0O#GAS2['1-!T73+2,16FG:3I&F06NGZ;8
M6L2K';V=G;PV\$8"11JH K:HHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ K\R?VF?^"QW_!-S]C_ .,"? ;]H#]IKP_X.^*L
M+:9_;WA;3/"'Q&\<R>#8]:TW^U-)D\<:EX"\'^)M(\)RWUI-IMQ'INLW]KK$
M5AK6DZY<Z=!X>N7U>']-J_D<_P""EW_!/W_@GG_P3Y_9U_X*9_M8_M':C8?M
M!_'']N6?QTGP*3XP^&?".I^/?A]\<?'Z>-=8TN#X)7]C96]SH=IX>\3>)[/Q
M;K6NZ39:/=:'X&\#6&@3WE[;-%I^J!4$F[.^MDE'=MNW7HEK\C^D7XQ_MH?L
ML? ']G^Q_:G^+/QN\$^%OV?]7T[0-4\/?$R*[N_$>C>++3Q79'4_#2^"[/PK
M9ZYK7C2]U[35EU'2M,\*:7K&IWVGV]U>V]H]M:7,L7/?L<_MZ_LG?M]>"-;\
M?_LI_%W2_B=HWA74;'1_&&GC2/$?A;Q3X/U74K1[RQL_$?A/QAI&A>(=/BOH
MX+U-+U<:?-H&N2Z9JRZ%JVIC3+UH/X??B7\,O'UA^S=_P;%?L-?M!V&IMX4^
M,'Q^USQW\0_!&N,\B77@GXT?M2_#V'X=Z%J-A=VEM=P3Z7\)OBEK45Q8ZFLT
MVF-XNO-!B\FRTR&(_IC^RGX$N_V6_P#@XD_X*9?LY_LK>%?"7PO\(_$+]B]_
M%OPO\"^&=/\ #V@>!_#'Q$?X>_ /QAX8U2R\,V.FCP]H^FZ;\0/$?C:"TT)]
M,M]+L]*\0S2&TEL1#%.%N"2>KO[S3TM:,E'UN[W[:']+WC+]M[]FSP'^UK\(
MOV'O$'C[9^TM\;O"WB3QIX%^']AHNL:FS^&O"^@>+/$M_J?B#6K&SFT;PS'=
MZ3X&\5S:/%K5[:3ZM)HUQ%912N\'F\W^V5_P42_8X_8!T3PSK?[5WQIT?X9-
MXUEU"'P;H$>B^*/&'B_Q.=*2%M2N-*\)>"=$\1>(&TNP:YM(+[7KNPM= L;N
M]L;.\U2"YO;6*;^3']FW]BOX_?L>_P#!PO\ \$ZM1_:N^/TG[17[3/[1?PQ_
M:+^-/QC\90+>2Z%I'B";X _M'^#['PGX;U/4H-/O=7T70M'\,V5O872Z!X3T
MJPLS;>'] \*:/HNBV7VCA_\ @I%\>K*3_@XL^)FG_$']B[Q#_P %$F^"7P/\
M"?#?X&?LJ6,*>(-,\2Z]K_P6\(_%R^UC5?#UQX(^(,,NB^&+7XD_$OQ,UK%X
M)\321>(+/2-<\NU:V6]TL#D5U9MKDYFU97LVK*]DE?J^FI_;7^SI^TI\#/VM
M?A/X>^./[.GQ'T/XI?"[Q0UW%I/B?1(]2LREYI\QM]0TK6-$URQTKQ'X;URP
MEVB^T'Q'I&E:S9K+!)<V,4=Q \G5?%_XM_#OX"_"[Q]\:/BWXE@\'?#/X8>%
MM7\:>./$]S9:IJ<>B^'-"M)+W4KU=+T.QU36]5G2&,K:Z7HVF:CJ^I73PV.F
MV-W>SP6\GXM?\&]>L?L4ZY^R-\1=3_8M\._%OX8Z5>_&[Q!<_&7X%_&'QI#X
MPUSX5?%G^Q=%M+NVT>6#3M(A7PYK'ABS\.1:7J::;92ZE#HGV'4[:WUW0]7M
MX?&?^#GSXY>(_#G[%7PO_9)^'$D]Q\4OVXOCOX-^%ND:'9W26E[K'@_PIJFE
M^(]=M[:4-]H<7OCRZ^%/AN\MXQ';7.F^);V"^N1;R&QU )Y??Y=4K]=TMW?I
MHK^74_;C]D_]L?\ 9M_;C^%]S\9OV6?B9;?%7X;V7BO5O ][X@@\-^,O"4MC
MXKT.RTG4M3T6]T'Q[X=\+>([2YM].UW1[]'N=(BM[FSU*TN;2:>&97KZ:K^/
MG_@@KHNH?\$[_P#@I9_P4+_X).>,/$=[K.F"V\,?&7X.ZQJ\,5BVNVOA_3=,
MN9KBWBA2."[USQ3\-?B-X.U'5'M8X[4GX=ZJ]O;V'DSV:W_$/_!43_@LU^T'
M^W#^W[^Q9^P_\/?V<-:N/V9_'7C"Y\.^,O&&D2Z3JN@?#[P)XIU+0X?#\O\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MNQ/+J0MDB-K<B1E,$NW^N2B@;J7=[=9/?^:/+^&Y_%IX_P#VC/B'_P $M_\
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MI=-6W26K;>DN:]WOV/Y?O^#E3P-XU\:_\.S?^$.\'^*?%O\ 8O[8VGZAK/\
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MW>WE%+[K_P"84444""BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MKPKX8N(];L/#OB#PKK5S;I8:Y=S0I8>(--D6\CMY'EDA26WF_#/Q+K;^)?\
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M(/"E]^Q?\1_$EC\1O@_\1-6\+Z7+KWB6ZTWXFWHL/&6K>*?#%EI%_P"+]/\
M#7BWP3X:O]!MM$\2W6D^(]0T[4[_ ,-Z<"Y%RN2DW:^R[6WUNKZV=FK+4_N2
MHHHH,PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#\"/V-_^"-VH>#/VT_V
MY?VR_P!N6+]GC]I#Q%^TWXK-Y\,/"K>"7\<Z+\-/"EUXGUC5KG2[JW^)?A9+
M:+4=/T"Q^'GA71KK2X;JXCTSP[J"76HR_;!YA\3_ /@CQXH\.?\ !5O]E_\
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MG>*='2[NM8U:SN[J:RO[B022R1M-^/W_  6+^"WQ@_:"_P"#B7]@[X7?L_\
MQ@;X"?&O4/V+8O%7PP^+/V!]4MO"GC+X8ZY^VG\3]&&IZ<J3+>:'KUSX.7PS
MK\$]EJUH^BZS?_;-#UZT\[1K[^TJOG_Q%^RO^SUXL_:'\"?M8^(_A3X8U?\
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M^A_.;^TI_P $:?CE\;/^"-O[-'_!-S0OBG\*-)^*/P2\1^!-9U[QWJY\7_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M2/'.N^(M1Q<74;O_ &[X5\.8A5V&YPL;?(VD?\%[/V/]:_8^_:!_;7M?AO\
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M7:)93R6*7EGHLPG!J$7K9VM+1MZM24;W2;ZWLD]?(_MQ_9;_ &G/@_\ MC_
MCX?_ +1OP(\0R^)?AE\1].N[W1+R\L9M+U:QN]+U.]T/7="UW2K@F;3-<T#7
M--U#2=3M"\T/VFT:>QNKW3YK2]N/Q;_X*C?\$^/VWO\ @H]^VQ\"/A<?B/XV
M^"7_  3:\%_#J^U7XC>*_AE\0O#VF>+O$?Q@NCXJU S7'@J35X-0U=8%L? '
MAOP]>ZWH&N:=X6%SXLUK3XWDUBZBBU_^#:?X>>"OAO\ \$\?$&D_#GX_:?\
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M/AKXY^*?B-^V3X!^/?\ P5B_X*-?#/XLZ-JVD'4[[6O%'@;PYK_@C7?&FK>
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M>Z\8^(]/\,:9)86'BKQ5X+T66W@O]2@FOWN/$%K)%9I+);Q74RI;R?CQH_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MVZL[#6]:TS5/$=JFL5^QM%!/-+7WGKJ]7KZZGRQ\/?V*?V9/A7^TI\7?VOO
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MWD:&W,7JOBS]BG]F3QQ^UA\,OVX?%/PT_M3]J/X.>![_ .&_PX^)_P#PF7Q
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M_7_(.91C'2\K36DM%=M:I7OO='<T444S(**** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M4S_@JO\ M8_#O]K7X8_\$V/^"9_PG\+?%;]K?QSX=LO&?CGQ-XN@&IZ!\,]
MU*UU+4+'2CIE[J'A_0+#4DT"S@\:Z_XM\6:U)X<T'PY>Z/I\&C:SK/B*-M$\
MW_X)Z?\ !4G_ (*!^%/V_P"V_P""8?\ P55^&'@S2OC!XY\(:AXR^$7Q6^'U
MEI=G9:Y!I^@:GKMH-6'A2]O?!>K^%/%6F>%/%2:-XCTJW\.ZCHWC/39O!NMZ
M/+?WRVWAX+Y':^FU[7UMWMV/Z>:*\(\7?M2_LR?#_P ;VWPS\>?M&? CP3\2
M+V2WBL_A]XN^+OP_\-^-[N6[2WDM8[;PIK/B&RUZ>2YCO+1[=(K!VF2ZMVC#
M">(M^5'_  4=_;U_:%_9H_X*+?\ !+']FOX6ZKX8LOA?^UC\2-3\-?&"SUCP
MO9:QK%_I5KXT^'^B11Z'K%Q(L^A3"P\0ZFC36R,[2212_>A2@E)MV\F]>R3?
MZ'[G45^!6@_\% /VJ?@EX]_X*X^/_P!JCQ!^SS)^S_\ LL:)XR\2?LE^'M%^
M+'P!E\;>)KOPW;?$[5]%\ >-=$\%_$O6?B!H'BSQA!X9\.Z%H>A?$/P]X4\2
M:GJT]W8Z983ZI!?6]OP?_!"/]M3]O?\ ;>\*?$+]HO\ :O\ C1^R_P")/@EJ
MOAW5;_PE\.OAH?#NC?%/X1:]9^/M?\/9^*&@6$7]H>#O!]_I7@GQ3>^"Y/%^
MM:OJ_B'2$779=0DM8ED(/E=F]+*W7=M7LM-[;]C^C&BO)OAS\>_@7\8;W6M-
M^$?QI^$WQ3U'PW(\7B*P^'/Q&\'^-[W094>*-XM:M?#.LZG/I<B// CI?1P,
MKS1*0#(@;GO$W[57[+_@J]U[3?&7[2'P%\):CX5U[2?"WBC3_$WQ@^'N@WOA
MOQ/KSW,>A^'->M=5\16D^CZ]K4EE>)I.D:A';ZAJ+VERMG;S-!*$";/L_N9[
MU17@NO?M5?LO^%K+QAJ7B?\ :0^ OAS3OAYJVFZ!X_U#7OC!\/=(LO ^NZTF
MK2:/HOC"ZU#Q%;P>&=6U9-!UU]-T[6I+*\OTT75FM891IUX8?C/_ (*?_M#?
MM&_#O]BG_A<?[ GBWX(:Q\2-6\:>!8?#/BKXA?$?X*^'_A?JW@W5[F^76KJP
M\:_%KQ[X)^&U[/<0PP_V8L?BA[V\*RC3+:[=) @-)MI;7=KO1?>?J-17SE'^
MT#\/?A1\#_AA\1?VG_B_\'_A#<>(/ _A"[\1^)_'7Q(\!>#/!-UXNO?#.G:C
MK\.B>)=3\0P>%M1M/M\UU-9RZ-J]_83V)BN;&ZN;-XIW]H\(>,_!_P 0?#NG
M>+_ /BSPUXW\)ZQ')+I'BCPAKNE^)?#NJ10S26\LFG:UHMU>Z;?1Q7$4L$CV
MUS*J31R1,0Z,H!'2T5^&/_!83_@I'^T'^RGXP_9:_9*_8H\!^#?'G[8/[8?B
MN_T;P1+X^;S?"O@CP[IM]I6DMK%[82:GHEE<:CK>J:M(FG7^K:JNAZ)IWASQ
M%J&JZ?J16SMF^>?^"?O_  69^.-UX9_X*#_";_@I#\.?#?@_]IO_ ()S?#[Q
M?\6_'$/P\%EI=K\2? 'A+3-0N]3M;#33K&K:*/$<.I1>'[31M=T&^3POXKTW
MQWX5N+/3]/E@N+G5PKDE;FT]+ZVO:]NU]#^E2BOXB](_X+N_\%>/AC\/?@I_
MP4/_ &A?V=?@9)_P3K^/'Q=G^'^E:#X0M9K;QWI.@V]_XHM&O=&U)O&FI>);
M/5IX/"?B@Z1K?C+0Y_#_ (GU#PI/#'H_AJQ\1^'[NZ_5O_@MS_P6]\"?\$]?
MAI+\*_@-XD\/^,/VS/'6G>'-8\(:0VGKXD\*_#;P5JUS;:B_Q!\:DF/2M037
M="AN['P7X?M[^2\U"[U"V\0W<*Z%8%=2!^SE=+1MW6CNDUO?M;J?T,T5^!O[
M77_!6?QW^Q]_P1L_9=_;>U/P_P"&O'G[1G[1WP>_9CM_#&C:A:7&G>#+SXP_
M&7X.6/Q)\4:_J6BZ-=6U^GAK1;#3?%NL6^AZ7>6OVF]CT;0/[1T^&^-]#\S_
M +$G_!4/_@IC\/\ _@H-\(?V"?\ @JC\'?ACX:UG]J/X<77Q$^#7BKX;6UK8
MWWA:Z30_%OB.#0O$<7A_7_%.DZC:-/X/UWP/J&FW$6F^(/#7B.TT_4K[5-7\
M/7Z:G.!R.S>FE^NKY=[+K8_J*HK^4+_@H!_P<%7'A3]OK]FO]BK]B+7/#?B*
MWA_:'\$?#']J/XB:SX:BUS0Y[KQ%\0_#?@S5/AGX"EOG@;^U?#45QKH\5>*;
M:%[2WUI]/TK1[FXETW6&']7M G%Q2;TYE=>@4444$A1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% 'Y6_P#!:#]M/Q5^P9_P3U^-7QP^'MO(WQ-U&/2/A?\
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M_"QO^$J^//[3O_"&>?\ \(?-%Y__  B'_"-^*_*_M'=Y?_"3R?9,>9=9_P!
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M=G=^%)?#[O#X[^&-_;6>G3^#)M-\10S>(=9D73_W5\5_L/?LY>-?^#I2_P#
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MUEI;$YQV4OLS5_>ZM-7;5^^VB>B5C^2#P[X$UK_@H&__  4A^,_C_P#8&_;
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M][WXEWGASP=XO\+2>(],UD>)%@\,VUW)XGCO$TZZT_698DM'A:[=IED3F/\
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M)=P>)M#UWPSH?AW3YM"L[G15OKP&W:UY.[51*335KN-M-[6NK_=HCXG_ ."
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ME\W\^^Y^"W[+UW;^%O\ @[%_;SL_B1/8+KWCW]EC3[3X5W%YIX3^U[B/X?\
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MZ>)1H-O /$>@Z-K=CK&FZU'J5QY/]7?@C_@CGXG\)>._^"QWC&7X[:#>Q?\
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MX N/%7@ZVBU.-8+O4O#FD:<LGA/6F\F+5=&TC6],\6:-J<"W$'U5_P $C?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HK\6OVLO^"]7[!O[%'QU\8?LZ_'\_''PU\2/!:Z1<7\-C\);
M_5=#U33-?TFSUK1];\.:W#JL=KK>CWUC>QJE]:@K#?07VF72P:CI][:P?.'_
M !%,?\$H_P#H9?CM_P"&9U'_ .7-!2A-ZJ+:?D?T:45\+_L(?\%"_@)_P47\
M!>+_ (G_ +.=C\3)/ 7@WQ/#X-N_$WCWP-<^#=-UCQ(=.CU74-+\.2W-[=G6
M)M"L;O2YM;>)4BL3K.EQ>9++-*D'U7KOQ5^%_A?Q/9^"/$OQ(\!>'?&>H>']
M4\66'A'7?&'A[2/$]]X6T2&]N=9\2V>@:AJ-OJMSX?TBWTW49]4UF&T?3K"&
MPO9;NYB2UG:,$TT[-:KH=[17S+9?MJ_L;:E>6FG:=^UK^S+?ZA?W,%E8V-E\
M>?A9=7E[>74J06MI:6L'BJ2>YN;F>1(8((4>6:5TCC1G8 ^M^./BO\+?AC+X
M>@^)7Q*\ ?#V;Q=J?]B^%(?''C+P[X3E\3ZQNMT_LGP]'K^HZ>^M:GON[5?L
M&FBYNMUS;KY69HPP*S[/[F=_17#>*_BA\-/ >L^#_#GCCXB>!O!OB'XAZHVA
M^ -!\5^+= \.ZSXXUM;C3[1M'\'Z7J^H6=]XFU1;K5]*MFT_18+V[%QJ>GPF
M$27MLLO)>*/VCOV>O!'CFQ^%_C3X\?!GPA\2]46U?3/AWXH^*'@C0/'.HI>J
MCV36/A+5M<M-?NUNTDC:U:WT^07"R(T1<.I(![-17%^(_B1\._!_B#PAX3\6
M^/?!?A;Q3\0KN^L/ /AKQ'XIT/1/$'CB_P!+%DVIV7A#1M3OK74?$MWIPU+3
MC?6VBVU[-:"_LC<)&+J#S"V^)'P[O/'>H?"VT\>^"[KXFZ5H*>*=4^'-MXIT
M.?QWIOAB2XLK6/Q'J'A"*^;Q!9Z#)=:EIULFKW&GQZ>UQ?V4*W!DNH%D .TH
MKB_$?Q(^'?@_Q!X0\)^+?'O@OPMXI^(5W?6'@'PUXC\4Z'HGB#QQ?Z6+)M3L
MO"&C:G?6NH^);O3AJ6G&^MM%MKV:T%_9&X2,74'F%M\2/AW>>.]0^%MIX]\%
MW7Q-TK04\4ZI\.;;Q3H<_CO3?#$EQ96L?B/4/"$5\WB"ST&2ZU+3K9-7N-/C
MT]KB_LH5N#)=0+( =I17#6OQ0^&E]X^U+X4V7Q$\#7GQ1T;1X_$6K_#:U\6Z
M!<>/M*\/R_8!%KFI>#H=0?Q%8Z/(=5TOR]3NM.BLG_M*PVSG[9;^8_P)\2OA
MS\4M+OM<^&7C_P $_$71-,UB\\.ZEK'@3Q5H7B[2]/\ $&GPVMQ?Z'?:AX?O
M]0M+36+&"^LI[S3+B:.]MH;RUDF@1+B)G .VHKYPN?VQOV1;/2=,U^[_ &J/
MV<+70M;N=3LM&UJY^.'PR@TG5[S118G6;33-2E\3K9W]SI(U/33J<%I-++8#
M4+$W21?:[?S.X^&_QY^!OQDGU:U^$'QG^%'Q5NM!AM+C7+;X;_$7PAXYGT:"
M_>>.QGU:'PQK&J2:=#>R6MS':27BPI</;SK"SM%(%+A9]F>KT5Q+?$OX<KX\
M3X5MX_\ !*_$^30SXF3X<-XJT(>/'\-B5H#XA3P@;_\ X2%M#$R/"=6&G&P\
MU&C^T;U(%CP]\0/ ?B[6/%?AWPIXV\(^)_$'@/4;?2/'&A>'O$FC:UK'@S5K
MN.6:UTOQ7IFFWMS>^'=1N8H)Y;>RU>"SN9HX97CB98W*@'745X_X3_:&^ /C
MWQAJ?P\\#?''X/\ C3Q_HLEU%K/@;PG\3/!?B/QAI,MEYOVV/4_#.CZW>:U8
M26GD3_:DNK*)K?R9?-">6^.6\1_M??LF>#]>U;PMXN_:A_9V\+>)] O[C2M=
M\.>(_C9\-=$U[1=3M)#%=Z=JVD:GXFM=0TV_M95:.XL[RWAN() 4EC5@10%G
MV?W,^B:*X+PW\5?A?XR\$S_$OPA\2/ 7BOX<VMMJU[<^/_#?C#P]KG@FWL]
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M"_MX[RQGN]$U_P 0:?J=O#>VDL5U:236J)<6\L<\+/$ZL<3_ (;(_9"_L?\
MX2+_ (:J_9N_X1_^T_[%_MS_ (7E\,?['_MC[+]N_LG^T_\ A*/L7]I_8O\
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M2VDSVUU';ZII-S=V,TEM<1R6]PD<[-#-&\4@61&4 '0T5Y9\2OCI\$O@S_9
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MIKZ'X$_ []I+QIIW_!4KX:_\%G]5\;VD?P,_:F_X*)_%G]CBYT?4)A+?V'P
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MISZEX)M/VG+GXZ^'+7XB:=\$?$&N7>J:WX$^P1^(%\2_V+J5GJ.H6>IZ%/\
M#K6-:2SO+CP=I/Q$A\)+;/"Q0O9V=GS)MZZI;JZ3OK?3K<N?M5_M&_LV?'CX
MS?\ !'S]H3_@IK\/?'_QJ^$/B?\ X)I:C=?&?0O \GC6V\8^*?&'ACQ5\7_"
M]GXYFN/#?C#X=>)$CO/%>@0>-->O+;Q-9Z6]O<7ETIU'16C$_P"M_P#P;B>"
M=&O?VA/^"@GQ[_9/^%OQ9^"G_!-#XFW_ ,/-#_9S\'_%?5M2U6YU_P 9>$$O
M]/\ %FMZ#=:QJ_B.]U*#1+U/$-K?Z@?$6MR:;;^(M#\&ZIXC\2ZYX4U*;3//
MO#'BS_@G;\(O^"A?_!.CQ]\-OVV_V.=:_9-_9$_87\7?LP>+]3U_XX^ H_$>
MN>(-4T/XCZ5]OO/!TU[<'5E\77GBB#5_$<D3/8+>:QJ,?EM;Q,@]U_X(RW7P
MM_9U_;X_:_\ V;_V7OVH_P!F[XW?L0?'6[U/XZ_ +P+\/_C1X5\1?$3X7^-8
M$T>Z\3>'+3X<V5P-1M_"5CHFH:CX8NM9MC?M<:7X"\ W]WY=Q>ZN\*77U*;]
MQI)K2]G>UN=O16LI)6Z[7/-O^#HW]AK]EJP_99\<_MTVGPO\K]JC6OB5\%?
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M^'&T[X=:H/AO\5/ ^A_\)3I.N/XB\2WINM)N-5_LGQ=HGGZC-9_8;:T^RO\
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M"7P8TZQ6Q\)V^K7G@F\T:WNM1&BG1?#?V?4)[RXM8/!Z3QP6*:@QN_&?"/\
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M[,W[7/P$^,/Q376_$MIHD5EX*^'VDO9^([G1I;F-QK-_#,0+73[<)-=J=T9
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MX<? +X:7>@WFH73F)"L\MG\!M%B:[V7=K!;7\UK?W=IYFE6WY>?'K1%^,?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MQN39!RT9R55\.Y7D;Q,[5L4\17C&K'X]_:Y_9M^*_P"T7IO@BQ^%G[57Q/\
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MNZ>-I4J>.P^&Q=#X3_:U_9.^-7[1'B7PGKGPN_;/^+_[,.G>'M#N]*U3P_\
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M\OA/%Q481YH8R6*A4=Y585)2E*71C_&'CO,L)P=@<7BN')8;@+&Y9F'#2H<
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MDQ%,Y\M_NGZX_:]_9C^+O[1O_"O?^%5_M;?%3]EK_A#?^$L_M[_A6=K+<_\
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M+:?P=#I5OJ4-[9Z2)/$/B O#K+WUO/=D26P#Z?;_ "29W)]A45S?VKC?[/\
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M/WA?2K'6[2\^&/CJPG@\-ZQ-JNDW6GV=Y=R2>,]943:/=7$6IV@^P2$W-M&
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M#\6/AU+\%/C[JG@+_@IG\4]4_9.\:Z5=_L#^,_ OB;X3W?PG\>^-OV=?B/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M\0/AO\-C\*_ 7C3P5\?!^S)\1OBE\%?VF/V2]&^-?PE\0:#\1O\ AEW^Q/\
MA;O[1D-KJ/B[]HVY^('[>]S/%\<4OOVS_ _P/\+_ +;'C7^IVOY*O^"%GP%\
M%^#_ -MOXS_%-?$_QP_X6&W@?]J3P9/X0_:P_9IU7X$_MG6_@OQY\6_V4OCU
M:C]L'QWXB^(EAH?Q_P#CAH^N>.;SQ;%XT^#OPV^+>JV_PJ^,OPP\2_M)?'/X
M16?Q)_92_9=\'_UJT&-3XODOZZA11100%?Y'7_!8']M.P_;X_P""A'Q_^/\
MX4U;7-3^%#ZYI_P[^"$>K:[XDU:PA^$_PVTRV\*:#KGAC2O%6B>&M4\#:'\3
MM4L==^,]QX!D\.Z3-X7\2_$GQ#9ZJNIZ^^L:[JO^A'_P<"_M2V'[+/\ P2N_
M:3O%O-#C\8?'W0T_9:\!:5XAT7Q)K%AK]_\ &ZTU+0OB#9V\GAR2T31=<T7X
M&6GQ9\9^&-:\1:E8>&[?Q+X7TFUOX]>N+VR\*:__ "'?\&IW[/?_  M3_@I9
M?_&74],\<+H?[+_P/\?^-])\2:#98\%P?$GXCQV?P:\/>$?'NL7&BZC9Q?\
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M!^"%OX+\4?#ZV_1?_@H'\7+_ . W[%?[2OQBM?V?M#_:FTOX??"OQ!XA\<_
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M  =1_MT_$GXO_MG-^PY_9_\ PBWP@_9(_P"$9U_R;#Q+KUU_PM;XD_%SX5>
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M]J:'JG@9/CA8V_C7QQX+\4?$GX>Z1J'A76=3\.>'/#>K7G^>Y_P4U_Y21_\
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MGPN^!^G_  Y_98N?B_X>^)7Q>^"NA_LN>,;GX%^.?B3\/IOC'\-O&7CGQ/\
M _PAXL^'W]7.D_\ !,#]B+2K_P 3Z[/\(M<\5^,/&.N6_BWQ!\1_B1\:OCU\
M5?BQ=>.M'\-^'O"'@3XDVOQ;^)?Q/\6?$S2/BI\&?#?AR+2OV>/BGH_BNP^(
M?[-T/B'XA2? 7Q+\.;CXI?$J;Q8&TW"Z<DY72:U\WYZ+?JWL[GX@_M#_ /!4
M[X:?\%8OV5?B1^S]^RGXQUSP7X[\4Z'\/?B;X4UOX5>%_P!K;Q?^TQ\/OBQ\
M#?C+=?M=Z%\*O"?AO2OV8_A[\$;G]HO6?V6?V7OB/X_^&6D:#^V1I</B/]I3
MPAJ_P6^''BSQ3X$T*/\ :5N_HS_@BK??"WQ=\9_VO?''PCT[P/\  'X>:1\<
M/C7\%/ _[(EQHWQ>\.?$GP9JOPX\*?LD^,?VBHO UMX\^)'@.+_AECX;?M1_
M%OXK^(/A3\*_&/[&7PX\:? /7OVF?%6I:9:_LY7GQ^^)/P#U#V_]JW_@@M_P
M33^-'P#M? MM^S=XXT#4/A!X'GT[X.W/[/WQ'DT'XO:)I6B6WAW4Y/AO\/+[
MXS^+;WX07/\ PL#4/"E]/<6/Q=BD\%R?%+XK?&3XW:GK/ACXO_&CXL?%W7_R
MQ_X($Q:]\0_VTK+XM>)_B7\#_&UGX"_X)T>+?@/\,-6_9^^!_P -OV7_ (6_
M$_PIJ'[:^M?%WQKX^^'GP2U#5_@?\:]5\#^#/&?B>W^&=Q\;/#W["?PG^#'C
M'XO6/QD^&^K>(3\0_@\GC[]HP%[KA+ENDNC^7WWMY-6>]V?V&5^!/_!Q+\6O
M@Q\%/V0_@?X]^.?P\\<>/?#&F_M3V[^$K[X3_$;Q7\)/C/\ #+XSV?[+G[4V
ML_ GXL?![XD>&_$>E:?X+\<>"_B_I7@R9_$_C3PM\6_"GAWPI>>)]>'P>\>^
M)]-\,Z='^^U?EC_P6&U_X%^"_P!CK4?B%\?O&_\ PA_A/P!XXTGQ'9Z;IUI^
MSUJ7C3XB_:/#'C'PUX]^'/PXT3]I'Q=X \&>+?'&N?!3Q#\5+^Q^'ECXLN/^
M%I:5HVL_#+XC_"7]J;X">,/C#^R)\? SA\4=WKTWZGRO_P $%?$_PM\4?#;]
MH:Y^"'[0O_#0/P\T_P <>"M%UGQ/I?PP^+W@SPIXE^*6BZ#J^DZC\3M'N/B1
M^SQ^SWX,^$W]N_!2Q^ 'PB\-_L(_ >Q^(/PA_8L^#'P$^#6F:%\1O%UY\6K[
MQ#JW[[5^(/\ P1X^&GQ \'^//^"@NM>/?C)X'^).N:9\</@S\#/B!H_PI^)'
M[3?Q<^&UO\?/A)^S;\./%_QI\:6_Q _:H_:7_:0^(>N^.+2\^-/A;]EKQ49K
MSP'<V^@_LB>!H]>\&>&]<^V>#?!_[?4!/XG\OR7DOR"BBB@D**** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M]&[;MVZWUTTU;LW>ZT9M_P#!#GQ+X%\'_P#!13X]?LHVOPLT/X9>,/@AH?\
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M#_[!X'L/^$CA\3_'SXD6WB?PW\ _"&J^&]*TC5+CPMK/Q!TGPSXD^W^.+_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M?Y[G[3O@[P1XRN?$6L_M'77CCXGKX7_X02PL?%?C"_\ ^"=%C^TWXU\*:G\
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M_&W@?PMKGPO^-NBZP/"?P-6Y\(:]X/TNU\5^,[=O$'ANV\3>(?\ !M?\&O\
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MXF#P9X7/Q#U[P=<^&_#TW_"B?"6C_'+X[>-II_$]G]O_ +;'C[Q)_P $??\
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MRC<^-O\ V>_\2?\ U0W[-5!%O=FW&S3@K:Z7O?=O>RWV/OO_ ()E_P#!2O\
M:_\ ^"BEAX!^+-Y_P3LT/X#?LD^/=#\=ZMI7[1.K?ME>#OB'?ZM?^"/$NL>
MI/#'ACX,Z%\'M%\=W>N7?CO1=2L+BX\9M\/_  W9^&]$\0^(K7Q#JM^GA3PU
MXQX?Q9_P74^$_P ,?^"M^K_\$M/BS\(-<\(6]SKGPJ^'_P /OVA=)\6S>+K#
MQ+\6/C+X"^&7C/P%X0\3_#"R\#V.J>#=#UW5/B"W@2W\96'B[QE#8^)8?#U_
MXBT;0?!^L^(_$W@;\E?^#9CX]?L8^%-!^ GPC_X;O_:G\2?M??$SP/\ '?P1
M_P ,(>+-:^*NL?LG_#_[!\2?&'QA_P"$N^&7AO\ X5+;?##PIXXO?AA\/_\
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M#&J>-H_#5MJGBOPW\/\ Q;>7^CZF==^'WA2X1;"OYFO^"UGP*^-O[2O_  <
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MJWBOQ-<?#_2OAAJMA8_#SP#XA\9R>,I$M=2TK2<3_@A/I'Q)^+GQG_X*@?\
M!1+7_@?_ ,,\_"#]NCXX?"75_P!GOP%JGPTU[X2^*_%/PV^'7A3QEKVB_'#6
M/"U[%J7AC6_^%U>%_C#X1\7>)/B7X(\;>+M!^(_QG/QEU^TEL=/.F3:G^!/_
M  2*_P""=&O?MC?\$D_&WQE_9PE\#_#G]N;]E?\ X*+^)/C[\!OBM_PJ3X;>
M+_B3X[U[X'_LT?#7Q5\+OV=O^$Y\=ZSX8T_PQX'\3_%_Q/H?B3S/&6J>(?AM
MHNO6/]L>(O ^K07-Y<6X/EA[]]+."3O?E<D[W[I/1_\  9_6K^P+_P %+_\
MAN+]I+_@HC^SW_PI7_A6'_#!'QP@^#7_  EW_"Q_^$U_X6OY_CSXW^"/^$D_
ML#_A _"7_""[?^%-?VG_ &/_ &UXQW?\)']B_M0?V/\ :]4_4ZOX\_\ @UQ\
M;_$GXF?M)?\ !9_XC_&7PC_PK_XO_$#XX?!GQO\ %;P%_8&O>%/^$(^)/BOQ
MY^V!KWCGPC_PBWBJ[O\ Q/X;_P"$;\47^J:-_8'B2^O=>T?[%_9VL7=SJ%M<
M3/\ V&4$32C)I=$O/[*;_&X4444$!1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M- ^!/_A9_$#_ .+K^WS_ (9;_9E_Z-T^!/\ X:+X?_\ S/4?\,M_LR_]&Z?
MG_PT7P__ /F>H#GI_P#/O_R8_B#_ .(PC]IK_HT#X$_^%G\0/_BZ/^(PC]IK
M_HT#X$_^%G\0/_BZ_M\_X9;_ &9?^C=/@3_X:+X?_P#S/4?\,M_LR_\ 1NGP
M)_\ #1?#_P#^9Z@.>G_S[_\ )C^(/_B,(_::_P"C0/@3_P"%G\0/_BZ/^(PC
M]IK_ *- ^!/_ (6?Q _^+K^WS_AEO]F7_HW3X$_^&B^'_P#\SU'_  RW^S+_
M -&Z? G_ ,-%\/\ _P"9Z@.>G_S[_P#)C^(/_B,(_::_Z- ^!/\ X6?Q _\
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M- ^!/_A9_$#_ .+K^WS_ (9;_9E_Z-T^!/\ X:+X?_\ S/4?\,M_LR_]&Z?
MG_PT7P__ /F>H#GI_P#/O_R8_B#_ .(PC]IK_HT#X$_^%G\0/_BZ/^(PC]IK
M_HT#X$_^%G\0/_BZ_M\_X9;_ &9?^C=/@3_X:+X?_P#S/4?\,M_LR_\ 1NGP
M)_\ #1?#_P#^9Z@.>G_S[_\ )C^(/_B,(_::_P"C0/@3_P"%G\0/_BZ/^(PC
M]IK_ *- ^!/_ (6?Q _^+K^WS_AEO]F7_HW3X$_^&B^'_P#\SU'_  RW^S+_
M -&Z? G_ ,-%\/\ _P"9Z@.>G_S[_P#)C^(/_B,(_::_Z- ^!/\ X6?Q _\
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M- ^!/_A9_$#_ .+K^WS_ (9;_9E_Z-T^!/\ X:+X?_\ S/4?\,M_LR_]&Z?
MG_PT7P__ /F>H#GI_P#/O_R8_B#_ .(PC]IK_HT#X$_^%G\0/_BZ/^(PC]IK
M_HT#X$_^%G\0/_BZ_M\_X9;_ &9?^C=/@3_X:+X?_P#S/4?\,M_LR_\ 1NGP
M)_\ #1?#_P#^9Z@.>G_S[_\ )C^(/_B,(_::_P"C0/@3_P"%G\0/_BZ/^(PC
M]IK_ *- ^!/_ (6?Q _^+K^WS_AEO]F7_HW3X$_^&B^'_P#\SU'_  RW^S+_
M -&Z? G_ ,-%\/\ _P"9Z@.>G_S[_P#)C^(/_B,(_::_Z- ^!/\ X6?Q _\
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M- ^!/_A9_$#_ .+K^WS_ (9;_9E_Z-T^!/\ X:+X?_\ S/4?\,M_LR_]&Z?
MG_PT7P__ /F>H#GI_P#/O_R8_B#_ .(PC]IK_HT#X$_^%G\0/_BZ/^(PC]IK
M_HT#X$_^%G\0/_BZ_M\_X9;_ &9?^C=/@3_X:+X?_P#S/4?\,M_LR_\ 1NGP
M)_\ #1?#_P#^9Z@.>G_S[_\ )C^(/_B,(_::_P"C0/@3_P"%G\0/_BZ/^(PC
M]IK_ *- ^!/_ (6?Q _^+K^WS_AEO]F7_HW3X$_^&B^'_P#\SU'_  RW^S+_
M -&Z? G_ ,-%\/\ _P"9Z@.>G_S[_P#)C^(/_B,(_::_Z- ^!/\ X6?Q _\
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M- ^!/_A9_$#_ .+K^WS_ (9;_9E_Z-T^!/\ X:+X?_\ S/4?\,M_LR_]&Z?
MG_PT7P__ /F>H#GI_P#/O_R8_B#_ .(PC]IK_HT#X$_^%G\0/_BZ/^(PC]IK
M_HT#X$_^%G\0/_BZ_M\_X9;_ &9?^C=/@3_X:+X?_P#S/4?\,M_LR_\ 1NGP
M)_\ #1?#_P#^9Z@.>G_S[_\ )C^(/_B,(_::_P"C0/@3_P"%G\0/_BZ/^(PC
M]IK_ *- ^!/_ (6?Q _^+K^WS_AEO]F7_HW3X$_^&B^'_P#\SU'_  RW^S+_
M -&Z? G_ ,-%\/\ _P"9Z@.>G_S[_P#)C^(/_B,(_::_Z- ^!/\ X6?Q _\
MBZ/^(PC]IK_HT#X$_P#A9_$#_P"+K^WS_AEO]F7_ *-T^!/_ (:+X?\ _P S
MU'_#+?[,O_1NGP)_\-%\/_\ YGJ YZ?_ #[_ /)C^(/_ (C"/VFO^C0/@3_X
M6?Q _P#BZ/\ B,(_::_Z- ^!/_A9_$#_ .+K^WS_ (9;_9E_Z-T^!/\ X:+X
M?_\ S/4?\,M_LR_]&Z? G_PT7P__ /F>H#GI_P#/O_R8_B#_ .(PC]IK_HT#
MX$_^%G\0/_BZ/^(PC]IK_HT#X$_^%G\0/_BZ_M\_X9;_ &9?^C=/@3_X:+X?
M_P#S/4?\,M_LR_\ 1NGP)_\ #1?#_P#^9Z@.>G_S[_\ )C^(/_B,(_::_P"C
M0/@3_P"%G\0/_BZ/^(PC]IK_ *- ^!/_ (6?Q _^+K^WS_AEO]F7_HW3X$_^
M&B^'_P#\SU'_  RW^S+_ -&Z? G_ ,-%\/\ _P"9Z@.>G_S[_P#)C^(/_B,(
M_::_Z- ^!/\ X6?Q _\ BZ/^(PC]IK_HT#X$_P#A9_$#_P"+K^WS_AEO]F7_
M *-T^!/_ (:+X?\ _P SU'_#+?[,O_1NGP)_\-%\/_\ YGJ YZ?_ #[_ /)C
M^(/_ (C"/VFO^C0/@3_X6?Q _P#BZ/\ B,(_::_Z- ^!/_A9_$#_ .+K^WS_
M (9;_9E_Z-T^!/\ X:+X?_\ S/4?\,M_LR_]&Z? G_PT7P__ /F>H#GI_P#/
MO_R8_B#_ .(PC]IK_HT#X$_^%G\0/_BZ/^(PC]IK_HT#X$_^%G\0/_BZ_M\_
MX9;_ &9?^C=/@3_X:+X?_P#S/4?\,M_LR_\ 1NGP)_\ #1?#_P#^9Z@.>G_S
M[_\ )C^(/_B,(_::_P"C0/@3_P"%G\0/_BZ/^(PC]IK_ *- ^!/_ (6?Q _^
M+K^WS_AEO]F7_HW3X$_^&B^'_P#\SU'_  RW^S+_ -&Z? G_ ,-%\/\ _P"9
MZ@.>G_S[_P#)C^(/_B,(_::_Z- ^!/\ X6?Q _\ BZ/^(PC]IK_HT#X$_P#A
M9_$#_P"+K^WS_AEO]F7_ *-T^!/_ (:+X?\ _P SU'_#+?[,O_1NGP)_\-%\
M/_\ YGJ YZ?_ #[_ /)C^(/_ (C"/VFO^C0/@3_X6?Q _P#BZ/\ B,(_::_Z
M- ^!/_A9_$#_ .+K^WS_ (9;_9E_Z-T^!/\ X:+X?_\ S/4?\,M_LR_]&Z?
MG_PT7P__ /F>H#GI_P#/O_R8_B#_ .(PC]IK_HT#X$_^%G\0/_BZ/^(PC]IK
M_HT#X$_^%G\0/_BZ_M\_X9;_ &9?^C=/@3_X:+X?_P#S/4?\,M_LR_\ 1NGP
M)_\ #1?#_P#^9Z@.>G_S[_\ )C^(/_B,(_::_P"C0/@3_P"%G\0/_BZ/^(PC
M]IK_ *- ^!/_ (6?Q _^+K^WS_AEO]F7_HW3X$_^&B^'_P#\SU'_  RW^S+_
M -&Z? G_ ,-%\/\ _P"9Z@.>G_S[_P#)C^(/_B,(_::_Z- ^!/\ X6?Q _\
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M- ^!/_A9_$#_ .+K^WS_ (9;_9E_Z-T^!/\ X:+X?_\ S/4?\,M_LR_]&Z?
MG_PT7P__ /F>H#GI_P#/O_R8_B#_ .(PC]IK_HT#X$_^%G\0/_BZ/^(PC]IK
M_HT#X$_^%G\0/_BZ_M\_X9;_ &9?^C=/@3_X:+X?_P#S/4?\,M_LR_\ 1NGP
M)_\ #1?#_P#^9Z@.>G_S[_\ )C^(/_B,(_::_P"C0/@3_P"%G\0/_BZ/^(PC
M]IK_ *- ^!/_ (6?Q _^+K^WS_AEO]F7_HW3X$_^&B^'_P#\SU'_  RW^S+_
M -&Z? G_ ,-%\/\ _P"9Z@.>G_S[_P#)C^(/_B,(_::_Z- ^!/\ X6?Q _\
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MW_#,G_"NO^%O_P!J?\-X?%'_ (1G^PO^%J?\49]@_M[[#_;O]H?Z1_9'VO\
ML_\ TWR:"E!.*;O=S46EVM^9_37XD_X*%_L:^$?V8O"_[9GB/XZ>']+_ &9/
M&=[::=X8^+,NB>,9=&U:]OM7U30;2"'2[;PW-XEA:;5]%U2R5KK1($62T=G9
M8GBDD^7-,_X+P_\ !(W5IWMK7]M[X912)"T[-J>A_$;18"BO'&52ZUGP586L
MDQ:12MO',T[H))%C:.*5D_!O_@I#_P *!_XAAO@#_P ,M_\ "X?^%!_\+)\
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MQ3:?9+N[!\D_Y7U_#?KYH_ICHKQ?PI^T3\$?&OP'TO\ :>\/?$KPM<? /5_
M#?%&W^*-YJ":3X6MO D.F2ZO>^(-6O-5%DVB6^E64%R=:M]6CLKS1KFTO++4
M[:UO;2X@C_G=\6_\'9O_  3I\/\ Q+N/!^A_#O\ :4\;>"+35H=,E^+&B>#O
M!VGZ#>VS2B.XU[1O#7B3QUHWC*ZT6W5EF U71M$URXCCN!%HA=;9;L$HRE>R
M;MOIM^1_4517Q3-_P4!_9LO_ -B3Q3_P4!\ >)]1^+/[//A7X9^)OBE<WWP^
ML;6?Q7?Z1X/M[J7Q#H%MX>\4ZCX573?&6EW5C=Z5?>'?$]_X?N-/U6"2TU&6
MSVF2OQ:\0?\ !U__ ,$[M.T'X<:SH'PU_:<\2WWCJ_U2'5O",/A3X9P>+? >
MF:;K(T6VU#Q':6?Q5U?1I;O7Y([R]T#0=+UV\UB?3+6*^U.VTF#5-&;40%&3
MO:+=G9^3\S^GNBOPV_X*"?\ !?\ _8I_X)Z_$"R^#?CK2/BK\3_C/_8OA_Q!
MXI^'?PTT/P^UW\.;#Q+ID6LZ19^/M8\4>)?#^E:3XBN]*N+34$\-:;+K6K6]
ME>V%[J4&GV6H6%S==3_P3V_X+J?L:?\ !16Y\>^%_AK8_$KX=_%+X=^"]=^(
MFJ?##XEZ/X>L];\0^#?#TD:ZIK7@C5M \2ZWH&O_ & 7>FIJ&F7=_HVLVDMZ
M9AITVD6MQJZ@<LK<W*[=[?U^1^ONH^,/"6C^(?#GA'5?$^@:;XK\8+JS^%/#
M-]K&GVNO^)8]!LQJ&N2Z%H\]PFH:M#HUDR76JS6-O/%I\$D4EV\*S1%_E3QW
M_P %"_V-?AE^TGX6_9 \=?'3P_X=_:1\:WOA33O"_P ++K1/&,^KZO>^-R%\
M*P0:I8^&[KPW$VL,P$#7.M0)"3BZ:#!K^"GX/_\ !:_X4>'/^"V7Q(_X*/?%
M>#]I'QM\ M4T#XA^$/AAX):T\):Y\3/!'@[Q%H%CIGACPS8^%]:^*%CX'\.:
M+IM_%?WU_IF@>-IK-+F^NM2BCO\ 4;^]D?\ <7]J_6?^"7_B/_@O!^RMXA^)
MD?[>L7[:.O:K^RSK/PUB\"I^STG[+\=SJD-K??#>/QRGB"6?XKI B3QKXW30
M)YI%8.-!ED 5R%NG9V=_@<M%U2VWV6EV?UOT5^:7_!1?_@J]^R7_ ,$R/"_A
M[5/C_KGB'6_&WC6.YF\#_"'X<Z?INN_$7Q)8VGGQ7.OFQU;6-!T?1/"UK>PB
MPN->US6+&&6\=K72H-5O+>YM8OC[]@O_ (.*?V$OV[?BYI7P(TVS^)7P)^*?
MBN[-A\/M(^,>G>&;30?B!JCK;?9/#GA[Q1X8\3>(+"#Q;J$DES'IF@Z[%I']
ML26\5CHM[J6LWUII3A'+)KF47;O;0_>ZBOR7_;M_X+,?LH?\$[OC]\&_V>OV
M@?#_ ,86U_XTZ+H?B/2?&_A#0_A_=?#;P?H.M^-+_P $-J_CW7/%7Q,\(:QH
M]AHM[IMYJ^N7&F>'=;CL]!B:\A-U=*UBOP!HO_!U?_P3?UGXY6GPK/AWX\:5
MX!O_ !.GABW^/FK^$_"]E\/HDEG%K#XKU'1F\8MX[TWP;).?,;4+GPTNMVE@
MR7VH>';-5N8K8!0DU=1;5KWMT_K_ (8_IGHJ"UNK6^M;:^L;FWO+*\MX;JSO
M+6:.XM;JUN(UFM[FVN(6>*>WGB=)89HG:.6-E=&96!,]!(4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MLFH+:*;^<FW^"LC^>G_@HW_P7J_X=^?M-:S^SE_PQ7\4OCC_ &1X2\(^*?\
MA/?"7C/^Q='N?^$JL)+[^S4L/^%?>(MEQINSR9Y/[3?S"P;RH?NU\(_\18O_
M %C,^/'_ (<C_P#%#7]@E%+7N2G&VL+OOS-7^5C^/O\ XBQ?^L9GQX_\.1_^
M*&O>_P!EK_@Y4_X:7_:,^"O[/W_#OSXR_#[_ (7%\1O#'P^_X3C6?'G]H:3X
M5_X234H=._MS4;+_ (5AI?VJTT_SO/GA_M&RWHA'VF+[P_J)HHL^X<T/Y/\
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MBV:*6=E4^6,92EU]U)-7UWM\NI^+'PX_X*1? ;PQ_P %\_#W[?/[/MCX_P#
M/[/_ ,8?C?I<_P 1-"^*.B^&/#'B'2=&^-F@V?@OXYZIKMCX2\8^-=!O["V\
M4Z[XA^*&F7"ZVL\MW!I[7=M!?69N9OU$_P"#P#2KW7?C+_P3_P!$TV-9M1UC
MPI\:M*L(GD2%9;W4/%7PMM+6-I966.)7GFC5I)&5$!+.P4$U[!_P< _\$//A
MIX=_9Z^#_P 4?^"<?[(6I0^//"/Q.OO#?Q(^'?[/W@CQGXW\4^+?!7C;0FEL
M?%%UX:T5/$FLW\'@?Q#X6L+!9+&T5;.V\;:A=W>;>%Y(/ES_ (*E?"[]NO\
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M7Q1^"WBS6/B@GBSQ186!U#7X/$WBH6FN7D4E\\,=]H.@1V$L>F:9!9O]U_\
M!U5^SM^T#^T/\!_V3]'^ 'P+^,7QSU;PY\7/'6I>(=+^#WPR\:_$W4=!TZ\\
M&V5K:7^LV/@K1-;N=+LKJY1[>WNKZ*"">=6ABD:12H[7_@NK\ ?CO\7?^"+O
M[-_PL^$_P4^+?Q/^)VA^)_V8+C6_AS\//AQXQ\:^/-'@\/\ PB\4:;KT^J^$
M/#>C:GX@T^'1-1N(-/U>2[TZ%--O9X;6\:&>5(V3_K[T3&6E+7[<KZ_GKYO<
M_(__ (+$75U>?\&]7_!&N:\N;BZE2W^"]JDMS-)/(MK8_LY^+;&QME>5F9;>
MSLK>WL[6$$1V]K!#;PJD42(OZ.^-?^"7?[%UA_P;E1Z_9_"+X3K\3=)_83T7
M]KF'XZ_V'H]K\0=2^+TGPIL/C3J-_9_$C^QK7Q7?Z7K][+<>!] \/7\RV5[X
M6NM&\,RVL!C@GM_S]_X+7^#O%WP]_P""!_\ P2,\#^/O"OB/P/XU\*:I\+-#
M\4>#_&&AZGX:\4^&];T_X!>-8+_1]?\ #^M6MEJVCZI8SHT-YI^HVEM=VTJM
M'-"C@J/ECQ5\<?\ @N=I'[ W@'_@EK%^RIXW\=?"SXH^ / =M\-_C=\._A3X
MY\=:YXN_9X\;6VF^)/"7P_T_X@>'7O/ -EH7]G75EH^J7&N:;I7BSPUX/5O#
M7B1=*BC>]IC2;C&TDK5)-W=KI2]=;=O,](_9R\<>)/%G_!I5^WSX?UR\EN]+
M^&7[6'@SP5X.C=W:/3?#NH_&[]C#XCW>G0K)/+Y:GQ;X^\3ZHZPPVUN9-59P
MDER]U,_O'B__ )4Y_A9_V/FH_P#KP?XCU]G_ !)_X)@_&S]E3_@V>^-7[)6@
M_#WQ7\4?VGOB3KGPI^+OC_X<_";PUJWQ#\37'CSQ!^TE\"=5U;PYH&B>#;;7
M=1\23?#_ .&_@[2--\0ZGHT5_82KX4US7[>9-#1)8O)_%/[+7[3EQ_P:E?#;
M]G:W_9S^.\_[0-CXUO[J^^!</PA^($OQCL[5_P!N;Q]XN2YNOABGAYO&UO;M
MX4O+/Q.LTVB)&WAZZMM:#'39XKE@+IZIJWMT^FUEKZ>9X5^U'_RJ3_LE_P#8
M]>#/_5V_%ROAC]C;]AW_ (."_CO^R)\,)OV8/C+\1O#?[)'Q \+>(]/\":!9
M?M3Z9X!\-V_A.X\0^(M+\0Z>?"=GXHM]=TBPU'78=>CN[)-,5KT7<\DD3VMV
M[-^KW[1_[+7[3>N?\&P7[,/P!T3]G/X[ZQ\=] \9^$[K7?@II?PB^(&H?%O1
M+6V^+_Q0U.XN=7^&]IX>F\8Z;!;Z;J%AJ$TUYHT,<5C?6EV[+!<PR/\ O;_P
M1)^'GC_X4?\ !+/]D'X>_%+P-XP^&OC[PSX*\66OB3P/X_\ #.M>#O&'A^ZN
M?BCXZU"WMM;\->(K+3M:TJXN+"\M+Z&&_LK>26SNK>Y16AGB=EV$Y<L7;E;]
MI+=)_.WZGQY_P0>_X(P^(/\ @E_X5^)GQ&^-WBGPIXP_:-^,MEHWA[4;?P1)
M>W_A+X<^ -$NY]4B\+Z5KNIZ=I.H:]K'B+5Y;35?%M__ &;9Z7%)HF@:9I$=
MU'IUUK.L?S]?\&F7[+GPA^-WQQ_:R^*GQ6^&/A'XDO\ !GP%\+O#_A!?&^AZ
M)XGT?P[K'Q6UCQU+?:I::'KD%Y!_;EQI/PZNM/L]8BLWDT[3[C5[3[1;G556
M?_0:K^//_@T\_9D_:2_9S_X;X_X:$_9\^.'P(_X3'_AEG_A$?^%R_"?QY\,/
M^$J_X1[_ (:-_M__ (1O_A-] T/^W/[#_MS1?[8_LS[5_9G]L:7]M\C^T+3S
MF2I-QJMO5\OEUZ:]CY&_X):> M$^ O\ P<Z_M8?";X<Z3I/@[P':W7[5&CZ7
MX4\.VL5OH.D^$-0O=(\<:+X;TNS:WC32M,TBXAT9;33]/2"VTZ/3HM-LG;38
ME26[_P $>?\ E9G_ ."D'_8^?\%"/_6H].KZ@_8]_9B_:4\,_P#!S1^TY\>O
M$G[/7QQ\/? S7[OX[-H7QGUSX3>/=)^$^M+J_A/1+;26TGXBW^@6_@_4EU2X
MBE@TXV>L3"]FBDBMC*Z,HY;_ ()4_LM?M.?#O_@X:_;\^-?Q _9S^._@;X->
M,O&O[<]UX0^+7C'X0_$#PS\,O%5KXN_:/L=<\*7/AOQYK7AZQ\*ZY;^)]$1]
M8\/3:7JMU'K6EJVH::US:*9@%MJT]5K2AU6KNO/?\3^T&O\ ,[_:0_8>U;_@
MHG_P<&_M9_LKZ)\0].^%NH^-/BU\5-;B\9:KX=N?%-E8)X+\"#Q3+;R:-::M
MHD]PVH1Z8UG'(NH1"W>99F254,;?Z8E?YT/[7?P\_P""J7[,_P#P6F_:H_;'
M_8]_8X_:8\6ZFOQ5\?+X!\?Z;^RE\6?B?\/=>T#QAX4B\-:GJ&D7FF^$+O0-
M>M+C3[R\AM+^ROKB".<>9'(SQ8 12O>5FD^71MI*]UW/*_\ @H-_P;V_M"_\
M$P_@R?VQ;7XQ?"#]H/X=_"OQEX#D\9:'J'P_O]-GT^+7_%&E:!H5]KG@KQ-)
MXJ\+>+/"-YXLU'1?#>NZ5>ZL)+F+7+57TR[LI+]K/];?^"H'[9Q_;Y_X-M?A
MA^TC?>'M.\)^*?$'Q>^%GA3Q[X<T:)+;0M.\=^ /%'B;P?XDF\/6:W%T^G>&
M]:NM)7Q#X>TJ>XN+K2=%U>QTRZN+F>TDN9OS7_:2^(W_  <B?\%.?AM;_LR?
M%O\ 9-^.VF_#O7_&'AK4=7TF;]E[5OV?]'UW5-,NGNO#R^*_&7C[2?#=C%X:
MTC4TBUF<W.L6.AVNI66FZAJTIELM/:+]@?\ @H#_ ,$T_C+^SQ_P;R_"3]B/
MX4^ ?'7Q_P#C1X.^)'P[\6>/-%^#/@SQ;\2-7U+Q=XH\8>+/'/Q N]"T3PUH
MU]KMYX4\+:KXC?0-.UAM&L1+H>F:;J&I6UG>7<Z4&C>L.>47)3W36D;=;:;^
MA^8__!2SXH>+/#'_  ;F?\$E/A?HNH36'AKXI:I'?^,XK>62)]8M/A]I_C'4
M=$T:\5"$N-+_ +;URVUV6WE!7^U= T6Z7#VJFOVBO?\ @CY^PH__  0M_LO_
M (4EX 3XF6W[%D?[18^/MEX7T@?%V;XQVWP?'Q5;Q%_PGAA/B:?P]=:^K:3)
MX/?6/^$>?PA*="CM(D$5S'P_Q _X)5?%K]MC_@WP_9(_9W7P?JWPY_:K^ _A
M'1/B1X$\"_$_1[_P!K[>+M'N/&>DZ[\,_%%MXI@TF]\(7'BWPQXANA8OK\%C
M80>)+3PO<ZS-I^D)<ZE:_B-'^U%_P7_O/V0X/^"34?[&OQBBTMO#B_ \>-Y/
MV=?BI9?%!_A(MD='7X>S_$*YN8?AA%X)_P"$="Z"WCAM-A#^"$$<GBE[)Y-4
MD!?$K1DDXU)-ZI:-Z/?4['_@G+\(OVC?V^O^"!'[<W[)'PCDO?%GBKX0?M'^
M /B1\+/!#7MG#-XETFYC\/\ C'Q;\-M)GU*>SL[$3WVB:UXUT*V:Z U+QA>2
MV(\EM4,M?'?PW_X*5Q_ ?X!:/_P3>_X*)_\ !-KX<_$+X/>![^V@O;1/#>N_
MLV?M0^'GL/%#ZG<:VWC Z9<SWOB%-3LKRQO=6M-*\)ZWXGTTZIH.K^+2E]<7
M\7]/7PC_ ."1'[9W['__  1>U[X _LH_&36/AK^WQK_CE/VCO&.I?#GQ=:>'
MK?Q5XKGTFU\/7WP&T_QM>R6]G9Z=:>!+'2],L=:74=,T.[^).C_VT-5T_P /
MZG/=K^)?Q:_:K_X+!_M ?L=?\.UOC_\ \$L/BC\<?C!8V%G\/=-_:2^)OP0^
M,OCGXJ:980Z[8W$'B]_$NNZ)JFD-XP2W@LK9_C,OC2UT2XTR*+Q%K U M=:K
M<@TU)R^%QY[_ !<LEHES+576C?<^V?\ @K!^T-^RO)_P;I_ FR_X)X:)K'@7
M]EOXO?M)>"_A&GP]UG6_$ESXD\"1:<_Q=^-OB[P=XL_X2'Q-XSU6XUB'XF?#
MRRU34+>Y\3ZOI^H2:C#XBTW4K^QNK&XNOT _8 _X(_\ [$_[1_\ P11^ ?PI
M\9_#+PQ9^)?C_P#"CPW\6O$_QVT#PKX67XTZ1\0O%-__ ,);::[HGC?5-+U;
M4;>;PQ;30>#+/3WE;2KCPK:W6CW>G"WU348IO,_ 7_!#'XKWW_! W4_V%/&-
MUHNB_M4ZWXPO_P!IW2=)DU:SN/#OACXR1WUK)HOPYU7Q#9WFI:1=?;? >G_\
M(-K/B#2[@:%I?B+7+K5+2;5=+TK[=JWX.:/\:_\ @N[X4_8K\0_\$>H?V(?C
M!?>%KG^T?AQ'XL/[/?Q3U/XAZ-\.M:U^?6-=\#6'Q#TZXD^&%]X$O[J]EM+3
MQM=6M_9V'@O4;_3[3Q*^C-HE[H83NK1DE:HVVY6;3V>MKVU]?F?M-_P6U_8N
M^&'[ /\ P0;7]F7X-^)/B1XF^'?A#]HKX=:MH=S\4O$.E>)/$5G/XH\1:[K>
MMVT-WH?AWPKI-KIUYKUUJ>N_8+#1+2VBU36-4GB1$N1%'^.W_!4SXI:WH?\
MP0O_ ."(_P &[+4]1M=#^(_A_P"*7C[6]-MI7CT_5+CX3_V)HVD'4E211.UB
M_P 6+V:R@ECEB\V22X^2:WA)_5#]L7_@FU^U;\$_^#>+P9^R])X8^+/[1_[4
M&K?&_P"'OQ4^(_@_X=Z9XQ^-GB/P[J&M:A>27'A/0[3PU'XJU"[T'X;^&K3P
M]X;U;4=%-QX8DUFQU75]+N/[,U.UEDL_M(?\$G/VA/VPO^"!_P"P7X$\(?#[
MQ'X:_:N_95\+R^*[?X-_$'3+SP%XNUO1M9/B#3_'7P_ET;Q99Z3>:%XVN4@\
M+>(-!MM?DTFWNQHD^DR@7&LV%S; XM+EO)/][+7OI9/TOUL?B7^V=^TC\)?V
MCOV%_@]^RI\&?^"/_P 4/@3X_P#@Q_P@C^$OCOI_A2^U+Q%J<6BZ.VD>-CXE
MNM'^%>A>(?$O_"Q!<SZ[K,FO>(M76?Q%'8ZS<K=:A:6]Y%]+?\%@O%7Q!\8_
M\$._^",NI_%+3]<TOQUIC^+?!6LV?B:UU"R\0K#\.?#4_P /M%N-9M]5@MM2
M74;W0?#&EWMU)>Q&YN);AKB66X:4W$O?O^V]_P '$?[27PS_ &=OV%_AI^RO
M\?/V??B?\,=5\'Z%XD_: T;X8_%SX1:[XETSPEI$OAC0)_BKXI\6V5CX \(^
M%&TR\LM8\<7$Q72?%NM6&GW^F65C;SP>'[K[N_X.*/V0_P!L7XA?L+?\$]OA
M=X>\(?&[]L[XU_#/7=3A^-'CCX5?"SQ;\1=6UGQ.?AQI-EKOC#5-*\ >%)I=
M%T/6?$:W\>ARZAI=@S6BVUO</-?I<.X.]I03Y5[TG\?,]GK=Z)/M?Y&=_P %
M#_V$/V7/A1_P;2>!O%G@[X/> -(^(GP_^$7[''Q=A^)6G>$M&LO'>O?$?XJ^
M,?A#X<^(OB/7?%4=L_B'4?\ A)[/XF>)HYM/OM5O+*SLAHNE6D<>GZ!H\%G^
M>G[2WQ+\6^'/^#33]@+PYI^HZB;'XI?M1>+_  'XOEE:XN(+SPEX8^-/[7_C
MG2-"FN&G'EK;>(OA]X-NM+M)$FMTL_#[Q01PBT@:/^AC_@I=\%?C)X\_X-W+
MCX)^!_A+\3/&?QF;]G#]AG0U^$?A3P'XI\1?$XZWX1^)'[.E]XKT<> M(TJ\
M\5'5/#%CH>M7GB'3QI/VO1;72-4N-2AMH=/NWA^-/A3_ ,$M_C)^UQ_P;5?
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHKR?Q-\>_@7X*UN]\,^,?C1\)O"7B33?LW]H^'_$WQ&\
M'Z#K>G_;+2WU"S^VZ5JNL6M_:_:K"[M;VV\^WC\^TN;>YBWPS1NP!ZQ17A/_
M  U)^S+_ -'%_ G_ ,.[\/\ _P":&C_AJ3]F7_HXOX$_^'=^'_\ \T- [/L_
MN?\ D>[45X3_ ,-2?LR_]'%_ G_P[OP__P#FAH_X:D_9E_Z.+^!/_AW?A_\
M_-#0%GV?W/\ R/=J*\)_X:D_9E_Z.+^!/_AW?A__ /-#1_PU)^S+_P!'%_ G
M_P .[\/_ /YH: L^S^Y_Y'NU?SW_ /!<OX=?\%E/BA8_#SP'_P $Q9]6O_A5
MX^^'GQ)\&?M(>'])\0?LT>$+Z7^U9M(M-!?3O%7QEN?#_CS1Y]7T*_\ $FGW
M5W\/?%5IY$-K 94L+J07%Y^S7_#4G[,O_1Q?P)_\.[\/_P#YH:/^&I/V9?\
MHXOX$_\ AW?A_P#_ #0T#3<6G:]NC3:_(_*'_@@I_P $L_%__!,G]F?QK9?&
M.[T&Z_:"^/'BW2_%GQ(M/#-ZFJ:-X2\/^%=-NM,\!^ X];B18=>O]$.K^*=<
MU?5;/&F#4O%5SI6F->VFE1ZSJO[J5X3_ ,-2?LR_]'%_ G_P[OP__P#FAH_X
M:D_9E_Z.+^!/_AW?A_\ _-#0#<I-MWN_)_Y'NU%>$_\ #4G[,O\ T<7\"?\
MP[OP_P#_ )H:/^&I/V9?^CB_@3_X=WX?_P#S0T"L^S^Y_P"1[M17A/\ PU)^
MS+_T<7\"?_#N_#__ .:&C_AJ3]F7_HXOX$_^'=^'_P#\T- 6?9_<_P#(]VHK
MPG_AJ3]F7_HXOX$_^'=^'_\ \T-'_#4G[,O_ $<7\"?_  [OP_\ _FAH"S[/
M[G_D>[45X3_PU)^S+_T<7\"?_#N_#_\ ^:&C_AJ3]F7_ *.+^!/_ (=WX?\
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M_P"&I/V9?^CB_@3_ .'=^'__ ,T- 6?9_<_\CW:BO"?^&I/V9?\ HXOX$_\
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M /S0T?\ #4G[,O\ T<7\"?\ P[OP_P#_ )H: L^S^Y_Y'NU%>$_\-2?LR_\
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MY'NU%>$_\-2?LR_]'%_ G_P[OP__ /FAH_X:D_9E_P"CB_@3_P"'=^'_ /\
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M1[M17A/_  U)^S+_ -'%_ G_ ,.[\/\ _P":&C_AJ3]F7_HXOX$_^'=^'_\
M\T- 6?9_<_\ (]VHKPG_ (:D_9E_Z.+^!/\ X=WX?_\ S0T?\-2?LR_]'%_
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M^!/_ (=WX?\ _P T- 6?9_<_\CW:BO"?^&I/V9?^CB_@3_X=WX?_ /S0T?\
M#4G[,O\ T<7\"?\ P[OP_P#_ )H: L^S^Y_Y'NU%>$_\-2?LR_\ 1Q?P)_\
M#N_#_P#^:&C_ (:D_9E_Z.+^!/\ X=WX?_\ S0T!9]G]S_R/=J*\)_X:D_9E
M_P"CB_@3_P"'=^'_ /\ -#1_PU)^S+_T<7\"?_#N_#__ .:&@+/L_N?^1[M1
M7A/_  U)^S+_ -'%_ G_ ,.[\/\ _P":&C_AJ3]F7_HXOX$_^'=^'_\ \T-
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M3W4>A^$_B!X3\1:O):VJA[FY33='U:\O7@MU(:>98#'$I!D900:]1H$%%%%
M!1110 4444 %%%% !1110 4444 %?R%?\%1/^#;GXZ?M\_MT_'+]K/P=^T?\
M)O 7AOXK_P#"L_[.\)^)O#/C#4-;TG_A!?@]\/\ X:WGVV\TI383?;K_ ,&W
M6I6WD']W:7EO%+^^22OZ]:*"HR<7>.CM;:Y_ ;_Q![_M-?\ 1W_P)_\ ",^(
M'_Q%'_$'O^TU_P!'?_ G_P (SX@?_$5_?E107[:IW7W(_@-_X@]_VFO^CO\
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M\0/_ (BC_B#W_::_Z._^!/\ X1GQ _\ B*_ORHH#VU3NON1_ ;_Q![_M-?\
M1W_P)_\ ",^('_Q%'_$'O^TU_P!'?_ G_P (SX@?_$5_?E10'MJG=?<C^ W_
M (@]_P!IK_H[_P"!/_A&?$#_ .(H_P"(/?\ ::_Z._\ @3_X1GQ _P#B*_OR
MHH#VU3NON1_ ;_Q![_M-?]'?_ G_ ,(SX@?_ !%'_$'O^TU_T=_\"?\ PC/B
M!_\ $5_?E10'MJG=?<C^ W_B#W_::_Z._P#@3_X1GQ _^(H_X@]_VFO^CO\
MX$_^$9\0/_B*_ORHH#VU3NON1_ ;_P 0>_[37_1W_P "?_",^('_ ,11_P 0
M>_[37_1W_P "?_",^('_ ,17]^5% >VJ=U]R/X#?^(/?]IK_ *._^!/_ (1G
MQ _^(H_X@]_VFO\ H[_X$_\ A&?$#_XBO[\J* ]M4[K[D?P&_P#$'O\ M-?]
M'?\ P)_\(SX@?_$4?\0>_P"TU_T=_P# G_PC/B!_\17]^5% >VJ=U]R/X#?^
M(/?]IK_H[_X$_P#A&?$#_P"(H_X@]_VFO^CO_@3_ .$9\0/_ (BO[\J* ]M4
M[K[D?P&_\0>_[37_ $=_\"?_  C/B!_\11_Q![_M-?\ 1W_P)_\ ",^('_Q%
M?WY44![:IW7W(_@-_P"(/?\ ::_Z._\ @3_X1GQ _P#B*/\ B#W_ &FO^CO_
M ($_^$9\0/\ XBO[\J* ]M4[K[D?P&_\0>_[37_1W_P)_P#",^('_P 11_Q!
M[_M-?]'?_ G_ ,(SX@?_ !%?WY44![:IW7W(_@-_X@]_VFO^CO\ X$_^$9\0
M/_B*/^(/?]IK_H[_ .!/_A&?$#_XBO[\J* ]M4[K[D?P&_\ $'O^TU_T=_\
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M $=_\"?_  C/B!_\17]^5% >VJ=U]R/X#?\ B#W_ &FO^CO_ ($_^$9\0/\
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M_B#W_::_Z._^!/\ X1GQ _\ B*_ORHH#VU3NON1_ ;_Q![_M-?\ 1W_P)_\
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MO_@3_P"$9\0/_B*/^(/?]IK_ *._^!/_ (1GQ _^(K^_*B@/;5.Z^Y'\!O\
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M^('_ ,17]^5% >VJ=U]R/X#?^(/?]IK_ *._^!/_ (1GQ _^(H_X@]_VFO\
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M .!/_A&?$#_XBO[\J* ]M4[K[D?P&_\ $'O^TU_T=_\  G_PC/B!_P#$4?\
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M=&&L_P#"-^*]$UG1TU5M%T:348K..]ETG37G:RA^LJ!-6;3W6@4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M &]OVL="_8:_8_\ CS^U7XATAO$%M\(O!JZGI/AX2M;1>(?&/B'6=*\&^ =
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M#(F@0ZUING741BEMO^$AU)VD;=%Y7I?P"_X*.^!_VA/^"E/[*OP__P""HO\
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M43O$$67*]+W]HV^5.S3=O>;7+;33K?J?H5^T1^UO_P %3?\ @IQ_P4T_:/\
MV+_^";/QZT']E_X4?L71^)M#\7>+-7NU\/R>+_'G@K6?^$*\2W'B35K'PEXR
M\6WGV_XC_P!K>%/#&A:/8)X7M_#/A^7Q7K:RZO<VMK+Y#IW[>/\ P4(_;?\
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MT*'7M!A@\1>&;JYN]3\,:WHGBG4_#=X19ZEHWAW6]/UZQO/Z+_\ @@[\1_\
M@E=^T-\0_P!I#]HG]BWX;^/O@;^T[XV74-3_ &BOA'XZ\:ZSJ]M9Z3X]\=WW
MC"WUGP)I46IS>"-1\%6WB6&;3-+OO#NDZ/J?A."2VT36-&T:WUO2GUK\Q_V"
M/^#A%/A9H_[2'[+'_!;RP^(/Q"^(>A?$W6HXK[7/@WX"\1VUA_9\=EX?\6_!
MGQM\/?#NF>'-&LU\.>)M#N-<\-WD?AW5K"\;7==LKS4]-L-)\-P7?+?\&Z^F
M:+\:_P#@L-^VM^U+^S'\(M<^#?['B_#[XH:9H'A[[(=,T'PY;?$/XD^ M5^'
MOP^N;71Y[SP[IVL:A8>&M9\91>"]-O[_ $3PG:Z--IVDW<UEINCW%T&DDW&;
M:Y6DFY1?NSVMIU[GYX?\$5?AS_P5B^-OP(_:J\!_\$YOC)X4^ GA+P+K/A[X
MF?$GQ->S2:;XW^)7CB7PSK-GX#^%?@_6H?#'BNZLFN;+P_KE[<-;1>'M.%Y?
M:=%XCUN>TN]/M(_Z*?\ @D!_P4Y_;H_:Y_X)5?M1^+=(\++^TM^VW^SEK%_X
M)^%IU&3PCX<G^)?_  DV@Z1J'@;5?%S7M[X)\,ZAJ/@E[OQ#>:[$FIZ=J_C+
M0O#%C:1RW_C#6#-J7A?_  9Z?\F[?MD_]EI^'O\ Z@U_7Y(_\$Q/C%\<_@/_
M ,$+_P#@K7\2_P!G?4O$'A_XBZ5\4?@1I3>+_"<]W:^*/!/A+Q3>:%X8\:^*
M]!N].EBU/3M1TSPUJ^HJNNZ:Z7GA>"XG\4QSV:Z*]]:@2]YS5HW4H6=N^CN]
MVG_PQ[)^TU\=?^"_G[!/P=^%?[:/[0G[?/A31_%GCKQU8KJ/[(OB?7/!=Q\2
M=!M]:?7;NR7Q/\%9? VG^$9O#%]8Z%<KJUAX+U":]\*V6K:1/:R:??QZA<^'
M_P!!_P#@MG_P50_;A^ TG_!*CXA_LI>.KKX?WO[3'PDL_BMXO^%6GZ%X<\2^
M'_'/B/6&^#NN:'X,U'_A(-(OM8FTN27Q5J'AQH]+U32;R[LM0ES=171AN(?Y
ME_C]8?\ !,*U_P""<WPB\9?#;XC?%?XU?\%+_BOXKT/6/CQ<^/KSQRUE\)-*
MTQ?$*>-+6V!M-&\'ZC;:UJ:^$].\/:GJ^J_$77]6TZYO-6,WAV9S8Z=^TO\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M]\,O!7PRT[7M1LX&M;2_UFQ\%:)HEMJE[:VSO;V]U?13SP0,T,4BQL5/L5%
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M/"'PYTZTNXEU[0 NCWNBZ*ZZ=_0110"=FGO9WL[V_/?SW/\ /MU7X>_MB?\
M!7[XT_L1_ _P%_P2AA_X)U_LR_L]?%"Z\=_$_4_#'POU7X5_#)[OQ3?^ KOX
MD>*EN-1^''PNT*/6'T;P68O"W@OP_8:]XJN[[6X_[:U?5;:&#4M/_P!!*BB@
M<I<UM$DKV2;>[NVV[MG@WQ__ &7?V=/VJ?"UKX,_:.^"GPW^-'AO3YKJYTBP
M^(/A72O$,F@WE[%'!=W_ (<U&\MVU/PYJ-S#%%%-J&A7NGWLD<42-.5C0#5^
M!W[._P "?V:/!H^'W[/OPA^'GP;\%F[?49_#WP[\*:1X6L+_ %.5$BEU75AI
M=K;S:QJTL4<4,NJZK+>:A+#%#"]RT<4:K[)10*[M:[MVOI]VQXOX&_9O_9W^
M&'C_ ,:?%?X:_ 7X+_#SXI?$FXU:Z^(GQ*\#?"WP/X2\?^/KK7]:'B37;GQI
MXRT#0M/\1>*;C6O$0&OZM-KFHWTFHZT!JMXTU]^_KVBBB@1\;_M ?\$\_P!A
MS]JCQ&GC/]H3]E;X)_%/QJMO9V<GC?Q)X&TC_A-KNQT]8X]/T[4?&&GPV/B3
M4],T^*(16&FZCJEU8V4+SPVUO%%<7"2^^?"3X+_"'X!^"['X<?!#X8> OA'X
M"TV62YL_"'PY\)Z)X.\/1WL\<$5UJ,FEZ#96-K<:I?);0'4-5N8YM1U"2));
MVZGE&^O3**!W=K7=NUW;[KGCOP>_9V_9^_9XT[6='^ 'P+^#OP,TGQ'>V^I>
M(=+^#WPR\%?#+3M>U&S@:UM+_6;'P5HFB6VJ7MK;.]O;W5]%//! S0Q2+&Q4
MY7PY_9:_9D^#WA7Q=X$^$G[.?P(^%O@CX@1R1>/?!OPY^$7P_P#!'A7QO%+8
M3:7+'XN\/>&?#VF:1XECDTRXGTZ1-9L[U7L)YK-@;>1XV]WHH"[[O[W_ )GP
M]X)_X)G?\$]/AWH_CSP[X1_8J_9ET_P]\3UTZ+X@:#=_!OP/KFB^*[/1]8T_
MQ%I&E:MI6OZ-JEA-H>E>(=)TOQ!IF@I;QZ-8:[IMAK%I8PZE9V]S'ZMJ/['O
M[).KP?"RUU;]EO\ 9SU2V^!BQ)\$[?4?@C\,[V#X/)!J-EK$"_"R&Y\,2Q_#
MY8=6TW3M4B7PDND"/4;"RO4 N;6"6/Z+HH"[[O[WZ=^VGH9.OZ!H7BK0]8\,
M^*-%TGQ)X;\0Z9>Z+K_A[7]-L]8T/7-'U.VDL]2TG6-)U&&XL-2TS4+2:6UO
M;"]MY[6[MI9()XI(G93\K?!#_@G]^Q'^S7XWU#XD_ 3]E?X'?";Q]J2WD4OB
M[P3\/= T;7;.UU&WBM+_ $_1+^"T\[P[I=[;1"*ZTK0&TW39U>?S+5C<W)E^
MOZ* N^[UWUW/';K]G;]GZ^^,&F_M"WWP+^#MY\?=&LI--T?XXW7PR\%7'Q@T
MK3I=%U#PY+8:;\2YM$?QI8V4GA[5=4T&2UM=;B@?1=2U#2VC-C>7$$A=?L[?
ML_7WQ@TW]H6^^!?P=O/C[HUE)INC_'&Z^&7@JX^,&E:=+HNH>');#3?B7-HC
M^-+&RD\/:KJF@R6MKK<4#Z+J6H:6T9L;RX@D]BHH"[[OMN]NV^WEMY'R]^T1
M^Q-^R/\ M:OHEQ^TI^SI\)/C/J/AJ$6OA[6_'7@W2=6\1Z)8_;5U"32]*\2F
M"/7[#1[J]47%]H]MJ4>EW\A?[;:7"R.&]>^'WPC^%GPG\ Z=\*_AC\./ _P^
M^&FDV$VEZ=X!\'>%]%\.^$+2PND9+RUC\/Z596NEF.^5Y#?[[9FOWEEDO&FD
MED9O0Z* N]KNW:^GW'DGP@^ /P(_9[T35/#7P"^"GPD^!_AS6]4_MS6= ^$'
MPW\'?#31-7UO[);V']L:II7@O1M%L;_5/L-I:67]H7<$MW]DM;>V\[R88T7P
MKP[_ ,$Y?V!O"?BKQWXU\/?L;?LU:;XE^)VDZWH'CW4(_@YX%FB\3:%XGBD@
M\4:+?Z;=:+/I2Z3XIBEEC\4:;;64%GXC620:W#?;VS]H44!=ZZO7?5Z^NNIY
M5H'P(^!_A/X4M\"/"WP:^%/AKX'-IFN:*WP:T#X>>$=&^%+:/XGU#4=6\2Z2
MWP[T[1[;P@=,\0ZIJ^K:EKE@='-KJVH:GJ-Y?Q7%S>W,DOCGP*_8(_8K_9C\
M7:KX^_9]_9=^"/PB\;ZS:W%A>^+/ _P_T#1?$":;=B 7>DZ?JL%I]LT?1[PV
MUN]WI&D2V.F74L*33VLDJ[Z^N** N]=7KOJ]?777YGB\/[-_[.]O\8[K]HFW
M^ OP7@_:!OK=;6^^.D/PM\#Q?&.\M4\/6WA%+:Z^)R:$OC:XMU\*6=GX86&;
M6WC7P]:VVBA1IL$5LLGQO_9W^!/[2WA#_A ?V@?A#\//C'X.6[BU"#P_\1/"
MFD>*+"RU""2.2+4--75+6XETR_4Q(AO=/DMKEX=]N\K0221O[)10*[[O3;4^
M=_V??V2/V8OV4M'O]"_9N^ OPK^"MAJZVBZV_P /O!NC>']3\0&QC$5F_B/7
M+2U76_$4MLF?)FUO4+^9&>617$DLC/\ 1%%% ;[A1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 5X)^U'^T7\/OV2/V>OB[^TE\4KB>#P-\'_!>J>+
MM8ALU#:CJ]Q;".UT/PUI*O\ NCK7BOQ!=Z5X:T47+PVG]JZM9_;+BVM?.GC]
M[K^>C_@Z!U;6M._X))_$ZSTMK@6.O?%GX(Z3XD$*2O&VBP^-[;7(%NFC(2*W
M'B+1M 97GS$;I;:-1Y\D) .*O)+NTC\0?A1^V'_P<G?\%7%\>?M!_L<ZCIGP
M?^!?AW7=:T3PIX<\/)\'/!?A:]U&WE>Z_P"$5T'Q+\5M)O?$WQ&\1:7IUY86
M.M>([Z_L_"%OJ,&%'AS4)KC3E_5S_@B+_P %F/CM^TW\6/BU^PM_P4%T'2O!
M7[6/P:T[Q#JMGXFF\/VGP_OO%]IX&OH],^(OAKQUX4M8[3PYHOCWPA-*NMK=
M^&+31]!USPNNJ7$6@Z8?#-QJ6O?H]_P0XTKP]I'_  2:_8=M_#,,,-A<_!R'
M5;P0V5O8"3Q#K'B7Q!JGBJ:2&VDE26:7Q+=ZJTMZ[BXU!\WMU'#<7$L$?\U7
M[6/PR\.^/?\ @ZDMOA-X;O;_ ,/P_&[X6ZKX ^)]WX3LK&+4[.+XG?L,>.O"
M?B^_2%K.XL[F_/@;4+/7)[W4[2Z5;AA?W1(MUD0-?=DYQY8I13<6EJN5]7UO
MJ>G>)OVZ?^"K/[>'_!6?]J#]G']C;]LOX3?LW_!;]ESQIK%A:V7B&'P):^'-
M?\*?#;Q[HWP\\1S:7JNN?##XDW?CWX@>*=:N=1U*ST;7YK3P1Y,+69NM*L($
M>\M:E^W#_P %:/V_O^"LO[3G[/?[%G[6GPO^ /P3_99^)E[X;MM(UZQ\(6WA
MSQ1H'@'XCV/PVU:#3-2UOX7^/-6^(/Q!\=:M#K>K:;HFJ7%EX-NK.SGM=-U"
MST^&TN=1_*K_ ()H_P#!('X*?M/_ /!4K]MO]DGQ9\3OBEX>\&_L7>//BM_P
M@GB;PZ?"?_"3^*O^%/\ [1-M\,]$_P"$M_M+P]>Z4?[4TJ)=0U7^Q[#3?^)@
M3]D^SVV(1Z__ ,$;/^"6GP@^(?\ P5\_:B^'FI_$+XD66G_\$S?VF_\ A,_A
M1?V#^&!>>/;S]G[]IZ\T/P]9_$-;C0)H&MM<@\&:=-K+>&TT.59;F]%BUNCP
M"W"FHKFV]V"M[BZVU>NK?X7ZV/ZJ?^":/B3_ (*E:U^TY^W+8_MVZ_HNK? 7
M2_&\L7[)EGIFJ_LM7]UIWA3_ (6#\0H8X[^W^!$\OCVSD_X0R'P9%L^+21ZM
MYD4B,/[936@/UJUCXI?#+P]XDT_P9K_Q&\":'XPU>2"+2O"FL>+_  _IGB34
MY;HH+:/3]"O=0@U2]DN3(@@2VM96F+H(PQ89_A\_X)7?'V[_ &6?B[_P<D?M
M$:7'93Z]\'X/B;XV\+6VI& :=>>,M)^*G[13^#+&_%Q- DEE?>*GT>TNX8W>
MYF@FDAL[>ZNW@M9O$_V"_P#@A3J7_!5/]@KXI_MT^//VA_'^H_ME_&7Q_P"/
M;WX4:OXR\31OX!O-6\'ZZ-&U&^^,6K2^%?&/CO5[OQ7KUEKD']J:#=6+^&K"
MWT:XMM*U=4GM)0AP5VY-12Y%HNKBGM?HM6_5G^A'=75K8VMS?7US;V=E9V\U
MU>7EU-';VMK:V\;37%S<W$S)%!;P1(\LTTKK'%&K.[*JDCE/!OQ%^'WQ&M;N
M^^'OCOP;X[L;":.WOKSP;XGT3Q/:V4\JNT4%W<:)?7T-O-(L;M'',Z.ZHY52
M%)'\0_\ P7&^(W[5O[)__!/C_@G-_P $WOVC/VA-'UWQ=\3-1\91_M+?'7P9
M_P )OJEMK'PL^%.O>%]&^'^D:O'>Z;IWB;QSI=CHWCN*_P#%Z/:6NN>*]5^%
MVBW<]F\VN7,4OPQ\'?C+^PM_P3T_X*;_ +"OC7_@E-^U[\4/CE\&OB=XC\(_
M"7]JWPQ\1]$\?^!D-GXF\3:3X&U;4M9'B[X8_!_0/$&CZEH_BVY\<>$]._L[
M68O!7C?P9-J-UJUA8WVCV\ "IWC>_P#-:R;34;[OI>VFA_HN>-/B5\.?AO!8
MW7Q$\?\ @GP%;:I--;Z9<^-/%6A>%H-1GMD22X@L9M<O[&.[F@CDCDFCMVD>
M))$9U564GI-)U?2=?TRQUK0M4T[6M&U2VBO=,U;2;VVU+3-1LYU#P7=C?V<L
MUK=VTR$/%/;RR12*0R.0<U_G ?\ !1[Q;\ XO^"T_P"UY:_\%=?!_P"U;XH^
M%#W,>A? AO@MXAT#0[[P;\/)8M+@^''B?0]"\76EEI?B'P2_AR*[O+D>&=:L
M4'C ^([O5M-\6Z_+JEM%_2I_P;??#CX'?#C]GGXUVG[-/[=]W^UO\&=;^(]G
MK>D?"_7OAIJ?PT\5_LW:O=#78IM-U[2]<\3:CJEQ?_$#1K?1KS5;^R\.>'_!
MNJZWX7U'4?"!U!9=9OKH%*'+%2N]4GM[NO9WW76Z7D?T>5P5U\5?A?9>,H/A
MU>?$CP%:?$&Y:!+;P+=>,/#UOXRN'NK3[?;+!X8EU%-;E:XL?],@6.Q8RVG^
MD1AH?GKX"_X+(?M8>+_V*_\ @G!^TM\>OAS?+IGQ+TOPYH'@OX=:F8'GET;Q
M9\3?&'A_X?6GB6T!BFM5U'PA8^(]0\7:9_:*G3YM0T*VM;F.Z$ZV=S_'5\-?
M^""MO\6?^"1'B;_@IWJ7[0OQ.N/VL;GX>?$;]JS1M*BN[;5O!]]X1^'TWB+Q
M/>:-JU]<:._Q&U7XL^)M(\,7VNV?C"U\5V]EI_BC4;/1Y="U9;>;Q%<@HQ35
MY2Y5?E6E[OS[+8_K2_X+A_MP?$7]@K]@#XD?%WX*:KH^D?&K5M;\&^!O &J:
MI:Z1K+>&9?%/B"UM-:\7P>&]82XL]8FT71([^+3EO;"_TJVUV^TBXU2ROK*.
M6QN?#?\ @A++_P %*/&GPCUSXZ_MV_M1>!_CWX#^./PT^"?Q)^ /ACPW=>%=
M2\5^ +7QIIOB?Q-XAA^([^'OAYX./A_7KSP]J/@">V\-PZWXLT^U6YOX))-'
MU/3;RTF_EV_;/UK6O^"@O_!"O]FK]O3XY^-O&&M_'_\ 9'^*GB']DB2]DN+"
M;2OB7I?B76O#&HP^-?&D]_97FNZAXMM/"5CX7T^\U*#5[;^V==CUC7-32>:^
M\F/^K/\ X(%?L'?#O]C;]AKX;?$+P/XQ\:>*=3_;&^$W[/O[1GCBR\5G0S8^
M%_$_B_X0:#K=[H7A0:1I6G7 T&UN/$-U#:_VO-J.H>3!!YMY(_F.X4THT[:<
MW.TW:^UM$^BMKYWMYGN/_!83_@I/I/\ P3$_9&U7XS6.D:/XL^+OC+Q!:_#K
MX'^"M=>[;1M7\<:C8WVJ7&M^)8-,N;/5)/"/A#0]-U#6M:6RN]/?4;Q=&\,I
MJVD7GB.SU"#^6'Q%^TW_ ,'17@CX!K_P4D\1>+;NR^!$^FV/Q#O_  %=>"O@
M/+#I7PKO7MKBS\1:I\'1X8_X3'1_ <^FFVEN-82Z@\=V/AZX?Q9J5_96,EUX
MD'TQ_P '>=X;CQ9_P3-\->()/L?P_P!2\1?M$WFNS-JTEM:WAAU+]G2PU&2]
MM42+[%_86BZA<O:ZL;EY/+UW48XDM?LTDES_ &5>*=%\ ?\ " >(_#OC;2?!
M_P#PJW_A#]7T7Q=H7BFPT7_A /\ A /[%N+'7M)\1Z9JT7_"._\ "'_\([]K
ML]7L-3@_L7^Q?M%O>Q?8?,2@$U",7RJ3DW>ZOHG:R['PY_P2R_;XT3_@I%^Q
MO\/_ -I2ST.T\)^*[J_UGP/\4_!UA</=:?X6^)?A-[9-=L=+FFN+JZ.BZK87
M^C>*= COYY-1@T'Q!IL&H/)>1S2/]J:9\5_A;K7BV]\ Z-\2O &K>.M-DOHM
M1\%Z9XQ\.W_BVPETQMNI17OARUU&76+633V^6^2>SC:T;B<1FOPK_P""]_[6
M-U^P[_P2L.J?LCW'A[P"OQT^(?@SX#>!/%WPABT?1M)\'>&O&GA;QOXXU[Q'
MX'NO"LUCINFW&I^$OA[JWA[2==T-9I].EU^'4]*:VO;:UU*Q_G,_:&_X(+R?
MLC_\$K/ 7_!2GP-^T+\4++]K#P5X<^$7QX\=:;::AI^@>%M&TGXDZMX86VT[
MX>W^G:78>.=%\>_#ZY\9:/?:AXIU+QA?6WB)]%UO^S=#T6ZO-.B0$H*6K?*I
M2:BK7U\WI9*Z1_HB.Z1JSNRHB*SN[L%5$4$LS,2 JJ 2S$@  DG%<-X-^*7P
MR^(LNHP?#[XC>!/'4VD>5_:T/@WQ?X?\3RZ9Y[2)#_:,>B:A?/9><\4JQ?:1
M%YC1R*F2C ?PL?\ !2O_ (*6_M"?MO?\$^_^"2?[/'@SQFOAGQI_P4 LKS2/
MVA->LWO/#EKXQ\0^!/BM9?LZV>E:PEC;!K?P3XK^*&G^+/%_BK2]/!L[HZ+H
M\%O:RZ./LMSP'_!2#_@F7K?_  ;[:C^R/^W?^Q5^T%\5-?UBV^)-G\-OB%'X
M^31;>UU?Q9/X>U'Q>=*2+PAI>AVDOPO^(NA>$?%VD:_\/_$;Z[J%I:VEO)#X
MGUB9FN=+!JGLG*TFVHJUT^5M:OI=IV/W3_;L_;\_:V^#7_!>#_@G_P#L9?#;
MXL_\(Y^S7\;OAA\,O$7Q/^&__""?#36/^$GUCQ#\3OC_ .'M8O/^$PU[P;JG
MCW1?MFC^"?#%G]G\/>*=)M;?^S/M%K!!=7NH3W?]#7C+XD?#OX=1:=/\0?'O
M@OP+#J\\MKI,WC+Q3H?AB+4[J!8WFMM.DUN^L4O9X4EB:6&V,LD:R1LZ@.I/
M\>'[>_C*R^(O_!R#_P $<?B#IMM/9:=XZ_9F_9S\96%G=%&NK2R\3_$[]IS6
M[6VN6C_=M/!!?1Q3%/D,B,5^7%?E9\;?B_\ L._M_P#_  5=_;<\8?\ !5O]
MJ_XG?!'X$_"?Q+XZ^$'[-OA_X<^'?'/BN[N]-\$>,-6\!^'(-+;PI\,OB]I_
MA33;72]#N/B'XIM9=$LX_$WCCQ/YT.J75E%J=K= ^3F4>EH7=E=M\S6W5_HC
M_1ZO?$_AK3=*M==U'Q#H>GZ)?+;/9:Q>ZM86NE7B7D)N+-K74)[B.TN%NH 9
M[9HIG$\(,L1=!NJS)K6C0Z2->FU;3(M#-I%J UF2_M8])-A.B2P7HU%I19FT
MFCDCDBN1-Y,B2(Z.592?\^3_ ()ZR:W^V]_P2R_X*Y?\$X[?XA7GQH\-_LP6
M>C_'W]C3QCJL&LVNKZAHG@O7O%FO)I?A?1?$L2Z[X4T'Q9;_  QT*'0O#%SI
MUJ^AS?%KQ1I^H)HTUT-NCXT_X*+G4?\ @UO\!_!Y/$*GXF:E\<8_V*=5BM[E
M'U5? _@G6'^.,-P]O(R2V>CQ?"Z/P1\/[J6/[4ERFI>1%L%S<KIX+V;O:^O,
MH[=&KI_=?3HUN?Z!FE:OI.NV4>I:)JFG:QITS2)%?Z5>VVH64KPNT4JQW5I+
M- [12*T<BK(2CJR, P('\V/_  6*_P""DO[6O[('_!0?_@G;\ /@5XYT/PW\
M,?VA?$'@?3_BCHVI>!_"7B2\UFVUOXVZ#X*U%;+6-=TJ]U/1FF\/W]S:J^F7
M-LT4K+=1E;A%DK]</^"8G[-"?LA?L!_LJ_ ">P73M?\ !OPD\/:AXZM5B$93
MXE>-EE\=_$E6)CBDE6+QQXEUZWMY9XUN&M(;=951EV+_ #/_ /!Q-_REO_X)
M ?\ 8V_#+_UICPK0*"7.UNK3_!.S_"Y_:?7\U?B+_@I#^UCI_P#P<;^ _P#@
MG9:^-]#3]E?7?"EYJNI>"V\$>%'UN:]A_9#\9_%N.1/&CZ6?%,*CQQH]AJ)C
MBU-4-M$VG%392R0M_2I7\7_B_P#Y7&/A9_V(>H_^N^/B/2[?UT%!)\UU>T)-
M>J6C/[0*_@;\&?M]_P#!PW^V+^V7^V-\!?V)OVA-%UK3_P!G_P"+/Q1LX_#F
MM?#C]CSP[%X=\ :1\5/$/@WPO:P:UX^^%4=YK<EI!8VEBTESJ6HZM,L7VN_G
MGE>6=_[Y*_S0OV2_V[/VHOV$?^"D'_!2GQC^RY^ROJO[4OB+QU\9OC'X8\2Z
M)IOASXA^)4\):59?'?QAJEEK%S:_#O3;^^A6]OHQ:(]^]M;2".6.)VF.8V53
M5^?2+:2MS6MOYZ;'[Q_\$A_^"M7_  4'U?\ X*"^+/\ @F-_P5%T32O^%TR>
M'_$%SX5UM_#'@3PGXQT;QKX3\(K\1Y_#VK)\+8K3X;>+/"OBOX91:IXN\/\
MB;PQ:",IIUG<6-_K>D:]'/I?];5?Q;_\$D_V6/\ @H?^V%_P5OUW_@K7^W+\
M%?$O[.FG^$?#OB3_ (17PWXH\#^(/AD_B/7/$'PKU#X&^%O"/@_P)XTSXR7P
M?X7^'NK:OK6I^+M99O[4UN#1Y+>[U>76]1FTW^TB@FI925K+174=E+K8****
M" HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MSQ5KT]SXLC\*RR6OB:TU75]1,\N@WFHW6F6_Z4_\$*/^"<G[8GBG]K[XK?\
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M_"'Q!X+\/W'A[Q7IT]_<7FO^"_B)H7BO2&\%^(/%-SJM]-<7=G:6.G?Z)5%
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M.Z1\6K/Q;;^%].\)ZI87,\6H7MDGB"X_T/Z* C/E5G%25^97OHUUT_(_C/\
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MFVS:IHW]^]% *HU:Z3:NXR=[KFNWIL]6VNQ_)C^W5^RE\:9/^#@G_@ECX_\
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MPJ\1W7B7]FBY^$WB.VD\2_#G0_*O+C0HO%.JEX=-UQ)+/6]/BMK]2L=S;/\
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M>W2W+L\]SY^N_";6'N+BZ=KB2^-V69D"$_U<_M??M^_\%N?BK^W%\;OV8/\
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M_P $^?\ LR#]E#_U0W@&OM^@S>C:[-K[FPHHHH$%%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M\/\ @J3XF;O'<ND%M?&D320ZZ;M(A\&YM;U(JH.F1S6NQFZ[_@D'^U;\&/\
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M^V_^$T_X61_PL/\ X^/WG]F_\)9_9'\'V#9\M >TC=NSUG&7391L^N]SN_\
M@F5_RC<_X)\_]F0?LH?^J&\ U]OUP_PR^&_@OX.?#;X>_"+X<:-_PCGP\^%?
M@?PG\-_ 7A[^T=5U?^P?!?@?0;#PQX6T;^UM>OM4US5/[+T/2[&Q_M'6=3U'
M5;WR/M.HWUW>2S7$G<4&3U;?=M_>V_U"BBB@04444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !117Y@?\ !9[]H3XI?LL?\$Q?VL_C?\%M
M0N]%^)OACP?X4T+PQX@TX-_:?AB3XC_$[P/\,M5\5Z5(D4[6VK>%=#\8ZGXA
MTJ^\O;8:AIEM>L\2P-*@-*[2[M+[S]'SXL\*C7AX5/B7P^/$[*S+X<.LZ=_;
MS*EHM^[#1_M/]H%5L72\8BWPMHZW!(A8.>@K_-O_ &4/^")7@7]O+]A7Q#^U
ME\#OVYW^*?[=MMX8\7?$B_\ V>+1M%F\467CSPSJUY>6/@7Q-JFM>+H?'MGX
MO\6VNGV_]@>/M6M]*\.3^(M?TBZ6XGT*"76[G^P'_@EG\2_VG_@-_P $V8=?
M_P""J]QJOPE\<_L]7OC32O%?Q$^,?BS0]9U?6?A+H,6F:SX2\:>*O%6DZ_XD
M36]0BM-:F\%Q75U>2^)]?O?#=LMU;:GKFH"]U4*E!+:5VG9JS3OY+JO,_8^B
MOP9^'/\ P<G?\$G_ (E?$W1OAE8?&7QIX9F\0Z\/#NB^-O&WPL\7>'/ -W?7
M%X+'2IKO6Y[6:^\/Z;K$[PFWU3Q/I&B6.FPSI/XCGT2*.Y>#[G_:=_X*>?L8
M_L<_&WX8_L__ +1?Q4;X<>/_ (M:'!XF\*2ZIX<U^3PA#X?GUG5-"?6?$GC6
MWL)/#/A;3K2^T;46OKK7-1LHK.TMS>3LD#*Y!.,D[.+OO:SV/O\ HK\AOV6/
M^"YW_!.']LCX^V_[-WP2^,&N7_Q(UE=4/@E?%7@#Q9X,T'XARZ+97.J:C9^$
M=5\0:?9M)J,6EV5YJ-OIFO6NA:AJ%K:S_P!FVUY-&T(_7F@336C33\] HK_.
M'TS_ ()K:%_P5+_X+O\ _!3#]G[Q#\6=7^#EEX/\6?M!_&.+Q/HWA*S\975]
M=>'_ (U_#[P2F@R:7?:[X>B@M[J+XA3Z@]^M[+)%)I<5N+5UNGE@]S\*>"OV
MI/\ @VU_X*3?LR?#*^_:!U/XS?L;_M0:GI.E>([(:;J/AWPQK/AG4O&%MX3\
M77=U\-;_ ,4:[IOAGXG?"J]\1:-XRTOQ%H.NO%K&GZK!IMQJ7]GZ[XH\.PAI
M[-;*7O<JERV:NK7LG>U['^@+17\R_P 0?A7^RO<_\'+/P,^*6I?M8ZUIO[4=
MA\+-7M- _923]G?Q3?:+X@TE_P!E_P",.DS:O+^T)'XTA\+Z-)!X3O=:\7#3
M9_!EU++/HD?AP3K=ZK#>VWZ ?MF_\%M_^">G["'Q9@^!WQU^*VM/\48K33=0
M\2^%?A_X-UOQS=>!+'6;:WO])E\:W&E1BST>[U'2[JWUBVT..XN_$3:/<66J
M/I"6.IZ5/?!'*]$KMM7M9^?WKSV/UHHKY[^"O[5G[//[0WP%TW]IWX1_%;PI
MXH^!>H>']6\33?$)KTZ+I.@:7X>MY[GQ,?%T>NQZ;>^#[WPO%:W3>)M-\36N
MEWV@BVF;4[>V1-Q_+'2?^#CS_@DQJ_C+QYX/C_:!UBR7P+H_BG64\5:C\.?&
M5IX/\:Q>$+6>^U*Q\":L=,>?6]4OK2TNY/#=C=6&F2>*IH(['PX=3U'4-*M+
M\$HR=[)NV^CT]3]TJ*^,_A!_P4!_9/\ C7^RE>?MM^%?BI8:-^S/IL'BFZU7
MXE>/=.U7P'8Z7!X.URZ\.:T]_8>)K33]4BD_MNU;3-,MEM'N];OI[*STB"]N
M[ZT@F^#/@?\ \'$7_!+#X]_%W2/@SX7^-^O^&?$/B?7(_#G@_7_B/\//%/@G
MP3XJUF[U!=/TFSL_$NJ6GD:&VMR/$^EOXSA\+QR&:&SN7M=3FCL& 49.]HO3
M?1Z>I^T^G^'?#^D7FHZCI6A:/IFH:O,UQJU]I^F65E>:I.TLL[3ZC=6T$4][
M,T\\TS27+RN99I9"Q>1R=BBB@1#<7$%I!/=74\-M:VT,EQ<W-Q(D,%O!"C23
M3SS2,L<4,4:M)))(RI&BLS,%!-9^BZ_H7B2S;4/#NM:3KU@L\MJU]HNI6>J6
M:W5N0)[9KFQFGA$\)91+"7\R,L ZKD5_$I_P5(\>?M(_\%AO^"MMK_P2+^"?
MQ*N?AE^SI\%&%S\6=7M$OIM'U#6-!\-:?XD^)7CWQAI>FW=I/XL;PC-K5C\,
M_ 'A+4;FST<>-'>[N;[3(?$$^L:;PGBC_@CW_P %"_\ @C;^UY^S=\9/^":G
MB3XO_M9^#O'&N6]C\4_!FB>'!X2M+C3?#-YIL^M>"/C.EMXF7P)=>!O&FDZG
MJ<GA+Q1XAU'0#X:UN"[-O)::OIFFZ[?AIR*RO)*35TFM+=+O9-]#^[RBOSJ_
M;G_X*H?L:_\ !.G3_!+_ +4'C[5/#7BGXAVTU_X4^'/AGP[>^,_'E[I=G)';
MZEK%UIF@M<Z9I>CZ==R?87U35-8L['4;Z&ZM-"GU:>SNTA9^PA_P56_8L_X*
M.-XOT[]F7XCZCJ_B[P';0ZGXI\ >,/#.J^#O&>GZ!=7,=C:^);?3=2C:SUCP
M_+?316,^H:)J.HC2[V>SM=9CTV;4=-2\".5VYK.W>VA^C%%?PF?\$+='\'^(
M?V&_^#@'0/B%XRN/ASX!USP1\0='\<?$*U\,WGC6Z\">#]3^$'[1UEXE\96W
M@W3[_2[_ ,6W'AC19[W6X?#-CJ>G7FO26*Z5;7]G-=I<1GC7]HO]F;]AW_@W
M2\9?!']F7]K?QC\8=?\ VE_B5\1_!?P9^*$/P.\;_ ^_\07-K\2_A)-\>O"=
MUH6H:_XMG\+0:?\ "G6=>LHM;U3Q%:V_B)=2EL],B%T/(=)W1?L];)MOFC'9
MVU5[WV5NW7<_N7T7Q/X:\2"[/AWQ#H>OBPF^SWQT75K#5193[I4\B[-C<3BV
MFWP3)Y<VQ]T,J[<QN!N5_&O_ ,&S/AG_ ()U_![X*?'#]JSP=\>?'0^-/@'X
M'>#[3]M@?%.VTKPQ\'O@YIOB7Q-XV\5Z$_@K6K[P-X?OI[*33_AQ<QZ]<?\
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MTJWUD^$M2CU#2?$K:5J>DZK:67R=_P %^/AW^R3\7/B[_P $LO$?QY_:^O\
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M "U/Z0**_P W[XK?\$B/VR?AS_P3^^+'_!73]I?]H[XU?"C]L_P5\01XIO?
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M([>QAO(FM+BXTF6*8/'YBC>^._\ P09_X*W_ /#?/[5?[8W['/[7'P ^ /\
MPO[XA_$75=+U72OC!\=?!/Q#_P"%>>-O%UAXK7PMXI;PI\!]:L(_,O\ 1="O
MM2TVQUW5=/\ [0TJSEBO+C[/%+7T;^P!_P &_G[1/A#]L/PK^W)_P4X_:HL/
MVH?B]\+]3TW7_AOHFA^+?B)\1[1_%/AZ2:7P;KWBGQ]\4M \+:\-,\!WDB:W
MX3\&:%X=LM.L?$-OIU[_ &J-/T^?2-473^O,TO%-3YD[02Y5>]^6W:W4\?\
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MBOPK+?6.LK R3)IWB6/5["VNM0T73/-^<+'_ ((*_P#!93]IU/@_^S#^W/\
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MX \8PZK\4]7\3:)X373/"EUJ$^HP2WWA+PAXWUA;^9+N,642:$]O(RN)[JV
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M;2DI14I.6][J.NBLGJ^I^NW_  7=\$^#/#W_  2C_P""A'BO0/"/AC0_%/Q
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MT^'Q1X;TGQ+/J'B'PM<:3KVFWOA_Q+X2UG6_$5UI$[:-?)K]Y_;4VGZ/^[%
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M,?B6XTWQR_Q"L?MNN7GASPAXDT+PEXZ\;:]K.L_%OX8::^F/XAUD0Z%X-\&
M>,[O2XU>PDU6[6\EL_ZW*"G%QM>VJO9.[MTOVN%%%%!(445_+)_P73_X+R_'
M#_@FK^T)\+?V??V:?!'P.\;^(-3^%[_$CXIW?QA\/>/?$B:./$7B"^T?P/HV
M@KX(^)7P[&G7HL_#>OZOKB:H=8>YLM7\-RV8TY4N#?A48N3LM_\ (_J;HKQ#
M]FCXY>&OVF?V>O@I^T)X0,8\/?&7X8^#/B+I]LDHF;3#XIT*RU2]T2Y<8(O]
M!O[BZT748F D@O["YAD59(V ]OH)"BBB@ HHHH **** "BOP3_8[_P""I/[0
M/[0G_!9#]M;_ ()Y^,_!_P '=,^"W[.'P]^('BSP/XG\,>'_ !K9?%#5=1\*
M?$'X*^$].A\5ZUJOQ"UKPI?64VG?$?7)KV/2/!6A3R7MKI4D%S;007EM??M%
M\9O&.I_#KX/_ !7^(.B06%UK/@7X:^.O&.D6VJQ7$^F7.I^&/"^J:W80:C#:
M75C=36$UU8Q1WD5M>V=Q);M(D-U;R%94!N+32>[2?R>QZ517\A__  18_P"#
MA#]IW_@H3^VI;?LR?M&_#W]G/PAX=\3_  K\>^(?!>H_"+PM\2O#OB6Y\>^$
M'T/78K"^NO&GQ;^(&F76AR>"[;QK=7-E:Z1::BU_::;=1ZI#:6EY9WW&?\%?
MO^#C3]J;]A7]NGXD_LL_LZ_#K]FKQ?X0^%_AWX?)XAUGXJ>$?BAX@\1MXU\6
M>#]*\<:I90:CX/\ C#X$T4Z9I^D^)-"M%MDT::ZM=2BU."[OY9D:VM OV<N;
MELKVOOI;U/[(Z*YKP7K-UXC\'>$_$-]';Q7NO>&=!UF\BM4D2UCNM4TNUOKB
M.V2:6>5+=)9W6%)9YI%C"AY9&!<]+09A117R[^VC^UG\.?V&?V8OBQ^U5\6+
M#Q'JW@7X3:5HMYJ>D>$;*VO_ !'K&H^*/%>@^!O"^CZ7!>W=A9)-JWBOQ/HF
MG2WM]>6UEIUO<S:C>2K;6LM )7=EN]$?45%?BMK/_!1C]I[XH_\ !'!/^"AO
M[*7[.5MXX_:+\8:=HVN_#;]G>T\+?$'XV1W6G7O[2=C\+M6L9?#WPWNO"?CK
MQ?>Z'\,_[9\4ZC>Z#)HT%IJ&F7.MW-E'X?L+K3V^_P#]A_XJ?&_XW?LF_ SX
MK_M)?#C_ (5%\=/''@J'6OB7\-?^$0\7> ?^$/\ $3ZCJ%O)I/\ PAWCW4=6
M\8>']MI;VL_V#7]1N[Y?/\UI3%)&J@W%I7=MW&U];KR[>9]54444""BBB@ H
MHHH ***_GW_X+B_\%7/VB/\ @F?XQ_8B\/? GP9\%_%EE^TIXF^+.C>.I?BW
MX=\<:]=:3:^ ]4^"%CI$GA-_!WQ%\!Q6-Q<Q?$K76U)]8@UZ.:2TTDVL5FL%
MXE^#2<G9;Z_@K_H?T$4444""BBB@ HHHH **_*;_ (*^?\%/?#?_  2U_9GL
M_BV_@^#XC_$[Q]XI3P%\)/ -[J5WHVD:GK[:;=ZKJOB'Q)JEG97MQ!X:\*:;
M;"\U"SM!!?ZU>W6EZ':7NE_VE-K.F?C-^S%_P<#?MR>%?VK_ -G[]G__ (*=
M?L:>$OV?/"?[4T_ABW^%7C/PIX6^)7@+5M*@\>ZQ!X>\&Z[K6C>.O&/Q BU_
M1I/$$]KI'B:."?PIJ_AB+48-8U/3HK>W%G>A2A)JZ6FO57=M[+=V\C^O*BOY
ML?\ @J=_P6E_:3_9Y_; \#?\$_O^">/[.GA;]I#]J#4?#5MXP\<V7C#2?%?B
MK3=)@U+0-0\76'@_0_"?@GQ?X%U>?7K;P18#QWX@U[5/$MKHVD>'M0TE(;+4
M9[J^ETKZG_X(N?\ !6.Z_P""GGPJ^)UI\3/AYIOPB_:5_9_\2Z9X:^,/@31?
M[8M] N;;Q -67P_XH\/Z3XEFNO$GA^.;4?#WB;P]KGA36-1US4/#VJZ")+K6
M9X]:L[>V <)*/-TTZJ]GLVM[,_:>BBOST_X*@?\ !0/P?_P32_9)\5_M*>)_
M#4GCG6DU[0O 7PV\ QZI_8:^-/B)XH%_<:7I-UK1L]0_LO3-.T71_$'BC6;I
M+*ZN#H_A^_M[&"6_GM8V!)-M):MZ(_0NBOXQOA-_P<;_ +?'PH^*G[/5]_P4
M?_8B\'_!?]E[]IR[L9?A[\4/"OA'XI> =7LO"&KW.CB/QY;77CSQMXVT;QSI
M/AG3O$6@ZWXDTFRT_P )ZO/X=U.UUW3HU2]TJPU+])/^"OG_  6-^,W[&/QR
M^"'[&/[%/P-\.?M#_M>_&?2[3Q5'X=\3V?B3Q%H?A_P_JFIZMI'AS2(_"O@K
MQ!X5US6/$_B*;0/$&JS?:/%6@V7A?P[I,&MZE%?V.LV\UD%>SE=*RUN[IIK3
M?796ZG]"M%?@Y_P1D_X*]^.O^"A>J?'GX"?M+?"/1?@9^US^S=J93QYX.\-6
M_B#3/#NLZ-%KEYX6UJ>R\.>*M3U[Q)X3U[P/XKM$\.>+=!U;Q!K2K-J>BWUA
MJ4AO+_3M(^6O^"U?_!PI%^P-XY\)_ 3]CZ'X,_&7X]Z?J-W??&]/'UAXI\7>
M!OAGH8L2FD>$IG\">._ MP?B1JM_.FI7U@VN7B>&-$L/(UG25O\ Q!ITEB!R
M2<N6VOX6WO?:Q_4117QU^WO^VA\.?^"?_P"RO\3_ -J+XEV=QK>E^!+"SMO#
M_@^QO4T_5/'GC?7[V'2/"7@S3;U[34!8R:QJUS%_:.J_V?J":#H=OJVOW%C=
M6NE3PO\ R\_!G_@Y(_;Q\+?$W]G#QG^W'^Q=X ^%?[%_[4WB)M/^&_Q0\)>&
M/B;X8U]?#5UJEGIB^,M.\4>-/'WB+POXUTSPNNKZ5J^N6T/A?PG/KWAZ1]:T
M%X+>YL4F!*$I)M+1>:5W:]EW=C^TNBBB@D**** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH *_'W_@OK_RB#_;9_[$/P9_ZMSX>5^P5?C[_P %]?\ E$'^VS_V(?@S_P!6
MY\/*3V94?BC_ (E^:/Y-OV9O^#C+PQ^S3_P3$\(?L+>#OV9/$7C+XL^'_A5\
M0?A=8^.M?\6:.G@&2_\ B#K7C.]AUN;PK;:-J&M:Y!I<?BN"(^&Y)[%=:FMI
M+>34[.&8;O5_V>_V>OVD/V'_ /@VF_;S^.&O7?Q(^!/Q,^.7Q4^ 7CCX>0Z?
MJ.O_  _\?>'?A[IWQV^ _@G3_$(ELGTCQ+X=N?'*:AXLC\AIH#JO@R72+K:^
MGZTRS?TJ?\$!O"OAB+_@D[^Q3XDB\.:#'XBD\!^-?,UZ/1]/36I-_P 5OB%;
M/OU1;<7S[[8"W;=.=T $1S&-M8/_  <>?\H8_P!LG_NWG_UJOX&TT:<RYN51
MM>HN9MWO:3[JR7D?AI_P3$^!7[9OPW^"G@G_ (+F_M0?M>?$7XE_"_X5?LT_
M'CQ;IW[.VJ>.OB5<ZYXD\-?#'P+XK^'/PMLO$%U'K<_AK7=.\1ZEHTWBF\T_
M4[:-A?2:#XKUR^U;7+_6H[#YE_9K_8G_ ."K/_!8/X$_&G_@IC>_MZ?$/X?_
M !%M/%/C&+X#?"K0-1^(6EZ=XQO/ "1ZI=:+X(N?!7C;1K#X-^&K'6KJZ\*^
M!8=&\,>+=4U+Q/I6IW.MP:>;A?$FK?T:?L(? 6;]J/\ X-Y?A7^SM:7MMINI
M_&;]BSQS\/\ 0M3O0#9:9XE\0Q>,++PSJ=\/*F8V6G>('TV]O!%'YYMH)1 \
M<WER)_-Q^PE_P6W\=?\ !(?]DKXV?\$]OCG^S+\2K3]I/X7^+?B8GP=FG?3]
M(TCP_P"(O&@DG2S^(>F:W+'J9TG0_&,E[XJT?6?"-MKMCXVT35;:SLXM-B2/
MQ%J84FWS\J3DI))66D$WT]=WO8_1+]C_ .,O[4?_  6W_P"",OQE\$P?%_XB
M>$?VZ?V2_&P7P'\5/ 'C+7_A]K?Q<?3?"O\ PD/@S2?&^J>%=4T47M[X_P!(
MN?%/P^UE9Q#IBZ_HOA/QY?\ GZ@+Y%_(WX&_MN?\%*/^"IVJ?L'?\$K_  M\
M1OBS\(?%'P@\2^*;'XY_&[PYXP\;^'_B1K?@WPO<264GBKXIZA;WMAKR7_P>
M^'D.M>'(-+UC6+>/QWX[U32;7Q!CQ%-I5S%^@W[!7B3QO_P0N_X(H?'3]J7X
MPZ++X*_:5_;$\=6UM^SA\+/$EC;6/BFW=?"4VA_#;Q%XHT#4X;758(=&6X\:
M?%+5]'O1-!%X4C\,V4L>GZUXHFLS^2?PP^&/[;'_  2(NOV"/^"QGB=]5\0^
M'_VE?$_B#6?B'X>NOMO]N:EX1\<74^NS^&/'^I7LOV>XU7X]_#"75_B%X+O[
MA)CI6KZ9;:Y>I)J.E10@&DKSLH_$_9W7VN76VFJ^]7/WC_:G\5?%/_@F7_P7
ML_8,FM?C%\9;W]C[]H_PA\-_A6_@[Q[\6O'GBOP+;ZS)X>3]F[7+G5;+Q'KM
MUITNL:!JC_#'XM^(_$EQ$UQ<:]K]]KFH7#27VHJ_?Z%\6_C!^V=_P<Y^(_AS
MX-^*_P 4-*_9P_8B^'1G\:^"?#/CWQ%HW@+Q/K/P_P##=M9W<7B'PO87\'AS
M4KV/X\_%JVTG48=1L-1U#5=&\'21-)#;6J#2^K_X.0/!?A;]KG_@EU\"/V^?
M@#K/]OQ? SQI\/OC9X(\;:,J27T7PE^,L.D>'-6FMEB)O=-U*R\93_"K6-7B
MWM+H;^%]3M]6LHY;*6YTW)_X-7OA3XI\7?#/]LC_ (*!_%-O[4^)O[6OQ_U>
MQD\07(<7.J6GAJ\U+QIXXU^TC*%(;3Q3\2/B-K%M>?Z5/)->>#HT>.!;6.6[
M"-.3GTNHN%K+=O?;?EOYG]6FKZ59:[I.J:)J4;3:=K&G7NE7\*2/"\MEJ%M+
M:74:RQ,LD3/!-(JR1LKH2&1@P!K_ #T;7X6?\%K/^#>OXI?%N#]G7X>ZQ\:/
MV2O$7B]O$2ZU'\.[KXP_"7QCH=E<3VGAKQ+X\MO!7]G>.?A+XR3P]:0Z'XI>
M/5?!UA<7;16\-]K]A#X6U&O] 3XI>$=3\?\ PQ^(W@31?%&M>"-9\;>!/%_A
M'2?&GAO4M0T?Q%X0U/Q)X?U#1K#Q1H.KZ1=6.K:5K6@75[%JNEZEIE[9ZA8W
MUI!=65U;W,44R?P;_L8?\%N?VI?^"._B/X^_L>?\%(OA/\<OCUXOT[XDZIXO
MT'Q9XJ^)&M:CX^LK^[M[7P_J1T_Q%\3(M1?QK\*/%P\/6OB?P9XATW4;>WBN
M;O7+^W@U9->9=*!4[VE9*6UX/JNZ]/U/UC_X(U?\%0/V$_VA= _;!^/>B_L@
M_#7]ES]KCX8_"[Q_\=OVAI/AGIEA-_PN;X;V=[<^-O%_C+1?$IT_3]:>0^,$
M@/B+PUX@2\;2=4UC0+RQUO68M0N(]+_)']EK]E[_ (*<?\%^;']HG]NC5OVY
M?%?[/]IX3^(.M>"O@9\.-)O/'4'@=?$6EZ7IGBZ+P'X:@\*>+O"%I\._!OA7
M3?$/A'2G^(,&B^-_%'B/67OM3\066J:[8ZCJ5WZS_P $3/V</BY_P4)_:U_X
M*5_MT>)OA4WP#^ '[5OP*_:*^"NAV]EI$D/@S5O$O[1NKZ(+W2-"6XM-)A\?
M:5X,T/1KW5/&^K6-E:V6H^,+W2[B?[%>7L]C#X)_P3T_X*U?$#_@@[\/_P!I
MS]@?]K/]F+Q[K7Q*\,?$CQ+X_P#A9%IMYI^BZ7+XJUKP_IGAJ:VU[4=9%C+?
M?"CQ!<^#]$\3>%O'GA*U\1W.H6.K:R]MIUU VG>0%VLY\EG+W-&U)I->\E>^
MSLGV1],_L^_\%"?CE^V)_P $(/\ @JG\$/VG=:UCQ7\=?V0?!&B^%-9\:>)W
MGN/%_B3P?XUU^\A\.P^-M1N))9-<\9>&M>\!>,M"U?7))&OM0TZ#09]9:[UB
M2]U74_+_ (@?$WXD_";_ (-/?V'_ !3\+/B#XX^&GB=_VE/&NE/XC^'_ (LU
M[P;KSZ9=_M"?M<RW>G-J_AR_TW4&L+J6UMI+BS-P;>:2W@>2-FAC*R?L@?L?
M_&?X/?\ !##_ (*[?M:?'SPKJ?@WQI^V?X2T'Q'X9T+Q#I<VCZ[)X#\(>(M3
MUFW\8G2+ZTAU'1=-\=^)/B1KMSI5M<RYU70]!T/7(8/[.O=+O+S@_P!H#_E4
M?_8=_P"SH_%O_K0/[8%)_P!?>@LKV5K>UCMM?EU\K7N?</\ P5&_;&_:[\2_
M#;_@CS_P3B_9?^+WB?X8_$S]M+X#_LZ:U\4_BK8>)=5TKQEJL7CG3_ W@SPK
M%>^.;,CQ7I&CR>(+3QCXI^(-_HFJIX@\3VEC;:7<2S:?<ZKIFN_0'[#W_!-S
M_@K-_P $VO\ @H5\.M'\$?'KQ3^U[^PCXY\+:;-^T!XH^(?C2T\)Z3H6JZC;
M:MH]XVC_  Q\8?$GQIXDB\<>%=6L-+\4:1K?@R/4K;6_"ERGA;Q#J-I<R*%^
M!_\ @K!\,_C#^SUI7_!$O_@K/\-_ %Q\0?"/[.'[-?[)/A;XEV]K'>/:Z*WP
M[30?B5X,M/%=S;VMY_87AKQY_P )CXO\*P^*%MVBTC6!:VUQ+'J.J:!#=?9_
M[+W_  6]_:\_X*>?\%+/@;\-/V'OAQKWPV_8Y\/Z#H^J_M/?\+4\#>%?%.HV
M>F:5J.KZ[XMUNX\6Z#-=#P9/XEL(M'^&OP_LH/$5[)>Z[=GQ#<Z0$:[M=+%L
MO1?D*SY%RJ/+:7/>VCN^N][6Y3YP_8UTC]IW]MK]NW_@OY^R=HO[6/Q>^'-Q
M>?$7XM>'_A-XKOO'?Q!U_3/@TGA[]M'6)H)/!.@VGB[29/#L*^&M#D\*VT'A
MJ_T46VDW0L4;[!&UH_Q%_P &YW@OQ[\)_"'[5W_!2$?&W7M+^"_[%G@3XM>)
M/B!^S5!=Z_9>'_C#JZ? 7Q?KF@:E=3V_B*#PVFKZ=<V4%GIQU3PIK%^;D6B:
M=<QSO$B?J!_P0L_Y3??\%Q?^RT_'S_UKGQW7Y=_\$*/B-INH^!OVZ_\ @C1X
MX\!>*?#?QZ_;2\+_ !R\':)K7B)[+0] ^&_BKP+\ ?B/IUYIOBO3KFX7Q*_B
M+2?$NF0SG2[/2IH8(+"_N;^7R[&2SNF-[32M:U)O1;67,]NWX^9X#X6\6_M"
M_M6_L_\ [17_  4Y^(__  68\+?!;]K?P;XI\4>+?A7^RI+^T%IG@+QSXJT#
MP);VWB*^TKP+X0D^+GAW4_!UI=I=:EI'PD^'_ASP!XB@\57FB#2@+FZ\3QW$
M?ZS?MM_\%N_VA/$W_!"C]E'XK^"?$NH_#_\ :5_:=\9^)O@?\4/B7X/O=.T+
M6=+A^"TFIV/Q$\4>%6TAX[KPSK_Q,6V\(7[R:1::0?#-GXJ\06^B'3 OAV\E
M_#KX)_%?]A7]D+]GSXW_ +./[9__  3/USXF?\%&_ ?Q!U?2/AU??$&?Q]I'
M@J\74[C2+:VT/XH:/X<^*7P_\4Z>OAN1=5O-#7PAH>JCQOIU]HZP:UI4<QU)
M_P!A?^"E?[!/Q0\;?\$+OV3OC!\/_P!D/2/V:?%WP;^)?B[XX?$K]FGX;?\
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M=0B29,/;_:/%FO>!9Q.KJ5EL84 +NC+J?';X*CX5_P#!NI^Q?XRGL5M-2_:
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M:C>V_ACQC>^*UT>U"WFKR>%(;/3X[S4WL=/N_P"4SX__ +=GQ!_X+0_L[_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M6]UN\L+6WN-5NU0!!<WTD\P4;0^.*Z6B@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M=L)-*U;Q%HTD>KZ%IM^MO>:OICI?Z?#<6K+*>N\9_%#X:?#GPA)\0OB%\1/
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M#5K2W%U=Z7X6TW4;RWO?$&HVMJRW-Q9:3#=W,-NPFDB6,AJ!'5T5Y?I?QO\
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M/A"R^(TOC?3_  /HVCZ'X@U.X\-^(++Q-H-UK<>K6XL9+W2[W?:@*Y6_NO\
MA?MO;H?M]17&^&/B+\/O&W@ZW^(G@SQWX-\7?#^[LKS4K3QUX8\3Z)K_ (.N
MM.TYITU"_M_$^E7UWHDUE8/:W27EU'?-!:M;3K/(AAD"X'@?XX_!3XFZ#K_B
MGX;?&#X6_$+PQX4DO(O%'B/P/\0/"?BS0?#<NGQW$M_'K^KZ#J]_I^CR6,5I
M=R7B:C<6S6T=M</,$6&0J$GJ-%>6>!_CI\$OB=K-YX=^&OQB^%GQ"\0:?H>F
M>)[_ $+P/\0O"7BS6;'PWK<<$VC>(;S3-!U?4+VVT/5XKJUETS5IH$L+^.Y@
M>UN)5FC+:WQ%^*OPO^#^@+XK^+7Q(\!?"[PN][!IJ>)/B+XP\/>"= ;4;H.U
MM8+K'B74=,TYKVX6*4P6HN3/,(W,<;!&P =[17Y;_P#!4G]OVY_8Q_9-TGXI
M_!G5_@YXC^*_QB\;?#OX:_ >7XC>+[*V^&]Y??$+Q!I.F7'Q$U6;3-7LK[7_
M  -X.T34QKVL7N@WOV2UBN=+N]1O(=+FD>3Z[_9]\<>.4_9I\%?$/]I#XD?
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MI/\ %WX46WA/0/'MS\3_ (>6_@7Q9?Z5I7A;QI/XU\-Q>$_$NIZ[=&QT33M
M\1R:DNCZS?ZS>JUGI5GIUY<W&HW2FWM(YI@4H ]#HKB/ 'Q-^&WQ8T.7Q/\
M"SX@^!_B7X:@U.\T6;Q#X \6:#XRT.'6-.\K^T-)EU;P[?ZE81ZG8^?!]LL'
MN!=6OG1>?$GF)G&\5?&_X+^!/%OA[P!XW^+WPO\ !OCOQ<UNGA3P5XJ\?^%/
M#WBWQ.]W/):VJ^'O#FKZM9ZQK37-S#+;6ZZ;9W)FGBDAC#2(R@ ]0HK\2_\
M@H'_ ,%!_C=\,_VR/V6_V'/V2O'O['GA/XH_%72O%_COXI>*/VI]>\2OX>\*
M:+X?D\-CP1\/K;2O!>MZ-J5IXR^*TVJ7\&@6=U<2:IJ5O'8G2+2T^VV^I/\
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M_BG0_!WAJSEF#F*.[UWQ%?:=I=O)*(Y#&DUTC.(W*@A6Q\&?\%)?V_\ P_\
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ML(I+R"-[=&D !V%%>&-^T_\ LTIXCT7P<_[0_P #$\7>)->O?"WAWPLWQ:\
MKXCU[Q/IVHW.CZAX<T70SX@&IZIKUAJ]E>:7>Z18VL^H6NHVES8SV\=S!+$G
M3_$CXT_!SX.1:)-\7?BS\,_A7#XEO7TWPY+\2/'GA;P/%X@U&.2TB>PT23Q/
MJNEKJMZDM_8Q/:V!GG62]M$,8:YA#@6/3**_,3_@F_\ MS^)_P!J;]E[XD_M
M _M"2_"KX:1^ /V@OCK\+KO5M#?4/!O@?3O!WPP\8?\ ".Z'K.O7WC?Q=XA6
MSU.YMC&VLZA+K5EI<UVZFST_3XV6"ON_1OC3\'/$?P_OOBQX>^+/PSUWX6:7
M;7U[J?Q+T;QYX6U3X?Z=9Z9&)=2N[[QE8ZK/X<M+;3XF62^GN-2CBM(V#W#Q
MJ0:!M--I]-#TRBO$&_::_9N31_&_B%OV@_@@N@?#/5K30/B/KC?%?P&NC_#_
M %V_+K8Z+XWU,Z^++PIJUZT<BVFFZ]/87ER4<0PN5;'A'[3W[1WC?3/@+X+^
M+'['OCO]E7QK)XF^+/PY\-#Q=\6_B7I$7P@U7P-K7B,Z9XS'A?QAH7COPSI>
MJ^/$LDEB\):9;>(+T7NL1M:MI&I.IMJ L_\ A_\ AC[FHKR[Q;\<?@IX \4Z
M'X&\=_&#X6^"O&WB>-9?#7@_Q;\0/"?AOQ3XAB=YXTDT/P_K.KV6K:M&\EM<
MHKV%I<*SV\Z@EHI N+?_ +2O[.6E:-IWB+5/C]\$]-\/ZOX6N?'.DZ[?_%7P
M+9Z-J?@JRU*'1KSQAIVIW&O1V5[X6M-8N;?2KGQ!;3RZ3!J5Q#8RW:74J1,"
ML>UT5Q_AKXA^ /&?@^V^(?@_QSX/\5^ +RPNM5M/'/AKQ-HNN^#[K3+'SOMN
MI6WB;2[VZT6>PM/L]Q]JO(KUK>W\B;S9$\I]N3\./C%\(_C'8:EJOPB^*?PY
M^*FEZ-?OI6KZE\./&_AGQQ8:5J<;2I)INI7GAC4]4M[&_C>"='L[J2*X5H95
M:,&-P #T:BORY_;J_P""B/AW]G[PYX%LO@)\0?@#\2?BO=_M7?LZ? SXF?#R
M_P#%=CXQ\0^"/!_Q;^)>G>!O%>IZGX2\&>-M%\2>&O$.F17Z1:->Z^C:79:M
M) FI:1J2N+1_U&H'9I)][_@%%<T/&?@\^,'^'@\6>&CX_C\-1^,Y/ PUW2SX
MPC\'S:I+H</BQ_#(NO[:7PU+K4$^CQZZUD-+DU2&73UNC=QO".4'QO\ @N?!
M.L_$L?%[X7GX<^'=4ET/Q!X_'C_PH?!.A:W!JEKH<^CZSXJ_M;^PM,U2'6KV
MRT>73[V_@NX]4N[73WA6[N(H7!'J%%?BQ\=O^"G?CK]DSX8ZCXR^.UK^S7K^
MN^,/^"E.I?LE?"FP^'OQ8T^QTS0/@%/\0;+1[;XA?%:2Y\2>+[FW^*7P[\&-
M<7GQ<\,PMX6L_#GB#4-$35]+\)V,QBG]?^%G_!1KP9J/[5?[=_PH^-?Q/_9X
M^&7P7_9W\3_LI:'\"_B#K?C72O!<GQ#@^/W[.VB?&/5FU7Q9XL\</X4\6W+:
MIJI'A$^#].T1#X<:W^TPZS<-_:DA<?*]_P"MTM/FT?J114%K=6M]:VU]8W-O
M>65Y;PW5G>6LT=Q:W5K<1K-;W-M<0L\4]O/$Z2PS1.T<L;*Z,RL"9Z!!1110
M 4444 %%%% !1110 4444 %%%% !7XW?\%V?^3#8?^SI?V-__6E?AO7[(U\T
M_M8_LK_#W]L;X2+\&OB;K'C+0O"Z>/OAI\11?^!-0T33->_MOX5^.-$\?^'K
M4W7B#P]XGT_^RKS6-!L[;68/[+%W<:9)<PV-]IUT\5Y"#3LT^S3/YAM*0VNK
M>+?^"%8CN(X[W_@L'8ZS#X5A6V")_P $]=<BG_X*!WUJ4ENY8?+<Z%>>$KJ8
M6B:1>'6&,VG2WGVW0;C]4?\ @WG_ .4:7A#_ ++Q^U+_ .K]\>5]QI^P#\!$
M_;WE_P""C 7Q;_POJ;X%CX#MI?\ :>C+\/!I U>.^_X3C^QT\.KXE?XA_P!B
MQ+X*_M*7Q?)X<'A(_9AX6&KK'K*>3> /^"5WP0^&7P._9X^ /@WXJ_M%:/X.
M_9N_:ZT[]LGPOJ5CXY\(Z?XF\9^.K#Q?XR\:3?#[XE7FE?#RPTOQ%\'M6U3Q
MMJ-OK/A/3M&T+6+_ $^PT>)O%"7-K/=79U*<DU;:]F].MG?\E;U?8^U?V@O'
MGPZ^%OP'^,_Q*^,%A-JGPE\ _"OQ]XP^*&G0:*_B-[WX>>'?"VJ:MXTMSH*!
MFUB&3PW:ZDMQI^"MU!YD3X1F-?S01?L5_M)_L6?LK2_MM?\ !(S_ (*,>.)/
MV5]%^#^I?M+>&OV0OVJ;.R^*/PAO_A>_AB;XH7_A/PCXGFOOM'@&>733J%JN
MG:=IFC:[<ZW,MKKOQ(T[4$U+7+G^JW5](TOQ!I.J:#KFG66KZ)K>G7ND:QI.
MI6T-[IVJ:7J5M+9ZAIU_9W"207=E>VDTUM=6TZ/#/!+)%(C([ _@B_\ P;M_
MLN02W?@70OVGOV]_#7[)FJ:Y<:[K/[$>B_M,Z];_ +-]^;K4(]1NO#YT!M+?
MQ"/#%]/%&U^MWX@OO%T\VZYA\8VTZV[VX$6E>[MJM.7F37:W1]G?J>!_!Z[^
M$?\ P5=_X*5?!CQO^U%\*_#7C?X<Z+_P20^"/[2/P@_9X^)VCZ;XN^'^B^-O
MVAO'N?BAXXC\-Z]!<67BZ?1EL]'\#6FM:MI9L'M;/2-2ATV"^BTS4&\?\/\
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MJ%]^T;\>/B=\0X?$O[0'Q&UVYM([/2-:O?&IT&UTBVD\'1PQ#PAI:>&)-#L
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M)M(T_0H/#UQ<>)9;&QTS3[S4=:LH7EUF2STW3[.XN;FY:WL;2!T@C_$+6O\
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M;1^'K[PM.FKK'/+<S68:P?S/]@OX!_$[X%']LZ\^)-UXF-K\=?V]?V@_C_\
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MR7-C*89I-6OH(K7^I[]C;_@G+\(?V/=6^*OC]?'7QA_:)^._QTM]#T_XN_M
M?M(^,HOB'\2_%WA_PW9&QT'P9%/%I>D:)HG@O28I)OL^BZ?I N;U#9P:]JFM
M0:+H,>E_,X_X(4?L4C]A>_\ ^"? U3XT+\#[_P".9_:!;65\5>"T^)-MXU-Y
M;O\ 8K7Q$GPZ71TT%=#MU\'JLOAJ;7U\,.]N/$']IB/58P%..SN]DW;5IJTG
MWOI&U]=#^??PI\"OBUI?Q"_X)'_LWZQ^R'X2_;G.F_L'?$S]NSQ7^SA\6_B_
MX2^"O@?QK^T'^T3\6IO$GCKQOX[O?&/A?Q?X6^(OB;X<Z3XBT718? NM>$KR
M&VTVYNVM+J71;'5+*;F_VC_@E\4/!'[&_P"V;\!OB'\*/ '[,OP@\4_\%*?V
M'/$O@']ESX8_M,_#K]H*[_9TU'XQ1WUM\5_"S7_@./1]9^&]AX@GT[PY\0/!
M/AC6_"GA&PLM*\3H/"EE?0V6IZQ??UG_ +87_!.[X._M>P?"76KCQA\6?V?_
M (N_ #^V%^!GQV_9R\81_#OXG?#>RU_3K'2];\.:??OIFKZ3J?@_7;#3-/L-
M8\.ZGI4R2:?#/;:7>:/)>W=S+X%8?\$6_P!E:U_9\U7X!7OC?]H+Q!<^,/VC
M?!?[57Q2^./BCX@Z#XG^/'Q>^,/@75XM7T?5/B#XR\1>"=5T>^TF1X5LKG2M
M(\+Z-BU>[N+2ZM=8U'4]6O4"FM&^^JL_YF[[VZK97Z7L??W[.G[,/P#_ &2?
MAX?A1^SC\,O#_P )OAXVN7WB5_"_AMM1>QDU_4[33['4-6EDU2^U&\FO;RUT
MK3XKB:6Y<R_94=LR,[O_ #?_  #_ &-?V7OVS_V;/^"O_P"TI^UKX(\*?$+X
M[ZY^U+^W%X+O?BIXVTZ.^\:_LX>&/@%;7.F_"[PM\.-3N7OM1^'$/PTTNQL?
M$,8TA[?4]9L[FTTWQ7-XBT:VL[0_U<5^.7Q^_P"")_[.7QW^*?Q<^(%M\:?V
MK_@MX/\ VD=7T[7?VHO@/\$/C&O@SX*_M"ZOIZ1I-J?CKPO<>'-8O[2_\1QP
MQVGC"?PWK&CKK]D]X1%8ZKJ-_JUPR(NU[MINVNK>CN^J>OKTUT/QK_9 \+^$
M?VCOVY_^")WQ5^/?PL^'GCWXD?$/_@F5XO\ 'WCOQ-XV\ >%=>U[QSXZ^%5S
MINA?#'XI>)[_ %;1I[G6_'&BZ/H.BZKX8\6WS3ZQHDCPW&BWUJJQ,/W(_P""
MS7P2\3_M#_L1:Q\*O!7C[X/>$/%^N_%WX)7OAGPI\>?%\?@GX7?';7-!^(FC
M:YIO[/\ X@U9K_3YKN?XGW5A'INAZ!:2FY\1:[;:;HPFTR&\FUK3/H:W_8,^
M!FE_M&?LZ_M)^')/&'A;Q!^RY\!-<_9O^%'@#0]4T9/AG8_#/6;6RL(;35-,
MU'P]J/BN\U/0M/TZSL-$N[;QC86T5M"O]H6.HRDRGN?VO/V2_A-^VQ\#?$?P
M#^,B^)[7POK>HZ!X@TOQ)X%UY_"WCWP/XQ\)ZK;ZYX5\;^!_$B6U\NC>)_#V
MJVL5U875Q8:A8RHT]EJ.GW^GW5U:3 W).47LEY7MK)Z+KHUV_(_DUU[6_AAX
M,^%G_!67X6>.OV =8_X)I?MD>)O^"8WC+7O$WP;^'&O^#;O]DGXS?#7X;ZKJ
M7AC_ (6Y\,=+\$Z'H^@VOC*T\0^(X])F.G7NO07>B3ZQ=#4[W5X/%.HW?ZH?
MM3ZC8^1_P;R6'VJ$WE]^TM\#M1LX%;<US8V'[+?B:&\NHBN5:&"75=.1V#=;
MN';D$D?7?P3_ ."1GP.^'4WQVUWXR?%_]I']L;X@?M"_!#7_ -F;QM\2/VH?
MB:OC3Q9I?[/7B.6XN-6^%'@RZT31O#4?AG0=3OY8M=U2ZM4EU.Y\30+KMI=Z
M?,QA'C7P9_X(3? 'X3?$[]G?XJZU^T]^VW\9=:_9+\4Z;JG[.6A?%[XS>'_%
M7@SX8>#M(TZ^TVS^&6D>&&^'UO8V_A.X@N-,&I3:3_8VN20>%/">F:7JFCZ)
MI4VF7P/FC?=Z:[-W?(XZ7=TKM;WT/QU\ _L%_L@?$S_@F'_P67_:4^(OPY\+
M:O\ '?0OVB?^"BWCCPE\8M5^PQ^.OAKXH^!6M>*?$_PLT3P+XHCMAK'A/2;K
MQ/8VEYK>@Z9<+<>,I?$EY9:@;V"YT:UL-;XB_"7X^_%GQU\-_P!L+Q)^Q]^S
MW_P5JL_B+_P3<_8J\,_M*?L[>(/B+X)O/VG_ -D_Q-XL^&+^+=5\5?#_ ,,>
M*O\ A*;_ ,,W/Q/U/6/$GB[PUK'AS1KCQ?XFU6'Q!/I']F6NGZAXAU3]6KK_
M (( ?LNWGB;XA/<?M"_MJ2?![XU_&#Q%\<OCY^S5'\;=)TOX%_&GQQKOC4>-
M8H_&7A7P]X%T2Z30;&;R=#EM]'U+3M=U30]&\+1W_B*34] 74[SZ$_:>_P""
M3GPN^/\ \8%^/'PX_:#_ &I?V-_B=JGPZT#X/^/-8_9*^)>G?#33OB/\,?##
MSKX>\/>)]#NO#.NZ<M[X9LIWTWPOK&E1V#:18+#;RV=^EG8"T!\Z[OYIZ>[%
M6T::U5[Q:V6FK/QR^!_P_P#V*/V@?CQ_P;S>,/AK\'(?&?PJ\3? +_@H!X6M
M8_VE/!O@7QW\5IH?V;M$^'^B^"?"?Q(URYT![;Q1-\"/B#!XRLOAC=20?9/"
MH,FJ^%H-)GU&X>3P;3?@[\(_B5\'OV1KCXB_"SX<>/KC5/\ @YC^,OPRU.?Q
MKX'\,^*IM1^&WC'Q1^T!J?B[X>W\NNZ7?O>>!_%6I>&O#FH>)/"=PTF@ZY?:
M!HEWJ=A=7&E6,D'] /B__@CQ^RWK'@/]BGP'\.?%OQ^_9VC_ &![_P 5WGP$
M\6? +XFV_@WQU';_ !#.GS?%#2?%WB76/#/BB?6M,^*-]IZZAX\2QAT:[UJ2
M]U:Q2\M-&U;4-+N(?'?_  1Z_9P\=_L\:A^SJ_Q,_:/\(:8_[7_B;]N#PM\4
M? 'Q"\,>$_C)\./CMXHU[Q'KMQJGP_\ %UC\/SIFBZ7I7_"6:]I>A+=^'-3U
MW3=/O1.NOR:U:VFKP+N',N[_ !TUF[[]I+:VQ\'?L>Z7IGA7Q'_P<7Z18Z=8
M>'-"T+XI^*K73=,M+.WT?2='T*R_9GU5=-MK&RACM[/3])M-,2W%C#;Q0V=O
M8)"(%2W5,?%7[$'P2^#/C'Q9_P &S^M^+OA'\,?%6M>(/V8?VYKK7M7\2> ?
M"NN:IK=U\)- ^'?B?X4W.KZAJ>DW5WJ5Q\,O$FM:SXA^'LU[+-)X+US5M3U;
MPVVFW]_=7$O[#_&'_@B)\ /B_P#%3QC\1YOV@_VP_ NE?&KP3X#\$_M3?#CP
M!\:5T'P=^U5;_#;PW9^$_#VM?&5?^$<N-4U/7-6T.T^P>.9M)O\ 2[#Q5#<:
MA(NGZ3>ZYXDO-<[C4_\ @CM^SW<?#7]AKX>>&_C'^U3\-M1_X)]-XHM_@7\4
MOAC\5/#_ ()^*E_H/CK^RT\=^$_'OB#2O ":1K'AOQK9Z)I>E^)+30?#WA>Z
MOM&MY](6^AT[5-8MM08<RUU>OD]/<Y>^NOX/U/YQ/V4?".@?'FY_X)I?LE?%
MRU76OV:OC+_P5%_X*I_$'XL^#=1O1;^%O'GBS]GWPO%XU^#OA#Q78.AM]?T?
M5?$NJZH)_#]_(=/UB**:PDMKF\N+'RO7/^"A_P */AM^R9\3?^"Q'[.O[,_A
MS1_AY\!?BS_P2G^&_P"TU\0?A3X+33]+^'?@;X]:?^T<WPSL&\,>#;'98>"6
M\1?#QUUJZT?P]9:9I4R3P3S6:VZ:%';_ +NS_P#!&G]E2;]FZ+]FZ/Q9\=].
MM]#_ &C?%/[5?PW^-.A>.O#OASX]_![XS>+==GUR_P!?^&7CCP_X'TS2=(M+
M4W5UIMGINK^%M>A>PFBFU)M1U?3M)U6P@\+_ /!&[]G?2_@1^U1\'_&OQ6_:
M1^+OC?\ ;2T'PUX<_:&_:7^)WQ#T/Q5\?_$VC^#X(8/"VCZ'X@U/P;<^$_#N
M@^&46X@T/2QX.U$QV5REMJ]WK3:=I,]B!SJ][NU]K/7WHOFWM=)>NW0_.W5/
MV*/V=OV-/VI?^""^N_ 7X9>&/AM\0_$'B'XC_#CXH^/O!]O-I'B+XN:?J'[+
M&M:[X@O/B7J<,D=SX[U'5?$<=SJW]J>)_P"T-0M/MD]G9S6M@4M(_P"H&OE+
MXD_L??#3XI>/OV2/B+X@USQU9ZW^QEXGUKQ9\+[71]3T"WTK7M1UWX=WOPSN
MX?'L%[X9U"[U2RCT&_FN[:/P]?>%ITU=8YY;F:S#6#^:_L'_  "^)GP(E_;3
MN?B+=^)Y;'XX_M[_ +0/Q]^&6F>+_&FG>-]7T+X9^-[/P-I.E6EM>:.[:9H'
MAC5O$/A;Q/XM\#>"X0FH^$/ _B3P[H7B=!XOM/$!(0W=)MZI=>MY/\D_T/S
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MZ%XD:U\7>&3=>*?$FI_$/5[M[#5O[/T'1- TCPQXFNK"Y_2OX5Z]H[_\$O\
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MEQ9VWV35'CUF(Z?+\;?YBYUIJ]XW6NR<_/6_,M/O/SJ^ /[*G[.G[?G[??\
MP5[\0?ME_"WPA\=/$GPV^)OPQ_9I^''A?XC:8-87X0_!&'X40ZUIFI?#A)XX
MI?!6L>/M8U;6?$:^,?#T]IXHM=3L[F^T75M--]?2ZA^5/[.'P6\+_ML7'_!
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M;3?#]AK]_K&GQ2^&-734?$YAU;Q(FN6UGI^FV7LWQU_X)W?L]_M%?LG?#?\
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MDEU14FMY;6T#63']?F$IK6S>M[:-6O).UVWT72R[+4_F%_8U^&GPS^-6F?\
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M_;&_8Q\&^-OAQX/_ &M/!_BCX(_\%G/V%?B1X&\4ZY\6O&GB3XG>(H_#-_\
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M>N_"C]I']L']G#QE\%?V8_AU^Q[?^._@5\4_#'A'Q5\7?@1\,-%M=&\+:/\
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MV<_@%\'/^"@7_!13]I!OVV_"&A_'X?!__@G[^P)H'PB\&?%:Q'B'1H=*^/\
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M?Q?^(ND^+?CA<^ H=*NM(TGPQX+U;4/"D_A;PKHN@P7DL^EV#^%M71[I+/\
MM9]5M=,TFTL ;FN[W[/7WHN^]NG9N^SLS\COC;_P2]^'W@+]FK_@FO=?L;_!
MW]E;XC?%F>;P9\:?B/\ L?\ [1GCK3] M/\ @H/XG\/?L]7 UG79=-\:^(X]
M.\=^.OAC#XL\6^/#IE[)%X1T>R\4:UJGB&";0K3^P=5^._BUXM^!DG['?[0G
MPP^'O[,'Q0_8=^,_@S_@J#^P3XT_:0_8]\7ZWH&L?#?X2>+/B?<6\OA36O@@
MGAG0_#FDV'@7X@>'O"4FIQQ0:/81W,>F:=>:7;)X;GT%G_J:_:9_X)O_  <_
M::^%'[/_ ,.]3\>_&CX5^+OV6+C0]0^ /QX^#WC.P\'?&GX?ZIH?A.#P;)<V
MWB(^'[_1[NT\2:/:64?B[2SH$%GK)LX!;KIHCC\OYWTK_@B7^S.OP?\ %_PU
M\9?%G]IKXE>-_BA\>?A%^T9\8/VAO'GQ'\/^)?C?\3_'WP0G:7X>:1X@U[6_
M!&I^'K;P%X=AGO=)TGPYI?AJTU&PT.[?3XO$+2Q0WB *:TNV];]>[?>S5O*Z
M>E['YE_#7]D3]F+]LOPU_P %[_CU^UQX+\*>//C=X4_:T_:V^#7A_P ?^,5B
MN?$GP)^#G[/'PTT*?X#Z]\.K^^GU#4? 4UAI;?VW<^(]':QM?$46CIHE]97.
MCZ3?Z7/\L_L*?LQ_![]JCXO_ /!#?P;\=/!'ASXE?#_P7_P3%^.'Q*N? 7C'
M2X=<\)>)M7T7XQ2>']%MO$>A7F_3=;T[3K_Q3'KJZ9JUM>Z9<WNE6@N[.X10
MM=U_P44\-_ K6OVC_P!N'P_\4OV9_P#@I!\+OV@/B+='0? OPM_8V\0_%R__
M &9O^"F6AR>#K?1_@QXL^,EEX4\'/H*:K9:W/%H_CW1-)UC3$L9= N9IK_Q!
MXJN->LKG]Q?^"?\ _P $YM"^!?@']@OXJ_$&X\5Z'^T)^SE^P_9?LVZWX,TS
M5]%F^'UM-X^N_#7C[XB'5+6;0;O7K_Q/I7C/3IK"TU+3?%=EH7D?;0-&N5EM
M9K<&Y6C>[UV7;W$M+/;S5O/6Y_.3\?O#]U\&OV<OVW/V1/@1X"N+SX*?$'_@
MOY\&/V?)?@5HWQ*D^%/A2X^%_P 1/ /A;QUK?PLL/'&HQ:K9?#+P=X\\9>&_
M#GA*[U06K:'X4L-9COY["XTC3)=,N?HC5O 7[37[*/QX^-/Q\^$_[#?P&_X)
MC2W'_!-#]LFRUGX0?"#]KSX/?$S4/C%XK^$OPCUWQY\%_B5X8^!G@OPO\/=<
MN_$?P_\ &VAV>G:UXK\)>&-2U6\C\0RWNOZ]:O)J8UK]_/%G_!+;]E[Q]\/_
M -L?X:>.T\>^+?#'[;/QB7X\?$4:EX@T>TU7P'\2[/1_"VE:!KWP?UC0_#6D
M:AX3F\,7'@_1M:T236)O%%V=2%]:ZM=ZIH&H7>B2\[^R_P#\$K?A#^SO\5?$
MWQS\;_&C]I/]KWXPZ]\.M0^#6E^/OVM_B+IGQ1U3P;\(-1OWO+SP%X5MK'PM
MX;TZRLM878OB6]N+2ZN=9F?4'B&G6FJW]A*A<ZL_G?1ZW4?.WV7NF^J/P"^,
M/["?['/PM_X)L_\ !&']HCX9^"/ NE?&O6/VDO\ @G7XCUGXU:5I>G:9X_\
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M0[,@C?Z$K^.[_@J5^U-X\_; ^"O_  47UWP/XOURS_9?^#O_  3,_8LUG5/
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M$;XT:W-H'@^76EN=1TX6/AR.^A<ZQJ<#7ES908DATZ\8^6/YPO@O^US^V?\
MM+?LZ?\ !*_]E3P7^TKXA^'7QC_;8^)?[?VO_&[]ILZ?HOB3XJ>%O@E^RG\=
M_BA:6?A[P;'K5E/I-EXB\6:,FA^#-!U]K":YT2T\+J^](3=&XJ?M_P#P8_X*
M+_"KX$?"[X*?$/\ :*L/B_J%I_P5S_82C_8-_:9\<Z=X;O\ XJI=^+YO$=S
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M<V-EX7\??M2_'[6_#/PA^%WA+QZL*0K>+X1\7:'XK\5Q6-B;9#$]S;:<AO\
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M6TS]FGXD?M??$/\ :O\ A1^UI^Q]^UAXZ^#WCKXM:9X,TGXK_"/]H/\ 9?\
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MP]'>V=SX6M="O;V,-HT7G:FVIWNHV\GA_P#/3XN_$O\ X*H^,_\ @E=\1_\
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M:0Z4FLZA(66Z@NYQ?:. X6;U5E>^^EK:>;U6WGV/U_\ B_\ M/?#;X)?%/\
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MPGC5Y%CF$,Z"1%D=5?<H=@ QU:_D/_:F_P""B>FZQ^V1XU_9:^(W_!3C7_\
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M8Z3>^,?%,NFVEAITOB/Q-<VDNM:Y)86-E9/J=[=-:VEM 8X4_BQ_X*@?'_\
M98_:/_:[_P""K%E\7OVC/!/PM\<?LO?LM?#G]F[]BK2M6U*>#5=>^/G@GQUI
M?[4/Q!USPS)!9W*^'/$]E\7OA[X5^"]YX@EGLGGTF_OK$W)L(+Z( 1BI-[VU
MVOU=ETON[OR3/[@**_FP_:)_;<_:)_:H_9/_ .".GQ+_ &2_C=/^S]XS_;F^
M.WA/X7_$GQ?I6DZ7XHL?#,^M_"?XD^'OB[!%X>OO^)9XCO/AQXWT#Q)JG@_3
M;^6PM+OQ7X5T ZL+& 74$/A.@?"G_@J'X[_:#_X*$_L7V/\ P5(^+NC_  Y_
M8@\'?#CXP> ?BZ_@_P $O\;_ (@^)_C[\+;[Q?X!\$?$+Q19:99[?AQX.O\
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M4?A)X!^''P;U^&U\1Z!;'4?$]Z?#FHMXW:.;0].M?+M;S3=-7[5)9P6OB_\
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M!3FVWHK.^EM[VWUWT6NFWFS^>[PM_P $\/\ @H)^R/\ LW_ 2Y_9D^,WPO\
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M_P!BOXK3W%S\ ?V?]:\47RZ_HOBSX?:MX&\?_%"UU&[\*:=H&F_9]/ATC2_
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M/I][X:NTM-2L_P"IVB@:DUT3UOJKZKMJC^?J^_X(SW=[\=F\*'Q!I,?[*/\
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M"-.UJS$KRZ=:LEP)H@C*@D?[^HHH$W=MOJ[_ 'A1110(**** "BBB@ HHHH
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M5[\-O!%GJ>O^'M3N==^(_P 0='LY]8TO39UT>QTO37@N[B;4%MO$4?AS\O\
M1OA_XXC_ .#<[]N#P>?!/BN/QAJWCK]L>XL/"W_"-ZNOB74TU#]JKQ+>:?/:
M:)]B&J7JWNG>5=6<D-K*+FR\N>!G@VM7B7[4OP&_9X^!W_!07XO?&G]O3X9?
MM@ZG\"_VJOV=_P!E/Q#\'/BO^S-JOQ[L=)\,_$[X/_"W2?@YXP^"WC_3/@GJ
M.DWDWB?Q)'I6@>)?"0\11W%KIOVRZBM;R%O$&I)IX.T6WHM'))*[O;E_O*^[
M>C5_.Q_3I^Q'^UQX3_;;_9Y\+?'?PQX8\0> +^]U7Q/X,^('PS\6^6WBGX8?
M$_P#KU[X6\>> M=EBBMXKJYT+7=/G%GJ"6UF=3TBXT[4I=/TR>[ETZT_-O\
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MB^%++PYK-@VC>-H-5?0-$TWQ5;01W$VCBTM;>[EBT2RCM+G[%&K?MZ_M"?\
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MN$W/^"<6@?\ !+R3]N?]DV/]A^Q_:3_9+^)/@WX._$F&S?XN?!?QGX'\%_\
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M'_A06L^&_%'BCXS^!?V;8+S]G[6_#"ZC::G)>Z_XMU;0_#]@/#^MZE)?ZGJ
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MB;_P1"NOAEX'N+?1M4ET[Q'X[U]_CSI6F>&-*OH+.:"_UJ:\U2PC.EV37.H
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M,T&QM=/M[8ZQ)>/XUU>'0X[:^O+6VTW6?UO^.?QSM_V>_P!G7X@_'[QQX/\
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MB;X9?#R[\'1ZQXATKPKI6H^&=2\3WURXM7UC5M5TJT-MI?A76_$,/T_\??\
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M/Z-IF6P4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OD3]NO]LS
MX8?L!_LP?$G]J'XLVVJZKX<\!VVFVNF^%] -J-?\9>+/$>J6NA^%_"NCM>21
MV\,VIZK>PM?W\OFQ:-HEOJFMS6]S#ILD$GUW7Y+_ /!;'P#^RM\5_P!@/XB?
M"_\ :X^.FD?LW>!_'/B'POI_@;XPZSI&I:_9^%?BWHDE]XQ\',^BZ7!+<ZK;
MZA;>&=;T[5-,2:PGU'1+G5+#3M1LM7N=.G4'&SDD[VNKVWMY'P!^SM_P<(?$
M/Q#^T%^SW\&OVT/^"=OQ?_8Q\(_M;^(+'0_V>OBYXH\2:_K.@>(KWQ+<:%I_
MA&RO]-\2?"OX?_:]/O=3\1:!:ZQXKT35KE-"'BCP[?:MX9T_0[F76Q^IG[-W
M_!0'_AH3]N7]N/\ 8O\ ^%2_\(C_ ,,8_P#"JO\ BY/_  GG]O\ _"R/^%FZ
M#-K?_(G?\(9HO_"'_P!B>5]E_P"1I\4_VEN\[_0,>4?Y>/$WC[_@J-_P2/\
MB3^Q]X8_X*/:?^SG^WK^Q3-\7_#/PX^%?Q$\5^'?"?Q6\9_#6&ZCTZ*/7?AC
MXT\5>%]"^*_ACQ[I?A2TCUG34\3P>*=#U.#PU=^'=.\06X:QURWW_%/["%A^
MWA_P5[_X+:^$O%GQ4^,/P\\"?#;P)\/?'JZ3\*O&$/@^R\4?%2'X1Z59_#"Z
M\<SRZ=K1U;0?#$+^,KN+2$TB0W$U_+*U]:B$6NHAHXQU>B7*VFFY+225[.S3
ML[-/U/[@Z*_@YTKXZ^&_BI_P0H_X)YZ)^UQ^VA^TSX*M?$?[0?Q(\(0?#/X
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M5?AG?7T!.FVWG <FC?-I&SV>JDDXM>M[-/:Q_?#17^=8G[0WQM7_ ()O7_\
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M^"Q_^"D_Q4^*'Q"_X)"?&G2/$WB*Z\'_ /!/3X-_L]6/[2^J3:UJ*6IN[?\
M:>O/@]K%MXK629K?5M3\8_"[PUX"OYM2O'N-1U"/6]4U.><75F[GLOVD_$GC
MKXJ_\$P/V]O^"ATOB?Q78S_M<?\ !6K0['X:SKKFMV\FE_!OP#HOQ@U3PYI_
MA\_:81INAK?>/K[PW/;VL5M/?R^![)M8%U)IVGO"F4J335VMTK:[N35M-=ES
M>A_8'XQ_X*O?\(G^W+^VC^Q?_P *$_M#_AD+]B#Q5^V5_P +)_X6E]E_X6'_
M ,(SH/PVUO\ X5Q_PAW_  KFY_X1/[;_ ,+#^R_\)?\ \)3XF^S?V1YW_"+W
M']H>59?4?_!.']LK_AX'^QC\&_VN_P#A7'_"I/\ A;?_  L/_BWO_"7_ /">
M_P#"/_\ "!?%7QS\,O\ D;/^$7\%_P!J_P!J_P#"%_VW_P BUIOV'^TO[-_T
MS[']ONOYVOC%_P IRO\ @M%_VA!^*?\ Z@?[-E?J-_P;A_\ *&/]C;_NX;_U
MJOXY4+^OO8I12C=+7W/QC)O\4CZ._8I_X**?\-A?M1?\%"?V;/\ A3W_  KO
M_A@_XI>#OAK_ ,)I_P +!_X2[_A:G_"6:K\6-,_MK_A'?^$(\,?\(/\ V?\
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MS/\ A%]*\,:G_;7_  D7_"$> -GV[_A(_(_L[^PF^R_8_-^WW'VCRX#X@?\
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MAU";Q_K45_)H:W$EKIZ:FT6F_K$B)&JHBJB(JHB(H5410 JJH "JH "J
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M.6NH:1KR>&[37U!*%X\U^MK6O;5+773>ZTMYG]VU%?P??M.^+_%EO_P;A_\
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M-.M?#6DMIOAOQ#?B_P!3MS9Z'JUP(["X_P V7]GSXT_'C3-$^ _[>?P;T/\
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M (*>?]I@M._](+2O[\OBC_R8M\1/^S3?%W_JG]0H%.*5K+[3779*'^;/-/\
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M1?\ "G/^%._\* _:&\5? ;['_P +"_X6%_PEG_",Z?IM]_PE?VC_ (0?P/\
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M &I/=6][IVJ7]X?@XD]K<:Y:ZQHFE:OXS\4^(&\-ZC=:1IEG+X/XW\:?&/\
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M_P $3O\ @K9_P3_^"'P/_:0^,_Q?^!_[=>C>)?!GQK^'_P 8==M=:CNO&.C
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MZ<O\3&H_LW_&WX*?\$MOA7_P7C\,_MN?M#7_ .VGX@^*.G>,_$\6L^,K;5?
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M[4]!NM0TN1['4[:XT;7?#_B+1M1B2TEO="U[3)[W3=*OWNM-M-)_V]O@_/\
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M_P"#=3XD?M'>(OV2_BE\*_VA= ^/VGVOP0^.&O>&?@;KO[27@OQ5X0^*&N?
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MT6KW9N+RTELE273K7]-*_&#_ ((#?LX>$?V=_P#@F-\ KSPGXG\>^)9/VA-
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M::Y+X5\0OI&H:+-J5AJ5MI=Q>V=S-9F*>0'S3>O96;LK:VWTL[V6]WH>%?\
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M!<C5(&MM37P#9PVG@OX:VQA94*Z3J&DZ!J/CK1))%>:YL_';77G-;3VL%O\
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MU"[N_$_PX\21V'Q@TV[\;W]G]L=]'\0B3PI$]N^JZ3)I5G%KLVH6/T!\9_\
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M7K1KC1;C4[!GTZ5DNVBD@>4!2DDTMO1:7:ZVNDVEUU9_-/9_\&QOQ7U/X7^
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M_,EX(_X-R?B3X6_8Z_:?_8;NO^"A'B#5/@;\8_&WP_\ %?PFTC5?@C)K%O\
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MM(T_3K^:\N?!WB6))=$O-4MT;2IC+-&LMLT_T)03=I-=[-_I^?XGYC_M$_\
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M^M[K^??IUZ?@?ACJ_P#P;R_VK^Q7^T]^Q_\ \->^1_PT?^V#;?M7_P#"Q/\
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MVWS_ !MXB\8_V'_PK+_A<$?V;9_;_P#9W]I_\+"GW?9/MG]GKY_V6%W[1/\
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M5]>9=EM\DO/73KJ?%'[-G_!$KXH_#']L&#]LW]H;]O?QE^U1X_\ &GP&\<_
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MB?'O]O'XW_\ "U_^%A?\-M_'"Q^,O_",?\(+_P (G_PK+['+XND_X1O^VO\
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M,I_LN_ 3]FS_ (2W_A//^%(?"WPC\-?^$T_L'_A%_P#A)_\ A%=*@TS^VO\
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M=4MAHVLK^OQ*2C=?!HX.6JMM+FMKJKVNE?4_7C]LG]OS_@KAK?\ P57^.?\
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M3X;:7J__  G'A'3=:T#P(='\5^*_$,UM9VVC>+-6'CKPE\0%T&UNO$GA[4-
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M!VLQ:X\<NK^$+D7^12Y7K:%[:)Z+2;3O=[\OW[K4],_:%_X+>_M>_$OX9?\
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MMM?FCTE=<G\<>%([=?$[Z&\!UF WBVRPW1@6OY?K_P  /<7\KMHKZ[U6N_\
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MB6UQJ%Q9V%O<:KK6HV5A#-?7=K9Q27"R7-Q!"KRK_-OXU_X)9_MN:E_P2?\
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MWFMS^$8-7][^"O[&G_!1+]L?X]_ML_\ !1_]LKX":9^SWXT\3_L*_&/]EO\
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M[H/@?PUXAU35_&!TX:E>:O>Z!86^C7=YJ-\6DN:VC_\ !7G_ (*$_!SX??\
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MI!;)?R>-(KI],L5M(!+^;]S^QQ_P6._8;^&7[<'_  3'_98_9<\(?'C]EO\
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M:UH5CI4UCX%\6ZY!XR\)V-G+%:#QGXK^(TSW-KK+^ #JWA_W"T_9:T+]J_\
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M+\3&Q\$7/A.>YO6UOP1J0&C;NHWMHG/F7Q*^K>CMLO5K4V_A#_P69_;>\9?
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MNK>+]<OX-+O-*\=6Y^(G@#Q;KVE?\3WPU=:5K^KZ'9Z?X;U^QFTWPY9\:?\
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MJ_LVUHNLD[:Z6T^]OJ?JE^RK_P %*?C-\*OVY_@S^RI^T7??#[P[^R[\8?\
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MQ!+))X2EU?P39ZG-9>)?"NAZWJ.NZA:'2;73M"\/+_:_KG_!2;]D+X\_'?\
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MZU_P6]_;O\#_ + ?_!0>Q^*6D?#3P?\ M^_\$]OCW\'_ (5>,/$^F^'+'4_
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MT7P[HFH/<W%Y;+K\OU!*+UM"WN<U]$KQES6UWT6F]S].=0^(>E:S_P %O/\
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M4O%OA:V>Z:9(M$U8^'DD?0=+TNTA_3+]@7]G_P#X*#_$S]D?XZ?\$O?VAO\
M@GU\*OV*_P!F36OV-OBIX4^'?Q2TG6H_$&M:]^T-K=YX3TCPUXA\>S6OQ%\>
M7.KZMJ]YJ_B+XB^(]8B\.02B]\,6MGI$NF65OIFCU\N?L4_L$?\ !4/XN_M
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MZ_8,T+X5?&31OCG\ ]9^%/@3X=^)] >?QMX2M#XQN?'NMWEYXA^*7B+38/\
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MPOH?Q%\=O?:[KHM-+\/W]QX_^'VMZ-)XMUO4K7P]H&M:^-0C\1WOAW_2OO\
M_P""/W_!1KX_?M*?%C]JO]CK]K;7_@1\1?CQ^R[<>#]?T[XU_LQZI;Z_\&OB
MU\//&UG'<V^IZ7K-A<'2[C4]&NKS2D::RTOPX\MIJZZ1JWAK2/$GAG7OM7Y$
M?M%_\$6OVJ;O]@O]@[XC6/[*G[/OC7]H_P#9G^-'CWXK?&W]BSX:6>F>$_ /
MQ#^''Q8O? ,VN>"]0UC_ (2V]M_$_C#1],^%'A>T\10>%?$UA82IXN\8KX*3
M6-1T32IO$GZ=?\$2?V1?C+\+_B-^TC^T;\5/V$O@;^P%X5^(EMHO@WX(_!KP
M<9-?^,.G^#8[FVUGQ#_PL#QG;ZY):7FAOJ>F:*VF6^K^&]%\3ZAK2:Q=RZ3X
M=T.QT>+7 4E#E=K;NVJO?FT2UNUR]E:VM[H^6_\ @X'_ &>OCWI?[67[&O[?
M_AC]DC3OV\/V??V?/!OB?PC\5_V<M8T;4_&>@?;;_4=?O;?Q#XI\$Z;8Z]=W
M7A^\M_$%CJ UV+PMXBT#2=;\ Z/_ ,)_IE_X>EMM-O?B[]A_XB_L>_'SPW_P
M5)^.?_!-+0/&'['_ .V]XX_9<UN+Q3^Q;\2)? 47[+OA#X>:9J?@!/B=XU^$
M=KX1^'MIXDF?2X])\16GV:ZN?#%OX6\1_$NXT[3/A[8:-<>'+W1/U[_X*I?!
M7_@IK\-?VROV=O\ @H)_P3ST_6/COHWP_P# 6I_#CXS_ +)>K?$"_L/!WB*
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MFK:I8P:HL&O:IIUEX=M=3M8-6;5[+VKX)?LY_P#!?+]A'X9>,O\ @F1^R?\
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M_16L6;R-4NX"BPIO)B"I^8?[0G["O[8?Q$_X*[?MF_'/X9^#M3\*?#_XM_\
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MWP"_X)Q_'_P]^SA\1_@_\;OB5\0?&7P5T7XP^#8_A=I7AW5K3Q!)XB\=>,_
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MB?#[5?B1KNN_%5/[:;4+9M&T+PWXM@O8O#MGK9_M/POJEA 9IQ LOR/\'O\
M@Y0_9&^+GQL^$OPU/P&_:K\!_#;X^?$I/A-\&?VB?&_P^T/3/A3XT\7S^)$\
M)VS1W</BBXOH=%?7;K3-/OKVPBU?4?#<^IP'Q=H_A^VMM1N;(#DD^C[_ )^?
MD_N9_157->,_">D>/?!_BSP-X@2XDT'QGX:UWPGK<=K.UM=/I'B+2[K1]22V
MN5#-;W#65Y,L,ZJS12%9 "5Q7X5_$S_@X0_9R^&W[9'BW]B$?L__ +2/C3XM
M^$?COX&^"%Q/X+T+P;JVAZG)XQUJU\.3^+=/ED\76UY%IFD:]K7A724L-5M=
M-NM6O/$=M%:R1-!('Q_%W_!R)^Q/X0^/NO\ PLN/AW^T)J7P<\&_%M_@9XW_
M &N]+\$Z5<_L]^&?B,E_+I[P3^(1X@%_=>'()+6^NY=8BLTU&\T>QGU[0- U
MS0V@U&8#DE_*]K_+H]_NZOHC]<?V//V0_@Y^PS\!_#7[.7P&M/$-E\-?">I^
M)=6TBW\4Z[+XCUE;SQ9KU]XCU=KC5IH+9YXVU+4+AK>,PJ((2D0+!=Q^H*CB
MEBGBCG@DCFAFC26&:)UDBEBD4/')'(A*21R(0R.I*LI#*2"#7\W7_!R]^W_\
M:?V+OV4OASX$^ &K_$7X??$+]HSQ/XIT>Y^,?@FRLDM?!/@GP18Z"OBGP]+X
MIF#ZGX-\7>-Y/&^D'P=KGAY;;78+7PUXIFTW5=*N[>"X("3E)+JWN_Q;/Z2:
M_+*X_P"".G[%.I?M[WO_  4;U[PWXV\2_M 3>(-%\8:9IVO>,'O/AIX<\9^'
M_"^D^%M(\6:+X1CTV"Y_MC3X=(AUJQ75M;U73-.\2S/K>FZ=9W-II/\ 9WS?
M\:/^"_?[,_P1^"W[-/Q!\0?!;]HO6?B]^U/X?U_Q7\/_ -EGP]X/TB[^-^A^
M&/#WBK7O"5QK_CG1Y]<MK30M/U+4_#>JIH"6DVK:EK9L[]K'3I+;2-9NM/\
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MQIJ+:7I-]=V*1_VAHUW/9W>C+KR:ZVFZ9J?ZV?'[XZ_#/]F3X,_$?X^_&/Q
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M$HN-GT=M?5)]_P#A[,^GJ*_$/]NC_@NG^SY^Q3\<_%?[.]I\$OVB/VD/B/\
M"_P38_$/XVQ_ KPCI>NZ!\&O"NIZ;9ZW977CK5]0UFR;3IAH&I:7K]_/+91:
M'I>DZQI,E_KL-U=M9P?IQ^RG^TW\+?VROV>OA?\ M,_!>\U2\^&OQ8T.YUKP
M]_;MG;:=KUA+IFLZGX;U[0]=L;.^U.SM-<\.^)-%UC0-8M[/4M1LXM2TVZ2U
MOKRW$=Q("<6DFT[/9_U^%[7."_8A_8<^!'_!/KX,W/P'_9WL_%-CX NO&FN>
M/98/%_B.7Q1JO_"0>(;'1M/U%UU.:VM7%HUOH5AY-MY9$3B9@Y\S"GBG]ASX
M$>,/VU/AO^WUK-GXI;]H/X5?":^^"WA.^MO$<L'A*/P1J-SX]NKF'4/#(MFA
MO=2,WQ(\2E-0:ZC= ]DOED6@W_E_^U'_ ,'#'[./[+WQ_P#VBOV:=3_9[_:9
M^)GQ1_9VN-#FURS^&?A7P]K^DZSX8NO"=KXS\5^.CJ0\0QMX:\'> M(U#2X_
M$6J>(;6SD^VZM8_9;6338]4U/3.<\(_\'+/[$'C;XD? OPSH_P ,?VFK7X8?
M&_7/"W@2#X_Z]\,[71_A=X-^*OBF#2Y6^&^MZA)KTT^KZQX0GUBRL_'5YX3&
MNV6CO*M_I#>(=")U=0KEF_>L]4]>Z:OWZK[S^B2BOPV_;<_X+U_LO_L5_'_Q
M+^SU<_"?]H+X^^)_A7X>TKQ=^T%K7P*\(Z+XB\/? [P]K,>GW-H_BN_UCQ%H
M<#ZG#8:OH]]J4<LVFZ#IBZUI.GW?B1-<FN])L=3]K_\ X+P?LC?LB^'OV5O&
MU[X9^*GQB\!_M@?#+Q/\3_A)XG^%&CZ+?FZT_1-.T6?2-!U#0_$&M:%K=KXD
M\3:OXATKPU;Z8]F)=#UJ2ZM_$?\ 9?V"[\H%RRTT>NWGI?OVUUMIJ?MK17\_
MOQ _X.'/V;O 7@?]E[4(_P!G;]J7QQ\9OVGO!.J?$S3/V:_A[X+\.>*/B]X"
M^'ND^(?%/A[_ (23Q9IMKXGCLY&\1#P=KWB#PEH^ESW6JW?A:REUOQ/;>$(C
M#'-Z)\'?^"^7[%WQ9_9E_:M_:ZETKXI>"/@O^RIXXTGP+J5YXET305\6?$_4
M_$\[6W@R'X=^%;?Q$UU+J?BJ9K1+32/$ESH-QI:W,MWX@ETG3-,U?4+$#DE:
M_*[7M\[V[]S]OJ*_&+]A?_@MO^SU^V]XM\??#&#X4?'/X ?%WP;\+;KXX:-\
M._CAX:TKP[J'Q)^$L,%O<P^+? %];:Q=0ZOYEM>V%Z]E/#9I<:9?1ZQH5[KN
MDV6LWVE<#^P'_P %\OV>O^"A_P =O!?P'^$/P#_:-\/ZIXI\+>./$.J^-?%V
M@^#H_ G@V\\$137T^AZYK.E>+]0EN+S4=*?1KF"72+34!;7GBCP[87,*BXU&
M[TP#EEKH]-7Y+[_RN?NW17P5\;O^"@?PS^ 7[:?[*_[%GCKP=XXA\1?M<:3X
MSNOAS\3[9-#_ .%=6&N^"[#5+V[\)Z[+<:M!KZZUJ,MIHVFZ>-,T?4;?^T?%
MGA^.ZEMK>:ZN;7XQ\)_\%[/V2?&'P=_;_P#C5I_A3XF6_AK_ ()]>*]#\+^.
M["\3PA#J_P 2%\7^.];^'/@?6/A["WB;R#IWBOQ3HK6-FOB&?1[NW-]9+<0"
M>804"Y9/9/I^+LOO>A^X=%?R+W'_  4&^'?A#]N_]M+]KWPCIO[8<GQ7?_@D
MY\,_CI8?L[ZOI?@G7/AQX/T7XG_\,DGP=JND>';+QO?W-Q\2?#USXW\*ZIXQ
ML;G1[73(-*_X3N ZI+-%!#>_DU\8?^"C'[0/[3/_  0/UC7O'?C/XZCXZ_#_
M /;A\%/XP^.>K:M?>'K/XC6/Q1?X_:]IND_#_6-"O;%QX;\$Z?H5KX8OO#UC
M;:;H?A^2ST[2-+L([.SACB5_Z^=BU3;MV;BGILY7\]4K;G^B;17XJ?L<?\%S
M?V9?VQ_VJW_9*T7X6_M!?![QSXF\+:OXZ^"NL_&KP-9>#M'^-G@S1;&[UB;7
M/"U@VLW7B*PCU?P[INL^+/#)U/2%L-7\,Z%J]S/J6FZS:KH4OZ+?M>?M8_!W
M]B']GOX@_M+_ !WU34]-^'7P[M-.DOX- L(]7\3Z]JNN:M8Z!X?\->%]'EN[
M&/4]>US6=2LK&TBN+ZPTZSCDGU76=2TO1-/U+4[-D.+32:=WLN]^Q]*T5^*'
M["O_  7"^!7[;'[0D/[+MY\"/VC?V;/C'KG@2^^)7@/0?CQX/TOP]:^/O"-@
MLUY+>:!/9ZS=:CY\VB03Z[9/<:2FC:CI^G:R=/UJZETX)=?%NF_\'5'[&FH>
M$O"_C\?LW?M?_P#""77B>/PO\1_&UIX \,W_ (1^$]_?WLD.B6/B#Q)#XM71
M]6\0:OI5O<^)8/#VBWD]X=$6+[-)>:L;O2;('R2O;E?3MUO;KUL[']0-%?CS
M^V__ ,%I_P!FO]C#QG\%?A=9?#[XX?M,_%KX[>!+/XL>#OAM^SQX,@\4>)(?
MA7J$5]<Z;XTU.SUC4]$NQ'K5II&O7>CZ/I]G?ZG]D\/ZO>Z[%H%A%:W=Y\ _
M\&Z_[0<W[3/QM_X+!_%K3/%7C;Q#\._''[8B>.OA58>-K[5'O/#O@'QWXM^.
M'B7PWI<&B:A?W\/AAHM#O-*AN]$L'6VL9;9+1=ZVL9 '(^5R:LE:WG=V/Z4/
MB1X"\/\ Q5^'?CWX7^+$NY/"WQ(\%^*? 7B6.PN397[^'_&&AWWA[64LKQ4D
M-I=MIVHW*VUR(W,$Q24(Q3:?)OV2OV6?A1^Q5^S[\/\ ]F;X'VVO6?PO^&G_
M  E7_",6WB;69/$.MQ_\)EXV\2?$#6OMNL2PV\EWO\0^*M6DMMT*?9[1K>U&
MY8 S?E!^VSXN^&FE_P#!:7_@EYX8\0^//VA-%^(&N^$?BE)X.\&>!9M 7X'^
M)X(='\;&\F^*L5]XFT[6WO+9(KEM+.E^'M93S8+#S9(0)&C\&\3?\'0W[)'A
MNW\>S1_LT_M=>(U^$_Q6UKX>?%.\\,^"/"6I^'O FAZ7JEKH6F>-];\5GQC!
MX=M+?QCKK:OI/A#P_>ZC9:IJ%SX?U+^T7TE;C2#J0-1DTDDVFE)KINTMWKL]
M?D?TRT5_()_P46_X+C^+_AK^WS^P#!\&=.^.OC#]DO4?A?X?_:1\8>!_AAX3
MTU->_:3TSXI_#;5M=^'MOH5Q-<PZSK.G^"=.UJQU3Q1X+N[W3=)T_7;%K[6+
M34]1T;2I-,_2#]M3_@X%_9'_ &-OC]XE_9V7X<?'O]H;QI\+M,.N_'F\^ WA
M/0]?T3X-Z1%;VMW?IKVH^(/$GARTU#5M'M+_ $^XUV."XM?#FA/?0Z9K/BJP
MUZ"_TBS Y):65[IO3R=M>W]==#]VZ*\2_9Q_:(^$O[6'P3^'W[0GP-\3+XN^
M%WQ,T>36/#&M&SN]-NB+6_N](U;3-3TR_BAO--UC0M;T[4M$UBPN(P]KJ6GW
M4*O+$J32?E+^V]_P7A_9V_8O^/WC7]G.'X'_ +1_[1'CGX1>";+X@_'2^^!G
M@[1=>\-_!WPUJ6DV6OVT_B[5-3\0::UJUKH&I:9K>N7UQ;67AS1+#5]+2ZU]
MM1EOM/TX)46W9)W[?U8_<>BO"OV9?VBOAK^UK\!/A=^T?\(+O5+SX<_%OPQ!
MXH\--KNG'2=<M(FN;G3]1TC6].$]U#::QH>L6.H:-JD=I>ZAIYO["X?3=1U&
MP:VO9_QY_:=_X.$_V<_V9?V@?VB_V8[[]GC]I[XH_%O]GJ;1&O\ 2_A9X0\/
M^)-+\1:)>^%+3QAXC\9-J*>(XYO#'@WP1IFHZ5!XBUC7+!+E;_5K 66FW6G)
MJFI:8 HMMI)MK==NGD?OW17XX>+/^"XW[&'A?]@CX8_M_1+\2?$'@OXR^)W^
M'/PX^$.B>'=*N/C7K_Q7MKS5]/U;X>GPU)K\>D07N@76AZA-K&MQZ]<Z"=-.
MFW>C7VLW'B#PW8ZQXYH/_!P7^S?K7[+/[1O[1=Q\!OVC?#7B[]DKQ#\.-$^/
M_P"SGXM\.>&O#/Q@\&Z=\4_$L/A3PKXPMK#6?$=G8:GX6?6;F"QU.6>?3-;T
M:X8'5=#M+.[TF]U0'RR_E>]OGM^>G:_4_?*BORIU/_@KO^S;8?MN_LL_L-V^
MC^--5\9_M8_!?P]\:_ _Q#L$\/M\/M"T?QAX8\=^+/".@^)9;C6H/$4>O>(]
M-\#%+"/3=#O[43^)O#7G7$<%U>S6'XE?\%"?^"F6A_MK:=^QMXA_9^T[XO\
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M9])E?61.MR^MV]ZCZ9J^GW>FVFHV$EJ07+)I.SLW9?-V77OIV\S]U**_"O\
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M6FC>*W>XM=;L-,AV^']<NH[A[*T^T$#EE9:.UKKTT\]-T^F]S]6Z*_!/3_\
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ML*6L]Z-!&A>"3K\>FZ'KT6JZ;^(_Q#^'7B74/^"5&N?';6? -_X"^"W[6?\
MP7.\"_$'X*> =<LS:6\GPTNO@Y^T/"^IV&DI%%IH\.WJ:O'X0M+JTMX8=3'@
MZZ,,3:5%I4TW^D;X\^%_PT^*FG6FC_$_X=^!OB/I%A>Q:E8Z5X\\):!XOTZR
MU&$JT-_:6/B'3]1MK:]B9$:*ZAB2>,JI60%1B?Q!\.OA]XLT32?#7BGP)X-\
M2^'- N;"]T+0/$'AC1-9T31;S2K2:PTN[TG2M1L;FQTVYTVQN;BRL)[."&6S
MM)YK:W>.&5T8&JB5M'?W4W?2T4TK*VCUU]--S^;;Q586$/\ P=5?"^2*RM(G
M_P"'?5]=;X[:%'^U)'\0M-2YW*@/GKIT:6"S9\Q;)$M0P@41C^<'4E6+_@WR
M_:*2+3H=26/_ (+CZHL>DNMV(+]4^ 7@4)IS)IL]G?"&Z %LRV%U:W820BUG
M@F\N1?\ 20?P-X*D\6Q>/I/!_A:3QU!IIT:#QJ_A_26\6PZ.3(QTF+Q&UH=8
MCTTM-,QL4O!:DRR$Q9D;/Y=_\%0/^";EY^V5^R_X2^ 7[/G_  J3X*W6C?M+
M?#;X\ZU)>>'Y?#GAK5D\'V>MV6ML]IX)T"ZDN?$^JP7VF0Q7UW98F@T](KN]
M1(+=0G_7WICC-7BFMN17O_*Y/\;V/P4\3_MD_#/_ (*;_P#!8C_@G/\ %_\
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MHL]A;WD=JS7]Z6B)NI_,!<RYI-*RDFK+I=)?I^)_G_\ [:-S/^RY_P %4_\
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MB&V\4^(?$/B#2O#:Z'J%]::=J&N/HUAC?%S]L?X%_P#!5W]JO_@A1\'/V$]
M\07OQ"_9K^(/@?XJ?&35I/ &M: O[/G@?P'=_!S5_$OA1-2O].L]%UC3M!L?
MAYJMS=76FK<^"[[4[+P)HFD:[/J'B.?3K;^VWPEX.\(^ = L/"G@7PMX<\%^
M%M*65-+\->$M#TSPYH&FI<3R74ZV&C:/:V>G6:S7,TUQ*MO;1B2>625PTCLQ
MP?!?PE^%7PWO=<U+X=_#/X?> M1\3S07'B2_\%^#/#GA:]\0SVJ>5;3ZY=:'
MIMC/JTUO'^[@DOY+AXD^2-E7BF'.EM%Z7Y==N:/*[]^^ENVQ_,'_ ,$)=)TV
M+5/^"[6NQV<*ZO>_M?\ Q>TFZOP"9YM-TNX^+]Y86;$DJL-M=:QJ4RA%4L]T
MYD+A(@G\_7[/_P#P4!_9E\-_\$!OVC?^">FN:7KTG[5/Q:^-%EJ'PQ\#:=X
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M'?#WC31=4\+^)M3U"3P4OA\ZE;VFH/X4O]0BTZ=]%\2^(?"-[)_H0>!_AYX
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M^NZOX]T?QS9^*-"\1ZU"VCZ?)\/_ !)#JUYI^MVUO<V^G>&9M5TO[;_X.;_
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MMW=SY,/GW.I6]S--Y4?F.WEKAC4[)*VW+U_EDY?C>Q_#'XF^,?@#]D[XD?\
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MPNMS!&DRM%$P<&-2+?B3X>> /&6@6GA3Q?X&\'^*_"UA)9RV/AKQ)X9T77-
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MQ1;?3M2C2//_ ."#GP<^*/C']L#]H6S^+[SZC:?\$J/V3/CK^R=X4:2T>/\
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M&_BU9?"+X;^-?%N@?%B'3-3O_C+KFH:1J]G=>&[9_%.B:):Z=<MH<5WH^O\
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M  DGB5FT6[L+R;6-$T;6]830)9+IK73KV_;4Q:2ZA::=<V7XG^ ?&NM^(/\
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M?$VI^,].TR&VN%U 07$%U+9:9<6=W<S"VN[6>;D/^"X'_*)S]N;_ +(M>?\
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M/AZUT[3XY;<?$7[!WB+3_@[_ ,''?_!4SX;?%;64\/\ C#XZ>!/!WBWX0_\
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MI'),N3XY_;5_8X^&.I>--%^(_P"UA^S9X#UKX;ZCH6D?$/1?%_QQ^&7AW6?
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M;Q/\2+Y88))XH_[2\?:WXDU JMQ<G==$O<W+EIY/Y,/V>/V4OV5OV_/V@_\
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M3H8[.]L_%<SS>-K7Q),/",MI?:MXCE^0+OP5HGQ]_P"">/\ P;$?"GXHB_\
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MM=/M]#N-9FL=7&J:3!^IO_!2W]MC2_\ @GM^QC\8?VI;S0;+Q=K7@FRT32?
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M'K]MK'BJ6YU&YTVY&JS:Q;WWPWT2S\3-X2UJTT"+PRL^D7VL4_'OCOPOK?\
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MO&&JZWJ7_"-:AI%C!<*$\BYW%O17UT5]$UOHM]WI]Z/VO_X*K?\ !6KX;?\
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M?\$__P!K_P 5_",WND>,/AI^R7\<M9^'UUI%UY&H^'-6\*?";Q+<Z!K.ESW
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M@ZZN+*TM?%GB#0/$'B33M5T;PU<W6I:=;0:[J-I;:7-<7]E#'=-)=0+)Z/\
M#7XI?#/XS>#M*^(?P@^(?@?XI^ =<^T_V-XV^'7BO0O&OA/539W$EG>)I_B'
MPY?:EI-W)9W<,UI>1P7;R6MU#+;3K'-&Z+_%QX"_9[\#_P#!0;_@NC\#[/\
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MV(OAG/\ %FZ^)'@A8O"WPT^)/A^UL-#N8_"]MXDU[7[SP1)XU\2R^-?AT?!
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MU"P,VN^))[/1],T>#3;+1_0/^"9O_!!?]CKX3Z!^Q5^V+XS\#_&JQ_:(\,_
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MUZ6[U_PI%X:O-;M8CKAO=7MK+P[XIT*STN_U2]FT:#3MMDMG^QOP+^+OAO\
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MVUO8C6/$^LQ66EV+R6NFVEII]A8:/I&CZ/96\+RV^FI>WFH75YXY_P %&/\
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M"TL_'?B9_P &Z'_!.#XI_M!>)?CWKNC_ !BTJS\;^/8_B=X\^!'AGXCV^D?
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MDK^2B[K[OZZGK?\ P3X_X(M?L7?\$V_%7Q#\>?!2U^)'CGQY\1M _P"$,O\
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MOYMU+K'Q M?&M[9ZE+>^+?%)U#58O$\^KZ?J.D:I::E)8?V/#8V.C6VF=O\
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M&WQ/\?7VDK?C25\0:_#INBZ?]DTV;5]:O;>TTO1=-ADU#6=3O[M;FZNC*OZ
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MZ*!\TM5=V;N]=WN?DOK_ /P1A_8_\2?L5?L^_L%:C?\ Q@'P-_9J^,,OQO\
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M:YH&J6\ZZN!>%WK'1MZK>]-JRM&SM+R6NIX]_P %B?VLOCY\)/VDOVJM5/\
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MM)?"N@^,5^P/$W_!*?X^2_MN_P#!*W]H>R^,?@OXA>"?V%_A/XF\#_&7Q/\
M$2^UW0_BW\4?%?B'1/%5K>^*_"_ACPWX)U;P>(-2UOQ";^6PU?QAH\VEV):T
M%UK5S;?;;X#FAI;E^%V[WY+6:Y?YMKMZZW2/P!^(_C;]M+Q#^R!_P74_8.^.
M7[9'Q!^,MO\ L->*?A9XV\.?%KQ3::AJ/C#XB^!KKQ+XKTGQ?\-/$ES?>)IM
M5M/#GC.VL?!6L1Z;?:YXIL/"&KZ9KEO8Q:U::I;SV?\ 23_P0&^$7Q&^$_\
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M/@!#:2ZQHMWX-MO"EOX8@T[X3:S;VUY9>.=4U5FN-&$FD(+B]?3_ (G\6_\
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MX<TFZ\):-9>#-0\*W^EV]]\2]"EU&?6/&F@W<5K::L]M8W<T%G!?_$G[?/\
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M;6EG8:5-<>']7NKO0 F#CS2<FM^JT:N[M:/[DDWW5CU;XU?$K]OW]M?_ (+
M6_[*/[//[;OQ,_9*^%?Q6_83^$WQJ\5OX:%]K]KX(T[5/#'@WQGJEY\//")\
M1:2FD>-M;\57GAW0;G7]+\4Z-JMGX9U+Q,G]L7UO<W>FZK\;_$;_ (*/?\%
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M^'&D6TMH-#TZ+5;"Z^TVNL:/J7A_1DG^/? W_!$[_@H4OAS_ (*PGXS?&_\
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MM+7NBZ7X?\"_#I]9EAA\03ZUXD\5^++^/P[KZWT/AFQT+PQ9Q:]@_%?]M_\
MX*$?M&:9_P $#=)^$'[5'BWX*_$W]M/X;_%'P5\7/&.D6,4?AO6=>L?%&B?#
M34?B;X@^'<,]IX=\2>(=!TA-=\6^'K5DT_3W\3R6]UID>BP2V\=G]=?'W_@B
MY_P45F_:F_X*'>(?V6/V@OV9_"OP!_X*3Z+J=K\7O%?Q4\.^)M4^-_@K1-7M
MM<'B+X9>#$TSPEJEK9Z#XGE\5ZQX<O\ 4;/Q1:6VI^"6AFU/3+;Q+X7\-&][
MWX0_\$9?VO\ PEKW_!%?6?&?CS]G>X/_  3;D^+-E\9/[$\;?$S4Y?%VC>*_
MB"_B#P:?AA_:7P>T8:I<V?AF.SLM8LO%3^#[?3]0B-KIU[JMFJ7A O!*.L6T
MNR_D>C7+_-;=N[UTN?'GP)_;M_;2_P""?NO?\%O/@;\8OVD_%O[7UW^Q/\*O
M"OC[X'_$'XPF]U'5;#QIX[O]+T+PW+=PWEQK^JMHL]W\2?"%UKGA6;7;O0;>
M[\*2V^AS:)8:OJ%V/I[_ ()\?L_?\%J;B_\ V"OVV[[]O";]H7X8?M+^'-"^
M*W[4OP&^-&H-H7@SP1\)OB;IV@^(_#1^%UOHUCXFL[CQE_PA6O)X@TRQ\,^'
M/AQIVB^+]'MO#NH73^&-7U;'TO-_P1M\<_$?]KK_ (*T_$GXR^-? $/P"_X*
M)?!OPY\,?!,7@C6/%-_\5? VJ:+HWA.WM_$_B30M6\'Z%X4BDT/Q!X;AUW2[
M/3?&'B&VU0VEI9ZI##;75W%'\Q?LH_\ !(3_ (*L>'/BM^QMX*_:F_;4^&L_
M['O[ WB$ZQ\)]!^!.I^-M"^)?Q/T;3[W2K[P[X#\>2)X-\&(W@O[%H^F^%]=
MLM=\4>)5L_"EOJ'A?3+#68]7?Q-:@-Q:=G%.RO=;^Y9I:;\W:VMG?0_!SXC?
M\%I/VD/B/KG[1/[96A?\%/?%'P5^+/@3X]VUM^S#_P $^--^'?Q-\0?"3XA_
M [3M=TA#/XH\1:+X;D^#DLDGA_4"DC^-;A/$_B:^\+>+[FXN/#?_  D'A%V_
MO5B_:JTF7]A&/]MY=#\W0I/V24_:J7PU:W<MWYFDO\'1\7!H=M?16OGW.^S/
MV"&[CLO-FRLR6N]A#7\Y%W_P1&_X*;?!+QE\;O@)^Q=^U%\ OAK^Q9\>?CXO
MQS;X@>)]&UI_VF_A/'?ZEH5SK?AGP[J%CX,OYM5E72] T;07A@\;Z5HWCO3=
M"0:Q/X*C\1^([*\_J?E^%'AK5/@S)\#?%<E_XL\'ZC\,7^%'B275)Q!J?B7P
MU>>%3X0UB34;G3DLQ#?ZSI<ERUY/8):B.XN9)+5( (PH3-Q?+:WRWM9:/1=G
MNV]]=3^'B/XU_P#!8[3O^"?,'_!>&3_@H-K4^D/\4FU*Z_8XU+PM<+\(9/A7
M<_'V'X'V=M#I4>M1>'UCF\:N--718/"-KKY\ RP^([;XF_\ "1%H9?0/%_P-
M^/\ ^T]_P7E_97^(/@O]MGXE?#.]_:<_8C\!_MJ_#O7K3PUJ&JZK\&?@AXKU
MGQMKLW[)^CM!\2]);5/"5\NE^(GN_$]G?:!8[_&^J*/ \RP2MJ7N[_\ !!+_
M (*@CX5+_P $WD_;9^#S?\$N#\8?^%A&1M+UM/CXO@L>,(_&#>#3H'_"!-H9
MNSXG9_&\6B+X_/A!O&T1\327D(9/#A_9>3_@G%X\T+_@K#^S7^V?X#U3X;Z+
M^S7\ ?V"[7]D6S\"7.M>*C\3H-5T;Q%\3+K0)=(TE?"5UX8N_"ECX?\ %OA^
MR?4;_P <6>M&ZLM14Z+)'%;7%X%N45>SCJIVLELTN5/3>]^_FSRO_@XO^/'Q
MF_9R_P"";6O_ !*^ _Q.\:?"/Q_;_&3X5:-!XP\!:]?>'/$$6E:M?:M'J>GI
MJ6GRPW M+Y(HUN8-^R41IN!VC%3]IS]H?XM:1_P7._X)4?!KP3\5O&&G? GX
MR_!#]I+Q1XY^'>CZ]?VO@;Q_<Z'\'_B_K_A36-?T*.1++59],O=+T?4]+GNH
M6DM[BQLYDVO FWZR_P""NW["'B+_ (*-?L0?$+]FSP3XOT7P1X^OM>\'^-_
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M:#H^KIJ&F>)-)T'7/$M]I.EZ/X:M;+PG:GQMJ^MP_N'_ ,$>_P#@G?\ $_\
M8.^%7QJ\1?M&?$7P_P#%7]JG]JSXS:]\=/CWXN\*)<MX;77M7EN[BTT73=0O
MM*T*[UN:/4M6\2^)=6U9M"T.T.L^*K_2]-TPZ=I5KJ>I^!_\%&/V#_\ @I;\
M5OVD;_XR?LC?'']GWXB?!;QY\,;7X=^.OV0?VW['Q)XZ^ _AK77-AIEW\1/
MG@)/"GC3PBVK7&G:?8:A=W]QIVD^(-.N6\66]O<^)=*\97_AY E./.WHU:UW
MU:45=-IV>CM=?F?AY_P4Q^)GQ=^,W_!)?_@EKXIO/VJ_A7^UO\6Y_P!N71-%
M\._M ^!-+UC3=%U77['P]XT@\)6?CG1/%GAWPSK]KXN\*W,NG:=XI3Q)X0T+
M5=4M[2UU?5M)DNM3GN[W]!OV4OB%^WC^QS_P61\>?L(_&7]M?Q%^V'X*^*7[
M(OB#X^Z1XB^.-I<>'-!\%>.[*RO+[3[VRTRRU;7$\$>&;/5_"^OZ?JND>%KZ
MV\/OX3UJ&\71XM:TJWFCQC_P;W?'WPE^P7^R!^R_X%^,/P<UWXE_"K]NFU_;
M(^./B#Q3J'C?PSX#F^T^'K?PUJ/A/X3P:-X#\3:G<KINDZ+X?@L$US1_"5CJ
MU^NL:O*N@B]BTN'[_P#V@_\ @EI\8?CI_P %2/$O[8(\??#CPW\"O&'[!OQ$
M_9)U.UBU#Q1=_%_2/$_C[PYX_P##I\4:9X7_ .$2@\'7VBZ7'XPM;R-KCXA6
M&H3RVD\1L(E\N60&Y1LU=-?O.BW;BXVTTZVM:Y_,?KW_  4)_:G^!GQ]^ 'C
M/PW_ ,%E?$/[9_QD\0_M5^%O"?Q^^#/PE\*>/[W]C;0OAYXG\8ZC'I&F>&/'
M/B[0/"WP_P!?N/$V@6D]O+I/@;P-91Z2+^]7PSXEO?\ A!X]=U+]--0L_P#@
MHM^VI_P6H_;R_9D^$'_!03XL_LZ? S]GK7_@U\2KKPMI.KZ[J%O=:,FD?#J*
MZ\">#[>QU/33X5L/$$/B'Q9JFL3Q7%SI-]J<&DQ:QX?U>-X[C2_*M-_X(%?\
M%:1^SO\ !#]F:\^/O[#D7PF_9*_:#7XV_!_PA9V_Q,T6X^*WB&^\4ZUXEU'Q
M9\6OB!IOPDO_ !#9ZEHEGKVH^'O"FG0Z)XB:/3-6U'1[V_BL- \-W]Q^_7[)
M?[!7Q5^ _P#P4F_X*+_ME>,M<^&>J?#[]KB'X-V_POTSPYJ?B.]^(/AZ#P#X
M=&E>)(/&EEJO@[1]$TF'4KZ&SGL(_#WBCQ*EY%:PRWZV<T$48 E**V<6^5I:
M+^:-M.5*]K][;7;/XW_B+_P6E_:(^)6I_M!?MG^'O^"H/C#X*_&'P1\?X[;]
MF;_@GC8_#+XFZW\'_'_P&T[6= %M=^)O$^D:#)\(Y[NXT+4[N&\A\=1VOB;7
M+SPAXHNYK[0W\4>%5MON/_@IK_P4P^/&N?M7_",_$#]K+]J?]@O]D'XR?L5_
M!CXX?L\>,OV:O#"^(]&\2?$+XH^"_#_C:;5OB%JFC^(O#'B/Q3X.T37-2UCP
MMK]KX<N=<U:WM="T5;'PO:VGB&^UBZ^N;G_@B)_P4R^"GBSXU?L^?L8_M1?
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M_P#;NBVMS)I%SXZT+Q?XOBTRUEM3#/'JWPP7P\96MM*G2>Q\/?VEOVT/'?\
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MAO0OA[J&M:AIMCH<NI:_+XEF\1PZYJ@A\0W_ .F/A+_@BG_P43FTG_@JO/\
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M^-_QZT']FSX;_#7QU^R]^T?\0+;6?!'QJTRP\3^)->TC4-1DDU.^U3Q?IO\
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M?$7Q!X%T#4]2AMX=*M-%FU'6_%$]QX=#K?01^/-1L[;6$_?_ /X*<_LN^/\
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MM?MJY._96/RB^,UM_P %$?VS?^"V'_!1+]B;X"?\%!/BG^RG\(_AK\&?@_\
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M-ID?F1SM.\#._P#/W\/]1_X*O_M>Z3_P5L^*?PX_X*5?%OX1^#/V"OCK\?\
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M_MI&O/#?BN\AD\5)KVCV=YJ?,?"[_@BM^WW9ZG_P57\;?'?X]_LY?$[XG_\
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M /"66UEX1M[@^#-7?5/#0$7"Z;<5HKJRM\4K_9>RMM9M6UT/HW]H+Q=^W?\
MM<_\%H?$_P"QK\#?VY_BE^R/\+_&G[#_ ( ^*VOCP@M[XIM?"[2:7X.U^^F^
M'WAR76_#\>B>+-8\47>AV%_XIT[7-!U=/"<WBBQCU!QJL]C>_'?@W_@KY^W5
M\,O^"-_Q=L=:^+]WXR_:WT3_ (*)S_L'>!/CKX@M].UCQ#H_AC7O!#^/KOQ+
M=ZAJPN)M;U[2KKP[XW\.Z7XHU72-3O-'TWQ#X49;>:_TF"^M_P![_@Q_P3B_
M:%\%_P#!6*R_;^\9^)?@RWPYF_8A\%?L[ZQX5\,>(O&]]XVA^)>C:/X%MM;U
M#3=/U7X?:5H4_@4ZAX<U0:5JEUXHM]?N+.2PEN_#EI-+<0VWP-H'_!O?\7/%
M?["_[8?[,/Q;^+GPO\._$GXI_MNZE^V7^SKX\^'6H>-/$V@^$-=L_#TWAW0-
M/\?PZUX0\"ZO9W6HZ+K'BG0M5?PTFMKH UBU\0:==:Y<:9_8UX G'1/ELO9]
M%O[W-TN^E_(^@_@7^RO_ ,%:OV)/$G[1MS\5?VY;W]KS]EG4/V/?'OBJ;QQ\
M4-:\0Z=\7?A]^T'I?A+Q/?6?_"I].N[GQKJEOI6CZI8FZFN+_P 7^'M#N?#W
MB+2VM].E\2>#H8KC\:O$G[9__!0SQ9_P3O\ ^""&I_"7]K#XIZ!^T1^U5^T]
M^T!\,?$OQ$UKQ3=ZNWCS64_:O/P^^&EO\3X-5>XLO&?ACPY#=Z=ICZ'XABO-
M*FT"*;2[FWDL99(C^OW[-G_!,[_@J+XN^,OQ,_:(_P""A_[6WPZ\>^.+7]E/
MQ_\ LP_!WX>_!OQ!XTTOX::Q>>(O#GBCPQ8?$7XLZ=!X'\#Z)?,7\4^(M<*Q
M>#==UFXU'7K369$T6?PQI7AN/S7P/_P1%_:L\-? /_@B5\++_P"('[/<OB'_
M ()M?M8^,?CO\<KRT\5_$>31O%?A'Q#^U%I_QLLM.^%%Q-\)X+[7/$<7A6TD
MT^ZL_%^G>!=,3Q R6D6L3Z:6U94"<>KBW=:I67P3\M=>6^BN[::7/!O@!^U1
M^V9_P3I_;;_X*H?LU?'?]K7QW^VMX+_9E_X)X>-/VR/ >N?&"WU".]N/B+X<
ML?A?KGAGP]:VAU7Q3J/A;1=:OOBK>^&=7T[2->?0OLUEHVI1VNF1V2Q67YR_
MM"_$7_@KS\,_^"6?PO\ ^"H6I_\ !3/XR7<W[57Q.M;7Q-\&=$N)?#VG?#CP
M[X@UGQI=>"-7^'OB'3-16'0/M)\&"+7/"7AG0O#.DVVE>)K;37_M$Z)--/\
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M1L_@1\/_ /@X6TVY_P""97Q@_;1^*?P#_P"$:^//PD^/TO[+,?[/VD^([_\
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M3?RA^*G[2WCBW_X(K_LTZ9^RC^S\_P  _@3\2O\ @HY\1='^*^F^$/C!X_\
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MLDEK=6;LE=.UNNJW;ZL_S\_^"87[,7AGXB_M;?L#>&O"?_!/+]N/P?\ $?\
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M?B+Q!IT%Q9V5I/)!X<\->(+SQ@FCW/B71?#"?T'?\%$M8_:Z\.?L>?&7Q/\
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MR[:'\0G[4_@O]L']DGQ;_P %<?\ @G'X'_9$^-WQ:_X>9_M">&/B/^S-\5/
MV@ZO?>#(_#'B?XF7?C?Q58ZKKMI8/8ZC-:^&]3L?!NL"YUG2;7POJ>FZSJ_B
MX6_AV:.2[^R/VD?@M\;?^"/'[6?_  34_;2\-?L__$G]I?X4?"#_ ()^^&?V
M-OC7H_PCL-1UO4-(^)O@OP?X@TAM=NM3BTS6E\/Z'XTU_P 5:-J&C3W]E#8R
MR:%XCT^RN4EN=+TFO[,Z*!^TV]U;/FU?O7BH_+1+;J?P-VO_  2V_;!\,_\
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MTW2= T^.^\3:Q)IL/^C710'M-?A5M+*[T:YFGYZR>_EV,7Q)_;G_  CNO_\
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M-&TSQ5+8&YO-),%?Z%5%%OZ^=P4VNBVBNOV;_GS._P"!_&W\(?CQ^T3_ ,%
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M3^)+'4/ EOJ%EX;N_$]A)9"'4M+Z[]@_]@']I[XW_LL_\%</@C^SGX2_:O\
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M_A_QUX%^/GP]^#WPM\!P^!_'-Q;0ROX8LKD>!2]]H-_:VD.HKXF7Q#H$&O\
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MMZMX"\4>+?V==>^&OB/5O#EUXB\2WNKZ-/HUG=:+)%;.@\76?BNT\/:#X?\
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M"DTO1GO=9NM/TC4OW'HH)YG>+T]U)>MKK\;L_CW\#?$7]J#_ (+0_P#!3?\
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MK=V]G+];_L:?\%?/^"?O[>_C?5_AC^S;\<X?$?Q)T?3KW6SX%\4>#_&GP_\
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M&#4]<>+0/A^UYH%_I5AJ>K>%M9\>:EHOAO6==\,3ZC9Z&UX7U*\T\2V<L_\
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M5(I]!@O9M?M[C2XOSS_: ^!'P]^"/_!P;_P1U\-_![PMX6\"BU_9-_:*\#6
MT?PSHVE:<UOX _9]_:%TCPE>:I8:%::2^HR6-O?^1,DERH-E!#:69LU#L_\
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M*OA?P?XF@DT/Q=+XHTJ2:WT9="NOLHN-&O=0MI#=R_E-\ OVBOA-_P $PO\
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M1+NTOP=XG\7^&M&T34=4N'B\G2=+NKNPU'Q)/)##X9M=9>0+7Y$?M1?\%/\
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MI)SWW=G%;\NW79_=J?V$?M ?\%5?V$?V8M"_9X\7_&'X[:/H7@3]J;PYXO\
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M^%7TJ*\]E_:BO_!WQ@_X*%?\%G/%_P#P3KU#PGXJ^&C?\$I?$MM\2?%'[/\
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MT[QKJGBG_@ZIMO ,.ISZU%>_LP:CJ46D[A>?\(5I'Q[TW5?B-,[++%LTRU\
M67B6[UW=YBR:%!J4)B?S./U)_92_:9_X(P>(=6_X(K> ?"WPNT?XR?M=?\*<
M\*^$OA5JGP-M[!]6_9P\<Z?X7\$CX@2_M$Z3IWQ \(SV6HR^)=)\5Z_%<^)_
M#GQ"UNVM-%\<>*]+M;?1/&1U;Q<R7!6;LWHMK:6@I7?D[^75W;W_ *6_CQ\>
M/A)^S)\)/&OQT^.GC73/AY\*_AYID6J^+/%FJQ7US;Z?;W-]:Z78006&EVM]
MJNJ:GJFJWUCI6D:1I5C>ZGJNIWMI86%I<75Q%$WQ-^Q9_P %@?V!/V_O'FM_
M"W]FWXR7.O\ Q(T/0[WQ/+X*\5>"?&/@76=3\-Z=>V]A>ZSH+>*-%T_3=<AM
M);RSFN[#3+^XUFRL[E+V]TRVMH[B6#PC_@X _: \'_LY_P#!-_Q_XN\9?L_?
M#[]I&V\2>.? G@31/ WQ7TV^U;X<Z/XEUJYU'4=+\;^*K'2;W2M9GM?#@T6X
M.F1:1K6AW\^OWFD6Z:O90S3N?YK?@;??&G7_ /@LSX+TBU_:2_9P_:*^,^J_
M\$W_ (Z>'=(U;]C#PIX>\(?"'X=^)+WX&_&K4_ GP;\.ZAX&30CXSU7PM>R^
M&/$0\6W<UGXC4^(-)\/37&GGPO9V]D"C!.+;NGK9WTTMTMYZMM>5S^HY/^"Z
M/_!+V7]I./\ 97B_:<T.7XD2^+V^'XUM?#OBM?A8/&PN7L!X>_X6L^C)X&=G
MU)!ID6MQ:Q)X7EU&2.SCUUIF*CN_VQO^"PG_  3Z_8.^(NC_  D_:0^.2^&O
MB/JNG6FM7/A'PUX,\;>/]6\.:'?J7T_5O%<?@O0-:CT"'4(\3:=8WTBZSJ%H
MZ7]EID]@PNJ_E&_8"_:'_P""-7PT_P""/WP@^'_[</PJT'XW?%O3?VL_$I\3
M_ KP'8Z=>_M*7/Q#O=?\1Q>"O'K>&;3Q?\.?&5[X(TGP%-I/AG49KK7KGP_>
M3JWAA;+6-<FM?#I^D_A7\4?V+_@C_P %5_\ @NF?^"EMKX)LSXQ^'VB7?@+1
M_C1<Z6=?\8?!NY\%WE_K/PR\!2^([V]U76O'/B[X?:E\+=.\/:3X2\6VVKZD
MVC>1H=I*+2W;0@;A&[TG9)]KR::5XZ;:W>CZ:[V_IO\ CO\ \%,?V'_V</V=
M_ G[5/Q0^/\ X2M/@G\5(].?X6^)_#<>J>,KWXCMJ=O]JBB\'>'/"]AJGB'5
MY+&W#OKY738XO##1R0^))-)G0Q5S?PB_X*K_ +"OQX_9H^+O[6?PG^-=MXO^
M$7P$\/WWB/XR&T\,^*[+QQ\/+'3]+N]7E77_ (>ZIHUEXO1KNRT_46T:ZL]*
MN]+\1/INI+X?U#5!87;0_P JGQ;^(?[#$G[67_!!K]H)?A)XO^!__!*"7PI\
M=K'X=^!?CSHI;PSX&^(=IXX\>+-XB\3V.K>*_B3I-GH>H_%*]^%WC'5=4OO$
MNHZ=J/AG2E\5&9M(B:\7"\2WGPK^(W[6O_!Q7\0_V*(-%U7]D/\ X=I>,=/\
M4:W\*K;37^$.M?&Z;1?AEJ#:[X7E\.B71KRSO9/#/QUU:'5]-:/3M2GB\8Z]
M9_:=+O(-0E Y%;[5][Z67OJ/*_[VO??I8_K(\8?\%3OV,? GP%_9N_:5\2?$
M#Q!:?"/]K'Q=H?@;X)Z[#\/_ !G=WWB'Q'XB_M,:7::CH5MH\FK^'893I%\)
M+O6K2SMX?*7S)%\V/=XY^T1_P7+_ .";7[+'Q(^+GP?^-'QLU?PW\3O@MK7A
MGP]XM\%VGPX\>ZUJ]YJWBO06\2Z;#X9.EZ#<V6O6EMH_E7&LZO;W::-HD]YI
MMCJ>H6U_JNFVUU_)O^T+^TS\"/&G_!+;_@@Y^S]X,^*?@?Q;\7O"G[07@7Q+
MXX\!^'/$VD:QXI\ V'A;Q)K_ (7NE\<Z#8W<VJ^$I]1U7Q-:IH46O6M@VN6U
MIJ%[I0O+.TEG7]4_V=_A9\-OB7_P7&_X+IK\0O GA3QI_9O[/FAZ?IC>)M#T
M_67TNU\2?#GP%9ZZNER7T$TFG2ZG:6L%M=75DT%TT$?E+,J,ZL!R15V^:RYG
M;1-J,E%;KJG_ )'T1_P54_X+P> _@7^SS^QU\2OV-_B=X2\2Z9^UOX\743\1
MKKP9XAUQ_#GP(\%:Q%H_Q9UC1M'U&QMHM(^(>A>(+BQ\*W7A[Q7HM]K.E3OK
M")X8DU*R2XL?>/ /[<7A#XE_\%*- ^(/A']LCQ!??LV^)?\ @FK_ ,-*:1^R
MU/\ #?X@V,,_AK^W)=8_X7K)JEWX?BT:#51H4,FF_P#"*2WB^*?EVC3"I!/\
MEMG_ &'#_P $1/\ @FAXI\5IIBZ1X8_X*N^)=*O_ !!KT=LUCH/A"XL]7\0Z
MSI=SJ5\IAT[P]<RVU_K6HZ>\T.G3RP7>H7$+R1S2C]U/BIKWPV\4?\%JOBQX
MB^#FI>#]9^%>L_\ !"+XEW_P_P!5^'TVDW'@?4/"MQ>Z\^CW?A2?0?\ B2S:
M#-:>6^FRZ63826Q1K8F(J2#<4E9)Z>T3>FMG%+IO9_GW/TETK_@XP_X)&ZOJ
M'P\TR+]IFXM;CXC7?V2RDU#X8_$VTM/"[2:]>>'+6?Q]>OX5-IX-@N]0LI+A
M&UB:%[30YK+Q+J<=CX=OK35)OK/]M#_@JK^PM_P3^\3^"/!'[47QK@\$>-/'
M]HFL:'X3TCPIXP\<:_;>%FU";2G\8Z]I_@S0M<ET#PT-0MKNTL[S5?LUSK<^
MGZM%X=L]8DT76%L?XO$^!?PPB_X-3)OBM#X1\/Q_$&Z_:IB\;7GBW^P-!;Q%
M<:K!\9W^$,$!U[^S%UE;*'P<WV..,W[S('GMEF73KA[*OT7B^*/[-G[-O_!P
M1\2OB+^WS>^#?"7PK\9_\$Z?A-!^S]XO^*VD+>^![6Z?X=?!G1];6WAU32M6
MM9M1U=O"OQN\.V&J64EG:M++K/A(Z?J6L:^CH X1N[<SMSIJZNW'EVT_O=GL
M?T^_L??MU_LS_MX>&/B!XS_9A\=W'Q!\+?#3Q_??#7Q+KC>'=?T"P;Q-8:?8
MZJ_]C2:[I]@=;TBYT[4K*\L=9TY9]/NX9U:&9CD#^:#_ (+;_P#!3CQMIW_!
M1[X&_L)?";]M[XD_L4^!/ NEH_[2/Q1^'/PUUOQEK.C?$GQ]X3T[Q[\*=,FT
M/3KC0=7\>Z'=:-?^!]/;3]"\2V'A^SN/'NK3^*'NO[!EM['Z$_X-7-2\&ZQ^
MS[^W-J_PZT^32?A]JO[<?C34O FE2HD<NF>#;[P3X/NO#&GR1Q6EA%')9:)+
M8VSI'8V2*T15+2V4"%+G[:G@'P+KG_!S/_P2[LM:\%^$]8LO%O[-?QPU3Q5:
M:IX<T?4+7Q-J>A_"C]IZ'1=1\0V]W9S1:U?Z/%H6B1:7>:DES<:?'H^E):20
MKI]H(022C.2LVHJ35[;J*>MTUU[;GKW['?[<WAC]FFW_ ."L_P 5OVKOV\/%
M_P"TA\*OV5OVHM)\ :Q'>_"[XA0ZK^SQ%J_Q>\;?"S2O 5III\.Q)XN:[\37
MN@Z/>:EX'35]$@31&OQ=+IA@G;Z-TW_@X&_X)7ZMI.K>(;+]H+5&\,:%\5/
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M%/%GQ"LM!G\+:1J=E?LMAKERVH2Z+X6OEN;/Q5JNB76GZE%9_I-\6/B;X/\
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M_P %</V!OVX=.^)]_P# 7XY6%Y-\&_#VH>-?B-I7CC0M?^'6K>'? &E@M?\
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MNHK+7/$NFVX"W'F^)<MG/9<K<4M.CZ];/3N?VE6G_!1C]BJZ_9*M_P!N<_M
M>#[3]ERYM#<+\3KZ'7+9$ODU.319/#3^%'TG_A-F\:1ZS%+I?_"$P^')?%<M
M\AAM](FW(S^=?L:_\%8_V$/V\H_B(O[/'QLLM4U+X4Z/<^*/'>A>-=#UWX<Z
MQHG@JUD6*?QX]OXRL-)@NO!MK(\<>IZ[9W,]OH$D]G%XB&D2:AIZ77\-/CGP
M<?"?_!)GPEXEMOB]X1^//[*TG_!870?'/Q5?X7?#[XO>$_A[X._M#X57=IXF
M\*P>'/B!X.\(K=^$(88X_P"RV\#KXH\*27OB+3-)?5-/\1K#9W_[;_MO?'K_
M ()D?&RX_;U\'_\ !/?X6K\1OVR]5_X)K^,=8UG]HO\ 9QMM-U7X-V?P*LM&
MM?\ A+_AU>GPQXZ72;+Q7%X/GTK0=:L=,^%\FK+?ZOX<\+:IK5OK?AV:P\/!
M+@NG,[MI/HDG%>]=+^;RV6FNG[2_LU_\%K/^";W[6OQZD_9L^"/[0%OX@^*=
MS<:Y;^%]/U?P?XS\*Z)X_D\.PO<ZHG@3Q+XCT/3=%\07 M(;R^L+".[@U+6-
M.L+[4]'LK[3[9[JO-?BO_P ' ?\ P2U^"GC/XB_#KXA_'O6M(\=?"GXP^*O@
MCXX\+6OPJ^)FK:MI/B[P/K=]X>\77Z1:7X8NXK[PMH>JZ?=6S:]933P:J\;1
MZ!%JTL<L<?\ (Y^RAHU[X]N?^"+5C>?MJ_L,^&I?!GQS\#:W\$/AA\(_A/\
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M3WBBQTO33']NO1\/KSX5?$&[@M8WCE-S,UCX7N2ME"AN[_'V*RVW<\##\_\
M]DVS_8Z\'^/_ /@WG\6_L,>(;1?VS_%'QS@\-?ME:3X.U[5;[Q9-X/U'QMX:
MTWXIM\4=$O-5GC\.VD/@_5?B!9^%E@LM.M_$7P]?4;R&*_L='TXP);#LO?LE
M?F:V322A?_MU::-=;>=_]%ZBOGCX#_M8?L]?M.:C\5=)^!/Q,TKXAZA\$/'5
M[\-/BI;:;IGB'3V\'^.=.GOK:]\/7KZ[H^E1W=U;SZ=>QO/I3W]D3 Q2Z96C
M+_0],P"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MQ%I.I:%K>EW09K74M(U>SFT_4K"Y5&1C!>65Q-;S!65C'(P5E."/S _X<?\
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MNMG3O"/_  GFL0>(/%_]EB/64F7^WM9MH-0OO/FGS/&IB\M,J3P#_P $D?\
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M&KZ.?#^J0>.)M<?5-0\80W^A%]'NH_$EYJ:2Z9)+9,IMYI8W\"\#_P#!(?\
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MIZ65JENUG"EI"HM]JD'Z:HH"[[O3;5^G?MH?/?@W]E']G+X??$'XT_%3P?\
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M<NCWFFZG=:M/J&FZ;IDM]<RV/ANPN;?PS:RNLD.CH\,+1_5WAK]E3]G?P?\
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MTN!+:PTO2M,LHX;6SM+:%%5(XHQD[G<M([LW6T4!=[7=O5GBGP+_ &<O@?\
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M>'=6U;5]2$"Z=I\<%O;W5W'>ZAIUM=^5? ;]L/\ 9R_:;\:_'WX=_!#XB_\
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M7?B'QII=_8:Q?2PW-K=#2M6N0MT[7LT[.2U>ZBD]--]7<_JXHK^$KQS_ ,'
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M+Q5K-K01R.U[QZ=>C=E+;9OK\[']7%?,_P"RA^V'^SE^W!\+IOC1^R[\1?\
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M_"6:%JTEH+NTM/%OQ'TC4!I_BK2X]5VPZ/KT@)1<DVK:=+ZZ*_;\[=C^RFN
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M>%]-\&:_]L@U;3W\OPQXBUJ:W^T;;J.!XIUC^G*_ABM[7_@I#_P^8_X*Z?\
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M1_$&I:C9>'/#FGW^OOQ&K_\ !7?_ (*>?"'_ ()\?L=ZG\:O'/P4\"_M>?\
M!13]HOQ+)\$?BQ\8?#_@?X=_#7X-_LCZ!H/PKT[_ (6#\2+5M.T?P7X?FO\
MQ9XM'BNPUGQ/:ZPI^&?B&355L+_48-.T^P/E^0O9M[-;M6OJK7O?3HE=VO\
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M[;TZT\)+?:)=Z;J#7/CFTGCNHY;&"2(%RNZ5T[[-/1WOUMW5MMS]K:*_G/\
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M+/PYX>CTH:/-J^J7.G@^26EK.]M+ZZMI-^5T?U\45_+'\#_V[?\ @K9^QO\
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MG=^&5MJGP_\ ^"TO[7(_8D_X*G^'O%OQE_9]^*'[6'[!UO\ #/7_ (9_M+_
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MJ'C&QF\7>,]7TG2-#B\(1ZIK7@OQAX<\/IX2\::#;6X\+PWNJ>&=1BFO=0N
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M>)O,UW6O"MEI%R^D,PU.274-.%[^]E% .;=]$KIIV765KO?=V7EY'\>?[/\
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M>ZS-X?M-4N8=4TO5-1\+7&LQ$)I\/C/1M/U+PB\]Z\6D[=;*:S/!I+WLT?\
M*_\ LL?\$T/^"E>A?M _\$I/'VM_\$V_@C^SC\,OV,/B#H/AKXMZC\.OB7\"
M9/BU\3[O58_"?A_XF_M0?%O4;7QQ'>>+X;FQ\.V%_IOA?3]8\4^*M/N=,\3-
MX2T&YT3Q%H=J_P#<910$9N*:26M][]5;NNG>]C^)_P 7?\$_?^"POPAOO^"M
M/[(O[/\ ^S5\-_'_ ,#OV]/B#\4/BYH'[1.M?%7PCH,MMX2UN\\8>(+7X?Z7
MH>H^+M'N5\>^.M.OK'X;+;^(=)TG1/"_B2^NO$6JZM<>!98O$5EW7Q:_X)T_
M\%)?A'\"_P#@AO\ %WX$?LWZ3\4?VB_V!=(\>>'OBW\#-9^)'PZM+72]4\3Z
MWH&J^%KB;Q';>-]/\-:KHH^P:W:>(-2\/>,K\:9)=Z#<B%K)=8N+3^R:B@/:
M/32/GH]?=Y==>W:Q_/%^R3^Q?^USX1_X*8_\%1OVH?BC\'5\&?#C]J?X%^ -
M$^&&L)X[^&NLKKOC:V\!>$+'Q#X=71] \;:UX@T1=(URQU335U'Q'I^F:7="
MS%S9ZE>6DUO<S?E_\//^"+/_  4$T'_@EW^R=!X;\#^'?AW^WY^PS^VAXQ_:
M=^%7PQ\6^.?AQX@T+QAI&I:UX/UNUTU?%/AGQ;K?@&WUJ?7O!'A'7=.@UWQ7
MINFRV>BZMH^L7.ERZK:7EO\ VNT4!SM=%]G_ ,E326_5-W/Y3_@M^Q#_ ,%*
M?VR/VQ?C%_P42_;Z^"7@+X!>+_ O['/Q/_9L_9;^ GA;Q?X3\3ZC>>(?&O@C
MXA>%I-8FUS3_ !?XETO1=/>?XA?$-)=2\2Z]INH7\_C73H+>&W\,:*U[=]K^
MS_\ \$\/VQ/!'_!NQ\5/V%/$_P (/[,_:J\2>'?C#8Z+\+/^%@?"Z]^VW7BG
MXO7/BC08O^$WT_QM=_#FW^WZ%(E]ON_%\$=KG[+>/;W@-N/Z>Z* <WIHDDXM
M)7LN6]EOMJ[]3^#W]KO_ ()M_P#!:KXH^#_^"<?P>T+]CSP=\7O@+^Q?^SS\
M$$O?@UXR^-/P3T[X=^*OCAINAVP^)6G_ !0TZU_:)\$:YXPM[-K2W\'0WOAK
M6].TG_A&SJ=OX<UEAX@UZ_U+ZE_;!_8M_P""O_\ P4&^!'P$_:!_:;_8M_9A
MTG]IW]BC]H?5K[P/^R;H&M>"[GX9?M ?LV^+="^&>I>*=)UZXN?CS\6/#DVH
MVWBOP%#HH\,ZCXU\'M=^$;S7GT6"+78](CUW^QVB@?M'II'2]G9WUO?KUOKU
MVUT/Y'/@-_P2,_:;_:-_9?\ ^"BWA_XX?LM_LH_L!7_[3G@#0_!W[-7P9^%W
M@OX;KK?@^?P?XJ\,?%3PW)\6/BE\-K;6]:O?!]UX_P#A]X)\^TOGUKQ+;RW_
M (JUU_#>E_V3X6\/O\T:U^QM_P %U_VEK#_@F9\./CW^R?\ #KPK\-O^">'Q
MU^"NE7>M:%\6?A$?&7Q!\(^"=4\)V<_Q7U-+KXF7>GW6E>#O 7@C3]+NK'PY
M/!KOBK7M>N-2L/#.HNEQ:^'O[>J*!>T>NB\M'IIRZ:WV[W/GG]KKX3:O\>_V
M4/VG?@7X?N(+37_C3^SS\:?A-HEU=2K#:VVK_$;X;^)?!^FW%S,ZNL4$-[K,
M,DTK(RQQJS,K $'^2WPE_P $R?\ @J-\9_\ @EY\$/@AXI^!/A'X"_M._P#!
M-3X^Z%\2_P!DJ'7?'W@K5;#X\:3#K_C/Q5XOL=9NM)\:^*?#F@ZY9>(+[PHW
MA>]\0GP]X:UG^PC')J4&F>([[4/#_P#:Q10)2<596W3U[I-?BFTS^9/]D?\
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M^#7_  6N_9XU/]D/X5>#_BC^T3\#/^"4WPDD\7_!+QKXBTK2[#QKX;T:+6O
MOQ \)Z9XCBUK3]*'B+3-0UBUUC1;FS\0PVU]=Z"([.;5X[B/2M4]0T'_ ((6
M_M>_M%_\$]_V\M7_ &DIO!/@#]O']M7]IK1/VM=+\#1ZQI^H>&/"6N?#_4_'
M=YH'@'Q+XIT/4/$UA:0^)+'XJ_%'3- T[3-<U[1? =CJ_@]KS4Y+B#Q'IEG_
M % ?\,=_ ;_AKC_AN'_A&=3_ .&BO^%1?\*._P"$K_X277O[)_X5U_;']O?V
M5_PBGV[_ (1W[7_:7[W^U?[/_M'9^Y^T>7\M?4%!7M'I9)-*-W;5V;=M]KOM
M<_E%^$_[)_\ P5P_X*"?MP?L/_&O_@I9\%/AK^SC\)O^">D\GC328O#OBOP7
MXOU;XV_&BVN/"NIGQ+9Z5X2\<^-;;3/[4\1^#O!6OR7LZZ;H'AZRT'5+3PU-
M?:MJCKI^E^R;_P $W/VTOAG_ ,$T_P#@L5^S_P"-_@S_ &)\7/VJ/B?^T)XB
M^ WA+_A8GPHU+_A.]'\<^"-.T?PM>?V]I'CJ_P##/AC^U-1@EM_L_C+6O#UU
M9;/.U&"T@993_5110)S>UDEI9).RL^;OU;U/BO\ X)Q?"3X@_ 7]@S]D?X+_
M !8\/_\ "*?$OX8? 7X=>"_'/AO^U=$UW^P_$V@^'[2QU73?[8\-ZEK&@:G]
MENHGB^V:/JNH:?/MWVUU-&0Y_E)_;]_X)E_\%1OVD?B'^T;\.OB#^P3^S=^U
M!XO^*'Q*L=3^ /\ P42\*^*/A!^SWXN^&WPWT;4=&MXM,^(GA3PEK7@[5?']
MVOA6U6PN8_B9HGBK7K&]U77H?#&K>.-*T/PE8>&_[BJ*!*3BVTE=ZZW[WZ-/
MY;/J?R>?M(_L#?\ !27]E;]J7_@E_P#M<?LA_#'PK^VAXR_96_87\!_L2_%/
MP[KGC?PYX#MM3UKPKX=\<^&9_&\U_P"+=>\)WZ^'-=D^)E]>:?JD-SJ>IZ.W
MA>"7Q@DL5_=7]UX5\*_^"+'[>?QE_9._X*^_#']J7PMX'^'7Q[_:S^/_ ,/?
MVE?@_P")]'\:>$]>^''C7XG:!XI^(/Q#\5068T#6O$/B3PGX6UG4O%=]X0LI
M_%^F:'K&GP:];:LUC?6^FWUO)_9Q10/VCMLKZ:VUT;DEO:UV^FS/YL?V$_#?
M_!=WXH?M/?L[7G[8GA_0?V2_V8/V8?A5)X&^(GAKP?XZ\!>,IOVL?%NEZ-<:
M/HFK7VGZ/XK^(MSID\UXOAK7=9UE/^$;TV*QTS7M/\/WTM]X@DL=!^-O@_\
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MO_:\OQ 30O%V-"9;[^S_  +J?B?5#G[,+(W@-O7T/\?/^"5W[17[27_!3_\
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MN?X[_$GX\?$/6_BCH#?%3X Z;J.E^,M*\7_!^;P5<^)=+\96GQ.^(EEI6N_
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M""BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 5^+W_!>W6;W3?^"?[Z48K5_"OB[]IO\
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M@'3M'\5"&X\3:#J-IH^G>&/!VFZ387=G%JGA[59]4@M88O%%Q>S?U ?LG_\
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MJ?[0_P#P3)L_%'@3]F";6-5^!W@3Q/XO^*?P:&N0>&(M;M]$NKOQ+!-<0O\
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MZ=IUA: G)-6VO;IV<G?XO/:R>^IX?^V+JL.D_P#!93_@C1#HT<<NN>*/!?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
**** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
